PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gillmann, C; Coras, R; Rossler, K; Doerfler, A; Uder, M; Blumcke, I; Bauerie, T				Gillmann, Clarissa; Coras, Roland; Roessler, Karl; Doerfler, Arnd; Uder, Michael; Bluemcke, Ingmar; Baeuerie, Tobias			Ultra-high field MRI of human hippocampi: Morphological and multiparametric differentiation of hippocampal sclerosis subtypes	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HUMAN BRAIN; FORMALIN FIXATION; RELAXATION-TIMES; PATHOLOGY; SURGERY; PATTERNS; OUTCOMES; GLIOSIS; VIVO	The aim of the present study is to differentiate subtypes of hippocampal sclerosis (HS) using ex vivo ultra-high field magnetic resonance imaging (MRI). Included were 14 surgically resected hippocampi of patients with medically intractable temporal lobe epilepsy. The resected hippocampi were histologically categorized into subtypes of hippocampal sclerosis (HS type 1 (n = 10), HS type 2 (n = 2) and no-HS (n = 2)) and subsequently scanned on a preclinical 7T MRI acquiring T2-weighted morphology, relaxometry and diffusion tensor imaging. On the morphological images, the pyramidal cell layer (PCL) of the hippocampus was segmented and the following parameters were derived: T2 signal intensity, Ti-, T2- and T2*-relaxation times, apparent diffusion coefficient (ADC), fractional anisotropy (FA) and mean diffusivity (MD). Furthermore, the area of the PCL was determined, as well as the parameter product which refers to the widths of the PCL parallel and perpendicular to the stratum moleculare. Spearman correlation coefficient was used to demonstrate relationships between MR-parameters and type of sclerosis. In comparison to no-HS specimens, the PCL was significantly narrower in HS type 1 and HS type 2 hippocampi. This narrowing affected the entire cornu ammonis sector (CA) 1 in HS type 1, while it was limited to the upper half of CA1 in direction to CA2 in HS type 2. The parameter product median increased from 0.43 to 1.67 and 2.91 mm(2) for HS type 1, HS type 2 and no-HS, respectively. Correlation coefficients were significant for the PCL parameters product (0.73), area (0.71), T2*-time (-0.67), FA (0.65) and ADC (0.55). Our initial results suggest that HS type 1, HS type 2 and no-HS subtypes can be distinguished from each other using ex vivo UHF MRI based on T2-weighted morphologic images and the assessment of the parameter product. Upon clinical translation, UHF-MRI may provide a promising technique for the preoperative differentiation of HS subtypes in patients.	[Gillmann, Clarissa; Uder, Michael; Baeuerie, Tobias] Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany; [Coras, Roland; Bluemcke, Ingmar] Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany; [Roessler, Karl] Univ Hosp Erlangen, Dept Neurosurg, Erlangen, Germany; [Doerfler, Arnd] Univ Hosp Erlangen, Dept Neuroradiol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Gillmann, C (corresponding author), Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany.	clarissa.gillmann@gmx.de	Rössler, Karl/AAN-5096-2021	Rössler, Karl/0000-0002-9249-8082; Bauerle, Tobias/0000-0002-0206-6199	Erlanger Leistungsbezogene Anschubfinanzierung (ELAN) [DR-14-09-10-1]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Erlanger Leistungsbezogene Anschubfinanzierung (ELAN); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	This work was supported by the Erlanger Leistungsbezogene Anschubfinanzierung (ELAN; DR-14-09-10-1-Gillmann), Dr. Clarissa Gillmann, University of Erlangen-Nuremberg, Germany and by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing.	Al Sufiani Fahd, 2012, Epilepsy Res Treat, V2012, P624519, DOI 10.1155/2012/624519; Balchandani P, 2015, AM J NEURORADIOL, V36, P1204, DOI 10.3174/ajnr.A4180; Birkl C, 2016, NMR BIOMED, V29, P458, DOI 10.1002/nbm.3477; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Briellmann RS, 2002, NEUROLOGY, V58, P265, DOI 10.1212/WNL.58.2.265; Coras R, 2015, NEUROSCIENCE, V309, P153, DOI 10.1016/j.neuroscience.2015.08.003; Coras R, 2014, EPILEPSIA, V55, P2003, DOI 10.1111/epi.12828; Dawe RJ, 2009, MAGN RESON MED, V61, P810, DOI 10.1002/mrm.21909; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Deleo F, 2016, EPILEPSIA, V57, P306, DOI 10.1111/epi.13277; ENGEL J, 1992, CLIN NEUR, V38, P514; Goubran M, 2016, HUM BRAIN MAPP, V37, P1103, DOI 10.1002/hbm.23090; Hennessy MJ, 2000, BRAIN, V123, P2445, DOI 10.1093/brain/123.12.2445; JACKSON GD, 1995, MAGN RESON IMAGING, V13, P1081, DOI 10.1016/0730-725X(95)02016-M; JACKSON GD, 1993, NEUROLOGY, V43, P1793, DOI 10.1212/WNL.43.9.1793; JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869; KUZNIECKY R, 1987, ANN NEUROL, V22, P341, DOI 10.1002/ana.410220310; Liacu D, 2010, NEUROPHYSIOL CLIN, V40, P151, DOI 10.1016/j.neucli.2010.01.003; Mueller SG, 2007, NEUROBIOL AGING, V28, P719, DOI 10.1016/j.neurobiolaging.2006.03.007; Peixoto-Santos JE, 2017, EPILEPSIA, V58, P149, DOI 10.1111/epi.13620; Prada Jardim A, 2017, BRAIN PATHOL; Salmenpera TM, 2006, EPILEPSY RES, V71, P102, DOI 10.1016/j.eplepsyres.2006.05.020; Santyr BG, 2017, J MAGN RESON IMAGING, V45, P1359, DOI 10.1002/jmri.25447; Shepherd TM, 2009, MAGN RESON MED, V62, P26, DOI 10.1002/mrm.21977; Stefanits H, 2017, INVEST RADIOL, V52, P666, DOI 10.1097/RLI.0000000000000388; Thivard L, 2005, NEUROIMAGE, V28, P682, DOI 10.1016/j.neuroimage.2005.06.045; Thom M, 2010, EPILEPSIA, V51, P1801, DOI 10.1111/j.1528-1167.2010.02681.x; TOVI M, 1992, ACTA RADIOL, V33, P400; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieser HG, 2003, J NEUROSURG, V98, P751, DOI 10.3171/jns.2003.98.4.0751; Yong-Hing CJ, 2005, MAGN RESON MED, V54, P324, DOI 10.1002/mrm.20578	31	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196008	10.1371/journal.pone.0196008	http://dx.doi.org/10.1371/journal.pone.0196008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668721	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200074
J	Dias, RSG; Soares, JHN; Castro, DDE; Gress, MAKD; Machado, ML; Otero, PE; Ascoli, FO				Goncalves Dias, Raquel Sartori; Neves Soares, Joao Henrique; Castro, Douglas dos Santos e; Kuster de Albuquerque Gress, Maria Alice; Machado, Marcela Lemos; Otero, Pablo E.; Ascoli, Fabio Otero			Cardiovascular and respiratory effects of lumbosacral epidural bupivacaine in isoflurane-anesthetized dogs: The effects of two volumes of 0.25% solution	PLOS ONE			English	Article							ANESTHESIA; ANALGESIA; SURGERY; MORPHINE; HYPOTENSION; PRESSURE; BLOCK; CATS; ROPIVACAINE; EPINEPHRINE	The purpose of this study was to compare cardiovascular and respiratory effects of two volumes of bupivacaine 0.25% (0.2 mL kg(-1)-treatment BUP02-and 0.4 mL kg(-1) treatment BUP04) administered epidurally at the lumbosacral intervertebral space in dogs anesthetized with isoflurane. This experimental prospective randomized crossover design trial used six mixed breed adult dogs, four neutered males and two spayed females. Each dog was anesthetized on three different occasions: the first for isoflurane minimum alveolar concentration (MAC) measurement, and the following two assigned treatments (BUP02 or BUP04). On the two treatment days, anesthesia was induced and maintained with isoflurane at 1.3 MAC during the experiments. Cardiovascular and respiratory measurements were recorded before (TO) and 5, 15, 30, 60 and 90 minutes after the epidural administration of bupivacaine. Comparisons between and within groups were performed by a mixed-model ANOVA and Friedman's test when appropriate followed by Bonferroni post-hoc test or Dunnet's test to compare time points within each treatment with TO (p < 0.05). Mean arterial pressure decreased significantly from 15 to 90 minutes after the administration of BUP02 and from 5 to 60 minutes in BUP04, with lower values in BUP04 than in BUP02 lasting up to 30 minutes after bupivacaine administration. No significant changes in cardiac output and systemic vascular resistance were observed in either treatment. Hypoventilation was only detected in BUP04. Hemoglobin concentration and arterial oxygen content decreased after both treatment of bupivacaine with no significant decrease in oxygen delivery. Two dogs in BUP04 developed Horner's syndrome. The epidural administration of 0.4 mL.kg(-1) of bupivacaine to dogs in sternal recumbency anesthetized with isoflurane 1.3 MAC caused more cardiovascular and respiratory depression than 0.2 mL.kg(-1).	[Goncalves Dias, Raquel Sartori; Machado, Marcela Lemos; Ascoli, Fabio Otero] Fluminense Fed Univ UFF, Coll Med, Grad Program Cardiovasc Sci, Niteroi, RJ, Brazil; [Neves Soares, Joao Henrique] Virginia Tech, Dept Small Anim Clin Sci, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Castro, Douglas dos Santos e] Univ Florida, Dept Large Anim Clin Sci, Anesthesia & Pain Management Serv, Gainesville, FL USA; [Kuster de Albuquerque Gress, Maria Alice] Fluminense Fed Univ, Lab Anim Res, Vet Sch, Niteroi, RJ, Brazil; [Otero, Pablo E.] Univ Buenos Aires, Fac Ciencias Vet, Catedra Anestesiol & Algiol, Buenos Aires, DF, Argentina; [Ascoli, Fabio Otero] Fluminense Fed Univ, Biomed Inst, Dept Physiol & Pharmacol, Niteroi, RJ, Brazil	Universidade Federal Fluminense; Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida; Universidade Federal Fluminense; University of Buenos Aires; Universidade Federal Fluminense	Soares, JHN (corresponding author), Virginia Tech, Dept Small Anim Clin Sci, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA.	jhsoares@vt.edu	Soares, Joao/AAD-7928-2019; Otero, Pablo Ezequiel/I-4638-2019	Otero, Pablo Ezequiel/0000-0002-0901-7269	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [110.507/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [114.339.947-12]; Virginia TEch Open Access Subvention Fund	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Virginia TEch Open Access Subvention Fund	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - n.o 110.507/2011, http://www.faperj.br - FOA; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - n.o 114.339.947-12, http://www.capes.gov.br - RSGD; the Virginia TEch Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RM, 2010, VET ANAESTH ANALG, V37, P542, DOI 10.1111/j.1467-2995.2010.00563.x; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Borghi B, 2002, J CLIN ANESTH, V14, P102, DOI 10.1016/S0952-8180(01)00362-2; Bornscheuer A, 1996, J EXP ANIM SCI, V38, P20; Bosmans T, 2012, VET ANAESTH ANALG, V39, P618, DOI 10.1111/j.1467-2995.2012.00744.x; Bosmans T, 2011, VET ANAESTH ANALG, V38, P146, DOI 10.1111/j.1467-2995.2011.00595.x; BROMAGE PR, 1962, BRIT J ANAESTH, V34, P161, DOI 10.1093/bja/34.3.161; Capdevila X, 1999, ANESTHESIOLOGY, V91, P8, DOI 10.1097/00000542-199907000-00006; Castro DS, 2016, VET ANAESTH ANALG, V43, P235, DOI 10.1111/vaa.12320; Figueiro MR, 2016, VET ANAESTH ANALG, V43, P464, DOI 10.1111/vaa.12341; Freire CD, 2010, VET ANAESTH ANALG, V37, P63, DOI 10.1111/j.1467-2995.2009.00493.x; Freise H, 2008, ANESTHESIOLOGY, V109, P1107, DOI 10.1097/ALN.0b013e31818db16c; de Segura IAG, 2009, VET ANAESTH ANALG, V36, P485, DOI 10.1111/j.1467-2995.2009.00469.x; GREITZ T, 1983, ACTA ANAESTH SCAND, V27, P211, DOI 10.1111/j.1399-6576.1983.tb01937.x; Hodgson PS, 1999, ANESTHESIOLOGY, V91, P1687, DOI 10.1097/00000542-199912000-00021; Hogan QH, 1998, ANESTHESIOLOGY, V88, P761, DOI 10.1097/00000542-199803000-00028; HURLEY RJ, 1991, REGION ANESTH, V16, P303; Iff I, 2007, VET REC, V161, P22, DOI 10.1136/vr.161.1.22; Iff I, 2008, VET ANAESTH ANALG, V35, P265, DOI [10.1111/j.1467-2995.2007.00373.x, 10.1111/j.1467-2987.2007.00373.x]; Igarashi T, 1998, ACTA ANAESTH SCAND, V42, P698, DOI 10.1111/j.1399-6576.1998.tb05304.x; Ilkiw JE, 1999, CLIN TECH SMALL AN P, V14, P27, DOI 10.1016/S1096-2867(99)80024-3; JONG RHD, 1975, ANESTHESIOLOGY, V42, P384, DOI 10.1097/00000542-197504000-00003; KLIDE AM, 1968, J AM VET MED ASSOC, V153, P165; Kona-Boun JJ, 2006, JAVMA-J AM VET MED A, V229, P1103, DOI 10.2460/javma.229.7.1103; Korkmaz M, 2013, ACTA SCI VET, V41; LEBEAUX MI, 1973, BRIT J ANAESTH, V45, P549, DOI 10.1093/bja/45.6.549; Meissner A, 1999, ANESTH ANALG, V89, P1378, DOI 10.1097/00000539-199912000-00009; Missant C, 2010, BRIT J ANAESTH, V104, P143, DOI 10.1093/bja/aep354; Monteiro ER, 2010, AM J VET RES, V71, P1133, DOI 10.2460/ajvr.71.10.1133; NAKAO S, 1986, CIRCULATION, V73, P579, DOI 10.1161/01.CIR.73.3.579; NESS TJ, 1990, PAIN, V41, P167, DOI 10.1016/0304-3959(90)90021-5; Otero PE, 2013, SMALL ANIMAL REGIONAL ANESTHESIA AND ANALGESIA, P227; Otero PE, 2009, 10 WORLD C VET AN 31; Penderis J, 2015, IN PRACTICE, V37, DOI 10.1136/inp.h861; PETERS J, 1990, ANESTHESIOLOGY, V73, P694, DOI 10.1097/00000542-199010000-00015; Romano M, 2016, VET ANAESTH ANALG, V43, P44, DOI 10.1111/vaa.12275; SHIBATA K, 1994, ANESTHESIOLOGY, V81, P1454, DOI 10.1097/00000542-199412000-00021; Sibanda S, 2006, VET ANAESTH ANALG, V33, P246, DOI 10.1111/j.1467-2995.2005.00261.x; STEFFEY EP, 1977, AM J VET RES, V38, P1833; TAKASAKI M, 1980, BRIT J ANAESTH, V52, P1271, DOI 10.1093/bja/52.12.1271; Troncy E, 2002, J AM VET MED ASSOC, V221, P666, DOI 10.2460/javma.2002.221.666; Valverde A, 2008, VET CLIN N AM-SMALL, V38, P1205, DOI 10.1016/j.cvsm.2008.06.004; Veering B Th, 2003, Minerva Anestesiol, V69, P433	43	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195867	10.1371/journal.pone.0195867	http://dx.doi.org/10.1371/journal.pone.0195867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668768	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200063
J	Loveday, M; Wallengren, K; Reddy, T; Besada, D; Brust, JCM; Voce, A; Desai, H; Ngozo, J; Radebe, Z; Master, I; Padayatchi, N; Daviaud, E				Loveday, Marian; Wallengren, Kristina; Reddy, Tarylee; Besada, Donela; Brust, James C. M.; Voce, Anna; Desai, Harsha; Ngozo, Jacqueline; Radebe, Zanele; Master, Iqbal; Padayatchi, Nesri; Daviaud, Emmanuelle			MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; HOSPITALIZATION; IMPACT	Background South Africa has a high burden of MDR-TB, and to provide accessible treatment the government has introduced different models of care. We report the most cost-effective model after comparing cost per patient successfully treated across 5 models of care: centralized hospital, district hospitals (2), and community-based care through clinics or mobile injection teams. Methods In an observational study five cohorts were followed prospectively. The cost analysis adopted a provider perspective and economic cost per patient successfully treated was calculated based on country protocols and length of treatment per patient per model of care. Logistic regression was used to calculate propensity score weights, to compare pairs of treatment groups, whilst adjusting for baseline imbalances between groups. Propensity score weighted costs and treatment success rates were used in the ICER analysis. Sensitivity analysis focused on varying treatment success and length of hospitalization within each model. Results In 1,038 MDR-TB patients 75% were HIV-infected and 56% were successfully treated. The cost per successfully treated patient was 3 to 4.5 times lower in the community-based models with no hospitalization. Overall, the Mobile model was the most cost-effective. Conclusion Reducing the length of hospitalization and following community-based models of care improves the affordability of MDR-TB treatment without compromising its effectiveness.	[Loveday, Marian; Besada, Donela; Daviaud, Emmanuelle] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Loveday, Marian; Padayatchi, Nesri] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, SA Med Res Council, Extramural TB Pathogenesis Res Unit, Durban, South Africa; [Wallengren, Kristina] TB & HIV Invest Network Think, Durban, South Africa; [Reddy, Tarylee] South African Med Res Council, Biostat Unit, Cape Town, South Africa; [Brust, James C. M.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Brust, James C. M.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Voce, Anna] Univ KwaZulu Natal, Discipline Publ Hlth Med, Durban, South Africa; [Desai, Harsha] Deloitte Consulting, Johannesburg, South Africa; [Ngozo, Jacqueline; Radebe, Zanele] KwaZulu Natal Dept Hlth, Pietermaritzburg, South Africa; [Master, Iqbal] King Dinuzulu Hosp, KwaZulu Natal Dept Hlth, Durban, South Africa	South African Medical Research Council; South African Medical Research Council; University of Kwazulu Natal; South African Medical Research Council; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Kwazulu Natal; Deloitte Touche Tohmatsu Limited	Loveday, M (corresponding author), South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa.; Loveday, M (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, SA Med Res Council, Extramural TB Pathogenesis Res Unit, Durban, South Africa.	marian.loveday@mrc.ac.za	Loveday, Marian/M-8016-2013; padayatchi, nesri/Q-2780-2019; Voce, Anna Silvia/AAF-9039-2020	Loveday, Marian/0000-0001-9205-9314; padayatchi, nesri/0000-0003-2543-9071; Voce, Anna Silvia/0000-0001-9082-4449; Reddy, Tarylee/0000-0002-9521-2692; Besada, Donela/0000-0002-2020-5244	South African Medical Research Council; Izumi Foundation; University Research Co-operation (URC); United Way Worldwide grant [17245]; National Institute of Allergy and Infectious Diseases [K23AI083088, P30AI051519]	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Izumi Foundation; University Research Co-operation (URC); United Way Worldwide grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by the South African Medical Research Council (www.mrc.ac.za), Izumi Foundation (http://izumi.org), University Research Co-operation (URC) and a United Way Worldwide grant (grant ID #: 17245) made possible by the Lilly Foundation on behalf of the Lilly MDR TB Partnership (https://www.lilly.com/who-we-are). JCMB is supported by the National Institute of Allergy and Infectious Diseases (K23AI083088, P30AI051519). The funders had no role in study design, the collection, analysis, or interpretation of data; in report writing; or the decision to submit the paper for publication. All researchers were independent of funders and sponsors. The funders provided support in the form of salaries for authors ML and ED, they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. HD is employed by Deloitte Consulting. Her contribution to this manuscript was done in her own time and her employee had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the author contributions section.	Ahmed S, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-015-0361-7; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bang HJ, 2012, J STAT THEORY PRACT, V6, P428, DOI 10.1080/15598608.2012.695571; Bassili A, 2013, AM J TROP MED HYG, V89, P271, DOI 10.4269/ajtmh.13-0004; Colvin CJ, 2015, INT J TUBERC LUNG D, V19, P1326, DOI 10.5588/ijtld.15.0262; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Cox H, 2015, TROP MED INT HEALTH, V20, P1337, DOI 10.1111/tmi.12544; Day C, 2012, DISTRICT HLTH BAROME; Department of Public Service and Administration, 2012, SAL SCAL ANN C NURS; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Floyd K, 2012, EUR RESPIR J, V40, P133, DOI 10.1183/09031936.00169411; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; KwaZulu-Natal Department of Health, 2012, KWAZULU NAT FIN REP; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Loveday M, 2018, INT J TUBERC LUNG D, V22, P40, DOI 10.5588/ijtld.17.0371; Loveday M, 2015, INT J TUBERC LUNG D, V19, P163, DOI 10.5588/ijtld.14.0369; Loveday M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094016; National Department of Health, 2011, MULT RES TUB POL FRA; National Health Laboratory Service, 2014, GENEXPERT MTB RIF PR; National Institute for Communicable Diseases, 2016, S AFR TUB DRUG RES S; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Sinanovic E, 2015, INT J TUBERC LUNG D, V19, P172, DOI 10.5588/ijtld.14.0421; Statistics South Africa, 2013, CENS 2011 STAT REL P; StatsSA, 2014, CONS PRIC IND REL P0; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; United Nations, 2015, UN OP RAT EXCH; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; WHO, 2015, END TB STRAT GLOB ST; Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675; World Health Organisation, 2017, WHOHTMTB2017232017; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2016, WHOHTMTB201604	35	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196003	10.1371/journal.pone.0196003	http://dx.doi.org/10.1371/journal.pone.0196003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668748	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200073
J	Aguayo-Ortiz, A; Mendoza, S; Olvera, D				Aguayo-Ortiz, A.; Mendoza, S.; Olvera, D.			A direct Primitive Variable Recovery Scheme for hyperbolic conservative equations: The case of relativistic hydrodynamics	PLOS ONE			English	Article								In this article we develop a Primitive Variable Recovery Scheme (PVRS) to solve any system of coupled differential conservative equations. This method obtains directly the primitive variables applying the chain rule to the time term of the conservative equations. With this, a traditional finite volume method for the flux is applied in order avoid violation of both, the entropy and "Rankine-Hugoniot" jump conditions. The time evolution is then computed using a forward finite difference scheme. This numerical technique evades the recovery of the primitive vector by solving an algebraic system of equations as it is often used and so, it generalises standard techniques to solve these kind of coupled systems. The article is presented bearing in mind special relativistic hydrodynamic numerical schemes with an added pedagogical view in the appendix section in order to easily comprehend the PVRS. We present the convergence of the method for standard shock-tube problems of special relativistic hydrodynamics and a graphical visualisation of the errors using the fluctuations of the numerical values with respect to exact analytic solutions. The PVRS circumvents the sometimes arduous computation that arises from standard numerical methods techniques, which obtain the desired primitive vector solution through an algebraic polynomial of the charges.	[Aguayo-Ortiz, A.; Mendoza, S.] Univ Nacl Autonoma Mexico, Inst Astron, AP 70-264, Mexico City 04510, DF, Mexico; [Olvera, D.] Univ Bristol, Sch Math, Univ Walk, Bristol BS8 1TW, Avon, England	Universidad Nacional Autonoma de Mexico; University of Bristol	Aguayo-Ortiz, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Astron, AP 70-264, Mexico City 04510, DF, Mexico.	aaguayo@astro.unam.mx	Mendoza, Sergio/AAI-8250-2021	Olvera Cabrera, Daniel/0000-0002-7935-9715; Aguayo-Ortiz, Alejandro/0000-0001-5729-7958; Mendoza, Sergio/0000-0002-2143-5973	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM project) [IN112616]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [CB-2014-1, 240512]; CONACyT [788898, 26344, 255602]	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM project); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM project number IN112616, http://dgapa.unam.mx) and Consejo Nacional de Ciencia y Tecnologia (CONACyT project ID:CB-2014-1 #240512 http://www.conacyt.gob.mx). MO, SM and DO acknowledge economic support from CONACyT (788898, 26344, 255602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOK DL, 1975, J COMPUT PHYS, V18, P248, DOI 10.1016/0021-9991(75)90002-9; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; FONT JA, 1994, ASTRON ASTROPHYS, V282, P304; Godunov S.K., 1959, MAT SB, V47; Harten A, 1983, SIAM REV, V04, P25, DOI [10.2307/2030019, DOI 10.2307/2030019]; Laney, 1998, COMPUTATIONAL GASDYN; Lea Rezzolla, 2013, RELATIVISTIC HYDRODY; LeVeque RJ, 2002, CAMBRIDGE TEXTS APPL, V31, DOI DOI 10.1017/CBO9780511791253; Lora-Clavijo F. D., 2013, Rev. mex. fís. E, V59, P28; Lora-Clavijo FD, 2015, ASTROPHYS J SUPPL S, V218, DOI 10.1088/0067-0049/218/2/24; MacCormack RW, 1972, COMPUTATIONAL EFFICI; Miyoshi T, 2005, J COMPUT PHYS, V208, P315, DOI 10.1016/j.jcp.2005.02.017; Muller E, 2003, LIVING REV RELATIVIT, V6; Radice D, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219735; Riccardi G, 2008, INT MATH FORUM, V42, P2081; ROE PL, 1986, ANNU REV FLUID MECH, V18, P337, DOI 10.1146/annurev.fl.18.010186.002005; SOD GA, 1978, J COMPUT PHYS, V27, P1, DOI 10.1016/0021-9991(78)90023-2; St-Cyr A, 2008, MON WEATHER REV, V136, P1898, DOI 10.1175/2007MWR2108.1; TOOPER RF, 1965, ASTROPHYS J, V142, P1541, DOI 10.1086/148435; Toro E.F., 2009, RIEMANN SOLVERS NUME, Vthird, DOI DOI 10.1007/B79761; VAN LEER B, 1977, J COMPUT PHYS, V23, P276, DOI [10.1016/0021-9991(77)90095-X, 10.1016/0021-9991(77)90094-8]; VONNEUMANN J, 1950, J APPL PHYS, V21, P232, DOI 10.1063/1.1699639; Weinberg S., 1972, GRAVITATION COSMOLOG; Yousaf M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128698	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195494	10.1371/journal.pone.0195494	http://dx.doi.org/10.1371/journal.pone.0195494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659602	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100018
J	Finnegan, L; Pigeon, KE; Cranston, J; Hebblewhite, M; Musiani, M; Neufeld, L; Schmiegelow, F; Duval, J; Stenhouse, GB				Finnegan, Laura; Pigeon, Karine E.; Cranston, Jerome; Hebblewhite, Mark; Musiani, Marco; Neufeld, Lalenia; Schmiegelow, Fiona; Duval, Julie; Stenhouse, Gordon B.			Natural regeneration on seismic lines influences movement behaviour of wolves and grizzly bears	PLOS ONE			English	Article							BIALOWIEZA-PRIMEVAL-FOREST; WOODLAND CARIBOU; HABITAT SELECTION; RESOURCE SELECTION; PREDATION; VEGETATION; ECOSYSTEM; PATTERNS; FEATURES; ALBERTA	Across the boreal forest of Canada, habitat disturbance is the ultimate cause of caribou (Rangifer tarandus caribou) declines. Habitat restoration is a focus of caribou recovery efforts, with a goal to finding ways to reduce predator use of disturbances, and caribou-predator encounters. One of the most pervasive disturbances within caribou ranges in Alberta, Canada are seismic lines cleared for energy exploration. Seismic lines facilitate predator movement, and although vegetation on some seismic lines is regenerating, it remains unknown whether vegetation regrowth is sufficient to alter predator response. We used Light Detection and Ranging (LiDAR) data, and GPS locations, to understand how vegetation and other attributes of seismic lines influence movements of two predators, wolves (Canis lupus) and grizzly bears (Ursus arctos). During winter, wolves moved towards seismic lines regardless of vegetation height, while during spring wolves moved towards seismic lines with higher vegetation. During summer, wolves moved towards seismic lines with lower vegetation and also moved faster near seismic lines with vegetation <0.7 m. Seismic lines with lower vegetation height were preferred by grizzly bears during spring and summer, but there was no relationship between vegetation height and grizzly bear movement rates. These results suggest that wolves use seismic lines for travel during summer, but during winter wolf movements relative to seismic lines could be influenced by factors additional to movement efficiency; potentially enhanced access to areas frequented by ungulate prey. Grizzly bears may be using seismic lines for movement, but could also be using seismic lines as a source of vegetative food or ungulate prey. To reduce wolf movement rate, restoration could focus on seismic lines with vegetation <1 m in height. However our results revealed that seismic lines continue to influence wolf movement behaviour decades after they were built, and even at later stages of regeneration. Therefore it remains unknown at what stage of natural regeneration, if any, wolves cease to respond to seismic lines. To reduce wolf response to seismic lines, active restoration tactics like blocking seismic lines and tree planting, along with management of alternate prey, could be evaluated.	[Finnegan, Laura; Pigeon, Karine E.] fRI Res, Caribou Program, Hinton, AB, Canada; [Cranston, Jerome] Arctos Ecol Consultants, Edmonton, AB, Canada; [Hebblewhite, Mark] Univ Montana, WA Franke Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Wildlife Biol Program, Missoula, MT 59812 USA; [Musiani, Marco] Univ Calgary, Dept Biol Sci, Fac Sci, Calgary, AB, Canada; [Neufeld, Lalenia] Jasper Natl Pk, Parks Canada, Jasper, AB, Canada; [Schmiegelow, Fiona] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Duval, Julie] fRI Res, GIS Program, Hinton, AB, Canada; [Stenhouse, Gordon B.] fRI Res, Grizzly Bear Program, Hinton, AB, Canada	University of Montana System; University of Montana; University of Calgary; Parks Canada; University of Alberta	Finnegan, L (corresponding author), fRI Res, Caribou Program, Hinton, AB, Canada.	lfinnegan@friresearch.ca	Hebblewhite, Mark/AAI-8101-2020; Pigeon, Karine E./C-6336-2014; hebblewhite, mark/G-6164-2013; Musiani, Marco/ABB-9387-2021	Hebblewhite, Mark/0000-0001-5382-1361; Pigeon, Karine E./0000-0002-7409-5511; Musiani, Marco/0000-0002-6097-5841; Finnegan, Laura/0000-0002-4797-6284	Government of Canada/Dans le cadre du Plan de conservation national, ce projet a ete realise avec l'appui financier du gouvernement du Canada [HSP6617, 6699, 7195]; Alberta Environment and Parks; Foothills Landscape Management Forum; Sustainable Forestry Initiative [2013-003]; fRI Research Caribou Program; fRI Research Grizzly Bear Program; fRI Research; Government of Alberta (GoA); fRI Research Grizzly Bear Program partners; University of Alberta and University of Montana; NASA's Arctic Boreal Vulnerability Experiment (ABOVE) grant [NNX15AW71A]	Government of Canada/Dans le cadre du Plan de conservation national, ce projet a ete realise avec l'appui financier du gouvernement du Canada; Alberta Environment and Parks; Foothills Landscape Management Forum; Sustainable Forestry Initiative; fRI Research Caribou Program; fRI Research Grizzly Bear Program; fRI Research; Government of Alberta (GoA); fRI Research Grizzly Bear Program partners; University of Alberta and University of Montana; NASA's Arctic Boreal Vulnerability Experiment (ABOVE) grant	Part of the National Conservation Plan, this project was undertaken with the financial support of the Government of Canada/Dans le cadre du Plan de conservation national, ce projet a ete realise avec l'appui financier du gouvernement du Canada (HSP6617, 6699, 7195) [www.ec.gc.ca/hsp-pih]. Additional support was provided by Alberta Environment and Parks [http://aep.alberta.ca/], the Foothills Landscape Management Forum [https.//friresearch.ca/content/foothills-landscape-management-forum-flmf], the Sustainable Forestry Initiative (2013-003) [http.//www.sfiprogram.org/], partners of the fRI Research Caribou and Grizzly Bear Programs, and fRI Research [www.frireseamh.ca]. Animal GPS data were collected as part of research supported by the Government of Alberta (GoA), fRI Research Grizzly Bear Program partners, and funders of graduate research at the University of Alberta and University of Montana. MH was also funded by NASA's Arctic Boreal Vulnerability Experiment (ABOVE) grant # NNX15AW71A [www.nasa.goy]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K., 2015, MUMIN MULTIMODEL INF; Basille M, 2015, HAB HABITAT MOVEMENT; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bowman J, 2010, CAN J ZOOL, V88, P454, DOI 10.1139/Z10-019; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bradley Mark, 2012, Rangifer, V32, P183; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Canada Environment, 2012, REC STRAT WOODL CAR; Canadell J, 1996, Oecologia, V108, P583, DOI 10.1007/BF00329030; Canadian Council on Animal Care, 2003, CCAC GUID CAR US WIL; Cattet M, 2008, J MAMMAL, V89, P973, DOI 10.1644/08-MAMM-A-095.1; Cattet MRL, 2003, J WILDLIFE DIS, V39, P649, DOI 10.7589/0090-3558-39.3.649; Cattet MRL, 2003, URSUS-SERIES, V14, P88; Courbin N, 2014, ECOL MONOGR, V84, P265, DOI 10.1890/12-2118.1; Courbin N, 2009, LANDSCAPE ECOL, V24, P1375, DOI 10.1007/s10980-009-9389-x; Cristescu B, 2015, GLOB ECOL CONSERV, V4, P207, DOI 10.1016/j.gecco.2015.06.007; Dawe CA, 2017, FORESTS, V8, DOI 10.3390/f8100398; DeCesare NJ, 2010, ANIM CONSERV, V13, P353, DOI 10.1111/j.1469-1795.2009.00328.x; DeCesare N. J, 2012, RESOURCE SELECTION P; DeCesare NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4626, DOI 10.1098/rspb.2012.1698; DeMars CA, 2017, J ANIM ECOL, DOI [10.1111/13, DOI 10.1111/13]; Dickie M, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1936; Dickie M, 2017, J APPL ECOL, V54, P253, DOI 10.1111/1365-2664.12732; Downing D. J., 2006, NATURAL REGIONS COMM, VT/852; Droghini A, 2018, CAN J ZOOL, V96, P39, DOI 10.1139/cjz-2017-0041; Duchesne T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122947; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Environment Canada, 2011, BOR POP CAN 2011 UPD, P102; Environment Canada, 2014, SPECIES RISK ACT REC; ESRI, 2015, ARCGIS DESKT REL 10; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Finnegan L, 2018, FOREST ECOL MANAG, V409, P634, DOI 10.1016/j.foreco.2017.12.010; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Gustine DD, 2006, J WILDLIFE MANAGE, V70, P1601, DOI 10.2193/0022-541X(2006)70[1601:IRSADS]2.0.CO;2; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hebblewhite M, 2009, FOREST ECOL MANAG, V257, P1053, DOI 10.1016/j.foreco.2008.11.009; Hebblewhite M, 2007, J WILDLIFE MANAGE, V71, P2026, DOI 10.2193/2006-238; Hebblewhite M, 2005, OIKOS, V111, P101, DOI 10.1111/j.0030-1299.2005.13858.x; Hebblewhite M, 2010, LINEAR FEATURES FORE; Hebblewhite M, 2017, BIOL CONSERV, V206, P102, DOI 10.1016/j.biocon.2016.12.014; Hervieux D, 2013, CAN J ZOOL, V91, P872, DOI 10.1139/cjz-2013-0123; James ARC, 2004, J WILDLIFE MANAGE, V68, P799, DOI 10.2193/0022-541X(2004)068[0799:SSOCFM]2.0.CO;2; Jedrzejewski W, 2001, CAN J ZOOL, V79, P1993, DOI 10.1139/z01-147; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Latham ADM, 2011, CAN J ZOOL, V89, P267, DOI [10.1139/z10-115, 10.1139/Z10-115]; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Latham ADM, 2011, J WILDLIFE MANAGE, V75, P204, DOI 10.1002/jwmg.28; Lee P, 2006, J ENVIRON MANAGE, V78, P240, DOI 10.1016/j.jenvman.2005.03.016; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; McDermid GJ, 2009, FOREST ECOL MANAG, V257, P2262, DOI 10.1016/j.foreco.2009.03.005; Mckay T, 2014, WILDLIFE BIOL, V20, P310, DOI 10.2981/wlb.00046; McKenzie HW, 2012, INTERFACE FOCUS, V2, P205, DOI 10.1098/rsfs.2011.0086; McKenzie HW, 2009, ENVIRON ECOL STAT, V16, P531, DOI 10.1007/s10651-008-0095-7; Mech L. David, 2003, P1; Melin M, 2013, INT J APPL EARTH OBS, V23, P389, DOI 10.1016/j.jag.2012.11.004; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; Mills KJ, 2006, WILDLIFE SOC B, V34, P1463, DOI 10.2193/0091-7648(2006)34[1463:EOVSFO]2.0.CO;2; Mumma MA, 2017, ECOL EVOL, V7, P10266, DOI 10.1002/ece3.3563; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Murtaugh PA, 2007, ECOLOGY, V88, P56, DOI 10.1890/0012-9658(2007)88[56:SACIED]2.0.CO;2; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neufeld L., 2006, SPATIAL DYNAMICS WOL; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielson SE, 2002, URSUS, V13, P45; Noss R, 2009, SPATIAL CONSERVATION, P158; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Revel RD., 1984, FOREST GROWTH REVEGE; Roever CL, 2008, FOREST ECOL MANAG, V256, P1253, DOI 10.1016/j.foreco.2008.06.040; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Roffler GH, 2018, FOREST ECOL MANAG, V409, P190, DOI 10.1016/j.foreco.2017.11.025; Rowcliffe JM, 2012, METHODS ECOL EVOL, V3, P653, DOI 10.1111/j.2041-210X.2012.00197.x; Serrouya R, 2017, PEERJ, V5, DOI 10.7717/peerj.3736; Serrouya R, 2015, J ANIM ECOL, V84, P1600, DOI 10.1111/1365-2656.12413; Serrouya R, 2011, J APPL ECOL, V48, P935, DOI 10.1111/j.1365-2664.2011.01998.x; Singh NJ, 2010, BIOL CONSERV, V143, P1770, DOI 10.1016/j.biocon.2010.04.026; Sonderegger D.L., 2012, SIZER SIGNIFICANT ZE; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; Stenhouse G, 2005, URSUS, V16, P31, DOI 10.2192/1537-6176(2005)016[0031:GBAATE]2.0.CO;2; Therneau T., 2015, PACKAGE SURVIVAL ANA; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Tigner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118720; Tigner J, 2014, J WILDLIFE MANAGE, V78, P282, DOI 10.1002/jwmg.664; van Rensen CK, 2015, BIOL CONSERV, V184, P127, DOI 10.1016/j.biocon.2015.01.020; Visscher DR, 2006, FOREST ECOL MANAG, V222, P348, DOI 10.1016/j.foreco.2005.10.035; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; White B, 2012, CAN WATER RESOUR J, V37, P333, DOI 10.4296/cwrj2011-909; Whittington J, 2011, J APPL ECOL, V48, P1535, DOI 10.1111/j.1365-2664.2011.02043.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x; Wittmer HU, 2005, OECOLOGIA, V144, P257, DOI 10.1007/s00442-005-0055-y; Zuur Alain F., 2009, P1	100	24	25	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195480	10.1371/journal.pone.0195480	http://dx.doi.org/10.1371/journal.pone.0195480			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659615	gold, Green Published, Green Submitted			2022-12-27	WOS:000430061100016
J	Wu, W; Yang, MF; Xu, M; Ding, C; Li, YT; Xu, KJ; Shen, JF; Li, LJ				Wu, Wei; Yang, Meifang; Xu, Min; Ding, Cheng; Li, Yongtao; Xu, Kaijin; Shen, Jifang; Li, Lanjuan			Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China	PLOS ONE			English	Article							SOLID-ORGAN TRANSPLANTATION; MATCHED COHORT; RECIPIENTS; INFECTIONS; OUTCOMES; POPULATION; CANDIDATES; EXPERIENCE; DISEASES; COUNTRY	TB infection in patients after kidney transplantation remains a concern in a successful long-term outcome. This retrospective, descriptive study was performed on tuberculosis infection after kidney transplantation in the Department of Infectious Disease of the First Affiliated Hospital of Zhejiang University, a tertiary care hospital in China, from January 2011 to April 2017, with the aim to explain the clinical features of active tuberculosis after kidney transplantation and explore the correlated factors for diagnostic delay and mortality. It included 48 cases. All these cases were followed up for at least 12 months after anti-tuberculosis therapy, except the ones who died during this period. The median time of transplantation to active tuberculosis of these 48 patients was about 5.4 years. The time from a first hospital visit to the diagnosis (diagnostic delay) of 12 (25%) cases was more than 30 days. The correlated factors for the diagnostic delay more than 30 days were a fever for more than 2 weeks and antibiotic use for more than 2 weeks. Nine (18.8%) cases died during the anti-tuberculosis therapy or following-up period due to TB relapse. The risk factors for mortality were severe complications, such as encephaledema, severe pneumonia, intestinal perforation, liver function failure, and the following multiple-organ failure. In conclusion, the possibility of tuberculosis infection should be carefully assessed and sometimes diagnostic anti-tuberculosis therapy may be required for patients who had a fever for more than 2 weeks or used antibiotics for more than 2 weeks after kidney transplantation. Severe complications and the following multiple-organ failure might increase the mortality among these patients.	[Wu, Wei; Yang, Meifang; Xu, Min; Ding, Cheng; Li, Yongtao; Xu, Kaijin; Shen, Jifang; Li, Lanjuan] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wu, Wei; Yang, Meifang; Ding, Cheng; Li, Yongtao; Xu, Kaijin; Shen, Jifang; Li, Lanjuan] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Li, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Li, LJ (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	ljli@zju.edu.cn		Wu, Wei/0000-0003-4657-4088				Agarwal SK, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12626; Aguado JM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TNMI7-0005-2016; Benito N, 2015, CLIN MICROBIOL INFEC, V21, P651, DOI 10.1016/j.cmi.2015.03.010; Bumbacea D, 2012, EUR RESPIR J, V40, P990, DOI 10.1183/09031936.00000712; Chee CBE, 2012, SINGAP MED J, V53, P505; Chen CY, 2015, AM J TRANSPLANT, V15, P2180, DOI 10.1111/ajt.13235; de Castilla DL, 2010, TRANSPL INFECT DIS, V12, P106, DOI 10.1111/j.1399-3062.2009.00475.x; Gondos AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144266; Green M, 2013, AM J TRANSPLANT, V13, P3, DOI 10.1111/ajt.12093; Grim SA, 2015, TRANSPL INFECT DIS, V17, P768, DOI 10.1111/tid.12436; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Iliyasu G, 2016, TRANSPL INFECT DIS, V18, P566, DOI 10.1111/tid.12548; Jambaldorj E, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0506-9; Kant S, 2017, RURAL REMOTE HEALTH, V17, DOI [10.22605/rrh4158, 10.22605/RRH4158]; Lange B, 2010, EUR RESPIR J, V35, P1179, DOI 10.1183/09031936.00122109; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, P111, DOI 10.1093/cid/ciw778; Li Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-156; Lin J, 2013, J CLIN EXP MED, V12, P680; Mathur M, 2017, CLIN DIAGN RES, V11, pTC06; Meinerz G, 2016, TRANSPL INFECT DIS, V18, P176, DOI 10.1111/tid.12501; Morris MI, 2012, AM J TRANSPLANT, V12, P2288, DOI 10.1111/j.1600-6143.2012.04205.x; Subramanian AK, 2013, AM J TRANSPLANT, V13, P68, DOI 10.1111/ajt.12100; Subramanian AK, 2014, CURR OPIN INFECT DIS, V27, P316, DOI 10.1097/QCO.0000000000000082; Ulubay G, 2015, EXP CLIN TRANSPLANT, V13, P214, DOI 10.6002/ect.mesot2014.P16; Virenfeldt J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004818; Williams E, 2018, INTERN MED J, V48, P184, DOI 10.1111/imj.13551; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742; Yoo JW, 2016, TRANSPL INT, V29, P549, DOI 10.1111/tri.12752; Zhang XL, 2015, TROP MED INT HEALTH, V20, P1431, DOI 10.1111/tmi.12566; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	30	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195695	10.1371/journal.pone.0195695	http://dx.doi.org/10.1371/journal.pone.0195695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659613	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100026
J	Pasquau, J; Hidalgo-Tenorio, C; Montes, ML; Romero-Palacios, A; Vergas, J; Sanjoaquin, I; Hernandez-Quero, J; Aguirrebengoa, K; Orihuela, F; Imaz, A; Rios-Villegas, MJ; Flores, J; Farinas, MC; Vazquez, P; Galindo, MJ; Garcia-Merce, I; Lozano, F; de los Santos, I; de Jesus, SE; Garcia-Vallecillos, C				Pasquau, Juan; Hidalgo-Tenorio, Carmen; Luisa Montes, Maria; Romero-Palacios, Alberto; Vergas, Jorge; Sanjoaquin, Isabel; Hernandez-Quero, Jose; Aguirrebengoa, Koldo; Orihuela, Francisco; Imaz, Arkaitz; Jose Rios-Villegas, Maria; Flores, Juan; Carmen Farinas, Maria; Vazquez, Pilar; Jose Galindo, Maria; Garcia-Merce, Isabel; Lozano, Fernando; de los Santos, Ignacio; Elizabeth de Jesus, Samantha; Garcia-Vallecillos, Coral		QoLKAMON Study Grp	High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial	PLOS ONE			English	Article							LOPINAVIR-RITONAVIR MONOTHERAPY; PROTEASE INHIBITOR MONOTHERAPY; PSEUDORANDOM NUMBER GENERATOR; MAINTENANCE THERAPY; INFECTED PATIENTS; MONARK TRIAL; ANTIRETROVIRAL TREATMENT; OPEN-LABEL; SIMPLIFICATION; RESISTANCE	Trial design The QoLKAMON study evaluated quality of life, efficacy and treatment safety in HIV patients receiving lopinavir/ritonavir in monotherapy (MT) versus continuing combined antiretroviral triple treatment with a boosted protease inhibitor (TT). Methods This was a 24-week, open-label, multicentre study in virologically-suppressed HIV-infected participants (N = 225) with a 2:1 randomization: 146 patients who switched to MT were compared with 79 patients who remained on a TT regimen. The primary endpoint was change in patient-reported outcomes in quality of life as measured by the MOS-HIV and EQ-5D questionnaires. Secondary endpoints included treatment adherence, patient satisfaction, incidence of adverse events and differences in plasma HIV-1 RNA viral load (VL) and CD4 cell counts. Results Baseline quality of life, measured with the MOS-HIV score, was very good (overall score of 83 +/- 10.5 in the MT arm and 82.3 +/- 11.3 in the TT arm) and suffered no change during the study in any of the arms (at week 24, 83.5 +/- 12.2 in MT arm and 81.9 +/- 12.7 in TT arm), without statistically significant differences when compared. In regards to adherence to therapy and patient satisfaction, some aspects (number of doses forgotten in the last week and satisfaction of treatment measured with the CESTA score, dimension 1) improved significantly with MT. There were also no differences in the incidence and severity of adverse events, even though 22.8% of those in the MT arm switched their treatment when they were included in the study. Moreover, there was also no significant difference between the immunological and virological evolution of MT and TT. In the MT arm, the VL was always undetectable in 83% of patients (vs 90.7% in the TT arm) and there were only 6.7% of virological failures with VL > 50 copies/mL (vs 2.3% in the TT arm), without resistance mutations and with resuppression of VL after switching back to TT. Conclusions In a new clinical trial, monotherapy as a treatment simplification strategy in HIV-1 infected patients with sustained viral suppression has demonstrated quality of life, safety and efficacy profiles comparable to those of conventional triple therapy regimens.	[Pasquau, Juan; Hidalgo-Tenorio, Carmen; Elizabeth de Jesus, Samantha; Garcia-Vallecillos, Coral] Hosp Univ Virgen de las Nieves, Infect Dis, Granada, Spain; [Luisa Montes, Maria] Hosp Univ La Paz, Internal Med HIV Unit, Madrid, Spain; [Romero-Palacios, Alberto] Hosp Univ Puerto Real, Infect Dis, Cadiz, Spain; [Vergas, Jorge] Hosp Clin San Carlos, Infect Dis, Granada, Spain; [Sanjoaquin, Isabel] Hosp Clin Univ Lozano Blesa, Infect Dis, Zaragoza, Spain; [Hernandez-Quero, Jose] Hosp Univ San Cecilio, Infect Dis, Granada, Spain; [Aguirrebengoa, Koldo] Hosp Univ Cruces, Infect Dis, Bilbao, Spain; [Orihuela, Francisco] Hosp Reg Univ Malaga, Infect Dis, Malaga, Spain; [Imaz, Arkaitz] Hosp Univ Bellvitge, Infect Dis, Barcelona, Spain; [Jose Rios-Villegas, Maria] Hosp Univ Virgen Macarena, Infect Dis & Clin Microbiol, Seville, Spain; [Flores, Juan] Hosp Arnau Vilanova, Infect Dis, Valencia, Spain; [Carmen Farinas, Maria] Hosp Univ Marques de Valdecilla, Infect Dis, Santander, Spain; [Vazquez, Pilar] Hosp Univ Juan Canalejo, Infect Dis, La Coruna, Spain; [Jose Galindo, Maria] Hosp Clin Univ Valencia, Infect Dis, Valencia, Spain; [Garcia-Merce, Isabel] Hosp Gen Hosp, Infect Dis, Barcelona, Spain; [Lozano, Fernando] Hosp Univ Nuestra Senora de Valme, Infect Dis, Seville, Spain; [de los Santos, Ignacio] Hosp Univ La Princesa, Infect Dis, Madrid, Spain	Hospital Universitario Virgen de las Nieves; Hospital Universitario La Paz; Universidad de Cadiz; Hospital Universitario Puerto Real; Hospital Clinico San Carlos; Lozano Blesa University Clinical Hospital; Hospital Universitario San Cecilio; Hospital Universitario Cruces; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Universitario Virgen Macarena; Hospital Universitario Marques de Valdecilla (HUMV); Complejo Hospitalario Universitario A Coruna	Pasquau, J (corresponding author), Hosp Univ Virgen de las Nieves, Infect Dis, Granada, Spain.	jpasquau@gmail.com	Ramirez, Maria Luisa Montes/H-8065-2017	Ramirez, Maria Luisa Montes/0000-0003-1748-813X; Romero Palacios, Alberto/0000-0003-1345-4901; De Los Santos Gil, Ignacio/0000-0001-7073-5211; Pasquau, Juan/0000-0001-9409-9205; de Jesus, Samantha/0000-0002-9905-2737	AbbVie Spain [ACA-SPAI-08-16]; Sociedad Andaluza de Enfermedades Infecciosas (SAEI)	AbbVie Spain(AbbVie); Sociedad Andaluza de Enfermedades Infecciosas (SAEI)	The authors received funding from AbbVie Spain (ACA-SPAI-08-16). The study was sponsored by the Sociedad Andaluza de Enfermedades Infecciosas (SAEI). AbbVie Spain had a role in study design, preparation of the final report, and manuscript writing.	Arribas JR, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-3; Arribas JR, 2009, JAIDS-J ACQ IMM DEF, V51, P147, DOI 10.1097/QAI.0b013e3181a56de5; Avettand-Fenoel V, 2010, J ANTIMICROB CHEMOTH, V65, P1005, DOI 10.1093/jac/dkq084; Berenguer J, 2002, DOCUMENTO CONSENSO G; Cahn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023726; Calza L, 2012, CURR HIV RES, V10, P661, DOI 10.2174/157016212803901419; Cameron DW, 2008, J INFECT DIS, V198, P234, DOI 10.1086/589622; Chandwani Ashish, 2008, Ther Clin Risk Manag, V4, P1023; Condes E, 2005, ENFERM INFEC MICR CL, V23, P586, DOI 10.1157/13081566; Delaugerre C, 2009, ANTIMICROB AGENTS CH, V53, P2934, DOI 10.1128/AAC.01643-08; Escobar I, 2006, ENFERM INFEC MICR CL, V24, P490, DOI 10.1157/13092464; Falco V, 2002, CLIN INFECT DIS, V34, P838, DOI 10.1086/339041; Ferretti F, 2014, SEMIN NEUROL, V34, P78, DOI 10.1055/s-0034-1372345; Giordano TP, 2004, HIV CLIN TRIALS, V5, P74, DOI 10.1310/JFXH-G3X2-EYM6-D6UG; Gonzalez Rivas L, 2011, Farm Hosp, V35, P317, DOI 10.1016/j.farma.2011.01.003; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; Knobel H, 2002, AIDS, V16, P605, DOI 10.1097/00002030-200203080-00012; Leung GPH, 2012, ADV EXP MED BIOL, V942, P347, DOI 10.1007/978-94-007-2869-1_16; Lopez Aldeguer Jose, 2008, Enferm Infecc Microbiol Clin, V26 Suppl 16, P21; Lubeck D P, 1992, Qual Life Res, V1, P359, DOI 10.1007/BF00704430; McKinnon JE, 2006, AIDS, V20, P2331, DOI 10.1097/QAD.0b013e32801189f6; MCLEOD AI, 1985, J R STAT SOC C-APPL, V34, P198; Menendez-Arias L, 2010, ANTIVIR RES, V85, P210, DOI 10.1016/j.antiviral.2009.07.006; Meynard JL, 2010, J ANTIMICROB CHEMOTH, V65, P2436, DOI 10.1093/jac/dkq327; Molto J, 2007, J ANTIMICROB CHEMOTH, V60, P436, DOI 10.1093/jac/dkm198; Molto Jose, 2008, Enferm Infecc Microbiol Clin, V26 Suppl 16, P24; Nunes EP, 2009, HIV CLIN TRIALS, V10, P368, DOI 10.1310/hct1006-368; Pasquau J, 2012, APPL HEALTH ECON HEA, V10, P139, DOI 10.2165/11598380-000000000-00000; Paton N SW, 2014, 21 C RETR OPP INF CR; Paton NI, 2015, LANCET HIV, V2, pE417, DOI 10.1016/S2352-3018(15)00176-9; Paton NI, 2014, NEW ENGL J MED, V371, P234, DOI 10.1056/NEJMoa1311274; Perez-Valero I, 2011, CURR OPIN INFECT DIS, V24, P7, DOI 10.1097/QCO.0b013e3283422cdf; Pulido F, 2008, J ANTIMICROB CHEMOTH, V61, P1359, DOI 10.1093/jac/dkn103; Pulido F, 2010, AIDS REV, V12, P127; Pulido Ortega Federico, 2008, Enferm Infecc Microbiol Clin, V26 Suppl 16, P12; Spire B, 2008, ANTIVIR THER, V13, P591; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Wallis CL, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/769627; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; WICHMANN BA, 1982, J R STAT SOC C-APPL, V31, P188; Wu AW, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-42	42	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195068	10.1371/journal.pone.0195068	http://dx.doi.org/10.1371/journal.pone.0195068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649309	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900021
J	Prince, MJ; Acosta, D; Guerra, M; Huang, YQ; Jimenez-Velazquez, IZ; Rodriguez, JJL; Salas, A; Sosa, AL; Dewey, ME; Guerchet, MM; Liu, ZR; Guerra, JJL; Prina, AM				Prince, Martin J.; Acosta, Daisy; Guerra, Mariella; Huang, Yueqin; Jimenez-Velazquez, Ivonne Z.; Llibre Rodriguez, Juan J.; Salas, Aquiles; Luisa Sosa, Ana; Dewey, Michael E.; Guerchet, Maelenn M.; Liu, Zhaorui; Llibre Guerra, Jorge J.; Prina, A. Matthew			Leg length, skull circumference, and the incidence of dementia in Latin America and China: A 10/66 population-based cohort study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HEAD CIRCUMFERENCE; BIRTH COHORT; INTRACRANIAL VOLUME; ALZHEIMERS-DISEASE; KOREAN POPULATION; TRUNK LENGTH; LIFE-COURSE; RISK; ASSOCIATIONS	Background Adult leg length is influenced by nutrition in the first few years of life. Adult head circumference is an indicator of brain growth. Cross-sectional studies indicate inverse associations with dementia risk, but there have been few prospective studies. Methods Population-based cohort studies in urban sites in Cuba, Dominican Republic Puerto Rico and Venezuela, and rural and urban sites in Peru, Mexico and China. Sociodemographic and risk factor questionnaires were administered to all participants, and anthropometric measures taken, with ascertainment of incident dementia, and mortality, three to five years later. Results Of the original at risk cohort of 13,587 persons aged 65 years and over, 2,443 (18.0%) were lost to follow-up; 10,540 persons with skull circumference assessments were followed up for 40,466 person years, and 10,400 with leg length assessments were followed up for 39,954 person years. There were 1,009 cases of incident dementia, and 1,605 dementia free deaths. The fixed effect pooled meta-analysed adjusted subhazard ratio (ASHR) for leg length (highest vs. lowest quarter) was 0.80 (95% CI, 0.66-0.97) and for skull circumference was 1.02 (95% CI, 0.84-1.25), with no heterogeneity of effect between sites (I-2 = 0%). Leg length measurements tended to be shorter at follow-up, particularly for those with baseline cognitive impairment and dementia. However, leg length change was not associated with dementia incidence (ASHR, per cm 1.006, 95% CI 0.992-1.020), and the effect of leg length was little altered after adjusting for baseline frailty (ASHR 0.82, 95% CI 0.67-0.99). A priori hypotheses regarding effect modification by gender or educational level were not supported. However, the effect of skull circumference was modified by gender (M vs F ASHR 0.86, 95% CI 0.75-0.98), but in the opposite direction to that hypothesized with a greater protective effect of larger skull dimensions in men. Conclusions Consistent findings across settings provide quite strong support for an association between adult leg length and dementia incidence in late-life. Leg length is a relatively stable marker of early life nutritional programming, which may confer brain reserve and protect against neurodegeneration in later life through mitigation of cardiometabolic risk. Further clarification of these associations could inform predictive models for future dementia incidence in the context of secular trends in adult height, and invigorate global efforts to improve childhood nutrition, growth and development.	[Prince, Martin J.; Dewey, Michael E.; Guerchet, Maelenn M.; Prina, A. Matthew] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London, England; [Acosta, Daisy] UNPHU, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Guerra, Mariella] Natl Inst Mental Hlth Honorio Delgado Hideyo Nogu, Psychogeriatr Unit, Lima, Peru; [Guerra, Mariella] Inst Memoria & Desordenes Relacionados, Lima, Peru; [Huang, Yueqin; Liu, Zhaorui] Peking Univ, Inst Mental Hlth, Beijing, Peoples R China; [Jimenez-Velazquez, Ivonne Z.] Univ Puerto Rico, Sch Med, Dept Internal Med, Geriatr Program, Med Sci Campus, San Juan, PR 00936 USA; [Llibre Rodriguez, Juan J.] Med Univ Havana, Fac Med Finley Albarran, Havana, Cuba; [Salas, Aquiles] Univ Cent Venezuela, Dept Med, Caracas Univ Hosp, Fac Med, Caracas, Venezuela; [Luisa Sosa, Ana] Autonomous Natl Univ Mexico, Lab Dementias, Natl Inst Neurol & Neurosurg Mexico, Mexico City, DF, Mexico; [Llibre Guerra, Jorge J.] Inst Neurol Dr Rafael Estrada, Havana, Cuba	University of London; King's College London; Universidad Nacional Pedro Henriquez Urena; Peking University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Central Venezuela; Universidad Nacional Autonoma de Mexico	Prince, MJ (corresponding author), Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London, England.	martin.prince@kcl.ac.uk	Prince, Martin J/A-9170-2010; Dewey, Michael E/E-2049-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Prina, Matthew/B-4188-2013; Guerchet, Maëlenn/ABB-5594-2020; Llibre Rodriguez, Juan/D-2380-2010	Prince, Martin J/0000-0003-1379-7146; Dewey, Michael E/0000-0002-7522-3677; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Prina, Matthew/0000-0001-6698-3263; Guerchet, Maëlenn/0000-0002-0470-5556; Guerra, Mariella/0000-0001-8923-349X; Llibre Rodriguez, Juan/0000-0002-8215-3160; Llibre Guerra, Jorge Jesus/0000-0002-2137-7750	Wellcome Trust [GR066133, GR080002]; World Health Organization; US Alzheimer's Association [IIRG - 04 - 1286]; FONACIT/CDCH/UCV; Puerto Rico Legislature; European Research Council [ERC-2013-ADG 340755 LIFE2YEARS1066]; MRC [MR/K021907/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization(World Health Organization); US Alzheimer's Association(Alzheimer's Association); FONACIT/CDCH/UCV; Puerto Rico Legislature; European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Wellcome Trust (GR066133-Prevalence phase in Cuba; GR080002- Incidence phase in Peru, Mexico, Cuba, Dominican Republic, Venezuela and China and data analysis across all centres) - http://www.wellcome.ac.uk/, World Health Organization (Prevalence phase in Dominican Republic and China) - www.who.int, US Alzheimer's Association (IIRG - 04 - 1286 - Prevalence phase in Peru, and Mexico) - http://www.alz.org/research/alzheimers_grants!, FONACIT/CDCH/UCV (data collection in Venezuela) - http://www.fonacit.gob.ve/, and Puerto Rico Legislature (data collection in Puerto Rico). European Research Council ERC-2013-ADG 340755 LIFE2YEARS1066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Baten J, 2012, ECON HIST DEV REG, V27, pS66, DOI 10.1080/20780389.2012.657489; Bickel H, 2006, PSYCHIAT PRAX, V33, P138, DOI 10.1055/s-2005-915464; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Edland SD, 2002, NEUROLOGY, V59, P272, DOI 10.1212/WNL.59.2.272; Ferri CP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001179; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Ganguli M, 1996, Int Psychogeriatr, V8, P507, DOI 10.1017/S1041610296002852; Gigante DP, 2009, EUR J CLIN NUTR, V63, P375, DOI 10.1038/sj.ejcn.1602949; Grasset L, 2015, ALZHEIMERS DEMENT, V10; Graves AB, 2001, NEUROLOGY, V57, P1453, DOI 10.1212/WNL.57.8.1453; HALL KS, 1993, INT J METHOD PSYCH, V3, P1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang TL, 2008, NEUROLOGY, V70, P1818, DOI 10.1212/01.wnl.0000311444.20490.98; Jenkins R, 2000, ARCH NEUROL-CHICAGO, V57, P220, DOI 10.1001/archneur.57.2.220; Jotheeswaran AT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0378-4; Jotheeswaran AT, 2011, INT PSYCHOGERIATR, V23, P328, DOI 10.1017/S1041610210001171; Kim JM, 2008, INT J GERIATR PSYCH, V23, P41, DOI 10.1002/gps.1833; Kim JM, 2003, J NEUROL NEUROSUR PS, V74, P427, DOI 10.1136/jnnp.74.4.427; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Mak Z, 2006, INT J GERIATR PSYCH, V21, P266, DOI 10.1002/gps.1458; Miller DB, 2008, METABOLISM, V57, pS44, DOI 10.1016/j.metabol.2008.07.011; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; Prina AM, 2016, INT J EPIDEMIOL; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2010, INT PSYCHOGERIATR, P1; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Prince M, 2012, LANCET, V380, P50, DOI 10.1016/S0140-6736(12)60399-7; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Scazufca M, 2008, INT J EPIDEMIOL, V37, P879, DOI 10.1093/ije/dyn125; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Stewart R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124163; TANNER JM, 1982, ANN HUM BIOL, V9, P411, DOI 10.1080/03014468200005951; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195133	10.1371/journal.pone.0195133	http://dx.doi.org/10.1371/journal.pone.0195133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649337	gold, Green Submitted, Green Published			2022-12-27	WOS:000429791900026
J	Weng, LC; Roetker, NS; Lutsey, PL; Alonso, A; Guan, WH; Pankow, JS; Folsom, AR; Steffen, LM; Pankratz, N; Tang, WH				Weng, Lu-Chen; Roetker, Nicholas S.; Lutsey, Pamela L.; Alonso, Alvaro; Guan, Weihua; Pankow, James S.; Folsom, Aaron R.; Steffen, Lyn M.; Pankratz, Nathan; Tang, Weihong			Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: A Mendelian randomization study	PLOS ONE			English	Article							IMPROVED LIPOLYTIC EFFICIENCY; RISK-FACTORS; LIPOPROTEIN CHOLESTEROL; ENZYMATIC DETERMINATION; ATHEROSCLEROSIS RISK; INSTRUMENTS; METAANALYSIS; ASSOCIATION; COMMUNITIES; SMOKING	Studies have reported that higher circulating levels of total cholesterol (TC), low-density lipoprotein (LDL) cholesterol and lower of high-density lipoprotein (HDL) cholesterol may be associated with increased risk of abdominal aortic aneurysm (AAA). Whether dyslipidemia causes AAA is still unclear and is potentially testable using a Mendelian randomization (MR) approach. We investigated the associations between blood lipids and AAA using two-sample MR analysis with SNP-lipids association estimates from a published genome-wide association study of blood lipids (n = 188,577) and SNP-AAA association estimates from European Americans (EAs) of the Atherosclerosis Risk in Communities (ARIC) study (n = 8,793). We used inverse variance weighted (IVW) MR as the primary method and MR Egger regression and weighted median MR estimation as sensitivity analyses. Over a median of 22.7 years of follow-up, 338 of 8,793 ARIC participants experienced incident clinical AAA. Using the IVW method, we observed positive associations of plasma LDL cholesterol and TC with the risk of AAA (odds ratio (OR) = 1.55, P = 0.02 for LDL cholesterol and OR = 1.61, P = 0.01 for TC per 1 standard deviation of lipid increment). Using the MR-Egger regression and weighted median methods, we were able to validate the association of AAA risk with TC, although the associations were less consistent for LDL cholesterol due to wider confidence intervals. Triglycerides and HDL cholesterol were not associated with AAA in any of the MR methods. Assuming instrumental variable assumptions are satisfied, our finding suggests that higher plasma TC and LDL cholesterol are causally associated with the increased risk of AAA in EAs.	[Weng, Lu-Chen; Roetker, Nicholas S.; Lutsey, Pamela L.; Alonso, Alvaro; Pankow, James S.; Folsom, Aaron R.; Steffen, Lyn M.; Tang, Weihong] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Guan, Weihua] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Pankratz, Nathan] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Weng, Lu-Chen] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Alonso, Alvaro] Emory Univ, Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Emory University	Tang, WH (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	tang0097@umn.edu	Alonso, Alvaro/A-4917-2010	Alonso, Alvaro/0000-0002-2225-8323; Steffen, Lyn M/0000-0002-4053-6729; Pankow, James/0000-0001-7076-483X; Lutsey, Pamela/0000-0002-1572-1340	National Heart, Lung, and Blood Institute (NHLBI) [R01 HL103695]; National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The National Heart, Lung, and Blood Institute (NHLBI) supported this research through R01 HL103695. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. The authors thank the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERBACH O, 1980, CHEST, V78, P805, DOI 10.1378/chest.78.6.805; Baumgartner I, 2008, J VASC SURG, V48, P808, DOI 10.1016/j.jvs.2008.05.026; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998; Cornuz J, 2004, EUR J PUBLIC HEALTH, V14, P343, DOI 10.1093/eurpub/14.4.343; ERNST CB, 1993, NEW ENGL J MED, V328, P1167; Forsdahl SH, 2009, CIRCULATION, V119, P2202, DOI 10.1161/CIRCULATIONAHA.108.817619; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Golledge J, 2013, CURR OPIN CARDIOL, V28, P290, DOI 10.1097/HCO.0b013e32835f0d55; Harrison SC, 2018, JAMA CARDIOL, V3, P26, DOI 10.1001/jamacardio.2017.4293; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Holmes MV, 2015, EUR HEART J, V36, P539, DOI 10.1093/eurheartj/eht571; Jahangir E, 2015, J EPIDEMIOL COMMUN H, V69, P481, DOI 10.1136/jech-2014-204920; JOHNSON G, 1985, ARCH SURG-CHICAGO, V120, P1138; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lindblad B, 2005, EUR J VASC ENDOVASC, V30, P346, DOI 10.1016/j.ejvs.2005.04.021; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Pankow JS, 2017, ARTERIOSCL THROM VAS, V37, P589, DOI 10.1161/ATVBAHA.116.308109; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rodin MB, 2003, HYPERTENSION, V42, P61, DOI 10.1161/01.HYP.0000078829.02288.98; Sandiford P, 2012, J EPIDEMIOL COMMUN H, V66, P1097, DOI 10.1136/jech-2011-200754; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Tang WH, 2016, ARTERIOSCL THROM VAS, V36, P2468, DOI 10.1161/ATVBAHA.116.308147; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Tornwall ME, 2001, EPIDEMIOLOGY, V12, P94; Van Kuijk JP, 2009, J CARDIOVASC SURG, V50, P599; WARNICK GR, 1982, AM J CLIN PATHOL, V78, P718; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	33	26	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195719	10.1371/journal.pone.0195719	http://dx.doi.org/10.1371/journal.pone.0195719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649275	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900076
J	Lodenstein, E; Ingemann, C; Molenaar, JM; Dieleman, M; Broerse, JEW				Lodenstein, Elsbet; Ingemann, Christine; Molenaar, Joyce M.; Dieleman, Marjolein; Broerse, Jacqueline E. W.			Informal social accountability in maternal health service delivery: A study in Northern Malawi	PLOS ONE			English	Article							CARE; INITIATIVES	Despite the expansion of literature on social accountability in low-and middle-income countries, little is known about how health providers experience daily social pressure and citizen feedback. This study used a narrative inquiry approach to explore the function of daily social accountability relations among maternal health care workers in rural Malawi. Through semi-structured interviews with 32 nurses and 19 clinicians, we collected 155 feedback cases allowing the identification of four main strategies social actors use to express their opinion and concerns about maternal health services. We found that women who used delivery care express their appreciation for successful deliveries directly to the health worker but complaints, such as on absenteeism and poor interpersonal behaviour, follow an indirect route via intermediaries such as the health workers' spouse, co-workers or the health committee who forward some cases of misbehaviour to district authorities. The findings suggest that citizen feedback is important for the socialization, motivation and retention of maternal healthcare workers in under resourced rural settings. Practitioners and external development programmes should understand and recognize the value of already existing accountability mechanisms and foster social accountability approaches that allow communities as well as health workers to challenge the systemic obstacles to quality and respectful service delivery.	[Lodenstein, Elsbet; Ingemann, Christine; Molenaar, Joyce M.; Dieleman, Marjolein; Broerse, Jacqueline E. W.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands; [Lodenstein, Elsbet] KIT Gender, Royal Trop Inst, Amsterdam, Netherlands; [Dieleman, Marjolein] KIT Hlth, Royal Trop Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Lodenstein, E (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands.; Lodenstein, E (corresponding author), KIT Gender, Royal Trop Inst, Amsterdam, Netherlands.	e.lodenstein@kit.nl	Lodenstein, Elsbet/AAZ-9369-2021	Lodenstein, Elsbet/0000-0003-3379-8488; Ingemann, Christine/0000-0002-1390-4952	Fund for Global Health Policy and Health Systems Research of the Netherlands Organisation for Scientific Research (NWO/VVOTRO) [W 07.45.201]	Fund for Global Health Policy and Health Systems Research of the Netherlands Organisation for Scientific Research (NWO/VVOTRO)	This research is funded by the Fund for Global Health Policy and Health Systems Research of the Netherlands Organisation for Scientific Research (NWO/VVOTRO)(grant number W 07.45.201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AM, 2013, DEV POLICY REV, V31, pS89, DOI 10.1111/dpr.12021; Austin A, 2014, REPROD HLTH MATTE S2, V11, P1; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Bosch-Capblanch X, 2008, TROP MED INT HEALTH, V13, P369, DOI 10.1111/j.1365-3156.2008.02012.x; Bovens M, 2007, EUR LAW J, V13, P447, DOI 10.1111/j.1468-0386.2007.00378.x; Bowser D, 2010, EXPLORING EVIDENCE D; Bradley S, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-43; Centre for the Future State, 2010, UPS DOWN VIEW GOV; District Health Office, 2015, HMIS DAT ANC MAT HLT; Fox JA, 2015, WORLD DEV, V72, P346, DOI 10.1016/j.worlddev.2015.03.011; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gauri V, 2013, WORLD DEV, V41, P109, DOI 10.1016/j.worlddev.2012.05.027; Gaventa J., 2010, SYNTHESIS REPORT REV; Gaventa J, 2006, IDS BULL-I DEV STUD, V37, P23, DOI 10.1111/j.1759-5436.2006.tb00320.x; Georgakopoulou A, 2006, NARRAT INQ, V16, P122, DOI 10.1075/ni.16.1.16geo; George A, 2003, REPROD HEALTH MATTER, V11, P161, DOI 10.1016/S0968-8080(03)02164-5; Giddens A, 1984, CONSTITUTION SOC OUT; Grandvoinnet H., 2015, NEW FRONTIERS SOCIAL; Gray DE., 2014, DOING RES; Halloran B, 2015, TRANSPARENCY ACCOUNT; Hoffmann KD, 2014, ROLE SOCIAL ACCOUNTA; Hossain N., 2009, 319 IDS; Hupe P, 2007, PUBLIC ADMIN, V85, P279, DOI 10.1111/j.1467-9299.2007.00650.x; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Jones S, 2013, LOCAL PERCEPTIONS PA; Joshi A, 2014, IDS BULL-I DEV STUD, V45, P23, DOI 10.1111/1759-5436.12101; Joshi A, 2012, PUBLIC MANAG REV, V14, P145, DOI 10.1080/14719037.2012.657837; Kamwendo N., COMMUNITIES DEMANDIN; Lodenstein E, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2344-7; Lodenstein E, 2017, HEALTH POLICY PLANN, V32, P125, DOI 10.1093/heapol/czw089; Loewenson R, 2014, EQUINET HLTH CTR COM; Mackie G., 2015, WHAT ARE SOCIAL NORM; Malawi Afrobarometer; University of Malawi, 2012, CIV POL PART; Malawi Health Equity Network, 2013, HAC TRAIN MAN; Management Sciences for Health, 2010, EV MAL EM HUM RES PR; McAuliffe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058415; Ministry of Health Malawi, 2010, HUM RES HLTH COUNTR; Ministry of Health Malawi and ICF, 2014, MAL SERV PROV ASS MS; Ministry of Health Malawi and ICF International, 2014, MAL SERV PROV ASS SU; National Statistical Office, 2016, DEM HLTH SURV 2015 2, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; National Statistical Office ICF Macro, 2010, MAL DEM HLTH SURV 20; Newell Peter, 2006, RIGHTS RESOURCES POL; Nove A., 2011, MIDWIFERY MALAWI IND; OMeally SC, 2013, MAPPING CONTEXT SOCI; Riessman C. K., 2005, NARRATIVE MEMORY EVE, P1, DOI DOI 10.2307/1252124; Rosen HE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0728-4; Scharf W., 2002, ACCESS JUSTICE POOR; Stones W, 2014, LANCET, V384, P1169, DOI 10.1016/S0140-6736(14)60857-6; Tembo F., 2012, 343 ODI; Tembo F., 2013, RETHINKING SOCIAL AC; Therkildsen O, 2014, AFR-EUR GROUP INTERD, V12, P113; Tsai LL, 2007, AM POLIT SCI REV, V101, P355, DOI 10.1017/S0003055407070153; VeneKlasen L., 2007, NEW WEAVE POWER PEOP; Warren N, 2015, MIDWIFERY, V31, P1073, DOI 10.1016/j.midw.2015.07.007; White Ribbon Alliance, 2011, RESPECTFUL MATERNITY; World Health Organization, 2015, PREVENTION ELIMINATI	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195671	10.1371/journal.pone.0195671	http://dx.doi.org/10.1371/journal.pone.0195671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641612	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900084
J	Tam, P; Nijjar, AP; Fok, M; Little, C; Shingina, A; Bittman, J; Raghavan, R; Khan, NA				Tam, Penny; Nijjar, Aman P.; Fok, Mark; Little, Chris; Shingina, Alexandra; Bittman, Jesse; Raghavan, Rashmi; Khan, Nadia A.			Structured patient handoff on an internal medicine ward: A cluster randomized control trial	PLOS ONE			English	Article							IMPLEMENTATION; CURRICULUM; PROGRAM; ERRORS; SYSTEM; CARE	Background The effect of a multi-faceted handoff strategy in a high volume internal medicine inpatient setting on process and patient outcomes has not been clearly established. We set out to determine if a multi-faceted handoff intervention consisting of education, standardized handoff procedures, including fixed time and location for face-to-face handoff would result in improved rates of handoff compared with usual practice. We also evaluated resident satisfaction, health resource utilization and clinical outcomes. Methods This was a cluster randomized controlled trial in a large academic tertiary care center with 18 inpatient internal medicine ward teams from January-April 2013. We randomized nine inpatient teams to an intervention where they received an education session standardizing who and how to handoff patients, with practice and feedback from facilitators. The control group of 9 teams continued usual non-standardized handoffs. The primary process outcome was the rate of patients handed over per 1000 patient nights. Other process outcomes included perceptions of inadequate handoff by overnight physicians, resource utilization overnight and hospital length of stay. Clinical outcomes included medical errors, frequency of patients requiring higher level of care overnight, and in-hospital mortality. Results The intervention group demonstrated a significant increase in the rate of patients handed over to the overnight physician (62.90/1000 person-nights vs. 46.86/1000 person-nights, p = 0.002). There was no significant difference in other process outcomes except resource utilization was increased in the intervention group (26.35/1000 person-days vs. 17.57/1000 person-days, p-value = 0.01). There was no significant difference between groups in medical errors (4.8% vs. 4.1%), need for higher level of care or in hospital mortality. Limitations include a dependence of accurate record keeping by the overnight physician, the possibility of cross-contamination in the handoff process, analysis at the cluster level and an overall low number of clinical events. Conclusions Implementation of a multi-faceted resident handoff intervention did not result in a significant improvement in patient safety although did improve number of patients handed off. Novel methods to improve handoff need to be explored.	[Tam, Penny; Nijjar, Aman P.; Little, Chris; Bittman, Jesse; Khan, Nadia A.] Univ British Columbia, Dept Med, Div Gen Internal Med, Vancouver, BC, Canada; [Fok, Mark] Univ British Columbia, Div Geriatr Med, Dept Med, Vancouver, BC, Canada; [Shingina, Alexandra] Univ Toronto, Dept Med, Toronto, ON, Canada; [Raghavan, Rashmi] Univ British Columbia, Div Family Practice, Dept Med, Vancouver, BC, Canada; [Khan, Nadia A.] Univ British Columbia, Ctr Hlth Evaluat & Outcomes Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Toronto; University of British Columbia; University of British Columbia	Nijjar, AP (corresponding author), Univ British Columbia, Dept Med, Div Gen Internal Med, Vancouver, BC, Canada.	apnijjar@gmail.com			Canadian Medical Protective Agency [GRNT-2706]; Michael Smith Foundation for Health Research	Canadian Medical Protective Agency; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the Canadian Medical Protective Agency GRNT-2706 to PT and the Michael Smith Foundation for Health Research to NAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accreditation Council for Graduate Medical Education, COMM PROGR REQ; Allen S, 2014, ACAD MED, V89, P1366, DOI 10.1097/ACM.0000000000000462; [Anonymous], 2014, POL STAT HAND ED CAN; Bittman J, 2017, POSTGRAD MED J, V93, P313, DOI 10.1136/postgradmedj-2016-133999; Borowitz SM, 2008, QUAL SAF HEALTH CARE, V17, P6, DOI 10.1136/qshc.2006.019273; Chu ES, 2009, ACAD MED, V84, P347, DOI 10.1097/ACM.0b013e3181970829; Clanton J, 2017, AM J SURG, V213, P299, DOI 10.1016/j.amjsurg.2016.10.015; Colligan L, 2015, NEW ENGL J MED, V372, P490, DOI 10.1056/NEJMc1414788; Gakhar B, 2010, ACAD MED, V85, P1182, DOI 10.1097/ACM.0b013e3181da8370; Horwitz LI, 2007, J GEN INTERN MED, V22, P1470, DOI 10.1007/s11606-007-0331-0; Johnson David P, 2015, Hosp Pediatr, V5, P154, DOI 10.1542/hpeds.2014-0050; *JOINT COMM, 2009 HOSP NAT PAT SA; Pattani R, 2014, CAN MED ASSOC J, V186, P761, DOI 10.1503/cmaj.131053; Payne CE, 2012, BMJ QUAL SAF, V21, P925, DOI 10.1136/bmjqs-2011-000308; Rayar M, 2014, 2014 CAN C MED ED OT; Riebschleger M, ACGME ENHANCING QUAL; Riesenberg LA, 2009, ACAD MED, V84, P1775, DOI 10.1097/ACM.0b013e3181bf51a6; Schouten WM, 2015, J HOSP MED, V10, P137, DOI 10.1002/jhm.2293; Starmer AJ, 2014, NEW ENGL J MED, V371, P1803, DOI 10.1056/NEJMsa1405556; Starmer AJ, 2013, JAMA-J AM MED ASSOC, V310, P2262, DOI 10.1001/jama.2013.281961; Starmer AJ, 2012, PEDIATRICS, V129, P201, DOI 10.1542/peds.2011-2966; Van Eaton EG, 2005, J AM COLL SURGEONS, V200, P538, DOI 10.1016/j.jamcollsurg.2004.11.009; WHO, 2010, HIGH 5S PROJ ACT PAT	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195216	10.1371/journal.pone.0195216	http://dx.doi.org/10.1371/journal.pone.0195216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672526	Green Submitted, Green Published, gold			2022-12-27	WOS:000430446800023
J	Li, WY; Luo, XJ; Liu, ZY; Chen, YQ; Li, ZH				Li, Wenyi; Luo, Xujun; Liu, Zhongyue; Chen, Yanqiao; Li, Zhihong			Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; TO-LYMPHOCYTE RATIO; POOR SURVIVAL; NEUTROPHIL; INDICATOR; PLATELET	Objective The aim of this study was to conduct a meta-analysis of retrospective studies that investigated the association of preoperative C-reactive protein (CRP) levels with the overall survival (OS) of patients with bone neoplasms. Methods A detailed literature search was performed in the Cochrane Library, Web of Science, Embase and PubMed databases up to August 28, 2017, for related research publications written in English. We extracted the data from these studies and combined the hazard ratios (HR) and 95% confidence intervals (CIs) to assess the correlation between CRP levels and OS in patients with bone neoplasms. Results Five studies with a total of 816 participants from several countries were enrolled in this current meta-analysis. In a pooled analysis of all the publications, increased serum CRP levels had an adverse prognostic effect on the overall survival of patients with bone neoplasms. However, the combined data showed no significant relationship between the level of CRP and OS in Asian patients (HR = 1.73; 95% CI: 0.86-3.49; P = 0.125). Similar trends were observed in patients with bone neoplasms when stratified by ethnicity, histology, metastasis and study sample size. Conclusions The results of this meta-analysis suggest that increased CRP expression indicates a poorer prognosis in patients with bone neoplasms. More prospective studies are needed to confirm the prognostic significance of CRP levels in patients with bone neoplasms.	[Li, Wenyi; Luo, Xujun; Liu, Zhongyue; Li, Zhihong] Cent South Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China; [Chen, Yanqiao] Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Li, ZH (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China.	lizhihong@csu.edu.cn			National Natural Science Foundation of China [81372180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China grant no. 81372180 to Z. Li. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Natural Science Foundation of China (No.81372180).	Aggerholm-Pedersen N, 2016, TRANSL ONCOL, V9, P322, DOI 10.1016/j.tranon.2016.05.006; Alifano M, 2011, J THORAC CARDIOV SUR, V142, P1161, DOI 10.1016/j.jtcvs.2011.07.021; Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; Eggers H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0705-6; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Evola FR, 2017, FRONT PHARMACOL, P8; Funovics PT, 2011, INT ORTHOP, V35, P1529, DOI 10.1007/s00264-011-1208-8; Gagnon B, 2010, BRIT J CANCER, V102, P1113, DOI 10.1038/sj.bjc.6605603; Gakis G, 2011, BJU INT, V108, P1800, DOI 10.1111/j.1464-410X.2011.10234.x; Gockel I, 2006, WORLD J GASTROENTERO, V12, P3746, DOI 10.3748/wjg.v12.i23.3746; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Hefler LA, 2008, CLIN CANCER RES, V14, P710, DOI 10.1158/1078-0432.CCR-07-1044; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Howlader N, 2017, SEER CANC STAT REV; Johnson T, 2011, CRP BASED CLASSIFICA, pe667; Kinoshita A, 2012, MED ONCOL, V29, P2800, DOI 10.1007/s12032-012-0220-1; Kos M, 2016, WIEN KLIN WOCHENSCHR, V128, P635, DOI 10.1007/s00508-015-0724-8; Lamb GWA, 2006, BRIT J CANCER, V94, P781, DOI 10.1038/sj.bjc.6603034; Lan HD, 2017, ONCOTARGET, V8, P35301, DOI 10.18632/oncotarget.13312; Li XC, 2015, TUMOR BIOL, V36, P5663, DOI 10.1007/s13277-015-3240-6; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064158; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39862; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Morris-Stiff G, 2008, EJSO-EUR J SURG ONC, V34, P727, DOI 10.1016/j.ejso.2008.01.016; Muir KW, 1999, STROKE, V30, P981, DOI 10.1161/01.STR.30.5.981; Nakamura T, 2013, BONE JOINT J, V95B, P411, DOI 10.1302/0301-620X.95B3.30344; Nozoe T, 2001, AM J SURG, V182, P197, DOI 10.1016/S0002-9610(01)00684-5; O'Rourke K, 2001, APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY: WITH CASE STUDIES USING S-PLUS, P397; Oh BS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-78; Prins RC, 2012, UROL ONCOL-SEMIN ORI, P22, DOI [10.18632/oncotarget.12601, DOI 10.18632/ONCOTARGET.12601]; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Qian BZ, 2017, SEMIN CANCER BIOL, V47, P170, DOI 10.1016/j.semcancer.2017.08.006; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Sanchez-Salcedo P, 2016, LUNG CANCER, V97, P28, DOI 10.1016/j.lungcan.2016.04.010; Shao N, 2015, TUMOR BIOL, V36, P8465, DOI 10.1007/s13277-015-3611-z; Su KJ, 2016, INT J CLIN EXP MED, V9, P16353; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701; Thomsen M, 2016, ONCOTARGET, V7, P75013, DOI 10.18632/oncotarget.12601; TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561; Tomita M, 2012, ANTICANCER RES, V32, P3535; Wang X, 2016, ONCOTARGETS THER, V9, P5761, DOI 10.2147/OTT.S106296; Yi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094632; Zhou F, 2017, ONCOTARGET, V8, P100384, DOI 10.18632/oncotarget.22233	51	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195769	10.1371/journal.pone.0195769	http://dx.doi.org/10.1371/journal.pone.0195769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668751	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200056
J	Sheffield, PE; Speranza, R; Chiu, YHM; Hsu, HHL; Curtin, PC; Renzetti, S; Pajak, A; Coull, B; Schwartz, J; Kloog, I; Wright, RJ				Sheffield, Perry E.; Speranza, Rosa; Chiu, Yueh-Hsiu Mathilda; Hsu, Hsiao-Hsien Leon; Curtin, Paul C.; Renzetti, Stefano; Pajak, Ashley; Coull, Brent; Schwartz, Joel; Kloog, Itai; Wright, Rosalind J.			Association between particulate air pollution exposure during pregnancy and postpartum maternal psychological functioning	PLOS ONE			English	Article							POSTNATAL DEPRESSION SCALE; WOMEN; COMMUNITY; SYMPTOMS; ANXIETY; STRESS; PREVALENCE; PREDICTORS; ANHEDONIA; DISEASE	Postpartum psychological functioning impacts both women's health and outcomes in children. Lower income, ethnic minority women may be at particular risk for adverse postpartum mental health outcomes. Studies link ambient air pollution exposure with psychological dysfunction in adults although this association has not been examined among postpartum women. Methods We studied associations between prenatal exposure to particulate matter with diameter <= 2.5 pm (PM2.5) and postpartum psychological functioning in a lower income, ethnically mixed sample of urban US women enrolled in a pregnancy cohort study. Analyses included 557 mothers who delivered at >= 37 weeks gestation. Daily estimates of residential PM2.5 over gestation were derived using a satellite-based spatio-temporally resolved model. Outcomes included the Edinburgh Postnatal Depression Scale (EPDS) score from 6 or 12 months postpartum and subscale scores for anhedonia, depressive and anxiety symptoms. Associations were also examined within racial/ethnic groups. Distributed lag models (DLMs) were implemented to identify windows of vulnerability during pregnancy. Results Most mothers had less than a high school education (64%) and were primarily Hispanic (55%) and Black (29%). In the overall sample, a DLM adjusted for age, race, education, prenatal smoking, and season of delivery, we found significant associations between higher PM2.5 exposure in the second trimester and increased anhedonia subscale scores postpartum. In race stratified analyses, mid-pregnancy PM2.5 exposure was significantly associated with increased total EPDS scores as well as higher anhedonia and depressive symptom subscale scores among Black women. Conclusions Increased PM2.5 exposure in mid-pregnancy was associated with increased depressive and anhedonia symptoms, particularly in Black women.	[Sheffield, Perry E.; Chiu, Yueh-Hsiu Mathilda; Hsu, Hsiao-Hsien Leon; Curtin, Paul C.; Pajak, Ashley] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Sheffield, Perry E.; Chiu, Yueh-Hsiu Mathilda; Wright, Rosalind J.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Sheffield, Perry E.; Wright, Rosalind J.] Icahn Sch Med Mt Sinai, Inst Expos Res, New York, NY 10029 USA; [Speranza, Rosa] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA; [Renzetti, Stefano] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Brescia, Italy; [Coull, Brent; Schwartz, Joel] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Kloog, Itai] Ben Gurion Univ Negev, Dept Geog & Environm Dev, Fac Humanities & Social Sci, Beer Sheva, Israel	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Oregon Health & Science University; University of Brescia; Harvard University; Harvard T.H. Chan School of Public Health; Ben Gurion University	Sheffield, PE (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.; Sheffield, PE (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.; Sheffield, PE (corresponding author), Icahn Sch Med Mt Sinai, Inst Expos Res, New York, NY 10029 USA.	perry.sheffield@mssm.edu		Renzetti, Stefano/0000-0002-4467-765X; Chiu, Yueh-Hsiu Mathilda/0000-0003-1656-660X; Sheffield, Perry/0000-0001-9156-1193; Hsu, Hsiao-Hsien/0000-0001-8704-197X	National Institutes of Health [R01 ES010932, U01 HL072494, R21ES021318, R01 HL080674]; NIH [P30 ES023515, P30 ES000002, K23 ES024127]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080674, U01HL072494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R21ES021318, K23ES024127, P30ES023515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Asthma Coalition on Community, Environment, and Social Stress (ACCESS) project has been funded by the National Institutes of Health [grant numbers R01 ES010932, U01 HL072494, R21ES021318, and R01 HL080674 (Wright RJ, PI)], and phenotyping and biostatistical support was funded by the NIH [grant numbers P30 ES023515 and P30 ES000002]. During preparation of this manuscript, PS was supported by the NIH [grant number K23 ES024127]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Backes CH, 2013, TOXICOL LETT, V216, P47, DOI 10.1016/j.toxlet.2012.11.007; Chiu YHM, 2017, ARCH WOMEN MENT HLTH, V20, P803, DOI 10.1007/s00737-017-0765-2; Cho J, 2014, J AFFECT DISORDERS, V157, P45, DOI 10.1016/j.jad.2014.01.002; Clark C, 2008, J URBAN HEALTH, V85, P22, DOI 10.1007/s11524-007-9229-8; Coates R, 2017, PSYCHOL ASSESSMENT, V29, P1016, DOI 10.1037/pas0000397; Costa Lucio G, 2014, Biomed Res Int, V2014, P736385, DOI 10.1155/2014/736385; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cunningham NK, 2015, ARCH WOMEN MENT HLTH, V18, P793, DOI 10.1007/s00737-014-0485-9; Entringer S, 2010, STRESS, V13, P258, DOI 10.3109/10253890903349501; Frumkin H., 2022, J CLIMATE CHANGE HLT, V5, DOI [10.1016/j.joclim.2022.100115, DOI 10.1016/J.JOCLIM.2022.100115]; Fung J, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0428-7; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Grevendonk L, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0095-2; Hartley CM, 2014, J CLIN PSYCHOL, V70, P1240, DOI 10.1002/jclp.22101; Hou RH, 2017, BRAIN BEHAV IMMUN, V62, P212, DOI 10.1016/j.bbi.2017.01.021; Howell EA, 2005, OBSTET GYNECOL, V105, P1442, DOI 10.1097/01.AOG.0000164050.34126.37; Hsu HHL, 2015, AM J RESP CRIT CARE, V192, P1052, DOI 10.1164/rccm.201504-0658OC; Kanazawa Asako, 2007, Cultur Divers Ethnic Minor Psychol, V13, P35, DOI 10.1037/1099-9809.13.1.35; King PAL, 2012, ARCH WOMEN MENT HLTH, V15, P77, DOI 10.1007/s00737-012-0260-8; Kloog I, 2014, ATMOS ENVIRON, V95, P581, DOI 10.1016/j.atmosenv.2014.07.014; Lim YH, 2012, ENVIRON HEALTH PERSP, V120, P1023, DOI 10.1289/ehp.1104100; Liu CH, 2014, EPIDEMIOL PSYCH SCI, V23, P201, DOI 10.1017/S2045796013000413; Mokoena ML, 2015, PSYCHOPHARMACOLOGY, V232, P2921, DOI 10.1007/s00213-015-3928-8; Oudin A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010004; Pan Z, CURR PHARM DESIGN, DOI [10.1289/ehp.1408549, DOI 10.1289/EHP.1408549]; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Pawluski JL, 2017, TRENDS NEUROSCI, V40, P106, DOI 10.1016/j.tins.2016.11.009; Posillico CK, 2016, BEHAV BRAIN RES, V298, P218, DOI 10.1016/j.bbr.2015.11.011; Power MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1111; Pun VC, 2017, ENVIRON HEALTH PERSP, V125, P342, DOI 10.1289/EHP494; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Rier Sherry E, 2008, Fertil Steril, V89, pe103, DOI 10.1016/j.fertnstert.2007.12.040; Saenen ND, 2015, ENVIRON HEALTH PERSP, V123, P834, DOI 10.1289/ehp.1408549; Salimi S, 2015, J SUBST ABUSE TREAT, V56, P34, DOI 10.1016/j.jsat.2015.03.004; Sibitz I, 2010, J AFFECT DISORDERS, V126, P245, DOI 10.1016/j.jad.2010.03.023; Stewart DE, 2016, NEW ENGL J MED, V375, P2177, DOI 10.1056/NEJMcp1607649; Sylven SM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.022; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Vigod SN, 2010, BJOG-INT J OBSTET GY, V117, P540, DOI 10.1111/j.1471-0528.2009.02493.x; Weetman AP, 2010, NAT REV ENDOCRINOL, V6, P311, DOI 10.1038/nrendo.2010.46; Wilson A, 2017, AM J EPIDEMIOL, V186, P1281, DOI 10.1093/aje/kwx184; Wright RJ, 2008, CIENC SAUDE COLETIVA, V13, P1729, DOI 10.1590/S1413-81232008000600008; Zhang X, 2015, INT J ENV RES PUB HE, V12, P15692, DOI 10.3390/ijerph121215011	44	24	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195267	10.1371/journal.pone.0195267	http://dx.doi.org/10.1371/journal.pone.0195267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668689	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200036
J	Igarashi, Y; Tagami, T; Hagiwara, J; Kanaya, T; Kido, N; Omura, M; Tosa, R; Yokota, H				Igarashi, Yutaka; Tagami, Takashi; Hagiwara, Jun; Kanaya, Takahiro; Kido, Norihiro; Omura, Mariko; Tosa, Ryoichi; Yokota, Hiroyuki			Long-term outcomes of patients evacuated from hospitals near the Fukushima Daiichi nuclear power plant after the Great East Japan Earthquake	PLOS ONE			English	Article							HURRICANE-KATRINA; DISASTER RESPONSE; TRAUMA CENTER; LESSONS; CARE; EMERGENCY; ACCIDENT	Introduction After the accident of the Fukushima Daiichi nuclear power plant due to the Great East Japan Earthquake in March 2011, the Japanese government issued a mandatory evacuation order for people living within a 20 km radius of the nuclear power plant. The aim of the current study was to investigate long-term outcomes of these patients and identify factors related to mortality. Materials and methods Patients who were evacuated from hospitals near the Fukushima Daiichi nuclear power plant to the Aizu Chuo Hospital from 15 to 26 March, 2011 were included in this study. The following data were collected from medical records: age, sex, activities of daily life, hospital they were admitted in at the time of earthquake, distance between the facility and the nuclear power plant, reasons of evacuation and number of transfers. The patient outcomes were collected from medical records and/or investigated on the telephone in January 2012. Results A total of 97 patients (28 men and 69 women) were transferred from 10 hospitals via ambulances or buses. No patients died or experienced exacerbation during transfer. Median age of the patients was 86 years. Of the total, 36 patients were not able to obey commands, 44 were bed-ridden and 61 were unable to sustain themselves via oral intake of food. Among 86 patients who were followed-up, 41 (48%) died at the end of 2011. Multiple-regression analysis showed that non-oral intake [Hazard Ratio (HR): 6.07, 95% Confidence interval (CI): 1.94 +/- 19.0] and male sex [HR: 8.35, 95% CI: 2.14 +/- 32.5] had significant impact on mortality. Conclusion This study found that 48% of the evacuated patients died 9 months after the earthquake and they had significantly higher mortality rate than the nursing home residents. Non-oral intake and male sex had significant impact on mortality. These patients should be considered as especially vulnerable in case of hospital evacuation.	[Igarashi, Yutaka; Hagiwara, Jun; Kanaya, Takahiro; Yokota, Hiroyuki] Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Tagami, Takashi] Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore; [Tagami, Takashi] Nippon Med Sch, Tama Nagayama Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Kido, Norihiro] Nippon Med Sch, Musashi Kosugi Hosp, Dept Emergency & Crit Care Med, Kawasaki, Kanagawa, Japan; [Omura, Mariko; Tosa, Ryoichi] Aizu Chuo Hosp, Dept Emergency & Crit Care Med, Fukushima, Japan; [Igarashi, Yutaka] Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo, Japan	Nippon Medical School; National University of Singapore; Nippon Medical School; Nippon Medical School; Nippon Medical School	Igarashi, Y (corresponding author), Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan.; Igarashi, Y (corresponding author), Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo, Japan.		Tagami, Takashi/HGA-3038-2022	Tagami, Takashi/0000-0001-6953-1932				Adini B, 2012, J PUBLIC HEALTH POL, V33, P257, DOI 10.1057/jphp.2012.2; [Anonymous], 2007, ED Manag, V19, P37; Augustine Jim, 2005, Disaster Manag Response, V3, P68, DOI 10.1016/j.dmr.2005.05.005; Barnett J, 2009, ORTHOP NURS, V28, P17, DOI 10.1097/01.NOR.0000345849.32424.0a; Bernard M, 2008, MCN-AM J MATERN-CHIL, V33, P213, DOI 10.1097/01.NMC.0000326075.03999.11; Brevard SB, 2008, J TRAUMA, V65, P1126, DOI 10.1097/TA.0b013e318188d6e5; Burgess JL, 1999, AM J EMERG MED, V17, P50, DOI 10.1016/S0735-6757(99)90016-5; Chavez C W, 1996, J Emerg Med, V14, P445, DOI 10.1016/0736-4679(96)00083-2; Cocanour CS, 2002, ARCH SURG-CHICAGO, V137, P1141, DOI 10.1001/archsurg.137.10.1141; DOSA D, 2012, J AM MED DIR ASSOC, V13; Gallagher JJ, 2006, J BURN CARE RES, V27, P596, DOI 10.1097/01.BCR.0000235462.17349.03; Gautam S, 2009, DISASTER MED PUBLIC, V3, P144, DOI 10.1097/DMP.0b013e3181b9db91; Gray BH, 2007, J HEALTH CARE POOR U, V18, P283, DOI 10.1353/hpu.2007.0031; Henderson J, 1998, Nurs BC, V30, P18; HENRY S, 1980, CAN MED ASSOC J, V122, P582; Hogan Catherine, 2002, AORN J, V75, P793, DOI 10.1016/S0001-2092(06)61635-9; Kawakami Y, 2012, RESP CARE, V57, P1674, DOI 10.4187/respcare.01701; Lai TI, 2003, ACAD EMERG MED, V10, P1109, DOI 10.1197/S1069-6563(03)00368-3; Little M, 2012, ACAD EMERG MED, V19, pE1088, DOI 10.1111/j.1553-2712.2012.01439.x; Martchenke J, 1994, Prehosp Disaster Med, V9, P146; MAXWELL C, 1982, AM J PUBLIC HEALTH, V72, P275, DOI 10.2105/AJPH.72.3.275; Maybauer DM, 2009, ANAESTHESIST, V58, P1244, DOI 10.1007/s00101-009-1643-8; Murakami M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137906; Nakagawa I, 2009, HEART, V95, P2009, DOI 10.1136/hrt.2009.174201; Nates JL, 2004, CRIT CARE MED, V32, P686, DOI 10.1097/01.CCM.0000114995.14120.6D; Nomura S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010080; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Ogawa K, 2000, INT J EPIDEMIOL, V29, P449, DOI 10.1093/ije/29.3.449; Okie S, 2008, NEW ENGL J MED, V358, P1, DOI 10.1056/NEJMp0707917; Perrin K, 2006, PEDIATRICS, V117, pS381, DOI 10.1542/peds.2006-0099H; Schultz CH, 2003, NEW ENGL J MED, V348, P1349, DOI 10.1056/NEJMsa021807; Seale GS, 2010, REHABIL PSYCHOL, V55, P247, DOI 10.1037/a0020599; Sexton KH, 2007, ACAD MED, V82, P792, DOI 10.1097/ACM.0b013e3180d096b9; Siders C, 1998, J Healthc Risk Manag, V18, P33; Tagami T, 2012, CIRCULATION, V126, P589, DOI 10.1161/CIRCULATIONAHA.111.086173; Tanigawa K, 2012, LANCET, V379, P889, DOI 10.1016/S0140-6736(12)60384-5; Taylor Ian L, 2007, Trans Am Clin Climatol Assoc, V118, P69; Thomas J, 2008, J PSYCHOSOC NURS MEN, V46, P35, DOI 10.3928/02793695-20080101-13; Yanagawa Y, 2011, PREHOSP DISASTER MED, V26, P391, DOI 10.1017/S1049023X11006418	39	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195684	10.1371/journal.pone.0195684	http://dx.doi.org/10.1371/journal.pone.0195684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664960	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300027
J	Michel, G; Blery, P; Henoux, M; Guicheux, J; Weiss, P; Dugast, E; Brouard, S; Malard, O; Espitalier, F				Michel, Guillaume; Blery, Pauline; Henoux, Michael; Guicheux, Jerome; Weiss, Pierre; Dugast, Emilie; Brouard, Sophie; Malard, Olivier; Espitalier, Florent			Bone marrow cell extract promotes the regeneration of irradiated bone (vol 12, e0178060, 2017)	PLOS ONE			English	Correction									[Michel, Guillaume; Henoux, Michael; Malard, Olivier; Espitalier, Florent] CHU Nantes, Serv ORL & Chirurg Cervicofaciale, Nantes, France; [Michel, Guillaume; Blery, Pauline; Henoux, Michael; Guicheux, Jerome; Weiss, Pierre; Malard, Olivier; Espitalier, Florent] Univ Nantes, INSERM, UMRS 791, LIOAD, Nantes, France; [Michel, Guillaume; Blery, Pauline; Henoux, Michael; Guicheux, Jerome; Weiss, Pierre; Malard, Olivier; Espitalier, Florent] CHU Nantes, OTONN PHU4, Nantes, France; [Blery, Pauline; Weiss, Pierre] CHU Nantes, Serv Odontol Restauratrice & Chirurg, Nantes, France; [Dugast, Emilie; Brouard, Sophie] Univ Nantes, INSERM UMR 1064, ITUN, Nantes, France; [Dugast, Emilie; Brouard, Sophie] CHU Nantes, Lab Immunol CIMNA, Nantes, France	Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Michel, G (corresponding author), CHU Nantes, Serv ORL & Chirurg Cervicofaciale, Nantes, France.; Michel, G (corresponding author), Univ Nantes, INSERM, UMRS 791, LIOAD, Nantes, France.; Michel, G (corresponding author), CHU Nantes, OTONN PHU4, Nantes, France.		Bléry, Pauline/P-6279-2014; guicheux, Jerome/F-7767-2013; Malard, Olivier/A-4742-2012; WEISS, Pierre/AAE-9260-2020; Weiss, Pierre/P-1372-2014; Espitalier, Florent/P-6582-2014	guicheux, Jerome/0000-0003-2754-3024; Malard, Olivier/0000-0003-1783-5066; WEISS, Pierre/0000-0002-6159-8590; Weiss, Pierre/0000-0002-6159-8590; Dugast, Emilie/0000-0001-7439-1903				Michel G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178060	1	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196145	10.1371/journal.pone.0196145	http://dx.doi.org/10.1371/journal.pone.0196145			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664946	Green Published, gold			2022-12-27	WOS:000430262300057
J	Andriessen, P; Zwanenburg, A; van Laar, JOEH; Vullings, R; Hermans, BM; Niemarkt, HJ; Jellema, RK; Ophelders, DRMG; Wolfs, TGAM; Kramer, BW; Delhaas, T				Andriessen, Peter; Zwanenburg, Alex; van Laar, Judith O. E. H.; Vullings, Rik; Hermans, Ben J. M.; Niemarkt, Hendrik J.; Jellema, Reint K.; Ophelders, Daan R. M. G.; Wolfs, Tim G. A. M.; Kramer, Boris W.; Delhaas, Tammo			ST waveform analysis for monitoring hypoxic distress in fetal sheep after prolonged umbilical cord occlusion	PLOS ONE			English	Article							HEART-RATE; ANIMAL-MODELS; ECG; ELECTROCARDIOGRAM; LABOR; ISCHEMIA; PATTERNS; INSIGHTS; SEGMENT; INJURY	Introduction The inconclusive clinical results for ST-waveform analysis (STAN) in detecting fetal hypoxemia may be caused by the signal processing of the STAN-device itself. We assessed the performance of a clinical STAN device in signal processing and in detecting hypoxemia in a fetal sheep model exposed to prolonged umbilical cord occlusion (UCO). Methods Eight fetal lambs were exposed to 25 minutes of UCO. ECG recordings were analyzed during a baseline period and during UCO. STAN-event rates and timing of episodic T/QRS rise, baseline T/QRS rise and the occurrence of biphasic ST-waveforms, as well as signal loss, were assessed. Results During baseline conditions of normoxemia, a median of 40 (IQR, 25-70) STAN-events per minute were detected, compared to 10 (IQR, 2-22) during UCO. During UCO STAN-events were detected in five subjects within 10 minutes and in six subjects after 18 minutes, respectively. Two subjects did not generate any STAN-event during UCO. Biphasic ST event rate was reduced during UCO (median 0, IQR 0-5), compared to baseline (median 32, IQR, 6-55). ST-waveforms could not be assessed in 62% of the recording time during UCO, despite a good quality of the ECG signal. Conclusions The STAN device showed limitations in detecting hypoxemia in fetal sheep after prolonged UCO. The STAN device produced high false positive event rates during baseline and did not detect T/QRS changes adequately after prolonged fetal hypoxemia. During 14% of baseline and 62% of the UCO period, the STAN-device could not process the ECG signal, despite its good quality. Resolving these issues may improve the clinical performance of the STAN device.	[Andriessen, Peter; Niemarkt, Hendrik J.; Jellema, Reint K.] Maxima Med Ctr, Dept Pediat, Veldhoven, Netherlands; [Andriessen, Peter; Jellema, Reint K.; Ophelders, Daan R. M. G.; Wolfs, Tim G. A. M.; Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Zwanenburg, Alex; Hermans, Ben J. M.; Wolfs, Tim G. A. M.; Delhaas, Tammo] Maastricht Univ, Dept Biomed Engn, Maastricht, Netherlands; [Zwanenburg, Alex; Delhaas, Tammo] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Zwanenburg, Alex; Ophelders, Daan R. M. G.; Wolfs, Tim G. A. M.; Kramer, Boris W.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Laar, Judith O. E. H.] Maxima Med Ctr, Dept Obstet & Gynecol, Veldhoven, Netherlands; [Vullings, Rik] Eindhoven Univ Technol, Dept Elect Engn, Signal Proc Syst Grp, Eindhoven, Netherlands	Maxima Medical Center; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maxima Medical Center; Eindhoven University of Technology	Andriessen, P (corresponding author), Maxima Med Ctr, Dept Pediat, Veldhoven, Netherlands.; Andriessen, P (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands.	p.andriessen@mmc.nl	Kramer, Boris/AAO-3183-2021; Jellema, Reint/AAW-1214-2020; Zwanenburg, Alex/AAF-6476-2020; Hermans, Ben/AAN-4280-2020; Vullings, Rik/GQP-6225-2022; Niemarkt, Hendrik/AAN-5063-2020	Jellema, Reint/0000-0002-6918-0930; Zwanenburg, Alex/0000-0002-0342-9545; Hermans, Ben/0000-0001-7780-4427; Vullings, Rik/0000-0002-2392-6098; Niemarkt, Hendrik/0000-0002-0844-7208; Wolfs, Tim/0000-0003-4417-4144; Ophelders, Daan/0000-0001-7410-5102; Andriessen, Peter/0000-0002-5159-6874				Alfirevic Z, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub3; Amer-Wahlin I, 2005, EUR CLIN OBSTET GYNA, V1, P61; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; BALL RH, 1992, AM J OBSTET GYNECOL, V166, P1683, DOI 10.1016/0002-9378(92)91557-Q; Becker JH, 2015, ACTA OBSTET GYN SCAN, V94, P175, DOI 10.1111/aogs.12548; Becker JH, 2012, ACTA OBSTET GYN SCAN, V91, P189, DOI 10.1111/j.1600-0412.2011.01320.x; Belfort MA, 2015, NEW ENGL J MED, V373, P632, DOI 10.1056/NEJMoa1500600; Bennet L, 2009, CLIN PERINATOL, V36, P655, DOI 10.1016/j.clp.2009.06.009; Doria V, 2007, BJOG-INT J OBSTET GY, V114, P1202, DOI 10.1111/j.1471-0528.2007.01480.x; GREENE KR, 1982, AM J OBSTET GYNECOL, V144, P950, DOI 10.1016/0002-9378(82)90190-9; Gunn AJ, 2009, CLIN PERINATOL, V36, P579, DOI 10.1016/j.clp.2009.06.007; Jellema RK, 2013, EXP NEUROL, V250, P293, DOI 10.1016/j.expneurol.2013.09.026; Jellema RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073031; Jellema RK, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-13; Anneke K, 2007, EUR J OBSTET GYN R B, V135, P28, DOI 10.1016/j.ejogrb.2006.10.022; LILJA H, 1984, J PERINAT MED, V12, P115, DOI 10.1515/jpme.1984.12.3.115; Melin M, 2008, BJOG-INT J OBSTET GY, V115, P1669, DOI 10.1111/j.1471-0528.2008.01949.x; Neilson JP., 2013, COCHRANE DB SYST REV, V3; Remme CA, 2001, J CARDIOVASC PHARM, V38, P406, DOI 10.1097/00005344-200109000-00009; Rosen KG, 2004, BEST PRACT RES CL OB, V18, P485, DOI 10.1016/j.bpobgyn.2004.02.008; ROSEN KG, 1976, BIOL NEONATE, V30, P17; ROSEN KG, 1975, ACTA PHYSIOL SCAND, V93, P59, DOI 10.1111/j.1748-1716.1975.tb05790.x; Salmelin A, 2013, ACTA OBSTET GYN SCAN, V92, P28, DOI 10.1111/aogs.12009; Verdurmen KMJ, 2016, EUR J OBSTET GYN R B, V207, P243, DOI 10.1016/j.ejogrb.2016.10.030; Vullings R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175823; Wassink G, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/314159; Welin AK, 2005, ACTA OBSTET GYN SCAN, V84, P122, DOI 10.1111/j.0001-6349.2005.00594.x; Westerhuis MEMH, 2007, BJOG-INT J OBSTET GY, V114, P1194, DOI 10.1111/j.1471-0528.2007.01236.x; Zwanenburg A, 2016, PEDIATR RES, V79, P907, DOI 10.1038/pr.2016.21	29	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195978	10.1371/journal.pone.0195978	http://dx.doi.org/10.1371/journal.pone.0195978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659625	gold, Green Submitted, Green Published			2022-12-27	WOS:000430061100045
J	Kawakita, N; Uri, K; Miyoshi, T; Kohno, K; Nakahama, M; Doi, M; Munemasa, M; Murakami, M; Nakamura, K; Ito, H				Kawakita, Norifumi; Uri, Kentaro; Miyoshi, Toru; Kohno, Kunihisa; Nakahama, Makoto; Doi, Masayuki; Munemasa, Mitsuru; Murakami, Masaaki; Nakamura, Kazufumi; Ito, Hiroshi		RINC Investigators	Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC)	PLOS ONE			English	Article							CREATINE-KINASE-MB; CARDIAC TROPONIN-I; MICROVASCULAR DYSFUNCTION; CRISP STENT; ELEVATION; INFARCTION; CHANNELS; OUTCOMES; MARKERS; IMPACT	Background Our previous study examined an effect of remote ischemic preconditioning (RIPC) or intravenous nicorandil on reduction of periprocedural myocardial injury (pMI) following percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD). We further investigated the effect of RIPC or nicorandil on pMI in older patients. Methods Patients with stable CAD who planned to undergo PCI were assigned to a 1:1:1 ratio to control, intravenous nicorandil, or upper-limb RIPC groups. This substudy analyzed patients aged >65 years (n = 282) from the principal cohort. The primary outcome was the incidence of pMI following PCI. We defined pMI as an elevated level of high-sensitive cardiac troponin T or creatine kinase myocardial band 12 or 24 hours after PCI. Results We found that pMI following PCI was significantly reduced in the nicorandil group compared with the control group (37.2% vs. 53.7%, multiplicity-adjusted p = 0.046), but not in the RIPC group compared with the control group (43.0% vs. 53.7%, multiplicity-adjusted p = 0.245). The adjusted odds ratios (95% confidence interval) for pMI in the RIPC and nicorandil groups versus the control group were 0.63 (0.34 to 1.16) and 0.51 (0.27 to 0.96), respectively. Conclusion Intravenous nicorandil significantly reduces pMI following PCI in a subgroup of older patients with stable CAD. Phase 3 trials are required to validate our results.	[Kawakita, Norifumi; Uri, Kentaro; Miyoshi, Toru; Kohno, Kunihisa; Nakamura, Kazufumi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dens & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan; [Nakahama, Makoto] Fukuyama City Hosp, Dept Cardiol, Hiroshima, Japan; [Doi, Masayuki] Kagawa Prefectural Cent Hosp, Dept Cardiol, Takamatsu, Kagawa, Japan; [Munemasa, Mitsuru] Okayama Med Ctr, Dept Cardiol, Okayama, Japan; [Murakami, Masaaki] Okayama Heart Clin, Dept Cardiol, Okayama, Japan	Okayama University	Miyoshi, T (corresponding author), Okayama Univ, Grad Sch Med Dens & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan.	miyoshit@cc.okayama-u.ac.jp		Miyoshi, Toru/0000-0002-9039-3439	Okayama Medical Foundation; Chugai Pharmaceutical Co.	Okayama Medical Foundation; Chugai Pharmaceutical Co.	This study was funded by the Okayama Medical Foundation, http://omf.umin.ac.jp. TM received honorarium from Chugai Pharmaceutical Co. HI received a research grant and honorarium from Chugai Pharmaceutical Co. The funder provided support in the form of salaries for authors [TM and HI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed RM, 2013, CATHETER CARDIO INTE, V82, pE647, DOI 10.1002/ccd.24825; Cavallini C, 2005, EUR HEART J, V26, P1494, DOI 10.1093/eurheartj/ehi173; Davies WR, 2013, CIRC-CARDIOVASC INTE, V6, P246, DOI 10.1161/CIRCINTERVENTIONS.112.000184; Feldman DN, 2011, CATHETER CARDIO INTE, V77, P1020, DOI 10.1002/ccd.22962; Fuchs S, 1999, J AM COLL CARDIOL, V34, P1704, DOI 10.1016/S0735-1097(99)00434-9; Fujiwara H, 2013, CIRC J, V77, P1590, DOI 10.1253/circj.CJ-66-0065; Garg V, 2007, AM J PHYSIOL-HEART C, V293, pH322, DOI 10.1152/ajpheart.01035.2006; Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Higuchi Y, 2014, INT HEART J, V55, P391, DOI 10.1536/ihj.14-005; Hirohata A, 2014, EUROINTERVENTION, V9, P50, DOI 10.4244/EIJV919A178; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Hwang J, 2013, J CARDIOL, V62, P77, DOI 10.1016/j.jjcc.2013.03.017; Isono T, 2008, INT J CARDIOL, V123, P123, DOI 10.1016/j.ijcard.2006.11.219; Ito N, 2013, CARDIOVASC DRUG THER, V27, P279, DOI 10.1007/s10557-013-6456-y; Kawai Y, 2009, EUR HEART J, V30, P765, DOI 10.1093/eurheartj/ehp077; Kim S, 2011, APPL WATER SCI, V1, P11, DOI 10.1007/s13201-011-0003-4; Kizer JR, 2003, EUR HEART J, V24, P1314, DOI 10.1016/S0195-668X(03)00258-6; Lansky AJ, 2010, CIRC-CARDIOVASC INTE, V3, P602, DOI 10.1161/CIRCINTERVENTIONS.110.959080; Lavi S, 2014, CIRC-CARDIOVASC INTE, V7, P225, DOI 10.1161/CIRCINTERVENTIONS.113.000948; Lee JM, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002857; Li J, 2014, CARDIOLOGY, V127, P133, DOI 10.1159/000355574; Luo SJ, 2013, CAN J CARDIOL, V29, P1084, DOI 10.1016/j.cjca.2012.11.022; Matsuo H, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.07.036; Miyoshi T, 2017, INT J CARDIOL, V236, P36, DOI 10.1016/j.ijcard.2017.02.028; Murakami M, 2006, INT J CARDIOL, V107, P48, DOI 10.1016/j.ijcard.2005.02.034; O'Rourke B, 2000, CIRC RES, V87, P845, DOI 10.1161/01.RES.87.10.845; PIRAN U, 1987, CLIN CHEM, V33, P1517; Prasad A, 2013, CATHETER CARDIO INTE, V81, P930, DOI 10.1002/ccd.24443; Roe MT, 2004, EUR HEART J, V25, P313, DOI 10.1016/j.ehj.2003.12.009; Selvanayagam JB, 2005, CIRCULATION, V111, P1027, DOI 10.1161/01.CIR.0000156328.28485.AD; Testa L, 2009, AM J CARDIOL, V103, P1622, DOI 10.1016/j.amjcard.2009.03.008; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Wu AHB, 2004, CLIN CHIM ACTA, V346, P211, DOI 10.1016/j.cccn.2004.03.036; Xu XH, 2014, ANGIOLOGY, V65, P660, DOI 10.1177/0003319713507332; Yamanaka T, 2015, INT J CARDIOL, V178, P136, DOI 10.1016/j.ijcard.2014.10.135; Zeitouni M, 2018, EUROPEAN HEART J; Zhou C, 2017, HUM MOL GENET, V26, P2258, DOI 10.1093/hmg/ddx116; Zografos TA, 2014, AM J CARDIOL, V113, P2013, DOI 10.1016/j.amjcard.2014.03.043	40	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194623	10.1371/journal.pone.0194623	http://dx.doi.org/10.1371/journal.pone.0194623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659585	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100003
J	Rubenstein, BL; MacFarlane, M; Jensen, C; Stark, L				Rubenstein, Beth L.; MacFarlane, Matthew; Jensen, Celina; Stark, Lindsay			Measuring movement into residential care institutions in Haiti after Hurricane Matthew: A pilot study	PLOS ONE			English	Article							CHILDREN; INTERVENTION	Background Governments have an ethical imperative to safeguard children in residential care institutions at all times, including in the aftermath of an emergency. Yet, a lack of accurate data about how the magnitude and characteristics of this population may change due to an emergency impedes leaders' ability to formulate responsive policies and services, mobilize resources and foster accountability. The purpose of this study was therefore to determine the feasibility of evaluating movement of children into residential care following an emergency. Methods The pilot study took place in Les Cayes commune in the Sud Department of Haiti in April 2017. Six months prior to the pilot, the area was severely affected by Hurricane Matthew, with widespread devastation to property, livestock and livelihoods. Using a two-stage process, the team created a comprehensive list of residential care institutions in Les Cayes. At each facility, the data collectors attempted to administer four separate tools: a group count tool, a record review tool, interviews with staff, and interviews with children 10 years of age and older. Results Out of 27 known institutions in Les Cayes, 22 institutions consented to participate in the research. Within these 22 institutions, the prevalence of new arrivals to residential care since Hurricane Matthew varied significantly across the four tools, ranging from 0.69% according to the aggregated child interviews to 20.96% according to the aggregated staff interviews. Record availability and quality was very poor and child participation was difficult to arrange due to travel and scheduling constraints. Interpretation Robust measurement of new arrivals to residential care institutions was not feasible in Haiti following Hurricane Matthew. Moreover, many of the challenges encountered are likely to be encountered in humanitarian emergencies in other settings. Therefore, the research team does not recommend scale-up of these methods in most humanitarian settings. Alternative approaches that incorporate household survey methods to ascertain movement into residential care based on reports from caregivers may be more realistic in places with poor pre-existing governance systems and weak registries and records for residential care institutions.	[Rubenstein, Beth L.; MacFarlane, Matthew; Stark, Lindsay] Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10027 USA; [Rubenstein, Beth L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Jensen, Celina] Save Children UK, London, England	Columbia University; Columbia University; Save the Children	Stark, L (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10027 USA.	ls2302@cumc.columbia.edu			 [AID-OFDA15-00176]		This work was supported by AID-OFDA15-00176 (https://www.usaid.gov/who-we-are/organization/bureaus/bureau-democracy-conflict-and-humanitarian-assistance/office-us), administered via the Office of U.S. Foreign Disaster Assistance. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addley E., 2010, HAITI EARTHQUAKE AID; Bakermans-Kranenburg MJ, 2012, CHILD DEV PERSPECT, V6, P174, DOI 10.1111/j.1750-8606.2011.00231.x; Bick J., 2015, JAMA PEDIAT; Dozier M, 2012, SOC ISS POLICY REV, V6, P1, DOI 10.1111/j.1751-2409.2011.01033.x; Kendrick A., 2011, CHILDREN BEHAV BADLY, P71, DOI [DOI 10.1002/9780470976586.CH6, 10.1002/9780470976586.ch6]; Martin F., 2007, SOMEONE MATTERS QUAL; McCall RB, 2013, CHILD DEV, V84, P1734, DOI 10.1111/cdev.12098; Merz EC, 2013, J CLIN CHILD ADOLESC, V42, P726, DOI 10.1080/15374416.2013.764826; Mulheir G., 2016, ORPHANAGE ENTREPRENE; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Padgett T, 2010, MAGNITUDE 7 0 HUMAN; Petrowski N, 2017, CHILD ABUSE NEGLECT; Powell G, 2004, CHILDREN RESIDENTIAL; Robinson C, 2015, SYSTEMATIC LIT REV C; Rubenstein BL, 2015, CHILD ABUSE NEGLECT; Saboula N.E., 2015, IOSR J NURSING HLTH, V4, P26; Stark L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013888; Stark L, 2016, CHILD ABUSE NEGLECT, V52, P38, DOI 10.1016/j.chiabu.2015.12.012; vanDoore K., 2015, BUSINESS ORPHANAGES; Williamson John, 2010, FAMILIES NOT ORPHANA	20	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195515	10.1371/journal.pone.0195515	http://dx.doi.org/10.1371/journal.pone.0195515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659597	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100020
J	Boo, G; Leyk, S; Brunsdon, C; Graf, R; Pospischil, A; Fabrikant, SI				Boo, Gianluca; Leyk, Stefan; Brunsdon, Christopher; Graf, Ramona; Pospischil, Andreas; Fabrikant, Sara Irina			The importance of regional models in assessing canine cancer incidences in Switzerland	PLOS ONE			English	Article							GEOGRAPHICALLY WEIGHTED REGRESSION; SPATIAL NON-STATIONARITY; TUMOR REGISTRY; DOGS; DISEASE; SIZE; OVERDISPERSION; EPIDEMIOLOGY; ASSOCIATIONS; SENTINELS	Fitting canine cancer incidences through a conventional regression model assumes constant statistical relationships across the study area in estimating the model coefficients. However, it is often more realistic to consider that these relationships may vary over space. Such a condition, known as spatial non-stationarity, implies that the model coefficients need to be estimated locally. In these kinds of local models, the geographic scale, or spatial extent, employed for coefficient estimation may also have a pervasive influence. This is because important variations in the local model coefficients across geographic scales may impact the understanding of local relationships. In this study, we fitted canine cancer incidences across Swiss municipal units through multiple regional models. We computed diagnostic summaries across the different regional models, and contrasted them with the diagnostics of the conventional regression model, using value-by-alpha maps and scalograms. The results of this comparative assessment enabled us to identify variations in the goodness-of-fit and coefficient estimates. We detected spatially non-stationary relationships, in particular, for the variables related to biological risk factors. These variations in the model coefficients were more important at small geographic scales, making a case for the need to model canine cancer incidences locally in contrast to more conventional global approaches. However, we contend that prior to undertaking local modeling efforts, a deeper understanding of the effects of geographic scale is needed to better characterize and identify local model relationships.	[Boo, Gianluca; Fabrikant, Sara Irina] Univ Zurich, Dept Geog, Zurich, Switzerland; [Boo, Gianluca; Graf, Ramona; Pospischil, Andreas] Univ Zurich, Coll Helveticum, Zurich, Switzerland; [Boo, Gianluca; Graf, Ramona; Pospischil, Andreas] Swiss Fed Inst Technol Zurich, Zurich, Switzerland; [Leyk, Stefan] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Brunsdon, Christopher] Univ Maynooth, Natl Ctr Geocomputat, Maynooth, Kildare, Ireland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Colorado System; University of Colorado Boulder; Maynooth University	Boo, G (corresponding author), Univ Zurich, Dept Geog, Zurich, Switzerland.; Boo, G (corresponding author), Univ Zurich, Coll Helveticum, Zurich, Switzerland.; Boo, G (corresponding author), Swiss Fed Inst Technol Zurich, Zurich, Switzerland.	gianluca.boo@geo.uzh.ch	Leyk, Stefan/S-4945-2019; Fabrikant, Sara/B-9320-2014	Fabrikant, Sara/0000-0003-1263-8792; Boo, Gianluca/0000-0002-4078-8221	University of Zurich; Swiss Federal Institute of Technology in Zurich; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD066613] Funding Source: NIH RePORTER	University of Zurich; Swiss Federal Institute of Technology in Zurich; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was founded by the Collegium Helveticum Zurich a joint initiative by the University of Zurich and the Swiss Federal Institute of Technology in Zurich through a grant accorded to its fellows Andreas Pospischil and Kay W. Axhausen, and by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1997, UNDERSTANDING REGRES, P160; ANIS. Animal Identity Service AG, 2017, AN ID SERV AG; [Anonymous], 2016, PLYR TOOLS SPLITTING; Atkinson PM, 2000, PROF GEOGR, V52, P607, DOI 10.1111/0033-0124.00250; Bartlett PC, 2010, PREV VET MED, V94, P264, DOI 10.1016/j.prevetmed.2010.01.007; Beale L, 2008, ENVIRON HEALTH PERSP, V116, P1105, DOI 10.1289/ehp.10816; Berk R, 2008, J QUANT CRIMINOL, V24, P269, DOI 10.1007/s10940-008-9048-4; Bivand R., 2017, RGDAL BINDINGS GEOSP; Bivand R., 2017, MAPTOOLS TOOLS READI; Bonnett BN, 2010, J COMP PATHOL, V141, pS33, DOI 10.1016/j.jcpa.2009.10.008; Boo G, 2015, ISPRS ANN PHOTO REM, VII-3, P263, DOI 10.5194/isprsannals-II-3-W5-263-2015; Boo G, 2016, 9 INT C GISCIENCE SH, P29; Boo G, 2017, GEOSPATIAL HEALTH, V12, P121, DOI 10.4081/gh.2017.539; Bronden LB, 2007, VET COMP ONCOL, V5, P133, DOI 10.1111/j.1476-5829.2007.00126.x; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Cameron A. C., 1986, J APPL ECONOMET, V1, P29, DOI DOI 10.1002/JAE.3950010104; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Cameron AC, 1997, J ECONOMETRICS, V77, P329; Champely S., 2018, PACKAGE PWR; Cho SH, 2010, APPL ECON LETT, V17, P767, DOI 10.1080/13504850802314452; Cressie N, 1993, STAT SPATIAL DATA, P453; Delamater PL, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-15; Dobson Jane M, 2013, ISRN Vet Sci, V2013, P941275, DOI 10.1155/2013/941275; Domencich TA, 1975, URBAN TRAVEL DEMAND, P101; Dykes J, 2007, IEEE T VIS COMPUT GR, V13, P1161, DOI 10.1109/TVCG.2007.70558; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fotheringham AS, 1998, ENVIRON PLANN A, V30, P1905, DOI 10.1068/a301905; Fox J, 2015, APPL REGRESSION ANAL, P307; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; Gavazza A, 2001, J VET INTERN MED, V15, P190, DOI 10.1892/0891-6640(2001)015&lt;0190:ABCMLL&gt;2.3.CO;2; Gruntzig K, 2015, J COMP PATHOL, V152, P161, DOI 10.1016/j.jcpa.2015.02.005; Gruntzig K, 2016, J COMP PATHOL, V155, P156, DOI 10.1016/j.jcpa.2016.05.011; Gujarati D., 2003, BASIC ECONOMETRICS, P341; Lee L.H., 2015, **DATA OBJECT**; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Leyk S, 2012, SPAT SPATIO-TEMPORAL, V3, P95, DOI 10.1016/j.sste.2012.04.003; Lloyd CD, 2010, LOCAL MODELS SPATIAL, P23; Maclaurin G, 2015, T GIS, V19, P877, DOI 10.1111/tgis.12134; Maimon OZ, 2005, DATA MINING KNOWLEDG; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Mohebbi M, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-133; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; Nodtvedt A, 2012, VET COMP ONCOL, V10, P95, DOI 10.1111/j.1476-5829.2011.00279.x; O'Neill Dan G, 2014, Canine Genet Epidemiol, V1, P2, DOI 10.1186/2052-6687-1-2; Openshaw S, 1984, MODIFIABLE AREAL UNI; P Elliott, 1996, METHODS SMALL AREA S, P10; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Pospischil A, 2013, SCHWEIZ ARCH TIERH, V155, P219, DOI 10.1024/0036-7281/a000450; Pospischil A, 2015, P GRF 1 HLTH SUMM 20, P108; Reif JS, 2011, PUBLIC HEALTH REP, V126, P50, DOI 10.1177/00333549111260S108; Roth RE, 2010, CARTOGR J, V47, P130, DOI 10.1179/000870409X12488753453372; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Schmidt PL, 2009, VET CLIN N AM-SMALL, V39, P241, DOI 10.1016/j.cvsm.2008.10.010; Swisscom Ltd, 2017, OFF PHON YELL PAG SW; Tate N, 2001, MODELLING SCALE GEOG, P159; Team RStudio, 2016, RSTUDIO INT DEV ENV; Tiefelsdorf M., 2006, MODELLING SPATIAL PR; van Etten J, 2017, GDISTANCE DISTANCES; Vascellari M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-39; Wall MM, 2004, J STAT PLAN INFER, V121, P311, DOI 10.1016/S0378-3758(03)00111-3; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Wickham H., 2016, GGPLOT2 CREATE ELEGA; Wickham H, 2017, RESHAPE FLEXIBLY RES; Zeileis A, 2017, SANDWICH ROBUST COVA	71	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195970	10.1371/journal.pone.0195970	http://dx.doi.org/10.1371/journal.pone.0195970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652921	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000430026900050
J	Rejmund, M; Mrozek-Wilczkiewicz, A; Malarz, K; Pyrkosz-Bulska, M; Gajcy, K; Sajewicz, M; Musiol, R; Polanski, J				Rejmund, Marta; Mrozek-Wilczkiewicz, Anna; Malarz, Katarzyna; Pyrkosz-Bulska, Monika; Gajcy, Kamila; Sajewicz, Mieczyslaw; Musiol, Robert; Polanski, Jaroslaw			Piperazinyl fragment improves anticancer activity of Triapine	PLOS ONE			English	Article							3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE 3-AP; RIBONUCLEOTIDE REDUCTASE INHIBITOR; SELECTIVE ANTITUMOR-ACTIVITY; IRON OVERLOAD DISEASE; PHASE-I; ANTIPROLIFERATIVE ACTIVITY; BIOLOGICAL-PROPERTIES; LUNG-CANCER; CHELATORS; METABOLISM	A new class of TSCs containing piperazine (piperazinylogs) of Triapine, was designed to fulfill the di-substitution pattern at the TSCs N4 position, which is a crucial prerequisite for the high activity of the previously obtained TSC compounds-DpC and Dp44mT. We tested the important physicochemical characteristics of the novel compounds L-1-L-12. The studied ligands are neutral at physiological pH, which allows them to permeate cell membranes and bind cellular Fe pools more readily than less lipid-soluble ligands, e.g. DFO. The selectivity and anti-cancer activity of the novel TSCs were examined in a variety of cancer cell types. In general, the novel compounds demonstrated the greatest promise as anti-cancer agents with both a potent and selective anti-proliferative activity. We investigated the mechanism of action more deeply, and revealed that studied compounds inhibit the cell cycle (G1/S phase). Additionally we detected apoptosis, which is dependent on cell line's specific genetic profile. Accordingly, structure-activity relationship studies suggest that the combination of the piperazine ring with Triapine allows potent and selective anticancer chelators that warrant further in vivo examination to be identified. Significantly, this study proved the importance of the di-substitution pattern of the amine N4 function.	[Rejmund, Marta; Malarz, Katarzyna; Pyrkosz-Bulska, Monika; Gajcy, Kamila; Sajewicz, Mieczyslaw; Musiol, Robert; Polanski, Jaroslaw] Univ Silesia, Inst Chem, Katowice, Poland; [Mrozek-Wilczkiewicz, Anna] Univ Silesia, A Chelkowski Inst Phys, Katowice, Poland; [Mrozek-Wilczkiewicz, Anna; Malarz, Katarzyna] Univ Silesia, Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice	Polanski, J (corresponding author), Univ Silesia, Inst Chem, Katowice, Poland.	jaroslaw.polanski@us.edu.pl	Malarz, Katarzyna/AAA-2689-2020; Musioł, Robert/J-4790-2019	Malarz, Katarzyna/0000-0003-4283-3126; Polanski, Jaroslaw/0000-0001-7361-2671; Pyrkosz-Bulska, Monika/0000-0002-3524-6065; Gajcy, Kamila/0000-0003-3141-6562; Musiol, Robert/0000-0002-6219-7369; Sajewicz, Mieczyslaw/0000-0001-7575-0760; Mrozek-Wilczkiewicz, Anna/0000-0003-2228-1475	National Center of Science [2014/13/D/NZ7/00322, 2013/09/B/NZ7/00423]; NCBiR Warsaw ORGANOMET [PBS2/A5/40/2014]	National Center of Science(National Science Centre, Poland); NCBiR Warsaw ORGANOMET	The financial support of the National Center of Science grants 2014/13/D/NZ7/00322 (AMW), 2013/09/B/NZ7/00423 (RM) and NCBiR Warsaw ORGANOMET No: PBS2/A5/40/2014 (JP) is greatly appreciated.; The financial support of the National Center of Science grants 2014/13/D/NZ7/00322 (AMW), 2013/09/B/NZ7/00423 (RM) and NCBiR Warsaw ORGANOMET No: PBS2/A5/40/2014 (JP) is greatly appreciated.	Ae N., 2011, [No title captured], Patent No. [US 20110263847 A1, 20110263847, U.S. 20110263847 A1]; Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; [Anonymous], 1991, STRUCT BOND; Attia S, 2008, INVEST NEW DRUG, V26, P369, DOI 10.1007/s10637-008-9123-6; ATTWOOD D, 1981, J PHARM PHARMACOL, V33, P136, DOI 10.1111/j.2042-7158.1981.tb13735.x; Aye Y, 2012, J BIOL CHEM, V287, P35768, DOI 10.1074/jbc.M112.396911; Bacher F, 2015, DALTON T, V44, P9071, DOI 10.1039/c5dt01076d; Beck MT, 1990, CHEMISTRY OF COMPLEX; Becker EM, 2003, BRIT J PHARMACOL, V138, P819, DOI 10.1038/sj.bjp.0705089; Brazdova M, 2009, NUCLEIC ACIDS RES, V37, P1486, DOI 10.1093/nar/gkn1085; BROCKMAN RW, 1956, CANCER RES, V16, P167; Chao J, 2012, CANCER CHEMOTH PHARM, V69, P835, DOI 10.1007/s00280-011-1779-5; Chaston TB, 2003, AM J HEMATOL, V73, P200, DOI 10.1002/ajh.10348; Chekhun VF, 2013, INT J ONCOL, V43, P1481, DOI 10.3892/ijo.2013.2063; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Easmon J, 2001, J MED CHEM, V44, P2164, DOI 10.1021/jm000979z; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enyedy EA, 2012, EUR J INORG CHEM, P4036, DOI 10.1002/ejic.201200360; Enyedy EA, 2011, DALTON T, V40, P5895, DOI 10.1039/c0dt01835j; Enyedy EA, 2010, EUR J INORG CHEM, P1717, DOI 10.1002/ejic.200901174; Evans RW, 2012, BBA-GEN SUBJECTS, V1820, P282, DOI 10.1016/j.bbagen.2011.11.007; Faist J, 2012, EUR J MED CHEM, V47, P510, DOI 10.1016/j.ejmech.2011.11.022; Feun L, 2002, CANCER CHEMOTH PHARM, V50, P223, DOI 10.1007/s00280-002-0480-0; Fischer B, 2016, RSC ADV, V6, P55848, DOI 10.1039/c6ra07659a; Gans P, 2000, HYPSPEC; Gao HL, 2003, MOL PHARMACOL, V63, P1382, DOI 10.1124/mol.63.6.1382; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Giles FJ, 2003, LEUKEMIA RES, V27, P1077, DOI 10.1016/S0145-2126(03)00118-8; GomezManzano C, 1997, J NATL CANCER I, V89, P1036, DOI 10.1093/jnci/89.14.1036; Gosselaar PH, 2002, EUR J CLIN INVEST, V32, P61, DOI 10.1046/j.1365-2362.2002.0320s1061.x; Hou XL, 2006, BIOORG MED CHEM LETT, V16, P4214, DOI 10.1016/j.bmcl.2006.05.085; Hu WX, 2006, BIOORG MED CHEM LETT, V16, P2213, DOI 10.1016/j.bmcl.2006.01.048; Hua LM, 2016, BIOORG MED CHEM LETT, V26, P5830, DOI 10.1016/j.bmcl.2016.10.007; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Knox JJ, 2007, INVEST NEW DRUG, V25, P471, DOI 10.1007/s10637-007-9044-9; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kowol CR, 2009, J MED CHEM, V52, P5032, DOI 10.1021/jm900528d; Kubicek V, 2010, INORG CHEM, V49, P10960, DOI 10.1021/ic101378s; Lacivita E, 2009, BIOORGAN MED CHEM, V17, P1339, DOI 10.1016/j.bmc.2008.12.015; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Lee JC, 2016, INT J MOL SCI, V17, P1; Legendre C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2074-y; Legendre C, 2015, TRENDS ENDOCRIN MET, V26, P322, DOI 10.1016/j.tem.2015.03.008; Liang Y, 2001, ONCOGENE, V20, P6570, DOI 10.1038/sj.onc.1204815; LIU MC, 1992, J MED CHEM, V35, P3672, DOI 10.1021/jm00098a012; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Ma B, 2008, INVEST NEW DRUG, V26, P169, DOI 10.1007/s10637-007-9085-0; Mackenzie MJ, 2007, INVEST NEW DRUG, V25, P553, DOI 10.1007/s10637-007-9066-3; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Mrozek-Wilczkiewicz A, 2014, ACS MED CHEM LETT, V5, P336, DOI 10.1021/ml400422a; Ochi T, 2005, BIOORG MED CHEM LETT, V15, P1055, DOI 10.1016/j.bmcl.2004.12.028; Odenike OM, 2008, INVEST NEW DRUG, V26, P233, DOI 10.1007/s10637-008-9115-6; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Perrin DD, 1981, PK A PREDICTION FOR; Pinnix ZK, 2010, SCI TRANSL MED, V2; Proschak Ewgenij, 2008, P217, DOI 10.1039/9781847558879-00217; Rathi AK, 2016, EXPERT OPIN THER PAT, V26, P777, DOI 10.1080/13543776.2016.1189902; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; RICHARDSON DR, 1990, INORG CHIM ACTA, V170, P165, DOI 10.1016/S0020-1693(00)80471-5; Schiller DS, 2007, CLIN THER, V29, P1862, DOI 10.1016/j.clinthera.2007.09.015; Serda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110291; Serda M, 2013, J MOL STRUCT, V1037, P63, DOI 10.1016/j.molstruc.2012.11.050; Serda M, 2012, MOLECULES, V17, P13483, DOI 10.3390/molecules171113483; Serda M, 2012, BIOORG MED CHEM LETT, V22, P5527, DOI 10.1016/j.bmcl.2012.07.030; Sestak V, 2015, ONCOTARGET, V6, P42411, DOI 10.18632/oncotarget.6389; Shen J, 2014, CELL REP, V7, P180, DOI 10.1016/j.celrep.2014.02.042; SIEGERS CP, 1992, CANCER LETT, V65, P245, DOI 10.1016/0304-3835(92)90239-R; SMYTH MR, 1976, ANAL CHIM ACTA, V86, P185, DOI 10.1016/S0003-2670(01)83033-6; Stanojkovic TP, 2010, J INORG BIOCHEM, V104, P467, DOI 10.1016/j.jinorgbio.2009.12.021; Tarushi A, 2011, DALTON T, V40, P9461, DOI 10.1039/c1dt10870k; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; Torti Suzy V., 2013, Critical Reviews in Oncogenesis, V18, P435; Wang YX, 2011, J MED CHEM, V54, P2127, DOI 10.1021/jm101340q; Xie WL, 2014, EUR J MED CHEM, V81, P22, DOI 10.1016/j.ejmech.2014.05.001; Yen Y, 2004, CANCER CHEMOTH PHARM, V54, P331, DOI 10.1007/s00280-004-0821-2; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu Y, 2012, BRIT J PHARMACOL, V165, P148, DOI 10.1111/j.1476-5381.2011.01526.x; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Yu Y, 2009, J MED CHEM, V52, P5271, DOI 10.1021/jm900552r; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	83	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0188767	10.1371/journal.pone.0188767	http://dx.doi.org/10.1371/journal.pone.0188767			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652894	Green Published, gold, Green Submitted			2022-12-27	WOS:000430026900001
J	Nam, SY; Ko, ES; Lim, Y; Han, BK; Ko, EY; Choi, JS; Lee, JE				Nam, Sang Yu; Ko, Eun Sook; Lim, Yaeji; Han, Boo-Kyung; Ko, Eun Young; Choi, Ji Soo; Lee, Jeong Eon			Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer	PLOS ONE			English	Article							ENHANCED SPECTRAL MAMMOGRAPHY; CONTRAST ENHANCEMENT; MICROVESSEL DENSITY; MRI PARAMETERS; CAD SYSTEM; LESIONS; ANGIOGENESIS; METASTASIS; ULTRASOUND; CARCINOMA	Objectives To evaluate whether preoperative breast dynamic contrast-enhanced (DCE) magnetic resonance (MR) imaging kinetic features, assessed using computer-aided diagnosis (CAD), can predict survival outcome and tumor aggressiveness in patients with invasive breast cancer. Materials and methods Between March and December 2011, 301 women who underwent preoperative DCE MR imaging for invasive breast cancer, with CAD data, were identified. All MR images were retrospectively evaluated using a commercially available CAD system. The following kinetic parameters were prospectively recorded for each lesion: initial peak enhancement, the proportion of early phase medium and rapid enhancement, and the proportion of delayed phase persistent, plateau, and washout enhancement. The Cox proportional hazards model was used to determine the association between the kinetic features assessed by CAD and disease-free survival (DFS). The peak signal intensity and kinetic enhancement profiles were compared with the clinical-pathological variables. Results There were 32 recurrences during a mean follow-up time of 55.2 months (range, 5-72 months). Multivariate analysis revealed that a higher peak enhancement (DFS hazard ratio, 1.004 [95% confidence interval (CI): 1.001, 1.006]; P = .013) on DCE MR imaging and a triple-negative subtype (DFS hazard ratio, 21.060 [95% CI: 2.675, 165.780]; P = .004) were associated with a poorer DFS. Higher peak enhancement was significantly associated with a higher tumor stage, clinical stage, and histologic grade. Conclusions Patients with breast cancer who showed higher CAD-derived peak enhancement on breast MR imaging had worse DFS. Peak enhancement and volumetric analysis of kinetic patterns were useful for predicting tumor aggressiveness.	[Nam, Sang Yu] Gachon Univ Med & Sci, Gachon Univ, Dept Radiol, Gil Med Ctr, Incheon, South Korea; [Ko, Eun Sook; Han, Boo-Kyung; Ko, Eun Young; Choi, Ji Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, 81 Irwon Ro, Seoul, South Korea; [Lim, Yaeji] Chung Ang Univ, Dept Appl Stat, 84 Heukseok Ro, Seoul, South Korea; [Lee, Jeong Eon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, 81 Irwon Ro, Seoul, South Korea	Gachon University; Sungkyunkwan University (SKKU); Samsung Medical Center; Chung Ang University; Sungkyunkwan University (SKKU); Samsung Medical Center	Ko, ES (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, 81 Irwon Ro, Seoul, South Korea.	mathilda0330@gmail.com		Ko, Eun Sook/0000-0002-0399-7956				American College of Radiology, 2013, BREAST IM REP DAT SY; Meinel LA, 2007, J MAGN RESON IMAGING, V25, P89, DOI 10.1002/jmri.20794; Baltzer PAT, 2012, TECHNOL CANCER RES T, V11, P553, DOI 10.7785/tcrt.2012.500266; Baltzer PAT, 2009, ACAD RADIOL, V16, P1070, DOI 10.1016/j.acra.2009.03.017; Bhooshan N, 2010, RADIOLOGY, V254, P680, DOI 10.1148/radiol.09090838; Blaschke E, 2015, J MAGN RESON IMAGING, V42, P920, DOI 10.1002/jmri.24884; Chaudhury B, 2015, J MAGN RESON IMAGING, V42, P1421, DOI 10.1002/jmri.24921; Choi WWL, 2005, MODERN PATHOL, V18, P143, DOI 10.1038/modpathol.3800253; Dietzel M, 2013, J MAGN RESON IMAGING, V37, P146, DOI 10.1002/jmri.23812; Dromain C, 2013, EUR J RADIOL, V82, P417, DOI 10.1016/j.ejrad.2012.03.005; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fallenberg EM, 2014, EUR RADIOL, V24, P256, DOI 10.1007/s00330-013-3007-7; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Huang J, 2016, ONCOL LETT, V11, P3522, DOI 10.3892/ol.2016.4422; Jansen SA, 2009, AM J ROENTGENOL, V193, P832, DOI 10.2214/AJR.08.2025; Kim JJ, 2017, RADIOLOGY, V284, P45, DOI 10.1148/radiol.2017162079; Kuhl CK, 2006, RADIOLOGY, V239, P666, DOI 10.1148/radiol.2392050509; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Lee SH, 2008, KOREAN J RADIOL, V9, P10, DOI 10.3348/kjr.2008.9.1.10; Lehman CD, 2006, AM J ROENTGENOL, V187, P51, DOI 10.2214/AJR.05.0269; Leng XL, 2017, MED SCI MONITOR, V23, P3428, DOI 10.12659/MSM.901734; Leong LCH, 2015, AM J ROENTGENOL, V204, pW348, DOI 10.2214/AJR.13.11486; Liu H, 2008, BREAST, V17, P532, DOI 10.1016/j.breast.2008.04.004; Lobbes MBI, 2014, EUR RADIOL, V24, P1668, DOI 10.1007/s00330-014-3154-5; Loiselle CR, 2011, J MAGN RESON IMAGING, V33, P96, DOI 10.1002/jmri.22389; Loiselle CR, 2010, INT J RADIAT ONCOL, V76, P1314, DOI 10.1016/j.ijrobp.2009.03.053; Meeuwis C, 2010, EUR RADIOL, V20, P522, DOI 10.1007/s00330-009-1573-5; Pineda FD, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150021; Rahbar H, 2016, MAGN RESON IMAGING C, V24, P223, DOI 10.1016/j.mric.2015.08.012; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Song SE, 2015, CANCER IMAGING, V15, DOI 10.1186/s40644-015-0036-2; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Stomper PC, 1997, BREAST CANCER RES TR, V45, P39, DOI 10.1023/A:1005897227030; Su MY, 2003, J MAGN RESON IMAGING, V18, P467, DOI 10.1002/jmri.10380; Taylor JS, 1999, J MAGN RESON IMAGING, V10, P903, DOI 10.1002/(SICI)1522-2586(199912)10:6<903::AID-JMRI1>3.0.CO;2-A; Tennant SL, 2016, CLIN RADIOL, V71, P1148, DOI 10.1016/j.crad.2016.05.009; Tuncbilek Nermin, 2003, Breast J, V9, P403, DOI 10.1046/j.1524-4741.2003.09508.x; Tuncbilek N, 2012, EUR J RADIOL, V81, P863, DOI 10.1016/j.ejrad.2011.02.021; Turetschek K, 2001, RADIOLOGY, V218, P562, DOI 10.1148/radiology.218.2.r01fe37562; Vajuvalli NN, 2016, PHYS MED BIOL, V61, P8462, DOI 10.1088/0031-9155/61/24/8462; Wan CF, 2012, RADIOLOGY, V262, P450, DOI 10.1148/radiol.11110789; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yi A, 2013, RADIOLOGY, V268, P662, DOI 10.1148/radiol.13121801; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9; Zhao YX, 2017, ONCOTARGETS THER, V10, P1123, DOI 10.2147/OTT.S124134; Zwiener I, 2011, DTSCH ARZTEBL INT, V108, P163, DOI [10.3238/arztebl.2011.0163, 10.3238/arztebl.2010.0163]	47	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195756	10.1371/journal.pone.0195756	http://dx.doi.org/10.1371/journal.pone.0195756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649266	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900080
J	Niazi, MKK; Tavolara, TE; Arole, V; Hartman, DJ; Pantanowitz, L; Gursan, MN				Niazi, Muhammad Khalid Khan; Tavolara, Thomas Erol; Arole, Vidya; Hartman, Douglas J.; Pantanowitz, Liron; Gursan, Metin N.			Identifying tumor in pancreatic neuroendocrine neoplasms from Ki67 images using transfer learning	PLOS ONE			English	Article							NEURAL-NETWORKS; DIAGNOSIS	The World Health Organization (WHO) has clear guidelines regarding the use of Ki67 index in defining the proliferative rate and assigning grade for pancreatic neuroendocrine tumor (NET). WHO mandates the quantification of Ki67 index by counting at least 500 positive tumorcells in a hotspot. Unfortunately, Ki67 antibody may stain both tumor and non-tumor cells as positive depending on the phase of the cell cycle. Likewise, the counter stain labels both tumor and non-tumor as negative. This non-specific nature of Ki67 stain and counter stain therefore hinders the exact quantification of Ki67 index. To address this problem, we present a deep learning method to automatically differentiate between NET and non-tumor regions based on images of Ki67 stained biopsies. Transfer learning was employed to recognize and apply relevant knowledge from previous learning experiences to differentiate between tumor and non-tumor regions. Transfer learning exploits a rich set of features previously used to successfully categorize non-pathology data into 1,000 classes. The method was trained and validated on a set of whole-slide images including 33 NETs subject to Ki67 immunohistochemical staining using a leave-one-out cross-validation. When applied to 30 high power fields (HPF) and assessed against a gold standard (evaluation by two expert pathologists), the method resulted in a high sensitivity of 97.8% and specificity of 88.8%. The deep learning method developed has the potential to reduce pathologists' workload by directly identifying tumor boundaries on images of Ki67 stained slides. Moreover, it has the potential to replace sophisticated and expensive imaging methods which are recently developed for identification of tumor boundaries in images of Ki67-stained NETs.	[Niazi, Muhammad Khalid Khan; Tavolara, Thomas Erol; Gursan, Metin N.] Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA; [Arole, Vidya] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Hartman, Douglas J.; Pantanowitz, Liron] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Wake Forest University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Niazi, MKK (corresponding author), Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA.	khalid.niazi@gmail.com	Pantanowitz, Liron/AFP-8163-2022	Gurcan, Metin/0000-0002-2421-8229; Niazi, Muhammad Khalid Khan/0000-0002-1278-7512	National Institute of Allergy and Infectious Diseases [R01CA134451, U24CA199374, U01 CM 98945, R21 A1115038]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported in part by awards number R01CA134451 (Pls: Gurcan, Lozanski), U24CA199374 (Pls: Gurcan, Madabushi, Martel), and U01 CM 98945 (PI: Bilgin) from the National Cancer Institute, and by number R21 A1115038 (Pls: Campos-Neto, Beamer) from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, or the National Institutes of Health.	Alsidawi S, 2017, PANCREATIC NEUROENDO; Belhomme P, 2015, COMPUT MED IMAG GRAP, V42, P51, DOI 10.1016/j.compmedimag.2014.11.006; Bosman F. T., 2010, WHO CLASSIFICATION T; Chefd'hotel c, 2014, INT WORKSH MACH LEAR; Ciresan DC, 2013, IT C MED IM COMP COM; Deng L, 2013, IEEE INT NEW CIRC; Goodell PP, 2012, AM J CLIN PATHOL, V137, P576, DOI 10.1309/AJCP92UCXPJMMSDU; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Ilya S., 2013, INT C MACH LEARN, P1139, DOI DOI 10.1007/S00287-015-0911-Z; Kingeter LM, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-49; Kloppel G, 2007, BEST PRACT RES CL EN, V21, P15, DOI 10.1016/j.beem.2007.01.004; Kloppel G, 2017, AJSP-REV REP, V22, P233, DOI 10.1097/PCR.0000000000000211; Krizhevsky A., P 25 INT C NEUR INF, P1097; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li LT, 2015, MOL MED REP, V11, P1566, DOI 10.3892/mmr.2014.2914; Lopez XM, 2012, CYTOM PART A, V81A, P765, DOI 10.1002/cyto.a.22085; MKKNGBMN Gurcan, 2018, SPIE MED IMAGI UNPUB; Niazi MKK, 2014, J MICROSC-OXFORD, V256, P213, DOI 10.1111/jmi.12176; Niazi MKK, 2017, SPIE MED IMAGING; Niazi MKK, 2014, SPIE MED IMAGING; Niazi MKK, 2013, SPIE MED IMAGING; Niazi MKK, 2016, SPIE MED IMAGING, V2016; Nystrom I, 2010, IEEE INT C PATT REC; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Phan AT, 2010, PANCREAS, V39, P784, DOI 10.1097/MPA.0b013e3181ec1380; Polley MYC, 2015, MODERN PATHOL, V28, P778, DOI 10.1038/modpathol.2015.38; Roge R, 2016, BREAST CANCER RES TR, V158, P11, DOI 10.1007/s10549-016-3852-6; Ruskey Frank, 1997, ELECTRON J COMB, V4, P3; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Sobecki M, 2017, CANC RES; SZEGEDY C, 2016, PROC CVPR IEEE, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C., 2015, P IEEE C COMPUTER VI, P1; Toomey D, 2015, SPIE MED IMAGING; Torrey Lisa, HDB RES MACHINE LEAR, P242; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Wang L-W, 2016, SCI REPORTS, V6; Yuan JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122734	40	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195621	10.1371/journal.pone.0195621	http://dx.doi.org/10.1371/journal.pone.0195621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649302	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900061
J	Arts, DL; Medlock, SK; van Weert, HCPM; Wyatt, JC; Abu-Hanna, A				Arts, Derk L.; Medlock, Stephanie K.; van Weert, Henk C. P. M.; Wyatt, Jeremy C.; Abu-Hanna, Ameen			Acceptance and barriers pertaining to a general practice decision support system for multiple clinical conditions: A mixed methods evaluation	PLOS ONE			English	Article							METAANALYSIS; IMPROVE; SUCCESS; ALERTS; CARE	Background Many studies have investigated the use of clinical decision support systems as a means to improve care, but have thus far failed to show significant effects on patient-related outcomes. We developed a clinical decision support system that attempted to address issues that were identified in these studies. The system was implemented in Dutch general practice and was designed to be both unobtrusive and to respond in real time. Despite our efforts, usage of the system was low. In the current study we perform a mixed methods evaluation to identify remediable barriers which led to disappointing usage rates for our system. Methods A mixed methods evaluation employing an online questionnaire and focus group. The focus group was organized to clarify free text comments and receive more detailed feedback from general practitioners. Topics consisted of items based on results from the survey and additional open questions. Results The response rate for the questionnaire was 94%. Results from the questionnaire and focus group can be summarized as follows: The system was perceived as interruptive, despite its design. Participants felt that there were too many recommendations and that the relevance of the recommendations varied. Demographic based recommendations (e.g. age) were often irrelevant, while specific risk-based recommendations (e.g. diagnosis) were more relevant. The other main barrier to use was lack of time during the patient visit. Conclusion These results are likely to be useful to other researchers who are attempting to address the problems of interruption and alert fatigue in decision support.	[Arts, Derk L.; van Weert, Henk C. P. M.] Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Arts, Derk L.; Medlock, Stephanie K.; Abu-Hanna, Ameen] Acad Med Ctr, Dept Med Informat, Amsterdam, Netherlands; [Wyatt, Jeremy C.] Univ Southampton, Wessex Inst Hlth Res, Southampton, Hants, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Southampton	Arts, DL (corresponding author), Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands.; Arts, DL (corresponding author), Acad Med Ctr, Dept Med Informat, Amsterdam, Netherlands.	d.l.arts@amc.nl		Abu-Hanna, Ameen/0000-0003-4324-7954; Arts, Derk/0000-0001-5702-5856	Boehringer Ingelheim; ZonMw (The Netherlands Organization for Health Research and Development) [311020302]; ZORRO	Boehringer Ingelheim(Boehringer Ingelheim); ZonMw (The Netherlands Organization for Health Research and Development)(Netherlands Organization for Health Research and DevelopmentNetherlands Government); ZORRO	DA was funded by an unrestricted grant from Boehringer Ingelheim. AAH and SM were funded by ZonMw (The Netherlands Organization for Health Research and Development) for the ICOVE (#311020302) projects. HVW was funded by ZORRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchala R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047064; Arts DL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-193; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Cook DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122153; DeLone WH, 1992, INFORM SYST RES, V3, P60, DOI 10.1287/isre.3.1.60; Dutch College of General Practitioners Guideline Development Group for Atrial fibrillation, 2013, HUISARTS WETENSCHAP, V56, P392; Eslami S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-81; GmbH VSCS, 2016, MAXQDA SOFTW QUAL DA; Hemens BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-89; Hersh WR, 2013, MED CARE, V51, pS30, DOI 10.1097/MLR.0b013e31829b1dbd; Jeffery R, 2013, DIABETIC MED, V30, P739, DOI 10.1111/dme.12087; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kesselheim AS, 2011, HEALTH AFFAIR, V30, P2310, DOI 10.1377/hlthaff.2010.1111; Li SYW, 2012, J AM MED INFORM ASSN, V19, P6, DOI 10.1136/amiajnl-2010-000024; Lugtenberg M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0205-z; Matui P, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.5; McCoy AB, 2012, J AM MED INFORM ASSN, V19, P346, DOI 10.1136/amiajnl-2011-000185; Medlock S, 2016, J AM MED INFORM ASSN, V23, P1001, DOI 10.1093/jamia/ocv177; Medlock S, 2013, STUD HEALTH TECHNOL, V186, P56, DOI 10.3233/978-1-61499-240-0-56; Moja L, 2014, AM J PUBLIC HEALTH, V104, pE12, DOI 10.2105/AJPH.2014.302164; Mukherjee M, 2016, ALLERGY; Mutasingwa DR, 2011, CAN FAM PHYSICIAN, V57, pE253; Payne TH, 2015, J AM MED INFORM ASSN, V22, P1243, DOI 10.1093/jamia/ocv011; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI [10.1186/1748-5908-6-92, 10.1186/1748-5908-6-88]; Shortliffe EH, 2013, BIOMEDICAL INFORM CO; van der Ploeg E, 2008, QUAL SAF HEALTH CARE, V17, P291, DOI 10.1136/qshc.2007.023226; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Zhang Yan., QUALITATIVE ANAL CON	29	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0193187	10.1371/journal.pone.0193187	http://dx.doi.org/10.1371/journal.pone.0193187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672521	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000430446800006
J	Rosli, R; Amiruddin, N; Ab Halim, MA; Chan, PL; Chan, KL; Azizi, N; Morris, PE; Low, ETL; Ong-Abdullah, M; Sambanthamurthi, R; Singh, R; Murphy, DJ				Rosli, Rozana; Amiruddin, Nadzirah; Ab Halim, Mohd Amin; Chan, Pek-Lan; Chan, Kuang-Lim; Azizi, Norazah; Morris, Priscilla E.; Low, Eng-Ti Leslie; Ong-Abdullah, Meilina; Sambanthamurthi, Ravigadevi; Singh, Rajinder; Murphy, Denis J.			Comparative genomic and transcriptomic analysis of selected fatty acid biosynthesis genes and CNL disease resistance genes in oil palm	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; SEQUENCE ALIGNMENT; DESATURASE; ANNOTATION; EXPRESSION; FAMILY; EVOLUTION; ISOFORMS; TOPHAT; FUTURE	Comparative genomics and transcriptomic analyses were performed on two agronomically important groups of genes from oil palm versus other major crop species and the model organism, Arabidopsis thaliana. The first analysis was of two gene families with key roles in regulation of oil quality and in particular the accumulation of oleic acid, namely stearoyl ACP desaturases (SAD) and acyl-acyl carrier protein (ACP) thioesterases (FAT). In both cases, these were found to be large gene families with complex expression profiles across a wide range of tissue types and developmental stages. The detailed classification of the oil palm SAD and FAT genes has enabled the updating of the latest version of the oil palm gene model. The second analysis focused on disease resistance (R) genes in order to elucidate possible candidates for breeding of pathogen tolerance/resistance. Ortholog analysis showed that 141 out of the 210 putative oil palm R genes had homologs in banana and rice. These genes formed 37 clusters with 634 orthologous genes. Classification of the 141 oil palm R genes showed that the genes belong to the Kinase (7), CNL (95), MLO-like (8), RLK (3) and Others (28) categories. The CNL R genes formed eight clusters. Expression data for selected R genes also identified potential candidates for breeding of disease resistance traits. Furthermore, these findings can provide information about the species evolution as well as the identification of agronomically important genes in oil palm and other major crops.	[Rosli, Rozana; Murphy, Denis J.] Univ South Wales, Genom & Computat Biol Res Grp, Pontypridd, M Glam, Wales; [Rosli, Rozana; Amiruddin, Nadzirah; Ab Halim, Mohd Amin; Chan, Pek-Lan; Chan, Kuang-Lim; Azizi, Norazah; Morris, Priscilla E.; Low, Eng-Ti Leslie; Ong-Abdullah, Meilina; Sambanthamurthi, Ravigadevi; Singh, Rajinder] Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia	University of South Wales; Malaysian Palm Oil Board	Murphy, DJ (corresponding author), Univ South Wales, Genom & Computat Biol Res Grp, Pontypridd, M Glam, Wales.	denis.murphy@southwales.ac.uk	Low, Eng Ti Leslie/AHD-7011-2022; Murphy, Denis J/ABC-1734-2020	Low, Eng Ti Leslie/0000-0003-3414-8401; Murphy, Denis J/0000-0002-5291-2445; Ong-Abdullah, Meilina/0000-0003-4825-5021	Malaysian Palm Oil Board; MPOB	Malaysian Palm Oil Board; MPOB	Funding was provided by a PhD studentship grant from Malaysian Palm Oil Board.; We thank the Director General of MPOB, Dr. Ahmad Kushairi Din, for his support and encouragement throughout the project. The first author would like to acknowledge MPOB for the Ph.D. sponsorship. Special thanks to MPOB Bioinformatics team member for their kind assistance. We also extend our appreciation to Dr. David Marshall and colleagues at the James Hutton Institute, Dundee, UK for their valuable advice and assistance with the comparative genome analysis and to Kirstie Goggin, USW, for helpful comments on the manuscript.	Abrizah O., 1999, Journal of Oil Palm Research, P81; Akmar ASN, 2008, J OIL PALM RES, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Basiron Y., 2015, PALM OIL TRADE FAIR; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Chan KL, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-017-0191-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dehesh K, 1996, PLANT J, V9, P167, DOI 10.1046/j.1365-313X.1996.09020167.x; Delteil A, 2010, RICE, V3, P56, DOI 10.1007/s12284-009-9035-x; DORMANN P, 1993, PLANTA, V189, P425, DOI 10.1007/BF00194441; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; Facciotti MT, 1998, FETT-LIPID, V100, P167; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Han YJ, 2017, THEOR APPL GENET, V130, P151, DOI 10.1007/s00122-016-2800-5; Haralampidis K, 1998, J EXP BOT, V49, P1661, DOI 10.1093/jexbot/49.327.1661; Huang RM, 2017, J AGR FOOD CHEM, V65, P4223, DOI 10.1021/acs.jafc.7b00922; Jia YX, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0208-x; Jin JJ, 2016, DNA RES, V23, P527, DOI 10.1093/dnares/dsw036; Jing FY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-44; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Koch MA, 2000, COMP GENOMICS REGULA, P1882; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lim FH, 2014, J OIL PALM RES, V26, P170; Liu Q, 2017, PLANT BIOTECHNOL J, V15, P132, DOI 10.1111/pbi.12598; Low E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100973; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Murphy DJ, 2007, EUR J LIPID SCI TECH, V109, P296, DOI 10.1002/ejlt.200600229; Murphy DJ, 2014, J OIL PALM RES, V26, P1; Murphy DJ, 1999, CURR OPIN BIOTECH, V10, P175, DOI 10.1016/S0958-1669(99)80031-7; NAGAI J, 1968, J BIOL CHEM, V243, P4626; Nurnadiah E, 2014, AGRIC AGRIC SCI PROC, V2, P90, DOI 10.1016/j.aaspro.2014.11.013; Parveez G. K. A., 2003, AgBiotechNet, V5, P1; Peraza-Echeverria S, 2007, MOL GENET GENOMICS, V278, P443, DOI 10.1007/s00438-007-0262-9; Rasid OA, 2014, J OIL PALM RES, V26, P265; Sambanthamurthi R, 2000, PROG LIPID RES, V39, P507, DOI 10.1016/S0163-7827(00)00015-1; Sambanthamurthi R, 1999, J OIL PALM RES, P23; Sambanthamurthi R, 1990, PLANT LIPID BIOCH ST; Sambanthamurthi R, 2010, MPOB INF SER; Sambanthamurthi R, 2011, BRIT J NUTR, V106, P1655, DOI 10.1017/S0007114511002121; Sanseverino W, 2013, NUCLEIC ACIDS RES, V41, pD1167, DOI 10.1093/nar/gks1183; Shah FH, 2000, PLANT SCI, V152, P27, DOI 10.1016/S0168-9452(99)00209-5; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Song WY, 1997, PLANT CELL, V9, P1279, DOI 10.1105/tpc.9.8.1279; Tamura K, 2013, MOL BIOL EVOLUTION N, V30; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tisne S, 2017, G3-GENES GENOM GENET, V7, P1683, DOI 10.1534/g3.117.041764; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pW78, DOI 10.1093/nar/gkv487; Yun ChoongHyo, 1999, Plant Pathology Journal, V15, P105	57	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0194792	10.1371/journal.pone.0194792	http://dx.doi.org/10.1371/journal.pone.0194792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672525	gold, Green Published, Green Submitted			2022-12-27	WOS:000430446800013
J	Abid, M; Nazir, HZ; Tahir, M; Riaz, M				Abid, Muhammad; Nazir, Hafiz Zafar; Tahir, Muhammad; Riaz, Muhammad			On designing a new cumulative sum Wilcoxon signed rank chart for monitoring process location	PLOS ONE			English	Article								In this paper, ranked set sampling is used for developing a non-parametric location chart which is developed on the basis of Wilcoxon signed rank statistic. The average run length and some other characteristics of run length are used as the measures to assess the performance of the proposed scheme. Some selective distributions including Laplace (or double exponential), logistic, normal, contaminated normal and student's t-distributions are considered to examine the performance of the proposed Wilcoxon signed rank control chart. It has been observed that the proposed scheme shows superior shift detection ability than some of the competing counterpart schemes covered in this study. Moreover, the proposed control chart is also implemented and illustrated with a real data set.	[Abid, Muhammad; Tahir, Muhammad] Govt Coll Univ, Dept Stat, Faisalabad, Pakistan; [Nazir, Hafiz Zafar] Univ Sargodha, Dept Stat, Sargodha, Pakistan; [Riaz, Muhammad] King Fahad Univ Petr & Minerals, Dept Math & Stat, Dhahran, Saudi Arabia	Government College University Faisalabad; University of Sargodha; King Fahd University of Petroleum & Minerals	Abid, M (corresponding author), Govt Coll Univ, Dept Stat, Faisalabad, Pakistan.	mabid@gcuf.edu.pk	Abid, Muhammad/AAI-1558-2020; Riaz, Muhammad/I-8259-2015	Riaz, Muhammad/0000-0002-7599-6928; Abid, Muhammad/0000-0001-8996-1120				Abid M, 2017, QUAL RELIAB ENG INT, V33, P669, DOI 10.1002/qre.2048; Abid M, 2017, QUAL RELIAB ENG INT, V33, P203, DOI 10.1002/qre.2000; Abid M, 2016, J CHIN INST ENG, V39, P627, DOI 10.1080/02533839.2016.1152165; Abujiya MR, 2004, J APPL STAT, V31, P1185, DOI 10.1080/0266476042000285549; Abujiya MR, 2012, QUALITY RELIABILITY, V30, P571; Abujiya MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124520; Al-Omari AI, 2012, J APPL STAT, V39, P745, DOI 10.1080/02664763.2011.611488; BAKIR ST, 1979, TECHNOMETRICS, V21, P175, DOI 10.2307/1268514; BARNARD GA, 1959, J ROY STAT SOC B, V21, P239; Chakraborti S, 2001, J QUAL TECHNOL, V33, P304; Gan FF, 1993, COMMUNICATIONS STAT, V23, P485; Gibbson JD, 2003, NONPARAMETRIC STAT I; Graham MA, 2011, COMPUT STAT DATA AN, V55, P2490, DOI 10.1016/j.csda.2011.02.013; Graham MA, 2011, 0904 U PRET DEP STAT; Haq A, 2016, QUAL RELIAB ENG INT, V32, P269, DOI 10.1002/qre.1747; Haq A, 2015, QUAL RELIAB ENG INT, V31, P1587, DOI 10.1002/qre.1694; Haq A, 2015, QUAL RELIAB ENG INT, V31, P1305, DOI 10.1002/qre.1712; Hettmansperger T.P., 1995, J NONPARAMETR STAT, V4, P263, DOI [10.1080/10485259508832617, DOI 10.1080/10485259508832617]; Kim D.H., 1996, KOREAN J COMPUTATION, V3, P235, DOI [10.1007/bf03008904, DOI 10.1007/BF03008904]; MCINTYRE GA, 1952, AUST J AGR RES, V3, P385, DOI 10.1071/AR9520385; Mehmood R, 2013, J APPL STAT, V40, P483, DOI 10.1080/02664763.2012.740624; Montgomery D.C., 2011, INTRO STAT QUALITY C, V6th; Muttlak HA., 2003, PAK J STAT, V19, P107; Salazar R. D., 1997, COMUNICACION TECICA; Tapang W, 2016, CHIANG MAI J SCI, V43, P914; WOODALL WH, 1983, TECHNOMETRICS, V25, P295, DOI 10.2307/1268615	26	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195762	10.1371/journal.pone.0195762	http://dx.doi.org/10.1371/journal.pone.0195762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664919	gold, Green Published, Green Submitted			2022-12-27	WOS:000430262300032
J	Kaur, A; Singh, B; Ohri, P; Wang, J; Wadhwa, R; Kau, SC; Pati, PK; Kaurl, A				Kaur, Amandeep; Singh, Baldev; Ohri, Puja; Wang, Jia; Wadhwa, Renu; Kau, Sunil C.; Pati, Pratap Kumar; Kaurl, Arvinder			Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost	PLOS ONE			English	Article							WITHANIA-SOMNIFERA; PLANT-GROWTH; HUMIC SUBSTANCES; CANCER-CELLS; LEAF EXTRACT; FOOD WASTE; GERMINATION; ACIDS; LEACHATE; SOIL	Withania somnifera (Ashwagandha) has recently been studied extensively for its health-supplementing and therapeutic activities against a variety of ailments. Several independent studies have experimentally demonstrated pharmaceutical potential of its active Withanolides, Withaferin A (Wi-A), Withanone (Wi-N) and Withanolide A (Wil-A). However, to promote its use in herbal industry, an environmentally sustainable cultivation and high yield are warranted. In modern agriculture strategies, there has been indiscriminate use of chemical fertilizers to boost the crop-yield, however the practice largely ignored its adverse effect on the quality of soil and the environment. In view of these, we attempted to recruit Vermicompost (Vcom, 20-100%) as an organic fertilizer of choice during the sowing and growing phases of Ashwagandha plants. We report that (i) pre-soaking of seeds for 12 h in Vermicompost leachate (Vcom-L) and Vermicompost tea (Vcom-T) led to higher germination, (ii) binary combination of pre-soaking of seeds and cultivation in Vcom (up to 80%) resulted in further improvement both in germination and seedling growth, (iii) cultivated plants in the presence of Vcom+Vcom-L showed higher leaf and root mass, earlier onset of flowering and fruiting and (iv) leaves from the Vcom+Vcom-L cultivated plants showed higher level of active Withanolides, Withanone (Wi-N), Withanolide A (Wil-A) and Withaferin A (Wi-A) and showed anticancer activities in cell culture assays. Taken together, we report a simple and inexpensive method for improving the yield and pharmaceutical components of Ashwagandha leaves.	[Kaur, Amandeep; Ohri, Puja; Kaurl, Arvinder] Guru Nanak Dev Univ, Dept Zool, Amritsar, Punjab, India; [Singh, Baldev; Pati, Pratap Kumar] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Wang, Jia; Wadhwa, Renu; Kau, Sunil C.] Natl Inst Adv Ind Sci & Technol, DAILAB, Drug Discovery & Assets Innovat Lab, Tsukuba, Ibaraki, Japan	Guru Nanak Dev University; Guru Nanak Dev University; National Institute of Advanced Industrial Science & Technology (AIST)	Kaurl, A (corresponding author), Guru Nanak Dev Univ, Dept Zool, Amritsar, Punjab, India.; Pati, PK (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.; Kau, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, DAILAB, Drug Discovery & Assets Innovat Lab, Tsukuba, Ibaraki, Japan.	s-kaul@aist.go.jp; pkpati@yahoo.com; arvinder165@gmail.com	Wadhwa, Renu/L-8898-2018; Kaul, Sunil/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil/0000-0002-0046-3916; pati, pratap/0000-0001-9017-7608; Ohri, Puja/0000-0002-4528-2385	INSPIRE Fellowship (Department of Science and Technology, Government of India); UPE grant (UGC); SAP grant (UGC); DBT (Govt. of India); AIST (Japan) funds	INSPIRE Fellowship (Department of Science and Technology, Government of India); UPE grant (UGC); SAP grant (UGC); DBT (Govt. of India)(Department of Biotechnology (DBT) India); AIST (Japan) funds	Financial assistance in the form of INSPIRE Fellowship (Department of Science and Technology, Government of India) to AmK as well as UPE and SAP grants (UGC) are duly acknowledged. The work was supported by DBT (Govt. of India) and AIST (Japan) funds.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arancon NQ, 2008, APPL SOIL ECOL, V39, P91, DOI 10.1016/j.apsoil.2007.11.010; Arancon NQ, 2006, EUR J SOIL BIOL, V42, pS65, DOI 10.1016/j.ejsobi.2006.06.004; Arancon NQ, 2012, HORTSCIENCE, V47, P1722, DOI 10.21273/HORTSCI.47.12.1722; Arancon NQ, 2004, BIORESOURCE TECHNOL, V93, P139, DOI 10.1016/j.biortech.2003.10.015; Aremu AO, 2015, PLANT GROWTH REGUL, V75, P483, DOI 10.1007/s10725-014-0011-0; Aremu AO, 2014, ACTA PHYSIOL PLANT, V36, P721, DOI 10.1007/s11738-013-1450-3; Atiyeh RM, 2000, PEDOBIOLOGIA, V44, P579, DOI 10.1078/S0031-4056(04)70073-6; Atiyeh RM, 2002, BIORESOURCE TECHNOL, V84, P7, DOI 10.1016/S0960-8524(02)00017-2; Ayyobi H., 2014, International Journal of Vegetable Science, V20, P21, DOI 10.1080/19315260.2012.753496; Bhattacharya SK, 2003, PHARMACOL BIOCHEM BE, V75, P547, DOI 10.1016/S0091-3057(03)00110-2; Biau A, 2012, EUR J SOIL BIOL, V53, P56, DOI 10.1016/j.ejsobi.2012.08.008; Campbell BJ, 2008, ENVIRON MICROBIOL, V12, P1842; Canellas LP, 2002, PLANT PHYSIOL, V130, P1951, DOI 10.1104/pp.007088; Canellas LP, 2013, PLANT SOIL, V366, P119, DOI 10.1007/s11104-012-1382-5; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Chen Y., 1990, Humic substances in soil and crop sciences: selected readings. Proceedings of a symposium cosponsored by the International Humic Substances Society, Chicago, Illinois, December 2, 1985., P161; Clapp CE., 2010, UNDERSTANDING MANAGI, P243; Coolon JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067884; Dinesh Giri, 2012, Scientific Research and Essays, V7, P1835, DOI 10.5897/SRE11.1349; Dominguez Jorge, 2004, P401; Garcia Martinez Ignacio, 2002, Crop Research (Hisar), V24, P323; Gupta R., 2011, INT J RECYCL ORG WAS, V3, P47, DOI [10.1007/s40093-014-0047-1, DOI 10.1007/S40093-014-0047-1]; Kattimani KN, 1999, SEED SCI TECHNOL, V27, P483; Kaul SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166945; Kaur A, 2010, BIORESOURCE TECHNOL, V101, P8192, DOI 10.1016/j.biortech.2010.05.041; KHAN A A, 1978, Acta Horticulturae (Wageningen), P267; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Lazcano C, 2011, J SCI FOOD AGR, V91, P1244, DOI 10.1002/jsfa.4306; Matejovic I, 1997, COMMUN SOIL SCI PLAN, V28, P1499, DOI 10.1080/00103629709369892; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Muscolo A, 1999, SOIL BIOL BIOCHEM, V31, P1303, DOI 10.1016/S0038-0717(99)00049-8; Muscolo A, 1998, SOIL BIOL BIOCHEM, V30, P1199, DOI 10.1016/S0038-0717(98)00005-4; Najar I., 2013, ACTA BIOL MALAYS, V2, P12; Powell KI, 2009, INT J PLANT SCI, V170, P918, DOI 10.1086/600140; Reigosa MJ, 1999, PLANT GROWTH REGUL, V28, P83, DOI 10.1023/A:1006269716762; Sangwan Pritam, 2010, Environmentalist, V30, P123, DOI 10.1007/s10669-009-9251-3; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Savci S, 2012, APCBEE PROC, V1, P287, DOI 10.1016/j.apcbee.2012.03.047; Singh J, 2010, ECOTOX ENVIRON SAFE, V73, P430, DOI 10.1016/j.ecoenv.2009.08.019; Singh P, 2015, BIOTECHNOL GENET ENG, V31, P1, DOI 10.1080/02648725.2015.1020467; Singh R, 2010, SCI HORTIC-AMSTERDAM, V124, P34, DOI 10.1016/j.scienta.2009.12.002; Singh R, 2008, BIORESOURCE TECHNOL, V99, P8507, DOI 10.1016/j.biortech.2008.03.034; Singh S, 2014, SEED SCI RES, V24, P63, DOI 10.1017/S0960258513000408; Sinha R. K., 2010, Agricultural Sciences, V1, P76, DOI 10.4236/as.2010.12011; Tattini M., 1991, Acta Horticulturae, P75; Trevisan S, 2011, ENVIRON EXP BOT, V74, P45, DOI 10.1016/j.envexpbot.2011.04.017; Vadiraj B. A., 1998, Journal of Spices and Aromatic Crops, V7, P141; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Winters M, 2006, ALTERN MED REV, V11, P269; Yeoung YR, 1996, SEED SCI TECHNOL, V24, P429; Yu Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.33	55	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194314	10.1371/journal.pone.0194314	http://dx.doi.org/10.1371/journal.pone.0194314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659590	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100002
J	Logroscino, G; Marin, B; Piccininni, M; Arcuti, S; Chio, A; Hardiman, O; Rooney, J; Zoccolella, S; Couratier, P; Preux, PM; Beghi, E				Logroscino, Giancarlo; Marin, Benoit; Piccininni, Marco; Arcuti, Simona; Chio, Adriano; Hardiman, Orla; Rooney, James; Zoccolella, Stefano; Couratier, Philippe; Preux, Pierre-Marie; Beghi, Ettore		EURALS	Referral bias in ALS epidemiological studies	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EL-ESCORIAL; ASSESSING SURVIVAL; CLINICAL-TRIALS; POPULATION; CRITERIA; IRELAND; DIAGNOSIS; PROGNOSIS; DISEASE	Background Despite concerns about the representativeness of patients from ALS tertiary centers as compared to the ALS general population, the extent of referral bias in clinical studies remains largely unknown. Using data from EURALS consortium we aimed to assess nature, extent and impact of referral bias. Methods Four European ALS population-based registries located in Ireland, Piedmont, Puglia, Italy, and Limousin, France, covering 50 million person-years, participated. Demographic and clinic characteristics of ALS patients diagnosed in tertiary referral centers were contrasted with the whole ALS populations enrolled in registries in the same geographical areas. Results Patients referred to ALS centers were younger (with difference ranging from 1.1 years to 2.4 years), less likely to present a bulbar onset, with a higher proportion of familial antecedents and a longer survival (ranging from 11% to 15%) when compared to the entire ALS population in the same geographic area. Conclusions A trend for referral bias is present in cohorts drawn from ALS referral centers. The magnitude of the possible referral bias in a particular tertiary center can be estimated through a comparison with ALS patients drawn from registry in the same geographic area. Studies based on clinical cohorts should be cautiously interpreted. The presence of a registry in the same area may improve the complete ascertainment in the referral center.	[Logroscino, Giancarlo; Marin, Benoit; Zoccolella, Stefano] Univ Ban Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Logroscino, Giancarlo; Marin, Benoit; Piccininni, Marco; Arcuti, Simona; Preux, Pierre-Marie] Univ Ban Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Lecce, Italy; [Marin, Benoit; Couratier, Philippe; Preux, Pierre-Marie] INSERM, UMR1094, Trop Neuroepidemiol, Limoges, France; [Marin, Benoit; Couratier, Philippe; Preux, Pierre-Marie] Univ Limoges, Sch Med, Inst Neuroepidemiol & Trop Neurol, CNRS,FR 3503,GEIST, Limoges, France; [Marin, Benoit] CHU Limoges, Ctr Epiderniol Biostat & Methodol Rech, Limoges, France; [Marin, Benoit; Beghi, Ettore] IRCCS Ist Ric Farmacol Mario Negri, Dipartimento Neurosci, La Malattie Neurol, Milan, Italy; [Chio, Adriano] Univ Turin, Dept Neurosci, ALS Ctr, Turin, Italy; [Chio, Adriano] NIT, Turin, Italy; [Chio, Adriano] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Hardiman, Orla; Rooney, James] Trinity Coll Dublin, Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland; [Couratier, Philippe] CHU Limoges, Serv Neurol, Ctr Expert SLA, Limoges, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Franche-Comte; Universite de Limoges; CHU Limoges; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Trinity College Dublin; CHU Limoges	Logroscino, G (corresponding author), Univ Ban Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy.; Logroscino, G (corresponding author), Univ Ban Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Lecce, Italy.	giancarlo.logroscino@uniba.it	Rooney, James/J-9190-2019; Hardiman, Orla/Y-3441-2019; Preux, Pierre-Marie/N-3538-2019; MARIN, Benoit/E-2356-2015; Beghi, Ettore/AAA-7426-2020; zoccolella, stefano/AAA-2515-2020; Logroscino, Giancarlo/K-5148-2016	Rooney, James/0000-0001-6346-0731; Hardiman, Orla/0000-0003-2610-1291; Preux, Pierre-Marie/0000-0002-2171-2977; MARIN, Benoit/0000-0001-8857-0910; Beghi, Ettore/0000-0003-2542-0469; Chio, Adriano/0000-0001-9579-5341; Logroscino, Giancarlo/0000-0003-0423-3242; Piccininni, Marco/0000-0002-1397-0060	Health Research Programme Clinical Fellowship Programme; Health Research Board Clinician Scientist Programme; Euro-MOTOR FP7 [259867]; Motor Neurone Disease Association; ALS Association; National Institute for Health Research; European Commission; Medical Research Council; Economic and Social Research Council; Italian Ministry of Health (Ricerca Finalizzata); University of Turin; Fondazione Vialli e Mauro onlus	Health Research Programme Clinical Fellowship Programme; Health Research Board Clinician Scientist Programme; Euro-MOTOR FP7; Motor Neurone Disease Association; ALS Association; National Institute for Health Research(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy); University of Turin; Fondazione Vialli e Mauro onlus	James Rooney was funded by the Health Research Programme Clinical Fellowship Programme. Marwa Elamin, Alice Vajda and Mark Heverin report no disclosures and no conflicts of interest. Orla Hardiman is funded by the Health Research Board Clinician Scientist Programme. Prof. Hardiman has received speaking honoraria from Novarits, Biogen Idec, Sanofi Aventis and Merck-Serono. She has been a member of advisory panels for Biogen Idec, Allergen, Ono Pharmaceuticals, Novartis, Cytokinetics and Sanofi Aventis. She serves as Editor-in-Chief of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. She funded by Euro-MOTOR FP7/2007-2013, grant agreement 259867 Giancarlo Logroscino, serves as associate editor for the Neuroepidemiolgy journal, Karger. He received founding from Ministry of Health, Ministry of University and Research, Regione Puglia Special program for research. He funded by Euro-MOTOR FP7/2007-2013, grant agreement 259867. Adriano Chia has grants from the Motor Neurone Disease Association, ALS Association, National Institute for Health Research, European Commission, Medical Research Council and Economic and Social Research Council. He has grants from Italian Ministry of Health (Ricerca Finalizzata), University of Turin, and Fondazione Vialli e Mauro onlus. Ettore Beghi reports research grants from European Union [Euro-MOTOR (FP7/2007-2013, grant agreement 259867)], The American ALS Association, UCB-Pharma, the Italian Ministry of Health, the Italian Drug Agency, the Fondazione Borgonovo, and the Associazione IDIC-15, outside the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghi E, 2007, NEUROLOGY, V68, P141, DOI 10.1212/01.wnl.0000250339.14392.bb; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Byrne S, 2013, ANN NEUROL, V74, P699, DOI 10.1002/ana.23969; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; Chio A, 2001, NEUROLOGY, V56, P239; Chio A, 2006, J NEUROL NEUROSUR PS, V77, P948, DOI 10.1136/jnnp.2005.083402; Chio A, 2011, NEUROLOGY, V77, P1432, DOI 10.1212/WNL.0b013e318232ab9b; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Dandaba M, 2017, NEUROEPIDEMIOLOGY, V49, P64, DOI 10.1159/000479969; Di Poggio MB, 2013, AMYOTROPH LAT SCL FR, V14, P52, DOI 10.3109/17482968.2012.729062; Donaghy C, 2010, AMYOTROPH LATERAL SC, V11, P374, DOI 10.3109/17482960903329569; Dreyer P, 2014, AMYOTROPH LAT SCL FR, V15, P62, DOI 10.3109/21678421.2013.837929; Forbes RB, 2004, AGE AGEING, V33, P131, DOI 10.1093/ageing/afh013; Gladman M, 2014, AMYOTROPH LAT SCL FR, V15, P426, DOI 10.3109/21678421.2014.932382; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; KURLAND LT, 1955, NEUROLOGY, V5, P249, DOI 10.1212/WNL.5.4.249; Langefeld CD, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.07.017; LEE JRJ, 1995, J NEUROL SCI, V132, P207, DOI 10.1016/0022-510X(95)00154-T; Liu MS, 2014, ACTA NEUROL SCAND, V129, P163, DOI 10.1111/ane.12157; Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828; Logroscino G, 2007, NEUROLOGY, V69, P939, DOI 10.1212/01.wnl.0000281904.21495.cb; Logroscino G, 2005, J NEUROL NEUROSUR PS, V76, P1094, DOI 10.1136/jnnp.2004.039180; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Mandrioli J, 2014, AMYOTROPH LAT SCL FR, V15, P262, DOI 10.3109/21678421.2013.865752; Marin B, 2014, EUR J NEUROL, V21, P1292, DOI 10.1111/ene.12474; Marin B, 2016, EUR J EPIDEMIOL, V31, P229, DOI 10.1007/s10654-015-0090-x; Millul A, 2005, NEUROEPIDEMIOLOGY, V25, P114, DOI 10.1159/000086353; Mitsumoto H, 2014, LANCET NEUROL, V13, P1127, DOI 10.1016/S1474-4422(14)70129-2; Ng L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007425.pub2; Pradas J, 2013, AMYOTROPH LAT SCL FR, V14, P278, DOI 10.3109/21678421.2012.749915; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rooney J, 2015, J NEUROL NEUROSUR PS, V86, P496, DOI 10.1136/jnnp-2014-309601; Rooney J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074733; Rooney JPK, 2017, NEUROLOGY, V88, P2321, DOI 10.1212/WNL.0000000000004038; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sabatelli M, 2013, CLIN GENET, V83, P408, DOI 10.1111/cge.12117; Sorenson EJ, 2007, NEUROLOGY, V68, P600, DOI 10.1212/01.wnl.0000254501.58158.e7; Spataro R, 2011, J NEUROL SCI, V304, P44, DOI 10.1016/j.jns.2011.02.016; STRONG MJ, 1991, CAN J NEUROL SCI, V18, P45, DOI 10.1017/S0317167100031280; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; Traynor BJ, 2003, J NEUROL NEUROSUR PS, V74, P1258, DOI 10.1136/jnnp.74.9.1258; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101186; Zoccolella S, 2007, J NEUROL, V254, P1107, DOI 10.1007/s00415-006-0401-y	46	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195821	10.1371/journal.pone.0195821	http://dx.doi.org/10.1371/journal.pone.0195821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659621	Green Submitted, Green Published, gold			2022-12-27	WOS:000430061100034
J	Baker, J; Falconer, AMD; Wilkinson, DJ; Europe-Finner, GN; Litherland, GJ; Rowan, AD				Baker, Jonathan; Falconer, Adrian M. D.; Wilkinson, David J.; Europe-Finner, G. Nicholas; Litherland, Gary J.; Rowan, Andrew D.			Protein kinase D3 modulates MMP1 and MMP13 expression in human chondrocytes	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CARTILAGE COLLAGEN BREAKDOWN; ONCOSTATIN-M; MATRIX METALLOPROTEINASES; PROINFLAMMATORY CYTOKINES; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; GENE-EXPRESSION; FACTOR-ALPHA; IN-VITRO	Many catabolic stimuli, including interleukin-1 (IL-1) in combination with oncostatin M (OSM), promote cartilage breakdown via the induction of collagen-degrading collagenases such as matrix metalloproteinase 1 (MMP1) and MMP13 in human articular chondrocytes. Indeed, joint diseases with an inflammatory component are characterised by excessive extracellular matrix (ECM) catabolism. Importantly, protein kinase C (PKC) signalling has a primary role in cytokine-induced MMP1/13 expression, and is known to regulate cellular functions associated with pathologies involving ECM remodelling. At present, substrates downstream of PKC remain undefined. Herein, we show that both IL-1-and OSM-induced phosphorylation of protein kinase D (PKD) in human chondrocytes is strongly associated with signalling via the atypical PKC. isoform. Consequently, inhibiting PKD activation with a pan-PKD inhibitor significantly reduced the expression of MMP1/13. Specific gene silencing of the PKD isoforms revealed that only PKD3 (PRKD3) depletion mirrored the observed MMP repression, indicative of the pharmacological inhibitor specifically affecting only this isoform. PRKD3 silencing was also shown to reduce serine phosphorylation of signal transducer and activator of transcription 3 (STAT3) as well as phosphorylation of all three mitogen-activated protein kinase groups. This altered signalling following PRKD3 silencing led to a significant reduction in the expression of the activator protein-1 (AP-1) genes FOS and JUN, critical for the induction of many MMPs including MMP1/13. Furthermore, the AP-1 factor activating transcription factor 3 (ATF3) was also reduced concomitant with the observed reduction in MMP13 expression. Taken together, we highlight an important role for PKD3 in the pro-inflammatory signalling that promotes cartilage destruction.	[Baker, Jonathan; Falconer, Adrian M. D.; Wilkinson, David J.; Europe-Finner, G. Nicholas; Litherland, Gary J.; Rowan, Andrew D.] Newcastle Univ, Inst Med Genet, Skeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Baker, Jonathan] Imperial Coll, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Litherland, Gary J.] Univ West Scotland, Sch Sci & Sport, Paisley Campus, Paisley, Renfrew, Scotland	Newcastle University - UK; Imperial College London; University of West Scotland	Rowan, AD (corresponding author), Newcastle Univ, Inst Med Genet, Skeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.	drew.rowan@ncl.ac.uk	Litherland, Gary J/K-9755-2015	Falconer, Adrian/0000-0001-7362-0313; Wilkinson, David/0000-0002-6262-3575	Arthritis Research UK [19322]; NIHR Newcastle Biomedical Research Centre; Northumberland, Tyne and Wear Comprehensive Local Research Network	Arthritis Research UK(Versus Arthritis); NIHR Newcastle Biomedical Research Centre; Northumberland, Tyne and Wear Comprehensive Local Research Network	ADR and GJL received funding from Arthritis Research UK (grant 19322; http//www.arthritisresearchuk.org/), and the NIHR Newcastle Biomedical Research Centre. Clinical and translational research was supported by the Northumberland, Tyne and Wear Comprehensive Local Research Network. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Catterall JB, 2001, ARTHRITIS RHEUM-US, V44, P2296, DOI 10.1002/1529-0131(200110)44:10<2296::AID-ART392>3.0.CO;2-9; Chan CM, 2017, J BIOL CHEM, V292, P1625, DOI 10.1074/jbc.M116.756601; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Higashiyama R, 2010, MOD RHEUMATOL, V20, P11, DOI 10.1007/s10165-009-0224-7; Huesa C, 2016, ANN RHEUM DIS, V75, P1989, DOI 10.1136/annrheumdis-2015-208268; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Hui W, 2003, ANN RHEUM DIS, V62, P172, DOI 10.1136/ard.62.2.172; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jeong YJ, 2015, INT IMMUNOPHARMACOL, V25, P400, DOI 10.1016/j.intimp.2015.02.021; Jones SW, 2006, OSTEOARTHR CARTILAGE, V14, P597, DOI 10.1016/j.joca.2006.01.007; JUBB RW, 1980, J PATHOL, V130, P159, DOI 10.1002/path.1711300304; Kim YI, 2010, J IMMUNOL, V184, P3145, DOI 10.4049/jimmunol.0903718; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McEneaney V, 2010, J STEROID BIOCHEM, V118, P18, DOI 10.1016/j.jsbmb.2009.09.014; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239; Rey O, 2006, J BIOL CHEM, V281, P5149, DOI 10.1074/jbc.M508014200; Rogers EM, 2005, MECH DEVELOP, V122, P1194, DOI 10.1016/j.mod.2005.07.002; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Rowan AD, 2007, FRONT BIOSCI-LANDMRK, V12, P536, DOI 10.2741/2080; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Staunton D, 1998, PROTEIN ENG, V11, P1093, DOI 10.1093/protein/11.11.1093; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Waldron RT, 2007, BIOCHEM BIOPH RES CO, V356, P361, DOI 10.1016/j.bbrc.2007.02.142; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	46	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195864	10.1371/journal.pone.0195864	http://dx.doi.org/10.1371/journal.pone.0195864			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652915	gold, Green Submitted, Green Published			2022-12-27	WOS:000430026900041
J	Kristoffersen, DT; Helgeland, J; Clench-Aas, J; Laake, P; Veierod, MB				Kristoffersen, Doris Tove; Helgeland, Jon; Clench-Aas, Jocelyne; Laake, Petter; Veierod, Marit B.			Observed to expected or logistic regression to identify hospitals with high or low 30-day mortality?	PLOS ONE			English	Article							SURGERY; MODELS; IMPACT; BAYES; BIAS	Introduction A common quality indicator for monitoring and comparing hospitals is based on death within 30 days of admission. An important use is to determine whether a hospital has higher or lower mortality than other hospitals. Thus, the ability to identify such outliers correctly is essential. Two approaches for detection are: 1) calculating the ratio of observed to expected number of deaths (OE) per hospital and 2) including all hospitals in a logistic regression (LR) comparing each hospital to a form of average over all hospitals. The aim of this study was to compare OE and LR with respect to correctly identifying 30-day mortality outliers. Modifications of the methods, i.e., variance corrected approach of OE (OE-Faris), bias corrected LR (LR-Firth), and trimmed mean variants of LR and LR-Firth were also studied. Materials and methods To study the properties of OE and LR and their variants, we performed a simulation study by generating patient data from hospitals with known outlier status (low mortality, high mortality, non-outlier). Data from simulated scenarios with varying number of hospitals, hospital volume, and mortality outlier status, were analysed by the different methods and compared by level of significance (ability to falsely claim an outlier) and power (ability to reveal an outlier). Moreover, administrative data for patients with acute myocardial infarction (AMI), stroke, and hip fracture from Norwegian hospitals for 2012-2014 were analysed. Results None of the methods achieved the nominal (test) level of significance for both low and high mortality outliers. For low mortality outliers, the levels of significance were increased four-to fivefold for OE and OE-Faris. For high mortality outliers, OE and OE-Faris, LR 25% trimmed and LR-Firth 10% and 25% trimmed maintained approximately the nominal level. The methods agreed with respect to outlier status for 94.1% of the AMI hospitals, 98.0% of the stroke, and 97.8% of the hip fracture hospitals. Conclusion We recommend, on the balance, LR-Firth 10% or 25% trimmed for detection of both low and high mortality outliers.	[Kristoffersen, Doris Tove; Helgeland, Jon] Norwegian Inst Publ Hlth, Div Hlth Serv, Oslo, Norway; [Clench-Aas, Jocelyne] Norwegian Inst Publ Hlth, Div Phys & Mental Hlth, Oslo, Norway; [Laake, Petter; Veierod, Marit B.] Univ Oslo, Inst Basic Med Sci, Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway	Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); University of Oslo	Kristoffersen, DT (corresponding author), Norwegian Inst Publ Hlth, Div Hlth Serv, Oslo, Norway.	DorisTove.Kristoffersen@fhi.no	Veierød, Marit B/J-8229-2019; Kristoffersen, Doris Tove/GWQ-3158-2022	Veierød, Marit B/0000-0002-2083-2758; Kristoffersen, Doris Tove/0000-0002-8220-2532	Research Council of Norway [160340]	Research Council of Norway(Research Council of Norway)	DTK received support from the Research Council of Norway, grant number 160340. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu R, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0029-x; Alexandrescu R, 2011, J AM COLL SURGEONS, V213, P392, DOI 10.1016/j.jamcollsurg.2011.06.423; Austin PC, 2007, STAT MED, V26, P2937, DOI 10.1002/sim.2770; BENDRE SM, 1989, COMMUN STAT THEORY, V18, P697, DOI 10.1080/03610928908829928; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bottle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7116; Brand C, 2013, HOSP MORTALITY INDIC; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; Ettinger WH, 2008, AM J MED QUAL, V23, P90, DOI 10.1177/1062860607313141; Faris PD, 2003, J CLIN EPIDEMIOL, V56, P553, DOI 10.1016/S0895-4356(03)00048-9; Fedeli U, 2007, J CLIN EPIDEMIOL, V60, P858, DOI 10.1016/j.jclinepi.2006.11.017; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Guo WG, 2015, J STAT PLAN INFER, V163, P21, DOI 10.1016/j.jspi.2015.02.009; Hannan EL, 2005, MED CARE, V43, P726, DOI 10.1097/01.mlr.0000167802.27044.44; Hassani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136547; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; HOSMER DW, 1995, STAT MED, V14, P2161, DOI 10.1002/sim.4780141909; Huang IC, 2005, MED DECIS MAKING, V25, P20, DOI 10.1177/0272989X04273138; KIM SJ, 1992, ANN STAT, V20, P1534, DOI 10.1214/aos/1176348783; Kristoffersen DT, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006741; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Little RJ, 2006, AM STAT, V60, P213, DOI 10.1198/000313006X117837; Manktelow BN, 2014, BMJ QUAL SAF, V23, P782, DOI 10.1136/bmjqs-2013-002608; Mohammed MA, 2016, STAT METHODS MED RES, V25, P706, DOI 10.1177/0962280212465165; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; OECD /EU, HLTH GLANC EUR 2016; Pouw ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059160; Racz MJ, 2010, J AM STAT ASSOC, V105, P48, DOI 10.1198/jasa.2010.ap07175; Ryan A, 2012, HEALTH SERV RES, V47, P1699, DOI 10.1111/j.1475-6773.2012.01382.x; SCHEFFE H, 1956, ANN MATH STAT, V27, P251, DOI 10.1214/aoms/1177728258; Scheffe H., 1959, ANAL VARIANCE, P331; Searle SR., 2009, VARIANCE COMPONENTS; Shahian DM, 2015, BMJ QUAL SAF, V24, P95, DOI 10.1136/bmjqs-2015-003934; Sosunov EA, 2016, MED CARE, V54, P373, DOI 10.1097/MLR.0000000000000476; STIGLER SM, 1973, ANN STAT, V1, P472, DOI 10.1214/aos/1176342412; Team RC., 2013, R LANG ENV STAT COMP; THOMAS N, 1994, STAT MED, V13, P889, DOI 10.1002/sim.4780130902; WHO, 2018, INT CLASS DIS ICD; Wilcox R.R., 2014, INTRO ROBUST ESTIMAT	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195248	10.1371/journal.pone.0195248	http://dx.doi.org/10.1371/journal.pone.0195248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652941	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900019
J	Wurschinger, F; Wittmann, S; Goldfuss, S; Zech, N; Debl, K; Hilker, M; Graf, BM; Zausig, YA				Wurschinger, Fabian; Wittmann, Sigrid; Goldfuss, Sophia; Zech, Nina; Debl, Kurt; Hilker, Michael; Graf, Bernhard M.; Zausig, York A.			Complications after transcatheter aortic valve implantation using transfemoral and transapical approach in general anaesthesia	PLOS ONE			English	Article							PERMANENT PACEMAKER IMPLANTATION; REPLACEMENT; STENOSIS; MANAGEMENT; DISEASE; RISK; PREDICTORS; OUTCOMES; SURGERY; PATIENT	Background Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure used to treat degenerative heart valve disease. The implantation requires a highly specific and interdisciplinary management approach. Currently, TAVI is performed with the patient under local or general anaesthesia. Methods This study was a retrospective analysis of all TAVI procedures performed at the University Hospital of Regensburg between January 2009 and July 2015. All pre-, intra and postoperative data focusing on perioperative complications were recorded. Results A total of 853 transfemoral-and transapical-TAVI patients were included in the study. All patients underwent general anaesthesia. The ASA classifications were primarily 3-4. The average logistic EuroScores for the transfemoral-and transapical-TAVI patients were 18 +/- 12% and 21 +/- 15% (p = 0.002), respectively. The anaesthesia coverage time was 170 +/- 49 min., including 37 +/- 12 minutes for anaesthetic management. Overall, 458 complications were recorded; with pneumonia, acute renal failure, indication for a permanent pacemaker and non-extubation in the operating theatre the most frequently recorded complications. Conclusion In the present study, we showed that our patients' outcomes are comparable to those reported in the available literature. Compared to TF, TA patients show an overall worse physical condition as well as a higher perioperative morbidity and mortality. Consequently TA patients need additional care and should only be operated in appropriately experienced medical centres.	[Wurschinger, Fabian; Wittmann, Sigrid; Goldfuss, Sophia; Zech, Nina; Graf, Bernhard M.; Zausig, York A.] Univ Klinikum Regensburg, Klin Andsthesiol, Regensburg, Germany; [Debl, Kurt] Univ Klinikum Regensburg, Med Klin 2, Intens Med, Regensburg, Germany; [Hilker, Michael] Univ Klinikum Regensburg, Klin Herz Thorax Chirurg, Regensburg, Germany	University of Regensburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; University of Regensburg	Zausig, YA (corresponding author), Univ Klinikum Regensburg, Klin Andsthesiol, Regensburg, Germany.	York.zausig@ukr.de						Barbash IM, 2012, AM HEART J, V163, P1031, DOI 10.1016/j.ahj.2012.01.009; Biancari F, 2016, AM J CARDIOL, V117, P245, DOI 10.1016/j.amjcard.2015.10.036; Brecker SJD, 2016, AM J CARDIOL, V117, P1332, DOI 10.1016/j.amjcard.2016.01.027; Covello RD, 2010, MINERVA ANESTESIOL, V76, P100; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Erdogan HB, 2006, J CARDIAC SURG, V21, P211, DOI 10.1111/j.1540-8191.2006.00216.x; Frohlich GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-41; Hamm CW, 2016, INTERNIST, V57, P304, DOI 10.1007/s00108-016-0028-8; Hamm CW, 2016, EUR HEART J, V37, P803, DOI 10.1093/eurheartj/ehv574; Hare GMT, 2013, CAN J ANESTH, V60, P168, DOI 10.1007/s12630-012-9861-y; Hausman MS, 2015, ANESTH ANALG, V120, P1405, DOI 10.1213/ANE.0000000000000574; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1093/ejcts/ezs533, 10.1016/j.jacc.2012.09.001]; Klein AA, 2014, ANESTH ANALG, V119, P784, DOI 10.1213/ANE.0000000000000400; Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Lynch JP, 2001, CHEST, V119, p373S, DOI 10.1378/chest.119.2_suppl.373S; Martinsson A, 2015, CIRCULATION, V131, P988, DOI 10.1161/CIRCULATIONAHA.114.012906; Oguri A, 2014, CIRC-CARDIOVASC INTE, V7, P602, DOI 10.1161/CIRCINTERVENTIONS.113.000403; Pascual I, 2017, J THORAC DIS, V9, pS478, DOI 10.21037/jtd.2017.05.73; Polanczyk CA, 2001, ANN INTERN MED, V134, P637, DOI 10.7326/0003-4819-134-8-200104170-00008; Riediger C, 2011, ANAESTHESIST, V60, P1095, DOI 10.1007/s00101-011-1972-2; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Siontis GCM, 2014, J AM COLL CARDIOL, V64, P129, DOI 10.1016/j.jacc.2014.04.033; Stahli BE, 2013, CARDIOLOGY, V126, P15, DOI 10.1159/000351438; Steinberg BA, 2012, AM HEART J, V164, P664, DOI 10.1016/j.ahj.2012.07.028; Walther T, 2012, ANN CARDIOTHORAC SUR, V1, P216, DOI 10.3978/j.issn.2225-319X.2012.07.10	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0193558	10.1371/journal.pone.0193558	http://dx.doi.org/10.1371/journal.pone.0193558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652895	gold, Green Published, Green Submitted			2022-12-27	WOS:000430026900003
J	Choi, SY; Lim, HA; Yim, HW; Park, YH				Choi, Seung Yong; Lim, Hyun-A.; Yim, Hyeon Woo; Park, Young-Hoon			Administration of oral fluoroquinolone and the risk of rhegmatogenous retinal detachment: A nationwide population-based study in Korea	PLOS ONE			English	Article							ASSOCIATION; OFLOXACIN; CIPROFLOXACIN; PENETRATION; FLUMEQUINE; METFORMIN; TENDON	Purpose To investigate the association between oral fluoroquinolones (FQ) and the risk of rhegmatogenous retinal detachment (RRD) using a nationwide population-based study in Korea, designed to control for time-related bias. Methods As a nested case-control study within a cohort, the KNHIS-NSC 2002-2013 (Korean National Health Insurance Service National Sample Cohort) data used for the investigation. The subjects who visited an ophthalmologist were included in a cohort. Subjects with infectious ocular diseases, severe ocular trauma, and congenital diseases were excluded. Within the cohort, subjects who underwent surgery for RRD were defined as cases, and controls were matched by age group, sex, and cohort entry date using an incidence density sampling method. After investigating the exposure to oral FQ, the odds ratio was calculated by the FQ exposure rate of both groups and adjusted by the confounding factors of demography, health service utilization, and comorbidities. Results A total of 1,151 subjects in the case group and 11,470 subjects in the control group were included. There were intergroup differences in household income, numbers of ophthalmologic visits and drug prescriptions, events of intraocular surgeries, and prevalence of diabetes and degenerative myopia (all P's<0.05). The crude odds ratio of the total group was 1.06 (P = 0.53, 95% CI 0.88-1.28), and the odds ratio adjusted for all pre-defined confounders was 1.00 (P = 0.99, 95% CI 0.81-1.24). The crude and adjusted odds ratios were not showed statistical significance (all P's>0.05). Conclusions By the nested case-control design, this study showed that oral administration of FQ was not associated with the increased risk of development of RRD.	[Choi, Seung Yong; Park, Young-Hoon] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea; [Lim, Hyun-A.; Yim, Hyeon Woo] Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea; [Park, Young-Hoon] Catholic Univ Korea, Catholic Inst Visual Sci, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Park, YH (corresponding author), Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea.; Park, YH (corresponding author), Catholic Univ Korea, Catholic Inst Visual Sci, Coll Med, Seoul, South Korea.	parkyh@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1A6A1A03010528]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	Young-Noon Park was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1A6A1A03010528) for data preparation.r This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1A6A1A03010528) for data preparation.	Alves C, 2016, ACTA OPHTHALMOL, V94, pe251, DOI 10.1111/aos.12931; Bidell MR, 2016, PHARMACOTHERAPY, V36, P679, DOI 10.1002/phar.1761; Bu SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134325; Cekic O, 1999, BRIT J OPHTHALMOL, V83, P1183, DOI 10.1136/bjo.83.10.1183; Cekic O, 2000, BRIT J OPHTHALMOL, V84, P1061, DOI 10.1136/bjo.84.9.1061; Chan EW, 2015, BRIT J CLIN PHARMACO, V80, P855, DOI 10.1111/bcp.12474; Chien LN, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007611; Chui CSL, 2014, J ANTIMICROB CHEMOTH, V69, P2563, DOI 10.1093/jac/dku145; Cohen SM, 2005, AM J OPHTHALMOL, V139, P777, DOI 10.1016/j.ajo.2005.01.014; Collins B, 2016, PHARMACOECONOMICS, V34, P101, DOI 10.1007/s40273-015-0306-7; Combs J L, 1982, Trans Am Ophthalmol Soc, V80, P64; Daneman N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-010077; DELIGNY BH, 1984, THERAPIE, V39, P595; Douros A, 2015, EXPERT OPIN DRUG MET, V11, P25, DOI 10.1517/17425255.2014.970166; Eftekhari K, 2014, PHARMACOEPIDEM DR S, V23, P745, DOI 10.1002/pds.3623; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Etminan M, 2012, JAMA-J AM MED ASSOC, V307, P1414, DOI 10.1001/jama.2012.383; Fife D, 2014, DRUG SAFETY, V37, P171, DOI 10.1007/s40264-014-0138-y; Fu P.K, 2015, THESIS NATL TAIWAN U, DOI [10.6342/NTU.2015.00289, DOI 10.6342/NTU.2015.00289]; Golozar A, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0697-z; Kapoor KG, 2014, OPHTHALMOLOGY, V121, P1269, DOI 10.1016/j.ophtha.2013.12.006; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Kuo SC, 2014, CLIN INFECT DIS, V58, P197, DOI 10.1093/cid/cit708; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Ohneberg K, 2015, METHOD INFORM MED, V54, P505, DOI 10.3414/ME14-01-0113; Pasternak B, 2013, JAMA-J AM MED ASSOC, V310, P2184, DOI 10.1001/jama.2013.280500; Raguideau F, 2016, JAMA OPHTHALMOL, V134, P415, DOI 10.1001/jamaophthalmol.2015.6205; Rampal S, 2008, HUM EXP TOXICOL, V27, P409, DOI 10.1177/0960327108092295; Rim TH, 2015, OPHTHALMOLOGY, V122, P1187, DOI 10.1016/j.ophtha.2015.01.020; Shakibaei M, 2001, ARCH TOXICOL, V75, P97, DOI 10.1007/s002040000203; SIRBAT D, 1983, J FR OPHTALMOL, V6, P829; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; Tsai WC, 2011, J ORTHOP RES, V29, P67, DOI 10.1002/jor.21196; U.S. Department of Health and Human Services Food and Drug Administration, 2011, 21158S018 NDA US DEP; Verbraeken H, 1996, GRAEF ARCH CLIN EXP, V234, pS59, DOI 10.1007/BF02343049; Walsh MC, 2012, CANCER EPIDEM BIOMAR, V21, P881, DOI 10.1158/1055-9965.EPI-11-1066	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195563	10.1371/journal.pone.0195563	http://dx.doi.org/10.1371/journal.pone.0195563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649310	gold, Green Submitted, Green Published			2022-12-27	WOS:000429791900057
J	Roberts, JM; Maniskas, ME; Bix, GJ				Roberts, Jill M.; Maniskas, Michael E.; Bix, Gregory J.			Bilateral carotid artery stenosis causes unexpected early changes in brain extracellular matrix and blood-brain barrier integrity in mice	PLOS ONE			English	Article							CHRONIC CEREBRAL HYPOPERFUSION; WHITE-MATTER LESIONS; SMALL VESSEL DISEASE; MOUSE MODEL; ALPHA-5-BETA-1 INTEGRIN; ISCHEMIC-STROKE; ACTIVATION; ENCEPHALOMYELITIS; MECHANISMS; REDUCTION	Bilateral carotid artery stenosis (BCAS) is one experimental model of vascular dementia thought to preferentially impact brain white matter. Indeed, few studies report hippocampal and cortical pathology prior to 30 days post-stenosis; though it is unclear whether those studies examined regions outside the white matter. Since changes in the blood-brain barrier (BBB) permeability precede more overt brain pathology in various diseases, we hypothesized that changes within the BBB and/or BBB-associated extracellular matrix (ECM) could occur earlier after BCAS in the hippocampus, cortex and striatum and be a precursor of longer term pathology. Here, C57BI/6 mice underwent BCAS or sham surgeries and changes in the BBB and ECM were analyzed by collagen IV (vascular basement membrane component), alpha 5 integrin (marker of endothelial activation), claudin-5 and occludin (tight junction proteins), Evans blue (permeability marker), Ki-67 (cell proliferation marker), and GFAP and CD11b (glial cell markers) immunohistochemistry after 14 days. Significant changes in markers of cerebrovascular integrity and glial activation were detected, not only in the striatum, but also in the hippocampus and cortex. In conclusion, this study demonstrates for the first time that changes in the BBB/ECM occur shortly after BCAS and within multiple brain regions and suggests such changes might underlie the gradual development of BCAS non-white matter pathology.	[Roberts, Jill M.; Maniskas, Michael E.; Bix, Gregory J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Roberts, Jill M.; Maniskas, Michael E.; Bix, Gregory J.] Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA; [Maniskas, Michael E.; Bix, Gregory J.] Univ Kentucky, Dept Neurosurg, Lexington, KY 40506 USA; [Bix, Gregory J.] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Maniskas, Michael E.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Texas System; University of Texas Health Science Center Houston	Bix, GJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Bix, GJ (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA.; Bix, GJ (corresponding author), Univ Kentucky, Dept Neurosurg, Lexington, KY 40506 USA.; Bix, GJ (corresponding author), Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA.	gregorybix@uky.edu			National Institutes of Health [1 R01 NS089515-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (www.nih.gov), Grant # 1 R01 NS089515-01 to GJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Clarke DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045257; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Hattori Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32179; Holland PR, 2015, J CEREBR BLOOD F MET, V35, P1005, DOI 10.1038/jcbfm.2015.12; Hunt BJ, 1998, BRIT MED J, V316, P1328, DOI 10.1136/bmj.316.7141.1328; Huveneers S, 2007, INT J RADIAT BIOL, V83, P743, DOI 10.1080/09553000701481808; Ilzecka J, 1996, Ann Univ Mariae Curie Sklodowska Med, V51, P123; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; Levine DA, 2011, NEUROTHERAPEUTICS, V8, P361, DOI 10.1007/s13311-011-0047-z; Li LX, 2012, EXP NEUROL, V237, P46, DOI 10.1016/j.expneurol.2012.06.005; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; Miki K, 2009, J NEUROSCI RES, V87, P1270, DOI 10.1002/jnr.21925; Miyamoto N, 2014, NEUROSCI LETT, V573, P40, DOI 10.1016/j.neulet.2014.05.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Paul D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0755-8; Roberts J, 2017, J CEREBR BLOOD F MET, V37, P85, DOI 10.1177/0271678X15616979; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Toyama K, 2014, ARTERIOSCL THROM VAS, V34, P616, DOI 10.1161/ATVBAHA.113.302440; Wang D, 2016, J NEUROPHYSIOL, V116, P2173, DOI 10.1152/jn.00510.2016; Yang Z, 2014, CURR NEUROVASC RES, V11, P223, DOI 10.2174/1567202611666140520124407; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	27	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195765	10.1371/journal.pone.0195765	http://dx.doi.org/10.1371/journal.pone.0195765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649307	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900084
J	Gildea, JJ; Xu, P; Kemp, BA; Carlson, JM; Tran, HT; Wang, DB; Langouet-Astrie, CJ; McGrath, HE; Carey, RM; Jose, PA; Felder, RA				Gildea, John J.; Xu, Peng; Kemp, Brandon A.; Carlson, Julia M.; Tran, Hanh T.; Wang, Dora Bigler; Langouet-Astrie, Christophe J.; McGrath, Helen E.; Carey, Robert M.; Jose, Pedro A.; Felder, Robin A.			Sodium bicarbonate cotransporter NBCe2 gene variants increase sodium and bicarbonate transport in human renal proximal tubule cells	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RAT; SERUM ANION GAP; BLOOD-PRESSURE; SALT SENSITIVITY; NA+-HCO3-COTRANSPORTER; EPITHELIAL-CELLS; ANGIOTENSIN-II; DEPENDENT REGULATION; CL-/HCO3-EXCHANGER; AFRICAN-AMERICAN	Rationale Salt sensitivity of blood pressure affects >30% of the hypertensive and >15% of the normo-tensive population. Variants of the electrogenic sodium bicarbonate cotransporter NBCe2 gene, SLC4A5, are associated with increased blood pressure in several ethnic groups. SLC4A5 variants are also highly associated with salt sensitivity, independent of hypertension. However, little is known about how NBCe2 contributes to salt sensitivity, although NBCe2 regulates renal tubular sodium bicarbonate transport. We hypothesized that SLC4A5 rs10177833 and rs7571842 increase NBCe2 expression and human renal proximal tubule cell (hRPTC) sodium transport and may be a cause of salt sensitivity of blood pressure. Objective To characterize the hRPTC ion transport of wild-type (WT) and homozygous variants (HV) of SLC4A5. Methods and results The expressions of NBCe2 mRNA and protein were not different between hRPTCs carrying WT or HV SLC4A5 before or after dopaminergic or angiotensin (II and III) stimulation. However, luminal to basolateral sodium transport, NHE3 protein, and Cl-/HCO3- exchanger activity in hRPTCs were higher in HV than WT SLC4A5. Increasing intracellular sodium enhanced the apical location of NBCe2 in HV hRPTCs (4.24 +/- 0.35% to 11.06 +/- 1.72% (P<0.05, N = 3, 2-way ANOVA, Holm-Sidak test)) as determined by Total Internal Reflection Fluorescence Microscopy (TIRFM). In hRPTCs isolated from kidney tissue, increasing intracellular sodium enhanced bicarbonate-dependent pH recovery rate and increased NBCe2 mRNA and protein expressions to a greater extent in HV than WT SLC4A5 (+38.00 +/- 6.23% vs HV normal salt (P<0.01, N = 4, 2-way ANOVA, Holm-Sidak test)). In hRPTCs isolated from freshly voided urine, bicarbonate-dependent pH recovery was also faster in those from salt-sensitive and carriers of HV SLC4A5 than from salt-resistant and carriers of WT SLC4A5. The faster NBCe2-specific bicarbonate-dependent pH recovery rate in HV SCL4A5 was normalized by SLC4A5-but not SLC4A4-shRNA. The binding of purified hepatocyte nuclear factor type 4A (HNF4A) to DNA was increased in hRPTCs carrying HV SLC4A5 rs7571842 but not rs10177833. The faster NBCe2-specific bicarbonate-dependent pH recovery rate in HV SCL4A5 was abolished by HNF4A antagonists. Conclusion NBCe2 activity is stimulated by an increase in intracellular sodium and is hyper-responsive in hRPTCs carrying HV SLC4A5 rs7571842 through an aberrant HNF4A-mediated mechanism.	[Gildea, John J.; Xu, Peng; Carlson, Julia M.; Tran, Hanh T.; Wang, Dora Bigler; Langouet-Astrie, Christophe J.; McGrath, Helen E.; Felder, Robin A.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Kemp, Brandon A.; Carey, Robert M.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Jose, Pedro A.] George Washington Univ, Dept Med, Sch Med & Hlth Sci, Div Renal Dis & Hypertens, Washington, DC USA; [Jose, Pedro A.] George Washington Univ, Dept Pharmacol & Physiol, Washington, DC USA	University of Virginia; University of Virginia; George Washington University; George Washington University	Felder, RA (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.	raf7k@virginia.edu		Langouet-Astrie, Christophe/0000-0002-1867-3815	National Heart Lung and Blood Institute [HL074940]; National Institute of Diabetes, Digestive Diseases and Kidney [DK039308]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039308] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes, Digestive Diseases and Kidney; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart Lung and Blood Institute HL074940, and National Institute of Diabetes, Digestive Diseases and Kidney DK039308.	Abramowitz MK, 2012, KIDNEY INT, V81, P1033, DOI 10.1038/ki.2011.479; Abuladze N, 2004, AM J PHYSIOL-CELL PH, V287, pC781, DOI 10.1152/ajpcell.00590.2003; Amlal H, 2001, KIDNEY INT, V60, P1824, DOI 10.1046/j.1523-1755.2001.00995.x; Banday AA, 2015, HYPERTENSION, V65, P1064, DOI 10.1161/HYPERTENSIONAHA.115.05255; Barkley RA, 2004, HYPERTENSION, V43, P477, DOI 10.1161/01.HYP.0000111585.76299.f7; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; BOYER MJ, 1992, CANCER RES, V52, P4441; Carey RM, 2012, HYPERTENSION, V60, P1359, DOI 10.1161/HYPERTENSIONAHA.112.196071; Chen LJ, 2013, J CELL MOL MED, V17, P437, DOI 10.1111/jcmm.12031; Chiolero A, 2000, HYPERTENSION, V36, P631, DOI 10.1161/01.HYP.36.4.631; Cooper RS, 2002, HYPERTENSION, V40, P629, DOI 10.1161/01.HYP.0000035708.02789.39; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Doris PA, 2000, J HYPERTENS, V18, P509, DOI 10.1097/00004872-200018050-00002; Du ZP, 2012, AM J PHYSIOL-RENAL, V303, pF386, DOI 10.1152/ajprenal.00531.2011; Efendiev R, 2007, BRIT J PHARMACOL, V151, P1006, DOI 10.1038/sj.bjp.0707304; Efendiev R, 2002, J BIOL CHEM, V277, P11489, DOI 10.1074/jbc.M108182200; Felder RA, 2013, CURR OPIN NEPHROL HY, V22, P65, DOI 10.1097/MNH.0b013e32835b3693; FerrerMartinez A, 1996, BIOCHEM J, V319, P337, DOI 10.1042/bj3190337; Findeisen HM, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0319-7; Forman JP, 2008, J HUM HYPERTENS, V22, P122, DOI 10.1038/sj.jhh.1002286; Furey TS, 2013, SCIENCE, V342, P705, DOI 10.1126/science.1246755; Gallegos TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040796; Gildea JJ, 2008, HYPERTENSION, V51, P360, DOI 10.1161/HYPERTENSIONAHA.107.100099; Gildea JJ, 2015, AM J PHYSIOL-REG I, V309, pR1447, DOI 10.1152/ajpregu.00150.2015; Gildea JJ, 2013, CLIN CHIM ACTA, V421, P236, DOI 10.1016/j.cca.2013.02.021; Gildea John J, 2013, Methods Mol Biol, V945, P329, DOI 10.1007/978-1-62703-125-7_20; Gildea JJ, 2012, HYPERTENSION, V60, P396, DOI 10.1161/HYPERTENSIONAHA.112.194175; Gildea JJ, 2009, HYPERTENSION, V54, P1070, DOI 10.1161/HYPERTENSIONAHA.109.134338; GOOD DW, 1993, SEMIN NEPHROL, V13, P225; Groger N, 2012, HUM MOL GENET, V21, P1025, DOI 10.1093/hmg/ddr533; Guo L, 2016, J HUM HYPERTENS, V30, P543, DOI 10.1038/jhh.2015.113; HABER RS, 1987, AM J PHYSIOL, V253, pF26, DOI 10.1152/ajprenal.1987.253.1.F26; Hahn-Windgassen A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000553; Horita S, 2002, HYPERTENSION, V40, P707, DOI 10.1161/01.HYP.0000036449.70110.DE; Hrdlickova B, 2014, BBA-MOL BASIS DIS, V1842, P1910, DOI 10.1016/j.bbadis.2014.03.011; Hunt SC, 2006, HYPERTENSION, V47, P532, DOI 10.1161/01.HYP.0000196949.26088.3c; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; Joe B, 2005, PHYSIOL GENOMICS, V23, P318, DOI 10.1152/physiolgenomics.00164.2004; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kempson S, 2007, NITRIC OXIDE-BIOL CH, V17, P33, DOI 10.1016/j.niox.2007.05.002; Kowolik CM, 2004, ONCOGENE, V23, P5950, DOI 10.1038/sj.onc.1207801; Kunimi M, 2000, KIDNEY INT, V57, P534, DOI 10.1046/j.1523-1755.2000.00873.x; Kurtz I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00350; LaPointe MS, 2002, KIDNEY INT, V62, P157, DOI 10.1046/j.1523-1755.2002.00406.x; Lee SH, 2013, STEM CELLS, V31, P2396, DOI 10.1002/stem.1496; Lifton R. P., 2005, HARVEY LECT, V100, P71; Lynn KS, 2009, BIOINFORMATICS, V25, P981, DOI 10.1093/bioinformatics/btp106; Martovetsky G, 2013, MOL PHARMACOL, V84, P808, DOI 10.1124/mol.113.088229; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; MOORE EDW, 1993, P NATL ACAD SCI USA, V90, P8058, DOI 10.1073/pnas.90.17.8058; Nakamura M, 2015, KIDNEY INT, V87, P535, DOI 10.1038/ki.2014.351; Nakamura M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/504808; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ortiz PA, 2001, HYPERTENSION, V38, P621, DOI 10.1161/hy09t1.093361; Pedrosa R, 2004, AM J PHYSIOL-RENAL, V286; Pedrosa R, 2008, HYPERTENSION, V51, P1332, DOI 10.1161/HYPERTENSIONAHA.107.102434; Pedrosa R, 2007, HYPERTENSION, V49, P1186, DOI 10.1161/HYPERTENSIONAHA.106.083444; Perry C, 2008, AM J PHYSIOL-CELL PH, V295, pC1385, DOI 10.1152/ajpcell.00153.2008; Rao DC, 2003, AM J HYPERTENS, V16, P148, DOI 10.1016/S0895-7061(02)03247-8; Rice T, 2006, AM J HYPERTENS, V19, P270, DOI 10.1016/j.amjhyper.2005.09.006; Rice T, 2002, HYPERTENSION, V39, P1037, DOI 10.1161/01.HYP.0000018911.46067.6E; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; SHARMA AM, 1993, HYPERTENSION, V22, P884, DOI 10.1161/01.HYP.22.6.884; Sharma AM, 1994, AM J MED SCI S1, V307, DOI [10.1038/ki.2011.479, DOI 10.1038/KI.2011.479]; Simao S, 2010, BIOCHEM PHARMACOL, V80, P913, DOI 10.1016/j.bcp.2010.05.013; Simao S, 2008, BIOCHEM PHARMACOL, V75, P2224, DOI 10.1016/j.bcp.2008.03.003; Simao S, 2013, LIFE SCI, V93, P435, DOI 10.1016/j.lfs.2013.07.026; Soleimani M, 2015, KIDNEY INT, V87, P497, DOI 10.1038/ki.2014.392; Stutz AM, 2009, EUR J HUM GENET, V17, P1481, DOI 10.1038/ejhg.2009.64; Svetkey LP, 1996, HYPERTENSION, V28, P854, DOI 10.1161/01.HYP.28.5.854; Taylor EN, 2007, HYPERTENSION, V50, P320, DOI 10.1161/HYPERTENSIONAHA.107.092643; Taylor JY, 2013, BIOL RES NURS, V15, P105, DOI 10.1177/1099800411419026; Taylor JY, 2009, BIOL RES NURS, V11, P53, DOI 10.1177/1099800409334817; Thiagarajan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017286; Turban S, 2006, KIDNEY INT, V70, P660, DOI 10.1038/sj.ki.5001571; Udali S, 2013, MOL ASPECTS MED, V34, P883, DOI 10.1016/j.mam.2012.08.001; Wang T, 1999, AM J PHYSIOL-RENAL, V277, pF298, DOI 10.1152/ajprenal.1999.277.2.F298; Wang XY, 2009, CURR OPIN NEPHROL HY, V18, P412, DOI 10.1097/MNH.0b013e32832f5775; Wang YC, 2012, J NEUROPHYSIOL, V108, P2024, DOI 10.1152/jn.00361.2012; Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429; Weinberger Myron H, 2006, J Cardiometab Syndr, V1, P217, DOI 10.1111/j.1559-4564.2006.05613.x; Wen DH, 2015, HYPERTENSION, V66, P68, DOI 10.1161/HYPERTENSIONAHA.115.05394; Whitehead A, 2012, J EXP BIOL, V215, P1293, DOI 10.1242/jeb.062075; Xu J, 2003, AM J PHYSIOL-RENAL, V284, pF41, DOI 10.1152/ajprenal.00055.2002; Yanai K, 1999, J BIOL CHEM, V274, P34605, DOI 10.1074/jbc.274.49.34605; Zhang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16188; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324; Zhuo JL, 2013, COMPR PHYSIOL, V3, P1079, DOI 10.1002/cphy.c110061	90	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0189464	10.1371/journal.pone.0189464	http://dx.doi.org/10.1371/journal.pone.0189464			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29642240	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900004
J	Nikalje, GC; Variyar, PS; Joshi, MV; Nikam, TD; Suprasanna, P				Nikalje, Ganesh C.; Variyar, P. S.; Joshi, M. V.; Nikam, T. D.; Suprasanna, P.			Temporal and spatial changes in ion homeostasis, antioxidant defense and accumulation of flavonoids and glycolipid in a halophyte Sesuvium portulacastrum (L.) L.	PLOS ONE			English	Article							VACUOLAR NA+/H+ ANTIPORTER; SALT STRESS; SALINITY TOLERANCE; WATER-STRESS; H+-ATPASE; RESPONSES; PLANT; TRANSPORT; GROWTH; PROLINE	Salinity is an important environmental constraint limiting plant productivity. Understanding adaptive responses of halophytes to high saline environments may offer clues to manage and improve salt stress in crop plants. We have studied physiological, biochemical and metabolic changes in a perennial, fast growing halophyte, Sesuvium portulacastrum under 0 mM (control), 150 mM (low salt, LS) and 500 mM (high salt, HS) NaCl treatments. The changes in growth, relative water content, cation, osmolyte accumulation, H2O2 and antioxidant enzyme activity (SOD, CAT and APX) were observed under different treatment conditions. A positive correlation was revealed for sodium ion accumulation with malondialdehyde (r(2) = 0.77), proline (r(2) = 0.88) and chlorophyll content (r(2) = 0.82) under salt treatment while a negative correlation was observed with relative tissue water content (r(2) = -0.73). The roots and leaves showed contrasting accumulation of potassium and sodium ions under LS treatment. Temporal and spatial study of sodium and potassium ion content indicated differential accumulation pattern in roots and leaves, and, high potassium levels in root. Higher H2O2 content was recorded in roots than leaves and the antioxidant enzyme activities also showed significant induction under salt treatment conditions. Gene expression profiling of sodium transporters, Sodium proton exchanger (NHX3), Vacuolar ATPase (vATPase) and Salt overly sensitive1 (SOS1) showed up regulation under salt stress after 6-24 hr of NaCl treatment. Metabolite changes in the salt stressed leaves showed increased accumulation of flavonoids (3,5-dihydroxy-6,4'-dimethoxy-flavone-7-O-[alpha-L-rhamnopyranosyl-(1 -> 6)-beta-D-glucopyranoside], and 3,5-dihydroxy-6,3',4'-trimethoxy-flavone-7-O-[alpha-L-rhamnopyranosyl-(1 -> 6)-beta-D-glucopyranoside] in both LS and HS treatments, while a glycolipid, 1-O-linolenyl-2-O-(palmitoyl)-3-O-galactopyranosyl glycerol, accumulated more in LS over HS treatments and control. The results suggest that differential spatial and temporal cation levels in roots and leaves, and accumulation of flavanoid and glycolipid could be responsible for salt adaptation of S. portulacastrum.	[Nikalje, Ganesh C.; Nikam, T. D.] Savitribai Phule Pune Univ, Dept Bot, Pune, Maharashtra, India; [Nikalje, Ganesh C.; Suprasanna, P.] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India; [Nikalje, Ganesh C.] RK Talreja Coll Arts Sci & Commerce, Dept Bot, Ulhasnagar, Thane, India; [Variyar, P. S.] Bhabha Atom Res Ctr, Food Technol Div, Bombay, Maharashtra, India; [Joshi, M. V.] Tata Inst Fundamental Res, Natl Facil High Field NMR, Bombay, Maharashtra, India	Savitribai Phule Pune University; Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC); Tata Institute of Fundamental Research (TIFR)	Suprasanna, P (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India.	prasanna@barc.gov.in	Nikalje, Ganesh/X-2455-2019; PENNA, Suprasanna/AAE-1208-2022		Department of Atomic Energy, Government of India, Bhabha Atomic Research Centre, Trombay, Mumbai; Savitribai Phule Pune University, Pune	Department of Atomic Energy, Government of India, Bhabha Atomic Research Centre, Trombay, Mumbai; Savitribai Phule Pune University, Pune	GN is thankful to Department of Atomic Energy, Government of India, Bhabha Atomic Research Centre, Trombay, Mumbai and Savitribai Phule Pune University, Pune for the Ph.D. fellowship grant. No other funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GN is thankful to Department of Atomic Energy, Government of India, Bhabha Atomic Research Centre, Trombay, Mumbai and Savitribai Phule Pune University, Pune for the Ph.D. fellowship grant and Dr. Archana Rai, Bhabha Atomic research Centre, Mumbai for guiding the expression analysis work.	Abideen Z, 2014, ENVIRON EXP BOT, V105, P70, DOI 10.1016/j.envexpbot.2014.04.009; Aebi H., 1974, METHOD ENZYMAT AN, V2, P674; Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Agoramoorthy G, 2008, ASIAN J CHEM, V20, P1311; Al Hassan M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00473; Al-fadhli AA, 2008, THESIS; Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Boscaiu M, 2013, J PLANT ECOL, V6, P177, DOI 10.1093/jpe/rts017; Bose J, 2014, J EXP BOT, V65, P1241, DOI 10.1093/jxb/ert430; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Demidchik V, 2010, J CELL SCI, V123, P1468, DOI 10.1242/jcs.064352; DIAZPEREZ JC, 1995, J EXP BOT, V46, P111, DOI 10.1093/jxb/46.1.111; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Gargallo-Garriga A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06829; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; Guo R, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0994-6; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Hariadi Y, 2011, J EXP BOT, V62, P185, DOI 10.1093/jxb/erq257; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hsiao TC, 2000, J EXP BOT, V51, P1595, DOI 10.1093/jexbot/51.350.1595; Iwanaga F, 2015, LANDSC ECOL ENG, V11, P199, DOI 10.1007/s11355-014-0265-8; Jithesh MN, 2006, J GENET, V85, P237, DOI 10.1007/BF02935340; Joshi R., 2015, ELUCIDATION ABIOTIC; Kannan PR, 2013, APPL BIOCHEM BIOTECH, V171, P1925, DOI 10.1007/s12010-013-0475-9; Katschnig D, 2015, PLANT SCI, V234, P144, DOI 10.1016/j.plantsci.2015.02.011; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Kosova K, 2013, FUNCT PLANT BIOL, V40, P775, DOI 10.1071/FP12375; Kumari A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00537; Lokhande VH, 2013, AGRON SUSTAIN DEV, P4; Lokhande VH, 2010, PLANT CELL TISS ORG, V102, P17, DOI 10.1007/s11240-010-9699-3; Lowry OH, 1951, PROTEIN MEASUREMENT, P265; Maathuis FJM, 2014, J EXP BOT, V65, P849, DOI 10.1093/jxb/ert326; Mane AV, 2011, J ENVIRON BIOL, V32, P753; Mansour MMF, 2013, BIOL PLANTARUM, V57, P1, DOI 10.1007/s10535-012-0144-9; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Moshaei MR, 2014, SAUDI J BIOL SCI, V21, P394, DOI 10.1016/j.sjbs.2014.05.001; Mostofa MG, 2015, SCI REP-UK, V5, DOI 10.1038/srep11433; Muchate NS, 2016, BOT REV, V82, P371, DOI 10.1007/s12229-016-9173-y; Muchate NS, 2016, FLORA, V224, P96, DOI 10.1016/j.flora.2016.07.009; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Negrao S, 2017, ANN BOT-LONDON, V119, P1, DOI 10.1093/aob/mcw191; Nikalje GC, 2017, CURR GENOMICS, V18, P542, DOI [10.2174/1389201918666170228143007, 10.2174/1389202918666170228143007]; Nikalje GC, 2018, PLANT GENE, V13, P18, DOI DOI 10.1016/J.PLGENE.2017.11.003; Nikalje GC, 2017, LAND DEGRAD DEV, P1, DOI [10.1002/19r.2819, DOI 10.1002/19R.2819]; Ogawa A, 2006, PLANT PROD SCI, V9, P27, DOI 10.1626/pps.9.27; Pandey S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144469; Pardo-Domenech LL, 2016, PLANT BIOSYST, V150, P904, DOI 10.1080/11263504.2014.990943; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parida AK, 2004, PLANT GROWTH REGUL, V42, P213, DOI 10.1023/B:GROW.0000026508.63288.39; Parida AK, 2013, J PLANT GROWTH REGUL, V32, P342, DOI 10.1007/s00344-012-9303-7; Parks GE, 2002, J EXP BOT, V53, P1055, DOI 10.1093/jexbot/53.371.1055; Popova OV, 2007, J PLANT PHYSIOL, V164, P1278, DOI 10.1016/j.jplph.2006.08.011; Qiu NW, 2007, PLANT SCI, V172, P1218, DOI 10.1016/j.plantsci.2007.02.013; Rabhi M, 2009, AFR J ECOL, V47, P463, DOI 10.1111/j.1365-2028.2008.00989.x; Rakhmankulova ZF, 2015, RUSS J PLANT PHYSL+, V62, P71, DOI 10.1134/S1021443715010112; Ramani B, 2004, Z NATURFORSCH C, V59, P835; Reginato MA, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu042; Sanadhya P, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv055; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Sengupta S, 2009, PLANTA, V229, P911, DOI 10.1007/s00425-008-0878-y; Shabala L, 2012, PHYSIOL PLANTARUM, V146, P26, DOI 10.1111/j.1399-3054.2012.01599.x; Shabala S, 2014, PHYSIOL PLANTARUM, V151, P257, DOI 10.1111/ppl.12165; Shabala S, 2011, ADV BOT RES, V57, P151, DOI 10.1016/B978-0-12-387692-8.00005-9; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Silva P, 2009, PLANT SIGNAL BEHAV, V48, P718; Slama I, 2015, ANN BOT-LONDON, V115, P433, DOI 10.1093/aob/mcu239; Srivastava AK, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00019; Stankovic MS, 2015, J ARID ENVIRON, V120, P26, DOI 10.1016/j.jaridenv.2015.04.008; Stepien P, 2009, PLANT PHYSIOL, V149, P1154, DOI 10.1104/pp.108.132407; STEWART GR, 1974, PLANTA, V120, P279, DOI 10.1007/BF00390296; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Vera-Estrella R, 2005, PLANT PHYSIOL, V139, P1507, DOI 10.1104/pp.105.067850; Wang SW, 2014, PLANT PHYSIOL, V165, P1144, DOI 10.1104/pp.114.238899; Watanabe S, 2000, PLANT CELL TISS ORG, V63, P199, DOI 10.1023/A:1010619503680; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Yang J, 2002, PLANT PHYSIOL, V130, P1032, DOI 10.1104/pp.004325; Yang YL, 2010, J PLANT GROWTH REGUL, V29, P465, DOI 10.1007/s00344-010-9158-8; Yi LP, 2007, SCI CHINA SER D, V50, P97, DOI 10.1007/s11430-007-5012-7; Yu BZ, 2014, PHYTOCHEMISTRY, V108, P77, DOI 10.1016/j.phytochem.2014.09.012; Yu JJ, 2011, J PROTEOME RES, V10, P3852, DOI 10.1021/pr101102p; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	93	16	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193394	10.1371/journal.pone.0193394	http://dx.doi.org/10.1371/journal.pone.0193394			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641593	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900013
J	Shimono, J; Miyoshi, H; Kiyasu, J; Kamimura, T; Eto, T; Miyagishima, T; Nagafuji, K; Seto, M; Teshima, T; Ohshima, K				Shimono, Joji; Miyoshi, Hiroaki; Kiyasu, Junichi; Kamimura, Tomohiko; Eto, Tetsuya; Miyagishima, Takuto; Nagafuji, Koji; Seto, Masao; Teshima, Takanori; Ohshima, Koichi			Clinicopathological analysis of polyploid diffuse large B-cell lymphoma	PLOS ONE			English	Article							CHOP CONSORTIUM PROGRAM; CHROMOSOMAL INSTABILITY; DNA-PLOIDY; GENOMIC INSTABILITY; POOR-PROGNOSIS; CANCER; HETEROGENEITY; EVOLUTION; SURVIVAL; EXPRESSION	Polyploid chromosomes are those with more than two sets of homologous chromosomes. Polyploid chromosomal abnormalities are observed in various malignant tumors. The prognosis in such cases is generally poor. However, there are no studies examining the prognosis of diffuse large B-cell lymphoma (DLBCL) with polyploid chromosomal abnormalities. Therefore, we statistically compared the clinicopathological features between polyploid DLBCL and DLBCL without polyploid abnormalities. Herein, 51 polyploid DLBCL and 53 control (without polyploid chromosomal abnormalities) cases were examined. G-banding method was employed to define polyploidy by cytogenetic analysis. Subsequently, flow cytometric immunophenotyping and immunohistochemical staining were performed. Polyploid DLBCL was defined as DLBCL with either near-tetraploid or greater number of chromosomes, as detected by the G-band. In a survival analysis, a significantly worse overall survival (OS) was observed for polyploid DLBCL (p = 0.04; p = 0.02 in cases who received R-CHOP regimens). In a multivariate analysis of OS, polyploid chromosomal abnormalities were an independent prognostic factor. Our results suggest that polyploid chromosomal abnormalities detected through G-band may represent a new poor prognostic factor for DLBCL.	[Shimono, Joji; Miyoshi, Hiroaki; Seto, Masao; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan; [Shimono, Joji; Teshima, Takanori] Hokkaido Univ, Fac Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Kiyasu, Junichi] Iizuka Hosp, Dept Hematol, Iizuka, Fukuoka, Japan; [Kamimura, Tomohiko] Harasanshin Hosp, Dept Hematol, Fukuoka, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Miyagishima, Takuto] Kushiro Rosai Hosp, Dept Hematol, Kushiro, Hokkaido, Japan; [Nagafuji, Koji] Kurume Univ, Sch Med, Dept Hematol, Kurume, Fukuoka, Japan	Kurume University; Hokkaido University; Kurume University	Miyoshi, H (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan.	miyoshi_hiroaki@med.kurume-u.ac.jp						Araujo SEA, 2007, DIS COLON RECTUM, V50, P1800, DOI 10.1007/s10350-007-9013-6; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Coiffier B, 2001, CURR OPIN ONCOL, V13, P325, DOI 10.1097/00001622-200109000-00003; Davaadelger B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110844; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Falzetti D, 1999, HAEMATOLOGICA, V84, P298; Furuya T, 2000, CLIN CANCER RES, V6, P2815; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Horn H, 2015, LEUKEMIA, V29, P1564, DOI 10.1038/leu.2015.43; Huang LS, 2017, LEUKEMIA RES, V53, P20, DOI 10.1016/j.leukres.2016.11.016; Kiyasu J, 2015, BLOOD, V126, P2193, DOI 10.1182/blood-2015-02-629600; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lipinski KA, 2016, TRENDS CANCER, V2, P49, DOI 10.1016/j.trecan.2015.11.003; Liu YY, 2010, LEUKEMIA LYMPHOMA, V51, P1692, DOI 10.3109/10428194.2010.502584; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Miyazaki M, 1999, CANCER RES, V59, P5283; Niitsu N, 2009, CANCER SCI, V100, P233, DOI 10.1111/j.1349-7006.2008.01035.x; Pantic M, 2006, ONCOGENE, V25, P4413, DOI 10.1038/sj.onc.1209486; Pinto AE, 2013, ANN SURG ONCOL, V20, P1530, DOI 10.1245/s10434-012-2804-6; Rossi Davide, 2002, Hematology, V7, P239, DOI 10.1080/1024533021000024058; Sawyer JR, 2005, GENE CHROMOSOME CANC, V42, P95, DOI 10.1002/gcc.20109; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shimono J, 2017, PATHOL INT, V67, P17, DOI 10.1111/pin.12478; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Suguro M, 2014, CANCER SCI, V105, P897, DOI 10.1111/cas.12442; Swerdlow SH, 2008, WHO CLASSIFICATION T; Umino A, 2011, BLOOD, V117, P5473, DOI 10.1182/blood-2010-12-327791; Xie Y, 2014, AM J CLIN PATHOL, V141, P593, DOI 10.1309/AJCPPHMZ6VHF0WQV; Xu-Monette ZY, 2013, BLOOD, V122, P2630, DOI 10.1182/blood-2012-12-473702; Xu-Monette ZY, 2012, BLOOD, V120, P3986, DOI 10.1182/blood-2012-05-433334; Yoshida M, 2015, PATHOL INT, V65, P519, DOI 10.1111/pin.12335; Yoshida M, 2012, PATHOL INT, V62, P518, DOI 10.1111/j.1440-1827.2012.02835.x; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194525	10.1371/journal.pone.0194525	http://dx.doi.org/10.1371/journal.pone.0194525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641580	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900034
J	Kim, SJ; Yee, S; Ha, E; Chun, EM				Kim, Soo Jung; Yee, Shinhee; Ha, Eunhee; Chun, Eun Mi			Association of body mass index with incident tuberculosis in Korea	PLOS ONE			English	Article							INFLAMMATORY PROCESSES; ACTIVE TUBERCULOSIS; RISK; OBESITY	Introduction Overweight or obesity might be protective factors of tuberculosis (TB), but the evidence is inconclusive. The objective of study was to evaluate association between BMI and incident TB. Methods The National Health Insurance database was used. Eligible participants were individuals aged 20-89 years without history of TB before 2007, and who underwent national health examinations between January 2002 and December 2006. The latest record of BMI was used as the exposure and categorized as follows: <18.5, 18.5-23, 23-25, 25-30, and >= 30 kg/m(2). TB was defined as the first recorded diagnosis of TB, using ICD-10 between January 2007 and December 2013. Results Among 301,081 individuals, 3,772 (1.26%) incident TB cases were detected. The incidence rate of the event was 19.65 per 10,000 person-years. After adjusting age, sex, household income, smoking status, alcohol use, and diabetes, incident TB was decreased as BMI was increased in an inverse dose-response relationship. However, when stratified by age and sex, BMI >30 kg/m(2) did not show protective effect of TB in female under 50 years. Additionally, BMI >30 kg/m(2) did not decrease incident TB in diabetics. Conclusion Our study suggests that high BMI might be associated with decreased risk of TB. However, very high BMI did not reduce the risk of TB in young females or diabetics participants with in Korean population.	[Kim, Soo Jung; Chun, Eun Mi] Ewha Womans Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea; [Yee, Shinhee; Ha, Eunhee] Ewha Womans Univ, Coll Med, Dept Occupat & Environm Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Chun, EM (corresponding author), Ewha Womans Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea.	cem@ewha.ac.kr		Chun, Eun Mi/0000-0001-9616-2722				Anuradha R, 2016, TUBERCULOSIS, V101, P56, DOI 10.1016/j.tube.2016.08.004; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Cao J, 2012, AGING MALE, V15, P85, DOI 10.3109/13685538.2012.666585; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Cegielski JP, 2012, AM J EPIDEMIOL; Danley Joshua, 2014, Ann Am Thorac Soc, V11, P908, DOI 10.1513/AnnalsATS.201312-422OC; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Fantuzzi G, 2009, JAMA-J AM MED ASSOC, V302, P1754, DOI 10.1001/jama.2009.1514; Ilavska S, 2012, HUM IMMUNOL, V73, P480, DOI 10.1016/j.humimm.2012.02.023; Imtiaz S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00216-2017; Bini EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093831; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kaminski DA, 2010, TRENDS IMMUNOL, V31, P384, DOI 10.1016/j.it.2010.08.001; Kelly DM, 2015, OBES REV, V16, P581, DOI 10.1111/obr.12282; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Region WWP, 2000, INT ASS STUD OB INT; Roth J, 2009, JAMA-J AM MED ASSOC, V301, P2586, DOI 10.1001/jama.2009.930; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; Yen YF, 2017, INT J OBESITY, V41, P971, DOI 10.1038/ijo.2017.64; Zhang H, 2017, SCI REPORTS, V7	28	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195104	10.1371/journal.pone.0195104	http://dx.doi.org/10.1371/journal.pone.0195104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668698	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200027
J	Kim, YC; Shin, N; Lee, S; Hyuk, H; Kim, YH; Kim, H; Park, SK; Cho, JH; Kim, CD; Ha, J; Chae, DW; Lee, JP; Kim, YS				Kim, Yong Chul; Shin, Nara; Lee, Sunhwa; Hyuk, Huh; Kim, Young Hoon; Kim, Hyosang; Park, Su-Kil; Cho, Jang-Hee; Kim, Chan-Duck; Ha, Jongwon; Chae, Dong-Wan; Lee, Jung Pyo; Kim, Yon Su			Effect of post-transplant glycemic control on long-term clinical outcomes in kidney transplant recipients with diabetic nephropathy: A multicenter cohort study in Korea	PLOS ONE			English	Article							STAGE RENAL-DISEASE; ISLET TRANSPLANTATION; PATIENT SURVIVAL; ASSOCIATION; IMPROVEMENT; MORTALITY; PANCREAS; MELLITUS; INJURY; TRIAL	Purpose Diabetic nephropathy is the leading cause of end stage renal disease. The number of kidney transplantation (KT) due to diabetic nephropathy is increasing and there is debate on glycemic control after KT. In this study, we used a multi-center database to determine the relationship between post-transplant glycemic control and the outcomes of KT in patients with diabetic nephropathy. Methods We conducted a retrospective chart review of kidney transplant recipients (KTRs) with diabetic nephropathy from three tertiary hospitals to analyze the association between post transplant glycemic control and the clinical outcomes of graft failure, including patient death and biopsy-proven acute rejection (BPAR). We assessed time-averaged glucose level and hemoglobin A1c (HbA1c) for 36 months after KT. Results Among 3,538 KTRs, a total of 476 patients received kidney transplantation because of diabetic nephropathy. Mean time-averaged glucose and HbA1 c levels were 147 +/- 46 mg/dl and 7.7 +/- 1.5%, respectively. Patients with diabetic nephropathy had poor graft and patient survival rate compared with non-diabetic nephropathy. Among KTRs with diabetic nephropathy, the highest quartile of time-averaged glucose was related to poor graft outcomes and the 3rd quartile of time-averaged HbA1c was associated with significantly better graft outcomes than the 1st, 2nd or 4th quartiles. There were no significant differences in the risk of BPAR across the 4 quartiles of glucose and HbA1c. Conclusions Strict glycemic control before KT might not be related to successful outcomes but poor glycemic control after KT is associated with poor graft outcomes. There was no significant relationship between pre- or post-transplant glycemic control and BPAR.	[Kim, Yong Chul; Lee, Sunhwa; Hyuk, Huh] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Shin, Nara] Seoul Natl Univ, Clin Med Sci, Coll Med, Seoul, South Korea; [Kim, Young Hoon] Asan Med Ctr, Div Kidney Transplantat, Dept Surg, Seoul, South Korea; [Kim, Young Hoon; Kim, Hyosang; Park, Su-Kil] Univ Ulsan, Coll Med, Seoul, South Korea; [Kim, Hyosang; Park, Su-Kil] Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Cho, Jang-Hee; Kim, Chan-Duck] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Ha, Jongwon] Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea; [Chae, Dong-Wan] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Lee, Jung Pyo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Med Sci, Seoul, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center; Kyungpook National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Med Sci, Seoul, South Korea.; Kim, YS (corresponding author), Seoul Natl Univ, Coll Med, Kidney Res Inst, Seoul, South Korea.	yonsukim@snu.ac.kr	Cho, Jang-hee/ABD-3534-2020; Kim, Yong Chul/L-8653-2019	Cho, Jang-hee/0000-0002-7031-5214; Kim, Yong Chul/0000-0003-3215-8681				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; BARBOSA J, 1994, JAMA-J AM MED ASSOC, V272, P600, DOI 10.1001/jama.272.8.600; Brunkhorst R, 2003, TRANSPLANTATION, V76, P115, DOI 10.1097/01.TP.0000070225.38757.81; Cosio FG, 2008, AM J TRANSPLANT, V8, P593, DOI 10.1111/j.1600-6143.2007.02101.x; D'Addio F, 2014, DIABETES CARE, V37, P267, DOI 10.2337/dc13-1663; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Fiorina P, 2005, DIABETES CARE, V28, P1358, DOI 10.2337/diacare.28.6.1358; Fiorina P, 2005, DIABETES CARE, V28, P1303, DOI 10.2337/diacare.28.6.1303; Fiorina P, 2003, J AM SOC NEPHROL, V14, P2150, DOI 10.1097/01.ASN.0000077339.20759.A3; Fiorina P, 2012, DIABETES CARE, V35, P367, DOI 10.2337/dc11-1697; Fukasawa H, 2006, KIDNEY INT, V69, P1733, DOI 10.1038/sj.ki.5000261; GALL MA, 1995, DIABETES, V44, P1303, DOI 10.2337/diabetes.44.11.1303; Hermayer KL, 2012, J CLIN ENDOCR METAB, V97, P4399, DOI 10.1210/jc.2012-1979; Hirose R, 2008, ANESTHESIOLOGY, V108, P402, DOI 10.1097/ALN.0b013e318164cff8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matas AJ, 2014, AM J TRANSPLANT, V14, P11, DOI 10.1111/ajt.12579; Molnar MZ, 2011, DIABETES CARE, V34, P2536, DOI 10.2337/dc11-0906; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; Parekh J, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/652458; Ramirez SC, 2014, ENDOCR PRACT, V20, P894, DOI 10.4158/EP13463.OR; */* S  11, 2013, DIABETES CARE S1, V36, pS1, DOI DOI 10.2337/DC13-S011; Taber DJ, 2013, CLIN TRANSPLANT, V27, P274, DOI 10.1111/ctr.12080; Wiesbauer F, 2010, TRANSPLANTATION, V89, P612, DOI 10.1097/TP.0b013e3181c6ffa4; Wojtusciszyn A, 2013, Diabetes Metab, V39, P404, DOI 10.1016/j.diabet.2012.10.007	24	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195566	10.1371/journal.pone.0195566	http://dx.doi.org/10.1371/journal.pone.0195566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668755	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200048
J	Liu, CH; Cheng, Y; Hsu, ASC; Chen, CS; Liu, J; Yu, GL				Liu, Conghui; Cheng, Ying; Hsu, Anna S. C.; Chen, Chuansheng; Liu, Jie; Yu, Guoliang			Optimism and self-efficacy mediate the association between shyness and subjective well-being among Chinese working adults	PLOS ONE			English	Article							LIFE SATISFACTION; SOCIAL SUPPORT; PERSONALITY; LONELINESS; BELIEFS; ESTEEM; PREDICTORS; BEHAVIOR; SCALE; STYLE	The aim of the current study was to investigate whether optimism and self-efficacy mediated the association between shyness and subjective well-being in a sample of Chinese working adults. Two hundred and eight participants completed the Revised Cheek and Buss Shyness Scale, Life Orientation Rest-Revised, Satisfaction with Life Scale, and Positive and Negative Affect Scale. Structural equation modeling results showed that optimism mediated the relationship between shyness and measures of subjective well-being (life satisfaction, positive and negative affect). Self-efficacy mediated the association between shyness and positive subjective well-being (life satisfaction and positive affect). These results suggest that optimism and self-efficacy play unique mediating roles in the relationship between shyness and subjective well-being. They also have important implications for the development of intervention programs aimed at promoting subjective well-being of Chinese working adults through enhancing self-efficacy and optimism.	[Liu, Conghui; Cheng, Ying] Renmin Univ China, Dept Psychol, Beijing, Peoples R China; [Liu, Conghui; Cheng, Ying; Hsu, Anna S. C.; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Liu, Jie] Dalian Maritime Univ, Students Psychol Dev Serv Ctr, Dalian, Peoples R China; [Yu, Guoliang] Renmin Univ China, Sch Educ, Beijing, Peoples R China	Renmin University of China; University of California System; University of California Irvine; Dalian Maritime University; Renmin University of China	Yu, GL (corresponding author), Renmin Univ China, Sch Educ, Beijing, Peoples R China.	yuglixl@sina.com		Chen, Chuansheng/0000-0002-8224-1005	National Natural Science Foundation of China [81571337]; Research Funds of Renmin University of China [14XNLQ05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Funds of Renmin University of China	The National Natural Science Foundation of China (grant 81571337 to GY) and the Research Funds of Renmin University of China (grant number 14XNLQ05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CA, 1985, SOC COGNITION, V3, P16, DOI 10.1521/soco.1985.3.1.16; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; [Anonymous], 2009, SCI WELL BEING; Baker L, 2010, PERS SOC PSYCHOL B, V36, P665, DOI 10.1177/0146167210367489; BRODT SE, 1981, J PERS SOC PSYCHOL, V41, P437, DOI 10.1037/0022-3514.41.3.437; Caprara GV, 2005, EUR PSYCHOL, V10, P275, DOI 10.1027/1016-9040.10.4.275; Caprara GV, 2003, J PERS, V71, P943, DOI 10.1111/1467-6494.7106003; Cheek JM, 1999, VARIETIES SHYNESS AD; Coffman DL, 2005, MULTIVAR BEHAV RES, V40, P235, DOI 10.1207/s15327906mbr4002_4; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eid M, 2004, SOC INDIC RES, V65, P245, DOI 10.1023/B:SOCI.0000003801.89195.bc; EISENBERG N, 1995, J PERS SOC PSYCHOL, V68, P505, DOI 10.1037/0022-3514.68.3.505; Findlay LC, 2008, CAN J BEHAV SCI, V40, P153, DOI 10.1037/0008-400X.40.3.153; Findlay LC, 2009, INT J BEHAV DEV, V33, P47, DOI 10.1177/0165025408098017; Ho MY, 2010, PERS INDIV DIFFER, V48, P658, DOI 10.1016/j.paid.2010.01.008; Hopko DR, 2005, J PERS ASSESS, V84, P185, DOI 10.1207/s15327752jpa8402_08; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson T, 2000, SOC BEHAV PERSONAL, V28, P463, DOI 10.2224/sbp.2000.28.5.463; JOHNSON JE, 1995, J CLIN PSYCHOL, V51, P532, DOI 10.1002/1097-4679(199507)51:4<532::AID-JCLP2270510410>3.0.CO;2-K; Kahneman D., 1999, WELL BEING FDN HEDON; Karademas EC, 2006, PERS INDIV DIFFER, V40, P1281, DOI 10.1016/j.paid.2005.10.019; Karademas EC, 2007, PERS INDIV DIFFER, V43, P277, DOI 10.1016/j.paid.2006.11.031; Kline RB, 2006, J AM STAT ASSOC, V101, P354; Lent RW, 2005, J COUNS PSYCHOL, V52, P429, DOI 10.1037/0022-0167.52.3.429; Leung BWC, 2005, INT J AGING HUM DEV, V61, P335, DOI 10.2190/FQTB-EBAJ-H9WP-LMYA; Li CN, 2014, COMPUT HUM BEHAV, V34, P89, DOI 10.1016/j.chb.2014.01.032; Little D., 2013, LONGITUDINAL STRUCTU; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Lyubomirsky S, 2001, AM PSYCHOL, V56, P239, DOI 10.1037/0003-066X.56.3.239; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; NETO F, 1993, J YOUTH ADOLESCENCE, V22, P125, DOI 10.1007/BF01536648; Rowsell HC, 2013, CAN J BEHAV SCI, V45, P287, DOI 10.1037/a0029853; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1989, J PERS SOC PSYCHOL, V57, P1024, DOI 10.1037/0022-3514.57.6.1024; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1992, COGNITIVE THER RES, V16, P201, DOI 10.1007/BF01173489; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23, DOI [10.13287/j.1001-9332.202201.010, DOI 10.1002/0470010940]; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Smith N, 2004, J HEALTH PSYCHOL, V9, P741, DOI 10.1177/1359105304045373; Srivastava PratyushKumar., 2015, INDIAN J POSITIVE PS, V6, P380; Steca P, 2009, J SOC CLIN PSYCHOL, V28, P824, DOI 10.1521/jscp.2009.28.7.824; Strobel M, 2011, SCAND J PSYCHOL, V52, P43, DOI 10.1111/j.1467-9450.2010.00826.x; TAYLOR SE, 1992, J PERS SOC PSYCHOL, V63, P460, DOI 10.1037/0022-3514.63.3.460; Tu YD, 2015, SOC INDIC RES, V124, P963, DOI 10.1007/s11205-014-0809-1; Wang C.K., 2001, CHINESE J APPL PSYCH, V7, P37, DOI [DOI 10.3969/J.ISSN.1006-6020.2001.01.007, 10.3969/j.issn.1006-6020.2001.01.007]; Wang JN, 2014, SOC INDIC RES, V119, P341, DOI 10.1007/s11205-013-0487-4; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wheaton B., 1977, SOCIOL METHODOL, V8, P84, DOI [10.2307/270754, DOI 10.2307/270754]; Wright T A, 2000, J Occup Health Psychol, V5, P84, DOI 10.1037/1076-8998.5.1.84; Zhang RP, 2016, J HAPPINESS STUD, V17, P2007, DOI 10.1007/s10902-015-9682-0; Zhao JJ, 2013, SOC INDIC RES, V114, P891, DOI 10.1007/s11205-012-0178-6; Zhao JJ, 2013, PERS INDIV DIFFER, V54, P577, DOI 10.1016/j.paid.2012.11.003; Zhao JJ, 2012, PERS INDIV DIFFER, V52, P686, DOI 10.1016/j.paid.2011.12.024	57	17	17	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194559	10.1371/journal.pone.0194559	http://dx.doi.org/10.1371/journal.pone.0194559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668678	Green Published, gold			2022-12-27	WOS:000430290200010
J	Ponsonby, AL; Pezic, A; Cameron, FJ; Rodda, C; Kemp, AS; Carlin, JB; Hyoty, H; Sioofy-Khojine, A; Dwyer, T; Ellis, JA; Craig, ME				Ponsonby, Anne-Louise; Pezic, Angela; Cameron, Fergus J.; Rodda, Christine; Kemp, Andrew S.; Carlin, John B.; Hyoty, Heikki; Sioofy-Khojine, Amirbabak; Dwyer, Terence; Ellis, Justine A.; Craig, Maria E.			Higher parental occupational social contact is associated with a reduced risk of incident pediatric type 1 diabetes: Mediation through molecular enteroviral indices	PLOS ONE			English	Article							DIFFERENT EUROPEAN POPULATIONS; INFECTION; PLASMA; SERUM; EXPOSURE; RNA; VARICELLA; RESPONSES; CHILDREN; ZOSTER	We aimed to examine the association between parental occupational social contact and hygiene factors on type 1 diabetes (T1D) risk and possible mediation of these effects through child enteroviral infection. We interviewed 333 incident T1D cases and 660 controls from 2008-2011 in Melbourne, Australia. Enteroviral indices (ribonucleic acid by reverse transcription polymerase chain reaction and Coxsackie B virus antibody levels) in peripheral blood were measured in nested case control samples. Parent occupational social contact was assessed by the number of well or sick children, adults or animals contacted daily through work. Higher parental occupational social contact was strongly associated with reduced T1D risk with evidence of dose response (contact with the well or sick score, Adjusted odds ratio (AOR) per category: 0.73 (95% Confidence Interval (CI): 0.66, 0.81); P<0.001 or AOR 0.63 (95% CI: 0.53, 0.75); P<0.001) respectively). Nine of the ten parental social contact indices, were significant mediated through one or more enteroviral indices. The strength of association between enterovirus presence and T1D onset increased with child age (1.2 fold increase per year; P = 0.05). Lower child hand hygiene enhanced the adverse effect of low parental occupational contact with the sick; Synergy Index 5.16 (95% CI: 3.61, 7.36). The interaction between hand washing and parental occupational contact is more consistent with protection against parental enteroviral shedding than the sharing of a protective infectious agent or microbiome.	[Ponsonby, Anne-Louise; Pezic, Angela; Cameron, Fergus J.; Rodda, Christine; Kemp, Andrew S.; Carlin, John B.; Dwyer, Terence; Ellis, Justine A.] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Flemington Rd, Parkville, Vic, Australia; [Ponsonby, Anne-Louise] Australian Natl Univ, Natl Ctr Epidemiol, Canberra, ACT, Australia; [Rodda, Christine] Sunshine Hosp, Western Ctr Hlth Res & Educ, St Albans, Vic, Australia; [Hyoty, Heikki; Sioofy-Khojine, Amirbabak] Univ Tampere, Sch Med, Virol, Laakarinkatu, Finland; [Dwyer, Terence] Univ Oxford, George Inst Global Hlth, Oxford Martin Sch, Oxford, England; [Ellis, Justine A.] Deakin Univ, Fac Hlth, Ctr Social & Early Emot Dev, Burwood, Vic, Australia; [Craig, Maria E.] Univ New South Wales, Sch Womens & Childrens Hlth, Kensington, NSW, Australia; [Craig, Maria E.] Univ Sydney, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Australian National University; Tampere University; University of Oxford; Deakin University; University of New South Wales Sydney; University of Sydney	Ponsonby, AL (corresponding author), Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Flemington Rd, Parkville, Vic, Australia.; Ponsonby, AL (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol, Canberra, ACT, Australia.	anne-louise.ponsonby@mcri.edu.au	Sioofy-Khojine, Amir-Babak/M-6008-2019; Carlin, John B/B-3492-2012; Carlin, John/AAG-4332-2020; Ponsonby, Anne-Louise/AAE-4351-2019	Sioofy-Khojine, Amir-Babak/0000-0001-5538-5153; Carlin, John B/0000-0002-2694-9463; Carlin, John/0000-0002-2694-9463; Hyoty, Heikki/0000-0003-0370-4145; Ellis, Justine/0000-0003-4103-4445; Craig, Maria E/0000-0001-6004-576X; Ponsonby, Anne-Louise/0000-0002-6581-3657	National Health and Medical Research Council of Australia; Australian Research Council; Arthritis Australia; Diabetes Australia; Rebecca L Cooper Medical Research Foundation; L.E.W. Carty Charitable Fund; ANZ Medical Research and Technologies in Victoria Fund; Equity Trustees Lynne Quayle Charitable Trust Fund; Australian Academy of Science; Victorian State Government Operational Infrastructure Support Program; Murdoch Childrens Research Institute; National Health and Medical Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Arthritis Australia; Diabetes Australia; Rebecca L Cooper Medical Research Foundation; L.E.W. Carty Charitable Fund; ANZ Medical Research and Technologies in Victoria Fund; Equity Trustees Lynne Quayle Charitable Trust Fund; Australian Academy of Science; Victorian State Government Operational Infrastructure Support Program; Murdoch Childrens Research Institute; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding was obtained from the National Health and Medical Research Council of Australia, the Australian Research Council, Arthritis Australia, Diabetes Australia, Rebecca L Cooper Medical Research Foundation, L.E.W. Carty Charitable Fund, ANZ Medical Research and Technologies in Victoria Fund, Equity Trustees Lynne Quayle Charitable Trust Fund, the Australian Academy of Science, The Victorian State Government Operational Infrastructure Support Program, and the Murdoch Childrens Research Institute Internal Grant Scheme. JAE was supported by an Australian Research Council Future Fellowship. ALP was supported by a National Health and Medical Research Council Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidjinou EK, 2014, DISCOV MED, V18, P273; Blacksell SD, 2012, AM J TROP MED HYG, V87, P573, DOI 10.4269/ajtmh.2012.12-0043; Boom R, 1999, J CLIN MICROBIOL, V37, P1489, DOI 10.1128/JCM.37.5.1489-1497.1999; Cairns CJS, 2002, INTENS CARE MED, V28, P1357, DOI 10.1007/s00134-002-1399-y; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Dink B., 2006, INTRO SOCIOECONMIC I; Ejemot-Nwadiaro RI, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub3; Elfaitouri A, 2007, J MED VIROL, V79, P1861, DOI 10.1002/jmv.21008; Fear NT, 1999, DIABETIC MED, V16, P1025, DOI 10.1046/j.1464-5491.1999.00204.x; Fouchet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002306; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; Ginocchio CC, 1997, J CLIN MICROBIOL, V35, P2886, DOI 10.1128/JCM.35.11.2886-2893.1997; He XX, 2003, BIOMED ENVIRON SCI, V16, P40; Hicks R, 2011, STATA J, V11, P605, DOI 10.1177/1536867X1101100407; Juhela S, 2000, DIABETES, V49, P1308, DOI 10.2337/diabetes.49.8.1308; Kaila B, 2001, DIABETES CARE, V24, P1353, DOI 10.2337/diacare.24.8.1353; Kinlen LJ, 1997, BRIT J CANCER, V76, P1539, DOI 10.1038/bjc.1997.592; Krogvold L, 2015, DIABETES, V64, P1682, DOI 10.2337/db14-1370; Little R.J.A., 2002, STAT ANAL MISSING DA; McIver CJ, 2005, J CLIN MICROBIOL, V43, P5102, DOI 10.1128/JCM.43.10.5102-5110.2005; Miller J, 2015, ARTHRITIS RHEUMATOL, V67, P1951, DOI 10.1002/art.39129; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nair S, 2010, J MED VIROL, V82, P1950, DOI 10.1002/jmv.21900; Needell JC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0781-z; Ogunjimi B, 2014, CLIN VACCINE IMMUNOL, V21, P417, DOI 10.1128/CVI.00818-13; Oikarinen M, 2012, DIABETES, V61, P687, DOI 10.2337/db11-1157; Oikarinen S, 2014, DIABETES, V63, P655, DOI 10.2337/db13-0620; Oikarinen S, 2011, DIABETES, V60, P276, DOI 10.2337/db10-0186; Parslow RC, 2001, INT J EPIDEMIOL, V30, P533, DOI 10.1093/ije/30.3.533; Parslow RC, 2001, INT J EPIDEMIOL, V30, P8; Ponsonby AL, 2014, NATURE, V507, P169, DOI 10.1038/507169b; Ponsonby Anne-Louise, 2012, Results Immunol, V2, P125, DOI 10.1016/j.rinim.2012.06.002; Rodriguez RJ, 1997, J ACQ IMMUN DEF SYND, V15, P49, DOI 10.1097/00042560-199705010-00008; Salvatoni A, 2013, PEDIATR DIABETES, V14, P407, DOI 10.1111/pedi.12056; Sherriff A, 2002, ARCH DIS CHILD, V87, P26, DOI 10.1136/adc.87.1.26; Siev M, 2011, CLIN VACCINE IMMUNOL, V18, P173, DOI 10.1128/CVI.00325-10; Skrondal A, 2003, AM J EPIDEMIOL, V158, P251, DOI 10.1093/aje/kwg113; STAGNO S, 1984, J MED VIROL, V13, P347, DOI 10.1002/jmv.1890130405; Stata Corp, 2015, STAT STAT SOFTW REL; Sun C, 2017, CANCER EPIDEM BIOMAR, V26, P1146, DOI [10.1158/1055-9965.EPI-16-0846, 10.1158/1055-9965.epi-16-0846]; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; VanderWeele TJ, 2016, ANNU REV PUBL HEALTH, V37, P17, DOI 10.1146/annurev-publhealth-032315-021402; Viskari H, 2004, J MED VIROL, V72, P610, DOI 10.1002/jmv.20033; Weldon WC, 2016, METHODS MOL BIOL, V1387, P145, DOI 10.1007/978-1-4939-3292-4_8; YEUNG WCG, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D35; Ziegler AG, 2011, J AUTOIMMUN, V37, P3, DOI 10.1016/j.jaut.2011.02.004	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0193992	10.1371/journal.pone.0193992	http://dx.doi.org/10.1371/journal.pone.0193992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664909	Green Published, gold			2022-12-27	WOS:000430262300005
J	Gardner, JK; Cornwall, SMJ; Musk, AW; Alvarez, J; Mamotte, CDS; Jackaman, C; Nowak, AK; Nelson, DJ				Gardner, Joanne K.; Cornwall, Scott M. J.; Musk, Arthur W.; Alvarez, John; Mamotte, Cyril D. S.; Jackaman, Connie; Nowak, Anna K.; Nelson, Delia J.			Elderly dendritic cells respond to LPS/IFN-gamma and CD40L stimulation despite incomplete maturation	PLOS ONE			English	Article							INTERFERON-GAMMA; AGED MICE; IMMUNITY; INNATE; MACROPHAGES; EXPRESSION; SECRETION; MONOCYTES; INFECTION; EXPANSION	There is evidence that dendritic cells (DCs) undergo age-related changes that modulate their function with their key role being priming antigen-specific effector T cells. This occurs once DCs develop into antigen-presenting cells in response to stimuli/danger signals. However, the effects of aging on DC responses to bacterial lipopolysaccharide (LPS), the proinflammatory cytokine interferon (IFN)-gamma and CD40 ligand (CD40L) have not yet been systematically evaluated. We examined responses of blood myeloid (m) DC1s, mDC2s, plasmacytoid (p) DCs, and monocyte-derived DCs (MoDCs) from young (21 +/- 40 years) and elderly (60 +/- 84 years) healthy human volunteers to LPS/IFN-gamma or CD40L stimulation. All elderly DC subsets demonstrated comparable up-regulation of co-stimulatory molecules (CD40, CD80 and/or CD86), intracellular pro-inflammatory cytokine levels (IFN-gamma, tumour necrosis factor (TNF)-alpha, IL-6 and/or IL-12), and/or secreted cytokine levels (IFN-alpha, IFN-gamma, TNF-alpha, and IL-12) to their younger counterparts. Furthermore, elderly-derived LPS/IFN-gamma or CD40L-activated MoDCs induced similar or increased levels of CD8(+) and CD4(+) T cell proliferation, and similar T cell functional phenotypes, to their younger counterparts. However, elderly LPS/IFN-gamma-activated MoDCs were unreliable in their ability to up-regulate chemokine (IL-8 and monocyte chemoattractant protein (MCP)-1) and IL-6 secretion, implying an inability to dependably induce an inflammatory response. A key age-related difference was that, unlike young-derived MoDCs that completely lost their ability to process antigen, elderly-derived MoDCs maintained their antigen processing ability after LPS/IFN-gamma maturation, measured using the DQ-ovalbumin assay; this response implies incomplete maturation that may enable elderly DCs to continuously present antigen. These differences may impact on the efficacy of anti-pathogen and anti-tumour immune responses in the elderly.	[Gardner, Joanne K.; Cornwall, Scott M. J.; Mamotte, Cyril D. S.; Jackaman, Connie; Nelson, Delia J.] Curtin Univ, Sch Pharm & Biomed Sci, Bentley, WA, Australia; [Gardner, Joanne K.; Cornwall, Scott M. J.; Mamotte, Cyril D. S.; Jackaman, Connie; Nelson, Delia J.] Curtin Hlth Innovat Res Inst, Bentley, WA, Australia; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia; [Alvarez, John] Mt Hosp, Perth, WA, Australia; [Nowak, Anna K.] Univ WA, Sch Med, Perth, WA, Australia; [Nowak, Anna K.] Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia	Curtin University; University of Western Australia; University of Western Australia; University of Western Australia	Nelson, DJ (corresponding author), Curtin Univ, Sch Pharm & Biomed Sci, Bentley, WA, Australia.; Nelson, DJ (corresponding author), Curtin Hlth Innovat Res Inst, Bentley, WA, Australia.	Delia.Nelson@curtin.edu.au	Mamotte, Cyril/AAF-9603-2020; Nowak, Anna K/B-2487-2013	Nowak, Anna K/0000-0002-9317-9526; Mamotte, Cyril/0000-0003-1831-3921; Jackaman, Connie/0000-0002-4583-7029; Nelson, Delia/0000-0002-8698-5300	School of Biomedical Sciences, Curtin University; Cancer Council Western Australia; Cancer Council Western Australia PhD Topup Scholarship	School of Biomedical Sciences, Curtin University; Cancer Council Western Australia(Cancer Council Western Australia); Cancer Council Western Australia PhD Topup Scholarship	This study was funded by the School of Biomedical Sciences, Curtin University, and the Cancer Council Western Australia (DJN). JKG was supported by a Cancer Council Western Australia PhD Top-up Scholarship. DJN is wholly salaried by Curtin University and also acts as Chief Scientific Officer for Selvax. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the Curtin Health Innovation Research Institute and the School of Biomedical Sciences, Curtin University for provision of research facilities and technology platforms utilised in this study. The authors gratefully acknowledge the School of Biomedical Sciences, Curtin University, and the Cancer Council Western Australia for the financial support to conduct this study. Joanne K. Gardner was supported by a Cancer Council Western Australia PhD Topup Scholarship. The authors also thank all volunteers who donated blood samples for this study.	Agrawal A, 2008, J CLIN IMMUNOL, V28, P14, DOI 10.1007/s10875-007-9127-6; Agrawal A, 2007, EXP GERONTOL, V42, P421, DOI 10.1016/j.exger.2006.11.007; Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Agrawal A, 2012, EXPERT REV CLIN IMMU, V8, P73, DOI [10.1586/ECI.11.77, 10.1586/eci.11.77]; Agrawal A, 2011, AGEING RES REV, V10, P336, DOI 10.1016/j.arr.2010.06.004; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Ciaramella A, 2011, CELL IMMUNOL, V269, P82, DOI 10.1016/j.cellimm.2011.04.010; DAVILA DR, 1990, FASEB J, V4, P2906, DOI 10.1096/fasebj.4.11.2165948; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; DING A, 1994, J IMMUNOL, V153, P2146; Grolleau-Julius A, 2006, J GERONTOL A-BIOL, V61, P1039, DOI 10.1093/gerona/61.10.1039; Gupta S, 2014, EXP GERONTOL, V54, P47, DOI 10.1016/j.exger.2013.12.009; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Hopp AK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00055; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Janssen N, 2016, J GERONTOL A-BIOL, V71, P1117, DOI 10.1093/gerona/glv119; Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005; Jones SC, 2010, J IMMUNOL, V185, P6783, DOI 10.4049/jimmunol.0901296; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Khong A, 2012, INT REV IMMUNOL, V31, P246, DOI 10.3109/08830185.2012.698338; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; Lee N, 2012, J GERONTOL A-BIOL, V67, P254, DOI 10.1093/gerona/glr237; Li G, 2012, AGING CELL, V11, P968, DOI 10.1111/j.1474-9726.2012.00867.x; Lung TL, 2000, VACCINE, V18, P1606, DOI 10.1016/S0264-410X(99)00494-6; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; McColl SR, 2002, IMMUNOL CELL BIOL, V80, P489, DOI 10.1046/j.1440-1711.2002.01113.x; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Murakami N, 2014, TRANSPLANTATION, V98, P3, DOI 10.1097/TP.0000000000000169; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; PALACIOS R, 1982, J IMMUNOL, V128, P337; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Pereira LF, 2011, MECH AGEING DEV, V132, P187, DOI 10.1016/j.mad.2011.03.005; Prakash S, 2013, AGE, V35, P1785, DOI 10.1007/s11357-012-9477-8; Qian F, 2011, J INFECT DIS, V203, P1415, DOI 10.1093/infdis/jir048; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Salam N, 2013, INDIAN J MED RES, V138, P595; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shurin MR, 2007, CRIT REV ONCOL HEMAT, V64, P90, DOI 10.1016/j.critrevonc.2007.03.002; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Tesar BM, 2006, AGING CELL, V5, P473, DOI 10.1111/j.1474-9726.2006.00245.x; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Wong CP, 2010, EXP GERONTOL, V45, P163, DOI 10.1016/j.exger.2009.11.005; Wong C, 2013, CURR OPIN IMMUNOL, V25, P535, DOI 10.1016/j.coi.2013.05.016; Wordsworth DTHJ, 2011, REV CLIN GERONTOL, V21, P110, DOI 10.1017/S0959259810000407; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Yoon P, 2004, MECH AGEING DEV, V125, P137, DOI 10.1016/j.mad.2003.11.010; You JL, 2013, IMMUNOBIOLOGY, V218, P1077, DOI 10.1016/j.imbio.2013.02.002; You J, 2013, J APPL MATH, DOI 10.1155/2013/840628; Zacca ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140672; Zhao JC, 2011, J CLIN INVEST, V121, P4921, DOI 10.1172/JCI59777	60	9	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195313	10.1371/journal.pone.0195313	http://dx.doi.org/10.1371/journal.pone.0195313			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652910	Green Published, gold, Green Submitted			2022-12-27	WOS:000430026900021
J	Wong, W; Kim, YM; Kim, A; Cloutier, M; Gauthier-Loiselle, M; Gagnon-Sanschagrin, P; Guerin, A				Wong, William; Kim, Yeun Mi; Kim, Ashley; Cloutier, Martin; Gauthier-Loiselle, Marjolaine; Gagnon-Sanschagrin, Patrick; Guerin, Annie			Assessment of costs associated with adverse events in patients with cancer	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; ECONOMIC BURDEN; UNITED-STATES; CARE; CHEMOTHERAPY; MELANOMA; IMPACT	Adverse event (AE)-related costs represent an important component of economic models for cancer care. However, since previous studies mostly focused on specific AEs, treatments, or cancer types, limited information is currently available. Therefore, this study assessed the incremental healthcare costs associated with a large number of AEs among patients diagnosed with some of the most prevalent types of cancer. Data were obtained from a large US claims database. Adult patients were included if diagnosed with and treated for one of the following cancer types: breast, digestive organs and peritoneum, genitourinary organs (including bladder and ovary and other uterine adnexa), lung, lymphatic and hematopoietic tissue, and skin. Treatment episodes were defined as the period from initiation of the first antineoplastic pharmacologic therapy to discontinuation (i.e., gap of >= 45 days), or change in treatment regimen, or end of data availability. A total of 36 AEs were selected from the product inserts of 104 treatments recommended by practice guidelines. A retrospective matched cohort design was used, matching a treatment episode with a certain AE with a treatment episode without that AE. A total of 412,005 patients were selected, for a total of 794,243 treatment episodes, resulting in 1,617,368 matched treatment episodes across all 36 AEs. Incremental healthcare costs associated with AEs of any severity ranged from $546 for cough/upper respiratory infections to $24,633 for gastrointestinal perforation. The three most costly AEs when considering any severity were gastrointestinal perforation ($24,633), central nervous system hemorrhage ($24,322), and sepsis/septicemia ($23,510). Incremental healthcare costs associated with severe AEs ranged from $15,709 for dermatitis and rash to $48,538 for gastrointestinal fistula. The three most costly severe AEs were gastrointestinal fistula ($48,538), gastrointestinal perforation ($41,281), and central nervous system hemorrhage ($38,428). In conclusion, AEs during treatment episodes for cancer were frequent and associated with a substantial economic burden.	[Wong, William; Kim, Yeun Mi; Kim, Ashley] Genentech Inc, Hlth Econ & Outcomes Res, US Med Affairs, San Francisco, CA 94080 USA; [Cloutier, Martin; Gauthier-Loiselle, Marjolaine; Gagnon-Sanschagrin, Patrick; Guerin, Annie] Anal Grp Inc, Montreal, PQ, Canada	Roche Holding; Genentech; Analysis Group Inc.	Cloutier, M (corresponding author), Anal Grp Inc, Montreal, PQ, Canada.	martin.cloutier@analysisgroup.com		Wong, William/0000-0002-6054-278X	Genentech, Inc.; Genentech	Genentech, Inc.(Roche HoldingGenentech); Genentech(Roche HoldingGenentech)	This study was funded by Genentech, Inc. The sponsor (Genentech, Inc.) was involved in study design, data collection, analysis and interpretation, preparation of the manuscript, and decision to publish. Analysis Group, Inc. received consulting fees from Genentech for this study. MC, MGL, PGS, and AG are employees of Analysis Group, Inc. Analysis Group, Inc. is not a funder of this study. The specific roles of all authors are articulated in the 'author contributions' section.	Arondekar Bhakti, 2015, J Manag Care Spec Pharm, V21, P158; Banz K, 2011, LUNG CANCER, V74, P529, DOI 10.1016/j.lungcan.2011.04.010; Bilir SP, 2016, AM HEALTH DRUG BENEF, V9, P203; Borovicka JH, 2011, ARCH DERMATOL, V147, P1403, DOI 10.1001/archdermatol.2011.719; Caggiano V, 2005, CANCER-AM CANCER SOC, V103, P1916, DOI 10.1002/cncr.20983; Clement FM, 2009, HEALTH ECON, V18, P377, DOI 10.1002/hec.1363; Fishman PA, 2009, MED CARE, V47, pS70, DOI 10.1097/MLR.0b013e3181a75a7f; Frick KD, 2009, MED CARE, V47, pS76, DOI 10.1097/MLR.0b013e31819bc064; Hansen RN, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-259; Heerey Adrienne, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P29, DOI 10.1586/14737167.2.1.29; Hurvitz S, 2014, ONCOLOGIST, V19, P901, DOI 10.1634/theoncologist.2014-0059; Institute for Clinical and Economic Review (ICER), OV ICER VAL ASS FRAM; Latremouille-Viau D, 2017, J MED ECON, V20, P54, DOI 10.1080/13696998.2016.1225577; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Nazer Lama H, 2013, J Oncol Pharm Pract, V19, P298, DOI 10.1177/1078155212465995; Pike Crystal T, 2012, Chemother Res Pract, V2012, P913848, DOI 10.1155/2012/913848; Rashid N, 2015, J MANAG CARE SPEC PH, V21, P863, DOI 10.18553/jmcp.2015.21.10.863; SCHNIPPER L.E., 2015, J CLIN ONCOL, V2015, P6706, DOI DOI 10.1200/JC0.2015.61.6706; Schnipper LE, 2016, ONCOLOGIST, V21, P654, DOI 10.1634/theoncologist.2016-0177; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Tachi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124169; Vouk K, 2016, J MED ECON, V19, P900, DOI 10.1080/13696998.2016.1184155; Weycker D, 2008, ANN ONCOL, V19, P454, DOI 10.1093/annonc/mdm525; Weycker D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-362; Xu X, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-47	25	61	61	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0196007	10.1371/journal.pone.0196007	http://dx.doi.org/10.1371/journal.pone.0196007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652926	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900053
J	Lee, JS; Cho, KS; Lee, SH; Yoon, YE; Kang, DH; Jeong, WS; Jung, HD; Kwon, JK; Lee, JY				Lee, Jong Soo; Cho, Kang Su; Lee, Seung Hwan; Yoon, Young Eun; Kang, Dong Hyuk; Jeong, Won Sik; Jung, Hae Do; Kwon, Jong Kyou; Lee, Joo Yong			Stone heterogeneity index on single-energy noncontrast computed tomography can be a positive predictor of urinary stone composition	PLOS ONE			English	Article							SHOCK-WAVE LITHOTRIPSY; CALCIUM; CALCULI; UROLITHIASIS; FRAGILITY	The aim of this study was to investigate the correlation between stone composition and single-energy noncontrast computed tomography (NCCT) parameters, including stone heterogeneity index (SHI) and mean stone density (MSD), in patients with urinary calculi. We retrospectively reviewed medical records of 255 patients who underwent operations or procedures for urinary stones or had spontaneous stone passage between December 2014 and October 2015. Among these, 214 patients with urinary calculi who underwent NCCT and stone composition analyses were included in the study. Maximal stone length (MSL), mean stone density (MSD), and stone heterogeneity index (SHI) were determined on pretreatment NCCT. The mean MSD (454.68 +/- 177.80 HU) and SHI (115.82 +/- 96.31 HU) of uric acid stones were lower than those of all other types. Based on post hoc tests, MSD was lower for uric acid stones than for the other types (vs. CaOx: P<0.001; vs. infection stones: P<0.001). SHI was lower for uric acid stones than for the other types (vs. CaOx: P<0.001; vs. infection stones: P<0.001) Receiver operating characteristic curves of uric acid stones for MSD and SHI demonstrated that SHI (cut-off value: 140.4 HU) was superior to MSD (cut-off value: 572.3 HU) in predicting uric acid stones (P<0.001).	[Lee, Jong Soo; Lee, Seung Hwan; Lee, Joo Yong] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Severance Hosp, Seoul, South Korea; [Cho, Kang Su] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Urol,Urol Sci Inst, Seoul, South Korea; [Yoon, Young Eun] Hanyang Univ, Coll Med, Dept Urol, Seoul, South Korea; [Kang, Dong Hyuk] Inha Univ, Dept Urol, Sch Med, Incheon, South Korea; [Jeong, Won Sik] Kwangju Christian Hosp, Dept Urol, Gwangju, South Korea; [Jung, Hae Do] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Dept Urol, Yongin, South Korea; [Kwon, Jong Kyou] Yonsei Univ Hlth Syst, Severance Check Up, Dept Urol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University; Inha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JY (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Severance Hosp, Seoul, South Korea.	joouro@yuhs.ac	; Lee, Joo Yong/C-3851-2013	Lee, Jongsoo/0000-0002-9984-1138; Yoon, Young Eun/0000-0001-8059-6649; Cho, Kang Su/0000-0002-3500-8833; Lee, Seung Hwan/0000-0001-7358-8544; Lee, Joo Yong/0000-0002-3470-1767	Yonsei University College of Medicine [6-2016-0119]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from the Yonsei University College of Medicine for 2016 (6-2016-0119).	Ahn SH, 2015, KOREAN J UROL, V56, P644, DOI 10.4111/kju.2015.56.9.644; Bres-Niewada E, 2014, CENT EUR J UROL, V67, P392, DOI 10.5173/ceju.2014.04.art15; Cho KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144912; Chung DY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123800; Eliahou R, 2010, SEMIN ULTRASOUND CT, V31, P315, DOI 10.1053/j.sult.2010.05.002; Gucuk Adnan, 2014, World J Nephrol, V3, P282, DOI 10.5527/wjn.v3.i4.282; Han DH, 2016, INVESTIG CLIN UROL, V57, P229, DOI 10.4111/icu.2016.57.4.229; Kachrilas S, 2013, UROLITHIASIS, V41, P323, DOI 10.1007/s00240-013-0575-6; Kang DH, 2016, INVESTIG CLIN UROL, V57, P408, DOI 10.4111/icu.2016.57.6.408; Kang SK, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009119; Kim JH, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0013-x; Lee JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23988; Marchini GS, 2013, UROLOGY, V82, P539, DOI 10.1016/j.urology.2013.03.092; Mostafavi MR, 1998, J UROLOGY, V159, P673, DOI 10.1016/S0022-5347(01)63698-X; Motley G, 2001, UROLOGY, V58, P170, DOI 10.1016/S0090-4295(01)01115-3; Narepalem N, 2002, J UROLOGY, V167, P1235, DOI 10.1016/S0022-5347(05)65272-X; Park SH, 2014, KOREAN J UROL, V55, P581, DOI 10.4111/kju.2014.55.9.581; Patel SR, 2009, UROL INT, V83, P175, DOI 10.1159/000230020; Ringden I, 2007, SCAND J UROL NEPHROL, V41, P316, DOI 10.1080/00365590601154551; Spek A, 2016, WORLD J UROL; Spettel S, 2013, UROLOGY, V82, P22, DOI 10.1016/j.urology.2013.01.015; Turk C, 2016, EUR UROL, V69, P475, DOI 10.1016/j.eururo.2015.07.041; Williams JC, 2003, UROLOGY, V61, P1092, DOI 10.1016/S0090-4295(03)00349-2; Wolf JS, 2007, UROL CLIN N AM, V34, P421, DOI 10.1016/j.ucl.2007.04.010; Zarse CA, 2007, UROL RES, V35, P201, DOI 10.1007/s00240-007-0104-6	25	3	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0193945	10.1371/journal.pone.0193945	http://dx.doi.org/10.1371/journal.pone.0193945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649219	Green Published, gold			2022-12-27	WOS:000429791900006
J	Lin, LY; Peng, CC; Chen, Y; Huang, BC; Chang, CC; Peng, RY				Lin, Li-Yun; Peng, Chiung-Chi; Chen, Yeh; Huang, Boa-Chan; Chang, Chun Chao; Peng, Robert Y.			Aminoazo dye-protein-adduct enhances inhibitory effect on digestibility and damages to Gastro-Duodenal-Hepatic axis (vol 12, e0170555, 2017)	PLOS ONE			English	Correction																		Lin LY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170555; LY L, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0170555	2	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0196026	10.1371/journal.pone.0196026	http://dx.doi.org/10.1371/journal.pone.0196026			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649322	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900109
J	Silva, FD; Liotti, RG; Boleti, APD; Reis, ED; Passos, MBS; dos Santos, EL; Sampaio, OM; Januario, AH; Branco, CLB; da Silva, GF; de Mendonca, EAF; Soares, MA				Silva, Fabio de Azevedo; Liotti, Rhavena Graziela; de Araujo Boleti, Ana Paula; Reis, Erica de Melo; Silva Passos, Marilene Borges; dos Santos, Edson Lucas; Sampaio, Olivia Moreira; Januario, Ana Helena; Bassi Branco, Carmen Lucia; da Silva, Gilvan Ferreira; Furtado de Mendonca, Elisabeth Aparecida; Antonio Soares, Marcos			Diversity of cultivable fungal endophytes in Paullinia cupana (Mart.) Ducke and bioactivity of their secondary metabolites	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; DARK SEPTATE ENDOPHYTES; IN-VITRO; 3-HYDROXYPROPIONIC ACID; TRICHODERMA-HARZIANUM; DI-(2-ETHYLHEXYL) PHTHALATE; FUSARIUM-OXYSPORUM; THEOBROMA-CACAO; COLLETOTRICHUM-GLOEOSPORIOIDES; XYLOGONE-GANODERMOPHTHORA	Paullinia cupana is associated with a diverse community of pathogenic and endophytic microorganisms. We isolated and identified endophytic fungal communities from the roots and seeds of P. cupana genotypes susceptible and tolerant to anthracnose that grow in two sites of the Brazilian Amazonia forest. We assessed the antibacterial, antitumor and genotoxic activity in vitro of compounds isolated from the strains Trichoderma asperellum (1BDA) and Diaporthe phaseolorum (8S). In concert, we identified eight fungal species not previously reported as endophytes; some fungal species capable of inhibiting pathogen growth; and the production of antibiotics and compounds with bacteriostatic activity against Pseudomonas aeruginosa in both susceptible and multiresistant host strains. The plant genotype, geographic location and specially the organ influenced the composition of P. cupana endophytic fungal community. Together, our findings identify important functional roles of endophytic species found within the microbiome of P. cupana. This hypothesis requires experimental validation to propose management of this microbiome with the objective of promoting plant growth and protection.	[Silva, Fabio de Azevedo; Liotti, Rhavena Graziela; Antonio Soares, Marcos] Univ Fed Mato Grosso, Inst Biociencias, Dept Bot & Ecol, Cuiaba, Mato Grosso, Brazil; [Liotti, Rhavena Graziela] Inst Fed Mato Grosso, Caceres, Mato Grosso, Brazil; [de Araujo Boleti, Ana Paula; dos Santos, Edson Lucas] Fundacao Univ Fed Grande Dourados, Escola Ciencias Biol & Ambientais, Dourados, MS, Brazil; [Reis, Erica de Melo; Silva Passos, Marilene Borges; Bassi Branco, Carmen Lucia] Univ Fed Mato Grosso, Fac Med, Cuiaba, Mato Grosso, Brazil; [Sampaio, Olivia Moreira] Univ Fed Mato Grosso, Dept Quim, Cuiaba, Mato Grosso, Brazil; [Januario, Ana Helena] Univ Franca, Ctr Pesquisa Ciencias Exatas & Tecnol, Sao Paulo, Brazil; [da Silva, Gilvan Ferreira] Embrapa Amazonia Ocidental, Manaus, Amazonas, Brazil; [Furtado de Mendonca, Elisabeth Aparecida] Univ Fed Mato Grosso, Fac Agron, Cuiaba, Mato Grosso, Brazil	Universidade Federal de Mato Grosso; Instituto Federal de Mato Grosso (IFMT); Universidade Federal da Grande Dourados; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Universidad de Franca; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Mato Grosso	Soares, MA (corresponding author), Univ Fed Mato Grosso, Inst Biociencias, Dept Bot & Ecol, Cuiaba, Mato Grosso, Brazil.	drmasoares@gmail.com	Sampaio, Olívia Moreira/V-1187-2019; Soares, Marcos/Y-7844-2019; dos Santos, Edson Lucas/AAU-5857-2020; Januario, Ana Helena AH/G-9375-2012; Januario, Ana Helena/U-2283-2019; Soares, Marcos A/B-7683-2013	Sampaio, Olívia Moreira/0000-0001-9624-6029; Soares, Marcos/0000-0002-8938-3188; dos Santos, Edson Lucas/0000-0002-6557-7914; Januario, Ana Helena AH/0000-0002-3815-6903; Januario, Ana Helena/0000-0002-3815-6903; Soares, Marcos A/0000-0002-8938-3188	Comissao de Aperfeicoamento de Pessoal do Nivel Superior - CAPES [3348/2013]	Comissao de Aperfeicoamento de Pessoal do Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Comissao de Aperfeicoamento de Pessoal do Nivel Superior - CAPES - grant number: 3348/2013 (MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsul MG, 2007, BIORESOURCE TECHNOL, V98, P1467, DOI 10.1016/j.biortech.2006.02.036; Akonda MMR, 2016, PLANT SCI TODAY, V3, P267, DOI 10.14719/pst.2016.3.3.194; Al-Bari MAA, 2005, INT J SYST EVOL MICR, V55, P1973, DOI 10.1099/ijs.0.63516-0; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; AMADE P, 1994, J ANTIBIOT, V47, P201, DOI 10.7164/antibiotics.47.201; [Anonymous], 2015, PLOS ONE, DOI DOI 10.1371/journal.pone.0118204; Arevalo J, 2009, TROP PLANT PATHOL, V34, P158, DOI 10.1590/S1982-56762009000300004; Arivudainambi USE, 2011, FEMS IMMUNOL MED MIC, V61, P340, DOI 10.1111/j.1574-695X.2011.00780.x; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; AYER WA, 1989, J NAT PROD, V52, P119, DOI 10.1021/np50061a015; Azevedo J.L., 2014, MICROBIAL DIVERSITY, P17, DOI 10.1007/978-81-322-1801-2_2; Bailey BA, 2009, MYCOL RES, V113, P1365, DOI 10.1016/j.mycres.2009.09.004; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; Barata RA, 2002, J BIOSCI BIOENG, V94, P304, DOI 10.1016/S1389-1723(02)80168-2; Barnett H.L., 1955, T BR MYCOL SOC, V47, P616, DOI [10.2307/3755678, DOI 10.1016/S0007-1536(55)80058-7]; Basile A, 2013, NAT PROD RES, V27, P2084, DOI 10.1080/14786419.2013.784868; Batista BD, 2017, DIVERSITY AND BENEFITS OF MICROORGANISMS FROM THE TROPICS, P293, DOI 10.1007/978-3-319-55804-2_13; Bech L., 2015, FUNGAL GENOM BIOL, V5, P126, DOI 10.4172/2165-8056.1000116; Bhatti HN, 2007, APPL MICROBIOL BIOT, V73, P1290, DOI 10.1007/s00253-006-0597-x; Bittencourt LS, 2013, FOOD CHEM TOXICOL, V53, P119, DOI 10.1016/j.fct.2012.11.041; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bogas AC, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1037-0; Bonatelli ML, 2016, J PLANT PATHOL, V98, P197, DOI 10.4454/JPP.V98I2.029; Bottomly T, 2004, DIVERSITY ENDOPHYTIC; Brader G, 2017, ANNU REV PHYTOPATHOL, V55, P61, DOI 10.1146/annurev-phyto-080516-035641; Brissow ER, 2017, PARASITOL RES, V116, P1823, DOI 10.1007/s00436-017-5451-9; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; BYDLOWSKI SP, 1991, BRAZ J MED BIOL RES, V24, P421; BYDLOWSKI SP, 1988, BRAZ J MED BIOL RES, V21, P535; Cai L, 2006, MYCOL RES, V110, P137, DOI 10.1016/j.mycres.2005.09.014; Cai L, 2010, MYCOL PROG, V9, P337, DOI 10.1007/s11557-009-0641-1; CAPPELLINI RA, 1966, B TORREY BOT CLUB, V93, P52, DOI 10.2307/2483885; CARROLL G, 1995, CAN J BOT, V73, pS1316, DOI 10.1139/b95-393; Casella TM, 2013, PHYTOCHEMISTRY, V96, P370, DOI 10.1016/j.phytochem.2013.10.004; Lopez DC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103891, 10.1371/journal.pone.0093811]; Celinska E, 2010, BIOTECHNOL ADV, V28, P519, DOI 10.1016/j.biotechadv.2010.03.003; Chandrasekaran M, 2016, J GEN PLANT PATHOL, V82, P233, DOI 10.1007/s10327-016-0672-9; Channabasava, 2014, BANGL J PHARMACOL, V9, P129, DOI 10.3329/bjp.v9i1.15622; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chen SH, 2018, PHYTOCHEMISTRY, V146, P8, DOI 10.1016/j.phytochem.2017.11.011; de Souza ADC, 2012, CROP BREED APPL BIOT, V12, P47, DOI 10.1590/S1984-70332012000500006; Crous PW, 2014, PERSOONIA, V32, P184, DOI 10.3767/003158514X682395; da Costa WM, 2012, RESOURCES AND ENVIRO, V2, P253, DOI [10.5923/j.re.20120206.02, DOI 10.5923/J.RE.20120206.02]; da Mota PR, 2016, BIOL CONTROL, V95, P1, DOI 10.1016/j.biocontrol.2015.12.013; da Silva IP, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2228-3; Dalonso N, 2012, FOOD CHEM, V134, P1804, DOI 10.1016/j.foodchem.2012.03.088; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; de Melo Sette Claudia Vaz, 2018, Journal of Dietary Supplements, V15, P673, DOI 10.1080/19390211.2017.1384781; de Oliveira AN, 2010, BRAZ ARCH BIOL TECHN, V53, P653, DOI 10.1590/S1516-89132010000300021; de Siqueira KA, 2017, SYMBIOSIS, V71, P211, DOI 10.1007/s13199-016-0427-6; De Stefano S, 1999, PHYTOCHEMISTRY, V52, P1399, DOI 10.1016/S0031-9422(99)00320-9; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; del Giglio A, 2015, BIOACTIVE NUTRACEUTICALS AND DIETARY SUPPLEMENTS IN NEUROLOGICAL AND BRAIN DISEASE: PREVENTION AND THERAPY, P57, DOI 10.1016/B978-0-12-411462-3.00006-0; Dighton J., 2017, FUNGAL COMMUNITY ITS, V4th ed., DOI [10.1201/9781315119496, DOI 10.1201/9781315119496]; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Marinho AMD, 2011, HELV CHIM ACTA, V94, P835, DOI 10.1002/hlca.201000309; Domsch K.H., 2008, EUROPEAN J SOIL SCI, V59, P1007, DOI [10.1111/j.1365-2389.2008.01052_1.x, DOI 10.1111/J.1365-2389.2008.01052_1.X]; Driche EH, 2015, ANN MICROBIOL, V65, P1341, DOI 10.1007/s13213-014-0972-2; Duarte O., 2015, Exotic fruits and nuts of the New World, DOI 10.1079/9781780645056.0000; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; El-Sayed M. H., 2012, World Applied Sciences Journal, V20, P1202; ELEK SD, 1954, J CLIN PATHOL, V7, P37, DOI 10.1136/jcp.7.1.37; Elena K, 2006, PLANT PATHOL, V55, P300, DOI 10.1111/j.1365-3059.2005.01265.x; Erexson GL, 2001, MUTAT RES-GEN TOX EN, V495, P75, DOI 10.1016/S1383-5718(01)00199-1; ERICKSON HT, 1984, ECON BOT, V38, P273, DOI 10.1007/BF02859006; Erythropel HC, 2014, APPL MICROBIOL BIOT, V98, P9967, DOI 10.1007/s00253-014-6183-8; Evans Harry C., 2003, Mycological Progress, V2, P149, DOI 10.1007/s11557-006-0053-4; Feng Hang, 2013, African Journal of Microbiology Research, V7, P1311; Fernandes PI, 2013, REV BIOL TROP, V61, P991; Ferreira MC, 2015, BIOCHEM SYST ECOL, V59, P36, DOI 10.1016/j.bse.2014.12.017; Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Fukuda T, 2011, J NAT PROD, V74, P1327, DOI 10.1021/np200035m; Fukumasu H, 2011, PHYTOTHER RES, V25, P11, DOI 10.1002/ptr.3216; Garrido-Jurado I, 2017, J PEST SCI, V90, P319, DOI 10.1007/s10340-016-0767-2; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Girija Smiline, 2014, Int Sch Res Notices, V2014, P820745, DOI 10.1155/2014/820745; Gonzaga LL, 2015, J APPL MICROBIOL, V118, P485, DOI 10.1111/jam.12696; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; GUNASEKA.M, 1972, MYCOLOGIA, V64, P1180, DOI 10.2307/3758087; Guzman-Trampe S, 2015, ANTIBIOTICS: CURRENT INNOVATIONS AND FUTURE TRENDS, P175; Habib M. Rowshanul, 2009, Mycobiology, V37, P31, DOI 10.4489/MYCO.2009.37.1.031; HAGERMAN AE, 1985, ANAL BIOCHEM, V151, P334, DOI 10.1016/0003-2697(85)90184-8; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanada RE, 2010, FUNGAL BIOL-UK, V114, P901, DOI 10.1016/j.funbio.2010.08.006; Hancock, 2014, DICT BIOINFORMATICS, DOI [10.1002/9780471650126.dob0956, DOI 10.1002/9780471650126.DOB0956]; HANKIN L, 1975, MYCOLOGIA, V67, P597, DOI 10.2307/3758395; Hayasaka Y, 2014, J CHROMATOGR A, V1372, P120, DOI 10.1016/j.chroma.2014.10.096; HELANDER ML, 1995, NEW PHYTOL, V131, P223, DOI 10.1111/j.1469-8137.1995.tb05723.x; Posada RH, 2012, FUNGAL BIOL-UK, V116, P747, DOI 10.1016/j.funbio.2012.04.003; Herrera J, 2013, FUNGAL ECOL, V6, P65, DOI 10.1016/j.funeco.2012.08.002; Herrera J, 2011, MICROB ECOL, V61, P239, DOI 10.1007/s00248-010-9744-0; Higgins KL, 2014, FUNGAL ECOL, V8, P1, DOI 10.1016/j.funeco.2013.12.005; HIROTA A, 1993, BIOSCI BIOTECH BIOCH, V57, P492, DOI 10.1271/bbb.57.492; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Hoffman MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073132; Hoyos-Carvajal L, 2009, BIOL CONTROL, V51, P409, DOI 10.1016/j.biocontrol.2009.07.018; ICHIKAWA T, 1971, FOLIA MICROBIOL, V16, P218, DOI 10.1007/BF02884210; Jaber LR, 2018, BIOL CONTROL, V116, P36, DOI 10.1016/j.biocontrol.2017.01.018; Ji SH, 2014, MICROBIOL RES, V169, P83, DOI 10.1016/j.micres.2013.06.003; Jia M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00906; Jian ZY, 2017, MEDICINE, V96, DOI [10.1097/md.0000000000007406, 10.1097/MD.0000000000007406]; Jiang XL, 2009, APPL MICROBIOL BIOT, V82, P995, DOI 10.1007/s00253-009-1898-7; Joshi BK, 2002, J NAT PROD, V65, P1734, DOI 10.1021/np020295p; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 2001, MYCORRHIZA, V11, P207, DOI 10.1007/s005720100112; Kang HJ, 2013, Patent No. [US 8591911 B2, 8591911]; Kang HJ, 2011, PLANT PATHOLOGY J, V27, P138, DOI 10.5423/PPJ.2011.27.2.138; Kang HJ, 2010, MYCOLOGIA, V102, P1167, DOI 10.3852/09-304; Kang Z, 2000, PHYSIOL MOL PLANT P, V57, P255, DOI 10.1006/pmpp.2000.0305; Katoch M, 2014, BRAZ ARCH BIOL TECHN, V57, P714, DOI 10.1590/S1516-8913201402502; Katoch M, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-52; Kern ME, 1999, MICOLOGIA MEADICA; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; 강효중, 2015, [Research in Plant Disease, 식물병 연구], V21, P309, DOI 10.5423/RPD.2015.21.4.309; Koske RE., 1983, MYCOL SOC AM NEWSL, V34, P59, DOI DOI 10.1007/S00265-005-0945-3; Kovics GJ, 2014, CRIT REV MICROBIOL, V40, P49, DOI 10.3109/1040841X.2012.755948; Krishnamurthy YL, 2008, MICROBES ENVIRON, V23, P24, DOI 10.1264/jsme2.23.24; Kumar V, 2013, BIOTECHNOL ADV, V31, P945, DOI 10.1016/j.biotechadv.2013.02.008; Kytoviita MM, 2007, AM J BOT, V94, P1309, DOI 10.3732/ajb.94.8.1309; Kytoviita MM, 2005, FEMS MICROBIOL ECOL, V53, P27, DOI 10.1016/j.femsec.2004.09.014; Lee KH, 2000, J PHARM PHARMACOL, V52, P593, DOI 10.1211/0022357001774246; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Leveau JHJ, 2015, PRINCIPLES PLANT MIC, P17; Li XC, 2015, REC NAT PROD, V9, P503; Liew ECY, 2002, MYCOLOGIA, V94, P803, DOI 10.2307/3761695; Liotti RG, 2018, MICROBIOL RES, V207, P8, DOI 10.1016/j.micres.2017.10.011; Loro M, 2012, J ARID ENVIRON, V85, P46, DOI 10.1016/j.jaridenv.2012.04.009; LOUGHMAN R, 1986, PLANT PATHOL, V35, P443, DOI 10.1111/j.1365-3059.1986.tb02041.x; Lowe RGT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00962; Maeda RN, 2011, PROCESS BIOCHEM, V46, P1196, DOI 10.1016/j.procbio.2011.01.022; Mandeel Q, 1999, PHARM BIOL, V37, P181, DOI 10.1076/phbi.37.3.181.6301; Mandyam K, 2005, STUD MYCOL, P173; Mandyam K, 2010, MYCOLOGIA, V102, P813, DOI 10.3852/09-212; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marega M, 2013, J CHROMATOGR A, V1273, P105, DOI 10.1016/j.chroma.2012.11.076; Marfori EC, 2002, Z NATURFORSCH C, V57, P465; Marinelli E., 2012, Asian Journal of Plant Pathology, V6, P66, DOI 10.3923/ajppaj.2012.66.74; Maroldi MMC, 2018, APPL BIOCHEM BIOTECH, V184, P806, DOI 10.1007/s12010-017-2590-5; Martinez-Klimova E, 2017, BIOCHEM PHARMACOL, V134, P1, DOI 10.1016/j.bcp.2016.10.010; Martinez-Medina A, 2014, J CHEM ECOL, V40, P804, DOI 10.1007/s10886-014-0478-1; Martins M., 2014, African Journal of Biotechnology, V13, P131; MATHUR SP, 1974, J ENVIRON QUAL, V3, P189, DOI 10.2134/jeq1974.00472425000300030001x; Matsumura E, 2013, FUNGAL BIOL-UK, V117, P191, DOI 10.1016/j.funbio.2013.01.007; Mishra PD, 2015, LETT APPL MICROBIOL, V60, P387, DOI 10.1111/lam.12384; Mithofer A, 2017, TOXINOLOGY, P3, DOI 10.1007/978-94-007-6464-4_21; Mohamed SA, 2014, MOLECULES, V19, P8027, DOI 10.3390/molecules19068027; Mohan JE, 2014, FUNGAL ECOL, V10, P3, DOI 10.1016/j.funeco.2014.01.005; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOUBASHER AH, 1991, J BASIC MICROB, V31, P59, DOI 10.1002/jobm.3620310113; Muharni, 2014, INDONES J CHEM, V14, P290, DOI 10.22146/ijc.21241; Murali TS, 2006, CAN J MICROBIOL, V52, P673, DOI 10.1139/W06-020; Nguyen DH, 2008, KOREAN J CHEM ENG, V25, P1136, DOI 10.1007/s11814-008-0186-z; Nutaratat P, 2014, FUNGAL BIOL-UK, V118, P683, DOI 10.1016/j.funbio.2014.04.010; Ogorek R, 2016, EUR J PLANT PATHOL, V145, P469, DOI 10.1007/s10658-016-0860-7; Ola ARB, 2014, TETRAHEDRON LETT, V55, P3147, DOI 10.1016/j.tetlet.2014.03.110; Oliveira AN, 2004, REV BRAS CIENC SOLO, V28, P1063, DOI 10.1590/S0100-06832004000600015; Padhi S, 2013, ANN MICROBIOL, V63, P793, DOI 10.1007/s13213-012-0534-4; Pashley CH, 2012, FUNGAL BIOL-UK, V116, P214, DOI 10.1016/j.funbio.2011.11.004; Peterson RA, 2009, LETT APPL MICROBIOL, V48, P218, DOI 10.1111/j.1472-765X.2008.02513.x; Peterson R, 2011, MYCOL PROG, V10, P207, DOI 10.1007/s11557-010-0690-5; PETRINI L E, 1986, Mycologia Helvetica, V1, P501; Petrini O., 1991, MICROBIAL ECOLOGY LE, V1st ed., P179, DOI [10.1007/978-1-4612-3168-4_9, DOI 10.1007/978-1-4612-3168-4_9]; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Photita W, 2001, MYCOL RES, V105, P1508, DOI 10.1017/S0953756201004968; Piernas V, 1997, J FOOD SCI, V62, P611, DOI 10.1111/j.1365-2621.1997.tb04443.x; Polishook JD, 1996, J IND MICROBIOL, V17, P284, DOI 10.1007/BF01574703; Porras-Alfaro A, 2011, MYCOLOGIA, V103, P10, DOI 10.3852/09-297; PRESTON PN, 1983, J CHEM SOC PERK T 1, P1001, DOI 10.1039/p19830001001; Punja ZK, 2003, ELSEVIER CURRENT TRE, P400, DOI [10.1016/S0167-7799(03)00193-8, DOI 10.1016/S0167-7799(03)00193-8]; Qadri M, 2015, WORLD J MICROB BIOT, V31, P1647, DOI 10.1007/s11274-015-1910-6; Raghuwanshi S, 2014, FUEL, V124, P183, DOI 10.1016/j.fuel.2014.01.107; Rajeshkumar KC, 2016, MYCOL PROG, V15, P1119, DOI 10.1007/s11557-016-1234-4; Ramos AM, 2009, NORMAIS CLIMATOLO A; Redman RS, 2001, NEW PHYTOL, V151, P705, DOI 10.1046/j.0028-646x.2001.00210.x; Reid AM, 2007, INT J ENVIRON AN CH, V87, P125, DOI 10.1080/03067310601071183; Renfrew EC, 2016, CHEMISTRY AND TECHNOLOGY OF SOFT DRINKS AND FRUIT JUICES, 3RD EDITION, P15; Rinnan R, 2005, GLOBAL CHANGE BIOL, V11, P564, DOI 10.1111/j.1365-2486.2005.00933.x; Rodgers K, 2014, TOXICANTS IN FOOD PA, DOI [10.1007/978-1-4471-6500-2, DOI 10.1007/978-1-4471-6500-2]; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; Roncon CM, 2011, PLANTA MED, V77, P236, DOI 10.1055/s-0030-1250315; Rosa L. H., 2012, American Journal of Plant Sciences, V3, P1105, DOI 10.4236/ajps.2012.38133; Rosa LH, 2009, POLAR BIOL, V32, P161, DOI 10.1007/s00300-008-0515-z; Rossman Amy Y., 2007, Mycoscience, V48, P135, DOI 10.1007/s10267-007-0347-7; ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609; Rudrappa T, 2007, PLANT SIGNAL BEHAV, V2, P349, DOI 10.4161/psb.2.5.4117; Silva MCSE, 2016, MICROB PATHOGENESIS, V98, P16, DOI 10.1016/j.micpath.2016.06.023; Saucedo-Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098454; Schimpl FC, 2013, J ETHNOPHARMACOL, V150, P14, DOI 10.1016/j.jep.2013.08.023; Schlegel M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3369-8; Schroth G, 2000, AGROFOREST SYST, V50, P199, DOI 10.1023/A:1006468103914; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Schwarz M, 2004, PHYTOCHEMISTRY, V65, P2239, DOI 10.1016/j.phytochem.2004.06.035; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sebastianes FLS, 2012, CURR MICROBIOL, V65, P622, DOI 10.1007/s00284-012-0206-4; Setala H, 2004, OECOLOGIA, V139, P98, DOI 10.1007/s00442-003-1478-y; Shannon C, 2009, A MATHEMATICAL THEOR, DOI [10.1109/9780470544242.ch1, DOI 10.1109/9780470544242.CH1]; Shearer JF, 2010, WEED TECHNOL, V24, P202, DOI 10.1614/WT-D-09-00001.1; Sia ED, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-579; SIEBER TN, 1989, MYCOL RES, V92, P322, DOI 10.1016/S0953-7562(89)80073-5; SIERRA GONZALO, 1957, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V23, P15; Silva HSA, 2012, BIOL CONTROL, V63, P62, DOI 10.1016/j.biocontrol.2012.06.005; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smetanina OF, 2004, RUSS CHEM B+, V53, P2643, DOI 10.1007/s11172-005-0167-x; Soares MA, 2016, MICROB ECOL, V72, P407, DOI 10.1007/s00248-016-0793-x; Soares MA, 2016, PLANT SOIL, V405, P107, DOI 10.1007/s11104-015-2638-7; Soares MA, 2016, BIOL INVASIONS, V18, P2689, DOI 10.1007/s10530-016-1160-z; Soares MA, 2014, EUR J PLANT PATHOL, V140, P769, DOI 10.1007/s10658-014-0508-4; Speit G, 2016, MUTAT RES-GEN TOX EN, V803, P22, DOI 10.1016/j.mrgentox.2016.05.001; Stevens KJ, 2010, AQUAT BOT, V92, P105, DOI 10.1016/j.aquabot.2009.10.013; Su MY, 2015, BIOTECHNOL LETT, V37, P717, DOI 10.1007/s10529-014-1730-z; Syed A, 2013, SPECTROCHIM ACTA A, V106, P41, DOI 10.1016/j.saa.2013.01.002; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Tayung K, 2011, MYCOSPHERE, V2, P203; Tchameni SN, 2011, CROP PROT, V30, P1321, DOI 10.1016/j.cropro.2011.05.003; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.3.CO;2-H; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Udayanga D, 2011, FUNGAL DIVERS, V50, P189, DOI 10.1007/s13225-011-0126-9; UECKER FA, 1991, MYCOLOGIA, V83, P192, DOI 10.2307/3759934; Uzor PF, 2017, DRUG RES, V67, P308, DOI 10.1055/s-0042-122777; VAJNA L, 1985, PHYTOPATHOL Z, V114, P338; Varma A, 1998, MYCORRHIZA MANUAL, P541, DOI [10.1007/978-3-642-60268-9, DOI 10.1007/978-3-642-60268-9]; Vaz ABM, 2012, APPL SOIL ECOL, V61, P288, DOI 10.1016/j.apsoil.2011.10.017; Vega FE, 2005, J BASIC MICROB, V45, P371, DOI 10.1002/jobm.200410551; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Vidal S, 2015, CURR SCI INDIA, V109, P46; Vieira MLA, 2012, CAN J MICROBIOL, V58, P54, DOI [10.1139/w11-105, 10.1139/W11-105]; Viterbo A, 2004, FEMS MICROBIOL LETT, V238, P151, DOI 10.1016/j.femsle.2004.07.028; [Wang Jie 王洁], 2015, [微生物学通报, Microbiology China], V42, P238; Wang LW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01251; Wani ZA, 2015, APPL MICROBIOL BIOT, V99, P2955, DOI 10.1007/s00253-015-6487-3; Wearn JA, 2012, J ECOL, V100, P1085, DOI 10.1111/j.1365-2745.2012.01997.x; Wellensiek Brian P, 2013, Open Virol J, V7, P72, DOI 10.2174/1874357920130624002; West ER, 2010, CAN J MICROBIOL, V56, P209, DOI [10.1139/w10-004, 10.1139/W10-004]; WHITE JF, 1987, PLANT DIS, V71, P340, DOI 10.1094/PD-71-0340; White TJ., 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353; Wu LS, 2013, CURR MICROBIOL, V66, P40, DOI 10.1007/s00284-012-0235-z; Xu JX, 2015, BIORESOURCE TECHNOL, V181, P18, DOI 10.1016/j.biortech.2014.12.080; Yamaguti-Sasaki E, 2007, MOLECULES, V12, P1950, DOI 10.3390/12081950; Yang CA, 2011, FEBS J, V278, P3381, DOI 10.1111/j.1742-4658.2011.08262.x; Yang ZY, 2014, ACTA HORTIC, V1029, P301, DOI 10.17660/ActaHortic.2014.1029.37; Yeo TC, 2014, COMB CHEM HIGH T SCR, V17, P192, DOI 10.2174/1386207317666140109114553; Yin JY, 2012, ACTA HORTIC, V950, P293; Zabalgogeazcoa I, 2008, SPAN J AGRIC RES, V6, P138, DOI 10.5424/sjar/200806S1-382; Zeidan-Chulia F, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/791795; Zereini F, 2011, URBAN AIRBORNE PARTI, DOI [10.1007/978-3-642-12278-1, DOI 10.1007/978-3-642-12278-1]; Zhang GJ, 2011, PHYTOCHEMISTRY, V72, P1436, DOI 10.1016/j.phytochem.2011.04.014; Zhang RY, 2015, CHEM REV, V115, P3803, DOI 10.1021/acs.chemrev.5b00067; Zhao Y, 2005, EUR J SOIL BIOL, V41, P21, DOI 10.1016/j.ejsobi.2005.03.002; Zheng P, 2006, PROCESS BIOCHEM, V41, P2160, DOI 10.1016/j.procbio.2006.06.012; Zolfaghari M, 2014, ENVIRON POLLUT, V194, P281, DOI 10.1016/j.envpol.2014.07.014	261	30	31	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195874	10.1371/journal.pone.0195874	http://dx.doi.org/10.1371/journal.pone.0195874			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649297	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900100
J	Beekman, C; Janson, AA; Baghat, A; van Deutekom, JC; Datson, NA				Beekman, Chantal; Janson, Anneke A.; Baghat, Aabed; van Deutekom, Judith C.; Datson, Nicole A.			Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy	PLOS ONE			English	Article							MOLECULAR-BASIS; MUTATIONS; SEVERITY; PROTEINS; DELETION; GENE	Duchenne muscular dystrophy (DMD) is a neuromuscular disease characterized by progressive weakness of the skeletal and cardiac muscles. This X-linked disorder is caused by open reading frame disrupting mutations in the DMD gene, resulting in strong reduction or complete absence of dystrophin protein. In order to use dystrophin as a supportive or even surrogate biomarker in clinical studies on investigational drugs aiming at correcting the primary cause of the disease, the ability to reliably quantify dystrophin expression in muscle biopsies of DMD patients pre- and post-treatment is essential. Here we demonstrate the application of the ProteinSimple capillary immunoassay (Wes) method, a gel-and blot-free method requiring less sample, antibody and time to run than conventional Western blot assay. We optimized dystrophin quantification by Wes using 2 different antibodies and found it to be highly sensitive, reproducible and quantitative over a large dynamic range. Using a healthy control muscle sample as a reference and a-actinin as a protein loading/muscle content control, a panel of skeletal muscle samples consisting of 31 healthy controls, 25 Becker Muscle dystrophy (BMD) and 17 DMD samples was subjected to Wes analysis. In healthy controls dystrophin levels varied 3 to 5-fold between the highest and lowest muscle samples, with the reference sample representing the average of all 31 samples. In BMD muscle samples dystrophin levels ranged from 10% to 90%, with an average of 33% of the healthy muscle average, while for the DMD samples the average dystrophin level was 1.3%, ranging from 0.7% to 7% of the healthy muscle average. In conclusion, Wes is a suitable, efficient and reliable method for quantification of dystrophin expression as a biomarker in DMD clinical drug development.	[Beekman, Chantal; Janson, Anneke A.; Baghat, Aabed; van Deutekom, Judith C.; Datson, Nicole A.] BioMarin Nederland BV, Leiden, Netherlands		Datson, NA (corresponding author), BioMarin Nederland BV, Leiden, Netherlands.	nicole.datson@bmm.com	Datson, Nicole A./O-8797-2014	Datson, Nicole/0000-0003-2887-0238				Abbs Stephen, 2010, Neuromuscul Disord, V20, P422, DOI 10.1016/j.nmd.2010.04.005; Allen DG, 2016, PHYSIOL REV, V96, P253, DOI 10.1152/physrev.00007.2015; Anthony K, 2014, NEUROLOGY, V83, P2062, DOI 10.1212/WNL.0000000000001025; Anthony K, 2011, BRAIN, V134, P3544, DOI 10.1093/brain/awr291; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Brown K, 2013, J INTERV STATEBUILD, V7, P492, DOI 10.1080/17502977.2012.727539; BYERS TJ, 1991, J CELL BIOL, V115, P411, DOI 10.1083/jcb.115.2.411; Carr S, 2017, PROTEOMICS CLIN APPL; Chen JQ, 2013, ANAL BIOCHEM, V442, P97, DOI 10.1016/j.ab.2013.07.022; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; COMI GP, 1994, BRAIN, V117, P1, DOI 10.1093/brain/117.1.1-a; Doriguzzi C, 1997, EUR J CLIN INVEST, V27, P352, DOI 10.1046/j.1365-2362.1997.1090650.x; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Fung P.A., 2011, NAT METHODS, V8; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; HOKIM MA, 1992, FEBS LETT, V304, P187, DOI 10.1016/0014-5793(92)80615-N; Hulsker Margriet, 2016, J Neuromuscul Dis, V3, P77; Kaspar RW, 2009, CIRC-CARDIOVASC GENE, V2, P544, DOI 10.1161/CIRCGENETICS.109.867242; KOENIG M, 1989, AM J HUM GENET, V45, P498; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; McCourt JL, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0040-z; MIYATAKE M, 1989, J NEUROL SCI, V93, P11, DOI 10.1016/0022-510X(89)90157-3; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Ryder S, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0631-3; Taylor LE, 2012, NEUROPATH APPL NEURO, V38, P591, DOI 10.1111/j.1365-2990.2012.01250.x; van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P747, DOI 10.1136/jnnp-2013-306350	30	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195850	10.1371/journal.pone.0195850	http://dx.doi.org/10.1371/journal.pone.0195850			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641567	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900095
J	Li, JR; Zhao, YS; Chang, Y; Yang, SC; Guo, YJ; Ji, ES				Li, Jie-Ru; Zhao, Ya-Shuo; Chang, Yue; Yang, Sheng-Chang; Guo, Ya-Jing; Ji, En-Sheng			Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; RHO-KINASE; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; COMBINATION THERAPY; ANGIOTENSIN-II; MECHANISMS; HYPERTENSION; INHIBITION; ISCHEMIA	Endothelial dysfunction is one of the main pathological changes in Obstructive sleep apnoea (OSA). The Rho kinase (ROCK) pathway is associated with endothelial dysfunction. However, the interaction between ROCK and nuclear factor of activated T cells isoform c3 (NFATc3) in the development of this pathological response under chronic intermittent hypoxia (CIH) is unclear. To simulate the OSA model, we established a moderate CIH rat model by administering the fraction of inspired O-2 (FiO(2)) from 21% to 9%, 20 times/h, 8 h/day for 3 weeks. Fasudil (ROCK inhibitor, 8 mg/kg/d, i.p.) was administrated in the rats exposed to CIH for 3 weeks. Our results demonstrated that CIH caused significantly endothelial dysfunction, accompanying with increased ET-1 level, decreased eNOS expression and NO production, which reduced ACh-induced vascular relaxation responses. Moreover, RhoA/ROCK-2/NFATc3 expressions were up-regulated. Fasudil significantly improved CIH induced endothelial dysfunction. Data suggested that the ROCK activation is necessary for endothelial dysfunction during CIH.	[Li, Jie-Ru; Chang, Yue; Yang, Sheng-Chang; Ji, En-Sheng] Hebei Univ Chinese Med, Dept Physiol, Shijiazhuang, Hebei, Peoples R China; [Zhao, Ya-Shuo; Guo, Ya-Jing] Hebei Univ Chinese Med, Sci Res Ctr, Shijiazhuang, Hebei, Peoples R China	Hebei University of Chinese Medicine; Hebei University of Chinese Medicine	Ji, ES (corresponding author), Hebei Univ Chinese Med, Dept Physiol, Shijiazhuang, Hebei, Peoples R China.	jesphy@126.com	Zhao, Yashuo/CAH-2686-2022	Ji, ensheng/0000-0002-5858-7567; Zhao, Yashuo/0000-0002-5793-5574	National Natural Science Foundation of China [30971195, 81170069]; Education Department, Hebei Province [ZD2014043, ZD2014005]; Natural Science Foundation of Hebei Province [C2011206031, C2009001053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department, Hebei Province; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was supported by grants from the National Natural Science Foundation of China (Numbers 30971195 and 81170069), the Education Department, Hebei Province (Number ZD2014043 and ZD2014005) and the Natural Science Foundation of Hebei Province (Numbers C2011206031 and C2009001053) (ESJ).	Cleland SJ, 2000, CLIN SCI, V98, P531, DOI 10.1042/CS20000013; Daskoulidou N, 2015, J MOL MED, V93, P511, DOI 10.1007/s00109-014-1234-2; de Frutos S, 2008, AM J PHYSIOL-HEART C, V294, pH2382, DOI 10.1152/ajpheart.00132.2008; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; de Frutos S, 2009, AM J PHYSIOL-LUNG C, V297, pL475, DOI 10.1152/ajplung.00060.2009; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Duchna HW, 2006, WIEN MED WOCHENSCHR, V156, P596, DOI 10.1007/s10354-006-0341-2; Dumitrascu R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/234631; Duong-Quy S, 2013, PHARMACOL THERAPEUT, V137, P352, DOI 10.1016/j.pharmthera.2012.12.003; Durand MJ, 2010, AM J PHYSIOL-HEART C, V299, pH1024, DOI 10.1152/ajpheart.00328.2010; Durgan DJ, 2015, J CEREBR BLOOD F MET, V35, P402, DOI 10.1038/jcbfm.2014.214; Durgan DJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000091; Elias-Al-Mamun M, 2014, CIRC J, V78, P967, DOI 10.1253/circj.CJ-13-1174; Fava C, 2011, SEMIN THROMB HEMOST, V37, P280, DOI 10.1055/s-0031-1273092; Finch J, 2016, CARDIOVASC TOXICOL, V16, P260, DOI 10.1007/s12012-015-9334-y; Gentry PL KS, 2006, J PHARMACOLOGY TOXIC, V1, P19, DOI [10.3923/jpt.2006.19.32, DOI 10.3923/JPT.2006.19.32]; Gkaliagkousi E, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0596-3; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Guo QH, 2013, CLIN EXP PHARMACOL P, V40, P449, DOI 10.1111/1440-1681.12109; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Hartmann S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00276; Hassona MDH, 2010, AM J PHYSIOL-HEART C, V298, pH2112, DOI 10.1152/ajpheart.00016.2010; Hernandez-Guerra M, 2013, HEPATOLOGY, V57, P1564, DOI 10.1002/hep.26152; Nguyen H, 2013, CARDIOVASC RES, V97, P696, DOI 10.1093/cvr/cvs422; Kanbay A, 2015, ANN THORAC MED, V10, P199, DOI 10.4103/1817-1737.160840; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; Konukoglu D, 2017, ADV EXP MED BIOL, V956, P511, DOI 10.1007/5584_2016_90; Leguina-Ruzzi A, 2015, METAB SYNDR RELAT D, V13, P373, DOI 10.1089/met.2015.0061; Liu HX, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2916017; Lurie A, 2011, ADV CARDIOL, V46, P1, DOI 10.1159/000327660; Maspero C, 2015, MINERVA STOMATOL, V64, P97; Ohike Y, 2005, CIRC J, V69, P221, DOI 10.1253/circj.69.221; Philippi NR, 2010, RESP PHYSIOL NEUROBI, V170, P157, DOI 10.1016/j.resp.2009.12.003; Pietropaoli N, 2015, SLEEP BREATH, V19, P1431, DOI 10.1007/s11325-015-1157-3; Satoh S, 2012, BIOCHEM BIOPH RES CO, V424, P338, DOI 10.1016/j.bbrc.2012.06.136; Shin HK, 2007, J CEREBR BLOOD F MET, V27, P998, DOI 10.1038/sj.jcbfm.9600406; Smith CJ, 2013, MICROVASC RES, V87, P58, DOI 10.1016/j.mvr.2013.02.005; Soga J, 2011, ARTERIOSCL THROM VAS, V31, P2353, DOI 10.1161/ATVBAHA.111.227892; Sugimoto M, 2007, BIOCHEM BIOPH RES CO, V361, P462, DOI 10.1016/j.bbrc.2007.07.030; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Tahawi Z, 2001, J APPL PHYSIOL, V90, P2007, DOI 10.1152/jappl.2001.90.5.2007; Teramoto S, 2003, SLEEP MED, V4, P403, DOI 10.1016/S1389-9457(03)00102-3; Thapa Amrit, 2015, Med J Armed Forces India, V71, pS369, DOI 10.1016/j.mjafi.2014.07.001; Tsounapi P, 2012, EUR J PHARMACOL, V691, P182, DOI 10.1016/j.ejphar.2012.07.016; Varadharaj S, 2015, RESP PHYSIOL NEUROBI, V207, P40, DOI 10.1016/j.resp.2014.12.012; Wang QM, 2012, VASC MED, V17, P379, DOI 10.1177/1358863X12459790; Wu N, 2014, PHARMAZIE, V69, P704, DOI 10.1692/ph.2014.4562; Yaghi A, 2005, AM J PHYSIOL-LUNG C, V289, pL1061, DOI 10.1152/ajplung.00096.2005; Zamarron C, 2013, PULM MED, V2013, DOI 10.1155/2013/521087; Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002; Zhou Q, 2009, CURR PHARM DESIGN, V15, P3108, DOI 10.2174/138161209789057986	52	8	10	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195604	10.1371/journal.pone.0195604	http://dx.doi.org/10.1371/journal.pone.0195604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641598	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900077
J	Hagenfeld, D; Koch, R; Junemann, S; Prior, K; Harks, I; Eickholz, P; Hoffmann, T; Kim, TS; Kocher, T; Meyle, J; Kaner, D; Schlagenhauf, U; Ehmke, B; Harmsen, D				Hagenfeld, Daniel; Koch, Raphael; Juenemann, Sebastian; Prior, Karola; Harks, Inga; Eickholz, Peter; Hoffmann, Thomas; Kim, Ti-Sun; Kocher, Thomas; Meyle, Joerg; Kaner, Dogan; Schlagenhauf, Ulrich; Ehmke, Benjamin; Harmsen, Dag			Do we treat our patients or rather periodontal microbes with adjunctive antibiotics in periodontal therapy? A 16S rDNA microbial community analysis	PLOS ONE			English	Article							AMOXICILLIN PLUS METRONIDAZOLE; SUBGINGIVAL MICROBIOTA; SYSTEMIC ANTIBIOTICS; SEQUENCE DATA; PATHOGENS; PROFILES; HEALTH	Empiric antibiotics are often used in combination with mechanical debridement to treat patients suffering from periodontitis and to eliminate disease-associated pathogens. Until now, only a few next generation sequencing 16S rDNA amplicon based publications with rather small sample sizes studied the effect of those interventions on the subgingival micro biome. Therefore, we studied subgingival samples of 89 patients with chronic periodontitis (solely non-smokers) before and two months after therapy. Forty-seven patients received mechanical periodontal therapy only, whereas 42 patients additionally received oral administered amoxicillin plus metronidazole (500 and 400 mg, respectively; 3x/day for 7 days). Samples were sequenced with Illumina MiSeq 300 base pairs paired end technology (V3 and V4 hypervariable regions of the 16S rDNA). Inter-group differences before and after therapy of clinical variables (percentage of sites with pocket depth >= 5mm, percentage of sites with bleeding on probing) and microbiome variables (diversity, richness, evenness, and dissimilarity) were calculated, a principal coordinate analysis (PCoA) was conducted, and differential abundance of agglomerated ribosomal sequence variants (aRSVs) classified on genus level was calculated using a negative binomial regression model. We found statistically noticeable decreased richness, and increased dissimilarity in the antibiotic, but not in the placebo group after therapy. The PCoA revealed a clear compositional separation of microbiomes after therapy in the antibiotic group, which could not be seen in the group receiving mechanical therapy only. This difference was even more pronounced on aRSV level. Here, adjunctive antibiotics were able to induce a microbiome shift by statistically noticeably reducing aRSVs belonging to genera containing disease-associated species, e.g., Porphyromonas, Tannerella, Treponema, and Aggregatibacter, and by noticeably increasing genera containing health-associated species. Mechanical therapy alone did not statistically noticeably affect any disease-associated taxa. Despite the difference in micro biome modulation both therapies improved the tested clinical parameters after two months. These results cast doubt on the relevance of the elimination and/or reduction of disease associated taxa as a main goal of periodontal therapy.	[Hagenfeld, Daniel; Prior, Karola; Harks, Inga; Ehmke, Benjamin; Harmsen, Dag] Munster Univ Hosp, Dept Periodontol & Restaurat Dent, Munster, Germany; [Koch, Raphael] Univ Munster, Inst Biostat & Clin Res, Munster, Germany; [Juenemann, Sebastian] Univ Bielefeld, Ctr Biotechnol CeBiTec, Bielefeld, Germany; [Eickholz, Peter] Goethe Univ Frankfurt, Dept Periodontol, Frankfurt, Germany; [Hoffmann, Thomas] Tech Univ Dresden, Dept Periodontol, Dresden, Germany; [Kim, Ti-Sun] Univ Hosp Heidelberg, Sect Periodontol, Dept Conservat Dent, Heidelberg, Germany; [Kocher, Thomas] Univ Med Greifswald, Unit Periodontol, Greifswald, Germany; [Meyle, Joerg] Univ Giessen, Dept Periodontol, Giessen, Germany; [Kaner, Dogan] Univ Witten Herdecke, Dent Sch, Fac Hlth, Dept Periodontol, Witten, Germany; [Kaner, Dogan] Charite, Dept Periodontol, Berlin, Germany; [Kaner, Dogan] Charite, Dept Synopt Dent, Berlin, Germany; [Schlagenhauf, Ulrich] Univ Hosp Wurzburg, Dept Periodontol, Wurzburg, Germany	University of Munster; University of Munster; University of Bielefeld; Goethe University Frankfurt; Technische Universitat Dresden; Ruprecht Karls University Heidelberg; Greifswald Medical School; Justus Liebig University Giessen; Witten Herdecke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg	Hagenfeld, D (corresponding author), Munster Univ Hosp, Dept Periodontol & Restaurat Dent, Munster, Germany.	daniel.hagenfeld@ukmuenster.de	Hagenfeld, Daniel/ABA-9972-2021; Koch, Raphael/A-7857-2013	Koch, Raphael/0000-0002-5581-5122; Junemann, Sebastian/0000-0002-3714-0328; Hagenfeld, Daniel/0000-0003-1072-4865				Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x; Bizzarro S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20205; Callahan Ben J, 2016, F1000Res, V5, P1492; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Eickholz P, 2016, J CLIN PERIODONTOL, V43, P839, DOI 10.1111/jcpe.12594; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hajishengallis G, 2016, TRENDS MICROBIOL, V24, P477, DOI 10.1016/j.tim.2016.02.010; Harks I., 2014, APPL CLIN RES CLIN T, V1, P43, DOI [10.2174/2213476X01666140327211914, DOI 10.2174/2213476X01666140327211914]; Harks I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160142; Harks I, 2015, J CLIN PERIODONTOL, V42, P832, DOI 10.1111/jcpe.12441; Illumina, 2013, 16S MET SEQ LIB PREP; Jonsson V, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2386-y; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Keestra JAJ, 2015, J PERIODONTAL RES, V50, P689, DOI 10.1111/jre.12252; KEMPTON RA, 1976, NATURE, V262, P818, DOI 10.1038/262818a0; Kirst ME, 2015, APPL ENVIRON MICROB, V81, P783, DOI 10.1128/AEM.02712-14; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Laksmana T, 2012, OPEN DENT J, V6, P255, DOI 10.2174/1874210601206010255; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magurran A.E, 2003, MEASURING BIOL DIVER; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Oliveira RRDS, 2016, J DENT RES, V95, P711, DOI 10.1177/0022034516634619; PAVICIC MJAMP, 1991, ANTIMICROB AGENTS CH, V35, P961, DOI 10.1128/AAC.35.5.961; Perez-Chaparro PJ, 2014, J DENT RES, V93, P846, DOI 10.1177/0022034514542468; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Development Core Team, 2017, R LANG ENV STAT COMP; RStudio Team, 2016, RSTUDIO INT DEV ENV; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schwarzberg K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086708; Segelnick SL, 2006, J PERIODONTOL, V77, P1598, DOI 10.1902/jop.2006.050358; Shi BC, 2015, MBIO, V6, DOI 10.1128/mBio.01926-14; Soares GMS, 2014, J CLIN PERIODONTOL, V41, P366, DOI 10.1111/jcpe.12217; Socransky SS, 2013, J CLIN PERIODONTOL, V40, P771, DOI 10.1111/jcpe.12117; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winkel EG, 2001, J CLIN PERIODONTOL, V28, P296, DOI 10.1034/j.1600-051x.2001.028004296.x; Wright ES, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0749-z	47	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195534	10.1371/journal.pone.0195534	http://dx.doi.org/10.1371/journal.pone.0195534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668720	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200046
J	Tieu, C; Lucas, EJ; DePaola, M; Rosman, L; Alexander, GC				Tieu, Carolyn; Lucas, Eleanor J.; DePaola, Mindi; Rosman, Lori; Alexander, G. Caleb			Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review	PLOS ONE			English	Review							GLARGINE LANTUS(R); CONTROLLED-TRIAL; LY2963016; INTERCHANGEABILITY; PHARMACODYNAMICS; PHARMACOKINETICS; PRESCRIPTION; BIOLOGICS	Importance For nearly a century, no generic form of insulin has been available in the United States. However, the first biosimilar insulin, Basaglar, was approved by the U.S. Food and Drug Administration in 2015, and subsequently Admelog and Lusduna in 2017. Objective To summarize the scientific evidence comparing the safety, efficacy, pharmacokinetics, and pharmacodynamics of biosimilar and reference insulin products. Data sources We conducted a systematic review using PubMed, Cochrane, Embase, Latin America and Caribbean Health Sciences, South Asian Database of Controlled Clinical Trials, and IndiaMED from their inception through January 14, 2018. Study selection We included randomized controlled trials (RCTs) comparing safety, clinical efficacy, pharmacokinetics and pharmacodynamics of any biosimilar insulin with a reference product in adults regardless of sample size and location. Data extraction and synthesis Two researchers independently reviewed all titles, abstracts and text; extracted data; and performed quality assessments. Main outcomes and measures Efficacy, safety, pharmacokinetics, and pharmacodynamics of biosimilar and reference insulin products Results Of 6945 articles screened, 11 studies were included in the data synthesis. LY2963016, Basalog, Basalin, and MK-1293 were compared to Lantus while SAR342434 was compared to Humalog. Three trials enrolled healthy volunteers, five enrolled type 1 diabetics, and two enrolled type 2 diabetics. One study enrolled both healthy and type 1 diabetics. Of the eleven studies, six examined pharmacokinetic and/or pharmacodynamic parameters and five examined clinical efficacy and immunogenicity. All studies included adverse events. All PK and/or PD studies showed that comparable parameters of biosimilar and reference products were within the pre-specified equivalence margins. Clinical studies suggested similar clinical efficacy and immunogenicity. Adverse events were similar between the groups across all studies. Conclusions and relevance Few published studies have compared biosimilar and reference insulins, though those that did suggest that the biosimilars have comparable safety and clinical efficacy as its reference product.	[Tieu, Carolyn; DePaola, Mindi; Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Tieu, Carolyn; Alexander, G. Caleb] Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Baltimore, MD 21218 USA; [Lucas, Eleanor J.] Pharmerit Int, Bethesda, MA USA; [Rosman, Lori] Johns Hopkins Univ, Sch Med, Welch Med Lib, Baltimore, MD USA; [Alexander, G. Caleb] Johns Hopkins Med, Div Gen Internal Med, Dept Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Alexander, GC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.; Alexander, GC (corresponding author), Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Baltimore, MD 21218 USA.; Alexander, GC (corresponding author), Johns Hopkins Med, Div Gen Internal Med, Dept Med, Baltimore, MD 21287 USA.	galexand@jhsph.edu		Rosman, Lori/0000-0002-6935-1672	Johns Hopkins Center of Excellence in Regulatory Science and Innovation [U01 FD004977-03]; Pharmerit International; FOOD AND DRUG ADMINISTRATION [U01FD004977] Funding Source: NIH RePORTER	Johns Hopkins Center of Excellence in Regulatory Science and Innovation; Pharmerit International; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	This work was supported in part through the Johns Hopkins Center of Excellence in Regulatory Science and Innovation (U01 FD004977-03). The funding source had no role in the design and conduct of the study, analysis or interpretation of the data, and preparation or final approval of the manuscript prior to publication. EL received support in the form of salaries from Pharmerit International. However, no external sources of funding were obtained for this study. Pharmerit International had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part through the Johns Hopkins Center of Excellence in Regulatory Science and Innovation (U01 FD004977-03). The funding source had no role in the design and conduct of the study, analysis or interpretation of the data, and preparation or final approval of the manuscript prior to publication.	[Anonymous], BIOPH; [Anonymous], 2014, AB FORM AB EPAR PUBL; [Anonymous], 2015, FDA APPR BAS 1 FOLL; [Anonymous], AB PREV AB; [Anonymous], 2016, HUM INS MARK PROD DR; [Anonymous], 2017, FDA APPR ADM 1 SHORT; [Anonymous], 2017, INS LISPR SAN EPAR D; [Anonymous], 2012, BIOC PFIZ CONCL COMM; [Anonymous], 2017, LUSD DNA 208722 DRUG; [Anonymous], GLOB US MED OUTL 201; [Anonymous], INSULIN; [Anonymous], 2016, SIM BIOL APPR MARK I; [Anonymous], 2017, LUSD EPAR SUMM PUBL; [Anonymous], 2016, WHAT HAPP BIOS 2015; [Anonymous], 2014, LUP LAUNCH BAS; [Anonymous], 2014, STAT LAWS LEG REL BI; [Anonymous], GLAR; Blackstone EA, 2013, AM HEALTH DRUG BENEF, V6, P469; Blandizzi C, 2017, CLIN THER, V39, P1026, DOI 10.1016/j.clinthera.2017.03.014; Blevins TC, 2015, DIABETES OBES METAB, V17, P726, DOI 10.1111/dom.12496; [程时武 CHENG Shi-wu], 2010, [中国糖尿病杂志, Chinese Journal of Diabetes], V18, P387; Chingcuanco F, 2016, ANN INTERN MED, V165, P565, DOI 10.7326/M16-0428; Crutchlow MFP J. S., 2017, DIABETES OBES METAB; Derwahl KM, 2018, DIABETES TECHNOL THE, V20, P49, DOI 10.1089/dia.2017.0281; DeVries JH, 2015, DIABETES OBES METAB, V17, P445, DOI 10.1111/dom.12410; Dowlat HA, 2016, DIABETES OBES METAB, V18, P737, DOI 10.1111/dom.12676; Edelman S, 2014, CURR MED RES OPIN, V30, P2217, DOI 10.1185/03007995.2014.952718; FDA, 2015, SCI CONS DEM BIOS RE; Garg SK, 2017, DIABETES TECHNOL THE, V19, P753, DOI 10.1089/dia.2017.0117.correx; Gough S, 2013, PRACT DIABETES, V30, P146, DOI 10.1002/pdi.1763; Heinemann L, 2016, J DIABETES SCI TECHN, V10, P457; Heinemann L, 2017, DIABETES TECHNOL THE, V19, P79, DOI 10.1089/dia.2016.0263; Heinemann Lutz, 2014, J Diabetes Sci Technol, V8, P6; Heinemann L, 2015, DIABETES TECHNOL THE, V17, P510, DOI 10.1089/dia.2014.0362; Heinemann L, 2012, EXPERT OPIN BIOL TH, V12, P1009, DOI 10.1517/14712598.2012.688024; Heinemann Lutz, 2011, J Diabetes Sci Technol, V5, P741; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Home P, 2018, DIABETES TECHNOL THE, V20, P160, DOI 10.1089/dia.2017.0373; Ilag LL, 2016, DIABETES OBES METAB, V18, P159, DOI 10.1111/dom.12584; Ilag LL, 2017, DIABETES THER, V8, P545, DOI 10.1007/s13300-017-0253-8; James J., 2017, INT DIABETES NURSING, V14, P32, DOI [10.1080/20573316.2017.1340246, DOI 10.1080/20573316.2017.1340246]; Joshi Shashank R, 2007, J Assoc Physicians India, V55 Suppl, P19; Kapitza C, 2017, DIABETES OBES METAB, V19, P622, DOI 10.1111/dom.12856; Kramer I, 2010, BR J DIABETES VASC D, V10, P163, DOI DOI 10.1177/1474651410369234; Kuhlmann M, 2006, NEPHROL DIAL TRANSPL, V21, P4, DOI 10.1093/ndt/gfl474; Lavalle-Gonzalez FJ, 2014, POSTGRAD MED, V126, P81, DOI 10.3810/pgm.2014.10.2823; Linnebjerg H, 2017, DIABETES OBES METAB, V19, P33, DOI 10.1111/dom.12759; Linnebjerg H, 2015, DIABETES CARE, V38, P2226, DOI 10.2337/dc14-2623; Minghetti P, 2015, NAT BIOTECHNOL, V33, P688, DOI 10.1038/nbt.3272; Mulcahy A.W., 2014, COST SAVINGS POTENTI; Olech E, 2016, SEMIN ARTHRITIS RHEU, V45, pS1, DOI 10.1016/j.semarthrit.2016.01.001; Owens DR, 2012, DIABETES TECHNOL THE, V14, P989, DOI 10.1089/dia.2012.0105; Pereira K, 2017, JNP-J NURSE PRACT, V13, P236, DOI 10.1016/j.nurpra.2016.11.022; Peters AL, 2015, ENDOCR PRACT, V21, P1387, DOI 10.4158/EP14595.RA; Pettus J, 2016, DIABETES-METAB RES, V32, P478, DOI 10.1002/dmrr.2763; Pineda C, 2016, BIODRUGS, V30, P195, DOI 10.1007/s40259-016-0174-5; Rosenstock J, 2015, DIABETES OBES METAB, V17, P734, DOI 10.1111/dom.12482; Schellekens H, 2009, CLIN KIDNEY J, V2, pI27, DOI 10.1093/ndtplus/sfn177; Schumock GT, 2016, AM J HEALTH-SYST PH, V73, P1058, DOI 10.2146/ajhp160205; Stokes V, 2016, BRIT J DIAB, V16, P198, DOI 10.15277/bjd.2016.110; US Food and Drug Administration, 2017, CONS DEM INT REF PRO; Verma M, 2011, INT J DIABETES DEV C, V31, P26, DOI 10.1007/s13410-010-0010-2; Wilkins Alasdair R, 2014, J Diabetes Sci Technol, V8, P23; Zhang X, 2017, CLIN PHARM DRUG DEV, V6, P556, DOI 10.1002/cpdd.392	64	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195012	10.1371/journal.pone.0195012	http://dx.doi.org/10.1371/journal.pone.0195012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668697	gold, Green Published			2022-12-27	WOS:000430290200020
J	Glass, DG; McAlinden, N; Millington, OR; Wright, AJ				Glass, David G.; McAlinden, Niall; Millington, Owain R.; Wright, Amanda J.			A minimally invasive optical trapping system to understand cellular interactions at onset of an immune response (vol 12, e0188581, 2017)	PLOS ONE			English	Correction													McAlinden, Niall/AAM-9767-2021	McAlinden, Niall/0000-0002-0369-8788				Glass DG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188581	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196266	10.1371/journal.pone.0196266	http://dx.doi.org/10.1371/journal.pone.0196266			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664948	gold, Green Published, Green Submitted			2022-12-27	WOS:000430262300070
J	Kashala-Abotnes, E; Sombo, MT; Okitundu, DL; Kunyu, M; Makila-Mabe, GB; Tylleskar, T; Sikorskii, A; Banea, JP; Ngoyi, DM; Tshala-Katumbay, D; Boivin, MJ				Kashala-Abotnes, Esperance; Sombo, Marie-Therese; Okitundu, Daniel L.; Kunyu, Marcel; Makila-Mabe, Guy Bumoko; Tylleskaer, Thorkild; Sikorskii, Alla; Banea, Jean-Pierre; Ngoyi, Dieudonne Mumba; Tshala-Katumbay, Desire; Boivin, Michael J.			Dietary cyanogen exposure and early child neurodevelopment: An observational study from the Democratic Republic of Congo	PLOS ONE			English	Article							CAREGIVER TRAINING-PROGRAM; DEVELOPING-COUNTRIES; CASSAVA CYANOGENS; KONZO; RISK	Background Dietary cyanogen exposure from ingesting bitter (toxic) cassava as a main source of food in sub-Saharan Africa is related to neurological impairments in sub-Saharan Africa. We explored possible association with early child neurodevelopmental outcomes. Methods We undertook a cross-sectional neurodevelopmental assessment of 12-48 month-old children using the Mullen Scale of Early Learning (MSEL) and the Gensini Gavito Scale (GGS). We used the Hopkins Symptoms Checklist-10 (HSCL-10) and Goldberg Depression Anxiety Scale (GDAS) to screen for symptoms of maternal depression-anxiety. We used the cyanogen content in household cassava flour and urinary thiocyanate (SCN) as biomarkers of dietary cyanogen exposure. We employed multivariable generalized linear models (GLM) with Gamma link function to determine predictors of early child neurodevelopmental outcomes. Results The mean (SD) and median (IQR) of cyanogen content of cassava household flour were above the WHO cut-off points of 10 ppm (52.18 [ 32.79]) and 50 (30-50) ppm, respectively. Mean (SD) urinary levels of thiocyanate and median (IQR) were respectively 817.81 (474.59) and 688 (344-1032) mu mole/l in mothers, and 617.49 (449.48) and 688 (344-688) mu mole/l in children reflecting individual high levels as well as a community-wide cyanogenic exposure. The concentration of cyanide in cassava flour was significantly associated with early child neurodevelopment, motor development and cognitive ability as indicated by univariable linear regression (p < 0.05). After adjusting for biological and socioeconomic predictors at multivariable analyses, fine motor proficiency and child neurodevelopment remained the main predictors associated with the concentration of cyanide in cassava flour: coefficients of -0.08 to -.15 (p < 0.01). We also found a significant association between child linear growth, early child neurodevelopment, cognitive ability and motor development at both univariable and multivariable linear regression analyses coefficients of 1.44 to 7.31 (p < 0.01). Conclusion Dietary cyanogen exposure is associated with early child neurodevelopment, cognitive abilities and motor development, even in the absence of clinically evident paralysis. There is a need for community-wide interventions for better cassava processing practices for detoxification, improved nutrition, and neuro-rehabilitation, all of which are essential for optimal development in exposed children.	[Kashala-Abotnes, Esperance; Tylleskaer, Thorkild] Univ Bergen, Dept Global Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Sombo, Marie-Therese; Okitundu, Daniel L.; Kunyu, Marcel; Makila-Mabe, Guy Bumoko; Tshala-Katumbay, Desire] Univ Kinshasa, Dept Neurol, Congo Kinshasa, DEM REP CONGO; [Sikorskii, Alla; Boivin, Michael J.] Michigan State Univ, Dept Psychiat, E Lansing, MI 48824 USA; [Banea, Jean-Pierre] Minist Hlth, Natl Nutr Program, Congo Kinshasa, DEM REP CONGO; [Banea, Jean-Pierre] Univ Kinshasa, Sch Publ Hlth, Congo Kinshasa, DEM REP CONGO; [Ngoyi, Dieudonne Mumba] Univ Kinshasa, Dept Trop Med, Congo Kinshasa, DEM REP CONGO; [Ngoyi, Dieudonne Mumba; Tshala-Katumbay, Desire] Natl Inst Biomed Res INRB, Congo Kinshasa, DEM REP CONGO; [Tshala-Katumbay, Desire] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Tshala-Katumbay, Desire] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Boivin, Michael J.] Michigan State Univ, Dept Neurol, E Lansing, MI 48824 USA; [Boivin, Michael J.] Michigan State Univ, Dept Ophthalmol, E Lansing, MI 48824 USA	University of Bergen; Universite de Kinshasa; Michigan State University; Universite de Kinshasa; Universite de Kinshasa; Institute Nacional de Recherche Biomedical; Oregon Health & Science University; Oregon Health & Science University; Michigan State University; Michigan State University	Kashala-Abotnes, E (corresponding author), Univ Bergen, Dept Global Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway.	esperance_kashala@yahoo.com	Tylleskär, Thorkild/S-5529-2017	Tylleskär, Thorkild/0000-0003-4801-4324; Kashala-Abotnes, Esperance/0000-0002-6441-7003	Research Council of Norway through the Global Health and Vaccination Program (GLOBVAC) [234469]; NIH [NIEHS/FIC R01ES019841]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019841] Funding Source: NIH RePORTER	Research Council of Norway through the Global Health and Vaccination Program (GLOBVAC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was funded by the Research Council of Norway through the Global Health and Vaccination Program (GLOBVAC), project number 234469 with Esperance Kashala-Abotnes as PI, and the NIH GRANT NIEHS/FIC R01ES019841 with Desire Tshala-Katumbayi as PI. The funding agencies of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.; The study was funded by the Research Council of Norway through the Global Health and Vaccination Program (GLOBVAC), project number 234469 with Esperance Kashala-Abotnes as PI, and the NIH GRANT NIEHS/FIC R01ES019841 with Desire Tshala-Katumbayi as PI.	[Anonymous], 2003, 360 FHI FOOD NUTR TE; Banea JP, 2012, FOOD CHEM TOXICOL, V50, P1517, DOI 10.1016/j.fct.2012.02.001; BANEA M, 1992, ANN SOC BELG MED TR, V72, P295; Bangirana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007898; Bass JK, 2016, AIDS CARE, V28, P76, DOI 10.1080/09540121.2016.1146215; Belmont L., 1986, SCI TECHNOLOGY MENTA, P389; Boivin MJ, 2013, J PEDIATR-US, V163, P1409, DOI 10.1016/j.jpeds.2013.06.055; Boivin MJ, 2013, J DEV BEHAV PEDIATR, V34, P269, DOI 10.1097/DBP.0b013e318285fba9; Boivin MJ, 2013, PEDIATRICS, V131, pE1231, DOI 10.1542/peds.2012-3011; Bonmarin I, 2002, J TROP PEDIATRICS, V48, P234, DOI 10.1093/tropej/48.4.234; Bradbury JH, 2011, FOOD CHEM TOXICOL, V49, P539, DOI 10.1016/j.fct.2010.04.049; Chabwine JN, 2011, FOOD CHEM TOXICOL, V49, P644, DOI 10.1016/j.fct.2010.07.050; DURKIN MS, 1995, J EPIDEMIOL COMMUN H, V49, P431, DOI 10.1136/jech.49.4.431; Essam BI, 2012, MED SANTE TROP, V22, P379, DOI 10.1684/mst.2012.0087; FAO/WHO, 1991, JOINT FAO WHO FOOD S; Gensini H, 1987, REPERES SURVEILLANCE; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; H R. Cassava toxicity and food security, 1988, CASSAVA TOXICITY FOO; Haavet OR, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-41; Haavet OR, 2011, FAM PRACT, V28, P233, DOI 10.1093/fampra/cmq078; Haque MR, 1999, CLIN CHEM, V45, P1459; Kambale KJ, 2017, NEUROTOXICOLOGY, V59, P256, DOI 10.1016/j.neuro.2016.05.016; Katumbay DT, 2000, CLIN ELECTROENCEPHAL, V31, P196, DOI 10.1177/155005940003100408; Koura KG, 2013, J DEV BEHAV PEDIATR, V34, P486, DOI 10.1097/DBP.0b013e31829d211c; Lu CL, 2016, LANCET GLOB HEALTH, V4, pE916, DOI [10.1016/S2214-109X(16)30266-2, 10.1016/s2214-109x(16)30266-2]; Makila-Mabe BG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107191; Mullen E.M., 1995, MULLEN SCALES EARLY; Mwanza JC, 2005, ENVIRON TOXICOL PHAR, V19, P491, DOI 10.1016/j.etap.2004.12.012; Ngudi DD, 2011, FOOD CHEM TOXICOL, V49, P613, DOI 10.1016/j.fct.2010.06.053; Ngudi DD, 2003, FOOD CHEM TOXICOL, V41, P1193, DOI 10.1016/S0278-6915(03)00111-X; PARLOFF MB, 1954, AM J PSYCHIAT, V111, P343, DOI 10.1176/ajp.111.5.343; Sagatun A, 2008, SOC PSYCH PSYCH EPID, V43, P87, DOI 10.1007/s00127-007-0275-z; Tshala-Katumbay D, 2002, MUSCLE NERVE, V25, P230, DOI 10.1002/mus.10029; TYLLESKAR T, 1991, B WORLD HEALTH ORGAN, V69, P581; TYLLESKAR T, 1992, LANCET, V339, P208, DOI 10.1016/0140-6736(92)90006-O; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; WHO, 2004, SCAL ANT THER RES LI; World Health Organization, 2015, WHO EST GLOB BURD FO, DOI DOI 10.1016/J.FM.2014.07.009; World Health Organization (WHO), 2006, WHO CHILD GROWTH STA, DOI DOI 10.4067/S0370-41062009000400012	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0193261	10.1371/journal.pone.0193261	http://dx.doi.org/10.1371/journal.pone.0193261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664942	Green Submitted, gold, Green Published			2022-12-27	WOS:000430262300003
J	Taberna, M; Mena, M; Tous, S; Pavon, MA; Oliva, M; Leon, X; Garcia, J; Guix, M; Hijano, R; Bonfill, T; Aguila, A; Alemany, L; Mesia, R				Taberna, Miren; Mena, Marisa; Tous, Sara; Angel Pavon, Miguel; Oliva, Marc; Leon, Xavier; Garcia, Jacinto; Guix, Marta; Hijano, Rafael; Bonfill, Teresa; Aguila, Anton; Alemany, Laia; Mesia, Ricard			HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients' survival	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; STAGING SYSTEM; CARCINOMAS; HEAD	Background Given the different nature and better outcomes of oropharyngeal carcinoma (OPC) associated with human papillomavirus (HPV) infection, a novel clinical stage classification for HPV-related OPC has been accepted for the 8 th edition AJCC TNM (ICON-S model). However, it is still unclear the HPV-relatedness definition with best diagnostic accuracy and prognostic value. Material and methods The aim of this study was to compare different staging system models proposed for HPV-related OPC patients: 7 th edition AJCC TNM, RPA stage with non-anatomic factors (Princess Margaret), RPA with N categories for nasopharyngeal cancer (MD-Anderson) and AHR-new (ICON-S), according to different HPV-relatedness definitions: HPV-DNA detection plus an additional positive marker (p16(INK4a) or HPV-mRNA), p16(INK4a) positivity alone or the combination of HPV-DNA/p16(INK4a) positivity as diagnostic tests. Results A total of 788 consecutive OPC cases diagnosed from 1991 to 2013 were considered eligible for the analysis. Of these samples, 66 (8.4%) were positive for HPV-DNA and (p16(INK4a) or HPV-mRNA), 83 (10.5%) were p16(INK4a) positive and 58 (7.4%) were double positive for HPV-DNA/p16(INK4a). ICON-S model was the staging system, which performed better in our series when using at least two biomarkers to define HPV-causality. When the same analysis was performed considering only p16(INK4a)-positivity, RPA stage with non-anatomic factors (Princess Margaret) has the best classification based on AIC criteria. Conclusion HPV-relatedness definition for classifying HPV-related OPC patient do impact on TNM classification and patients' survival. Further studies assessing HPV-relatedness definitions are warranted to better classify HPV-related OPC patients in the era of de-escalation clinical trials.	[Taberna, Miren; Oliva, Marc] IDIBELL, ONCOBELL, Catalan Inst Oncol ICO, Dept Med Oncol, Barcelona, Spain; [Taberna, Miren; Mena, Marisa; Tous, Sara; Angel Pavon, Miguel; Alemany, Laia] IDIBELL, Canc Epidemiol Res Program, Catalan Inst Oncol ICO, Barcelona, Spain; [Taberna, Miren; Mesia, Ricard] Univ Barcelona, Barcelona, Spain; [Mena, Marisa; Tous, Sara] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Angel Pavon, Miguel; Alemany, Laia] Ctr Invest Biomed Red Canc CIBERESP, Madrid, Spain; [Leon, Xavier; Garcia, Jacinto] Hosp Santa Creu & Sant Pau, Dept Otorhinolaryngol, Barcelona, Spain; [Leon, Xavier] CIBER BBN, Madrid, Spain; [Guix, Marta] Hosp del Mar, Canc Res Program, IMIM, Barcelona, Spain; [Guix, Marta] Hosp del Mar, Dept Med Oncol, Barcelona, Spain; [Hijano, Rafael] Hosp del Mar, Dept Otorhinolaryngol, Barcelona, Spain; [Bonfill, Teresa] Hosp Univ Parc Tauli, Dept Med Oncol, Barcelona, Spain; [Aguila, Anton] Hosp Univ Parc Tauli, Dept Otorhinolaryngol, Barcelona, Spain; [Mesia, Ricard] Catalan Inst Oncol ICO, Dept Med Oncol, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Catalan Institute of Oncology	Taberna, M (corresponding author), IDIBELL, ONCOBELL, Catalan Inst Oncol ICO, Dept Med Oncol, Barcelona, Spain.; Taberna, M (corresponding author), IDIBELL, Canc Epidemiol Res Program, Catalan Inst Oncol ICO, Barcelona, Spain.; Taberna, M (corresponding author), Univ Barcelona, Barcelona, Spain.	mtaberna@iconcologia.net	Alemany, Laia/G-9643-2015; León, Xavier/AAB-7837-2019; Lorenzo, Jacinto Garcia/H-9124-2017; Pavon, Miguel Angel/N-3538-2014; Tous, Sara/G-5052-2015	Alemany, Laia/0000-0003-0945-6015; León, Xavier/0000-0001-6286-630X; Lorenzo, Jacinto Garcia/0000-0002-6123-7808; Guix, Marta/0000-0002-2143-0697; Pavon, Miguel Angel/0000-0003-3677-5329; Taberna, Miren/0000-0002-2446-186X; Oliva Bernal, Marc/0000-0001-5352-8130; Tous, Sara/0000-0002-5423-7092	Institute de Salud Carlos III-ISCIII (Spanish Government) - FEDER funds/European Regional Development Fund (ERDF) [PI14/01819, PI15/00500, PI11/02096]; Ayudas Merck Serono-Fundacion Salud de investigacion; Agenda de Gestio d'Ajuts Universitaris i de Recerca, AGAUR [2017SGR1085, 2017SGR1718]; European Commission 7th Framework Programme COHEAHR [Health-F3-2013-603019]; Rio Hortega-SEOM (ISCIII-Spanish Society of Medical Oncology)	Institute de Salud Carlos III-ISCIII (Spanish Government) - FEDER funds/European Regional Development Fund (ERDF); Ayudas Merck Serono-Fundacion Salud de investigacion; Agenda de Gestio d'Ajuts Universitaris i de Recerca, AGAUR; European Commission 7th Framework Programme COHEAHR; Rio Hortega-SEOM (ISCIII-Spanish Society of Medical Oncology)	This work was partially supported by grants from the Institute de Salud Carlos III-ISCIII (Spanish Government) cofunded by FEDER funds/European Regional Development Fund (ERDF) - a way to build Europe (PI14/01819, PI15/00500 and PI11/02096); Ayudas Merck Serono-Fundacion Salud 2000 de investigacion 2015; Agenda de Gestio d'Ajuts Universitaris i de Recerca, AGAUR (2017SGR1085 and 2017SGR1718), European Commission 7th Framework Programme COHEAHR (Health-F3-2013-603019) and Rio Hortega-SEOM (ISCIII-Spanish Society of Medical Oncology) (personal grant to MT). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MT gratefully acknowledges the Rio Hortega-SEOM (ISCIII-Spanish Society of Medical Oncology) grant.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; [Anonymous], 2017, TNM CLASSIFICATION M; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Boscolo-Rizzo P, 2017, INT J CANCER, V141, P1490, DOI 10.1002/ijc.30837; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403; Dahlstrom KR, 2016, J CLIN ONCOL, V34, P1848, DOI 10.1200/JCO.2015.64.6448; Gillison Maura L., 2016, J CLIN ONCOL, V34, DOI [10.1200/JCO.2016.66.6081, DOI 10.1200/JCO.2016.66.6081]; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Halec G, 2013, INT J CANCER, V132, P63, DOI 10.1002/ijc.27605; Huang SH, 2015, J CLIN ONCOL, V33, P836, DOI 10.1200/JCO.2014.58.6412; Larsen CG, 2014, BRIT J CANCER, V110, P1587, DOI 10.1038/bjc.2014.42; Marur S, 2016, E1308 PHASE 2 TRIAL; Mena M, 2018, ORAL ONCOL IN PRESS; Nauta IH, 2018, ANN ONCOL, V29, P1273, DOI 10.1093/annonc/mdy060; O'Sullivan B, 2016, LANCET ONCOL, V17, P440, DOI 10.1016/S1470-2045(15)00560-4; Prigge ES, 2017, INT J CANCER, V140, P1186, DOI 10.1002/ijc.30516; Rietbergen MM, 2013, ANN ONCOL, V24, P2740, DOI 10.1093/annonc/mdt319; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; St Guily JL, 2011, J CLIN VIROL, V51, P100, DOI 10.1016/j.jcv.2011.03.003; Taberna M., 2017, ANN ONCOL, P1	20	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194107	10.1371/journal.pone.0194107	http://dx.doi.org/10.1371/journal.pone.0194107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664911	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300007
J	Valero, C; Amaveda, H; Mora, M; Garcia-Aznar, JM				Valero, Clara; Amaveda, Hippolyte; Mora, Mario; Manuel Garcia-Aznar, Jose			Combined experimental and computational characterization of crosslinked collagen-based hydrogels	PLOS ONE			English	Article							SEMIFLEXIBLE BIOPOLYMER NETWORKS; TENSILE MECHANICAL-PROPERTIES; CELL-MIGRATION; DEFORMATION MECHANISMS; MATRIX STIFFNESS; ACTIN NETWORKS; ELASTIC-MODULI; LINKING; GELS; BEHAVIOR	Collagen hydrogels are widely used for in-vitro experiments and tissue engineering applications. Their use has been extended due to their biocompatibility with cells and their capacity to mimic biological tissues; nevertheless their mechanical properties are not always optimal for these purposes. Hydrogels are formed by a network of polymer filaments embedded on an aqueous substrate and their mechanical properties are mainly defined by the filament network architecture and the individual filament properties. To increase properties of native collagen, such as stiffness or strain-stiffening, these networks can be modified by adding crosslinking agents that alter the network architecture, increasing the unions between filaments. In this work, we have investigated the effect of one crosslinking agent, transglutaminase, in collagen hydrogels with varying collagen concentration. We have observed a linear dependency of the gel rigidity on the collagen concentration. Moreover, the addition of transglutaminase has induced an earlier strain-stiffening of the collagen gels. In addition, to better understand the mechanical implications of collagen concentration and crosslinkers inclusion, we have adapted an existing computational model, based on the worm-like chain model (WLC), to reproduce the mechanical behavior of the collagen gels. With this model we can estimate the parameters of the biopolymer networks without more sophisticated techniques, such as image processing or network reconstruction, or, inversely, predict the mechanical properties of a defined collagen network.	[Valero, Clara; Manuel Garcia-Aznar, Jose] Univ Zaragoza, Aragon Inst Engn Res I3A, Dept Mech Engn, M2BE, Zaragoza, Spain; [Amaveda, Hippolyte; Mora, Mario] Univ Zaragoza, Inst Ciencia Mat Aragon, CSIC, Dept Ciencia & Tecnol Mat & Fluidos, Zaragoza, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); University of Zaragoza	Valero, C (corresponding author), Univ Zaragoza, Aragon Inst Engn Res I3A, Dept Mech Engn, M2BE, Zaragoza, Spain.	claraval@unizar.es	Garcia-Aznar, Jose Manuel/F-8256-2010; Alfonso, Mario Juan Mora/K-9646-2015; Angurel, Luis Alberto/L-8491-2014; Valero, Clara/AAY-9640-2021	Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Alfonso, Mario Juan Mora/0000-0003-4747-7327; Angurel, Luis Alberto/0000-0001-5685-2366; Valero Lazaro, Clara/0000-0001-9318-7107; Amaveda Metonou, Hippolyte/0000-0003-2212-447X	European Research Council (ERC) [ERC-2012-StG 306571]; Spanish Ministry of Economy and Competitiveness [DPI2015-64221-C2-1-R]; Gobierno de Aragon (research group T86); Spanish Ministry of Economy and Competitiveness; European FEDER Program [ENE1014-52105-R]; Gobierno de Aragon (research group T12)	European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Gobierno de Aragon (research group T86)(Gobierno de Aragon); Spanish Ministry of Economy and Competitiveness(Spanish Government); European FEDER Program(European Commission); Gobierno de Aragon (research group T12)	The work corresponding to C. Valero and J.M. Garcia-Aznar was supported by the European Research Council (ERC) through project ERC-2012-StG 306571 and the Spanish Ministry of Economy and Competitiveness through the project DPI2015-64221-C2-1-R and by the Gobierno de Aragon (research group T86). The work corresponding to H. Amaveda and M.Mora was supported by the Spanish Ministry of Economy and Competitiveness and the European FEDER Program (project ENE1014-52105-R) and by the Gobierno de Aragon (research group T12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6; Aznar JMG, 2016, BIOMANUFACTURING REV, V1, P2, DOI DOI 10.1007/S40898-016-0002-1; Bishop CM., 1995, NEURAL NETWORKS PATT; Broedersz CP, 2014, REV MOD PHYS, V86, P995, DOI 10.1103/RevModPhys.86.995; Broedersz CP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.238101; Broedersz CP, 2010, SOFT MATTER, V6, P4120, DOI 10.1039/c0sm00285b; Buehler MJ, 2007, BIOPHYS J, V93, P37, DOI 10.1529/biophysj.106.102616; Castro APG, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5688-3; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Cyron CJ, 2013, J COMPUT PHYS, V244, P236, DOI 10.1016/j.jcp.2012.10.025; Del Amo C, 2017, INTEGR BIOL-UK, V9, P339, DOI 10.1039/c7ib00022g; Del Amo C, 2016, J BIOMECH, V49, P1340, DOI 10.1016/j.jbiomech.2015.10.026; Depalle B, 2015, J MECH BEHAV BIOMED, V52, P1, DOI 10.1016/j.jmbbm.2014.07.008; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720; Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004; Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fortunati D, 2014, AMINO ACIDS, V46, P1751, DOI 10.1007/s00726-014-1732-0; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Frauchiger DA, 2017, EUR CELLS MATER, V34, P271, DOI 10.22203/eCM.v034a17; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Garijo N, 2014, COMPUT METHOD APPL M, V268, P437, DOI 10.1016/j.cma.2013.10.005; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Holzapfel GA, 2014, J MECH BEHAV BIOMED, V38, P78, DOI 10.1016/j.jmbbm.2014.05.014; Islam MM, 2015, ACTA BIOMATER, V12, P70, DOI 10.1016/j.actbio.2014.10.035; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; Jones CAR, 2014, SOFT MATTER, V10, P8855, DOI 10.1039/c4sm01772b; Kook YM, 2017, J TISSUE ENG, V8, DOI 10.1177/2041731417724640; Kuhl E, 2005, J MECH PHYS SOLIDS, V53, P1552, DOI 10.1016/j.jmps.2005.03.002; Kurniawan NA, 2012, BIOMACROMOLECULES, V13, P691, DOI 10.1021/bm2015812; Kwansa AL, 2016, BIOPHYS CHEM, V214, P1, DOI 10.1016/j.bpc.2016.04.001; Lee B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111896; Licup AJ, 2015, P NATL ACAD SCI USA, V112, P9573, DOI 10.1073/pnas.1504258112; Lin SM, 2015, MATERIALS, V8, P551, DOI 10.3390/ma8020551; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Moreno-Arotzena O, 2015, ANN BIOMED ENG, V43, P3025, DOI 10.1007/s10439-015-1343-2; Moreno-Arotzena O, 2015, MATERIALS, V8, P1636, DOI 10.3390/ma8041636; Movilla N, 2017, BONE; Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110; Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110; Palmer JS, 2008, ACTA BIOMATER, V4, P597, DOI 10.1016/j.actbio.2007.12.007; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Raab M, 2016, MATRIX RIGIDITY REGU; Reddy N, 2015, TRENDS BIOTECHNOL, V33, P362, DOI 10.1016/j.tibtech.2015.03.008; Rens R, 2016, J PHYS CHEM B, V120, P5831, DOI 10.1021/acs.jpcb.6b00259; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Sanami M, 2016, J BIOMED MATER RES B, V104, P914, DOI 10.1002/jbm.b.33445; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Sharma A, 2016, NAT PHYS, V12, P584, DOI [10.1038/NPHYS3628, 10.1038/nphys3628]; Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Sunyer R, 2016, SCIENCE, V353, P1157, DOI 10.1126/science.aaf7119; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Umashankar P R, 2012, Toxicol Int, V19, P51, DOI 10.4103/0971-6580.94513; van Oosten ASG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19270; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; von der Heydt A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032701; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Wen Q, 2012, SOFT MATTER, V8, P8039, DOI 10.1039/c2sm25364j; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031	69	46	47	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195820	10.1371/journal.pone.0195820	http://dx.doi.org/10.1371/journal.pone.0195820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664953	Green Published, gold			2022-12-27	WOS:000430262300035
J	Bonizzoni, E; Gussoni, G; Agnelli, G; Incalzi, RA; Bonfanti, M; Mastroianni, F; Candela, M; Franchi, C; Frasson, S; Greco, A; La Regina, M; Re, R; Vescovo, G; Campanini, M				Bonizzoni, Erminio; Gussoni, Gualberto; Agnelli, Giancarlo; Incalzi, Raffaele Antonelli; Bonfanti, Moira; Mastroianni, Franco; Candela, Marco; Franchi, Carlotta; Frasson, Stefania; Greco, Antonio; La Regina, Micaela; Re, Roberta; Vescovo, Giorgio; Campanini, Mauro			The complexity of patients hospitalized in Internal Medicine wards evaluated by FADOI-COMPLIMED score(s). A hypothetical approach	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; PROGNOSTIC INDEX; CO-MORBIDITY; OLDER-ADULTS; PRIMARY-CARE; VALIDATION; COMORBIDITY	Objectives The aim of this study is to develop a new predictive model to measure complexity of patients in medical wards. Setting 29 Internal Medicine departments in Italy. Materials and methods The study cohort was made of 541 consecutive patients hospitalized for any cause, aged more than 40 years and with at least two chronic diseases. First, we applied a hierarchical cluster analysis and the principal component analysis (PCA) to a panel of questionnaires [comorbidity (Charlson, CIRS), clinical stability (MEWS), social frailty (Flugelman), cognitive dysfunction (SPSMQ), depression (5-item GDS), functional dependence (ADL, IADL, Barthel), risk of sore threats (Exton-Smith scale), nutrition (MNA), pain (NRPS), adherence to therapy (Morisky scale)], in order to select domains informative for the definition of complexity. The following step was to create the score(s) needed to quantify it. Results Two main clusters were identified: the first includes 7 questionnaires whose common denominator is dependence and frailty, the second consists of 3 questionnaires representative of comorbidity. Globally, they account for about 70% of the total variance (55.2% and 13.8%, respectively). The first principal component was simplified in "Complimed Score 1" (CS1) as a recalibrated average between the Barthel Index and the Exton Smith score, whereas the second cluster was approximated to "Complimed Score 2" (CS2), by using the Charlson score only. Conclusions Complexity is a two-dimensional clinical phenomenon. The FADOI-Complimed Score(s) is a new tool useful for the routine evaluation of complexity in medical patients, simple to use and taking around 10 minutes to complete.	[Bonizzoni, Erminio] Univ Milan, Fac Med & Surg, Sect Med Stat Biometry & Epidemiol, Dept Clin Sci & Community, Milan, Italy; [Gussoni, Gualberto; Frasson, Stefania] FADOI Fdn, Res Dept, Milan, Italy; [Agnelli, Giancarlo] Univ Perugia, S Maria Misericordia Hosp, Internal Med & Cardiovasc Stroke Unit, Perugia, Italy; [Incalzi, Raffaele Antonelli] Univ Hosp Campus Biomed, Gerontol Unit, Rome, Italy; [Bonfanti, Moira] San Giuseppe Hosp, Internal Med, Empoli, Italy; [Mastroianni, Franco] F Miulli Hosp, Internal Med, Acquaviva Fonti, Bari, Italy; [Candela, Marco] E Profili Hosp, Internal Med, Ancona, Italy; [Franchi, Carlotta] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Lab Qual Assessment Geriatr Therapies & Serv, Milan, Italy; [Greco, Antonio] Hosp Casa Sollievo Sofferenza, Internal Med, San Giovanni Rotondo, Italy; [La Regina, Micaela] Hosp La Spezia, Internal Med, La Spezia, Italy; [Re, Roberta; Campanini, Mauro] Hosp Maggiore Carita, Dept Internal Med, Novara, Italy; [Vescovo, Giorgio] St Antonio Hosp, Internal Med, Padua, Italy	University of Milan; University of Perugia; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Casa Sollievo Della Sofferenza; Azienda Ospedaliera Maggiore della Carita di Novara; ULSS 6 Euganea; Ospedale Sant'antonio Padova	Frasson, S (corresponding author), FADOI Fdn, Res Dept, Milan, Italy.	stefania.frasson@fadoi.org	FRANCHI, CARLOTTA/AAB-8774-2019; MASTROIANNI, FRANCO/AAO-6820-2021; Franchi, Carlotta/AAB-9666-2019; Greco, Antonio/C-1100-2017	FRANCHI, CARLOTTA/0000-0001-6802-8710; Franchi, Carlotta/0000-0001-6802-8710; Greco, Antonio/0000-0001-6674-5468; Mastroianni, Franco/0000-0003-0506-8031	FADOI Foundation; Italian Scientific Society of Hospital Internal Medicine	FADOI Foundation; Italian Scientific Society of Hospital Internal Medicine	The study was funded by FADOI Foundation, a not-for-profit organization (Italian Scientific Society of Hospital Internal Medicine). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bliss M R, 1966, Mon Bull Minist Health Public Health Lab Serv, V25, P238; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chavannes NH, 2012, PRIM CARE RESP J, V21, P245, DOI 10.4104/pcrj.2012.00066; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; FLUGELMAN MY, 1986, GERONTOLOGY, V32, P272, DOI 10.1159/000212801; Garcia-Morillo JS, 2007, REV CLIN ESP, V207, P1, DOI 10.1157/13098491; Grant RW, 2011, ANN INTERN MED, V155, P797, DOI 10.7326/0003-4819-155-12-201112200-00001; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Ickowicz E, 2012, J AM GERIATR SOC, V60, P1957, DOI 10.1111/j.1532-5415.2012.04187.x; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kim Yu Jin, 2016, J Clin Med Res, V8, P531, DOI 10.14740/jocmr2594w; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LESHER EL, 1994, J CLIN PSYCHOL, V50, P256, DOI 10.1002/1097-4679(199403)50:2<256::AID-JCLP2270500218>3.0.CO;2-E; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; MAHONEY F I, 1965, Md State Med J, V14, P61; Marengoni A, 2010, REJUV RES, V13, P469, DOI 10.1089/rej.2009.1002; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Nardi R, 2007, EUR J INTERN MED, V18, P359, DOI 10.1016/j.ejim.2007.05.002; Nardi R, 2013, ITAL J MED, V7, P142, DOI [10.4081/itjm.2013.142, 10.4081/itjm.2013.231]; Osborne JW, 2004, PRACTICAL ASSESSMENT, V9, P15; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Pilotto A, 2008, REJUV RES, V11, P151, DOI 10.1089/rej.2007.0569; Safford MM, 2007, J GEN INTERN MED, V22, P382, DOI 10.1007/s11606-007-0307-0; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Turner BJ, 2011, ANN INTERN MED, V155, P851, DOI 10.7326/0003-4819-155-12-201112200-00009; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zulman DM, 2014, J GEN INTERN MED, V29, P529, DOI 10.1007/s11606-013-2616-9	29	15	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195805	10.1371/journal.pone.0195805	http://dx.doi.org/10.1371/journal.pone.0195805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659593	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100033
J	Chae, MS; Moon, KU; Chung, HS; Park, CS; Lee, J; Choi, JH; Hong, SH				Chae, Min Suk; Moon, Kwang Uck; Chung, Hyun Sik; Park, Chul Soo; Lee, Jaemin; Choi, Jong Ho; Hong, Sang Hyun			Serum interleukin-6 and tumor necrosis factor-alpha are associated with early graft regeneration after living donor liver transplantation	PLOS ONE			English	Article							PARTIAL-HEPATECTOMY; INFLAMMATORY RESPONSE; ACUTE REJECTION; MICE; CYTOKINES; FAILURE; DISEASE; PROLIFERATION; METAANALYSIS; DYSFUNCTION	Background Liver graft regeneration is orchestrated by specific and sequential stimuli, including hepatocyte growth factors, cytokines, and catecholamines. We evaluated the association between preoperative serum cytokines and early liver graft regeneration in human living donor liver transplantation (LDLT). Patients and methods We retrospectively reviewed the data of adult patients who underwent LDLT from January 2010 to December 2014. Serum cytokines, including interleukin (IL)-2, 6, 10, 12, 17, interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha were measured in the recipients 1 day before surgery and on postoperative day (POD) 7. Liver graft volume was estimated using abdominal computed tomography images of the donors and recipients. Results In total, 226 patients were analyzed in this study. Median preoperative levels of serum cytokines were as follows: IL-2, 0.1 (0.1-1.6) pg/mL; IL-6, 7.3 (0.1-30.2) pg/mL; IL-10, 0.5 (0.111.0) pg/mL; IL-12, 0.1 (0.1-0.1) pg/mL; IL-17, 2.0 (0.1-16.4) pg/mL; IFN-gamma, 3.2 (0.1-16.0) pg/mL; and TNF-alpha, 9.8 (5.4-17.9) pg/mL. Higher preoperative serum levels of IL-6, IL-10, and TNF-alpha, dichotomized at the median, were associated with increased relative liver volumes by POD 7. Multivariate analysis revealed that higher levels of serum IL-6 and TNF-alpha were independently associated with increased graft volume during the first 1 week after LDLT, based on the lower levels of those cytokines. Conclusions IL-6 and TNF-alpha were important mediators of the success of early graft regeneration in patients who underwent LDLT.	[Chae, Min Suk; Moon, Kwang Uck; Chung, Hyun Sik; Park, Chul Soo; Lee, Jaemin; Choi, Jong Ho; Hong, Sang Hyun] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Hong, SH (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.	shhong7272@gmail.com		Hong, Sang Hyun/0000-0002-7091-8963; Chung, Hyun Sik/0000-0001-7527-1866				BELLOMO R, 1993, CRIT CARE MED, V21, P522, DOI 10.1097/00003246-199304000-00011; BELLOMO R, 1995, RENAL FAILURE, V17, P457, DOI 10.3109/08860229509037609; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Brown RS, 2002, LIVER TRANSPLANT, V8, P278, DOI 10.1053/jlts.2002.31340; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Chae MS, 2017, ANN TRANSPL, V22, P83, DOI 10.12659/AOT.902103; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Demetris AJ, 1997, HEPATOLOGY, V25, P658; DIEHL AM, 1994, AM J PHYSIOL-GASTR L, V267, pG552, DOI 10.1152/ajpgi.1994.267.4.G552; Fabrega E, 2009, LIVER TRANSPLANT, V15, P629, DOI 10.1002/lt.21724; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Grenz A, 2000, CLIN CHEM LAB MED, V38, P1183, DOI 10.1515/CCLM.2000.184; Heinemann A, 1999, LIVER TRANSPLANT SUR, V5, P366, DOI 10.1002/lt.500050516; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Karakhanova S, 2016, TRANSPL IMMUNOL, V34, P14, DOI 10.1016/j.trim.2015.12.001; Karimi MH, 2011, MOL BIOL REP, V38, P4437, DOI 10.1007/s11033-010-0572-6; Kim SJ, 2012, J GASTROINTEST SURG, V16, P1160, DOI 10.1007/s11605-012-1865-y; Kitaoka S, 2003, HEPATO-GASTROENTEROL, V50, P1569; Kiuchi T, 2003, LIVER TRANSPLANT, V9, pS29, DOI 10.1053/jlts.2003.50198; KUMA S, 1990, IMMUNOBIOLOGY, V180, P235, DOI 10.1016/S0171-2985(11)80331-1; Le Moine O, 2000, HEPATOLOGY, V31, P1266, DOI 10.1053/jhep.2000.7881; LEMOINE O, 1994, HEPATOLOGY, V20, P889; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Marcos A, 2000, TRANSPLANTATION, V69, P1375, DOI 10.1097/00007890-200004150-00028; Matsushita T, 1999, INT IMMUNOL, V11, P657, DOI 10.1093/intimm/11.5.657; Na GH, 2016, HPB, V18, P98, DOI 10.1016/j.hpb.2015.08.008; Nishizaki T, 2001, ANN SURG, V233, P575, DOI 10.1097/00000658-200104000-00014; OHZATO H, 1993, SURG TODAY, V23, P521, DOI 10.1007/BF00730628; Olthoff KM, 2015, LIVER TRANSPLANT, V21, P79, DOI 10.1002/lt.23966; Olthoff KM, 2003, LIVER TRANSPLANT, V9, pS35, DOI 10.1053/jlts.2003.50229; Peng YZ, 2005, BURNS, V31, P623, DOI 10.1016/j.burns.2005.02.004; Rattanasiri S, 2013, TRANSPL IMMUNOL, V28, P62, DOI 10.1016/j.trim.2012.10.003; Sasturkar SV, 2016, LIVER TRANSPLANT, V22, P344, DOI 10.1002/lt.24373; Selzner N, 2003, GASTROENTEROLOGY, V124, P692, DOI 10.1053/gast.2003.50098; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Tarakcioglu M, 2003, MEDIAT INFLAMM, V12, P15, DOI 10.1080/0962935031000096935; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Thai N L, 1997, Liver Transpl Surg, V3, P118, DOI 10.1002/lt.500030204; van den Broek MAJ, 2008, LIVER INT, V28, P767, DOI 10.1111/j.1478-3231.2008.01777.x; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Yagi S, 2005, LIVER TRANSPLANT, V11, P68, DOI 10.1002/lt.20317; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yin S, 2011, AM J PATHOL, V178, P1614, DOI 10.1016/j.ajpath.2011.01.001; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhang Y, 2017, ANN MED, V49, P365, DOI 10.1080/07853890.2016.1257862	47	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195262	10.1371/journal.pone.0195262	http://dx.doi.org/10.1371/journal.pone.0195262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649247	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900035
J	Hong, JC; Ayala-Peacock, DN; Lee, J; Blackstock, AW; Okunieff, P; Sung, MW; Weichselbaum, RR; Kao, J; Urbanic, JJ; Milano, MT; Chmura, SJ; Salama, JK				Hong, Julian C.; Ayala-Peacock, Diandra N.; Lee, Jason; Blackstock, A. William; Okunieff, Paul; Sung, Max W.; Weichselbaum, Ralph R.; Kao, Johnny; Urbanic, James J.; Milano, Michael T.; Chmura, Steven J.; Salama, Joseph K.			Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; CELL LUNG-CANCER; DOSE-ESCALATION TRIAL; PHASE I/II TRIAL; RADIATION-THERAPY; PROGNOSTIC-FACTORS; EXTRACRANIAL OLIGOMETASTASES; COLORECTAL METASTASES; CONCURRENT SUNITINIB; SUGGEST IMPLICATIONS	Background Radiotherapy is increasingly used to treat oligometastatic patients. We sought to identify prognostic criteria in oligometastatic patients undergoing definitive hypofractionated image guided radiotherapy (HIGRT). Methods Exclusively extracranial oligometastatic patients treated with HIGRT were pooled. Characteristics including age, sex, primary tumor type, interval to metastatic diagnosis, number of treated metastases and organs, metastatic site, prior systemic therapy for primary tumor treatment, prior definitive metastasis-directed therapy, and systemic therapy for metastasis associated with overall survival (OS), progression-free survival (PFS), and treated metastasis control (TMC) were assessed by the Cox proportional hazards method. Recursive partitioning analysis (RPA) identified prognostic risk strata for OS and PFS based on pretreatment factors. Results 361 patients were included. Primary tumors included non-small cell lung (17%), colorectal (19%), and breast cancer (16%). Three-year OS was 56%, PFS was 24%, and TMC was 72%. On multivariate analysis, primary tumor, interval to metastases, treated metastases number, and mediastinal/hilar lymph node, liver, or adrenal metastases were associated with OS. Primary tumor site, involved organ number, liver metastasis, and prior primary disease chemotherapy were associated with PFS. OS RPA identified five classes: class 1: all breast, kidney, or prostate cancer patients (BKP) (3-year OS 75%, 95% CI 66-85%); class 2: patients without BKP with disease-free interval of 75+ months (3-year OS 85%, 95% CI 67-100%); class 3: patients without BKP, shorter disease-free interval, <= two metastases, and age < 62 (3-year OS 55%, 95% CI 48-64%); class 4: patients without BKP, shorter disease-free interval, >= three metastases, and age < 62 (3-year OS 38%, 95% CI 24-60%); class 5: all others (3-year OS 13%, 95% CI 5-35%). Higher biologically effective dose (BED) (p < 0.01) was associated with OS. Conclusions We identified clinical factors defining oligometastatic patients with favorable outcomes, who we hypothesize are most likely to benefit from metastasis-directed therapy.	[Hong, Julian C.; Salama, Joseph K.] Duke Univ, Dept Radiat Oncol, Durham, NC 27708 USA; [Ayala-Peacock, Diandra N.] Vanderbilt Univ, Dept Radiat Oncol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Lee, Jason] Mem & St Elizabeths Canc Treatment Ctr, Swansea, IL USA; [Blackstock, A. William] Wake Forest Univ, Dept Radiat Oncol, Winston Salem, NC 27109 USA; [Okunieff, Paul] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA; [Sung, Max W.] Mt Sinai Sch Med, Div Hematol & Med Oncol, New York, NY USA; [Weichselbaum, Ralph R.; Chmura, Steven J.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Kao, Johnny] Good Samaritan Hosp Med Ctr, Dept Radiat Oncol, West Islip, NY USA; [Urbanic, James J.] Univ Calif San Diego, Dept Radiat Med & Appl Sci, La Jolla, CA 92093 USA; [Milano, Michael T.] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA	Duke University; Vanderbilt University; Wake Forest University; State University System of Florida; University of Florida; Icahn School of Medicine at Mount Sinai; University of Chicago; University of California System; University of California San Diego; University of Rochester	Salama, JK (corresponding author), Duke Univ, Dept Radiat Oncol, Durham, NC 27708 USA.	joseph.salama@duke.edu	Hong, Julian/X-6397-2018; Chmura, Steven Joseph/ACU-8438-2022	Hong, Julian/0000-0001-5172-6889; 	Pfizer; Brain-Lab AG; Ludwig Center for Metastasis Research, University of Chicago Research Center [5-30,073]; Chicago Tumor Institute Center for Radiation Therapy; University of Chicago Comprehensive Cancer Center [P30 CM14599]	Pfizer(Pfizer); Brain-Lab AG; Ludwig Center for Metastasis Research, University of Chicago Research Center; Chicago Tumor Institute Center for Radiation Therapy; University of Chicago Comprehensive Cancer Center	The Mount Sinai study was funded in part by Pfizer (www.pfizer.com). The University of Rochester study was funded in part by Brain-Lab AG (www.brainlab.com). This work was also supported by Ludwig Center for Metastasis Research, University of Chicago Research Center. Grant Number: 5-30,073; The Chicago Tumor Institute Center for Radiation Therapy; University of Chicago Comprehensive Cancer Center. Grant Number: P30 CM14599. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2016, INT J RADIAT ONCOL, V95, P1399, DOI 10.1016/j.ijrobp.2016.03.050; Ahmed KA, 2015, INT J RADIAT ONCOL, V92, P837, DOI 10.1016/j.ijrobp.2015.01.036; Al-Hallaq HA, 2016, PRACT RADIAT ONCOL, V6, pE291, DOI 10.1016/j.prro.2016.05.004; Albain KS, 2008, J CLIN ONCOL, V26, P3950, DOI 10.1200/JCO.2007.11.9362; Ashworth AB, 2014, CLIN LUNG CANCER, V15, P346, DOI 10.1016/j.cllc.2014.04.003; Breiman L., 1984, CLASSIFICATION REGRE; Bujold A, 2012, J CLIN ONCOL, V44, P1659, DOI DOI 10.1200/JC0.2012.44.1659; Chang JY, 2015, LANCET ONCOL, V16, P630, DOI 10.1016/S1470-2045(15)70168-3; Collen C, 2014, ANN ONCOL, V25, P1954, DOI 10.1093/annonc/mdu370; Dagan R, 2016, ACTA ONCOL, V55, P633, DOI 10.3109/0284186X.2015.1118659; de Vin T, 2014, ANN ONCOL, V25, P467, DOI 10.1093/annonc/mdt537; Fode MM, 2015, RADIOTHER ONCOL, V114, P155, DOI 10.1016/j.radonc.2014.12.003; Fong YM, 1997, J CLIN ONCOL, V15, P938, DOI 10.1200/JCO.1997.15.3.938; Gomez DR, 2016, LANCET ONCOL, V17, P1672, DOI 10.1016/S1470-2045(16)30532-0; Griffioen GHMJ, 2013, LUNG CANCER, V82, P95, DOI 10.1016/j.lungcan.2013.07.023; Guckenberger M, 2016, J THORAC ONCOL, V11, pS143, DOI 10.1016/S1556-0864(16)30307-0; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; HELLMAN S, 1994, J CLIN ONCOL, V12, P2229, DOI 10.1200/JCO.1994.12.10.2229; Herman JM, 2015, CANCER-AM CANCER SOC, V121, P1128, DOI 10.1002/cncr.29161; Hoyer M, 2006, ACTA ONCOL, V45, P823, DOI 10.1080/02841860600904854; Iyengar P, 2014, J CLIN ONCOL, V32, P3824, DOI 10.1200/JCO.2014.56.7412; Kao J, 2014, TARGET ONCOL, V9, P145, DOI 10.1007/s11523-013-0280-y; Kao J, 2009, CANCER-AM CANCER SOC, V115, P3571, DOI 10.1002/cncr.24412; King CR, 2013, RADIOTHER ONCOL, V109, P217, DOI 10.1016/j.radonc.2013.08.030; Klement RJ, 2017, RADIOTHER ONCOL, V123, P227, DOI 10.1016/j.radonc.2017.01.013; Kress MAS, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-148; Lester-Coll NH, 2016, INT J RADIAT ONCOL, V95, P663, DOI 10.1016/j.ijrobp.2016.01.020; Lewis SL, 2017, AM J CLIN ONCOL-CANC, V40, P418, DOI 10.1097/COC.0000000000000169; Milano MT, 2008, CANCER-AM CANCER SOC, V112, P650, DOI 10.1002/cncr.23209; Milano MT, 2012, INT J RADIAT ONCOL, V83, P878, DOI 10.1016/j.ijrobp.2011.08.036; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Palma DA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-305; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Rieber J, 2017, INT J RADIAT ONCOL, V98, P511, DOI 10.1016/j.ijrobp.2016.09.026; Rieber J, 2016, LUNG CANCER, V97, P51, DOI 10.1016/j.lungcan.2016.04.012; Ruers T, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.3501; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1572, DOI 10.1200/JCO.2008.19.6329; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1579, DOI 10.1200/JCO.2008.19.6386; Salama JK, 2008, CLIN CANCER RES, V14, P5255, DOI 10.1158/1078-0432.CCR-08-0358; Salama Joseph K, 2015, Am Soc Clin Oncol Educ Book, pe8, DOI 10.14694/EdBook_AM.2015.35.e8; Salama JK, 2014, J CLIN ONCOL, V32, P2902, DOI 10.1200/JCO.2014.55.9567; Salama JK, 2012, CANCER-AM CANCER SOC, V118, P2962, DOI 10.1002/cncr.26611; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tong CCL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036979; Wahl DR, 2016, J CLIN ONCOL, V34, P452, DOI 10.1200/JCO.2015.61.4925; Wong AC, 2016, CANCER-AM CANCER SOC, V122, P2242, DOI 10.1002/cncr.30058	47	75	76	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195149	10.1371/journal.pone.0195149	http://dx.doi.org/10.1371/journal.pone.0195149			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649281	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900028
J	Van Meulebroek, L; Wauters, J; Pomian, B; Bussche, JV; Delahaut, P; Fichant, E; Vanhaecke, L				Van Meulebroek, Lieven; Wauters, Jella; Pomian, Beata; Bussche, Julie Vanden; Delahaut, Philippe; Fichant, Eric; Vanhaecke, Lynn			Discovery of urinary biomarkers to discriminate between exogenous and semi-endogenous thiouracil in cattle: A parallel-like randomized design	PLOS ONE			English	Article							MASS-SPECTRA; IDENTIFICATION; VALIDATION; LIVESTOCK	In the European Union, the use of thyreostats for animal fattening purposes has been banned and monitoring plans have been established to detect potential abuse. However, this is not always straightforward as thyreostats such as thiouracil may also have a semi-endogenous origin. Therefore, this study aimed at defining urinary metabolites, which may aid in defining the origin of detected thiouracil. Hereto, a parallel-like randomized in vivo study was conducted in which calves (n = 8) and cows (n = 8) were subjected to either a control treatment, rapeseed-enriched diet to induce semi-endogenous formation, or thiouracil treatment. Urine samples (n = 330) were assessed through metabolic fingerprinting, employing liquid chromatography and Q-Exactive (TM) Orbitrap mass spectrometry. Urinary fingerprints comprised up to 40,000 features whereby multivariate discriminant analysis was able to point out significant metabolome differences between treatments (Q(2)(Y) >= 0.873). Using the validated models, a total of twelve metabolites (including thiouracil) were assigned marker potential. Combining these markers into age-dependent biomarker panels rendered a tool by which sample classification could be improved in comparison with thiouracil-based thresholds, and this during on-going thiouracil treatment (specificities >= 95.2% and sensitivities >= 85.7%), post-treatment (sensitivities >= 80% for >= 24 h after last administration), and simulated low-dose thiouracil treatment (exogenous thiouracil below 30 ng mu L-1). Moreover, the metabolic relevance of revealed markers was supported by the suggested identities, for which a structural link with thiouracil could be determined in most cases. The proposed biomarker panels may contribute to a more justified decision-making in monitoring thiouracil abuse.	[Van Meulebroek, Lieven; Wauters, Jella; Pomian, Beata; Bussche, Julie Vanden; Vanhaecke, Lynn] Univ Ghent, Chem Anal Lab, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Salisburylaan, Merelbeke, Belgium; [Delahaut, Philippe; Fichant, Eric] CER Grp, Dept Hlth, Rue Point Jour, Marloie, Belgium	Ghent University	Van Meulebroek, L (corresponding author), Univ Ghent, Chem Anal Lab, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Salisburylaan, Merelbeke, Belgium.	lieven.vanmeulenbroek@ugent.be	Delahaut, Philippe/ABC-8350-2021; Vanhaecke, Lynn/N-1061-2017	Vanhaecke, Lynn/0000-0003-0400-2188; Delahaut, Philippe/0000-0003-2328-3042; Wauters, Jella/0000-0002-7046-1764	Federal Public Service Health [RF 12/6260]	Federal Public Service Health	This work was supported by Federal Public Service Health (RF 12/6260); URL https://www.health.belgium.be/en. LVM, JW, and JVB received the funding. The funders contributed to this project with regard to the study design and supervision. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anizan S, 2012, J MASS SPECTROM, V47, P131, DOI 10.1002/jms.2035; Batjoens P, 1996, J CHROMATOGR A, V750, P127, DOI 10.1016/0021-9673(96)00406-2; Bussche JV, 2012, ANAL BIOANAL CHEM, V403, P2973, DOI 10.1007/s00216-012-5739-7; Bussche JV, 2011, FOOD ADDIT CONTAM A, V28, P166, DOI 10.1080/19440049.2010.544681; Bussche JV, 2010, J CHROMATOGR A, V1217, P4285, DOI 10.1016/j.chroma.2010.04.030; Bussche JV, 2011, J AGR FOOD CHEM, V59, P5786, DOI 10.1021/jf200556x; Cho HW, 2008, INT J DATA MIN BIOIN, V2, P176, DOI 10.1504/IJDMB.2008.019097; De Clercq N, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0887-3; DEBRABANDER HF, 1984, TRAC-TREND ANAL CHEM, V3, P162, DOI 10.1016/0165-9936(84)88011-5; Dervilly-Pinel G, 2015, METABOLOMICS, V11, P403, DOI 10.1007/s11306-014-0705-3; Dervilly-Pinel G, 2011, ANAL CHIM ACTA, V700, P144, DOI 10.1016/j.aca.2011.02.008; Duhrkop K, 2015, P NATL ACAD SCI USA, V112, P12580, DOI 10.1073/pnas.1509788112; EFSA . (European Food Safety Authority) and RIVM (the Dutch National Institute for Public health and the Environment), 2015, EFSA J, V12, P1, DOI DOI 10.2903/SP.EFSA.2015.EN-824; Egli CP, 1998, J VET MED A, V45, P99, DOI 10.1111/j.1439-0442.1998.tb00806.x; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; *EUR COMM, 1981, OFFICIAL J EUROPEA L, V222, P32; Frolkis A, 2010, NUCLEIC ACIDS RES, V38, pD480, DOI 10.1093/nar/gkp1002; Hardikar W, 2003, MED PHYSL, P975; Hawkins DM, 2003, J CHEM INF COMP SCI, V43, P579, DOI 10.1021/ci025626i; International Agency for Research on Cancer, IARC MONOGRAPHS EVAL; Kiebooms JAL, 2012, J AGR FOOD CHEM, V60, P7769, DOI 10.1021/jf3017145; Laparre J, 2017, ANAL CHIM ACTA, V951, P99, DOI 10.1016/j.aca.2016.11.055; Le Bizec B, 2011, FOOD ADDIT CONTAM A, V28, P840, DOI 10.1080/19440049.2011.565483; Melanie Spornraft, 2015, Biomol Detect Quantif, V5, P15, DOI 10.1016/j.bdq.2015.08.001; Pinel G, 2006, FOOD ADDIT CONTAM A, V23, P974, DOI 10.1080/02652030600806370; Pluskal T, 2012, ANAL CHEM, V84, P4396, DOI 10.1021/ac3000418; Ridder L, 2012, RAPID COMMUN MASS SP, V26, P2461, DOI 10.1002/rcm.6364; Scarth JP, 2010, CHROMATOGRAPHIA, V72, P297, DOI 10.1365/s10337-010-1652-4; Shankar BP, 2010, VET WORLD, V3, P241, DOI 10.5455/vetworld.2010.241-246; Sterk S. S., 2014, EURL REFLECTION PAPE, P1; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Wager S, 2013, RANDOM FORESTS, V15, P1625, DOI [10.1016/j.surg.2006.10.010, DOI 10.1016/J.SURG.2006.10.010]; Wauters J, 2017, J AGR FOOD CHEM, V65, P6231, DOI 10.1021/acs.jafc.7b01920; Wauters J, 2015, J AGR FOOD CHEM, V63, P1339, DOI 10.1021/jf504475f; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wozniak B, 2012, B VET I PULAWY, V56, P611, DOI 10.2478/v10213-012-0108-z; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xie GX, 2008, METABOLOMICS, V4, P248, DOI 10.1007/s11306-008-0115-5	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195351	10.1371/journal.pone.0195351	http://dx.doi.org/10.1371/journal.pone.0195351			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649241	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900039
J	Araujo, T; Mendonca, AM; Campilho, A				Araujo, Teresa; Mendonca, Ana Maria; Campilho, Aurelio			Parametric model fitting-based approach for retinal blood vessel caliber estimation in eye fundus images	PLOS ONE			English	Article								Background Changes in the retinal vessel caliber are associated with a variety of major diseases, namely diabetes, hypertension and atherosclerosis. The clinical assessment of these changes in fundus images is tiresome and prone to errors and thus automatic methods are desirable for objective and precise caliber measurement. However, the variability of blood vessel appearance, image quality and resolution make the development of these tools a non-trivial task. Metholodogy A method for the estimation of vessel caliber in eye fundus images via vessel cross-sectional intensity profile model fitting is herein proposed. First, the vessel centerlines are determined and individual segments are extracted and smoothed by spline approximation. Then, the corresponding cross-sectional intensity profiles are determined, post-processed and ultimately fitted by newly proposed parametric models. These models are based on Difference-of-Gaussians (DoG) curves modified through a multiplying line with varying inclination. With this, the proposed models can describe profile asymmetry, allowing a good adjustment to the most difficult profiles, namely those showing central light reflex. Finally, the parameters of the best-fit model are used to determine the vessel width using ensembles of bagged regression trees with random feature selection. Results and conclusions The performance of our approach is evaluated on the REVIEW public dataset by comparing the vessel cross-sectional profile fitting of the proposed modified DoG models with 7 and 8 parameters against a Hermite model with 6 parameters. Results on different goodness of fitness metrics indicate that our models are constantly better at fitting the vessel profiles. Furthermore, our width measurement algorithm achieves a precision close to the observers, outperforming state-of-the art methods, and retrieving the highest precision when evaluated using cross-validation. This high performance supports the robustness of the algorithm and validates its use in retinal vessel width measurement and possible integration in a system for retinal vasculature assessment.	[Araujo, Teresa; Mendonca, Ana Maria; Campilho, Aurelio] Univ Porto, Fac Engn, P-4200465 Porto, Portugal; [Araujo, Teresa; Mendonca, Ana Maria; Campilho, Aurelio] Inst Engn Sistemas & Comp Tecnol & Ciencia INESC, P-4200 Porto, Portugal	Universidade do Porto; INESC TEC	Araujo, T (corresponding author), Univ Porto, Fac Engn, P-4200465 Porto, Portugal.; Araujo, T (corresponding author), Inst Engn Sistemas & Comp Tecnol & Ciencia INESC, P-4200 Porto, Portugal.	tfaraujo@inesctec.pt	Mendonça, Ana Maria/AIC-8438-2022; Araújo, Teresa/F-5629-2016; Mendonça, Ana Maria/M-7629-2013; Campilho, Aurelio/M-4869-2013	Mendonça, Ana Maria/0000-0002-4319-738X; Araújo, Teresa/0000-0001-9687-528X; Mendonça, Ana Maria/0000-0002-4319-738X; Campilho, Aurelio/0000-0002-5317-6275	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/122365/2016]; ERDF European Regional Development Fund through the Operational Programme for Competitiveness and Internationalisation - COMPETE Programme; FCT [CMUP-ERI/TIC/0028/2014]; Doctoral Program in Electrical and Computer Engineering (PDEEC) from Faculdade de Engenharia da Universidade do Porto (FEUP)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); ERDF European Regional Development Fund through the Operational Programme for Competitiveness and Internationalisation - COMPETE Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Doctoral Program in Electrical and Computer Engineering (PDEEC) from Faculdade de Engenharia da Universidade do Porto (FEUP)	Teresa Araujo is funded by the Fundacao para a Ciencia e a Tecnologia (FCT) grant contract SFRH/BD/122365/2016. This work is financed by the ERDF European Regional Development Fund through the Operational Programme for Competitiveness and Internationalisation - COMPETE 2020 Programme, and by National Funds through the FCT within project CMUP-ERI/TIC/0028/2014. Publication fees are partially financed by the Doctoral Program in Electrical and Computer Engineering (PDEEC) from Faculdade de Engenharia da Universidade do Porto (FEUP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Al-Diri B, 2008, IEEE ENG MED BIO, P2262, DOI 10.1109/IEMBS.2008.4649647; Aliahmad B., 2012, P BIOS BIOR C, P1; Araujo T, 2017, SPIE MED IMAGING; Arlinghaus S. L., 1994, PRACTICAL HDB CURVE; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; Besenczi R, 2016, COMPUT STRUCT BIOTEC, V14, P371, DOI 10.1016/j.csbj.2016.10.001; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brinchmann-Hansen O., 2009, ACTA OPHTHALMOL, V64, P33, DOI [DOI 10.1111/J.1755-3768.1986.TB00701.X, 10.1111/j.1755-3768.1986.tb00701.x]; Cavinato A, 2013, I S BIOMED IMAGING, P872; Chapman N, 2001, BRIT J OPHTHALMOL, V85, P74, DOI 10.1136/bjo.85.1.74; Coleman T., 1999, USE MATLAB USERS GUI; Elhami M, 2017, J MED IMAGING, V4; Gang L, 2002, IEEE T BIO-MED ENG, V49, P168, DOI 10.1109/10.979356; Gao XH, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P881, DOI 10.1109/ICIP.2001.958635; Girard F, 2014, P OPHTH MED IM AN 1, P41, DOI DOI 10.17077/OMIA; Gonzalez R. C., 2006, DIGITAL IMAGE PROCES, V3rd; GREGSON PH, 1995, COMPUT BIOMED RES, V28, P291, DOI 10.1006/cbmr.1995.1020; Hunter A, 2005, P 3 EUR MED BIOL ENG, V11, P3; Ikram MK, 2013, OPHTHALMOLOGICA, V229, P125, DOI 10.1159/000342158; Kumar Dinesh K, 2012, ISRN Ophthalmol, V2012, P151369, DOI [10.5402/2012/474830, 10.5402/2012/151369]; LAM L, 1992, IEEE T PATTERN ANAL, V14, P869, DOI 10.1109/34.161346; LEE ETY, 1989, COMPUT AIDED DESIGN, V21, P363, DOI 10.1016/0010-4485(89)90003-1; Leontidis G, 2016, COMPUT BIOL MED, V72, P65, DOI 10.1016/j.compbiomed.2016.03.006; Li HQ, 2003, IEEE IMAGE PROC, P1069; Li YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087505; Lowell J, 2004, IEEE T MED IMAGING, V23, P1196, DOI 10.1109/TMI.2004.830524; Lupascu CA, 2013, MED IMAGE ANAL, V17, P1164, DOI 10.1016/j.media.2013.07.006; Martinez-Perez ME, 2000, COMPUTER ANAL GEOMET; Mendonca AM, 2014, IMAGE ANALYSIS AND MODELING IN OPHTHALMOLOGY, P85; Nguyen TT, 2007, DIABETES CARE, V30, P2708, DOI 10.2337/dc07-0732; Poletti E, 2012, IEEE ENG MED BIO, P4958, DOI 10.1109/EMBC.2012.6347105; Rice J. R., 1969, APPROXIMATION FUNCTI, V2; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Trucco E, 2013, ISSNIP BIOSIG BIOROB, P363; Vazquez SG, 2013, COMP MED SY, P71, DOI 10.1109/CBMS.2013.6627767; Wang L, 2007, IEEE T MED IMAGING, V26, P137, DOI 10.1109/TMI.2006.889732; Xu X, 2011, I S BIOMED IMAGING, P641, DOI 10.1109/ISBI.2011.5872488; Yin Y, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/260410; Yuan Y., 2000, P 4 INT C IND APPL M, P271; ZHOU LA, 1994, IEEE T MED IMAGING, V13, P619, DOI 10.1109/42.363106	43	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194702	10.1371/journal.pone.0194702	http://dx.doi.org/10.1371/journal.pone.0194702			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668759	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200013
J	Dondzilo, L; Rieger, E; Palermo, R; Byrne, S; Bell, J				Dondzilo, Laura; Rieger, Elizabeth; Palermo, Romina; Byrne, Susan; Bell, Jason			The mediating role of rumination in the relation between attentional bias towards thin female bodies and eating disorder symptomatology (vol 12, e0177870, 2017)	PLOS ONE			English	Correction													Rieger, Elizabeth/ABE-7589-2020					Dondzilo L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177870	1	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196143	10.1371/journal.pone.0196143	http://dx.doi.org/10.1371/journal.pone.0196143			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668767	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200077
J	Kuntz, AB; Chopp-Hurley, JN; Brenneman, EC; Karampatos, S; Wiebenga, EG; Adachi, JD; Noseworthy, MD; Maly, MR				Kuntz, Alexander B.; Chopp-Hurley, Jaclyn N.; Brenneman, Elora C.; Karampatos, Sarah; Wiebenga, Emily G.; Adachi, Jonathan D.; Noseworthy, Michael D.; Maly, Monica R.			Efficacy of a biomechanically-based yoga exercise program in knee osteoarthritis: A randomized controlled trial	PLOS ONE			English	Article							CLINICALLY IMPORTANT IMPROVEMENT; ASSESS PHYSICAL FUNCTION; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; PERFORMANCE-MEASURES; DISEASE PROGRESSION; MUSCLE STRENGTH; FLEXION MOMENTS; SELF-REPORT; PAIN	Objective Certain exercises could overload the osteoarthritic knee. We developed an exercise program from yoga postures with a minimal knee adduction moment for knee osteoarthritis. The purpose was to compare the effectiveness of this biomechanically-based yoga exercise (YE), with traditional exercise (TE), and a no-exercise attention-equivalent control (NE) for improving pain, self-reported physical function and mobility performance in women with knee osteoarthritis. Design Single-blind, three-arm randomized controlled trial. Setting Community in Southwestern Ontario, Canada. Participants A convenience sample of 31 women with symptomatic knee osteoarthritis was recruited through rheumatology, orthopaedic and physiotherapy clinics, newspapers and word-of-mouth. Interventions Participants were stratified by disease severity and randomly allocated to one of three 12-week, supervised interventions. YE included biomechanically-based yoga exercises; TE included traditional leg strengthening on machines; and NE included meditation with no exercise. Participants were asked to attend three 1-hour group classes/sessions each week. Measurements Primary outcomes were pain, self-reported physical function and mobility performance. Secondary outcomes were knee strength, depression, and health-related quality of life. All were assessed by a blinded assessor at baseline and immediately following the intervention. Results The YE group demonstrated greater improvements in KOOS pain (mean difference of 22.9 [95% CI, 6.9 to 38.8; p = 0.003]), intermittent pain (mean difference of -19.6 [95% CI, -34.8 to -4.4; p = 0.009]) and self-reported physical function (mean difference of 17.2 [95% CI, 5.2 to 29.2; p = 0.003]) compared to NE. Improvements in these outcomes were similar between YE and TE. However, TE demonstrated a greater improvement in knee flexor strength compared to YE (mean difference of 0.1 [95% CI, 0.1 to 0.2]. Improvements from baseline to follow-up were present in quality of life score for YE and knee flexor strength for TE, while both also demonstrated improvements in mobility. No improvement in any outcome was present in NE. Conclusions The biomechanically-based yoga exercise program produced clinically meaningful improvements in pain, self-reported physical function and mobility in women with clinical knee OA compared to no exercise. While not statistically significant, improvements in these outcomes were larger than those elicited from the traditional exercise-based program. Though this may suggest that the yoga program may be more efficacious for knee OA, future research studying a larger sample is required.	[Kuntz, Alexander B.; Brenneman, Elora C.; Maly, Monica R.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Chopp-Hurley, Jaclyn N.; Karampatos, Sarah; Wiebenga, Emily G.; Maly, Monica R.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Adachi, Jonathan D.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada; [Maly, Monica R.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; University of Waterloo	Maly, MR (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.; Maly, MR (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.; Maly, MR (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	mrmaly@uwaterloo.ca			Canadian Institutes for Health Research (CIHR) [137147]; Canada Foundation for Innovation; Ontario Research Fund; Joint Motion Program (A CIHR training initiative); Ontario Graduate Scholarship; Michael G. DeGroote Fellowship Award in Clinical Research at McMaster University; CIHR fellowship award; CIHR New Investigator Award	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; Joint Motion Program (A CIHR training initiative)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Michael G. DeGroote Fellowship Award in Clinical Research at McMaster University; CIHR fellowship award(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	Project funding was received through a Canadian Institutes for Health Research (CIHR) Bridge Grant #137147 (MRM). Funding for certain equipment used in this research was received through the Canada Foundation for Innovation and the Ontario Research Fund. Alexander Kuntz was supported by the Joint Motion Program (A CIHR training initiative) and the Ontario Graduate Scholarship. Jaclyn Chopp-Hurley was supported through the Michael G. DeGroote Fellowship Award in Clinical Research at McMaster University and a CIHR fellowship award. Elora Brenneman was supported by an Ontario Graduate Scholarship. Monica Maly was supported by a CIHR New Investigator Award.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bennell KL, 2013, RHEUM DIS CLIN N AM, V39, P145, DOI 10.1016/j.rdc.2012.11.003; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; Binkley JM, 1999, PHYS THER, V79, P371; BLALOCK SJ, 1989, ARTHRITIS RHEUM, V32, P991, DOI 10.1002/anr.1780320808; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brenneman EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136854; Cahalin LP, 1996, CHEST, V110, P325, DOI 10.1378/chest.110.2.325; Chang AH, 2015, OSTEOARTHR CARTILAGE, V23, P1099, DOI 10.1016/j.joca.2015.02.005; Chehab EF, 2014, OSTEOARTHR CARTILAGE, V22, P1833, DOI 10.1016/j.joca.2014.08.009; Colak TK, 2017, RHEUMATOL INT, V37, P399, DOI 10.1007/s00296-016-3646-5; Collins NJ, 2011, ARTHRITIS CARE RES; Dobson F, 2013, OSTEOARTHR CARTILAGE, V21, P1042, DOI 10.1016/j.joca.2013.05.002; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; Ferreira AH, 2015, REV BRAS REUMATOL, V55, P434, DOI 10.1016/j.rbr.2015.03.001; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fogarty FA, 2015, ANN RHEUM DIS, V74, P472, DOI 10.1136/annrheumdis-2014-205946; Fransen M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub3; GOLDSMITH CH, 1993, J RHEUMATOL, V20, P561; Haaz S, 2011, RHEUM DIS CLIN N AM, V37, P33, DOI 10.1016/j.rdc.2010.11.001; Hawker GA, 2008, OSTEOARTHR CARTILAGE, V16, P409, DOI 10.1016/j.joca.2007.12.015; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hoogeboom TJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-117; Juhl C, 2014, ARTHRITIS RHEUMATOL, V66, P622, DOI 10.1002/art.38290; Kabat-Zinn J., 1990, FULLCATASTROPHE LIVI; Kennedy DM, 2011, J ORTHOP SPORT PHYS, V41, P232, DOI 10.2519/jospt.2011.3516; Kennedy DM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-3; Liu Anna, 2012, ARTHRITIS RHEUMA S10, V24, P244; Longpre HS, 2015, CLIN BIOMECH, V30, P820, DOI 10.1016/j.clinbiomech.2015.06.007; Losina E, 2013, OSTEOARTHR CARTILAGE, V21, P1264, DOI 10.1016/j.joca.2013.04.013; Lun V, 2015, CLIN J SPORT MED, V25, P509, DOI 10.1097/JSM.0000000000000170; Maly MR, 2007, DISABIL REHABIL, V29, P1423, DOI 10.1080/09638280601029985; McCall MC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/945895; McCarthy EK, 2004, J GERONTOL A-BIOL, V59, P1207, DOI 10.1093/gerona/59.11.1207; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Pua YH, 2009, J CLIN EPIDEMIOL, V62, P1103, DOI 10.1016/j.jclinepi.2008.11.011; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Robbins SM, 2011, ARTHRIT CARE RES, V63, P991, DOI 10.1002/acr.20476; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Rosemann T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-48; Rosenzweig S, 2010, J PSYCHOSOM RES, V68, P29, DOI 10.1016/j.jpsychores.2009.03.010; Sharma M, 2014, J EVID-BASED INTEGR, V19, P51, DOI 10.1177/2156587213499918; Singh JA, 2014, J RHEUMATOL, V41, P509, DOI 10.3899/jrheum.130609; Stratford PW, 2010, PHYS THER, V90, P1288, DOI 10.2522/ptj.20100058; Stratford PW, 2006, J CLIN EPIDEMIOL, V59, P160, DOI 10.1016/j.jclinepi.2005.07.012; Stratford PW, 2003, ARTHRIT RHEUM-ARTHR, V49, P535, DOI 10.1002/art.11196; Tubach F, 2012, ARTHRIT CARE RES, V64, P1699, DOI 10.1002/acr.21747; Zacharias A, 2014, OSTEOARTHR CARTILAGE, V22, P1752, DOI 10.1016/j.joca.2014.07.005; Zambon S, 2015, ARTHRITIS CARE RES; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	51	21	22	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195653	10.1371/journal.pone.0195653	http://dx.doi.org/10.1371/journal.pone.0195653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664955	gold, Green Published, Green Submitted			2022-12-27	WOS:000430262300024
J	Scanga, SE; Hasanspahic, B; Zvornicanin, E; Kozenjic, JS; Rahme, AK; Shinn-Thomas, JH				Scanga, Sara E.; Hasanspahic, Bilal; Zvornicanin, Edin; Kozenjic, Jasmina Samardzic; Rahme, Andrew K.; Shinn-Thomas, Jessica H.			Erythritol, at insecticidal doses, has harmful effects on two common agricultural crop plants	PLOS ONE			English	Article							SPOTTED WING DROSOPHILA; SUGAR ALCOHOLS; SWEETENERS; SURVIVAL; SUZUKII; STRESS; METABOLISM; LUFENURON; MANNITOL; POLYOLS	Erythritol, a non-nutritive polyol, is the main component of the artificial sweetener Truvia (R). Recent research has indicated that erythritol may have potential as an organic insecticide, given its harmful effects on several insects but apparent safety for mammals. However, for erythritol to have practical use as an insecticide in agricultural settings, it must have neutral to positive effects on crop plants and other non-target organisms. We examined the dose-dependent effects of erythritol (0, 5, 50, 500, 1000, and 2000 mM) on corn (Zea mays) and tomato (Solanum lycopersicum) seedling growth and seed germination. Erythritol caused significant reductions in both belowground (root) and aboveground (shoot) dry weight at and above the typical minimum insecticidal dose (500 mM erythritol) in tomato plants, but not in corn plants. Both corn and tomato seed germination was inhibited by erythritol but the tomato seeds appeared to be more sensitive, responding at concentrations as low as 50 mM erythritol (in contrast to a minimum damaging dose of 1000 mM erythritol for corn seeds). Our results suggest erythritol may have damaging non-target effects on certain plant crops when used daily at the typical doses needed to kill insect pests. Furthermore, if erythritol's damaging effects extend to certain weed species, it also may have potential as an organic herbicide.	[Scanga, Sara E.; Hasanspahic, Bilal; Zvornicanin, Edin; Kozenjic, Jasmina Samardzic; Rahme, Andrew K.; Shinn-Thomas, Jessica H.] Utica Coll, Dept Biol, Utica, NY 13502 USA; [Kozenjic, Jasmina Samardzic] Salus Univ, Elkins Pk, PA USA		Scanga, SE (corresponding author), Utica Coll, Dept Biol, Utica, NY 13502 USA.	sescanga@utica.edu						Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Barthlott W, 2017, NANO-MICRO LETT, V9, DOI 10.1007/s40820-016-0125-1; Baudier KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098949; Bernt WO, 1996, REGUL TOXICOL PHARM, V24, pS191, DOI 10.1006/rtph.1996.0098; Burgess ER, 2017, J ECON ENTOMOL, V110, P2252, DOI 10.1093/jee/tox190; Choi MY, 2017, J INSECT PHYSIOL, V99, P86, DOI 10.1016/j.jinsphys.2017.04.001; Claeys H, 2014, PLANT PHYSIOL, V165, P519, DOI 10.1104/pp.113.234641; Dayan FE, 2010, WEED SCI, V58, P340, DOI 10.1614/WS-09-092.1; de Cock P, 2016, INT J DENT, V2016, DOI 10.1155/2016/9868421; FARMER AM, 1993, ENVIRON POLLUT, V79, P63, DOI 10.1016/0269-7491(93)90179-R; Fisher ML, 2017, J MED ENTOMOL, V54, P999, DOI 10.1093/jme/tjw241; Goffin J, 2017, ACTA HORTIC, V1156, P843, DOI [10.17660/actahortic.2017.1156.124, 10.17660/ActaHortic.2017.1156.124]; Jeffree CE, 2006, ANNU PLANT REV, V23, P11; Kaya C, 2013, J PLANT INTERACT, V8, P234, DOI 10.1080/17429145.2012.725480; Kuroda K, 2008, PLANT BIOTECHNOL-NAR, V25, P489, DOI 10.5511/plantbiotechnology.25.489; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; O'Donnell S, 2018, J APPL ENTOMOL, V142, P37, DOI 10.1111/jen.12409; O'Donnell S, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew031; Patel TK, 2016, TRENDS PLANT SCI, V21, P486, DOI 10.1016/j.tplants.2016.01.006; Sampson BJ, 2017, J ECON ENTOMOL, V110, P530, DOI 10.1093/jee/tow307; Sampson BJ, 2017, J APPL ENTOMOL, V141, P8, DOI 10.1111/jen.12350; SHINDOU T, 1989, J AGR FOOD CHEM, V37, P1474, DOI 10.1021/jf00090a004; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Tang SB, 2017, J INSECT PHYSIOL, V101, P178, DOI 10.1016/j.jinsphys.2017.07.015; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Williamson JD, 2002, J AM SOC HORTIC SCI, V127, P467, DOI 10.21273/JASHS.127.4.467; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Zhang XQ, 2017, J ECON ENTOMOL, V110, P593, DOI 10.1093/jee/tox038; Zheng CY, 2016, PEST MANAG SCI, V72, P990, DOI 10.1002/ps.4079	30	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0192749	10.1371/journal.pone.0192749	http://dx.doi.org/10.1371/journal.pone.0192749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664905	Green Submitted, Green Published, gold			2022-12-27	WOS:000430262300002
J	Yang, HT; Yang, JJ; Han, LD; Liu, XH; Pu, L; Chin, SM; Hwang, HL				Yang, Hongtai; Yang, Jianjiang; Han, Lee D.; Liu, Xiaohan; Pu, Li; Chin, Shih-miao; Hwang, Ho-ling			A Kriging based spatiotemporal approach for traffic volume data imputation	PLOS ONE			English	Article							TIME PREDICTION; MISSING DATA; FLOW	Along with the rapid development of Intelligent Transportation Systems, traffic data collection technologies have progressed fast. The emergence of innovative data collection technologies such as remote traffic microwave sensor, Bluetooth sensor, GPS-based floating car method, and automated license plate recognition, has significantly increased the variety and volume of traffic data. Despite the development of these technologies, the missing data issue is still a problem that poses great challenge for data based applications such as traffic forecasting, real-time incident detection, dynamic route guidance, and massive evacuation optimization. A thorough literature review suggests most current imputation models either focus on the temporal nature of the traffic data and fail to consider the spatial information of neighboring locations or assume the data follow a certain distribution. These two issues reduce the imputation accuracy and limit the use of the corresponding imputation methods respectively. As a result, this paper presents a Kriging based data imputation approach that is able to fully utilize the spatiotemporal correlation in the traffic data and that does not assume the data follow any distribution. A set of scenarios with different missing rates are used to evaluate the performance of the proposed method. The performance of the proposed method was compared with that of two other widely used methods, historical average and K-nearest neighborhood. Comparison results indicate that the proposed method has the highest imputation accuracy and is more flexible compared to other methods.	[Yang, Hongtai; Liu, Xiaohan] Southwest Jiaotong Univ, Sch Transportat & Logist, Natl United Engn Lab Integrated & Intelligent Tra, Chengdu, Sichuan, Peoples R China; [Yang, Jianjiang] Bank Amer, Model Risk Management, Charlotte, NC USA; [Han, Lee D.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA; [Pu, Li] Southwest Jiaotong Univ, Sch Architecture & Design, Chengdu, Sichuan, Peoples R China; [Chin, Shih-miao; Hwang, Ho-ling] Oak Ridge Natl Lab, Ctr Transportat Anal, Cherahala Blvd, Knoxville, TN USA	Southwest Jiaotong University; Bank of America Corporation; University of Tennessee System; University of Tennessee Knoxville; Southwest Jiaotong University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Han, LD (corresponding author), Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA.	lhan@utk.edu	Yang, Hongtai/AAZ-1699-2020	Yang, Hongtai/0000-0002-3608-1936				Al-Deek HM, 2004, TRANSPORT RES REC, P116; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; Chen C, 2003, TRANSPORT RES REC, P160, DOI 10.3141/1855-20; CRESSIE N, 1990, MATH GEOL, V22, P239, DOI 10.1007/BF00889887; D'Ambrosio A, 2012, J CLASSIF, V29, P227, DOI 10.1007/s00357-012-9108-1; Ding C, 2017, IEEE T INTELL TRANSP, VPP, P1; Ding C, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8111100; Hull J., 1998, J RISK, V1, P5, DOI DOI 10.21314/JOR.1998.001; Li YB, 2014, IET INTELL TRANSP SY, V8, P51, DOI 10.1049/iet-its.2013.0052; Liu YP, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040712; Liu ZB, 2008, TRANSPORT PLAN TECHN, V31, P525, DOI 10.1080/03081060802364505; Ma XL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102160; Ma XL, 2017, IEEE T INTELL TRANSP, V18, P2303, DOI 10.1109/TITS.2016.2635719; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Ni DH, 2005, TRANSPORT RES REC, P57; Potts J.F., 2010, GUIDE PLANNING OPERA; Qi Y, 2014, TRANSPORT RES C-EMER, V43, P95, DOI 10.1016/j.trc.2014.02.007; Qu L, 2008, INT VEH S IEEE; Qu L, 2009, IEEE T INTELL TRANSP, V10, P512, DOI 10.1109/TITS.2009.2026312; Smith BL, 2003, TRANSPORT RES REC, P132, DOI 10.3141/1836-17; Smith BL, 1994, 1994 IEEE INT C IEEE; Stathopoulos A, 2003, TRANSPORT RES C-EMER, V11, P121, DOI 10.1016/S0968-090X(03)00004-4; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Turner S, 2004, TRANSPORT RES REC, P62, DOI 10.3141/1870-08; Williams BM, 1998, TRANSPORT RES REC, P132, DOI 10.3141/1644-14; Williams BM, 2003, J TRANSP ENG, V129, P664, DOI 10.1061/(ASCE)0733-947X(2003)129:6(664); Wu CH, 2004, IEEE T INTELL TRANSP, V5, P276, DOI 10.1109/TITS.2004.837813; Yang H, 2016, J ADV TRANSPORTATION; Yang HT, 2017, TRANSPORT PLAN TECHN, V40, P213, DOI 10.1080/03081060.2016.1266168; Yang HT, 2012, J PUBLIC TRANSPORT, V15, P97, DOI 10.5038/2375-0901.15.3.6; Yang J., 2014, TRANSP RES BOARD 93; Zhong M, 2004, TRANSPORT RES REC, P71, DOI 10.3141/1879-09; Zhong M, 2006, TRANSPORT PLAN TECHN, V29, P141, DOI 10.1080/03081060600753461	34	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195957	10.1371/journal.pone.0195957	http://dx.doi.org/10.1371/journal.pone.0195957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664928	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300044
J	Kwan, BCH; McBain, RA; Luu, BL; Butler, JE; Bilston, LE; Gandevia, SC				Kwan, Benjamin C. H.; McBain, Rachel A.; Luu, Billy L.; Butler, Jane E.; Bilston, Lynne E.; Gandevia, Simon C.			Influence of respiratory mechanics and drive on genioglossus movement under ultrasound imaging	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; UPPER AIRWAY-RESISTANCE; CROSS-SECTIONAL AREA; MUSCLE ACTIVATION; LUNG-VOLUME; FLOW DYNAMICS; NEGATIVE-PRESSURE; HEALTHY HUMANS; NORMAL MEN; TONGUE	Genioglossus is the largest upper airway dilator and its dilatory movement can be measured non-invasively with magnetic resonance imaging and ultrasound. The present study used a novel ultrasound method to assess genioglossus movement in conditions in which ventilatory drive or respiratory mechanics were changed. Methods Twenty healthy subjects (10 males, age 28 +/- 5 years [mean +/- SD]) lay supine, awake, with the head in a neutral position. Ventilation was monitored with inductance bands. Real-time B-mode ultrasound movies were analysed. We measured genioglossus motion (i) during spontaneous breathing, voluntary targeted breathing (normal tidal volume Vt), and voluntary hyperpnoea (at 1.5Vt and 2 Vt); (ii) during inspiratory flow resistive loading; (iii) with changes in end-expiratory lung volume (EELV). Results Average peak inspiratory displacement of the infero-posterior region of genioglossus was 0.89 +/- 0.56 mm; 1.02 +/- 0.88 mm; 1.27 +/- 0.70 mm respectively for voluntary Vt, and during voluntary hyperpnoea at 1.5Vt and 2Vt. A change in genioglossus motion was observed with increased Vt. During increasing inspiratory resistive loading, the genioglossus displaced less anteriorly (p = 0.005) but more inferiorly (p = 0.027). When lung volume was altered, no significant changes in genioglossus movement were observed (p = 0.115). Conclusion In healthy subjects, we observed non-uniform heterogeneous inspiratory motion within the inferoposterior part of genioglossus during spontaneous quiet breathing with mean peak displacement between 0.5-2 mm, with more displacement in the posterior region than the anterior. This regional heterogeneity disappeared during voluntary targeted breathing. This may be due to different neural drive to genioglossus during voluntary breathing. During inspiratory resistive loading, the observed genioglossus motion may serve to maintain upper airway patency by balancing intraluminal negative pressure with positive pressure generated by upper airway dilatory muscles. In contrast, changes in EELV were not accompanied by major changes in genioglossus motion.	[Kwan, Benjamin C. H.; McBain, Rachel A.; Luu, Billy L.; Butler, Jane E.; Bilston, Lynne E.; Gandevia, Simon C.] Neurosci Res Australia NeuRA, Barker St, Sydney, NSW, Australia; [Kwan, Benjamin C. H.; Bilston, Lynne E.; Gandevia, Simon C.] Univ New South Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Kwan, BCH (corresponding author), Neurosci Res Australia NeuRA, Barker St, Sydney, NSW, Australia.; Kwan, BCH (corresponding author), Univ New South Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia.	ben.kwan@health.nsw.gov.au	Butler, Jane E/D-4186-2011; Bilston, Lynne/C-9665-2011	Luu, Billy/0000-0002-2529-6560; Butler, Jane/0000-0002-5834-8152; Bilston, Lynne/0000-0001-8250-9019	NHMRC (National Health and Medical Research Council) Australia	NHMRC (National Health and Medical Research Council) Australia	Jane Butler, Lynne Bilston, Simon Gandevia are supported by fellowship funding from NHMRC (National Health and Medical Research Council) Australia, https://www.nhmrc.gov.au/.	Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; Amis TC, 1999, J PHYSIOL-LONDON, V515, P293, DOI 10.1111/j.1469-7793.1999.293ad.x; BADR MS, 1990, J APPL PHYSIOL, V68, P1195, DOI 10.1152/jappl.1990.68.3.1195; Bailey EF, 2005, AM J RESP CRIT CARE, V171, P1403, DOI 10.1164/rccm.200411-1550OC; Bailey EF, 2004, J APPL PHYSIOL, V96, P440, DOI 10.1152/japplphysiol.00733.2003; Bilston LE, 2014, J APPL PHYSIOL, V116, P314, DOI 10.1152/japplphysiol.00539.2013; BONNEFOUS O, 1986, ULTRASONIC IMAGING, V8, P73, DOI 10.1016/0161-7346(86)90001-5; BROOKS LJ, 1992, AM REV RESPIR DIS, V146, P1394, DOI 10.1164/ajrccm/146.6.1394; Brown EC, 2013, SLEEP, V36, P1069, DOI 10.5665/sleep.2812; BROWN IG, 1986, J APPL PHYSIOL, V61, P890, DOI 10.1152/jappl.1986.61.3.890; Cai MS, 2016, J APPL PHYSIOL, V120, P758, DOI 10.1152/japplphysiol.00382.2015; Cheng S, 2008, J PHYSIOL-LONDON, V586, P4283, DOI 10.1113/jphysiol.2008.156430; Cheng S, 2011, J APPL PHYSIOL, V110, P69, DOI 10.1152/japplphysiol.00413.2010; Daugherty M, 2012, J SPEECH LANG HEAR R, V55, P609, DOI 10.1044/1092-4388(2011/10-0287); Davidson TM, 2003, SLEEP MED, V4, P185, DOI 10.1016/S1389-9457(02)00237-X; DAVIS J N, 1975, Journal of Physiology (Cambridge), V249, P561; Dilley A, 2001, ULTRASOUND MED BIOL, V27, P1211, DOI 10.1016/S0301-5629(01)00413-6; DOUGLAS NJ, 1993, AM REV RESPIR DIS, V148, P1341, DOI 10.1164/ajrccm/148.5.1341; Dutschmann M, 2012, COMPR PHYSIOL, V2, P2443, DOI 10.1002/cphy.c100015; Eastwood PR, 2003, J APPL PHYSIOL, V94, P1849, DOI 10.1152/japplphysiol.01017.2002; Fogel RB, 2001, AM J RESP CRIT CARE, V164, P2025, DOI 10.1164/ajrccm.164.11.2102048; Fregosi RF, 2014, J APPL PHYSIOL, V116, P291, DOI 10.1152/japplphysiol.00670.2013; HAMLET SL, 1972, IEEE T BIO-MED ENG, VBM19, P34, DOI 10.1109/TBME.1972.324156; HOFFSTEIN V, 1984, AM REV RESPIR DIS, V130, P175; HORNER RL, 1991, J PHYSIOL-LONDON, V436, P15, DOI 10.1113/jphysiol.1991.sp018536; HORNER RL, 1991, J PHYSIOL-LONDON, V436, P31, DOI 10.1113/jphysiol.1991.sp018537; How SC, 2007, RESP PHYSIOL NEUROBI, V157, P270, DOI 10.1016/j.resp.2007.01.008; HUDGEL DW, 1987, J APPL PHYSIOL, V63, P603, DOI 10.1152/jappl.1987.63.2.603; IBER C, 1982, J APPL PHYSIOL, V52, P607, DOI 10.1152/jappl.1982.52.3.607; Johns MW, 2002, J SLEEP RES, V11, P61, DOI 10.1046/j.1365-2869.2002.00274.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jordan AS, 2002, J APPL PHYSIOL, V92, P410, DOI 10.1152/japplphysiol.00461.2001; KELSEY CA, 1969, J SPEECH HEAR RES, V12, P564, DOI 10.1044/jshr.1203.564; Klawe J J, 2003, J Physiol Pharmacol, V54 Suppl 1, P14; Kundra P, 2011, INDIAN J ANAESTH, V55, P456, DOI 10.4103/0019-5049.89868; Kwan BCH, 2014, J APPL PHYSIOL, V117, P556, DOI 10.1152/japplphysiol.01257.2013; Laine CM, 2011, J NEUROPHYSIOL, V105, P380, DOI 10.1152/jn.00766.2010; LIISTRO G, 1988, J APPL PHYSIOL, V64, P1285, DOI 10.1152/jappl.1988.64.3.1285; Malhotra A, 2000, AM J RESP CRIT CARE, V161, P1746, DOI 10.1164/ajrccm.161.5.9907109; Malhotra A, 2002, AM J RESP CRIT CARE, V165, P71, DOI 10.1164/ajrccm.165.1.2011065; Martelli D, 2013, RESP PHYSIOL NEUROBI, V188, P318, DOI 10.1016/j.resp.2013.06.019; Martin SE, 1997, EUR RESPIR J, V10, P2087, DOI 10.1183/09031936.97.10092087; Mateika JH, 1999, AM J RESP CRIT CARE, V160, P1976, DOI 10.1164/ajrccm.160.6.9903001; MATHEW OP, 1982, J APPL PHYSIOL, V52, P445, DOI 10.1152/jappl.1982.52.2.445; MEZZANOTTE WS, 1992, J CLIN INVEST, V89, P1571, DOI 10.1172/JCI115751; Mu LC, 2000, ANAT REC, V260, P308, DOI 10.1002/1097-0185(20001101)260:3<308::AID-AR70>3.0.CO;2-N; Mu LC, 2010, CLIN ANAT, V23, P777, DOI 10.1002/ca.21011; Nakayama K, 1998, J COMP NEUROL, V398, P459; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; ONAL E, 1981, AM REV RESPIR DIS, V124, P215; PARISI RA, 1987, AM REV RESPIR DIS, V135, P378; Pataka A, 2014, SLEEP MED, V15, P776, DOI 10.1016/j.sleep.2014.03.012; PATRICK GB, 1982, J APPL PHYSIOL, V53, P1133, DOI 10.1152/jappl.1982.53.5.1133; Pillar F, 2000, AM J RESP CRIT CARE, V162, P1627, DOI 10.1164/ajrccm.162.5.2003131; Pillar G, 2001, RESP PHYSIOL, V127, P23, DOI 10.1016/S0034-5687(01)00230-4; POPOVIC RM, 1995, AM J RESP CRIT CARE, V152, P725, DOI 10.1164/ajrccm.152.2.7633734; Prasad A, 2011, J ULTRAS MED, V30, P965, DOI 10.7863/jum.2011.30.7.965; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931, DOI 10.1152/jappl.1978.44.6.931; Rowley JA, 1996, J APPL PHYSIOL, V80, P2171, DOI 10.1152/jappl.1996.80.6.2171; RUBINSTEIN I, 1989, EUR RESPIR J, V2, P344; RYAN CF, 1991, AM REV RESPIR DIS, V144, P939, DOI 10.1164/ajrccm/144.4.939; Saboisky JP, 2013, OPTIMAL LENGTH TONGU; Saigusa H, 2001, ANN OTO RHINOL LARYN, V110, P779, DOI 10.1177/000348940111000815; Sawczuk A, 2001, CRIT REV ORAL BIOL M, V12, P18, DOI 10.1177/10454411010120010101; SCHWAB RJ, 1993, AM REV RESPIR DIS, V148, P1385, DOI 10.1164/ajrccm/148.5.1385; Schwab RJ, 1998, CLIN CHEST MED, V19, P33, DOI 10.1016/S0272-5231(05)70430-5; Schwab RJ, 1996, SLEEP, V19, pS170; SERIES F, 1990, J APPL PHYSIOL, V68, P2159, DOI 10.1152/jappl.1990.68.5.2159; Sha BFB, 2000, J APPL PHYSIOL, V88, P1678, DOI 10.1152/jappl.2000.88.5.1678; Shepherd KL, 2006, CHEST, V130, P1757, DOI 10.1378/chest.130.6.1757; SPANN RW, 1971, J APPL PHYSIOL, V31, P708, DOI 10.1152/jappl.1971.31.5.708; Stanchina ML, 2003, SLEEP, V26, P851, DOI 10.1093/sleep/26.7.851; Stone M, 2005, CLIN LINGUIST PHONET, V19, P455, DOI 10.1080/02699200500113558; SURATT PM, 1988, AM REV RESPIR DIS, V137, P889, DOI 10.1164/ajrccm/137.4.889; Sustic A, 2007, CRIT CARE MED, V35, pS173, DOI 10.1097/CCM.0000260628.88402.8A; THUT DC, 1993, J APPL PHYSIOL, V75, P2084, DOI 10.1152/jappl.1993.75.5.2084; Trinder J, 1997, J APPL PHYSIOL, V83, P1986, DOI 10.1152/jappl.1997.83.6.1986; Tsui BCH, 2008, CAN J ANAESTH, V55, P790, DOI 10.1007/BF03016357; VANDEGRAAFF WB, 1988, J APPL PHYSIOL, V65, P2124, DOI 10.1152/jappl.1988.65.5.2124; VANDEGRAAFF WB, 1991, J APPL PHYSIOL, V70, P1328, DOI 10.1152/jappl.1991.70.3.1328; Vranish JR, 2015, J NEUROPHYSIOL, V113, P2692, DOI 10.1152/jn.00975.2014; WHEATLEY JR, 1993, AM REV RESPIR DIS, V148, P597, DOI 10.1164/ajrccm/148.3.597; WHITE DP, 1985, J APPL PHYSIOL, V58, P365, DOI 10.1152/jappl.1985.58.2.365; Wojtczak JA, 2012, J ULTRAS MED, V31, P523, DOI 10.7863/jum.2012.31.4.523; YILDIRIM N, 1991, AM REV RESPIR DIS, V144, P845, DOI 10.1164/ajrccm/144.4.845	85	5	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195884	10.1371/journal.pone.0195884	http://dx.doi.org/10.1371/journal.pone.0195884			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659626	gold, Green Submitted, Green Published			2022-12-27	WOS:000430061100039
J	Tomasi, G; Veronese, M; Bertoldo, A; Smith, CB; Schmidt, KC				Tomasi, Giampaolo; Veronese, Mattia; Bertoldo, Alessandra; Smith, Carolyn Beebe; Schmidt, Kathleen C.			Effects of shortened scanning intervals on calculated regional rates of cerebral protein synthesis determined with the L-[1-C-11] leucine PET method	PLOS ONE			English	Article							TISSUE AMINO-ACIDS; SPECTRAL-ANALYSIS; BRAIN; MODEL; IMPLEMENTATION; (CO2)-C-11; VALIDATION; PARAMETERS; DESIGN; PH	To examine effects of scan duration on estimates of regional rates of cerebral protein synthesis (rCPS), we reanalyzed data from thirty-nine previously reported L-[1-C-11] leucine PET studies. Subjects consisted of 12 healthy volunteers studied twice, awake and under propofol sedation, and 15 subjects with fragile X syndrome (FXS) studied once under propofol sedation. All scans were acquired on a high resolution scanner. We used a basis function method for voxelwise estimation of parameters of the kinetic model of L-[1-C-11] leucine and rCPS over the interval beginning at the time of tracer injection and ending 30, 45, 60, 75 or 90 min later. For each study and scan interval, regional estimates in nine regions and whole brain were obtained by averaging voxelwise estimates over all voxels in the region. In all three groups rCPS was only slightly affected by scan interval length and was very stable between 60 and 90 min. Furthermore, statistical comparisons of rCPS between awake and sedated healthy volunteers provided almost identical results when they were based on 60 min scan data as when they were based on data from the full 90 min interval. Statistical comparisons between sedated healthy volunteers and sedated subjects with FXS also yielded almost identical results when based on 60 and 90 min scan intervals. We conclude that, under the conditions of our studies, scan duration can be shortened to 60 min without loss of precision.	[Tomasi, Giampaolo; Smith, Carolyn Beebe; Schmidt, Kathleen C.] NIMH, Sect Neuroadaptat & Prot Metab, Bethesda, MD 20892 USA; [Veronese, Mattia] Kings Coll London, IoPPN, Dept Neu roimaging, London, England; [Bertoldo, Alessandra] Univ Padua, Dept Informat Engn, Padua, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of London; King's College London; University of Padua	Schmidt, KC (corresponding author), NIMH, Sect Neuroadaptat & Prot Metab, Bethesda, MD 20892 USA.	KSchmidt@mail.nih.gov	Veronese, Mattia/A-6012-2013	Veronese, Mattia/0000-0003-3562-0683	Intramural Research Program of the National Institute of Mental Health [NIMH ZIA MH00889]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002935] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the Intramural Research Program of the National Institute of Mental Health. Project No NIMH ZIA MH00889 DIRP to CBS (https://irp.nih.gov/) and by funding from the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishu S, 2008, J CEREBR BLOOD F MET, V28, P1502, DOI 10.1038/jcbfm.2008.43; Bishu S, 2009, J CEREBR BLOOD F MET, V29, P1035, DOI 10.1038/jcbfm.2009.7; Bloomfield PM, 2003, PHYS MED BIOL, V48, P959, DOI 10.1088/0031-9155/48/8/301; BROOKS DJ, 1984, J CEREBR BLOOD F MET, V4, P458, DOI 10.1038/jcbfm.1984.65; BUXTON RB, 1987, J CEREBR BLOOD F MET, V7, P709, DOI 10.1038/jcbfm.1987.125; Carson RE, 2004, IEEE NUCL SCI CONF R, P3281, DOI 10.1109/NSSMIC.2003.1352597; Collins R C, 1980, Trans Am Neurol Assoc, V105, P43; Fischer B, 2004, METHOD INFORM MED, V43, P327; Gunn RN, 2000, J NUCL MED, V41, P706; IIDA H, 1988, J CEREBR BLOOD F MET, V8, P285, DOI 10.1038/jcbfm.1988.60; INGVAR MC, 1985, BRAIN, V108, P155, DOI 10.1093/brain/108.1.155; Levkovitz R, 2001, IEEE T MED IMAGING, V20, P633, DOI 10.1109/42.932747; Nakanishi H, 1997, EUR J NEUROSCI, V9, P271, DOI 10.1111/j.1460-9568.1997.tb01397.x; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Qin M, 2013, J CEREBR BLOOD F MET, V33, P499, DOI 10.1038/jcbfm.2012.205; SCHMIDT K, 1991, J CEREBR BLOOD F MET, V11, P10, DOI 10.1038/jcbfm.1991.2; SCHMIDT K, 1992, J CEREBR BLOOD F MET, V12, P823, DOI 10.1038/jcbfm.1992.114; Schmidt KC, 2005, J CEREBR BLOOD F MET, V25, P617, DOI 10.1038/sj.jcbfm.9600067; SIESJO BK, 1964, EXPERIENTIA, V20, P98, DOI 10.1007/BF02151265; Smith CB, 2000, P NATL ACAD SCI USA, V97, P11014, DOI 10.1073/pnas.97.20.11014; Smith CB, 2005, J CEREBR BLOOD F MET, V25, P629, DOI 10.1038/sj.jcbfm.9600066; SUN Y, 1995, AM J PHYSIOL-REG I, V268, pR549, DOI 10.1152/ajpregu.1995.268.2.R549; Tomasi G, 2009, J CEREBR BLOOD F MET, V29, P1317, DOI 10.1038/jcbfm.2009.52; Veronese M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18890-x; Veronese M, 2012, J CEREBR BLOOD F MET, V32, P1073, DOI 10.1038/jcbfm.2012.27; Veronese M, 2010, J CEREBR BLOOD F MET, V30, P1460, DOI 10.1038/jcbfm.2010.26; WIDMANN R, 1992, J NEUROCHEM, V59, P18, DOI 10.1111/j.1471-4159.1992.tb08870.x; WIDMANN R, 1991, J NEUROCHEM, V56, P789, DOI 10.1111/j.1471-4159.1991.tb01993.x; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34	29	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195580	10.1371/journal.pone.0195580	http://dx.doi.org/10.1371/journal.pone.0195580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659612	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100023
J	Dudhate, A; Shinde, H; Tsugama, D; Liu, SK; Takano, T				Dudhate, Ambika; Shinde, Harshraj; Tsugama, Daisuke; Liu, Shen Kui; Takano, Tetsuo			Transcriptomic analysis reveals the differentially expressed genes and pathways involved in drought tolerance in pearl millet [Pennisetum glaucum (L.) R. Br]	PLOS ONE			English	Article							STRESS TOLERANCE; ABSCISIC-ACID; PHOTOSYNTHESIS; PROTEINS; SEQUENCE; FAMILY; MEMBER; COLD	y Pearl millet is a cereal crop known for its high tolerance to drought, heat and salinity stresses as well as for its nutritional quality. The molecular mechanism of drought tolerance in pearl millet is unknown. Here we attempted to unravel the molecular basis of drought tolerance in two pearl millet inbred lines, ICMB 843 and ICMB 863 using RNA sequencing. Under greenhouse condition, ICMB 843 was found to be more tolerant to drought than ICMB 863. We sequenced the root transcriptome from both lines under control and drought conditions using an Illumina Hi-Seq platform, generating 139.1 million reads. Mapping of sequenced reads against the foxtail millet genome, which has been relatively well-annotated, led to the identification of several differentially expressed genes under drought stress. Total of 6799 and 1253 differentially expressed genes were found in ICMB 843 and ICMB 863, respectively. Pathway and gene function analysis by KEGG online tool revealed that the drought response in pearl millet is mainly regulated by pathways related to photosynthesis, plant hormone signal transduction and mitogen-activated protein kinase signaling. The changes in expression of drought-responsive genes determined by RNA sequencing were confirmed by reverse-transcription PCR for 7 genes. These results are a first step to understanding the molecular mechanisms of drought tolerance in pearl millet and lay a foundation for its genetic improvement.	[Dudhate, Ambika; Shinde, Harshraj; Takano, Tetsuo] Univ Tokyo, Asian Nat Environm Sci Ctr ANESC, Nishitokyo, Tokyo, Japan; [Tsugama, Daisuke] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Liu, Shen Kui] Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China	University of Tokyo; Hokkaido University; Zhejiang A&F University	Takano, T (corresponding author), Univ Tokyo, Asian Nat Environm Sci Ctr ANESC, Nishitokyo, Tokyo, Japan.	takano@anesc.u-tokyo.ac.jp	Liu, Shenkui/AAC-5405-2019; Tsugama, Daisuke/N-6054-2014	Liu, Shenkui/0000-0001-5294-4765; Dudhate, Ambika/0000-0003-1448-2461; Tsugama, Daisuke/0000-0002-4946-678X				Agarwal P, 2010, MOL BIOL REP, V37, P1125, DOI 10.1007/s11033-009-9885-8; APELBAUM A, 1981, PLANT PHYSIOL, V68, P594, DOI 10.1104/pp.68.3.594; Atwell BJ, 2015, EMISSION RATE PLANTS, P2; Baldoni E, 2016, RICE, V9, DOI 10.1186/s12284-016-0098-1; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bates B.C., 2008, CLIMATE CHANGE WATER; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Chen YE, 2016, PHYSIOL PLANTARUM, V158, P225, DOI 10.1111/ppl.12438; Choudhary M, 2015, PHYSIOL MOL BIOL PLA, V21, P187, DOI 10.1007/s12298-015-0287-1; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Du H, 2012, J EXP BOT, V63, P6467, DOI 10.1093/jxb/ers300; Islam T, 2015, PLOS ONE, V10, P1; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; Jongeneel V., 2001, BIOINFORMA PRACT GUI, V10, P57; Jung H, 2015, PLANT SCI, V236, P304, DOI 10.1016/j.plantsci.2015.04.018; Kerr TCC, 2018, PLANT CELL ENVIRON, V41, P898, DOI 10.1111/pce.12906; Kudo M, 2017, PLANT BIOTECHNOL J, V15, P458, DOI 10.1111/pbi.12644; Kulik A, 2011, OMICS, V15, P859, DOI 10.1089/omi.2011.0091; KUMAR S, 2016, FRONT PLANT SCI, V7, P1636, DOI DOI 10.3389/FPLS.2016.01636; Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125001; Liu HQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/564149; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CM, 1999, J EXP BOT, V50, P1199, DOI 10.1093/jexbot/50.336.1199; Min HW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01080; Mishra RN, 2007, PLANT MOL BIOL, V64, P713, DOI 10.1007/s11103-007-9193-4; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Rajaram V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-159; Riemann M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01077; Saglam A, 2014, ACTA BIOL HUNG, V65, P178, DOI 10.1556/ABiol.65.2014.2.6; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Shivhare R, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02069; Shivhare R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23036; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Song K, 2017, FRONT PLANT SCI, V8, P1, DOI [10.3389/fpls.2017.00267/full, DOI 10.3389/FPLS.2017.00267/FULL]; Sun XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31654; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; Tullberg A, 2000, PLANT CELL PHYSIOL, V41, P1045, DOI 10.1093/pcp/pcd031; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Vadez V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00386; Varshney RK, 2017, NAT BIOTECHNOL, V35, P969, DOI 10.1038/nbt.3943; Wei T, 2017, FRONT PLANT SCI, V8, DOI [10.3389/fpls.2017.00052, 10.3389/fpls.2017.00526]; Wilkinson S, 2012, J EXP BOT, V63, P3499, DOI 10.1093/jxb/ers148; Woo NS, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-27; Wydrzynski T, 2007, PHOTOSYNTH RES, V94, P225, DOI 10.1007/s11120-007-9271-0; Xiang YL, 2017, MOL PLANT, V10, P456, DOI 10.1016/j.molp.2016.10.003; Zhang JH, 2013, MOL BIOL REP, V40, P2633, DOI 10.1007/s11033-012-2350-0	48	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195908	10.1371/journal.pone.0195908	http://dx.doi.org/10.1371/journal.pone.0195908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652907	Green Published, gold, Green Submitted			2022-12-27	WOS:000430026900046
J	Kingston, D; Kehler, H; Austin, MP; Mughal, MK; Wajid, A; Vermeyden, L; Benzies, K; Brown, S; Stuart, S; Giallo, R				Kingston, Dawn; Kehler, Heather; Austin, Marie-Paule; Mughal, Muhammad Kashif; Wajid, Abdul; Vermeyden, Lydia; Benzies, Karen; Brown, Stephanie; Stuart, Scott; Giallo, Rebecca			Trajectories of maternal depressive symptoms during pregnancy and the first 12 months postpartum and child externalizing and internalizing behavior at three years	PLOS ONE			English	Article							PROJECT ICE STORM; PHYSICAL AGGRESSION; POSTNATAL DEPRESSION; CANADIAN CHILDREN; CENTRAL ADIPOSITY; COMMUNITY SAMPLE; RISK-FACTORS; ANXIETY; METAANALYSIS; PSYCHOPATHOLOGY	Background Most evidence of the association between maternal depression and children's development is limited by being cross-sectional. To date, few studies have modelled trajectories of maternal depressive symptoms from pregnancy through the early postpartum years and examined their association with social emotional and behavior functioning in preschool children. The objectives of this study were to: 1) identify distinct groups of women defined by their trajectories of depressive symptoms across four time points from mid-pregnancy to one year postpartum; and 2) examine the associations between these trajectories and child internalizing and externalizing behaviors. Methods We analyzed data from the All Our Families (AOF) study, a large, population based pregnancy cohort of mother-child dyads in Alberta, Canada. The AOF study is an ongoing pregnancy cohort study designed to investigate relationships between the prenatal and early life period and outcomes for children and mothers. Maternal depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale. Children's behavioral functioning at age 3 was assessed using the Behavior Scales developed for the Canadian National Longitudinal Survey of Children and Youth. Longitudinal latent class analysis was conducted to identify trajectories of women's depressive symptoms across four time points from pregnancy to 1 year postpartum. We used multivariable logistic regression to assess the relationship between trajectories of maternal depressive symptoms and children's behavior, while adjusting for other significant maternal, child and psychosocial factors. Results 1983 participants met eligibility criteria. We identified four distinct trajectories of maternal depressive symptoms: low level (64.7%); early postpartum (10.9%); subclinical (18.8%); and persistent high (5.6%). In multivariable models, the proportion of children with elevated behavior symptoms was highest for children whose mothers had persistent high depressive symptoms, followed by mothers with moderate symptoms (early postpartum and subclinical trajectories) and lowest for minimal symptoms. After accounting for demographic, child and psychosocial factors, the relationships between depression trajectories and child hyperactivity/inattention, physical aggression (subclinical trajectory only) and separation anxiety symptoms remained significant. Conclusion These findings suggest both externalizing and internalizing children's behaviors are associated with prolonged maternal depressive symptoms. There is a good case for the need to move beyond overly simplistic clinical cutoff approaches of depressed/not depressed in screening for perinatal depression. Women with elevated depressive symptoms at clinical and subclinical levels need to be identified, provided with evidence-based treatment, and monitored with repeat screening to improve maternal mental health outcomes and reduce the risk of associated negative outcomes on children's early social-emotional and behavior development.	[Kingston, Dawn; Kehler, Heather; Mughal, Muhammad Kashif; Wajid, Abdul; Vermeyden, Lydia; Benzies, Karen] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Austin, Marie-Paule] St John God Hlth Care, Burwood, Australia; [Austin, Marie-Paule] Univ New South Wales, Sydney, NSW, Australia; [Brown, Stephanie; Giallo, Rebecca] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Stuart, Scott] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	University of Calgary; St John of God Health Care; University of New South Wales Sydney; Murdoch Children's Research Institute; University of Iowa	Kingston, D (corresponding author), Univ Calgary, Fac Nursing, Calgary, AB, Canada.	dawn.kingston@ucalgary.ca	Brown, Stephanie/AAE-1662-2019; Mughal, M. Kashif/O-1018-2019; Wajid, Abdul/AAN-1011-2020	Mughal, M. Kashif/0000-0002-1321-0619; Wajid, Abdul/0000-0001-9594-620X; Stuart, Scott/0000-0003-2301-3405; Giallo, Rebecca/0000-0002-1065-2921; Kingston, Dawn/0000-0002-7183-2803; Brown, Stephanie/0000-0001-9812-0067	NHMRC Career Development Fellowship; Victorian Government's Operational Infrastructure Support Program; Alberta Innovates Interdisciplinary Team Grant [200700595]; Alberta Children's Hospital Foundation; Max Bell Foundation	NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Alberta Innovates Interdisciplinary Team Grant; Alberta Children's Hospital Foundation; Max Bell Foundation	DK holds a CIHR New Investigator Award and the Lois Hole Hospital for Women Cross Provincial Chair in Perinatal Mental Health. RG is supported by NHMRC Career Development Fellowship and the Victorian Government's Operational Infrastructure Support Program. M-PA holds the St. John of God Chair in Perinatal and Women's Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the (non-financial) contribution and support of All Our Families participants and team. (All Our Families is funded through Alberta Innovates Interdisciplinary Team Grant #200700595, the Alberta Children's Hospital Foundation, and the Max Bell Foundation.)	Achenbach TM, 1983, MANUAL CHILD BEHAV C; Atzaba-Poria N, 2004, INT J BEHAV DEV, V28, P449, DOI 10.1080/01650250444000171; Beck CT, 1999, J ADV NURS, V29, P623, DOI 10.1046/j.1365-2648.1999.00943.x; Benzies K, 2009, CAN J PSYCHIAT, V54, P55, DOI 10.1177/070674370905400109; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Bogels SM, 2006, CLIN PSYCHOL REV, V26, P834, DOI 10.1016/j.cpr.2005.08.001; CAMPBELL SB, 1995, J CHILD PSYCHOL PSYC, V36, P113, DOI 10.1111/j.1469-7610.1995.tb01657.x; Cao-Lei L, 2017, NEUROSCI BIOBEHAV R, DOI [10.1016/j.neubiorev.2017.05.016, DOI 10.1016/J.NEUBIOREV.2017.05.016]; Cao-Lei L, 2016, EARLY HUM DEV, V103, P189, DOI 10.1016/j.earlhumdev.2016.09.013; Cao-Lei L, 2015, EPIGENETICS-US, V10, P749, DOI 10.1080/15592294.2015.1063771; Cents RAM, 2013, PSYCHOL MED, V43, P13, DOI 10.1017/S0033291712000657; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Giallo R, 2017, INT J BEHAV DEV; Giallo R, 2015, EUR CHILD ADOLES PSY, V24, P1233, DOI 10.1007/s00787-014-0672-2; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Gracie SK, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-87; Grant KA, 2008, J AFFECT DISORDERS, V108, P101, DOI 10.1016/j.jad.2007.10.002; Grover RL, 2005, CHILD PSYCHIAT HUM D, V36, P133, DOI 10.1007/s10578-005-3491-3; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Kingston D, 2014, MATERN CHILD HLTH J, V18, P1728, DOI 10.1007/s10995-013-1418-3; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Lei CL, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0219-0; McDonald SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S2; McHale JP, 1998, DEV PSYCHOPATHOL, V10, P39, DOI 10.1017/S0954579498001527; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Muthen L.K., 2010, MPLUS USERS GUIDE ST; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Park M, 2018, ARCH WOMEN MENT HLTH, V21, P353, DOI 10.1007/s00737-017-0803-0; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P22; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rubin KH, 2003, DEV PSYCHOL, V39, P164, DOI 10.1037//0012-1649.39.1.164; Santos H, 2016, ARCH WOMEN MENT HLTH, P1, DOI DOI 10.1007/S00737-016-0670-0; Smeekens S, 2007, J ABNORM CHILD PSYCH, V35, P347, DOI 10.1007/s10802-006-9095-y; Spielberger CD, 1970, MANUAL STATE TRAIT A; StataCorp, 2013, STATA STAT SOFTW REL; Statistics Canada, 2007, MICR US GUID NAT LON; Stuart S, 1998, J NERV MENT DIS, V186, P420, DOI 10.1097/00005053-199807000-00006; Tough SC, 2017, INT J EPIDEMIOL; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; van der Waerden J, 2015, J PEDIATR-US, V166, P1440, DOI 10.1016/j.jpeds.2015.03.002; Woolhouse H, 2015, BJOG-INT J OBSTET GY, V122, P312, DOI 10.1111/1471-0528.12837; Yap MBH, 2015, J AFFECT DISORDERS, V175, P424, DOI 10.1016/j.jad.2015.01.050	47	81	82	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195365	10.1371/journal.pone.0195365	http://dx.doi.org/10.1371/journal.pone.0195365			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652937	Green Published, gold			2022-12-27	WOS:000430026900022
J	Pisavadia, B; Arshad, A; Chappelow, I; Nightingale, P; Anderson, B; Nath, J; Sharif, A				Pisavadia, Bhavini; Arshad, Adam; Chappelow, Imogen; Nightingale, Peter; Anderson, Benjamin; Nath, Jay; Sharif, Adnan			Ethnicity matching and outcomes after kidney transplantation in the United Kingdom	PLOS ONE			English	Article							AFRICAN-AMERICANS; DONOR RACE; APOL1 GENE; SURVIVAL; RECIPIENTS; DIALYSIS; DISEASE; ASSOCIATION; PROGRESSION; MORTALITY	Background Kidneys from non-white donors have inferior outcomes, but it is unclear if ethnicity matching between donors and recipients achieves better post kidney transplant outcomes. Methods We undertook a retrospective, population cohort study utilising UK Transplant Registry data. The cohort comprised adult, kidney-alone, transplant recipients receiving their first kidney transplant between 2003-2015, with data censored at 1st October 2016. We included 27,970 recipients stratified into white (n = 23,215), black (n = 1,679) and south Asian (n = 3,076) ethnicity, with median post-transplant follow-up of 1,676 days (IQR 716-2,869 days). Unadjusted and adjusted Cox regression survival analyses were performed to investigate ethnicity effect on risk for graft loss and mortality. Results In unadjusted analyses, matched ethnicity between donors-recipients resulted in better outcomes for delayed graft function, one-year creatinine, graft and patient survival but these differed by ethnicity matches. Compared to white-to-white transplants, risk for death-censored graft loss was higher in black-to-black and similar among Asian-to-Asian transplants, but mortality risk was lower for both black-to-black and Asian-to-Asian transplants. In Cox regression models, compared to white donors, we observed higher risk for graft loss with both south Asian (HR 1.38, 95% CI 1.12-1.70, p = 0.003) and black (HR 1.66, 95% CI 1.30-2.11, p<0.001) donated kidneys independent of recipient ethnicity. We observed no mortality difference with south Asian donated kidneys but increased mortality with black donated kidneys (HR 1.68, 95% CI 1.21-2.35, p = 0.002). Matching ethnicities made no significant difference in any Cox regression model. Similar results were observed after stratifying our analysis by living and deceased-donor kidney transplantation. Conclusions Our data confirm inferior outcomes associated with non-white kidney donors for kidney transplant recipients of any ethnicity in a risk-adjusted model for the United Kingdom population. However, contrary to non-renal transplant literature, we did not identify any survival benefits associated with donor-recipient ethnicity matching.	[Pisavadia, Bhavini; Anderson, Benjamin] Queen Elizabeth Hosp, Dept Nephrol & Transplantat, Birmingham, W Midlands, England; [Arshad, Adam; Chappelow, Imogen; Sharif, Adnan] Univ Birmingham, Birmingham, W Midlands, England; [Nightingale, Peter] Queen Elizabeth Hosp, Dept Med Stat, Birmingham, W Midlands, England; [Nath, Jay; Sharif, Adnan] Univ Birmingham, Sch Immunol & Immunotherapy, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Sharif, A (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.; Sharif, A (corresponding author), Univ Birmingham, Sch Immunol & Immunotherapy, Birmingham, W Midlands, England.	adnan.sharif@uhb.nhs.uk	Nath, Jay/K-1437-2019	Sharif, Adnan/0000-0002-7586-9136				Allen JG, 2009, J HEART LUNG TRANSPL, V28, P1063, DOI 10.1016/j.healun.2009.06.012; Barbour SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2422, DOI 10.1093/ndt/gfq283; Brown KL, 2010, AM J SURG, V199, P305, DOI 10.1016/j.amjsurg.2009.08.025; Callender CO, 2009, TRANSPL P, V41, P4125, DOI 10.1016/j.transproceed.2009.06.182; Chakkera HA, 2005, J AM SOC NEPHROL, V16, P269, DOI 10.1681/ASN.2004040333; Cole N, 2014, CLIN NEPHROL, V82, P77, DOI 10.5414/CN108247; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Friedman DJ, 2011, J CLIN INVEST, V121, P3367, DOI 10.1172/JCI46263; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Glauser TA, 1999, J CHILD NEUROL, V14, P382, DOI 10.1177/088307389901400607; Johns TS, 2014, J AM SOC NEPHROL, V25, P2649, DOI 10.1681/ASN.2013111207; Kanter KR, 2009, ANN THORAC SURG, V87, P204, DOI 10.1016/j.athoracsur.2008.09.074; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kucirka LM, 2011, JAMA-J AM MED ASSOC, V306, P620, DOI 10.1001/jama.2011.1127; Locke JE, 2008, J AM SOC NEPHROL, V19, P2011, DOI 10.1681/ASN.2008010078; Molnar MZ, 2013, CLIN TRANSPLANT, V27, P37, DOI 10.1111/j.1399-0012.2012.01686.x; Pang PS, 2009, LIVER TRANSPLANT, V15, P1126, DOI 10.1002/lt.21835; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Smith RS, 2007, DNA SEQUENCE, V18, P47, DOI 10.1080/10425170601060707; Swanson SJ, 2002, AM J TRANSPLANT, V2, P68, DOI 10.1034/j.1600-6143.2002.020112.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	23	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e195038	10.1371/journal.pone.0195038	http://dx.doi.org/10.1371/journal.pone.0195038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652887	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900016
J	Sela, I; Wolf, YI; Koonin, EV				Sela, Itamar; Wolf, Yuri I.; Koonin, Eugene V.			Estimation of universal and taxon-specific parameters of prokaryotic genome evolution	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; DELETIONAL BIAS; DNA LOSS; BACTERIAL; DATABASE; ATGC	The results of our recent study on mathematical modeling of microbial genome evolution indicate that, on average, genomes of bacteria and archaea evolve in the regime of mutation-selection balance defined by positive selection coefficients associated with gene acquisition that is counter-acted by the intrinsic deletion bias. This analysis was based on the strong assumption that parameters of genome evolution are universal across the diversity of bacteria and archaea, and yielded extremely low values of the selection coefficient. Here we further refine the modeling approach by taking into account evolutionary factors specific for individual groups of microbes using two independent fitting strategies, an ad hoc hard fitting scheme and a mixture model. The resulting estimate of the mean selection coefficient of s similar to 10(-10) associated with the gain of one gene implies that, on average, acquisition of a gene is beneficial, and that microbial genomes typically evolve under a weak selection regime that might transition to strong selection in highly abundant organisms with large effective population sizes. The apparent selective pressure towards larger genomes is balanced by the deletion bias, which is estimated to be consistently greater than unity for all analyzed groups of microbes. The estimated values of s are more realistic than the lower values obtained previously, indicating that global and group-specific evolutionary factors synergistically affect microbial genome evolution that seems to be driven primarily by adaptation to existence in diverse niches.	[Sela, Itamar; Wolf, Yuri I.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Koonin, EV (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	koonin@ncbi.nlm.nih.gov		Wolf, Yuri/0000-0002-0247-8708	US Department of Health and Human Services	US Department of Health and Human Services	The authors' research is supported by intramural funds of the US Department of Health and Human Services (funding to the National Library of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doolittle WF, 1999, TRENDS CELL BIOL, V9, pM5, DOI 10.1016/S0962-8924(99)01664-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gweon HS, 2017, ISME J, V11, P821, DOI 10.1038/ismej.2016.142; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Iranzo J, 2017, P NATL ACAD IN PRESS; Koonin EV, 2009, INT J BIOCHEM CELL B, V41, P298, DOI 10.1016/j.biocel.2008.09.015; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kristensen DM, 2017, NUCLEIC ACIDS RES, V45, pD210, DOI 10.1093/nar/gkw934; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kuo CH, 2009, GENOME BIOL EVOL, V1, P145, DOI 10.1093/gbe/evp016; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2007, ORIGINS GENOME ARCHI; Lynch M, 2006, ANNU REV MICROBIOL, V60, P327, DOI 10.1146/annurev.micro.60.080805.142300; Lynch M, 2015, P NATL ACAD SCI USA, V112, P15690, DOI 10.1073/pnas.1514974112; McCandlish DM, 2015, THEOR POPUL BIOL, V99, P98, DOI 10.1016/j.tpb.2014.11.004; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Novichkov PS, 2009, NUCLEIC ACIDS RES, V37, pD448, DOI 10.1093/nar/gkn684; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Puigbo P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0066-4; Sela I, 2016, P NATL ACAD SCI USA, V113, P11399, DOI 10.1073/pnas.1614083113; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Wolf YI, 2016, NATURE MICR IN PRESS; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	32	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195571	10.1371/journal.pone.0195571	http://dx.doi.org/10.1371/journal.pone.0195571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652909	Green Published, gold, Green Submitted			2022-12-27	WOS:000430026900029
J	Suma, S; Naito, M; Wakai, K; Naito, T; Kojima, M; Umemura, O; Yokota, M; Hanada, N; Kawamura, T				Suma, Shino; Naito, Mariko; Wakai, Kenji; Naito, Toru; Kojima, Masaaki; Umemura, Osami; Yokota, Makoto; Hanada, Nobuhiro; Kawamura, Takashi			Tooth loss and pneumonia mortality: A cohort study of Japanese dentists	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PERIODONTAL-DISEASE; RISK-FACTORS; INFECTION	Although associations between oral health and pneumonia have been reported in previous studies, particularly in the institutionalized elderly, few prospective studies have investigated the association between oral condition and pneumonia among community-dwelling people and whether the findings among inpatients or patients in nursing homes are applicable to the general population is still unclear. The oral bacteria propagated in the periodontal regions may drop into the lung and increase the risk of pneumonia. We, therefore, investigated the association of tooth loss with mortality from pneumonia in a cohort study of Japanese dentists. Members of the Japan Dental Association (JDA) participated in the LEMONADE (Longitudinal Evaluation of Multi-phasic, Odontological and Nutritional Associations in Dentists) Study. From 2001 to 2006, they completed a baseline questionnaire on lifestyle and health factors including the number of teeth lost (excluding third molars). We followed 19,775 participants (mean age +/- standard deviation, 51.4 +/- 11.7 years; 1,573 women [8.0%] and 18,202 men [92.0%]) for mortality from pneumonia (ICD-10, J12-J18). Mortality data were collected via the fraternal insurance program of the JDA. The hazard ratios (HRs) were estimated with adjustment for sex, age, body mass index, smoking status, physical activity and diabetes history. During the median follow-up period of 9.5 years, we documented 68 deaths from pneumonia. Participants who were edentulous at baseline were at significantly increased risk of mortality from pneumonia. The multivariable-adjusted HRs were 2.07 (95% confidence interval [CI], 1.09 +/- 3.95) for the edentulous and 1.60 (95% CI, 0.83 +/- 3.10) for loss of 15 +/- 27 teeth relative to loss of 0 +/- 14 teeth (trend p = 0.026). The HR per one tooth loss was also significant; 1.031 (95% CI, 1.004 +/- 1.060). In conclusion, a large number of teeth lost may indicate an increased risk of mortality from pneumonia in community-dwelling populations.	[Suma, Shino; Naito, Mariko; Wakai, Kenji] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi, Japan; [Suma, Shino] Kyushu Univ, Fac Dent, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Fukuoka, Japan; [Naito, Mariko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Maxillofacial Funct Dev, Hiroshima, Hiroshima, Japan; [Naito, Toru] Fukuoka Dent Coll, Sect Geriatr Dent, Dept Gen Dent, Fukuoka, Fukuoka, Japan; [Kojima, Masaaki; Umemura, Osami] Aichi Dent Assoc, Nagoya, Aichi, Japan; [Yokota, Makoto] Yokota Dent Private Sch, Fukuoka, Fukuoka, Japan; [Hanada, Nobuhiro] Tsurumi Univ, Dept Translat Res, Sch Dent Med, Yokohama, Kanagawa, Japan; [Kawamura, Takashi] Kyoto Univ Hlth Serv, Kyoto, Kyoto, Japan	Nagoya University; Kyushu University; Hiroshima University; Fukuoka Dental College (FDC); Tsurumi University; Kyoto University	Suma, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi, Japan.; Suma, S (corresponding author), Kyushu Univ, Fac Dent, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Fukuoka, Japan.	suma.shino@dent.kyushu-u.ac.jp	NAITO, Mariko/I-7264-2014; Hanada, Nobuhiro/C-5308-2011; Hanada, Nobuhiro/HHM-6735-2022	NAITO, Mariko/0000-0003-3794-2643; Hanada, Nobuhiro/0000-0002-9130-7256	8020 (20 teeth until 80 years old) Promotion Foundation; Ministry of Health, Labour and Welfare of Japan [H19-Iryo-Ippan-008]; Ministry of Education, Culture, Sports, Science and Technology of Japan [14770166, 16390189, 20590642, 23590788, 26463161]	8020 (20 teeth until 80 years old) Promotion Foundation; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the 8020 (20 teeth until 80 years old) Promotion Foundation [KW] and from the Ministry of Health, Labour and Welfare of Japan (H19-Iryo-Ippan-008) [NH]. The LEMONADE study was supported by Grants for Scientific Research (nos. 14770166 [KW], 16390189 [KW], 20590642 [KW], 23590788 [KW] and 26463161 [MN]) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2006, J EPIDEMIOL, V16, P214, DOI 10.2188/jea.16.214; [Anonymous], 2004, LETS START OR CAR; [Anonymous], 2014, CORR VAR ISS SURR AC; [Anonymous], 2014, STOP PNEUM; [Anonymous], 2014, PNEUM INF ELD; [Anonymous], 2015, OR CAR PROM MAN LONG; [Anonymous], 2015, CAUS SPEC MORT RAT G; [Anonymous], 2015, RANK CAUS DEATH YEAR; Arnold FW, 2013, RESP MED, V107, P1101, DOI 10.1016/j.rmed.2013.04.003; Awano S, 2008, J DENT RES, V87, P334, DOI 10.1177/154405910808700418; Bansal M, 2013, J Med Life, V6, P244; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Buhlin K, 2002, COMMUNITY DENT ORAL, V30, P431, DOI 10.1034/j.1600-0528.2002.00014.x; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; D'Aiuto F, 2005, J DENT RES, V84, P269, DOI 10.1177/154405910508400312; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Neto JPD, 2013, EUR J CLIN MICROBIOL, V32, P27, DOI 10.1007/s10096-012-1710-y; Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341; Figueredo CMS, 2000, J CLIN PERIODONTOL, V27, P572, DOI 10.1034/j.1600-051x.2000.027008572.x; Geurs NC, 2003, PERIODONTOL 2000, V32, P105, DOI 10.1046/j.0906-6713.2003.03208.x; Gomes-Filho Isaac S, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5811; Gomes-Filho IS, 2014, J PERIODONTOL, V85, pE82, DOI [10.1902/jop.2013.130369, 10.1902/jop.2013.130509]; Grau AJ, 2004, STROKE, V35, P496, DOI 10.1161/01.STR.0000110789.20526.9D; Holm-Pedersen P, 2008, J AM GERIATR SOC, V56, P429, DOI 10.1111/j.1532-5415.2007.01602.x; Kelaiditi E, 2014, J AM MED DIR ASSOC, V15, P588, DOI 10.1016/j.jamda.2014.04.012; Marcenes Wagner, 2003, Cad. Saúde Pública, V19, P809, DOI 10.1590/S0102-311X2003000300013; Mufson Maurice A., 1999, American Journal of Medicine, V107, p34S, DOI 10.1016/S0002-9343(99)00098-4; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Paju S, 2007, ORAL DIS, V13, P508, DOI 10.1111/j.1601-0825.2007.01410a.x; Riquelme R, 1997, AM J RESP CRIT CARE, V156, P1908, DOI 10.1164/ajrccm.156.6.9702005; Saremi A, 2005, DIABETES CARE, V28, P27, DOI 10.2337/diacare.28.1.27; Scannapieco F A, 1998, Ann Periodontol, V3, P251, DOI 10.1902/annals.1998.3.1.251; Scannapieco FA, 1996, J PERIODONTOL, V67, P1114, DOI 10.1902/jop.1996.67.10s.1114; Scannapieco FA, 1999, J PERIODONTOL, V70, P793, DOI 10.1902/jop.1999.70.7.793; Scannapieco Frank A, 2003, Ann Periodontol, V8, P54, DOI 10.1902/annals.2003.8.1.54; Shah Divyang, 2009, Indian J Occup Environ Med, V13, P77, DOI 10.4103/0019-5278.55123; Singanayagam A, 2013, EUR RESPIR J, V42, P180, DOI 10.1183/09031936.00115312; Suzuki I, 1998, J Epidemiol, V8, P152; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; van der Maarel-Wierink CD, 2013, GERODONTOLOGY, V30, P3, DOI 10.1111/j.1741-2358.2012.00637.x; van der Maarel-Wierink CD, 2011, J AM MED DIR ASSOC, V12, P344, DOI 10.1016/j.jamda.2010.12.099; Wakai K, 2010, COMMUNITY DENT ORAL, V38, P43, DOI 10.1111/j.1600-0528.2009.00512.x; Wakai K, 2009, J EPIDEMIOL, V19, P72, DOI 10.2188/jea.JE20070458; Wilson M, 1996, J PERIODONTAL RES, V31, P393, DOI 10.1111/j.1600-0765.1996.tb00508.x; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Yoshida M, 2001, Nihon Ronen Igakkai Zasshi, V38, P481	47	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195813	10.1371/journal.pone.0195813	http://dx.doi.org/10.1371/journal.pone.0195813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652898	gold, Green Published, Green Submitted			2022-12-27	WOS:000430026900038
J	Paquette, SJ; Stanford, K; Thomas, J; Reuter, T				Paquette, Sarah-Jo; Stanford, Kim; Thomas, James; Reuter, Tim			Quantitative surveillance of shiga toxins 1 and 2, Escherichia coli O178 and O157 in feces of western-Canadian slaughter cattle enumerated by droplet digital PCR with a focus on seasonality and slaughterhouse location	PLOS ONE			English	Article							PREVALENCE; INFECTIONS; STEC; O145; O111; O103; IDENTIFICATION; SEROGROUPS; PATHOGEN; CULTURE	Often Escherichia coliare harmless and/or beneficial bacteria inhabiting the gastrointestinal tract of livestock and humans. However, Shiga toxin-producing E. coli (STEC) have been linked to human disease. Cattle are the primary reservoir for STEC and STEC "super-shedders" are considered to be a major contributor in animal to animal transmission. Among STEC, O157:H7 is the most recognized serotype, but in recent years, non-O157 STEC have been increasingly linked to human disease. In Argentina and Germany, O178 is considered an emerging pathogen. Our objective was to compare populations of E. coli O178, O157, shiga toxin 1 and 2 in western Canadian cattle feces from a sampling pool of similar to 80,000 beef cattle collected at two slaughterhouses. Conventional PCR was utilized to screen 1,773 samples for presence/absence of E. coli O178. A subset of samples (n = 168) was enumerated using droplet digital PCR (ddPCR) and proportions of O178, O157 and shiga toxins 1 & 2 specific-fragments were calculated as a proportion of generic E. coli (GEC) specific-fragments. Distribution of stx(1) and stx(2) was determined by comparing stx(1), stx(2) and O157 enumerations. Conventional PCR detected the presence of O178 in 873 of 1,773 samples and ddPCR found the average proportion of O178, O157, stx(1) and stx(2) in the samples 2.8%, 0.6%, 1.4% and 0.5%, respectively. Quantification of stx(1) and stx(2) revealed more virulence genes than could be exclusively attributed to O157. Our results confirmed the presence of E. coli O178 in western Canadian cattle and ddPCR revealed O178 as a greater proportion of GEC than was O157. Our results suggests: I) O178 may be an emerging subgroup in Canada and II) monitoring virulence genes may be a more relevant target for food-safety STEC surveillance compared to current serogroup screening.	[Paquette, Sarah-Jo; Stanford, Kim; Reuter, Tim] Alberta Agr & Forestry, Lethbridge, AB, Canada; [Paquette, Sarah-Jo; Thomas, James] Univ Lethbridge, Lethbridge, AB, Canada	University of Lethbridge	Reuter, T (corresponding author), Alberta Agr & Forestry, Lethbridge, AB, Canada.	tim.reuter@gov.ab.ca	Reuter, Tim/AAA-6443-2020	Reuter, Tim/0000-0002-0593-3163; Stanford, Kim/0000-0001-8784-0042	Growing Forward 2 grant, TR [9037070]	Growing Forward 2 grant, TR	This work was supported by the Growing Forward 2 grant, TR, 9037070. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FED REG; Baker CA, 2016, FOOD CONTROL, V59, P407, DOI 10.1016/j.foodcont.2015.06.011; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004; Brusa V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00171; CALLAWAY TR, 2013, AGR FOOD ANAL BACTER, V3, P39; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chui L, 2011, J CLIN MICROBIOL, V49, P4307, DOI 10.1128/JCM.05211-11; Cleary Thomas G, 2004, Semin Pediatr Infect Dis, V15, P260, DOI 10.1053/j.spid.2004.07.007; Conrad CC, 2014, J MICROBIOL METH, V105, P22, DOI 10.1016/j.mimet.2014.06.020; Dewsbury DM, 2015, FOODBORNE PATHOG DIS, V12, P726, DOI 10.1089/fpd.2015.1987; Dong HJ, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0169-x; Ekong PS, 2015, PREV VET MED, V121, P74, DOI 10.1016/j.prevetmed.2015.06.019; Fernandez D, 2010, LETT APPL MICROBIOL, V51, P377, DOI 10.1111/j.1472-765X.2010.02904.x; Fernandez D, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00009; Gannon VPJ, 2002, EPIDEMIOL INFECT, V129, P163, DOI 10.1017/S0950268802007100; Heiman KE, 2015, EMERG INFECT DIS, V21, P1293, DOI 10.3201/eid2108.141364; Kanki M, 2011, LETT APPL MICROBIOL, V53, P167, DOI 10.1111/j.1472-765X.2011.03085.x; Karch H, 1999, DIAGN MICR INFEC DIS, V34, P229, DOI 10.1016/S0732-8893(99)00031-0; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Karmali MA, 2017, CLIN INFECT DIS, V64, P371, DOI 10.1093/cid/ciw708; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Khalil RKS, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw037; Lindsey RL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00766; Maheux AF, 2009, WATER RES, V43, P3019, DOI 10.1016/j.watres.2009.04.017; Martin A, 2011, INT J FOOD MICROBIOL, V146, P99, DOI 10.1016/j.ijfoodmicro.2011.01.041; Masana MO, 2011, J FOOD PROTECT, V74, P2008, DOI 10.4315/0362-028X.JFP-11-189; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Mcpherson AS, 2015, EPIDEMIOL INFECT, V143, P2733, DOI 10.1017/S0950268815000011; Miko A, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00078; Munns KD, 2014, FOODBORNE PATHOG DIS, V11, P329, DOI 10.1089/fpd.2013.1621; Murphy BP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01850; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Pearce MC, 2006, APPL ENVIRON MICROB, V72, P653, DOI 10.1128/AEM.72.1.653-659.2006; Rahal EA, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00024; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Sodha SV, 2015, EPIDEMIOL INFECT, V143, P267, DOI 10.1017/S0950268814000880; Soysal N, 2016, EMERG INFECT DIS, V22, P1604, DOI 10.3201/eid2209.160304; Stanford K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159866; Stanford K, 2014, FOODBORNE PATHOG DIS, V11, P379, DOI 10.1089/fpd.2013.1693; Tahamtan Y, 2010, IRAN J MICROBIOL, V2, P9; Tanaro JD, 2012, FOODBORNE PATHOG DIS, V9, P878, DOI 10.1089/fpd.2012.1182; Venegas-Vargas C, 2016, APPL ENVIRON MICROB, V82, P5049, DOI 10.1128/AEM.00829-16; Verhaegen B, 2016, TOXINS, V8, DOI 10.3390/toxins8050157; Vimont A, 2007, VET MICROBIOL, V123, P274, DOI 10.1016/j.vetmic.2007.02.003; Yang R, 2017, AUST VET J, V95, P143, DOI 10.1111/avj.12572	46	7	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195880	10.1371/journal.pone.0195880	http://dx.doi.org/10.1371/journal.pone.0195880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649278	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900101
J	Petursson, HI; Kovacs, A; Mattsson, J; Bagge, RO				Petursson, Hafsteinn Ingi; Kovacs, Aniko; Mattsson, Jan; Bagge, Roger Olofsson			Evaluation of intraoperative touch imprint cytology on axillary sentinel lymph nodes in invasive breast carcinomas, a retrospective study of 1227 patients comparing sensitivity in the different tumor subtypes	PLOS ONE			English	Article							FROZEN-SECTION ANALYSIS; LOBULAR CARCINOMA; CANCER PATIENTS; METASTASES; DISSECTION; BIOPSY; TRIAL	Background Intraoperative evaluation of the axillary sentinel lymph node (SLN) in patients with breast carcinoma reduces the need of re-operations in cases where an axillary completion lymph node dissection (CLND) is indicated. Different methods have been used to determine the SLN status intraoperatively, e.g. frozen section histology (FS) and touch imprint cytology (TIC). The sensitivity of intraoperative TIC examination on SLN is not consistent between different studies and varies according to different tumor histologic subtypes, tumor size and the age of the patient. The aim of this study was to describe the specificity and sensitivity of TIC and to compare TIC sensitivity in the different histological subtypes of breast carcinoma. Methods A retrospective review was performed of 1227 consecutive clinically node negative breast cancer patients treated with sentinel lymph node biopsy (SLNB) with intraoperative TIC between the years 2003 and 2008. The SLN was bisected and stained using the May-Grun-wald-Giemsa method and immunocytochemically with the antibody MNF-116. Results The overall sensitivity of the TIC test was 68.6% and the specificity was 99.8%. There was no statistically significant difference between the detection of SLN metastases from ductal carcinoma versus lobular carcinoma. The sensitivity improved over the period of the study. Conclusion TIC is highly specific with an acceptable overall sensitivity. The sensitivity increased under the period of the study and it was higher in cases with larger size of the primary tumor. There was no difference in TIC sensitivity between the different histological subtypes.	[Petursson, Hafsteinn Ingi; Mattsson, Jan; Bagge, Roger Olofsson] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Surg,Inst Clin Sci, Gothenburg, Sweden; [Kovacs, Aniko] Sahlgrens Univ Hosp, Dept Clin Pathol & Genet, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital	Petursson, HI (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Surg,Inst Clin Sci, Gothenburg, Sweden.	hafsteinn.petursson@vgregion.se	Bagge, Roger Olofsson/H-3481-2019	Bagge, Roger Olofsson/0000-0001-5795-0355; Mattsson, Jan/0000-0002-2266-7629				Akay CL, 2017, BREAST J; Arlicot C, 2013, ANTICANCER RES, V33, P1045; Chen YZ, 2011, ONCOL LETT, V2, P277, DOI 10.3892/ol.2011.233; Creager AJ, 2004, ANN SURG, V239, P61, DOI 10.1097/01.sla.0000103072.34708.e3; Cserni G, 2001, AM SURGEON, V67, P86; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Howard-McNatt M, 2012, ANN SURG ONCOL, V19, P929, DOI 10.1245/s10434-011-2038-z; Lumachi F, 2012, ANTICANCER RES, V32, P3523; Nieweg OE, 2015, CANCER J, V21, P3, DOI 10.1097/PPO.0000000000000091; Nowikiewicz T, 2015, POL J PATHOL, V66, P22, DOI 10.5114/PJP.2015.51149; Petropoulou T, 2017, BREAST CANCER-TARGET, V9, P325, DOI 10.2147/BCTT.S130987; Teal CB, 2007, BREAST J, V13, P155, DOI 10.1111/j.1524-4741.2007.00392.x; Tian P, 2015, BRIT J SURG, V102, P1372, DOI 10.1002/bjs.9882; Wang YL, 2014, TUMOR BIOL, V35, P5741, DOI 10.1007/s13277-014-1761-z; Weaver DL, 2011, NEW ENGL J MED, V364, P412, DOI 10.1056/NEJMoa1008108	16	9	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195560	10.1371/journal.pone.0195560	http://dx.doi.org/10.1371/journal.pone.0195560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649327	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900056
J	Russell, B; Garmo, H; Beckmann, K; Stettin, P; Adolfsson, J; Van Hemelrijck, M				Russell, Beth; Garmo, Hans; Beckmann, Kerri; Stettin, Par; Adolfsson, Jan; Van Hemelrijck, Mieke			A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; COHORT PROFILE; ANTIBODIES; INFLAMMATION; REGISTER; DISEASES; SWEDEN	Objectives To investigate the association between lower urinary-tract infections, their associated antibiotics and the subsequent risk of developing PCa. Subjects/Patients (or materials) and methods Using data from the Swedish PCBaSe 3.0, we performed a matched case-control study (8762 cases and 43806 controls). Conditional logistic regression analysis was used to assess the association between lower urinary-tract infections, related antibiotics and PCa, whilst adjusting for civil status, education, Charlson Comorbidity Index and time between lower urinary-tract infection and PCa diagnosis. Results It was found that lower urinary-tract infections did not affect PCa risk, however, having a lower urinary-tract infection or a first antibiotic prescription 6-12 months before PCa were both associated with an increased risk of PCa (OR: 1.50, 95% CI: 1.23-1.82 and 1.96, 1.71-2.25, respectively), as compared to men without lower urinary-tract infections. Compared to men with no prescriptions for antibiotics, men who were prescribed >10 antibiotics, were 15% less likely to develop PCa (OR: 0.85, 95% CI: 0.78-0.91). Conclusion PCa was not found to be associated with diagnosis of a urinary-tract infection or frequency, but was positively associated with short time since diagnoses of lower urinary-tract infection or receiving prescriptions for antibiotics. These observations can likely be explained by detection bias, which highlights the importance of data on the diagnostic work-up when studying potential risk factors for PCa.	[Russell, Beth; Garmo, Hans; Beckmann, Kerri; Van Hemelrijck, Mieke] Kings Coll London, Div Canc Studies Translat Oncol & Urol Res TOUR, London, England; [Garmo, Hans] Reg Canc Ctr, Uppsala, Sweden; [Beckmann, Kerri] Univ South Australia, Ctr Populat Hlth Res, Adelaide, SA, Australia; [Stettin, Par] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Adolfsson, Jan] Karolinska Inst, CLINTEC Dept, Stockholm, Sweden	University of London; King's College London; University of South Australia; Uppsala University; Karolinska Institutet	Russell, B (corresponding author), Kings Coll London, Div Canc Studies Translat Oncol & Urol Res TOUR, London, England.	beth.russell@kcl.ac.uk		Van Hemelrijck, Mieke/0000-0002-7317-0858; Adolfsson, Jan/0000-0003-2992-1869; Russell, Beth/0000-0001-5640-8425; Beckmann, Kerri/0000-0002-9798-1479	Swedish Research Council for Working Life, Health, and Welfare [825-2012-5047]; Swedish Cancer Society [14-0570]; Cancer Society in Stockholm; Uppsala County council; National Institute for Health Research (NIHR); St Thomas' NHS Foundation Trust; King's College London	Swedish Research Council for Working Life, Health, and Welfare; Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Uppsala County council; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; King's College London	This work was supported by the Swedish Research Council for Working Life, Health, and Welfare (825-2012-5047), the Swedish Cancer Society (14-0570), the Cancer Society in Stockholm, and Uppsala County council. The research was also supported by the National Institute for Health Research (NIHR) BRC based at Guy's and St Thomas' NHS Foundation Trust and King's College London.	Anttila T, 2005, CANCER EPIDEM BIOMAR, V14, P385, DOI 10.1158/1055-9965.EPI-03-0325; Boehm K, 2016, WORLD J UROL, V34, P425, DOI 10.1007/s00345-015-1625-1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Davidsson S, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0074-9; Fan C-Y, 2017, PLOS ONE, V12; Hamoya T, 2017, J CLIN BIOCHEM NUTR, V60, P199, DOI 10.3164/jcbn.16-107; Jhamb M, 2007, CANCER CAUSE CONTROL, V18, P839, DOI 10.1007/s10552-007-9028-2; Korodi Z, 2005, CANCER EPIDEM BIOMAR, V14, P2952, DOI 10.1158/1055-9965.EPI-05-0602; Longhi C, 2016, NEW MICROBIOL, V39, P146; Masajtis-Zagajewska A, 2017, CLIN CHIM ACTA; NHS, 2017, ANT NHS CHOIC; Pelucchi C, 2006, EUR J CANCER PREV, V15, P254, DOI 10.1097/01.cej.0000198897.40303.d4; Severi G, 2010, BRIT J CANCER, V103, P411, DOI 10.1038/sj.bjc.6605757; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Stamm WE, 2002, AM J MED, V113, p1S; Sundaram S, 2017, J CLIN DIAGN RES, V11, pOC1, DOI 10.7860/JCDR/2017/24202.9333; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P939, DOI 10.1158/1055-9965.EPI-05-0781; Van Hemelrijck M, 2016, INT J EPIDEMIOL, V45, P73, DOI 10.1093/ije/dyv305; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195690	10.1371/journal.pone.0195690	http://dx.doi.org/10.1371/journal.pone.0195690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649268	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000429791900071
J	Silver, JD; Sutherland, MF; Johnston, FH; Lampugnani, ER; McCarthy, MA; Jacobs, SJ; Pezza, AB; Newbigin, EJ				Silver, Jeremy D.; Sutherland, Michael F.; Johnston, Fay H.; Lampugnani, Edwin R.; McCarthy, Michael A.; Jacobs, Stephanie J.; Pezza, Alexandre B.; Newbigin, Edward J.			Seasonal asthma in Melbourne, Australia, and some observations on the occurrence of thunderstorm asthma and its predictability	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; GRASS-POLLEN; CHILDHOOD ASTHMA; RISK-FACTORS; EPIDEMICS; AIR; EXACERBATIONS; VARIABILITY; CHILDREN; MODELS	We examine the seasonality of asthma-related hospital admissions in Melbourne, Australia, in particular the contribution and predictability of episodic thunderstorm asthma. Using a time-series ecological approach based on asthma admissions to Melbourne metropolitan hospitals, we identified seasonal peaks in asthma admissions that were centred in late February, June and mid-November. These peaks were most likely due to the return to school, winter viral infections and seasonal allergies, respectively. We performed non-linear statistical regression to predict daily admission rates as functions of the seasonal cycle, weather conditions, reported thunderstorms, pollen counts and air quality. Important predictor variables were the seasonal cycle and mean relative humidity in the preceding two weeks, with higher humidity associated with higher asthma admissions. Although various attempts were made to model asthma admissions, none of the models explained substantially more variation above that associated with the annual cycle. We also identified a list of high asthma admissions days (HAADs). Most HAADs fell in the late-February return-to-school peak and the November allergy peak, with the latter containing the greatest number of daily admissions. Many HAADs in the spring allergy peak may represent episodes of thunderstorm asthma, as they were associated with rainfall, thunderstorms, high ambient grass pollen levels and high humidity, a finding that suggests thunderstorm asthma is a recurrent phenomenon in Melbourne that occurs roughly once per five years. The rarity of thunderstorm asthma events makes prediction challenging, underscoring the importance of maintaining high standards of asthma management, both for patients and health professionals, especially during late spring and early summer.	[Silver, Jeremy D.] Univ Melbourne, Sch Earth Sci, Parkville, Vic, Australia; [Sutherland, Michael F.] Univ Melbourne, Inst Breathing & Sleep, Dept Med, Parkville, Vic, Australia; [Sutherland, Michael F.] Austin Hlth, Heidelberg, Vic, Australia; [Johnston, Fay H.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Lampugnani, Edwin R.; McCarthy, Michael A.; Newbigin, Edward J.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Jacobs, Stephanie J.] Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic, Australia; [Pezza, Alexandre B.] Greater Wellington Reg Council, Wellington, New Zealand; [Pezza, Alexandre B.] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand	University of Melbourne; Institute for Breathing & Sleep (IBAS); University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Tasmania; Menzies Institute for Medical Research; University of Melbourne; Monash University; Victoria University Wellington	Silver, JD (corresponding author), Univ Melbourne, Sch Earth Sci, Parkville, Vic, Australia.	jeremy.silver@unimelb.edu.au	Silver, Jeremy/Y-4174-2019; Lampugnani, Edwin/AAF-4238-2019; McCarthy, Michael/O-5655-2014	Silver, Jeremy/0000-0003-1502-6249; Lampugnani, Edwin/0000-0002-3666-7240; McCarthy, Michael/0000-0003-1039-7980; Johnston, Fay Helena/0000-0002-5150-8678	University of Melbourne; ARC [FT100100923]	University of Melbourne(University of Melbourne); ARC(Australian Research Council)	JD Silver's work was funded by the MacKenzie Postdoctoral Fellowship scheme of the University of Melbourne: https://research.unimelb.edu.au/support/funding/internal/mckenzie-fellowship. GPATS lightning data was purchased with fund from ARC Future Fellowship FT100100923 awarded to MA McCarthy (http://www.arc.gov.au/future-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2013, GREATER CAPITAL CITY; ABS, 2014, AUSTRALIAN HISTORICA; ABS, 2017, COMMUNITY PROFILES; ABS, 2016, ESTIMATED RESIDENT P; AMS. Thunderstorm, 2012, GLOSSARY OF METEOROL; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; BELLOMO R, 1992, MED J AUSTRALIA, V156, P834, DOI 10.5694/j.1326-5377.1992.tb136994.x; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; Bunn R, 2016, LIGHTNING STROKE COU; Chen CH, 2006, J ASTHMA, V43, P287, DOI 10.1080/02770900600622935; Cohen HA, 2014, PEDIATRICS, V133, pE923, DOI 10.1542/peds.2013-2022; D'Amato G, 2005, CLIN EXP ALLERGY, V35, P1113, DOI 10.1111/j.1365-2222.2005.02328.x; Dabrera G, 2013, QJM-INT J MED, V106, P207, DOI 10.1093/qjmed/hcs234; de Morton J, 2011, INT J BIOMETEOROL, V55, P613, DOI 10.1007/s00484-010-0361-x; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; EGAN P, 1985, MED J AUSTRALIA, V142, P330, DOI 10.5694/j.1326-5377.1985.tb113389.x; Eggo RM, 2016, P NATL ACAD SCI USA, V113, P2194, DOI 10.1073/pnas.1518677113; Erbas B, 2012, CLIN EXP ALLERGY, V42, P799, DOI 10.1111/j.1365-2222.2012.03995.x; Erbas B, 2014, WEEKLY POLLEN COUNT, DOI [10.4227/05/5344E4980DAF6, DOI 10.4227/05/5344E4980DAF6]; Graham B, 2016, ASTHMA REGISTER; Grundstein A, 2009, GEOGR COMPASS, V3, P45, DOI 10.1111/j.1749-8198.2008.00195.x; Haberle SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097925; Hamill TM, 2006, Q J ROY METEOR SOC, V132, P2905, DOI 10.1256/qj.06.25; Hekking PPW, 2014, J ALLER CL IMM-PRACT, V2, P671, DOI 10.1016/j.jaip.2014.09.007; Hoch H, 2015, B27 VIRAL INFECT PED, pA2639; Howden ML, 2011, MED J AUSTRALIA, V195, P512, DOI 10.5694/mja11.11044; IGEM, 2017, FINAL REPORT; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Kappos AD, 2004, INT J HYG ENVIR HEAL, V207, P399, DOI 10.1078/1438-4639-00306; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim KH, 2013, ENVIRON INT, V59, P41, DOI 10.1016/j.envint.2013.05.007; KNOX RB, 1993, CLIN EXP ALLERGY, V23, P354, DOI 10.1111/j.1365-2222.1993.tb00339.x; Kuleshov Y, 2002, AUST METEOROL MAG, V51, P145; Lincoln D, 2006, PUBLIC HEALTH, V120, P854, DOI 10.1016/j.puhe.2006.05.015; Lindstrom SJ, 2017, MED J AUSTRALIA, V207, P235, DOI 10.5694/mja17.00285; Marks GB, 2001, THORAX, V56, P468, DOI 10.1136/thorax.56.6.468; MCEVOY RJ, 1992, MED J AUSTRALIA, V157, P352, DOI 10.5694/j.1326-5377.1992.tb137214.x; Nasser SM, 2009, CURR ALLERGY ASTHM R, V9, P384, DOI 10.1007/s11882-009-0056-8; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Ong E. K., 1995, Aerobiologia, V11, P51, DOI 10.1007/BF02136145; Qiu H, 2015, SCI TOTAL ENVIRON, V505, P508, DOI 10.1016/j.scitotenv.2014.10.003; R Core Team, 2015, R A LANGUAGE AND ENV; REED BC, 1994, J VEG SCI, V5, P703, DOI 10.2307/3235884; Rice MB, 2015, AM J RESP CRIT CARE, V191, P501, DOI 10.1164/rccm.201411-1976ED; Sabariego S, 2000, INT J BIOMETEOROL, V44, P1, DOI 10.1007/s004840050131; Schaefer JT., 1986, WEA FORECASTING, V1, P164, DOI [10.1175/1520-0434(1986)0012.0.CO;2, DOI 10.1175/1520-0434(1986)001, 2.0.co;2]; Silverman RA, 2003, ANN EMERG MED, V42, P577, DOI 10.1067/S0196-0644(03)00410-4; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; Sofiev M, 2013, ALLERGENIC POLLEN A; Soyiri IN, 2013, CHRON RESP DIS, V10, P85, DOI 10.1177/1479972313482847; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V135, P1465, DOI 10.1016/j.jaci.2014.12.1942; Tham R., 2016, J ALLERGY CLIN IMMUN; University of Wyoming, 2016, ATMOSPHERIC SOUNDING; Victorian Department of Health and Human Services, 2017, EPIDEMIC THUNDERSTOR; Wisniewski JA, 2016, ALLERGY ASTHMA PROC, V37, P475, DOI 10.2500/aap.2016.37.3994; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102475	58	39	39	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194929	10.1371/journal.pone.0194929	http://dx.doi.org/10.1371/journal.pone.0194929			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649224	Green Accepted, Green Published, gold			2022-12-27	WOS:000429791900019
J	Soukupova, J; Zemankova, P; Lhotova, K; Janatova, M; Borecka, M; Stolarova, L; Lhota, F; Foretova, L; Machackova, E; Stranecky, V; Tavandzis, S; Kleiblova, P; Vocka, M; Hartmannova, H; Hodanova, K; Kmoch, S; Kleibl, Z				Soukupova, Jana; Zemankova, Petra; Lhotova, Klara; Janatova, Marketa; Borecka, Marianna; Stolarova, Lenka; Lhota, Filip; Foretova, Lenka; Machackova, Eva; Stranecky, Viktor; Tavandzis, Spiros; Kleiblova, Petra; Vocka, Michal; Hartmannova, Hana; Hodanova, Katerina; Kmoch, Stanislav; Kleibl, Zdenek			Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes	PLOS ONE			English	Article							BREAST-CANCER; GENETIC-VARIANTS; BRCA1 GENE; PREDISPOSITION GENES; SEQUENCE VARIATION; COLORECTAL-CANCER; MEDICAL GENETICS; AMERICAN-COLLEGE; HIGH PROPORTION; OVARIAN-CANCER	Background Carriers of mutations in hereditary cancer predisposition genes represent a small but clinically important subgroup of oncology patients. The identification of causal germline mutations determines follow-up management, treatment options and genetic counselling in patients' families. Targeted next-generation sequencing-based analyses using cancer-specific panels in high-risk individuals have been rapidly adopted by diagnostic laboratories. While the use of diagnosis-specific panels is straightforward in typical cases, individuals with unusual phenotypes from families with overlapping criteria require multiple panel testing. Moreover, narrow gene panels are limited by our currently incomplete knowledge about possible genetic dispositions. Methods We have designed a multi-gene panel called CZECANCA (CZEch CAncer paNel for Clinical Application) for a sequencing analysis of 219 cancer-susceptibility and candidate predisposition genes associated with frequent hereditary cancers. Results The bioanalytical and bioinformatics pipeline was validated on a set of internal and commercially available DNA controls showing high coverage uniformity, sensitivity, specificity and accuracy. The panel demonstrates a reliable detection of both single nucleotide and copy number variants. Inter-laboratory, intra- and inter-run replicates confirmed the robustness of our approach. Conclusion The objective of CZECANCA is a nationwide consolidation of cancer-predisposition genetic testing across various clinical indications with savings in costs, human labor and turnaround time. Moreover, the unified diagnostics will enable the integration and analysis of genotypes with associated phenotypes in a national database improving the clinical interpretation of variants.	[Soukupova, Jana; Zemankova, Petra; Lhotova, Klara; Janatova, Marketa; Borecka, Marianna; Stolarova, Lenka; Lhota, Filip; Kleiblova, Petra; Kleibl, Zdenek] Charles Univ Prague, Inst Biochem & Expt Oncol, Fac Med 1, Prague, Czech Republic; [Lhota, Filip] Gennet, Ctr Med Genet & Reprod Med, Prague, Czech Republic; [Foretova, Lenka; Machackova, Eva] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Stranecky, Viktor; Hartmannova, Hana; Hodanova, Katerina; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Res Unit Rare Dis, Prague, Czech Republic; [Stranecky, Viktor; Kleiblova, Petra; Vocka, Michal; Hartmannova, Hana; Hodanova, Katerina; Kmoch, Stanislav] Gen Univ Hosp Prague, Prague, Czech Republic; [Tavandzis, Spiros] AGEL Res & Training Inst, Dept Med Genet, AGEL Labs, Novy Jicin, Czech Republic; [Kleiblova, Petra] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Vocka, Michal] Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic	Charles University Prague; Masaryk Memorial Cancer Institute; Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague	Soukupova, J; Kleibl, Z (corresponding author), Charles Univ Prague, Inst Biochem & Expt Oncol, Fac Med 1, Prague, Czech Republic.	jana.soukupova@lf1.cuni.cz; zdekleje@lf1.cuni.cz	Kleibl, Zdenek/A-2009-2008; Soukupová, Jana/ABI-2077-2020; Borecka, Marianna/K-5127-2016; Kleiblova, Petra/K-9899-2017; Stranecky, Viktor/I-8524-2017	Kleibl, Zdenek/0000-0003-2050-9667; Borecka, Marianna/0000-0001-6413-222X; Janatova, Marketa/0000-0003-2816-6769; Machackova, Eva/0000-0002-0246-1471; Soukupova, Jana/0000-0003-2413-1542; Foretova, Lenka/0000-0003-0494-2620; Kleiblova, Petra/0000-0002-4806-9854; Stranecky, Viktor/0000-0002-2599-6479; Zemankova, Petra/0000-0001-7315-1975	Ministry of Health [15-27695A, 15-28830A, 16-29959A]; DRO MMCI [00209805]; Charles University [PROGRES Q28/LF1, SVV2017/260367]; Ministry of Education, Youth and Sports [CZ.02.1.01/0.0/0.0/16_013/0001634]	Ministry of Health; DRO MMCI; Charles University; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the grants of Ministry of Health (www.mzcr.cz) 15-27695A (JS), 15-28830A (ZK), 16-29959A (ZK), and DRO MMCI, 00209805 (LF), grants of Charles University (www.cuni.cz) PROGRES Q28/LF1 (ZK), and SVV2017/260367 (SK) and Ministry of Education, Youth and Sports (www.msmt.cz) project CZ.02.1.01/0.0/0.0/16_013/0001634 (SK).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Azimi M, 2016, MOL GENET GENOM MED, V4, P292, DOI 10.1002/mgg3.204; Borecka M, 2016, CANCER GENET-NY, V209, P199, DOI 10.1016/j.cancergen.2016.03.003; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Das R, 2017, DNA REPAIR, V52, P92, DOI 10.1016/j.dnarep.2017.02.013; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Espenschied CR, 2017, J CLIN ONCOL, V35, P2568, DOI 10.1200/JCO.2016.71.9260; Feero WG, 2014, JAMA-J AM MED ASSOC, V311, P1017, DOI 10.1001/jama.2014.1718; Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968; Grindedal EM, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3422-2; Hardwick SA, 2017, NAT REV GENET, V18, P473, DOI 10.1038/nrg.2017.44; Havranek O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140819; Janatova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127711; Janatova M, 2013, CANCER EPIDEM BIOMAR, V22, P2323, DOI 10.1158/1055-9965.EPI-13-0745-T; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kleibl Z, 2009, NEOPLASMA, V56, P303, DOI 10.4149/neo_2009_04_303; Kleibl Z, 2009, EUR J CANCER, V45, P618, DOI 10.1016/j.ejca.2008.09.022; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Kulkarni A, 2016, BRIT MED BULL, V120, P123, DOI 10.1093/bmb/ldw046; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lhota F, 2016, CLIN GENET, V90, P324, DOI 10.1111/cge.12748; Machackova E, 2016, Klin Onkol, V29 Suppl 1, pS35; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Matthijs G, 2016, EUR J HUM GENET, V24, P2, DOI 10.1038/ejhg.2015.226; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moran O, 2017, BREAST CANCER RES TR, V161, P135, DOI 10.1007/s10549-016-4038-y; Pearlman R, 2017, JAMA ONCOL, V3, P464, DOI 10.1001/jamaoncol.2016.5194; Pohlreich P, 2005, BREAST CANCER RES, V7, pR728, DOI 10.1186/bcr1282; Pohlreich P, 2003, MED PRIN PRACT, V12, P23, DOI 10.1159/000068163; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rahman N, 2014, CLIN MED, V14, P436, DOI 10.7861/clinmedicine.14-4-436; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shah PD, 2017, ANNU REV GENOM HUM G, V18, P201, DOI 10.1146/annurev-genom-091416-035305; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Soukupova J, 2016, Klin Onkol, V29 Suppl 1, pS46; Soukupova J, 2008, ONCOL REP, V19, P1505; Stoffel EM, 2016, SEMIN ONCOL, V43, P527, DOI 10.1053/j.seminoncol.2016.09.003; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Ticha I, 2010, BREAST CANCER RES TR, V124, P337, DOI 10.1007/s10549-010-0745-y; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1	49	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195761	10.1371/journal.pone.0195761	http://dx.doi.org/10.1371/journal.pone.0195761			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649263	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900083
J	Wanat, JJ; Logsdon, GA; Driskill, JH; Deng, Z; Lieberman, PM; Johnson, FB				Wanat, Jennifer J.; Logsdon, Glennis A.; Driskill, Jordan H.; Deng, Zhong; Lieberman, Paul M.; Johnson, F. Brad			TERRA and the histone methyltransferase Dot1 cooperate to regulate senescence in budding yeast	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; CEREVISIAE CDC13-1 MUTANTS; DNA-DAMAGE RESPONSE; DOMAIN PROTEIN MPS3; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; TELOMERE-LENGTH; NUCLEAR PERIPHERY; H3K79 METHYLATION; GENE-EXPRESSION	The events underlying senescence induced by critical telomere shortening are not fully understood. Here we provide evidence that TERRA, a non-coding RNA transcribed from subtelomeres, contributes to senescence in yeast lacking telomerase (tlc1 Delta). Levels of TERRA expressed from multiple telomere ends appear elevated at senescence, and expression of an artificial RNA complementary to TERRA (anti-TERRA) binds TERRA in vivo and delays senescence. Anti-TERRA acts independently from several other mechanisms known to delay senescence, including those elicited by deletions of EXO1, TEL1, SAS2, and genes encoding RNase H enzymes. Further, it acts independently of the senescence delay provided by RAD52-dependent recombination. However, anti-TERRA delays senescence in a fashion epistatic to inactivation of the conserved histone methyltransferase Dot1. Dot1 associates with TERRA, and anti-TERRA disrupts this interaction in vitro and in vivo. Surprisingly, the anti-TERRA delay is independent of the C-terminal methyltransferase domain of Dot1 and instead requires only its N-terminus, which was previously found to facilitate release of telomeres from the nuclear periphery. Together, these data suggest that TERRA and Dot1 cooperate to drive senescence.	[Wanat, Jennifer J.; Logsdon, Glennis A.; Driskill, Jordan H.; Johnson, F. Brad] Univ Penn, Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wanat, Jennifer J.] Washington Coll, Dept Biol, Chestertown, MD USA; [Logsdon, Glennis A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Driskill, Jordan H.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX USA; [Deng, Zhong; Lieberman, Paul M.] Wistar Inst Anat & Biol, Gene Express & Regulat, 3601 Spruce St, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; The Wistar Institute	Johnson, FB (corresponding author), Univ Penn, Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA.	johnsonb@pennmedicine.upenn.edu		Driskill, Jordan/0000-0003-4319-3845; Logsdon, Glennis/0000-0003-2396-0656	Ellison/AFAR postdoctoral fellowship; Penn-PORT IRACDA Grant; UPenn Cell and Molecular Biology Training Grant [GM007229]; American Heart Association [11SDG5330017]; Roy and Diana Vagelos Scholars Program in the Molecular Life Sciences;  [R01 AG021521];  [P01 AG031862];  [R01 CA140652]; NATIONAL CANCER INSTITUTE [R01CA140652, R50CA221838] Funding Source: NIH RePORTER	Ellison/AFAR postdoctoral fellowship; Penn-PORT IRACDA Grant; UPenn Cell and Molecular Biology Training Grant; American Heart Association(American Heart Association); Roy and Diana Vagelos Scholars Program in the Molecular Life Sciences; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JJW was funded by an Ellison/AFAR postdoctoral fellowship and the Penn-PORT IRACDA Grant. FBJ, JJW, and JHD are funded by R01 AG021521 and P01 AG031862. JHD is also funded by the Roy and Diana Vagelos Scholars Program in the Molecular Life Sciences. GAL is funded by the UPenn Cell and Molecular Biology Training Grant (GM007229). PL is funded by R01 CA140652 and ZD was supported by an American Heart Association Grant (11SDG5330017).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bah A, 2012, NUCLEIC ACIDS RES, V40, P2995, DOI 10.1093/nar/gkr1153; Balk B, 2014, RNA BIOL, V11, P95, DOI 10.4161/rna.27798; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Batey RT, 2007, RNA, V13, P1384, DOI 10.1261/rna.528007; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Caslini C, 2009, MOL CELL BIOL, V29, P4519, DOI 10.1128/MCB.00195-09; Chu HP, 2017, CELL, V170, P86, DOI 10.1016/j.cell.2017.06.017; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Cusanelli E, 2013, MOL CELL, V51, P780, DOI 10.1016/j.molcel.2013.08.029; Dang W, 2014, CELL METAB, V19, P952, DOI 10.1016/j.cmet.2014.04.004; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Dunn B, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1313s23; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Fallet E, 2014, NUCLEIC ACIDS RES, V42, P3648, DOI 10.1093/nar/gkt1328; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Gartenberg MR, 2009, GENE DEV, V23, P1027, DOI 10.1101/gad.1805309; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Graf M, 2017, CELL, V170, P72, DOI 10.1016/j.cell.2017.06.006; Grandin N, 2005, BIOL CELL, V97, P799, DOI 10.1042/BC20040526; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Iglesias N, 2011, EMBO REP, V12, P587, DOI 10.1038/embor.2011.73; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jia XD, 2004, GENETICS, V166, P753, DOI 10.1534/genetics.166.2.753; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Kozak ML, 2010, EMBO J, V29, P158, DOI 10.1038/emboj.2009.314; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; Le S, 1999, GENETICS, V152, P143; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LOUIS EJ, 1990, GENETICS, V124, P533; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maicher A, 2012, NUCLEIC ACIDS RES, V40, P6649, DOI 10.1093/nar/gks358; Maringele L, 2004, GENETICS, V166, P1641, DOI 10.1534/genetics.166.4.1641; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nautiyal S, 2002, P NATL ACAD SCI USA, V99, P9316, DOI 10.1073/pnas.142162499; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Pfeiffer V, 2013, EMBO J, V32, P2861, DOI 10.1038/emboj.2013.217; Pfeiffer V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002747; Platt JM, 2013, GENE DEV, V27, P1406, DOI 10.1101/gad.218776.113; Raschenberger J, 2013, ATHEROSCLEROSIS, V229, P469, DOI 10.1016/j.atherosclerosis.2013.05.027; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Sagie S, 2014, HUM MOL GENET, V23, P3629, DOI 10.1093/hmg/ddu071; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SANDELL LL, 1994, P NATL ACAD SCI USA, V91, P12061, DOI 10.1073/pnas.91.25.12061; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Stulemeijer IJE, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-2; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Takahashi YH, 2011, MOL CELL, V42, P118, DOI 10.1016/j.molcel.2011.03.006; Teng SC, 1999, MOL CELL BIOL, V19, P8083; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Vrbsky J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000986; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu Z, 2013, GENETICS, V194, P847, DOI 10.1534/genetics.113.152322; Yehezkel S, 2008, HUM MOL GENET, V17, P2776, DOI 10.1093/hmg/ddn177; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	85	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195698	10.1371/journal.pone.0195698	http://dx.doi.org/10.1371/journal.pone.0195698			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649255	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900073
J	Gumbs, R; Gray, CL; Wearn, OR; Owen, NR				Gumbs, Rikki; Gray, Claudia L.; Wearn, Oliver R.; Owen, Nisha R.			Tetrapods on the EDGE: Overcoming data limitations to identify phylogenetic conservation priorities	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; EVOLUTIONARY DISTINCTIVENESS; POPULATION DECLINES; TAXONOMIC BIAS; THREAT STATUS; BIODIVERSITY; MADAGASCAR; ALLOCATION; LIKELIHOOD; PRIMATES	The scale of the ongoing biodiversity crisis requires both effective conservation prioritisation and urgent action. As extinction is non-random across the tree of life, it is important to prioritise threatened species which represent large amounts of evolutionary history. The EDGE metric prioritises species based on their Evolutionary Distinctiveness (ED), which measures the relative contribution of a species to the total evolutionary history of their taxonomic group, and Global Endangerment (GE), or extinction risk. EDGE prioritisations rely on adequate phylogenetic and extinction risk data to generate meaningful priorities for conservation. However, comprehensive phylogenetic trees of large taxonomic groups are extremely rare and, even when available, become quickly out-of-date due to the rapid rate of species descriptions and taxonomic revisions. Thus, it is important that conservationists can use the available data to incorporate evolutionary history into conservation prioritisation. We compared published and new methods to estimate missing ED scores for species absent from a phylogenetic tree whilst simultaneously correcting the ED scores of their close taxonomic relatives. We found that following artificial removal of species from a phylogenetic tree, the new method provided the closest estimates of their "true" ED score, differing from the true ED score by an average of less than 1%, compared to the 31% and 38% difference of the previous methods. The previous methods also substantially under- and over-estimated scores as more species were artificially removed from a phylogenetic tree. We therefore used the new method to estimate ED scores for all tetrapods. From these scores we updated EDGE prioritisation rankings for all tetrapod species with IUCN Red List assessments, including the first EDGE prioritisation for reptiles. Further, we identified criteria to identify robust priority species in an effort to further inform conservation action whilst limiting uncertainty and anticipating future phylogenetic advances.	[Gumbs, Rikki] Imperial Coll London, Sci & Solut Changing Planet DTP, Silwood Pk Campus, Ascot, Berks, England; [Gumbs, Rikki] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England; [Gumbs, Rikki; Gray, Claudia L.; Wearn, Oliver R.; Owen, Nisha R.] Zool Soc London, EDGE Existence Programme, Regents Pk, London, England; [Wearn, Oliver R.] Zool Soc London, Inst Zool, Regents Pk, London, England	Imperial College London; Imperial College London; Zoological Society of London; Zoological Society of London	Gumbs, R (corresponding author), Imperial Coll London, Sci & Solut Changing Planet DTP, Silwood Pk Campus, Ascot, Berks, England.; Gumbs, R (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England.; Gumbs, R (corresponding author), Zool Soc London, EDGE Existence Programme, Regents Pk, London, England.	r.gumbs@imperial.ac.uk		Wearn, Oliver/0000-0001-8258-3534	Natural Environment Research Council Science and Solutions [NE/L002515/1]; Zoological Society of London; Natural Environment Research Council [1823139] Funding Source: researchfish	Natural Environment Research Council Science and Solutions; Zoological Society of London; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	RG is funded by the Natural Environment Research Council Science and Solutions for a Changing Planet Doctoral Training Programme (grant number NE/L002515/1), the CASE component of which is funded by the Zoological Society of London - https://www.imperial.ac.uk/grantham/education/science-and-solutions-for-achanging-planet-dtp/. The Zoological Society of London paid the salary of NRO, ORW and CLG during the time period of the study - https://www.zsl.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beastall C, 2016, BIRD CONSERV INT, V26, P137, DOI 10.1017/S0959270916000010; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BirdLife, 2017, BIRDLIFE TAX CHECKL; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chavanich S, 2015, ZOOLOGY, V118, P132, DOI 10.1016/j.zool.2015.01.002; Clark JA, 2002, SCIENCE, V297, P191; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Collar N.J., 2015, BirdingASIA, V24, P12; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Curnick DJ, 2015, ANIM CONSERV, V18, P303, DOI 10.1111/acv.12185; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dickman AJ, 2015, CONSERV BIOL, V29, P854, DOI 10.1111/cobi.12494; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FAITH DP, 2015, PHILOS T R SOC B, V370, DOI DOI 10.1098/RSTB.2014.0011; Faurby S, 2015, MOL PHYLOGENET EVOL, V84, P14, DOI 10.1016/j.ympev.2014.11.001; Frishkoff LO, 2014, SCIENCE, V345, P1343, DOI 10.1126/science.1254610; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Guillon JM, 2012, CONTRIB ZOOL, V81, P147, DOI 10.1163/18759866-08103002; Harrison CJ, 2006, PLANT J, V45, P561, DOI 10.1111/j.1365-313X.2005.02611.x; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hotaling S, 2016, MOL ECOL, V25, P2029, DOI 10.1111/mec.13604; Huang S, 2015, EVOLUTION, V69, P621, DOI 10.1111/evo.12611; Iqbal Muhammad, 2015, BirdingASIA, V24, P132; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jaffe AL, 2011, BIOL LETTERS, V7, P558, DOI 10.1098/rsbl.2010.1084; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Li BBV, 2016, CONSERV BIOL, V30, P329, DOI 10.1111/cobi.12618; Lips KR, 2005, BIOTROPICA, V37, P222, DOI 10.1111/j.1744-7429.2005.00029.x; Magnuson-Ford K, 2009, BIOL CONSERV, V142, P1787, DOI 10.1016/j.biocon.2009.03.020; Marin J, 2016, J BIOGEOGR, V43, P1069, DOI 10.1111/jbi.12709; Marshall AJ, 2016, FRONT ECOL ENVIRON, V14, P13, DOI 10.1002/14-0195.1; Mazel F, 2018, BIORXIV, DOI DOI 10.1101/243923; Meiri S, 2016, BIOL CONSERV, V204, P6, DOI 10.1016/j.biocon.2016.03.009; Mouillot D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10359; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nunes LA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0004; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Pearse WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126524; Poole C, 2003, CONSERV BIOL, V17, P661, DOI [10.1046/j.1523-1739.2003.01740.x, DOI 10.1046/J.1523-1739.2003.01740.X]; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Rabosky DL, 2015, EVOLUTION, V69, P3207, DOI 10.1111/evo.12817; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Redding DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141435; Redding DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113490; Redding DW, 2010, CONSERV BIOL, V24, P1052, DOI 10.1111/j.1523-1739.2010.01532.x; Rosauer D, 2009, MOL ECOL, V18, P4061, DOI 10.1111/j.1365-294X.2009.04311.x; Rowley JJL, 2013, ZOOTAXA, V 3737, P415, DOI 10.11646/zootaxa.3737.4.5; Safi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063582; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Secretariat of the Convention on Biological Diversity, 2006, GLOB BIOD OUTL 2; Seddon PJ, 2005, ANIM CONSERV, V8, P51, DOI 10.1017/S1367943004001799; Shirley MH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2483; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Stattersfield A, 1998, ENDEMIC BIRDS WORLD; Steel M, 2000, MOL BIOL EVOL, V17, P839, DOI 10.1093/oxfordjournals.molbev.a026364; Steel M, 2007, EVOL BIOINFORM, V3, P237; Stein RW, 2018, NAT ECOL EVOL, V2, P288, DOI 10.1038/s41559-017-0448-4; Swenson NG, 2014, ECOGRAPHY, V37, P105, DOI 10.1111/j.1600-0587.2013.00528.x; Tapley B, 2018, BIOL CONSERV, V220, P209, DOI 10.1016/j.biocon.2018.01.022; Thomas GH, 2013, METHODS ECOL EVOL, V4, P1011, DOI 10.1111/2041-210X.12117; Tonini JFR, 2016, BIOL CONSERV, V204, P23, DOI 10.1016/j.biocon.2016.03.039; van Balen S., 2011, BIRD CONSERV INT, V23, P91; VANDIJK PP, 2014, CHELONIAN RES MONOGR, V5, P329, DOI DOI 10.3854/CRM.5.000.CHECKLIST.V7.2014; Veron S, 2017, BIOL REV, V92, P271, DOI 10.1111/brv.12228; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Whitfield SM, 2016, COPEIA, V104, P351, DOI 10.1643/CH-15-300; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; Yoder AD, 2000, P NATL ACAD SCI USA, V97, P11325, DOI 10.1073/pnas.200121897; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	86	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194680	10.1371/journal.pone.0194680	http://dx.doi.org/10.1371/journal.pone.0194680			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641585	Green Submitted, gold, Green Published			2022-12-27	WOS:000429742900039
J	Lopez-Perez, B; Deeprose, C; Hanoch, Y				Lopez-Perez, Belen; Deeprose, Catherine; Hanoch, Yaniv			Prospective mental imagery as its link with anxiety and depression in prisoners (vol 13, e0191551, 2018)	PLOS ONE			English	Correction																		Lopez-Perez B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191551	1	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195929	10.1371/journal.pone.0195929	http://dx.doi.org/10.1371/journal.pone.0195929			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641574	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900099
J	Provenzani, R; Tarvainen, I; Brandoli, G; Lempinen, A; Artes, S; Turku, A; Jantti, MH; Talman, V; Yli-Kauhaluoma, J; Tuominen, RK; af Gennas, GB				Provenzani, Riccardo; Tarvainen, Ilari; Brandoli, Giulia; Lempinen, Antti; Artes, Sanna; Turku, Ainoleena; Jantti, Maria Helena; Talman, Virpi; Yli-Kauhaluoma, Jari; Tuominen, Raimo K.; af Gennas, Gustav Boije			Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase C	PLOS ONE			English	Article							PHORBOL ESTER RECEPTORS; BIOLOGICAL-ACTIVITY; DIACYLGLYCEROL DAG; CHEMICAL SPACE; PKC-ALPHA; DESIGN; SELECTIVITY; LIGAND; RASGRP; DERIVATIVES	Protein kinase C (PKC) isoforms play a pivotal role in the regulation of numerous cellular functions, making them extensively studied and highly attractive drug targets. Utilizing the crystal structure of the PKC delta C1B domain, we have developed hydrophobic isophthalic acid derivatives that modify PKC functions by binding to the C1 domain of the enzyme. In the present study, we aimed to improve the drug-like properties of the isophthalic acid derivatives by increasing their solubility and enhancing the binding affinity. Here we describe the design and synthesis of a series of multisubstituted pyrimidines as analogs of C1 domain - targeted isophthalates and characterize their binding affinities to the PKC alpha isoform. In contrast to our computational predictions, the scaffold hopping from phenyl to pyrimidine core diminished the binding affinity. Although the novel pyrimidines did not establish improved binding affinity for PKC alpha compared to our previous isophthalic acid derivatives, the present results provide useful structure-activity relationship data for further development of ligands targeted to the C1 domain of PKC.	[Provenzani, Riccardo; Brandoli, Giulia; Lempinen, Antti; Artes, Sanna; Turku, Ainoleena; Yli-Kauhaluoma, Jari; af Gennas, Gustav Boije] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Drug Res Program, Helsinki, Finland; [Tarvainen, Ilari; Jantti, Maria Helena; Talman, Virpi; Tuominen, Raimo K.] Univ Helsinki, Fac Pharm, Div Pharmacol & Pharmacotherapy, Drug Res Program, Helsinki, Finland	University of Helsinki; University of Helsinki	Yli-Kauhaluoma, J (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Drug Res Program, Helsinki, Finland.	jari.yli-kauhaluoma@helsinki.fi	Talman, Virpi/AAP-5146-2020; Provenzani, Riccardo/C-9940-2014; Boije af Gennas, Gustav/N-4545-2015	Provenzani, Riccardo/0000-0002-6780-1924; Turku, Ainoleena/0000-0003-0959-7221; Tarvainen, Ilari/0000-0003-3386-465X; Talman, Virpi/0000-0002-2702-6505; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Boije af Gennas, Gustav/0000-0002-0099-6085	Finnish Cultural Foundation; Jane and Aatos Erkko Foundation [4703673]; Academy of Finland [305533]; Finnish Foundation for Cardiovascular Research	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research	This work was supported by Finnish Cultural Foundation, RP, www.skr.fi; Magnus Ehrnrooth Foundation, RP, https://www.magnusehrnroothinsaatio.fi/; Jane and Aatos Erkko Foundation, RKT, 4703673, http://jaes.fi/; Academy of Finland, GBG, 305533, www.aka.fi; and Finnish Foundation for Cardiovascular Research, VT, http//www.sydantutkimussaatio.fi.	af Gennas GB, 2011, CURR TOP MED CHEM, V11, P1370, DOI 10.2174/156802611795589584; af Gennas GB, 2009, J MED CHEM, V52, P3969, DOI 10.1021/jm900229p; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Anderson ED, 2014, ORG LETT, V16, P5084, DOI 10.1021/ol502436n; ARECES LB, 1994, J BIOL CHEM, V269, P19553; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; DRIEDGER PE, 1980, P NATL ACAD SCI-BIOL, V77, P567, DOI 10.1073/pnas.77.1.567; Duerfeldt AS, 2014, J AM CHEM SOC, V136, P2119, DOI 10.1021/ja412298c; Elhalem E, 2017, BIOORGAN MED CHEM, V25, P2971, DOI 10.1016/j.bmc.2017.03.022; Garcia LC, 2014, BIOORGAN MED CHEM, V22, P3123, DOI 10.1016/j.bmc.2014.04.024; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Glide S, 2016, SCHRODINGER RELEASE; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; GOPALAKRISHNA R, 1992, ANAL BIOCHEM, V206, P24, DOI 10.1016/S0003-2697(05)80006-5; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Irie K, 2005, CHEM REC, V5, P185, DOI 10.1002/tcr.20044; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Larsson J, 2005, J NAT PROD, V68, P985, DOI 10.1021/np049655u; Larsson J, 2007, J NAT PROD, V70, P789, DOI 10.1021/np070002y; Lee J, 1998, ARCH PHARM RES, V21, P452, DOI 10.1007/BF02974642; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Nacro K, 2000, J MED CHEM, V43, P921, DOI 10.1021/jm9904607; Ohashi N, 2017, BIOCONJUGATE CHEM, V28, P2135, DOI 10.1021/acs.bioconjchem.7b00299; OTSUKA M, 1985, CHEM PHARM BULL, V33, P515; Pettit GR, 1996, J NAT PROD, V59, P286, DOI 10.1021/np960100b; Roffey J, 2009, CURR OPIN CELL BIOL, V21, P268, DOI 10.1016/j.ceb.2009.01.019; Rosen J, 2009, J COMPUT AID MOL DES, V23, P253, DOI 10.1007/s10822-008-9255-y; Shao L, 2001, J MED CHEM, V44, P3872, DOI 10.1021/jm010258f; Sigano DM, 2003, J MED CHEM, V46, P1571, DOI 10.1021/jm020476o; Talman V, 2014, BIOCHEM SOC T, V42, P1543, DOI 10.1042/BST20140181; Talman V, 2014, EUR J PHARM SCI, V55, P46, DOI 10.1016/j.ejps.2014.01.002; Talman V, 2013, PHARMACOL RES, V73, P44, DOI 10.1016/j.phrs.2013.04.008; Talman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020053; Tammela P, 2004, DRUG DEVELOP RES, V63, P76, DOI 10.1002/ddr.10399; Wender PA, 2008, ORG LETT, V10, P3331, DOI 10.1021/ol801235h; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	40	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195668	10.1371/journal.pone.0195668	http://dx.doi.org/10.1371/journal.pone.0195668			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641588	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900083
J	Pruksaphon, K; Intaramat, A; Ratanabanangkoon, K; Nosanchuk, JD; Vanittanakom, N; Youngchim, S				Pruksaphon, Kritsada; Intaramat, Akarin; Ratanabanangkoon, Kavi; Nosanchuk, Joshua D.; Vanittanakom, Nongnuch; Youngchim, Sirida			Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; MONOCLONAL-ANTIBODIES; URINARY ANTIGEN; SOUTHEAST-ASIA; IMMUNODEFICIENCY; IDENTIFICATION; ASSAY; SERODIAGNOSIS; QUANTITATION; SERUM	Talaromyces (Penicillium) marneffei is a thermally dimorphic fungus that can cause opportunistic systemic mycoses in patients infected with the human immunodeficiency virus (HIV). It has also been reported among patients with other causes of immunodeficiency, such as systemic lupus erythematosus, cancer, organ transplanted patients receiving immunosuppressive drug and adult onset immunodeficiency syndromes. Recent studies indicate that the clinical manifestations, laboratory findings and treatment strategies of talaromycosis (penicilliosis) marneffei are different between patients with and without HIV infection. Therefore early and accurate diagnosis of talaromycosis marneffei is crucial to the proper management and treatment. Since current diagnostic methods are currently inadequate, the aim of this study was to develop an immunochromatographic test (ICT) for the detection of T. marneffei yeast antigens in urine samples. The highly T. marneffei-specific monoclonal antibody 4D1 (MAb 4D1) conjugated with gold colloid at pH 6.5 was used as signal generator. The nitrocellulose membrane was lined with T. marneffei cytoplasmic yeast antigen (TM CYA) to serve as the test line, and rabbit anti-mouse IgG was the control line. Subjecting the assembled test strip to urine samples containing T. marneffei antigen produced a visible result within 20 minutes. The sensitivity limit of the assay was 3.125 mu g/ ml of TM CYA. The ICT was used to test urine samples from 66 patients with blood culture confirmed talaromycosis marneffei, 42 patients with other fungal or bacterial infections, and 70 normal healthy individuals from endemic area of T. marneffei. The test exhibited sensitivity, specificity and accuracy of 87.87%, 100% and 95.5%, respectively. This rapid, user-friendly test holds great promise for the serodiagnosis of T. marneffei infection.	[Pruksaphon, Kritsada; Vanittanakom, Nongnuch; Youngchim, Sirida] Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai, Thailand; [Intaramat, Akarin; Ratanabanangkoon, Kavi] Chulabhorn Res Inst, Lab Immunol, Bangkok, Thailand; [Intaramat, Akarin; Ratanabanangkoon, Kavi] Chulabhorn Grad Inst, Bangkok, Thailand; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Med Infect Dis, Bronx, NY 10467 USA; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10467 USA; [Ratanabanangkoon, Kavi] Mahidol Univ, Dept Microbiol, Fac Sci, Bangkok, Thailand	Chiang Mai University; Chulabhorn Research Institute; Chulabhorn Graduate Institute; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Mahidol University	Youngchim, S (corresponding author), Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai, Thailand.	syoungchim@gmail.com	Pruksaphon, Kritsada/AAZ-6487-2020; Nosanchuk, Joshua/AAS-7801-2021	Pruksaphon, Kritsada/0000-0002-1391-7163; youngchim, sirida/0000-0001-9013-0543	National Research University Project under Thailand's Office of the Higher Education Commission; Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Chulabhorn Research Institute, Thailand [CRI 474/2552]	National Research University Project under Thailand's Office of the Higher Education Commission; Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Chulabhorn Research Institute, Thailand	This work was supported by the National Research University Project under Thailand's Office of the Higher Education Commission for financial support, The Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand (SY); Chulabhorn Research Institute, Thailand Grant number CRI 474/2552 (Al).	Aybay C, 2000, J IMMUNOL METHODS, V233, P77, DOI 10.1016/S0022-1759(99)00195-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Chaiyaroj SC, 2003, J CLIN MICROBIOL, V41, P432, DOI 10.1128/JCM.41.1.432-434.2003; Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.18; Chan JFW, 2015, EMERG INFECT DIS, V21, P1101, DOI 10.3201/eid2107.150138; DENG ZL, 1988, REV INFECT DIS, V10, P640; Desakorn V, 1999, J CLIN MICROBIOL, V37, P117, DOI 10.1128/JCM.37.1.117-121.1999; Desakorn V, 2002, J CLIN MICROBIOL, V40, P3179, DOI 10.1128/JCM.40.9.3179-3183.2002; Drouhet E., 1993, Journal de Mycologie Medicale, V3, P195; Duong TA, 1996, CLIN INFECT DIS, V23, P125, DOI 10.1093/clinids/23.1.125; ESTRADA JA, 1992, INT J DERMATOL, V31, P410, DOI 10.1111/j.1365-4362.1992.tb02670.x; Hearn VM, 1997, FUNGAL DIS; Hien TV, 2001, CLIN INFECT DIS, V32, pE78, DOI 10.1086/318703; Intaramat A, 2016, MED MYCOL, V54, P641, DOI 10.1093/mmy/myw018; Jeavons L, 1998, J CLIN MICROBIOL, V36, P949, DOI 10.1128/JCM.36.4.949-954.1998; Kawila R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-464; Kozel Thomas R, 2012, Expert Opin Med Diagn, V6, P245, DOI 10.1517/17530059.2012.681300; Mabey D, 2001, SEX TRANSM INFECT, V77, P397, DOI 10.1136/sti.77.6.397; Panichakul T, 2002, AM J TROP MED HYG, V67, P443, DOI 10.4269/ajtmh.2002.67.443; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Prakit K, 2016, EUR J CLIN MICROBIOL, V35, P647, DOI 10.1007/s10096-016-2583-2; Rafferty K., 2002, Mycoses, V45, P49; Rafferty K., 2004, THESIS; Ranjana KH, 2002, J INFECTION, V45, P268, DOI 10.1053/jinf.2002.1062; SUPPARATPINYO K, 1994, LANCET, V344, P110, DOI 10.1016/S0140-6736(94)91287-4; Trewatcharegon S, 2000, MED MYCOL, V38, P91, DOI 10.1080/mmy.38.1.91.96; Tse E, 2015, ANN HEMATOL, V94, P165, DOI 10.1007/s00277-014-2120-2; TSUI WMS, 1992, HISTOPATHOLOGY, V20, P287, DOI 10.1111/j.1365-2559.1992.tb00985.x; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Vanittanakom Nongnuch, 1997, Current Topics in Medical Mycology, V8, P35; Viviani AM, 1998, TOPLEY WILSONS MICRO, P409; Wong SSY, 1999, J MED MICROBIOL, V48, P973, DOI 10.1099/00222615-48-11-973; Wong SSY, 2001, J CLIN MICROBIOL, V39, P4535, DOI 10.1128/JCM.39.12.4535-4540.2001; YUEN KY, 1994, LANCET, V344, P444, DOI 10.1016/S0140-6736(94)91771-X	35	15	19	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195596	10.1371/journal.pone.0195596	http://dx.doi.org/10.1371/journal.pone.0195596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641620	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900076
J	Zhang, Q; Xiong, Y; Ye, JX; Zhang, LY; Li, L				Zhang, Qian; Xiong, Yao; Ye, Jiaxiang; Zhang, Liying; Li, Li			Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis	PLOS ONE			English	Review							GYNECOLOGIC-ONCOLOGY-GROUP; UTERINE CERVIX; NEUROENDOCRINE CARCINOMA; RADIATION-THERAPY; STAGE; MULTICENTER; MANAGEMENT; DIAGNOSIS; FEATURES	Small cell carcinoma of the cervix (SCCC) is a rare primary neuroendocrine cervical carcinoma with a high degree of invasiveness. SCCC is prone to early-stage lymph node and distant metastases and characterized by a poor prognosis. Currently, there is no standard treatment. This study aimed to evaluate the clinicopathological factors and treatment models that influence SCCC prognosis through a systematic review and meta-analysis, to improve the diagnosis and treatment of SCCC. A comprehensive search was performed in multiple medical literature databases to retrieve studies on the clinical prognosis of SCCC published in China and abroad as of March 1, 2017. Twenty cohort studies with 1904 patients were analyzed. Meta-analysis showed statistical significance for the following factors: FIGO staging (hazard ratio [HR] = 2.63, 95% confidence interval [CI]: 2.13-3.24; odds ratio [OR] = 3.72, 95% CI: 2.46-5.62), tumor size (HR = 1.64, 95% CI: 1.25-2.15), parametrial involvement (HR = 2.40, 95% CI: 1.43-4.05), resection margin (HR = 4.09, 95% CI: 2.27-7.39), lymph node metastasis (OR = 2.09, 95% CI: 1.18-3.71), depth of stromal invasion (HR = 1.99, 95% CI: 1.33-2.97), neoadjuvant chemotherapy (HR = 2.06, 95% CI: 1.14-3.73), and adjuvant chemotherapy (HR = 1.63, 95% CI: 1.26-2.12; OR = 1.48, 95% CI: 1.02-2.16). FIGO staging, tumor size, parametrial involvement, resection margin, depth of stromal invasion, and lymph node metastasis can be used as clinicopathological characteristics for the prediction of SCCC prognosis. Neoadjuvant chemotherapy tended to improve prognosis. Our findings suggest that neoadjuvant chemotherapy plus adjuvant chemotherapy may be the preferred strategy. However, adjuvant radiotherapy appeared to cause no significant improvement in prognosis. Therefore, the clinical application of radiotherapy and the relationship between radiotherapy and clinicopathological factors need to be re-examined. The results of this study should be validated and developed in formal, well-designed multicenter clinical trials.	[Zhang, Qian; Zhang, Liying; Li, Li] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China; [Xiong, Yao; Ye, Jiaxiang] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Med Oncol, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University	Li, L (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China.	lili@gxmu.edu.cn			National Natural Science Foundation of China [81572579, 81660430]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81572579, No. 81660430). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boruta DM, 2001, GYNECOL ONCOL, V81, P82, DOI 10.1006/gyno.2000.6118; Burzawa J, 2015, EXPERT REV ANTICANC, V15, P805, DOI 10.1586/14737140.2015.1047767; Chan JK, 2003, CANCER, V97, P568, DOI 10.1002/cncr.11086; Chen J, 2008, OBSTET GYNECOL, V111, P1394, DOI 10.1097/AOG.0b013e318173570b; Chen TC, 2015, GYNECOL ONCOL, V137, P468, DOI 10.1016/j.ygyno.2015.03.015; Cohen JG, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.019; Frumovitz M, 2017, GYNECOL ONCOL, V144, P46, DOI 10.1016/j.ygyno.2016.10.040; Gadducci A, 2017, GYNECOL ONCOL, V144, P637, DOI 10.1016/j.ygyno.2016.12.003; Huang CY, 2009, ONCOL RES, V18, P279, DOI 10.3727/096504009X12598720314212; Intaraphet S, 2014, INT J GYNECOL CANCER, V24, P272, DOI 10.1097/IGC.0000000000000059; Kuji S, 2013, GYNECOL ONCOL, V129, P522, DOI 10.1016/j.ygyno.2013.02.025; Lan-Fang L, 2012, EUR J GYNAECOL ONCOL, V33, P68; Lee JM, 2008, ANN ONCOL, V19, P321, DOI 10.1093/annonc/mdm465; Lee SW, 2010, INT J GYNECOL CANCER, V20, P411, DOI 10.1111/IGC.0b013e3181ce427b; Lee SW, 2015, GYNECOL OBSTET INVES, V79, P172, DOI 10.1159/000367920; Li Hu, 2008, Journal of Practical Oncology, V23, P536; Li JD, 2011, J CLIN PATHOL, V64, P1102, DOI 10.1136/jclinpath-2011-200274; Li RG, 2015, CHINA MOD MED, V9, P107; Li X., 2015, GEOENVIRONMENTAL DIS, V2, P22, DOI DOI 10.1186/S40677-015-0029-2; Liao LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033674; Liu XL, 2015, J PRACT MED, V31, P3560, DOI [10.3969/j.issn.1006-5725.2015.21.032, DOI 10.3969/J.ISSN.1006-5725.2015.21.032]; Nasu K, 2011, RARE TUMORS, V3, P18, DOI 10.4081/rt.2011.e6; Ruiz MP, 2016, INT J GYNECOL CANCER, V26, P1290, DOI 10.1097/IGC.0000000000000759; SHEETS EE, 1988, OBSTET GYNECOL, V71, P10; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tsunoda S, 2005, INT J GYNECOL CANCER, V15, P295, DOI 10.1111/j.1525-1438.2005.15219.x; Wang KL, 2012, EUR J CANCER, V48, P1484, DOI 10.1016/j.ejca.2011.12.014; Wang L, 2015, J PRACT CANC, V30, P263; Xia M, 2016, CHIN J MOD OPERA SUR, V20, P129, DOI [10.1620/j.cnki.1009-2188.2016.02.014, DOI 10.1620/J.CNKI.1009-2188.2016.02.014]; Xie SX, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006361; Yin ZM, 2009, J ONCOL, V15, P756; Yuan L, 2015, INT J GYNECOL CANCER, V25, P1315, DOI 10.1097/IGC.0000000000000496; [袁馨 Yuan Xin], 2017, [实用妇产科杂志, Journal of Practical Obstetrics and Gynecology], V33, P281; Zhou J, 2017, ONCOTARGET, V8, P40425, DOI 10.18632/oncotarget.16390; Zhou J, 2016, CANCER MED-US, V5, P1108, DOI 10.1002/cam4.687; 龙再秋, 2012, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V28, P539	36	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0192784	10.1371/journal.pone.0192784	http://dx.doi.org/10.1371/journal.pone.0192784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641578	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900007
J	Hwang, SG; Hong, JK; Sharma, A; Pollack, GH; Bahng, G				Hwang, Seong G.; Hong, Jun Ki; Sharma, Abha; Pollack, Gerald H.; Bahng, GunWoong			Exclusion zone and heterogeneous water structure at ambient temperature	PLOS ONE			English	Article							LIQUID WATER	Earlier studies have reported the formation of an exclusion zone devoid of microspheres at the interface of water with a hydrophilic surface such as Nafion or the hydrophilic ceramic powder. We now report the formation of a 'three-dimensional cell-like structured exclusion zone' in water prepared by two different methods. In the first, the hydrophilic powder was agitated with deionized water and allowed to rest (contact method). Subsequently, the 'powder -supernatant water' was collected and termed 'contact water'. In the second method, deionized water in a closed container was kept in the close vicinity of the hydrophilic powder for an extended time-period and it was termed 'non-contact water'. The two kinds of waters were tested by standard methods for various physical properties. In addition, we carried out cryogenic scanning-electron microscopy of frozen samples of the two kinds of water. The powder-supernatant water showed a cell-like heterogeneous ice structure with the high density exclusion-zone water forming the walls of a cell-like structure. A similar cell-like ice structure was formed for water treated with the hydrophilic powder in a non-contact manner; the unit cell size depended on the 'degree of structure' in the water. When highly structured, the unit cell size was smaller with a concurrently enhanced dielectric constant and reduced redox potential. It was found that the electrical properties are more sensitive to the change in water structure compared to other physical properties such as surface tension, density, and specific heat. Based on our findings of an electric potential difference between the heterogeneous structured water and the ordinary water, we propose a new model to explain the relationship between heterogeneous, structured water and its electrical properties.	[Hwang, Seong G.] Hankyong Natl Univ, Dept Anim Life & Environm Sci, Anseong, South Korea; [Hong, Jun Ki] Ctr Excellence Wireless & Informat Technol, Incheon, South Korea; [Sharma, Abha; Pollack, Gerald H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Bahng, GunWoong] State Univ New York Korea, Dept Mech Engn, Incheon, South Korea	Hankyong National University; University of Washington; University of Washington Seattle	Bahng, G (corresponding author), State Univ New York Korea, Dept Mech Engn, Incheon, South Korea.	gwbahng@sunykorea.ac.kr			Quantum energy Co. Ltd. through SUNY Korea;  [2014-RD-01]	Quantum energy Co. Ltd. through SUNY Korea; 	This research work was conducted by a grant from the Quantum energy Co. Ltd. through SUNY Korea to GWB. The grant number is 2014-RD-01. The URL of the company is http://www.quantumenergy.co.kr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder supplied only the hydrophillic ceramic materials used in this research work.	Bahng GW, 2014, TEXT RES J, V84, P1220, DOI 10.1177/0040517513503732; Ball P, 2017, P NATL ACAD SCI USA, V114, P13327, DOI 10.1073/pnas.1703781114; Chai BH, 2010, J PHYS CHEM B, V114, P5371, DOI 10.1021/jp100200y; Chai BH, 2009, J PHYS CHEM B, V113, P13953, DOI 10.1021/jp908163w; Chen CS, 2012, J BIOL PHYS, V38, P113, DOI 10.1007/s10867-011-9237-5; Clark GNI, 2010, MOL PHYS, V108, P1415, DOI 10.1080/00268971003762134; Delgado AV, 2005, PURE APPL CHEM, V77, P1753, DOI 10.1351/pac200577101753; Despa F, 2005, ANN NY ACAD SCI, V1066, P1, DOI 10.1196/annals.1363.023; Dixit S, 2002, NATURE, V416, P829, DOI 10.1038/416829a; FALK M, 1966, CAN J CHEMISTRY, V44, P1699, DOI 10.1139/v66-255; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Hwang Seong Gu, 2017, Int J Cell Biol, V2017, P1917239, DOI 10.1155/2017/1917239; Lee JD, 2012, Korean Patent, Patent No. [10 1172018, 101172018]; Leung T. K., 2014, Hydrology: Current Research, V5, P174; Leung TK, 2012, J CHIN CHEM SOC-TAIP, V59, P589, DOI 10.1002/jccs.201100491; Mallamace F, 2009, P NATL ACAD SCI USA, V106, P15097, DOI 10.1073/pnas.0908198106; Nilsson A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9998; Palmer JC, 2014, NATURE, V510, P385, DOI 10.1038/nature13405; Pollack G.H., 2006, WATER CELL, P165, DOI DOI 10.1007/1-4020-4927-7_8; Pollack G.H., 2013, 4 PHASE WATER; Santana-Blank L, 2013, PHOTOMED LASER SURG, V31, P461, DOI 10.1089/pho.2013.3583; Sharma A, 2017, ADV MATER SCI ENG, V2017, DOI 10.1155/2017/2410794; Shimokawa S, 2004, JPN J APPL PHYS 2, V43, pL545, DOI 10.1143/JJAP.43.L545; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; Tokushima T, 2008, CHEM PHYS LETT, V460, P387, DOI 10.1016/j.cplett.2008.04.077; Vatansever Fatma, 2012, Photonics Lasers Med, V4, P255; Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205; Zhao Q, 2009, J PHYS CHEM B, V113, P10708, DOI 10.1021/jp9021568; Zheng JM, 2006, ADV COLLOID INTERFAC, V127, P19, DOI 10.1016/j.cis.2006.07.002	30	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195057	10.1371/journal.pone.0195057	http://dx.doi.org/10.1371/journal.pone.0195057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668733	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200023
J	Rylova, SN; Stoykow, C; Del Pozzo, L; Abiraj, K; Tamma, ML; Kiefer, Y; Fani, M; Maecke, HR				Rylova, Svetlana N.; Stoykow, Christian; Del Pozzo, Luigi; Abiraj, Keelara; Tamma, Maria Luisa; Kiefer, Yvonne; Fani, Melpomeni; Maecke, Helmut R.			The somatostatin receptor 2 antagonist Cu-64-NODAGA-JR11 outperforms Cu-64-DOTA-TATE in a mouse xenograft model	PLOS ONE			English	Article							COPPER RADIOPHARMACEUTICALS; NEUROENDOCRINE TUMORS; IN-VIVO; RADIONUCLIDE THERAPY; PET; AGONIST; CU-64; INTERNALIZATION; CHELATORS; ANALOGS	Copper-64 is an attractive radionuclide for PET imaging and is frequently used in clinical applications. The aim of this study was to perform a side-by-side comparison of the in vitro and in vivo performance of Cu-64-NODAGA-JR11 (NODAGA = 1,4,7-triazacyclononane,1-glutaric acid,4,7-acetic acid, JR11 = p-Cl-Phe-cyclo(D-Cys-Aph(Hor)-D-Aph(cbm)-Lys-Thr-Cys)D-Tyr-NH2), a somatostatin receptor 2 antagonist, with the clinically used sst2 agonist Cu-64-DOTA-TATE ((TATE = D-Phe-cyclo(Cys-Tyr-D-Trp-Lys-Thr-Cys)Thr). In vitro studies demonstrated K-d values of 5.7 +/- 0.95 nM (Bmax = 4.1 +/- 0.18 nM) for the antagonist Cu-64/nat-NODAGA-JR11 and 20.1 +/- 4.4. nM (Bmax = 0.48 +/- 0.18 nM) for the agonist Cu-64/nat-DOTA-TATE. Cell uptake studies showed the expected differences between agonists and antagonists. Whereas Cu-64-DOTA-TATE (the agonist) showed very effective internalization in the cell culture assay (with 50% internalized at 4 hours post-peptide addition under the given experimental conditions), Cu-64-NODAGA-JR11 (the antagonist) showed little internalization but strong receptor-mediated uptake at the cell membrane. Biodistribution studies of Cu-64-NODAGA-JR11 showed rapid blood clearance and tumor uptake with increasing tumor-to-relevant organ ratios within the first 4 hours and in some cases, 24 hours, respectively. The tumor washout was slow or non-existent in the first 4 hours, whereas the kidney washout was very efficient, leading to high and increasing tumor-to-kidney ratios over time. Specificity of tumor uptake was proven by co-injection of high excess of non-radiolabeled peptide, which led to >80% tumor blocking. Cu-64-DOTA-TATE showed less favorable pharmacokinetics, with the exception of lower kidney uptake. Blood clearance was distinctly slower and persistent higher blood values were found at 24 hours. Uptake in the liver and lung was relatively high and also persistent. The tumor uptake was specific and similar to that of Cu-64-NODAGA-JR11 at 1 h, but release from the tumor was very fast, particularly between 4 and 24 hours. Tumor-to-normal organ ratios were distinctly lower after 1 hour. This is indicative of insufficient in vivo stability. PET studies of Cu-64-NODAGA-JR11 reflected the biodistribution data with nicely delineated tumor and low background. Cu-64-NODAGA-JR11 shows promising pharmacokinetic properties for further translation into the clinic.	[Rylova, Svetlana N.] German Canc Consortium DKTK, Heidelberg, Germany; [Rylova, Svetlana N.; Stoykow, Christian; Kiefer, Yvonne; Maecke, Helmut R.] Univ Freiburg, Dept Nucl Med, Med Ctr, Fac Med, Freiburg, Germany; [Rylova, Svetlana N.] German Canc Res Ctr, Heidelberg, Germany; [Del Pozzo, Luigi; Abiraj, Keelara; Tamma, Maria Luisa; Fani, Melpomeni] Univ Hosp Basel, Div Radiol Chem, Basel, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Basel	Maecke, HR (corresponding author), Univ Freiburg, Dept Nucl Med, Med Ctr, Fac Med, Freiburg, Germany.	helmut.maecke@uniklinik.freiberg.de		Fani, Melpomeni/0000-0002-9309-1604	German Consortium for Translational Cancer Research (DKTK)	German Consortium for Translational Cancer Research (DKTK)	This work was supported by the German Consortium for Translational Cancer Research (DKTK).; We thank the German Consortium for Translational Cancer Research (DKTK) for financial support, Prof. Schulz for providing the cell line and Wolfgang Weber for bringing up the idea of species difference to explain the obvious Cu(II)DOTA stability difference in mice and men.	Cescato R, 2008, J MED CHEM, V51, P4030, DOI 10.1021/jm701618q; Cooper MS, 2012, BIOCONJUGATE CHEM, V23, P1029, DOI 10.1021/bc300037w; de Jong M, 1998, CANCER RES, V58, P437; Deupi X, 2014, NAT CHEM, V6, P7, DOI 10.1038/nchem.1832; Duijzentkunst DAS, 2017, J NUCL MED, V58, p54S, DOI 10.2967/jnumed.117.191015; Fani M, 2012, J NUCL MED, V53, P1481, DOI 10.2967/jnumed.112.102764; Fani M, 2011, J NUCL MED, V52, P1110, DOI 10.2967/jnumed.111.087999; Ghosh SC, 2015, NUCL MED BIOL, V42, P177, DOI 10.1016/j.nucmedbio.2014.09.009; Ginj M, 2006, P NATL ACAD SCI USA, V103, P16436, DOI 10.1073/pnas.0607761103; Gotzmann C, 2016, RSC ADV, V6, P119, DOI 10.1039/c5ra21131j; Hao GY, 2011, CURR RADIOPHARM, V4, P109, DOI 10.2174/1874471011104020109; Hu LY, 2014, MOL IMAGING BIOL, V16, P567, DOI 10.1007/s11307-013-0717-9; Isokawa M, 2016, J CHROMATOGR B, V1019, P59, DOI 10.1016/j.jchromb.2015.11.038; Isokawa M, 2013, ANALYST, V138, P3802, DOI 10.1039/c3an00527e; Johnbeck CB, 2017, J NUCL MED, V58, P451, DOI 10.2967/jnumed.116.180430; Kunz PL, 2015, J CLIN ONCOL, V33, P1855, DOI 10.1200/JCO.2014.60.2532; Lappchen T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170435; Marciniak A, 2017, J RADIOANAL NUCL CH, V313, P279, DOI 10.1007/s10967-017-5323-x; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; Nicolas GP, 2017, J NUCL MED, Vpii, DOI [10.29679numed.117.199760, DOI 10.29679/JNUMED.117.199760]; Nicolas GP, 2018, J NUCL MED, V59, P909, DOI 10.2967/jnumed.117.199737; Nicolas GP, 2017, J NUCL MED, V58, P1435, DOI 10.2967/jnumed.117.191684; Paterson BM, 2014, DALTON T, V43, P1386, DOI 10.1039/c3dt52647j; Pfeifer A, 2015, J NUCL MED, V56, P847, DOI 10.2967/jnumed.115.156539; Reubi JC, 2017, J NUCL MED, V58, P300, DOI 10.2967/jnumed.116.177733; Shokeen M, 2011, MED CHEM, V7, P413, DOI 10.2174/157340611796799177; Shokeen M, 2009, ACCOUNTS CHEM RES, V42, P832, DOI 10.1021/ar800255q; Sprague JE, 2007, J MED CHEM, V50, P2527, DOI 10.1021/jm070204r; Storch D, 2005, J NUCL MED, V46, P1561; Wadas TJ, 2007, CURR PHARM DESIGN, V13, P3, DOI 10.2174/138161207779313768; Waser B, 2009, J NUCL MED, V50, P936, DOI 10.2967/jnumed.108.061457; Wild D, 2014, J NUCL MED, V55, P1248, DOI 10.2967/jnumed.114.138834; Wild D, 2011, J NUCL MED, V52, P1412, DOI 10.2967/jnumed.111.088922; Woodin KS, 2005, EUR J INORG CHEM, P4829, DOI 10.1002/ejic.200500579	34	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195802	10.1371/journal.pone.0195802	http://dx.doi.org/10.1371/journal.pone.0195802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668724	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200059
J	Scott, AB; Singh, M; Groves, P; Hernandez-Jover, M; Barnes, B; Glass, K; Moloney, B; Black, A; Toribio, JA				Scott, Angela Bullanday; Singh, Mini; Groves, Peter; Hernandez-Jover, Marta; Barnes, Belinda; Glass, Kathryn; Moloney, Barbara; Black, Amanda; Toribio, Jenny-Ann			Biosecurity practices on Australian commercial layer and meat chicken farms: Performance and perceptions of farmers	PLOS ONE			English	Article							AVIAN INFLUENZA; POULTRY FARMS; VIRUSES	This paper describes the level of adoption of biosecurity practices performed on Australian commercial chicken meat and layer farms and farmer-perceived importance of these practices. On-farm interviews were conducted on 25 free range layer farms, nine cage layer farms, nine barn layer farms, six free range meat chicken farms and 15 barn meat chicken farms in the Sydney basin bioregion and South East Queensland. There was a high level of treatment of drinking water across all farm types; town water was the most common source. In general, meat chicken farms had a higher level of adoption of biosecurity practices than layer farms. Cage layer farms had the shortest median distance between sheds (7.75m) and between sheds and waterbodies (30m). Equipment sharing between sheds was performed on 43% of free range meat chicken farms compared to 92% of free range layer farms. There was little disinfection of this shared equipment across all farm types. Footbaths and visitor recording books were used by the majority of farms for all farm types except cage layer farms (25%). Wild birds in sheds were most commonly reported in free range meat chicken farms (73%). Dogs and cats were kept across all farm types, from 56% of barn layer farms to 89% of cage layer farms, and they had access to the sheds in the majority (67%) of cage layer farms and on the range in some free range layer farms (44%). Most biosecurity practices were rated on average as 'very important' by farmers. A logistic regression analysis revealed that for most biosecurity practices, performing a practice was significantly associated with higher perceived farmer importance of that biosecurity practice. These findings help identify farm types and certain biosecurity practices with low adoption levels. This information can aid decision-making on efforts used to improve adoption levels.	[Scott, Angela Bullanday; Singh, Mini; Groves, Peter; Toribio, Jenny-Ann] Univ Sydney, Camden, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Wagga Wagga, NSW, Australia; [Barnes, Belinda] Dept Agr, Canberra, ACT, Australia; [Glass, Kathryn] Australian Natl Univ, Canberra, ACT, Australia; [Moloney, Barbara; Black, Amanda] New South Wales Dept Primary Ind, Sydney, NSW, Australia	University of Sydney; Charles Sturt University; Australian National University; NSW Department of Primary Industries	Scott, AB (corresponding author), Univ Sydney, Camden, NSW, Australia.	angela.scott@sydney.edu.au	Moloney, Barbara Jean/G-2003-2011; Singh, Mini/AAE-5906-2019; Hernandez-Jover, Marta/F-8688-2016; Toribio, Jenny-Ann LML/B-5032-2011	Moloney, Barbara Jean/0000-0002-4416-3579; Groves, Peter/0000-0002-8984-3156; Glass, Kathryn/0000-0001-5905-1310; Hernandez-Jover, Marta/0000-0001-8803-9062; Barnes, Belinda/0000-0003-3295-4063	CRC; Woolworths Limited; Poultry CRC; Poultry Cooperative Research Centre (CRC)	CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Woolworths Limited; Poultry CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Poultry Cooperative Research Centre (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was conducted within the Poultry Cooperative Research Centre (CRC) http://www.chhivken.org.au/page.php?id=26) that provided the majority of funding with support from the CRC and Woolworths Limited (http://www.woolworths.com.au/). The first author, ABS, is also a recipient of a Post-graduate Scholarship and stipend from the Poultry CRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors extend thanks to the egg and chicken meat companies and producers for their participation. This research was conducted within the Poultry Cooperative Research Centre (CRC) with support from the CRC and Woolworths Limited. The first author is also a recipient of a Post-graduate Scholarship from the Poultry CRC.	ACMF, 2011, AUSTR CHICK MEAT IND; AECL, 2015, AUSTR EGG CORP LTD A; AECL, 2015, AUSTR EGG IND OV DEC; Agnew-Crumpton R, 2016, INFECT GENET EVOL, V43, P67, DOI 10.1016/j.meegid.2016.05.023; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Andres VM, 2015, COMPR REV FOOD SCI F, V14, P317, DOI 10.1111/1541-4337.12137; Animal Health Australia (AHA), 2015, AUSVETPLAN 2015; Animal Health Australia (AHA), 2015, EM AN DIS 2015; Animal Health Australia (AHA) Plant Health Australia (PHA), 2013, FARM BIOS PROGR 2013; Animal Welfare, 2008, AN WELF COMM REP CON; [Anonymous], 2015, VET REC, V176, P505, DOI 10.1136/vr.h2582; Atzeni M, 2016, DETERRENCE WILD WATE; Barnes H, 2009, DIS POULTRY, P941; Beltrame MAV, 2012, VET PARASITOL, V188, P225, DOI 10.1016/j.vetpar.2012.03.053; Bommel Lv, 2014, PLOS ONE, V9; CFFR (Council on Federal Financial Relations), 2014, HIGH PATH AV INFL LA; DAFF (Department of Agriculture Fisheries and Forestry), 2009, NAT FARM BIOS MAN PO; Department of Agriculture Fisheries and Forestry (DAFF), 2009, NAT WAT BIOS MAN POU; East IJ, 2007, AUST VET J, V85, P107, DOI 10.1111/j.1751-0813.2007.00113.x; East IJ, 2008, GEOSPATIAL HEALTH, V3, P17, DOI 10.4081/gh.2008.228; Fasina FO, 2012, PREV VET MED, V103, P178, DOI 10.1016/j.prevetmed.2011.09.016; Food and Agriculture Organization of the United Nations (FAO), 2011, 5 REP JAN 2011 JAN 2; Grillo T, 2015, CONTRIBUTION 2012 AV; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Jonges M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125401; Lee DH, 2017, EMERG INFECT DIS, V23, P365, DOI 10.3201/eid2302.161616; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Mino MH, 2007, INT J PEST MANAGE, V53, P311, DOI 10.1080/09670870601105949; Morrison V., 2008, INTRO HLTH PSYCHOL A; Nespeca R, 1997, PREV VET MED, V31, P73, DOI 10.1016/S0167-5877(96)01122-1; Racicot M, 2012, PREV VET MED, V103, P201, DOI 10.1016/j.prevetmed.2011.08.011; Saif Y, 2009, DIS POULTRY; Scott AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188505; Scott P., 2009, STRUCTURE DYNAMICS A; Swayne D.E., 2008, AVIAN INFLUENZA; The Australian Chicken Meat Industry, 2013, AUSTR CHICK MEAT IND; VANSAMBEEK F, 1995, AVIAN DIS, V39, P145, DOI 10.2307/1591994	37	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195582	10.1371/journal.pone.0195582	http://dx.doi.org/10.1371/journal.pone.0195582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668707	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200049
J	Betiku, OC; Yeoman, CJ; Gaylord, TG; Americus, B; Olivo, S; Duff, GC; Seeley, WM				Betiku, Omolola C.; Yeoman, Carl J.; Gaylord, T. Gibson; Americus, Benjamin; Olivo, Sarah; Duff, Glenn C.; Seeley, Wendy M.			Water system is a controlling variable modulating bacterial diversity of gastrointestinal tract and performance in rainbow trout	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS WALBAUM; SALMO-SALAR L.; SALVELINUS-ALPINUS L.; FLAVOBACTERIUM-PSYCHROPHILUM; ATLANTIC SALMON; GUT MICROBIOTA; COLDWATER DISEASE; FRY SYNDROME; COHO SALMON; COD LARVAE	A two-phase feeding study evaluating performance of rainbow trout and comparing luminal and mucosal gastrointestinal tract (GIT) bacterial community compositions when fed two alternative protein diets in two rearing systems was conducted. Alternative protein diets (animal protein and plant protein diets) balanced with crystalline amino acids: lysine, methionine and threonine or unbalanced, were fed to rainbow trout in two separate water systems (recirculating (RR) and flow-through (FF)) for a period of 16 weeks. The four diets, each contained 38% digestible protein and 20% fats, were fed to rainbow trout with an average weight of 12.02 +/- 0.61 g, and sorted at 30 fish/tank and 12 tanks per dietary treatment. Phase 1 lasted for 8 weeks after which fish from each tank were randomly divided, with one-half moved to new tanks of the opposing system (i.e. from RR to FF and vice versa). The remaining halves were retained in their initial tank and system, and fed their original diets for another 8 weeks (phase 2). After the 16th week, 3 fish/tank were sampled for each of proximate analysis, body indexes and 16S rRNA analysis of GIT microbiota. Fish weight (P = 0.0008, P = 0.0030, P<0.0010) and body fat (P = 0.0008, P = 0.0041, P = 0.0177) were significantly affected by diet, diet quality (balanced or unbalanced) and system, respectively. Feed intake (P = 0.0008) and body energy (P<0.0010) were altered by system. Body indexes were not affected by dietary treatment and water systems. Compositional dissimilarities existed between samples from the rearing water and GIT locations (ANOSIM: (R = 0.29, P = 0.0010), PERMANOVA: R = 0.39, P = 0.0010), but not in dietary samples (ANOSIM: R = 0.004, P = 0.3140, PERMANOVA: R = 0.008, P = 0.4540). Bacteria were predominantly from the phyla Proteobacteria, Firmicutes and Bacteroidetes. Their abundance differed with more dissimilarity in the luminal samples (ANOSIM: R = 0.40, P = 0.0010, PERMANOVA: R = 0.56, P = 0.0010) than those from the mucosal intestine (ANOSIM: R = 0.37, P = 0.0010, PERMANOVA: R = 0.41, P = 0.0010). Bacteria generally associated with carbohydrate and certain amino acids metabolism were observed in the mucosal intestine while rearing water appeared to serve as the main route of colonization of Aeromonas and Acinetobacter in the rainbow trout.	[Betiku, Omolola C.; Gaylord, T. Gibson; Seeley, Wendy M.] US Fish & Wildlife Serv, Bozeman Fish Technol Ctr, Bozeman, MT 59715 USA; [Betiku, Omolola C.; Yeoman, Carl J.; Americus, Benjamin; Olivo, Sarah] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Duff, Glenn C.] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA	United States Department of the Interior; US Fish & Wildlife Service; Montana State University System; Montana State University Bozeman; New Mexico State University	Betiku, OC (corresponding author), US Fish & Wildlife Serv, Bozeman Fish Technol Ctr, Bozeman, MT 59715 USA.; Betiku, OC (corresponding author), Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA.	ocbetiku@gmail.com	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Betiku, Omolola/0000-0002-8325-8474; Gaylord, Gibson/0000-0003-3037-0451	Western Regional Aquaculture Center from the USDA-NIFA (PI: WMS) [2010-38500-13198, 2011-38500-14698, 2012-38500-15812, 2013-38500-17048]; USDA-NIFA [2014-67004-2163]; Montana Institute on Ecosystems award; Schlumberger Foundation	Western Regional Aquaculture Center from the USDA-NIFA (PI: WMS); USDA-NIFA(United States Department of Agriculture (USDA)); Montana Institute on Ecosystems award; Schlumberger Foundation(Schlumberger)	This study was funded by Western Regional Aquaculture Center through grant numbers 2010-38500-13198, 2011-38500-14698, 2012-38500-15812, and grant number 2013-38500-17048 from the USDA-NIFA (PI: WMS) as well as USDA-NIFA award 2014-67004-2163 (PI: CJY), a Montana Institute on Ecosystems award (PI: CJY). OCB gratefully acknowledges the fellowship and grant from Schlumberger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Western Regional Aquaculture Center through grant numbers 2010-38500-13198, 2011-38500-14698, 2012-38500-15812, and grant number 2013-38500-17048 from the USDA-NIFA (PI: WMS) as well as USDA-NIFA award 2014-67004-2163 (PI: CJY), a Montana Institute on Ecosystems award (PI: CJY). OCB gratefully acknowledges the fellowship and grant from Schlumberger Foundation. OCB thank Dr. Rick Barrows, Jason Frost and Carly Stone for their assistance in feed manufacturing. Also, the assistance of Matt Toner, and Jason Ilgen in sampling, and Zachariah B. Conley, Sam Sawicki with laboratory analyses are greatly appreciated by OCB.	Allendorf F.W., 1988, Conservation Biology, V2, P145, DOI 10.1111/j.1523-1739.1988.tb00165.x; [Anonymous], 2008, FRESHWATER FISHERY; Attramadal KJK, 2014, AQUACULTURE, V432, P483, DOI 10.1016/j.aquaculture.2014.05.052; Attramadal KJK, 2012, AQUACULT ENG, V46, P27, DOI 10.1016/j.aquaeng.2011.10.003; Bakke I, 2013, ENV MICROBIOL REP, V5, P537, DOI 10.1111/1758-2229.12042; Baldo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127462; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Betiku OC, 2017, FRONTIERS MICROBIOLO; Buddington RK, 1996, ACTA PHYSL SCANDIN S, V638, P67; Burr G, 2005, J WORLD AQUACULT SOC, V36, P425, DOI 10.1111/j.1749-7345.2005.tb00390.x; Chen W, 2016, AQUAC RES, V26, P831; Chen YC, 2008, J FISH DIS, V31, P765, DOI 10.1111/j.1365-2761.2008.00950.x; CHO CY, 1982, COMP BIOCHEM PHYS B, V73, P25, DOI 10.1016/0305-0491(82)90198-5; Clements Kendall D., 1997, P156; d'Orbcastel ER, 2009, AQUACULT ENG, V40, P113, DOI 10.1016/j.aquaeng.2008.12.002; DABROWSKI K, 1989, AQUACULTURE, V77, P29, DOI 10.1016/0044-8486(89)90019-7; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Gajardo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30893; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gaylord TG, 2009, AQUACULTURE, V287, P180, DOI 10.1016/j.aquaculture.2008.10.037; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hu X, 2014, FORESTS, V5, P455, DOI 10.3390/f5030455; Huber I, 2004, J APPL MICROBIOL, V96, P117, DOI 10.1046/j.1365-2672.2003.02109.x; Ingerslev HC, 2014, AQUACULTURE, V424, P24, DOI [10.1016/j.actuaculture.2013.12.032, 10.1016/j.aquaculture.2013.12.032]; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Krogdahl A, 2005, COMP BIOCHEM PHYS A, V141, P450, DOI 10.1016/j.cbpb.2005.06.002; LaFrentz BR, 2003, J FISH DIS, V26, P377, DOI 10.1046/j.1365-2761.2003.00468.x; Lee SH, 2008, FEMS MICROBIOL LETT, V285, P263, DOI 10.1111/j.1574-6968.2008.01232.x; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lorenzen E, 1997, DIS AQUAT ORGAN, V31, P197, DOI 10.3354/dao031197; Mahious AS, 2006, AQUACULT INT, V14, P219, DOI 10.1007/s10499-005-9003-4; Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x; Michaud L, 2006, AQUACULT ENG, V34, P224, DOI 10.1016/j.aquaeng.2005.07.005; Michaud L, 2009, J APPL MICROBIOL, V107, P1935, DOI 10.1111/j.1365-2672.2009.04378.x; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; NIETO TP, 1984, AQUACULTURE, V42, P193, DOI 10.1016/0044-8486(84)90100-5; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; Perez T, 2010, MUCOSAL IMMUNOLOGY, DOI [10.1038/mi.2010, DOI 10.1038/MI.2010]; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Ray AK, 2012, AQUACULT NUTR, V18, P465, DOI 10.1111/j.1365-2095.2012.00943.x; Refstie S, 1999, ANIM FEED SCI TECH, V79, P331, DOI 10.1016/S0377-8401(99)00026-7; Ringo E, 1999, J APPL MICROBIOL, V86, P22, DOI 10.1046/j.1365-2672.1999.00631.x; Ringo E, 2001, J APPL MICROBIOL, V90, P294, DOI 10.1046/j.1365-2672.2001.01246.x; Ringo E, 2016, AQUACULTURE NUTR; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; USDA, 2013, TROUT PROD; Venkat HK, 2004, AQUAC RES, V35, P501, DOI 10.1111/j.1365-2109.2004.01045.x; Wang AR, 2018, REV AQUACULT, V10, P626, DOI 10.1111/raq.12191; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833; Zarkasi KZ, 2014, J APPL MICROBIOL, V117, P18, DOI 10.1111/jam.12514; Zarkasi KZ, 2017, RES MICROBIOL, V168, P751, DOI 10.1016/j.resmic.2017.07.003; Ziaei-Nejad S, 2006, AQUACULTURE, V252, P516, DOI 10.1016/j.aquaculture.2005.07.021	58	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195967	10.1371/journal.pone.0195967	http://dx.doi.org/10.1371/journal.pone.0195967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664968	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300045
J	Chai, JH; Lee, CK; Lee, HK; Wong, N; Teo, K; Tan, CS; Thokala, P; Tang, JWT; Tambyah, PA; Sen Oh, VM; Loh, TP; Yoong, J				Chai, Jia Hui; Lee, Chun Kiat; Lee, Hong Kai; Wong, Nicholas; Teo, Kahwee; Tan, Chuen Seng; Thokala, Praveen; Tang, Julian Wei-Tze; Tambyah, Paul Anantharajah; Sen Oh, Vernon Min; Loh, Tze Ping; Yoong, Joanne			Cost-benefit analysis of introducing next-generation sequencing (metagenomic) pathogen testing in the setting of pyrexia of unknown origin	PLOS ONE			English	Article							PRETERM INFANTS; FEVER; IDENTIFICATION; INFECTIONS; SPECIMENS; DIAGNOSIS; DNA; ENCEPHALITIS; OUTBREAK; DIARRHEA	Pyrexia of unknown origin (PUO) is defined as a temperature of >38.3 degrees C that lasts for > 3 weeks, where no cause can be found despite appropriate investigation. Existing protocols for the work-up of PUO can be extensive and costly, motivating the application of recent advances in molecular diagnostics to pathogen testing. There have been many reports describing various analytical methods and performance of metagenomic pathogen testing in clinical samples but the economics of it has been less well studied. This study pragmatically evaluates the feasibility of introducing metagenomic testing in this setting by assessing the relative cost of clinically-relevant strategies employing this investigative tool under various cost and performance scenarios using Singapore as a demonstration case, and assessing the price and performance benchmarks, which would need to be achieved for metagenomic testing to be potentially considered financially viable relative to the current diagnostic standard. This study has some important limitations: we examined only impact of introducing the metagenomic test to the overall diagnostic cost and excluded costs associated with hospitalization and makes assumptions about the performance of the routine diagnostic tests, limiting the cost of metagenomic test, and the lack of further work-up after positive pathogen detection by the metagenomic test. However, these assumptions were necessary to keep the model within reasonable limits. In spite of these, the simplified presentation lends itself to the illustration of the key insights of our paper. In general, we find the use of metagenomic testing as second-line investigation is effectively dominated, and that use of metagenomic testing at first-line would typically require higher rates of detection or lower cost than currently available in order to be justifiable purely as a cost-saving measure. We conclude that current conditions do not warrant a widespread rush to deploy metagenomic testing to resolve any and all uncertainty, but rather as a front-line technology that should be used in specific contexts, as a supplement to rather than a replacement for careful clinical judgement.	[Chai, Jia Hui; Tan, Chuen Seng; Yoong, Joanne] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Lee, Chun Kiat; Lee, Hong Kai; Loh, Tze Ping] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Wong, Nicholas; Tang, Julian Wei-Tze] Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Leicester, Leics, England; [Teo, Kahwee] Univ Hosp Leicester NHS Trust, Dept Paediat, Leicester, Leics, England; [Thokala, Praveen] Univ Sheffield, Sch Hlth & Related Res, Hlth Econ & Decis Sci, Sheffield, S Yorkshire, England; [Tang, Julian Wei-Tze] Univ Leicester, Dept Infect Immun Inflammat, Leicester, Leics, England; [Tambyah, Paul Anantharajah; Sen Oh, Vernon Min] Natl Univ Singapore, Dept Med, Singapore, Singapore	National University of Singapore; National University of Singapore; University Hospitals of Leicester NHS Trust; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of Sheffield; University of Leicester; National University of Singapore	Loh, TP (corresponding author), Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.	tploh@hotmail.com	Teo, Kah Wee/AFY-5401-2022; Tan, Chuen Seng/K-1078-2013	Tan, Chuen Seng/0000-0002-6513-2309; Teo, Kah Wee/0000-0003-4986-171X; Loh, Tze Ping/0000-0002-4272-0001; Tang, Julian/0000-0002-4963-1028; Thokala, Praveen/0000-0003-4122-2366	Centre for Personalised and Precision Health (National University Health System)	Centre for Personalised and Precision Health (National University Health System)	This work was supported by the Pitch for Funds (2015) from the Centre for Personalised and Precision Health (National University Health System) to HKL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316; Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858; Chung Pei-Wen, 2001, Journal of Microbiology Immunology and Infection, V34, P167; Feigelman R, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0234-1; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Fukui Yuto, 2015, J Infect Chemother, V21, P882, DOI 10.1016/j.jiac.2015.08.007; Gao D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1363-2; Graf EH, 2016, J CLIN MICROBIOL, V54, P1000, DOI 10.1128/JCM.03060-15; Hasan MR, 2016, J CLIN MICROBIOL, V54, P919, DOI 10.1128/JCM.03050-15; Hayakawa K, 2012, AM J MED SCI, V344, P307, DOI 10.1097/MAJ.0b013e31824ae504; Hilton SK, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00484; Hoyle E, 2016, AM J INFECT CONTROL, V44, P602, DOI 10.1016/j.ajic.2015.11.032; Jalal H, 2005, J CLIN MICROBIOL, V43, P2575, DOI 10.1128/JCM.43.6.2575-2580.2005; Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13; Moore NE, 2015, J CLIN MICROBIOL, V53, P15, DOI 10.1128/JCM.02029-14; Mourad O, 2003, ARCH INTERN MED, V163, P545, DOI 10.1001/archinte.163.5.545; Mukhopadhya I, 2013, J MED VIROL, V85, P1661, DOI 10.1002/jmv.23641; Mulders-Manders C, 2015, CLIN MED, V15, P280, DOI 10.7861/clinmedicine.15-3-280; Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912; Nicastri E, 2016, EUROSURVEILLANCE, V11, P21; Roth AR, 2003, AM FAM PHYSICIAN, V68, P2223; Sauvage V, 2016, BLOOD TRANSFUS-ITALY, V14, P400, DOI 10.2450/2016.0160-15; Schlaberg R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/arpa.2016-0539-RA; Sorensen HT, 2005, LANCET ONCOL, V6, P851, DOI 10.1016/S1470-2045(05)70346-6; Teunis PFM, 2015, EPIDEMIOL INFECT, V143, P1710, DOI 10.1017/S095026881400274X; Thoendel M, 2016, J MICROBIOL METH, V127, P141, DOI 10.1016/j.mimet.2016.05.022; Doan T, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0344-6; Unger M, 2016, WIEN KLIN WOCHENSCHR, V128, P796, DOI 10.1007/s00508-016-1083-9; Vanderschueren S, 2003, ARCH INTERN MED, V163, P1033, DOI 10.1001/archinte.163.9.1033; Vochem M, 1998, PEDIATR INFECT DIS J, V17, P53, DOI 10.1097/00006454-199801000-00012; Ward DV, 2016, CELL REP, V14, P2912, DOI 10.1016/j.celrep.2016.03.015; Wilson MR, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14058; Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Zhou YF, 2016, AM J TROP MED HYG, V95, P663, DOI 10.4269/ajtmh.16-0062; Zhou YJ, 2016, J CLIN MICROBIOL, V54, P368, DOI 10.1128/JCM.01965-15	36	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194648	10.1371/journal.pone.0194648	http://dx.doi.org/10.1371/journal.pone.0194648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664913	Green Published, gold, Green Accepted			2022-12-27	WOS:000430262300009
J	Dangi, N; Lim, UT				Dangi, Naresh; Lim, Un Taek			Identification and evaluation of a new entomopathogenic fungal strain against Riptortus pedestris (Hemiptera: Alydidae) and its two egg parasitoids	PLOS ONE			English	Article							MARMORATED STINK BUG; BEAUVERIA-BASSIANA; BIOLOGICAL-CONTROL; HETEROPTERA; PATHOGENICITY; SUSCEPTIBILITY; METARHIZIUM; COLEOPTERA; SELECTION; VIRULENCE	A strain (ARP14) of the entomopathogenic fungus Beauveria bassiana (Balsamo) Vuillemin was isolated from field-collected Riptortus pedestris (Fabricius) (Hemiptera: Alydidae). The lethal median concentration of the ARP14 strain was compared with that of a commercialized strain (GHA) of the same fungus against R. pedestris and its two egg parasitoids, Ooencyrtus nezarae Ishii (Hymenoptera: Encyrtidae) and Gryon japonicum (Ashmead) (Hymenoptera: Platygastridae). Mortality and mycosis rates were evaluated after exposure to five concentrations of the fungus, i.e., 1x10(9), 1x10(8), 1x10(7), 1x10(6), and 1x10(5) conidia/mL, using a glass scintillation vial as an exposure arena in 25.0 +/- 0.5 degrees C and 93.7 +/- 2.9% RH. The lethal median concentrations (LC50) for 2 nd and 4 th instar nymphs, and adults of R. pedestris were not significantly different between the two strains of B. bassiana. However, the mycosis rate of ARP14 was 1.3 and 1.8 times higher than that of the GHA strain in 4 th instar nymphs and adult females of R. pedestris, respectively, at the 1x10(8) conidia/mL concentration. More interestingly, the mycosis rates at 1x10(8) conidia/mL concentration in the parasitoids G. japonicum and O. nezarae were much lower in the ARP14 strain (15.0 and 0%) than in the GHA strain (73.3 and 66.0%), respectively, suggesting that the B. bassiana strain ARP14 is less virulent to these parasitoids than the commercially available strain. Our results suggest that B. bassiana ARP14 may be a potential new biopesticide against R. pedestris with fewer negative effects on beneficial parasitoids than currently available options.	[Dangi, Naresh] Nepal Agr Res Council, Div Entomol, Khumaltar, Lalitpur, Nepal; [Lim, Un Taek] Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea; [Lim, Un Taek] Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea	Andong National University; Andong National University	Lim, UT (corresponding author), Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea.; Lim, UT (corresponding author), Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea.	utlim@andong.ac.kr	Dangi/AAY-2559-2020	Dangi, Naresh/0000-0002-9583-8855	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) - Ministry of Agriculture, Food, and Rural Affairs (MAFRA) [116089-03-1-HD030]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) - Ministry of Agriculture, Food, and Rural Affairs (MAFRA)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) through Agri-Bio Industry Technology Development Program, funded by Ministry of Agriculture, Food, and Rural Affairs (MAFRA) (116089-03-1-HD030) awarded to UTL.	Alim MA, 2010, J ASIA-PAC ENTOMOL, V13, P139, DOI 10.1016/j.aspen.2010.01.004; BALTENSWEILER W, 1986, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V59, P267; Barta Marek, 2010, Czech Mycology, V62, P67; Bidochka MJ, 1990, MELANOPLUS SANGUINIP, V56, P362; Chi MH, 2009, PLANT PATHOLOGY J, V25, P108, DOI 10.5423/PPJ.2009.25.1.108; Cottrell TE, 2003, J INVERTEBR PATHOL, V84, P137, DOI 10.1016/j.jip.2003.09.003; Dean KM, 2012, J INVERTEBR PATHOL, V109, P303, DOI 10.1016/j.jip.2011.12.004; Down RE, 2009, BIOL CONTROL, V50, P172, DOI 10.1016/j.biocontrol.2009.03.010; Ekesi S, 1999, MYCOPATHOLOGIA, V148, P131, DOI 10.1023/A:1007122622650; FERRON P, 1978, ANNU REV ENTOMOL, V23, P409, DOI 10.1146/annurev.en.23.010178.002205; Gao YL, 2012, BIOCONTROL SCI TECHN, V22, P491, DOI 10.1080/09583157.2012.662478; Godonou I, 2009, CROP PROT, V28, P220, DOI 10.1016/j.cropro.2008.10.009; Goettel Mark S., 1997, P213, DOI 10.1016/B978-012432555-5/50013-0; Gore J, 2006, ENVIRON ENTOMOL, V35, P531, DOI 10.1603/0046-225X-35.2.531; Gouli V, 2012, PEST MANAG SCI, V68, P155, DOI 10.1002/ps.2310; Hu WJ, 1996, APPL ENTOMOL ZOOL, V31, P187, DOI 10.1303/aez.31.187; Humber RA, 2008, J INVERTEBR PATHOL, V98, P262, DOI 10.1016/j.jip.2008.02.017; KCPA, 2017, AGR US GUID BOOK; Kikuhara Yusaku, 2005, Japanese Journal of Systematic Entomology, V11, P299; Kim E, 2014, J ECON ENTOMOL, V107, P1785, DOI 10.1603/EC14236; Lee HeungSu, 2009, Korean Journal of Applied Entomology, V48, P485; Leland JE, 2005, BIOL CONTROL, V35, P104, DOI 10.1016/j.biocontrol.2005.06.005; Leland JE, 2005, BIOCONTROL SCI TECHN, V15, P309, DOI 10.1080/09583150400016936; Lim Un Taek, 2013, Korean Journal of Applied Entomology, V52, P437, DOI 10.5656/KSAE.2013.08.0.038; Liu HP, 2002, J ECON ENTOMOL, V95, P675, DOI 10.1603/0022-0493-95.4.675; Lohmeyer KH, 2006, J ECON ENTOMOL, V99, P1943, DOI 10.1603/0022-0493-99.6.1943; Ludwig SW, 2001, J AGR URBAN ENTOMOL, V18, P169; Mascarin GM, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2131-3; McGuire MR, 2006, BIOL CONTROL, V38, P390, DOI 10.1016/j.biocontrol.2005.12.010; Parker BL, 2015, INSECTS, V6, P319, DOI 10.3390/insects6020319; Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003; Rahman MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176187; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Rehner SA, 2011, MYCOLOGIA, V103, P1055, DOI 10.3852/10-302; Rohde C, 2006, NEOTROP ENTOMOL, V35, P231, DOI 10.1590/S1519-566X2006000200012; ROMANA CA, 1992, MEM I OSWALDO CRUZ, V87, P363, DOI 10.1590/S0074-02761992000300005; SAS Institute, 1995, SAS WIND REL 6 11; Strasser H, 2000, BIOCONTROL SCI TECHN, V10, P717, DOI 10.1080/09583150020011690; SUN YP, 1950, J ECON ENTOMOL, V43, P45, DOI 10.1093/jee/43.1.45; Wang JP, 2012, MICROBIOL RES, V167, P116, DOI 10.1016/j.micres.2011.05.002; White TJ., 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhukovskaya Marianna, 2013, Insects, V4, P609, DOI 10.3390/insects4040609; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006	45	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195848	10.1371/journal.pone.0195848	http://dx.doi.org/10.1371/journal.pone.0195848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664929	Green Submitted, Green Published, gold			2022-12-27	WOS:000430262300037
J	Dessery, Y; Pallari, J				Dessery, Yoann; Pallari, Jari			Measurements agreement between low-cost and high-level handheld 3D scanners to scan the knee for designing a 3D printed knee brace (vol 13, e0190585, 2018)	PLOS ONE			English	Correction																		Dessery Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190585	1	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196183	10.1371/journal.pone.0196183	http://dx.doi.org/10.1371/journal.pone.0196183			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29665579	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300060
J	Hoang, T; Moskwa, N; Halvorsen, K				Hoang, Tony; Moskwa, Nicholas; Halvorsen, Ken			A 'smart' tube holder enables real-time sample monitoring in a standard lab centrifuge	PLOS ONE			English	Article							MICROSCOPE; RECOVERY	The centrifuge is among the oldest and most widely used pieces of laboratory equipment, with significant applications that include clinical diagnostics and biomedical research. A major limitation of laboratory centrifuges is their "black box" nature, limiting sample observation to before and after centrifugation. Thus, optimized protocols require significant trial and error, while unoptimized protocols waste time by centrifuging longer than necessary or material due to incomplete sedimentation. Here, we developed an instrumented centrifuge tube receptacle compatible with several commercial benchtop centrifuges that can provide real-time sample analysis during centrifugation. We demonstrated the system by monitoring cell separations during centrifugation for different spin speeds, concentrations, buffers, cell types, and temperatures. We show that the collected data are valuable for analytical purposes (e. g. quality control), or as feedback to the user or the instrument. For the latter, we verified an adaptation where complete sedimentation turned off the centrifuge and notified the user by a text message. Our system adds new functionality to existing laboratory centrifuges, saving users time and providing useful feedback. This add-on potentially enables new analytical applications for an instrument that has remained largely unchanged for decades.	[Hoang, Tony; Halvorsen, Ken] SUNY Albany, RNA Inst, Albany, NY 12222 USA; [Hoang, Tony] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Moskwa, Nicholas] SUNY Albany, Dept Biol, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Halvorsen, K (corresponding author), SUNY Albany, RNA Inst, Albany, NY 12222 USA.	khalvorsen@albany.edu		Moskwa, Nicholas/0000-0002-9819-9227; Halvorsen, Ken/0000-0002-2578-1339	NIH through NIGMS [R35GM124720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124720] Funding Source: NIH RePORTER	NIH through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the NIH through NIGMS under award number R35GM124720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoye GO, 2007, PARASITOL INT, V56, P308, DOI 10.1016/j.parint.2007.06.007; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Baker F.J., 1976, INTRO MED LAB TECHNO; Birnie G. D., 1978, CENTRIFUGAL SEPARATI; Calam RR., 2004, PROCEDURES HANDLING, V2004, P24; Cole J L, 1999, J Biomol Tech, V10, P163; Desai A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155201; Dryden MW, 2005, VET THER, V6, P15; Halvorsen K, 2010, BIOPHYS J, V98, pL53, DOI 10.1016/j.bpj.2010.03.012; Harvey EN, 1930, SCIENCE, V72, P42, DOI 10.1126/science.72.1854.42; HIRAMOTO Y, 1995, INT REV CYTOL, V157, P99, DOI 10.1016/S0074-7696(08)62157-9; Hoang T, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4961477; Holland LL, 2012, LABMEDICINE, V43, P78, DOI 10.1309/LM920FFGFXLRAORQ; Katkov II, 1999, CELL BIOCHEM BIOPHYS, V31, P231, DOI 10.1007/BF02738241; Kowalczyk B, 2011, CURR OPIN COLLOID IN, V16, P135, DOI 10.1016/j.cocis.2011.01.004; Laue TM, 2001, CURRENT PROTOCOLS PR; Lippi G, 2007, LABMEDICINE, V38, P172, DOI 10.1309/D8TJCARUW575CXYH; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Minder EI, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-6; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Roush DJ, 2008, BIOTECHNOL PROGR, V24, P488, DOI 10.1021/bp070414x; Shteinshnaider M, 2010, EUR J INTERN MED, V21, P226, DOI 10.1016/j.ejim.2010.02.002; Yang D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11026; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059840	24	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195907	10.1371/journal.pone.0195907	http://dx.doi.org/10.1371/journal.pone.0195907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659624	Green Published, gold			2022-12-27	WOS:000430061100040
J	Campbell, H; Gustafson, P				Campbell, Harlan; Gustafson, Paul			Conditional equivalence testing: An alternative remedy for publication bias	PLOS ONE			English	Article							SAMPLE-SIZE; P-VALUES; STATISTICAL SIGNIFICANCE; REGISTERED-REPORTS; RANDOMIZED-TRIALS; CLINICAL-TRIALS; FOLLOW-UP; T TESTS; NONINFERIORITY; NULL	We introduce a publication policy that incorporates "conditional equivalence testing" (CET), a two-stage testing scheme in which standard NHST is followed conditionally by testing for equivalence. The idea of CET is carefully considered as it has the potential to address recent concerns about reproducibility and the limited publication of null results. In this paper we detail the implementation of CET, investigate similarities with a Bayesian testing scheme, and outline the basis for how a scientific journal could proceed to reduce publication bias while remaining relevant.	[Campbell, Harlan; Gustafson, Paul] Univ British Columbia, Dept Stat, Vancouver, BC, Canada	University of British Columbia	Campbell, H (corresponding author), Univ British Columbia, Dept Stat, Vancouver, BC, Canada.	harlan.campbell@stat.ubc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 183772-13]; Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by an award from the Natural Sciences and Engineering Research Council of Canada (NSERC), http://www.nserc-crsng.gc.ca/, RGPIN 183772-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge support from Natural Sciences and Engineering Research Council of Canada. We also wish to thank Drs. John Petkau and Will Welch for their valuable feedback.	Aberegg SK, 2018, J GEN INTERN MED, V33, P88, DOI 10.1007/s11606-017-4161-4; Academia StackExchange, 2018, WHY ISNT PRER REQ AL; Albers C, 2018, J EXP SOC PSYCHOL, V74, P187, DOI 10.1016/j.jesp.2017.09.004; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Amrhein V, 2017, PEERJ PREPRINTS; [Anonymous], 2013, GENE, DOI DOI 10.1016/j.gene.2013.03.137; [Anonymous], 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184; Bacchetti P, 2002, BRIT MED J, V324, P1271, DOI 10.1136/bmj.324.7348.1271; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Barker L, 2001, AM STAT, V55, P279, DOI 10.1198/000313001753272213; Bedard PL, 2007, J CLIN ONCOL, V25, P3482, DOI 10.1200/JCO.2007.11.3670; Benjamin D. J, 2017, NATURE HUMAN BEHAV; Berger JO, 1987, STAT SCI, V2, P317, DOI [10.1214/ss/1177013238distributionsininvariantsituations, DOI 10.1214/SS/1177013238DISTRIBUTIONSININVARIANTSITUATIONS, DOI 10.1214/SS/1177013238, 10.2307/2245772]; BERRY DA, 1990, BIOMETRICS, V46, P1227; Bland JM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3985; Bloomfield RJ, 2018, FREE RESP SURV C PAR; [BMC Biology Editorial BMC Biology-Registered Reports], 2018, BMC BIOL REG REP; Borm GF, 2009, J CLIN EPIDEMIOL, V62, P47, DOI 10.1016/j.jclinepi.2008.02.017; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chalmers I, 2006, LANCET, V367, P449, DOI 10.1016/S0140-6736(06)68153-1; Chambers CD, 2015, CORTEX, V66, pA1, DOI 10.1016/j.cortex.2015.03.022; Chambers CD, 2014, AIMS NEUROSCI, V1, P4, DOI 10.3934/Neuroscience.2014.1.4; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Charlton BG, 2006, BRIT MED J, V332, P1214, DOI 10.1136/bmj.332.7551.1214-c; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Chen JJ, 2000, DRUG INF J, V34, P569, DOI 10.1177/009286150003400225; Coffman LC, 2015, J ECON PERSPECT, V29, P81, DOI 10.1257/jep.29.3.81; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Cumming G, 2008, PERSPECT PSYCHOL SCI, V3, P286, DOI 10.1111/j.1745-6924.2008.00079.x; da Silva GT, 2009, BIOL BLOOD MARROW TR, V15, P120, DOI 10.1016/j.bbmt.2008.10.004; DANNENBERG O, 1994, BIOMETRIKA, V81, P91; de Winter J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066463; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dienes Z, 2018, PSYCHON B REV, V25, P207, DOI 10.3758/s13423-017-1266-z; Dienes Z, 2016, J MATH PSYCHOL, V72, P78, DOI 10.1016/j.jmp.2015.10.003; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1263, DOI 10.1038/jcbfm.2010.51; Dixon PM, 2005, ECOLOGY, V86, P1751, DOI 10.1890/04-1343; Djulbegovic B, 2011, J CLIN EPIDEMIOL, V64, P583, DOI 10.1016/j.jclinepi.2010.09.007; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Etz A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149794; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Findley MG, 2016, COMP POLIT STUD, V49, P1667, DOI 10.1177/0010414016655539; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gelman A, 2017, SOME NATURAL SOLUTIO; Gelman A, 2013, THESIS; Gelman A, 2013, POLIT ANAL, V21, P40, DOI 10.1093/pan/mps032; Gelman A, 2013, EPIDEMIOLOGY, V24, P69, DOI 10.1097/EDE.0b013e31827886f7; Gervais WM, 2015, SOC PSYCHOL PERS SCI, V6, P847, DOI 10.1177/1948550615584199; Goeman JJ, 2010, STAT MED, V29, P2117, DOI 10.1002/sim.4002; Gonen M, 2010, METHODS MOL BIOL, V620, P179, DOI 10.1007/978-1-60761-580-4_4; GOODMAN S., 2007, 135 J HOPK U DEP BIO; Greene CJ, 2008, J TRAUMA STRESS, V21, P433, DOI 10.1002/jts.20367; Greenland S, 2013, EPIDEMIOLOGY, V24, P62, DOI 10.1097/EDE.0b013e3182785741; Greenland S, 2012, ANN EPIDEMIOL, V22, P364, DOI 10.1016/j.annepidem.2012.02.007; GREENWALD AG, 1975, PSYCHOL BULL, V82, P1, DOI 10.1037/h0076157; Greve W, 2013, EUR PSYCHOL, V18, P286, DOI 10.1027/1016-9040/a000144; GUYATT G, 1995, CAN MED ASSOC J, V152, P169; Haak LL, 2012, LEARN PUBL, V25, P259, DOI 10.1087/20120404; HARTUNG J, 1983, ANESTHESIOLOGY, V58, P298, DOI 10.1097/00000542-198303000-00033; HAUCK WW, 1986, STAT MED, V5, P203, DOI 10.1002/sim.4780050302; HAUSCHKE D, 1990, INT J CLIN PHARM TH, V28, P72; Hedges LV, 1992, STAT SCI, V7, P246, DOI DOI 10.1214/SS/1177011364; Henderson P., 2017, ABS170906560 CORR; Higginson AD, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000995; Hoekstra R, 2017, NEW ENGLAND J UNPUB; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Hofmann MA, 2016, WINT SIMUL C PROC, P522, DOI 10.1109/WSC.2016.7822118; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Hung HMJ, 2005, BIOMETRICAL J, V47, P28, DOI 10.1002/bimj.200410084; Ioannidis JPA, 2006, CANCER EPIDEM BIOMAR, V15, P186, DOI 10.1158/1055-9965.EPI-05-0921; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jia B, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0727-9; Jiroutek MR, 2003, BIOMETRICS, V59, P580, DOI 10.1111/1541-0420.00068; Jonas KJ, 2017, GUIDELINES AUT UNPUB; Journal of Cognition Editorial, 2018, J COGNITION EDITORIA; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; Keefe RS, 2013, INNOVATIONS CLIN SA, V10, p4S; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Konijn EA, 2015, COMMUN METHODS MEAS, V9, P280, DOI 10.1080/19312458.2015.1096332; Koyama T, 2005, J BIOPHARM STAT, V15, P943, DOI 10.1080/10543400500265694; Kruschke JK, 2018, PSYCHON B REV, V25, P178, DOI 10.3758/s13423-016-1221-4; Kuhberger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105825; Lakens D, 2017, EQUIVALENCE TESTING; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Lakens D, 2014, EUR J SOC PSYCHOL, V44, P701, DOI 10.1002/ejsp.2023; Lash TL, 2017, AM J EPIDEMIOL, V186, P627, DOI 10.1093/aje/kwx261; Lauzon C, 2009, AM STAT, V63, P147, DOI 10.1198/tast.2009.0029; Lawlor DA, 2007, INT J EPIDEMIOL, V36, P940, DOI 10.1093/ije/dym168; Leek JT, 2017, ANNU REV STAT APPL, V4, P109, DOI 10.1146/annurev-statistics-060116-054104; Lew MJ., 2013, ARXIV13110081; Marsman M, 2017, EDUC PSYCHOL MEAS, V77, P529, DOI 10.1177/0013164416669201; Mathieu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059910; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; MATTHEWS JNS, 1995, STAT MED, V14, P115, DOI 10.1002/sim.4780140204; McShane B.B., 2017, ARXIV170907588; Mell LK, 2014, INT J RADIAT ONCOL, V90, P729, DOI 10.1016/j.ijrobp.2014.07.052; Meyners M, 2007, FOOD QUAL PREFER, V18, P541, DOI 10.1016/j.foodqual.2006.07.005; Meyners M, 2012, FOOD QUAL PREFER, V26, P231, DOI 10.1016/j.foodqual.2012.05.003; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Mulder J, 2016, J MATH PSYCHOL, V72, P1, DOI 10.1016/j.jmp.2016.01.002; Ng TH, 2008, STAT MED, V27, P5392, DOI 10.1002/sim.3367; Ng Tie-Hua, 2003, J Biopharm Stat, V13, P629, DOI 10.1081/BIP-120024199; Nosek B. A., 2017, PREREGISTRATION REVO; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; O'Hagan A, 2005, PHARM STAT, V4, P187, DOI 10.1002/pst.175; O'Hara B, 2011, NATURE, V471, P448, DOI 10.1038/471448e; Ocana J, 2008, SORT-STAT OPER RES T, V32, P151; Parkhurst DF, 2001, BIOSCIENCE, V51, P1051, DOI 10.1641/0006-3568(2001)051[1051:SSTEAR]2.0.CO;2; Pautasso M, 2010, SCIENTOMETRICS, V85, P193, DOI 10.1007/s11192-010-0233-5; Perez ME, 2014, STAT PROBABIL LETT, V85, P20, DOI 10.1016/j.spl.2013.10.018; Perlman MD, 1999, STAT SCI, V14, P355; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pocock SJ, 2016, NEW ENGL J MED, V375, P861, DOI 10.1056/NEJMra1510064; Ramsey S, 2008, ONCOLOGIST, V13, P925, DOI 10.1634/theoncologist.2008-0133; Reichardt CS, 2016, CONFIDENCE INTERVALS; Reysen S, 2006, PSYCHOL REP, V98, P169, DOI 10.2466/PRO.98.1.169-175; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Rouder JN, 2014, PSYCHON B REV, V21, P301, DOI 10.3758/s13423-014-0595-4; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SACKETT DL, 1993, ANN NY ACAD SCI, V703, P25, DOI 10.1111/j.1749-6632.1993.tb26331.x; Scholz F, 2016, MONOGR ELECTROCHEM, P1, DOI 10.1007/978-3-319-21251-7_1; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703; Shao YZ, 2008, STAT MED, V27, P504, DOI 10.1002/sim.3028; Shieh G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162093; Shields PG, 2009, CANCER EPIDEM BIOMAR, V18, P2347, DOI 10.1158/1055-9965.EPI-09-0684; Shields PG, 2000, CANCER EPIDEM BIOMAR, V9, P771; Aycaguer LCS, 2013, GAC SANIT, V27, P53, DOI 10.1016/j.gaceta.2012.01.017; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smaldino PE, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160384; Smulders YM, 2013, J CLIN EPIDEMIOL, V66, P946, DOI 10.1016/j.jclinepi.2013.03.023; Song FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110418; STERLING TD, 1995, AM STAT, V49, P108, DOI 10.2307/2684823; Sune P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054583; Szucs D, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00390; Toerien M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-52; Trafimow D, 2014, BASIC APPL SOC PSYCH, V36, P1, DOI [10.1080/01973533.2014.865505, 10.1080/01973533.2015.1064290]; Tsou HH, 2007, J BIOPHARM STAT, V17, P339, DOI 10.1080/10543400601183861; van Assen MALM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084896; van Lent M, 2015, J CLIN EPIDEMIOL, V68, P1059, DOI 10.1016/j.jclinepi.2014.11.019; Vasishth S., 2017, ARXIV170200556; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Wager E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5248; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; WALSTER GW, 1970, AM STAT, V24, P16, DOI 10.2307/2681924; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Wellek S, 2017, BIOMETRICAL J, V59, P854, DOI 10.1002/bimj.201700001; Wiens BL, 2002, CONTROL CLIN TRIALS, V23, P2, DOI 10.1016/S0197-2456(01)00196-9; Wiens BL, 2000, CONTROL CLIN TRIALS, V21, P127, DOI 10.1016/S0197-2456(99)00052-5; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785; Zhang X, 2011, CONTEMP CLIN TRIALS, V32, P393, DOI 10.1016/j.cct.2010.12.012; Zhao G, 2016, INT J STAT PROBABILI, V5, P16, DOI [10.5539/ijsp.v5n5p16, DOI 10.5539/IJSP.V5N5P16]; Zhu HY, 2017, STAT BIOPHARM RES, V9, P107, DOI 10.1080/19466315.2016.1225594; Zumbo BD, 1998, J ROY STAT SOC D-STA, V47, P385, DOI 10.1111/1467-9884.00139	160	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195145	10.1371/journal.pone.0195145	http://dx.doi.org/10.1371/journal.pone.0195145			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652891	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900018
J	Saint-Laurent, C; Garcia, S; Sarrazy, V; Dumas, K; Authier, F; Sorel, S; Tran, A; Gual, P; Gennero, I; Salles, JP; Gouze, E				Saint-Laurent, Celine; Garcia, Stephanie; Sarrazy, Vincent; Dumas, Karine; Authier, Florence; Sorel, Sophie; Tran, Albert; Gual, Philippe; Gennero, Isabelle; Salles, Jean-Pierre; Gouze, Elvire			Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; BODY-MASS INDEX; INSULIN-RESISTANCE; REFERENCE VALUES; ADIPOSE-TISSUE; FAT RATIO; CHILDREN; WEIGHT; AGE; COMPLICATIONS	Background Achondroplasia is a rare genetic disease is characterized by abnormal bone development and early obesity. While the bone aspect of the disease has been thoroughly studied, early obesity affecting approximately 50% of them during childhood has been somewhat neglected. It nevertheless represents a major health problem in these patients, and is associated to life-threatening complications including increasing risk of cardiovascular pathologies. We have thus decided to study obesity in patients and to use the mouse model to evaluate if soluble FGFR3 therapy, an innovative treatment approach for achondroplasia, could also impact the development of this significant complication. Methods and findings To achieve this, we have first fully characterized the metabolic deregulations in these patients by conducting a longitudinal retrospective study, in children with achondroplasia Anthropometric, densitometric measures as well as several blood parameters were recorded and compared between three age groups ranging from [0 +/- 3], [4 +/- 8] and [9 +/- 18] years old. Our results show unexpected results with the development of an atypical obesity with preferential fat deposition in the abdomen that is remarkably not associated with classical complications of obesity such as diabetes or hypercholosterolemia. Because it is not associated with diabetes, the atypical obesity has not been studied in the past even though it is recognized as a real problem in these patients. These results were validated in a murine model of achondroplasia (Fgfr3(ach/+)) where similar visceral adiposity was observed. Unexpected alterations in glucose metabolism were highlighted during high-fat diet. Glucose, insulin or lipid levels remained low, without the development of diabetes. Very interestingly, in achondroplasia mice treated with soluble FGFR3 during the growth period (from D3 to D22), the development of these metabolic deregulations was prevented in adult animals between 4 and 14 weeks of age). The lean-over-fat tissues ratio was restored and glucose metabolism showed normal levels. Treating Fgfr3(ach/+) mice with soluble FGFR3 during the growth period, prevented the development of these metabolic deregulations in adult animals and restored lean-over-fat tissues ratio as well as glucose metabolism in adult animals. Conclusion This study demonstrate that achondroplasia patients develop an atypical obesity with preferential abdominal obesity not associated with classical complications. These results suggest that achondroplasia induces an uncommon metabolism of energy, directly linked to the FGFR3 mutation. These data strongly suggest that this common complication of achondroplasia should be included in the clinical management of patients. In this context, sFGFR3 proved to be a promising treatment for achondroplasia by normalizing the biology at different levels, not only restoring bone growth but also preventing the atypical visceral obesity and some metabolic deregulations.	[Saint-Laurent, Celine; Authier, Florence; Sorel, Sophie; Gouze, Elvire] Univ Cote Azur, CNRS, INSERM, iBV, Nice, France; [Saint-Laurent, Celine; Garcia, Stephanie; Sarrazy, Vincent; Dumas, Karine; Tran, Albert; Gual, Philippe; Gouze, Elvire] Univ Cote Azur, CHU, INSERM, C3M, Nice, France; [Gennero, Isabelle; Salles, Jean-Pierre] Univ Paul Sabatier Toulouse III, INSERM, CPTP, Toulouse, France; [Gennero, Isabelle] Toulouse Univ Hosp, Inst Federatif Biol, Biochem Lab, Toulouse, France; [Salles, Jean-Pierre] Toulouse Univ Hosp, Childrens Hosp, Endocrine Bone Dis & Genet Unit, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; CHU de Toulouse	Gouze, E (corresponding author), Univ Cote Azur, CNRS, INSERM, iBV, Nice, France.; Gouze, E (corresponding author), Univ Cote Azur, CHU, INSERM, C3M, Nice, France.	elvire.gouze@inserm.fr	Gual, Philippe/M-8787-2017; Gual, Philippe/P-9833-2019	Gual, Philippe/0000-0001-7393-8356; Gual, Philippe/0000-0001-7393-8356; SALLES, jean Pierre/0000-0002-0941-8951; Albert, TRAN/0000-0003-0003-5361; Saint-Laurent, Celine/0000-0002-9829-0178; Sarrazy, Vincent/0000-0003-4598-6005	IRG Marie Curie, FP7 [PIRG03-GA-2008-226132]; Fondation pour la Recherche Medicale [FDT20170437294]	IRG Marie Curie, FP7; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Elvire Gouze was supported by IRG Marie Curie, FP7 (Grant number PIRG03-GA-2008-226132). Celine Saint-Laurent was supported by Fondation pour la Recherche Medicale (Grant number FDT20170437294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatzoglou KS, 2009, J CLIN ENDOCR METAB, V94, P3959, DOI 10.1210/jc.2009-0322; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aucouturier J, 2009, ARCH PEDIAT ADOL MED, V163, P826, DOI 10.1001/archpediatrics.2009.148; COLLIPP PJ, 1972, AM J DIS CHILD, V124, P682, DOI 10.1001/archpedi.1972.02110170060008; CRONK CE, 1982, AM J CLIN NUTR, V35, P347, DOI 10.1093/ajcn/35.2.347; Fischer DC, 2012, ANN CLIN BIOCHEM, V49, P546, DOI 10.1258/acb.2012.011274; Garcia S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006247; Haine E, 2015, J BONE MINER RES, V30, P1369, DOI 10.1002/jbmr.2471; HECHT JT, 1988, AM J MED GENET, V31, P597, DOI 10.1002/ajmg.1320310314; Hoover-Fong JE, 2007, AM J MED GENET A, V143A, P2227, DOI 10.1002/ajmg.a.31873; Hoover-Fong JE, 2008, AM J CLIN NUTR, V88, P364, DOI 10.1093/ajcn/88.2.364; Horton W A, 1977, Birth Defects Orig Artic Ser, V13, P101; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Hunter AGW, 1996, AM J MED GENET, V62, P255, DOI 10.1002/(SICI)1096-8628(19960329)62:3<255::AID-AJMG10>3.0.CO;2-J; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kursawe R, 2010, DIABETES, V59, P2288, DOI 10.2337/db10-0113; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Lafontan M, 2014, DIABETES METAB, V40, P16, DOI 10.1016/j.diabet.2013.08.002; Mellerio H, 2012, PEDIATRICS, V129, pE1020, DOI 10.1542/peds.2011-0449; Naski MC, 1998, DEVELOPMENT, V125, P4977; Nies VJM, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00193; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Pirgon O, 2008, J PAEDIATR CHILD H, V44, P602, DOI 10.1111/j.1440-1754.2008.01392.x; REVICKI DA, 1986, AM J PUBLIC HEALTH, V76, P992, DOI 10.2105/AJPH.76.8.992; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Samsell L, 2014, J OBES, V2014, DOI 10.1155/2014/846578; Schlueter N, 2014, PHARMACOL THERAPEUT, V144, P12, DOI 10.1016/j.pharmthera.2014.04.007; Schulze KJ, 2013, AM J MED GENET A, V161, P2110, DOI 10.1002/ajmg.a.35947; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STOKES DC, 1983, J PEDIATR-US, V102, P534, DOI 10.1016/S0022-3476(83)80180-2; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Trotter TL, 2005, PEDIATRICS, V116, P771, DOI 10.1542/peds.2005-1440; Unger S, 2017, CURR OSTEOPOROS REP, V15, P53, DOI 10.1007/s11914-017-0347-2; van der Sluis IM, 2002, ARCH DIS CHILD, V87, P341, DOI 10.1136/adc.87.4.341; WALTON C, 1995, AM J MED, V99, P459, DOI 10.1016/S0002-9343(99)80220-4; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Wendt DJ, 2015, J PHARMACOL EXP THER, V353, P132, DOI 10.1124/jpet.114.218560; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	41	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195876	10.1371/journal.pone.0195876	http://dx.doi.org/10.1371/journal.pone.0195876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652901	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900043
J	Stein, K; Hieggelke, L; Schneiker, B; Lysson, M; Stoffels, B; Nuding, S; Wehkamp, J; Kikhney, J; Moter, A; Kalff, JC; Wehner, S				Stein, Kathy; Hieggelke, Lena; Schneiker, Bianca; Lysson, Mariola; Stoffels, Burkhard; Nuding, Sabine; Wehkamp, Jan; Kikhney, Judith; Moter, Annette; Kalff, Joerg C.; Wehner, Sven			Intestinal manipulation affects mucosal antimicrobial defense in a mouse model of postoperative ileus	PLOS ONE			English	Article							TARGETED OLIGONUCLEOTIDE PROBES; INFLAMMATORY-BOWEL-DISEASE; IN-SITU HYBRIDIZATION; LECTIN REGIII-GAMMA; BACTERIAL TRANSLOCATION; GASTROINTESTINAL-TRACT; PEPTIDE EXPRESSION; GUT FLORA; MUSCULARIS; CELLS	Aim To explore the effects of abdominal surgery and interleukin-1 signaling on antimicrobial defense in a model of postoperative ileus. Methods C57BL/6 and Interleukin-1 receptor type I (IL-1R1) deficient mice underwent intestinal manipulation to induce POI. Expression of mucosal IL-1 alpha, IL-1 beta and IL-1R1 and several antimicrobial peptides and enzymes were measured by quantitative PCR or ELISA, western blotting or immunohistochemistry. Bacterial overgrowth was determined by fluorescent in-situ hybridization and counting of jejunal luminal bacteria. Translocation of aerobic and anaerobic bacteria into the intestinal wall, mesenteric lymph nodes, liver and spleen was determined by counting bacterial colonies on agar plates 48h after plating of tissue homogenates. Antimicrobial activity against E. coli and B. vulgatus was analyzed in total and cationic fractions of small bowel mucosal tissue homogenates by a flow cytometry-based bacterial depolarization assay. Results Jejunal bacterial overgrowth was detected 24h after surgery. At the same time point, but not in the early phase 3h after surgery, bacterial translocation into the liver and mesenteric lymph nodes was observed. Increased antimicrobial activity against E. coli was induced within early phase of POI. Basal antimicrobial peptide and enzyme gene expression was higher in the ileal compared to the jejunal mucosa. The expression of lysozyme 1, cryptdin 1, cryptdin 4 and mucin 2 were reduced 24h after surgery in the ileal mucosa and mucin 2 was also reduced in the jejunum. Postoperative IL-1 alpha and IL-1 beta were increased in the postoperative mucosa. Deficiency of IL-1R1 affected the expression of antimicrobial peptides during homeostasis and POI. Conclusion Small bowel antimicrobial capacity is disturbed during POI which is accompanied by bacterial overgrowth and translocation. IL-1R1 is partially involved in the gene expression of mucosal antimicrobial peptides. Altered small bowel antimicrobial activity may contribute also to POI development and manifestation in patients undergoing abdominal surgery.	[Stein, Kathy; Hieggelke, Lena; Schneiker, Bianca; Lysson, Mariola; Stoffels, Burkhard; Kalff, Joerg C.; Wehner, Sven] Univ Hosp Bonn, Dept Surg, Bonn, Germany; [Nuding, Sabine] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Wehkamp, Jan] Univ Hosp Tubingen, Internal Med 1, Tubingen, Germany; [Kikhney, Judith; Moter, Annette] Charite, Inst Microbiol & Hyg, Biofilmctr, Berlin, Germany	University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wehner, S (corresponding author), Univ Hosp Bonn, Dept Surg, Bonn, Germany.	sven.wehner@ukbonn.de	Stoffels, Burkhard/L-1415-2018; Kalff, Joerg C/U-8580-2017; Wehner, Sven/X-6326-2019	Kikhney, Judith/0000-0002-4849-7947; Hieggelke, Lena/0000-0002-1831-0387; Moter, Annette/0000-0003-1318-5780	BONFOR student grant from the University of Bonn [0-112.0054]; Flow Cytometry Core Facility (Medical faculty, University Bonn)	BONFOR student grant from the University of Bonn; Flow Cytometry Core Facility (Medical faculty, University Bonn)	This work was supported by a BONFOR student grant from the University of Bonn (0-112.0054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the support of the Flow Cytometry Core Facility (Medical faculty, University Bonn). KS, JCK and SW are members of the ImmunoSensation Cluster of Excellence.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Andus T, 1997, GUT, V41, P651, DOI 10.1136/gut.41.5.651; Asgeirsson T, 2010, J AM COLL SURGEONS, V210, P228, DOI 10.1016/j.jamcollsurg.2009.09.028; Bando M, 2007, IMMUNOL CELL BIOL, V85, P532, DOI 10.1038/sj.icb.7100078; Barletta JF, 2014, WORLD J SURG, V38, P1966, DOI 10.1007/s00268-014-2506-2; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Bures J, 2010, WORLD J GASTROENTERO, V16, P2978, DOI 10.3748/wjg.v16.i24.2978; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cobo ER, 2015, MUCOSAL IMMUNOL, V8, P1360, DOI 10.1038/mi.2015.27; Daims Holger, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5253; DEITCH EA, 1990, J TRAUMA, V30, pS184; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gong JF, 2010, CLIN IMMUNOL, V136, P245, DOI 10.1016/j.clim.2010.04.001; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hiroshima Y, 2011, ARCH ORAL BIOL, V56, P761, DOI 10.1016/j.archoralbio.2011.01.004; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kalff JC, 2003, ANN SURG, V237, P301, DOI 10.1097/00000658-200303000-00003; Kalff JC, 1998, J LEUKOCYTE BIOL, V63, P683, DOI 10.1002/jlb.63.6.683; Klag T, 2013, DIGEST DIS, V31, P310, DOI 10.1159/000354858; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Ludwiczek O, 2004, CLIN EXP IMMUNOL, V138, P323, DOI 10.1111/j.1365-2249.2004.02599.x; Mallmann C, 2010, CLIN MICROBIOL INFEC, V16, P767, DOI 10.1111/j.1469-0691.2009.02936.x; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Nuding S, 2006, J MICROBIOL METH, V65, P335, DOI 10.1016/j.mimet.2005.08.004; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schwarz NT, 2002, ANN SURG, V235, P31, DOI 10.1097/00000658-200201000-00005; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Snoek SA, 2012, NEUROGASTROENT MOTIL, V24, P172, DOI 10.1111/j.1365-2982.2011.01820.x; Stoffels B, 2014, GASTROENTEROLOGY, V146, P176, DOI 10.1053/j.gastro.2013.09.030; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vaishnavi C, 2013, INDIAN J MED MICROBI, V31, P334, DOI 10.4103/0255-0857.118870; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wehner S, 2012, LANGENBECK ARCH SURG, V397, P591, DOI 10.1007/s00423-012-0915-y; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017	48	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195516	10.1371/journal.pone.0195516	http://dx.doi.org/10.1371/journal.pone.0195516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652914	Green Published, gold, Green Submitted			2022-12-27	WOS:000430026900024
J	Dona, D; Masiero, S; Brisotto, S; Gottardello, L; Lundin, R; Borgia, E; Visentin, F; Da Dalt, L				Dona, Daniele; Masiero, Susanna; Brisotto, Sara; Gottardello, Lorena; Lundin, Rebecca; Borgia, Eleonora; Visentin, Federica; Da Dalt, Liviana			Special Immunization Service: A 14-year experience in Italy	PLOS ONE			English	Article							EGG ALLERGY; VACCINATION; CHILDREN; CHALLENGES; VACCINES; HISTORY; SAFETY; RISK	Background Concerns regarding vaccine safety are increasing along with lack of compliance to vaccination schedules. This study aimed to assess vaccination-related risks and the impact of a Special Immunization Service (SIS) at the Pediatric Emergency Department (PED) of Padua on vaccination compliance among participants. Materials and methods This retrospective cohort study included all children attending the SIS from January 1st 2002 to December 31St 2015. The Service is divided into a clinic (SIS-C) where all referred children undergo a pre-vaccination visit and an area within the Pediatric Emergency Department (SIS-PED) where children are vaccinated if indicated. During each SIS-C visit, age, gender, admission criteria and scheduled vaccinations were recorded, with any vaccine related adverse events captured during SIS-PED visits. Follow-up was conducted to evaluate vaccination plan completion. Results 359 children received 560 vaccine administrations (41.3% MMR/MMRV, 17.5% hexavalent) at the SIS during the 14 year study. Admission criteria were adverse events after previous vaccination (immediate, IgE/not IgE mediated, and late) in 27.2% of cases, non-anaphylactic allergies (mostly egg allergy) in 42.7% and anaphylaxis in 10.3%. After vaccination, 15/560 (2.7%) mild adverse events were observed. 96.3% of children vaccinated at least once at the SIS-PED and available for follow-up completed their vaccination plan, in contrast to 55.5% of children referred to the SIS-C who were not vaccinated in SIS-PED. Conclusions For children referred to SIS-C and available for follow-up, vaccination in SIS-PED was associated with more frequent completion of vaccination plans, indicating a benefit of the service to vaccine coverage. The low number and mild severity of adverse events reported after vaccination of high-risk children in SIS-PED attest to the safety of the service	[Dona, Daniele] Univ Padua, Div Pediat Infect Dis, Dept Woman & Child Hlth, Padua, Italy; [Masiero, Susanna; Brisotto, Sara; Borgia, Eleonora; Visentin, Federica; Da Dalt, Liviana] Univ Padua, Dept Woman & Child Hlth, Pediat Emergency Unit, Padua, Italy; [Gottardello, Lorena] Univ Padua, Dept Hyg & Publ Hlth, Padua, Italy; [Lundin, Rebecca] PENTA Fdn, Padua, Italy	University of Padua; University of Padua; University of Padua	Dona, D (corresponding author), Univ Padua, Div Pediat Infect Dis, Dept Woman & Child Hlth, Padua, Italy.	daniele.dona@phd.unipd.it	Donà, Daniele/W-7088-2019	Donà, Daniele/0000-0001-7105-2105; Lundin, Rebecca/0000-0002-8380-4834				Andrews RM, 1998, MED J AUSTRALIA, V168, P491, DOI 10.5694/j.1326-5377.1998.tb141412.x; Azzari C, 2004, RIV IMMUNOL E ALLERG, V5, P18; Betsch C, 2012, VACCINE, V30, P3727, DOI 10.1016/j.vaccine.2012.02.025; Chen RT, 1998, PEDIATR ANN, V27, P445, DOI 10.3928/0090-4481-19980701-11; Clark AT, 2010, CLIN EXP ALLERGY, V40, P1116, DOI 10.1111/j.1365-2222.2010.03557.x; Cronin J, 2012, ACTA PAEDIATR, V101, P941, DOI 10.1111/j.1651-2227.2012.02737.x; Epicentro, 2017, MORB IT B SETT; Gallo G, 2009, RAPP ISTISAN, V9, DOI [10.1016/S1359-6446(04)03234-9, DOI 10.1016/S1359-6446(04)03234-9]; Gold M, 2000, ARCH DIS CHILD, V83, P128, DOI 10.1136/adc.83.2.128; Goodyear-Smith F, 2005, HUM VACCINES, V1, P118, DOI 10.4161/hv.1.3.1888; Gust DA, 2008, PEDIATRICS, V122, P718, DOI 10.1542/peds.2007-0538; Halsey Neal A, 2002, Semin Pediatr Infect Dis, V13, P205, DOI 10.1053/spid.2002.125864; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; McNeil MM, 2016, J ALLERGY CLIN IMMUN, V137, P868, DOI 10.1016/j.jaci.2015.07.048; Moskosky S. B., 2011, Morbidity and Mortality Weekly Report, V60, P1; O'Hagan DT, 2004, DRUG DISCOV TODAY, V9, P846, DOI 10.1016/S1359-6446(04)03234-9; Pickering LK, 2009, RED BOOK 2009 REPORT; Sheehan WJ, 2009, J ALLERGY CLIN IMMUN, V124, P850, DOI 10.1016/j.jaci.2009.06.044; Wood David L, 2003, Pediatrics, V112, P993; World Health Organization, 2014, GLOB IMM DAT; World Health Organization, 2013, IMM SAF SURV GUID MA	22	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195881	10.1371/journal.pone.0195881	http://dx.doi.org/10.1371/journal.pone.0195881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649292	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900102
J	Almeida, ACF; de Paula, FJA; Monteiro, JP; Nogueira-de-Almeida, CA; Del Ciampo, LA; Aragon, DC; Ferraz, IS				Fayao Almeida, Ane Cristina; Albuquerque de Paula, Francisco Jose; Monteiro, Jacqueline Pontes; Nogueira-de-Almeida, Carlos Alberto; Del Ciampo, Luiz Antonio; Aragon, Davi Casale; Ferraz, Ivan Savioli			Do all infants need vitamin D supplementation?	PLOS ONE			English	Article							D DEFICIENCY; HEALTHY-CHILDREN; D INSUFFICIENCY; SERUM; RISK; PREVENTION; MANAGEMENT; EXPOSURE; CALCIUM; AGE	A high prevalence of vitamin D deficiency (VDD) in children has been observed worldwide, but there are few studies on the nutritional status of vitamin D (VD) in healthy infants. The main cause of deficiency in healthy children is breastfeeding without supplementation and lack or insufficiency of sun exposure. The aims of this study were to determine serum concentrations of 25(OH)D and verify its association with parathyroid hormone (PTH) concentrations and use of VD supplementation in healthy infants aged >= 6 to <= 24 months attended at two Primary Health Care Units in Ribeirao Preto city, Sao Paulo, Brazil. A crosssectional, observational and analytical study was performed in which serum concentrations of 25(OH)D, PTH, alkaline phosphatase (AP), calcium (Ca), phosphorus (P) and albumin were determined in 155 healthy infants. Information on sun exposure, sociodemographic aspects of mothers and clinical and nutritional characteristics of infants were obtained through interviews with responsible infants's legal representatives. Ten infants (6%) presented deficient 25(OH)D serum concentration (<= 20ng/ml) and 46 (30%), insufficient (21 to 29ng/ml). No changes in serum P, Ca and albumin concentrations were detected. Only one infant had an increase in PTH serum concentrations. 35% (55/155) of infants had high AP e 40% (22/55) presented insufficient serum concentrations of 25(OH)D but none presented deficient ones. There was a weak association between serum concentrations of 25(OH)D and PTH and an association between serum concentrations of 25(OH)D and P when adjusted for sex, age and BMI. There were no associations between inadequate serum concentrations of 25(OH)D (deficient ou insufficient), sun exposure and VD supplementation. This study found a low prevalence of deficient 25(OH)D serum concentration and high prevalence of insufficient ones which was not associated with changes in serum PTH, AP, P, Ca and albumin concentrations, VD supplementation and the formula volume intake.	[Fayao Almeida, Ane Cristina; Albuquerque de Paula, Francisco Jose; Monteiro, Jacqueline Pontes; Del Ciampo, Luiz Antonio; Aragon, Davi Casale; Ferraz, Ivan Savioli] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Ribeirao Preto, Brazil; [Nogueira-de-Almeida, Carlos Alberto] Fed Univ Sao Carlos UFSCAR, Dept Med, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Carlos	Nogueira-de-Almeida, CA (corresponding author), Fed Univ Sao Carlos UFSCAR, Dept Med, Ribeirao Preto, Brazil.	dr.nogueira@me.com	Nogueira-de-Almeida, Carlos Alberto/C-4421-2013; de Paula, Francisco/D-5026-2012; Aragon, Davi C/R-6604-2016; Ferraz, Ivan S/F-5355-2014	Nogueira-de-Almeida, Carlos Alberto/0000-0003-1272-4404; de Paula, Francisco/0000-0003-1262-3486; Aragon, Davi C/0000-0003-1019-3654; Ferraz, Ivan/0000-0003-3464-6523	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (CNPq) of Ministry of Innovation, Technology and Sciences of Brazil	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (CNPq) of Ministry of Innovation, Technology and Sciences of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was granted scholarships by the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (CNPq) of Ministry of Innovation, Technology and Sciences of Brazil to ACFA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAD, 2008, POS STAT VIT D; Abrams SA, 2011, PEDIATRICS, V127, P566, DOI 10.1542/peds.2010-3576; Absoud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022179; Alonso MA, 2015, PEDIATR NEPHROL, V30, P327, DOI 10.1007/s00467-014-2927-z; Akman AO, 2011, PEDIATR INT, V53, P968, DOI 10.1111/j.1442-200X.2011.03486.x; Alimentarius C., 721981 CODEX; Andersson Bjorn, 2016, Bone Rep, V5, P150, DOI 10.1016/j.bonr.2016.03.002; Atas E, 2013, EUR J PEDIATR, V172, P1039, DOI 10.1007/s00431-013-1997-4; Balasubramanian S, 2008, INDIAN J MED RES, V127, P250; Bassrawi Rolan, 2014, Sudan J Paediatr, V14, P85; Bener A, 2014, J PEDIATR NEUROSCI, V9, P227, DOI 10.4103/1817-1745.147574; Bener A, 2009, INT J FOOD SCI NUTR, V60, P60, DOI 10.1080/09637480802400487; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Binks MJ, 2016, MED J AUSTRALIA, V204, DOI 10.5694/mja15.00798; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Braegger C, 2013, J PEDIATR GASTR NUTR, V56, P692, DOI 10.1097/MPG.0b013e31828f3c05; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Carpenter TO, 2012, AM J CLIN NUTR, V95, P137, DOI 10.3945/ajcn.111.018721; Carroll A, 2014, CLIN PEDIATR, V53, P1345, DOI 10.1177/0009922814541999; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Center for Disease Control, 2012, 2 NAT REP BIOCH IND; Cetinkaya M, 2015, J PERINATOL, V35, P39, DOI 10.1038/jp.2014.146; Cole CR, 2010, PEDIATRICS, V125, P633, DOI 10.1542/peds.2009-1928; DALY JA, 1972, CLIN CHEM, V18, P263; Dori N, 2010, PEDIATR INT, V52, P866, DOI 10.1111/j.1442-200X.2010.03265.x; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Dyson A, 2014, J PAEDIATR CHILD H, V50, P47, DOI 10.1111/jpc.12413; Grant CC, 2009, PUBLIC HEALTH NUTR, V12, P1893, DOI 10.1017/S1368980009004820; Grant WB, 2008, PEDIATR INFECT DIS J, V27, P853, DOI 10.1097/INF.0b013e3181817bc1; Halicioglu O, 2012, PEDIATRICS, V130, pE921, DOI 10.1542/peds.2012-0017; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; IBGE, 2017, CONC COL RAC; INMET, 2017, MET NIO; Institute S, 2010, SAS STAT 9; IOM, 2011, DIETARY REFERENCE IN; Khor GL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-95; Kleinman RE, 2014, PEDIAT NUTR, P495; Koletzko B., 2008, NUTR PRACTICE; KRICKER A, 1995, INT J CANCER, V60, P489, DOI 10.1002/ijc.2910600411; Manson JE, 2016, NEW ENGL J MED, V375, P1817, DOI 10.1056/NEJMp1608005; McDonnell SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180483; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; MORGAN BR, 1993, CLIN CHEM, V39, P1608; Munns CF, 2016, HORM RES PAEDIAT, V85, P83, DOI [10.1159/000443136, 10.1210/jc.2015-2175]; Ozkan Behzat, 2010, J Clin Res Pediatr Endocrinol, V2, P137, DOI 10.4274/jcrpe.v2i4.137; Pludowski P, 2011, J PEDIATR GASTR NUTR, V53, P93, DOI 10.1097/MPG.0b013e318216920f; Poh BK, 2016, ASIA PAC J CLIN NUTR, V25, P538, DOI 10.6133/apjcn.092015.02; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reichrath J., SUNLIGHT VITAMIN D S; Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886; Slominski AT, 2017, J STEROID BIOCHEM, V173, P42, DOI 10.1016/j.jsbmb.2016.09.024; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Thorisdottir B, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020075; Valcour A, 2012, J CLIN ENDOCR METAB, V97, P3989, DOI 10.1210/jc.2012-2276; Vogiatzi MG, 2014, J CLIN ENDOCR METAB, V99, P1132, DOI 10.1210/jc.2013-3655; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wagner CL, 2016, J STEROID BIOCHEM, V155, P245, DOI 10.1016/j.jsbmb.2015.10.022; WHO, 2017, INF NUTR; World Health Organization, 2006, WHO CHILD GROWTH STA; Yorita KL, 2007, PEDIATR INFECT DIS J, V26, P1081, DOI 10.1097/INF.0b013e31812e62c2	66	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195368	10.1371/journal.pone.0195368	http://dx.doi.org/10.1371/journal.pone.0195368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649273	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900040
J	Khan, MT; Dalvin, S; Waheed, Q; Nilsen, F; Male, R				Khan, Muhammad Tanveer; Dalvin, Sussie; Waheed, Qaiser; Nilsen, Frank; Male, Rune			Molecular characterization of the lipophorin receptor in the crustacean ectoparasite Lepeophtheirus salmonis	PLOS ONE			English	Article							LIGAND-BINDING REPEAT; LIPID TRANSPORT; FAMILIAL HYPERCHOLESTEROLEMIA; MEDIATED ENDOCYTOSIS; GALLERIA-MELLONELLA; INSECT LIPOPROTEIN; ATLANTIC SALMON; KNOCK-DOWN; WAX MOTH; SEA LICE	The Salmon louse (Lepeophtheirus salmonis) is a marine ectoparasite of salmonid fish in the Northern Hemisphere and considered as a major challenge in aquaculture and a threat to wild populations of salmonids. Adult female lice produce a large number of lipid-rich eggs, however, the mechanism of maternal lipid transport into developing eggs during salmon louse reproduction has not been described. In the present study, a full-length L. salmonis lipophorin receptor (LsLpR) consisting of 16 exons was obtained by RACE and RT-PCR. The predicted ORF was 952 amino acids and structural analysis showed five functional domains that are similar to LpR of insects and decapods. Phylogenetic analysis placed the LsLpR together with LpRs from decapods and insects. Expression analysis revealed that the relative abundance of LsLpR transcripts was highest in the larvae and adult female lice. In adult females, the LsLpR transcripts and protein were found in the ovary and vitellogenic oocytes whereas, in larvae, the LsLpR transcripts were found in the neuronal somata of the brain and the intestine. Oil Red O stain results revealed that storage of neutral lipids was found in vitellogenic oocytes and ovaries of adult females, and in the yolk of larvae. Moreover, RNA interference (RNAi) was conducted to demonstrate the function of LsLpR in reproduction and lipid metabolism in L. salmonis. In larvae, the transcription of LsLpR was decreased by 44-54% while in an experiment LsLpR knockdown female lice produced 72% less offspring than control lice.	[Khan, Muhammad Tanveer; Nilsen, Frank] Univ Bergen, Dept Biol Sci, Sea Lice Res Ctr, Bergen, Norway; [Dalvin, Sussie] Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway; [Waheed, Qaiser; Male, Rune] Univ Bergen, Dept Biol Sci, Computat Biol Unit, Bergen, Norway	University of Bergen; Institute of Marine Research - Norway; University of Bergen	Male, R (corresponding author), Univ Bergen, Dept Biol Sci, Computat Biol Unit, Bergen, Norway.	rune.male@uib.no	Dalvin, Sussie/AAL-6893-2021	Dalvin, Sussie/0000-0002-6092-4710; Male, Rune/0000-0003-2415-8462; Waheed, Qaiser/0000-0002-7566-2506	Research Council of Norway [203513/O30]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway, Grant Number 203513/O30 (https://www.forskningsradet.no/en/Home_page/1177315753906) to MTK, SD, FN, and RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J MOL BIOCH; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; BEENAKKERS AMT, 1988, INSECT BIOCHEM, V18, P1, DOI 10.1016/0020-1790(88)90029-7; Benoit JB, 2011, J INSECT PHYSIOL, V57, P1553, DOI 10.1016/j.jinsphys.2011.08.009; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Cheon HM, 2001, INSECT BIOCHEM MOLEC, V31, P753, DOI 10.1016/S0965-1748(01)00068-6; CHINO H, 1981, INSECT BIOCHEM, V11, P491, DOI 10.1016/0020-1790(81)90085-8; Ciudad L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-53; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Dalvin S, 2013, J NAT HIST, V47, P889, DOI 10.1080/00222933.2012.738830; Dalvin S, 2011, DIS AQUAT ORGAN, V94, P211, DOI 10.3354/dao02331; Dalvin S, 2009, INT J PARASITOL, V39, P1407, DOI 10.1016/j.ijpara.2009.04.004; Dantuma NP, 1999, J LIPID RES, V40, P973; Dantuma NP, 1997, J LIPID RES, V38, P254; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Eichner C, 2015, EXP PARASITOL, V159, P79, DOI 10.1016/j.exppara.2015.09.001; Eichner C, 2014, EXP PARASITOL, V140, P44, DOI 10.1016/j.exppara.2014.03.014; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Fruttero LL, 2011, J INSECT PHYSIOL, V57, P475, DOI 10.1016/j.jinsphys.2011.01.009; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gopalapillai R, 2006, J LIPID RES, V47, P1005, DOI 10.1194/jlr.M500462-JLR200; Guidugli-Lazzarini KR, 2008, J INSECT PHYSIOL, V54, P1138, DOI 10.1016/j.jinsphys.2008.04.021; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Innerarity TL, 2002, SCIENCE, V298, P2337, DOI 10.1126/science.1080669; Jeon H, 2003, STRUCTURE, V11, P133, DOI 10.1016/S0969-2126(03)00010-8; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; KAWOOYA JK, 1988, J BIOL CHEM, V263, P8748; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan MT, 2017, J LIPID RES, V58, P1613, DOI 10.1194/jlr.M076430; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; Lee CS, 2003, ARCH INSECT BIOCHEM, V54, P14, DOI 10.1002/arch.10095; Lee CS, 2003, INSECT BIOCHEM MOLEC, V33, P761, DOI 10.1016/S0965-1748(03)00066-3; Lee JY, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045003; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Maddison WP., 2019, CHROMASEQ MESQUITE P; Parra-Peralbo E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001297; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ravikumar G, 2013, RESONANCE; Roosendaal SD, 2008, FEBS J, V275, P1751, DOI 10.1111/j.1742-4658.2008.06334.x; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233; Seo SJ, 2003, J BIOL CHEM, V278, P41954, DOI 10.1074/jbc.M308200200; SOULAGES JL, 1994, ADV PROTEIN CHEM, V45, P371; Sun JX, 2000, INSECT BIOCHEM MOLEC, V30, P1161, DOI 10.1016/S0965-1748(00)00093-X; Tocher JA, 2010, COMP BIOCHEM PHYS B, V156, P107, DOI 10.1016/j.cbpb.2010.02.010; TSUCHIDA K, 1988, INSECT BIOCHEM, V18, P263, DOI 10.1016/0020-1790(88)90090-X; Tucker CS, 2000, FISH PATHOL, V35, P137, DOI 10.3147/jsfp.35.137; Tufail M, 2009, INSECT MOL BIOL, V18, P281, DOI 10.1111/j.1365-2583.2009.00865.x; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; van der Horst DJ, 2002, MOL CELL BIOCHEM, V239, P113, DOI 10.1023/A:1020541010547; Van Hoof D, 2005, INSECT BIOCHEM MOLEC, V35, P117, DOI 10.1016/j.ibmb.2004.09.009; Van Hoof D, 2002, J CELL SCI, V115, P4001, DOI 10.1242/jcs.00113; VANANTWERPEN R, 1990, BIOL CHEM H-S, V371, P159, DOI 10.1515/bchm3.1990.371.1.159; VANHANDEL E, 1993, J INSECT PHYSIOL, V39, P831, DOI 10.1016/0022-1910(93)90115-8; Westcott JD, 2004, AQUAC RES, V35, P784, DOI 10.1111/j.1365-2109.2004.01101.x; Willnow TE, 1999, J MOL MED-JMM, V77, P306, DOI 10.1007/s001090050356; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014; Zou P, 2011, ACS CHEM BIOL, V6, P308, DOI 10.1021/cb100361k	68	5	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195783	10.1371/journal.pone.0195783	http://dx.doi.org/10.1371/journal.pone.0195783			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649335	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900087
J	Li, YM; Quigley, MA; Dattani, N; Gray, R; Jayaweera, H; Kurinczuk, JJ; Macfarlane, A; Hollowell, J				Li, Yangmei; Quigley, Maria A.; Dattani, Nirupa; Gray, Ron; Jayaweera, Hiranthi; Kurinczuk, Jennifer J.; Macfarlane, Alison; Hollowell, Jennifer			The contribution of gestational age, area deprivation and mother's country of birth to ethnic variations in infant mortality in England and Wales: A national cohort study using routinely collected data	PLOS ONE			English	Article							PRETERM BIRTH; RACIAL DISPARITIES; BACTERIAL-COLONIZATION; PERINATAL-MORTALITY; SOCIAL DETERMINANTS; UNITED-STATES; PREGNANCY; WOMEN; RISK; TERMINATION	Objectives We aimed to describe ethnic variations in infant mortality and explore the contribution of area deprivation, mother's country of birth, and prematurity to these variations. Methods We analyzed routine birth and death data on singleton live births (gestational age >= 22 weeks) in England and Wales, 2006-2012. Infant mortality by ethnic group was analyzed using logistic regression with adjustment for sociodemographic characteristics and gestational age. Results In the 4,634,932 births analyzed, crude infant mortality rates were higher in Pakistani, Black Caribbean, Black African, and Bangladeshi infants (6.92, 6.00, 5.17 and 4.40 per 1,000 live births, respectively vs. 2.87 in White British infants). Adjustment for maternal sociodemographic characteristics changed the results little. Further adjustment for gestational age strongly attenuated the risk in Black Caribbean (OR 1.02, 95% CI 0.89-1.17) and Black African infants (1.17, 1.06-1.29) but not in Pakistani (2.32, 2.15-2.50), Bangladeshi (1.47, 1.28-1.69), and Indian infants (1.24, 1.11-1.38). Ethnic variations in infant mortality differed significantly between term and preterm infants. At term, South Asian groups had higher risks which cannot be explained by sociodemographic characteristics. In preterm infants, adjustment for degree of prematurity (<28, 28-31, 32-33, 34-36 weeks) fully explained increased risks in Black but not Pakistani and Bangladeshi infants. Sensitivity analyses with further adjustment for small for gestational age, or excluding deaths due to congenital anomalies did not fully explain the excess risk in South Asian groups. Conclusions Higher infant mortality in South Asian and Black infants does not appear to be explained by sociodemographic characteristics. Higher proportions of very premature infants appear to explain increased risks in Black infants but not in South Asian groups. Strategies targeting the prevention and management of preterm birth in Black groups and suboptimal birthweight and modifiable risk factors for congenital anomalies in South Asian groups might help reduce ethnic inequalities in infant mortality.	[Li, Yangmei; Quigley, Maria A.; Gray, Ron; Kurinczuk, Jennifer J.; Hollowell, Jennifer] Univ Oxford, Policy Res Unit Maternal Hlth & Care, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford, England; [Dattani, Nirupa; Macfarlane, Alison] Univ London, Sch Hlth Sci, Ctr Maternal & Child Hlth Res, London, England; [Jayaweera, Hiranthi] Univ Oxford, Sch Anthropol, Oxford, England	University of Oxford; University of London; University of Oxford	Li, YM (corresponding author), Univ Oxford, Policy Res Unit Maternal Hlth & Care, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford, England.	yangmei.li@npeu.ox.ac.uk	Hollowell, Jennifer/B-5052-2009	Hollowell, Jennifer/0000-0002-4041-5732; Quigley, Maria/0000-0002-8058-6181	Policy Research Programme in the Department of Health [PRP 108/0001]; Policy Research Programme in the Department of Health	Policy Research Programme in the Department of Health; Policy Research Programme in the Department of Health	This work was supported by the Policy Research Programme in the Department of Health, Award Number: PRP 108/0001 to JJK. This paper reports on an independent study which is funded by the Policy Research Programme in the Department of Health. The views expressed are not necessarily those of the Department. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio AP, 2010, MATERN CHILD HLTH J, V14, P557, DOI 10.1007/s10995-009-0495-9; Alsulaiman A, 2012, PRENATAL DIAG, V32, P1109, DOI 10.1002/pd.3967; [Anonymous], 2015, TECHNICAL REPORT; Aveyard P, 2002, BJOG-INT J OBSTET GY, V109, P894, DOI 10.1016/S1470-0328(02)01197-7; Bakeo AC, 2006, PAEDIATR PERINAT EP, V20, P127, DOI 10.1111/j.1365-3016.2006.00708.x; Balchin I, 2007, EARLY HUM DEV, V83, P749, DOI 10.1016/j.earlhumdev.2007.09.003; Balchin I, 2007, BRIT MED J, V334, P833, DOI 10.1136/bmj.39132.482025.80; Berman S, 1996, AM J OBSTET GYNECOL, V175, P73, DOI 10.1016/S0002-9378(96)70253-3; Chen HY, 2013, AM J PERINAT, V30, P469, DOI 10.1055/s-0032-1326992; Datta-Nemdharry P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001088; Dattani N, 2002, HLTH STAT Q, P16; Ethnic group national identity and religion, MEAS EQ GUID COLL CL; Fieldhouse EA, 1996, ENVIRON PLANN A, V28, P237, DOI 10.1068/a280237; Fiscella K, 1996, PUBLIC HEALTH REP, V111, P104; GILLIES DRN, 1984, J EPIDEMIOL COMMUN H, V38, P214, DOI 10.1136/jech.38.3.214; Goldenberg R L, 1996, Am J Obstet Gynecol, V174, P1618; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; GRIFFITHS R, 1989, BRIT MED J, V298, P94, DOI 10.1136/bmj.298.6666.94; GRIFFITHS R, 1989, BRIT MED J, V298, P1099, DOI 10.1136/bmj.298.6680.1099-c; Hauck FR, 2011, SEMIN PERINATOL, V35, P209, DOI 10.1053/j.semperi.2011.02.018; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hessol NA, 2005, PEDIATRICS, V115, pE44, DOI 10.1542/peds.2004-0478; Hewison J, 2007, PRENATAL DIAG, V27, P419, DOI 10.1002/pd.1701; Hilder Lisa, 2007, Health Stat Q, P25; Hollowell J, 2011, SEMIN PERINATOL, V35, P240, DOI 10.1053/j.semperi.2011.02.021; Khalil A, 2013, ULTRASOUND OBST GYN, V41, P278, DOI 10.1002/uog.12313; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Loggins S, 2014, J COMMUN HEALTH, V39, P118, DOI 10.1007/s10900-013-9747-0; Lorch SA, 2016, PEDIATR RES, V79, P141, DOI 10.1038/pr.2015.199; MacDorman Marian F, 2011, NCHS Data Brief, P1; MacDorman MF, 2011, SEMIN PERINATOL, V35, P200, DOI 10.1053/j.semperi.2011.02.017; Moser Kath, 2008, Health Stat Q, P15; Moser Kath, 2008, Health Stat Q, P22; Moser Kath, 2009, Health Stat Q, P78; Norman Paul, 2008, Health Stat Q, P18; Oakley Laura, 2009, Health Stat Q, P22; Office for National Statistics, 2016, PARENTS COUNTRY OF B; Payne R. A., 2012, Health Statistics Quarterly, P22; Puthussery S, 2016, BEST PRACT RES CL OB, V32, P39, DOI 10.1016/j.bpobgyn.2015.09.003; Rowley DL, 2012, ANNU REV PUBL HEALTH, V33, P75, DOI 10.1146/annurev-publhealth-031811-124542; Schaaf JM, 2013, AM J PERINAT, V30, P433, DOI 10.1055/s-0032-1326988; Sheridan E, 2013, LANCET, V382, P1350, DOI 10.1016/S0140-6736(13)61132-0; Sidebotham P, 2014, LANCET, V384, P915, DOI 10.1016/S0140-6736(14)60581-X; Spong CY, 2011, OBSTET GYNECOL, V117, P948, DOI 10.1097/AOG.0b013e318211726f; StataCorp, 2013, PANCREATOLOGY; TERRY PB, 1987, ARCH DIS CHILD, V62, P709, DOI 10.1136/adc.62.7.709; TERRY PB, 1985, ARCH DIS CHILD, V60, P866, DOI 10.1136/adc.60.9.866; Troe EJWM, 2006, PAEDIATR PERINAT EP, V20, P140, DOI 10.1111/j.1365-3016.2006.00699.x; Vang ZM, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0101-5; Villadsen SF, 2009, J EPIDEMIOL COMMUN H, V63, P106, DOI 10.1136/jech.2008.078741; Weightman AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000964; Welsh Government, 2014, WELSH INDEX MULTIPLE; WIGGLESWORTH JS, 1980, LANCET, V2, P684; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Willis E, 2014, CLIN PERINATOL, V41, P847, DOI 10.1016/j.clp.2014.08.008; Yu JP, 2012, HEALTH SOC CARE COMM, V20, P329, DOI 10.1111/j.1365-2524.2011.01036.x	57	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195146	10.1371/journal.pone.0195146	http://dx.doi.org/10.1371/journal.pone.0195146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649290	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900027
J	Liu, YY; Sowmya, A; Khamis, H				Liu, Yingying; Sowmya, Arcot; Khamis, Heba			Single camera multi-view anthropometric measurement of human height and mid-upper arm circumference using linear regression	PLOS ONE			English	Article							PHOTOGRAMMETRY; RISK	Background Manually measured anthropometric quantities are used in many applications including human malnutrition assessment. Training is required to collect anthropometric measurements manually, which is not ideal in resource-constrained environments. Photogrammetric methods have been gaining attention in recent years, due to the availability and affordability of digital cameras. Objective The primary goal is to demonstrate that height and mid-upper arm circumference (MUAC) indicators of malnutrition can be accurately estimated by applying linear regression to distance measurements from photographs of participants taken from five views, and determine the optimal view combinations. A secondary goal is to observe the effect on estimate error of two approaches which reduce complexity of the setup, computational requirements and the expertise required of the observer. Methods Thirty-one participants (11 female, 20 male; 18-37 years) were photographed from five views. Distances were computed using both camera calibration and reference object techniques from manually annotated photos. To estimate height, linear regression was applied to the distances between the top of the participants head and the floor, as well as the height of a bounding box enclosing the participant's silhouette which eliminates the need to identify the floor. To estimate MUAC, linear regression was applied to the mid-upper arm width. Estimates were computed for all view combinations and performance was compared to other photogrammetric methods from the literature linear distance method for height, and shape models for MUAC. Results The mean absolute difference (MAD) between the linear regression estimates and manual measurements were smaller compared to other methods. For the optimal view combinations (smallest MAD), the technical error of measurement and coefficient of reliability also indicate the linear regression methods are more reliable. The optimal view combination was the front and side views. When estimating height by linear regression of the distance from the head to the floor, the mean MAD was 10.51 mm +/- 6.52 mm SD, and when estimating height from the bounding box using the reference object, the mean MAD per participant was 11.53 mm +/- 6.43 mm SD. When estimating MUAC from the mid-upper arm radius using the reference object, the mean MAD was 7.24 mm +/- 4.79 mm SD. The mean MAD for all methods when using camera calibration was 2-3 mm smaller. Conclusions Applying linear regression to distance measurements from photos of adults taken from multiple view angles has been shown to accurately estimate height and MUAC to within the accuracy required for nutrition assessment. Future work will focus on automating the landmark detection, and validating the methods on populations that include undernourished adults and children of all nutrition statuses. These future works will improve the practicality of this method as a potential tool for nutrition assessment by novice users.	[Liu, Yingying; Khamis, Heba] Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Sowmya, Arcot] Univ New South Wales, Sch Comp Sci & Engn, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Khamis, H (corresponding author), Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia.	h.khamis@unsw.edu.au	LIU, YING/GZL-7252-2022		Bill & Melinda Gates Foundation [OPP1140536]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Grant Number OPP1140536, awarded to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030345; Ayma VA, 2016, NUTR ASSESSMENT CHIL, P1; BenAbdelkader C, 2008, STAT BODY HEIGHT EST, P1; BRIEND A, 1986, NUTR RES, V6, P249, DOI 10.1016/S0271-5317(86)80129-4; Chagomoka T, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.29425; Chaput J. P., 2016, PEDIAT OBESITY; CHEN LC, 1980, AM J CLIN NUTR, V33, P1836, DOI 10.1093/ajcn/33.8.1836; Chen Y, 2016, IEEE T VIS COMPUT GR, V22, P2000, DOI 10.1109/TVCG.2015.2478779; Criminisi A, 2000, INT J COMPUT VISION, V40, P123, DOI 10.1023/A:1026598000963; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Dediu H., 2014, WILL SMARTPHONES SAT; GSMA, 2016, MOB EC AFR 2016; GURNEY JM, 1973, AM J CLIN NUTR, V26, P912, DOI 10.1093/ajcn/26.9.912; Herianto PS, 2010, DEV DIGITAL ANTHROPO, P7; Hung C., 2004, P 7 INT C WORK COMP, V29, P764; Jeges E, 2008, MEASURING HUMAN HEIG, P755; Li J, 2012, NORTHEAST BIOENGIN C, P426, DOI 10.1109/NEBC.2012.6206923; Li ZX, 2013, IEEE ENG MED BIO, P366, DOI 10.1109/EMBC.2013.6609513; Liu H, 2008, J ENG DESIGN, V19, P45, DOI 10.1080/09544820601186088; Liu XB, 2017, ADV MATER INTERFACES, V4, DOI 10.1002/admi.201601227; Liu ZB, 2017, IEEE T CYBERNETICS, V47, P695, DOI 10.1109/TCYB.2016.2524406; Madden AM, 2016, J HUM NUTR DIET, V29, P7, DOI 10.1111/jhn.12278; MathWorks, 2017, SINGL CAM CAL APP; Meunier P, 2000, APPL ERGON, V31, P445, DOI 10.1016/S0003-6870(00)00023-5; Mwangome MK, 2012, TROP MED INT HEALTH, V17, P622, DOI 10.1111/j.1365-3156.2012.02959.x; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Penders B, 2015, J PEDIATR ENDOCR MET, V28, P1357, DOI 10.1515/jpem-2015-0172; Pesce M, 2016, VIRTUAL PHYS PROTOTY, V11, P49, DOI 10.1080/17452759.2015.1101872; Peyer KE, 2015, PEERJ, V3, DOI 10.7717/peerj.831; Sicotte M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-102; Sultana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121456; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 2008, WHO CHILD GROWTH STA	35	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195600	10.1371/journal.pone.0195600	http://dx.doi.org/10.1371/journal.pone.0195600			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649306	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900059
J	Moeeni, M; Rashidian, A; Aghajanian, A				Moeeni, Maryam; Rashidian, Arash; Aghajanian, Akbar			Women's relative status and childbearing intentions: Empirical evidence from Iran	PLOS ONE			English	Article							FERTILITY INTENTIONS; PREFERENCE THEORY; ASIAN COUNTRIES; BEHAVIOR; BIRTH	Childbearing intentions are primary predictor of childbearing behaviors, particularly in low fertility societies. This study examined the role of relative status of women in childbearing intentions in Iran where fertility has been declining since 1986 and it has been around the replacement level during the last two decades. Data from the 2010 Iran's Multiple Indicator Demographic and Health Survey (IrMIDHS) were used to estimate the effect of relative status of women on intention to have more children among women with one child and those with two children. The results showed modest effect of relative status of women on future childbearing intentions at both parity one and two controlling for socioeconomic and demographic factors. One implication from this finding is that within low fertility regimes where fertility level is around or below replacement level, the relative status of women is no more as important determinant of childbearing intention as in situations of high fertility regimes. This interpretation is consistent with the fact that most of the studies showing strong effect from relative status of women on childbearing are based on data from the situations where fertility level has been at the pre-transitional level.	[Moeeni, Maryam] Isfahan Univ Med Sci, Social Determinants Hlth Res Ctr, Esfahan, Iran; [Moeeni, Maryam] Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran; [Rashidian, Arash] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran; [Aghajanian, Akbar] FSU UNC, Dept Sociol, Fayetteville, NC USA	Isfahan University Medical Science; Isfahan University Medical Science; Tehran University of Medical Sciences	Moeeni, M (corresponding author), Isfahan Univ Med Sci, Social Determinants Hlth Res Ctr, Esfahan, Iran.; Moeeni, M (corresponding author), Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran.	mmoeini1387@gmail.com	Moeeni, Maryam/K-3589-2016; Moeeni, Maryam/I-1344-2018	Moeeni, Maryam/0000-0002-4525-6574; 				Abbasi-Shavazi MJ, 2009, NATL PROVINCIAL LEVE; Abbasi-Shavazi MJ, 2007, ASIA PACIFIC POPULAT, V22; AbbasiShavazi MJ, 2009, FERTILITY TRANSITION IN IRAN: REVOLUTION AND REPRODUCTION, P1; Balbo N, 2013, EUR J POPUL, V29, P1, DOI 10.1007/s10680-012-9277-y; Barber JS, 2001, SOC PSYCHOL QUART, V64, P101, DOI 10.2307/3090128; BECKER GS, 1988, Q J ECON, V103, P1, DOI 10.2307/1882640; BECKER GS, 1992, J POPUL ECON, V5, P185; Behboodi-Moghadam Z, 2015, IRAN J PUBLIC HEALTH, V44, P1126; BULATAO RA, 1981, DEMOGRAPHY, V18, P1, DOI 10.2307/2061046; CHIAPPORI PA, 1988, ECONOMETRICA, V56, P63, DOI 10.2307/1911842; Erfani A, 2008, J BIOSOC SCI, V40, P459, DOI 10.1017/S002193200700243X; Erfani A, 2014, BIODEMOGR SOC BIOL, V60, P67, DOI 10.1080/19485565.2014.899428; Farzanegan MR, 2016, REV ECON HOUSEHOLD, V14, P1029, DOI 10.1007/s11150-014-9279-0; Freedman R., 1974, COMMUNITY LEVEL DATA; Gillmore MR, 2002, J MARRIAGE FAM, V64, P885, DOI 10.1111/j.1741-3737.2002.00885.x; GOLDBERG D, 1975, SOC FORCES, V54, P84, DOI 10.2307/2576079; Haddad GK, 2015, EMPIR ECON, V48, P1365, DOI 10.1007/s00181-014-0828-4; Hakim C, 1998, BRIT J SOCIOL, V49, P137, DOI 10.2307/591267; Hakim C, 2003, POPUL DEV REV, V29, P349, DOI 10.1111/j.1728-4457.2003.00349.x; Hayford SR, 2009, DEMOGRAPHY, V46, P765, DOI 10.1353/dem.0.0073; Heiland F, 2008, EUR J POPUL, V24, P129, DOI 10.1007/s10680-008-9162-x; Hindin MJ, 2000, POPUL RES POLICY REV, V19, P255, DOI 10.1023/A:1026590717779; HIRSCHMAN C, 1990, DEMOGRAPHY, V27, P369, DOI 10.2307/2061374; Iacovou M, 2011, POPUL DEV REV, V37, P89, DOI 10.1111/j.1728-4457.2011.00391.x; Komura M, 2013, J POPUL ECON, V26, P943, DOI 10.1007/s00148-012-0460-6; Liefbroer AC, 2009, EUR J POPUL, V25, P363, DOI 10.1007/s10680-008-9173-7; Mason KO, 2000, DEMOGRAPHY, V37, P299, DOI 10.2307/2648043; McQuillan J, 2015, SOCIOL PERSPECT, V58, P20, DOI 10.1177/0731121414534393; Moeeni M, 2014, INT J HEALTH POLICY, V3, P135, DOI 10.15171/ijhpm.2014.78; Namboodiri NK., 1983, SEQUENTIAL FERTILITY; Rocca CH, 2010, PERSPECT SEX REPRO H, V42, P186, DOI 10.1363/4218610; Samari G., 2017, POPULATION RES POLIC, P1; Samari G., 2015, WOMENS STATUS AUTONO; Samari G, 2015, CCPR WORKING PAPERS; Schoen R, 1999, J MARRIAGE FAM, V61, P790, DOI 10.2307/353578; Shreffler KM, 2013, J FAM ECON ISS, V34, P285, DOI 10.1007/s10834-012-9331-2; UDRY JR, 1983, DEMOGRAPHY, V20, P117, DOI 10.2307/2061230; Upadhyay UD, 2005, SOC SCI MED, V60, P2641, DOI 10.1016/j.socscimed.2004.11.032; Upadhyay UD, 2012, INT PERSPECT SEX R H, V38, P78, DOI 10.1363/3807812; YAMAGUCHI K, 1995, AM SOCIOL REV, V60, P272, DOI 10.2307/2096387	40	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195428	10.1371/journal.pone.0195428	http://dx.doi.org/10.1371/journal.pone.0195428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649246	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900044
J	Ryu, DH; Jung, YH; Jeung, KW; Lee, BK; Jeong, YW; Geun Yun, J; Lee, DH; Lee, SM; Heo, T; Min, YI				Ryu, Dong Hyun; Jung, Yong Hun; Jeung, Kyung Woon; Lee, Byung Kook; Jeong, Young Won; Geun Yun, Jong; Lee, Dong Hun; Lee, Sung Min; Heo, Tag; Min, Yong Il			Effect of one-lung ventilation on end-tidal carbon dioxide during cardiopulmonary resuscitation in a pig model of cardiac arrest	PLOS ONE			English	Article							HEART-ASSOCIATION GUIDELINES; LIFE-SUPPORT; INDICATOR; PRESSURE	Unrecognized endobronchial intubation frequently occurs after emergency intubation. However, no study has evaluated the effect of one-lung ventilation on end-tidal carbon dioxide (ETCO2) during cardiopulmonary resuscitation (CPR). We compared the hemodynamic parameters, blood gases, and ETCO2 during one-lung ventilation with those during conventional two-lung ventilation in a pig model of CPR, to determine the effect of the former on ETCO2. A randomized crossover study was conducted in 12 pigs intubated with double lumen endobronchial tube to achieve lung separation. During CPR, the animals underwent three 5-min ventilation trials based on a randomized crossover design: left-lung, right-lung, or two-lung ventilation. Arterial blood gases were measured at the end of each ventilation trial. Ventilation was provided using the same tidal volume throughout the ventilation trials. Comparison using generalized linear mixed model revealed no significant group effects with respect to aortic pressure, coronary perfusion pressure, and carotid blood flow; however, significant group effect in terms of ETCO2 was found (P < 0.001). In the post hoc analyses, ETCO2 was lower during the right-lung ventilation than during the two-lung (P = 0.006) or left-lung ventilation (P < 0.001). However, no difference in ETCO2 was detected between the left-lung and two-lung ventilations. The partial pressure of arterial carbon dioxide (PaCO2), partial pressure of arterial oxygen (PaO2), and oxygen saturation (SaO(2)) differed among the three types of ventilation (P = 0.003, P = 0.001, and P = 0.001, respectively). The post hoc analyses revealed a higher PaCO2, lower PaO2, and lower SaO(2) during right-lung ventilation than during two-lung or left-lung ventilation. However, the levels of these blood gases did not differ between the left-lung and two-lung ventilations. In a pig model of CPR, ETCO2 was significantly lower during right-lung ventilation than during two-lung ventilation. However, interestingly, ETCO2 during left-lung ventilation was comparable to that during two-lung ventilation.	[Ryu, Dong Hyun; Jung, Yong Hun; Jeung, Kyung Woon; Lee, Byung Kook; Jeong, Young Won; Lee, Dong Hun; Lee, Sung Min; Heo, Tag; Min, Yong Il] Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea; [Geun Yun, Jong] Honam Univ, Dept Emergency Med Serv, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital; Honam University	Jeung, KW (corresponding author), Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea.	neoneti@hanmail.net	Lee, Byung Kook/M-2236-2018	Lee, Byung Kook/0000-0003-3571-9448	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A09057248]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A09057248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISSINGER U, 1989, ANN EMERG MED, V18, P853, DOI 10.1016/S0196-0644(89)80211-2; BRUNEL W, 1989, CHEST, V96, P1043, DOI 10.1378/chest.96.5.1043; CALLAHAM M, 1990, CRIT CARE MED, V18, P358, DOI 10.1097/00003246-199004000-00002; Cheng Christopher P, 2006, Congenit Heart Dis, V1, P210, DOI 10.1111/j.1747-0803.2006.00037.x; Cho YC, 2011, EMERG MED J, V28, P40, DOI 10.1136/emj.2010.099911; DRONEN S, 1982, ANN EMERG MED, V11, P116, DOI 10.1016/S0196-0644(82)80328-4; GANDHI SK, 1991, J CLIN MONITOR, V7, P35, DOI 10.1007/BF01617896; Hamrick JL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000450; Jin XH, 2000, CRIT CARE MED, V28, P2415, DOI 10.1097/00003246-200007000-00037; JOHNSON DH, 1992, CAN J ANAESTH, V39, P184, DOI 10.1007/BF03008654; Kolar M, 2008, CRIT CARE, V12, DOI 10.1186/cc7009; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Markstaller K, 2002, RESUSCITATION, V53, P307, DOI 10.1016/S0300-9572(02)00031-X; Markstaller K, 2008, RESUSCITATION, V79, P125, DOI 10.1016/j.resuscitation.2008.03.228; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; ORNATO JP, 1983, CRIT CARE MED, V11, P79, DOI 10.1097/00003246-198302000-00004; Rubertsson S, 1998, ACTA ANAESTH SCAND, V42, P32, DOI 10.1111/j.1399-6576.1998.tb05077.x; Ryu SJ, 2016, ACTA ANAESTH SCAND, V60, P1012, DOI 10.1111/aas.12728; SANDERS AB, 1989, JAMA-J AM MED ASSOC, V262, P1347, DOI 10.1001/jama.262.10.1347; Sheak KR, 2015, RESUSCITATION, V89, P149, DOI 10.1016/j.resuscitation.2015.01.026; Sitzwohl C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5943; Spindelboeck W, 2013, RESUSCITATION, V84, P770, DOI 10.1016/j.resuscitation.2013.01.012; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; WEIL MH, 1985, CRIT CARE MED, V13, P907, DOI 10.1097/00003246-198511000-00011	24	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195826	10.1371/journal.pone.0195826	http://dx.doi.org/10.1371/journal.pone.0195826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649316	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900094
J	Chu, LSW; John, EM; Yang, BY; Kurian, AW; Zia, Y; Yu, K; Ingles, SA; Stanczyk, FZ; Hsing, AW				Chu, Lisa W.; John, Esther M.; Yang, Baiyu; Kurian, Allison W.; Zia, Yasaman; Yu, Kai; Ingles, Sue A.; Stanczyk, Frank Z.; Hsing, Ann W.			Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies	PLOS ONE			English	Article							PHASE-SHIFTS; MULTIETHNIC POPULATION; URINARY MELATONIN; MAGNETIC-FIELDS; HORMONE-LEVELS; BRIGHT LIGHT; NIGHT-WORK; RISK; 6-SULFATOXYMELATONIN; PROGESTERONE	Background Circulating melatonin is a good candidate biomarker for studies of circadian rhythms and circadian disruption. However, epidemiologic studies on circulating melatonin are limited because melatonin is secreted at night, yet most epidemiologic studies collect blood during the day when melatonin levels are very low, and assays are lacking that are ultrasensitive to detect low levels of melatonin reliably. Objective To assess the performance of a refined radioimmunoassay in measuring morning melatonin among women. Methods We used morning serum samples from 47 postmenopausal women ages 48 +/- 80 years without a history of breast cancer who participated in the San Francisco Bay Area Breast Cancer Study, including 19 women who had duplicate measurements. The coefficient of variation (CV) and intraclass coefficient (ICC) were estimated using the random effect model. Results Reproducibility for the assay was satisfactory, with a CV of 11.2% and an ICC of 98.9%; correlation between the replicate samples was also high (R = 0.96). In the 47 women, serum melatonin levels ranged from 0.6 to 62.6 pg/ml, with a median of 7.0 pg/ml. Conclusion Our results suggest that it is possible to reliably measure melatonin in postmenopausal women in morning serum samples in large epidemiologic studies to evaluate the role of melatonin in cancer etiology or prognosis.	[Chu, Lisa W.; John, Esther M.; Zia, Yasaman] Canc Prevent Inst Calif, Fremont, CA USA; [Chu, Lisa W.; John, Esther M.; Yang, Baiyu; Kurian, Allison W.; Hsing, Ann W.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [John, Esther M.; Kurian, Allison W.; Hsing, Ann W.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Kurian, Allison W.; Hsing, Ann W.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Yu, Kai] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Ingles, Sue A.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Ingles, Sue A.; Stanczyk, Frank Z.] Univ Southern Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Hsing, Ann W.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA	Cancer Prevention Institute of California; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; University of Southern California; Stanford University	Hsing, AW (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.; Hsing, AW (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA.; Hsing, AW (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Hsing, AW (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA.	annhsing@stanford.edu	; Kurian, Allison/A-4560-2019	Zia, Yasaman/0000-0001-6049-3706; Stanczyk, Frank/0000-0002-3607-121X; Kurian, Allison/0000-0002-6175-9470	Stanford Cancer Institute [CA63446]; National Cancer Institute [CA77305]; U.S. Department of Defense [DAMD1796-1-6071]	Stanford Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense)	This study was supported by a Development Cancer Research Award (to AWH) from the Stanford Cancer Institute (http://med.stanford.eduicancer.htd) and by grants (to EMJ) CA63446 and CA77305 from the National Cancer Institute (httpsiAmw.cancer.govi) and DAMD1796-1-6071 from the U.S. Department of Defense (https://www.defenselov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonde JP, 2012, SCAND J WORK ENV HLT; Davis S, 2001, AM J EPIDEMIOL, V154, P591, DOI 10.1093/aje/154.7.591; DEACON SJ, 1994, CLIN ENDOCRINOL, V40, P413; Dijk DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030037; Erren TC, 2009, J PINEAL RES, V46, P245, DOI 10.1111/j.1600-079X.2009.00665.x; Figueiro MG, 2013, NAT SCI SLEEP, V5, P133, DOI 10.2147/NSS.S52203; FOLKARD S, 1985, CHRONOBIOLOGIA, V12, P31; Forman JP, 2010, J HYPERTENS, V28, P446, DOI 10.1097/HJH.0b013e3283340c16; Gail MH, 1996, CANCER EPIDEM BIOMAR, V5, P835; He CL, 2015, INT ARCH OCC ENV HEA, V88, P533, DOI 10.1007/s00420-014-0986-x; Hsing AW, 2010, CANCER EPIDEM BIOMAR, V19, P932, DOI 10.1158/1055-9965.EPI-10-0004; John EM, 2003, CANCER EPIDEM BIOMAR, V12, P1143; John EM, 2007, AM J EPIDEMIOL, V166, P1409, DOI 10.1093/aje/kwm259; Langley A, 2011, EPIDEMIOLOGY, V22, pS108, DOI 10.1097/01.ede.0000391999.63861.49; Levallois P, 2001, AM J EPIDEMIOL, V154, P601, DOI 10.1093/aje/154.7.601; Mantele S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037123; Nogueira LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083208; Qin YY, 2014, INT J CANCER, V134, P1166, DOI 10.1002/ijc.28452; Schernhammer ES, 2006, J PINEAL RES, V40, P116, DOI 10.1111/j.1600-079X.2005.00285.x; Schernhammer ES, 2004, CANCER EPIDEM BIOMAR, V13, P936; Sharkey KM, 2002, AM J PHYSIOL-REG I, V282, pR454, DOI 10.1152/ajpregu.00135.2001; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Toffol E, 2014, MATURITAS; Toffol E, 2013, MENOPAUSE; Travis RC, 2004, JNCI-J NATL CANCER I, V96, P475, DOI 10.1093/jnci/djh077; Travis RC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw169; WEBLEY GE, 1986, J CLIN ENDOCR METAB, V63, P323, DOI 10.1210/jcem-63-2-323; WEITZMAN ED, 1978, J NEURAL TRANSM, P325; Wirz-Justice A, 2004, J PINEAL RES, V36, P192, DOI 10.1111/j.1600-079X.2004.00117.x	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195666	10.1371/journal.pone.0195666	http://dx.doi.org/10.1371/journal.pone.0195666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641614	Green Submitted, gold, Green Published			2022-12-27	WOS:000429742900082
J	Lee, JWO; Heo, W; Lee, J; Jin, N; Yoon, SM; Park, KY; Kim, EY; Kim, WT; Kim, JY				Lee, Jin Won; Heo, Woon; Lee, Jinu; Jin, Narae; Yoon, Sei Mee; Park, Ki Youl; Kim, Eun Yu; Kim, Woo Taek; Kim, Joo Young			The B cell death function of obinutuzumab-HDEL produced in plant (Nicotiana benthamiana L.) is equivalent to obinutuzumab produced in CHO cells (vol 13, e0191075, 2018)	PLOS ONE			English	Correction																		Lee JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191075	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195917	10.1371/journal.pone.0195917	http://dx.doi.org/10.1371/journal.pone.0195917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641595	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900098
J	Masuda, K; Tanabe, K; Ujike, H; Hinamoto, N; Miyake, H; Tanimura, S; Sugiyama, H; Sato, Y; Maeshima, Y; Wada, J				Masuda, Kana; Tanabe, Katsuyuki; Ujike, Haruyo; Hinamoto, Norikazu; Miyake, Hiromasa; Tanimura, Satoshi; Sugiyama, Hitoshi; Sato, Yasufumi; Maeshima, Yohei; Wada, Jun			Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEGATIVE FEEDBACK REGULATOR; RENAL ALTERATIONS; MESANGIAL CELLS; TUMOR-GROWTH; TGF-BETA; EXPRESSION; VEGF; DISEASE; INJURY	Angiogenesis has been implicated in glomerular alterations in the early stage of diabetic nephropathy. We previously reported the renoprotective effects of vasohibin-1 (VASH1), which is a novel angiogenesis inhibitor derived from endothelial cells, on diabetic nephropathy progression. Vasohibin-2 (VASH2) was originally identified as a VASH1 homolog and possesses pro-angiogenic activity in contrast to VASH1. In addition, VASH2 was recently shown to promote epithelial-to-mesenchymal transition via enhanced transforming growth factor (TGF)-beta signaling in cancer cells. Herein, we investigated the pathogenic roles of VASH2 in diabetic nephropathy using VAHS2-deficient mice. The type 1 diabetes model was induced by intraperitoneal injections of streptozotocin in VASH2 homozygous knockout (VASH2 LacZ/LacZ) or wild-type mice. These mice were euthanized 16 weeks after inducing hyperglycemia. Increased urine albumin excretion and creatinine clearance observed in diabetic wild-type mice were significantly prevented in diabetic VASH2-deficient mice. Accordingly, diabetes-induced increase in glomerular volume and reduction in glomerular slit-diaphragm density were significantly improved in VASH2 knockout mice. Increased glomerular endothelial area was also suppressed in VASH2-deficient mice, in association with inhibition of enhanced vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2), but not VEGF level. Furthermore, glomerular accumulation of mesangial matrix, including type IV collagen, and increased expression of TGF-beta were improved in diabetic VASH2 knockout mice compared with diabetic wild-type mice. Based on the immunofluorescence findings, endogenous VASH2 localization in glomeruli was consistent with mesangial cells. Human mesangial cells (HMCs) were cultured under high glucose condition in in vitro experiments. Transfection of VASH2 small interfering RNA (siRNA) into the HMCs resulted in the suppression of type IV collagen production induced by high glucose compared with control siRNA. These results indicate that VASH2 may be involved in diabetes-induced glomerular alterations, particularly impaired filtration barrier and mesangial expansion. Therefore, VASH2 is likely to represent a promising therapeutic target for diabetic nephropathy.	[Masuda, Kana; Tanabe, Katsuyuki; Ujike, Haruyo; Hinamoto, Norikazu; Miyake, Hiromasa; Tanimura, Satoshi; Maeshima, Yohei; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Resource Dev Dialysis Therapy Kidney D, Okayama, Japan; [Sato, Yasufumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Sendai, Miyagi, Japan	Okayama University; Okayama University; Tohoku University	Tanabe, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan.	tanabek@okayama-u.ac.jp	Sato, Yasufumi/AAF-3367-2019; Sugiyama, Hitoshi/B-2252-2011; WADA, Jun/B-2023-2011; Tanabe, Katsuyuki/J-1341-2019	Sugiyama, Hitoshi/0000-0002-4127-6471; WADA, Jun/0000-0003-1468-5170; Tanabe, Katsuyuki/0000-0003-4767-5892	Japan Society for the Promotion of Science, KAKENHI [JP23591193, JP26461228]; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	Support was provided by the Japan Society for the Promotion of Science, KAKENHI Grant Number JP23591193 and JP26461228 (2011-2014 to YM) and the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University (2014-2015 and 2017 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Dimke H, 2015, CURR OPIN NEPHROL HY, V24, P231, DOI 10.1097/MNH.0000000000000117; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Gilbert RE, 1998, LAB INVEST, V78, P1017; Guo M, 2005, J ANAT, V207, P813, DOI 10.1111/j.1469-7580.2005.00492.x; Hinamoto N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107934; Kim JC, 2015, HEPATO-GASTROENTEROL, V62, P251, DOI 10.5754/hge141015; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Kitahara S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-99; Koyanagi T, 2017, CANCER SCI, V108, P512, DOI 10.1111/cas.13149; Koyanagi T, 2013, ONCOL LETT, V5, P1058, DOI 10.3892/ol.2013.1119; Lanaspa MA, 2014, J AM SOC NEPHROL, V25, P2526, DOI 10.1681/ASN.2013080901; Makino H, 1996, DIABETES, V45, P488, DOI 10.2337/diabetes.45.4.488; Miyashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046459; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Norita R, 2017, CANCER SCI, V108, P419, DOI 10.1111/cas.13157; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P189, DOI 10.1007/BF00399948; Olmer R, 2010, STEM CELL RES, V5, P51, DOI 10.1016/j.scr.2010.03.005; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Sato W, 2011, AM J PATHOL, V179, P155, DOI 10.1016/j.ajpath.2011.03.024; Shankland SJ, 1998, MINER ELECTROL METAB, V24, P168, DOI 10.1159/000057366; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Shen ZL, 2012, MED ONCOL, V29, P2718, DOI 10.1007/s12032-012-0212-1; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Suzuki Y, 2017, CANCER SCI, V108, P2342, DOI 10.1111/cas.13411; Takahashi Y, 2012, MOL CANCER RES, V10, P1135, DOI 10.1158/1541-7786.MCR-12-0098-T; Tanabe K, 2007, KIDNEY INT, V71, P227, DOI 10.1038/sj.ki.5002040; Tanabe K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5724069; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; Tanabe K, 2012, AM J PHYSIOL-RENAL, V302, pF1151, DOI 10.1152/ajprenal.00596.2011; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Wang B, 2017, AM J TRANSL RES, V9, P2911; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Watatani H, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12054; Watatani H, 2015, ACTA MED OKAYAMA, V69, P1; Xue XF, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0062-x; Yamasaki H, 2011, PROSTAG LEUKOTR ESS, V84, P99, DOI 10.1016/j.plefa.2010.11.005	41	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195779	10.1371/journal.pone.0195779	http://dx.doi.org/10.1371/journal.pone.0195779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641565	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900091
J	Haque, E; Banik, U; Monowar, T; Anthony, L; Adhikary, AK				Haque, Ezazul; Banik, Urmila; Monowar, Tahmina; Anthony, Leela; Adhikary, Arun Kumar			Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon (vol 13, e0194516, 2018)	PLOS ONE			English	Correction																		Hague E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194516	1	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196263	10.1371/journal.pone.0196263	http://dx.doi.org/10.1371/journal.pone.0196263			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668738	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200081
J	Lan, Y; Mai, ZL; Zhou, SY; Liu, Y; Li, SJ; Zhao, ZJ; Duan, XL; Cai, C; Deng, T; Zhu, W; Wu, WQ; Zeng, GH				Lan, Yu; Mai, Zanlin; Zhou, Shiyu; Liu, Yang; Li, Shujue; Zhao, Zhijian; Duan, Xiaolu; Cai, Cao; Deng, Tuo; Zhu, Wei; Wu, Wenqi; Zeng, Guohua			Prevalence of metabolic syndrome in China: An up-dated cross-sectional study	PLOS ONE			English	Article							SERUM URIC-ACID; NATIONAL-HEALTH; US ADULTS; EDUCATION; OBESITY; AGE	Metabolic syndrome (MS) is an increasing public health concern because of rapid lifestyle changes. Although there have been previous studies on the prevalence of MS in China, the prevalence may have changed with lifestyle changes over the last decade. To update this prevalence, we performed a cross-sectional survey among adults over 18 years old across China from May 2013 to July 2014. Participants underwent questionnaires and provided blood and urine samples for analysis. MS was defined according to the criteria of the China Diabetes Society. A total of 12570 individuals (45.2% men) with an average age of 48.8 15.3 (18-96) years were selected and invited to participate in the study. In total, 9310 (40.7% men) individuals completed the investigation, with a response rate of 74.1%. The prevalence of MS in China was 14.39% [95% confidence interval (CI): -3.75-32.53%], and the age-adjusted prevalence was 9.82% (95% CI: 9.03-10.61%; 7.78% in men and 6.76% in women; 7.39% in rural residents and 6.98% in urban residents). The highest prevalence occurred among adults aged 50-59 years (1.95%, 95% CI: 1.40-2.50%), and the lowest prevalence occurred among adults aged 40-49 years (0.74%, 95% CI: 0.38-1.10%); the prevalence was the highest in the south region and lowest in the east region (4.46% and 1.23%, respectively). The results of logistic regression analyses showed that age, urolithiasis, hyperuricemia, coronary artery disease, thiazide drugs intake, family history of diabetes and hypertension were all significantly associated with an increased risk of metabolic syndrome (OR>1). In addition, education, vitamin D intake and family history of urolithiasis are all protective factors (OR<1). Our results indicate that there was a high prevalence of MS in Chinese adults. Compared to the previous study 10 years ago, some preventive strategies have worked; however, further work on the prevention and treatment of MS remains necessary.	[Lan, Yu; Mai, Zanlin; Liu, Yang; Li, Shujue; Zhao, Zhijian; Duan, Xiaolu; Cai, Cao; Deng, Tuo; Zhu, Wei; Wu, Wenqi; Zeng, Guohua] Guangzhou Med Univ, Dept Urol, Minimally Invas Surg Ctr, Guangdong Key Lab Urol,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhou, Shiyu] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zhou, Shiyu] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Dept Urol, Minimally Invas Surg Ctr, Guangdong Key Lab Urol,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.tom.com			National Natural Science Foundation of China [81670643, 81600542, 81570633]; Guangzhou Science Technology and Innovation Commission [201604020001, 201704020193]; Collaborative Innovation Project of Guangzhou Education Bureau [1201620011]; Science and Technology Project of Guangdong Province [2014A020209085, 20176030314108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science Technology and Innovation Commission; Collaborative Innovation Project of Guangzhou Education Bureau; Science and Technology Project of Guangdong Province	Our work was financed by these following grants: The National Natural Science Foundation of China (NO. 81670643, NO. 81600542 and NO. 81570633.), the Guangzhou Science Technology and Innovation Commission (No. 201604020001 and No. 201704020193), the Collaborative Innovation Project of Guangzhou Education Bureau (NO. 1201620011) and the Science and Technology Project of Guangdong Province (NO. 2014A020209085 and No.20176030314108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Antonelli JA, 2014, EUR UROL, V66, P724, DOI 10.1016/j.eururo.2014.06.036; Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P1637, DOI 10.2105/AJPH.2005.072884; Chen JH, 2016, J NUTR HEALTH AGING, V20, P912, DOI 10.1007/s12603-015-0633-6; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Further Study Of Risk Factors For Stroke And Coronary Heart Disease group, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P298; Ghanei L, 2015, J RES HEALTH SCI, V15, P32; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He SJ, 2017, GYNECOL ENDOCRINOL, V33, P141, DOI 10.1080/09513590.2016.1214261; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Maki KC, 2012, METAB SYNDR RELAT D, V10, P363, DOI 10.1089/met.2012.0020; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Tal S, 2014, J NUTR HEALTH AGING, V18, P22, DOI 10.1007/s12603-013-0360-9; The census office of the state council, TAB 2010 POP CENS PE; WHO, 2011, WHO TECHN REP SER, V894; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P1793, DOI 10.1001/jama.295.15.1793; Zeng GH, 2017, BJU INT, V120, P109, DOI 10.1111/bju.13828	20	35	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196012	10.1371/journal.pone.0196012	http://dx.doi.org/10.1371/journal.pone.0196012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668762	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200075
J	Ma, ZL; Zhao, WQ; Zhao, CZ; Wang, D; Liu, M; Li, DD; Liu, Q				Ma, Zhiliang; Zhao, Wenqiang; Zhao, Chunzhang; Wang, Dong; Liu, Mei; Li, Dandan; Liu, Qing			Plants regulate the effects of experimental warming on the soil microbial community in an alpine scrub ecosystem	PLOS ONE			English	Article							QINGHAI-TIBET PLATEAU; SIBIRAEA-ANGUSTATA SCRUB; TERM N ADDITION; CLIMATE-CHANGE; NITROGEN-FERTILIZATION; TALLGRASS PRAIRIE; RESPONSES; CARBON; BIOMASS; FOREST	Information on how soil microbial communities respond to warming is still scarce for alpine scrub ecosystems. We conducted a field experiment with two plant treatments (plant removal or undisturbed) subjected to warmed or unwarmed conditions to examine the effects of warming and plant removal on soil microbial community structures during the growing season in a Sibiraea angustata scrubland of the eastern Qinghai Tibetan Plateau. The results indicate that experimental warming significantly influenced soil microbial biomass carbon (MBC) and microbial biomass nitrogen (MBN), but the warming effects were dependent on the plant treatments and sampling seasons. In the plant-removal plots, warming did not affect most of the microbial variables, while in the undisturbed plots, warming significantly increased the abundances of actinomycete and Gram-positive bacterial groups during the mid-growing season (July), but it did not affect the fungi groups. Plant removal significantly reduced fungal abundance throughout the growing season and significantly altered the soil microbial community structure in July. The interaction between warming and plant removal significantly influenced the soil MBC and MBN and the abundances of total microbes, bacteria and actinomycete throughout the growing season. Experimental warming significantly reduced the abundance of rare taxa, while the interaction between warming and plant removal tended to have strong effects on the abundant taxa. These findings suggest that the responses of soil microbial communities to warming are regulated by plant communities. These results provide new insights into how soil microbial community structure responds to climatic warming in alpine scrub ecosystems.	[Ma, Zhiliang; Zhao, Wenqiang; Zhao, Chunzhang; Wang, Dong; Liu, Mei; Li, Dandan; Liu, Qing] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Sichuan Prov, Key Lab Mt Ecol Restorat & Bioresource Utilizat &, Chengdu, Sichuan, Peoples R China; [Ma, Zhiliang] Sichuan Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China; [Ma, Zhiliang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Key Lab Sichuan Prov, Key Lab Mt Ecol Restorat & Bioresource Utilizat &, Chengdu, Sichuan, Peoples R China.	liuqing@cib.ac.cn	Ma, Zhiliang/GXV-4296-2022		National Key R&D Program of China [2017YFC0505000]; National Natural Science Foundation of China [31570476, 31400424]; National Science and Technology Basic Work Project [2015FY110300]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Basic Work Project	This study was funded by the National Key R&D Program of China (2017YFC0505000 to Qing Liu), the National Natural Science Foundation of China (31570476 to Qing Liu; 31400424 to Dandan Li), and the National Science and Technology Basic Work Project (2015FY110300) to Qing Liu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Bai E, 2013, NEW PHYTOL, V199, P441, DOI 10.1111/nph.12252; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Barnard RL, 2015, ISME J, V9, P946, DOI 10.1038/ismej.2014.192; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Crowther TW, 2016, NATURE, V540, P104, DOI 10.1038/nature20150; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Fu G, 2012, APPL SOIL ECOL, V61, P158, DOI 10.1016/j.apsoil.2012.05.002; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; Hopkins FM, 2014, SOIL BIOL BIOCHEM, V76, P57, DOI 10.1016/j.soilbio.2014.04.028; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Joergensen RG, 2011, SOIL BIOL BIOCHEM, V43, P873, DOI 10.1016/j.soilbio.2010.09.024; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Jonathan R, 2017, ECOSYSTEMS, V19, P339; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; Klein JA, 2005, GLOBAL CHANGE BIOL, V11, P1440, DOI 10.1111/j.1365-2486.2005.00994.x; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Manzoni S, 2014, SOIL BIOL BIOCHEM, V73, P69, DOI 10.1016/j.soilbio.2014.02.008; Manzoni S, 2012, ECOLOGY, V93, P930, DOI 10.1890/11-0026.1; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Preusser S, 2017, SOIL BIOL BIOCHEM, V105, P138, DOI 10.1016/j.soilbio.2016.11.021; Rawlins BG, 2015, SOIL USE MANAGE, V31, P46, DOI 10.1111/sum.12079; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Romero-Olivares AL, 2017, SOIL BIOL BIOCHEM, V107, P32, DOI 10.1016/j.soilbio.2016.12.026; Rui JP, 2015, APPL ENVIRON MICROB, V81, P6070, DOI 10.1128/AEM.00557-15; Schindlbacher A, 2011, SOIL BIOL BIOCHEM, V43, P1417, DOI 10.1016/j.soilbio.2011.03.005; Solly EF, 2017, NEW PHYTOL, V215, P766, DOI 10.1111/nph.14603; Streit K, 2014, GLOBAL CHANGE BIOL, V20, P1327, DOI 10.1111/gcb.12396; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wang D, 2017, EUR J SOIL SCI, V68, P212, DOI 10.1111/ejss.12414; Wang D, 2017, AGR FOREST METEOROL, V247, P151, DOI 10.1016/j.agrformet.2017.07.026; Xiong JB, 2014, FEMS MICROBIOL ECOL, V89, P281, DOI 10.1111/1574-6941.12289; Xiong QL, 2016, APPL SOIL ECOL, V101, P72, DOI 10.1016/j.apsoil.2016.01.011; Xu MH, 2014, POL J ECOL, V62, P493; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Xue X, 2014, ARCT ANTARCT ALP RES, V46, P441, DOI 10.1657/1938-4246-46.2.441; Yang Lin, 2016, Yingyong Shengtai Xuebao, V27, P2855, DOI 10.13287/j.1001-9332.201609.026; Yin HJ, 2013, GLOBAL CHANGE BIOL, V19, P2158, DOI 10.1111/gcb.12161; Yu CQ, 2014, SCI WORLD J, DOI 10.1155/2014/152576; Yuge K, 2016, J AGR METEOROL, V60, P717; Zhang NL, 2011, SOIL BIOL BIOCHEM, V43, P2053, DOI 10.1016/j.soilbio.2011.06.001; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhao CZ, 2014, PLANT SOIL, V382, P189, DOI 10.1007/s11104-014-2153-2; Zhao J, 2015, EUR J SOIL BIOL, V68, P61, DOI 10.1016/j.ejsobi.2015.03.008; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zhou XQ, 2013, GEODERMA, V206, P24, DOI 10.1016/j.geoderma.2013.04.020	53	8	18	10	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195079	10.1371/journal.pone.0195079	http://dx.doi.org/10.1371/journal.pone.0195079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668711	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200025
J	Prato-Previde, E; Nicotra, V; Pelosi, A; Valsecchi, P				Prato-Previde, Emanuela; Nicotra, Velia; Pelosi, Annalisa; Valsecchi, Paola			Pet dogs' behavior when the owner and an unfamiliar person attend to a faux rival	PLOS ONE			English	Article							CANIS-FAMILIARIS; BASIC EMOTIONS; HUMAN INFANTS; JEALOUSY; ANIMALS; HUMANS; TODDLERS; CONTEXT; LIVES; FACE	While dog owners ascribe different emotions to their pets, including jealousy, research on secondary emotions in nonhuman animals is very limited and, so far, only one study has investigated jealousy in dogs (Canis familiaris). This work explores jealousy in dogs one step further. We conducted two studies adapting a procedure devised to assess jealousy in human infants. In each study 36 adult dogs were exposed to a situation in which their owner and a stranger ignored them while directing positive attention towards three different objects: a book, a puppet and a fake dog (Study 1: furry; Study 2: plastic). Overall, the results of both studies do not provide evidence that the behavioral responses of our dogs were triggered by jealousy: we did not find a clear indication that the fake dogs were perceived as real social rivals, neither the furry nor the plastic one. Indeed, dogs exhibited a higher interest (i.e. look at, interact with) towards the fake dogs, but differences in the behavior towards the fake dog and the puppet only emerged in Study 2. In addition, many of the behaviors (protest, stress, attention seeking, aggression) that are considered distinctive features of jealousy were not expressed or were expressed to a limited extent, revealing that dogs did not actively try to regain their owner's attention or interfere with the interaction between the owner and the faux rival. Finally, a differentiated response towards the attachment figure (the owner) and the unfamiliar person (the stranger) did not emerge. Differently from what reported in human infants, dogs' behavior towards the attachment figure and the stranger interacting with the potential competitor (in this case, the fake dog) did not significantly differ: in both studies dogs paid attention to the owner and the stranger manipulating the fake dog to the same extent. In conclusion, we do not exclude that dogs could possess a rudimentary form of jealousy, but we suggest that research on this topic should require the use of a real social interloper (conspecific or human) and more naturalistic procedures.	[Prato-Previde, Emanuela] Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, Milan, Italy; [Nicotra, Velia; Pelosi, Annalisa] Univ Parma, Dipartimento Med & Chirurg, Parma, Italy; [Nicotra, Velia; Valsecchi, Paola] Univ Parma, Dipartimento Sci Chim Vitae & Sostenibilita Ambie, Parma, Italy	University of Milan; University of Parma; University of Parma	Prato-Previde, E (corresponding author), Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, Milan, Italy.	emanuela.pratoprevide@unimi.it		Valsecchi, Paola/0000-0002-0491-9845	Velia Nicotra's Doctoral Grant - Universita degli Studi di Parma; University degli Studi di Parma	Velia Nicotra's Doctoral Grant - Universita degli Studi di Parma; University degli Studi di Parma	This work was partially funded by Velia Nicotra's Doctoral Grant supported by Universita degli Studi di Parma.; We are grateful to all the dog owners who kindly participated with their dogs in our studies. We thank Chiara Losacco and Irene Zantedeschi for their precious help in data collection and Sofia Fusar Poli for language revision. Velia Nicotra was supported by a doctoral grant from the University degli Studi di Parma.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Ainsworth M., 1978, PATTERNS ATTACHMENT; Albuquerque N, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0883; [Anonymous], 2014, THE SOCIAL DOG; Barnard S, 2012, APPL ANIM BEHAV SCI, V138, P79, DOI 10.1016/j.applanim.2012.02.017; BLACKSHAW JK, 1991, APPL ANIM BEHAV SCI, V30, P351, DOI 10.1016/0168-1591(91)90140-S; Brucks D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153799; Buck R, 1999, PSYCHOL REV, V106, P301, DOI 10.1037/0033-295X.106.2.301; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Chijiiwa H, 2015, ANIM BEHAV, V106, P123, DOI 10.1016/j.anbehav.2015.05.018; Custance D, 2012, ANIM COGN, V15, P851, DOI 10.1007/s10071-012-0510-1; de Waal FBM, 2011, ANN NY ACAD SCI, V1224, P191, DOI 10.1111/j.1749-6632.2010.05912.x; Dillon L., 2013, HUMAN ETHOLOGY B, V28, P13; Draghi-Lorenz R, 2001, DEV REV, V21, P263, DOI 10.1006/drev.2000.0524; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Essler JL, 2017, CURR BIOL, V27, P1861, DOI 10.1016/j.cub.2017.05.061; FILIATRE JC, 1991, APPL ANIM BEHAV SCI, V30, P341, DOI 10.1016/0168-1591(91)90139-O; Forbes S., 2010, HDB JEALOUSY THEORY, P121, DOI [10.1002/9781444323542.ch7, DOI 10.1002/9781444323542.CH7, DOI 10.1002/9781444323542.CH13]; Fox M., 1972, BEHAV WOLVES DOGS RE; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Harris CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094597; Harris CR, 2004, AM SCI, V92, P62, DOI 10.1511/2004.45.919; Hart S, 1998, SOC DEV, V7, P54, DOI 10.1111/1467-9507.00050; Hart S. L., 2016, EVOL PSYCHOL, V14, P1; Hart S.L., 2010, HDB JEALOUSY THEORY, P57, DOI [10.1002/9781444323542.ch4, DOI 10.1002/9781444323542.CH4]; Hart S. L., 2015, JEALOUSY INFANTS LAB; Hart S, 2002, INFANCY, V3, P395, DOI 10.1207/S15327078IN0303_6; Hobson Peter R., 2010, HDB JEALOUSY THEORY, P293, DOI DOI 10.1002/9781444323542.CH13; IZARD CE, 1992, PSYCHOL REV, V99, P561, DOI 10.1037/0033-295X.99.3.561; Kujala MV., 2017, ANIM SENTIENCE, V2, P1, DOI [10.51291/2377-7478.1114, DOI 10.51291/2377-7478.1114]; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Lewis M., 2008, HDB EMOTIONS, P304; Marshall-Pescini S, 2013, ANIM COGN, V16, P933, DOI 10.1007/s10071-013-0627-x; Marshall-Pescini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106530; Martens P, 2016, ANTHROZOOS, V29, P73, DOI 10.1080/08927936.2015.1075299; Massar K, 2009, EUR J SOC PSYCHOL, V39, P768, DOI 10.1002/ejsp.579; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Merola I, 2014, ANIM COGN, V17, P373, DOI 10.1007/s10071-013-0668-1; Merola I, 2012, ANIM COGN, V15, P175, DOI 10.1007/s10071-011-0443-0; Merola I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047653; MILLOT JL, 1987, APPL ANIM BEHAV SCI, V19, P189, DOI 10.1016/0168-1591(87)90216-4; Mize KD, 2014, INFANCY, V19, P338, DOI 10.1111/infa.12046; Mongillo P, 2010, ANIM BEHAV, V80, P1057, DOI 10.1016/j.anbehav.2010.09.014; Morris P, 2012, SOC ANIM, V20, P211, DOI 10.1163/15685306-12341234; Morris PH, 2008, COGNITION EMOTION, V22, P3, DOI 10.1080/02699930701273716; Muller CA, 2015, CURR BIOL, V25, P601, DOI 10.1016/j.cub.2014.12.055; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J., 2010, HDB JEALOUSY THEORY, P101, DOI [10.1002/9781444323542.ch6, DOI 10.1002/9781444323542.CH6]; Panksepp J, 2011, EMOT REV, V3, P387, DOI 10.1177/1754073911410741; Panksepp J, 2011, NEUROSCI BIOBEHAV R, V35, P1791, DOI 10.1016/j.neubiorev.2011.08.003; Panksepp J, 2010, P ROY SOC B-BIOL SCI, V277, P2905, DOI 10.1098/rspb.2010.1017; Prato Previde E, SOCIAL DOG BEHAV COG; Quervel-Chaumette M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152920; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Reisner IR, 2003, VET CLIN N AM-SMALL, V33, P303, DOI 10.1016/S0195-5616(02)00132-8; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Siniscalchi M, 2016, BEHAV BRAIN RES, V304, P34, DOI 10.1016/j.bbr.2016.02.011; Siniscalchi M, 2011, ANIM BEHAV, V82, P399, DOI 10.1016/j.anbehav.2011.05.020; Szabo N, 2014, SOC DEV, V23, P325, DOI 10.1111/sode.12039; Taylor AM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017069, 10.1371/journal.pone.0026651]; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Trisko RK, 2016, BEHAVIOUR, V153, P693, DOI 10.1163/1568539X-00003352; Volling BL, 2002, CHILD DEV, V73, P581, DOI 10.1111/1467-8624.00425	64	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194577	10.1371/journal.pone.0194577	http://dx.doi.org/10.1371/journal.pone.0194577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668684	Green Published, gold			2022-12-27	WOS:000430290200012
J	Xu, DF				Xu, Dafeng			Transportation assimilation revisited: New evidence from repeated cross-sectional survey data	PLOS ONE			English	Article							MASS MIGRATION; LAND-USE; CHINESE ETHNOBURB; ECONOMIC OUTCOMES; TRAVEL BEHAVIOR; GREAT-BRITAIN; IMMIGRANTS; AGE; US; PATTERNS	Background Based on single cross-sectional data, prior research finds evidence of "transportation assimilation" among U.S. immigrants: the length of stay in the U.S. is negatively correlated with public transit use. This paper revisits this question by using repeated cross-sectional data, and examines the trend of transportation assimilation over time. Methods and results Using 1980, 1990, 2000 1% census and 2010 (1%) American Community Survey, I examine the relationship between the length of stay in the U.S. and public transit ridership among immigrants. I first run regressions separately in four data sets: I regress public transit ridership on the length of stay, controlling for other individual and geographic variables. I then compare the magnitudes of the relationship in four regressions. To study how the rate of transportation assimilation changes over time, I pool the data set and regress public transit ridership on the length of stay and its interactions with year dummies to compare the coefficients across surveys. Results confirm the conclusion of transportation assimilation: as the length of stay in the U.S. increases, an immigrant's public transit use decreases. However, the repeated cross-section analysis suggests the assimilation rate has been decreasing in the past few decades. Conclusions This paper finds evidence of transportation assimilation: immigrants become less likely to ride public transit as the length of stay in the U.S. increases. The assimilation rate, however, has been decreasing over time. This paper finds that the rate of public transit ridership among new immigrants upon arrival, the geographic distribution of immigrants, and the changing demographics of the U.S. immigrants play roles in affecting the trend of transportation assimilation.	[Xu, Dafeng] Univ Minnesota, Minnesota Populat Ctr, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities	Xu, DF (corresponding author), Univ Minnesota, Minnesota Populat Ctr, Minneapolis, MN 55414 USA.	dafengxu@umn.edu		Xu, Dafeng/0000-0002-2626-2274				Abramitzky R, 2014, J POLIT ECON, V122, P467, DOI 10.1086/675805; Abramitzky R, 2013, J DEV ECON, V102, P2, DOI 10.1016/j.jdeveco.2012.08.004; Abramitzky R, 2012, AM ECON REV, V102, P1832, DOI 10.1257/aer.102.5.1832; Abramitzky Ran, 2016, 22381 NBER; BARTEL AP, 1989, J LABOR ECON, V7, P371, DOI 10.1086/298213; Beckman JD, 2008, TRANSPORTATION, V35, P655, DOI 10.1007/s11116-008-9172-x; Beirao G, 2007, TRANSPORT POLICY, V14, P478, DOI 10.1016/j.tranpol.2007.04.009; Bleakley H, 2004, REV ECON STAT, V86, P481, DOI 10.1162/003465304323031067; Bleakley H, 2010, AM ECON J-APPL ECON, V2, P165, DOI 10.1257/app.2.1.165; Blumenberg E, 2007, 2007 ANN C TRANSP RE; Blumenberg E, 2009, TRANSP LETT, V1, P169, DOI 10.3328/TL.2009.01.02.169-180; Casas J, 2004, 2004 ANN C TRANSP RE; Cervero R, 1997, TRANSPORT RES A-POL, V31, P309, DOI 10.1016/S0965-8564(96)00027-4; Chapman D, 2009, PUBLIC WORKS MANAGEM, V13, P312; Chatman DG, 2013, TRANSPORT POLICY, V30, P336, DOI 10.1016/j.tranpol.2013.10.002; CHISWICK BR, 1978, J POLIT ECON, V86, P897, DOI 10.1086/260717; Cutler DM, 2008, REV ECON STAT, V90, P478, DOI 10.1162/rest.90.3.478; Friedman S, 2005, GEOGR REV, V95, P210, DOI 10.1111/j.1931-0846.2005.tb00363.x; Gerhards J, 2009, AM J SOCIOL, V114, P1102, DOI 10.1086/595944; Giuliano G, 2006, TRANSPORT RES A-POL, V40, P106, DOI 10.1016/j.tra.2005.03.002; Giuliano G, 2003, URBAN STUD, V40, P2295, DOI 10.1080/0042098032000123303; Glaeser EL, 2008, J URBAN ECON, V63, P1, DOI 10.1016/j.jue.2006.12.004; Kain JF, 1999, TRANSPORT RES A-POL, V33, P601, DOI 10.1016/S0965-8564(99)00009-9; Krichene N, 2002, ENERG ECON, V24, P557, DOI 10.1016/S0140-9883(02)00061-0; Li W, 1998, URBAN STUD, V35, P479, DOI 10.1080/0042098984871; Li W, 1998, URBAN GEOGR, V19, P502, DOI 10.2747/0272-3638.19.6.502; MASSEY DS, 1985, AM SOCIOL REV, V50, P94, DOI 10.2307/2095343; Myers D, 1996, DEMOGRAPHY, V33, P51, DOI 10.2307/2061713; Passel Jeffrey S., 2005, RISE PEAK DECLINE TR; PORTES A, 1993, ANN AM ACAD POLIT SS, V530, P74, DOI 10.1177/0002716293530001006; PUCHER J, 1988, J AM PLANN ASSOC, V54, P509, DOI 10.1080/01944368808976677; Ruggles Steven, 2015, INTEGRATED PUBLIC US; Sanchez TW, 2004, URBAN STUD, V41, P1313, DOI 10.1080/0042098042000214815; Stead D, 2001, ENVIRON PLANN B, V28, P499, DOI 10.1068/b2677; Suro R., 2002, BROOKINGS I SURVEY S; Tal G, 2010, TRANSPORT POLICY, V17, P85, DOI 10.1016/j.tranpol.2009.11.003	36	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194296	10.1371/journal.pone.0194296	http://dx.doi.org/10.1371/journal.pone.0194296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668676	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200008
J	Ciurleo, R; Bonanno, L; De Salvo, S; Romeo, L; Rifici, C; Sessa, E; D'Aleo, G; Russo, M; Bramanti, P; Marino, S; Caminiti, F				Ciurleo, Roselle; Bonanno, Lilla; De Salvo, Simona; Romeo, Laura; Rifici, Carmela; Sessa, Edoardo; D'Aleo, Giangaetano; Russo, Margherita; Bramanti, Placido; Marino, Silvia; Caminiti, Fabrizia			Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study	PLOS ONE			English	Article							DISEASES	Multiple sclerosis (MS) is a chronic inflammatory disease and one of the leading causes of disability in young adults. Functional markers able to predict MS progression are still lacking. It is recognized that olfactory dysfunction may be an early symptom in MS. The aim of this study was to investigate whether alterations in olfactory event-related potentials could play a prognostic role in MS. Thirty patients affected by MS relapsing-remitting underwent an olfactory potential examination (T0). Three years after baseline (T1), 28 of 30 patients were clinically evaluated by expanded disability status scale. In addition, the number of Disease Modifying Therapies (DMTs) and the total number of relapses occurred in the last 3 years were collected. At T1, we observed a negative correlation between presence/absence of olfactory potentials and expanded disability status scale scores (rpb = -0.48; p = 0.009). A significant trend for a negative correlation between presence/absence of olfactory potentials and disease duration (rpb = -0.36; p = 0.06) and total number of relapses (rpb = -0.34; p = 0.08) was found. Only patients with olfactory potential absence showed a significant trend in the difference of the disability status scale (p = 0.06) between T0 and T1. In the sub-group of patients with reduced olfactory potential amplitude, we detected a trend for a negative correlation between the disability status scale and the amplitude of N1-P2 components more marked at T1 (r = -0.52; p = 0.06) than T0 (r = -0.47; p = 0.09). This is the first study that evaluated the prognostic role of olfactory event-related potentials in MS. Our results highlighted that olfactory alterations of MS patients were related to disability progression and, to a lesser extent, disease activity. The analysis of olfactory potential parameters confirmed the involvement in olfactory network damage of inflammatory and/or neurodegeneration processes which could predict the progressive course of the disease.	[Ciurleo, Roselle; Bonanno, Lilla; De Salvo, Simona; Romeo, Laura; Rifici, Carmela; Sessa, Edoardo; D'Aleo, Giangaetano; Russo, Margherita; Bramanti, Placido; Marino, Silvia; Caminiti, Fabrizia] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Marino, Silvia] Univ Messina, Dept Biomed & Dent Sci & Morphol & Funct Imaging, Messina, Italy	IRCCS Bonino Pulejo; University of Messina	Ciurleo, R (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.	rosella.ciurleo@irccsme.it	Russo, Margherita/AAB-8735-2019; Rifici, Carmela/ABH-4398-2020; Sessa, Edoardo/AAB-8544-2020; Ciurleo, Rosella/T-4590-2019; Caminiti, Fabrizia/B-9458-2017; Bonanno, Lilla/K-3937-2016; Bramanti, Placido/K-5117-2016; Marino, Silvia/T-5118-2019; De Salvo, Simona/K-3180-2016	Caminiti, Fabrizia/0000-0002-2527-8063; Bonanno, Lilla/0000-0002-0282-405X; Marino, Silvia/0000-0002-1088-6808; De Salvo, Simona/0000-0001-9501-3258; Romeo, Laura/0000-0002-5754-2244; Ciurleo, Rosella/0000-0003-0709-5914				Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; Caminiti F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103151; Chard D, 2009, J NEUROL SCI, V282, P5, DOI 10.1016/j.jns.2009.01.012; Comi G, 1999, EEG CL N SU, V50, P349; Fleiner F, 2010, AM J RHINOL ALLERGY, V24, pE93, DOI 10.2500/ajra.2010.24.3506; Jordy SS, 2016, ARQ NEURO-PSIQUIAT, V74, P697, DOI 10.1590/0004-282X20160128; Joseph A, 2016, J NEUROL NEUROSUR PS, V87, P1146, DOI 10.1136/jnnp-2015-312600; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Lee JY, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0097-7; Li LM, 2016, J NEUROL SCI, V365, P34, DOI 10.1016/j.jns.2016.03.045; Losy J, 2013, J NEURAL TRANSM, V120, P1459, DOI 10.1007/s00702-013-1079-9; Lucassen EB, 2016, MULT SCLER RELAT DIS, V6, P1, DOI 10.1016/j.msard.2015.12.002; Lutterotti A, 2011, MULT SCLER J, V17, P964, DOI 10.1177/1352458511399798; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Silva AM, 2012, MULT SCLER J, V18, P616, DOI 10.1177/1352458511427156; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Uecker FC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170492	18	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196006	10.1371/journal.pone.0196006	http://dx.doi.org/10.1371/journal.pone.0196006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664936	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300049
J	Maekawa, T; Anderson, SJ; de Brecht, M; Yamagishi, N				Maekawa, Toru; Anderson, Stephen J.; de Brecht, Matthew; Yamagishi, Noriko			The effect of mood state on visual search times for detecting a target in noise: An application of smartphone technology	PLOS ONE			English	Article							POSITIVE AFFECT; ANALOG SCALES; EMOTION; ATTENTION; HAPPY; INTEGRATION; PSYCHOLOGY; DECREASES; INDUCTION; RADIOLOGY	The study of visual perception has largely been completed without regard to the influence that an individual's emotional status may have on their performance in visual tasks. However, there is a growing body of evidence to suggest that mood may affect not only creative abilities and interpersonal skills but also the capacity to perform low-level cognitive tasks. Here, we sought to determine whether rudimentary visual search processes are similarly affected by emotion. Specifically, we examined whether an individual's perceived happiness level affects their ability to detect a target in noise. To do so, we employed pop-out and serial visual search paradigms, implemented using a novel smartphone application that allowed search times and self-rated levels of happiness to be recorded throughout each twenty-four-hour period for two weeks. This experience sampling protocol circumvented the need to alter mood artificially with laboratory-based induction methods. Using our smartphone application, we were able to replicate the classic visual search findings, whereby pop-out search times remained largely unaffected by the number of distractors whereas serial search times increased with increasing number of distractors. While pop-out search times were unaffected by happiness level, serial search times with the maximum numbers of distractors (n = 30) were significantly faster for high happiness levels than low happiness levels (p = 0.02). Our results demonstrate the utility of smartphone applications in assessing ecologically valid measures of human visual performance. We discuss the significance of our findings for the assessment of basic visual functions using search time measures, and for our ability to search effectively for targets in real world settings.	[Maekawa, Toru; de Brecht, Matthew; Yamagishi, Noriko] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks CiNet, Osaka, Japan; [Anderson, Stephen J.] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [de Brecht, Matthew; Yamagishi, Noriko] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [de Brecht, Matthew; Yamagishi, Noriko] Adv Telecommun Res Inst Int, Dept Cognit Neurosci, Kyoto, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Aston University; Osaka University; Advanced Telecommunications Research Institute International	Anderson, SJ (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England.	s.j.anderson@aston.ac.uk		Anderson, Stephen J/0000-0002-5719-2846	Japan Society for the Promotion of Science (KAKENHI) [25280053, 26540075]; Grants-in-Aid for Scientific Research [26540075] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded with grants from the Japan Society for the Promotion of Science (KAKENHI grant numbers 25280053, 26540075) to NY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn EP, 1997, J PSYCHIATR RES, V31, P569, DOI 10.1016/S0022-3956(97)00029-0; Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Bolte A, 2003, PSYCHOL SCI, V14, P416, DOI 10.1111/1467-9280.01456; Brady Adrian, 2012, Ulster Med J, V81, P3; Brady AP, 2016, INSIGHTS IMAGING, P1; Brown HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100662; Bruno MA, 2015, RADIOGRAPHICS, V35, P1668, DOI 10.1148/rg.2015150023; Bruyneel L, 2013, PSYCHOL RES-PSYCH FO, V77, P320, DOI 10.1007/s00426-012-0432-1; Coppetti T, 2017, EUR J PREV CARDIOL, V24, P1287, DOI 10.1177/2047487317702044; Couper MP, 2006, SOC SCI COMPUT REV, V24, P227, DOI 10.1177/0894439305281503; Cui WZ, 2014, INT SYMP ANT TECH; Dinges DF., 1991, SLEEP SLEEPINESS PER, P97; Donoghue JR., 2004, RECENT DEV MULTIPLE, P1, DOI [10.1214/lnms/1196285622, DOI 10.1214/LNMS/1196285622]; Eckstein MP, 2011, J VISION, V11, DOI 10.1167/11.5.14; Estrada CA, 1997, ORGAN BEHAV HUM DEC, V72, P117, DOI 10.1006/obhd.1997.2734; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fredrickson Barbara L, 1998, Rev Gen Psychol, V2, P300; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; FREDRICKSON BL, 2001, AM PSYCHOL, V56, P218, DOI DOI 10.1037/0003-066X.56.3.218; Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406; Gilet AL, 2008, ENCEPHALE, V34, P233, DOI 10.1016/j.encep.2006.08.003; Grubert A, 2013, ATTEN PERCEPT PSYCHO, V75, P41, DOI 10.3758/s13414-012-0385-x; HOLM S, 1979, SCAND J STAT, V6, P65; ISEN AM, 1985, J PERS SOC PSYCHOL, V48, P1413, DOI 10.1037/0022-3514.48.6.1413; ISEN AM, 1992, MOTIV EMOTION, V16, P65, DOI 10.1007/BF00996487; ISEN AM, 1972, J PERS SOC PSYCHOL, V21, P384, DOI 10.1037/h0032317; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Lee CS, 2013, AM J ROENTGENOL, V201, P611, DOI 10.2214/AJR.12.10375; Macnab D., 2005, PSYCHOMETRICS; Martin EA, 2011, COGNITION EMOTION, V25, P265, DOI 10.1080/02699931.2010.491652; Mcnab F, 2015, P NATL ACAD SCI USA, V112, P6515, DOI 10.1073/pnas.1504162112; Mcnab F, 2014, J EXP PSYCHOL HUMAN, V40, P960, DOI 10.1037/a0036013; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Moriya H, 2011, NEUROPSYCHOLOGIA, V49, P1162, DOI 10.1016/j.neuropsychologia.2011.02.036; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; RENFREW DL, 1992, RADIOLOGY, V183, P145, DOI 10.1148/radiology.183.1.1549661; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Rutledge RB, 2016, CURR BIOL, V26, P1634, DOI 10.1016/j.cub.2016.05.017; Rutledge RB, 2014, P NATL ACAD SCI USA, V111, P12252, DOI 10.1073/pnas.1407535111; Smittenaar P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140383; Takahashi M, 2004, ERGONOMICS, V47, P1003, DOI 10.1080/00140130410001686320; Teki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153916; TOOBY J, 1990, ETHOL SOCIOBIOL, V11, P375, DOI 10.1016/0162-3095(90)90017-Z; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vanlessen N, 2016, NEUROSCI BIOBEHAV R, V68, P816, DOI 10.1016/j.neubiorev.2016.07.001; Vanlessen N, 2013, COGN AFFECT BEHAV NE, V13, P60, DOI 10.3758/s13415-012-0130-x; Vastfjall D, 2001, MUSIC SCI, V5, P173; Wadlinger HA, 2006, MOTIV EMOTION, V30, P89, DOI 10.1007/s11031-006-9021-1; Wegbreit E, 2015, COGNITION EMOTION, V29, P668, DOI 10.1080/02699931.2014.922933; Woltman H., 2012, TUTORIALS QUANTITATI, V8, P52, DOI [10.20982/tqmp.08.1.p052, DOI 10.20982/TQMP.08.1.P052]; Youssef AR, 2017, EXPERT REV MED DEVIC, V14, P481, DOI 10.1080/17434440.2017.1325319	53	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195865	10.1371/journal.pone.0195865	http://dx.doi.org/10.1371/journal.pone.0195865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664952	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000430262300040
J	Manikis, GC; Marias, K; Lambregts, DMJ; Nikiforaki, K; van Heeswijk, MM; Bakers, FCH; Beets-Tan, RGH; Papanikolaou, N				Manikis, Georgios C.; Marias, Kostas; Lambregts, Doenja M. J.; Nikiforaki, Katerina; van Heeswijk, Miriam M.; Bakers, Frans C. H.; Beets-Tan, Regina G. H.; Papanikolaou, Nikolaos			Diffusion weighted imaging in patients with rectal cancer: Comparison between Gaussian and non-Gaussian models (vol 12, e0184197, 2017)	PLOS ONE			English	Correction									[Marias, Kostas] Technol Educ Inst Crete, Dept Informat Engn, Iraklion, Greece	Hellenic Mediterranean University	Marias, K (corresponding author), Technol Educ Inst Crete, Dept Informat Engn, Iraklion, Greece.		Man, George/AAC-4867-2019; Marias, Kostas/AAM-2330-2021; Beets-Tan, Regina/AAZ-9119-2020	Man, George/0000-0002-3396-0644; Marias, Kostas/0000-0003-3783-5223; Lambregts, Doenja/0000-0003-2990-0099				Manikis GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184197	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196262	10.1371/journal.pone.0196262	http://dx.doi.org/10.1371/journal.pone.0196262			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664935	Green Published, gold			2022-12-27	WOS:000430262300067
J	Moon, SJ; Lee, WY; Hwang, JS; Hong, YP; Morisky, DE				Moon, Sun Jae; Lee, Weon-Young; Hwang, Jin Seub; Hong, Yeon Pyo; Morisky, Donald E.			Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8 (vol 12, e0187139, 2017)	PLOS ONE			English	Correction													Morisky, Donald/AAU-4679-2021					Moon SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187139	1	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196138	10.1371/journal.pone.0196138	http://dx.doi.org/10.1371/journal.pone.0196138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664949	gold, Green Submitted, Green Published			2022-12-27	WOS:000430262300053
J	Tee, JYH; Gan, WY; Tang, KA; Chin, YS				Tee, Joyce Ying Hui; Gan, Wan Ying; Tang, Kit-Aun; Chin, Yit Siew			Obesity and unhealthy lifestyle associated with poor executive function among Malaysian adolescents	PLOS ONE			English	Article							DAILY PHYSICAL-ACTIVITY; COGNITIVE PERFORMANCE; AEROBIC FITNESS; SLEEP DURATION; CHILDREN; CHILDHOOD; BRAIN; BEHAVIORS; QUALITY; AGE	The understanding on the roles of obesity and lifestyle behaviors in predicting executive function of adolescents has been limited. Low executive function proficiency may have adverse effects on adolescents' school academic performance. This cross-sectional study aimed to examine the relationship between BMI-for-age and multiple lifestyle behaviors (operationalized as meal consumption, physical activity, and sleep quality) with executive function (operationalized as inhibition, working memory, and cognitive flexibility) on a sample of Malaysian adolescents aged between 12 and 16 years (N = 513). Participants were recruited from two randomly selected schools in the state of Selangor in Malaysia. Using a self-administered questionnaire, parent participants provided information concerning their sociodemographic data, whereas adolescent participants provided information regarding their meal consumptions, physical activity, and sleep quality. The modified Harvard step test was used to assess adolescents' aerobic fitness, while Stroop color-word, digit span, and trail-making tests were used to assess adolescents' inhibition, working memory, and cognitive flexibility, respectively. Three separate hierarchical regression analyses were conducted for each outcome namely, inhibition, working memory, and cognitive flexibility. After adjusted for sociodemographic factors and BMI-for-age, differential predictors of inhibition and working memory were found. Habitual sleep efficiency significantly and positively predicted inhibition. Regular dinner intakes, physical activity levels, and sleep quality significantly and positively predicted working memory. Household income emerged as a consistent predictor for all executive function domains. In conclusion, an increased trend of obesity and unhealthy lifestyles among adolescents were found to be associated with poorer executive function. Regular dinner intakes, higher physical activity levels and better sleep quality predicted better executive function despite the inverse relationship between obesity and executive function. Future studies may explore how lifestyle modifications can optimize the development of executive function in adolescents as well as relieve the burden of obesity.	[Tee, Joyce Ying Hui; Gan, Wan Ying; Chin, Yit Siew] Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Tang, Kit-Aun] Univ Putra Malaysia, Dept Psychiat, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Chin, Yit Siew] Univ Putra Malaysia, Res Ctr Excellence Nutr & Noncommunicable Dis, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Gan, WY (corresponding author), Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia.	wanying@upm.edu.my	Gan, Wan Ying/J-2476-2015; Chin, Yit Siew/G-2001-2015; Tan, Kit-Aun/AFL-6254-2022; Gan, Wan Ying/N-2445-2019	Gan, Wan Ying/0000-0002-9016-3414; Chin, Yit Siew/0000-0002-7609-1944; Tan, Kit-Aun/0000-0002-4310-9087; Gan, Wan Ying/0000-0002-9016-3414	Universiti Putra Malaysia, Putra Grant-Postgraduate Initiative [GP/IPS/2017/9519900]	Universiti Putra Malaysia, Putra Grant-Postgraduate Initiative	This study was supported by a grant from the Universiti Putra Malaysia, Putra Grant-Postgraduate Initiative (GP/IPS/2017/9519900) to WYG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Bajaj A., 2008, ASAC, V29; Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; Blair C, 2011, CHILD DEV, V82, P1970, DOI 10.1111/j.1467-8624.2011.01643.x; Bocarsly ME, 2015, P NATL ACAD SCI USA, V112, P15731, DOI 10.1073/pnas.1511593112; Buck SM, 2008, MED SCI SPORT EXER, V40, P166, DOI 10.1249/mss.0b013e318159b035; Buysse D J, 1989, Psychiatry Res, V28, P193; Carneiro P, 2013, J EUR ECON ASSOC, V11, P123, DOI 10.1111/j.1542-4774.2012.01096.x; Chaddock L, 2012, J SPORT SCI, V30, P421, DOI 10.1080/02640414.2011.647706; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Chin Y. S., 2009, Pakistan Journal of Nutrition, V8, P425; Chong KH, 2016, ASIA-PAC J PUBLIC HE, V28, p59S, DOI 10.1177/1010539516654260; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Conger RD, 2007, ANNU REV PSYCHOL, V58, P175, DOI 10.1146/annurev.psych.58.110405.085551; Cooper SB, 2012, BRIT J NUTR, V107, P1823, DOI 10.1017/S0007114511005022; Crabtree VM, 2005, SLEEP MED, V6, P319, DOI 10.1016/j.sleep.2005.02.001; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Dan S P Jr, 2007, Malays J Nutr, V13, P109; Defeyter MA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00789; Delgado-Rico E, 2012, OBESITY, V20, P1604, DOI 10.1038/oby.2012.47; Dencker M, 2011, J SPORT SCI, V29, P887, DOI 10.1080/02640414.2011.578148; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Erola J, 2016, RES SOC STRAT MOBIL, V44, P33, DOI 10.1016/j.rssm.2016.01.003; Esteban-Cornejo I, 2015, J SCI MED SPORT, V18, P534, DOI 10.1016/j.jsams.2014.07.007; Fatima S, 2016, NEUROPSYCHOLOGY, V30, P65, DOI 10.1037/neu0000216; Ferraro FR, 2015, COMPUT HUM BEHAV, V49, P44, DOI 10.1016/j.chb.2015.02.043; Golden ZL, 2002, PSYCHOL SCHOOLS, V39, P489, DOI 10.1002/pits.10047; Gunstad J, 2008, APPETITE, V50, P246, DOI 10.1016/j.appet.2007.07.008; Hackman DA, 2015, DEVELOPMENTAL SCI, V18, P686, DOI 10.1111/desc.12246; Hackman DA, 2014, CHILD DEV, V85, P1433, DOI 10.1111/cdev.12242; Institute for Public Health (IPH), 2014, NAT HLTH MORB SURV 2, V2; KEEN EN, 1958, J APPL PHYSIOL, V13, P241, DOI 10.1152/jappl.1958.13.2.241; Kopasz M, 2010, SLEEP MED REV, V14, P167, DOI 10.1016/j.smrv.2009.10.006; Lee Y, 2010, INT PSYCHOGERIATR, V22, P174, DOI 10.1017/S1041610209991189; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Lo JC, 2016, SLEEP MED, V17, P87, DOI 10.1016/j.sleep.2015.08.021; Maayan L, 2011, OBESITY, V19, P1382, DOI 10.1038/oby.2011.15; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Nasir MTM, 2012, APPETITE, V58, P525, DOI 10.1016/j.appet.2012.01.007; Nyberg L, 2009, EUR J COGN PSYCHOL, V21, P84, DOI 10.1080/09541440701862133; Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002; Padilla C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00049; Piccolo LD, 2016, PSICOL-REFLEX CRIT, V29, DOI 10.1186/s41155-016-0016-x; Poland SE, 2016, BRIT J DEV PSYCHOL, V34, P181, DOI 10.1111/bjdp.12122; Reinert KRS, 2013, J OBES, V2013, DOI 10.1155/2013/820956; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Salimpoor V.N., 2006, DEV DISABILITIES B, V34, P15; Scudder MR, 2014, MED SCI SPORT EXER, V46, P1025, DOI 10.1249/MSS.0000000000000199; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stea TH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-829; Stillman CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162100; Telzer EH, 2013, NEUROIMAGE, V71, P275, DOI 10.1016/j.neuroimage.2013.01.025; Ursache A, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.531; van der Niet AG, 2015, J SCI MED SPORT, V18, P673, DOI 10.1016/j.jsams.2014.09.006; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; Verdejo-Garcia A, 2010, OBESITY, V18, P1572, DOI 10.1038/oby.2009.475; Watkins J, 1984, Br J Sports Med, V18, P84; Wechsler D, 1974, WECHSLER INTELLIGENC; *WHO, 2007, WHO REF 2007 GROWTH; Yau PL, 2014, OBESITY, V22, P1865, DOI 10.1002/oby.20801	66	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195934	10.1371/journal.pone.0195934	http://dx.doi.org/10.1371/journal.pone.0195934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664932	Green Submitted, gold, Green Published			2022-12-27	WOS:000430262300042
J	Gibbs, A; Dunkle, K; Jewkes, R				Gibbs, Andrew; Dunkle, Kristin; Jewkes, Rachel			Emotional and economic intimate partner violence as key drivers of depression and suicidal ideation: A cross-sectional study among young women in informal settlements in South Africa	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DOMESTIC VIOLENCE; STEPPING STONES; ABUSE; HEALTH; HIV; MULTICOUNTRY; METAANALYSIS; ASSOCIATION; INFECTIONS	Little research has assessed the impact of emotional intimate partner violence (IPV) and economic IPV on women's mental health. Using cross-sectional data from the Stepping Stones and Creating Futures intervention trial baseline, in eThekwini Municipality, South Africa we assess three questions. First, whether emotional IPV and economic IPV make independent contributions to mental health outcomes; second what matters, severity, variety, or absolute experience? and third, are some items more important in driving mental health impacts than others? We assess associations between past 12-month emotional IPV, past 12-month economic IPV, and past week depressive symptoms and past four-week suicidal ideation. We describe the prevalence of each mental health outcome by individual items, including never/ever and frequency, and combined emotional IPV, and economic IPV, reporting depression scores and percentage of suicidal ideation and 95% confidence intervals (CI). Second, we created four-level categorical variables for combinations of emotional, economic, sexual and physical IPV, and present its frequency, and the mean/% and 95% CI for depression symptomatology and suicidal ideation. 680 women (aged 18-30) were enrolled. High levels of past year emotional IPV, economic IPV were reported. 45.3% reported clinically relevant symptoms of depression, and 30.0% past four-week suicidal ideation. All measures of emotional IPV and economic IPV showed a consistent positive correlation with CESD scores, and suicidal ideation. For all four-level categorical constructs the highest depression scores, and prevalence of suicidal ideation, were for combinations of emotional IPV or economic IPV with physical and/or sexual IPV. For depression in 17/18 combinations this was significantly different compared to women reporting no IPV. For suicidal ideation this was significant in 6/18 combinations all related to economic IPV. Emotional IPV and economic IPV have independent associations with women's mental health, beyond physical IPV and sexual IPV, and also have distinct patterns between each other.	[Gibbs, Andrew; Dunkle, Kristin; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Gibbs, Andrew] Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa; [Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	South African Medical Research Council; University of Kwazulu Natal; University of Witwatersrand	Gibbs, A (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.; Gibbs, A (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa.	Andrew.gibbs@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Jewkes, Rachel/0000-0002-4330-6267; Gibbs, Andrew/0000-0003-2812-5377	UK Government's Department for International Development (DFID)	UK Government's Department for International Development (DFID)	This trial is funded through the What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) funded by the UK Government's Department for International Development (DFID). However, the views expressed do not necessarily reflect the department's official policies. Funding was managed by the South African Medical Research Council (SAMRC), who also supported the project team. The funders had no role in study design; collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the paper for publication.	Alio AP, 2009, INT J GYNECOL OBSTET, V107, P35, DOI 10.1016/j.ijgo.2009.05.002; Antai D, 2014, GLOB PUBLIC HEALTH, V9, P808, DOI 10.1080/17441692.2014.917195; Bobonis GJ, 2013, AM ECON J-ECON POLIC, V5, P179, DOI 10.1257/pol.5.1.179; Devries KM, 2014, ADDICTION, V109, P379, DOI 10.1111/add.12393; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Dillon Gina, 2013, INT J FAMILY MED, V2013; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gibbs A, GLOBAL PUBL IN PRESS, P1; Gibbs A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4223-x; Gibbs A, 2015, CULT HEALTH SEX, V17, P208, DOI 10.1080/13691058.2014.966150; Haj-Yahia MM, 2000, J FAM ISSUES, V21, P435, DOI 10.1177/019251300021004002; Hunter M., 2010, LOVE TIME AIDS INEQU; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002381; Jewkes R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122001; Jewkes R, 2013, KEY ISSUES MENT HEAL, V178, P65, DOI 10.1159/000342013; Jewkes R, 2010, LANCET, V376, P851, DOI 10.1016/S0140-6736(10)61079-3; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Jina R, 2012, J INTERPERS VIOLENCE, V27, P862, DOI 10.1177/0886260511423247; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; Machisa M., 2011, WAR HOME GENDER BASE; Machisa MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175240; McLaughlin J, 2012, CLIN PSYCHOL REV, V32, P677, DOI 10.1016/j.cpr.2012.08.002; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Paben S., 1999, P SECT SURV RES METH; Postmus JL, 2012, J INTERPERS VIOLENCE, V27, P411, DOI 10.1177/0886260511421669; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; Sanders CK, 2015, VIOLENCE AGAINST WOM, V21, P3, DOI 10.1177/1077801214564167; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Sin NL, 2016, ANN BEHAV MED, V50, P523, DOI 10.1007/s12160-016-9777-9; Stockl H, 2015, J INTERPERS VIOLENCE, V30, P3089, DOI 10.1177/0886260514554427	39	50	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194885	10.1371/journal.pone.0194885	http://dx.doi.org/10.1371/journal.pone.0194885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659595	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100007
J	Keinan, Y; Braun, R; Keasar, T				Keinan, Yael; Braun, Rachel; Keasar, Tamar			Phenotypic plasticity of pre-adult egg maturation in a parasitoid: Effects of host-starvation and brood size	PLOS ONE			English	Article							POTATO-TUBER MOTH; COPIDOSOMA-KOEHLERI HYMENOPTERA; LIFE-HISTORY EVOLUTION; TRADE-OFFS; BODY-SIZE; PHTHORIMAEA-OPERCULELLA; OVIPOSITION SUCCESS; BIOLOGICAL-CONTROL; WASP; SUPERPARASITISM	Larvae of parasitoid wasps develop on a single arthropod host, and often face resource limitation that induces a tradeoff between egg maturation and somatic growth. Part of the variation in the growth-reproduction allocation was shown to be heritable, but how the larval developmental environment affects this allocation is not well-known. Detection of life history tradeoffs is often facilitated under stress conditions. We therefore exposed developing female larvae of the polyembryonic parasitoid Copidosoma koehleri (Hymenoptera: Encyrtidae) to laboratory manipulations aimed to restrict host resources (either host-starvation or high larval density). We compared the females' body sizes and egg loads shortly after adult emergence (<24 h) to those of closely related control females, which developed at a lower larval density within non-starved hosts. Host-starvation reduced the females' body sizes but not their initial egg loads. Females that experienced high larval density produced more eggs but were similar in body size to the low-density controls. Thus, the relative allocation to reproduction increased in response to both manipulations of host condition. Developmental duration and longevity were similar in all treatments. The negative correlation between body size and reproductive allocation, observed in the host-starvation treatment, is compatible with previous evidence from other parasitoids. In the high larval density treatment, however, reproductive allocation increased while body size was maintained, suggesting that the higher density increased rather than limited host resources per developing parasitoid female. The additional host resources that were diverted into egg production possibly resulted from increased feeding and body mass gain by hosts parasitized by large broods of wasps. Our results demonstrate phenotypic plasticity in resource allocation between growth and reproduction in a developing parasitoid. This plasticity may contribute to an adaptive balance between longevity and mobility vs. fecundity during the adult stage.	[Keinan, Yael] Univ Haifa, Evolutionary & Environm Biol, Haifa, Israel; [Braun, Rachel] Univ Haifa, Human Biol, Haifa, Israel; [Keasar, Tamar] Univ Haifa, Biol & Environm, Tivon, Israel	University of Haifa; University of Haifa; University of Haifa	Keasar, T (corresponding author), Univ Haifa, Biol & Environm, Tivon, Israel.	tkeasar@research.haifa.ac.il			Israel Science Foundation [414/10]	Israel Science Foundation(Israel Science Foundation)	The study was supported by the Israel Science Foundation, grant no. 414/10 to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram PK, 2016, BIOL J LINN SOC, V117, P620, DOI 10.1111/bij.12658; [Anonymous], 2021, LANG ENV STAT COMP; Baggen LR, 1998, BIOL CONTROL, V11, P9, DOI 10.1006/bcon.1997.0566; Berlinger M. J., 1997, TRENDS ENTOMOLOGY, V1, P137; Browder L.W., 1985, DEV BIOL COMPREHENSI; Cicero L, 2011, J INSECT PHYSIOL, V57, P1471, DOI 10.1016/j.jinsphys.2011.07.014; Cronin JT, 1996, HEREDITY, V76, P43, DOI 10.1038/hdy.1996.6; DOUTT R. L., 1952, CANADIAN ENT, V84, P247; DOUTT RL, 1947, AM NAT, V81, P435, DOI 10.1086/281554; Ellers J, 1997, J EVOLUTION BIOL, V10, P771, DOI 10.1007/s000360050053; Ellers J, 2003, OIKOS, V102, P164, DOI 10.1034/j.1600-0706.2003.12285.x; Ismail M, 2012, OIKOS, V121, P2072, DOI 10.1111/j.1600-0706.2012.20582.x; Jervis MA, 2003, FUNCT ECOL, V17, P375, DOI 10.1046/j.1365-2435.2003.00742.x; Jervis MA, 2001, J ANIM ECOL, V70, P442, DOI 10.1046/j.1365-2656.2001.00507.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Keasar T, 2008, BIOCONTROL SCI TECHN, V18, P325, DOI 10.1080/09583150801905596; Keasar T, 2007, BIOL CONTROL, V42, P55, DOI 10.1016/j.biocontrol.2007.03.012; Keasar T, 2006, ECOL ENTOMOL, V31, P277, DOI 10.1111/j.1365-2311.2006.00788.x; Keinan Y, 2017, ECOL ENTOMOL, V42, P587, DOI 10.1111/een.12422; Keinan Y, 2012, BEHAV ECOL, V23, P1263, DOI 10.1093/beheco/ars111; KFIR R, 1981, ANN APPL BIOL, V99, P225, DOI 10.1111/j.1744-7348.1981.tb04790.x; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Llandres AL, 2015, ECOL MONOGR, V85, P353, DOI 10.1890/14-0976.1; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Pelosse P, 2011, BIOL J LINN SOC, V104, P621, DOI 10.1111/j.1095-8312.2011.01741.x; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Saeki Y, 2013, FUNCT ECOL, V27, P155, DOI 10.1111/1365-2435.12014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segoli M, 2009, ARTHROPOD STRUCT DEV, V38, P84, DOI 10.1016/j.asd.2008.05.003; Segoli M, 2015, ECOL ENTOMOL, V40, P483, DOI 10.1111/een.12194; Segoli M, 2013, FUNCT ECOL, V27, P1224, DOI 10.1111/1365-2435.12109; Segoli M, 2010, EVOL ECOL RES, V12, P259; Segoli M, 2009, BEHAV ECOL, V20, P761, DOI 10.1093/beheco/arp057; Seltman H. J., 2018, EXPT DESIGN ANAL; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Thorne AD, 2006, P ROY SOC B-BIOL SCI, V273, P1099, DOI 10.1098/rspb.2005.3416; Visser B, 2010, P NATL ACAD SCI USA, V107, P8677, DOI 10.1073/pnas.1001744107; Wajnberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045915; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	39	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195767	10.1371/journal.pone.0195767	http://dx.doi.org/10.1371/journal.pone.0195767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659607	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100028
J	Salles, T; Ding, XS; Brocard, G				Salles, Tristan; Ding, Xuesong; Brocard, Gilles			pyBadlands: A framework to simulate sediment transport, landscape dynamics and basin stratigraphic evolution through space and time	PLOS ONE			English	Article							DEPENDENT RIVER INCISION; GREAT-BARRIER-REEF; SEQUENCE STRATIGRAPHY; EASTERN AUSTRALIA; FUZZY-LOGIC; SEA-LEVEL; MODEL; DRAINAGE; SLOPE; MORPHOLOGY	Understanding Earth surface responses in terms of sediment dynamics to climatic variability and tectonics forcing is hindered by limited ability of current models to simulate long-term evolution of sediment transfer and associated morphological changes. This paper presents pyBadlands, an open-source python-based framework which computes over geological time (1) sediment transport from landmasses to coasts, (2) reworking of marine sediments by longshore currents and (3) development of coral reef systems. pyBadlands is cross-platform, distributed under the GPLv3 license and available on GitHub (http://gthub.com/badlands-model). Here, we describe the underlying physical assumptions behind the simulated processes and the main options already available in the numerical framework. Along with the source code, a list of hands-on examples is provided that illustrates the model capabilities. In addition, pre and post-processing classes have been built and are accessible as a companion toolbox which comprises a series of workflows to efficiently build, quantify and explore simulation input and output files. While the framework has been primarily designed for research, its simplicity of use and portability makes it a great tool for teaching purposes.	[Salles, Tristan; Ding, Xuesong; Brocard, Gilles] Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia	University of Sydney	Salles, T (corresponding author), Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia.	tristan.salles@sydney.edu.au	Brocard, Gilles/K-4827-2019	Brocard, Gilles/0000-0002-0997-2995; Ding, Xuesong/0000-0003-3693-932X; Salles, Tristan/0000-0001-6095-7689	Australian Research Council [IH130200012]; ARC [IH130200012]; Australian Government; SIH at the University of Sydney	Australian Research Council(Australian Research Council); ARC(Australian Research Council); Australian Government(Australian GovernmentCGIAR); SIH at the University of Sydney	This work was supported by Australian Research Council Grant Number IH130200012 (Basin Genesis Hub).; The authors were supported by ARC IH130200012 grant. This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government and from Artemis HPC Grand Challenge supported by SIH at the University of Sydney.	Adams JM, 2017, GEOSCI MODEL DEV, V10, P1645, DOI 10.5194/gmd-10-1645-2017; Airy G. B., 1845, ENCY METROPOLITANA, V192, P241; ANDREWS DJ, 1987, J GEOPHYS RES-SOLID, V92, P12857, DOI 10.1029/JB092iB12p12857; [Anonymous], 1996, [No title captured], DOI DOI 10.1007/BFB0014497; Attal M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000893; Barrett SJ, 2017, MAR GEOL, V391, P108, DOI 10.1016/j.margeo.2017.07.007; Beaman R., 2010, CLIM CHANG AUSTR TEC; Braun J, 1997, BASIN RES, V9, P27, DOI 10.1046/j.1365-2117.1997.00030.x; Braun J, 2013, GEOMORPHOLOGY, V180, P170, DOI 10.1016/j.geomorph.2012.10.008; Campforts B, 2017, EARTH SURF DYNAM, V5, P47, DOI 10.5194/esurf-5-47-2017; Chen A, 2014, GEOMORPHOLOGY, V219, P68, DOI 10.1016/j.geomorph.2014.04.037; Collin A, 2015, ISPRS INT J GEO-INF, V4, P900, DOI 10.3390/ijgi4020900; Cowie PA, 2008, GEOLOGY, V36, P535, DOI 10.1130/G24681A.1; Crosby BT, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000566; Dechnik B, 2016, QUATERNARY RES, V85, P44, DOI 10.1016/j.yqres.2015.11.002; Dechnik B, 2015, MAR GEOL, V363, P174, DOI 10.1016/j.margeo.2015.02.014; Demicco RV, 2001, J PETROL SCI ENG, V31, P135, DOI 10.1016/S0920-4105(01)00126-7; Demicco RV, 1998, COMPUT GEOSCI, V24, P405, DOI 10.1016/S0098-3004(98)00024-7; DiBiase RA, 2010, EARTH PLANET SC LETT, V289, P134, DOI 10.1016/j.epsl.2009.10.036; Foufoula-Georgiou E, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001280; Gallop SL, 2014, CORAL REEFS, V33, P1167, DOI 10.1007/s00338-014-1205-7; Gasparini NM, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000567; Gasparini NM, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2009JF001655; GRANJEON D., 1999, SEPM SPECIAL PUBLICA, V62, P197, DOI DOI 10.2110/PEC.99.62.0197; Green MO, 2014, REV GEOPHYS, V52, P77, DOI 10.1002/2013RG000437; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hattab T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076430; Helland-Hansen W, 2009, BASIN RES, V21, P454, DOI 10.1111/j.1365-2117.2009.00425.x; Hobley DEJ, 2017, EARTH SURF DYNAM, V5, P21, DOI 10.5194/esurf-5-21-2017; Hobley DEJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001935; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; Hopley D., 1984, HOLOCENE HIGH ENERGY; Hopley D.H., 1982, GEOMORPHOLOGY GREAT; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; Hughes K, 2017, J QUATERNARY SCI, V32, P744, DOI 10.1002/jqs.2956; KOMAR PD, 1975, J SEDIMENT PETROL, V45, P697; Kwang JS, 2017, EARTH SURF DYNAM, V5, P807, DOI 10.5194/esurf-5-807-2017; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Larcombe P, 1999, AUST J EARTH SCI, V46, P141, DOI 10.1046/j.1440-0952.1999.00694.x; Larsen IJ, 2012, NAT GEOSCI, V5, P468, DOI 10.1038/ngeo1479; Lewis S., 2012, MAR GEOL, V32, P299; Longuet-Higgins M. S., 1970, J GEOPHYS RES, V75, P1, DOI DOI 10.1029/JC075I033P06790; MARSHALL JF, 1984, NATURE, V307, P44, DOI 10.1038/307044a0; Meesters EH, 1998, CONSERV BIOL, V12, P957, DOI 10.1046/j.1523-1739.1998.96421.x; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Moss PT, 2012, TERRA AUSTRALIS, V34, P329; Murphy BP, 2016, NATURE, V532, P223, DOI 10.1038/nature17449; Neal J, 2009, GEOLOGY, V37, P779, DOI 10.1130/G25722A.1; Neal JE, 2016, J GEOL SOC LONDON, V173, P803, DOI 10.1144/jgs2015-165; Nordlund U, 1999, COMPUT GEOSCI, V25, P449, DOI 10.1016/S0098-3004(98)00151-4; OCALLAGHAN JF, 1984, COMPUT VISION GRAPH, V28, P323, DOI [10.1016/S0734-189X(84)80011-0, 10.1016/0734-189X(89)90053-4]; Parker G., 2004, 118 U MINN ANTH FALL; Puga-Bernabeu A, 2014, MAR PETROL GEOL, V50, P40, DOI 10.1016/j.marpetgeo.2013.11.009; Puga-Bernabeu A, 2013, GEOMORPHOLOGY, V191, P35, DOI 10.1016/j.geomorph.2013.03.001; Roering JJ, 2001, J GEOPHYS RES-SOL EA, V106, P16499, DOI 10.1029/2001JB000323; Roering JJ, 2001, GEOLOGY, V29, P143, DOI 10.1130/0091-7613(2001)029<0143:HEBNCA>2.0.CO;2; Salles T, 2017, GEOCHEM GEOPHY GEOSY, V18, P280, DOI 10.1002/2016GC006617; Salles T, 2016, COMPUT GEOSCI-UK, V91, P77, DOI 10.1016/j.cageo.2016.03.011; Salles TB, 2011, MAR GEOL, V282, P268, DOI 10.1016/j.margeo.2011.02.014; Salles T, 2015, EARTH SURF PROC LAND, V40, P823, DOI 10.1002/esp.3674; Shulmeister J, 1999, QUATERN INT, V57-8, P81, DOI 10.1016/S1040-6182(98)00052-4; Sklar L, 1998, RIVERS ROCK FLUVIAL, P237, DOI DOI 10.1029/GM107P0237; Sklar LS, 2006, GEOMORPHOLOGY, V82, P58, DOI 10.1016/j.geomorph.2005.08.019; Sklar LS, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002496; Sklar LS, 2001, GEOLOGY, V29, P1087, DOI 10.1130/0091-7613(2001)029<1087:SARSCO>2.0.CO;2; Smith RB, 2004, J ATMOS SCI, V61, P1377, DOI 10.1175/1520-0469(2004)061<1377:ALTOOP>2.0.CO;2; Soulen RJ, 1995, INST PHYS CONF SER, V148, P23; SOULSBY RL, 1993, COAST ENG, V21, P41, DOI 10.1016/0378-3839(93)90045-A; Soulsby RL, 1997, DYNAMICS MARINE SAND, P429; STOKES G. G., 1847, MATH PHYS PAPERS, V8, P441, DOI DOI 10.1017/CBO9780511702242.013; Tetzlaff DM, 2005, J COASTAL RES, V21, P610, DOI 10.2112/04-704A.1; Thieulot C, 2014, GEOCHEM GEOPHY GEOSY, V15, P4936, DOI 10.1002/2014GC005490; Tucker G, 2001, CHANNEL HILLSLOPE IN, p349 ; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; Tucker GE, 2010, J GEOPHYS RES EARTH, V115; Tucker GE, 2010, EARTH SURF PROC LAND, V35, P28, DOI 10.1002/esp.1952; Turowski JM, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000697; VANRIJN LC, 1984, J HYDRAUL ENG-ASCE, V110, P1431, DOI 10.1061/(ASCE)0733-9429(1984)110:10(1431); Warrlich G, 2008, MAR PETROL GEOL, V25, P35, DOI 10.1016/j.marpetgeo.2007.04.005; Warrlich GMD, 2002, BASIN RES, V14, P379, DOI 10.1046/j.1365-2117.2002.00181.x; Watts K. F., 1993, P ODP SCI RESULTS; Webster JM, 2003, SEDIMENT GEOL, V159, P61, DOI 10.1016/S0037-0738(03)00095-2; Whipple KX, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000044; Wickert AD, 2016, GEOSCI MODEL DEV, V9, P997, DOI 10.5194/gmd-9-997-2016; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	85	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195557	10.1371/journal.pone.0195557	http://dx.doi.org/10.1371/journal.pone.0195557			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649301	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900055
J	Saxena, M; Delgado, Y; Sharma, RK; Sharma, S; Guzman, SLPD; Tinoco, AD; Griebenow, K				Saxena, Manoj; Delgado, Yamixa; Sharma, Rohit Kumar; Sharma, Shweta; Guzman, Solimar Liz Ponce De Leon; Tinoco, Arthur D.; Griebenow, Kai			Inducing cell death in vitro in cancer cells by targeted delivery of cytochrome c via a transferrin conjugate	PLOS ONE			English	Article							INTRACELLULAR DELIVERY; RECEPTOR EXPRESSION; DRUG-DELIVERY; LUNG-CANCER; APOPTOSIS; PROTEIN; NANOPARTICLES; ACTIVATION; CISPLATIN; TUMORS	One of the major drawbacks of many of the currently used cancer drugs are off-target effects. Targeted delivery is one method to minimize such unwanted and detrimental events. To actively target lung cancer cells, we have developed a conjugate of the apoptosis inducing protein cytochrome c with transferrin because the transferrin receptor is overexpressed by many rapidly dividing cancer cells. Cytochrome c and transferrin were cross-linked with a redox sensitive disulfide bond for the intra-cellular release of the protein upon endocytosis by the transferrin receptor. Confocal results demonstrated the cellular uptake of the cytochrome c-transferrin conjugate by transferrin receptor overexpressing A549 lung cancer cells. Localization studies further validated that this conjugate escaped the endosome. Additionally, an in vitro assay showed that the conjugate could induce apoptosis by activating caspase-3. The neo-conjugate not only maintained an IC50 value similar to the well known drug cisplatin (50 mu M) in A549 cancer cells but also was nontoxic to the normal lung (MRC5) cells. Our neo-conjugate holds promise for future development to target cancers with enhanced transferrin receptor expression.	[Saxena, Manoj; Sharma, Rohit Kumar; Sharma, Shweta] Univ Puerto Rico, Dept Environm Sci, Rio Piedras Campus, San Juan, PR 00936 USA; [Saxena, Manoj; Delgado, Yamixa; Guzman, Solimar Liz Ponce De Leon; Tinoco, Arthur D.; Griebenow, Kai] Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00936 USA; [Delgado, Yamixa] San Juan Bautista Sch Med, Biochem & Pharmacol Dept, Caguas, PR USA	University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras	Griebenow, K (corresponding author), Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00936 USA.	kai.griebenow@gmail.com	Griebenow, Kai H/AAS-2754-2021; Griebenow, Kai/AGK-1725-2022; Sharma, Rohit/L-8523-2018	Griebenow, Kai H/0000-0003-0495-9932; Delgado, Yamixa/0000-0002-0686-7145	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [P20GM103642]; NIH SC1 by NIGMS [5SC1CA190504-03]; NIH SC1 by NCI [5SC1CA190504-03]; Puerto Rico Science, Technology, and Research Trust [2013-000019]; University of Puerto Rico FIPI Grant from the office of the DEGI; NATIONAL CANCER INSTITUTE [SC1CA190504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103642] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH SC1 by NIGMS; NIH SC1 by NCI; Puerto Rico Science, Technology, and Research Trust; University of Puerto Rico FIPI Grant from the office of the DEGI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The confocal microscopy work was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under Award Number P20GM103642. A.D.T. and Y.D. are supported by the NIH SC1 (5SC1CA190504-03) provided by the NIGMS and NCI. A.D.T. is also supported by funding from the Puerto Rico Science, Technology, and Research Trust (Agreement No. 2013-000019), the University of Puerto Rico FIPI Grant from the office of the DEGI.	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Bansal R, 2011, J CONTROL RELEASE, V154, P233, DOI 10.1016/j.jconrel.2011.05.027; BLUM JS, 1991, J BIOL CHEM, V266, P22091; Cheng R, 2011, J CONTROL RELEASE, V152, P2, DOI 10.1016/j.jconrel.2011.01.030; Deming PB, 2004, MOL CELL BIOL, V24, P10289, DOI 10.1128/MCB.24.23.10289-10299.2004; Derfus AM, 2007, BIOCONJUGATE CHEM, V18, P1391, DOI 10.1021/bc060367e; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Egbelakin A, 2011, PEDIATR BLOOD CANCER, V56, P361, DOI 10.1002/pbc.22845; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Hall MD, 2014, CANCER RES, V74, P3913, DOI 10.1158/0008-5472.CAN-14-0247; HARRIS WR, 1991, BIOCHEMISTRY-US, V30, P6930, DOI 10.1021/bi00242a017; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; INOUE T, 1993, J CELL PHYSIOL, V156, P212, DOI 10.1002/jcp.1041560128; IPPOLITI R, 1995, FASEB J, V9, P1220, DOI 10.1096/fasebj.9.12.7672515; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jiang YY, 2007, J DRUG TARGET, V15, P672, DOI 10.1080/10611860701603414; Johnson CE, 2007, P NATL ACAD SCI USA, V104, P20820, DOI 10.1073/pnas.0709101105; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jones S, 2010, CHEM BIOL, V17, P735, DOI 10.1016/j.chembiol.2010.05.018; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Kelkar SS, 2011, BIOCONJUGATE CHEM, V22, P1879, DOI 10.1021/bc200151q; Kim SK, 2012, BIOMATERIALS, V33, P3959, DOI 10.1016/j.biomaterials.2012.02.010; Lai H, 2009, ANTICANCER RES, V29, P3807; Liu D, 2016, THERANOSTICS, V6, P1306, DOI 10.7150/thno.14858; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Meier R, 2010, RADIOLOGY, V255, P527, DOI 10.1148/radiol.10090050; Mendez J, 2014, MOL PHARMACEUT, V11, P102, DOI 10.1021/mp400400j; Merlen C, 2005, FEBS J, V272, P4385, DOI 10.1111/j.1742-4658.2005.04851.x; Monni O, 1997, BLOOD, V90, P1168, DOI 10.1182/blood.V90.3.1168.1168_1168_1174; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Morales-Cruz M, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0033-9; OTA E, 1995, BRIT J CANCER, V72, P550, DOI 10.1038/bjc.1995.372; Ozer I, 2017, BIOCONJUGATE CHEM, V28, P713, DOI 10.1021/acs.bioconjchem.6b00652; Piel DA, 2008, SHOCK, V29, P612, DOI 10.1097/SHK.0b013e318157e962; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; RASO V, 1984, J BIOL CHEM, V259, P1143; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Santra S, 2010, MOL PHARMACEUT, V7, P1209, DOI 10.1021/mp100043h; Saxena M, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0050-9; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Taguchi T, 2005, CONTRIB NEPHROL, V148, P107, DOI 10.1159/000086055; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Tinoco AD, 2016, J AM CHEM SOC, V138, P5659, DOI 10.1021/jacs.6b01966; VANDERKOOI JM, 1985, J CELL BIOL, V100, P435, DOI 10.1083/jcb.100.2.435; Voets IK, 2010, J PHYS CHEM B, V114, P11875, DOI 10.1021/jp103515b; WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410; Wang SS, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6010003; WHITNEY JF, 1995, CANCER, V76, P20, DOI 10.1002/1097-0142(19950701)76:1<20::AID-CNCR2820760104>3.0.CO;2-3; Wiley DT, 2013, P NATL ACAD SCI USA, V110, P8662, DOI 10.1073/pnas.1307152110; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Zhang Peilin, 2003, Mol Cancer, V2, P1; Zhivotovsky B, 1998, NATURE, V391, P449, DOI 10.1038/35060; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	62	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195542	10.1371/journal.pone.0195542	http://dx.doi.org/10.1371/journal.pone.0195542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649293	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900052
J	Taffon, P; Rossi, G; Kindermans, JM; Van den Bergh, R; Nguon, C; Debackere, M; Vernaevel, L; De Smet, M; Venables, E				Taffon, Pierluigi; Rossi, Gabriele; Kindermans, Jean-Marie; Van den Bergh, Rafael; Nguon, Chea; Debackere, Mark; Vernaevel, Lieven; De Smet, Martin; Venables, Emilie			'I could not join because I had to work for pay.': A qualitative evaluation of falciparum malaria pro-active case detection in three rural Cambodian villages	PLOS ONE			English	Article							LAO PDR LAOS; PLASMODIUM-FALCIPARUM; COMMUNITY ENGAGEMENT; ELIMINATION; RESISTANCE; STRATEGIES; PROVINCE; INFECTIONS	Background Pro-active case detection (Pro-ACD), in the form of voluntary screening and treatment (VSAT) following community mobilisation about 'asymptomatic malaria', is currently being evaluated as a tool for Plasmodium falciparum elimination in Preah Vihear Province, Cambodia. Methods A qualitative study was conducted to explore community understanding, perceptions, expectations and acceptability of the Pro-ACD intervention in order to identify aspects that could be improved in future Pro-ACD activities. This was ancillary to a three-round VSAT campaign, carried out in three villages between December 2015 and March 2016. Qualitative data collection began shortly after the end of the three rounds of screening. Purposive sampling was used to select participants. Nine focus group discussions with participants (n = 46) and non-participants (n = 40) in the Pro-ACD screening were conducted, in addition to in-depth interviews with key village figures (n = 9). Results Health promotion messages were well delivered and received, but it was difficult for many villagers to understand the messages around 'asymptomatic malaria'. Overall, villagers and village leaders had a positive opinion about the VSAT intervention. Acceptability was high, as a direct consequence of favourable perceptions towards the screening activity: the ProACD intervention was seen by the local population as an effective, inexpensive, reliable and readily available tool to protect individuals and the community from the insurgence of malaria. Physical absence and lack of time (both linked to work-related activities) were the main reasons for non-participation. Conclusions Although VSAT was generally well perceived and accepted, the 'time factor' related to the need to satisfy essential daily subsistence requirements played a significant role in determining participation in the screening. More well-adapted and meaningful Pro-ACD approaches could be implemented by improving the timing of the testing activites, and strengthening community participation and engagement to increase acceptability.	[Taffon, Pierluigi; Rossi, Gabriele; Debackere, Mark; Vernaevel, Lieven] Medecins Sans Frontieres, Phnom Penh, Cambodia; [Kindermans, Jean-Marie; Van den Bergh, Rafael; De Smet, Martin; Venables, Emilie] Medecins Sans Frontieres, Operat Ctr Belgium, Brussels, Belgium; [Nguon, Chea] Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Venables, Emilie] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa	Doctors Without Borders; National Center Parasitology, Entomology & Malaria Control; University of Cape Town	Venables, E (corresponding author), Medecins Sans Frontieres, Operat Ctr Belgium, Brussels, Belgium.; Venables, E (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa.	emilie.venables@brussels.msf.org		Van den Bergh, Rafael/0000-0001-6277-8713				Adhikari B, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2070-y; Adhikari B, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1366136; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; American Anthropological Association, AAA ETH BLOG; Atkinson JAM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-93; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Canavati SE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1276-8; Cao J L, 2014, INT J PHOTOENERGY, V2014, P1, DOI DOI 10.1371/J0URNAL.PMED.1001642; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Edwards HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124300; Falq G, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1487-z; Galatas B, 2015, TRENDS PARASITOL, pS1471; Grietens KP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16837; Kajeechiwa Ladda, 2017, Wellcome Open Res, V2, P59, DOI 10.12688/wellcomeopenres.12051.1; Lyttleton C, 2016, SOC SCI MED, V150, P144, DOI 10.1016/j.socscimed.2015.12.033; Malaria Consortium, 2013, STRAT ADDR MIGR MOB; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0921-y; Pell C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1854-4; Phommasone K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1336-0; Rossi G, CLIN INFECT IN PRESS; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Nguyen TN, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1662-2; Tripura R, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1703-5; Tynan A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-204; Verschuere J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1732-0; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; Whittaker M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0931-9; WHO, 2014, EM RESP ART RES GREA	33	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195809	10.1371/journal.pone.0195809	http://dx.doi.org/10.1371/journal.pone.0195809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649317	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900091
J	Klakotskaia, D; Agca, C; Richardson, RA; Stopa, EG; Schachtman, TR; Agca, Y				Klakotskaia, Diana; Agca, Cansu; Richardson, Rachel A.; Stopa, Edward G.; Schachtman, Todd R.; Agca, Yuksel			Memory deficiency, cerebral amyloid angiopathy, and amyloid-beta plaques in APP+PS1 double transgenic rat model of Alzheimer's disease	PLOS ONE			English	Article							FLUID DRAINAGE PATHWAYS; 3XTG-AD MOUSE MODEL; A-BETA; IMPAIRMENT; PATHOLOGY; HIPPOCAMPAL; DYSFUNCTION	Transgenic rat models of Alzheimer's disease were used to examine differences in memory and brain histology. Double transgenic female rats (APP+PS1) over-expressing human amyloid precursor protein (APP) and presenilin 1 (PS1) and single transgenic rats (APP21) over-expressing human APP were compared with wild type Fischer rats (WT). The Barnes maze assessed learning and memory and showed that both APP21 and APP+PS1 rats made significantly more errors than the WT rats during the acquisition phase, signifying slower learning. Additionally, the APP+PS1 rats made significantly more errors following a retention interval, indicating impaired memory compared to both the APP21 and WT rats. Immunohistochemistry using an antibody against amyloid-beta (A beta) showed extensive and mostly diffuse A beta plaques in the hippocampus and dense plaques that contained tau in the cortex of the brains of the APP+PS1 rats. Furthermore, the APP+PS1 rats also showed vascular changes, including cerebral amyloid angiopathy with extensive A beta deposits in cortical and leptomeningeal blood vessel walls and venous collagenosis. In addition to the A beta accumulation observed in arterial, venous, and capillary walls, APP+PS1 rats also displayed enlarged blood vessels and perivascular space. Overall, the brain histopathology and behavioral assessment showed that the APP+PS1 rats demonstrated behavioral characteristics and vascular changes similar to those commonly observed in patients with Alzheimer's disease.	[Klakotskaia, Diana; Richardson, Rachel A.; Schachtman, Todd R.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA; [Agca, Cansu; Agca, Yuksel] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Stopa, Edward G.] Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Lifespan Health Rhode Island; Rhode Island Hospital	Agca, Y (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.	agcay@missouri.edu		Klakotskaia, Diana/0000-0002-9851-5330	University of Missouri-Research Incentive Funds; National Institute of Health [P40 OD011062]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011062] Funding Source: NIH RePORTER	University of Missouri-Research Incentive Funds; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the University of Missouri-Research Incentive Funds to Yuksel Agca and the National Institute of Health (grant no. P40 OD011062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-28; Agca C, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0281-8; Alzheimer's Association, 2017, ALZHEIMERS DEMENT, V13, P325, DOI [DOI 10.1016/J.JALZ.2017.02.001, 10.1016/j.jalz.2017.02.001]; Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; Attems J, 2005, ACTA NEUROPATHOL, V110, P345, DOI 10.1007/s00401-005-1074-9; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Beauguis J, 2014, MEDICINA-BUENOS AIRE, V74, P282; Black S, 2009, STROKE, V40, pS48, DOI 10.1161/STROKEAHA.108.537704; Canete T, 2015, BEHAV BRAIN RES, V281, P156, DOI 10.1016/j.bbr.2014.11.004; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gao F., 2008, ALZHEIMERS DEMENT, V4, pT368, DOI [DOI 10.1016/J.JALZ.2008.05.1090, 10.1016/j.jalz.2008.05.1090]; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Johnson C, 2004, CEREBROSPINAL FLUID, V1; Joo IL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46427; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Moody DM, 1997, ANN NY ACAD SCI, V826, P103, DOI 10.1111/j.1749-6632.1997.tb48464.x; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Pietropaolo S, 2014, COGN AFFECT BEHAV NE, V14, P996, DOI 10.3758/s13415-014-0253-3; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Roher AE, 2003, MOL MED, V9, P112, DOI 10.1007/BF03402043; Sandoval-Hernandez AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145467; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Silverberg GD, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/2045-8118-12-2; Stepanichev MY, 2004, PHYSIOL BEHAV, V80, P647, DOI 10.1016/j.physbeh.2003.11.003; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; Stover KR, 2015, BEHAV BRAIN RES, V289, P29, DOI 10.1016/j.bbr.2015.04.012; Van Dorpe J, 2000, AM J PATHOL, V157, P1283, DOI 10.1016/S0002-9440(10)64644-5; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Vest RS, 2013, HORM BEHAV, V63, P301, DOI 10.1016/j.yhbeh.2012.04.006; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Walker JM, 2015, J ALZHEIMERS DIS, V44, P561, DOI 10.3233/JAD-140981; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Weller RO, 2000, ANN NY ACAD SCI, V903, P110, DOI 10.1111/j.1749-6632.2000.tb06356.x; Weller RO, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt6; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Wright AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059586	42	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195469	10.1371/journal.pone.0195469	http://dx.doi.org/10.1371/journal.pone.0195469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641600	gold, Green Submitted, Green Published			2022-12-27	WOS:000429742900070
J	Goossens, J; Verhaeghe, S; Van Hecke, A; Barrett, G; Delbaere, I; Beeckman, D				Goossens, Joline; Verhaeghe, Sofie; Van Hecke, Ann; Barrett, Geraldine; Delbaere, Ilse; Beeckman, Dimitri			Psychometric properties of the Dutch version of the London Measure of Unplanned Pregnancy in women with pregnancies ending in birth	PLOS ONE			English	Article							REDUCE UNINTENDED PREGNANCIES; PRECONCEPTION CARE; CONTRACEPTIVE USE; HEALTH OUTCOMES; INTENTION; RECOMMENDATIONS; AMBIVALENCE; PREVALENCE; VALIDATION; FLANDERS	Objective To evaluate the psychometric properties of the Dutch version of the London Measure of Unplanned Pregnancy in women with pregnancies ending in birth. Methods A two-phase psychometric evaluation design was set-up. Phase I comprised the translation from English into Dutch and pretesting with 6 women using cognitive interviews. In phase II, the reliability and validity of the Dutch version of the LMUP was assessed in 517 women giving birth recently. Reliability (internal consistency) was assessed using Cronbach's alpha, inter-item correlations, and corrected item-total correlations. Construct validity was assessed using principal components analysis and hypothesis testing. Exploratory Mokken scale analysis was carried out. Results 517 women aged 15-45 completed the Dutch version of the LMUP. Reliability testing showed acceptable internal consistency (alpha = 0.74, positive inter-item correlations between all items, all corrected item-total correlations > 0.20). Validity testing confirmed the unidimensional structure of the scale and all hypotheses were confirmed. The overall Loe-vinger's H coefficient was 0.57, representing a 'strong' scale. Conclusion The Dutch version of the LMUP is a reliable and valid measure that can be used in the Dutch-speaking population in Belgium to assess pregnancy planning. Future research is necessary to assess the stability of the Dutch version of the LMUP, and to evaluate its psychometric properties in women with abortions.	[Goossens, Joline; Verhaeghe, Sofie; Van Hecke, Ann; Beeckman, Dimitri] Univ Ghent, Univ Ctr Nursing & Midwifery, Dept Publ Hlth, Ghent, Belgium; [Van Hecke, Ann] Univ Hosp Ghent, Nursing Sci, Ghent, Belgium; [Barrett, Geraldine] UCL, Inst Womens Hlth, Res Dept Reprod Hlth, London, England; [Delbaere, Ilse] VIVES, Univ Coll, Kortrijk, Belgium	Ghent University; Ghent University; Ghent University Hospital; University of London; University College London	Goossens, J (corresponding author), Univ Ghent, Univ Ctr Nursing & Midwifery, Dept Publ Hlth, Ghent, Belgium.	jolgooss.goossens@ugent.be	Delbaere, Ilse/AAA-4093-2020; Beeckman, Dimitri/AAD-4377-2021; Beeckman, Dimitri/A-1573-2012	Barrett, Geraldine/0000-0002-9738-1051; Delbaere, Ilse/0000-0002-8522-2512; Beeckman, Dimitri/0000-0003-3080-8716; Verhaeghe, Sofie/0000-0002-2063-5033; Van Hecke, Ann/0000-0003-3576-7159	Research Foundation - Flanders (FWD) [G058113N]	Research Foundation - Flanders (FWD)(FWO)	This work was supported by the Research Foundation - Flanders (FWD), grant number: G058113N - http://www.fwo.be/ - J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaghaslah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185433; [Anonymous], 2016, STAT CIJF; Bachrach CA, 1999, FAM PLANN PERSPECT, V31, P251, DOI 10.2307/2991577; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Bartholomew LK, 2011, PLANNING HLTH PROMOT; Borrero S, 2015, CONTRACEPTION, V91, P150, DOI 10.1016/j.contraception.2014.09.014; Campbell A A, 2000, Matern Child Health J, V4, P163, DOI 10.1023/A:1009519329226; CDC/National Center for Health Statistics, 2016, 2013 2015 NAT SURV F; Chandra Anjani, 2005, Vital Health Stat 23, P1; Cheng D, 2009, CONTRACEPTION, V79, P194, DOI 10.1016/j.contraception.2008.09.009; Delbaere I, 2016, UPSALA J MED SCI, V121, P264, DOI 10.1080/03009734.2016.1216481; Devlieger R., 2016, PERINATALE ACTIVITEI; Dibaba Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-50; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; Dott M, 2010, MATERN CHILD HLTH J, V14, P373, DOI 10.1007/s10995-009-0458-1; Elaut E, 2015, EUR J CONTRACEP REPR, V20, P283, DOI 10.3109/13625187.2015.1015717; European Commission, 2010, INCOME LIVING CONDIT; Federal Public Service for Foreign Affairs Foreign Trade and Development Cooperation, 2015, D201597374 FED PUBL; Fischer RC, 1999, J FAM PRACTICE, V48, P117; Frayne DJ, 2016, OBSTET GYNECOL, V127, P863, DOI 10.1097/AOG.0000000000001379; Galle A, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0266-2; Gillet E, 2014, INT J GYNECOL OBSTET, V124, P128, DOI 10.1016/j.ijgo.2013.07.031; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Gisle L, 2014, GEZONDHEIDSENQUETE D; Goossens J, 2016, HUM REPROD, V31, P2821, DOI 10.1093/humrep/dew266; Habib MA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1339-z; Hall J, 2017, PATIENT RELAT OUTCOM; Hall J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-200; Hall JA, 2017, MATERN CHILD HLTH J, V21, P670, DOI 10.1007/s10995-016-2237-0; Higgins JA, 2012, PERSPECT SEX REPRO H, V44, P236, DOI 10.1363/4423612; Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067; Kincaid J. P., 1975, RBR875 NAV TECHN TRA; Klerman L V, 2000, Matern Child Health J, V4, P155, DOI 10.1023/A:1009534612388; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S6; Mallard SR, 2013, AUST NZ J OBSTET GYN, V53, P498, DOI 10.1111/ajo.12074; Maxson P, 2011, J WOMENS HEALTH, V20, P1215, DOI 10.1089/jwh.2010.2379; Mohllajee AP, 2007, OBSTET GYNECOL, V109, P678, DOI 10.1097/01.AOG.0000255666.78427.c5; Mokken R. J., 1971, THEORY PROCEDURE SCA, DOI DOI 10.1515/9783110813203; Mokkink LB., 2012, COSMIN CHECKLIST MAN; Morof D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035381; Nelson DB, 2013, J WOMENS HEALTH, V22, P673, DOI 10.1089/jwh.2012.4133; Petersen R, 1997, WOMEN HEALTH ISS, V7, P234, DOI 10.1016/S1049-3867(97)00009-1; Polit D., 2010, ESSENTIALS NURSING R, V7th; Postlethwaite D, 2010, MATERN CHILD HLTH J, V14, P227, DOI 10.1007/s10995-009-0446-5; Rocca CH, 2010, DEMOGR RES, V23, P293, DOI 10.4054/DemRes.2010.23.11; Roshanaei S, 2015, E MEDITERR HEALTH J, V21, P572, DOI 10.26719/2015.21.8.572; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1363/3509403; Schwarz EB, 2007, CONTRACEPTION, V75, P305, DOI 10.1016/j.contraception.2006.12.002; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Sedgh G, 2011, INT PERSPECT SEX R H, V37, P84, DOI 10.1363/3708411; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; Sijtsma K., 2002, INTRO NONPARAMETRIC, VVol. 5; Stanford J B, 2000, Matern Child Health J, V4, P183; Stewart ME, 2010, PERS INDIV DIFFER, V48, P845, DOI 10.1016/j.paid.2010.02.011; Streiner DL, 2014, HLTH MEASUREMENT SCA; Temel S, 2015, J COMMUN GENET, V6, P107, DOI 10.1007/s12687-014-0204-2; TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857; Trussell J, 1999, FAM PLANN PERSPECT, V31, P246, DOI 10.2307/2991573; U.S. Department of Health and Human Services, 2010, HLTH PEOP 2020 NAT H; *US DEP HHS, 1990, HLTH PEOPL 2000 NAT; Van Bavel J, 2016, RECENTE EVOLUTIE VRU; Borges ALV, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1037-2; Watson R, 2011, J CLIN NURS, V20, P3271, DOI 10.1111/j.1365-2702.2011.03993.x; World Health Organization, 2012, M DEV GLOB CONS PREC, P78; World Health Organization, 2009, MAN SUBST AB PROC TR; World Health Organization, 2010, PACK INT FAM PLANN S	68	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194033	10.1371/journal.pone.0194033	http://dx.doi.org/10.1371/journal.pone.0194033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668712	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200006
J	Marin-Arroyo, AB; Rios-Garaizar, J; Straus, LG; Jones, JR; de la Rasilla, M; Morales, MRG; Richards, M; Altuna, J; Mariezkurrena, K; Ocio, D				Marin-Arroyo, Ana B.; Rios-Garaizar, Joseba; Straus, Lawrence G.; Jones, Jennifer R.; de la Rasilla, Marco; Gonzalez Morales, Manuel R.; Richards, Michael; Altuna, Jesus; Mariezkurrena, Koro; Ocio, David			Chronological reassessment of the Middle to Upper Paleolithic transition and Early Upper Paleolithic cultures in Cantabrian Spain	PLOS ONE			English	Article							RADIOCARBON-DATES; NORTHERN IBERIA; MODERN HUMANS; LABEKO KOBA; BONE; BEHAVIOR; EUROPE; BP	Methodological advances in dating the Middle to Upper Paleolithic transition provide a better understanding of the replacement of local Neanderthal populations by Anatomically Modern Humans. Today we know that this replacement was not a single, pan-European event, but rather it took place at different times in different regions. Thus, local conditions could have played a role. Iberia represents a significant macro-region to study this process. Northern Atlantic Spain contains evidence of both Mousterian and Early Upper Paleolithic occupations, although most of them are not properly dated, thus hindering the chances of an adequate interpretation. Here we present 46 new radiocarbon dates conducted using ultra filtration pre-treatment method of anthropogenically manipulated bones from 13 sites in the Cantabrian region containing Mousterian, Aurignacian and Gravettian levels, of which 30 are considered relevant. These dates, alongside previously reported ones, were integrated into a Bayesian age model to reconstruct an absolute timescale for the transitional period. According to it, the Mousterian disappeared in the region by 47.9-45.1ka cal BP, while the Chatelperronian lasted between 42.6k and 41.5ka cal BP. The Mousterian and Chatelperronian did not overlap, indicating that the latter might be either intrusive or an offshoot of the Mousterian. The new chronology also suggests that the Aurignacian appears between 43.3-40.5ka cal BP overlapping with the Chatelperronian, and ended around 34.6-33.1ka cal BP, after the Gravettian had already been established in the region. This evidence indicates that Neanderthals and AMH co-existed <1,000 years, with the caveat that no diagnostic human remains have been found with the latest Mousterian, Chatelperronian or earliest Aurignacian in Cantabrian Spain.	[Marin-Arroyo, Ana B.; Jones, Jennifer R.; Gonzalez Morales, Manuel R.] Univ Cantabria, Inst Int Invest Prehist Cantabria, Gobierno Cantabria, Santander, Spain; [Marin-Arroyo, Ana B.] Univ Cambridge, Dept Archaeol, Leverhulme Ctr Evolutionary Studies, Cambridge, England; [Rios-Garaizar, Joseba] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Straus, Lawrence G.] Univ New Mexico, Dept Anthropol, MSC01 1040, Albuquerque, NM 87131 USA; [de la Rasilla, Marco] Univ Oviedo, Dept Hist, Oviedo, Spain; [Richards, Michael] Simon Fraser Univ, Dept Archaeol, Burnaby, BC, Canada; [Altuna, Jesus; Mariezkurrena, Koro] Ctr Conservac & Invest Mat Arqueol & Paleontol Gi, Donostia San Sebastian, Spain; [Ocio, David] Imperial Coll London, Dept Civil & Environm Engn, London, England	Universidad de Cantabria; Instituto Internacional de Investigaciones Prehistoricas de Cantabria (IIIPC); University of Cambridge; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of New Mexico; University of Oviedo; Simon Fraser University; Imperial College London	Marin-Arroyo, AB (corresponding author), Univ Cantabria, Inst Int Invest Prehist Cantabria, Gobierno Cantabria, Santander, Spain.; Marin-Arroyo, AB (corresponding author), Univ Cambridge, Dept Archaeol, Leverhulme Ctr Evolutionary Studies, Cambridge, England.	marinab@unican.es	Rios-Garaizar, Joseba/M-5604-2018; Marín-Arroyo, Ana B./AAT-6209-2020; Richards, Michael/O-3717-2016; Marín-Arroyo, Ana B./C-4828-2015; Jones, Julian/B-1007-2012	Rios-Garaizar, Joseba/0000-0001-8474-2156; Richards, Michael/0000-0001-5274-8887; Marín-Arroyo, Ana B./0000-0003-3353-5581; Jones, Jennifer/0000-0002-9247-7994; Jones, Julian/0000-0002-2647-8024	European Commission [322112]; Spanish Ministry of Economy and Competitiveness [HAR2012-33956, RYC-2011-00695]; Cantabria Campus International; University of Cantabria; Government of Cantabria; Banco Santander; Spanish Ministry of Education, Culture and Sports (Jose de Castillejo Program) [CAS15_00054]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness(Spanish Government); Cantabria Campus International; University of Cantabria; Government of Cantabria; Banco Santander; Spanish Ministry of Education, Culture and Sports (Jose de Castillejo Program)	This research has been supported by the European Commission through FP7-PEOPLE-2012-CIG (Ref: 322112), the Spanish Ministry of Economy and Competitiveness (HAR2012-33956 and RYC-2011-00695), Cantabria Campus International and University of Cantabria to ABMA. The Instituto Internacional de Investigaciones Prehistoricas de Cantabria is sponsored by the University of Cantabria, the Government of Cantabria and Banco Santander. This paper was mainly written during a research stay by one of us (ABMA) at the Leverhulme Centre for Evolutionary Studies, Department of Archaeology, University of Cambridge funded by Spanish Ministry of Education, Culture and Sports (Jose de Castillejo Program, Ref no. CAS15_00054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been supported by the European Commission through FP7-PEOPLE-2012-CIG (Ref: 322112), the Spanish Ministry of Economy and Competitiveness (HAR2012-33956 and RYC-2011-00695), Cantabria Campus International and University of Cantabria to ABMA. The Instituto Internacional de Investigaciones Prehistoricas de Cantabria is sponsored by the University of Cantabria, the Government of Cantabria and Banco Santander. The authors want to acknowledge the Museo de Prehistoria y Arqueologia de Cantabria, Museo Arqueologico de Bizkaia (specially to D. Garate) and the Centro de Patrimonio Cultural del Departamento de Cultura del Gobierno Vasco for the facilities provided during the sampling and studying material. They warmly appreciate the significant help of archaeologist P. Rasines, R. Montes and E. Munoz during sample selection. This paper was mainly written during a research stay by one of us (ABMA) at the Leverhulme Centre for Evolutionary Studies, Department of Archaeology, University of Cambridge funded by Spanish Ministry of Education, Culture and Sports (Jose de Castillejo Program, Ref no. CAS15_00054). ABMA and DO are grateful to Prof. Robert Foley and Prof. Marta MirazOn-Lahr for their institutional support.	Altuna J., 1984, YACIMIENTO PREHISTOR; Altuna J, 1990, CUEVA AMALDA ZESTOA; Altuna J., 1990, CUEVA AMALDA ZESTOA, P9; Altuna J, 2013, MUSEO NACL CENTRO IN, V23, P184; Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; Arrizabalaga A, 2015, BOLINKOBA ABADINO YA, P5; Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; Barandiaran JM, 1950, CUADERNOS HIST PRIMI, V5, P2; Barandiaran Maestu I., 1967, MONOGRAFIAS ARQUEOLO; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bernaldo de Quires F, 1982, SANTANDER MONOGRAFIA, V8; Bradtmoll er M, 2014, HOHLENLAGER GRAVETTI; Bradtmoller M., 2015, MUNIBE-ANTRO-ARKEOL, V66, DOI 10.21630/maa.2015.66.02; Brock F, 2010, J ARCHAEOL SCI, V37, P855, DOI 10.1016/j.jas.2009.11.015; Camps M, 2012, J HUM EVOL, V62, P89, DOI 10.1016/j.jhevol.2011.10.010; de los Terreros Jose Yravedra Sainz, 2013, P77; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Echegaray JG, 1966, EXCAVACIONES ARQUEOL, V53; Fedele FG, 2008, J HUM EVOL, V55, P834, DOI 10.1016/j.jhevol.2008.08.012; Fortea FJ., 1990, EXCAVACIONES ARQUEOL, V1983-86, P55; Fortea J., 1995, EXCAVACIONES ARQUEOL, V3, P33; Fortea J, 2004, B SOC PREHISTORIQUE, VLIX, P7; Fortea J., 1999, EXCAVACIONES ARQUEOL, V4, P31; FORTEA J., 1999, EXCAVACIONES ARQUEOL, V4, P59; Fortea J., 1996, ERAUL, V76, P329; Fortea J, 1995, EXCAVACIONES ARQUEOL, P19; Fortea J., 1992, EXCAVACIONES ARQUEOL, P19; Fortea J., 2007, EXCAVACIONES ARQUEOL, V5, P77; Fortea J., 1992, EXCAVACIONES ARQUEOL, V2, P9; Golovanova LV, 2010, CURR ANTHROPOL, V51, P655, DOI 10.1086/656185; Gonzalez Echegaray J., 1971, CUEVA MORIN EXCAVACI, VVI; Gonzalez-Urquijo JE, 2001, ARKEOIKUSKA INVESTIG, P90; Gutierrez-Zugasti I, QUATERN INT, DOI [10.10169/j.quaint.2017.06.059, DOI 10.10169/J.QUAINT.2017.06.059]; Higham TFG, 2006, RADIOCARBON, V48, P179, DOI 10.1017/S0033822200066388; Higham T, 2011, ANTIQUITY, V85, P235, DOI 10.1017/S0003598X00067570; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Lowe J, 2012, P NATL ACAD SCI USA, V109, P13532, DOI 10.1073/pnas.1204579109; Maillo-Fernandez JM, 2010, ANTHROPOLOGIE, V114, P1, DOI 10.1016/j.anthro.2010.01.001; Mariezkurrena K., 2011, OCUPACIONES HUMANAS; Maroto J, 2012, QUATERN INT, V247, P15, DOI 10.1016/j.quaint.2011.07.007; Munoz Fernandez E., 1991, ARQUENAS, P61; Munoz Fernandez E, 2007, INTERVENCIONES ARQUE, VIII; Munoz Fernandez E, 2009, SAUTUOLA, V15, P145; Munoz Fernandez E, 1999, SAUTUOLA REV I PREHI, V6, P161; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasines P., 2009, ARQUEOLOGIA CUEVA CO, VXV, P43; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rios-Garaizar J, 2011, OCUPACIONES HUMANAS, P81; Rios-Garaizar J., 2013, MUSEO NACL CTR INVES, V23, P369; Rios-Garaizar J, 2010, ZEPHYRUS, VLXV, P15; Rios-Garaizar J, 2012, ANTHROPOLOGIE, V116, P532, DOI 10.1016/j.anthro.2012.10.001; Ruebens K, 2013, J HUM EVOL, V65, P341, DOI 10.1016/j.jhevol.2013.06.009; Sanguino Gonzalez J, 2005, SANTANDER MUSEO ALTA, V20, P10; Straus LG, 2016, RADIOCARBON, V58, P943, DOI 10.1017/RDC.2016.84; Svensson A, 2006, QUATERNARY SCI REV, V25, P3258, DOI 10.1016/j.quascirev.2006.08.003; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Wood R, QUAT INT IN PRESS, DOI [10.1016/kquaint2016.03.005, DOI 10.1016/KQUAINT2016.03.005]; Wood R., 2011, THESIS; Wood RE, 2014, J HUM EVOL, V69, P91, DOI 10.1016/j.jhevol.2013.12.017; Wood RE, 2013, P NATL ACAD SCI USA, V110, P2781, DOI 10.1073/pnas.1207656110; Zilhao J., 2006, PYRENAE, V37, P7, DOI DOI 10.1039/C4CC09587A; Zilhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131181	65	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194708	10.1371/journal.pone.0194708	http://dx.doi.org/10.1371/journal.pone.0194708			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668700	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200014
J	Hugenholtz, F; Davids, M; Schwarz, J; Muller, M; Tome, D; Schaap, P; Hooiveld, GJEJ; Smidt, H; Kleerebezem, M				Hugenholtz, Floor; Davids, Mark; Schwarz, Jessica; Muller, Michael; Tome, Daniel; Schaap, Peter; Hooiveld, Guido J. E. J.; Smidt, Hauke; Kleerebezem, Michiel			Metatranscriptome analysis of the microbial fermentation of dietary milk proteins in the murine gut	PLOS ONE			English	Article							PROTEOLYSIS; MICROFLORA; BACTERIA; GENES; MODEL; RNA; DNA	Undigestible food ingredients are converted by the microbiota into a large range of metabolites, predominated by short chain fatty acids (SCFA). These microbial metabolites are subsequently available for absorption by the host mucosa and can serve as an energy source. Amino acids fermentation by the microbiota expands the spectrum of fermentation end-products beyond acetate, propionate and butyrate, to include in particular branched-SCFA. Here the long-term effects of high protein-diets on microbial community composition and functionality in mice were analyzed. Determinations of the microbiota composition using phylogenetic microarray (MITChip) technology were complemented with metatranscriptome and SCFA analyses to obtain insight in in situ expression of protein fermentation pathways and the phylogenetic groups involved. High protein diets led to increased luminal concentrations of branched-SCFA, in accordance with protein fermentation in the gut. Bacteria dominantly participating in protein catabolism belonged to the Lachnospiraceae, Erysipelotrichaceae and Clostridiaceae families in both normal- and high-protein diet regimes. This study identifies the microbial groups involved in protein catabolism in the intestine and underpins the value of in situ metatranscriptome analyses as an approach to decipher locally active metabolic networks and pathways as a function of the dietary regime, as well as the phylogeny of the microorganisms executing them.	[Hugenholtz, Floor; Smidt, Hauke] Wageningen Univ, Lab Microbiol, Wageningen, Netherlands; [Hugenholtz, Floor; Davids, Mark; Hooiveld, Guido J. E. J.; Smidt, Hauke] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Davids, Mark; Schaap, Peter] Wageningen Univ, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Schwarz, Jessica; Muller, Michael; Hooiveld, Guido J. E. J.] Wageningen Univ, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Tome, Daniel] AgroParisTech, INRA, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Schaap, Peter; Smidt, Hauke; Kleerebezem, Michiel] TI Food & Nutr, Wageningen, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, Wageningen, Netherlands; [Muller, Michael] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Top Institute Food & Nutrition; Wageningen University & Research; University of East Anglia	Kleerebezem, M (corresponding author), TI Food & Nutr, Wageningen, Netherlands.; Kleerebezem, M (corresponding author), Wageningen Univ, Host Microbe Interact Grp, Wageningen, Netherlands.	michiel.kleerebezem@wur.nl	Muller, Michael/M-5724-2019; Smidt, Hauke/D-7054-2014; Hooiveld, Guido JEJ/F-4912-2010; Kleerebezem, Michiel/AAT-2078-2021; Muller, Michael/B-5795-2008	Muller, Michael/0000-0002-5930-9905; Smidt, Hauke/0000-0002-6138-5026; Hooiveld, Guido JEJ/0000-0003-1954-3542; Muller, Michael/0000-0002-5930-9905; Schwarz, Jessica/0000-0002-2594-2200; Davids, Mark/0000-0003-3081-9124; Schaap, Peter/0000-0002-4346-6084; Kleerebezem, Michiel/0000-0001-8552-2235	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organization for Scientific Research	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organization for Scientific Research	This work was (co)financed by the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative / Netherlands Organization for Scientific Research.; This work was (co)financed by the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative / Netherlands Organization for Scientific Research.	Cani PD, 2014, M S-MED SCI, V30, P125, DOI 10.1051/medsci/20143002003; CHACKO A, 1988, GUT, V29, P809, DOI 10.1136/gut.29.6.809; Davids M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146423; El Aidy S, 2013, ISME J, V7, P743, DOI 10.1038/ismej.2012.142; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; GIBSON SAW, 1989, APPL ENVIRON MICROB, V55, P679, DOI 10.1128/AEM.55.3.679-683.1989; IJssennagger N, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043260, 10.1371/journal.pone.0049868]; Kiilerich P, 2016, AM J PHYSIOL-ENDOC M, V310, pE886, DOI 10.1152/ajpendo.00363.2015; Kim Eunjung, 2016, Prev Nutr Food Sci, V21, P57, DOI [10.3746/pnf.2016.21.1.73, 10.3746/pnf.2016.21.1.57]; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Leimena MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-530; Leimena MM, 2012, APPL ENVIRON MICROB, V78, P4141, DOI 10.1128/AEM.00470-12; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Liu XX, 2014, AM J PHYSIOL-GASTR L, V307, pG459, DOI 10.1152/ajpgi.00400.2013; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647; MACFARLANE GT, 1988, J APPL BACTERIOL, V64, P37, DOI 10.1111/j.1365-2672.1988.tb02427.x; Mu CL, 2017, ANAEROBE, V47, P218, DOI 10.1016/j.anaerobe.2017.06.003; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047303; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Vital M, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-8; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Westerterp-Plantenga MS, 2012, BRIT J NUTR, V108, pS105, DOI 10.1017/S0007114512002589; Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143; Zoetendal EG, 2014, CURR OPIN GASTROEN, V30, P189, DOI 10.1097/MOG.0000000000000048	38	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194066	10.1371/journal.pone.0194066	http://dx.doi.org/10.1371/journal.pone.0194066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664912	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000430262300006
J	Komenda, P; Tangri, N; Klajncar, E; Eng, A; Di Nella, M; Hiebert, B; Strome, T; de Faria, RL; Zacharias, JM; Verrelli, M; Sood, MM; Rigatto, C				Komenda, Paul; Tangri, Navdeep; Klajncar, Evan; Eng, Amanda; Di Nella, Michelle; Hiebert, Brett; Strome, Trevor; de Faria, Ricardo Lobato; Zacharias, James M.; Verrelli, Mauro; Sood, Manish M.; Rigatto, Claudio			Patterns of emergency department utilization by patients on chronic dialysis: A population-based study	PLOS ONE			English	Article							PATIENTS RECEIVING HEMODIALYSIS; STAGE RENAL-DISEASE; HEART-FAILURE; FREQUENT USERS; HOSPITAL READMISSION; RANDOMIZED-TRIAL; OUTCOMES; MANAGEMENT; MORTALITY; HEALTH	Importance Patients on dialysis are often elderly and frail, with multiple comorbid conditions, and are heavy users of Emergency Department (ED) services. However, objective data on the frequency and pattern of ED utilization by dialysis patients are sparse. Such data could identify periods of highest risk for ED visits and inform health systems interventions to mitigate these risks and improve outcomes Objective To describe the pattern and frequency of presentation to ER by dialysis patients Design Retrospective cohort study using administrative data collected over ten years (2000-2009) in the Province of Manitoba, Canada. Setting Patients presenting to any of 9 ED's in Winnipeg and Brandon Manitoba. These departments serve >90% of the population of Manitoba, Canada (population 1.2 million). Participants All patients presenting to an ED in any of 9 emergency departments in Manitoba, Canada. Exposure Dialysis status Main outcomes Presentation to the ED Results Over 2.1 million ED visits by more than 1.2 million non-dialysis patients and 17,782 ED visits by 3257 dialysis patients were included. Dialysis patients presented 8.5 times more frequently to the ED than the general population (age and sex adjusted, p<0.001). For dialysis patients, ED utilization was significantly higher following the long interdialytic interval (33.6% higher Mondays and 19.5% higher Tuesdays vs. other days of the week, p<0.001) and was 10-fold higher in the 7 days before and after the initiation of dialysis. Conclusion and relevance The heavy use of ED services by dialysis patients spikes upward following the long interdialytic interval and also in the week before and after dialysis initiation. The relative risks associated with these vulnerable periods were much higher than those reported for clinical patient characteristics. We propose that intrinsic gaps in the structure of care delivery (e.g. 3 times a week dialysis, imperfect surveillance and clinical monitoring of patients with low GFR) may be the fundamental drivers of this periodicity. Strategies to mitigate this excess health risk are needed.	[Komenda, Paul; Tangri, Navdeep; Klajncar, Evan; Eng, Amanda; Zacharias, James M.; Verrelli, Mauro; Rigatto, Claudio] Univ Manitoba, Fac Med, Winnipeg, MB, Canada; [Komenda, Paul; Tangri, Navdeep; Zacharias, James M.; Verrelli, Mauro; Rigatto, Claudio] Manitoba Renal Program, Winnipeg, MB, Canada; [Komenda, Paul; Tangri, Navdeep; Di Nella, Michelle; Zacharias, James M.; Sood, Manish M.; Rigatto, Claudio] Seven Oaks Gen Hosp, Chron Dis Innovat Ctr, Winnipeg, MB, Canada; [Hiebert, Brett] St Boniface Gen Hosp, Cardiac Sci Program, Winnipeg, MB, Canada; [Strome, Trevor; de Faria, Ricardo Lobato] Winnipeg Reg Hlth Author, Emergency Dept Program, Winnipeg, MB, Canada; [Sood, Manish M.] Univ Ottawa, Ottawa, ON, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Ottawa	Rigatto, C (corresponding author), Univ Manitoba, Fac Med, Winnipeg, MB, Canada.; Rigatto, C (corresponding author), Manitoba Renal Program, Winnipeg, MB, Canada.; Rigatto, C (corresponding author), Seven Oaks Gen Hosp, Chron Dis Innovat Ctr, Winnipeg, MB, Canada.	crigatto@sbgh.mb.ca	Sood, Manish M/H-3134-2019	Sood, Manish M/0000-0002-9146-2344	University of Manitoba Rady Faculty of Medicine BSc Medicine Studentships	University of Manitoba Rady Faculty of Medicine BSc Medicine Studentships	This work was supported by the University of Manitoba Rady Faculty of Medicine BSc Medicine Studentships (EK, AE).	Antonicelli R, 2008, J TELEMED TELECARE, V14, P300, DOI 10.1258/jtt.2008.071213; Breton M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0117-9; Canadian Institute for Health Information, 2006, CORR REP DIAL REN TR; Castillo EM, 2014, J EMERG MED, V47, P343, DOI 10.1016/j.jemermed.2014.03.014; Clermont G, 2002, KIDNEY INT, V62, P986, DOI 10.1046/j.1523-1755.2002.00509.x; Dendale P, 2012, EUR J HEART FAIL, V14, P333, DOI 10.1093/eurjhf/hfr144; Doupe M, 2008, INITIAL ANAL EMERGEN, V1, DOI [10.1681/ASN.2013080879, DOI 10.1681/ASN.2013080879]; Doupe MB, 2012, ANN EMERG MED, V60, P24, DOI 10.1016/j.annemergmed.2011.11.036; Erickson KF, 2014, J AM SOC NEPHROL, V25, P2079, DOI 10.1681/ASN.2013080879; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Giordano A, 2009, INT J CARDIOL, V131, P192, DOI 10.1016/j.ijcard.2007.10.027; Gordon JA, 2001, J URBAN HEALTH, V78, P104, DOI 10.1093/jurban/78.1.104; Hutchison CA, 2007, CRIT CARE, V11, DOI 10.1186/cc5785; Kasper EK, 2002, J AM COLL CARDIOL, V39, P471, DOI 10.1016/S0735-1097(01)01761-2; Kitsiou S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4174; Leventhal ME, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13171; Lovasik BP, 2016, JAMA INTERN MED, V176, P1563, DOI 10.1001/jamainternmed.2016.4975; Mandelberg JH, 2000, ACAD EMERG MED, V7, P637, DOI 10.1111/j.1553-2712.2000.tb02037.x; Miller JB, 2013, AM J EMERG MED, V31, P16, DOI 10.1016/j.ajem.2012.05.001; Niska Richard, 2010, Natl Health Stat Report, P1; Ondler C, 2014, AM J EMERG MED, V32, P1215, DOI 10.1016/j.ajem.2014.07.013; Ostermann M, 2008, CRIT CARE, V12, DOI 10.1186/cc7085; Pines Jesse M, 2011, Acad Emerg Med, V18, pe64, DOI 10.1111/j.1553-2712.2011.01086.x; Sood MM, 2011, NEPHROL DIAL TRANSPL, V26, P2965, DOI 10.1093/ndt/gfq835; Sood MM, 2010, CAN MED ASSOC J, V182, P1433, DOI 10.1503/cmaj.100105; Strijack B, 2009, J AM SOC NEPHROL, V20, P2441, DOI 10.1681/ASN.2009040366; Sun BC, 2003, ACAD EMERG MED, V10, P320, DOI 10.1111/j.1553-2712.2003.tb01344.x; U. S. Renal Data System, 2008, ATL CHRON KIDN END S	28	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195323	10.1371/journal.pone.0195323	http://dx.doi.org/10.1371/journal.pone.0195323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664922	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300017
J	Mashiba, T; Joko, K; Kurosaki, M; Ochi, H; Osaki, Y; Kojima, Y; Nakata, R; Goto, T; Takehiro, A; Kimura, H; Mitsuda, A; Kawanami, C; Uchida, Y; Ogawa, C; Kusakabe, A; Narita, R; Ide, Y; Abe, T; Tsuji, K; Kitamura, T; Okada, K; Sohda, T; Shigeno, M; Satou, T; Izumi, N				Mashiba, Toshie; Joko, Kouji; Kurosaki, Masayuki; Ochi, Hironori; Osaki, Yukio; Kojima, Yuji; Nakata, Ryo; Goto, Tohru; Takehiro, Akahane; Kimura, Hiroyuki; Mitsuda, Akeri; Kawanami, Chiharu; Uchida, Yasushi; Ogawa, Chikara; Kusakabe, Atsunori; Narita, Ryuichi; Ide, Yasushi; Abe, Takehiko; Tsuji, Keiji; Kitamura, Tadashi; Okada, Kazuhiko; Sohda, Tetsuro; Shigeno, Masaya; Satou, Takashi; Izumi, Namiki			Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group	PLOS ONE			English	Article							TERM FOLLOW-UP; B-VIRUS; SUSTAINED RESPONSE; REACTIVATION; METAANALYSIS; AGENTS; COINFECTION; INFECTION; CIRRHOSIS; RISK	Background and aim This study aimed to elucidate whether interferon (IFN)-free direct-acting antiviral (DAA) therapy for hepatitis C after curative treatment of hepatocellular carcinoma (HCC) promotes HCC recurrence in a real-world large-scale cohort. Methods This multicenter study was conducted by the Japanese Red Cross Hospital Liver Study Group. This retrospective study analyzed 516 patients who underwent antiviral treatment for hepatitis C with either IFN (n = 148) or IFN-free DAA (n = 368) after curative HCC treatment; 78 IFN-treated patients and 347 IFN-free DAA-treated patients achieved sustained virological response (SVR). The recurrence rate of HCC was compared between the antiviral therapies. Logistic analysis and Cox proportional hazards analysis identified factors associated with early recurrence of HCC within 24 weeks of antiviral therapy and recurrence throughout the observation period, respectively. Results AFP at the completion of antiviral therapy, clinical stage of HCC, and non-SVR were independent factors associated with early recurrence of HCC. Among patients who had achieved SVR, the clinical stage of HCC and the level of AFP at completion of antiviral therapy were independent factors associated with early recurrence of HCC. For recurrence throughout the observation period in SVR patients, AFP at completion of antiviral therapy, duration between last HCC treatment to antiviral therapy, and the number of treatments were independent factors. There was no significant difference in the rate of early recurrence of HCC or recurrence throughout the observation period between IFN and IFN-free DAA treated patients. Conclusions There were no differences in the early recurrence rate of HCC between patients who underwent IFN and those who underwent IFN-free DAA as antiviral therapies.	[Mashiba, Toshie; Joko, Kouji; Ochi, Hironori] Matsuyama Red Cross Hosp, Ctr Liver Biliary Pancreat Dis, Matsuyama, Ehime, Japan; [Kurosaki, Masayuki; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Osaki, Yukio] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Kojima, Yuji] Japanese Red Cross Ise Hosp, Dept Hepatol, Ise, Mie, Japan; [Nakata, Ryo] Japanese Red Cross Med Ctr, Dept Gastroenterol, Tokyo, Japan; [Goto, Tohru] Omori Red Cross Hosp, Dept Gastroenterol, Tokyo, Japan; [Takehiro, Akahane] Ishinomaki Red Cross Hosp, Dept Gastroenterol, Ishinomaki, Miyagi, Japan; [Kimura, Hiroyuki] Japanese Red Cross Kyoto Daiichi Hosp, Dept Gastroenterol, Kyoto, Japan; [Mitsuda, Akeri] Japanese Red Cross Tottori Hosp, Dept Internal Med, Tottori, Japan; [Kawanami, Chiharu] Otsu Red Cross Hosp, Dept Gastroenterol, Otsu, Shiga, Japan; [Uchida, Yasushi] Matsue Red Cross Hosp, Dept Gastroenterol, Matsue, Shimane, Japan; [Ogawa, Chikara] Takamatsu Red Cross Hosp, Dept Gastroenterol, Takamatsu, Kagawa, Japan; [Kusakabe, Atsunori] Japanese Red Cross Nagoya Daini Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Narita, Ryuichi] Oita Red Cross Hosp, Dept Gastroenterol, Oita, Japan; [Ide, Yasushi] Karatsu Red Cross Hosp, Dept Internal Med, Saga, Japan; [Abe, Takehiko] Maebashi Red Cross Hosp, Dept Gastroenterol, Gunma, Japan; [Tsuji, Keiji] Hiroshima Red Cross Hosp, Dept Gastroenterol, Hiroshima, Japan; [Tsuji, Keiji] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Kitamura, Tadashi] Japanese Red Cross Shizuoka Hosp, Dept Gastroenterol, Shizuoka, Japan; [Okada, Kazuhiko] Toyama Red Cross Hosp, Dept Gastroenterol, Toyama, Japan; [Sohda, Tetsuro] Japanese Red Cross Fukuoka Hosp, Hepatol Div, Fukuoka, Japan; [Shigeno, Masaya] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Gastroenterol, Nagasaki, Japan; [Satou, Takashi] Nasu Red Cross Hosp, Dept Gastroenterol, Otawara, Tochigi, Japan	Matsuyama Red Cross Hospital; Osaka Red Cross Hospital; Japanese Red Cross Medical Center; University of Tokyo; Japanese Red Cross Nagoya Daini Hospital; Maebashi Red Cross Hospital	Joko, K (corresponding author), Matsuyama Red Cross Hosp, Ctr Liver Biliary Pancreat Dis, Matsuyama, Ehime, Japan.	koujijoko@matsuyama.jrc.or.jp			Japan Agency for Medical Research and Development (AMED)	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This research was supported by research funds from Japan Agency for Medical Research and Development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitenstein S, 2009, BRIT J SURG, V96, P975, DOI 10.1002/bjs.6731; Camma C, 2016, J HEPATOL, V65, P861, DOI 10.1016/j.jhep.2016.04.033; Collins JM, 2015, CLIN INFECT DIS, V61, P1304, DOI 10.1093/cid/civ474; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; De Monte A, 2016, J CLIN VIROL, V78, P27, DOI 10.1016/j.jcv.2016.02.026; Enokimura N, 2003, ANTICANCER RES, V23, P593; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Joko K, 2016, HEPATOL RES, V46, P251, DOI 10.1111/hepr.12515; Kim SR, 2002, J GASTROENTEROL, V37, P663, DOI 10.1007/s005350200106; Kobayashi M, 2017, J MED VIROL, V89, P476, DOI 10.1002/jmv.24663; Kudo Masatoshi, 2008, Oncology, V75 Suppl 1, P30, DOI 10.1159/000173422; Makiyama A, 2004, CANCER-AM CANCER SOC, V101, P1616, DOI 10.1002/cncr.20537; Manthravadi S, 2017, INT J CANCER, V140, P1042, DOI 10.1002/ijc.30521; Meissner EG, 2014, J CLIN INVEST, V124, P3352, DOI 10.1172/JCI75938; Miyake Y, 2010, J VIRAL HEPATITIS, V17, P287, DOI 10.1111/j.1365-2893.2009.01181.x; Nagaoki Y, 2011, J GASTROENTEROL, V46, P799, DOI 10.1007/s00535-011-0384-z; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Serti E, 2015, GASTROENTEROLOGY, V149, P190, DOI 10.1053/j.gastro.2015.03.004; Shen YC, 2010, J HEPATOL, V52, P889, DOI 10.1016/j.jhep.2009.12.041; Shindo M, 2001, HEPATOLOGY, V33, P1299, DOI 10.1053/jhep.2001.24100; Takayama H, 2016, HEPATOL RES, V46, P489, DOI 10.1111/hepr.12578; Torres HA, 2016, J HEPATOL, V65, P862, DOI 10.1016/j.jhep.2016.05.034; Toshikuni N, 2017, GUT LIVER, V11, P335, DOI 10.5009/gnl15458; Toyoda H, 2000, J VIRAL HEPATITIS, V7, P414, DOI 10.1046/j.1365-2893.2000.00241.x; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785	26	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194704	10.1371/journal.pone.0194704	http://dx.doi.org/10.1371/journal.pone.0194704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659591	Green Submitted, Green Published, gold			2022-12-27	WOS:000430061100004
J	Gray, B; Gnanappa, GK; Bagnall, RD; Femia, G; Yeates, L; Ingles, J; Burns, C; Puranik, R; Grieve, SM; Semsarian, C; Sy, RW				Gray, Belinda; Gnanappa, Ganesh Kumar; Bagnall, Richard D.; Femia, Giuseppe; Yeates, Laura; Ingles, Jodie; Burns, Charlotte; Puranik, Rajesh; Grieve, Stuart M.; Semsarian, Christopher; Sy, Raymond W.			Relations between right ventricular morphology and clinical, electrical and genetic parameters in Brugada Syndrome	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; SUDDEN CARDIAC DEATH; BUNDLE-BRANCH BLOCK; EPICARDIAL SUBSTRATE; SYNDROME PHENOTYPE; CATHETER ABLATION; SCN5A MUTATIONS; ECG PHENOTYPE; OUTFLOW TRACT; DISEASE	Background Increasing evidence suggests the presence of structural changes affecting the right ventricular outflow tract (RVOT) in patients with Brugada Syndrome (BrS). The aim of this study was to characterise the RV morphology in BrS and explore associations between morphologic, clinical, electrical, and genetic parameters using non-invasive multimodality testing. Methods Consecutive BrS patients (recruited 2013 +/- 2015) underwent clinical assessment, dedicated RV imaging using cardiac magnetic resonance (CMR) imaging (unless contra-indicated), electrical assessment (electrocardiogram, Holter monitoring, signal-averaged ECG [SAECG]) and genotyping. Morphologic data were compared to matched control and unmatched ARVC (arrhythmogenic right ventricular cardiomyopathy) cohorts, and potential associations between morphologic parameters and other variables were explored. Results BrS patients (n = 42, male 86%, age 46 +/- 12 years) exhibited normal global RV volume and function, comparable to control, in contrast to significantly larger, impaired RVs in ARVC cohort (RVESV p = 0.0001; RVEDV p<0.0001, RVEF p = 0.002). Compared with control, BrS patients exhibited larger RVOT volumes (7.4 +/- 0.7 vs 5.8 +/- 0.7 mL/m(2), p<0.0001) and wall motion abnormalities (RWMA) (31% vs 0%, p = 0.005); compared with ARVC cohort, the RVOT volumes were similar (7.4 +/- 0.7 vs, 8.1 +/- 1.7, p = 0.52) and there were less RWMA (31% vs 76%, p = 0.01). Overall 67% BrS patients had abnormal RVOT morphology. Patients with abnormal RVOT tended to be older (48 +/- 12 y vs 41 +/- 12y, p = 0.06). Rare genetic variants were only observed in patients with abnormal RVOT morphology (36% vs 0%, p = 0.02). Conclusions Patients with BrS frequently exhibit structural abnormalities localised to the RVOT and these changes may be age- and gene-dependent.	[Gray, Belinda; Femia, Giuseppe; Yeates, Laura; Ingles, Jodie; Burns, Charlotte; Puranik, Rajesh; Grieve, Stuart M.; Semsarian, Christopher; Sy, Raymond W.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Gray, Belinda; Bagnall, Richard D.; Ingles, Jodie; Burns, Charlotte; Puranik, Rajesh; Grieve, Stuart M.; Semsarian, Christopher; Sy, Raymond W.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Gray, Belinda; Bagnall, Richard D.; Yeates, Laura; Ingles, Jodie; Burns, Charlotte; Semsarian, Christopher] Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW, Australia; [Gnanappa, Ganesh Kumar; Puranik, Rajesh] Cardiovasc Magnet Resonance, Newtown, Tas, Australia	University of Sydney; University of Sydney; University of Sydney; Centenary Institute	Sy, RW (corresponding author), Royal Prince Alfred Hosp, Sydney, NSW, Australia.; Sy, RW (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	raymond.sy01@gmail.com	Ingles, Jodie/J-3113-2019; gray, belinda/AFN-8884-2022; Grieve, Stuart/A-5093-2012	Ingles, Jodie/0000-0002-4846-7676; Grieve, Stuart/0000-0002-2712-157X	Heart Foundation Health Professionals PhD Scholarship [100294]; National Heart Foundation of Australia Future Leader Fellowship [100833]; National Health and Medical Research Council (NHMRC) Practitioner Fellowship [1059156]	Heart Foundation Health Professionals PhD Scholarship; National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia); National Health and Medical Research Council (NHMRC) Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	BG is the recipient of a Heart Foundation Health Professionals PhD Scholarship (#100294). JI is the recipient of a National Heart Foundation of Australia Future Leader Fellowship (#100833). CS is the recipient of a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (#1059156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2016, HEART RHYTHM; Bastiaenen R, 2017, HEART RHYTHM, V14, P583, DOI 10.1016/j.hrthm.2016.12.004; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Brugada J, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1373, DOI 10.1161/CIRCEP.115.003220; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Catalano O, 2009, EUR HEART J, V30, P2241, DOI 10.1093/eurheartj/ehp252; Cerrone M, 2014, CIRCULATION, V129, P1092, DOI 10.1161/CIRCULATIONAHA.113.003077; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Corrado D, 2001, CIRCULATION, V103, P710; Doesch C, 2014, HELL J CARDIOL, V55, P107; Frustaci A, 2005, CIRCULATION, V112, P3680, DOI 10.1161/CIRCULATIONAHA.105.520999; Gotschy A, 2017, EUR HEART J CARDIOVA; Gray B, 2016, HEART RHYTHM; Gray B, 2014, J CARDIOVASC ELECTR, V25, P450, DOI 10.1111/jce.12366; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Ingles J, 2013, INT J CARDIOL, V168, pE127, DOI 10.1016/j.ijcard.2013.08.036; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Morita H, 2008, CIRCULATION, V118, P1697, DOI 10.1161/CIRCULATIONAHA.108.770917; Nademanee K, 2015, J AM COLL CARDIOL, V66, P1976, DOI 10.1016/j.jacc.2015.08.862; Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612; Papavassiliu T, 2004, J CARDIOVASC ELECTR, V15, P1133, DOI 10.1046/j.1540-8167.2004.03681.x; Papavassiliu T, 2010, HEART RHYTHM, V7, P1790, DOI 10.1016/j.hrthm.2010.09.004; Peters S, 2004, INT J CARDIOL, V95, P207, DOI 10.1016/j.ijcard.2003.04.032; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Priori SG, 2012, J AM COLL CARDIOL, V59, P37, DOI 10.1016/j.jacc.2011.08.064; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Rudic B, 2016, J AM HEART ASSOC, V5, P11; Rudic B, 2016, EUROPACE, V18, P1411, DOI 10.1093/europace/euv300; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Saguner AM, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/1471-2261-15-4; Sarkozy A, 2009, CIRC-ARRHYTHMIA ELEC, V2, P154, DOI 10.1161/CIRCEP.108.795153; te Riele ASJM, 2017, CARDIOVASC RES, V113, P102, DOI 10.1093/cvr/cvw234; Teske AJ, 2009, J AM SOC ECHOCARDIOG, V22, P920, DOI 10.1016/j.echo.2009.05.014; Tessa C, 2012, INT J CARDIOVAS IMAG, V28, P1961, DOI 10.1007/s10554-012-0009-5; van Hoorn F, 2012, J CARDIOVASC MAGN S1, V14, P141; van Hoorn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042037; Veltmann C, 2012, HEART RHYTHM, V9, P414, DOI 10.1016/j.hrthm.2011.10.032; Zhang JJ, 2015, CIRCULATION, V131, P1950, DOI 10.1161/CIRCULATIONAHA.114.013698; Zhang P, 2016, HEART RHYTHM, V13, P2151, DOI 10.1016/j.hrthm.2016.07.025	41	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195594	10.1371/journal.pone.0195594	http://dx.doi.org/10.1371/journal.pone.0195594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652902	gold, Green Published, Green Submitted			2022-12-27	WOS:000430026900032
J	Jabeen, F; Hamid, Z; Abdul, W; Ghouzali, S; Khan, A; Malik, SUR; Khan, MS; Nawaz, S				Jabeen, Farhana; Hamid, Zara; Abdul, Wadood; Ghouzali, Sanaa; Khan, Abid; Malik, Saif Ur Rehman; Khan, Mansoor Shaukat; Nawaz, Sarfraz			Anonymity-preserving Reputation Management System for health sector	PLOS ONE			English	Article							TRUST; PRIVACY	In health sector, trust is considered important because it indirectly influences the quality of health care through patient satisfaction, adherence and the continuity of its relationship with health care professionals and the promotion of accurate and timely diagnoses. One of the important requirements of TRSs in the health sector is rating secrecy, which mandates that the identification information about the service consumer should be kept secret to prevent any privacy violation. Anonymity and trust are two imperative objectives, and no significant explicit efforts have been made to achieve both of them at the same time. In this paper, we present a framework for solving the problem of reconciling trust with anonymity in the health sector. Our solution comprises Anonymous Reputation Management (ARM) protocol and Context-aware Trustworthiness Assessment (CTA) protocol. ARM protocol ensures that only those service consumers who received a service from a specific service provider provide a recommendation score anonymously with in the specified time limit. The CTA protocol computes the reputation of a user as a service provider and as a recommender. To determine the correctness of the proposed ARM protocol, formal modelling and verification are performed using High Level Petri Nets (HLPN) and Z3 Solver. Our simulation results verify the accuracy of the proposed context-aware trust assessment scheme.	[Jabeen, Farhana; Hamid, Zara; Khan, Abid; Malik, Saif Ur Rehman] COMSATS Inst Informat Technol, Dept Comp Sci, Islamabad, Pakistan; [Abdul, Wadood] King Saud Univ, Dept Comp Engn, Coll Comp & Informat Sci, Riyadh, Saudi Arabia; [Ghouzali, Sanaa] King Saud Univ, Dept Informat Technol, Coll Comp & Informat Sci, Riyadh, Saudi Arabia; [Khan, Mansoor Shaukat] COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan; [Nawaz, Sarfraz] Univ Cambridge, Comp Lab, Cambridge, England	COMSATS University Islamabad (CUI); King Saud University; King Saud University; COMSATS University Islamabad (CUI); University of Cambridge	Jabeen, F (corresponding author), COMSATS Inst Informat Technol, Dept Comp Sci, Islamabad, Pakistan.	farhanakhan@comsats.edu.pk	Malik, Saif Ur Rehman/M-3948-2019; Abdul, Wadood/ABD-2040-2020; Abdul, Wadood/GZA-4884-2022; Malik, Saif Ur Rehman/F-2290-2019; Ghouzali, Sanaa/J-3682-2013; Khan, Mansoor Shaukat/AAE-4133-2019	Malik, Saif Ur Rehman/0000-0001-8195-1630; Abdul, Wadood/0000-0002-6871-6633; Malik, Saif Ur Rehman/0000-0001-8195-1630; Ghouzali, Sanaa/0000-0001-9381-4246; Khan, Mansoor Shaukat/0000-0001-5496-1585; Khan, Abid/0000-0003-2712-1956; Hamid, Zara/0000-0001-8182-7453	grant from the 'Research Center of the Female Scientific and Medical Colleges,' Deanship of Scientific Research, King Saud University	grant from the 'Research Center of the Female Scientific and Medical Colleges,' Deanship of Scientific Research, King Saud University	This research project was supported by a grant from the 'Research Center of the Female Scientific and Medical Colleges,' Deanship of Scientific Research, King Saud University.	Ahamed SI, 2010, J SYST SOFTWARE, V83, P253, DOI 10.1016/j.jss.2009.09.040; Ahmed Fathy, 2012, ADV MACH LEARN TECHN; Alhaqbani Bandar, 2009, J. theor. appl. electron. commer. res., V4, P64, DOI 10.4067/S0718-18762009000200006; Androulaki E., 2008, PRIVACY ENHANCING TE; [Anonymous], 2015, YOUR ONLINE DOCTOR R; Arasu A, 2006, VLDB J, V15, P121, DOI 10.1007/s00778-004-0147-z; Aslam W, 2017, J MED IMAG HEALTH IN, V7, P1380, DOI 10.1166/jmihi.2017.2147; Audun Josang, 2006, P NAT E HLTH PRIV SE; Bacon N, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1030; Barrett C, 2010, 8 INT WORKSH SAT MOD; Bayardo RJ, 2005, PROC INT CONF DATA, P217; Bjorner N., 2014, EPIC SERIES COMPUTIN, P1; Christin D, 2013, PERVASIVE MOB COMPUT, V9, P353, DOI 10.1016/j.pmcj.2013.01.003; De Moura L, 2011, COMMUN ACM, V54, P69, DOI 10.1145/1995376.1995394; Dellarocas C., 2000, EC'00. Proceedings of the 2nd ACM Conference on Electronic Commerce, P150, DOI 10.1145/352871.352889; Denko MK, 2011, COMPUT COMMUN, V34, P398, DOI 10.1016/j.comcom.2010.01.023; Dong-Huynha T, 2004, 16 EUR C ART INT AUG; Du W., 2002, P 2002 WORKSH NEW SE, P127, DOI [10.1145/844102.844125, DOI 10.1145/844102.844125]; Emmert M, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5889; Emmert M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2360; Evans David, 2007, P 5 IEEE INT C PERV; Friedman EJ, 2001, J ECON MANAGE STRAT, V10, P173, DOI 10.1162/105864001300122476; Gal-Oz N, 2010, IFIP ADV INF COMM TE, V321, P1; Galpin I, 2011, DISTRIB PARALLEL DAT, V29, P31, DOI 10.1007/s10619-010-7074-3; Ganai K, 2006, ACCELERATING HIGH LE, P794; Garms L, 2017, P 15 INT C PRIV SEC; Gilbert H, 2004, LECT NOTES COMPUT SC, V3006, P175; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Gravetter Frederick J., 2009, STAT BEHAV SCI; Housley R., 1999, INTERNET X 509 PUBLI; Iltaf N, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-189; Jabeen F, 2017, IEEE ACCESS, V5, P13308, DOI 10.1109/ACCESS.2017.2707584; Josang A., 2012, P 6 IFIPTM INT C TRU, P253, DOI [DOI 10.1007/978-3-642-29852-3_21, 10.1007/978-3-642-29852-3_21PavlouPA]; Kamara Seny, 2011, IACR CRYPTOLOGY EPRI, V2011, P272; Kamvar S.D., 2003, P 12 INT C WORLD WID, P640, DOI DOI 10.1145/775152.775242; Lagu T, 2010, J GEN INTERN MED, V25, P942, DOI 10.1007/s11606-010-1383-0; Li WJ, 2014, IEEE INT CONF MOB, P515, DOI 10.1109/MASS.2014.85; Fernandez-Aleman JL, 2013, J BIOMED INFORM, V46, P541, DOI 10.1016/j.jbi.2012.12.003; Malik Z, 2007, LECT NOTES COMPUT SC, V4831, P38; Marco Mendes J., 2008, IECON 2008 - 34th Annual Conference of IEEE Industrial Electronics Society, P1487, DOI 10.1109/IECON.2008.4758173; OASIS Standard, 2005, ASS PROT OASIS SEC A; Pavlov E, 2004, LECT NOTES COMPUT SC, V2995, P108; Recordon D., 2006, P 2 ACM WORKSH DIG I, P11, DOI [10.1145/1179529.1179532, DOI 10.1145/1179529.1179532]; RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI [10.1145/359340.359342, 10.1145/357980.358017]; Ruotsalainen PS, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2731; Seigneur JM, 2004, LECT NOTES COMPUT SC, V2995, P93; Singh A, 2003, THIRD INTERNATIONAL CONFERENCE ON PEER-TO-PEER COMPUTING (P2P2003), PROCEEDINGS, P142, DOI 10.1109/PTP.2003.1231514; Singh A. K., 2014, INT J COMPUT APPL, V90, P17; Su X., 2009, ADV ARTIF INTELL, V2009, DOI DOI 10.1155/2009/421425; Teacy WTL, 2006, AUTON AGENT MULTI-AG, V12, P183, DOI 10.1007/s10458-006-5952-x; Tormo GD, 2013, IEEE SECUR PRIV, V11, P34, DOI 10.1109/MSP.2013.80; van Deursen T, 2008, ELECTRON NOTES THEOR, V197, P159, DOI 10.1016/j.entcs.2007.12.025; Weng JS, 2006, IEICE T INF SYST, VE89D, P2502, DOI 10.1093/ietisy/e89-d.9.2502; Whitby A., 2004, 3 INT JOINT C AUT AG, P106; Yang K., 2014, SECURITY CLOUD STORA	55	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195021	10.1371/journal.pone.0195021	http://dx.doi.org/10.1371/journal.pone.0195021			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649267	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900020
J	Sadjadi, SJ; Asadi, H; Sadeghian, R; Sahebi, H				Sadjadi, Seyed Jafar; Asadi, Hashem; Sadeghian, Ramin; Sahebi, Hadi			Retailer Stackelberg game in a supply chain with pricing and service decisions and simple price discount contract	PLOS ONE			English	Article							CUSTOMER SATISFACTION; DISTRIBUTION CHANNELS; QUANTITY DISCOUNTS; DEMAND UNCERTAINTY; SENSITIVE DEMAND; COMPETITION; COORDINATION; CONFLICT; PRODUCTS; INTERNET	This paper studies the Retailer Stackelberg game in a supply chain consisting of two manufacturers and one retailer where they compete simultaneously under three factors including price, service and simple price discount contract. It is assumed that the second manufacturer provides service directly to his customers, and the retailer provides service for the first product's customers, while the retailer buys the first product under price discount from the first manufacturer. The analysis of the optimal equilibrium solutions and the results of the numerical examples show that if a manufacturer chooses the appropriate range of discount rate, he will gain more profit than when there is no discount given to the retailer. This situation can be considered as an effective tool for the coordination of the first manufacturer and the retailer to offer discount by manufacturer and to provide the service by the retailer. We obtain equilibrium solution of Retailer Stackelberg game and analyze the numerical examples under two cases: a) the manufacturers sell their products to the retailer without price discount contract. b) The first manufacturer sells his products to the retailer with the simple price discount contract. The preliminary results show that the service and the price discount contract can improve the performance of supply chain.	[Sadjadi, Seyed Jafar; Sahebi, Hadi] Iran Univ Sci & Technol, Dept Ind Engn, Tehran, Iran; [Asadi, Hashem; Sadeghian, Ramin] Iran Univ Payame Noor, Ind Engn Grp, Tehran, Iran	Iran University Science & Technology	Asadi, H (corresponding author), Iran Univ Payame Noor, Ind Engn Grp, Tehran, Iran.	Hashem.Asadi@gmail.com	Sahebi, Hadi/S-8959-2018; Sadjadi, Seyed Jafar/S-8969-2018	Sahebi, Hadi/0000-0002-0153-0420; Sadjadi, Seyed Jafar/0000-0002-9069-5453				Ali SM, 2018, J RETAIL CONSUM SERV, V40, P40, DOI 10.1016/j.jretconser.2017.08.025; Aust G., 2014, LECT NOTES MANAGEMEN, V6, P119; Bai SZ, 2008, WIR COMM NETW MOB CO, P1; Bernstein F, 2005, MANAGE SCI, V51, P18, DOI 10.1287/mnsc.1040.0218; Chen J, 2011, INT J PROD ECON, V130, P104, DOI 10.1016/j.ijpe.2010.11.025; Chen J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06386; Chen X, 2016, J OPER RES SOC, V67, P294, DOI 10.1057/jors.2015.6; Chen YC, 2013, EUR J OPER RES, V224, P542, DOI 10.1016/j.ejor.2012.09.003; Dan B, 2014, J APPL RES TECHNOL, V12, P212, DOI 10.1016/S1665-6423(14)72337-5; Dan B, 2012, INT J PROD ECON, V139, P312, DOI 10.1016/j.ijpe.2012.05.014; Dumrongsiri A, 2008, EUR J OPER RES, V187, P691, DOI 10.1016/j.ejor.2006.05.044; Cai G, 2009, INT J PROD ECON, V117, P80, DOI 10.1016/j.ijpe.2008.08.053; Hsieh CC, 2010, EUR J OPER RES, V207, P142, DOI 10.1016/j.ejor.2010.03.035; Hu W, 2012, ANN OPER RES, V192, P151, DOI 10.1007/s10479-010-0818-7; Jena SK, 2016, INT J PROD ECON, V173, P1, DOI 10.1016/j.ijpe.2015.11.019; Khouja M, 2013, OMEGA-INT J MANAGE S, V41, P665, DOI 10.1016/j.omega.2012.08.005; Kurata H, 2013, INT J PROD ECON, V144, P268, DOI 10.1016/j.ijpe.2013.02.014; Kurata H, 2010, INT J PROD ECON, V127, P136, DOI 10.1016/j.ijpe.2010.05.005; Li BQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086729; Li LY, 2016, APPL MATH MODEL, V40, P646, DOI 10.1016/j.apm.2015.06.006; Li QH, 2016, APPL MATH MODEL, V40, P7349, DOI 10.1016/j.apm.2016.03.010; Lisha Wang, 2014, WSEAS Transactions on Business and Economics, V11, P293; Lu JC, 2012, INT J PROD ECON, V137, P211, DOI 10.1016/j.ijpe.2012.01.038; Lu JC, 2011, ECON MODEL, V28, P1256, DOI 10.1016/j.econmod.2011.01.008; Lu QH, 2013, COMPUT IND ENG, V64, P122, DOI 10.1016/j.cie.2012.09.018; Luo CL, 2014, EUR J OPER RES, V235, P329, DOI 10.1016/j.ejor.2013.11.021; Nie TF, 2017, EUR J OPER RES, V258, P491, DOI 10.1016/j.ejor.2016.08.051; Pei Z, 2015, J BUS RES, V68, P1350, DOI 10.1016/j.jbusres.2014.12.005; Routroy S, 2015, MATER TODAY-PROC, V2, P2433, DOI 10.1016/j.matpr.2015.07.184; Tsay A. A., 2000, Manufacturing & Service Operations Management, V2, P372, DOI 10.1287/msom.2.4.372.12342; Tsay AA, 2004, PROD OPER MANAG, V13, P93, DOI 10.1111/j.1937-5956.2004.tb00147.x; Venegas BB, 2018, EUR J OPER RES, V264, P524, DOI 10.1016/j.ejor.2017.06.030; Wang B, 2012, J THEORETICAL APPL I, V46; Wang LS, 2017, COMPUT IND ENG, V105, P223, DOI 10.1016/j.cie.2016.12.034; Wu CH, 2012, INT J PROD ECON, V140, P496, DOI 10.1016/j.ijpe.2012.06.034; Xia YS, 2007, EUR J OPER RES, V181, P252, DOI 10.1016/j.ejor.2006.06.027; Xiao TJ, 2008, INT J PROD ECON, V114, P187, DOI 10.1016/j.ijpe.2008.01.006; Xiao TJ, 2013, INT J PROD ECON, V145, P743, DOI 10.1016/j.ijpe.2013.06.004; Xie JX, 2010, EUR J OPER RES, V200, P368, DOI 10.1016/j.ejor.2008.12.027; Xu M., 2014, COMPUT MODEL NEW TEC, V18, P244; Yan RL, 2009, J RETAIL CONSUM SERV, V16, P306, DOI 10.1016/j.jretconser.2009.02.006; Yao DQ, 2008, OMEGA-INT J MANAGE S, V36, P838, DOI 10.1016/j.omega.2006.04.003; Yao DQ, 2005, OMEGA-INT J MANAGE S, V33, P235, DOI 10.1016/j.omega.2004.04.007; Yu YL, 2017, COMPUT IND ENG, V111, P56, DOI 10.1016/j.cie.2017.07.001; Yue JF, 2006, EUR J OPER RES, V168, P65, DOI 10.1016/j.ejor.2004.05.005; Zhang ZZ, 2015, SUSTAINABILITY-BASEL, V7, P2373, DOI 10.3390/su7032373; Zhao J, 2015, APPL MATH COMPUT, V250, P580, DOI 10.1016/j.amc.2014.11.005; Zissis D, 2015, OMEGA-INT J MANAGE S, V53, P21, DOI 10.1016/j.omega.2014.11.007	48	14	15	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195109	10.1371/journal.pone.0195109	http://dx.doi.org/10.1371/journal.pone.0195109			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649315	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900024
J	Winterfeld, G; Becher, H; Voshell, S; Hilu, K; Roser, M				Winterfeld, Grit; Becher, Hannes; Voshell, Stephanie; Hilu, Khidir; Roser, Martin			Karyotype evolution in Phalaris (Poaceae): The role of reductional dysploidy, polyploidy and chromosome alteration in a wide-spread and diverse genus (vol 13, e0192869, 2018)	PLOS ONE			English	Correction													Becher, Hannes/AAQ-4878-2020	Becher, Hannes/0000-0003-3700-2942				Winterfeld G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192869	1	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195889	10.1371/journal.pone.0195889	http://dx.doi.org/10.1371/journal.pone.0195889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649295	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900103
J	Sircar, N; Turley, T; van der Windt, P; Voors, M				Sircar, Neelanjan; Turley, Ty; van der Windt, Peter; Voors, Maarten			Know your neighbor: The impact of social context on fairness behavior	PLOS ONE			English	Article							SIERRA-LEONE; DICTATOR GAMES; ULTIMATUM GAME; NETWORKS; ANONYMITY; CONFLICT; ALTRUISM; DISTANCE; GENDER	Laboratory experiments offer an opportunity to isolate human behaviors with a level of precision that is often difficult to obtain using other (survey-based) methods. Yet, experimental tasks are often stripped of any social context, implying that inferences may not directly map to real world contexts. We randomly allocate 632 individuals (grouped randomly into 316 dyads) from small villages in Sierra Leone to four versions of the ultimatum game. In addition to the classic ultimatum game, where both the sender and receiver are anonymous, we reveal the identity of the sender, the receiver or both. This design allows us to explore how fairness behavior is affected by social context in a natural setting where players are drawn from populations that are well-acquainted. We find that average offers increase when the receiver's identity is revealed, suggesting that anonymous ultimatum games underestimate expected fair offers. This study suggest that researchers wishing to relate laboratory behavior to contexts in which the participants are well-acquainted should consider revealing the identities of the players during game play.	[Sircar, Neelanjan] Ctr Policy Res, New Delhi, India; [Turley, Ty] Brigham Young Univ, Marriott Sch, Provo, UT 84602 USA; [van der Windt, Peter] New York Univ Abu Dhabi, Social Sci Div, Abu Dhabi, U Arab Emirates; [Voors, Maarten] Wageningen Univ, Dev Econ Grp, Wageningen, Netherlands	Brigham Young University; Wageningen University & Research	van der Windt, P (corresponding author), New York Univ Abu Dhabi, Social Sci Div, Abu Dhabi, U Arab Emirates.	petervanderwindt@nyu.edu		Voors, Maarten/0000-0001-5907-3253	Netherlands Organisation for Scientific Research [453-10-001]; Economic and Social Research Council [ES/J017620/1]; Cambridge Conservation Initiative; ESRC [ES/J017620/1] Funding Source: UKRI	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Cambridge Conservation Initiative; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was funded by grant 453-10-001 from the Netherlands Organisation for Scientific Research (www.nwo.nl/en) (MV), grant ES/J017620/1 from the Economic and Social Research Council (www.esrc.ac.uk/) (MV), and a grant from the Cambridge Conservation Initiative (www.conservation.cam.ac.uk/) (MV).	Binzel C, 2013, J DEV ECON, V103, P99, DOI 10.1016/j.jdeveco.2013.01.009; Bohnet I, 1999, J ECON BEHAV ORGAN, V38, P43, DOI 10.1016/S0167-2681(98)00121-8; Branas-Garza P, 2006, EXP ECON, V9, P253, DOI 10.1007/s10683-006-9126-0; Branas-Garza P, 2012, B ECON RES, V64, P172, DOI 10.1111/j.1467-8586.2010.00357.x; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Bulte E, 2017, J ECON BEHAV ORGAN, V133, P313, DOI 10.1016/j.jebo.2016.10.014; Burnham TC, 2003, J ECON BEHAV ORGAN, V50, P133, DOI 10.1016/S0167-2681(02)00044-6; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Charpak G, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/02/P02006; Cobo-Reyes R, 2012, EXP ECON, V15, P547, DOI 10.1007/s10683-012-9313-0; Cunnison Marcel., 1967, GIFT FORM REASON EXC; Dufwenberg M, 2006, J ECON BEHAV ORGAN, V61, P42, DOI 10.1016/j.jebo.2004.11.007; ECKEL C, 2002, POLITICAL ANAL, V0010; Fanthorpe R, 2001, AFR AFFAIRS, V100, P363, DOI 10.1093/afraf/100.400.363; Fanthorpe R, 2010, AFR AFFAIRS, V109, P251, DOI 10.1093/afraf/adq004; Glennerster R, 2013, ECON J, V123, P285, DOI 10.1111/ecoj.12030; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hoffman E, 1996, AM ECON REV, V86, P653; Humphreys M, 2008, AM J POLIT SCI, V52, P436, DOI 10.1111/j.1540-5907.2008.00322.x; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Kovarik J, 2012, PHYSICA A, V391, P849, DOI 10.1016/j.physa.2011.08.040; Leach M., 1994, RAINFOREST RELATIONS; Leider S, 2009, Q J ECON, V124, P1815, DOI 10.1162/qjec.2009.124.4.1815; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Ligon E, 2012, J DEV ECON, V99, P13, DOI 10.1016/j.jdeveco.2011.12.002; Mokuwa E, 2011, AFR AFFAIRS, V110, P339, DOI 10.1093/afraf/adr019; Naidu S., 2014, DEMOCRACY DOES CAUSE; Paul R., 2017, M DOUGLAS UNDERSTAND; Platteau JP., 2001, SOCIAL NORMS EC DEV; Richards P, 2005, AFR AFFAIRS, V104, P571, DOI 10.1093/afraf/adi068; RICHARDS P, 1990, AFR AFFAIRS, V89, P265, DOI 10.1093/oxfordjournals.afraf.a098288; Richards P., 1996, FIGHTING RAINFOREST; Roth A.E., 1995, HDB EXPT EC, P253; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Sawyer E, 2008, AFR AFFAIRS, V107, P387, DOI 10.1093/afraf/adn039; Solnick SJ, 1999, ORGAN BEHAV HUM DEC, V79, P199, DOI 10.1006/obhd.1999.2843; Voors M, 2017, J DEV STUD, V53, P278, DOI 10.1080/00220388.2016.1160068	38	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194037	10.1371/journal.pone.0194037	http://dx.doi.org/10.1371/journal.pone.0194037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641584	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900022
J	Bock, P; Fatti, G; Ford, N; Jennings, K; Kruger, J; Gunst, C; Louis, F; Grobbelaar, N; Shanaube, K; Floyd, S; Grimwood, A; Hayes, R; Ayles, H; Fidler, S; Beyers, N				Bock, Peter; Fatti, Geoffrey; Ford, Nathan; Jennings, Karen; Kruger, James; Gunst, Colette; Louis, Francoise; Grobbelaar, Nelis; Shanaube, Kwame; Floyd, Sian; Grimwood, Ashraf; Hayes, Richard; Ayles, Helen; Fidler, Sarah; Beyers, Nulda		HPTN 071 PopART Trial Team	Attrition when providing antiretroviral treatment at CD4 counts >500cells/mu L at three government clinics included in the HPTN 071 (PopART) trial in South Africa	PLOS ONE			English	Article							FOLLOW-UP; INCOME COUNTRIES; ADULT PATIENTS; CAPE-TOWN; THERAPY; HIV; INITIATION; OUTCOMES; PREVENTION; MORTALITY	Introduction WHO recommends antiretroviral treatment (ART) for all HIV-positive individuals. This study evaluated the association between baseline CD4 count and attrition in a cohort of HIV positive adults initiating ART at three department of health (DOH) clinics routinely providing ART at baseline CD4 counts >500cells/mu L for the HPTN 071 (PopART) trial. Methods All clients attending the DOH clinics were managed according to standard care guidelines with the exception that those starting ART outside of pertinent local guidelines signed research informed consent. DOH data on all HIV-positive adult clients recorded as having initiated ART between January 2014 and November 2015 at the three study clinics was analysed. Attrition, included clients lost to follow up or died, and was defined as 'being three or more months late for an antiretroviral pharmacy pick-up appointment'. All clients were followed until attrition, transfer out or end May 2016. Results A total of 2423 clients with a median baseline CD4 count of 328 cells/mu L (IQR 195-468) were included of whom 631 (26.0%) experienced attrition and 140 (5.8%) were TFO. Attrition was highest during the first six months of ART (IR 38.3/100 PY; 95% CI 34.8-42.1). Higher attrition was found amongst those with baseline CD4 counts > 500 cells/mu L compared to those with baseline CD4 counts of 0-500 cells/mu L (aHR 1.26, 95% CI 1.05 to 1.52) This finding was confirmed on subset analyses when restricted to individuals non-pregnant at baseline and when restricted to individuals with follow up of > 12months. Conclusions Attrition in this study was high, particularly during the first six months of treatment. Attrition was highest amongst clients starting ART at baseline CD4 counts > 500 cells/mu L. Strategies to improve retention amongst ART clients, particularly those starting ART at baseline CD4 counts > 500cells/mu L, need strengthening. Improved monitoring of clients moving in and out of ART care and between clinics will assist in better understanding attrition and ART coverage in high burden countries.	[Bock, Peter; Beyers, Nulda] Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Tygerberg Campus, Western Cape, South Africa; [Fatti, Geoffrey; Louis, Francoise; Grimwood, Ashraf] Kheth Impilo, Cape Town, South Africa; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Jennings, Karen] City Cape Town Hlth Serv, Cape Town, South Africa; [Kruger, James] Western Cape Dept Hlth HIV Treatment & PMTCT Prog, Cape Town, South Africa; [Gunst, Colette] Cape Winelands Dist Brewelskloof Hosp, Western Cape Dept Hlth, Worcester, South Africa; [Gunst, Colette] Stellenbosch Univ, Div Family Med & Primary Hlth Care, Fac Med & Hlth Sci, Tygerberg Campus, Western Cape, South Africa; [Grobbelaar, Nelis] ANOVA Healthcare, Paarl, South Africa; [Shanaube, Kwame; Ayles, Helen] Univ Zambia, Zambart, Ridgeway Campus, Lusaka, Zambia; [Floyd, Sian; Hayes, Richard] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Ayles, Helen] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Fidler, Sarah] Imperial Coll London, Dept Med, St Marys Campus, London, England	Stellenbosch University; University of Cape Town; Stellenbosch University; University of Zambia; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Bock, P (corresponding author), Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Tygerberg Campus, Western Cape, South Africa.	peterb@sun.ac.za	Fatti, Geoffrey/AAA-9217-2019	Fatti, Geoffrey/0000-0002-6467-662X; Bock, Peter/0000-0003-3211-6078; Ayles, Helen/0000-0003-4108-2842; Shanaube, Kwame/0000-0001-7899-0890; Fidler, Sarah/0000-0003-1676-7583; Hayes, Richard/0000-0002-1729-9892	National Institute of Allergy and Infectious Diseases (NIAID) [UM1-AI068619, UM1-AI068617, UM1-AI068613]; U.S. President's Emergency Plan for AIDS Relief (PEPFAR); NIAID; National Institute of Mental Health (NIMH); National Institute on Drug Abuse (NIDA); International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HPTN 071 is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) under Cooperative Agreements UM1-AI068619, UM1-AI068617, and UM1-AI068613, with funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Additional funding is provided through NIAID, the National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the International Initiative for Impact Evaluation (3ie) with support from the Bill & Melinda Gates Foundation to RH.	Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Bond V, 2016, AIDS PATIENT CARE ST, V30, P425, DOI 10.1089/apc.2016.0114; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Clouse K, 2013, AIDS, V27, P645, DOI 10.1097/QAD.0b013e32835c12f9; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Fatti G, 2011, JAIDS-J ACQ IMM DEF, V58, pE17, DOI 10.1097/QAI.0b013e318229baab; Fox MP, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20888; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Grimsrud A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19984; Gupta S, 2013, JAIDS-J ACQ IMM DEF, V62, pE87, DOI 10.1097/QAI.0b013e31827e4992; Hayes R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-57; Hennessey C., 2016, LOST FOUND SILENT TR; Kaplan R, 2014, SAMJ S AFR MED J, V104, P204, DOI [10.7196/samj.7696, 10.7196/SAMJ.7696]; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Lockman S, 2012, CURR OPIN HIV AIDS, V7, P131, DOI 10.1097/COH.0b013e32834fcf6b; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Matyanga CMJ, 2016, PUBLIC HEALTH ACTION, V6, P97, DOI 10.5588/pha.15.0077; Ndagijimana A, 2015, PUBLIC HEALTH ACTION, V5, P209, DOI 10.5588/pha.15.0093; Okoboi S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20841; Osler M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18908; Stinson K, 2014, CLIN INFECT DIS, V58, P1344, DOI 10.1093/cid/ciu072; Thida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108615; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2016, AIDSINFO DAT; Western Cape Department of Health, 2015, W CAP ANT TREATM GUI; Western Cape Department of Health, 2016, W CAP PROV HAST DIR; Western Cape Department of Health, 2015, GUID ART CLUBS; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434; World Health Organization, 2015, GUID START ANT THER; Yiannoutsos CT, 2012, SEX TRANSM INFECT, V88, pI33, DOI 10.1136/sextrans-2012-050658	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195127	10.1371/journal.pone.0195127	http://dx.doi.org/10.1371/journal.pone.0195127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672542	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000430446800019
J	Ohmido, N; Iwata, A; Kato, S; Wako, T; Fukui, K				Ohmido, Nobuko; Iwata, Aiko; Kato, Seiji; Wako, Toshiyuki; Fukui, Kiichi			Development of a quantitative pachytene chromosome map and its unification with somatic chromosome and linkage maps of rice (Oryza sativa L.)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; IMAGE ANALYZING SYSTEM; PLANT CHROMOSOMES; HISTONE H3; CONDENSATION PATTERN; DNA-SEQUENCES; PHYSICAL MAP; RDNA LOCI; METHYLATION; GENOME	A quantitative pachytene chromosome map of rice (Oryza sativa L.) was developed using imaging methods. The map depicts not only distribution patterns of chromomeres specific to pachytene chromosomes, but also the higher order information of chromosomal structures, such as heterochromatin (condensed regions), euchromatin (decondensed regions), the primary constrictions (centromeres), and the secondary constriction (nucleolar organizing regions, NOR). These features were image analyzed and quantitatively mapped onto the map by Chromosome Image Analyzing System ver. 4.0 (CHIAS IV). Correlation between H3K9me2, an epigenetic marker and formation and/or maintenance of heterochromatin, thus was, clearly visualized. Then the pachytene chromosome map was unified with the existing somatic chromosome and linkage maps by physically mapping common DNA markers among them, such as a rice A genome specific tandem repeat sequence (TrsA), 5S and 45S ribosomal RNA genes, five bacterial artificial chromosome (BAC) clones, four P1 bacteriophage artificial chromosome (PAC) clones using multicolor fluorescence in situ hybridization (FISH). Detailed comparison between the locations of the DNA probes on the pachytene chromosomes using multicolor FISH, and the linkage map enabled determination of the chromosome number and short/long arms of individual pachytene chromosomes using the chromosome number and arm assignment designated for the linkage map. As a result, the quantitative pachytene chromosome map was unified with two other major rice chromosome maps representing somatic prometaphase chromosomes and genetic linkages. In conclusion, the unification of the three rice maps serves as an indispensable basic information, not only for an in-depth comparison between genetic and chromosomal data, but also for practical breeding programs.	[Ohmido, Nobuko] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Iwata, Aiko] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Kato, Seiji] Yamanashi Prefectural Agritechnol Ctr, 1100 Shimoimai, Kai, Yamanashi, Japan; [Wako, Toshiyuki] Natl Agr & Food Res Org, Adv Anal Ctr, Tsukuba, Ibaraki, Japan; [Fukui, Kiichi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Kobe University; University System of Georgia; University of Georgia; National Agriculture & Food Research Organization - Japan; Osaka University	Fukui, K (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan.	kfukui@bio.eng.osaka-u.ac.jp		Iwata-Otsubo, Aiko/0000-0001-9378-3961	Female Researcher Training Systems: Reform and Acceleration Fund; "Japan Society for the Promotion of Science (JSPS)" (KAKENHI) [JP 20580006, JP 21248040, 25252064]; Active Aging research Hub	Female Researcher Training Systems: Reform and Acceleration Fund; "Japan Society for the Promotion of Science (JSPS)" (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Active Aging research Hub	We would like to thank Prof. Dr. Yasuo Ukai for useful discussions and suggestions. This work was supported in part by the grants from "Japan Society for the Promotion of Science (JSPS)" (KAKENHI Grant Number JP 20580006) to NO, and (KAKENHI Grant Number JP 21248040 and 25252064) to KF, and the Female Researcher Training Systems: Reform and Acceleration Fund and "Active Aging research Hub" to NO.; This work was supported in part by the grants from "Japan Society for the Promotion of Science (JSPS)" (KAKENHI Grant Number JP 20580006) to NO, and (KAKENHI Grant Number JP 21248040 and 25252064) to KF, and the Female Researcher Training Systems: Reform and Acceleration Fund and "Active Aging research Hub" to NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI SM, 1992, GENOME, V35, P551, DOI 10.1139/g92-082; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Cheng ZK, 2001, GENETICS, V157, P1749; Cheng ZK, 2001, GENOME RES, V11, P2133, DOI 10.1101/gr.194601; Cheng ZK, 2002, CHROMOSOME RES, V10, P379, DOI 10.1023/A:1016849618707; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; de Jong JH, 1999, TRENDS PLANT SCI, V4, P258; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; ENDO TR, 1986, JPN J GENET, V61, P89, DOI 10.1266/jjg.61.89; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Fransz P, 2006, CHROMOSOME RES, V14, P71, DOI 10.1007/s10577-005-1022-5; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Fujii K, 2011, THEOR APPL GENET, V123, P1433, DOI 10.1007/s00122-011-1678-5; FUKUI K, 1990, GENOME, V33, P450, DOI 10.1139/g90-067; FUKUI K, 1988, JPN J GENET, V63, P359, DOI 10.1266/jjg.63.359; FUKUI K, 1994, THEOR APPL GENET, V87, P893, DOI 10.1007/BF00225782; FUKUI K, 1986, THEOR APPL GENET, V72, P27, DOI 10.1007/BF00261449; FUKUI K, 1991, THEOR APPL GENET, V81, P589, DOI 10.1007/BF00226723; FUKUI K, 1994, GENOME, V37, P105, DOI 10.1139/g94-013; Fukui K., 1992, MISC PUB NATL I AGRO, V4, P1; Fukui K., 1985, CELL TOKYO, V17, P145; Fukui K, 1996, RICE GENETICS, P117; Fukui K, 1987, SITU HYBRIDIZATION 1; Ha S, 1999, PLANT MOL BIOL, V39, P1165, DOI 10.1023/A:1006133804170; Hasezawa S, 1991, BOT ACTA; Heslop-Harrison JS, 2011, PLANT J, V66, P18, DOI 10.1111/j.1365-313X.2011.04544.x; Heslop-Harrison JS, 1997, GENETICA, V100, P197, DOI 10.1023/A:1018337831039; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Houben A, 1999, PLANT J, V18, P675, DOI 10.1046/j.1365-313x.1999.00496.x; IIJIMA K, 1991, THEOR APPL GENET, V81, P597, DOI 10.1007/BF00226724; Iwata N., 1975, Japanese Journal of Breeding (Ikushugaku Zasshi), V25, P363; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jasencakova Z, 2003, PLANT J, V33, P471, DOI 10.1046/j.1365-313X.2003.01638.x; Jiang JM, 2006, GENOME, V49, P1057, DOI 10.1139/G06-076; Jiao YL, 2005, PLANT CELL, V17, P1641, DOI 10.1105/tpc.105.031575; KAMISUGI Y, 1994, MOL GEN GENET, V245, P133, DOI 10.1007/BF00283259; Kao FI, 2006, THEOR APPL GENET, V112, P891, DOI 10.1007/s00122-005-0191-0; Kato S, 1998, CHROMOSOME RES, V6, P473, DOI 10.1023/A:1009252429277; Kato S, 2003, GENES GENET SYST, V78, P155, DOI 10.1266/ggs.78.155; Kato Seiji, 2009, Chromosome Science, V12, P43; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Khush G. S., 1991, Rice biotechnology., P83; KHUSH GS, 1984, GENETICS, V107, P141; Koornneef M, 2003, CHROMOSOME RES, V11, P183, DOI 10.1023/A:1022827624082; Kulikova O, 2004, CHROMOSOMA, V113, P276, DOI 10.1007/s00412-004-0315-3; Kunzel G, 2000, GENETICS, V154, P397; KURATA N, 1978, JPN J GENET, V53, P251, DOI 10.1266/jjg.53.251; KURATA N, 1981, CYTOLOGIA, V46, P791, DOI 10.1508/cytologia.46.791; Kuwada Y., 1910, SHOKUBUTSUGAKU ZASSH, V24, pen267, DOI [10.15281/jplantres1887.24.287_267, DOI 10.15281/JPLANTRES1887.24.287_267]; LAPITAN NLV, 1984, THEOR APPL GENET, V68, P547, DOI 10.1007/BF00285012; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r52; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MUKAI Y, 1993, GENOME, V36, P489, DOI 10.1139/g93-067; NISHIMURA YONEHACHI, 1961, BULL NATL AGRIC SCI SER D PLANT PHYSIOL, V9, P171; Ohmido N, 1997, PLANT MOL BIOL, V35, P963, DOI 10.1023/A:1005822504690; Ohmido N, 1998, PLANT MOL BIOL, V38, P1043, DOI 10.1023/A:1006062905742; Ohmido N, 2001, PLANT MOL BIOL, V47, P413, DOI 10.1023/A:1011632111845; Ohmido N, 2007, CHROMOSOME RES, V15, P97, DOI 10.1007/s10577-006-1109-7; Ohmido N, 2010, CHROMOSOME RES, V18, P287, DOI 10.1007/s10577-009-9103-5; OHTSUBO H, 1991, JPN J GENET, V66, P241, DOI 10.1266/jjg.66.241; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Perrella G, 2010, PLANT J, V62, P796, DOI 10.1111/j.1365-313X.2010.04191.x; Raap AK, 1998, MUTAT RES-FUND MOL M, V400, P287, DOI 10.1016/S0027-5107(98)00029-3; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Shishido R, 2000, MOL GEN GENET, V263, P586, DOI 10.1007/s004380051205; Szinay D, 2010, CYTOGENET GENOME RES, V129, P199, DOI 10.1159/000313502; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; TRASK BJ, 1991, TRENDS GENET, V7, P149, DOI 10.1016/0168-9525(91)90378-4; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; Wako T, 2002, PLANT MOL BIOL, V49, P645, DOI 10.1023/A:1015554124675; Wako T, 1998, ANAL CHIM ACTA, V365, P9, DOI 10.1016/S0003-2670(97)00619-3; Wako T, 2015, PLANT IMAGE ANALYSIS: FUNDAMENTALS AND APPLICATIONS, P299; Wang CJR, 2006, PLANT CELL, V18, P529, DOI 10.1105/tpc.105.037838; Wang Z, 2015, P NATL ACAD SCI USA, V112, P8487, DOI 10.1073/pnas.1423325112; WERNER JE, 1992, P NATL ACAD SCI USA, V89, P11307, DOI 10.1073/pnas.89.23.11307; Wu HK, 1985, RICE GENET NEWSLETT, V2, P54; Wu JZ, 2008, RICE, V1, P119, DOI 10.1007/s12284-008-9021-8; Wu JZ, 2003, PLANT J, V36, P720, DOI 10.1046/j.1365-313X.2003.01903.x; Yin BL, 2008, MOL PLANT, V1, P816, DOI 10.1093/mp/ssn037; Zhang P, 2004, CHROMOSOMA, V112, P288, DOI 10.1007/s00412-004-0273-9; Zhao Q, 2002, GENOME RES, V12, P817, DOI 10.1101/gr.48902	85	1	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195710	10.1371/journal.pone.0195710	http://dx.doi.org/10.1371/journal.pone.0195710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672536	Green Published, Green Submitted, gold			2022-12-27	WOS:000430446800037
J	Vidondo, B				Vidondo, Beatriz			Amplification of the basic reproduction number in cattle farm networks	PLOS ONE			English	Article							DISEASE-CONTROL; MOVEMENTS	The popularly known 20-80 rule or Pareto rule states that 20% of efforts leads to 80% of results. This rule has been applied to the study of infection transmission in contact networks, and specifically, contact networks between cattle farms. Woolhouse and collaborators showed that targeting interventions for disease control and prevention to the 20% of the farms that contribute the most to the basic reproduction number (Ro), could reduce it by 80%. The rule results from the number of incoming and outgoing contacts per farm being highly heterogeneous. Besides, Woolhouse and collaborators showed that this high contact heterogeneity, together with a high positive correlation between the number of incoming and outgoing animal movements per farm leads to an amplification in the Ro. Two previous studies carried out with Scottish cattle transport data found either no correlation or only a weak correlation (rho up to 0.33) when using weighted data. Using data from the contacts between Swiss cattle farms in 2015, we found that the 20-80 rule applies with respect to Ro, although the proportion of highly active farms is smaller (11%). Besides, a positive strong correlation (rho = 0.64, weighted data) between the incoming and outgoing contacts of farms exists. This means that the amplification of Ro (due to the contact heterogeneities and the existing correlation) in cattle contact networks can be much higher than known until now. Our results highlight the importance of an effective active surveillance, more so than in other countries were these amplification mechanisms are absent.	[Vidondo, Beatriz] Univ Bern, Vet Publ Hlth Inst, Bern, Switzerland	University of Bern	Vidondo, B (corresponding author), Univ Bern, Vet Publ Hlth Inst, Bern, Switzerland.	beatriz.vidondo@gmx.ch		Vidondo, Beatriz/0000-0001-9693-2301				Amaral LAN, 2000, P NAT ACAD SCI US, V97, DOI [10.1073?pnas.200327197, DOI 10.1073?PNAS.200327197]; ANDERSON R M, 1991; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dutta BL, 2014, PREV VET MED, V117, P79, DOI 10.1016/j.prevetmed.2014.09.005; European Food Safety Authority, 2016, EUR FOOD SAF AUTH J, V14, DOI [10.2903/j.efsa.2016.4573/full, DOI 10.2903/J.EFSA.2016.4573/FULL]; Gillespie CS, 2014, J STAT SOFTW, V64, P1, DOI [DOI 10.18637/JSS.V064.I02, 10.18637/jss.v064.i02]; Identitas AG, 2015, TAT; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Klugman S., 2004, LOSS MODELS DATA DEC; Mweu MM, 2013, PREV VET MED, V110, P379, DOI 10.1016/j.prevetmed.2013.02.015; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Scharrer S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0468-8; Swiss Confederation, SWISS CONF; Swiss Federal Food Safety and Veterinary Office, 2016, TIERG 2015; Volkova VV, 2010, EPIDEMICS-NETH, V2, P116, DOI 10.1016/j.epidem.2010.05.004; Volkova VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011185; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0191257	10.1371/journal.pone.0191257	http://dx.doi.org/10.1371/journal.pone.0191257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672512	Green Published, Green Submitted, gold			2022-12-27	WOS:000430446800001
J	Bier, G; Bier, S; Bongers, MN; Othman, A; Ernemann, U; Hempel, JM				Bier, Georg; Bier, Simone; Bongers, Malte Niklas; Othman, Ahmed; Ernemann, Ulrike; Hempel, Johann-Martin			Value of computed tomography texture analysis for prediction of perioperative complications during laparoscopic partial nephrectomy in patients with renal cell carcinoma	PLOS ONE			English	Article							INVASIVE PARTIAL NEPHRECTOMY; MAYO ADHESIVE PROBABILITY; ADHERENT PERINEPHRIC FAT; TUMOR HETEROGENEITY; SCORING SYSTEM; PELVIC SCORE; CT; OUTCOMES; CLASSIFICATION; VARIABILITY	Purpose Tumorous texture is a marker for tumor tissue inhomogeneity. Based on this assumption, this study aims to evaluate the value of computed tomography texture analysis for imaging-based prediction of perioperative complications during laparoscopic partial tumor nephrectomy. Methods A total of 106 patients with histologically confirmed renal cell carcinoma and pre-operative CT were included and volumetric texture analysis of the tumors was performed by two readers. Texture analysis parameter ratios and differences were calculated using the kidney parenchyma as reference ("reference-corrected"). Regression analysis was performed, regarding the value of the texture analysis parameters, for assessment of the tumor nuclear grade and the prediction of peri- and postoperative complications and approximated blood loss. Moreover, the inter-rater agreement in terms of the intra-class correlation coefficient (ICC) was calculated. Results Regarding the reference-corrected values, the predictive value of texture analysis parameters for severe perioperative complications was highest for the standard deviation of the mean attenuation (Area under curve/AUC, .615; sensitivity, 93.8%, specificity, 30.0%), followed by the uniformity (AUC, .599; sensitivity, 62.5%, specificity, 60.0%), and the uniformity of distribution of positive pixels (AUC, .597; sensitivity, 62.5%; specificity, 61.1%). Regarding the blood loss, the uniformity of positive pixel values (UPP; AUC, 0.638), uniformity (AUC, 0.635), and entropy (AUC, 0.633) yielded the best predictive values, whilst the tumor grade was a weaker predictor (AUC, 0.574). The applied texture analysis parameters did not correlate with the time of surgery or the warm ischemic time. All measured parameters were better predictors for complications than the tumor diameter alone. The inter-rater agreement was almost perfect (ICC, .982). Conclusion CT and CT texture analysis parameters are valuable for prediction of perioperative outcome before laparoscopic partial nephrectomy in patients with renal cell carcinoma.	[Bier, Georg; Ernemann, Ulrike; Hempel, Johann-Martin] Eberhard Karls Univ Tuebingen, Dept Neuroradiol, Tubingen, Germany; [Bier, Simone] Eberhard Karls Univ Tuebingen, Dept Urol, Tubingen, Germany; [Bongers, Malte Niklas; Othman, Ahmed] Eberhard Karls Univ Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bier, G (corresponding author), Eberhard Karls Univ Tuebingen, Dept Neuroradiol, Tubingen, Germany.	georg.bier@med.uni-tuebingen.de		othman, ahmed mohamed abdel ghany/0000-0002-0405-8918; Bier, Georg/0000-0002-1034-5681; Othman, Ahmed/0000-0002-3827-8695				Benway BM, 2009, J UROLOGY, V182, P866, DOI 10.1016/j.juro.2009.05.037; Bier S, 2017, ANTICANCER RES, V37, P1369, DOI 10.21873/anticanres.11457; Chang XF, 2015, J UROLOGY, V194, P897, DOI 10.1016/j.juro.2015.03.095; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Davidiuk AJ, 2014, EUR UROL, V66, P1165, DOI 10.1016/j.eururo.2014.08.054; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Dercle L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08310-5; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ganeshan B, 2013, CANCER IMAGING, V13, P140, DOI 10.1102/1470-7330.2013.0015; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Haider MA, 2017, CANCER IMAGING, V17, DOI 10.1186/s40644-017-0106-8; Hempel JM, 2017, J NEURO-ONCOL, V131, P93, DOI 10.1007/s11060-016-2272-0; Hodgdon T, 2015, RADIOLOGY, V276, P787, DOI 10.1148/radiol.2015142215; Jain S, 2013, J UROLOGY, V189, P1643, DOI 10.1016/j.juro.2012.11.170; Kayser K, 1999, CELL TISSUE RES, V296, P443, DOI 10.1007/s004410051305; Kocher NJ, 2016, BJU INT, V117, P636, DOI 10.1111/bju.13378; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Lam JS, 2007, EUR UROL, V52, P155, DOI 10.1016/j.eururo.2007.01.106; Lubner MG, 2016, AM J ROENTGENOL, V207, P96, DOI 10.2214/AJR.15.15451; Mathieu R, 2013, BJU INT, V112, pE283, DOI 10.1111/bju.12222; Monn MF, 2014, J ENDOUROL, V28, P1132, DOI 10.1089/end.2014.0259; Raman SP, 2014, ACAD RADIOL, V21, P1587, DOI 10.1016/j.acra.2014.07.023; Ramani AP, 2005, J UROLOGY, V173, P42, DOI 10.1097/01.ju.0000147177.20458.73; Schieda N, 2015, AM J ROENTGENOL, V204, P1013, DOI 10.2214/AJR.14.13279; Shannon CE, 1997, M D COMPUT, V14, P306; Simmons MN, 2010, J UROLOGY, V183, P1708, DOI 10.1016/j.juro.2010.01.005; Spaliviero M, 2016, EUR UROL, V69, P72, DOI 10.1016/j.eururo.2015.08.008; Spaliviero M, 2015, WORLD J UROL, V33, P853, DOI 10.1007/s00345-014-1376-4; Tomaszewski JJ, 2014, UROLOGY, V84, P351, DOI 10.1016/j.urology.2014.05.001; Vilaseca Richard Mast, 2017, Radiol Bras, V50, P7, DOI 10.1590/0100-3984.2015.0174; Yagasaki H, 2003, INT J UROL, V10, P220, DOI 10.1046/j.0919-8172.2003.00608.x; Yasaka K, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006993	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195270	10.1371/journal.pone.0195270	http://dx.doi.org/10.1371/journal.pone.0195270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668695	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200037
J	Monteiro, JGM; Torres, DDC; da Silva, MCFC; Martins, CMD; da Silva, IK; do Nascimento, MEM; dos Santos, ACO; Montarroyos, UR; Sobral, DC				de Moura Monteiro Junior, Jose Gildo; Cipriano Torres, Dilenia de Oliveira; Freire Clementino da Silva, Maria Cleide; de Holanda Martins, Cyntia Maria; da Silva, Izadora Karina; Mendonca do Nascimento, Monique Evelyn; Oliveira dos Santos, Ana Celia; Montarroyos, Ulisses Ramos; Sobral Filho, Dario Celestino			Prognostic value of hematological parameters in patients with acute myocardial infarction: Intrahospital outcomes	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; CORONARY-ARTERY-DISEASE; MEAN PLATELET VOLUME; RED-BLOOD-CELLS; TERM PROGNOSIS; NEUTROPHIL; SEVERITY; ASSOCIATION; MORTALITY; INTERVENTION	Background The intensity of the inflammatory response and hemodynamic repercussion in acute myocardial infarction causing the presence in the peripheral circulation of nucleated red blood cells (NRBCs), increases in mean platelet volume (MPV) and neutrophil to lymphocyte ratio (NLR) are associated with a poorer prognosis. The aim of this study was to assess the role of these hematological biomarkers as predictors of all causes of mortality during the hospitalization of patients with acute myocardial infarction. Methods Nucleated red blood cells, mean platelet volume and neutrophil to lymphocyte ratio were measured daily during the hospitalization of the patients with acute myocardial infarction. We excluded patients younger than 18 years, on glucocorticoid therapy, with cancer or hematological diseases and those that were readmitted after hospital discharge. We performed a multiple logistic analysis to identify independent predictors of mortality. Results We included 466 patients (mean age 64.2 +/- 12.8 years, 61.6% male). The prevalence of NRBCs in the sample was 9.1% (42 patients), with levels > 200/mu L in 27 patients (5.8%). The mean MPV value was 10.9 +/- 0,9 and the mean NLR value was 3.71 (2,38; 5,72). In a multivariate analysis of serum NRBCs (HR 2.42, 95% CI: 1.35-4.36, p = 0.003), MPV (HR 2.97, 95% CI: 1.15-7.67, p = 0.024) and NLR (HR 5.02, 95% CI: 1.68-15.0, p = 0.004). The presence in the peripheral blood of NRBCs, increased in mean platelet volume and neutrophil to lymphocyte ratio were associated with higher mortality. Conclusions Nucleated red blood cells, mean platelet volume and neutrophil to lymphocyte ratio are independent predictors of intrahospital mortality. Therefore, an important tool in intrahospital clinical surveillance.	[de Moura Monteiro Junior, Jose Gildo; da Silva, Izadora Karina; Mendonca do Nascimento, Monique Evelyn] Univ Pernambuco UPE, Pernambuco Cardiac Emergency Hosp, Coronary Care Unit PROCAPE, Recife, PE, Brazil; [Cipriano Torres, Dilenia de Oliveira; Freire Clementino da Silva, Maria Cleide; de Holanda Martins, Cyntia Maria] Univ Pernambuco, Lab PROCAPE, Recife, PE, Brazil; [Oliveira dos Santos, Ana Celia; Montarroyos, Ulisses Ramos; Sobral Filho, Dario Celestino] Univ Pernambuco, Recife, PE, Brazil	Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE)	Monteiro, JGM (corresponding author), Univ Pernambuco UPE, Pernambuco Cardiac Emergency Hosp, Coronary Care Unit PROCAPE, Recife, PE, Brazil.	jgildojunior@uol.com.br	Filho, Dario Sobral/H-8624-2019; de Moura Monteiro Júnior, José Gildo/R-3977-2017; Montarroyos, Ulisses/AAJ-7527-2020; Santos, Ana/ABC-5276-2021	Filho, Dario Sobral/0000-0002-5301-7741; de Moura Monteiro Júnior, José Gildo/0000-0002-8983-8744; SANTOS, ANA CELIA OLIVEIRA DOS/0000-0002-9170-5684				Acet H, 2016, CLIN APPL THROMB-HEM, V22, P60, DOI 10.1177/1076029614533145; Acet H, 2015, ANATOL J CARDIOL, V15, P648, DOI 10.5152/akd.2014.5592; Akin F, 2013, ANGIOLOGY, V64, P592, DOI 10.1177/0003319712461931; Anderson JL, 2017, NEW ENGL J MED, V376, P2053, DOI 10.1056/NEJMra1606915; Ayca B, 2015, PLATELETS, V26, P816, DOI 10.3109/09537104.2015.1015410; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Bekler A, 2015, ANGIOLOGY, V66, P638, DOI 10.1177/0003319714545779; Bolca O, 2015, CORONARY ARTERY DIS, V26, P402, DOI 10.1097/MCA.0000000000000254; Budzianowski J, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/3041565; Choi YH, 2014, J KOREAN MED SCI, V29, P950, DOI 10.3346/jkms.2014.29.7.950; Monteiro JGD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144259; Dehghani Mohammad Reza, 2014, Indian Heart J, V66, P622, DOI 10.1016/j.ihj.2014.10.415; Desai S, 2012, SURG INFECT, V13, P360, DOI 10.1089/sur.2011.089; Gazi E, 2015, CLIN APPL THROMB-HEM, V21, P155, DOI 10.1177/1076029613492011; Hartopo AB, 2015, ACTA MED INDONES, V47, P3; He JY, 2014, INT J CLIN EXP PATHO, V7, P4045; Hudzik B, 2016, J DIABETES COMPLICAT, V30, P1097, DOI 10.1016/j.jdiacomp.2016.04.010; Kalay N, 2012, ANGIOLOGY, V63, P213, DOI 10.1177/0003319711412763; Kaya H, 2014, CLIN APPL THROMB-HEM, V20, P221, DOI 10.1177/1076029613499821; Klovaite J, 2011, J THROMB HAEMOST, V9, P49, DOI 10.1111/j.1538-7836.2010.04110.x; Kuert S, 2011, CLIN CHEM LAB MED, V49, P257, DOI 10.1515/CCLM.2011.041; Kurtul A, 2017, AM J CARDIOL, V120, P534, DOI 10.1016/j.amjcard.2017.05.020; Kurtul A, 2014, AM J CARDIOL, V114, P972, DOI 10.1016/j.amjcard.2014.07.005; Kurtul A, 2014, AM J CARDIOL, V114, P342, DOI 10.1016/j.amjcard.2014.04.045; Kurtul S, 2015, INT HEART J, V56, P18, DOI 10.1536/ihj.14-175; Larsen SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085566; Murat SN, 2013, ANGIOLOGY, V64, P131, DOI 10.1177/0003319711436247; Nakul-Aquaronne D, 2003, J CLIN LAB ANAL, V17, P113, DOI 10.1002/jcla.10083; Nunez J, 2010, CORONARY ARTERY DIS, V21, P1, DOI 10.1097/MCA.0b013e328332ee15; Oncel RC, 2015, CLIN APPL THROMB-HEM, V21, P383, DOI 10.1177/1076029613505763; Pipitone S, 2012, CLIN CHEM LAB MED, V50, P1857, DOI 10.1515/cclm-2012-0148; Rechcinski T, 2013, CARDIOL J, V20, P491, DOI 10.5603/CJ.2013.0134; Sabatine MS, 2002, J AM COLL CARDIOL, V40, P1761, DOI 10.1016/S0735-1097(02)02484-1; Sahin DY, 2013, ANGIOLOGY, V64, P423, DOI 10.1177/0003319712453305; Soylu K, 2015, REV PORT CARDIOL, V34, P465, DOI 10.1016/j.repc.2015.01.013; Stachon A, 2007, CRIT CARE, V11, DOI 10.1186/cc5932; Taskesen T, 2017, AM J CARDIOL, V119, P192, DOI 10.1016/j.amjcard.2016.09.042; Uysal HB, 2016, KOREAN J INTERN MED, V31, P1093, DOI 10.3904/kjim.2015.199; Verdoia M, 2016, ANGIOLOGY, V67, P75, DOI 10.1177/0003319715577529; Williams BA, 2013, HEART LUNG, V42, P436, DOI 10.1016/j.hrtlng.2013.07.013; Yalcinkaya E, 2015, ARQ BRAS CARDIOL, V104, P112, DOI 10.5935/abc.20140179; Zhang GY, 2014, GENET MOL RES, V13, P9382, DOI 10.4238/2014.November.11.4	42	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194897	10.1371/journal.pone.0194897	http://dx.doi.org/10.1371/journal.pone.0194897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668734	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200018
J	Albutt, K; Yorlets, RR; Punchak, M; Kayima, P; Namanya, DB; Anderson, GA; Shrime, MG				Albutt, Katherine; Yorlets, Rachel R.; Punchak, Maria; Kayima, Peter; Namanya, Didacus B.; Anderson, Geoffrey A.; Shrime, Mark G.			You pray to your God: A qualitative analysis of challenges in the provision of safe, timely, and affordable surgical care in Uganda	PLOS ONE			English	Article							UNIVERSAL HEALTH COVERAGE; MIDDLE-INCOME-COUNTRIES; POST-2015 DEVELOPMENT AGENDA; SURGERY WORLDWIDE; GLOBAL HEALTH; EXPENDITURE; ANESTHESIA; HOSPITALS; CANCER; NEED	Background Five billion people lack access to safe, affordable, and timely surgical and anesthesia care. Significant challenges remain in the provision of surgical care in low-resource settings. Uganda is no exception. Methods From September to November 2016, we conducted a mixed-methods countrywide surgical capacity assessment at 17 randomly selected public hospitals in Uganda. Researchers conducted 35 semi-structured interviews with key stakeholders to understand factors related to the provision of surgical care. The framework approach was used for thematic and explanatory data analysis. Results The Ugandan public health care sector continues to face significant challenges in the provision of safe, timely, and affordable surgical care. These challenges can be broadly grouped into preparedness and policy, service delivery, and the financial burden of surgical care. Hospital staff reported challenges including: (1) significant delays in accessing surgical care, compounded by a malfunctioning referral system; (2) critical workforce shortages; (3) operative capacity that is limited by inadequate infrastructure and overwhelmed by emergency and obstetric volume; (4) supply chain difficulties pertaining to provision of essential medications, equipment, supplies, and blood; (5) significant, variable, and sometimes catastrophic expenditures for surgical patients and their families; and (6) a lack of surgery-specific policies and priorities. Despite these challenges, innovative strategies are being used in the public to provide surgical care to those most in need. Conclusion Barriers to the provision of surgical care are cross-cutting and involve constraints in infrastructure, service delivery, workforce, and financing. Understanding current strengths and shortfalls of Uganda's surgical system is a critical first step in developing effective, targeted policy and programming that will build and strengthen its surgical capacity.	[Albutt, Katherine; Yorlets, Rachel R.; Punchak, Maria; Anderson, Geoffrey A.; Shrime, Mark G.] Harvard Med Sch, PGSSC, Boston, MA 02115 USA; [Albutt, Katherine; Anderson, Geoffrey A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Punchak, Maria] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kayima, Peter] MUST, Mbarara, Uganda; [Namanya, Didacus B.] Minist Hlth MOH, Kampala, Uganda; [Namanya, Didacus B.] UMU, Nkozi, Uganda; [Shrime, Mark G.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts Eye & Ear Infirmary	Albutt, K (corresponding author), Harvard Med Sch, PGSSC, Boston, MA 02115 USA.; Albutt, K (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.	kalbutt@partners.org		Shrime, Mark/0000-0002-3546-9867; Yorlets, Rachel/0000-0002-0986-5444	MGH Global Surgery Fund; MGH Center for Global Health; Ronda Stryker and William Johnston Global Surgery Fellowship Fund; Program in Global Surgery and Social Change at Harvard Medical School	MGH Global Surgery Fund; MGH Center for Global Health; Ronda Stryker and William Johnston Global Surgery Fellowship Fund; Program in Global Surgery and Social Change at Harvard Medical School	Project funding was provided by the MGH Global Surgery Fund, MGH Center for Global Health, Ronda Stryker and William Johnston Global Surgery Fellowship Fund, and Program in Global Surgery and Social Change at Harvard Medical School. KA was the recipient of all funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Albutt K, 2017, CAN J SURG, V60, pS46; Alkire BC, 2015, LANCET GLOB HEALTH, V3, pE316, DOI 10.1016/S2214-109X(15)70115-4; [Anonymous], 2015, NVIVO QUAL DAT AN SO; [Anonymous], 2011, REPORT WHO MED DEVIC; [Anonymous], 2016, HUMAN DEV REPORT 201; [Anonymous], 2013, J QUALITATIVE DATA A; Boerma T, 2014, MONITORING PROGR UNI; Esquivel MM, 2016, JAMA SURG, V151, P1064, DOI 10.1001/jamasurg.2016.2303; Esquivel MM, 2015, WORLD J SURG, V39, P2126, DOI 10.1007/s00268-015-3092-7; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Gakwaya A, 2008, BRIT J CANCER, V99, P63, DOI 10.1038/sj.bjc.6604435; Gallien J, 2014, NATL DRUG STOCKOUT R; Grimes CE, 2012, WORLD J SURG, V36, P8, DOI 10.1007/s00268-011-1330-1; Holmer H, 2015, LANCET, V385, P40, DOI 10.1016/S0140-6736(15)60835-2; Holmer H, 2015, LANCET GLOB HEALTH, V3, pS9, DOI 10.1016/S2214-109X(14)70349-3; Jan S, 2015, SURGERY, V157, P971, DOI 10.1016/j.surg.2015.02.012; Kraiselburd S, 2013, PROD OPER MANAG, V22, P377, DOI 10.1111/j.1937-5956.2011.01315.x; Kushner AL, 2010, ARCH SURG-CHICAGO, V145, P154, DOI 10.1001/archsurg.2009.263; LeBrun DG, 2014, SURGERY, V155, P365, DOI 10.1016/j.surg.2013.10.008; Linden AF, 2012, WORLD J SURG, V36, P1056, DOI 10.1007/s00268-012-1482-7; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Ministry of Health, 2016, ANN HLTH SECT PERF R; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Ng-Kamstra JS, 2015, LANCET, V385, P32; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Perry L, 2011, MED BIOL ENG COMPUT, V49, P719, DOI 10.1007/s11517-011-0786-3; Raykar NP, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000075; Rehmani R., 2004, JPMA Journal of the Pakistan Medical Association, V54, P233; Rose J, 2015, LANCET GLOB HEALTH, V3, pS13, DOI 10.1016/S2214-109X(15)70087-2; Scott JW, 2017, ANN SURG; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS38, DOI 10.1016/S2214-109X(15)70085-9; Tran TM, 2017, ANN SURG, V266, P389, DOI 10.1097/SLA.0000000000001970; Vega J, 2013, LANCET, V381, P179, DOI 10.1016/S0140-6736(13)60062-8; Wagenaar BH, 2014, TROP MED INT HEALTH, V19, P791, DOI 10.1111/tmi.12314; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	38	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195986	10.1371/journal.pone.0195986	http://dx.doi.org/10.1371/journal.pone.0195986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664956	gold, Green Published, Green Submitted			2022-12-27	WOS:000430262300047
J	Barry, DA; Parlange, JY				Barry, D. A.; Parlange, J. -Y.			Universal expression for the drag on a fluid sphere	PLOS ONE			English	Article							INTERMEDIATE REYNOLDS-NUMBERS; TERMINAL VELOCITY; FLOW; MOTION; COEFFICIENT; BUBBLES; LIQUID; DROP	An expression was developed for prediction of drag coefficients for any spherical particle, drop or bubble in an infinite, homogeneous liquid. The formula reproduces the limiting cases for gas bubbles and solid spheres, as well as the exact Hadamard-Rybczynski solution. The accuracy of the expression, which is valid for Reynolds numbers up to a few hundred, was confirmed by comparison with published numerical predictions of the drag coefficient for a range of physical circumstances.	[Barry, D. A.] Ecole Polytech Fed Lausanne, Fac Architecture Civil & Environm Engn ENAC, Environm Engn Inst IIE, Ecol Engn Lab ECOL, Lausanne, Switzerland; [Parlange, J. -Y.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University	Barry, DA (corresponding author), Ecole Polytech Fed Lausanne, Fac Architecture Civil & Environm Engn ENAC, Environm Engn Inst IIE, Ecol Engn Lab ECOL, Lausanne, Switzerland.	andrew.barry@epfl.ch	Barry, D. Andrew/C-6077-2008	Barry, D. Andrew/0000-0002-8621-0425				ABDELALIM AH, 1975, IND ENG CHEM FUND, V14, P308, DOI 10.1021/i160056a004; Baker Jr G. A., 1996, PADE APPROXIMANTS, V2nd; Barry DA, 2002, J FLUID MECH, V465, P293, DOI 10.1017/S0022112002001167; BHAGA D, 1981, J FLUID MECH, V105, P61, DOI 10.1017/S002211208100311X; Bozzano G, 2001, COMPUT CHEM ENG, V25, P571, DOI 10.1016/S0098-1354(01)00636-6; BRABSTON DC, 1975, J FLUID MECH, V69, P179, DOI 10.1017/S0022112075001371; Brown PP, 2003, J ENVIRON ENG-ASCE, V129, P222, DOI 10.1061/(ASCE)0733-9372(2003)129:3(222); CHANG CC, 1992, J FLUID MECH, V234, P219, DOI 10.1017/S0022112092000764; CHANG EJ, 1994, J FLUID MECH, V277, P347, DOI 10.1017/S002211209400279X; CLIFFE KA, 1986, J COMPUT PHYS, V62, P321, DOI 10.1016/0021-9991(86)90130-0; Clift R., 2005, BUBBLES DROPS PARTIC; DANDY DS, 1989, J FLUID MECH, V208, P161, DOI 10.1017/S0022112089002818; Davis PJ, 1964, HDB MATH FUNCTIONS, P875; Feng ZG, 2001, J FLUID ENG-T ASME, V123, P841, DOI 10.1115/1.1412458; FLEMMER RLC, 1986, POWDER TECHNOL, V48, P217, DOI 10.1016/0032-5910(86)80044-4; FORNBERG B, 1988, J FLUID MECH, V190, P471, DOI 10.1017/S0022112088001417; Gautschi W, 1964, HDB MATH FUNCTIONS, P295; HOMEIER HHH, 1990, J COMPUT PHYS, V87, P61, DOI 10.1016/0021-9991(90)90225-P; Juncu G, 1999, INT J HEAT FLUID FL, V20, P414, DOI 10.1016/S0142-727X(99)00003-X; Karamanev DG, 1996, CHEM ENG COMMUN, V147, P75, DOI 10.1080/00986449608936496; Kelbaliyev GI, 2011, THEOR FOUND CHEM EN+, V45, P248, DOI 10.1134/S0040579511020084; MAGNAUDET J, 1995, J FLUID MECH, V284, P97, DOI 10.1017/S0022112095000280; Mikhailov MD, 2013, POWDER TECHNOL, V237, P432, DOI 10.1016/j.powtec.2012.12.033; OLIVER DLR, 1985, J FLUID MECH, V154, P215, DOI 10.1017/S0022112085001495; OLIVER DLR, 1987, J FLUID MECH, V177, P1, DOI 10.1017/S002211208700082X; PARLANGE JY, 1970, ACTA MECH, V9, P323, DOI 10.1007/BF01179829; PROUDMAN I, 1957, J FLUID MECH, V2, P237, DOI 10.1017/S0022112057000105; Rivkind V.Y., 1976, FLUID DYNAM+, V11, P5; RIVKIND VI, 1976, PMM-J APPL MATH MEC+, V40, P687; Saboni A, 2002, AICHE J, V48, P2992, DOI 10.1002/aic.690481225; TURTON R, 1987, POWDER TECHNOL, V53, P127, DOI 10.1016/0032-5910(87)85007-6; Wegener M, 2014, INT J HEAT MASS TRAN, V71, P475, DOI 10.1016/j.ijheatmasstransfer.2013.12.024	33	7	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194907	10.1371/journal.pone.0194907	http://dx.doi.org/10.1371/journal.pone.0194907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659596	Green Submitted, Green Published, gold			2022-12-27	WOS:000430061100008
J	Nguyen, DT; Jenkins, HE; Graviss, EA				Nguyen, Duc T.; Jenkins, Helen E.; Graviss, Edward A.			Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients	PLOS ONE			English	Article							BAYESIAN MODEL SELECTION; LONG-TERM MORTALITY; TUBERCULOSIS; ADULTS; DIAGNOSIS; DEATH	Background Estimating mortality risk during TB treatment in HIV co-infected patients is challenging for health professionals, especially in a low TB prevalence population, due to the lack of a standardized prognostic system. The current study aimed to develop and validate a simple mortality prognostic scoring system for TB/HIV co-infected patients. Methods Using data from the CDC's Tuberculosis Genotyping Information Management System of TB patients in Texas reported from 01/2010 through 12/2016, age >= 15 years, HIV(+), and outcome being "completed" or "died", we developed and internally validated a mortality prognostic score using multiple logistic regression. Model discrimination was determined by the area under the receiver operating characteristic (ROC) curve (AUC). The model's good calibration was determined by a non-significant Hosmer-Lemeshow's goodness of fit test. Results Among the 450 patients included in the analysis, 57 (12.7%) died during TB treatment. The final prognostic score used six characteristics (age, residence in long-term care facility, meningeal TB, chest x-ray, culture positive, and culture not converted/unknown), which are routinely collected by TB programs. Prognostic scores were categorized into three groups that predicted mortality: low-risk (< 20 points), medium-risk (20-25 points) and high-risk (> 25 points). The model had good discrimination and calibration (AUC = 0.82; 0.80 in bootstrap validation), and a non-significant Hosmer-Lemeshow test p = 0.71. Conclusion Our simple validated mortality prognostic scoring system can be a practical tool for health professionals in identifying TB/HIV co-infected patients with high mortality risk.	[Nguyen, Duc T.; Graviss, Edward A.] Houston Methodist Hosp Inst, Houston, TX 77030 USA; [Jenkins, Helen E.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	The Methodist Hospital System; The Methodist Hospital - Houston; Boston University	Graviss, EA (corresponding author), Houston Methodist Hosp Inst, Houston, TX 77030 USA.	eagraviss@houstonmethodist.org	Nguyen, Duc/AAX-1819-2021; Nguyen, Duc T/ABH-7913-2020	Nguyen, Duc/0000-0002-5059-4404; Nguyen, Duc T/0000-0002-5059-4404; Jenkins, Helen/0000-0003-4749-1591	U.S. National Institutes of Health (US NIH) [K01AI102944]	U.S. National Institutes of Health (US NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HEJ was supported by the U.S. National Institutes of Health (US NIH K01AI102944 award). The content is solely the responsibility of the authors and does not necessarily represent the views of the U.S. National Institute of Allergy and Infectious Diseases or the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Bastos HN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162797; Boscoe FP, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140395; *CDCP, 2009, REP VER CAS TUB RVCT, DOI DOI 10.5588/IJTLD.12.0476; Centers for Disease Control and Prevention, 2015, REP TUB US; Centers for Disease Control and Prevention, 2015, NTSS DAT REF GUID; Centers for Disease Control and Prevention, 2013, COR CURR TUB WHAT CL; Christensen ASH, 2014, CLIN EPIDEMIOL, V6, P405, DOI 10.2147/CLEP.S65331; Djouma FN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0876-1; Dunson DB, 2005, LIFETIME DATA ANAL, V11, P213, DOI 10.1007/s10985-004-0384-x; Flacker JM, 2003, J AM GERIATR SOC, V51, P213, DOI 10.1046/j.1532-5415.2003.51060.x; Horita N, 2013, INT J TUBERC LUNG D, V17, P54, DOI 10.5588/ijtld.12.0476; Lee HG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1640-x; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lui G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092077; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Cruz-Hervert LP, 2012, AGE AGEING, V41, P488, DOI 10.1093/ageing/afs028; Padyana M, 2012, N AM J MED SCI, V4, P221, DOI 10.4103/1947-2714.95904; Podlekareva DN, 2013, INT J TUBERC LUNG D, V17, P198, DOI 10.5588/ijtld.12.0224; Podlekareva DN, 2014, EUR RESPIR J, V43, P166, DOI 10.1183/09031936.00138712; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Texas Department of State Health Services, TB HANS DIS BRANCH T; Texas Department of State Health Services. Epidemiology and Supplemental Projects Group, 2016, TEX TB SURV ANN REP; Texas Department of State Health Services. Epidemiology and Supplemental Projects Group, 2015, TEX TB SURV ANN REP; Thomas JM, 2013, J AM GERIATR SOC, V61, P902, DOI 10.1111/jgs.12273; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278; World Health Organization, GLOB TUB REP 2017	28	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0196022	10.1371/journal.pone.0196022	http://dx.doi.org/10.1371/journal.pone.0196022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659636	gold, Green Published			2022-12-27	WOS:000430061100046
J	Ramli, NM; Giatsis, C; Yusoff, FM; Verreth, J; Verdegem, M				Ramli, Norulhuda Mohamed; Giatsis, Christos; Yusoff, Fatimah Md; Verreth, Johan; Verdegem, Marc			Resistance and resilience of small-scale recirculating aquaculture systems (RAS) with or without algae to pH perturbation	PLOS ONE			English	Article							SP NOV.; HETEROTROPHIC NITRIFICATION; AEROBIC DENITRIFICATION; PHYLUM VERRUCOMICROBIA; NITROGEN REMOVAL; BACTERIA; COMMUNITY	The experimental set-up of this study mimicked recirculating aquaculture systems (RAS) where water quality parameters such as dissolved oxygen, pH, temperature, and turbidity were controlled and wastes produced by fish and feeding were converted to inorganic forms. A key process in the RAS was the conversion of ammonia to nitrite and nitrite to nitrate through nitrification. It was hypothesized that algae inclusion in RAS would improve the ammonia removal from the water; thereby improving RAS water quality and stability. To test this hypothesis, the stability of the microbiota community composition in a freshwater RAS with (RAS+A) or without algae (RAS-A) was challenged by introducing an acute pH drop (from pH 7 to 4 during three hours) to the system. Stigeoclonium nanum, a periphytic freshwater microalga was used in this study. No significant effect of the algae presence was found on the resistance to the acute pH drop on ammonia conversion to nitrite and nitrite conversion to nitrate. Also the resilience of the ammonia conversion to the pH drop disruption was not affected by the addition of algae. This could be due to the low biomass of algae achieved in the RAS. However, with regard to the conversion step of nitrite to nitrate, RAS+A was significantly more resilient than RAS-A. In terms of overall bacterial communities, the composition and predictive function of the bacterial communities was significantly different between RAS+A and RAS-A.	[Ramli, Norulhuda Mohamed; Giatsis, Christos; Verreth, Johan; Verdegem, Marc] Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [Ramli, Norulhuda Mohamed] Univ Putra Malaysia, Fac Engn, Dept Biol & Agr Engn, Serdang, Selangor, Malaysia; [Yusoff, Fatimah Md] Univ Putra Malaysia, Inst Biosci, Lab Marine Biotechnol, Serdang, Selangor, Malaysia; [Yusoff, Fatimah Md] Univ Putra Malaysia, Fac Agr, Dept Aquaculture, Serdang, Selangor, Malaysia	Wageningen University & Research; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Ramli, NM (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands.; Ramli, NM (corresponding author), Univ Putra Malaysia, Fac Engn, Dept Biol & Agr Engn, Serdang, Selangor, Malaysia.	norul49huda@gmail.com	Ramli, Norulhuda/Y-7734-2019; Verreth, Johan/ABD-7198-2020; Yusoff, Fatimah M/N-7065-2018; Verdegem, Marc/C-6659-2014	Verreth, Johan/0000-0001-7277-5129; Yusoff, Fatimah M/0000-0003-4438-9065; Verdegem, Marc/0000-0002-2058-3894	Ministry of Higher Education, Malaysia (Skim Latihan Akademik IPTA); International Foundation for Science [A/5348-1 - NMR]; Malaysia-Japan Collaborative Research SATREPS on COSMOS (Continuous Operating System for Microalgae Culture Optimized for Sustainable Tropical Aquaculture)	Ministry of Higher Education, Malaysia (Skim Latihan Akademik IPTA); International Foundation for Science(International Foundation for Science); Malaysia-Japan Collaborative Research SATREPS on COSMOS (Continuous Operating System for Microalgae Culture Optimized for Sustainable Tropical Aquaculture)	This study was supported by Ministry of Higher Education, Malaysia (Skim Latihan Akademik IPTA) -NMR; International Foundation for Science grant number A/5348-1 - NMR; Malaysia-Japan Collaborative Research SATREPS on COSMOS (Continuous Operating System for Microalgae Culture Optimized for Sustainable Tropical Aquaculture)- FMY.	Amengual-Morro C, 2012, J ENVIRON MANAGE, V95, pS71, DOI 10.1016/j.jenvman.2011.07.008; APHA, 1999, STANDARD METHOD EXAM, DOI [10.1089/acm.2013.0216, DOI 10.1089/ACM.2013.0216]; Attramadal KJK, 2014, AQUACULTURE, V432, P483, DOI 10.1016/j.aquaculture.2014.05.052; Baath E, 2015, APPL ENVIRON MICROB, V81, P7411, DOI 10.1128/AEM.02236-15; Blancheton JP, 2013, AQUACULT ENG, V53, P30, DOI 10.1016/j.aquaeng.2012.11.009; Brenner A., 2013, Handbook of microalgal culture: applied phycology and biotechnology, P595; Chen PZ, 2012, BIORESOURCE TECHNOL, V116, P266, DOI 10.1016/j.biortech.2012.02.050; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Cytryn E, 2012, APPL ENVIRON MICROB, V78, P6576, DOI 10.1128/AEM.01545-12; D'Argenio V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-384; Dandie CE, 2004, J APPL MICROBIOL, V97, P246, DOI 10.1111/j.1365-2672.2004.02087.x; Ebeling JM, 2006, AQUACULTURE, V257, P346, DOI 10.1016/j.aquaculture.2006.03.019; Gan HM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-431; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Hartzell P., 2006, PROKARYOTES, P82; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Krohn-Molt I, 2013, APPL ENVIRON MICROB, V79, P6196, DOI 10.1128/AEM.01641-13; Kundu P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436056; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee J, 2014, INT J SYST EVOL MICR, V64, P663, DOI 10.1099/ijs.0.052787-0; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Martinez-Cordova LR, 2015, REV AQUACULT, V7, P131, DOI 10.1111/raq.12058; Miyashita M, 2010, INT J SYST EVOL MICR, V60, P344, DOI 10.1099/ijs.0.009365-0; Narwal SK, 2017, ADV ENV ENG GREEN TE, P186, DOI 10.4018/978-1-5225-2325-3.ch008; Natrah FMI, 2014, REV AQUACULT, V6, P48, DOI 10.1111/raq.12024; Orwin KH, 2004, SOIL BIOL BIOCHEM, V36, P1907, DOI 10.1016/j.soilbio.2004.04.036; Park J, 2013, INT J SYST EVOL MICR, V63, P1891, DOI 10.1099/ijs.0.046664-0; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; Ramli NM, 2017, AQUACULT ENV INTERAC, V9, P213, DOI 10.3354/aei00225; Rurangwa E, 2015, REV AQUACULT, V7, P117, DOI 10.1111/raq.12057; Ryu BG, 2015, BIORESOURCE TECHNOL, V191, P496, DOI 10.1016/j.biortech.2015.03.136; Staley C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00414; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Timmons M. B., 2002, RECIRCULATING AQUACU; Unnithan VV, 2014, ALGAL RES, V4, P35, DOI 10.1016/j.algal.2013.11.009; Vadstein O, 2012, MAR ECOL PROG SER, V447, P55, DOI 10.3354/meps09473; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Yang XP, 2011, BIORESOURCE TECHNOL, V102, P854, DOI 10.1016/j.biortech.2010.09.007; Yoon J, 2008, INT J SYST EVOL MICR, V58, P998, DOI 10.1099/ijs.0.65520-0; Yoon J, 2007, INT J SYST EVOL MICR, V57, P2337, DOI 10.1099/ijs.0.65243-0; Zhang JB, 2011, BIORESOURCE TECHNOL, V102, P9866, DOI 10.1016/j.biortech.2011.07.118; Zhao B, 2010, BIORESOURCE TECHNOL, V101, P5194, DOI 10.1016/j.biortech.2010.02.043	44	7	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195862	10.1371/journal.pone.0195862	http://dx.doi.org/10.1371/journal.pone.0195862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659617	Green Submitted, Green Published, gold			2022-12-27	WOS:000430061100038
J	Ijiri, T; Todo, H; Hirabayashi, A; Kohiyama, K; Dobashi, Y				Ijiri, Takashi; Todo, Hideki; Hirabayashi, Akira; Kohiyama, Kenji; Dobashi, Yoshinori			Digitization of natural objects with micro CT and photographs	PLOS ONE			English	Article								In this paper, we present a three-dimensional (3D) digitization technique for natural objects, such as insects and plants. The key idea is to combine X-ray computed tomography (CT) and photographs to obtain both complicated 3D shapes and surface textures of target specimens. We measure a specimen by using an X-ray CT device and a digital camera to obtain a CT volumetric image (volume) and multiple photographs. We then reconstruct a 3D model by segmenting the CT volume and generate a texture by projecting the photographs onto the model. To achieve this reconstruction, we introduce a technique for estimating a camera position for each photograph. We also present techniques for merging multiple textures generated from multiple photographs and recovering missing texture areas caused by occlusion. We illustrate the feasibility of our 3D digitization technique by digitizing 3D textured models of insects and flowers. The combination of X-ray CT and a digital camera makes it possible to successfully digitize specimens with complicated 3D structures accurately and allows us to browse both surface colors and internal structures.	[Ijiri, Takashi] Shibaura Inst Technol, Coll Engn, Tokyo, Japan; [Todo, Hideki] Chuo Gakuin Univ, Fac Liberal Arts, Chiba, Japan; [Hirabayashi, Akira] Ritsumeikan Univ, Grad Sch Informat Sci & Engn, Kusatsu, Shiga, Japan; [Kohiyama, Kenji] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan; [Dobashi, Yoshinori] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan	Shibaura Institute of Technology; Ritsumeikan University; Keio University; Hokkaido University	Ijiri, T (corresponding author), Shibaura Inst Technol, Coll Engn, Tokyo, Japan.	takashi.ijiri80@gmail.com			Japan Society for the Promotion of Science [15H05924]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (15H05924) to TI, HT, and YD. There was no additional external funding received for this study.	[Anonymous], 2013, ACM T GRAPHIC, DOI DOI 10.1145/2461912.2461952; Boykov YY, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P105, DOI 10.1109/ICCV.2001.937505; Cohen-Steiner D., 2004, ACM T GRAPHICS, V22; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fisher S., P SOC PHOTOOPTICAL I; Fitzgibbon AW, 2003, IMAGE VISION COMPUT, V21, P1145, DOI 10.1016/j.imavis.2003.09.004; Holovachov O, 2014, J CONSERV MUS STUD, V12, DOI 10.5334/jcms.1021218; Hudson LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143402; Ijiri T, PROJECT PAGE THIS PA; Ijiri T, ROIPAINTER; Ijiri T, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2601097.2601124; Kwatra V, 2005, ACM T GRAPHIC, V24, P795, DOI 10.1145/1073204.1073263; Kwatra V., 2003, ACM T GRAPHICS, V22; Li YY, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2508363.2508368; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Mantle BL, 2012, ZOOKEYS, P147, DOI 10.3897/zookeys.209.3169; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Nguyen CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094346; Quan L, 2006, ACM T GRAPHIC, V25, P599, DOI 10.1145/1141911.1141929; Schmidt R, 2006, ACM T GRAPHIC, V25, P605, DOI 10.1145/1141911.1141930; Tan P, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239538; Yin K., 2016, COMPUTER GRAPHICS FO, V35; Zhang CX, 2014, PROC CVPR IEEE, P636, DOI 10.1109/CVPR.2014.87; Zhao S., 2011, ACM T GRAPHICS, V30	26	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195852	10.1371/journal.pone.0195852	http://dx.doi.org/10.1371/journal.pone.0195852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649299	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900098
J	Loyen, A; Chey, T; Engelen, L; Bauman, A; Lakerveld, J; van der Ploeg, HP; Brug, J; Chau, JY				Loyen, Anne; Chey, Tien; Engelen, Lina; Bauman, Adrian; Lakerveld, Jeroen; van der Ploeg, Hidde P.; Brug, Johannes; Chau, Josephine Y.			Recent trends in population levels and correlates of occupational and leisure sitting time in full-time employed Australian adults	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; MORTALITY; EPIDEMIOLOGY; ASSOCIATION; RISK	This study aimed to explore the trend in population levels, as well as the correlates, of occupational and leisure sitting time in full-time employed Australian adults between 2007 and 2015. We used data from the 2007/08, 2011/12 and 2014/15 Australian Health Surveys, in which nationally representative samples of the Australian population were interviewed. Fulltime (>= 35 hours/week) employed respondents reported sitting time at work and during leisure on a usual workday. Trends over time and associations between socio-demographic and health-related characteristics and sitting time were analysed in the combined dataset using multivariable logistic regression models. Over 21,000 observations were included in the analyses. Across the three surveys, approximately 51% of the respondents reported >= 4 hours/workday occupational sitting time, 40% reported >= 4 hours/workday leisure sitting time, and 55% reported >= 7 hours/workday combined occupational and leisure sitting time. There were no clear trends over time. All potential correlates were associated with occupational sitting time and all but educational level were associated with leisure sitting time. The directions of the associations with gender, age and leisure-time physical activity were reversed for occupational sitting time and leisure sitting time. These findings show that the average levels of occupational and leisure sitting time on workdays were high but stable over the past decade. The observed differences in correlates of occupational and leisure sitting time demonstrate the need to assess and address sedentary behaviour domains separately in research and policy.	[Loyen, Anne; van der Ploeg, Hidde P.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Chey, Tien; Engelen, Lina; Bauman, Adrian; van der Ploeg, Hidde P.; Chau, Josephine Y.] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW, Australia; [Chey, Tien; Engelen, Lina; Bauman, Adrian; van der Ploeg, Hidde P.; Chau, Josephine Y.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Lakerveld, Jeroen; Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Brug, Johannes] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Sydney; University of Sydney; Vrije Universiteit Amsterdam; University of Amsterdam	Loyen, A (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	a.loyen@vumc.nl	van der Ploeg, Hidde P/B-2599-2013; Brug, Johannes/A-8242-2018; Engelen, Lina/S-3572-2019; van der Ploeg, Hidde/ABD-6402-2021	van der Ploeg, Hidde P/0000-0002-3719-5249; Brug, Johannes/0000-0002-1904-7349; Engelen, Lina/0000-0003-1631-6328; Lakerveld, Jeroen/0000-0002-8551-6748; Chau, Josephine/0000-0001-6261-2545	National Heart Foundation of Australia [100567]	National Heart Foundation of Australia(National Heart Foundation of Australia)	JYC was supported by a Postdoctoral Fellowship (#100567) from the National Heart Foundation of Australia (https://www.heartfoundation.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2013, SCAND J PUBLIC HEALT, V41, P706, DOI 10.1177/1403494813493151; [Anonymous], 2000, WHO TECH REP SER, P894; [Anonymous], 2017, DUTCH PHYS ACTIVITY; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Chau JY, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-76; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Gebel Klaus, 2017, Prev Med Rep, V5, P289, DOI 10.1016/j.pmedr.2017.01.015; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Loyen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149320; Marshall AL, 2010, MED SCI SPORT EXER, V42, P1094, DOI 10.1249/MSS.0b013e3181c5ec18; Milton K, 2015, PREV MED, V77, P11, DOI 10.1016/j.ypmed.2015.04.016; O'Donoghue G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2841-3; Pavey TG, 2015, BRIT J SPORT MED, V49, P95, DOI 10.1136/bjsports-2012-091676; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; van der Ploeg HP, 2013, AM J PREV MED, V44, P382, DOI 10.1016/j.amepre.2012.11.034; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	21	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195177	10.1371/journal.pone.0195177	http://dx.doi.org/10.1371/journal.pone.0195177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649243	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900032
J	Siddarth, P; Burggren, AC; Eyre, HA; Small, GW; Merrill, DA				Siddarth, Prabha; Burggren, Alison C.; Eyre, Harris A.; Small, Gary W.; Merrill, David A.			Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; ENTORHINAL CORTEX NEURONS; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CORTICAL THICKNESS; AEROBIC FITNESS; HEALTH OUTCOMES; SITTING TIME; EXERCISE; RISK	Atrophy of the medial temporal lobe (MTL) occurs with aging, resulting in impaired episodic memory. Aerobic fitness is positively correlated with total hippocampal volume, a heavily studied memory-critical region within the MTL. However, research on associations between sedentary behavior and MTL subregion integrity is limited. Here we explore associations between thickness of the MTL and its subregions (namely CA1, CA23DG, fusiform gyrus, subiculum, parahippocampal, perirhinal and entorhinal cortex,), physical activity, and sedentary behavior. We assessed 35 non-demented middle-aged and older adults (25 women, 10 men; 45-75 years) using the International Physical Activity Questionnaire for older adults, which quantifies physical activity levels in MET-equivalent units and asks about the average number of hours spent sitting per day. All participants had high resolution MRI scans performed on a Siemens Allegra 3T MRI scanner, which allows for detailed investigation of the MTL. Controlling for age, total MTL thickness correlated inversely with hours of sitting/day (r = -0.37, p = 0.03). In MTL subregion analysis, parahippocampal (r = -0.45, p = 0.007), entorhinal (r = -0.33, p = 0.05) cortical and subiculum (r = -0.36, p = .04) thicknesses correlated inversely with hours of sitting/day. No significant correlations were observed between physical activity levels and MTL thickness. Though preliminary, our results suggest that more sedentary non-demented individuals have less MTL thickness. Future studies should include longitudinal analyses and explore mechanisms, as well as the efficacy of decreasing sedentary behaviors to reverse this association.	[Siddarth, Prabha; Small, Gary W.; Merrill, David A.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Burggren, Alison C.] Univ Calif Los Angeles, Ctr Cognit Neurosci, Los Angeles, CA USA; [Eyre, Harris A.] Univ Adelaide, Discipline Psychiat, Adelaide, SA, Australia	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Adelaide	Siddarth, P (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	psiddarth@mednet.ucla.edu	Eyre, Harris/AAT-2457-2021		National Institutes of Health [MH077650, AT003480, P01-AG024831, AG13308, P50 AG 16570, MH/AG58156, AG10123, M01-RR00865]; Department of Energy [DE-FC03-87-ER60615]; McLoughlin Gift Fund for Cognitive Health; Larry L. Hillblom Foundation; Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; Ahmanson Foundation; Lovelace Foundation; Sence Foundation; UCLA Claude Pepper Older Americans Independence Center - National Institute on Aging [5P30AG028748]; AFAR; John A. Hartford Foundation; Centers of Excellence National Program, National Institutes of Health/National Center for Advancing Translational Science (NCATS) University of California Los Angeles Center for Translational Science Investigation [UL1TR000124]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); McLoughlin Gift Fund for Cognitive Health; Larry L. Hillblom Foundation; Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; Ahmanson Foundation; Lovelace Foundation; Sence Foundation; UCLA Claude Pepper Older Americans Independence Center - National Institute on Aging; AFAR; John A. Hartford Foundation; Centers of Excellence National Program, National Institutes of Health/National Center for Advancing Translational Science (NCATS) University of California Los Angeles Center for Translational Science Investigation	The following agencies supported the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation of the manuscript: National Institutes of Health grants MH077650, AT003480, P01-AG024831, AG13308, P50 AG 16570, MH/AG58156, AG10123, M01-RR00865, Department of Energy contract DE-FC03-87-ER60615, the McLoughlin Gift Fund for Cognitive Health, the Larry L. Hillblom Foundation, Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research, Ahmanson Foundation, Lovelace Foundation, the Sence Foundation, the UCLA Claude Pepper Older Americans Independence Center funded by the National Institute on Aging (5P30AG028748), AFAR, the John A. Hartford Foundation and the Centers of Excellence National Program, National Institutes of Health/National Center for Advancing Translational Science (NCATS) University of California Los Angeles Center for Translational Science Investigation Grant Number UL1TR000124. These agencies were not involved in the approval and review of the manuscript nor in the decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding agencies.	Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Apostolova LG, 2007, NEUROTHERAPEUTICS, V4, P387, DOI 10.1016/j.nurt.2007.05.009; Arnardottir NY, 2016, BEHAV BRAIN RES, V296, P118, DOI 10.1016/j.bbr.2015.09.005; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Beckett MW, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0007-2; Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; Booth M, 2000, RES Q EXERCISE SPORT, V71, pS114; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Burggren A, 2014, BRAIN IMAGING BEHAV, V8, P251, DOI 10.1007/s11682-013-9278-4; Chastin SFM, 2014, PHYSIOL MEAS, V35, P2319, DOI 10.1088/0967-3334/35/11/2319; Craft LL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-122; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Donix M, 2013, PSYCHIAT RES-NEUROIM, V214, P212, DOI 10.1016/j.pscychresns.2013.09.006; Donix M, 2010, AM J PSYCHIAT, V167, P1399, DOI 10.1176/appi.ajp.2010.09111575; Donix M, 2010, NEUROIMAGE, V53, P37, DOI 10.1016/j.neuroimage.2010.06.009; Eichenbaum H, 2012, NEUROSCI BIOBEHAV R, V36, P1597, DOI 10.1016/j.neubiorev.2011.07.006; Ekstrom AD, 2009, NEUROIMAGE, V47, P42, DOI 10.1016/j.neuroimage.2009.03.017; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Falck RS, 2017, BRIT J SPORT MED, V51, P800, DOI 10.1136/bjsports-2015-095551; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GomezIsla T, 1996, J NEUROSCI, V16, P4491; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hurtig-Wennlof A, 2010, PUBLIC HEALTH NUTR, V13, P1847, DOI 10.1017/S1368980010000157; Jensen CS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00187; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Nishijima T, 2013, BEHAV BRAIN RES, V245, P34, DOI 10.1016/j.bbr.2013.02.009; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Rovio S, 2010, NEUROBIOL AGING, V31, P1927, DOI 10.1016/j.neurobiolaging.2008.10.007; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Tan ZS, 2017, J GERONTOL A-BIOL, V72, P789, DOI 10.1093/gerona/glw130; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tian Q, 2014, J GERONTOL A-BIOL, V69, P1284, DOI 10.1093/gerona/glt287; Voelcker-Rehage C, 2013, NEUROSCI BIOBEHAV R, V37, P2268, DOI 10.1016/j.neubiorev.2013.01.028; Voss MW, 2014, MENT HEALTH PHYS ACT, V7, P9, DOI 10.1016/j.mhpa.2014.01.001; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Wheeler Michael J, 2017, Alzheimers Dement (N Y), V3, P291, DOI 10.1016/j.trci.2017.04.001; Whiteman AS, 2016, NEUROIMAGE, V126, P229, DOI 10.1016/j.neuroimage.2015.11.049; Zlatar ZZ, 2014, J ALZHEIMERS DIS, V41, P809, DOI 10.3233/JAD-132252	45	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195549	10.1371/journal.pone.0195549	http://dx.doi.org/10.1371/journal.pone.0195549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649304	Green Submitted, gold, Green Published			2022-12-27	WOS:000429791900054
J	Wang, SF; Yue, YT				Wang, Shunfang; Yue, Yaoting			Protein subnuclear localization based on a new effective representation and intelligent kernel linear discriminant analysis by dichotomous greedy genetic algorithm	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PREDICTING SUBCELLULAR-LOCALIZATION; DIMENSIONALITY REDUCTION; ENSEMBLE CLASSIFIER; LOCATION PREDICTION; WEB-SERVER; PSEAAC; PLATFORM; MODES; PLOC	A wide variety of methods have been proposed in protein subnuclear localization to improve the prediction accuracy. However, one important trend of these means is to treat fusion representation by fusing multiple feature representations, of which, the fusion process takes a lot of time. In view of this, this paper novelly proposed a method by combining a new single feature representation and a new algorithm to obtain good recognition rate. Specifically, based on the position-specific scoring matrix (PSSM), we proposed a new expression, correlation position-specific scoring matrix (CoPSSM) as the protein feature representation. Based on the classic nonlinear dimension reduction algorithm, kernel linear discriminant analysis (KLDA), we added a new discriminant criterion and proposed a dichotomous greedy genetic algorithm (DGGA) to intelligently select its kernel bandwidth parameter. Two public datasets with Jackknife test and KNN classifier were used for the numerical experiments. The results showed that the overall success rate (OSR) with single representation CoPSSM is larger than that with many relevant representations. The OSR of the proposed method can reach as high as 87.444% and 90.3361% for these two datasets, respectively, outperforming many current methods. To show the generalization of the proposed algorithm, two extra standard datasets of protein subcellular were chosen to conduct the expending experiment, and the prediction accuracy by Jackknife test and Independent test is still considerable.	[Wang, Shunfang; Yue, Yaoting] Yunnan Univ, Sch Informat Sci & Engn, Kunming, Yunnan, Peoples R China	Yunnan University	Wang, SF (corresponding author), Yunnan Univ, Sch Informat Sci & Engn, Kunming, Yunnan, Peoples R China.	sfwang_66@ynu.edu.cn			National Natural Science Foundation of China [11661081]; Natural Science Foundation of Yunnan Province [2017FA032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This research is supported by grants from National Natural Science Foundation of China (11661081) and Natural Science Foundation of Yunnan Province (2017FA032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan M, 2017, BIOMED PHARMACOL J, V10, P1823, DOI [10.13005/bpj/1299, DOI 10.13005/bpj/1299]; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Chen J, 2016, BIOSYSTEMS, V139, P37, DOI 10.1016/j.biosystems.2015.12.002; Chou KC, 2005, J CHEM INF MODEL, V45, P407, DOI 10.1021/ci049686v; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2006, J PROTEOME RES, V5, P3420, DOI 10.1021/pr060404b; CLAYS K, 1993, SCIENCE, V262, P1419, DOI 10.1126/science.262.5138.1419; Ding YR, 2004, FEBS LETT, V569, P284, DOI 10.1016/j.febslet.2004.06.009; Du PF, 2014, INT J MOL SCI, V15, P3495, DOI 10.3390/ijms15033495; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Fan YN, 2014, INT J MOL SCI, V15, P4915, DOI 10.3390/ijms15034915; Feng ZP, 2002, INT J BIOCHEM CELL B, V34, P298, DOI 10.1016/S1357-2725(01)00121-2; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Gomez-Chova L, 2011, GEOSCIENCE REMOTE SE, V9, P312; Han GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057225; Hasan MA, 2017, MOL BIOSYST, V13, P785, DOI 10.1039/c6mb00860g; Hilario M, 2008, BRIEF BIOINFORM, V9, P102, DOI 10.1093/bib/bbn005; Jenssen R, 2013, IEEE SIGNAL PROC MAG, V30, P30, DOI 10.1109/MSP.2013.2249692; Jenssen R, 2010, IEEE T PATTERN ANAL, V32, P847, DOI 10.1109/TPAMI.2009.100; Kumar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098345; Li LQ, 2014, BIOCHIMIE, V104, P100, DOI 10.1016/j.biochi.2014.06.001; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Mika S., 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468), P41, DOI 10.1109/NNSP.1999.788121; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nasibov E, 2008, COMPUT BIOL CHEM, V32, P448, DOI 10.1016/j.compbiolchem.2008.07.011; Powers D., 2011, J MACH LEARN TECHNOL, V2, P37; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shekar BH, 2011, NEUROCOMPUTING, V74, P1053, DOI 10.1016/j.neucom.2010.10.012; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Shen HB, 2007, BIOCHEM BIOPH RES CO, V355, P1006, DOI 10.1016/j.bbrc.2007.02.071; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shen HB, 2006, J THEOR BIOL, V240, P9, DOI 10.1016/j.jtbi.2005.08.016; Thakur A, 2016, MOL BIOSYST, V12, P2572, DOI 10.1039/c6mb00241b; Wang SF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122718; Wang SF, 2015, INT J MOL SCI, V16, P30343, DOI 10.3390/ijms161226237; Wang T, 2010, PROTEIN PEPTIDE LETT, V17, P32, DOI 10.2174/092986610789909494; Wang T, 2009, MOL DIVERS, V13, P475, DOI 10.1007/s11030-009-9134-z; Wei LY, 2017, INFORM SCIENCES, V384, P135, DOI 10.1016/j.ins.2016.06.026; Xiang QL, 2017, ARTIF INTELL MED, V78, P41, DOI 10.1016/j.artmed.2017.05.007; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xie ZB, 2013, IEEE INT S MULTIMEDI, V7, P1; Xu YY, 2016, BIOINFORMATICS, V32, P2184, DOI 10.1093/bioinformatics/btw219; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zamani B, 2014, INFORM SCIENCES, V274, P95, DOI 10.1016/j.ins.2014.02.140; Zhang YP, 2016, NEUROCOMPUTING, V173, P518, DOI 10.1016/j.neucom.2015.07.011; Zhang Z, 2012, INT J PATTERN RECOGN, V26; Zhao Jian-hua, 2014, Computer Engineering and Design, V35, P631	52	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195636	10.1371/journal.pone.0195636	http://dx.doi.org/10.1371/journal.pone.0195636			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649330	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900065
J	Kannan, N; Sundar, SS; Balaji, S; Amuthan, A; Kumar, NVA; Balasubramanian, N				Kannan, N.; Sundar, Shanmuga S.; Balaji, S.; Amuthan, Arul; Kumar, Anil N., V; Balasubramanian, N.			Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals	PLOS ONE			English	Article							HEAVY-METALS; DRUG; HGS	Background The present study is aimed to evaluate the physiochemical properties and cytotoxicity of mercury-based formulation for the development of anticancer therapeuticals. Methods The elemental and morphological features of the formulation were characterized by FE-SEM, XPS and EDS. The described formulation was evaluated for its cytotoxicity on Hek293 and MCF7 cell lines using MTT assay to study the in vitro effects. The in vivo developmental toxicity was also studied on zebrafish embryos and the lethal concentration (LC50) values were calculated as per the OECD regulations. Results The elemental and morphological characterizations confirmed the presence of mercuric compounds. The particles were spherical and stable with the size ranges between 20 and 80nm. Although the PK formulation contains mercurials it was very effective only to cancerous cells (MCF-7) and it is less toxic to normal cells (HEK 293). The in vivo assessment of developmental toxicity on zebrafish embryo confirmed the safer dosage of 100 mu g/ml. However, a higher dosage of 1 mg/ml led to the malformation of embryos such as pericardial, tail and yolk sac edema. Conclusion The physiochemical characterization of PK formulation confirmed the presence of HgS. The results of both in vitro and in vivo studies showed that the formulation is less toxic. Although the test sample contains mercurials it was very effective against cancerous cells (MCF-7) and it is less toxic to normal cells (HEK 293).	[Kannan, N.; Balaji, S.] Manipal Acad Higher Educ, Manipal Inst Technol, Dept Biotechnol, Manipal, Karnataka, India; [Sundar, Shanmuga S.] Univ Debrecen, Dept Biochem & Mol Biol, Debrecen, Hungary; [Sundar, Shanmuga S.; Balasubramanian, N.] Anna Univ, Dept Chem Engn, Madras, Tamil Nadu, India; [Amuthan, Arul] Manipal Acad Higher Educ, Dept Pharmacol, Melaka Manipal Med Coll, Manipal, Karnataka, India; [Kumar, Anil N., V] Manipal Acad Higher Educ, Manipal Inst Technol, Dept Chem, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); University of Debrecen; Anna University; Anna University Chennai; Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE)	Balaji, S (corresponding author), Manipal Acad Higher Educ, Manipal Inst Technol, Dept Biotechnol, Manipal, Karnataka, India.	s.balaji@manipal.edu	Saravanabhavan, Shanmuga Sundar/AHE-0286-2022; Subramanian, Bala/F-7231-2011; Kumar, NV Anil/G-6962-2015; Seetharaman, Balaji/K-6868-2015; Amuthan, Arul/Q-1556-2017	Saravanabhavan, Shanmuga Sundar/0000-0003-0598-4187; Subramanian, Bala/0000-0003-0763-8595; Kumar, NV Anil/0000-0002-8016-8991; Seetharaman, Balaji/0000-0002-0557-4623; Amuthan, Arul/0000-0002-6331-1047				ALTMAN SA, 1993, BIOTECHNOL PROGR, V9, P671, DOI 10.1021/bp00024a017; [Anonymous], 2012, EVID-BASED COMPL ALT, DOI DOI 10.1155/2012/429103; [Anonymous], 2013, ESS DRUGS LIST SIDDH, P10; Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Choedon T, 2011, J ETHNOPHARMACOL, V137, P320, DOI 10.1016/j.jep.2011.05.031; Cooper K, 2007, J TOXICOL ENV HEAL A, V70, P1694, DOI 10.1080/15287390701434885; Duan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058640; Ernst E, 2001, CLIN PHARMACOL THER, V70, P497, DOI 10.1067/mcp.2001.120249; Florento Leila, 2012, Int J Biomed Sci, V8, P76; Frawley David, 2000, AYURVEDIC HEALING CO; Galib, 2011, J Ayurveda Integr Med, V2, P55, DOI 10.4103/0975-9476.82523; Jungwirth U, 2011, ANTIOXID REDOX SIGN, V15, P1085, DOI 10.1089/ars.2010.3663; Kamath SU, 2014, INDIAN J PHARM SCI, V76, P495; Kannan RR, 2015, INDIAN J PHARMACOL, V47, P195, DOI 10.4103/0253-7613.153429; Klug H.P., 1954, XRAY DIFFRACTION PRO; Kumar A, 2006, J RADIOANAL NUCL CH, V270, P173, DOI 10.1007/s10967-006-0326-z; Lambert M, 2000, ENV SCI TECHONOLOGY; Lippard S. J., 1994, BIOINORG CHEM, P505; Mahapatra AK, 2006, PHYSICA E, V35, P9, DOI 10.1016/j.physe.2006.03.164; Mohanty M, 2013, J STRESS PHYSL BIOCH, V9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukherjee I, 2010, COLLOID SURFACE A, V360, P142, DOI 10.1016/j.colsurfa.2010.02.023; Ndagi U, 2017, DRUG DES DEV THER, V11, P599, DOI 10.2147/DDDT.S119488; Nicolini M, 2012, P 5 INT S PLANT OTH; Obi E, 2006, SCI TOTAL ENVIRON, V369, P35, DOI 10.1016/j.scitotenv.2006.04.024; Patrick Lyn, 2003, Altern Med Rev, V8, P106; Patrick Lyn, 2002, Altern Med Rev, V7, P456; Paul S, ASSESSING ROLE AYURV; Prakash R, 1995, INDIAN DRUGS, V32, P225; Rodrigues S, 2012, J FUNCT BIOMATER, V3, P615, DOI 10.3390/jfb3030615; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093; Srinivasulu B, 2012, INT J PHARM PHYTOPHA, V2, P16; Ulukaya E, 2004, CHEMOTHERAPY, V50, P43, DOI 10.1159/000077285; Wadekar MP, 2005, J PHARMACEUT BIOMED, V39, P951, DOI 10.1016/j.jpba.2005.06.015; WERAGODA PB, 1980, J ETHNOPHARMACOL, V2, P71, DOI 10.1016/0378-8741(80)90033-1; Xu X, 2012, NANOMATER NANOTECHNO, V2, DOI 10.5772/55823; Zhu JJ, 2000, J SOLID STATE CHEM, V153, P342, DOI 10.1006/jssc.2000.8780; Zysk KG, 2008, SIDDHA MED TAMIL NAD	39	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195800	10.1371/journal.pone.0195800	http://dx.doi.org/10.1371/journal.pone.0195800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668739	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200058
J	Kulkarni, K; Xie, XY; de Velasco, EMF; Anderson, A; Martemyanov, KA; Wickman, K; Tolkacheva, EG				Kulkarni, Kanchan; Xie, Xueyi; de Velasco, Ezequiel Marron Fernandez; Anderson, Allison; Martemyanov, Kirill A.; Wickman, Kevin; Tolkacheva, Elena G.			The influences of the M2R-GIRK4-RGS6 dependent parasympathetic pathway on electrophysiological properties of the mouse heart	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; I-KACH; RESTITUTION; ACTIVATION; REGULATOR; ALTERNANS; PROTECTS; RECEPTOR; RGS6	A large body of work has established the prominent roles of the atrial M2R-I-KAch signaling pathway, and the negative regulatory protein RGS6, in modulating critical aspects of parasympathetic influence on cardiac function, including pace-making, heart rate (HR) variability (HRV), and atrial arrhythmogenesis. Despite increasing evidence of its innervation of the ventricles, and the expression of M2R, I-KACh channel subunits, and RGS6 in ventricle, the effects of parasympathetic modulation on ventricular electrophysiology are less clear. The main objective of our study was to investigate the contribution of M2R-I-KAch signaling pathway elements in murine ventricular electrophysiology, using in-vivo ECG measurements, isolated whole-heart optical mapping and constitutive knockout mice lacking I-KACh (Girk4(-/-) or RGS6 (Rgs6(-/-). Consistent with previous findings, mice lacking GIRK4 exhibited diminished HR and HRV responses to the cholinergic agonist carbachol (CCh), and resistance to CCh-induced arrhythmic episodes. In line with its role as a negative regulator of atrial M2R-I-KACh signaling, loss of RGS6 correlated with a mild resting bradycardia, enhanced HR and HRV responses to CCh, and increased propensity for arrhythmic episodes. Interestingly, ventricles from mice lacking GIRK4 or RGS6 both exhibited increased action potential duration (APD) at baseline, and APD was prolonged by CCh across all genotypes. Similarly, CCh significantly increased the slope of APD restitution in all genotypes. There was no impact of genotype or CCh on either conduction velocity or heterogeneity. Our data suggests that altered parasympathetic signaling through the M2R-I-KAch pathway can affect ventricular electrophysiological properties distinct from its influence on atrial physiology.	[Kulkarni, Kanchan; Xie, Xueyi; Tolkacheva, Elena G.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [de Velasco, Ezequiel Marron Fernandez; Anderson, Allison; Wickman, Kevin] Univ Minnesota, Dept Pharmacol, Minneapolis, MN USA; [Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute	Tolkacheva, EG (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	talkacal@umn.edu	Kulkarni, Kanchan/AAZ-9557-2021	Kulkarni, Kanchan/0000-0002-3185-0484; Marron Fernandez de Velasco, Ezequiel/0000-0003-0257-4457; Anderson, Allison/0000-0001-9841-8672	National Science Foundation [CAREER PHY-125541, DCSD-1662250]; National Institute of Health [HL128790, HL105550, HL139090]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105550, F31HL139090, R21HL128790] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Science Foundation grant CAREER PHY-125541 (EGT); National Science Foundation grant DCSD-1662250 (EGT); National Institute of Health grant HL128790 (EGT); National Institute of Health grant HL105550 (KW and KAM) and the National Institute of Health grant HL139090 (AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19719-x; Annoni EM, 2015, PHYSL REP; Armour JA, 1997, ANAT REC, V247, P289, DOI 10.1002/(SICI)1097-0185(199702)247:2<289::AID-AR15>3.0.CO;2-L; Beaumont E, 2015, AM J PHYSIOL-HEART C, V309, pH1198, DOI 10.1152/ajpheart.00393.2015; Bibevski S, 2011, HEART FAIL REV, V16, P129, DOI 10.1007/s10741-010-9190-6; Brack KE, 2007, J PHYSIOL-LONDON, V583, P695, DOI 10.1113/jphysiol.2007.138461; Brack KE, 2011, CARDIOVASC RES, V91, P437, DOI 10.1093/cvr/cvr105; Chu V, 2001, BMC PHYSL; Coote JH, 2013, J PHYSIOL-LONDON, V591, P4073, DOI 10.1113/jphysiol.2013.257758; De Ferrari GM, 2011, HEART FAIL REV, V16, P195, DOI 10.1007/s10741-010-9216-0; DIFRANCESCO D, 1989, SCIENCE, V243, P669, DOI 10.1126/science.2916119; Glaza I, 2011, POSTEP HIG MED DOSW, V65, P478, DOI 10.5604/17322693.954785; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Huang J, 2011, CANCER RES, V71, P6310, DOI 10.1158/0008-5472.CAN-10-3397; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; Kulkarni K, 2016, IEEE ENG MED BIO, P149, DOI 10.1109/EMBC.2016.7590662; Kulkarni K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/170768; Lee SW, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12786; Liang B, 2014, CARDIOVASC RES, V101, P175, DOI 10.1093/cvr/cvt240; McIntyre SD, 2014, J THEOR BIOL, V350, P90, DOI 10.1016/j.jtbi.2014.02.015; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Randall DC, 2003, AM J PHYSIOL-REG I, V285, pR1066, DOI 10.1152/ajpregu.00167.2003; Riccio ML, 1999, CIRC RES, V84, P955; Rorabaugh BR, 2017, J PHARMACOL EXP THER, V360, P409, DOI 10.1124/jpet.116.238345; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Sava C, 2014, REV FARMACIA; Schwartz PJ, 2009, HEART RHYTHM, V6, pS76, DOI 10.1016/j.hrthm.2009.08.012; Sved AF, 2003, CURR HYPERTENS REP, V5, P262, DOI 10.1007/s11906-003-0030-0; Tolkacheva EG, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031904; Ulphani JS, 2010, HEART RHYTHM, V7, P1113, DOI 10.1016/j.hrthm.2010.03.043; Visweswaran R, 2013, J CARDIOVASC ELECTR, V24, P1287, DOI 10.1111/jce.12200; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WICKMAN KD, 1995, CURR OPIN NEUROBIOL, V5, P278, DOI 10.1016/0959-4388(95)80039-5; Yang JQ, 2013, CANCER RES, V73, P1662, DOI 10.1158/0008-5472.CAN-12-3453; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0193798	10.1371/journal.pone.0193798	http://dx.doi.org/10.1371/journal.pone.0193798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668674	gold, Green Published			2022-12-27	WOS:000430290200005
J	Martins, MP; Gomes, EV; Sanches, PR; Pedersoli, WR; Martinez-Rossi, NM; Rossi, A				Martins, Maira P.; Gomes, Eriston V.; Sanches, Pablo R.; Pedersoli, Wellington R.; Martinez-Rossi, Nilce M.; Rossi, Antonio			mus-52 disruption and metabolic regulation in Neurospora crassa: Transcriptional responses to extracellular phosphate availability	PLOS ONE			English	Article							REPRESSIBLE ALKALINE-PHOSPHATASE; INTEGRATIVE GENOMICS VIEWER; REVEALS FUNCTIONS; CIRCADIAN CLOCK; GENE-EXPRESSION; PROTEIN; NUCLEOLUS; IDENTIFICATION; PH; DEFICIENT	Advances in the understanding of molecular systems depend on specific tools like the disruption of genes to produce strains with the desired characteristics. The disruption of any mutagen sensitive (mus) genes in the model fungus Neurospora crassa, i.e. mus-51, mus-52, or mus-53, orthologous to the human genes KU70, KU80, and LIG4, respectively, provides efficient tools for gene targeting. Accordingly, we used RNA-sequencing and reverse transcription-quantitative polymerase chain reaction amplification techniques to evaluate the effects of mus-52 deletion in N. crassa gene transcriptional modulation, and thus, infer its influence regarding metabolic response to extracellular availability of inorganic phosphate (Pi). Notably, the absence of MUS-52 affected the transcription of a vast number of genes, highlighting the expression of those coding for transcription factors, kinases, circadian clocks, oxi-reduction balance, and membrane- and nucleolus-related proteins. These findings may provide insights toward the KU molecular mechanisms, which have been related to telomere maintenance, apoptosis, DNA replication, and gene transcription regulation, as well as associated human conditions including immune system disorders, cancer, and aging.	[Martins, Maira P.; Gomes, Eriston V.; Sanches, Pablo R.; Pedersoli, Wellington R.; Martinez-Rossi, Nilce M.; Rossi, Antonio] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Rossi, A (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil.	nmmrossi@usp.br	Martins, Maíra/GQZ-2806-2022; Martinez-Rossi, Nilce Maria/AAL-2964-2021; Gomes, Eriston V/L-7063-2015; Martinez-Rossi, Nilce M/C-2234-2013; Martins, Maíra Pompeu/AAD-3482-2022	Martinez-Rossi, Nilce Maria/0000-0002-5723-4276; Gomes, Eriston V/0000-0002-5538-0106; Martins, Maíra Pompeu/0000-0002-9462-5145; Ramos Pedersoli, Wellington/0000-0002-3982-0626	Brazilian Funding Agency: Sao Paulo Research Foundation (FAPESP) [2014/03847-7, 2016/04274-6]; Brazilian Funding Agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305252/2013-5, 304222/2013-5]; Brazilian Funding Agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Funding Agency: Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA)	Brazilian Funding Agency: Sao Paulo Research Foundation (FAPESP); Brazilian Funding Agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Funding Agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Funding Agency: Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA)	This work was supported by the following Brazilian Funding Agencies: Sao Paulo Research Foundation (FAPESP, http://www.fapesp.br/en/) grant No. 2014/03847-7 and Postdoctoral Fellowship to EVG No. 2016/04274-6; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/) grant Nos. 305252/2013-5 and 304222/2013-5; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/) fellowships to MPM, and WRP; and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA, http://www.faepa.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ARMENTROUT VN, 1978, PHYTOPATHOLOGY, V68, P1597, DOI 10.1094/Phyto-68-1597; Becker K, 2015, MOL MICROBIOL, V96, P1002, DOI 10.1111/mmi.12987; Berg JM, 1997, ANNU REV BIOPH BIOM, V26, P357, DOI 10.1146/annurev.biophys.26.1.357; Blake J. A., 2008, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0702S23; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; BROWN RS, 1985, FEBS LETT, V186, P271, DOI 10.1016/0014-5793(85)80723-7; Antonieto ACC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169796; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; DELANGE AM, 1981, GENETICS, V97, P247; Dent KC, 2009, APPL MICROBIOL BIOT, V82, P271, DOI 10.1007/s00253-008-1735-4; Dick CF, 2014, BBA-GEN SUBJECTS, V1840, P2123, DOI 10.1016/j.bbagen.2014.03.014; Ezzi MI, 2005, ENZYME MICROB TECH, V36, P849, DOI 10.1016/j.enzmictec.2004.03.030; Fabbro D, 2015, BRIT J PHARMACOL, V172, P2675, DOI 10.1111/bph.13096; Fell VL, 2015, MUTAT RES-REV MUTAT, V763, P15, DOI 10.1016/j.mrrev.2014.06.002; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GLEASON MK, 1974, GENETICS, V78, P645; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gras DE, 2007, FEMS MICROBIOL LETT, V269, P196, DOI 10.1111/j.1574-6968.2006.00613.x; Gras DE, 2013, FUNGAL GENET BIOL, V60, P140, DOI 10.1016/j.fgb.2013.05.007; Gras DE, 2009, MICROBIOL RES, V164, P658, DOI 10.1016/j.micres.2008.12.005; Gullo C, 2006, BBA-REV CANCER, V1765, P223, DOI 10.1016/j.bbcan.2006.01.001; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hoi JWS, 2010, EUKARYOT CELL, V9, P480, DOI 10.1128/EC.00333-09; INOUE H, 1984, MUTAT RES, V125, P185, DOI 10.1016/0027-5107(84)90068-X; Inoue H, 2011, MUTAT RES-REV MUTAT, V728, P1, DOI 10.1016/j.mrrev.2011.06.003; Ishibashi K, 2006, P NATL ACAD SCI USA, V103, P14871, DOI 10.1073/pnas.0604477103; Kafer E, 1980, CAN J GENET CYTOL; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leal J, 2009, FEBS LETT, V583, P180, DOI 10.1016/j.febslet.2008.11.050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendes NS, 2016, FEBS OPEN BIO, V6, P358, DOI 10.1002/2211-5463.12047; METZENBERG RL, 1979, MICROBIOL REV, V43, P361, DOI 10.1128/MMBR.43.3.361-383.1979; NAHAS E, 1984, PHYTOCHEMISTRY, V23, P507, DOI 10.1016/S0031-9422(00)80368-4; NAHAS E, 1982, J GEN MICROBIOL, V128, P2017; Neuwald AF, 1999, GENOME RES, V9, P27; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; NYC JF, 1966, J BIOL CHEM, V241, P1468; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Olson MOJ, 2002, INT REV CYTOL, V219, P199; PALMA MS, 1989, PHYTOCHEMISTRY, V28, P3281, DOI 10.1016/0031-9422(89)80331-0; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Paul JA, 2014, EUKARYOT CELL, V13, P1328, DOI 10.1128/EC.00150-14; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roche CM, 2014, AM J BOT, V101, P2022, DOI 10.3732/ajb.1400377; Rossi A, 2013, IUBMB LIFE, V65, P930, DOI 10.1002/iub.1217; Sakai W, 2003, DNA REPAIR, V2, P337, DOI 10.1016/S1568-7864(02)00223-9; Sawamura R, 2014, BIOCHEM BIOPH RES CO, V443, P997, DOI 10.1016/j.bbrc.2013.12.084; SCHUTGENS RBH, 1986, EUR J PEDIATR, V144, P430, DOI 10.1007/BF00441734; Shaw P, 2005, CELL CYCLE, V4, P102, DOI 10.4161/cc.4.1.1467; Smith PM, 2012, BBA-BIOENERGETICS, V1817, P276, DOI 10.1016/j.bbabio.2011.11.009; Squina FM, 2010, CELL STRESS CHAPERON, V15, P225, DOI 10.1007/s12192-009-0131-z; Sun YJ, 2016, FUNGAL GENET BIOL, V95, P58, DOI 10.1016/j.fgb.2016.08.006; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Todd RB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-214; Toh-e A, 2015, FUNGAL GENET BIOL, V80, P19, DOI 10.1016/j.fgb.2015.04.019; Vencio RZN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-86; Vitalini MW, 2006, J BIOL RHYTHM, V21, P432, DOI 10.1177/0748730406294396; Wang Lei, 2010, Virologica Sinica, V25, P151, DOI 10.1007/s12250-010-3093-5; Wang Z, 2012, FUNGAL GENET BIOL, V49, P533, DOI 10.1016/j.fgb.2012.05.004; Xiong Y, 2014, FUNGAL GENET BIOL, V72, P21, DOI 10.1016/j.fgb.2014.05.005; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Zeilinger S, 2016, FEMS MICROBIOL REV, V40, P182, DOI 10.1093/femsre/fuv045	70	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195871	10.1371/journal.pone.0195871	http://dx.doi.org/10.1371/journal.pone.0195871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668735	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200064
J	Nagymate, G; Orlovits, Z; Kiss, RM				Nagymate, Gergely; Orlovits, Zsanett; Kiss, Rita M.			Reliability analysis of a sensitive and independent stabilometry parameter set	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; INTRACLASS CORRELATION-COEFFICIENT; AGE-RELATED DIFFERENCES; POSTURAL CONTROL; PRESSURE MEASURES; KNEE OSTEOARTHRITIS; FORCE-PLATFORM; STANDING BALANCE; LEG STANCE; FOOT TYPES	Recent studies have suggested reduced independent and sensitive parameter sets for stabilometry measurements based on correlation and variance analyses. However, the reliability of these recommended parameter sets has not been studied in the literature or not in every stance type used in stabilometry assessments, for example, single leg stances. The goal of this study is to evaluate the test-retest reliability of different time-based and frequency- based parameters that are calculated from the center of pressure (CoP) during bipedal and single leg stance for 30-and 60-second measurement intervals. Thirty healthy subjects performed repeated standing trials in a bipedal stance with eyes open and eyes closed conditions and in a single leg stance with eyes open for 60 seconds. A force distribution measuring plate was used to record the CoP. The reliability of the CoP parameters was characterized by using the intraclass correlation coefficient (ICC), standard error of measurement (SEM), minimal detectable change (MDC), coefficient of variation (CV) and CV compliance rate (CVCR). Based on the ICC, SEM and MDC results, many parameters yielded fair to good reliability values, while the CoP path length yielded the highest reliability (smallest ICC > 0.67 (0.54-0.79), largest SEM% = 19.2%). Usually, frequency type parameters and extreme value parameters yielded poor reliability values. There were differences in the reliability of the maximum CoP velocity (better with 30 seconds) and mean power frequency (better with 60 seconds) parameters between the different sampling intervals.	[Nagymate, Gergely; Kiss, Rita M.] Budapest Univ Technol & Econ, Dept Mechatron Opt & Mech Engn Informat, Budapest, Hungary; [Orlovits, Zsanett] Budapest Univ Technol & Econ, Inst Math, Budapest, Hungary	Budapest University of Technology & Economics; Budapest University of Technology & Economics	Kiss, RM (corresponding author), Budapest Univ Technol & Econ, Dept Mechatron Opt & Mech Engn Informat, Budapest, Hungary.	rikiss@mail.bme.hu	; Kiss, Rita/G-4315-2015	Nagymate, Gergely/0000-0002-3327-5049; Kiss, Rita/0000-0003-3607-8435	Hungarian Scientific Research Fund (OTKA) [K115894]; New National Excellence Program of the Hungarian Ministry of Human Resources [UNKP-16-3-I]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New National Excellence Program of the Hungarian Ministry of Human Resources	This work was supported by the Hungarian Scientific Research Fund (OTKA), grant number: K115894, (http://nkfih.gov.hu/palyazatok/palyazati-archivum/otka) and the New National Excellence Program of the Hungarian Ministry of Human Resources, grant number: UNKP-16-3-I (http://www.kormany.hu/hu/emberi-eratorrasok-miniszteriuma/oktatasert-felelos-allamtitkarsag/hirek/az-uj-nemzeti-kivalosag-program-2017- 2018-tanevi-palyazati-kiirasai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Baldini A, 2013, J ELECTROMYOGR KINES, V23, P1474, DOI 10.1016/j.jelekin.2013.08.003; Bujang MA, 2017, ARCH OROFAC SCI, V12, P1; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Cobb SC, 2004, J ORTHOP SPORT PHYS, V34, P79, DOI 10.2519/jospt.2004.34.2.79; da Silva RA, 2013, J ELECTROMYOGR KINES, V23, P634, DOI 10.1016/j.jelekin.2013.01.008; Duffell LD, 2013, GAIT POSTURE, V38, P745, DOI 10.1016/j.gaitpost.2013.03.015; Ferreira AD, 2014, J BIOMECH, V47, P2919, DOI 10.1016/j.jbiomech.2014.07.010; Fleiss J. L., 2011, DESIGN ANAL CLIN EXP, P1, DOI DOI 10.1002/9781118032923.CH1; Geldhof E, 2006, EUR J PEDIATR, V165, P779, DOI 10.1007/s00431-006-0173-5; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Gray VL, 2014, GAIT POSTURE, V40, P198, DOI 10.1016/j.gaitpost.2014.03.191; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Hernandez ME, 2012, CLIN BIOMECH, V27, P910, DOI 10.1016/j.clinbiomech.2012.06.007; Hertel J, 2002, J ATHL TRAINING, V37, P129; Hoffman M, 1998, J ATHL TRAINING, V33, P319; Jorgensen MG, 2012, GAIT POSTURE, V35, P653, DOI 10.1016/j.gaitpost.2011.12.018; Kapteyn T S, 1983, Agressologie, V24, P321; Karlsson A, 2000, CLIN BIOMECH, V15, P365, DOI 10.1016/S0268-0033(99)00096-0; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kottner J, 2011, INT J NURS STUD, V48, P661, DOI 10.1016/j.ijnurstu.2011.01.016; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Laroche D, 2015, OSTEOARTHR CARTILAGE, V23, P1357, DOI 10.1016/j.joca.2015.03.029; Lawson T, 2015, CLIN BIOMECH, V30, P330, DOI 10.1016/j.clinbiomech.2015.02.011; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; Nagymate G, 2016, PERIOD POLYTECH-MECH, V60, P238, DOI [10.3311/PPme.8999, DOI 10.3311/PPME.8999]; Nagymate G, 2015, 11 ANN INT C KIN EX, P24; Nagymate G, 2016, BIOMEDICAL ENG, P12; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Oskoei MA, 2008, IEEE T BIO-MED ENG, V55, P1956, DOI 10.1109/TBME.2008.919734; Pinsault N, 2009, MED ENG PHYS, V31, P276, DOI 10.1016/j.medengphy.2008.08.003; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Salavati M, 2009, GAIT POSTURE, V29, P460, DOI 10.1016/j.gaitpost.2008.11.016; Santos BR, 2008, GAIT POSTURE, V27, P408, DOI 10.1016/j.gaitpost.2007.05.008; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Sorensen RR, 2014, GAIT POSTURE, V39, P1040, DOI 10.1016/j.gaitpost.2014.01.002; Takacs J, 2014, GAIT POSTURE, V40, P270, DOI 10.1016/j.gaitpost.2014.03.016; Tamburella F, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-86; TEREKHOV Y, 1976, CAN MED ASSOC J, V115, P631; Tsai LC, 2006, J ORTHOP SPORT PHYS, V36, P942, DOI 10.2519/jospt.2006.2336; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	43	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195995	10.1371/journal.pone.0195995	http://dx.doi.org/10.1371/journal.pone.0195995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664938	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300048
J	Santiago, TR; Pereira, VM; de Souza, WR; Steindorff, AS; Cunha, BADB; Gaspar, M; Favaro, LCL; Formighieri, EF; Kobayashi, AK; Molinari, HBC				Santiago, Thais R.; Pereira, Valquiria M.; de Souza, Wagner R.; Steindorff, Andrei S.; Cunha, Barbara A. D. B.; Gaspar, Marilia; Favaro, Leia C. L.; Formighieri, Eduardo F.; Kobayashi, Adilson K.; Molinari, Hugo B. C.			Genome-wide identification, characterization and expression profile analysis of expansins gene family in sugarcane (Saccharum spp.) (vol 13, e0191081, 2018)	PLOS ONE			English	Correction													Gaspar, Marilia/J-4329-2014; de Souza, Wagner R/D-8907-2019; Formighieri, Eduardo F/F-2993-2012	Gaspar, Marilia/0000-0002-6430-1502; de Souza, Wagner R/0000-0002-6287-0074; 				Santiago TR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191081	1	1	2	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196140	10.1371/journal.pone.0196140	http://dx.doi.org/10.1371/journal.pone.0196140			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664939	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300054
J	Neeraja, CN; Kulkarni, KS; Babu, PM; Rao, DS; Surekha, K; Babu, VR				Neeraja, C. N.; Kulkarni, Kalyani S.; Babu, P. Madhu; Rao, D. Sanjeeva; Surekha, K.; Babu, V. Ravindra			Transporter genes identified in landraces associated with high zinc in polished rice through panicle transcriptome for biofortification (vol 13, e0192362, 2018)	PLOS ONE			English	Correction													Durbha, Sanjeeva Rao/ABQ-8624-2022	Durbha, Sanjeeva Rao/0000-0001-9191-5510				Neeraja CN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192362	1	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0196160	10.1371/journal.pone.0196160	http://dx.doi.org/10.1371/journal.pone.0196160			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659633	gold, Green Published			2022-12-27	WOS:000430061100049
J	Wall, NA; Dominguez-Medina, CC; Faustini, SE; Cook, CN; McClean, A; Jesky, MD; Perez-Toledo, M; Morgan, MD; Richter, AG; Ferro, CJ; Cocicwell, P; Moss, PA; Henderson, IR; Harper, L; Cunningham, AF				Wall, Nadezhda A.; Dominguez-Medina, C. Coral; Faustini, Sian E.; Cook, Charlotte N.; McClean, Andrew; Jesky, Mark D.; Perez-Toledo, Marisol; Morgan, Matthew D.; Richter, Alexandra G.; Ferro, Charles J.; Cocicwell, Paul; Moss, Paul A.; Henderson, Ian R.; Harper, Lorraine; Cunningham, Adam F.			Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease	PLOS ONE			English	Article							STAGE RENAL-DISEASE; GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; CYTOMEGALOVIRUS-INFECTION; HEMODIALYSIS-PATIENTS; PERITONEAL-DIALYSIS; POPULATION COHORTS; GENERAL-POPULATION; T-CELLS; VACCINATION	Patients with chronic kidney disease (CKD) have an increased risk of infection and poorer responses to vaccination. This suggests that CKD patients have an impaired responsiveness to all antigens, even those first encountered before CKD onset. To examine this we evaluated antibody responses against two childhood vaccine antigens, tetanus (TT) and diphtheria toxoids (DT) and two common pathogens, cytomegalovirus (CMV) and Salmonella enterica serovar Enteritidis (SEn) in two independent cohorts consisting of age-matched individuals with and without CKD. Sera were evaluated for antigen-specific IgG titres and the functionality of antibody to SEn was assessed in a serum bactericidal assay. Surprisingly, patients with CKD and control subjects had comparable levels of IgG against TT and DT, suggesting preserved humoral memory responses to antigens encountered early in life. Lipopolysaccharide-specific IgG titres and serum bactericidal activity in patients with CKD were also not inferior to controls. CMV-specific IgG titres in seropositive CKD patients were similar or even increased compared to controls. Therefore, whilst responses to new vaccines in CKD are typically lower than expected, antibody responses to antigens commonly encountered prior to CKD onset are not. The immunodeficiency of CKD is likely characterised by failure to respond to new antigenic challenges and efforts to improve patient outcomes should be focussed here.	[Wall, Nadezhda A.; Dominguez-Medina, C. Coral; Faustini, Sian E.; Cook, Charlotte N.; Jesky, Mark D.; Perez-Toledo, Marisol; Morgan, Matthew D.; Richter, Alexandra G.; Ferro, Charles J.; Cocicwell, Paul; Moss, Paul A.; Henderson, Ian R.; Harper, Lorraine; Cunningham, Adam F.] Univ Birmingham, Birmingham, W Midlands, England; [McClean, Andrew] Univ Hosp North Midlands NHS Trust, Stoke On Trent, Staffs, England; [Jesky, Mark D.; Morgan, Matthew D.; Richter, Alexandra G.; Ferro, Charles J.; Cocicwell, Paul; Moss, Paul A.; Harper, Lorraine] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Wall, NA (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	Nadya.Wall@nhs.net	Moss, Paul/D-1728-2009; Morgan, Matthew David/K-2240-2019; ferro, charles/L-7250-2019; Ferro, Charles J./O-8912-2016; Henderson, Ian/AAD-5369-2019	Moss, Paul/0000-0002-6895-1967; Morgan, Matthew David/0000-0002-7831-2245; ferro, charles/0000-0003-0577-7081; Ferro, Charles J./0000-0003-0577-7081; harper, lorraine/0000-0003-1343-9234; Henderson, Ian/0000-0002-9954-4977; Cockwell, Paul/0000-0003-1975-266X; Cunningham, Adam/0000-0003-0248-964X	NIHR Academic Clinical Fellowship; Wellcome Trust Joint Basic and Clinical PhD Studentship [105479/Z/14/Z]; JABBS Foundation (Birmingham, United Kingdom); Queen Elizabeth Hospital Birmingham Charity; MRC [MR/N027027/1, MR/N023706/1] Funding Source: UKRI	NIHR Academic Clinical Fellowship; Wellcome Trust Joint Basic and Clinical PhD Studentship; JABBS Foundation (Birmingham, United Kingdom); Queen Elizabeth Hospital Birmingham Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by an NIHR Academic Clinical Fellowship and subsequently a Wellcome Trust Joint Basic and Clinical PhD Studentship (105479/Z/14/Z; www.wellcome.ac.uk) awarded to NW. The RIISC study, from which some samples were sourced, is supported by the JABBS Foundation (Birmingham, United Kingdom) and The Queen Elizabeth Hospital Birmingham Charity (www.qehb.org). The funders had no role in the design of this study, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S K, 1999, J Assoc Physicians India, V47, P183; Aitken Grant R, 2014, BMJ Open, V4, pe005480, DOI 10.1136/bmjopen-2014-005480; Arias RA, 2013, J VIROL, V87, P4486, DOI 10.1128/JVI.02425-12; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 2013, DIPHTH GREEN BOOK IM; [Anonymous], 2013, TET GREEN BOOK IMM I; [Anonymous], 2006, WKLY EPIDEMIOL REC, V20, P197; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; ATKINS RC, 1978, AUST NZ J MED, V8, P222; Betjes MGH, 2008, KIDNEY INT, V74, P760, DOI 10.1038/ki.2008.301; Betjes MGH, 2007, NEPHROL DIAL TRANSPL, V22, P3298, DOI 10.1093/ndt/gfm348; Betjes MGH, 2014, CURR UROL REP, V16, DOI 10.1007/s11934-014-0471-9; Betjes MGH, 2010, NEPHROL DIAL TRANSPL, V25, P3640, DOI 10.1093/ndt/gfq203; Bouts AHM, 2004, CLIN EXP IMMUNOL, V137, P589, DOI 10.1111/j.1365-2249.2004.02571.x; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Dalrymple LS, 2008, CLIN J AM SOC NEPHRO, V3, P1487, DOI 10.2215/CJN.01290308; Dalrymple LS, 2012, AM J KIDNEY DIS, V59, P356, DOI 10.1053/j.ajkd.2011.07.012; DaRoza G, 2003, AM J KIDNEY DIS, V42, P1184, DOI 10.1053/j.ajkd.2003.08.019; Ferraro AJ, 2008, EUR J IMMUNOL, V38, P292, DOI 10.1002/eji.200737557; Hart PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145945; Ishigami J, 2017, AM J KIDNEY DIS, V69, P752, DOI 10.1053/j.ajkd.2016.09.018; Janus N, 2008, NEPHROL DIAL TRANSPL, V23, P800, DOI 10.1093/ndt/gfm851; JOHNSON DW, 1992, CLIN PHARMACOKINET, V22, P434, DOI 10.2165/00003088-199222060-00003; Koch S, ANN NEW YORK ACAD SC, V11142007, P23; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Mastalerz-Migas A, 2013, MED SCI MONITOR, V19, P1013, DOI 10.12659/MSM.889671; Mathew R, 2014, EXPERT REV VACCINES, V13, P285, DOI 10.1586/14760584.2014.874950; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McClean A, 2016, ARTHRIT CARE RES, V68, P1332, DOI 10.1002/acr.22827; MCVOY MA, 1989, J INFECT DIS, V160, P1, DOI 10.1093/infdis/160.1.1; National. Institute. for. Health. and. Care. Excellence, 2014, CHRON KIDN DIS AD AS; Pahl MV, 2010, NEPHROL DIAL TRANSPL, V25, P205, DOI 10.1093/ndt/gfp397; Parry HM, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-015-0056-6; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Pertosa G, 2000, KIDNEY INT, V58, pS104, DOI 10.1046/j.1523-1755.2000.07613.x; Pourfarziani V, 2008, ANN TRANSPL, V13, P43; Prosch S, 2000, VIROLOGY, V272, P357, DOI 10.1006/viro.2000.0367; Saad K, 2014, RENAL FAILURE, V36, P502, DOI 10.3109/0886022X.2013.875833; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Savva GM, 2013, AGING CELL, V12, P381, DOI 10.1111/acel.12059; Steenkamp R, 2016, NEPHRON, V132, P111, DOI 10.1159/000444819; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Teng YKO, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3770; Trebicka E, 2013, CLIN VACCINE IMMUNOL, V20, P1491, DOI 10.1128/CVI.00289-13; Tsouchnikas I, 2007, CLIN NEPHROL, V68, P228; Wall NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055686; Wells TJ, 2014, J EXP MED, V211, P1893, DOI 10.1084/jem.20132444; Whitelegg AME, 2012, J IMMUNOL METHODS, V377, P37, DOI 10.1016/j.jim.2012.01.007; WHO, 2006, WKLY EPIDEMIOL REC, V81, P21; Yadav AK, 2011, NEPHROL DIAL TRANSPL, V26, P1689, DOI 10.1093/ndt/gfr010	52	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195730	10.1371/journal.pone.0195730	http://dx.doi.org/10.1371/journal.pone.0195730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659606	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100027
J	Wolf, S; Hoffmann, VS; Habicht, A; Kauke, T; Bucher, J; Schoenberg, M; Werner, J; Guba, M; Andrassy, J				Wolf, Sebastian; Hoffmann, Verena S.; Habicht, Antje; Kauke, Teresa; Bucher, Julian; Schoenberg, Markus; Werner, Jens; Guba, Markus; Andrassy, Joachim			Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months	PLOS ONE			English	Review							CANCER INCIDENCE; RAPAMYCIN INHIBITORS; MAMMALIAN TARGET; REDUCED-EXPOSURE; HEPATOCELLULAR-CARCINOMA; KIDNEY-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; CLINICAL-OUTCOMES; AUSTRALIAN LIVER; SKIN-CANCER	Background mTOR-Is positively influence the occurrence and course of certain tumors after solid organ transplantation. The effect of mTOR-Is on the overall incidence of tumors irrespective of their origin is not entirely clear. Furthermore, conflicting data have been shown on mortality under mTOR-Is. Methods The current literature was searched for prospective randomized controlled renal transplantation trials. There were 1415 trials screened of which 13 could be included (pts. = 5924). A minimum follow-up of 24 months was mandatory for inclusion. Incidence of malignancies and patient survival was assessed in meta-analyses. Results The average follow-up of all trials was 40.6 months. Malignancy was significantly reduced under mTOR-Is compared to CNIs (RR 0.70, CI 0.49-0.99, p = 0.046). This effect remained stable when combined with CNIs (RR 0.58, CI 0.34-1.00, p = 0.05). When NMSCs were excluded the risk for malignancy remained significantly reduced under mTOR-I therapy (mono and combi) (RR 0.43, CI 0.24-0.77, p = 0.0046). Graft survival was minimally decreased under mTOR-Is (RR 0.99, CI 0.98-1.00, p = 0.054). This effect was abrogated when mTOR-Is were combined with CNIs (RR 0.99, CI 0.97-1.02, p = 0.50). Patient survival was not different (RR 1.00, CI 0.99-1.01, p = 0.54). Conclusions Posttransplant patients have a lower incidence of malignancy when treated with an mTOR-I no matter if it is used in combination with CNIs or not. This beneficial effect remains significant even when NMSCs are excluded. With currently used mTOR-I-based regimen patient and graft survival is not different compared to CNI therapies.	[Wolf, Sebastian; Kauke, Teresa; Bucher, Julian; Schoenberg, Markus; Werner, Jens; Guba, Markus; Andrassy, Joachim] Ludwig Maximilians Univ Munchen, Dept Gen Visceral & Transplant Surg, Munich, Germany; [Wolf, Sebastian] Augsburg Hosp, Dept Visceral & Transplant Surg, Augsburg, Germany; [Hoffmann, Verena S.] Ludwig Maximilians Univ Munchen, Inst Med Informat Sci Biometry & Epidemiol IBE, Munich, Germany; [Hoffmann, Verena S.] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Munich, Germany; [Habicht, Antje] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Transplant Ctr, Munich, Germany	University of Munich; Klinikum Augsburg; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Andrassy, J (corresponding author), Ludwig Maximilians Univ Munchen, Dept Gen Visceral & Transplant Surg, Munich, Germany.	joachim.andrassy@med.uni-muenchen.de	Schoenberg, Markus Bo/X-9202-2019; Guba, Markus/M-4309-2019	Schoenberg, Markus Bo/0000-0002-5806-8249; Hoffmann, Verena Sophia/0000-0003-1478-5390	Pfizer GmbH	Pfizer GmbH	J. A. had received financial funding for this project from Pfizer GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IARC MONOGRAPHS EVAL; Badve SV, 2016, CLIN J AM SOC NEPHRO, V11, P1845, DOI 10.2215/CJN.00190116; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Buchler M, 2007, AM J TRANSPLANT, V7, P2522, DOI 10.1111/j.1600-6143.2007.01976.x; Cibrik D, 2013, TRANSPLANTATION, V95, P933, DOI 10.1097/TP.0b013e3182848e03; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; Cortazar F, 2012, AM J TRANSPLANT, V12, P379, DOI 10.1111/j.1600-6143.2011.03826.x; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Domhan S, 2009, NEPHROL DIAL TRANSPL, V24, P1097, DOI 10.1093/ndt/gfn605; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Euvrard S, 2012, NEW ENGL J MED, V367, P329, DOI 10.1056/NEJMoa1204166; Flechner SM, 2011, AM J TRANSPLANT, V11, P1633, DOI 10.1111/j.1600-6143.2011.03573.x; Geissler EK, 2016, TRANSPLANTATION, V100, P116, DOI 10.1097/TP.0000000000000965; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Isakova T, 2013, AM J TRANSPLANT, V13, P100, DOI 10.1111/j.1600-6143.2012.04281.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kauffman HM, 2005, TRANSPLANTATION, V80, P883, DOI 10.1097/01.TP.0000184006.43152.8D; KNOLL GA, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G6679; Krynitz B, 2013, INT J CANCER, V132, P1429, DOI 10.1002/ijc.27765; Marcil I, 2001, LANCET, V358, P1042, DOI 10.1016/S0140-6736(01)06179-7; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Na R, 2013, AM J TRANSPLANT, V13, P1296, DOI 10.1111/ajt.12192; Na R, 2013, AM J TRANSPLANT, V13, P174, DOI 10.1111/j.1600-6143.2012.04302.x; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; Oh CK, 2015, TRANSPLANTATION, V99, P180, DOI 10.1097/TP.0000000000000225; Opelz G, 2012, AM J TRANSPLANT, V12, P3031, DOI 10.1111/j.1600-6143.2012.04226.x; Opelz G, 2016, NEPHROL DIAL TRANSPL, V31, P1360, DOI 10.1093/ndt/gfw088; Paul CF, 2003, J INVEST DERMATOL, V120, P211, DOI 10.1046/j.1523-1747.2003.12040.x; Pengel LHM, 2011, TRANSPL INT, V24, P1216, DOI 10.1111/j.1432-2277.2011.01357.x; Pengel LHM, 2009, TRANSPL INT, V22, P377, DOI 10.1111/j.1432-2277.2008.00789.x; Penn I, 1998, Clin Transpl, P147; Penn I, 1990, Clin Transpl, P53; Santos AH, 2017, TRANSPLANTATION, V101, P377, DOI 10.1097/TP.0000000000001520; Silva HT, 2013, AM J TRANSPLANT, V13, P3155, DOI 10.1111/ajt.12481; Silva HT, 2010, AM J TRANSPLANT, V10, P1401, DOI 10.1111/j.1600-6143.2010.03129.x; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Tapiawala SN, 2010, J AM SOC NEPHROL, V21, P153, DOI 10.1681/ASN.2009040412; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; Webster AC, 2006, TRANSPLANTATION, V81, P1234, DOI 10.1097/01.tp.0000219703.39149.85; Wimmer CD, 2007, KIDNEY INT, V71, P1271, DOI 10.1038/sj.ki.5002154; Yanik EL, 2016, AM J TRANSPLANT, V16, P2986, DOI 10.1111/ajt.13818; Yanik EL, 2015, CANCER MED-US, V4, P1448, DOI 10.1002/cam4.487; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189	51	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194975	10.1371/journal.pone.0194975	http://dx.doi.org/10.1371/journal.pone.0194975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659588	Green Submitted, gold, Green Published			2022-12-27	WOS:000430061100009
J	Langellotti, S; Romano, G; Feiguin, F; Barolle, FE; Romano, M				Langellotti, Simona; Romano, Giulia; Feiguin, Fabian; Barolle, Francisco Ernesto; Romano, Maurizio			RhoGAPp190: A potential player in tbph-mediated neurodegeneration in Drosophila	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; IN-VIVO; BINDING-PROPERTIES; SIGNALING PATHWAY; CFTR EXON-9; P190 RHOGAP; PROTEINS; MELANOGASTER	TDP-43 is an ubiquitous and highly conserved ribonucleoprotein involved in several cellular processes including pre-mRNA splicing, transcription, mRNA stability and transport. Not-withstanding the evidence of TDP-43 involvement in the pathogenesis of different neurodegenerative disorders (i.e. ALS and FTLD), the underlying mechanisms are still unclear. Given the high degree of functional similarity between the human and fly orthologs of TDP-43, Drosophila melanogaster is a simple and useful model to study the pathophysiological role of this protein in vivo. It has been demonstrated that the depletion of the TDP-43 fly ortholog (tbph) induces deficient locomotive behaviors and reduces life span and anatomical defects at the neuromuscular junction. In this study, using the known binding specificity of TDP-43/ tbph for (UG) repeated sequences, we performed a bioinformatic screening for fly genes with at least 6 (TG) repeats in a row within the 3'-UTR regions in order to identify the genes that might be regulated by this factor. Among these genes, we were able to identify RhoGAPp190 as a potential target of the tbph-mediated neurodegeneration. RhoGAPp190 is a negative regulator of Drosophila RhoA, a GTPase protein implicated in the fine modulation of critical cellular processes including axon branch stability and motor axon defasciculation at muscle level and cognitive processes. We were able to demonstrate that the RhoGAPp190 expression is upregulated in a tbph-null fly model, providing evidence that this deregulation is associated to tbph silencing. Our results introduce RhoGAPp190 as a novel potential mediator in the complex scenario of events resulting from in vivo tbph loss-of-function.	[Langellotti, Simona; Romano, Giulia; Feiguin, Fabian; Barolle, Francisco Ernesto] Int Ctr Genet Engn & Biotechnol, Trieste, Italy; [Romano, Maurizio] Univ Trieste, Dept Life Sci, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste	Romano, M (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	mromano@units.it	Romano, Giulia/U-4156-2018; Feiguin, Fabian/ABC-2514-2020; Romano, Maurizio/G-9431-2012	Romano, Giulia/0000-0003-0356-4947; Romano, Maurizio/0000-0002-4820-2897	AriSLA (CHRONOS)	AriSLA (CHRONOS)	This work was supported by AriSLA (CHRONOS, to F.F.); This work was supported by AriSLA (CHRONOS, to F.F.). The Authors thank Dr. Flavia Baralle for proofreading the article.	Ambegaokar SS, 2010, NEUROBIOL DIS, V40, P29, DOI 10.1016/j.nbd.2010.05.026; Appocher C, 2017, NUCLEIC ACIDS RES, V45, P8026, DOI 10.1093/nar/gkx477; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arthur LL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14112; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Broeck LV, 2014, TRENDS MOL MED, V20, P66, DOI 10.1016/j.molmed.2013.11.003; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Budini M, 2015, HUM MOL GENET, V24, P9, DOI 10.1093/hmg/ddu415; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cragnaz L, 2014, NEUROBIOL DIS, V71, P74, DOI 10.1016/j.nbd.2014.07.009; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Godena VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017808; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Jeong S, 2012, NEURON, V76, P721, DOI 10.1016/j.neuron.2012.09.018; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Majumder P, 2012, ACTA NEUROPATHOL, V124, P231, DOI 10.1007/s00401-012-1006-4; Mishra A, 2017, BRAIN, V140, P1437, DOI 10.1093/brain/awx066; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Romano G, 2014, NEUROBIOL DIS, V71, P95, DOI 10.1016/j.nbd.2014.07.007; Romano M, 2014, J BIOL CHEM, V289, P7121, DOI 10.1074/jbc.M114.548859; Romano Maurizio, 2012, J Amino Acids, V2012, P356081, DOI 10.1155/2012/356081; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Skoko N, 2016, EMBO J, V35, P115, DOI 10.15252/embj.201593603; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195845	10.1371/journal.pone.0195845	http://dx.doi.org/10.1371/journal.pone.0195845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652933	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900040
J	Lee, SM; Park, JY; Park, MS; Park, JH; Park, M; Yoon, HJ				Lee, Seung Min; Park, Ju-Young; Park, Min-Su; Park, Jong Heon; Park, Minseon; Yoon, Hyung-Jin			Association of renal hyperfiltration with incident proteinuria - A nationwide registry study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR OUTCOMES; DIABETIC-NEPHROPATHY; GENERAL-POPULATION; FASTING GLUCOSE; RISK-FACTORS; MEN; METAANALYSIS	To elucidate the association between renal hyperfiltration (RHF) and incident proteinuria, the data from 11,559,520 Korean adults who had undergone health screenings >= 3 times between 2009 and 2014 and had glomerular filtration rate (GFR) >= 60 mL/min/1.73m(2) and negative dipstick test for proteinuria at baseline, were retrospectively analyzed. GFR was estimated with the Chronic Kidney Disease Epidemiology Collaboration equation based on serum creatinine, and RHF was defined as GFR >95th percentile adjusted for sex, age, body size, and diabetes and/or hypertension medication. The adjusted hazard ratio (aHR) of incident proteinuria in the RHF was 1.083 (95% CI, 1.069 similar to 1.097) compared to that of the non-RHF with Cox regression model. The association between RHF and incident proteinuria was not only in diabetic but also in non-diabetic subjects. This association was not observed in women (p for interaction <0.001). A reverse J-shaped association was found between the adjusted GFR slope and aHR of incident proteinuria. Both lower and higher GFR were associated with incident proteinuria in men. In conclusion, RHF was associated with incident proteinuria in men. Clinical studies are necessary to study whether the alleviation of RHF can prevent incident proteinuria.	[Lee, Seung Min; Park, Ju-Young; Yoon, Hyung-Jin] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Park, Min-Su] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Seoul, South Korea; [Park, Jong Heon] Natl Hlth Insurance Serv, Big Data Steering Dept, Wonju, Gangwon, South Korea; [Park, Minseon] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Yonsei University; Yonsei University Health System; National Health Insurance Service; Seoul National University (SNU); Seoul National University Hospital	Yoon, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea.	hjyoon@snu.ac.kr		Yoon, Hyung-Jin/0000-0003-4432-4894; Park, Ju-young/0000-0003-0782-614X; Lee, SeungMin/0000-0001-5762-2618	Korean Meteorological Administration's Research and Development Program [KMIPA 2015-5120]	Korean Meteorological Administration's Research and Development Program	This work was funded by the Korean Meteorological Administration's Research and Development Program under Grant KMIPA 2015-5120. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2009, NAT REV CARDIOL, V6, P301, DOI 10.1038/nrcardio.2009.11; Astor BC, 2009, J AM SOC NEPHROL, V20, P2214, DOI 10.1681/ASN.2008090980; Ayodele OE, 2010, ADV CHRONIC KIDNEY D, V17, P215, DOI 10.1053/j.ackd.2010.02.001; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Cheol Seong S, 2016, INT J EPIDEMIOL; Donfrancesco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078475; Endlich N, 2012, SEMIN NEPHROL, V32, P327, DOI 10.1016/j.semnephrol.2012.06.004; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jerums G, 2010, DIABETOLOGIA, V53, P2093, DOI 10.1007/s00125-010-1794-9; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Katsiki N, 2015, CURR MED CHEM, V22, P3565, DOI 10.2174/0929867322666150904110053; Kwakernaak AJ, 2013, NEPHROL DIAL TRANSPL, V28, P42, DOI 10.1093/ndt/gft331; Maeda I, 2011, CLIN J AM SOC NEPHRO, V6, P2462, DOI 10.2215/CJN.00700111; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Melsom T, 2016, CLIN J AM SOC NEPHRO, V11, P2186, DOI 10.2215/CJN.04940516; Melsom T, 2012, CLIN J AM SOC NEPHRO, V7, P1801, DOI 10.2215/CJN.02980312; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Okada R, 2014, NUTR METAB CARDIOVAS, V24, P277, DOI 10.1016/j.numecd.2013.08.004; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Park M, 2013, MED SCI SPORT EXER, V45, P217, DOI 10.1249/MSS.0b013e318271b39f; Pisoni Roberto, 2002, Saudi J Kidney Dis Transpl, V13, P250; Porrini E, 2015, LANCET DIABETES ENDO, V3, P382, DOI 10.1016/S2213-8587(15)00094-7; Pugliese G, 2014, ACTA DIABETOL, V51, P905, DOI 10.1007/s00592-014-0650-7; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Sarnak MJ, 2011, ADV CHRONIC KIDNEY D, V18, P258, DOI 10.1053/j.ackd.2011.04.002; SCHMIEDER RE, 1990, JAMA-J AM MED ASSOC, V264, P2775, DOI 10.1001/jama.264.21.2775; So R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166495; Thomas G, 2015, CLEV CLIN J MED, V82, P716, DOI 10.3949/ccjm.82a.15038; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195784	10.1371/journal.pone.0195784	http://dx.doi.org/10.1371/journal.pone.0195784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652920	gold, Green Published, Green Submitted			2022-12-27	WOS:000430026900035
J	Wang, SF; Jiao, XY; Guo, WH; Lu, J; Bai, YG; Wang, LP				Wang, Shufang; Jiao, Xiyun; Guo, Weihua; Lu, Jian; Bai, Yungang; Wang, Liping			Adaptability of shallow subsurface drip irrigation of alfalfa in an arid desert area of Northern Xinjiang	PLOS ONE			English	Article							WATER-USE EFFICIENCY; PRODUCTIVITY; YIELD; POTATO; CROP; ROOT	A suitable irrigation method adopted to arid desert conditions, including a special soil structure and specialized plants, has been continuously studied and improved. A field study was conducted in the Awei irrigation area of Aletai in Xinjiang in 2015 and 2016 to investigate the applicability of shallow subsurface drip irrigation (SSDI) in an arid desert area. A completely randomized block design with three replications and three treatments for drip tape subsurface depths at 5, 10, 20 cm was established. The results indicated that the vertical distribution of the soil moisture of subsurface drip irrigation (SDI, buried depth at 20 cm) was mainly concentrated at 0-60 cm, while SSDI (buried depth at 5 and 10 cm) was concentrated at 0-30 cm. However, the roots distributions were concentrated at 0-30 cm for SDI and SSDI. The chlorophyll content and water consumption intensity for alfalfa first increased and then decreased in arid desert conditions. The dry yield and water use efficiency (WUE) of SSDI (buried depth at 10 cm) were higher than those of SDI. The SSDI was practical in arid desert conditions and the recommended buried depth was 10 cm.	[Wang, Shufang; Jiao, Xiyun; Guo, Weihua] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China; [Lu, Jian] Minist Water Resources, Sci & Technol Promot Ctr, Beijing, Peoples R China; [Bai, Yungang] Xinjiang Inst Water Resources & Hydropower Res, Urumqi, Peoples R China; [Wang, Liping] Yunnan Agr Univ, Coll Water Conservancy, Kunming, Yunnan, Peoples R China	Hohai University; China Institute of Water Resources & Hydropower Research; Ministry of Water Resources; Yunnan Agricultural University	Jiao, XY (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China.	xyjiao@hhu.edu.cn		SALAHOU, Mohamed Khaled/0000-0001-5604-8589	Science & Technology Program of Xinjiang [201431107]	Science & Technology Program of Xinjiang	This research was supported by a grant from Science & Technology Program of Xinjiang (No.201431107) to XJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2002, J AM WATER RESOUR AS, V38, P1715, DOI 10.1111/j.1752-1688.2002.tb04376.x; Ayars JE, 2015, AGR WATER MANAGE, V157, P39, DOI 10.1016/j.agwat.2015.01.001; Ayars JE, 1999, AGR WATER MANAGE, V42, P1, DOI 10.1016/S0378-3774(99)00025-6; Ayars JE, 2001, AGR WATER MANAGE, V47, P243, DOI 10.1016/S0378-3774(00)00106-2; Borza I., 2014, Analele Universitatii din Oradea, Fascicula: Protectia Mediului, V23, P25; Bozkurt S, 2018, AGR WATER MANAGE, V197, P1, DOI 10.1016/j.agwat.2017.11.009; Camp CR, 1998, T ASAE, V41, P1353, DOI 10.13031/2013.17309; Camp CR, 2000, NATIONAL IRRIGATION SYMPOSIUM, PROCEEDINGS, P363; Charlesworth PB, 2003, IRRIGATION SCI, V22, P171, DOI 10.1007/s00271-003-0082-6; [陈洪松 Chen Hongsong], 2003, [水科学进展, Advances in Water Science], V14, P513; ESTILL K, 1991, CROP SCI, V31, P1229, DOI 10.2135/cropsci1991.0011183X003100050030x; Finger L, 2015, IRRIGATION SCI, V33, P141, DOI 10.1007/s00271-014-0454-0; FOX R. L., 1955, SOIL SCI SOC AMER PROC, V19, P468; Godoy A. C., 2003, AGROCIENCIA, V37, P107; Guo ZG, 2014, PHILIPPINE AGRICULTU, V96, P370; Han QingFang, 2005, Pratacultural Science, V22, P22; Hussain K, 2010, AFR J AGR RES, V5, P3026; Ismail SM, 2013, IRRIG DRAIN, V62, P57, DOI 10.1002/ird.1705; Jeremiah Attram, 2016, CAN J PLANT SCI, V96, P165; Kandelous MM, 2012, AGR WATER MANAGE, V109, P81, DOI 10.1016/j.agwat.2012.02.009; Kazumba S, 2010, WATER SCI TECHNOL, V61, P625, DOI 10.2166/wst.2010.904; KOSMAS CS, 1993, SOIL TECHNOL, V6, P337, DOI 10.1016/0933-3630(93)90024-9; Lamm FR, 2012, T ASABE, V55, P1203; Lei ZD, 1992, SOIL HYDRODYNAMICS; [李扬 LI Yang], 2011, [草地学报, Acta Agrestia Sinica], V19, P872; Lu WeiHua, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P128; Montemayor Trejo José Alfredo, 2010, Rev. mex. de cienc. pecuarias, V1, P145; Pablo RG, 2007, J SUSTAIN AGR, V30, P153, DOI 10.1300/J064v30n01_10; Patel N, 2008, AGR WATER MANAGE, V95, P1335, DOI 10.1016/j.agwat.2008.06.002; Patel N, 2007, AGR WATER MANAGE, V88, P209, DOI 10.1016/j.agwat.2006.10.017; PENG SB, 1993, AGRON J, V85, P987, DOI 10.2134/agronj1993.00021962008500050005x; Rasse DP, 2000, SOIL SCI SOC AM J, V64, P725, DOI 10.2136/sssaj2000.642725x; Ren LD, 2016, SOIL RES, V54, P730, DOI 10.1071/SR15126; Reyes-Cabrera J, 2016, AGR WATER MANAGE, V169, P183, DOI 10.1016/j.agwat.2016.03.001; Santos LNS, 2014, VII CONGRESO IBERICO DE AGROINGENIERIA Y CIENCIAS HORTICOLAS, P1134; Sun HR, 2008, ACTA AGRESTIA SINICA, V16, P3; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]	37	7	9	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195965	10.1371/journal.pone.0195965	http://dx.doi.org/10.1371/journal.pone.0195965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652935	Green Published, gold			2022-12-27	WOS:000430026900049
J	Izhak, L; Wildbaum, G; Jung, S; Stein, A; Shaked, Y; Karin, N				Izhak, Liat; Wildbaum, Gizi; Jung, Steffen; Stein, Avi; Shaked, Yuval; Karin, Nathan			Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis (Vol 7, e28305, 2012)	PLOS ONE			English	Correction																		Izhak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028305	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195170	10.1371/journal.pone.0195170	http://dx.doi.org/10.1371/journal.pone.0195170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649286	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900030
J	Putcha, N; Paul, GG; Azar, A; Wise, RA; O'Neal, WK; Dransfield, MT; Woodruff, PG; Curtis, JL; Comellas, AP; Drummond, MB; Lambert, AA; Paulin, LM; Fawzy, A; Kanner, RE; Paine, R; Hans, MK; Martinez, FJ; Bowler, RP; Barr, RG; Hansel, NN				Putcha, Nirupama; Paul, Gabriel G.; Azar, Antoine; Wise, Robert A.; O'Neal, Wanda K.; Dransfield, Mark T.; Woodruff, Prescott G.; Curtis, Jeffrey L.; Comellas, Alejandro P.; Drummond, M. Bradley; Lambert, Allison A.; Paulin, Laura M.; Fawzy, Ashraf; Kanner, Richard E.; Paine, Robert, III; Hans, MeiLan K.; Martinez, Fernando J.; Bowler, Russell P.; Barr, R. Graham; Hansel, Nadia N.		SPIROMICS Investigators	Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS	PLOS ONE			English	Article							IMMUNOGLOBULIN-A DEFICIENCY; INFLAMMATION; DISEASE	Background Decreased but measurable serum IgA levels (<= 70 mg/dL) have been associated with risk for infections in some populations, but are unstudied in COPD. This study tested the hypothesis that subnormal serum IgA levels would be associated with exacerbation risk in COPD. Methods Data were analyzed from 1,049 COPD participants from the observational cohort study SPIROMICS (535 (51%) women; mean age 66.1 (SD 7.8), 338 (32%) current smokers) who had baseline serum IgA measured using the Myriad RBM biomarker discovery platform. Exacerbation data was collected prospectively (mean 944.3 (SD 281.3) days), and adjusted linear, logistic and zero-inflated negative binomial regressions were performed. Results Mean IgA was 269.1 mg/dL (SD 150.9). One individual had deficient levels of serum IgA (< 7 mg/dL) and 25 (2.4%) had IgA level <= 70 mg/dL. Participants with IgA <= 70 mg/dL were younger (62 vs. 66 years, p = 0.01) but otherwise similar to those with higher IgA. In adjusted models, IgA <= 70 mg/dL was associated with higher exacerbation incidence rates (IRR 1.71, 95% CI 1.01-2.87, p = 0.044) and greater risk for any severe exacerbation (OR 2.99, 95% CI 1.30-6.94, p = 0.010). In adjusted models among those in the lowest decile (< 120 mg/dL), each 10 mg/dL decrement in IgA (analyzed continuously) was associated with more exacerbations during follow-up (beta 0.24, 95% CI 0.017-0.46, p = 0.035). Conclusions Subnormal serum IgA levels were associated with increased risk for acute exacerbations, supporting mildly impaired IgA levels as a contributing factor in COPD morbidity. Additionally, a dose-response relationship between lower serum IgA and number of exacerbations was found among individuals with serum IgA in the lowest decile, further supporting the link between serum IgA and exacerbation risk. Future COPD studies should more comprehensively characterize immune status to define the clinical relevance of these findings and their potential for therapeutic correction.	[Putcha, Nirupama; Paul, Gabriel G.; Azar, Antoine; Wise, Robert A.; Lambert, Allison A.; Paulin, Laura M.; Fawzy, Ashraf; Hansel, Nadia N.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [O'Neal, Wanda K.; Drummond, M. Bradley] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Dransfield, Mark T.] Univ Alabama Birmingham, Birmingham, AL USA; [Woodruff, Prescott G.] Univ San Francisco, Sch Med, San Francisco, CA 94117 USA; [Curtis, Jeffrey L.; Hans, MeiLan K.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Curtis, Jeffrey L.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Comellas, Alejandro P.] Univ Iowa, Coll Med, Iowa City, IA USA; [Lambert, Allison A.] Univ Washington, Sch Med, Seattle, WA USA; [Kanner, Richard E.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [Paine, Robert, III] Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Paine, Robert, III] Univ Utah, Sch Med, Salt Lake City, UT USA; [Martinez, Fernando J.] Weill Cornell Med Coll, New York, NY USA; [Bowler, Russell P.] Natl Jewish Hlth, Denver, CO USA; [Barr, R. Graham] Columbia Univ, Sch Med, New York, NY USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Alabama System; University of Alabama Birmingham; University of San Francisco; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Iowa; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Cornell University; National Jewish Health; Columbia University	Putcha, N (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	nputchal@thmi.edu	Facility, Biospecimen Processing/AAC-7837-2022; Comellas, Alejandro/AAE-5661-2019	Comellas, Alejandro/0000-0003-1521-7520; Putcha, Nirupama/0000-0002-0688-1836; Drummond, Michael/0000-0002-6968-4610; Fawzy, Ashraf/0000-0002-6089-366X; Wise, Robert/0000-0002-8353-2349; Paulin, Laura/0000-0003-0265-6858	National Institutes of Health/National Heart, Lung, and Blood Institute [K23HL123594]; Department of Veterans affairs [I01 CX000911]; NIH/NHLBI [HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002319] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL137880, K23HL123594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES025781, P30ES005605] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000911] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans affairs(US Department of Veterans Affairs); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	Nirupama Putcha is supported by National Institutes of Health/National Heart, Lung, and Blood Institute (K23HL123594). Jeffrey L Curtis is supported by the Merit Review award I01 CX000911 from the Department of Veterans affairs. SPIROMICS is funded by contract from the NIH/NHLBI (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C), which were supplemented by contributions made through the Foundation for the NIH from AstraZeneca; Bellerophon Therapeutics; Boehringer-Ingelheim Pharmaceuticals, Inc; Chiesi Farmaceutici SpA; Forest Research Institute, Inc; GSK; Grifols Therapeutics, Inc; Ikaria, Inc; Nycomed GmbH; Takeda Pharmaceutical Company; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals, Inc; and Sanofi.	Couper D, 2014, THORAX, V69, P491, DOI 10.1136/thoraxjnl-2013-203897; Cowan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142205; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Furst DE, 2009, SEMIN ARTHRITIS RHEU, V39, P18, DOI 10.1016/j.semarthrit.2008.05.002; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Keene JD, 2017, AM J RESP CRIT CARE, V195, P473, DOI 10.1164/rccm.201607-1330OC; Latiff AHA, 2007, ANN CLIN BIOCHEM, V44, P131, DOI 10.1258/000456307780117993; Leitao FS, 2016, AM J RESP CRIT CARE, V193; McCormack MC, 2015, EUR RESPIR J, V45, P1248, DOI 10.1183/09031936.00081414; McCullagh BN, 2017, ANTIBODY DEFICIENCY, V12; O'Neal WK, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-9; Pallav K, 2011, GASTROENTEROLOGY, V140, pS439; Papi Alberto, 2006, Proc Am Thorac Soc, V3, P245, DOI 10.1513/pats.200512-125SF; Pilette Charles, 2004, Proc Am Thorac Soc, V1, P125, DOI 10.1513/pats.2306032; Polosukhin VV, 2017, AM J RESP CRIT CARE, V195, P1010, DOI 10.1164/rccm.201604-0759OC; Polosukhin VV, 2011, AM J RESP CRIT CARE, V184, P317, DOI 10.1164/rccm.201010-1629OC; Richmond BW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11240; Safaeian M, 2009, CANCER EPIDEM BIOMAR, V18, P2672, DOI 10.1158/1055-9965.EPI-09-0348; WEBB DR, 1974, ANN INTERN MED, V80, P618, DOI 10.7326/0003-4819-80-5-618; Weber-Mzell D, 2004, EUR J CLIN INVEST, V34, P224, DOI 10.1111/j.1365-2362.2004.01311.x	20	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194924	10.1371/journal.pone.0194924	http://dx.doi.org/10.1371/journal.pone.0194924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649230	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900017
J	Sanchez-Siancas, LE; Rodriguez-Medina, A; Piscoya, A; Bernabe-Ortiz, A				Sanchez-Siancas, Luis E.; Rodriguez-Medina, Angelica; Piscoya, Alejandro; Bernabe-Ortiz, Antonio			Association between perceived social support and induced abortion: A study in maternal health centers in Lima, Peru	PLOS ONE			English	Article							UNITED-STATES; UNSAFE ABORTION; RISK-FACTORS; WOMEN; LIFE; EPIDEMIOLOGY; POPULATION; SERVICES; COUNTRY; STIGMA	Objectives This study aimed to assess the association between perceived social support and induced abortion among young women in Lima, Peru. In addition, prevalence and incidence of induced abortion was estimated. Methods/Principal findings A cross-sectional study enrolling women aged 18-25 years from maternal health centers in Southern Lima, Peru, was conducted. Induced abortion was defined as the difference between the total number of pregnancies ended in abortion and the number of spontaneous abortions; whereas perceived social support was assessed using the DUKE-UNC scale. Prevalence and incidence of induced abortion (per 100 person-years risk) was estimated, and the association of interest was evaluated using Poisson regression models with robust variance. A total of 298 women were enrolled, mean age 21.7 (+/- 2.2) years. Low levels of social support were found in 43.6% (95%CI 38.0%-49.3%), and 17.4% (95%CI: 13.1%-21.8%) women reported at least one induced abortion. The incidence of induced abortion was 2.37 (95%CI: 1.81-3.11) per 100 person-years risk. The multivariable model showed evidence of the association between low perceived social support and induced abortion (RR = 1.94; 95%CI: 1.14-3.30) after controlling for confounders. Conclusions There was evidence of an association between low perceived social support and induced abortion among women aged 18 to 25 years. Incidence of induced abortion was similar or even greater than rates of countries where abortion is legal. Strategies to increase social support and reduce induced abortion rates are needed.	[Sanchez-Siancas, Luis E.; Rodriguez-Medina, Angelica; Piscoya, Alejandro; Bernabe-Ortiz, Antonio] Univ Peruana Ciencias Aplicadas UPC, Sch Med, Lima, Peru; [Bernabe-Ortiz, Antonio] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England	Universidad Peruana de Ciencias Aplicadas (UPC); University of London; London School of Hygiene & Tropical Medicine	Sanchez-Siancas, LE (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Sch Med, Lima, Peru.	lesanchezsiancas@gmail.com	Piscoya, Alejandro/C-6380-2012	Piscoya, Alejandro/0000-0002-4420-2419; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	Wellcome Trust [103994/Z/14/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors received no specific funding for this work. AB-O is a research training fellow in public health and tropical medicine funded by the Wellcome Trust (103994/Z/14/Z).	Balogun O, 2016, ETHIOP J HEALTH SCI, V26, P439, DOI 10.4314/ejhs.v26i5.5; Barrett Allison, 2005, BMJ, V331, P310, DOI 10.1136/bmj.331.7512.310-f; Bennett SJ, 2001, QUAL LIFE RES, V10, P671, DOI 10.1023/A:1013815825500; Berard DM, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/616372; Bernabe-Ortiz A, 2009, CAN MED ASSOC J, V180, P298, DOI 10.1503/cmaj.071399; Bingham A, 2011, J HEALTH COMMUN, V16, P245, DOI 10.1080/10810730.2010.529495; Cabezas-Garcia E, 1998, SALUD PUBLICA MEXICO, V40, P265; Calderón S Jully, 2006, Rev. perú. med. exp. salud publica, V23, P247; Campbell C, 2011, AIDS BEHAV, V15, P1204, DOI 10.1007/s10461-010-9766-0; de la Revilla Ahumada L, 1991, Aten Primaria, V8, P688; Ferrando D., 2006, ABORTO CLANDESTINO P; Finer LB, 2003, PERSPECT SEX REPRO H, V35, P6, DOI 10.1111/j.1931-2393.2003.tb00079.x; Fusco CLB, 2012, CAD SAUDE PUBLICA, V28, P709, DOI 10.1590/S0102-311X2012000400010; Guttmacher Institute, 2012, FACTS IND AB WORLW; Harris LH, 2011, SOC SCI MED, V73, P1062, DOI 10.1016/j.socscimed.2011.07.004; Heaney CA, 1997, HLTH BEHAV HLTH ED T, V9, P179; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; *I NAC EST INF, 2007, CENS NAC 2007 11 POB; Jones RK, 2008, PERSPECT SEX REPRO H, V40, P6, DOI 10.1363/4000608; Jones RK, 2017, PERSPECT SEX REPRO H, V49, P17, DOI 10.1363/psrh.12015; Kuo C, 2012, J COMMUNITY PSYCHOL, V40, P631, DOI 10.1002/jcop.20521; LIN N, 1985, J HEALTH SOC BEHAV, V26, P247, DOI 10.2307/2136756; MAJOR B, 1990, J PERS SOC PSYCHOL, V59, P452, DOI 10.1037/0022-3514.59.3.452; Maxson P, 2011, J WOMENS HEALTH, V20, P1215, DOI 10.1089/jwh.2010.2379; Mookadam F, 2004, ARCH INTERN MED, V164, P1514, DOI 10.1001/archinte.164.14.1514; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Norris A, 2011, WOMEN HEALTH ISS, V21, pS49, DOI 10.1016/j.whi.2011.02.010; Pallikadavath S, 2006, INT FAM PLAN PERSPEC, V32, P120, DOI 10.1363/3212006; Perez G, 2014, EUR J PUBLIC HEALTH, V24, P162, DOI 10.1093/eurpub/ckt104; Rossier C, 2003, STUD FAMILY PLANN, V34, P87, DOI 10.1111/j.1728-4465.2003.00087.x; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4; Shah IH, 2012, REPROD HEALTH MATTER, V20, P169, DOI 10.1016/S0968-8080(12)39598-0; Shah MK, 2014, J PEDIATR ADOL GYNEC, V27, P14, DOI 10.1016/j.jpag.2013.08.002; Svanemyr J, 2007, Afr J Reprod Health, V11, P13, DOI 10.2307/25549712; World Health Organization, 1970, SPONT IND AB REP WHO; World Health Organization, 2017, HLTH STAT INF SYST M; Wu SH, 2011, GYNECOL OBSTET INVES, V71, P87, DOI 10.1159/000320739	39	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0192764	10.1371/journal.pone.0192764	http://dx.doi.org/10.1371/journal.pone.0192764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649229	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000429791900003
J	Sheridan, D; Yu, ZX; Zhang, YC; Patel, R; Sun, F; Lasaro, MA; Bouchard, K; Andrien, B; Marozsan, A; Wang, Y; Tamburini, P				Sheridan, Douglas; Yu, Zhao-Xue; Zhang, Yuchun; Patel, Rekha; Sun, Fang; Lasaro, Melissa A.; Bouchard, Keith; Andrien, Bruce; Marozsan, Andre; Wang, Yi; Tamburini, Paul			Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; HEMOLYTIC-UREMIC SYNDROME; SERUM HALF-LIFE; ECULIZUMAB TREATMENT; MONOCLONAL-ANTIBODY; 5TH COMPONENT; HUMAN IGG1; IN-VIVO; COMPLEMENT; DISEASE	Eculizumab, a monoclonal antibody (mAb) directed against complement protein C5, is considered to be the current standard of care for patients with paroxysmal nocturnal hemoglo-binuria (PNH) and atypical hemolytic uremic syndrome. This study describes the generation and preclinical attributes of ALXN1210, a new long-acting anti-C5 mAb, obtained through select modifications to eculizumab to both largely abolish target-mediated drug disposition (TMDD) and increase recycling efficiency via the neonatal Fc receptor (FcRn). To attenuate the effect of TMDD on plasma terminal half-life (t(1/2)), histidine substitutions were engineered into the complementarity-determining regions of eculizumab to enhance the dissociation rate of the mAb:C5 complex in the acidic early endosome relative to the slightly basic pH of blood. Antibody variants with optimal pH-dependent binding to C5 exhibited little to no TMDD in mice in the presence of human C5. To further enhance the efficiency of FcRn-mediated recycling of the antibody, two additional substitutions were introduced to increase affinity for human FcRn. These substitutions yielded an additional doubling of the t(1/2) of surrogate anti-mouse C5 antibodies with reduced TMDD in transgenic mice expressing the human FcRn. In conclusion, ALXN1210 is a promising new therapeutic candidate currently in clinical development for treatment of patients with PNH and atypical hemolytic uremic syndrome.	[Sheridan, Douglas; Yu, Zhao-Xue; Zhang, Yuchun; Sun, Fang; Lasaro, Melissa A.; Bouchard, Keith; Marozsan, Andre; Wang, Yi; Tamburini, Paul] Alexion Pharmaceut Inc, Res, New Haven, CT 06510 USA; [Patel, Rekha] Alexion Pharmaceut Inc, Prod Characterizat, New Haven, CT USA; [Andrien, Bruce] Alexion Pharmaceut Inc, Early Assay Dev, New Haven, CT USA		Sheridan, D (corresponding author), Alexion Pharmaceut Inc, Res, New Haven, CT 06510 USA.	douglas.sheridan@alexion.com		Sheridan, Douglas/0000-0001-9505-1668	Alexion Pharmaceuticals, Inc.	Alexion Pharmaceuticals, Inc.	This study was funded by Alexion Pharmaceuticals, Inc. (http://www.alexion.com/). Alexion Pharmaceuticals, Inc., was involved with study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Brodsky RA, 2014, BLOOD, V124, P2804, DOI 10.1182/blood-2014-02-522128; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Cugno M, 2014, J THROMB HAEMOST, V12, P1440, DOI 10.1111/jth.12615; FREI Y, 1987, MOL CELL PROBE, V1, P141, DOI 10.1016/0890-8508(87)90022-3; Fukuzawa T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01087-7; Groth M, 2017, ANN HEMATOL, V96, P171, DOI 10.1007/s00277-016-2867-8; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Lee JW, 2016, HAEMATOLOGICA, V101, P414; LEE JW, 2016, BLOOD, V128; Licht C, 2015, KIDNEY INT, V87, P1061, DOI 10.1038/ki.2014.423; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Nakayama H, 2016, BIOL PHARM BULL, V39, P285, DOI 10.1248/bpb.b15-00703; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195; Roopenian DC, 2010, METHODS MOL BIOL, V602, P93, DOI 10.1007/978-1-60761-058-8_6; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; RUDDY S, 1975, MEDICINE, V54, P165, DOI 10.1097/00005792-197554020-00004; Sahelijo A.M. Leonardo, 2015, BLOOD, V126, P4777, DOI DOI 10.1182/blood.V126.23.4777.4777; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Schatz-Jakobsen JA, 2016, J IMMUNOL, V197, P337, DOI 10.4049/jimmunol.1600280; SISSONS JGP, 1977, J CLIN INVEST, V59, P704, DOI 10.1172/JCI108689; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	27	97	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195909	10.1371/journal.pone.0195909	http://dx.doi.org/10.1371/journal.pone.0195909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649283	gold, Green Submitted, Green Published			2022-12-27	WOS:000429791900105
J	Alehagen, U; Aaseth, J; Alexander, J; Johansson, P				Alehagen, Urban; Aaseth, Jan; Alexander, Jan; Johansson, Peter			Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; OXIDATIVE STRESS; SERUM SELENIUM; ENDOTHELIAL DYSFUNCTION; THIOREDOXIN REDUCTASE; NATIONAL-HEALTH; VITAMIN-E; BIOMARKERS; AGE; ADULTS	Background Selenium and coenzyme Q10 are both necessary for optimal cell function in the body. The intake of selenium is low in Europe, and the endogenous production of coenzyme Q10 decreases as age increases. Therefore, an intervention trial using selenium and coenzyme Q10 for four years as a dietary supplement was performed. The main publication reported reduced cardiovascular mortality as a result of the intervention. In the present sub-study the objective was to determine whether reduced cardiovascular (CV) mortality persisted after 12 years, in the supplemented population or in subgroups with diabetes, hypertension, ischemic heart disease or reduced functional capacity due to impaired cardiac function. Methods From a rural municipality in Sweden, four hundred forty-three healthy elderly individuals were included. All cardiovascular mortality was registered, and no participant was lost to the follow-up. Based on death certificates and autopsy results, mortality was registered. Findings After 12 years a significantly reduced CV mortality could be seen in those supplemented with selenium and coenzyme Q10, with a CV mortality of 28.1% in the active treatment group, and 38.7% in the placebo group. A multivariate Cox regression analysis demonstrated a reduced CV mortality risk in the active treatment group (HR: 0.59; 95% CI 0.42-0.81; P = 0.001). In those with ischemic heart disease, diabetes, hypertension and impaired functional capacity we demonstrated a significantly reduced CV mortality risk. Conclusions This is a 12-year follow-up of a group of healthy elderly participants that were supplemented with selenium and coenzyme Q10 for four years. Even after twelve years we observed a significantly reduced risk for CV mortality in this group, as well as in subgroups of patients with diabetes, hypertension, ischemic heart disease or impaired functional capacity. The results thus validate the results obtained in the 10-year evaluation. The protective action was not confined to the intervention period, but persisted during the follow-up period. The mechanisms behind this effect remain to be fully elucidated, although various effects on cardiac function, oxidative stress, fibrosis and inflammation have previously been identified. Since this was a small study, the observations should be regarded as hypothesis-generating.	[Alehagen, Urban] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Aaseth, Jan] Innlandet Hosp Trust, Res Dept, Elverum, Norway; [Aaseth, Jan] Inland Norway Univ Appl Sci, Elverum, Norway; [Alexander, Jan] Norwegian Inst Publ Hlth, Oslo, Norway; [Johansson, Peter] Linkoping Univ, Dept Social & Welf Studies, Norrkoping, Sweden; [Johansson, Peter] Linkoping Univ, Dept Med & Hlth Sci, Norrkoping, Sweden	Linkoping University; Innlandet Hospital Trust; Inland Norway University of Applied Sciences; Norwegian Institute of Public Health (NIPH); Linkoping University; Linkoping University	Alehagen, U (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden.	Urban.Alehagen@liu.se	Johansson, Peter/ABH-4364-2020		Pharma Nord Aps, Denmark; County Council of Ostergotland, Linkoping University	Pharma Nord Aps, Denmark; County Council of Ostergotland, Linkoping University	Part of the analysis costs was supported by grants from Pharma Nord Aps, Denmark, the County Council of Ostergotland, Linkoping University. The funding organizations had no role in the design, management, analysis, or interpretation of the data, nor in the preparation, review or approval of the manuscript. No economic compensation was distributed.	Alehagen U, 2016, EUR J CLIN NUTR, V70, P91, DOI 10.1038/ejcn.2015.92; Alehagen U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157541; Alehagen U, 2015, BIOFACTORS, V41, P443, DOI 10.1002/biof.1245; Alehagen U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141641; Alehagen U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137680; Alehagen U, 2013, INT J CARDIOL, V167, P1860, DOI 10.1016/j.ijcard.2012.04.156; Alexander J, 2014, SELENIUM; Bleys J, 2009, AM J EPIDEMIOL, V169, P996, DOI 10.1093/aje/kwn414; Bullon P, 2015, PHARMACOL RES, V91, P1, DOI 10.1016/j.phrs.2014.10.007; Burk RF, 2006, CANCER EPIDEM BIOMAR, V15, P804, DOI 10.1158/1055-9965.EPI-05-0950; Burri J, 2008, J TRACE ELEM MED BIO, V22, P112, DOI 10.1016/j.jtemb.2007.11.002; Conti V, 2015, AGING CLIN EXP RES, V27, P547, DOI 10.1007/s40520-015-0357-9; EFSA Scientific Committe on Dietetic Products NaA, 2004, TOL UPP INT LEV VIT; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Galan-Chilet I, 2014, FREE RADICAL BIO MED, V74, P229, DOI 10.1016/j.freeradbiomed.2014.07.005; Gradinaru D, 2015, MECH AGEING DEV, V151, P101, DOI 10.1016/j.mad.2015.03.003; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hubbard RE, 2010, BIOGERONTOLOGY, V11, P635, DOI 10.1007/s10522-010-9292-5; Hurst R, 2013, CRIT REV FOOD SCI, V53, P1077, DOI 10.1080/10408398.2012.742861; Jensen-Urstad K, 1998, AM J CARDIOL, V81, P538, DOI 10.1016/S0002-9149(97)00964-8; Kafai MR, 2003, J TRACE ELEM MED BIO, V17, P13, DOI 10.1016/S0946-672X(03)80040-8; KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072; Lee BJ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-142; Letsiou S, 2009, BIOL TRACE ELEM RES, V128, P8, DOI 10.1007/s12011-008-8252-2; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Littarru GP, 2011, BIOFACTORS, V37, P366, DOI 10.1002/biof.154; Ministers NCo, 2014, NORD NUTR REC 2012; Onur S, 2015, BIOFACTORS, V41, P35, DOI 10.1002/biof.1198; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rees K, 2013, COCHRANE DB SYST REV, V1; Rumley A, 2006, J THROMB HAEMOST, V4, P982, DOI 10.1111/j.1538-7836.2006.01889.x; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Spina A, 2013, FREE RADICAL BIO MED, V65, P1315, DOI 10.1016/j.freeradbiomed.2013.09.025; U.S. Department of Agriculture ARS, 2008, NUTR INT FOOD MEAN A; Van Cauwenbergh R, 2004, J TRACE ELEM MED BIO, V18, P99, DOI 10.1016/j.jtemb.2004.04.004; vanRoyen N, 1996, AM J CARDIOL, V77, P843, DOI 10.1016/S0002-9149(97)89179-5; Vassalle C, 2012, CLIN CHEM LAB MED, V50, P1463, DOI 10.1515/cclm-2011-0919; Violi F, 2017, ANTIOXID REDOX SIGN, V27, P1083, DOI 10.1089/ars.2016.6963; Wu DY, 2008, J LEUKOCYTE BIOL, V84, P900, DOI 10.1189/jlb.0108023; Xia L, 2003, J BIOL CHEM, V278, P2141, DOI 10.1074/jbc.M210456200; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642	41	47	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193120	10.1371/journal.pone.0193120	http://dx.doi.org/10.1371/journal.pone.0193120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641571	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900009
J	Liu, XL; Yu, Y; Zhu, SM				Liu, Xuling; Yu, Yang; Zhu, Shengmei			Inflammatory markers in postoperative delirium (POD) and cognitive dysfunction (POCD): A meta-analysis of observational studies	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CONFUSION ASSESSMENT METHOD; MECHANICALLY VENTILATED PATIENTS; RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; GROWTH-FACTOR-I; ELDERLY-PATIENTS; CARDIAC-SURGERY; HIP-FRACTURE; CARDIOPULMONARY BYPASS	Background The aim of this study was to summarize and discuss the similarities and differences in inflammatory biomarkers in postoperative delirium (POD) and cognitive dysfunction (POCD). Methods A systematic retrieval of literature up to June 2017 in PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure database, and the Wanfang database was conducted. Extracted data were analyzed with STATA (version 14). The standardized mean difference (SMD) and the 95% confidence interval (95% CI) of each indicator were calculated using a random effect model. We also performed tests of heterogeneity, sensitivity analysis, assessments of bias, and meta-regression in this meta-analysis. Results A total of 54 observational studies were included. By meta-analysis we found significantly increased C-reactive protein (CRP) (9 studies, SMD 0.883, 95% CI 0.130 to 1.637, P = 0.022 in POD; 10 studies, SMD -0.133, 95% CI -0.512 to 0.246, P = 0.429 in POCD) and interleukin (IL)-6 (7 studies, SMD 0.386, 95% CI 0.054 to 0.717, P = 0.022 in POD; 16 studies, SMD 0.089, 95% CI -0.133 to 0.311, P = 0.433 in POCD) concentrations in both POD and POCD patients. We also found that the SMDs of CRP and IL-6 from POCD patients were positively correlated with surgery type in the meta-regression (CRP: Coefficient = 1.555365, P = 0.001, 10 studies; IL-6: Coefficient = -0.6455521, P = 0.086, 16 studies). Conclusion Available evidence from medium-to-high quality observational studies suggests that POD and POCD are indeed correlated with the concentration of peripheral and cerebrospinal fluid (CSF) inflammatory markers. Some of these markers, such as CRP and IL-6, play roles in both POD and POCD, while others are specific to either one of them.	[Liu, Xuling; Yu, Yang; Zhu, Shengmei] Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Zhu, Shengmei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhu, SM (corresponding author), Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Zhu, SM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China.	1185027@zju.edu.cn			National Natural Science Foundation of China [81471171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Grant No. 81471171). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis D, 2007, INT J GERIATR PSYCH, V22, P688, DOI 10.1002/gps.1732; Arthur GL, 2001, PSYCHOL PSYCHIAT AUT; Association A. P., 2010, DIAGN STAT MAN MENT; Baranyi A, 2012, PSYCHIAT RES, V200, P957, DOI 10.1016/j.psychres.2012.05.030; Beloosesky Y, 2004, GERONTOLOGY, V50, P216, DOI 10.1159/000078350; Beloosesky Y, 2007, J GERONTOL A-BIOL, V62, P420, DOI 10.1093/gerona/62.4.420; Blazer DG, 2012, CURR OPIN PSYCHIATR, V25, P239, DOI 10.1097/YCO.0b013e3283523ce8; Burkhart CS, 2010, J CARDIOTHOR VASC AN, V24, P555, DOI 10.1053/j.jvca.2010.01.003; Burkhart CS, 2011, EUROPEAN J ANAESTHES, V28, P223; Butterfield NN, 2004, ANESTH ANALG, V98, P1305, DOI 10.1213/01.ANE.0000108484.91089.13; Cape E, 2014, J PSYCHOSOM RES, V77, P219, DOI 10.1016/j.jpsychores.2014.06.014; Capri M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00173; Cerejeira J, 2013, J GERIATR PSYCH NEUR, V26, P185, DOI 10.1177/0891988713495449; Cerejeira J, 2012, J AM GERIATR SOC, V60, P669, DOI 10.1111/j.1532-5415.2011.03883.x; Chen M, 2016, ZHEJIANG J TRAUMATIC, P104; Chen Y, 2011, CHINESE J HLTH LABRA, P2431; Chu CS, 2016, PSYCHIAT INVEST, V13, P327, DOI 10.4306/pi.2016.13.3.327; Cinari MA, 2014, NOROPSIKIYATRI ARS, V51, P376, DOI 10.5152/npa.2014.6999; Clarke RM, 2008, J BIOL CHEM, V283, P1808, DOI 10.1074/jbc.M707442200; Davis N, 2014, J NEUROSURG ANESTH, V26, P369, DOI 10.1097/ANA.0000000000000120; Djaiani G, 2016, ANESTHESIOLOGY, V124, P362, DOI 10.1097/ALN.0000000000000951; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Fan X, 2011, PROGR MODERN BIOMEDI, P1191; Fodale V, 2010, ANAESTHESIA, V65, P388, DOI 10.1111/j.1365-2044.2010.06244.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goettel N, 2017, ANESTH ANALG, V124, P934, DOI 10.1213/ANE.0000000000001803; Guangdong Z., 2014, THESIS CITY U HONG K; Guenther U, 2013, ANN SURG, V257, P1160, DOI 10.1097/SLA.0b013e318281b01c; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hu X, 2015, J NEW MED, P448; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jia N, 2017, CHINESE J GERONTOLOG, P431; Jiang H, 2014, CHIN J PRIM MED PHAR, P2944; Kapila AK, 2014, J ALZHEIMERS DIS, V41, P1, DOI 10.3233/JAD-132258; Kazmierski J, 2014, INT PSYCHOGERIATR, V26, P845, DOI 10.1017/S1041610213002378; Kazmierski J, 2013, CRIT CARE, V17, DOI 10.1186/cc12548; Le Strat Y, 2012, NEW ENGL J MED, V367, P1164, DOI 10.1056/NEJMc1209366; Lee HJ, 2011, PSYCHIAT INVEST, V8, P340, DOI 10.4306/pi.2011.8.4.340; Li X, 2013, HEPATOB PANCREAT DIS, V12, P370, DOI 10.1016/S1499-3872(13)60058-2; Li YC, 2012, ACTA ANAESTH SCAND, V56, P595, DOI 10.1111/j.1399-6576.2011.02616.x; [李颖川 LI Yingchuan], 2011, [上海医学, Shanghai Medical Journal], V34, P249; Lin GX, 2014, ACTA ANAESTH SCAND, V58, P668, DOI 10.1111/aas.12320; Lin J, 2016, CHINA MED, V11, P1055; LIPOWSKI ZJ, 1989, NEW ENGL J MED, V320, P578; Liu C., 2013, THESIS; Liu P, 2013, CHINESE MED J-PEKING, V126, P3621, DOI 10.3760/cma.j.issn.0366-6999.20130211; Liu W, 2012, RELATIONSHIPS EMERGE, V12, P4298; Lyketsos CG, 2012, JAMA-J AM MED ASSOC, V307, P197, DOI 10.1001/jama.2011.2005; Ma J, 2014, J TROP MED; MacLullich AMJ, 2008, J PSYCHOSOM RES, V65, P229, DOI 10.1016/j.jpsychores.2008.05.019; Mandal PK, 2010, J ALZHEIMERS DIS, V22, pS27, DOI 10.3233/JAD-2010-101128; Mandal PK, 2010, J ALZHEIMERS DIS, V21, P1303, DOI 10.3233/JAD-2010-100396; Mandal PK, 2010, J ALZHEIMERS DIS, V22, pS135, DOI 10.3233/JAD-2010-101300; Marcantonio ER, 2012, JAMA-J AM MED ASSOC, V308, P73, DOI 10.1001/jama.2012.6857; Mason SE, 2010, J ALZHEIMERS DIS, V22, pS67, DOI 10.3233/JAD-2010-101086; Monk TG, 2011, CURR OPIN CRIT CARE, V17, P376, DOI 10.1097/MCC.0b013e328348bece; Mrak RE, 1997, J NEUROPATH EXP NEUR, V56, P1269, DOI 10.1097/00005072-199712000-00001; Nadelson MR, 2014, BRIT J ANAESTH, V112, P440, DOI 10.1093/bja/aet420; Neerland BE, 2016, J AM GERIATR SOC, V64, P1456, DOI 10.1111/jgs.14238; Nelson JE, 2006, ARCH INTERN MED, V166, P1993, DOI 10.1001/archinte.166.18.1993; Organization WH, 1993, ICD 10 CLASS MENT BE, V10, P86; Pac-Soo C, 2011, J ALZHEIMERS DIS, V27, P1, DOI [10.3233/JAD-2011-110524, 10.1097/WAD.0b013e31821f5787]; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Peng M, 2013, J SURG RES, V179, pE219, DOI 10.1016/j.jss.2012.05.047; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Plaschke K, 2010, INTENS CARE MED, V36, P2081, DOI 10.1007/s00134-010-2004-4; Raja PV, 2004, CNS SPECTRUMS, V9, P763, DOI 10.1017/S1092852900022409; Ramlawi B, 2006, ANN SURG, V244, P593, DOI 10.1097/01.sla.0000239087.00826.b4; Ramlawi B, 2006, SURGERY, V140, P221, DOI 10.1016/j.surg.2006.03.007; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Ren Q. Z., 2015, THESIS; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rudolph JL, 2008, J GERONTOL A-BIOL, V63, P184, DOI 10.1093/gerona/63.2.184; Rudolph JL, 2007, AM J MED, V120, P807, DOI 10.1016/j.amjmed.2007.02.026; Saczynski JS, 2013, DELIRIUM ELDERLY PEO; Seymour DG, 2009, AGE AGEING, V38, P147, DOI 10.1093/ageing/afn289; She Y, 2014, JIANGSU MED J, P234; Shen HC, 2016, CURR PHARM DESIGN, V22, P5879, DOI 10.2174/1381612822666160813234311; [施丽燕 Shi Liyan], 2012, [上海医学, Shanghai Medical Journal], V35, P115; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Su X, 2016, LANCET, V388, P1893, DOI 10.1016/S0140-6736(16)30580-3; Sun LL, 2016, NEUROPSYCH DIS TREAT, V12, P2789, DOI 10.2147/NDT.S113077; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; TRZEPACZ PT, 1988, PSYCHIAT RES, V23, P89, DOI 10.1016/0165-1781(88)90037-6; van Munster BC, 2008, J AM GERIATR SOC, V56, P1704, DOI 10.1111/j.1532-5415.2008.01851.x; van Munster BC, 2011, REJUV RES, V14, P425, DOI 10.1089/rej.2011.1155; van Munster BC, 2010, BRAIN COGNITION, V74, P18, DOI 10.1016/j.bandc.2010.05.010; Vizcaychipi MP, 2014, ANN SURG, V259, P1235, DOI 10.1097/SLA.0000000000000257; Wei LA, 2008, J AM GERIATR SOC, V56, P823, DOI 10.1111/j.1532-5415.2008.01674.x; Wells G., 2014, S SYST REV BAS; Westhoff D, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-122; WHITFIELD W, 1993, J ROY SOC HEALTH, V113, P103, DOI 10.1177/146642409311300216; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wu CS, 2016, MED SCI MONITOR, V22, P4503, DOI 10.12659/MSM.898397; Yang Y, 2014, J KUNMING MED U, P61; Yang Z, 2010, J CLIN ANESTHESIAL, P764; Yen TE, 2016, SCI REP-UK, V6, DOI 10.1038/srep20736; Young J, 2007, BMJ-BRIT MED J, V334, P842, DOI 10.1136/bmj.39169.706574.AD; Zhang F, 2012, J ZHEJIANG U TRADITI, P1290; Zhang J, 2014, CHINESE J GERONTOLOG, P5097; Zhang Q., 2016, THESIS; Zhang T, 2004, THESIS; Zhang YH, 2015, INT J NEUROSCI, V125, P501, DOI 10.3109/00207454.2014.949341; Zhang Yuan, 2015, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V31, P231; Zhang ZH, 2014, J CRIT CARE, V29, P88, DOI 10.1016/j.jcrc.2013.09.002; Zheng X, 2014, CHINA J MODERN MED, P36	111	97	103	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195659	10.1371/journal.pone.0195659	http://dx.doi.org/10.1371/journal.pone.0195659			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641605	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900081
J	Olimpio, RMC; de Oliveira, M; De Sibio, MT; Moretto, FCF; Depra, IC; Mathias, LS; Goncalves, BM; Rodrigues, BM; Tilli, HP; Coscrato, VE; Costa, SMB; Mazeto, GMFS; Fernandes, CJC; Zambuzzi, WF; Saraiva, PP; Maria, DA; Nogueira, CR				Olimpio, Regiane M. C.; de Oliveira, Miriane; De Sibio, Maria T.; Moretto, Fernanda C. F.; Depra, Igor C.; Mathias, Lucas S.; Goncalves, Bianca M.; Rodrigues, Bruna M.; Tilli, Helena P.; Coscrato, Virginia E.; Costa, Sarah M. B.; Mazeto, Glaucia M. F. S.; Fernandes, Celio J. C.; Zambuzzi, Willian F.; Saraiva, Patricia P.; Maria, Durvanei A.; Nogueira, Celia R.			Cell viability assessed in a reproducible model of human osteoblasts derived from human adipose-derived stem cells	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; STROMAL CELLS; IN-VIVO; GENE-EXPRESSION; BONE-FORMATION; TISSUE; PROLIFERATION; FABRICATE; MINERALIZATION; REGENERATION	Human adipose tissue-derived stem cells (hASCs) have been subjected to extensive investigation because of their self-renewal properties and potential to restore damaged tissues. In the literature, there are several protocols for differentiating hASCs into osteoblasts, but there is no report on the control of cell viability during this process. In this study, we used osteoblasts derived from hASCs of patients undergoing abdominoplasty. The cells were observed at the beginning and end of bone matrix formation, and the expression of proteins involved in this process, including alkaline phosphatase and osteocalcin, was assessed. RANKL, Osterix, Runx2, Collagen3A1, Osteopontin and BSP expression levels were analyzed using real-time PCR, in addition to a quantitative assessment of protein levels of the markers CD45, CD105, STRO-1, and Nanog, using immunofluorescence. Rhodamine (Rho123), cytochrome-c, caspase-3, P-27, cyclin D1, and autophagy cell markers were analyzed by flow cytometry to demonstrate potential cellular activity and the absence of apoptotic and tumor cell processes before and after cell differentiation. The formation of bone matrix, along with calcium nodules, was observed after 16 days of osteoinduction. The gene expression levels of RANKL, Osterix, Runx2, Collagen3A1, Osteopontin, BSP and alkaline phosphatase activity were also elevated after 16 days of osteoinduction, whereas the level of osteocalcin was higher after 21 days of osteoinduction. Our data also showed that the cells had a high mitochondrial membrane potential and a low expression of apoptotic and tumor markers, both before and after differentiation. Cells were viable after the different phases of differentiation. This proposed methodology, using markers to evaluate cell viability, is therefore successful in assessing different phases of stem cell isolation and differentiation.	[Olimpio, Regiane M. C.; de Oliveira, Miriane; De Sibio, Maria T.; Moretto, Fernanda C. F.; Depra, Igor C.; Mathias, Lucas S.; Goncalves, Bianca M.; Rodrigues, Bruna M.; Tilli, Helena P.; Coscrato, Virginia E.; Costa, Sarah M. B.; Mazeto, Glaucia M. F. S.; Saraiva, Patricia P.; Nogueira, Celia R.] Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil; [Fernandes, Celio J. C.; Zambuzzi, Willian F.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Chem & Biochem, Botucatu, SP, Brazil; [Maria, Durvanei A.] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Instituto Butantan	Olimpio, RMC (corresponding author), Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil.	m.regianemarques@gmail.com	Nogueira, Celia Regina/AAF-7440-2022; Gonçalves, Bianca Mariani/S-2058-2017; Mathias, Lucas Solla/AAS-8928-2020; Mazeto, Gláucia/E-7729-2012; Fernandes, Célio/AAD-1278-2019; De Sibio, Maria/AAM-4561-2020; Fernandes, Célio/L-3873-2018; Zambuzzi, Willian/ABD-8339-2020; Zambuzzi, Willian Fernando/F-9519-2012; Nogueira, Celia Regina/AFK-0463-2022	Nogueira, Celia Regina/0000-0002-4014-0660; Gonçalves, Bianca Mariani/0000-0001-9054-9125; Mathias, Lucas Solla/0000-0002-1415-9536; Mazeto, Gláucia/0000-0003-2129-7256; Fernandes, Célio/0000-0003-1009-3127; Fernandes, Célio/0000-0003-1009-3127; Zambuzzi, Willian Fernando/0000-0002-4149-5965; Nogueira, Celia Regina/0000-0002-4014-0660; Costa, Sarah/0000-0003-4108-7715	CNPQ National Council for Scientific and Technological Development; FAPESP - Foundation for Research Support of the State of Sao Paulo [2009 / 51727-2]	CNPQ National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP - Foundation for Research Support of the State of Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by CNPQ National Council for Scientific and Technological Development and FAPESP - Foundation for Research Support of the State of Sao Paulo (process no 2009 / 51727-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrari Iman, 2013, Iran Red Crescent Med J, V15, P324, DOI 10.5812/ircmj.4506; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Calabrese G, 2015, INT J MOL SCI, V16, P15609, DOI 10.3390/ijms160715609; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen L, 2014, STEM CELLS, V32, P902, DOI 10.1002/stem.1615; Connolly PF, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00149; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Ferraro GA, 2013, J CELL BIOCHEM, V114, P1039, DOI 10.1002/jcb.24443; Prado AAF, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0531-5; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Halvorsen Y D, 2000, Pharmacogenomics, V1, P179, DOI 10.1517/14622416.1.2.179; Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681; Huang L, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0061-x; Jin ES, 2013, J KOREAN NEUROSURG S, V53, P207, DOI 10.3340/jkns.2013.53.4.207; Kassem M, 2008, ARCH BIOCHEM BIOPHYS, V473, P183, DOI 10.1016/j.abb.2008.03.028; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Liu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Furno D, 2016, STEM CELLS DEV, V25, P1615, DOI 10.1089/scd.2016.0135; Luna Arthur C L, 2014, BMC Res Notes, V7, P552, DOI 10.1186/1756-0500-7-552; Mamalis A, 2011, ARCH ORAL BIOL, V56, P446, DOI 10.1016/j.archoralbio.2010.11.001; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Nishimura I, 2015, REGEN THER, V2, P24, DOI 10.1016/j.reth.2015.09.001; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Okolicsanyi RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137255; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Roberts CL, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/1513281; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Shang FQ, 2014, BIOMATERIALS, V35, P2789, DOI 10.1016/j.biomaterials.2013.12.061; Togashi AY, 2007, J APPL ORAL SCI, V15, P442, DOI 10.1590/S1678-77572007000500013; Tsuji Wakako, 2014, World J Stem Cells, V6, P312, DOI 10.4252/wjsc.v6.i3.312; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wall DM, 2014, CELL MICROBIOL, V16, P1746, DOI 10.1111/cmi.12368; Waters S, 2010, AUTOPHAGY, V6, P981, DOI 10.4161/auto.6.7.13155; Wyles CC, 2015, CLIN ORTHOP RELAT R, V473, P3080, DOI 10.1007/s11999-015-4385-8; Yamamoto M, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/576358; Yoon DS, 2011, CELL PROLIFERAT, V44, P428, DOI 10.1111/j.1365-2184.2011.00770.x; Zhang Chi, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P659; Zhang F, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0599-7; Zhang Y, 2013, PLOS ONE, V18; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	46	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194847	10.1371/journal.pone.0194847	http://dx.doi.org/10.1371/journal.pone.0194847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641603	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900049
J	Ordonez, C; Cabo, C; Menendez, A; Bello, A				Ordonez, Celestino; Cabo, Carlos; Menendez, Agustin; Bello, Antonio			Detection of human vital signs in hazardous environments by means of video magnification	PLOS ONE			English	Article								In cases of natural disasters, epidemics or even in dangerous situations like an act of terrorism, battle fields, a shooting or a mountain accident, finding survivors is a challenge. In these kind of situations it is sometimes critical to know if a person has vital signs or not, without the need to be in contact with the victim, thus avoiding jeopardizing the lives of the rescue workers. In this work, we propose the use of video magnification techniques to detect small movements in human bodies due to breathing that are invisible to the naked eye. Two different video magnification techniques, intensity-based and phase-based, were tested. The utility of these techniques to detect people who are alive but injured in risk situations was verified by simulating a scene with three people involved in an accident. Several factors such as camera stability, distance to the object, light conditions, magnification factor or computing time were analyzed. The results obtained were quite positive for both techniques, intensity-based method proving more adequate if the interest is in almost instant results whereas the phase-based method is more appropriate if processing time is not so relevant but the degree of magnification without excessive image noise.	[Ordonez, Celestino; Cabo, Carlos] Univ Oviedo, Dept Min Engn, Geomat & Comp Graph Res Grp, Mieres, Asturias, Spain; [Menendez, Agustin; Bello, Antonio] Univ Oviedo, Dept Mfg Engn, Gijon, Asturias, Spain	University of Oviedo; University of Oviedo	Ordonez, C (corresponding author), Univ Oviedo, Dept Min Engn, Geomat & Comp Graph Res Grp, Mieres, Asturias, Spain.	ordonezcelestino@uniovi.es	Garcia, Antonio Bello/L-7238-2014; Ordóñez, Celestino/AAP-9826-2020	Garcia, Antonio Bello/0000-0001-8691-3342; Ordóñez, Celestino/0000-0002-6912-6299; Cabo, Carlos/0000-0002-0387-9052	Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) (Spain) [FC-15-GRUPIN14-033]; FEDER	Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) (Spain); FEDER(European Commission)	This study was made possible by financial funding from FC-15-GRUPIN14-033 of the Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) (Spain), with FEDER support included. We thank Leticia Teran for helping us with the laboratory experiments.	Bhatia S, ALIVE HUMAN BODY DET; Cavagnini G, 2009, P SPIE INT SOC OPT E, V7239; Cocca P, 2016, SAFETY SCI, V84, P140, DOI 10.1016/j.ssci.2015.12.005; Freeman W. T., 1990, Proceedings. Third International Conference on Computer Vision (Cat. No.90CH2934-8), P406, DOI 10.1109/ICCV.1990.139562; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Gao T, 2005, P ANN INT IEEE EMBS, P102; Kumar MB, 2015, INT J AD RES COMP EN, V4, P981; Li CT, 2015, SENSORS-BASEL, V15, P14830, DOI 10.3390/s150714830; Li J, 2014, IEEE J-STARS, V7, P783, DOI 10.1109/JSTARS.2013.2259801; Liao ZL, 2012, SAFETY SCI, V50, P150, DOI 10.1016/j.ssci.2011.07.014; Madheswari BJ, 2016, INT C INF ENG MAN SE, V2016, P116; Nakashima H, 2011, INT C MULT TECHN ICM, P2160; Nangalia V, 2010, CRIT CARE, V14, DOI 10.1186/cc9208; Poh M, 2011, IEEE T BIOMED ENG, V58, P4119, DOI [10.1109/TEME.2010.2086456, DOI 10.1109/TEME.2010.2086456]; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Purnima G, 2014, INT J AD ENG, V4, P624; Reyes BA, 2017, IEEE J BIOMED HEALTH, V21, P764, DOI 10.1109/JBHI.2016.2532876; SIMONCELLI EP, 1992, IEEE T INFORM THEORY, V38, P587, DOI 10.1109/18.119725; Wadhwa N, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461966; Wu HY, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185561; Zancajo-Blazquez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118719	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195290	10.1371/journal.pone.0195290	http://dx.doi.org/10.1371/journal.pone.0195290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641613	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900064
J	Kim, S; Oh, J; Heo, J; Lee, HY; Lee, JK; Subramanian, SV; Kang, D				Kim, Sujin; Oh, Juhwan; Heo, Jongho; Lee, Hwa-Young; Lee, Jong-Koo; Subramanian, S. V.; Kang, Daehee			Socioeconomic inequalities in the prevalence of biomarkers of cardio-metabolic disease in South Korea: Comparison of the Health Examinees Study to a nationally representative survey	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR-DISEASE; GENDER; ASSOCIATION; DISPARITIES; POSITION; BELIEFS; OBESITY; COHORT; AGE	Background/Objectives This study aimed to examine socioeconomic inequalities in the prevalence of biomarkers of cardiovascular disease and diabetes in the newly developed large-scale genomic cohort study of Korean adults, the Health Examinees-Gem (HEXA-G), with a comparison of the nationally representative cross-sectional study, the Korea National Health and Nutrition Examination Survey (K-NHANES). Subjects/Methods Using the HEXA-G and the K-NHANES from 2007-2012, we analyzed the age-adjusted relative risk (RR) and prevalence of enlarged waist circumference (EWC), elevated triglycerides (ET), low HDL cholesterol (LHC), elevated blood pressure (EBP) and elevated blood glucose (EBG) by income and educational groups for adults at age 40-69. Results For men, the prevalence of risk factors was similar across different income and educational groups (p>0.1), and between the K-NHANES and the HEXA-G. Among five risk factors, EBG showed the greatest discrepancy by 7 to 11 percentage points (i.e., the prevalence of 0.43 and 0.36 for college graduates, respectively, in K-NHANES and HEXA-G). For women, socioeconomic inequalities appeared for the five risk factors. Prevalence of risk factors was mostly lower in the HEXA-G than the K-NHANES, by approximately 11.0 percentage points. Especially, the discrepancy between K-NHANES and HEXA-G was largest in EBG (i.e., the prevalence of 0.31 and 0.20 for the lowest income groups, respectively). Conclusion The HEXA-G shows broadly similar socioeconomic inequality in prevalence of cardio-metabolic risk factors to the nationally representative sample with more modest socioeconomic inequality among women in the HEXA-G than the K-NHANES.	[Kim, Sujin] Korea Inst Hlth & Social Affairs, Sejong City, South Korea; [Kim, Sujin] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Oh, Juhwan; Heo, Jongho; Lee, Hwa-Young; Lee, Jong-Koo] Seoul Natl Univ, Coll Med, JW Lee Ctr Global Med, Seoul, South Korea; [Lee, Hwa-Young] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Lee, Jong-Koo] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Subramanian, S. V.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kang, Daehee] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kang, Daehee] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Kang, Daehee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea	Korea Institute for Health and Social Affairs; Seoul National University (SNU); Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health; Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Oh, J (corresponding author), Seoul Natl Univ, Coll Med, JW Lee Ctr Global Med, Seoul, South Korea.; Subramanian, SV (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA.	oh328@snu.ac.kr; svsubram@hsph.harvard.edu	Oh, Juhwan/O-6517-2019	Oh, Juhwan/0000-0003-0983-4872; Kim, Sujin/0000-0002-4251-6318; Heo, Jongho/0000-0002-6405-3860; Kang, Daehee/0000-0003-4031-5878; Lee, Hwa-Young/0000-0003-2591-1436	National Genome Research Institute, Korea Centers for Disease Control and Prevention; Seoul National University Hospital	National Genome Research Institute, Korea Centers for Disease Control and Prevention; Seoul National University Hospital	This study was supported by the National Genome Research Institute, Korea Centers for Disease Control and Prevention, and by a grant from the Seoul National University Hospital (2017).	Andreeva VA, 2015, J EPIDEMIOL COMMUN H, V69, P893, DOI 10.1136/jech-2014-205263; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Health Examinees Study Group, 2015, Asian Pac J Cancer Prev, V16, P1591; Khang YH, 2006, PREV MED, V42, P415, DOI 10.1016/j.ypmed.2006.02.010; Kim YJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014070; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee HK, 2010, ALCOHOL, V44, P297, DOI 10.1016/j.alcohol.2010.02.005; Lim H, 2012, DIABETES CARE, V35, P2028, DOI 10.2337/dc11-1841; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Madsen M, 2014, SOC SCI MED, V118, P182, DOI 10.1016/j.socscimed.2014.04.016; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Park HS, 2008, OBES REV, V9, P104, DOI 10.1111/j.1467-789X.2007.00421.x; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Park MJ, 2007, ANN EPIDEMIOL, V17, P320, DOI 10.1016/j.annepidem.2006.10.007; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rosenquist JN, 2015, P NATL ACAD SCI USA, V112, P354, DOI 10.1073/pnas.1411893111; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Shin S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070687; Silveira PP, 2016, JAMA PEDIATR, V170, P359, DOI 10.1001/jamapediatrics.2015.4253; Song YM, 2006, AM J PUBLIC HEALTH, V96, P152, DOI [10.2105/AJPH.2005.061853, 10.2105/AJPH.2004.061853]; Thurston RC, 2005, AM J EPIDEMIOL, V162, P57, DOI 10.1093/aje/kwi159; Vernay M, 2013, INT J PUBLIC HEALTH, V58, P855, DOI 10.1007/s00038-013-0501-2; Walter S, 2016, JAMA-J AM MED ASSOC, V316, P63, DOI 10.1001/jama.2016.8729; Wardle J, 2004, ANN BEHAV MED, V27, P107, DOI 10.1207/s15324796abm2702_5; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; Wu HF, 2017, ANN EPIDEMIOL, V27, P315, DOI 10.1016/j.annepidem.2017.04.003; Young AI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12724; Zhan YQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-921	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195091	10.1371/journal.pone.0195091	http://dx.doi.org/10.1371/journal.pone.0195091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668714	Green Submitted, gold, Green Published			2022-12-27	WOS:000430290200026
J	Wagner, S; Helmreich, I; Wollschlager, D; Meyer, K; Kaaden, S; Reiff, J; Rolls, SC; Braus, D; Tuscher, O; Muller-Dahlhaus, F; Tadic, A; Lieb, K				Wagner, Stefanie; Helmreich, Isabella; Wollschlaeger, Daniel; Meyer, Konstantin; Kaaden, Sabine; Reiff, Julia; Rolls, Sibylle C.; Braus, Dieter; Tuescher, Oliver; Muller-Dahlhaus, Florian; Tadic, Andre; Lieb, Klaus			Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder	PLOS ONE			English	Article							COGNITIVE DYSFUNCTION; TRAIL; METAANALYSIS; IMPAIRMENT	Executive dysfunctions frequently occur in patients with Major Depressive Disorder and have been shown to improve during effective antidepressant treatment. However, the time course of improvement and its relationship to treatment outcome is unknown. The aim of the study was to assess the test performance and clinical outcome by repetitive assessments of executive test procedures during antidepressant treatment. Executive test performance was assessed in 209 patients with Major Depressive Disorder (mean age 39.3 +/- 11.4 years) and 84 healthy controls five times in biweekly intervals from baseline to week 8. Patients were treated by a defined treatment algorithm within the early medication change study (EMC trial; ClinicalTrials.gov NCT00974155), controls did not receive any intervention. Cognitive domains were processing speed, cognitive flexibility, phonemic and semantic verbal fluency. Intelligence was assessed at baseline. Depression severity was tested once a week by the Hamilton Depression Rating Scale (HAMD(17)). 130 patients (62%) showed executive dysfunctions in at least one of four tests at baseline. Linear mixed regression models revealed that the course of depression severity was associated to the course of cognitive flexibility (p = 0.004) and semantic verbal fluency (p = 0.020). Cognitive flexibility and semantic verbal fluency may be candidates easily to apply for therapy response prediction in clinical routine, which should be tested in further prospective studies.	[Wagner, Stefanie; Helmreich, Isabella; Tuescher, Oliver; Muller-Dahlhaus, Florian; Tadic, Andre; Lieb, Klaus] Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany; [Wollschlaeger, Daniel] Univ Med Ctr, IMBEI, Mainz, Germany; [Meyer, Konstantin] Sana Klinikum Offenbach, Offenbach, Germany; [Kaaden, Sabine; Reiff, Julia; Braus, Dieter] HELIOS Dr Horst Schmidt Kliniken, Dept Psychiat & Psychotherapy, Wiesbaden, Germany; [Rolls, Sibylle C.] Vitos Rheingau, Dept Psychiat & Psychotherapy, Eltville, Germany; [Tadic, Andre] Agaplesion Elisabethenstift, Dept Psychiat Psychosomat & Psychotherapy, Darmstadt, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Sana Klinikum Offenbach	Wagner, S; Lieb, K (corresponding author), Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany.	stefwagn@uni-mainz.de; Klaus.lieb@unimedizin-mainz.de	Tuescher, Oliver/F-9903-2014; Helmreich, Isabella/CAF-3562-2022		German Federal Ministry for Education and Research (BMBF) [01 KG 0906]; German Research Foundation ("Deutsche Forschungsgemeinschaft, DFG") [WA 2970/1-1]	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation ("Deutsche Forschungsgemeinschaft, DFG")(German Research Foundation (DFG))	The EMC trial was funded by the German Federal Ministry for Education and Research (BMBF grant no: 01 KG 0906; applicants: KL, AT, CH, ND, KK); the herein presented additional investigations are not part of the funding. The BMBF had no role in the conception of the study design, in the writing of the manuscript or the decision to submit the manuscript for publication. The assessment of neuropsychological functioning was funded by the German Research Foundation ("Deutsche Forschungsgemeinschaft, DFG" (funding number: WA 2970/1-1). The DFG had no role in the conception of the study design, in the writing of the manuscript or the decision to submit the manuscript for publication.	Ackenheil M, 1998, INT NEUROPSYCHIATRIC; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beblo T., 1999, COGN NEUROPSYCHIATRY, V4, P333, DOI [10.1080/135468099395864, DOI 10.1080/135468099395864]; Beblo T, 2011, NEUROPSYCHOL REV, V21, P337, DOI 10.1007/s11065-011-9171-0; Bortolato B, 2014, CNS NEUROL DISORD-DR, V13, P1804; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; CIPS, 1977, INT SKALEN PSYCHIAT; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hammar A, 2010, SCAND J PSYCHOL, V51, P304, DOI 10.1111/j.1467-9450.2009.00765.x; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Herrera-Guzman I, 2010, PSYCHIAT RES, V177, P323, DOI 10.1016/j.psychres.2010.03.006; Hinkelmann K, 2012, PSYCHONEUROENDOCRINO, V37, P685, DOI 10.1016/j.psyneuen.2011.08.012; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lehrl S., 1969, MEHRFACHWAHL WORTSCH; Leuchter Andrew F, 2009, Dialogues Clin Neurosci, V11, P435; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakano Y, 2011, J AFFECT DISORDERS, V111, P46; Neu P, 2005, J PSYCHIAT RES, V39, P129, DOI 10.1016/j.jpsychires.2004.06.004; Nicod N, 2016, BIOL PSYCHIAT, V26, P165; Pachet AK, 2003, PSYCHOPHARMACOLOGY, V170, P225, DOI 10.1007/s00213-003-1592-x; R Development Core Team, 2009, R LANG ENV STAT COMP; Reitan RM., 1979, TRAIL MAKING TEST MA; Reppermund S, 2009, PSYCHOL MED, V39, P603, DOI 10.1017/S003329170800411X; Reppermund S, 2007, BIOL PSYCHIAT, V62, P400, DOI 10.1016/j.biopsych.2006.09.027; Rosenblat JD, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv082; Shilyansky C, 2016, LANCET PSYCHIAT, V3, P425, DOI 10.1016/S2215-0366(16)00012-2; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Stassen HH, 2007, J CLIN PSYCHIAT, V68, P1195, DOI 10.4088/JCP.v68n0805; Szegedi A, 2009, J CLIN PSYCHIAT, V70, P344, DOI 10.4088/JCP.07m03780; Tadic A, 2016, EUR NEUROPSYCHOPHARM, V26, P705, DOI 10.1016/j.euroneuro.2016.02.003; Tadic A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-16; Tadic A, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-21; Thomas AJ, 2009, PSYCHOL MED, V39, P725, DOI 10.1017/S0033291708004042; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2003, ARCH CLIN NEUROPSYCH, V8, P1; Wagner S, 2012, ACTA PSYCHIAT SCAND, V125, P281, DOI 10.1111/j.1600-0447.2011.01762.x; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024; Wagner S, 2011, PSYCHOPATHOLOGY, V44, P68, DOI 10.1159/000318162; Wittchen HU, 1996, SKID 1 2 STRUKTURIER	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194574	10.1371/journal.pone.0194574	http://dx.doi.org/10.1371/journal.pone.0194574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668746	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200011
J	Bogaert, KA; Manoharan-Basil, SS; Perez, E; Levine, RD; Remacle, F; Remacle, C				Bogaert, Kenny A.; Manoharan-Basil, Sheeba S.; Perez, Emilie; Levine, Raphael D.; Remacle, Francoise; Remacle, Claire			Surprisal analysis of genome-wide transcript profiling identifies differentially expressed genes and pathways associated with four growth conditions in the microalga Chlamydomonas	PLOS ONE			English	Article							REINHARDTII; METABOLISM; RESPONSES; COHORTS; SYSTEM	The usual cultivation mode of the green microalga Chlamydomonas is liquid medium and light. However, the microalga can also be grown on agar plates and in darkness. Our aim is to analyze and compare gene expression of cells cultivated in these different conditions. For that purpose, RNA-seq data are obtained from Chlamydomonas samples of two different labs grown in four environmental conditions (agar@light, agar@dark, liquid@light, liquid@dark). The RNA-seq data are analyzed by surprisal analysis, which allows the simultaneous meta-analysis of all the samples. First we identify a balance state, which defines a state where the expression levels are similar in all the samples irrespectively of their growth conditions, or lab origin. In addition our analysis identifies additional constraints needed to quantify the deviation with respect to the balance state. The first constraint differentiates the agar samples versus the liquid ones; the second constraint the dark samples versus the light ones. The two constraints are almost of equal importance. Pathways involved in stress responses are found in the agar phenotype while the liquid phenotype comprises ATP and NADH production pathways. Remodeling of membrane is suggested in the dark phenotype while photosynthetic pathways characterize the light phenotype. The same trends are also present when performing purely statistical analysis such as K-means clustering and differentially expressed genes.	[Bogaert, Kenny A.; Remacle, Francoise] Univ Liege, Theoret Phys Chem, UR MOLSYS, Liege, Belgium; [Manoharan-Basil, Sheeba S.; Perez, Emilie; Remacle, Claire] Univ Liege, Genet & Physiol Microalgae, UR InBios, Liege, Belgium; [Levine, Raphael D.] Hebrew Univ Jerusalem, Inst Chem, Fritz Haber Res Ctr Mol Dynam, Jerusalem, Israel; [Levine, Raphael D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of Liege; University of Liege; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Remacle, F (corresponding author), Univ Liege, Theoret Phys Chem, UR MOLSYS, Liege, Belgium.; Remacle, C (corresponding author), Univ Liege, Genet & Physiol Microalgae, UR InBios, Liege, Belgium.	fremacle@ulg.ac.be; c.remacle@ulg.ac.be	Basil, Sheeba Santhini/ABG-2141-2020; bogaert, kenny/AAK-6095-2021	Basil, Sheeba Santhini/0000-0001-8421-5137; bogaert, kenny/0000-0003-1482-7618; Remacle, Francoise/0000-0001-7434-5245; Remacle, Claire/0000-0002-5016-9547	FP7-Future and Emerging Technologies-Open Project: BAMBI project [GA 618024]; FRS-FNRS [CDR J.0265.17]	FP7-Future and Emerging Technologies-Open Project: BAMBI project; FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	This study was supported by FP7-Future and Emerging Technologies-Open Project: BAMBI project, GA 618024, http//cordis.europa.eu/fp7/ict/fet-open/home_en.html, to KB, SM-B, EP, RL, FR, CR (all the authors); and FRS-FNRS: CDR J.0265.17, http://www.fnrs.be, to CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale SI, 2009, CHLAMYDOMONAS SOURCE, P731; Benstein R, 2014, MAR BIOTECHNOL, V16, P621, DOI 10.1007/s10126-014-9581-0; Blaby IK, 2014, TRENDS PLANT SCI, V19, P672, DOI 10.1016/j.tplants.2014.05.008; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brumfield KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008659; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hohner R, 2013, MOL CELL PROTEOMICS, V12, P2774, DOI 10.1074/mcp.M113.029991; Kim KS, 2005, GENETICS, V170, P631, DOI 10.1534/genetics.105.041574; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Kravchenko-Balasha N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108549; Kravchenko-Balasha N, 2012, P NATL ACAD SCI USA, V109, P4702, DOI 10.1073/pnas.1200790109; Kravchenko-Balasha N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-42; Levine R. D., 2004, MOL REACTION DYNAMIC; Lopez D, 2015, PLANT PHYSIOL, V169, P2730, DOI 10.1104/pp.15.00861; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; NEWMAN SM, 1990, GENETICS, V126, P875; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; Piras V, 2015, GENOMICS, V105, P137, DOI 10.1016/j.ygeno.2014.12.007; Plancke C, 2014, PLANT J, V77, P404, DOI 10.1111/tpj.12392; Pootakham W, 2010, PLANT PHYSIOL, V153, P1653, DOI 10.1104/pp.110.157875; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Remacle F, 2015, EUR BIOPHYS J BIOPHY, V44, P709, DOI 10.1007/s00249-015-1069-y; Remacle F, 2010, P NATL ACAD SCI USA, V107, P10324, DOI 10.1073/pnas.1005283107; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Rochaix JD, 2002, FEBS LETT, V529, P34, DOI 10.1016/S0014-5793(02)03181-2; Rosenberg JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092460; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SMITH SJ, 1993, YEAST, V9, P1177, DOI 10.1002/yea.320091104; Sole A, 2016, CHEMOSPHERE, V164, P516, DOI 10.1016/j.chemosphere.2016.08.047; Strenkert D, 2016, J BIOL CHEM, V291, P19118, DOI 10.1074/jbc.M116.717413; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Tibiletti T, 2016, PLANT PHYSIOL, V171, P2717, DOI 10.1104/pp.16.00572; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang YJ, 2015, PLANT J, V82, P429, DOI 10.1111/tpj.12829; Willamme R, 2015, J BIOTECHNOL, V215, P20, DOI 10.1016/j.jbiotec.2015.04.013; Zadran S, 2013, P NATL ACAD SCI USA, V110, P19160, DOI 10.1073/pnas.1316991110	39	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195142	10.1371/journal.pone.0195142	http://dx.doi.org/10.1371/journal.pone.0195142			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664904	Green Submitted, Green Published, gold			2022-12-27	WOS:000430262300014
J	Khokhar, JS; Sareen, S; Tyagi, BS; Singh, G; Chowdhury, AK; Dhar, T; Singh, V; King, IP; Young, SD; Broadley, MR				Khokhar, Jaswant S.; Sareen, Sindhu; Tyagi, Bhudeva S.; Singh, Gyanendra; Chowdhury, Apurba K.; Dhar, Tapamay; Singh, Vinod; King, Ian P.; Young, Scott D.; Broadley, Martin R.			Characterising variation in wheat traits under hostile soil conditions in India (vol 12, e0179208, 2017)	PLOS ONE			English	Correction													Broadley, Martin/AAW-4638-2021; Khokhar, Jaswant/ABG-8288-2020; broadley, martin r/E-9081-2011; Tyagi, Bhudeva/AAR-8225-2021	Broadley, Martin/0000-0003-3964-7226; Khokhar, Jaswant/0000-0003-4870-6208; broadley, martin r/0000-0003-3964-7226; 				Khokhar JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179208	1	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196168	10.1371/journal.pone.0196168	http://dx.doi.org/10.1371/journal.pone.0196168			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664934	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300058
J	Chiam, E; Bellomo, R; Churilov, L; Weinberg, L				Chiam, Elizabeth; Bellomo, Rinaldo; Churilov, Leonid; Weinberg, Laurence			The hemodynamic effects of intravenous paracetamol (acetaminophen) vs normal saline in cardiac surgery patients: A single center placebo controlled randomized study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE PATIENTS; DOUBLE-BLIND; PAIN; METAMIZOL; FEVER	The hemodynamic effects of intravenous (IV) paracetamol in patients undergoing cardiac surgery are unknown. We performed a prospective single center placebo controlled randomized study with parallel group design in adult patients undergoing elective cardiac surgery. Participants received paracetamol (1 gram) IV or placebo (an equal volume of 0.9% saline) preoperatively followed by two postoperative doses 6 hours apart. The primary endpoint was the absolute change in systolic (SBP) 30 minutes after the preoperative infusion, analysed using an ANCOVA model. Secondary endpoints included absolute changes in mean arterial pressure (MAP) and diastolic blood pressure (DPB), and other key hemodynamic variables after each infusion. All other endpoints were analysed using random-effect generalized least squares regression modelling with individual patients treated as random effects. Fifty participants were randomly assigned to receive paracetamol (n = 25) or placebo (n = 25). Post preoperative infusion, paracetamol decreased SBP by a mean (SD) of 13 (18) mmHg, p = 0.02, compared to a mean (SD) of 1 (11) mmHg with saline. Paracetamol decreased MAP and DBP by a mean (SD) of 9 (12) mmHg and 8 (9) mmHg (p = 0.01 and 0.02), respectively, compared to a mean (SD) of 1 (8) mmHg and 0 (6) mmHg with placebo. Postoperatively, there were no significant differences in pressure or flow based hemodynamic parameters in both groups. This study provides high quality evidence that the administration of IV paracetamol in patients undergoing cardiac surgery causes a transient decrease in preoperative blood pressure when administered before surgery but no adverse hemodynamic effects when administered in the postoperative setting.	[Chiam, Elizabeth; Weinberg, Laurence] Univ Melbourne, Austin Hosp, Dept Surg, Heidelberg, Vic, Australia; [Bellomo, Rinaldo] Austin Hosp, Dept Intens Care, Heidelberg, Vic, Australia; [Churilov, Leonid] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Weinberg, Laurence] Univ Melbourne, Anesthesia Perioperat & Pain Med, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Weinberg, L (corresponding author), Univ Melbourne, Austin Hosp, Dept Surg, Heidelberg, Vic, Australia.; Weinberg, L (corresponding author), Univ Melbourne, Anesthesia Perioperat & Pain Med, Melbourne, Vic, Australia.	laurence.weinberg@austin.org.au		Weinberg, Laurence/0000-0001-7403-7680				Apfel CC, 2013, PAIN, V154, P677, DOI 10.1016/j.pain.2012.12.025; Atef A, 2008, EUR ARCH OTO-RHINO-L, V265, P351, DOI 10.1007/s00405-007-0451-5; Avellaneda C, 2000, EUR J ANAESTH, V17, P85, DOI 10.1046/j.1365-2346.2000.00607.x; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; Boyle M, 2010, AUST CRIT CARE, V23, P208, DOI 10.1016/j.aucc.2010.06.004; Chiam E, 2016, BRIT J CLIN PHARMACO, V81, P605, DOI 10.1111/bcp.12841; de Maat MM, 2010, EUR J CLIN PHARMACOL, V66, P713, DOI 10.1007/s00228-010-0806-5; Douzjian DJ, 2017, J CARDIOTHOR VASC AN, V31, P694, DOI 10.1053/j.jvca.2016.03.134; Duncan CN, 2012, AUST CRIT CARE, V25, P131, DOI 10.1016/j.aucc.2011.12.028; Kelly SJ, 2016, ANAESTHESIA, V71, P1153, DOI 10.1111/anae.13562; Krajcova A, 2013, AUST CRIT CARE, V26, P136, DOI 10.1016/j.aucc.2012.02.002; Mamoun NF, 2016, J THORAC CARDIOV SUR, V152, P881, DOI 10.1016/j.jtcvs.2016.04.078; Memis D, 2010, J CRIT CARE, V25, P458, DOI 10.1016/j.jcrc.2009.12.012; Needleman Steven M, 2013, Proc (Bayl Univ Med Cent), V26, P235; Picetti E, 2013, CRIT CARE, V17, P329; Picetti E, 2014, ACTA NEUROCHIR, V156, P1953, DOI 10.1007/s00701-014-2129-2; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Sinatra RS, 2005, ANESTHESIOLOGY, V102, P822, DOI 10.1097/00000542-200504000-00019; Vera P, 2012, MED INTENSIVA, V36, P619, DOI 10.1016/j.medin.2012.02.003; Wininger SJ, 2010, CLIN THER, V32, P2348, DOI 10.1016/j.clinthera.2010.12.011; Young P, 2015, NEW ENGL J MED, V373, P2215, DOI 10.1056/NEJMoa1508375	21	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195931	10.1371/journal.pone.0195931	http://dx.doi.org/10.1371/journal.pone.0195931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659631	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100042
J	Chou, L; Ellis, L; Papandony, M; Seneviwickrama, KLMD; Cicuttini, FM; Sullivan, K; Teichtahl, AJ; Wang, YY; Briggs, AM; Wluka, A				Chou, Louisa; Ellis, Lisa; Papandony, Michelle; Seneviwickrama, K. L. Maheeka D.; Cicuttini, Flavia M.; Sullivan, Kaye; Teichtahl, Andrew J.; Wang, Yuanyuan; Briggs, Andrew M.; Wluka, Anita			Patients' perceived needs of osteoarthritis health information: A systematic scoping review	PLOS ONE			English	Review							GENERAL-PRACTITIONERS; CARE; KNEE; HIP; PEOPLE; MANAGEMENT; COMMUNITIES; EXPERIENCE; EXPECTATIONS; REPLACEMENT	Background Optimal management of osteoarthritis requires active patient participation. Understanding patients' perceived health information needs is important in order to optimize health service delivery and health outcomes in osteoarthritis. We aimed to review the existing literature regarding patients' perceived health information needs for OA. Methods A systematic scoping review was performed of publications in MEDLINE, EMBASE, CINAHL and PsycINFO (1990-2016). Descriptive data regarding study design and methodology were extracted and risk of bias assessed. Aggregates of patients' perceived needs of osteoarthritis health information were categorized. Results 30 studies from 2876 were included: 16 qualitative, 11 quantitative and 3 mixed-methods studies. Three areas of perceived need emerged: (1) Need for clear communication: terms used were misunderstood or had unintended connotations. Patients wanted clear explanations. (2) Need for information from various sources: patients wanted accessible health professionals with specialist knowledge of arthritis. The Internet, whilst a source of information, was acknowledged to have dubious reliability. Print media, television, support groups, family and friends were utilised to fulfil diverse information needs. (3) Needs of information content: patients desired more information about diagnosis, prognosis, management and prevention. Conclusions Patients desire more information regarding the diagnosis of osteoarthritis, its impact on daily life and its long-term prognosis. They want more information not only about pharmacological management options, but also non-pharmacological options to help them manage their symptoms. Also, patients wanted this information to be delivered in a clear manner from multiple sources of health information. To address these gaps, more effective communication strategies are required. The use of a variety of sources and modes of delivery may enable the provision of complementary material to provide information more successfully, resulting in better patient adherence to guidelines and improved health outcomes.	[Chou, Louisa; Ellis, Lisa; Papandony, Michelle; Seneviwickrama, K. L. Maheeka D.; Cicuttini, Flavia M.; Teichtahl, Andrew J.; Wang, Yuanyuan; Wluka, Anita] Monash Univ, Sch Publ Hlth & Preventat Med, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia; [Sullivan, Kaye] Monash Univ, Monash Univ Lib, Melbourne, Vic, Australia; [Teichtahl, Andrew J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Briggs, Andrew M.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia; [Briggs, Andrew M.] Move Muscle Bone & Joint Hlth, Melbourne, Vic, Australia	Monash University; Monash University; Baker Heart and Diabetes Institute; Curtin University	Wluka, A (corresponding author), Monash Univ, Sch Publ Hlth & Preventat Med, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia.	anita.wluka@monash.edu	Wluka, Anita E/H-5349-2011; Cicuttini, Flavia/H-4978-2014	Wluka, Anita E/0000-0001-8024-9049; Seneviwickrama, Maheeka/0000-0002-4182-284X; Cicuttini, Flavia/0000-0002-8200-1618	Australian Postgraduate Award; Arthritis Foundation Scholarship; NHMRC Early Career Fellowship [1073284]; NHMRC Career Development Fellowships [1065464, 1063574]	Australian Postgraduate Award(Australian Government); Arthritis Foundation Scholarship; NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	This work was performed in partnership with Move: muscle, bone & joint health and supported by a partnership grant from the organization. L.C is the recipient of an Australian Postgraduate Award and Arthritis Foundation Scholarship. A.J.T is the recipient of an NHMRC Early Career Fellowship (#1073284). Y.W and A.E.W are the recipients of NHMRC Career Development Fellowships (Clinical Level 1 #1065464 and Clinical Level 2 #1063574, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taiar Abdullah, 2013, BMC Res Notes, V6, P406, DOI 10.1186/1756-0500-6-406; Alami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019634; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Armstrong R, 2011, J PUBLIC HEALTH-UK, V33, P147, DOI 10.1093/pubmed/fdr015; Baird Carol L, 2003, J Gerontol Nurs, V29, P32; Barker KL, 2014, DISABIL REHABIL, V36, P367, DOI 10.3109/09638288.2013.793409; Baumann M, 2007, CLIN EXP RHEUMATOL, V25, P404; Bayliss EA, 2008, FAM PRACT, V25, P287, DOI 10.1093/fampra/cmn040; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Brand C, 2006, INTERN MED J, V36, P170, DOI 10.1111/j.1445-5994.2006.01018.x; Brembo EA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1342-5; Briggs AM, 2010, PAIN, V150, P275, DOI 10.1016/j.pain.2010.04.031; (CASP) CASP, 2014, CASP CHECKL URL US; Chan KKW, 2011, RHEUMATOL REP, V3, P9, DOI 10.4081/rr.2011.e3; Clarke SP, 2014, DISABIL REHABIL, V36, P163, DOI 10.3109/09638288.2013.782364; Cuperus N, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-181; Dahlberg LE, 2016, OSTEOARTHR CARTILAGE, V24, pS490, DOI 10.1016/j.joca.2016.01.898; Dragoi RG, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4339; du Long J, 2016, KNEE SURG SPORT TR A, V24, P1710, DOI 10.1007/s00167-016-3993-5; Fedutes BA, 2004, AM J HEALTH-SYST PH, V61, P1338, DOI 10.1093/ajhp/61.13.1338; Fernandes L, 2013, ANN RHEUMATIC DIS; French SD, 2015, ARTHRIT CARE RES, V67, P809, DOI 10.1002/acr.22518; Gibbs L., 2007, INT J MENS HLTH, V6; Gignac MAM, 2006, ARTHRIT RHEUM-ARTHR, V55, P905, DOI 10.1002/art.22338; Gill TK, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-174; Grime J, 2014, HEALTH EXPECT, V17, P164, DOI 10.1111/j.1369-7625.2011.00741.x; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Hill Jackie, 2003, Musculoskeletal Care, V1, P5, DOI 10.1002/msc.35; Hill S, 2011, DISABIL REHABIL, V33, P1866, DOI 10.3109/09638288.2010.550381; Hinman RS, 2015, ARTHRIT CARE RES, V67, P305, DOI 10.1002/acr.22395; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hofstede SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147406; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Hunter DJ, 2009, MED CLIN N AM, V93, P127, DOI [10.1016/j.rdc.2008.05.008, 10.1016/j.mcna.2008.07.009]; Hunter DJ, 2014, NAT REV RHEUMATOL, V10, P437, DOI 10.1038/nrrheum.2014.44; Ilic D, 2005, TELEMED J E-HEALTH, V11, P703, DOI 10.1089/tmj.2005.11.703; Jinks C, 2007, BMC MUSCULOSKEL DIS, V8, P1; Johnston AC, 2013, INFORM TECHNOL PEOPL, V26, P213, DOI 10.1108/ITP-02-2013-0040; Kao MH, 2014, J ADV NURS, V70, P1564, DOI 10.1111/jan.12313; Kingsbury Sarah R, 2012, Prim Health Care Res Dev, V13, P373, DOI 10.1017/S1463423612000072; Lambert BL, 2000, SEMIN ARTHRITIS RHEU, V30, P100, DOI 10.1053/sarh.2000.9203; Larson CO, 1996, INT J QUAL HEALTH C, V8, P447, DOI 10.1093/intqhc/8.5.447; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Lober William B, 2011, Semin Oncol Nurs, V27, P169, DOI 10.1016/j.soncn.2011.04.002; Loke YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040210; Lugtenberg M, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-98; Mann C, 2011, ARTHRIT CARE RES, V63, P963, DOI 10.1002/acr.20459; March LM, 1997, BAILLIERE CLIN RHEUM, V11, P817, DOI 10.1016/S0950-3579(97)80011-8; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Memel DS, 2000, BRIT J GEN PRACT, V50, P645; Mora M, 2012, GENDER MED, V9, P457, DOI 10.1016/j.genm.2012.10.002; Nambisan P, 2011, HEALTH CARE MANAGE R, V36, P124, DOI 10.1097/HMR.0b013e3182099f82; Ndosi M, 2014, ANN RHEUM DIS, V73, P1975, DOI 10.1136/annrheumdis-2013-203403; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Nilsen ES, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004563.pub2; Papandony MC, 2017, OSTEOARTHR CARTILAGE, V25, P1010, DOI 10.1016/j.joca.2017.02.799; Parsons GE, 2009, MUSCULOSKELET CARE, V7, P121, DOI 10.1002/msc.145; Paskins Z, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-46; Pellinen T, 2016, J ADV NURSING; Rosemann T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-48; Runciman WB, 2012, MED J AUSTRALIA, V197, P100, DOI 10.5694/mja12.10510; Rupert DJ, 2014, PATIENT EDUC COUNS, V96, P320, DOI 10.1016/j.pec.2014.05.015; Saroop-D'Souza P., 2001, J ORTHOPAEDIC NURSIN, V5, P192; Stark AJ, 2014, INT J NURS STUD, V51, P1491, DOI 10.1016/j.ijnurstu.2014.03.006; Umapathy H, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4376; Victor CR, 2004, J EVAL CLIN PRACT, V10, P63, DOI 10.1111/j.1365-2753.2003.00395.x; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x; Washington K, 2015, MUSCULOSKELET CARE, V13, P116, DOI 10.1002/msc.1086; Willis E, 2014, J HEALTH PSYCHOL, V19, P1613, DOI 10.1177/1359105313496446; Wluka A, 2016, UNDERSTANDING NEEDS; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Woolf AD, 2004, ANN RHEUM DIS, V63, P342, DOI 10.1136/ard.2003.010223; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	73	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195489	10.1371/journal.pone.0195489	http://dx.doi.org/10.1371/journal.pone.0195489			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659609	Green Published, gold			2022-12-27	WOS:000430061100017
J	McCoy, KS; Williams, ID; Friedlander, AM; Ma, HG; Teneva, L; Kittinger, JN				McCoy, Kaylyn S.; Williams, Ivor D.; Friedlander, Alan M.; Ma, Hongguang; Teneva, Lida; Kittinger, John N.			Estimating nearshore coral reef-associated fisheries production from the main Hawaiian Islands	PLOS ONE			English	Article							SUSTAINABILITY; COMANAGEMENT; CATCH	Currently, information on nearshore reef-associated fisheries is frequently disparate or incomplete, creating a challenge for effective management. This study utilized an existing non-commercial fishery dataset from Hawai'i, covering the period 2004 +/- 13, to estimate a variety of fundamental fishery parameters, including participation, effort, gear use, and catch per unit effort. We then used those data to reconstruct total catches per island. Non-commercial fisheries in this case comprise recreational, subsistence, and cultural harvest, which may be exchanged, but are not sold. By combining those data with reported commercial catch data, we estimated annual catch of nearshore reef-associated fisheries in the main Hawaiian Islands over the study period to be 1,167,758 +/- 43,059 kg year(-1) (mean +/- standard error). Average annual commercial reef fish catch over the same time period-184,911 kg year-1-was 16% of the total catch, but that proportion varied greatly among islands, ranging from 23% on O'ahu to 5% on Moloka'i. These results emphasize the importance of reef fishing in Hawai'i for reasons beyond commerce, such as food security and cultural practice, and highlight the large differences in fishing practices across the Hawaiian Islands.	[McCoy, Kaylyn S.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [McCoy, Kaylyn S.; Friedlander, Alan M.] Univ Hawaii Manoa, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [McCoy, Kaylyn S.; Williams, Ivor D.] Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Program, Ecosyst Sci Div, Honolulu, HI 96818 USA; [Friedlander, Alan M.] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Ma, Hongguang] Pacific Isl Fisheries Sci Ctr, Insular Fisheries Monitoring Program, Fisheries Res & Monitoring Div, Honolulu, HI USA; [Teneva, Lida; Kittinger, John N.] Ctr Oceans, Conservat Int, Honolulu, HI USA; [Kittinger, John N.] Arizona State Univ, Ctr Biodivers Outcomes, Julie Ann Wrigley Global Inst Sustainabil, Life Sci Ctr, Tempe, AZ USA; [Kittinger, John N.] Betty & Gordon Moore Ctr Sci, Conservat Int, Arlington, VA USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Geographic Society; Conservation International; Arizona State University; Arizona State University-Tempe; Conservation International	McCoy, KS (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.; McCoy, KS (corresponding author), Univ Hawaii Manoa, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.; McCoy, KS (corresponding author), Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Program, Ecosyst Sci Div, Honolulu, HI 96818 USA.	Kaylyn.mccoy@noaa.gov		McCoy, Kaylyn/0000-0002-4875-9863	National Oceanic and Atmospheric Administration's Saltonstall-Kennedy Grant Program [NA15NMF4270332]	National Oceanic and Atmospheric Administration's Saltonstall-Kennedy Grant Program	This work was supported by the National Oceanic and Atmospheric Administration's Saltonstall-Kennedy Grant Program, award NA15NMF4270332 https:/www.fisheries.noaa.gov/grant/salton stalI-kennedy-grant-program) to Dr. John N Kittinger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R., 2014, DEV TESTING RECREATI; Ayers AL, 2017, INT J COMMONS, V11, P388, DOI 10.18352/ijc.709; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Brander LM, 2007, ECOL ECON, V63, P209, DOI 10.1016/j.ecolecon.2006.11.002; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Dalzell P., 1996, REEF FISHERIES, P161, DOI DOI 10.1007/978-94-015-8779-2; Delaney DG, 2017, PATTERNS ARTISANAL C; Everson A, 2001, P 2001 FISH S AM FIS, P108; Friedlander Alan M., 2015, P208; Friedlander AM, 2014, ADV MAR BIOL, V69, P153, DOI 10.1016/B978-0-12-800214-8.00005-0; Friedlander AM, 2013, PAC SCI, V67, P441, DOI 10.2984/67.3.10; Friedlander AM, 2014, MARINE HSITORICAL EC; Grafeld S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182104; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolsys.33.010802.150524; Jupiter S. D., 2011, J MARINE BIOL, V2011, DOI [10.1155/2011/940765, 940710.941155/942011/940765, DOI 10.1155/2011/940765]; JUVIK SP, 1998, ATLAS HAWAII; Kittinger JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123856; Laurans Y, 2013, J ENV MANAGE; Ma H, 2015, RESULTS PILOT STUDY; Ma H, 2016, HAWAII MARINE RECREA, DOI [10.7289/V5/TM-PIFSC-55, DOI 10.7289/V5/TM-PIFSC-55]; Ma HG, 2018, FISH RES, V204, P197, DOI 10.1016/j.fishres.2018.02.010; Ma Hongguang, 2013, REN POW GEN C RPG 20, P1; McCoy K., 2015, ESTIMATING NEARSHORE; Nadon MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133960; Nadon MO, 2017, STOCK ASSESSMENT COR; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 2014, CURR OPIN ENV SUST, V7, P44, DOI 10.1016/j.cosust.2013.11.027; Pooley SG, 1993, MAR FISH REV, V55, P12; Schemmel E, 2016, ECOL SOC, V21, DOI 10.5751/ES-08818-210434; Schug D., 2001, HAWAIIAN J HIST, V35, P15; Severance C, 2013, PAC SCI, V67, P383, DOI 10.2984/67.3.6; Smith M. Kimberly, 1994, U S National Marine Fisheries Service Marine Fisheries Review, V55, P34; Turner RA, 2007, CORAL REEFS, V26, P997, DOI 10.1007/s00338-007-0238-6; Vaughan MB, 2013, PAC SCI, V67, P329, DOI 10.2984/67.3.3; Weijerman M, 2016, FISH B-NOAA, V114, P237, DOI 10.7755/FB.114.2.9; Williams I, 2013, H1304 NOAA PAC ISL F, P53; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8; Zeller D, 2008, FISH RES, V91, P88, DOI 10.1016/j.fishres.2007.11.010	40	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195840	10.1371/journal.pone.0195840	http://dx.doi.org/10.1371/journal.pone.0195840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659616	gold, Green Published, Green Submitted			2022-12-27	WOS:000430061100035
J	de Jaeger, L; Carreres, BM; Springer, J; Schaap, PJ; Eggink, G; Dos Santos, VAPM; Wijffels, RH; Martens, DE				de Jaeger, Lenny; Carreres, Benoit M.; Springer, Jan; Schaap, Peter J.; Eggink, Gerrit; Dos Santos, Vitor A. P. Martins; Wijffels, Rene H.; Martens, Dirk E.			Neochloris oleoabundans is worth its salt: Transcriptomic analysis under salt and nitrogen stress	PLOS ONE			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; LIPID-ACCUMULATION; WATER-STRESS; GREEN-ALGAE; TOLERANCE; PROLINE; GENES; MECHANISMS; EXPRESSION	Neochloris oleoabundans is an oleaginous microalgal species that can be cultivated in fresh water as well as salt water. Using salt water gives the opportunity to reduce production costs and the fresh water footprint for large scale cultivation. Production of triacylglycerols (TAG) usually includes a biomass growth phase in nitrogen-replete conditions followed by a TAG accumulation phase under nitrogen-deplete conditions. This is the first report that provides insight in the saline resistance mechanism of a fresh water oleaginous microalgae. To better understand the osmoregulatory mechanism of N. oleoabundans during growth and TAG accumulating conditions, the transcriptome was sequenced under four different conditions: fresh water nitrogen-replete and -deplete conditions, and salt water (525 mM dissolved salts, 448mM extra NaCl) nitrogen-replete and -deplete conditions. In this study, several pathways are identified to be responsible for salt water adaptation of N. oleoabundans under both nitrogen-replete and -deplete conditions. Proline and the ascorbate-glutathione cycle seem to be of importance for successful osmoregulation in N. oleoabundans. Genes involved in Proline biosynthesis were found to be upregulated in salt water. This was supported by Nuclear magnetic resonance (NMR) spectroscopy, which indicated an increase in proline content in the salt water nitrogen-replete condition. Additionally, the lipid accumulation pathway was studied to gain insight in the gene regulation in the first 24 hours after nitrogen was depleted. Oil accumulation is increased under nitrogen- deplete conditions in a comparable way in both fresh and salt water. The mechanism behind the biosynthesis of compatible osmolytes can be used to improve N. oleoabundans and other industrially relevant microalgal strains to create a more robust and sustainable production platform for microalgae derived products in the future.	[de Jaeger, Lenny; Eggink, Gerrit; Wijffels, Rene H.; Martens, Dirk E.] Wageningen Univ & Res, Bioproc Engn & AlgaePARC, Wageningen, Netherlands; [Carreres, Benoit M.; Schaap, Peter J.; Dos Santos, Vitor A. P. Martins] Wageningen Univ & Res, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Springer, Jan; Eggink, Gerrit] Wageningen Univ & Res, Food & Biobased Res & AlgaePARC, Wageningen, Netherlands; [Dos Santos, Vitor A. P. Martins] LifeGlimmer GmbH, Berlin, Germany; [Wijffels, Rene H.] Nord Univ, Bodo, Norway	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Nord University	Martens, DE (corresponding author), Wageningen Univ & Res, Bioproc Engn & AlgaePARC, Wageningen, Netherlands.	dirk.martens@wur.nl		Carreres, Benoit/0000-0002-7532-7572; Wijffels, Rene/0000-0001-7630-4295; Schaap, Peter/0000-0002-4346-6084	Food and Nutrition Delta program of Agentschap: NL [FND10007]; Unilever; Wageningen University and Research Systems Biology [KB-17-003.02-29]	Food and Nutrition Delta program of Agentschap: NL; Unilever(Unilever); Wageningen University and Research Systems Biology	This study was supported by the Food and Nutrition Delta program of Agentschap: NL (FND10007), Unilever, and Wageningen University and Research Systems Biology (KB-17-003.02-29). Author VMDS is affiliated with LifeGlimmer GmbH but is not an employee nor has any financial or competing conflict whatsoever. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1984, PLANT PHYSIOL, V74, P1010, DOI 10.1104/pp.74.4.1010; Al-Karaki GN, 2000, J PLANT NUTR, V23, P1, DOI 10.1080/01904160009381992; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Azachi M, 2002, PLANT PHYSIOL, V129, P1320, DOI 10.1104/pp.001909; BAND CJ, 1992, PLANT CELL ENVIRON, V15, P129, DOI 10.1111/j.1365-3040.1992.tb01466.x; Bhargava P, 2005, J PLANT PHYSIOL, V162, P1220, DOI 10.1016/j.jplph.2004.12.006; BLUMWALD E, 1982, ARCH MICROBIOL, V132, P168, DOI 10.1007/BF00508725; Bohnert HJ, 1996, TRENDS BIOTECHNOL, V14, P89, DOI 10.1016/0167-7799(96)80929-2; Bold, 1962, SOME ALGAE ARID SOIL; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Bremauntz M. D. P., 2011, NAT RESOUR, V2, P173, DOI DOI 10.4236/NR.2011.23023; Breuer G, 2014, BIOTECHNOL BIOFUELS, V7, DOI [10.1186/1754-6834-7-69, 10.1186/1754-6834-7-70]; Breuer G, 2013, JOVE-J VIS EXP, DOI 10.3791/50628; Breuer G, 2013, BIORESOURCE TECHNOL, V143, P1, DOI 10.1016/j.biortech.2013.05.105; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Chaurasia N, 2008, BIOCHEM BIOPH RES CO, V376, P225, DOI 10.1016/j.bbrc.2008.08.129; Chen M, 2010, PLANT CELL, V22, P77, DOI 10.1105/tpc.109.071837; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Conesa A., 2008, INT J PLANT GENOMICS; CSONKA LN, 1988, GENE, V64, P199, DOI 10.1016/0378-1119(88)90335-6; Curatti L, 2000, PLANTA, V211, P729, DOI 10.1007/s004250000343; de Fraiture C, 2008, WATER POLICY, V10, P67, DOI 10.2166/wp.2008.054; de Winter L, 2013, ALGAL RES, V2, P313, DOI 10.1016/j.algal.2013.09.001; Deng XD, 2012, MOL PLANT, V5, P945, DOI 10.1093/mp/sss040; Desplats P, 2005, PLANT PHYSIOL BIOCH, V43, P133, DOI 10.1016/j.plaphy.2005.01.008; Dunahay TG, 1996, APPL BIOCHEM BIOTECH, V57-8, P223, DOI 10.1007/BF02941703; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; FLOWERS TJ, 1977, ANNU REV PLANT PHYS, V28, P89, DOI 10.1146/annurev.pp.28.060177.000513; Gao CF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-582; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P821, DOI 10.1007/s10295-009-0559-2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; HELLEBUST JA, 1976, ANNU REV PLANT PHYS, V27, P485, DOI 10.1146/annurev.pp.27.060176.002413; HELLEBUST JA, 1989, PLANT CELL ENVIRON, V12, P621, DOI 10.1111/j.1365-3040.1989.tb01230.x; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Horton P, 2006, WORLD SCI, P39; HOWE G, 1992, PLANT PHYSIOL, V98, P127, DOI 10.1104/pp.98.1.127; Hsieh HJ, 2012, J MICROBIOL, V50, P526, DOI 10.1007/s12275-012-2041-5; Hu SX, 2001, PLANT SCI, V161, P987, DOI 10.1016/S0168-9452(01)00501-5; Jia J, 2015, ALGAL RES, V7, P66, DOI 10.1016/j.algal.2014.11.005; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kim HK, 2010, PHYTOCHEMISTRY, V71, P773, DOI 10.1016/j.phytochem.2010.02.001; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Klok AJ, 2013, BIORESOURCE TECHNOL, V134, P233, DOI 10.1016/j.biortech.2013.02.006; Krell A, 2007, J PHYCOL, V43, P753, DOI 10.1111/j.1529-8817.2007.00366.x; La Russa M, 2012, J BIOTECHNOL, V162, P13, DOI 10.1016/j.jbiotec.2012.04.006; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Lunn JE, 2002, PLANT PHYSIOL, V128, P1490, DOI 10.1104/pp.010898; MACKAY MA, 1983, MAR BIOL, V73, P301, DOI 10.1007/BF00392256; Mallick N, 2004, J PLANT PHYSIOL, V161, P591, DOI 10.1078/0176-1617-01230; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Mastrobuoni G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-215; Mehta SK, 1999, NEW PHYTOL, V143, P253, DOI 10.1046/j.1469-8137.1999.00447.x; Morales-Sanchez D, 2016, ALGAL RES, V20, P22, DOI 10.1016/j.algal.2016.09.006; Moya JL, 2003, J EXP BOT, V54, P825, DOI 10.1093/jxb/erg064; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Niu YF, 2013, MAR DRUGS, V11, P4558, DOI 10.3390/md11114558; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; Page-Sharp M, 1999, BBA-GEN SUBJECTS, V1472, P519, DOI 10.1016/S0304-4165(99)00155-5; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Rangasamy D, 2000, PLANT PHYSIOL, V122, P1225, DOI 10.1104/pp.122.4.1225; Rathmann R, 2010, RENEW ENERG, V35, P14, DOI 10.1016/j.renene.2009.02.025; Rismani-Yazdi H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-74; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; Santos AM, 2012, BIORESOURCE TECHNOL, V104, P593, DOI 10.1016/j.biortech.2011.10.084; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sharma P, 2005, J PLANT PHYSIOL, V162, P854, DOI 10.1016/j.jplph.2004.09.011; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Streeter JG, 2001, PLANT CELL ENVIRON, V24, P429, DOI 10.1046/j.1365-3040.2001.00690.x; Tardif M, 2012, MOL BIOL EVOLUTION, V178; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Wang DM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004094; WEGMANN K, 1986, FEMS MICROBIOL LETT, V39, P37; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Zhang HY, 2005, PLANT SCI, V169, P1059, DOI 10.1016/j.plantsci.2005.07.010; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017; Zhang YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069225	87	21	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194834	10.1371/journal.pone.0194834	http://dx.doi.org/10.1371/journal.pone.0194834			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652884	Green Submitted, gold, Green Published			2022-12-27	WOS:000430026900011
J	Feng, B; Yi, SV; Zhang, MM; Zhou, XY				Feng, Bing; Yi, Soojin V.; Zhang, Manman; Zhou, Xiaoyun			Development of novel EST-SSR markers for ploidy identification based on de novo transcriptome assembly for Misgurnus anguillicaudatus	PLOS ONE			English	Article							GENETIC DIVERSITY; TETRAPLOID LOACH; MICROSATELLITE LOCI; NATURAL OCCURRENCE; HEXAPLOID LOACH; HUBEI PROVINCE; CRUCIAN CARP; 1ST RECORD; CHINA; VALIDATION	The co-existence of several ploidy types in natural populations makes the cyprinid loach Misgurnus anguillicaudatus an exciting model system to study the genetic and phenotypic consequences of ploidy variations. A first step in such effort is to identify the specific ploidy of an individual. Currently popular methods of karyotyping via cytological preparation or flow cytometry require a large amount of tissue (such as blood) samples, which can be damaging or fatal to the fishes. Here, we developed novel microsatellite markers (SSR markers) from M. anguillicaudatus and show that they can effectively discriminate ploidy using samples collected in a minimally invasive way. Specifically, we generated whole genome transcriptomes from multiple M. anguillicaudatus using the Illumina paired-end sequencing. Approximately 150 million raw reads were assembled into 76,544 non-redundant unigenes. A total of 8,194 potential SSR markers were identified. We selected 98 pairs with more than five tandem repeats for further assays. Out of 45 putative EST-SSR markers that successfully amplified and harbored polymorphism in diploids, 11 markers displayed high variability in tetraploids. We further demonstrate that a set of five EST-SSR markers selected from these are sufficient to distinguish ploidy levels, by first validating them on 69 reference specimens with known ploidy levels and then subsequently using fresh-collected 96 ploidy-unknown specimens. The results from EST-SSR markers are highly concordant with those from independent flow cytometry analysis. The novel EST-SSR markers developed here should facilitate genetic studies of polyploidy in the emerging model system M. anguillicaudatus.	[Feng, Bing; Zhang, Manman; Zhou, Xiaoyun] Huazhong Agr Univ, Coll Fisheries, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Hubei, Peoples R China; [Yi, Soojin V.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Huazhong Agricultural University; University System of Georgia; Georgia Institute of Technology	Zhou, XY (corresponding author), Huazhong Agr Univ, Coll Fisheries, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Hubei, Peoples R China.	zhouxy@mail.hzau.edu.cn		Zhou, Xiaoyun/0000-0002-8488-3829	National Natural Science Foundation of China [31472267]; Georgia Tech Zoo Atlanta Collaborative grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Georgia Tech Zoo Atlanta Collaborative grant	This study is supported by the National Natural Science Foundation of China (No. 31472267) to Xiaoyun Zhou and a Georgia Tech Zoo Atlanta Collaborative grant to Soojin V. Yi. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2009, J FISH BIOL, V75, P435, DOI 10.1111/j.1095-8649.2009.02320.x; ARAI K, 1993, AQUACULTURE, V117, P227, DOI 10.1016/0044-8486(93)90322-P; Arai K, 2003, FOLIA BIOL-KRAKOW, V51, P107; ARAI K, 1991, NIPPON SUISAN GAKK, V57, P2173; Arai K, 1999, FISHERIES SCI, V65, P186, DOI 10.2331/fishsci.65.186; Arai K, 1995, AQUACULTURE, V137, P131, DOI 10.1016/0044-8486(95)01106-4; Bai ZY, 2011, INT J BIOL SCI, V7, P279, DOI 10.7150/ijbs.7.279; Biasi A, 2015, J MICROBIOL METH, V110, P61, DOI 10.1016/j.mimet.2015.01.012; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boron A, 2000, FOLIA ZOOL, V49, P37; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cui L, 2013, FOLIA ZOOL, V62, P14; Drozd B, 2010, J FISH BIOL, V77, P2163, DOI 10.1111/j.1095-8649.2010.02794.x; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Ene C, 2000, FOLIA ZOOL, V49, P91; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Feng B, 2017, ENVIRON BIOL FISH, V100, P815, DOI 10.1007/s10641-017-0608-z; Ferrante SP, 2010, EUPHYTICA, V173, P223, DOI 10.1007/s10681-009-0093-3; Flajoulot S, 2005, THEOR APPL GENET, V111, P1420, DOI 10.1007/s00122-005-0074-4; Ghose K, 2013, SCI HORTIC-AMSTERDAM, V160, P251, DOI 10.1016/j.scienta.2013.01.016; Glover KA, 2016, BIOL INVASIONS, V18, P1287, DOI 10.1007/s10530-016-1066-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo W, 2016, SCI REP-UK, V6, DOI 10.1038/srep37702; Hernandez-Urcera J, 2012, AQUACULTURE, V330, P179, DOI 10.1016/j.aquaculture.2011.11.039; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Lampert KP, 2006, J GENET, V85, P67, DOI 10.1007/BF02728973; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; Lemer S, 2011, J HERED, V102, P243, DOI 10.1093/jhered/esq123; Li Kang, 1983, Zoological Research, V4, P75; Li YJ, 2008, NIPPON SUISAN GAKK, V74, P177, DOI 10.2331/suisan.74.177; Li YJ, 2011, GENETICA, V139, P805, DOI 10.1007/s10709-011-9585-x; Li Ya-juan, 2009, Dalian Shuichan Xueyuan Xuebao, V24, P236; Li YH, 2011, INDIAN J EXP BIOL, V49, P953; Lopez-Pujol J, 2004, ANN BOT-LONDON, V93, P323, DOI 10.1093/aob/mch039; Lopez-Pujol J, 2007, BOT J LINN SOC, V155, P211, DOI 10.1111/j.1095-8339.2007.00689.x; Mishina T, 2014, ICHTHYOL RES, V61, P169, DOI 10.1007/s10228-014-0388-9; Mousavi S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01283; Nie HT, 2014, BIOCHEM SYST ECOL, V54, P326, DOI 10.1016/j.bse.2014.03.007; Ohara K, 1999, ZOOL SCI, V16, P909, DOI 10.2108/zsj.16.909; Ohara K, 2000, ZOOL SCI, V17, P357, DOI 10.2108/jsz.17.357; OJIMA Y, 1979, P JPN ACAD B-PHYS, V55, P487, DOI 10.2183/pjab.55.487; Palop-Esteban M, 2011, GENETICA, V139, P1309, DOI 10.1007/s10709-012-9632-2; Park SDE, 2001, THESIS; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rungis D, 2004, THEOR APPL GENET, V109, P1283, DOI 10.1007/s00122-004-1742-5; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; Spoz A, 2017, FOLIA BIOL-KRAKOW, V65, P62, DOI 10.3409/fb65_1.63; Van Puyvelde K, 2010, MOL ECOL RESOUR, V10, P331, DOI 10.1111/j.1755-0998.2009.02748.x; Yu YY, 2014, PAK J AGR SCI, V51, P273; Zala HN, 2017, J PLANT BIOCHEM BIOT, V26, P356, DOI 10.1007/s13562-017-0398-6; Zhong Jia, 2015, Journal of Fisheries of China, V39, P1089; Zhou XY, 2008, J APPL ICHTHYOL, V24, P664, DOI 10.1111/j.1439-0426.2008.01116.x	54	9	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195829	10.1371/journal.pone.0195829	http://dx.doi.org/10.1371/journal.pone.0195829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649332	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900096
J	Gunnarsen, KS; Hoydahl, LS; Neumann, RS; Bjerregaard-Andersen, K; Nilssen, NR; Sollid, LM; Sandlie, I; Loset, GA				Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Neumann, Ralf Stefan; Bjerregaard-Andersen, Kaare; Nilssen, Nicolay Rustad; Sollid, Ludvig Magne; Sandlie, Inger; Loset, Geir Age			Soluble T-cell receptor design influences functional yield in an E. coli chaperone-assisted expression system	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELIAC-DISEASE; CANCER-IMMUNOTHERAPY; PHAGE DISPLAY; RECOGNITION; AFFINITY; BINDING; ANTIBODIES; COMPLEXES; PEPTIDES	There is a quest for production of soluble protein of high quality for the study of T-cell receptors (TCRs), but expression often results in low yields of functional molecules. In this study, we used an E. coli chaperone-assisted periplasmic production system and compared expression of 4 different soluble TCR formats: single-chain TCR (scTCR), two different disulfide-linked TCR (dsTCR) formats, and chimeric Fab (cFab). A stabilized version of scTCR was also included. Additionally, we evaluated the influence of host (XL1-Blue or RosettaBlue (TM)) and the effect of IPTG induction on expression profiles. A celiac disease patient-derived TCR with specificity for gluten was used, and we achieved detectable expression for all formats and variants. We found that expression in RosettaBlue (TM) without IPTG induction resulted in the highest periplasmic yields. Moreover, after large-scale expression and protein purification, only the scTCR format was obtained in high yields. Importantly, stability engineering of the scTCR was a prerequisite for obtaining reliable biophysical characterization of the TCR-pMHC interaction. The scTCR format is readily compatible with high-throughput screening approaches that may enable both development of reagents allowing for defined peptide MHC (pMHC) characterization and discovery of potential novel therapeutic leads.	[Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Neumann, Ralf Stefan; Nilssen, Nicolay Rustad; Sollid, Ludvig Magne; Sandlie, Inger; Loset, Geir Age] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Neumann, Ralf Stefan; Nilssen, Nicolay Rustad; Sollid, Ludvig Magne; Sandlie, Inger; Loset, Geir Age] Natl Hosp Norway, Oslo Univ Hosp, Oslo, Norway; [Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Neumann, Ralf Stefan; Nilssen, Nicolay Rustad; Sollid, Ludvig Magne; Sandlie, Inger; Loset, Geir Age] Univ Oslo, Dept Immunol, Oslo, Norway; [Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Nilssen, Nicolay Rustad; Sandlie, Inger; Loset, Geir Age] Univ Oslo, Dept Biosci, Oslo, Norway; [Bjerregaard-Andersen, Kaare] Univ Oslo, Dept Chem, Oslo, Norway; [Sollid, Ludvig Magne] Univ Oslo, KG Jebsen Coeliac Dis Res Ctr, Oslo, Norway; [Sollid, Ludvig Magne] Univ Oslo, Dept Immunol, Oslo, Norway; [Loset, Geir Age] Nextera AS, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Loset, GA (corresponding author), Univ Oslo, Ctr Immune Regulat, Oslo, Norway.; Loset, GA (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Oslo, Norway.; Loset, GA (corresponding author), Univ Oslo, Dept Immunol, Oslo, Norway.; Loset, GA (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.; Loset, GA (corresponding author), Nextera AS, Oslo, Norway.	g.a.loset@ibv.uio.no	Høydahl, Lene/AAN-6511-2021; Løset, Geir/I-6413-2015	Løset, Geir/0000-0002-5257-8571; Bjerregaard-Andersen, Kaare/0000-0003-3609-3408; Hoydahl, Lene Stokken/0000-0001-6070-1413	South-Eastern Norway Regional Health Authority [2012046]; Research Council of Norway [197085]; Research Council of Norway through its Centers of Excellence funding scheme [179573N40]	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Research Council of Norway through its Centers of Excellence funding scheme	The study was funded with grants from South-Eastern Norway Regional Health Authority (grant 2012046, https://www.helse-sorost.no/, KSG), the Research Council of Norway (grant number 197085, https://www.forskningsradet.no/en/Home_page/1177315753906 LSH), and the Research Council of Norway through its Centers of Excellence funding scheme, project number 179573N40, LSH and GAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GAL is in part employed by the commercial company Nextera AS. The funder provided support in the form of salary for author GAL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bailey LJ, 2018, J MOL BIOL, V430, P337, DOI 10.1016/j.jmb.2017.12.012; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Broughton SE, 2012, IMMUNITY, V37, P611, DOI 10.1016/j.immuni.2012.07.013; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; CHUNG S, 1994, P NATL ACAD SCI USA, V91, P12654, DOI 10.1073/pnas.91.26.12654; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; Gunnarsen KS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01162; Gunnarsen KS, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-8; Gunnarsen KS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95193; June CH, 2017, NAT MED, V23, P540, DOI 10.1038/nm.4321; Kipriyanov SM, 1997, J IMMUNOL METHODS, V200, P69, DOI 10.1016/S0022-1759(96)00188-3; Lebowitz MS, 1999, CELL IMMUNOL, V192, P175, DOI 10.1006/cimm.1999.1441; Liddy N, 2010, MOL BIOTECHNOL, V45, P140, DOI 10.1007/s12033-010-9250-0; Loset GA, 2007, PROTEIN ENG DES SEL, V20, P461, DOI 10.1093/protein/gzm044; Lunde E, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-61; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Molloy PE, 2005, CURR OPIN PHARMACOL, V5, P438, DOI 10.1016/j.coph.2005.02.004; Nieba L, 1997, PROTEIN ENG, V10, P435, DOI 10.1093/protein/10.4.435; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NOVOTNY J, 1991, P NATL ACAD SCI USA, V88, P8646, DOI 10.1073/pnas.88.19.8646; Pecorari F, 1999, J MOL BIOL, V285, P1831, DOI 10.1006/jmbi.1998.2422; Petersen J, 2016, STRUCTURE, V24, P1643, DOI 10.1016/j.str.2016.07.010; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; Quarsten H, 2001, J IMMUNOL, V167, P4861, DOI 10.4049/jimmunol.167.9.4861; Raman MCC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18851; Richman SA, 2009, MOL IMMUNOL, V46, P902, DOI 10.1016/j.molimm.2008.09.021; Robinson MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9072; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schmitt TM, 2017, NAT BIOTECHNOL, V35, P1188, DOI 10.1038/nbt.4004; Sharma P., 2016, F1000RESEARCH, V5, P2344, DOI [DOI 10.12688/F1000RESEARCH.9073.1, 10.12688/f1000research.9073.1]; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; VIKEN HD, 1995, HUM IMMUNOL, V42, P319, DOI 10.1016/0198-8859(94)00110-C; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; Welschof M, 1997, P NATL ACAD SCI USA, V94, P1902, DOI 10.1073/pnas.94.5.1902; Willcox BE, 1999, PROTEIN SCI, V8, P2418	44	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195868	10.1371/journal.pone.0195868	http://dx.doi.org/10.1371/journal.pone.0195868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649333	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900099
J	Kilsdonk, MJ; Siesling, S; van Dijk, BAC; Wouters, MW; van Hartenm, WH				Kilsdonk, Melvin J.; Siesling, Sabine; van Dijk, Boukje A. C.; Wouters, Michel W.; van Hartenm, Wim H.			What drives centralisation in cancer care?	PLOS ONE			English	Article							HOSPITAL VOLUME; SURGEON VOLUME; MORTALITY; OUTCOMES; QUALITY; REGISTRATION; IMPACT	Background To improve quality of care, centralisation of cancer services in high-volume centres has been stimulated. Studies linking specialisation and high (surgical) volumes to better outcomes already appeared in the 1990's. However, actual centralisation was a difficult process in many countries. In this study, factors influencing the centralisation of cancer services in the Netherlands were determined. Material and methods Centralisation patterns were studied for three types of cancer that are known to benefit from high surgical caseloads: oesophagus-, pancreas- and bladder cancer. The Netherlands Cancer Registry provided data on tumour and treatment characteristics from 2000-2013 for respectively 8037,4747 and 6362 patients receiving surgery. By plotting timelines of centralisation of cancer surgery, relations with the appearance of (inter)national scientific evidence, actions of medical specialist societies, specific regulation and other important factors on the degree of centralisation were ascertained. Results For oesophagus and pancreas cancer, a gradual increase in centralisation of surgery is seen from 2005 and 2006 onwards following (inter)national scientific evidence. Centralisation steps for bladder cancer surgery can be seen in 2010 and 2013 anticipating on the publication of norms by the professional society. The most influential stimulus seems to have been regulations on minimum volumes. Conclusion Scientific evidence on the relationship between volume and outcome lead to the start of centralisation of surgical cancer care in the Netherlands. Once a body of evidence has been established on organisational change that influences professional practice, in addition some form of regulation is needed to ensure widespread implementation.	[Kilsdonk, Melvin J.; Siesling, Sabine; van Dijk, Boukje A. C.] Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands; [Kilsdonk, Melvin J.; Siesling, Sabine; van Hartenm, Wim H.] Univ Twente, Sch Management & Governance, Dept Hlth Technol & Serv Res, Enschede, Netherlands; [van Dijk, Boukje A. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wouters, Michel W.; van Hartenm, Wim H.] Netherlands Canc Inst, Amsterdam, Netherlands	University of Twente; University of Groningen; Netherlands Cancer Institute	Kilsdonk, MJ (corresponding author), Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands.; Kilsdonk, MJ (corresponding author), Univ Twente, Sch Management & Governance, Dept Hlth Technol & Serv Res, Enschede, Netherlands.	mkilsdonk@hotmail.com	Wouters, Michel/B-5882-2019	Wouters, Michel/0000-0001-6173-0662				[Anonymous], 2015, CBS STAT NETHERLANDS; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; de Vries RR, 2010, WORLD J UROL, V28, P431, DOI 10.1007/s00345-010-0512-z; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Dutch Society for Urology, 2015, KWAL BLAASC; Elting LS, 2005, CANCER-AM CANCER SOC, V104, P975, DOI 10.1002/cncr.21273; Goossens-Laan C A, 2010, Eur J Surg Oncol, V36 Suppl 1, pS100, DOI 10.1016/j.ejso.2010.06.003; Goossens-Laan CA, 2012, BJU INT, V110, P226, DOI 10.1111/j.1464-410X.2011.10694.x; Gouma D J, 1997, Ned Tijdschr Geneeskd, V141, P1738; Gouma DJ, 2000, ANN SURG, V232, P786, DOI 10.1097/00000658-200012000-00007; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Ho VKY, 2008, EUR J CANCER, V44, P683, DOI 10.1016/j.ejca.2008.01.027; Hollenbeck BK, 2007, J UROLOGY, V177, P2095, DOI 10.1016/j.juro.2007.01.153; Killeen SD, 2005, BRIT J SURG, V92, P389, DOI 10.1002/bjs.4954; Liu CJ, 2015, CANCER-AM CANCER SOC, V121, P2782, DOI 10.1002/cncr.29356; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; SCHOUTEN LJ, 1993, BRIT J CANCER, V68, P974, DOI 10.1038/bjc.1993.464; SCHOUTEN LJ, 1993, INT J EPIDEMIOL, V22, P369, DOI 10.1093/ije/22.3.369; Schrag D, 2003, J SURG ONCOL, V83, P68, DOI 10.1002/jso.10244; Smolders KHA, 2012, INT J QUAL HEALTH C, V24, P129, DOI 10.1093/intqhc/mzs003; Stichting Oncologische Samenwerking, 2015, MULT NORM ONC ZORG N; van Heek NT, 2005, ANN SURG, V242, P781, DOI 10.1097/01.sla.0000188462.00249.36; van Lanschot JJB, 2001, CANCER-AM CANCER SOC, V91, P1574, DOI 10.1002/1097-0142(20010415)91:8<1574::AID-CNCR1168>3.0.CO;2-2; Wouters M W J M, 2010, Eur J Surg Oncol, V36 Suppl 1, pS3, DOI 10.1016/j.ejso.2010.06.004; Wouters MWJM, 2009, ANN SURG ONCOL, V16, P1789, DOI 10.1245/s10434-009-0458-9	28	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195673	10.1371/journal.pone.0195673	http://dx.doi.org/10.1371/journal.pone.0195673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649250	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900069
J	An, WD; Du, YF; Ye, KQ				An, Weidong; Du, Yifei; Ye, Keqiong			Structural and functional analysis of Utp24, an endonuclease for processing 18S ribosomal RNA	PLOS ONE			English	Article							PIN DOMAIN; EARLIEST PRECURSORS; 90S PRERIBOSOME; ASSEMBLY EVENTS; YEAST; NUCLEASE; PROTEINS; SITE; BIOGENESIS; SUBUNITS	The precursor ribosomal RNA is processed by multiple steps of nucleolytic cleavage to generate mature rRNAs. Utp24 is a PIN domain endonuclease in the early 90S precursor of small ribosomal subunit and is proposed to cleave at sites A1 and A2 of pre-rRNA. Here we determine the crystal structure of Utp24 from Schizosaccharomyces pombe at 2.1 angstrom resolution. Utp24 structurally resembles the ribosome assembly factor Utp23 and both contain a Zn-finger motif. Functional analysis in Saccharomyces cerevisiae shows that depletion of Utp24 disturbs the assembly of 90S and abolishes cleavage at sites A0, A1 and A2. The 90S assembled with inactivated Utp24 is arrested at a post-A0-cleavage state and contains enriched nuclear exosome for degradation of 5' ETS. Despite of high sequence conservation, Utp24 from other organisms is unable to form an active 90S in S. cerevisiae, suggesting that Utp24 needs to be precisely positioned in 90S. Our study provides biochemical and structural insight into the role of Utp24 in 90S assembly and activity.	[An, Weidong] China Agr Univ, Coll Biol Sci, Beijing, Peoples R China; [An, Weidong] Natl Inst Biol Sci, Beijing, Peoples R China; [An, Weidong; Du, Yifei; Ye, Keqiong] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing, Peoples R China; [Du, Yifei; Ye, Keqiong] Univ Chinese Acad Sci, Beijing, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, KQ (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing, Peoples R China.; Ye, KQ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	yekeqiong@ibp.ac.cn		Du, Yifei/0000-0002-9362-8766; Ye, Keqiong/0000-0001-6169-7049	Strategic Priority Research Program of Chinese Academy of Sciences [XDB08010203]; National Key R&D Program of China [2017YFA0504600]; National Natural Science Foundation of China [31430024, 91540201, 31325007]; 100 Talents Program of CAS	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Talents Program of CAS(Chinese Academy of Sciences)	The study was supported by Strategic Priority Research Program of Chinese Academy of Sciences [XDB08010203], National Key R&D Program of China [2017YFA0504600], National Natural Science Foundation of China [31430024, 91540201, 31325007] and 100 Talents Program of CAS to Keqiong Ye. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Barandun J, 2017, NAT STRUCT MOL BIOL, V24, P944, DOI 10.1038/nsmb.3472; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Chaker-Margot M, 2017, SCIENCE, V355, DOI 10.1126/science.aal1880; Chaker-Margot M, 2015, NAT STRUCT MOL BIOL, V22, P920, DOI 10.1038/nsmb.3111; Chen W, 2017, NUCLEIC ACIDS RES, V45, P6837, DOI 10.1093/nar/gkx254; Cheng JD, 2017, NAT STRUCT MOL BIOL, V24, P954, DOI 10.1038/nsmb.3476; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hoareau-Aveilla C, 2011, NUCLEIC ACIDS RES, V40, P3641; Horn DM, 2011, J BIOL CHEM, V286, P34082, DOI 10.1074/jbc.M111.268649; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kornprobst M, 2016, CELL, V166, P380, DOI 10.1016/j.cell.2016.06.014; Kos-Braun IC, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000245; Lin JZ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001669; Lu J, 2013, RNA, V19, P1815, DOI 10.1261/rna.040808.113; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Perez-Fernandez J, 2011, NUCLEIC ACIDS RES, V39, P8105, DOI 10.1093/nar/gkr508; Rempola B, 2006, BIOCHEM BIOPH RES CO, V346, P546, DOI 10.1016/j.bbrc.2006.05.140; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Senissar M, 2017, PROTEIN SCI, V26, P1474, DOI 10.1002/pro.3193; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Tanaka N, 2011, RNA, V17, P595, DOI 10.1261/rna.2571811; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Tomecki R, 2015, RNA BIOL, V12, P1010, DOI 10.1080/15476286.2015.1073437; Wang B, 2017, NUCLEIC ACIDS RES, V45, P3559, DOI 10.1093/nar/gkw1323; Wells GR, 2017, NUCLEIC ACIDS RES, V45, P4796, DOI 10.1093/nar/gkw1344; Wells GR, 2016, NUCLEIC ACIDS RES, V44, P5399, DOI 10.1093/nar/gkw213; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115; Zhu JY, 2016, MOL CELL BIOL, V36, P965, DOI 10.1128/MCB.00773-15	44	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195723	10.1371/journal.pone.0195723	http://dx.doi.org/10.1371/journal.pone.0195723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641590	gold, Green Published			2022-12-27	WOS:000429742900088
J	Deb, D; Mackey, D; Opiyo, SO; McDowell, JM				Deb, Devdutta; Mackey, David; Opiyo, Stephen O.; McDowell, John M.			Application of alignment-free bioinformatics methods to identify an oomycete protein with structural and functional similarity to the bacterial AvrE effector protein	PLOS ONE			English	Article							PLANT IMMUNE-SYSTEM; STEWARTII SUBSP STEWARTII; PARTIAL LEAST-SQUARES; PSEUDOMONAS-SYRINGAE; PATHOGEN EFFECTORS; ERWINIA-AMYLOVORA; PHYTOPHTHORA-INFESTANS; DISEASE SUSCEPTIBILITY; ARABIDOPSIS-THALIANA; VIRULENCE EFFECTORS	Diverse plant pathogens export effector proteins to reprogram host cells. One of the most challenging goals in the molecular plant-microbe field is to functionally characterize the complex repertoires of effectors secreted by these pathogens. For bacterial pathogens, the predominant class of effectors is delivered to host cells by Type III secretion. For oomycetes, the predominant class of effectors is defined by a signal peptide that mediates secretion from the oomycete and a conserved RxLR motif. Downy mildew pathogens and Phytophthora species maintain hundreds of candidate RxLR effector genes in their genomes. Although no primary sequence similarity is evident between bacterial Type III effectors (T3Es) and oomycete RXLR effectors, some bacterial and oomycete effectors have convergently evolved to target the same host proteins. Such effectors might have evolved domains that are functionally similar but sequence-unrelated. We reasoned that alignment-free bioinformatics approaches could be useful to identify structural similarities between bacterial and oomycete effectors. To test this approach, we used partial least squares regression, alignment-free bioinformatics methods to identify effector proteins from the genome of the oomycete Hyaloperonospora arabidopsidis that are similar to the well-studied AvrE1 effector from Pseudomonas syringae. This approach identified five RxLR proteins with putative structural similarity to AvrE1. We focused on one, HaRxL23, because it is an experimentally validated effector and it is conserved between distantly related oomycetes. Several experiments indicate that HaRxL23 is functionally similar to AvrE1, including the ability to partially rescue an AvrE1 loss-of-function mutant. This study provides an example of how an alignment-free bioinformatics approach can identify functionally similar effector proteins in the absence of primary sequence similarity. This approach could be useful to identify effectors that have convergently evolved regardless of whether the shared host target is known.	[Deb, Devdutta; McDowell, John M.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Mackey, David] Ohio State Univ, Dept Hort, Columbus, OH 43210 USA; [Mackey, David] Ohio State Univ, Dept Crop Sci, Columbus, OH 43210 USA; [Mackey, David] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Opiyo, Stephen O.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Mol & Cellular Imaging Ctr Columbus, Columbus, OH 43210 USA	Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	McDowell, JM (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.; Opiyo, SO (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Mol & Cellular Imaging Ctr Columbus, Columbus, OH 43210 USA.	opiyo.1@osu.edu; johnmcd@vt.edu		McDowell, John/0000-0002-9070-4874	National Science Foundation Division of Integrative Organismal Systems Grant [IOS-1353366]; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2009-03008, 2016-67013-24727]	National Science Foundation Division of Integrative Organismal Systems Grant; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This work was supported by the National Science Foundation Division of Integrative Organismal Systems Grant no. IOS-1353366 (JM) and by Agriculture and Food Research Initiative Competitive Grant nos. 2009-03008 (JM) and 2016-67013-24727 (DM) from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaro TMMM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00099; Anderson RG, 2015, MOL PLANT MICROBE IN, V28, P1063, DOI 10.1094/MPMI-01-15-0022-CR; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cohn M, 2014, MOL PLANT MICROBE IN, V27, P1186, DOI 10.1094/MPMI-06-14-0161-R; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Cumbie JS, 2010, 10 JAP US SEM GEN EN; Da Cunha L, 2007, CURR OPIN PLANT BIOL, V10, P349, DOI 10.1016/j.pbi.2007.04.018; Dalio RJD, 2018, MOL PLANT MICROBE IN, V31, P22, DOI 10.1094/MPMI-07-17-0174-FI; Deb D, 2018, MOL PLANT MICROBE IN, V31, P374, DOI 10.1094/MPMI-07-17-0169-FI; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Gangadharan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082032; Garbutt CC, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00312; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Geng XQ, 2012, PLANT CELL, V24, P4763, DOI 10.1105/tpc.112.105312; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Ham JH, 2008, MOL PLANT PATHOL, V9, P633, DOI 10.1111/J.1364-3703.2008.00489.X; Ham JH, 2006, MOL PLANT MICROBE IN, V19, P1092, DOI 10.1094/MPMI-19-1092; Ham JH, 2009, MOL PLANT MICROBE IN, V22, P703, DOI 10.1094/MPMI-22-6-0703; Hein I, 2009, MOL PLANT PATHOL, V10, P547, DOI [10.1111/J.1364-3703.2009.00547.X, 10.1111/j.1364-3703.2009.00547.x]; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/annurev-phyto-081211-172912; Jin L, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005609; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Khan M, 2016, CURR OPIN MICROBIOL, V29, P49, DOI 10.1016/j.mib.2015.10.006; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; Links MG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-503; LORANG JM, 1995, MOL PLANT MICROBE IN, V8, P49, DOI 10.1094/MPMI-8-0049; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; McDowell JM, 2014, GENOMICS PLANT ASS F, P209; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Opiyo S. O., 2013, African Journal of Biotechnology, V12, P5804; Opiyo SO, 2007, J PROTEOME RES, V6, P846, DOI 10.1021/pr060534k; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; Petsko G.A., 2003, PROTEIN STRUCTURE FU; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Siamer S, 2013, FEMS MICROBIOL LETT, V342, P54, DOI 10.1111/1574-6968.12108; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Streubel J, 2013, NEW PHYTOL, V200, P808, DOI 10.1111/nph.12411; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Toruno TY, 2016, ANNU REV PHYTOPATHOL, V54, P419, DOI 10.1146/annurev-phyto-080615-100204; Tyler B.M., 2014, GENOMICS PLANT ASS F, P133, DOI [10.1007/978-3-662-44056-8_7, DOI 10.1007/978-3-662-44056-8_7]; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Tyler BM, 2013, MOL PLANT MICROBE IN, V26, P611, DOI 10.1094/MPMI-02-13-0051-IA; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Verdier V, 2012, NEW PHYTOL, V196, P1197, DOI 10.1111/j.1469-8137.2012.04367.x; Wawra S, 2013, MOL PLANT MICROBE IN, V26, P528, DOI 10.1094/MPMI-08-12-0200-R; Wehrens R., 2007, PLS PARTIAL LEAST SQ; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Wright CA, 2004, P NATL ACAD SCI USA, V101, P3269, DOI 10.1073/pnas.0400461101; Xin XF, 2016, NATURE, V539, P524, DOI 10.1038/nature20166; Xin XF, 2015, PLANT PHYSIOL, V169, P793, DOI 10.1104/pp.15.00547; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	79	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195559	10.1371/journal.pone.0195559	http://dx.doi.org/10.1371/journal.pone.0195559			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641586	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900073
J	Wang, P; Ni, HJ; Wang, RH				Wang, Peng; Ni, Hongjian; Wang, Ruihe			RETRACTED: A new drilling method-Earthworm-like vibration drilling (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							TANGENTIAL VIBRATIONS; REDUCTION; FRICTION	The load transfer difficulty caused by borehole wall friction severely limits the penetration rate and extended-reach limit of complex structural wells. A new friction reduction technology termed "earthworm-like drilling" is proposed in this paper to improve the load transfer of complex structural wells. A mathematical model based on a "soft-string" model is developed and solved. The results show that earthworm-like drilling is more effective than single-point vibration drilling. The amplitude and frequency of the pulse pressure and the installation position of the shakers have a substantial impact on friction reduction and load transfer. An optimization model based on the projection gradient method is developed and used to optimize the position of three shakers in a horizontal well. The results verify the feasibility and advantages of earthworm-like drilling, and establish a solid theoretical foundation for its application in oil field drilling.	[Wang, Peng; Ni, Hongjian] China Univ Petr East China, Res Inst Unconvent Oil & Gas & Renewable Energy, Qingdao, Peoples R China; [Wang, Ruihe] China Univ Petr East China, Sch Petr Engn, Qingdao, Peoples R China	China University of Petroleum; China University of Petroleum	Ni, HJ (corresponding author), China Univ Petr East China, Res Inst Unconvent Oil & Gas & Renewable Energy, Qingdao, Peoples R China.	h20160011@upc.edu.cn			National Natural Science Foundation of China [51704323, 41604103]; China postdoctoral science foundation [2016M602224]; Natural Science Foundation of Shandong Province [ZR2017BEE053]; Fundamental Research Funds for the Central Universities [18CX02177A, 18CX02009A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China postdoctoral science foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research leading to these results has received funding from the National Natural Science Foundation of China (Grant No. 51704323, 41604103). Funding was also provided from the China postdoctoral science foundation (Grant No. 2016M602224) and the Natural Science Foundation of Shandong Province (Grant no. ZR2017BEE053) and the Fundamental Research Funds for the Central Universities (18CX02177A, 18CX02009A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2011, BRAS OFFSH C EXH HEL; Gao B. K., 1995, OIL DRILL PROD TECHN, V17, P6; Gao DL, 2009, PETROL SCI, V6, P166, DOI 10.1007/s12182-009-0026-8; Gao DL, 2011, OPTIMIZED DESIGN CON; Gutowski P, 2015, TRIBOL INT, V90, P455, DOI 10.1016/j.triboint.2015.04.044; Gutowski P, 2012, TRIBOL INT, V55, P108, DOI 10.1016/j.triboint.2012.05.023; Ho H., 1988, SPE ANN TECHN C EXH, P2; Jones S, 2016, IADC SPE DRILL C EXH; Maidla E, 2005, SPE IADC DRILL C HEL; Mccormick JE, 2011, SPE ANN TECHN C EXH; Mezoff S, 2004, J EXP BIOL, V207, P3043, DOI 10.1242/jeb.01136; Pabon J, 2010, SPE DEEPW DRILL COMP; Ren LQ, 2009, SCI CHINA SER E, V52, P273, DOI 10.1007/s11431-009-0042-3; Ritto TG, 2013, J SOUND VIB, V332, P145, DOI 10.1016/j.jsv.2012.08.007; Roper WF, 1983, US Patent, Patent No. 4384625; Skyles L.P., 2012, IADC SPE DRILL C EXH; Tolstoi DM, 1973, SOV PHYS DOKL, V17, P80; Wang XM, 2017, J NAT GAS SCI ENG, V39, P118, DOI 10.1016/j.jngse.2017.01.018; Wicks N, 2012, SPE DEEPW DRILL COMP	19	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194582	10.1371/journal.pone.0194582	http://dx.doi.org/10.1371/journal.pone.0194582			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641615	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900037
J	Zhang, XR; Duan, HF; Yu, Y; Ma, CL; Ren, ZL; Lei, YX; He, TP; Zhang, M				Zhang, Xirong; Duan, Haifeng; Yu, Yong; Ma, Chunling; Ren, Zhanli; Lei, Yuxin; He, Taiping; Zhang, Ming			Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ATTENUATION VALUES; THORACOSCOPY	Purpose To investigate the value of spectral CT in the differential diagnosis of benign from malignant pleural effusion. Method and materials 14 patients with benign pleural effusion and 15 patients with malignant pleural effusion underwent non-contrast spectral CT imaging. These patients were later verified by the combination of disease history, clinical signs and other information with the consensus of surgeons and radiologists. Various Spectral CT image parameters measured for the effusion were as follows: CT numbers of the polychromatic 140kVp images, monochromatic images at 40keV and 100keV, the material density contents from the water, fat and blood-based material decomposition images, the effective atomic number and the spectral curve slope. These values were statistically compared with t test and logistic regression analysis between benign and malignant pleural effusion. Results The CT value of benign and malignant pleural effusion in the polychromatic 140kVp images showed no differences (12.61 +/- 3.39HU vs. 14.71 +/- 5.03HU) (P>0.05), however, they were statistically different on the monochromatic images at 40keV (43.15 +/- 3.79 vs. 39.42 +/- 2.60, p=0.005) and 100keV (9.11 +/- 1.38 vs. 6.52 +/- 2.04, p< 0.001). There was difference in the effective atomic number value between the benign (7.87 +/- 0.08) and malignant pleural effusion (7.90 +/- 0.02) (P=0.02). Using 6.32HU as the threshold for CT value measurement at 100keV, one could obtain sensitivity of 100% and specificity of 66.7% with area-under-curve of 0.843 for differentiating benign from malignant effusion. In addition, age and disease history were potential confounding factors for differentiating malignant pleural effusion from benign, since the older age (61.13 +/- 12.51 year-old vs48.57 +/- 12.33 year-old) as well as longer disease history (70.00 +/- 49.28 day vs. 28.36 +/- 21.64 day) were more easily to be found in the malignant pleural effusion group than those in the benign pleural effusion group. By combining above five factors, one could obtain sensitivity of 100% and specificity of 71.4% with area-under-curve of 0.933 for differentiating benign from malignant effusion. Conclusion The CT value measurement at both high and low energy levels and the effective atomic number obtained in a single spectral CT scan can assist the differential diagnosis of benign from malignant pleural effusion. Combining them with patient age and disease history can further improve diagnostic performance. Clinical relevance/Application Clinical findings and Spectral CT imaging can provide significant evidences about the nature of pleural effusion.	[Zhang, Xirong; Zhang, Ming] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China; [Zhang, Xirong; Duan, Haifeng; Yu, Yong; Ma, Chunling; Ren, Zhanli; Lei, Yuxin; He, Taiping] Shaanxi Univ Chinese Med, Affiliated Hosp, Dept Radiol, Xianyang City, Shaanxi, Peoples R China; [Zhang, Xirong] Shaanxi Univ Chinese Med, Dept Med Tech, Xianyang City, Shaanxi, Peoples R China; [Duan, Haifeng] Dept Med Imaging, 2 Weiyangxi Rd, Xianyang City, Shaanxi, Peoples R China	Xi'an Jiaotong University; Shaanxi University of Chinese Medicine; Shaanxi University of Chinese Medicine	Zhang, M (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China.; He, TP (corresponding author), Shaanxi Univ Chinese Med, Affiliated Hosp, Dept Radiol, Xianyang City, Shaanxi, Peoples R China.	htpkeyan@163.com; zhangming01@mail.xjtu.edu.cn						Abramowitz Y, 2009, AM J ROENTGENOL, V192, P618, DOI 10.2214/AJR.08.1286; Aleman C, 2007, QJM-INT J MED, V100, P351, DOI 10.1093/qjmed/hcm032; Chen S, 2015, CLIN CHIM ACTA, V441, P142, DOI 10.1016/j.cca.2014.12.029; Cullu N, 2014, DIAGN INTERV RADIOL, V20, P116, DOI 10.5152/dir.2013.13066; Deng K, 2012, KOREAN J RADIOL, V13, P743, DOI 10.3348/kjr.2012.13.6.743; Dong Y, 2015, EUR J RADIOL, V84, P901, DOI 10.1016/j.ejrad.2015.01.007; Han D, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160632; Heffner JE, 2008, MAYO CLIN PROC, V83, P235, DOI 10.4065/83.2.235; Li MY, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-118; Liao P, 2017, STAT BIOSCIENCES, V1-14, DOI [10.1007/s12561-016-9144-1, DOI 10.1007/S12561-016-9144-1]; Liu JY, 2017, J THORAC DIS, V9, P406, DOI 10.21037/jtd.2017.02.39; Ma GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150985; Maskell NA, 2003, THORAX, V58, pII8, DOI 10.1136/thorax.58.suppl_2.ii8; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; McCollough CH, 2015, RADIOLOGY, V276, P637, DOI 10.1148/radiol.2015142631; Nandalur KR, 2005, ACAD RADIOL, V12, P987, DOI 10.1016/j.acra.2005.05.002; Porcel JM, 2015, RESPIROLOGY, V20, P654, DOI 10.1111/resp.12496; Rahman NM, 2010, THORAX, V65, P54, DOI 10.1136/thx.2010.137018; Traill ZC, 2001, CLIN RADIOL, V56, P193, DOI 10.1053/crad.2000.0573; Wang MS, 2014, CLINICS, V69, P799, DOI 10.6061/clinics/2014(12)02; YAO JH, 2009, P IEEE ISBI, P241, DOI DOI 10.1109/SBI.2009.5193028; Yilmaz U, 2005, Monaldi Arch Chest Dis, V63, P17; Zaric B, 2008, LUNG, V186, P233, DOI 10.1007/s00408-008-9085-7	23	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193714	10.1371/journal.pone.0193714	http://dx.doi.org/10.1371/journal.pone.0193714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641601	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900017
J	Esser, D; Geleijnse, JM; Matualatupauw, JC; Dower, JI; Kromhout, D; Hollman, PCH; Afman, LA				Esser, Diederik; Geleijnse, Johanna M.; Matualatupauw, Juri C.; Dower, James I.; Kromhout, Daan; Hollman, Peter C. H.; Afman, Lydia A.			Pure flavonoid epicatechin and whole genome gene expression profiles in circulating immune cells in adults with elevated blood pressure: A randomised double-blind, placebo-controlled, crossover trial	PLOS ONE			English	Article							VASCULAR FUNCTION; NITRIC-OXIDE; ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; (-)-EPICATECHIN; COCOA; CHOCOLATE; HUMANS; HEALTH; SUPPLEMENTATION	Cocoa consumption has beneficial cardiometabolic effects, but underlying mechanisms remain unclear. Epicatechin, the cocoa major monomeric flavan-3-ol, is considered to contribute to these cardio-protective effects. We investigated effects of pure epicatechin supplementation on gene expression profiles of immune cells in humans. In a double blind, placebo-controlled cross-over trial, 32 (pre) hypertensive subjects aged 30 to 80, received two 4-week interventions, i.e. epicatechin (100mg/day) or placebo with a 4-week wash-out between interventions. Gene expression profiles of peripheral blood mononuclear cells were determined before and after both interventions. Epicatechin regulated 1180 genes, of which 234 differed from placebo. Epicatechin upregulated gene sets involved in transcription and tubulin folding and downregulated gene sets involved in inflammation, PPAR signalling and adipogenesis. Several negatively enriched genes within these gene sets were involved in insulin signalling. Most inhibited upstream regulators within the epicatechin intervention were cytokines or involved in inflammation. No upstream regulators were identified compared to placebo. Epicatechin, a cocoa flavan-3-ol, reduces gene expression involved in inflammation, PPAR-signalling and adipogenesis in immune cells. Effects were mild but our findings increase our understanding and provide new leads on how epicatechin rich products like cocoa may affect immune cells and exert cardiometabolic protective effects.	[Esser, Diederik; Geleijnse, Johanna M.; Dower, James I.; Hollman, Peter C. H.] Top Inst Food & Nutr, Wageningen, Netherlands; [Esser, Diederik; Geleijnse, Johanna M.; Matualatupauw, Juri C.; Dower, James I.; Kromhout, Daan; Hollman, Peter C. H.; Afman, Lydia A.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	Afman, LA (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	lydia.afman@wur.nl	Geleijnse, Johanna Marianna M/B-5749-2012	Geleijnse, Johanna Marianna M/0000-0001-7638-0589	Top Institute Food and Nutrition	Top Institute Food and Nutrition	This work was supported by Top Institute Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition.	Actis-Goretta L, 2013, AM J CLIN NUTR, V98, P924, DOI 10.3945/ajcn.113.065789; Actis-Goretta L, 2012, FREE RADICAL BIO MED, V53, P787, DOI 10.1016/j.freeradbiomed.2012.05.023; Ali F, 2014, MOL NUTR FOOD RES, V58, P33, DOI 10.1002/mnfr.201300277; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Buitrago-Lopez A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4488; Cifuentes-Gomez T, 2015, J AGR FOOD CHEM, V63, P7615, DOI 10.1021/acs.jafc.5b00443; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dang ZC, 2004, J BONE MINER RES, V19, P853, DOI 10.1359/JBMR.040120; Dang ZC, 2003, J BIOL CHEM, V278, P962, DOI 10.1074/jbc.M209483200; Dower JI, 2015, AM J CLIN NUTR, V101, P914, DOI 10.3945/ajcn.114.098590; Dower JI, 2015, CROSSOVER TRIAL J NU, DOI [10.3945/jn.115.211888, DOI 10.3945/JN.115.211888]; Esser D, 2015, MOL NUTR FOOD RES, V59, P1563, DOI 10.1002/mnfr.201400853; Esser D, 2014, FASEB J, V28, P1464, DOI 10.1096/fj.13-239384; European Food Safety Authority, 2012, EFSA J, V10, P2809, DOI DOI 10.2903/j.efsa.2012.2809; Fernandez-Millan E, 2014, FOOD CHEM TOXICOL, V66, P245, DOI 10.1016/j.fct.2014.01.044; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671; Gu YY, 2013, MOL NUTR FOOD RES, V57, P948, DOI 10.1002/mnfr.201200837; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Katz DL, 2011, ANTIOXID REDOX SIGN, V15, P2779, DOI 10.1089/ars.2010.3697; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Loke WM, 2008, AM J CLIN NUTR, V88, P1018, DOI 10.1093/ajcn/88.4.1018; Mann GE, 2007, CARDIOVASC RES, V75, P261, DOI 10.1016/j.cardiores.2007.04.004; Min SY, 2013, INT J OBESITY, V37, P584, DOI 10.1038/ijo.2012.85; Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Morrison M, 2014, ATHEROSCLEROSIS, V233, P149, DOI 10.1016/j.atherosclerosis.2013.12.027; Rodriguez-Mateos A, 2014, ARCH BIOCHEM BIOPHYS, V559, P17, DOI 10.1016/j.abb.2014.03.014; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Steffen Y, 2005, BIOCHEM BIOPH RES CO, V331, P1277, DOI 10.1016/j.bbrc.2005.04.035; Steffen Y, 2007, BIOCHEM BIOPH RES CO, V359, P828, DOI 10.1016/j.bbrc.2007.05.200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van der Velpen V, 2016, FOOD CHEM TOXICOL, V95, P203, DOI 10.1016/j.fct.2016.07.013; van der Velpen V, 2014, AM J CLIN NUTR, V100, P1269, DOI 10.3945/ajcn.114.088484; van der Velpen V, 2013, J NUTR, V143, P774, DOI 10.3945/jn.113.174037; Vazquez-Agell M, 2013, NUTR METAB CARDIOVAS, V23, P257, DOI 10.1016/j.numecd.2011.03.015; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.230S, 10.1093/ajcn/81.1.243S]	43	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0194229	10.1371/journal.pone.0194229	http://dx.doi.org/10.1371/journal.pone.0194229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672527	Green Submitted, Green Published, gold			2022-12-27	WOS:000430446800009
J	Cai, XL; Akber, M; Spirov, A; Baumgartner, S				Cai, Xiaoli; Akber, Mira; Spirov, Alexander; Baumgartner, Stefan			Cortical movement of Bicoid in early Drosophila embryos is actin- and microtubule-dependent and disagrees with the SDD diffusion model (vol 12, e0185443, 2017)	PLOS ONE			English	Correction													Spirov, Alexander V/G-4806-2010	Spirov, Alexander V/0000-0002-0509-6203				Cai XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185443	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196144	10.1371/journal.pone.0196144	http://dx.doi.org/10.1371/journal.pone.0196144			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668742	Green Published, gold			2022-12-27	WOS:000430290200078
J	Phillips, RC; Gorse, D				Phillips, Ross C.; Gorse, Denise			Cryptocurrency price drivers: Wavelet coherence analysis revisited	PLOS ONE			English	Article							EXUBERANCE	Cryptocurrencies have experienced recent surges in interest and price. It has been discovered that there are time intervals where cryptocurrency prices and certain online and social media factors appear related. In addition it has been noted that cryptocurrencies are prone to experience intervals of bubble-like price growth. The hypothesis investigated here is that relationships between online factors and price are dependent on market regime. In this paper, wavelet coherence is used to study co-movement between a cryptocurrency price and its related factors, for a number of examples. This is used alongside a well-known test for financial asset bubbles to explore whether relationships change dependent on regime. The primary finding of this work is that medium-term positive correlations between online factors and price strengthen significantly during bubble-like regimes of the price series; this explains why these relationships have previously been seen to appear and disappear over time. A secondary finding is that short-term relationships between the chosen factors and price appear to be caused by particular market events (such as hacks / security breaches), and are not consistent from one time interval to another in the effect of the factor upon the price. In addition, for the first time, wavelet coherence is used to explore the relationships between different cryptocurrencies.	[Phillips, Ross C.; Gorse, Denise] UCL, Dept Comp Sci, London, England	University of London; University College London	Phillips, RC (corresponding author), UCL, Dept Comp Sci, London, England.	r.phillips@cs.ucl.ac.uk			Engineering and Physical Sciences Research Council (EPSRC); DTC in Financial Computing Analytics [EP/L015129/1]	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DTC in Financial Computing Analytics	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC). The funding was received by Ross Phillips (RP) via the DTC in Financial Computing & Analytics; reference number: EP/L015129/1; http://gow.epsrc.ac.uk/ NGBOViewGrant.aspx?GrantRef=EP/L015129/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloui C, 2014, ECON MODEL, V36, P421, DOI 10.1016/j.econmod.2013.09.043; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Balcilar M, 2017, ECON MODEL, V64, P74, DOI 10.1016/j.econmod.2017.03.019; Bouri E., 2017, FINANCE RES LETT; Brandvold M, 2015, J INT FINANC MARK I, V36, P18, DOI 10.1016/j.intfin.2015.02.010; Cheah ET, 2015, ECON LETT, V130, P32, DOI 10.1016/j.econlet.2015.02.029; Chen C.W., 2003, J ECON BUS, V55, P487, DOI DOI 10.1016/S0148-6195(03)00051-1; Garcia D, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150288; Garcia D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0623; Gi Kim Jun, 2016, PLOS ONE, V11; Glaser F, 2014, P EUROPEAN C INFORM; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Kristoufek L., 2015, PLOS ONE, V10; Kristoufek L, 2013, SCI REP-UK, V3, DOI [10.1038/srep03415, 10.1038/srep02857]; Lim S.J., 2017, EXPLORING PORTFOLIO; Madaleno M, 2014, ENERG ECON, V45, P120, DOI 10.1016/j.eneco.2014.06.024; Mitchell J, 2001, J FUTURES MARKETS, V21, P395, DOI 10.1002/fut.2; MOORE T, 2013, LECT NOTES COMPUTER, V7859; Nakamoto S., 2008, DECENTRALIZED BUS RE, V4, P21260; Phillips PCB, 2015, INT ECON REV, V56, P1043, DOI 10.1111/iere.12132; Phillips PCB, 2011, INT ECON REV, V52, P201, DOI 10.1111/j.1468-2354.2010.00625.x; Phillips R. C, 2017, IEEE S SERIES COMPUT; Shiller RJ, 2014, AM ECON REV, V104, P1486, DOI 10.1257/aer.104.6.1486; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vacha L, 2012, ENERG ECON, V34, P241, DOI 10.1016/j.eneco.2011.10.007; Xu Y., 2017, PLOS ONE, V12	26	57	57	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195200	10.1371/journal.pone.0195200	http://dx.doi.org/10.1371/journal.pone.0195200			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668765	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200031
J	Gschwantler-Kaulich, D; Weingartshofer, S; Rappaport-Furhauser, C; Zeillinger, R; Pils, D; Muhr, D; Braicu, EI; Kastner, MT; Tan, YY; Semmler, L; Sehouli, J; Singer, CF				Gschwantler-Kaulich, Daphne; Weingartshofer, Sigrid; Rappaport-Furhauser, Christine; Zeillinger, Robert; Pils, Dietmar; Muhr, Daniela; Braicu, Elena I.; Kastner, Marie-Therese; Tan, Yen Y.; Semmler, Lorenz; Sehouli, Jalid; Singer, Christian F.			Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers (vol 12, e0189641, 2017)	PLOS ONE			English	Correction													Tan, Yen/AAW-2357-2021	Tan, Yen/0000-0003-1063-5352				Gschwantler-Kaulich D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189641	1	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196142	10.1371/journal.pone.0196142	http://dx.doi.org/10.1371/journal.pone.0196142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664962	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300056
J	Vijarnsorn, C; Durongpisitkul, K; Chungsomprasong, P; Bositthipichet, D; Ketsara, S; Titaram, Y; Chanthong, P; Kanjanauthai, S; Soongswang, J				Vijarnsorn, Chodchanok; Durongpisitkul, Kritvikrom; Chungsomprasong, Paweena; Bositthipichet, Densiri; Ketsara, Salisa; Titaram, Yuttapon; Chanthong, Prakul; Kanjanauthai, Supaluck; Soongswang, Jarupim			Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts	PLOS ONE			English	Article							HEART-DISEASE; EISENMENGER-SYNDROME; PREDICTORS; DIAGNOSIS; OUTCOMES; ADULTS; EPIDEMIOLOGY; MORTALITY; DEATH	Objective To compare survival of patients with newly diagnosed pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) according to various clinical classifications with classifications of anatomical-pathophysiological systemic to pulmonary shunts in a single-center cohort. Methods All prevalent cases of PAH-CHD with hemodynamic confirmation by cardiac catheterization in 1995 +/- 2015 were retrospectively reviewed. Patients who were younger than three months of age, or with single ventricle following surgery were excluded. Baseline characteristics and clinical outcomes were retrieved from the database. The survival analysis was performed at the end of 2016. Prognostic factors were identified using multivariate analysis. Results A total of 366 consecutive patients (24.5 +/- 17.6 years of age, 40% male) with PAH-CHD were analyzed. Most had simple shunts (85 pre-tricuspid, 105 post-tricuspid, 102 combined shunts). Patients with pre-tricuspid shunts were significantly older at diagnosis in comparison to post-tricuspid, combined, and complex shunts. Clinical classifications identified patients as having Eisenmenger syndrome (ES, 26.8%), prevalent left to right shunt (66.7%), PAH with small defect (3%), or PAH following defect correction (3.5%). At followup (median = 5.9 years; 0.1-20.7 years), no statistically significant differences in survival rate were seen among the anatomical-pathophysiological shunts (p = 0.1). Conversely, the clinical classifications revealed that patients with PAH-small defect had inferior survival compared to patients with ES, PAH post-corrective surgery, or PAH with prevalent left to right shunt (p = 0.01). Significant mortality risks were functional class III, age < 10 years, PAH-small defect, elevated right atrial pressure > 15 mmHg, and baseline PVR > 8 WU.m.(2) Conclusion Patients with PAH-CHD had a modest long-term survival. Different anatomical-pathophysiological shunts affect the natural presentation, while clinical classifications indicate treatment strategies and survival. Contemporary therapy improves survival in deliberately selected patients.	[Vijarnsorn, Chodchanok; Durongpisitkul, Kritvikrom; Chungsomprasong, Paweena; Bositthipichet, Densiri; Ketsara, Salisa; Titaram, Yuttapon; Chanthong, Prakul; Kanjanauthai, Supaluck; Soongswang, Jarupim] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok, Thailand	Mahidol University	Vijarnsorn, C (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok, Thailand.	cvijarnsorn@yahoo.corn	Chungsomprasong, Paweena/ABG-8953-2020	Vijarnsorn, Chodchanok/0000-0001-7124-2064				Alonso-Gonzalez R, 2015, INT J CARDIOL, V184, P717, DOI 10.1016/j.ijcard.2015.02.031; Arnott C, 2016, HEART ASIA, V8, P3, DOI 10.1136/heartasia-2015-010702; Barst RJ, 2014, AM J CARDIOL, V113, P147, DOI 10.1016/j.amjcard.2013.09.032; Beghetti M, 2010, REV ESP CARDIOL, V63, P1179, DOI 10.1016/S0300-8932(10)70250-5; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Diller GP, 2006, EUR HEART J, V27, P1737, DOI 10.1093/eurheartj/ehl116; Dimopoulos K, 2010, CIRCULATION, V121, P20, DOI 10.1161/CIRCULATIONAHA.109.883876; Duffels MGJ, 2007, INT J CARDIOL, V120, P198, DOI 10.1016/j.ijcard.2006.09.017; Engelfriet PM, 2007, HEART, V93, P682, DOI 10.1136/hrt.2006.098848; Farber HW, 2015, CHEST, V148, P1043, DOI 10.1378/chest.15-0300; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gatzoulis MA, 2014, INT J CARDIOL, V177, P340, DOI 10.1016/j.ijcard.2014.09.024; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Jansa P, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-45; Kempny A, 2017, CIRCULATION, V135, P1432, DOI 10.1161/CIRCULATIONAHA.116.023033; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Manes A, 2014, EUR HEART J, V35, P716, DOI 10.1093/eurheartj/eht072; Ramjug S, 2016, J HEART LUNG TRANSPL, V35, P610, DOI 10.1016/j.healun.2015.12.016; Schuijt MTU, 2017, INT J CARDIOL, V243, P449, DOI 10.1016/j.ijcard.2017.05.101; Schuuring MJ, 2015, INT J CARDIOL, V181, P270, DOI 10.1016/j.ijcard.2014.11.222; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; van Loon RLE, 2011, CIRCULATION, V124, P1755, DOI 10.1161/CIRCULATIONAHA.110.969584; Zhang R, 2011, CHEST, V140, P301, DOI 10.1378/chest.10-2327	26	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195092	10.1371/journal.pone.0195092	http://dx.doi.org/10.1371/journal.pone.0195092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664959	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300013
J	Mokdad, AH; Palmisano, EB; Zuniga-Brenes, P; Rios-Zertuche, D; Johanns, CK; Schaefer, A; Desai, SS; Haakenstad, A; Gagnier, MC; McNellan, CR; Colombara, DV; Romero, SL; Castillo, L; Salvatierra, B; Hernandez, B; Betancourt-Cravioto, M; Mujica-Rosales, R; Regalia, F; Tapia-Conyer, R; Iriarte, E				Mokdad, Ali H.; Palmisano, Erin B.; Zuniga-Brenes, Paola; Rios-Zertuche, Diego; Johanns, Casey K.; Schaefer, Alexandra; Desai, Sima S.; Haakenstad, Annie; Gagnier, Marielle C.; McNellan, Claire R.; Colombara, Danny V.; Lopez Romero, Sonia; Castillo, Leolin; Salvatierra, Benito; Hernandez, Bernardo; Betancourt-Cravioto, Miguel; Mujica-Rosales, Ricardo; Regalia, Ferdinando; Tapia-Conyer, Roberto; Iriarte, Emma			Supply-side interventions to improve health: Findings from the Salud Mesoamerica Initiative	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; 187 COUNTRIES; CHILD HEALTH; 21 REGIONS; DISEASE; PERFORMANCE; MORTALITY; INJURIES; SERVICES	Background Results-based aid (RBA) is increasingly used to incentivize action in health. In Mesoamerica, the region consisting of southern Mexico and Central America, the RBA project known as the Salud Mesoamearica Initiative (SMI) was designed to target disparities in maternal and child health, focusing on the poorest 20% of the population across the region. Methods and findings Data were first collected in 365 intervention health facilities to establish a baseline of indicators. For the first follow-up measure, 18 to 24 months later, 368 facilities were evaluated in these same areas. At both stages, we measured a near-identical set of supply-side performance indicators in line with country-specific priorities in maternal and child health. All countries showed progress in performance indicators, although with different levels. El Salvador, Honduras, Nicaragua, and Panama reached their 18-month targets, while the State of Chiapas in Mexico, Guatemala, and Belize did not. A second follow-up measurement in Chiapas and Guatemala showed continued progress, as they achieved previously missed targets nine to 12 months later, after implementing a performance improvement plan. Conclusions Our findings show an initial success in the supply-side indicators of SMI. Our data suggest that the RBA approach can be a motivator to improve availability of drugs and services in poor areas. Moreover, our innovative monitoring and evaluation framework will allow health officials with limited resources to identify and target areas of greatest need.	[Mokdad, Ali H.; Palmisano, Erin B.; Johanns, Casey K.; Schaefer, Alexandra; Desai, Sima S.; Haakenstad, Annie; Gagnier, Marielle C.; McNellan, Claire R.; Colombara, Danny V.; Hernandez, Bernardo] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Zuniga-Brenes, Paola; Rios-Zertuche, Diego; Iriarte, Emma] Interamer Dev Bank, Salud Mesoamer Initiat, Edificio Tower Financial Ctr Towerbank, Panama City, Panama; [Lopez Romero, Sonia] UNIMER, San Salvador, El Salvador; [Castillo, Leolin] Univ Belize, Belmopan, Belize; [Salvatierra, Benito] Colegio Frontera Sur, San Cristobal de las Casa, Chiapas, Mexico; [Betancourt-Cravioto, Miguel; Mujica-Rosales, Ricardo; Tapia-Conyer, Roberto] Fdn Carlos Slim, Delegac Miguel Hidalgo, Mexico City, DF, Mexico; [Regalia, Ferdinando] Interamer Dev Bank, Washington, DC USA	Institute for Health Metrics & Evaluation; El Colegio de la Frontera Sur (ECOSUR); Inter-American Development Bank	Mokdad, AH (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA USA.	mokdaa@uw.edu	McNellan, Claire/GMW-6098-2022; Mokdad, Ali H./AAD-1232-2022; Rios-Zertuche, Diego/AAG-2710-2020; Prado, Bernardo Hernandez/AAG-9292-2019	Mokdad, Ali H./0000-0002-4994-3339; Rios-Zertuche, Diego/0000-0003-1853-728X; Prado, Bernardo Hernandez/0000-0002-5960-8841; Tapia-Conyer, Roberto/0000-0001-9425-7322	Bill & Melinda Gates Foundation; Spanish Agency for International Development Cooperation; Carlos Slim Foundation through the Inter American Development Bank	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Spanish Agency for International Development Cooperation(Spanish Government); Carlos Slim Foundation through the Inter American Development Bank	This study was funded by the Bill & Melinda Gates Foundation, the Spanish Agency for International Development Cooperation, and the Carlos Slim Foundation, through the Inter American Development Bank.	[Anonymous], 2011, INF RES ENC SAL SEX; Asociacion Demografica (ADS) Division of Reproductive Health-Centers for Disease Control and Prevention (CDC)., 2009, SALV REPR HLTH SURV; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Beane CR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-92; Blacklock C, 2016, STUD FAMILY PLANN, V47, P309, DOI 10.1111/sifp.12001; Braveman P, 2002, SOC SCI MED, V54, P1621, DOI 10.1016/S0277-9536(01)00331-8; Costa Rican Institute for Research and Education on Nutrition and Health Costa Rican Social Security Fund (CCCS) Institute of Nutrition of Central America and Panama Ministry of Health (Costa Rica) National Institute of Statistics and Censuses (Costa Rica), 2009, COST RIC NAT NUTR SU; Das A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2982-4; Directorate of Statistics and Census (Panama) Ministry of Economy and Finance (Panama) World Bank, 2008, PAN LIV STAND MEAS S; El Bcheraoui C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187107; Fox S, 2014, HEALTH POLICY PLANN, V29, P96, DOI 10.1093/heapol/czs138; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Grace Chee NH, 2007, GAVI IMMUNIZATION SE; Grittner, 2013, RESULTS BASED FINANC; Honda A., 2012, HLTH POLICY PLAN; ICF International National Institute of Statistics (Honduras), 2013, HOND DEM HLTH SURV 2; Instituto Conmemorativo Gorgas de Estudios de la Salud (Panama), 2010, PAN NAT SURV SEX REP; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Klingebiel S., 2012, RESULTS BASED AID RB; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Meessen B, 2017, HEALTH SYST REFORM, V3, P129, DOI 10.1080/23288604.2017.1303561; Meessen B, 2011, B WORLD HEALTH ORGAN, V89, P153, DOI 10.2471/BLT.10.077339; Ministry of Health (Nicaragua) National Institute for Development Information (Nicaragua), 2013, NIC NAT DEM HLTH SUR; Mokdad AH, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0034-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Institute of Public Health (Mexico), 2012, MEX NAT SURV HLTH NU; National Institute of Statistics and Censuses (INEC) (Costa Rica), 2009, COST RIC MULT HOUS S; Oxman Andrew D, 2009, J Evid Based Med, V2, P70, DOI 10.1111/j.1756-5391.2009.01020.x; Pearson M, 2010, REV MAJOR RESULTS BA; Perakis R, 2015, 052 CTR GLOB DEV; Renmans D, 2017, HEALTH POLICY PLANN, V32, P860, DOI 10.1093/heapol/czx030; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Statistical Institute of Belize United Nations Children's Fund (UNICEF), 2006, BEL MULT IND CLUST S; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; WHO, LEARN LESS IMPL PERF	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195292	10.1371/journal.pone.0195292	http://dx.doi.org/10.1371/journal.pone.0195292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659586	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100012
J	Bougle, A; Bombled, C; Margetis, D; Lebreton, G; Vidal, C; Coroir, M; Hajage, D; Amour, J				Bougle, Adrien; Bombled, Camille; Margetis, Dimitri; Lebreton, Guillaume; Vidal, Charles; Coroir, Marine; Hajage, David; Amour, Julien			Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: Epidemiology and risk factors of treatment failure	PLOS ONE			English	Article							CARDIOPULMONARY BYPASS; NOSOCOMIAL INFECTIONS; CARDIOGENIC-SHOCK; THERAPY; PHARMACOKINETICS; OUTCOMES	Introduction Ventilator-associated pneumonia (VAP) is frequent in Intensive Care Unit (ICU) patients. In the specific case of patients treated with Veno-Arterial Extracorporeal Membrane Oxygenation Support (VA-ECMO), VAP treatment failures (VAP-TF) have been incompletely investigated. Methods To investigate the risk factors of treatment failure (VAP-TF) in a large cohort of ICU patients treated with VA-ECMO, we conducted a retrospective study in a Surgical ICU about patients assisted with VA-ECMO between January 1, 2013, and December 31, 2014. Diagnosis of VAP was confirmed by a positive quantitative culture of a respiratory sample. VAP-TF was defined as composite of death attributable to pneumonia and relapse within 28 days of the first episode. Results In total, 152 patients underwent ECMO support for > 48h. During the VA-ECMO support, 85 (55.9%) patients developed a VAP, for a rate of 60.6 per 1000 ECMO days. The main pathogens identified were Pseudomonas aeruginosa and Enterobacteriaceae. VAP-TF occurred in 37.2% of patients and was associated with an increased 28-day mortality (Hazard Ratio 3.05 [1.66; 5.63], P<0.001), and VA-ECMO assistance duration (HR 1.47 [1.05-2.05], P = 0.025). Risk factors for VAP-TF were renal replacement therapy (HR 13.05 [1.73; 98.56], P = 0.013) and documentation of Pseudomonas aeruginosa (HR 2.36 [1.04; 5.35], P = 0.04). Conclusions VAP in patients treated with VA-ECMO is associated with an increased morbidity and mortality. RRT and infection by Pseudomonas aeruginosa appear as strong risks factors of treatment failure. Further studies seem necessary to precise the best antibiotic management in these patients.	[Bougle, Adrien; Bombled, Camille; Margetis, Dimitri; Vidal, Charles; Coroir, Marine; Amour, Julien] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Anesthesiol & Crit Care Med,Inst Cardiol, Paris, France; [Lebreton, Guillaume; Amour, Julien] Sorbonne Univ, Pitie Salpetriere Hosp, INSERM, UMR 1166,IHU ICAN, Paris, France; [Lebreton, Guillaume] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Thorac & Cardiovasc Surg,Inst Cardiol, Paris, France; [Hajage, David] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Biostat Publ Hlth & Med Informat, Paris, France; [Hajage, David] Univ Paris Diderot, Sorbonne Paris Cite, ECEVE, UMR 1123, Paris, France; [Hajage, David] INSERM, UMR 1123, ECEVE, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bougle, A (corresponding author), Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Anesthesiol & Crit Care Med,Inst Cardiol, Paris, France.	adrien.bougle@aphp.fr	Hajage, David/D-5226-2014; Charles, Vidal/AAI-3248-2020	Hajage, David/0000-0002-8475-4090; Lebreton, Guillaume/0000-0003-4308-506X				Allou N, 2014, CRIT CARE MED, V42, P1150, DOI 10.1097/CCM.0000000000000143; Aubron C, 2013, INFECT CONT HOSP EP, V34, P24, DOI 10.1086/668439; Beumier M, 2014, CRIT CARE, V18, DOI 10.1186/cc13886; Bizzarro MJ, 2011, PEDIATR CRIT CARE ME, V12, P277, DOI 10.1097/PCC.0b013e3181e28894; Chalk K, 2013, CRIT CARE, V17, DOI 10.1186/cc13148; Cheng R, 2014, ANN THORAC SURG, V97, P610, DOI 10.1016/j.athoracsur.2013.09.008; Donadello K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0632-8; Donadello K, 2015, INT J ANTIMICROB AG, V45, P278, DOI 10.1016/j.ijantimicag.2014.11.005; Filsoufi F, 2008, CHEST, V133, P713, DOI 10.1378/chest.07-1028; Hadley JS, 2007, SHOCK, V27, P466, DOI 10.1097/01.shk.0000245033.69977.c5; Karagiannidis C, 2016, INTENS CARE MED, V42, P889, DOI 10.1007/s00134-016-4273-z; Lauzier F, 2008, J CRIT CARE, V23, P50, DOI 10.1016/j.jcrc.2008.01.006; Meduri GU, 1994, CHEST; Mekontso-Dessap A, 2005, SHOCK, V24, P109, DOI 10.1097/01.shk.0000171871.50524.81; O'Neill JM, 2001, INTENS CARE MED, V27, P1247, DOI 10.1007/s001340101029; Roberts DM, 2012, CRIT CARE MED, V40, P1523, DOI 10.1097/CCM.0b013e318241e553; Roberts JA, 2009, CRIT CARE MED, V37, P840, DOI 10.1097/CCM.0b013e3181961bff; Schmidt M, 2012, CLIN INFECT DIS, V55, P1633, DOI 10.1093/cid/cis783; Shekar K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0565-2; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Sun HY, 2010, J THORAC CARDIOV SUR, V140, P1125, DOI 10.1016/j.jtcvs.2010.07.017; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wilhelm W, 2002, SHOCK, V17, P354, DOI 10.1097/00024382-200205000-00002	23	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194976	10.1371/journal.pone.0194976	http://dx.doi.org/10.1371/journal.pone.0194976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652913	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900015
J	Ge, YQ; Zhong, YJ; Ji, GZ; Lu, QL; Dai, XY; Guo, ZR; Zhang, P; Peng, G; Zhang, KZ; Li, YT				Ge, Yaoqi; Zhong, Yuejiao; Ji, Guozhong; Lu, Qianling; Dai, Xinyu; Guo, Zhirui; Zhang, Peng; Peng, Gang; Zhang, Kangzhen; Li, Yuntao			Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma	PLOS ONE			English	Article							GOLD NANOPARTICLES; BRAIN-TUMORS; IN-VIVO; ANTIBODIES; RECEPTOR; CELLS; SPECTROSCOPY; COMBINATION; ADSORPTION; ERLOTINIB	Objective To study the characterization of Fe3O4@Au-C225 composite targeted MNPs. Methods Fe3O4@Au-C225 was prepared by the absorption method. The immunosorbent assay was used to evaluate its absorption efficiency at C225 Fc. ZETA SIZER3000 laser particle size analyzer, ultraviolet photometer and its characteristics were analyzed by VSM. the targeting effect of Fe3O4@Au-C225 composite targeted MNPs on U251 cells in vitro were detected by 7.0 Tesla Micro-MR; and subcutaneous transplanted human glioma in nude mice were performed the targeting effect in vivo after tail vein injection of Fe3O4@Au-C225 composite targeted MNPs by MRI. Results The self-prepared Fe3O4@Au composite MNPs can adsorb C225 with high efficiency of adsorption so that Fe3O4@Au-C225 composite targeted MNPs were prepared successfully. Fe3O4@Au-C225 composite targeted MNPs favorably targeted human glioma cell line U251 in vitro; Fe3O4@Au-C225 composite targeted MNPs have good targeting ability to xenografted glioma on nude mice in vivo, and can be traced by MRI. Conclusion The Fe3O4@Au-C225 composite targeted MNPs have the potential to be used as a tracer for glioma in vivo.	[Ge, Yaoqi; Ji, Guozhong; Lu, Qianling; Dai, Xinyu; Guo, Zhirui; Zhang, Peng; Peng, Gang; Zhang, Kangzhen; Li, Yuntao] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Zhong, Yuejiao] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Zhong, Yuejiao] Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Li, YT (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China.	422780515@qq.com	Li, Yuntao/AFE-3730-2022		National Natural Science Foundation of China [81301313]; Natural Science Foundation of Jiangsu Province [BK20131015, BK20141015]; Jiangsu Provincial College Students' Practical Innovation Training Program [201410312015Z]; Nanjing Developing Project of Medical Science [YKK13174]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial College Students' Practical Innovation Training Program; Nanjing Developing Project of Medical Science	This work was supported by the National Natural Science Foundation of China [grant number: 81301313], the Natural Science Foundation of Jiangsu Province [grant number: BK20131015 and BK20141015], the Jiangsu Provincial College Students' Practical Innovation Training Program [grant number: 201410312015Z], and the Nanjing Developing Project of Medical Science [grant number: YKK13174]. We would like to thank Prof. Yang Shao, Dr. Xiao Tan and Dr. Jinyan Wang for the critical reading, advice, and comments of the manuscript.	Aioub M, 2016, J AM CHEM SOC, V138, P1258, DOI 10.1021/jacs.5b10997; Barth RF, 2016, ONCOTARGETS THER, V9, P2769, DOI 10.2147/OTT.S99242; Berger C, 2012, EXP CELL RES, V318, P2578, DOI 10.1016/j.yexcr.2012.09.001; Bos C, 2004, RADIOLOGY, V233, P781, DOI 10.1148/radiol.2333031714; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Chung EJ, 2013, INT J ONCOL, V42, P2028, DOI 10.3892/ijo.2013.1890; de Robles P, 2015, NEURO-ONCOLOGY, V17, P776, DOI 10.1093/neuonc/nou283; England CG, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15231-1; Garcinuno RM, 2000, TALANTA, V52, P825, DOI 10.1016/S0039-9140(00)00435-5; Jin B, 2012, LANGMUIR, V28, P9460, DOI 10.1021/la300819u; John Mendelsohn, 2008, MOL TARGETING ONCOLO; Johnson BN, 2012, LANGMUIR, V28, P6928, DOI 10.1021/la3009128; Joshi PP, 2013, BIOCONJUGATE CHEM, V24, P878, DOI 10.1021/bc3004815; [居胜红 JU Shenghong], 2006, [中华放射学杂志, Chinese Journal of Radiology], V40, P127; Kao HW, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/29/295102; Karyakin AA, 2000, ANAL CHEM, V72, P3805, DOI 10.1021/ac9907890; Kelton C, 2012, ARCH BIOCHEM BIOPHYS, V526, P219, DOI 10.1016/j.abb.2012.03.005; Kim ES, 2001, CURR OPIN ONCOL, V13, P506, DOI 10.1097/00001622-200111000-00014; Klingler S, 2015, CANCER RES, V75, P2109, DOI 10.1158/0008-5472.CAN-14-3122; Kustermann E, 2005, NMR BIOMED, V18, P362, DOI 10.1002/nbm.967; Lee JR, 2013, EXPERT REV PROTEOMIC, V10, P65, DOI [10.1586/epr.12.67, 10.1586/EPR.12.67]; Li YT, 2011, INT J NANOMED, V6, P2805, DOI 10.2147/IJN.S24596; Llavero F, 2016, CELL SIGNAL, V28, P1713, DOI 10.1016/j.cellsig.2016.07.014; Pare-Brunet L, 2014, HUM MUTAT, V35, P227, DOI 10.1002/humu.22475; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Sato MR, 2015, CURR TOP MED CHEM, V15, P287, DOI 10.2174/1568026615666150108145614; Serkova Natalie J., 2013, CURRENT MOL IMAGING, V2, P53, DOI [10.2174/2211555211302010007, DOI 10.2174/2211555211302010007]; Sokolov K, 2003, CANCER RES, V63, P1999; [汤俊琪 Tang Junqi], 2010, [食品与生物技术学报, Journal of Food Science and Biotechnology], V29, P533; Unger EC, 2003, RADIOLOGY, V229, P615, DOI 10.1148/radiol.2293031017; Wang Y, 2014, TALANTA, V119, P320, DOI 10.1016/j.talanta.2013.11.026; Wen PY, 2014, NEURO-ONCOLOGY, V16, P567, DOI 10.1093/neuonc/not247; Wu ZS, 2005, ANAL BIOCHEM, V337, P308, DOI 10.1016/j.ab.2004.10.051; Yung WKA, 2010, NEURO-ONCOLOGY, V12, P1061, DOI 10.1093/neuonc/noq072; Zhou Y, 2012, MOL CANCER THER, V11, P1467, DOI 10.1158/1535-7163.MCT-11-1038	35	13	13	9	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195703	10.1371/journal.pone.0195703	http://dx.doi.org/10.1371/journal.pone.0195703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652919	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900033
J	Rivera-Valdes, JJ; Garcia-Banuelos, J; Salazar-Montes, A; Garcia-Benavides, L; Dominguez-Rosales, A; Armendariz-Borunda, J; Sandoval-Rodriguez, A				Rivera-Valdes, Juan Jose; Garcia-Banuelos, Jesus; Salazar-Montes, Adriana; Garcia-Benavides, Leonel; Dominguez-Rosales, Alfredo; Armendariz-Borunda, Juan; Sandoval-Rodriguez, Ana			Human adipose derived stem cells regress fibrosis in a chronic renal fibrotic model induced by adenine (vol 12, e0187907, 2017)	PLOS ONE			English	Correction													Armendáriz-Borunda, Juan/AAU-1471-2021	Rivera-Valdes, Juan Jose/0000-0001-7424-7979				Rivera-Valdes JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187907	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0196045	10.1371/journal.pone.0196045	http://dx.doi.org/10.1371/journal.pone.0196045			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652943	gold, Green Published, Green Submitted			2022-12-27	WOS:000430026900057
J	Yoshimura, EH; Santos, NW; Machado, E; Agustinho, BC; Pereira, LM; de Aguiar, SC; Sa-Nakanishi, AB; Mareze-da-Costa, CE; Zeoula, LM				Yoshimura, Emerson H.; Santos, Nadine W.; Machado, Erica; Agustinho, Bruna C.; Pereira, Lucelia M.; de Aguiar, Silvia C.; Sa-Nakanishi, Anacharis B.; Mareze-da-Costa, Cecilia E.; Zeoula, Lucia M.			Functionality of cow milk naturally enriched with polyunsaturated fatty acids and polyphenols in diets for diabetic rats	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BROWN ADIPOSE-TISSUE; DAIRY CONSUMPTION; MEDICINAL-PLANTS; KIDNEY-DISEASE; INSULIN; RISK; SUPPLEMENTATION; COMPLICATIONS; METAANALYSIS	The increasing incidence of diabetes mellitus is becoming a serious threat to human health in various parts of the world. Studies with dairy products have shown a potential beneficial effect against diabetes. This experiment evaluated the supplementation of milk naturally enriched with polyunsaturated fatty acids (PUFA) and polyphenols in rats with streptozotocin-induced diabetes. Forty male 28-day-old Wistar rats were distributed in four experimental treatments of diabetic animals (streptozotocin induction) and a normal group (non-induced). Experimental treatments were: control (water), whole common milk (COM-M), milk enriched with PUFA (PUFA-M), milk enriched with PUFA and polyphenols (PUFA/P-M) through a special diet offered to dairy cows. Milk supplementation at a dose 5 mL/kg body weight was performed for 77 days, 42 days before and 35 days after diabetes induction. The COM-M supplementation increased brown fat deposits, reduced post-induction glucose levels, reduced blood fructosamine levels, and improved glucose tolerance. Milk enriched with PUFA reduced final fasting glucose, LDL levels, and improved blood antioxidant capacity. Milk enriched with PUFA and polyphenols promoted an increase in gastrocnemius muscle mass, and a reduction in mesenteric fat and LDL levels. Milk intake, with an emphasis on milk enriched with PUFA and polyphenols, attenuated the metabolic disorders of streptozotocin-induced diabetes in rats.	[Yoshimura, Emerson H.; Santos, Nadine W.; Machado, Erica; Agustinho, Bruna C.; Pereira, Lucelia M.] Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil; [de Aguiar, Silvia C.] Univ Estado Mato Grosso, Dept Zootecnia, Pontes E Lacerda, Brazil; [Sa-Nakanishi, Anacharis B.] Univ Estadual Maringa, Dept Bioquim, Maringa, Parana, Brazil; [Mareze-da-Costa, Cecilia E.] Univ Estadual Maringa, Dept Ciencias Fisiol, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade do Estado de Mato Grosso; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Santos, NW (corresponding author), Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil.	santos.woruby.n@gmail.com	Nakanishi, Anacharis/AAQ-1911-2020; de Aguiar, Silvia/N-1453-2019	Nakanishi, Anacharis/0000-0002-2300-1861; de Aguiar, Silvia/0000-0001-5497-2559; Calvo Agustinho, Bruna/0000-0001-5917-234X; Woruby Santos, Nadine/0000-0003-0996-8213	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, DF, Brazil) [485566/2012-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, DF, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, DF, Brazil), statement number 485566/2012-5, Universal/2012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, REP HLTH SOC SUBJ LO, V46, P1; Aune D, 2013, AM J CLIN NUTR, V98, P1066, DOI 10.3945/ajcn.113.059030; Ballali S, 2012, INT J FOOD SCI NUTR, V63, P51, DOI 10.3109/09637486.2011.637487; BERNARDIS LL, 1968, J ENDOCRINOL, V40, P527, DOI 10.1677/joe.0.0400527; Brazilian Institute of Geography and Statistics, 2008, ANTHR NUTR STAT CHIL; Brazilian Ministry of Health, 2008, FEED GUID BRAZ POP P; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Connell JEO, 2001, SIGNIFICANCE APPL PH, V11, P103; DiGirolamo M, 1998, AM J PHYSIOL-REG I, V274, pR1460, DOI 10.1152/ajpregu.1998.274.5.R1460; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Faure P, 1995, ANAL FREE RADICALS B, P238; Flachs P, 2014, PHYSIOL RES, V63, pS93, DOI 10.33549/physiolres.932715; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gagnon N, 2009, BRIT J NUTR, V102, P1015, DOI 10.1017/S0007114509344104; Guadarrama-Lopez AL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/860703; Harlev E, 2013, PLANTA MED, V79, P425, DOI 10.1055/s-0032-1328331; Hirahatake KM, 2014, METABOLISM, V63, P618, DOI 10.1016/j.metabol.2014.02.009; Horton WB, 2015, BMJ OPEN DIAB RES CA, V3, DOI [10.1136/bmjdrc-2015-000082, 10.1136/bmjdrc-2015000082]; Jakubowicz D, 2013, J NUTR BIOCHEM, V24, P1, DOI 10.1016/j.jnutbio.2012.07.008; Koga M, 2014, CLIN CHIM ACTA, V433, P96, DOI 10.1016/j.cca.2014.03.001; Kollias AN, 2010, DTSCH ARZTEBL INT, V107, P75, DOI 10.3238/arztebl.2010.0075; Lidell ME, 2014, J INTERN MED, V276, P364, DOI 10.1111/joim.12255; Malviya N, 2010, ACTA POL PHARM, V67, P113; Mirmiran P, 2014, WORLD J DIABETES, V5, P267, DOI 10.4239/wjd.v5.i3.267; Muley A, 2014, CURR DIABETES REV, V10, P158, DOI 10.2174/1573399810666140515113137; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Palsson R, 2014, ADV CHRONIC KIDNEY D, V21, P273, DOI 10.1053/j.ackd.2014.03.003; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P320, DOI 10.1016/S2221-1691(12)60032-X; Payne AJ, 2014, INT J MOL SCI, V15, P1865, DOI 10.3390/ijms15021865; Qidwai Waris, 2014, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V13, P3; Rice BH, 2013, NUTR REV, V71, P209, DOI 10.1111/nure.12007; Santos NW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172909; Santos NW, 2016, LIVEST SCI, V191, P132, DOI 10.1016/j.livsci.2016.07.012; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Silva S, 2015, AM J CLIN NUTR, V101, P44, DOI 10.3945/ajcn.114.094219; Smith-Palmer J, 2014, DIABETES RES CLIN PR, V105, P273, DOI 10.1016/j.diabres.2014.06.007; Sponer Pavel, 2013, Acta Medica (Hradec Kralove), V56, P3; Strahan Stephen, 2013, Asian Cardiovasc Thorac Ann, V21, P281, DOI 10.1177/0218492312451983; Struijk EA, 2013, NUTR METAB CARDIOVAS, V23, P822, DOI 10.1016/j.numecd.2012.05.011; Sun X, 2006, INT J OBESITY, V30, P1341, DOI 10.1038/sj.ijo.0803294; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823	43	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195839	10.1371/journal.pone.0195839	http://dx.doi.org/10.1371/journal.pone.0195839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652940	gold, Green Submitted, Green Published			2022-12-27	WOS:000430026900039
J	You, CH; Choi, JH; Kang, S; Oh, EH; Kwon, YD				You, Chang Hoon; Choi, Ji Heon; Kang, Sungwook; Oh, Eun-Hwan; Kwon, Young Dae			Association between supplementary private health insurance and visits to physician offices versus hospital outpatient departments among adults with diabetes in the universal public insurance system	PLOS ONE			English	Article							CARE; DEMAND; DETERMINANTS; SELECTION; SERVICES; COVERAGE	Background Diabetes mellitus is a chronic disease with a high prevalence across the world as well as in South Korea. Most cases of diabetes can be adequately managed at physician offices, but many diabetes patients receive outpatient care at hospitals. This study examines the relationship between supplementary private health insurance (SPHI) ownership and the use of hospitals among diabetes outpatients within the universal public health insurance scheme. Methods Data from the 2011 Korea Health Panel, a nationally representative sample of Korean individuals, was used. For the study, 6,379 visits for diabetes care were selected while controlling for clustered errors. Multiple logistic regression models were used to examine determinants of hospital outpatient services. Results This study demonstrated that the variables of self-rated health status, comorbidity, unmet need, and alcohol consumption significantly correlated with the choice to use a hospital services. Patients with SPHI were more likely to use medical services at hospitals by 1.71 times (95% CI 1.068-2.740, P = 0.026) compared to patients without SPHI. Conclusions It was confirmed that diabetic patients insured by SPHI had more use of hospital services than those who were not insured. People insured by SPHI seem to be more likely to use hospital services because SPHI lightens the economic burden of care.	[You, Chang Hoon] Catholic Univ Korea, Grad Sch Healthcare Management & Policy, Seoul, South Korea; [Choi, Ji Heon] Int Inst Hlth, Seoul, South Korea; [Kang, Sungwook] Daegu Haany Univ, Dept Publ Hlth, Gyongsan, South Korea; [Oh, Eun-Hwan] Hyupsung Univ, Dept Healthcare Management, Hwaseong, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea	Catholic University of Korea; Daegu Haany University; Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.; Kwon, YD (corresponding author), Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017	Kwon, Young Dae/0000-0002-8781-6832; You, Chang Hoon/0000-0001-7938-266X				Bausell RB, 2001, MED CARE, V39, P190, DOI 10.1097/00005650-200102000-00009; Bryan RN, 2013, EUR RADIOL, V23, P1, DOI 10.1007/s00330-012-2713-x; Buchmueller TC, 2004, HEALTH ECON, V13, P669, DOI 10.1002/hec.879; Casagrande SS, 2012, DIABETES CARE, V35, P2243, DOI 10.2337/dc12-0257; Doiron D, 2008, HEALTH ECON, V17, P317, DOI 10.1002/hec.1267; Emmerson C., 2001, SHOULD PRIVATE MEDIC, P49; HAYES TM, 1984, BRIT MED J, V289, P728, DOI 10.1136/bmj.289.6447.728; Jeon B, 2013, HEALTH POLICY, V113, P69, DOI 10.1016/j.healthpol.2013.05.007; Jung Y., 2010, REPORT KOREA HLTH PA; Kang S, 2009, J FORMOS MED ASSOC, V108, P912, DOI 10.1016/S0929-6646(10)60003-4; Kiil A, 2014, EUR J HEALTH ECON, V15, P813, DOI 10.1007/s10198-013-0526-8; King D, 2005, HEALTH SERV RES, V40, P195, DOI 10.1111/j.1475-6773.2005.00349.x; Korean Diabetes Association National Health Insurance Service, 2015, KOR DIAB FACT SHEET; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lee JC, 2012, J KOREAN MED ASSOC, V55, P1215, DOI 10.5124/jkma.2012.55.12.1215; Liu TC, 2002, SOC SCI MED, V55, P755, DOI 10.1016/S0277-9536(01)00201-5; LOHR KN, 1986, MED CARE, V24, pUS1; MANNING WG, 1987, AM ECON REV, V77, P251; Oh HJ, 2011, J KOREAN MED ASSOC, V54, P205, DOI 10.5124/jkma.2011.54.2.205; POHLMEIER W, 1995, J HUM RESOUR, V30, P339, DOI 10.2307/146123; Rodriguez M, 2004, HEALTH ECON, V13, P689, DOI 10.1002/hec.832; Sapelli C, 2003, J HEALTH ECON, V22, P459, DOI 10.1016/S0167-6296(02)00121-2; Song Y.J., 2009, JAPAN MED ASS J, V52, P206; Vera-Hernandez AM, 1999, HEALTH ECON, V8, P579, DOI 10.1002/(SICI)1099-1050(199911)8:7<579::AID-HEC478>3.0.CO;2-P; Victoor A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-272; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Yip WC, 1998, HEALTH POLICY PLANN, V13, P311, DOI 10.1093/heapol/13.3.311; Yoon Chai-Hyun, 2007, J Prev Med Public Health, V40, P51; You CH, 2012, J KOREAN MED ASSOC, V55, P898, DOI 10.5124/jkma.2012.55.9.898; 박영희, 2012, [The Korean Journal of Health Service Management, 보건의료산업학회지], V6, P83	31	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0192205	10.1371/journal.pone.0192205	http://dx.doi.org/10.1371/journal.pone.0192205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652882	Green Submitted, gold, Green Published			2022-12-27	WOS:000430026900002
J	Dunne, EM; Murad, C; Sudigdoadi, S; Fadlyana, E; Tarigan, R; Indriyani, SAK; Pell, CL; Watts, E; Satzke, C; Hinds, J; Dewi, NE; Yani, FF; Rusmil, K; Mulholland, EK; Kartasasmita, C				Dunne, Eileen M.; Murad, Chrysanti; Sudigdoadi, Sunaryati; Fadlyana, Eddy; Tarigan, Rodman; Indriyani, Sang Ayu Kompiyang; Pell, Casey L.; Watts, Emma; Satzke, Catherine; Hinds, Jason; Dewi, Nurhandini Eka; Yani, Finny Fitry; Rusmil, Kusnandi; Mulholland, E. Kim; Kartasasmita, Cissy			Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional study	PLOS ONE			English	Article							NASOPHARYNGEAL CARRIAGE; HEALTHY-CHILDREN; LOMBOK ISLAND; OTITIS-MEDIA; RESISTANCE; VACCINATION; PREVALENCE; BACTERIAL; DENSITY	Streptococcus pneumoniae is an important cause of infection and commonly colonizes the nasopharynx of young children, along with other potentially pathogenic bacteria. The objectives of this study were to estimate the carriage prevalence of S. pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in young children in Indonesia, and to examine interactions between these bacterial species. 302 healthy children aged 12-24 months were enrolled in community health centers in the Bandung, Central Lombok, and Padang regions. Nasopharyngeal swabs were collected and stored according to World Health Organization recommendations, and bacterial species detected by qPCR. Pneumococcal serotyping was conducted by microarray and latex agglutination/Quellung. Overall carriage prevalence was 49.5% for S. pneumoniae, 27.5% for H. influenzae, 42.7% for M. catarrhalis, and 7.3% for S. aureus. Prevalence of M. catarrhalis and S. pneumoniae, as well as pneumococcal serotype distribution, varied by region. Positive associations were observed for S. pneumoniae and M. catarrhalis (OR 3.07 [95%CI 1.91-4.94]), and H. influenzae and M. catarrhalis (OR 2.34 [95%CI 1.40-3.91]), and a negative association was found between M. catarrhalis and S. aureus (OR 0.06 [95%CI 0.01-0.43]). Densities of S. pneumoniae, H. influenzae, and M. catarrhalis were positively correlated when two of these species were present. Prior to pneumococcal vaccine introduction, pneumococcal carriage prevalence and serotype distribution varies among children living in different regions of Indonesia. Positive associations in both carriage and density identified among S. pneumoniae, H. influenzae, and M. catarrhalis suggest a synergistic relationship among these species with potential clinical implications.	[Dunne, Eileen M.; Pell, Casey L.; Watts, Emma; Satzke, Catherine] Murdoch Childrens Res Inst, Pneumococcal Res, Parkville, Vic, Australia; [Dunne, Eileen M.; Satzke, Catherine; Mulholland, E. Kim] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Murad, Chrysanti; Sudigdoadi, Sunaryati] Univ Padjadjaran, Fac Med, Div Microbiol, Dept Biomed Sci, Bandung, West Java, Indonesia; [Fadlyana, Eddy; Tarigan, Rodman; Rusmil, Kusnandi; Kartasasmita, Cissy] Univ Padjadjaran, Dept Child Hlth, Hasan Sadikin Gen Hosp, Bandung, West Java, Indonesia; [Indriyani, Sang Ayu Kompiyang] West Nusa Tenggara Prov Gen Hosp, Mataram, West Nusa Tengg, Indonesia; [Satzke, Catherine] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Hinds, Jason] St Georges Univ London, Inst Infect & Immun, London, England; [Hinds, Jason] London Biosci Innovat Ctr, BUGS Biosci, London, England; [Dewi, Nurhandini Eka] Dist Hlth Off Cent Lombok, Praya, West Nusa Tengg, Indonesia; [Yani, Finny Fitry] Univ Andalas, Dept Child Hlth, Padang, West Sumatra, Indonesia; [Mulholland, E. Kim] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England	Murdoch Children's Research Institute; University of Melbourne; Universitas Padjadjaran; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; University of Melbourne; St Georges University London; University of London; University of London Royal Veterinary College; Universitas Andalas; University of London; London School of Hygiene & Tropical Medicine	Kartasasmita, C (corresponding author), Univ Padjadjaran, Dept Child Hlth, Hasan Sadikin Gen Hosp, Bandung, West Java, Indonesia.	cbkarta@gmail.com	Dunne, Eileen M/M-3203-2019	Dunne, Eileen M/0000-0001-5542-0780	BUGS Bioscience; PATH Vaccine Solutions; Victorian Government's Operational Infrastructure Support Program	BUGS Bioscience; PATH Vaccine Solutions; Victorian Government's Operational Infrastructure Support Program	JH is affiliated with BUGS Bioscience, London Bioscience Innovation Centre but is not employed by and receives no personal income from BUGS Bioscience. This study was funded by PATH Vaccine Solutions https"//www.path.org/.Murdoch Children's Research Institute was supported by the Victorian Government's Operational Infrastructure Support Program. PATH Vaccine Solutions was involved in discussions relating to study design and provided salary support for EMD, CM, SS, RT, SAKI, CLP, EW, NED, FFY, KR, EKM, and CK. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103293; [Anonymous], 2011, LAB METHODS DIAGNOSI, V2nd; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Chochua S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167725; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Farida H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087431; Gessner BD, 1998, PEDIATR INFECT DIS J, V17, pS179, DOI 10.1097/00006454-199809001-00018; Habib M, 2014, JOVE-J VIS EXP, DOI 10.3791/51208; Hadinegoro SR, 2016, SE ASIAN J TROP MED, V47, P485; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kandasamy R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114286; Lewnard JA, 2016, J INFECT DIS, V214, P1411, DOI 10.1093/infdis/jiw381; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Manna S, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.06.031; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Ortika Belinda D, 2013, BMC Res Notes, V6, P49, DOI 10.1186/1756-0500-6-49; Perez AC, 2014, PATHOG DIS, V70, P280, DOI 10.1111/2049-632X.12129; Porter BD, 2014, JOVE-J VIS EXP, DOI 10.3791/51747; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Ruohola A, 2013, J INFECTION, V66, P247, DOI 10.1016/j.jinf.2012.12.002; Salter SJ, 2012, MICROBIOL-SGM, V158, P1560, DOI 10.1099/mic.0.056580-0; Satzke C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001903; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Short KR, 2012, MBIO, V3, DOI 10.1128/mBio.00255-12; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Soewignjo S, 2001, CLIN INFECT DIS, V32, P1039, DOI 10.1086/319605; Turner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038271; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; Vergison A, 2008, VACCINE, V26, pG5, DOI 10.1016/j.vaccine.2008.11.006; Weimer KED, 2011, J INFECT DIS, V203, P549, DOI 10.1093/infdis/jiq087	36	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195098	10.1371/journal.pone.0195098	http://dx.doi.org/10.1371/journal.pone.0195098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649269	Green Published, Green Accepted, gold			2022-12-27	WOS:000429791900023
J	Erdei, Z; Schamberger, A; Torok, G; Szebenyi, K; Varady, G; Orban, TI; Homolya, L; Sarkadi, B; Apati, A				Erdei, Zsuzsa; Schamberger, Anita; Torok, Gyorgy; Szebenyi, Kornelia; Varady, Gyorgy; Orban, Tamas I.; Homolya, Laszlo; Sarkadi, Balks; Apati, Agota			Generation of multidrug resistant human tissues by overexpression of the ABCG2 multidrug transporter in embryonic stem cells	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; PROTEIN TRANSPORTER; EXPRESSION PATTERN; DRUG TRANSPORTERS; NULL ALLELES; DIFFERENTIATION; SYSTEM; LOCALIZATION; BCRP/ABCG2; PHENOTYPE	The ABCG2 multidrug transporter provides resistance against various endo- and xenobiotics, and protects the stem cells against toxins and stress conditions. We have shown earlier that a GFP-tagged version of ABCG2 is fully functional and may be used to follow the expression, localization and function of this transporter in living cells. In the present work we have overexpressed GFP-ABCG2, driven by a constitutive (CAG) promoter, in HUES9 human embryonic stem cells. Stem cell clones were generated to express the wild-type and a substrate-mutant (R482G) GFP-ABCG2 variant, by using the Sleeping Beauty transposon system. We found that the stable overexpression of these transgenes did not change the pluripotency and growth properties of the stem cells, nor their differentiation capacity to hepatocytes or cardiomyocytes. ABCG2 overexpression provided increased toxin resistance in the stem cells, and protected the derived cardiomyocytes against doxorubicin toxicity. These studies document the potential of a stable ABCG2 expression for engineering toxin-resistant human pluripotent stem cells and selected stem cell derived tissues.	[Erdei, Zsuzsa; Schamberger, Anita; Torok, Gyorgy; Szebenyi, Kornelia; Varady, Gyorgy; Orban, Tamas I.; Homolya, Laszlo; Sarkadi, Balks; Apati, Agota] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Sarkadi, Balks] Semmelweis Univ, Inst Biophys & Radiat Biol, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University	Apati, A (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	apati@biomembranc.hu	György, Várady/J-8118-2017; Apáti, Ágota/N-1697-2019; Homolya, Laszlo/N-1154-2016; Orban, Tamas/N-1160-2016	Apáti, Ágota/0000-0003-0380-8139; Homolya, Laszlo/0000-0003-1639-8140; Orban, Tamas/0000-0002-3424-3428; Szebenyi, Kornelia/0000-0003-1558-8372	National Research, Development and Innovation Office [KTIAAIK 12-1-2012-0025]; OTKA (Hungary) [K115375, PD121287, K112112]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); OTKA (Hungary)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research has been supported by National Research, Development and Innovation Office (http//nkfihgov.hu/english) grants KTIAAIK 12-1-2012-0025 (LH) and OTKA K115375 (BS), PD121287 (AS), K112112 (TIO) (Hungary). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apati A, 2016, EXPERT OPIN DRUG MET, V12, P77, DOI 10.1517/17425255.2016.1121382; Apati A, 2008, BBA-BIOMEMBRANES, V1778, P2700, DOI 10.1016/j.bbamem.2008.08.010; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Cai J, 2008, PROTOCOL DIRECTED DI; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Das B, 2012, STEM CELLS, V30, P1685, DOI 10.1002/stem.1142; de Jonge-Peeters SDPWM, 2007, CRIT REV ONCOL HEMAT, V62, P214, DOI 10.1016/j.critrevonc.2007.02.003; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Doyle MJ, 2016, STEM CELLS DEV, V25, P277, DOI 10.1089/scd.2015.0272; Erdei Z, 2014, CYTOM PART B-CLIN CY, V86, P299, DOI 10.1002/cyto.b.21168; Erdei Z, 2013, EUR BIOPHYS J BIOPHY, V42, P169, DOI 10.1007/s00249-012-0838-0; Homolya L, 1996, BRIT J CANCER, V73, P849, DOI 10.1038/bjc.1996.151; Honjo Y, 2001, CANCER RES, V61, P6635; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kolacsek O, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-5; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2011, CURR PHARM BIOTECHNO, V12, P647, DOI 10.2174/138920111795163995; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; Liang Y, 2015, PROTEIN CELL, V6, P334, DOI 10.1007/s13238-015-0148-2; Maillet A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25333; Maliepaard M, 2001, CANCER RES, V61, P3458; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Nerada Z, 2016, CYTOM PART A, V89A, P826, DOI 10.1002/cyto.a.22931; Orban TI, 2008, BIOCHEM BIOPH RES CO, V367, P667, DOI 10.1016/j.bbrc.2007.12.172; Orban TI, 2009, STEM CELLS, V27, P1077, DOI 10.1002/stem.45; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Padmanabhan R, 2012, STEM CELLS, V30, P2175, DOI 10.1002/stem.1195; Saison C, 2012, NAT GENET, V44, P174, DOI 10.1038/ng.1070; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sarkadi B, 2010, STEM CELLS, V28, P174, DOI 10.1002/stem.262; Schwabedissen HEMZ, 2011, HANDB EXP PHARMACOL, V201, P325, DOI 10.1007/978-3-642-14541-4_9; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Swierczek M, 2012, EXPERT OPIN BIOL TH, V12, P139, DOI 10.1517/14712598.2012.642358; Szebenyi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12645; Telford WG, 2010, CURR PROTOC CYTOM; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Vander Borght S, 2006, J HISTOCHEM CYTOCHEM, V54, P1051, DOI 10.1369/jhc.5A6912.2006; Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110; Yellamilli A, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00102; Zelinski T, 2012, NAT GENET, V44, P131, DOI 10.1038/ng.1075; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194925	10.1371/journal.pone.0194925	http://dx.doi.org/10.1371/journal.pone.0194925			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649238	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000429791900018
J	Florez, G; Ferrer, V; Garcia, LS; Crespo, MR; Perez, M; Saiz, PA; Cooke, DJ				Florez, Gerardo; Ferrer, Ventura; Garcia, Luis S.; Crespo, Maria R.; Perez, Manuel; Saiz, Pilar A.; Cooke, David J.			Clinician ratings of the Comprehensive Assessment of Psychopathic Personality (CAPP) in a representative sample of Spanish prison inmates: New validity evidence	PLOS ONE			English	Article							PROTOTYPICALITY VALIDATION; PCL-R; CONSTRUCT; MODEL; DISORDERS; BEHAVIOR; CHECKLIST; VIOLENCE; TRAITS	The Comprehensive Assessment of Psychopathic Personality (CAPP) is a concept map of psychopathic personality disorder (PPD). The CAPP-Institutional Rating Scale (IRS) is a tool designed to assess CAPP symptoms in institutional settings. The CAPP contains 33 personality traits organized in six domains: attachment, behavioural, cognitive, dominance, emotional and self. Until now, much of the CAPP research has been conducted out of clinical, forensic and correctional settings using self-ratings. In the current study, the psychometric properties and construct validity of the CAPP-IRS were evaluated in a non-convenience sample of 204 Spanish convicts. Clinician ratings were employed. Participants had been imprisoned for at least 6 months at Pereiro de Aguiar Penitentiary. This group of inmates was heterogeneous with respect to type of official charges, and representative as all convicts interned for at least 6 months in this prison were screened for participation. Classical test theory indexes of reliability, correlations between CAPP items and domains and external correlations and structural analyses demonstrated that CAPP assessment is a solid and robust way of evaluating psychopathy in a correctional setting. Best fit was found for a three factor model: attachment and emotional items associated with a callous and unemotional trait, dominance and self items associated with a pathological interpersonal style, and behavioural and residual items from other domains associated with impulsivity.	[Florez, Gerardo; Saiz, Pilar A.] Ctr Invest Biorned Red Salud Mental CIBERSAM, Oviedo, Spain; [Florez, Gerardo; Ferrer, Ventura; Garcia, Luis S.; Crespo, Maria R.; Perez, Manuel] Pereiro de Aguiar Prison, Dept Hlth, Orense, Spain; [Saiz, Pilar A.] Univ Oviedo, Dept Psychiat, Oviedo, Spain; [Cooke, David J.] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Oviedo; University of Bergen	Florez, G (corresponding author), Ctr Invest Biorned Red Salud Mental CIBERSAM, Oviedo, Spain.; Florez, G (corresponding author), Pereiro de Aguiar Prison, Dept Hlth, Orense, Spain.	gerardof@mundo-r.com	Saiz, Pilar A./ABF-5814-2021	Saiz, Pilar A./0000-0002-5705-4523; , Gerardo/0000-0001-7850-2594	Secretaria de Estado de Servicios Sociales e Igualdad, Ministerio de Sanidad, Servicios Sociales e Igualdad. Gobierno de Espana [2014/009]; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental, CIBERSAM	Secretaria de Estado de Servicios Sociales e Igualdad, Ministerio de Sanidad, Servicios Sociales e Igualdad. Gobierno de Espana; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental, CIBERSAM(Instituto de Salud Carlos III)	This work was supported by Secretaria de Estado de Servicios Sociales e Igualdad, Ministerio de Sanidad, Servicios Sociales e Igualdad. Gobierno de Espana. Grant number: 2014/009 to G.F The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental, CIBERSAM.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Blackburn R, 2007, J PERS DISORD, V21, P142, DOI 10.1521/pedi.2007.21.2.142; Blair RJR, 2013, SOC NEUROSCI-UK, V8, P108, DOI 10.1080/17470919.2012.757869; Cale J, 2015, J CRIM JUST, V43, P337, DOI 10.1016/j.jcrimjus.2015.04.005; Cooke DJ, 2007, BRIT J PSYCHIAT, V190, pS39, DOI 10.1192/bjp.190.5.s39; Cooke DJ, 2015, J CRIM JUST, V43, P262, DOI 10.1016/j.jcrimjus.2015.04.004; Cooke DJ, 2012, INT J FORENSIC MENT, V11, P242, DOI 10.1080/14999013.2012.746759; Cooke DJ, 2010, LAW HUMAN BEHAV, V34, P259, DOI 10.1007/s10979-009-9176-x; Cooke DJ, 2001, PSYCHOL ASSESSMENT, V13, P171, DOI 10.1037//1040-3590.13.2.171; Cooke DJ, 2004, J PERS DISORD, V18, P337, DOI 10.1521/pedi.2004.18.4.337; Coolidge FL, 2011, BEHAV SCI LAW, V29, P741, DOI 10.1002/bsl.997; Corrado RR, 2015, J CRIM JUST, V43, P357, DOI 10.1016/j.jcrimjus.2015.04.007; D'Silva K, 2004, J PERS DISORD, V18, P163, DOI 10.1521/pedi.18.2.163.32775; Drislane LE, 2017, J PERS DISORD, V31, P110, DOI 10.1521/pedi_2016_30_240; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Florez G, 2015, J PERS DISORD, V29, P707, DOI 10.1521/pedi_2014_28_167; Fowler KA, 2009, PSYCHOL ASSESSMENT, V21, P68, DOI 10.1037/a0014938; Hall JR, 2014, PSYCHOL ASSESSMENT, V26, P447, DOI 10.1037/a0035665; Hare RD, 2000, BEHAV SCI LAW, V18, P623, DOI 10.1002/1099-0798(200010)18:5<623::AID-BSL409>3.0.CO;2-W; Hare Robert D, 2005, Curr Psychiatry Rep, V7, P57, DOI 10.1007/s11920-005-0026-3; Hare RD, 2010, PSYCHOL ASSESSMENT, V22, P446, DOI 10.1037/a0013635; Haslam N, 2012, PSYCHOL MED, V42, P903, DOI 10.1017/S0033291711001966; Herpers PCM, 2012, SOC PSYCH PSYCH EPID, V47, P2045, DOI 10.1007/s00127-012-0513-x; Hoff HA, 2015, PERSONAL DISORD, V6, P117, DOI 10.1037/per0000111; Hoff HA, 2012, J PERS DISORD, V26, P414, DOI 10.1521/pedi.2012.26.3.414; Kreis MKF, 2012, J PERS DISORD, V26, P402, DOI 10.1521/pedi.2012.26.3.402; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; McCuish EC, 2015, J CRIM JUST, V43, P345, DOI 10.1016/j.jcrimjus.2015.04.008; Murphy B, 2016, PSYCHOL ASSESSMENT, V28, P1597, DOI 10.1037/pas0000288; Olver ME, 2015, PERSONAL DISORD, V6, P97, DOI 10.1037/per0000095; Patrick CJ, 2007, J PERS DISORD, V21, P118, DOI 10.1521/pedi.2007.21.2.118; Pedersen L., 2010, INT J FORENSIC MENTA, V9, P308, DOI [10.1080/14999013.2010.526681, DOI 10.1080/14999013.2010.526681]; Pereira Nedra, 2008, Crim Behav Ment Health, V18, P216, DOI 10.1002/cbm.699; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Rotter M, 2002, PSYCHIAT QUART, V73, P337, DOI 10.1023/A:1020468117930; Sellbom M, 2015, INT J FORENSIC MENT, V14, P172, DOI 10.1080/14999013.2015.1085112; Shaffer C, 2015, J CRIM JUST, V43, P321, DOI 10.1016/j.jcrimjus.2015.05.008; Skeem JL, 2010, PSYCHOL ASSESSMENT, V22, P433, DOI 10.1037/a0008512; Verschuere B, 2017, WHAT FEATURES PSYCHO; Vitacco MJ, 2010, PSYCHOL ASSESSMENT, V22, P638, DOI 10.1037/a0019780; Walters GD, 2015, J CRIM JUST, V43, P327, DOI 10.1016/j.jcrimjus.2015.04.002; Wright EM, 2009, INT J OFFENDER THER, V53, P464, DOI 10.1177/0306624X08319416; Wygant DB, 2012, J PERS DISORD, V26, P717, DOI 10.1521/pedi.2012.26.5.717; Yu RQ, 2012, J PERS DISORD, V26, P775, DOI 10.1521/pedi.2012.26.5.775	44	13	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195483	10.1371/journal.pone.0195483	http://dx.doi.org/10.1371/journal.pone.0195483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649258	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900047
J	Jia, PL; Tang, L; Yu, JJ; Liu, JL; Kang, DY; Sun, X				Jia, Pengli; Tang, Li; Yu, Jiajie; Liu, Jiali; Kang, Deying; Sun, Xin			The quality of reporting in randomized controlled trials of acupuncture for knee osteoarthritis: A cross-sectional survey	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY	Objective To assess the reporting quality of acupuncture trials for knee osteoarthritis (KOA), and explore the factors associated with the reporting. Method Three English and four Chinese databases were searched from inception to December 2016 for randomized control trials testing effects of acupuncture for knee osteoarthritis. We used the standard CONSORT (2010 version), CONSORT Extension for Non-Pharmacological Treatments, and STRICTA for measuring the quality of reporting. Using pre-specified study characteristics, we undertook regression analyses to examine factors associated with the reporting quality. Results A total of 318 RCT reports were included. For the standard CONSORT, ten items were substantially under-reported (reported in less than 5% of RCTs), including specification of important changes to methods after trial commencement (0.6%), description of any changes to trial outcomes (0.0%), implementation of interim analyses and stopping guidelines (0.6%), statement about why the trial ended or was stopped (1.6%), statement about the registration status (4.4%), accessibility of full trial protocol (4.7%), implementation of randomization (4.7%), description of the similarity of interventions (3.5%), conduct of ancillary analyses (3.8%) and presentation of methods for additional analyses (4.4%). Four of the STRICTA items were under-reported (reported in less than 10% of RCTs), including description of acupuncture style (8.5%), presentation of extent to which treatment varied (1.3%), statement of practitioner background (7.2%) and rationale for the control (9.1%). For CONSORT Extension, the reporting was poor across all items (reported in less than 10% of trials). Trials including authors with expertise in epidemiology or statistics, published in English, or enrolling patients from multiple centers were more likely to have better reporting. Conclusions The reporting in RCTs of acupuncture for KOA was generally poor. To improve the reporting quality, journals should encourage strict adherence to the reporting guidelines.	[Jia, Pengli; Tang, Li; Yu, Jiajie; Liu, Jiali; Kang, Deying; Sun, Xin] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University	Sun, X (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Sichuan, Peoples R China.	sunx79@hotmail.com	jiajia, yu/AAP-4507-2020		National Natural Science Foundation of China [81590955]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China No. 81590955.	Adetugbo K, 2000, ARCH DERMATOL, V136, P381, DOI 10.1001/archderm.136.3.381; Adie S, 2013, ANN SURG, V258, P872, DOI 10.1097/SLA.0b013e31829664b9; Al Rashoud AS, 2014, PHYSIOTHERAPY, V100, P242, DOI 10.1016/j.physio.2013.09.007; Bala MM, 2013, J CLIN EPIDEMIOL, V66, P286, DOI 10.1016/j.jclinepi.2012.10.005; Bath FJ, 1998, STROKE, V29, P2203, DOI 10.1161/01.STR.29.10.2203; BERMAN BM, 1995, OSTEOARTHR CARTILAGE, V3, P139, DOI 10.1016/S1063-4584(05)80046-9; Berman BM, 1999, RHEUMATOLOGY, V38, P346, DOI 10.1093/rheumatology/38.4.346; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P388, DOI 10.2106/00004623-200203000-00009; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brinkhaus B, 2007, COMPLEMENT THER MED, V15, P180, DOI 10.1016/j.ctim.2006.04.003; Chen LX, 2013, JCR-J CLIN RHEUMATOL, V19, P308, DOI 10.1097/RHU.0b013e3182a21848; Chen RX, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-32; Chen XY, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0071-9; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06482; Foster NE, 2007, BMJ-BRIT MED J, V335, P436, DOI 10.1136/bmj.39280.509803.BE; Halpern SH, 2004, INT J OBSTET ANESTH, V13, P207, DOI 10.1016/j.ijoa.2004.03.009; He J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-122; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Huang W, 2010, J AM GERIATR SOC, V58, P1218, DOI 10.1111/j.1532-5415.2010.02886.x; Jubb RW, 2008, ACUPUNCT MED, V26, P69, DOI 10.1136/aim.26.2.69; Karner M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/427265; Kim KH, 2014, BMJ OPEN, V7; Kim K, 2014, ADV MECH ENG, DOI 10.1155/2014/124037; Lansdown H, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-130; Liu Xue-Ting, 2015, J Evid Based Med, V8, P192, DOI 10.1111/jebm.12173; Lu LM, 2017, CHIN J INTEGR MED, V23, P10, DOI 10.1007/s11655-016-2451-z; Lu X, 2011, PLOS ONE, V2; Ma B, 2016, PLOS ONE, V1; MacPherson H., 2010, J EVID-BASED MED, V3, P140, DOI [10.1111/j.1756-5391.2010.01086.x, DOI 10.1111/J.1756-5391.2010.01086.X]; Magden ER, 2013, J AM ASSOC LAB ANIM, V52, P475; [毛兵 Mao Bing], 2006, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V6, P297; Martins F, 2014, CLIN J PAIN, V30, P953, DOI 10.1097/AJP.0000000000000062; Miao Edwin Yong, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P1133; Moher D, 2001, JAMA-J AM MED ASSOC, V15, P1992, DOI DOI 10.1001/jama.285.15.1992; Paramore LC, 1997, J PAIN SYMPTOM MANAG, V13, P83, DOI 10.1016/S0885-3924(96)00299-0; Prady SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001577; Purepong N., 2008, ACUPUNCTURE MANAGEME; Purepong N, 2012, ACUPUNCT MED, V30, P187, DOI 10.1136/acupmed-2012-010140; Sangdee Chaichan, 2002, BMC Complement Altern Med, V2, P3, DOI 10.1186/1472-6882-2-3; Scharf HP, 2006, ANN INTERN MED, V145, P12, DOI 10.7326/0003-4819-145-1-200607040-00005; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Singh BB, 2001, ALTERN THER HEALTH M, V7, P58; Spaeth RB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/204259; Tukmachi E, 2004, ACUPUNCT MED, V1, P14; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; White Adrian, 2016, Pilot Feasibility Stud, V2, P10, DOI 10.1186/s40814-016-0051-5; White P, 2010, ACUPUNCT MED, V28, P120, DOI 10.1136/aim.2009.001768; Williamson L, 2007, RHEUMATOLOGY, V46, P1445, DOI 10.1093/rheumatology/kem119; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7	51	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195652	10.1371/journal.pone.0195652	http://dx.doi.org/10.1371/journal.pone.0195652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649270	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900067
J	Boloni, L; Bhatia, TS; Khan, SA; Streater, J; Fiore, SM				Boloni, Ladislau; Bhatia, Taranjeet Singh; Khan, Saad Ahmad; Streater, Jonathan; Fiore, Stephen M.			Towards a computational model of social norms	PLOS ONE			English	Article							POLITENESS PHENOMENA; EMOTIONS; SELF; FORMALIZATION	We describe a computational model of social norms based on identifying values that a certain culture finds desirable such as dignity, generosity and politeness. The model quantifies these values in the form of Culture-Sanctioned Social Metrics (CSSMs) and treats social norms as the requirement to maximize these metrics from the perspective of the self, peers and public. This model can be used to create realistic social simulations, to explain or predict human behavior in specific scenarios, or as a component of robots or agents that need to interact with humans in specific social-cultural settings. We validate the model by using it to represent a complex deception scenario and showing that it can yield non-trivial insights such as the explanation of apparently irrational human behavior.	[Boloni, Ladislau; Bhatia, Taranjeet Singh; Khan, Saad Ahmad] Univ Cent Florida, Dept Comp Sci, Orlando, FL 32826 USA; [Streater, Jonathan; Fiore, Stephen M.] Univ Cent Florida, Inst Simulat & Training, Orlando, FL 32826 USA; [Streater, Jonathan; Fiore, Stephen M.] Univ Cent Florida, Dept Philosophy, Orlando, FL 32826 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Boloni, L (corresponding author), Univ Cent Florida, Dept Comp Sci, Orlando, FL 32826 USA.	lboloni@cs.ucf.edu		Boloni, Ladislau/0000-0001-5336-9651	U.S. Army Research Laboratory [W911NF-10-2-0016]	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL))	The research reported in this document/presentation was performed in connection with Contract Number W911NF-10-2-0016 with the U.S. Army Research Laboratory. The views and conclusions contained in this document/presentation are those of the authors and should not be interpreted as presenting the official policies or position, either expressed or implied, of the U.S. Army Research Laboratory, or the U.S. Government unless so designated by other authorized documents. Citation of manufacturer's or trade names does not constitute an official endorsement or approval of the use thereof. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation hereon.	Adam C, 2009, SYNTHESE, V168, P201, DOI 10.1007/s11229-009-9460-9; BATES J, 1992, P 14 ANN C COGN SCI; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Bhatia TS, 2013, LNCS, V7838, P13; Bhatia TS, P 2 INT WORKSH HUM A; Bosse T, 2008, CONSCIOUS COGN, V17, P94, DOI 10.1016/j.concog.2007.06.006; Bramsen Philip, 2011, P 49 ANN M ASS COMP, P773; Brown Penelope, 1987, STUDIES INTERACTIONA, V4; Damasio A.R., 2000, FEELING WHAT HAPPENS; Danescu-Niculescu-Mizil Cristian, 2013, P ASS COMP LING; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; El-Nasr MS, 2000, AUTON AGENT MULTI-AG, V3, P219, DOI 10.1023/A:1010030809960; Elliott C., 1992, AFFECTIVE REASONER P; Elster J, 1998, J ECON LIT, V36, P47; Fishbein M., 1977, BELIEF ATTITUDE INTE; Gailliot MT, 2007, PERS SOC PSYCHOL REV, V11, P303, DOI 10.1177/1088868307303030; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Gratch J., 2004, COGN SYST RES, V5, P269, DOI [10.1016/j.cogsys.2004.02.002, DOI 10.1016/J.COGSYS.2004.02.002]; GU YG, 1990, J PRAGMATICS, V14, P237, DOI 10.1016/0378-2166(90)90082-O; Hadlicka Eva, 2011, International Journal of Strategic Synthetic Emotions, V1, P26, DOI 10.4018/jse.2011010103; Hagger MS, 2009, HEALTH PSYCHOL REV, V3, P208, DOI 10.1080/17437190903414387; Hoftede G., 2010, CULTURES ORG SOFTWAR; Houser D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041568; Khan SA, P 25 INT FLAIRS C; Khan SA, 2012, 21 BEH REPR MOD SIM; Klimecki OM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151028; Kurt L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084608; Loyall A. B., 1997, BELIEVABLE AGENTS BU; Marsella S., 2010, BLUEPRINT AFFECTIVE, P21; MATSUMOTO Y, 1988, J PRAGMATICS, V12, P403, DOI 10.1016/0378-2166(88)90003-3; Miller CA, 2008, IEEE INTELL SYST, V23, P28, DOI 10.1109/MIS.2008.55; Miller CA, 2009, LECT NOTES COMPUT SC, V5614, P568, DOI 10.1007/978-3-642-02707-9_64; Morgan J.L., 1975, SYNTAX SEMANTICS, P41, DOI DOI 10.1163/9789004368811_003; Nisbett Richard E., 1996, CULTURE HONOR PSYCHO; Orr MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062490; Ortony A, 1990, COGNITIVE STRUCTURE; Prendinger H, 2002, APPL ARTIF INTELL, V16, P519, DOI 10.1080/08839510290030381; PRICE DD, 1985, MOTIV EMOTION, V9, P19, DOI 10.1007/BF00991548; Reilly WSN, 1996, BELIEVABLE SOCIAL EM; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Roseman I. J., 2001, APPRAISAL PROCESSES, P68; Shafer G. A., 1978, MATH THEORY EVIDENCE, V20, P106; Staller A, 1998, P GROUND EM AD SYST; Tsai JL, 2007, J PERS SOC PSYCHOL, V92, P1102, DOI 10.1037/0022-3514.92.6.1102; YAGER RR, 1987, INFORM SCIENCES, V41, P93, DOI 10.1016/0020-0255(87)90007-7	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195331	10.1371/journal.pone.0195331	http://dx.doi.org/10.1371/journal.pone.0195331			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641583	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900065
J	Park, SK; Garland, CF; Gorham, ED; BuDoff, L; Barrett-Connor, E				Park, Sue K.; Garland, Cedric F.; Gorham, Edward D.; BuDoff, Luke; Barrett-Connor, Elizabeth			Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study	PLOS ONE			English	Article							PARATHYROID-HORMONE LEVELS; BONE-MINERAL DENSITY; VITAMIN-D DEFICIENCY; SERUM 25-HYDROXYVITAMIN-D; METABOLIC SYNDROME; INTENSE EXERCISE; PROGRESSION; ASSOCIATION; PREVENTION; HYPERPARATHYROIDISM	Background It has been reported that higher plasma 25-hydroxyvitamin D is associated with lower risk of type 2 diabetes. However the results to date have been mixed and no adequate data based on a cohort are available for the high end of the normal range, above approximately 32 ng/ml or 80 nmol/L. Methods We performed a cohort study of 903 adults who were known to be free of diabetes or prediabetes during a 1997-1999 visit to a NIH Lipid Research Centers clinic. Plasma 25(OH) D was measured at Visit 8 in 1977-1979. The mean age was 74 years. The visit also included fasting plasma glucose and oral glucose tolerance testing. Follow-up continued through 2009. Results There were 47 cases of diabetes and 337 cases of pre-diabetes. Higher 25(OH) D concentrations (> 30 ng/ml) were associated with lower hazard ratios (HR) for diabetes: 30-39 ng/ml or 75-98 nmol/L: HR = 0.31, 95% CI = 0.14-0.70; for 40-49 ng/ml or 100-122 nmol/L: HR = 0.29, CI = 0.12-0.68; for > 50 ng/ml or 125 nmol/L: HR = 0.19, CI = 0.06-0.56. All HRs are compared to < 30 ng/ml or 75 nmol/L. There was an inverse dose-response gradient between 25(OH) D concentration and risk of diabetes with a p for trend of 0.005. Each 10 ng/mL or 25 nmol/L higher 25(OH) D concentration was associated with a HR of 0.64, CI = 0.48-0.86. 25(OH) D concentrations were more weakly inversely associated with pre-diabetes risk, and the trend was not significant. Conclusion Further research is needed on whether high 25(OH) D might prevent type 2 diabetes or transition of prediabetes to diabetes.	[Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Garland, Cedric F.; Gorham, Edward D.; BuDoff, Luke; Barrett-Connor, Elizabeth] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of California System; University of California San Diego	Garland, CF (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	cgarland@ucsd.edu			National Institutes of Health/National Institute on Aging [AG07181, AG028507]; National Institute of Diabetes and Digestive and Kidney Diseases [DK31801]	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/National Institute on Aging grants AG07181 and AG028507 (EBC); National Institute of Diabetes and Digestive and Kidney Diseases, grant DK31801 (EBC).	Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; [Anonymous], 1976, Prev Med, V5, P207; Antoniucci DM, 2005, CLIN CHEM, V51, P258; Barker T, 2014, CYTOKINE, V65, P134, DOI 10.1016/j.cyto.2013.12.004; Binkley N, 2004, J CLIN ENDOCR METAB, V89, P3152, DOI 10.1210/jc.2003-031979; Bischoff-Ferrari Heike A, 2014, Adv Exp Med Biol, V810, P500; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Burgi AA, 2011, J BONE MINER RES, V26, P2371, DOI 10.1002/jbmr.451; Chacko SA, 2011, AM J CLIN NUTR, V94, P209, DOI 10.3945/ajcn.110.010272; Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016; CHEN TC, 1990, J NUTR BIOCHEM, V1, P315, DOI 10.1016/0955-2863(90)90067-U; Chiu KC, 2000, METABOLISM, V49, P1501, DOI 10.1053/meta.2000.17708; Conroy S, 2003, AGE AGEING, V32, P571, DOI 10.1093/ageing/afg122; Deleskog A, 2012, DIABETOLOGIA, V55, P1668, DOI 10.1007/s00125-012-2529-x; Forouhi NG, 2012, DIABETOLOGIA, V55, P2173, DOI 10.1007/s00125-012-2544-y; Gagnon C, 2011, DIABETES CARE, V34, P1133, DOI 10.2337/dc10-2167; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gonzalez-Molero I, 2012, CLIN NUTR, V31, P571, DOI 10.1016/j.clnu.2011.12.001; Grimnes G, 2010, DIABETIC MED, V27, P1107, DOI 10.1111/j.1464-5491.2010.03092.x; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Heikes KE, 2008, DIABETES CARE, V31, P1040, DOI 10.2337/dc07-1150; Hidayat Rudy, 2010, Acta Med Indones, V42, P123; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Husemoen LLN, 2012, EUR J CLIN NUTR, V66, P1309, DOI 10.1038/ejcn.2012.134; Jorde R, 2016, J CLIN ENDOCR METAB, V101, P1647, DOI 10.1210/jc.2015-4013; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; LaDochy S, 2007, CLIM RES, V33, P159, DOI 10.3354/cr033159; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lips P, 2007, J BONE MINER RES, V22, P1668, DOI 10.1359/JBMR.070716; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; Pittas AG, 2012, DIABETES CARE, V35, P565, DOI 10.2337/dc11-1795; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Robinson JG, 2011, DIABETES CARE, V34, P628, DOI 10.2337/dc10-1632; Saquib N, 2006, OSTEOPOROSIS INT, V17, P1734, DOI 10.1007/s00198-006-0191-1; Schafer AL, 2014, DIABETIC MED, V31, P564, DOI 10.1111/dme.12368; Schottker B, 2013, EUR J EPIDEMIOL, V28, P267, DOI 10.1007/s10654-013-9769-z; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; STAMP TCB, 1974, NATURE, V247, P563, DOI 10.1038/247563a0; Thorand B, 2011, DIABETES CARE, V34, P2320, DOI 10.2337/dc11-0775; Tohidi M, 2013, DIABETIC MED, V30, P934, DOI 10.1111/dme.12180; Tsur A, 2013, DIABETES CARE, V36, P1361, DOI 10.2337/dc12-1050; von Muhlen DG, 2005, OSTEOPOROSIS INT, V16, P1721, DOI 10.1007/s00198-005-1910-8; Wolden-Kirk H, 2011, MOL CELL ENDOCRINOL, V347, P106, DOI 10.1016/j.mce.2011.08.016	52	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0193070	10.1371/journal.pone.0193070	http://dx.doi.org/10.1371/journal.pone.0193070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672520	Green Published, gold, Green Submitted			2022-12-27	WOS:000430446800005
J	Berg, L; Brannstrom, L				Berg, Lisa; Brannstrom, Lars			Evicted children and subsequent placement in out-of-home care: A cohort study	PLOS ONE			English	Article							FAMILY STRESS MODEL; FOSTER-CARE; FINANCIAL CRISIS; PUBLIC CARE; HEALTH; RISK; MALTREATMENT; FORECLOSURE; INVOLVEMENT; EVICTIONS	Background Evictions may have serious consequences for individuals' health and wellbeing. Even though an eviction may be experienced as a significant crisis for the family, there is little previous knowledge on consequences for evicted children. This study represents the first attempt to examine to what extent children from evicted households were separated from their parents and placed in out-of-home care (foster family or residential care) using population-based data, net of observed confounding factors related to the socioeconomic and psychosocial circumstances of their parents. Methods This study takes advantage of information from a Swedish national database, consisting of about 8 000 evicted individuals and a random sample of 770 000 individuals from the national population, linked to individual-level, longitudinal data from Swedish national registers. Our analytical sample consists of information for more than 250 000 children born in 1995-2008, including 2 224 children from evicted households. We used binary logistic regression based on the Karlson/Holm/Breen method to account for observed imbalances at baseline between evicted and non-evicted children. Results Compared to non-evicted children, the crude odds ratio for placement in out-of-home care in evicted children was 12.10 (95% CI 8.54-17.14). Net of observed confounding factors related to the socioeconomic and psychosocial circumstances of the parents, evicted children had a twofold elevated risk of being placed in out-of-home care (odds ratio 2.26, 95% CI 1.55-3.27). Crude OR for evicted children in comparison with children under threat of eviction (eviction not formally executed) was 1.71 (95% CI 1.17-2.49) and adjusted OR 1.58 (95% CI 1.06-2.35). Conclusion Children who experience eviction constitute a disadvantaged group and are at significant risk of being separated from their parents and placed in out-of-home care. These results demonstrate the importance of providing support for these children and their parents. Strategies to prevent households with children from being evicted seem to be an important and viable intervention path.	[Berg, Lisa] Stockholm Univ, Dept Publ Hlth Sci, Ctr Hlth Equ Studies, Stockholm, Sweden; [Berg, Lisa] Stockholm Univ, Swedish Inst Social Res, Stockholm, Sweden; [Brannstrom, Lars] Stockholm Univ, Dept Social Work, Stockholm, Sweden	Stockholm University; Stockholm University; Stockholm University	Berg, L (corresponding author), Stockholm Univ, Dept Publ Hlth Sci, Ctr Hlth Equ Studies, Stockholm, Sweden.; Berg, L (corresponding author), Stockholm Univ, Swedish Inst Social Res, Stockholm, Sweden.	lisa.berg@su.se		Berg, Lisa/0000-0002-8707-180X	Swedish Research Council for Health, Working Life and Welfare [2013-0452]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by the Swedish Research Council for Health, Working Life and Welfare, grant number 2013-0452, http://forte.se/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SH, 2014, SOC FORCES, V93, P269, DOI 10.1093/sf/sou027; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2014, THESIS; Berger LM, 2015, PEDIATRICS, V136, P299, DOI 10.1542/peds.2014-2832; Bergstrom M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-868; Brannstrom L, 2017, CHILD MALTREATMENT, V22, P205, DOI 10.1177/1077559517701855; Caliendo M, 2017, LABOUR ECON, V46, P14, DOI 10.1016/j.labeco.2017.02.001; Cameron CA, 2011, HDB EMPIRICAL EC FIN, P1; Conger RD, 2010, J MARRIAGE FAM, V72, P685, DOI 10.1111/j.1741-3737.2010.00725.x; Coulton CJ, 1999, CHILD ABUSE NEGLECT, V23, P1019, DOI 10.1016/S0145-2134(99)00076-9; Coulton CJ, 2007, CHILD ABUSE NEGLECT, V31, P1117, DOI 10.1016/j.chiabu.2007.03.023; Cowal K, 2002, AM J COMMUN PSYCHOL, V30, P711, DOI 10.1023/A:1016325332527; Crane M, 2000, HOUSING STUD, V15, P757, DOI 10.1080/02673030050134592; Culhane JF, 2003, J SOCIOLOGY SOCIAL W, V30; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; Desmond M, 2016, URBAN AFF REV, V52, P421, DOI 10.1177/1078087415589192; Desmond M, 2016, SOC PROBL, V63, P46, DOI 10.1093/socpro/spv025; Desmond M, 2015, SOC FORCES, V94, P295, DOI 10.1093/sf/sov044; Desmond M, 2012, AM J SOCIOL, V118, P88, DOI 10.1086/666082; Eisenstein Qvarfordt, 2016, THESIS; Fernandez E., 2010, DOES FOSTER CARE WOR; Fowler KA, 2015, AM J PUBLIC HEALTH, V105, P311, DOI 10.2105/AJPH.2014.301945; Fowler PJ, 2013, AM J COMMUN PSYCHOL, V52, P106, DOI 10.1007/s10464-013-9580-8; Fox O'Mahony L., 2006, CONCEPTUALISING HOME; Fransson E, 2016, SCAND J PUBLIC HEALT, V44, P177, DOI 10.1177/1403494815614463; Franzen E, 2008, BRIT J SOC WORK, V38, P1043, DOI 10.1093/bjsw/bcl380; Hartman C, 2003, HOUS POLICY DEBATE, V14, P461; Hertzman C., 2010, CHAOS ITS INFLUENCE; Kaariala A, 2017, CHILD YOUTH SERV REV, V79, P107, DOI 10.1016/j.childyouth.2017.05.030; Karlson KB, 2012, SOCIOL METHODOL, V42, P286, DOI 10.1177/0081175012444861; Kenna P, 2016, PILOT PROJECT PROMOT; Kling S, 2016, ACTA PAEDIATR, V105, P416, DOI 10.1111/apa.13304; Kohler M, 2015, ACTA PAEDIATR, V104, P508, DOI 10.1111/apa.12901; Kohler U, 2011, STATA J, V11, P420, DOI 10.1177/1536867X1101100306; Kronofogdemyndigheten [Swedish Enforment Agency], 2015, AVHYSN 1982 2015; McLaughlin KA, 2012, PSYCHOL MED, V42, P1441, DOI 10.1017/S0033291711002613; Molnar BE, 2016, CHILD ABUSE NEGLECT, V51, P41, DOI 10.1016/j.chiabu.2015.11.007; Neppl TK, 2016, J FAM PSYCHOL, V30, P12, DOI 10.1037/fam0000168; Nilsson A, 2004, EKONOMISKT UTSATTA B, V2004, P41; Nilsson A, 2004, MARGINALISERINGSPROC, V1, P14; Park JM, 2004, CHILD WELFARE, V83, P423; Pollack CE, 2009, AM J PUBLIC HEALTH, V99, P1833, DOI 10.2105/AJPH.2009.161380; Rodriguez JM, 2016, CHILD ABUSE NEGLECT, V57, P41, DOI 10.1016/j.chiabu.2016.06.004; Rojas Y, 2016, J EPIDEMIOL COMMUN H, V70, P409, DOI 10.1136/jech-2015-206419; Rosenberg R, 2018, J PUBLIC CHILD WELF, V12, P99, DOI 10.1080/15548732.2017.1347551; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; Shuey EA, 2017, CHILD YOUTH SERV REV, V72, P52, DOI 10.1016/j.childyouth.2016.09.031; Simkiss DE, 2013, CHILD CARE HLTH DEV, V39, P628, DOI 10.1111/cch.12010; Stenberg S, 2011, VARFOR VRAKS BARN FO; Swann CA, 2006, DEMOGRAPHY, V43, P309, DOI 10.1353/dem.2006.0019; Tsai AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123182; Turney K, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1118; van Laere IR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-3; Vasquez-Vera H, 2017, SOC SCI MED, V175, P199, DOI 10.1016/j.socscimed.2017.01.010; Viner RM, 2005, PEDIATRICS, V115, P894, DOI 10.1542/peds.2004-1311; von Otter C., 2017, EUROPEAN J HOMELESSN, V11, P1; Wallgren A, 2007, ADM DATA STAT PURPOS; Warren EJ, 2015, SOC SERV REV, V89, P9, DOI 10.1086/680043; Zlotnick C, 1998, AM J PUBLIC HEALTH, V88, P1368, DOI 10.2105/AJPH.88.9.1368; Zlotnick C, 2003, ADDICT BEHAV, V28, P1373, DOI 10.1016/S0306-4603(02)00261-7	60	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195295	10.1371/journal.pone.0195295	http://dx.doi.org/10.1371/journal.pone.0195295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668737	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200038
J	Levi, A; Sabuco, J; Small, M; Sanjuan, MAF				Levi, Asaf; Sabuco, Juan; Small, Michael; Sanjuan, Miguel A. F.			From local uncertainty to global predictions: Making predictions on fractal basins	PLOS ONE			English	Article							WADA BASINS; BOUNDARIES; DIMENSION	In nonlinear systems long term dynamics is governed by the attractors present in phase space. The presence of a chaotic saddle gives rise to basins of attraction with fractal boundaries and sometimes even to Wada boundaries. These two phenomena involve extreme difficulties in the prediction of the future state of the system. However, we show here that it is possible to make statistical predictions even if we do not have any previous knowledge of the initial conditions or the time series of the system until it reaches its final state. In this work, we develop a general method to make statistical predictions in systems with fractal basins. In particular, we have applied this new method to the Duffing oscillator for a choice of parameters where the system possesses the Wada property. We have computed the statistical properties of the Duffing oscillator for different phase space resolutions, to obtain information about the global dynamics of the system. The key idea is that the fraction of initial conditions that evolve towards each attractor is scale free-which we illustrate numerically. We have also shown numerically how having partial information about the initial conditions of the system does not improve in general the predictions in the Wada regions.	[Levi, Asaf; Sabuco, Juan; Sanjuan, Miguel A. F.] Univ Rey Juan Carlos, Dept Fis, Nonlinear Dynam Chaos & Complex Syst Grp, Madrid, Spain; [Sabuco, Juan] Univ Oxford, Inst New Econ Thinking, Math Inst, Oxford Martin Sch, Oxford, England; [Small, Michael] Univ Western Australia, Sch Math & Stat, Crawley, Australia; [Sanjuan, Miguel A. F.] Kaunas Univ Technol, Dept Appl Informat, Kaunas, Lithuania; [Sanjuan, Miguel A. F.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA	Universidad Rey Juan Carlos; University of Oxford; University of Western Australia; Kaunas University of Technology; University System of Maryland; University of Maryland College Park	Sabuco, J (corresponding author), Univ Rey Juan Carlos, Dept Fis, Nonlinear Dynam Chaos & Complex Syst Grp, Madrid, Spain.; Sabuco, J (corresponding author), Univ Oxford, Inst New Econ Thinking, Math Inst, Oxford Martin Sch, Oxford, England.	juan.sabuco@urjc.es	Sanjuán, Miguel AF/B-7709-2011; Small, Michael/C-9807-2010	Sanjuán, Miguel AF/0000-0003-3515-0837; Small, Michael/0000-0001-5378-1582	Spanish Ministry of Economy and Competitiveness [FIS2013-40653-P]; Spanish State Research Agency (AEI); European Regional Development Fund (FEDER) [FIS2016-76883-P]; Fulbright Program; Spanish Ministry of Education [FMECD-ST-2016]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish State Research Agency (AEI)(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Fulbright Program; Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness under project number FIS2013-40653-P and by the Spanish State Research Agency (AEI) and the European Regional Development Fund (FEDER) under project number FIS2016-76883-P. MAFS acknowledges the jointly sponsored financial support by the Fulbright Program and the Spanish Ministry of Education (Program No. FMECD-ST-2016).	Aguirre J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066208; Aguirre J, 2002, PHYSICA D, V171, P41, DOI 10.1016/S0167-2789(02)00565-1; Aguirre J, 2009, REV MOD PHYS, V81, P333, DOI 10.1103/RevModPhys.81.333; Cuomo K. M., 1993, ICASSP-93. 1993 IEEE International Conference on Acoustics, Speech, and Signal Processing (Cat. No.92CH3252-4), P137, DOI 10.1109/ICASSP.1993.319454; Daza A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31416; Dudul SV, 2005, APPL SOFT COMPUT, V5, P333, DOI 10.1016/j.asoc.2004.07.005; Duffing G., 1918, ZAMM Z ANGEW MATH ME; El-Dib Y. O., 2017, NONLINEAR SCI LETT A, V9, P352; He JH, 2016, NONLINEAR SCI LETT, V7, P77; Kapitaniak M, 2012, CHAOS, V22, DOI 10.1063/1.4746038; KENNEDY J, 1991, PHYSICA D, V51, P213, DOI 10.1016/0167-2789(91)90234-Z; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Mandelbrot B.B., 1982, FRACTAL GEOMETRY NAT, P480; MCDONALD SW, 1985, PHYSICA D, V17, P125, DOI 10.1016/0167-2789(85)90001-6; Menck PJ, 2013, NAT PHYS, V9, P89, DOI 10.1038/nphys2516; Metze K, 2013, EXPERT REV MOL DIAGN, V13, P719, DOI 10.1586/14737159.2013.828889; Poon L, 1996, INT J BIFURCAT CHAOS, V6, P251, DOI 10.1142/S0218127496000035; SOMMERER JC, 1995, J HOPKINS APL TECH D, V16, P333; Toroczkai Z, 1997, PHYSICA A, V239, P235, DOI 10.1016/S0378-4371(96)00482-7; Ungar S, 2007, AM MATH MON, V114, P61, DOI 10.1080/00029890.2007.11920392	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194926	10.1371/journal.pone.0194926	http://dx.doi.org/10.1371/journal.pone.0194926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668687	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200019
J	Muthee, V; Bochner, AF; Osterman, A; Liku, N; Akhwale, W; Kwach, J; Prachi, M; Wamicwe, J; Odhiambo, J; Onyango, F; Puttkammer, N				Muthee, Veronica; Bochner, Aaron F.; Osterman, Allison; Liku, Nzisa; Akhwale, Willis; Kwach, James; Prachi, Mehta; Wamicwe, Joyce; Odhiambo, Jacob; Onyango, Fredrick; Puttkammer, Nancy			The impact of routine data quality assessments on electronic medical record data quality in Kenya	PLOS ONE			English	Article							HEALTH INFORMATION-TECHNOLOGY; CLINICAL-RESEARCH; CARE; MANAGEMENT; SYSTEM; IMPROVEMENT; EFFICIENCY; SETTINGS	Background Routine Data Quality Assessments (RDQAs) were developed to measure and improve facility-level electronic medical record (EMR) data quality. We assessed if RDQAs were associated with improvements in data quality in KenyaEMR, an HIV care and treatment EMR used at 341 facilities in Kenya. Methods RDQAs assess data quality by comparing information recorded in paper records to KenyaEMR. RDQAs are conducted during a one-day site visit, where approximately 100 records are randomly selected and 24 data elements are reviewed to assess data completeness and concordance. Results are immediately provided to facility staff and action plans are developed for data quality improvement. For facilities that had received more than one RDQA (baseline and follow-up), we used generalized estimating equation models to determine if data completeness or concordance improved from the baseline to the follow-up RDQAs. Results 27 facilities received two RDQAs and were included in the analysis, with 2369 and 2355 records reviewed from baseline and follow-up RDQAs, respectively. The frequency of missing data in KenyaEMR declined from the baseline (31% missing) to the follow-up (13% missing) RDQAs. After adjusting for facility characteristics, records from follow-up RDQAs had 0.43-times the risk (95% CI: 0.32-0.58) of having at least one missing value among nine required data elements compared to records from baseline RDQAs. Using a scale with one point awarded for each of 20 data elements with concordant values in paper records and KenyaEMR, we found that data concordance improved from baseline (11.9/20) to follow-up (13.6/20) RDQAs, with the mean concordance score increasing by 1.79 (95% Cl: 0.25-3.33). Conclusions This manuscript demonstrates that RDQAs can be implemented on a large scale and used to identify EMR data quality problems. RDQAs were associated with meaningful improvements in data quality and could be adapted for implementation in other settings.	[Muthee, Veronica; Liku, Nzisa; Akhwale, Willis] I TECH, Nairobi, Kenya; [Bochner, Aaron F.; Puttkammer, Nancy] I TECH, Seattle, WA USA; [Bochner, Aaron F.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Osterman, Allison; Puttkammer, Nancy] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Kwach, James; Prachi, Mehta] US Ctr Dis Control & Prevent, Nairobi, Kenya; [Wamicwe, Joyce; Odhiambo, Jacob] Minist Hlth, Natl AIDS & STI Control Programme, Nairobi, Kenya; [Onyango, Fredrick] EGPAF, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Puttkammer, N (corresponding author), I TECH, Seattle, WA USA.; Puttkammer, N (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	jwamicwe@nascop.or.ke; nputt@uw.edu		Bochner, Aaron/0000-0001-8348-3375	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) from the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA) [U91HA06801]; NIH [AI027757]; NIAID; NCI; NIMH; NIDA; NICHD; NHLBI; NIA; NIGMS; NIDDK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) from the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The publication was made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreement U91HA06801 from the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA). We would like to thank Kenneth Tapia and the University of Washington Center for AIDS Research (CFAR) biostatistics core, an NIH funded program under award number AI027757 which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abera E, 2016, RES HLTH SCI, V1, P98, DOI [10.22158/rhs.v1n2p98, DOI 10.22158/RHS.V1N2P98]; [Anonymous], 2009, CIHI ACCURACY TIMELI; [Anonymous], 2017, DAT QUAL REV TOOLK F; Beltrami J., 2016, J PUBLIC HLTH MANAG; Brouwer HJ, 2006, FAM PRACT, V23, P529, DOI 10.1093/fampra/cml040; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Chen H, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27463; Clifford GD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-18; De Cock KM, 2014, CLIN INFECT DIS, V58, P1012, DOI 10.1093/cid/ciu026; El-Sadr WM, 2016, AIDS, V30, P2145, DOI 10.1097/QAD.0000000000001192; Frieden TR, 2014, AM J PUBLIC HEALTH, V104, P17, DOI 10.2105/AJPH.2013.301608; Fritz F, 2015, J AM MED INFORM ASSN, V22, P479, DOI 10.1093/jamia/ocu038; Greiver M, 2015, CAN FAM PHYSICIAN, V61, P92; Hahn D, 2012, GLOB HLTH ACTION, V6, P21424; Hersh WR, 2013, MED CARE, V51, pS30, DOI 10.1097/MLR.0b013e31829b1dbd; Institute of Medicine Committee on Assuring the Health of the Public in the 21st C, 2002, FUT PUBL HLTH 21 CEN; Jamal A, 2009, HEALTH INF MANAG J, V38, P26, DOI 10.1177/183335830903800305; Jawhari B, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0354-8; Kahn MG, 2012, MED CARE, V50, pS21, DOI 10.1097/MLR.0b013e318257dd67; Kalogriopoulos Nicholas A, 2009, Annu Int Conf IEEE Eng Med Biol Soc, V2009, P1730, DOI 10.1109/IEMBS.2009.5333561; Ledikwe JH, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-7; McGinn CA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-46; Mphatswe W, 2012, B WORLD HEALTH ORGAN, V90, P176, DOI 10.2471/BLT.11.092759; Muthee V, 2018, INT J MED INFORM, V109, P23, DOI 10.1016/j.ijmedinf.2017.10.019; Nisingizwe MP, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25829; O'Malley AS, 2010, J GEN INTERN MED, V25, P177, DOI 10.1007/s11606-009-1195-2; Oluoch T, 2012, INT J MED INFORM, V81, pE83, DOI 10.1016/j.ijmedinf.2012.07.010; Parsons A, 2012, J AM MED INFORM ASSN, V19, P604, DOI 10.1136/amiajnl-2011-000557; Puttkammer N, 2016, INT J MED INFORM, V86, P104, DOI 10.1016/j.ijmedinf.2015.11.003; Qazi MS, 2011, BIOSCI TRENDS, V5, P245, DOI 10.5582/bst.2011.v5.6.245; Shekelle Paul G, 2006, Evid Rep Technol Assess (Full Rep), P1; Snee NL, 2004, IEEE ENG MED BIOL, V23, P81, DOI 10.1109/MEMB.2004.1297178; Taggart J, 2015, INT J MED INFORM, V84, P1094, DOI 10.1016/j.ijmedinf.2015.09.008; UNAIDS, 2014, AMB TREATM TARG WRIT; UNAIDS, 2015, UND FAST TRACK; Wagenaar BH, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0043-3; Wang R. Y., 1996, Journal of Management Information Systems, V12, P5; Weiskopf NG, 2013, J AM MED INFORM ASSN, V20, P144, DOI 10.1136/amiajnl-2011-000681; Wu R. C., 2006, BMC MED INFORM DECIS, V6; Xiao N, 2012, HEALTH POLICY TECHN, V1, P28, DOI 10.1016/j.hlpt.2012.01.009; 2010, MON BUILD BLOCKS HLT, V949, P1	43	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195362	10.1371/journal.pone.0195362	http://dx.doi.org/10.1371/journal.pone.0195362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668691	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200040
J	Sutton, E; Herbert, G; Burden, S; Lewis, S; Thomas, S; Ness, A; Atkinson, C				Sutton, Eileen; Herbert, Georgia; Burden, Sorrel; Lewis, Stephen; Thomas, Steve; Ness, Andy; Atkinson, Charlotte			Using the Normalization Process Theory to qualitatively explore sense-making in implementation of the Enhanced Recovery After Surgery programme: "It's not rocket science"	PLOS ONE			English	Article							BARRIERS; CARE	Introduction The Enhanced Recovery After Surgery programme (ERAS) is an approach to the perioperative care of patients encompassing multiple interventions and involving a wide range of different actors. It can thus be defined as a complex intervention. Despite the strength of the evidence-base in its support, the implementation of ERAS has been slow. This paper specifically explores the utility of Normalization Process Theory (NPT) as a methodological framework to aid exploration of ERAS implementation, with a focus on the core NPT construct coherence. Methods and materials The study employed qualitative methods guided by NPT. Semi-structured interviews were conducted with twenty-six healthcare professionals working in three specialities (thoracic, colorectal, head and neck) in a UK hospital. Data were analysed using an adapted Framework Approach. Results Coherence, or sense-making work, was key to successful implementation and demonstrated in the importance of participants believing in ERAS both as an individual and as a team. In order to invest in ERAS individuals needed to be able to differentiate its practices favourably with those enacted pre-implementation (differentiation). Participants also needed to understand their specific tasks and responsibilities (individual specification) and build a shared understanding (communal specification), resolving differences in planning meetings. Belief in the worth of ERAS was often aligned to evidence for its effectiveness or benefit to patients (internalization), so implementing ERAS therefore 'made sense'. Sense-making work had strong links with aspects of implementation related to other NPT constructs including resource issues such as funding for data collection and feedback (reflexive monitoring: systemization) and failure to replace key staff members (collective action: skill set workability). Conclusions NPT was found to be a valuable heuristic device to employ in the exploration of ERAS implementation processes. NPT was useful in facilitating recognition of the importance of coherence work to successful implementation. However despite participants' strong beliefs in the worth of ERAS, it was in translating these beliefs into action that barriers were encountered, highlighting the interconnectedness of NPT constructs and the complicated nature of implementing complex interventions.	[Sutton, Eileen; Herbert, Georgia; Burden, Sorrel; Lewis, Stephen; Thomas, Steve; Ness, Andy; Atkinson, Charlotte] Univ Hosp Bristol NHS Fdn Trust, NIHR Bristol Biomed Res Ctr Nutr Theme, Bristol, Avon, England; [Sutton, Eileen; Herbert, Georgia; Burden, Sorrel; Lewis, Stephen; Thomas, Steve; Ness, Andy; Atkinson, Charlotte] Univ Bristol, Bristol, Avon, England; [Herbert, Georgia; Thomas, Steve; Ness, Andy; Atkinson, Charlotte] Univ Bristol, Bristol Dent Sch, Lower Maudlin St, Bristol, Avon, England; [Burden, Sorrel] Univ Manchester, Sch Nursing Midwifery & Social Work, Oxford Rd, Manchester, Lancs, England; [Lewis, Stephen] Derriford Hosp, Derriford Rd, Plymouth, Devon, England	University of Bristol; University of Bristol; University of Bristol; University of Manchester; Derriford Hospital	Sutton, E (corresponding author), Univ Hosp Bristol NHS Fdn Trust, NIHR Bristol Biomed Res Ctr Nutr Theme, Bristol, Avon, England.; Sutton, E (corresponding author), Univ Bristol, Bristol, Avon, England.	e.sutton@bristol.ac.uk	Atkinson, Charlotte/AGA-4037-2022; Ness, Andy R/M-7612-2013; Burden, Sorrel/C-6101-2015	Ness, Andy R/0000-0003-3548-9523; Burden, Sorrel/0000-0002-4967-647X	NIHR Biomedical Research Unit in Nutrition, Diet and Lifestyle at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol; NIHR Bristol Biomedical Research Unit in Nutrition, Diet and Lifestyle at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol	NIHR Biomedical Research Unit in Nutrition, Diet and Lifestyle at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol; NIHR Bristol Biomedical Research Unit in Nutrition, Diet and Lifestyle at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol	The study was funded by the NIHR Biomedical Research Unit in Nutrition, Diet and Lifestyle at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the NIHR Bristol Biomedical Research Unit in Nutrition, Diet and Lifestyle at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Alawadi ZM, 2014, SURGERY, P700; Ament SMC, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0641-y; Bamford C, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-106; Ong BN, 2014, SOC SCI MED, V106, P101, DOI 10.1016/j.socscimed.2014.01.036; Bissaillon A, 2014, IMPLEMENTATION ENHAN; Blakeman T, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636056; Conn LG, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0289-y; Connell LA, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0090-3; Enhanced Recovery Partnership Programme, 2010, DEL ENH REC HELP PAT; Finch TL, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-43; Franx G, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-8; Herbert G, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2547-y; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Knowles SE, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-110; Li L., 2014, INT J ANTENN PROPAG, V2014, P12, DOI DOI 10.1016/J.0CEM0D.2014.09.004; Lloyd A, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-102; Lyon A, 2014, WORLD J SURG, V38, P1374, DOI 10.1007/s00268-013-2441-7; May C, NPT CORE CONSTRUCTS; May C, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-18; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; McEvoy R, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-2; Pearsall EA, 2015, ANN SURG, V261, P92, DOI 10.1097/SLA.0000000000000604; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Sanders T, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-49; Zhuang CL, 2013, DIS COLON RECTUM, V56, P667, DOI 10.1097/DCR.0b013e3182812842	26	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195890	10.1371/journal.pone.0195890	http://dx.doi.org/10.1371/journal.pone.0195890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668717	Green Submitted, gold, Green Published			2022-12-27	WOS:000430290200065
J	Brunwasser, SM; Gebretsadik, T; Gold, DR; Turi, KN; Stone, CA; Datta, S; Gern, JE; Hertert, TV				Brunwasser, Steven M.; Gebretsadik, Tebeb; Gold, Diane R.; Turi, Kedir N.; Stone, Cosby A., Jr.; Datta, Soma; Gern, James E.; Hertert, Tina V.			A new model of wheezing severity in young children using the validated ISAAC wheezing module: A latent variable approach with validation in independent cohorts	PLOS ONE			English	Article							ASTHMA CONTROL; CHILDHOOD ASTHMA; FIT INDEXES; RISK-FACTORS; RMSEA; INVARIANCE; ALLERGIES; EXPOSURE; BIRTH	Background The International Study of Asthma and Allergies in Children (ISAAC) Wheezing Module is commonly used to characterize pediatric asthma in epidemiological studies, including nearly all airway cohorts participating in the Environmental Influences on Child Health Outcomes (ECHO) consortium. However, there is no consensus model for operationalizing wheezing severity with this instrument in explanatory research studies. Severity is typically measured using coarsely-defined categorical variables, reducing power and potentially underestimating etiological associations. More precise measurement approaches could improve testing of etiological theories of wheezing illness. Methods We evaluated a continuous latent variable model of pediatric wheezing severity based on four ISAAC Wheezing Module items. Analyses included subgroups of children from three independent cohorts whose parents reported past wheezing: infants ages 0-2 in the INSPIRE birth cohort study (Cohort 1; n = 657), 6-7-year-old North American children from Phase One of the ISAAC study (Cohort 2; n = 2,765), and 5-6-year-old children in the EHAAS birth cohort study (Cohort 3; n = 102). Models were estimated using structural equation modeling. Results In all cohorts, covariance patterns implied by the latent variable model were consistent with the observed data, as indicated by non-significant chi(2) goodness of fit tests (no evidence of model misspecification). Cohort 1 analyses showed that the latent factor structure was stable across time points and child sexes. In both cohorts 1 and 3, the latent wheezing severity variable was prospectively associated with wheeze-related clinical outcomes, including physician asthma diagnosis, acute corticosteroid use, and wheeze-related outpatient medical visits when adjusting for confounders Conclusion We developed an easily applicable continuous latent variable model of pediatric wheezing severity based on items from the well-validated ISAAC Wheezing Module. This model prospectively associates with asthma morbidity, as demonstrated in two ECHO birth cohort studies, and provides a more statistically powerful method of testing etiologic hypotheses of childhood wheezing illness and asthma.	[Brunwasser, Steven M.; Turi, Kedir N.; Stone, Cosby A., Jr.; Hertert, Tina V.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, T-1218 Med Ctr North, Nashville, TN 37235 USA; [Brunwasser, Steven M.] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, B-1118 MCN, Nashville, TN 37232 USA; [Gebretsadik, Tebeb] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Gold, Diane R.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Gold, Diane R.] Harvard Med Sch, Dept Environm Hlth, Boston, MA USA; [Gold, Diane R.; Datta, Soma] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Gern, James E.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, K4-918 CSC, Madison, WI USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Wisconsin System; University of Wisconsin Madison	Brunwasser, SM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, T-1218 Med Ctr North, Nashville, TN 37235 USA.; Brunwasser, SM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, B-1118 MCN, Nashville, TN 37232 USA.	steven.brunwasser@vanderbilt.edu		Turi, Kedir/0000-0002-3853-9357; Brunwasser, Steven/0000-0002-3476-5437	National Institutes of Health/National Institute of Allergy and Infectious Diseases [U19 Al 095227]; National Institutes of Health/Office of the Director [UG3 0D023282]; National Institutes of Health Midcareer Investigator Award [K24 Al 077930]; Agency for Healthcare Research and Quality [K12 HS022990]; National Institute of Allergy and Infectious Diseases [RO1 A1035786]; CREW consortium, Office of The Director, National Institutes of Health [UG3 0D023282]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS022990] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445, UL1TR002243] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095227, K24AI077930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018921] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023282] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000624] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Midcareer Investigator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CREW consortium, Office of The Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by U19 Al 095227, National Institutes of Health/National Institute of Allergy and Infectious Diseases (https://www.niaidsiih.gov/) to TVH; UG3 0D023282, National Institutes of Health/Office of the Director (https://www.nih.gov/institutes-nihinih-office-director) to JEG; K24 Al 077930, National Institutes of Health Midcareer Investigator Award (https:// www.nih.gov/) to TVH; K12 HS022990, Agency for Healthcare Research and Quality (https://www.ahm.gov/) to SMB; RO1 A1035786, National Institute of Allergy and Infectious Diseases to DRG. Research reported in this publication was supported by the CREW consortium, Office of The Director, National Institutes of Health under award number UG3 0D023282. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher I, 2007, PEDIATR PULM, V42, P100, DOI 10.1002/ppul.20525; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Asparouhov T., 2010, MPLUSTECHNICAL APPEN; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; BAILEY WC, 1992, AM J MED, V93, P263, DOI 10.1016/0002-9343(92)90231-Y; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Bauer DJ, 2003, J EDUC BEHAV STAT, V28, P135, DOI 10.3102/10769986028002135; Bentler P M, 1992, Stat Methods Med Res, V1, P159, DOI 10.1177/096228029200100203; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bollen K., 1989, STRUCTURAL EQUATIONS; Bollen KA, 2002, ANNU REV PSYCHOL, V53, P605, DOI 10.1146/annurev.psych.53.100901.135239; Bollen KA, 2011, PSYCHOL METHODS, V16, P265, DOI 10.1037/a0024448; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2016, J ALLER CL IMM-PRACT, V4, P1111, DOI 10.1016/j.jaip.2016.05.003; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Cockcroft DW, 1996, J ALLERGY CLIN IMMUN, V98, P1016, DOI 10.1016/S0091-6749(96)80185-0; Cole DA, 2014, PSYCHOL METHODS, V19, P300, DOI 10.1037/a0033805; Correia MAD, 2017, J PEDIAT-BRAZIL, V93, P148, DOI [10.1016/j.jped.2016.05.006, 10.1015/j.jped.2016.05.006]; Ellwood P, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01605-2016; Geier DA, 2019, J MATERN-FETAL NEO M, V32, P833, DOI 10.1080/14767058.2017.1393068; Gold DR, 1999, AM J RESP CRIT CARE, V160, P227, DOI 10.1164/ajrccm.160.1.9807104; Hirschfeld G, 2014, PRACT ASSESS RES EVA, P19; Horner SD, 2006, J ASTHMA, V43, P533, DOI 10.1080/02770900600857192; Hox J, 2004, MATH MODEL-THEOR APP, V19, P135; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Larkin EK, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0040-0; Lim RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010134; Little TD, 2007, INT J BEHAV DEV, V31, P357, DOI 10.1177/0165025407077757; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Liu Y, 2017, PSYCHOL METHODS, V22, P486, DOI 10.1037/met0000075; Ly NP, 2006, PEDIATRICS, V117, pE1132, DOI 10.1542/peds.2005-2271; Magzoub A, 2017, INT J MED SCI PUBLIC, P6; Millsap RE, 2004, MULTIVAR BEHAV RES, V39, P479, DOI 10.1207/S15327906MBR3903_4; Moncrief T, 2014, J ASTHMA, V51, P260, DOI 10.3109/02770903.2013.873806; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Muthen B., 2002, MPLUS WEB NOTES, V4, P1; Muthen B.O., 2004, MPLUS TECHNICAL APPE; Muthen L. K., 2017, MPLUS USERS GUIDE ST, V8th, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; O'Byrne PM, 2010, EUR RESPIR J, V36, P269, DOI 10.1183/09031936.00124009; Oluwole O, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0352-8; Pearson WS, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140139; R Core Team, 2015, R LANGUAGE ENV STAT; Rigdon EE, 2012, LONG RANGE PLANN, V45, P341, DOI 10.1016/j.lrp.2012.09.010; Rigdon EE, 1996, STRUCT EQU MODELING, V3, P369, DOI 10.1080/10705519609540052; Rosas-Salazar C, 2016, J INFECT DIS, V214, P1924, DOI 10.1093/infdis/jiw456; ROSIER MJ, 1994, AM J RESP CRIT CARE, V149, P1434, DOI 10.1164/ajrccm.149.6.8004295; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Satorra A, 2000, ADV ST THEO, V36, P233; Schmidt CW, 2015, ENVIRON HEALTH PERSP, V123, pA260, DOI 10.1289/ehp.123-A260; Stapleton LM, 2016, J EDUC BEHAV STAT, V41, P481, DOI 10.3102/1076998616646200; Steiger J, 1980, M PSYCH SOC MAY LOW; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Steiger JH, 2000, STRUCT EQU MODELING, V7, P149, DOI 10.1207/S15328007SEM0702_1; Taylor AB, 2006, EDUC PSYCHOL MEAS, V66, P228, DOI 10.1177/0013164405278580; Thakur N, 2013, AM J RESP CRIT CARE, V188, P1202, DOI 10.1164/rccm.201306-1016OC; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Toledo M F, 2016, Allergol Immunopathol (Madr), V44, P439, DOI 10.1016/j.aller.2016.02.006; Tse SM, 2016, J ALLERGY CLIN IMMUN, V138, P1561, DOI 10.1016/j.jaci.2016.04.005; Tse SM, 2015, PEDIATR PULM, V50, P955, DOI 10.1002/ppul.23113; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Westland JC, 2010, ELECTRON COMMER R A, V9, P476, DOI 10.1016/j.elerap.2010.07.003; Wildfire JJ, 2012, J ALLERGY CLIN IMMUN, V129, P694, DOI 10.1016/j.jaci.2011.12.962; Zein JG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157301	69	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194739	10.1371/journal.pone.0194739	http://dx.doi.org/10.1371/journal.pone.0194739			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664908	Green Submitted, gold, Green Published			2022-12-27	WOS:000430262300010
J	Chen, YM; Liu, XY; Zhang, FB; Liao, SF; He, XY; Zhuo, DX; Huang, HB; Wu, YY				Chen, YongMing; Liu, XinYu; Zhang, FaBiao; Liao, ShanFan; He, XiYuan; Zhuo, DeXiang; Huang, HuaiBin; Wu, YongYang			Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5	PLOS ONE			English	Article							CIRCULATING 25-HYDROXYVITAMIN D-3; CANCER-CELLS; BREAST-CANCER; COLORECTAL-CANCER; LUNG-CANCER; E-CADHERIN; RISK; METAANALYSIS; DIFFERENTIATION; SURVIVAL	We previously demonstrated that transient receptor potential vanilloid subfamily 5 (TRPV5) expression was decreased in renal cell carcinoma (RCC) compared with that in normal kidney tissues, a finding that was correlated with vitamin D receptor (VDR) expression, but further investigations is warranted. The aim of this study was to elucidate whether VDR could regulate the expression of TRPV5 and affect proliferation and metastasis in RCC. In this study, we used lentivirus to conduct the model of VDR overexpression and knockdown caki-1 and 786-O RCC cell lines in vitro. The results demonstrated that VDR overexpression significantly inhibited RCC cells proliferation, migration and invasion, and promoted apoptosis by the MTT, transwell cell migration/invasion and flow cytometry assays, respectively. However, VDR knockdown in RCC cells had the opposite effect. The RNA-sequence assay, which was assessed in caki-1 cells after VDR overexpression and knockdown, also indicated that significantly differentially expressed genes were associated with cell apoptotic, differentiation, proliferation and migration. RT-PCR and western blot analysis showed that VDR knockdown increased TRPV5 expression and VDR overexpression decreased TRPV5 expression in caki-1 cells. Furthermore, knockdown of TRPV5 expression suppressed the VDR knockdown-induced change in the proliferation, migration and invasion in caki-1 cells. Taken together, these findings confirmed that VDR functions as a tumour suppressor in RCC cells and suppresses the proliferation, migration and invasion of RCC through regulating the expression of TRPV5.	[Chen, YongMing; Zhang, FaBiao; Liao, ShanFan; He, XiYuan; Zhuo, DeXiang; Huang, HuaiBin; Wu, YongYang] Fujian Med Univ, Affiliated Sanming Hosp 1, Dept Urol, Sanming, Fujian, Peoples R China; [Liu, XinYu] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Liu, XinYu] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China; [Liu, XinYu] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China	Fujian Medical University; Sichuan University; Sichuan University	Wu, YY (corresponding author), Fujian Med Univ, Affiliated Sanming Hosp 1, Dept Urol, Sanming, Fujian, Peoples R China.	wuyyfj@126.com		YongYang, Wu/0000-0001-5375-9422; Wu, YongYang/0000-0001-5212-6033	National Natural Science Foundation of China [81372734]; Special Foundation of Fujian Medical University for Scientific and Technological Development [FZS13035Y]; Trained Foundation of Fujian Provincial Health Family Planning Commission for the Young and Middle-aged Core Talent [2014-ZQN-ZD-30]; Natural Science Foundation of Fujian Province, China [2014J01440]; Sichuan University; Collaborative Innovation Center for Biotherapy	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation of Fujian Medical University for Scientific and Technological Development; Trained Foundation of Fujian Provincial Health Family Planning Commission for the Young and Middle-aged Core Talent; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Sichuan University(Sichuan University); Collaborative Innovation Center for Biotherapy	This work was supported by "National Natural Science Foundation of China" (No.81372734) to YYW, "Special Foundation of Fujian Medical University for Scientific and Technological Development" (No.FZS13035Y) to YYW, "Trained Foundation of Fujian Provincial Health Family Planning Commission for the Young and Middle-aged Core Talent" (No.2014-ZQN-ZD-30) to YYW and "Natural Science Foundation of Fujian Province, China" (No.2014J01440) to YYW which provided funds for our research.	Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Blomberg Jensen M, 2010, J STEROID BIOCHEM, V121, P376, DOI DOI 10.1016/J.JSBMB.2010.03.069; Chen PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049312; Chiang KC, 2011, J GASTROEN HEPATOL, V26, P1597, DOI 10.1111/j.1440-1746.2011.06892.x; Daniel C, 2007, J CELL BIOCHEM, V102, P1420, DOI 10.1002/jcb.21361; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Ditsch N, 2012, J HISTOCHEM CYTOCHEM, V60, P121, DOI 10.1369/0022155411429155; Dutcher JP, 2013, THER ADV UROL, V5, P338, DOI 10.1177/1756287213505672; Fan H, 2014, ASIAN PAC J CANCER P, V15, P2559, DOI 10.7314/APJCP.2014.15.6.2559; Fleet JC, 2002, AM J PHYSIOL-GASTR L, V283, pG618, DOI 10.1152/ajpgi.00269.2001; Fujioka T, 1998, J UROLOGY, V160, P247, DOI 10.1016/S0022-5347(01)63098-2; Giusti L, 2014, J CELL MOL MED, V18, P1944, DOI 10.1111/jcmm.12372; Hendrickson WK, 2011, J CLIN ONCOL, V29, P2378, DOI 10.1200/JCO.2010.30.9880; Hoenderop JGJ, 2001, J AM SOC NEPHROL, V12, P1342, DOI 10.1681/ASN.V1271342; Joh HK, 2013, JNCI-J NATL CANCER I, V105, P726, DOI 10.1093/jnci/djt082; Kanemaru M, 2013, HEPATO-GASTROENTEROL, V60, P1199, DOI 10.5754/hge11073; Kim Y, 2014, BRIT J CANCER, V110, P2772, DOI 10.1038/bjc.2014.175; Liao Y, 2015, TUMOR BIOL, V36, P1567, DOI 10.1007/s13277-014-2728-9; Liu WH, 2006, HUM PATHOL, V37, P1268, DOI 10.1016/j.humpath.2006.04.029; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Muller DC, 2015, CANCER EPIDEM BIOMAR, V24, P1277, DOI 10.1158/1055-9965.EPI-14-1351; Muller DC, 2014, AM J EPIDEMIOL, V180, P810, DOI 10.1093/aje/kwu204; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Obara W, 2007, J UROLOGY, V178, P1497, DOI 10.1016/j.juro.2007.05.119; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Sanchez-Gastaldo A, 2017, CANCER TREAT REV, V60, P77, DOI 10.1016/j.ctrv.2017.08.010; Schwarz EC, 2006, CELL CALCIUM, V39, P163, DOI 10.1016/j.ceca.2005.10.006; Serra R, 1996, NAT MED, V2, P390, DOI 10.1038/nm0496-390; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sozucan Y., 2015, Experimental Oncology, V37, P208; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Verlinden L, 2000, CANCER RES, V60, P2673; Wang W, 2015, CELL PHYSIOL BIOCHEM, V35, P1999, DOI 10.1159/000374007; Wu YY, 2011, J UROLOGY, V186, P2419, DOI 10.1016/j.juro.2011.07.086; Zhang LQ, 2015, CELL PHYSIOL BIOCHEM, V36, P299, DOI 10.1159/000374072; Zheng Y, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.23; Zhou Q, 2017, MOL IMMUNOL, V91, P156, DOI 10.1016/j.molimm.2017.09.006	40	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195844	10.1371/journal.pone.0195844	http://dx.doi.org/10.1371/journal.pone.0195844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659618	Green Submitted, Green Published, gold			2022-12-27	WOS:000430061100036
J	Fleuren, M; Quicazan-Rubio, EM; van Leeuwen, JL; Pollux, BJA				Fleuren, Mike; Quicazan-Rubio, Elsa M.; van Leeuwen, Johan L.; Pollux, Bart J. A.			Why do placentas evolve? Evidence for a morphological advantage during pregnancy in live-bearing fish	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC-RELATIONSHIPS; HISTORY FACILITATION HYPOTHESIS; GUPPY POECILIA-RETICULATA; LIFE-HISTORY; SWIMMING PERFORMANCE; GENUS POECILIOPSIS; LIVEBEARING FISH; CYPRINODONTIFORMES POECILIIDAE; VERTEBRATE VIVIPARITY; INDEPENDENT ORIGINS	A live-bearing reproductive strategy can induce large morphological changes in the mother during pregnancy. The evolution of the placenta in swimming animals involves a shift in the timing of maternal provisioning from pre-fertilization (females supply their eggs with sufficient yolk reserves prior to fertilization) to post-fertilization (females provide all nutrients via a placenta during the pregnancy). It has been hypothesised that this shift, associated with the evolution of the placenta, should confer a morphological advantage to the females leading to a more slender body shape during the early stages of pregnancy. We tested this hypothesis by quantifying three-dimensional shape and volume changes during pregnancy and in full-grown virgin controls of two species within the live-bearing fish family Poeciliidae: Poeciliopsis gracilis (non-placental) and Poeciliopsis turneri (placental). We show that P. turneri is more slender than P. gracilis at the beginning of the interbrood interval and in virgins, and that these differences diminish towards the end of pregnancy. This study provides the first evidence for an adaptive morphological advantage of the placenta in live-bearing fish. A similar morphological benefit could drive the evolution of placentas in other live-bearing (swimming) animal lineages.	[Fleuren, Mike; Quicazan-Rubio, Elsa M.; van Leeuwen, Johan L.; Pollux, Bart J. A.] Wageningen Univ & Res, Dept Anim Sci, Expt Zool Chair Grp, Wageningen, Netherlands	Wageningen University & Research	Pollux, BJA (corresponding author), Wageningen Univ & Res, Dept Anim Sci, Expt Zool Chair Grp, Wageningen, Netherlands.	bart.pollux@wur.nl	van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019; Fleuren, Mike/S-5575-2018	van Leeuwen, Johan/0000-0002-4433-880X; Fleuren, Mike/0000-0002-3186-3840; Quicazan-Rubio, Elsa M./0000-0002-7320-8924	ALW Open Programme [821.02.024]; VIDI grant of the Netherlands Organisation for Scientific Research [864.14.008]; Francisco Jose de Caldas doctorate grant from the Administrative Department of Science, Technology and Innovation (COLCIENCIAS) [512-2010]	ALW Open Programme; VIDI grant of the Netherlands Organisation for Scientific Research; Francisco Jose de Caldas doctorate grant from the Administrative Department of Science, Technology and Innovation (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was supported by ALW Open Programme grant 821.02.024 to J.L.V.L. and VIDI grant 864.14.008 of the Netherlands Organisation for Scientific Research to B.J.A.P. and a Francisco Jose de Caldas doctorate grant from the Administrative Department of Science, Technology and Innovation (COLCIENCIAS) call 512-2010 to E.M.Q. The authors declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, REPROD BIOL PHYLOGEN; Banet AI, 2008, FUNCT ECOL, V22, P323, DOI 10.1111/j.1365-2435.2007.01367.x; Banet AI, 2016, OECOLOGIA, V181, P87, DOI 10.1007/s00442-015-3542-9; Banet AI, 2010, EVOLUTION, V64, P3172, DOI 10.1111/j.1558-5646.2010.01059.x; Bassar RD, 2014, FUNCT ECOL, V28, P999, DOI 10.1111/1365-2435.12233; Belk MC, 2010, OIKOS, V119, P163, DOI 10.1111/j.1600-0706.2009.17742.x; Blackburn DG, 2015, J MORPHOL, V276, P961, DOI 10.1002/jmor.20272; BLACKBURN DG, 1984, P NATL ACAD SCI-BIOL, V81, P4860, DOI 10.1073/pnas.81.15.4860; Blake RW, 2005, J FISH BIOL, V67, P834, DOI 10.1111/j.0022-1112.2005.00788.x; Uribe MC, 2014, J MORPHOL, V275, P1406, DOI 10.1002/jmor.20315; Dulvy NK, 1997, P ROY SOC B-BIOL SCI, V264, P1309, DOI 10.1098/rspb.1997.0181; Frias-Alvarez P, 2016, OECOLOGIA, V181, P645, DOI 10.1007/s00442-015-3477-1; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Hamlett William C., 2005, P395; Holbrook GL, 2004, P NATL ACAD SCI USA, V101, P5595, DOI 10.1073/pnas.0400209101; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Ingley SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090274; James RS, 1998, J FISH BIOL, V53, P485, DOI 10.1006/jfbi.1998.0722; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Meredith RW, 2011, MOL PHYLOGENET EVOL, V59, P148, DOI 10.1016/j.ympev.2011.01.014; Meredith RW, 2010, MOL PHYLOGENET EVOL, V55, P631, DOI 10.1016/j.ympev.2009.11.006; Mossman HW, 1937, CONTRIB EMBRYOL, V26, P133; Noren SR, 2011, J EXP BIOL, V214, P4151, DOI 10.1242/jeb.059121; Ostrovsky AN, 2016, BIOL REV, V91, P673, DOI 10.1111/brv.12189; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Pires MN, 2011, FUNCT ECOL, V25, P757, DOI 10.1111/j.1365-2435.2011.01842.x; Pires MN, 2010, BIOL J LINN SOC, V99, P784, DOI 10.1111/j.1095-8312.2010.01391.x; Plaut I, 2002, FUNCT ECOL, V16, P290, DOI 10.1046/j.1365-2435.2002.00638.x; Pollux BJA, 2014, NATURE, V513, P233, DOI 10.1038/nature13451; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Pollux BJA, 2011, FUNCT ECOL, V25, P747, DOI 10.1111/j.1365-2435.2011.01831.x; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; Reznick D.N., 1989, P125; Reznick D, 2007, EVOLUTION, V61, P2570, DOI 10.1111/j.1558-5646.2007.00207.x; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; Schindler JF, 2015, J MORPHOL, V276, P991, DOI 10.1002/jmor.20292; Schrader M, 2005, COPEIA, P649; Schwarzkopf L, 2010, AUSTRAL ECOL, V35, P82, DOI 10.1111/j.1442-9993.2009.02015.x; Scrimshaw Nevin S., 1944, COPEIA, V1944, P180, DOI 10.2307/1437814; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Shaffer LR, 1996, ANIM BEHAV, V51, P1017, DOI 10.1006/anbe.1996.0104; SHINE R, 1980, Oecologia (Berlin), V46, P92, DOI 10.1007/BF00346972; Singer J.D., 2003, APPL LONGITUDINAL DA; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; THIBAULT RE, 1978, EVOLUTION, V32, P320, DOI 10.1111/j.1558-5646.1978.tb00648.x; Tokic G, 2012, P ROY SOC B-BIOL SCI, V279, P3065, DOI 10.1098/rspb.2012.0057; Trexler JC, 1997, ECOLOGY, V78, P1370, DOI 10.1890/0012-9658(1997)078[1370:RAAPIO]2.0.CO;2; Trexler JC, 2003, AM NAT, V162, P574, DOI 10.1086/378822; TURNER C. L., 1940, COPEIA, V1940, P88, DOI 10.2307/1439048; Turner CL, 1937, BIOL BULL-US, V72, P145, DOI 10.2307/1537249; Tytell ED, 2010, INTEGR COMP BIOL, V50, P1140, DOI 10.1093/icb/icq057; Uribe M.C., 2010, VIVIPAROUS FISHES; Van Wassenbergh S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0461; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Voesenek CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146682; WAKE MH, 1992, AM ZOOL, V32, P256; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; Weihs D, 2002, INTEGR COMP BIOL, V42, P127, DOI 10.1093/icb/42.1.127; Wesner JS, 2011, BIOL J LINN SOC, V104, P386, DOI 10.1111/j.1095-8312.2011.01715.x; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Winne CT, 2006, FUNCT ECOL, V20, P1054, DOI 10.1111/j.1365-2435.2006.01180.x; Wourms J.P., 1988, P1; WOURMS JP, 1992, AM ZOOL, V32, P276; WOURMS JP, 1981, AM ZOOL, V21, P473; Wu WH, 2004, CLIN BIOMECH, V19, P480, DOI 10.1016/j.clinbiomech.2004.02.003; Zuniga-Vega JJ, 2011, J FISH BIOL, V79, P1029, DOI 10.1111/j.1095-8649.2011.03081.x; Zuniga-Vega JJ, 2007, OIKOS, V116, P995, DOI 10.1111/j.2007.0030-1299.15763.x	68	12	12	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195976	10.1371/journal.pone.0195976	http://dx.doi.org/10.1371/journal.pone.0195976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659620	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100044
J	Overton, ET; Lawrence, SJ; Wagner, E; Nopora, K; Rosch, S; Young, P; Schmidt, D; Kreusel, C; De Carli, S; Meyer, TP; Weidenthaler, H; Samy, N; Chaplin, P				Overton, Edgar Turner; Lawrence, Steven J.; Wagner, Eva; Nopora, Katrin; Roesch, Siegfried; Young, Philip; Schmidt, Darja; Kreusel, Christian; De Carli, Sonja; Meyer, Thomas P.; Weidenthaler, Heinz; Samy, Nathaly; Chaplin, Paul			Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial	PLOS ONE			English	Article							ANKARA; COMPLICATIONS	Background Modified Vaccinia Ankara (MVA) is a live, viral vaccine under advanced development as a non-replicating smallpox vaccine. A randomised, double-blind, placebo-controlled phase III clinical trial was conducted to demonstrate the humoral immunogenic equivalence of three consecutively manufactured MVA production lots, and to confirm the safety and tolerability of MVA focusing on cardiac readouts. Methods The trial was conducted at 34 sites in the US. Vaccinia-naive adults aged 18-40 years were randomly allocated to one of four groups using a 1:1:1:1 randomization scheme. Subjects received either two MVA injections from three consecutive lots (Groups 1-3), or two placebo injections (Group 4), four weeks apart. Everyone except personnel involved in vaccine handling and administration was blinded to treatment. Safety assessment focused on cardiac monitoring throughout the trial. Vaccinia-specific antibody titers were measured using a Plaque Reduction Neutralization Test (PRNT) and an Enzyme-Linked Immunosorbent Assay (ELISA). The primary immunogenicity endpoint was Geometric Mean Titers (GMTs) after two MVA vaccinations measured by PRNT at trial visit 4. This trial is registered with Clinical Trials.gov, number NCT01144637. Results Between March 2013 and May 2014, 4005 subjects were enrolled and received at least one injection of MVA (n = 3003) or placebo (n = 1002). The three MVA lots induced equivalent antibody titers two weeks after the second vaccination, with seroconversion rates of 99.8% (PRNT) and 99.7% (ELISA). Overall, 180 (6.0%) subjects receiving MVA and 29 (2.9%) subjects in the placebo group reported at least one unsolicited Adverse Event (AE) that was considered trial-related. Vaccination was well tolerated without significant safety concerns, particularly regarding cardiac assessment. Conclusions The neutralizing and total antibody titers induced by each of the three lots were equivalent. No significant safety concerns emerged in this healthy trial population, especially regarding cardiac safety, thus confirming the excellent safety and tolerability profile of MVA.	[Overton, Edgar Turner] Univ Alabama Birmingham, Div Infect Dis, Sch Med, Birmingham, AL USA; [Lawrence, Steven J.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Wagner, Eva; Nopora, Katrin; Roesch, Siegfried; Young, Philip; Schmidt, Darja; Kreusel, Christian; De Carli, Sonja; Meyer, Thomas P.; Weidenthaler, Heinz; Samy, Nathaly; Chaplin, Paul] Bavarian Nord GmbH, Martinsried, Germany	University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Bavarian Nordic	Nopora, K (corresponding author), Bavarian Nord GmbH, Martinsried, Germany.	kan@bavarian-nordic.com	Young, Philip/ABI-1480-2020	Young, Philip/0000-0003-0201-9277; Weidenthaler, Heinz/0000-0002-6866-4028; Overton, Edgar/0000-0002-4013-536X	Biomedical Advanced Research and Development Authority (BARDA); BARDA [HHS0100200700034C]; Bavarian Nordic	Biomedical Advanced Research and Development Authority (BARDA); BARDA; Bavarian Nordic	The trial was funded by the Biomedical Advanced Research and Development Authority (BARDA, http://www.phe.gov/about/BARDA/Pages/default.aspx). Bavarian Nordic was the sponsor receiving the fund (BARDA Contract No.: HHS0100200700034C). Bavarian Nordic reimbursed the clinical trial investigators (i.e. ETO and SJL) for their efforts. Bavarian Nordic provided support in form of salaries for authors EW, KN, SR, PY, DS, CK, SDC, TPM, HW, NS and PC. The statistical analysis plan was written by PY (Bavarian Nordic). Data collection, management and analysis were performed by Chiltern International Inc. (Bristol, TN). The specific roles of the authors are articulated in the "author contributions" section. Bavarian Nordic did not have any additional role in the data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2007, ADV COMMM VRBPAC BRE; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Artenstein AW, 2008, EXPERT REV VACCINES, V7, P1225, DOI 10.1586/14760584.7.8.1225; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; Elizaga ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054407; Engler RJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118283; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; Frey SE, 2015, VACCINE, V33, P5225, DOI 10.1016/j.vaccine.2015.06.075; Frey SE, 2014, VACCINE, V32, P2732, DOI 10.1016/j.vaccine.2014.02.043; Greenberg RN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157335; Greenberg RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138348; Greenberg RN, 2013, J INFECT DIS, V207, P749, DOI 10.1093/infdis/jis753; Greenberg RN, NON INFERIOR IMMUNOG; Haldiman Lindsey J, 2014, J Insur Med, V44, P184; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hingorani P, 2012, INDIAN J MED RES, V135, P322; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; Mayr A, 2003, COMP IMMUNOL MICROB, V26, P423, DOI 10.1016/S0147-9571(03)00025-0; McNeil MM, 2014, VACCINE, V32, P4758, DOI 10.1016/j.vaccine.2014.06.034; Mora LF, 2009, SOUTH MED J, V102, P615, DOI 10.1097/SMJ.0b013e31819fe55b; Overton ET, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv040; ROSE G, 1978, BRIT HEART J, V40, P636; Schwier NC, 2015, PHARMACOTHERAPY, V35, P99, DOI 10.1002/phar.1527; Sharma Umesh, 2011, WMJ, V110, P291; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Suter M, 2009, VACCINE, V27, P7442, DOI 10.1016/j.vaccine.2009.05.095; Vollmar J, 2006, VACCINE, V24, P2065, DOI 10.1016/j.vaccine.2005.11.022; von Krempelhuber A, 2010, VACCINE, V28, P1209, DOI 10.1016/j.vaccine.2009.11.030; von Sonnenburg F, 2014, VACCINE, V32, P5696, DOI 10.1016/j.vaccine.2014.08.022; Zitzmann-Roth EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122653	30	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195897	10.1371/journal.pone.0195897	http://dx.doi.org/10.1371/journal.pone.0195897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652929	gold, Green Submitted, Green Published			2022-12-27	WOS:000430026900044
J	Xu, Y; Li, N; Lu, MS; Dixon, E; Myers, RP; Jolley, RJ; Quan, H				Xu, Yuan; Li, Ning; Lu, Mingshan; Dixon, Elijah; Myers, Robert P.; Jolley, Rachel J.; Quan, Hude			The effects of patient cost sharing on inpatient utilization, cost, and outcome (vol 12, e0187096, 2017)	PLOS ONE			English	Correction																		Xu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187096; Xu YM, 2017, INT J CLIN EXP MED, V10, P1371	2	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0196039	10.1371/journal.pone.0196039	http://dx.doi.org/10.1371/journal.pone.0196039			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652928	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900056
J	Barnett, AG; Zardo, P; Graves, N				Barnett, Adrian G.; Zardo, Pauline; Graves, Nicholas			Randomly auditing research labs could be an affordable way to improve research quality: A simulation study	PLOS ONE			English	Article							TRIAL	The "publish or perish" incentive drives many researchers to increase the quantity of their papers at the cost of quality. Lowering quality increases the number of false positive errors which is a key cause of the reproducibility crisis. We adapted a previously published simulation of the research world where labs that produce many papers are more likely to have "child" labs that inherit their characteristics. This selection creates a competitive spiral that favours quantity over quality. To try to halt the competitive spiral we added random audits that could detect and remove labs with a high proportion of false positives, and also improved the behaviour of "child" and "parent" labs who increased their effort and so lowered their probability of making a false positive error. Without auditing, only 0.2% of simulations did not experience the competitive spiral, defined by a convergence to the highest possible false positive probability. Auditing 1.35% of papers avoided the competitive spiral in 71% of simulations, and auditing 1.94% of papers in 95% of simulations. Audits worked best when they were only applied to established labs with 50 or more papers compared with labs with 25 or more papers. Adding a +/- 20% random error to the number of false positives to simulate peer reviewer error did not reduce the audits' efficacy. The main benefit of the audits was via the increase in effort in "child" and "parent" labs. Audits improved the literature by reducing the number of false positives from 30.2 per 100 papers to 12.3 per 100 papers. Auditing 1.94% of papers would cost an estimated $15.9 million per year if applied to papers produced by National Institutes of Health funding. Our simulation greatly simplifies the research world and there are many unanswered questions about if and how audits would work that can only be addressed by a trial of an audit.	[Barnett, Adrian G.; Graves, Nicholas] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Zardo, Pauline] Queensland Univ Technol, Data & Policy, Fac Law, Gardens Point, Qld, Australia; [Zardo, Pauline] Queensland Univ Technol, Digital Media Res Ctr, Gardens Point, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Barnett, AG (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.	a.barnett@qut.edu.au		Barnett, Adrian/0000-0001-6339-0374; Graves, Nicholas/0000-0002-5559-3267	Australian National Health Medical Research Council Senior Research Fellowships [APP1117784, APP1059565]	Australian National Health Medical Research Council Senior Research Fellowships	Adrian Barnett and Nicholas Graves are supported by Australian National Health Medical Research Council Senior Research Fellowships (APP1117784 and APP1059565; http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; [Anonymous], 2021, LANG ENV STAT COMP; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Begley CG, 2015, NATURE, V525, P25, DOI 10.1038/525025a; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Biagioli M, 2016, NATURE, V535, P201, DOI 10.1038/535201a; Bik EM, 2016, MBIO, V7, DOI 10.1128/mBio.00809-16; Chakma J, 2014, NEW ENGL J MED, V370, P3, DOI 10.1056/NEJMp1311068; Chalmers I, 2009, LANCET, V374, P86, DOI DOI 10.1016/S0140-6736(09)60329-; Clarke P, 2016, J CLIN EPIDEMIOL, V69, P147, DOI 10.1016/j.jclinepi.2015.04.010; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; Djulbegovic B, 2013, NATURE, V500, P395, DOI 10.1038/500395a; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Fecher B, 1454 DIW; Gall T, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001846; Goldacre, COMPARE TRIALS PROJE; Goldacre B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3334; Goldacre B, 2016, NATURE, V530, P7, DOI 10.1038/530007a; Graves N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4797; Grimes DR, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171511; Guthrie S, 2017, WHAT WE KNOW GRANT P, DOI [10.12688/f1000research.11917.1, DOI 10.12688/F1000RESEARCH.11917.1]; Higginson AD, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000995; Horbach SPJM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186281; Hutchins BI, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002541; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Ioannidis JPA, 2012, PERSPECT PSYCHOL SCI, V7, P645, DOI 10.1177/1745691612464056; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000016.pub3; Judith R, 1988, WASHINGTON POST; Lauer M, PUBLICATION IMPACT N; Matosin N, 2014, DIS MODEL MECH, V7, P171, DOI 10.1242/dmm.015123; Merz JF, 2004, LANCET, V363, P89, DOI [DOI 10.1016/S0140-6736(03)15221-X, 10.1016/S0140-6736(03)15221-X]; Moher D, 2016, EUR J CLIN INVEST, V46, P383, DOI 10.1111/eci.12612; Moher D, 2016, LANCET, V387, P1573, DOI 10.1016/S0140-6736(15)00307-4; Moore S, 2017, PALGR COMMUN, V3, DOI 10.1057/palcomms.2016.105; National Health and Medical Research Council, 2013, MEAS UP 2013; Norman G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5278; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Prasad V, 2013, MAYO CLIN PROC, V88, P790, DOI 10.1016/j.mayocp.2013.05.012; Schneider Friedrich., 2005, EUR J POLIT ECON, V21, P598, DOI [DOI 10.1016/J.EJPOLECO.2004.10.002, 10.1016/j.ejpoleco.2004.10.002]; Schroter S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-62; Schulze-Cleven T, 2017, HIGH EDUC, V73, P795, DOI 10.1007/s10734-017-0114-4; Science and Technology Committee, 2011, PEER REV SCI PUBL; Smaldino PE, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160384; Smith R, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2742; Stephan P, 2017, NATURE, V544, P411, DOI 10.1038/544411a; Terer K, 2014, EFFECTIVE DRINK DRIV; US Census Bureau, 2011, STAT ABSTR US; van Dijk D, 2014, CURR BIOL, V24, pR516, DOI 10.1016/j.cub.2014.04.039; Van Noorden R, 2014, NATURE, V510, P325, DOI 10.1038/510325a; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Yordanov Y, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h809, 10.1136/bmj.h809]	52	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195613	10.1371/journal.pone.0195613	http://dx.doi.org/10.1371/journal.pone.0195613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649314	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900060
J	Katchanov, J; Asar, L; Klupp, EM; Both, A; Rothe, C; Konig, C; Rohde, H; Kluge, S; Maurer, FP				Katchanov, Juri; Asar, Lucia; Klupp, Eva-Maria; Both, Anna; Rothe, Camilla; Koenig, Christina; Rohde, Holger; Kluge, Stefan; Maurer, Florian P.			Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel beta-lactam/beta-lactamase inhibitor combinations	PLOS ONE			English	Article							MULTICENTER EVALUATION; KLEBSIELLA-PNEUMONIAE; MULTIPLEX PCR; ORGANISMS; ENTEROBACTERIACEAE; INFECTIONS; CEFTOLOZANE/TAZOBACTAM; AVIBACTAM; STRATEGY; BACTERIA	Objectives To determine the spectrum of infections with multidrug-resistant Gram-negative bacteria (MDR-GNB) and the clinical impact of the newly available betalactam/betalactamase inhibitor combinations ceftolozane/tazobactam and ceftazidime/avibactam in a German academic tertiary care center. Methods Retrospective analysis. Results Between September 1, 2015 and August 31, 2016, 119 individual patients (0.22% of all hospital admissions) were colonized or infected with carbapenem-resistant MDR-GNB. The species distribution was Pseudomonas aeruginosa, n = 66; Enterobacteriaceae spp., n = 44; and Acinetobacter baumannii, n = 18. In 9 patients, carbapenem-resistant isolates belonging to more than one species were detected. Infection was diagnosed in 50 patients (total: 42.0%; nosocomial pneumonia: n = 23, 19.3%; bloodstream infection: n = 11, 9.2%). Antimicrobial treatment with broad-spectrum antibiotics prior to detection of a carbapenem-resistant isolate was documented in 105 patients (88.2%, prior administration of carbapenems: 62.2%). Nosocomial transmission was documented in 29 patients (24.4%). In 26 patients (21.8%), at least one carbapenem-susceptible, third-generation cephalosporin non-susceptible isolate was documented prior to detection of a carbapenem-resistant isolate belonging to the same species (median 38 days, IQR 23-78). 12 patients (10.1%) had documented previous contact to the healthcare system in a country with high burden of carbapenemase-producing strains. Genes encoding carbapenemases were detected in 60/102 patient isolates (58.8%; VIM-2, n = 25; OXA-48, n = 21; OXA-23-like, n = 10). Susceptibility to colistin was 94.3%. Ceftolozane/tazobactam and ceftazidime/avibactam were administered to 3 and 5 patients, respectively (in-hospital mortality: 66% and 100%). Development of drug-resistance under therapy was observed for both antimicrobials. Conclusions i) The major predisposing factors for acquisition of carbapenem-resistant MDR-GNB were selective pressure due to preceding antimicrobial therapy and nosocomial transmission. ii) Colistin remains the backbone of antimicrobial chemotherapy for infections caused by carbapenem-resistant MDR-GNB. iii) Novel beta-lactam/beta-lactamase inhibitor combinations are of limited usefulness in our setting because of the high prevalence of Ambler class B carbapenemases and the emergence of nonsusceptibility under therapy.	[Katchanov, Juri; Koenig, Christina; Kluge, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany; [Asar, Lucia; Klupp, Eva-Maria; Both, Anna; Rohde, Holger; Maurer, Florian P.] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Rothe, Camilla] Univ Med Ctr Hamburg Eppendorf, Div Infect Dis & Trop Med, Med Dept 1, Hamburg, Germany; [Koenig, Christina] Univ Med Ctr Hamburg Eppendorf, Hosp Pharm, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Maurer, FP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.	f.maurer@uke.de	König, Christina/G-4743-2016; Maurer, Florian/ABA-1918-2020; Maurer, Florian/Z-5028-2019	Maurer, Florian/0000-0001-8353-5964; Maurer, Florian/0000-0001-8353-5964; Rohde, Holger/0000-0001-8587-4433				Andes D, 2005, CLIN MICROBIOL INFEC, V11, P10, DOI 10.1111/j.1469-0691.2005.01265.x; [Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5; Biedenbach DJ, 2015, ANTIMICROB AGENTS CH, V59, P4239, DOI 10.1128/AAC.00206-15; Both A, 2017, J ANTIMICROB CHEMOTH, V72, P2483, DOI 10.1093/jac/dkx179; Carmeli Y, 2016, LANCET INFECT DIS, V16, P661, DOI 10.1016/S1473-3099(16)30004-4; Castanheira M, 2014, ANTIMICROB AGENTS CH, V58, P6844, DOI 10.1128/AAC.03681-14; Dalfino L, 2012, CLIN INFECT DIS, V54, P1720, DOI 10.1093/cid/cis286; European Committee on Antimicrobial Susceptibility Testing (EUCAST), ANT SUSC TEST COL PR; Falagas ME, 2014, ANTIMICROB AGENTS CH, V58, P654, DOI 10.1128/AAC.01222-13; Fussen R, 2016, MED KLIN-INTENSIVMED, V111, P743, DOI 10.1007/s00063-016-0223-3; Gatermann S., 2014, EPIDEMIOL B, P421; Grundmann H, 2017, LANCET INFECT DIS, V17, P153, DOI 10.1016/S1473-3099(16)30257-2; Hentschke M, 2011, DIAGN MICR INFEC DIS, V71, P312, DOI 10.1016/j.diagmicrobio.2011.07.011; Heudorf U, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.2.30109; Heudorf U, 2016, GMS HYG INFECT CONTR, V11, DOI 10.3205/dgkh000270; Hogardt M, 2015, EURO SURVEILL, V20; Humphries RM, 2015, ANTIMICROB AGENTS CH, V59, P6605, DOI 10.1128/AAC.01165-15; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Livermore DM, 2017, J ANTIMICROB CHEMOTH, V72, P2278, DOI 10.1093/jac/dkx136; Lubbert C, 2014, INFECTION, V42, P309, DOI 10.1007/s15010-013-0547-3; Maechler F, 2015, INFECTION, V43, P163, DOI 10.1007/s15010-014-0701-6; Marshall S, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02243-16; Martin-Loeches I, 2014, CURR OPIN CRIT CARE, V20, P516, DOI 10.1097/MCC.0000000000000124; Munita JM, 2017, CLIN INFECT DIS, V65, P158, DOI 10.1093/cid/cix014; Mutters NT, 2016, J HOSP INFECT, V93, P191, DOI 10.1016/j.jhin.2016.02.013; Mutters NT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1173-8; Mutters R, 2016, MED KLIN-INTENSIVMED, V111, P261, DOI 10.1007/s00063-016-0155-y; Perez F, 2016, EXPERT OPIN PHARMACO, V17, P761, DOI 10.1517/14656566.2016.1145658; Ruhnke M, 2014, LANCET ONCOL, V15, pE606, DOI 10.1016/S1470-2045(14)70344-4; Schroter M, 2004, APPL ENVIRON MICROB, V70, P613, DOI 10.1128/AEM.70.1.613-615.2004; Stocker H, 2013, INTERNIST, V54, P936, DOI 10.1007/s00108-012-3141-3; Tenenbaum T, 2016, INFECT CONT HOSP EP, V37, P1310, DOI 10.1017/ice.2016.179; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van der Zee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-27; van Duin D, 2016, CLIN INFECT DIS, V63, P234, DOI 10.1093/cid/ciw243; van Duin D, 2013, DIAGN MICR INFEC DIS, V75, P115, DOI 10.1016/j.diagmicrobio.2012.11.009; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004	37	38	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195757	10.1371/journal.pone.0195757	http://dx.doi.org/10.1371/journal.pone.0195757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649276	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900081
J	Massolt, ET; Chaker, L; Visser, TJ; Gillis, AJM; Dorssers, LCJ; Beukhof, CM; Kam, BLR; Franssen, GJ; Brigante, G; van Ginhoven, TM; Visser, WE; Looijenga, LHJ; Peeters, RP				Massolt, Elske T.; Chaker, Layal; Visser, Theo J.; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Beukhof, Carolien M.; Kam, Boen L. R.; Franssen, Gaston J.; Brigante, Giulia; van Ginhoven, Tessa M.; Visser, W. Edward; Looijenga, Leendert H. J.; Peeters, Robin P.			Serum microRNA profiles in athyroid patients on and off levothyroxine therapy	PLOS ONE			English	Article							CIRCULATING MICRORNAS; THYROXINE; CANCER; DIAGNOSIS; MIRNA; REPLACEMENT; BIOMARKERS	Background Levothyroxine replacement treatment in hypothyroidism is unable to restore physiological thyroxine and triiodothyronine concentrations in serum and tissues completely. Normal serum thyroid stimulating hormone (TSH) concentrations reflect only pituitary euthyroidism and, therefore, novel biomarkers representing tissue-specific thyroid state are needed. MicroRNAs (miRNAs), small non-coding regulatory RNAs, exhibit tissue-specific expression patterns and can be detectable in serum. Previous studies have demonstrated differential expression of (precursors of) miRNAs in tissues under the influence of thyroid hormone. Objective To study if serum miRNA profiles are changed in different thyroid states. Design and methods We studied 13 athyroid patients (6 males) during TSH suppressive therapy and after 4 weeks of thyroid hormone withdrawal. A magnetic bead capture system was used to isolate 384 defined miRNAs from serum. Subsequently, the TaqMan Array Card 3.0 platform was used for profiling after individual target amplification. Results Mean age of the subjects was 44.0 years (range 20-61 years). Median TSH levels were 88.9 mU/I during levothyroxine withdrawal and 0.006 mU/I during LT4 treatment with a median dosage of 2.1 fag/kg. After normalization to allow inter-sample analysis, a paired analysis did not demonstrate a significant difference in expression of any of the 384 miRNAs analyzed on and off LT4 treatment. Conclusion Although we previously showed an up-regulation of pri-miRNAs 133b and 206 in hypothyroid state in skeletal muscle, the present study does not supply evidence that thyroid state also affects serum miRNAs in humans.	[Massolt, Elske T.; Chaker, Layal; Visser, Theo J.; Beukhof, Carolien M.; Brigante, Giulia; Visser, W. Edward; Peeters, Robin P.] Erasmus MC, Div Endocrinol, Rotterdam, Netherlands; [Massolt, Elske T.; Chaker, Layal; Visser, Theo J.; Beukhof, Carolien M.; Brigante, Giulia; Visser, W. Edward; Peeters, Robin P.] Erasmus MC, Acad Ctr Thyroid Dis, Dept Internal Med, Rotterdam, Netherlands; [Chaker, Layal] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Gillis, Ad J. M.; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Kam, Boen L. R.] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands; [Franssen, Gaston J.; van Ginhoven, Tessa M.] Erasmus MC, Inst Canc, Dept Surg, Div Surg Oncol, Rotterdam, Netherlands; [Brigante, Giulia] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Unit Endocrinol, Modena, Italy	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Universita di Modena e Reggio Emilia	Massolt, ET (corresponding author), Erasmus MC, Div Endocrinol, Rotterdam, Netherlands.; Massolt, ET (corresponding author), Erasmus MC, Acad Ctr Thyroid Dis, Dept Internal Med, Rotterdam, Netherlands.	e.massolt@erasmusmc.nl	Brigante, Giulia/J-8775-2018; Looijenga, Leendert/B-8145-2019	Brigante, Giulia/0000-0001-8426-4502; Looijenga, Leendert/0000-0002-8146-1911; Peeters, Robin/0000-0001-7732-9371	Zon-MW TOP grant [91212044]; Erasmus MC MRACE grant	Zon-MW TOP grant; Erasmus MC MRACE grant	R.P.P. is supported by a Zon-MW TOP grant (number 91212044) and an Erasmus MC MRACE grant.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carreras-Badosa G, 2015, J CLIN ENDOCR METAB, V100, pE1446, DOI 10.1210/jc.2015-2872; Celano M, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/6496570; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dong HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012136; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; EscobarMorreale HF, 1996, ENDOCRINOLOGY, V137, P2490, DOI 10.1210/en.137.6.2490; Gillis AJM, 2013, MOL ONCOL, V7, P1083, DOI 10.1016/j.molonc.2013.08.002; Gullo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022552; Hiratsuka I, 2016, THYROID, V26, P1431, DOI 10.1089/thy.2016.0062; Hoermann R, 2013, EUR J ENDOCRINOL, V168, P271, DOI 10.1530/EJE-12-0819; Janssen R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00171; Ladenson PW, 2002, CLIN ENDOCRINOL, V57, P575, DOI 10.1046/j.1365-2265.2002.01682.x; Le Carre J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00413; Lee JC, 2013, CANCER-AM CANCER SOC, V119, P4358, DOI 10.1002/cncr.28254; Links T P, 2007, Ned Tijdschr Geneeskd, V151, P1777; Lodewijk L, 2012, CANCER BIOMARK, V11, P229, DOI 10.3233/CBM-2012-0273; Looijenga LH, 2016, ONCOTARGET; Massolt ET, 2018, J CLIN ENDOCR METAB, V103, P169, DOI 10.1210/jc.2017-01144; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Panicker V, 2009, CLIN ENDOCRINOL, V71, P574, DOI 10.1111/j.1365-2265.2008.03521.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rijlaarsdam MA, 2015, ANDROLOGY-US, V3, P85, DOI 10.1111/andr.298; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Vanderpump MPJ, 2002, THYROID, V12, P839, DOI 10.1089/105072502761016458; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visser WE, 2009, J CLIN ENDOCR METAB, V94, P3487, DOI 10.1210/jc.2009-0782; Weetman AP, 2006, CLIN ENDOCRINOL, V64, P231, DOI 10.1111/j.1365-2265.2006.02478.x; Wekking EM, 2005, EUR J ENDOCRINOL, V153, P747, DOI 10.1530/eje.1.02025; Yamada H, 2014, CLIN ENDOCRINOL, V81, P276, DOI 10.1111/cen.12432; Yu S, 2012, J CLIN ENDOCR METAB, V97, P2084, DOI 10.1210/jc.2011-3059	36	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194259	10.1371/journal.pone.0194259	http://dx.doi.org/10.1371/journal.pone.0194259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649216	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900009
J	Xing, QQ; Wang, BS; Wang, XF; Tao, J				Xing, Qianqian; Wang, Baosheng; Wang, Xiaofeng; Tao, Jing			Unbounded and revocable hierarchical identity-based encryption with adaptive security, decryption key exposure resistant, and short public parameters	PLOS ONE			English	Article							DUAL SYSTEM ENCRYPTION; HIBE	Revocation functionality and hierarchy key delegation are two necessary and crucial requirements to identity-based cryptosystems. Revocable hierarchical identity-based encryption (RHIBE) has attracted a lot of attention in recent years, many RHIBE schemes have been proposed but shown to be either insecure or bounded where they have to fix the maximum hierarchical depth of RHIBE at setup. In this paper, we propose a new unbounded RHIBE scheme with decryption key exposure resilience and with short public system parameters, and prove our RHIBE scheme to be adaptively secure. Our system model is scalable inherently to accommodate more levels of user adaptively with no adding workload or restarting the system. By carefully designing the hybrid games, we overcome the subtle obstacle in applying the dual system encryption methodology for the unbounded and revocable HIBE. To the best of our knowledge, this is the first construction of adaptively secure unbounded RHIBE scheme.	[Xing, Qianqian; Wang, Baosheng; Wang, Xiaofeng; Tao, Jing] Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Wang, BS (corresponding author), Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China.	bswang@nudt.edu.cn			National Basic Research and Development Program of China (973 Program) [2012C6315906]; National Key Research and Development Program of China [2017YFB0802301]	National Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); National Key Research and Development Program of China	This work was supported by National Basic Research and Development Program of China (973 Program), No. 2012C6315906, http://program.most.gov.cn/, Baosheng Wang (study design, and decision to publish is his role); and National Key Research and Development Program of China, No. 2017YFB0802301, http://program.most.gov.cn/, Xiaofeng Wang (data analysis and preparation of the manuscript is his role).	Boldyreva A, 2008, CCS'08: PROCEEDINGS OF THE 15TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P417; Horwitz J, 2002, LECT NOTES COMPUT SC, V2332, P466, DOI 10.1007/3-540-46035-7_31; Jae Hong Seo, 2015, Topics in Cryptology - CT-RSA 2015. The Cryptographers' Track at the RSA Conference 2015. Proceedings: LNCS 9048, P106, DOI 10.1007/978-3-319-16715-2_6; Jae Hong Seo, 2013, Topics in Cryptology - CT-RSA 2013. The Cryptographers Track at the RSA Conference 2013. Proceedings, P343, DOI 10.1007/978-3-642-36095-4_22; Lee K, 2016, IACR CRYPTOLOGY EPRI, V2016, P460; Lee K., 2016, IACR CRYPTOLOGY EPRI, V2016, P749; Lee K, 2017, DESIGN CODE CRYPTOGR, V85, P39, DOI 10.1007/s10623-016-0287-3; Lee K, 2013, LECT NOTES COMPUT SC, V8269, P235, DOI 10.1007/978-3-642-42033-7_13; Lewko A, 2011, LECT NOTES COMPUT SC, V6632, P547, DOI 10.1007/978-3-642-20465-4_30; Lewko A, 2010, LECT NOTES COMPUT SC, V5978, P455, DOI 10.1007/978-3-642-11799-2_27; Naor D., 2001, Advances in Cryptology - CRTPTO 2001. 21st Annual International Cryptology Conference, Proceedings (Lecture Notes in Computer Science Vol.2139), P41; Rouselakis Y., 2013, ACM CCS 2013, P463, DOI DOI 10.1145/2508859.2516672; Ryu G., 2016, LNCS, V9503, P122, DOI [DOI 10.1007/978-3-319-31875-2.11, 10.1007/ 978- 3- 319-31875-2 _11, DOI 10.1007/978-3-319-31875-2_11]; Seo JH, 2015, LECT NOTES COMPUT SC, V9241, P21, DOI 10.1007/978-3-319-22425-1_2; Seo JH, 2014, IEEE T INF FOREN SEC, V9, P1193, DOI 10.1109/TIFS.2014.2327758; Tsai TT, 2014, INFORMATICA-LITHUAN, V25, P299; WATANABE Y, 2017, CRYPT TRACK RSA C, V159, P432, DOI DOI 10.1007/978-3-319-52153-4_25; Waters B, 2009, LECT NOTES COMPUT SC, V5677, P619, DOI 10.1007/978-3-642-03356-8_36; Xing QQ, 2016, PROCEEDINGS OF 2016 IEEE 18TH INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS; IEEE 14TH INTERNATIONAL CONFERENCE ON SMART CITY; IEEE 2ND INTERNATIONAL CONFERENCE ON DATA SCIENCE AND SYSTEMS (HPCC/SMARTCITY/DSS), P430, DOI 10.1109/HPCC-SmartCity-DSS.2016.0068	19	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195204	10.1371/journal.pone.0195204	http://dx.doi.org/10.1371/journal.pone.0195204			76	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649326	Green Submitted, gold, Green Published			2022-12-27	WOS:000429791900033
J	Lee, J; Noh, Y; Lee, S				Lee, Jimin; Noh, Yoojin; Lee, Sukhyang			Evaluation of preventable adverse drug reactions by implementation of the nationwide network of prospective drug utilization review program in Korea	PLOS ONE			English	Review							MEDICATION USE; SYSTEMS; EVENTS	Background A prospective Drug Utilization Review (DUR) program has been implemented in Korea to improve the quality and safety of medication use. Objective To evaluate the influence of the DUR program in reducing incidence of preventable adverse drug reactions (pADRs). Methods This study was performed using administrative data from the Health Insurance Review and Assessment Service (HIRA). The claims data for all adult patients with adverse drug events (ADE)-related diagnoses from 2009 to 2014 were obtained. Incidence rates of first-time and repeat pADRs prior to and after DUR program implementation were evaluated. Quarterly trends in incidence rates of overall ADE, allergic reactions, and ADRs were analyzed. Results Data extraction covering the period from 2009 to 2014 led to the identification of 3,927,662 records. First-time pADR rates decreased gradually after implementation of the DUR program (change in slope: -0.016, p = 0.02). The program had a similar influence on repeat pADR rates (change in slope: -0.006, p <= 0.01). The program did not decrease rates of firsttime or repeat allergic reactions (change in slope: 0.018, p = 0.07 and 0.003, p = 0.04, respectively). In the cohort aged <= 65 years, first-time pADR rate reduction was significant (28.2% [27.1-29.3] in <= 18 years, and 19.8% [18.1-21.5] in 19-64 years). In contrast, firsttime pADR rate was increased by 0.6% [-0.7-1.9] in patients >= 65 years. Conclusion Implementation of the prospective DUR program effectively reduced the number of pADRs. In the future, to reduce non-preventable ADRs such as allergic reactions, provision of clinical information including allergy history should be added to the DUR program.	[Lee, Jimin; Noh, Yoojin; Lee, Sukhyang] Ajou Univ, Coll Pharm, Suwon, South Korea	Ajou University	Lee, S (corresponding author), Ajou Univ, Coll Pharm, Suwon, South Korea.	suklee@ajou.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science, ICT & Future Planning, Republic of Korea [2013M3A9B5075838]; Health Insurance Review and Assessment Service [2015-99]	Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science, ICT & Future Planning, Republic of Korea; Health Insurance Review and Assessment Service	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (No. 2013M3A9B5075838) and the Health Insurance Review and Assessment Service (No. 2015-99).	Angalakuditi M, 2011, CLINICOECONOMIC OUTC, V3, P105, DOI 10.2147/CEOR.S21789; Armstrong EP, 1996, ANN PHARMACOTHER, V30, P1088, DOI 10.1177/106002809603001004; Ducoffe AR, 2016, AM J MED QUAL, V31, P476, DOI 10.1177/1062860615588105; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fulda Thomas R, 2004, J Am Pharm Assoc (2003), V44, P69, DOI 10.1331/154434504322713255; Hennessy S, 2003, JAMA-J AM MED ASSOC, V290, P1494, DOI 10.1001/jama.290.11.1494; Heo JH, 2013, INT J MED INFORM, V82, P987, DOI 10.1016/j.ijmedinf.2013.07.001; Hohl CM, 2014, J AM MED INFORM ASSN, V21, P547, DOI 10.1136/amiajnl-2013-002116; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Kim DS, 2015, INT J CLIN PHARM TH, V53, P819, DOI 10.5414/CP202429; Kohn LT, 2000, ERR IS HUMAN BUILDIN, Vxxi; Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037; Laatikainen O, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00358; Lee S., 2016, MOB INF SYST, V2016, P1, DOI DOI 10.1016/J.SMRV.2016.02.001; O'Mahony D, 2010, EUR GERIATR MED, V1, P45, DOI 10.1016/j.eurger.2010.01.007; Patel Hitesh, 2007, BMC Clin Pharmacol, V7, P9, DOI 10.1186/1472-6904-7-9; Song I, 2017, PEDIATR INT, V59, P720, DOI 10.1111/ped.13258; Stausberg J, 2010, DTSCH ARZTEBL INT, V107, P23, DOI 10.3238/arztebl.2010.0023; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yang JH, 2015, INT J MED INFORM, V84, P912, DOI 10.1016/j.ijmedinf.2015.08.007; Yu YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132916; Zhen CL, 2001, JAMA-J AM MED ASSOC, V286, P2823, DOI 10.1001/jama.286.22.2823	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195434	10.1371/journal.pone.0195434	http://dx.doi.org/10.1371/journal.pone.0195434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641617	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900069
J	Parmar, MM; Sachdeva, KS; Dewan, PK; Rade, K; Nair, SA; Pant, R; Khaparde, SD				Parmar, Malik M.; Sachdeva, Kuldeep Singh; Dewan, Puneet K.; Rade, Kiran; Nair, Sreenivas A.; Pant, Rashmi; Khaparde, Sunil D.			Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement	PLOS ONE			English	Article							AFRICA; IMPACT	Background Globally, India has the world's highest burden of multidrug-resistant tuberculosis (MDR-TB). Programmatic Management of Drug Resistant TB (PMDT) in India began in 2007 and nationwide coverage was achieved in early 2013. Poor initial microbiological outcomes under the Revised National Tuberculosis Control Programme (RNTCP) prompted detailed analysis. This is the first study on factors significantly associated with poor outcomes in MDR-TB patients treated under the RNTCP. Objective To evaluate initial sputum culture conversion, culture reversion and final treatment outcomes among MDR-TB patients registered in India from 2007 to early 2011 who were treated with a standard 24-month regimen under daily-observed treatment. Methods This is a retrospective cohort study. Clinical and microbiological data were abstracted from PMDT records. Initial sputum culture conversion, culture reversion and treatment outcomes were defined by country adaptation of the standard WHO definitions (2008). Cox proportional hazards modeling with logistic regression, multinomial logistic regression and adjusted odds ratio was used to evaluate factors associated with interim and final outcomes respectively, controlling for demographic and clinical characteristics. Results In the cohort of 3712 MDR-TB patients, 2735 (73.6%) had initial sputum culture conversion at 100 median days (IQR 92-125), of which 506 (18.5%) had culture reversion at 279 median days (IQR 202-381). Treatment outcomes were available for 2264 (60.9%) patients while 1448 (39.0%) patients were still on treatment or yet to have a definite outcome at the time of analysis. Of 2264 patients, 781 (34.5%) had treatment success, 644 (28.4%) died, 670 (29.6%) were lost to follow up, 169 (7.5%) experienced treatment failure or were changed to XDR-TB treatment. Factors significantly associated with either culture non-conversion, culture reversion and/or unfavorable treatment outcomes were baseline BMI < 18; >= seven missed doses in intensive phase (IP) and continuation phase (CP); cavitary disease; prior treatment episodes characterized by re-treatment regimen taken twice, longer duration and more episodes of treatment; any weight loss during treatment; males and additional resistance to first line drugs (Ethambutol, Streptomycin). In a subgroup of 104 MDR-TB patients, 62 (59.6%) had Ofloxacin resistance among whom only 25.8% had treatment success, half of the success (54.8%) seen in Ofloxacin sensitive patients. Baseline susceptibility to Ofloxacin (HR 2.04) and Kanamycin (HR 4.55) significantly doubled and quadrupled the chances for culture conversion respectively while baseline susceptibility to Ofloxacin (AOR 0.37) also significantly reduced the odds of unfavorable treatment outcomes (p value <= 0.05) in multinomial logistic regression model. Conclusion India's initial MDR-TB patients' cohort treated under the RNTCP experienced poor treatment outcomes. To address the factors associated with poor treatment outcomes revealed in our study, a systematic multi-pronged approach would be needed. A series of policies and interventions have been developed to address these factors to improve DR-TB treatment outcomes and are being scaled-up in India.	[Parmar, Malik M.; Rade, Kiran; Nair, Sreenivas A.] WHO, Country Off India, New Delhi, India; [Sachdeva, Kuldeep Singh] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Dewan, Puneet K.] India Country Off, Bill & Melinda Gates Fdn, New Delhi, India; [Pant, Rashmi] Publ Hlth Fdn India, Hyderabad, Andhra Pradesh, India; [Khaparde, Sunil D.] Govt India, Minist Hlth & Family Welf, Cent TB Div, New Delhi, India	World Health Organization; Public Health Foundation of India	Parmar, MM (corresponding author), WHO, Country Off India, New Delhi, India.	parmarm@who.int	Pant, Rashmi/AAU-6881-2021; Rade, Kiran/AAU-9564-2020; Pant, Rashmi/AAH-5146-2019	Rade, Kiran/0000-0001-7601-0780; Nair, Sreenivas/0000-0002-2586-6797	National Institute of Tuberculosis and Respiratory Diseases, New Delhi	National Institute of Tuberculosis and Respiratory Diseases, New Delhi	We are thankful to the Central TB Division; State Programme Managers of Gujarat, Maharashtra, Andhra Pradesh, New Delhi, West Bengal, Kerala, Rajasthan and their technical staff for providing the necessary support for the study. We are grateful to the Central TB Division, WHO India and the WHO RNTCP Medical Consultants who have contributed to this effort. We thank the National Institute of Tuberculosis and Respiratory Diseases, New Delhi for their support in training of the key programme staff in the study protocol and the National Institute for Research in Tuberculosis, Chennai for their support in proving second line drug susceptibility test results in the initial year of PMDT implementation to the state of Gujarat.	[Anonymous], 2000, CROFTON DOUGLASS RES, P517; [Anonymous], 2016, PREVENTION MANAGEMEN; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Central TB Division, 2010, DOTS PLUS GUID; Central TB Division, 2011, RNTCP PERF REP; Central TB Division, 2014, TB IND 2014 RNTCP AN; Central TB Division, TB IND 2016 D RNTCP; Central TB Division Directorate General of Health Services, TECHN OP GUID TB CON; Central TB Division Directorate General of Health Services, 2016, GUID US BED RNTCP CO; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Dalal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116798; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; Deshmukh RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135802; Drug Controller General of India, 2013, 1945 4 AMM; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Joseph P, 2011, INDIAN J MED RES, V133, P529; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Liu XF, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/950262; Masjedi MR, 2008, INT J TUBERC LUNG D, V12, P750; Meressa D, 2015, THORAX, V70, P1181, DOI 10.1136/thoraxjnl-2015-207374; Metcalfe JZ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001877; Paresh Dave, 2013, National Journal of Community Medicine, V4, P189; Podewils LJ, 2011, EPIDEMIOL INFECT, V139, P113, DOI 10.1017/S0950268810000907; Podewils LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070064; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Salvo F, 2014, INT J TUBERC LUNG D, V18, P655, DOI 10.5588/ijtld.13.0516; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046943; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Soman Rajeev, 2014, J Assoc Physicians India, V62, P567; Subbaraman R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002149; Sudarsanam TD, 2011, TROP MED INT HEALTH, V16, P699, DOI 10.1111/j.1365-3156.2011.02761.x; THISTLETHWAITE DL, 1960, J EDUC PSYCHOL, V51, P309, DOI 10.1037/h0044319; Udwadia ZF, 2016, LUNG INDIA, V33, P253, DOI 10.4103/0970-2113.180800; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; *WHO, 2016, SHORT MDR TB REG; WHO, 2017, GLOB TUB REP 2017; World Health Organisation Geneva, 2014, DRUG RES TB D SURV R; World Health Organisation Geneva, 2016, MOL LIN PROB ASS DET; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; World Health Organization, GLOB STRAT TARG TUB; World Health Organization Geneva, 2007, DIG HLTH END TB STRA, V1, P7	47	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193903	10.1371/journal.pone.0193903	http://dx.doi.org/10.1371/journal.pone.0193903			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641576	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900019
J	Rabilloud, T				Rabilloud, Thierry			Optimization of the cydex blue assay: A one-step colorimetric protein assay using cyclodextrins and compatible with detergents and reducers	PLOS ONE			English	Article							BETA-CYCLODEXTRIN; ELECTROPHORESIS; QUANTITATION; SENSITIVITY; G-250	Sodium dodecyl sulfate electrophoresis (SDS) is a protein separation technique widely used, for example, prior to immunoblotting. Samples are usually prepared in a buffer containing both high concentrations of reducers and high concentrations of SDS. This conjunction renders the samples incompatible with common protein assays. By chelating the SDS, cyclodextrins make the use of simple, dye-based colorimetric assays possible. In this paper, we describe the optimization of the assay, focussing on the cyclodextrin/SDS ratio and the use of commercial assay reagents. The adaptation of the assay to a microplate format and using other detergent-containing conventional extraction buffers is also described.	[Rabilloud, Thierry] Univ Grenoble Alpes, Chem & Biol Met, UMR5249, CNRS,CEA,BIG LCBM, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Rabilloud, T (corresponding author), Univ Grenoble Alpes, Chem & Biol Met, UMR5249, CNRS,CEA,BIG LCBM, Grenoble, France.	thierry.rabilloud@cea.fr						Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; FRIEDENAUER S, 1989, ANAL BIOCHEM, V178, P263, DOI 10.1016/0003-2697(89)90636-2; FUJITA Y, 1984, CHEM PHARM BULL, V32, P4161; Ghosh R, 2014, EXPERT REV PROTEOMIC, V11, P549, DOI 10.1586/14789450.2014.939635; Hagner-McWhirter A, 2015, ANAL BIOCHEM, V486, P54, DOI 10.1016/j.ab.2015.06.017; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; OLSON BJ, 2007, CURR PROTOC PROTEIN; PALEPU R, 1988, CAN J CHEM, V66, P325, DOI 10.1139/v88-056; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PIERCE J, 1977, ANAL BIOCHEM, V81, P478, DOI 10.1016/0003-2697(77)90723-0; Pineiro A, 2007, J PHYS CHEM B, V111, P4383, DOI 10.1021/jp0688815; Rabilloud T, 2016, ELECTROPHORESIS, V37, P2595, DOI 10.1002/elps.201600270; RAMAGLI LS, 1985, ELECTROPHORESIS, V6, P559, DOI 10.1002/elps.1150061109; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STOSCHECK CM, 1990, ANAL BIOCHEM, V184, P111, DOI 10.1016/0003-2697(90)90021-Z; Tastet C, 2003, ELECTROPHORESIS, V24, P1787, DOI 10.1002/elps.200305400; WATANABE N, 1986, CLIN CHEM, V32, P1551; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Yamamoto E, 2008, ANAL BIOCHEM, V381, P273, DOI 10.1016/j.ab.2008.06.010; Zeng L, 2013, ELECTROPHORESIS, V34, P2234, DOI 10.1002/elps.201300140	28	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195755	10.1371/journal.pone.0195755	http://dx.doi.org/10.1371/journal.pone.0195755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641569	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900089
J	Ryan, DJ; Wullems, JA; Stebbings, GK; Morse, CI; Stewart, CE; Onambele-Pearson, GL				Ryan, Declan J.; Wullems, Jorgen A.; Stebbings, Georgina K.; Morse, Christopher I.; Stewart, Claire E.; Onambele-Pearson, Gladys L.			Reliability and validity of the international physical activity questionnaire compared to calibrated accelerometer cut-off points in the quantification of sedentary behaviour and physical activity in older adults	PLOS ONE			English	Article							METABOLIC SYNDROME; SOCIAL DESIRABILITY; SITTING-TIME; LIFE-STYLE; IPAQ-L; INTENSITY; INTERVAL; HEALTH; EXERCISE; RISK	Background The aim was to determine the reliability and validity of IPAQ measured sedentary behaviour (SB) and moderate-vigorous physical activity (MVPA) in older persons whilst examining any sex differences in reliability and validity results. Method 89 participants (73.7 +/- 6.3 years, 54% female) completed the IPAQ. Participants were fitted with a thigh mounted triaxial accelerometer (GeneActiv Original) for seven consecutive days and subsequently completed a second IPAQ. Results IPAQ showed weak reliability qualities for Total SB (h.week(-1)) and 10 minute MVPA (accumulated in bouts >= 10 continuous minutes, h.week(-1)). IPAQ had poor concurrent validity qualities for Total SB, 10 minute MVPA, but not Sporadic MVPA (accumulated in bouts < 10 continuous minutes, h.week(-1)). IPAQ only categorised participant physical behaviour classification correctly 2% of the time. Sex differences were only present for the correlation slope of IPAQ 10 minute MVPA reliability measures. Conclusion Our data suggests that the IPAQ is not suitable for assessing older adults habitual physical behaviour.	[Ryan, Declan J.; Wullems, Jorgen A.; Stebbings, Georgina K.; Morse, Christopher I.; Onambele-Pearson, Gladys L.] Manchester Metropolitan Univ, Dept Exercise & Sport Sci, Hlth Exercise & Act Living Res Ctr, Manchester, Cheshire, England; [Stewart, Claire E.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England	Manchester Metropolitan University; Liverpool John Moores University	Ryan, DJ (corresponding author), Manchester Metropolitan Univ, Dept Exercise & Sport Sci, Hlth Exercise & Act Living Res Ctr, Manchester, Cheshire, England.	Declan.Ryan@stu.mmu.ac.uk	Stewart, Claire E/I-3177-2013; Morse, Christopher/AAE-7913-2022; Onambélé-Pearson, Gladys Leopoldine/F-1679-2013; Ryan, Declan/R-3804-2019	Morse, Christopher/0000-0002-5261-2637; Onambélé-Pearson, Gladys Leopoldine/0000-0002-1466-3265; Ryan, Declan/0000-0003-1769-3248; Stewart, Claire/0000-0002-8104-4819; Wullems, Jorgen/0000-0002-4892-1349; Stebbings, Georgina/0000-0003-0706-2864				Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Belza B, 2004, PREVENTING CHRONIC D, V1; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Cerin E, 2012, J AGING PHYS ACTIV, V20, P402, DOI 10.1123/japa.20.4.402; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Craig R, 2009, HEALTH SURVEY FOR EN, V1, P8; Edwardson CL, 2016, ACCURACY POSTURE ALL; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gennuso KP, 2015, DIABETOLOGIA, V58, P485, DOI 10.1007/s00125-014-3453-z; Gennuso KP, 2013, MED SCI SPORT EXER, V45, P1493, DOI 10.1249/MSS.0b013e318288a1e5; Grimm EK, 2012, J AGING PHYS ACTIV, V20, P64, DOI 10.1123/japa.20.1.64; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Hebert JR, 1997, AM J EPIDEMIOL, V146, P1046, DOI 10.1093/oxfordjournals.aje.a009233; Heesch KC, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-35; Hurtig-Wennlof A, 2010, PUBLIC HEALTH NUTR, V13, P1847, DOI 10.1017/S1368980010000157; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; Jago R, 2007, HEALTH EDUC RES, V22, P438, DOI 10.1093/her/cyl107; Kelly P, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0351-4; Kolbe-Alexander TL, 2006, J AGING PHYS ACTIV, V14, P98, DOI 10.1123/japa.14.1.98; Kriska A, 2000, RES Q EXERCISE SPORT, V71, pS47, DOI 10.1080/02701367.2000.11082786; Krustrup P, 2004, J PHYSIOL-LONDON, V559, P335, DOI 10.1113/jphysiol.2004.062232; Madsen SM, 2015, ARCH PHYSIOL BIOCHEM, V121, P178, DOI 10.3109/13813455.2015.1087033; Marschollek M, 2016, HUM MOVEMENT SCI, V45, P1, DOI 10.1016/j.humov.2015.10.003; Marschollek M, 2014, STUD HEALTH TECHNOL, V205, P763, DOI 10.3233/978-1-61499-432-9-763; Mcewan T, 2017, GERONTOLOGIST, V57, P735, DOI 10.1093/geront/gnv689; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; Miller NE, 2010, J AGING PHYS ACTIV, V18, P158, DOI 10.1123/japa.18.2.158; MONK TH, 1992, SLEEP, V15, P322, DOI 10.1093/sleep/15.4.322; Montoye AHK, 2015, MED SCI SPORT EXER, V47, P1735, DOI 10.1249/MSS.0000000000000597; National Health Service, 2013, PHYS ACT GUID AD; Office for National Statistics, 2012, HLTH LIF EXP BIRTH A; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Onambele-Pearson GL, 2017, PLAGRAVE HDB AGEING; Pavey TG, 2012, BRIT J SPORT MED, V0, P1, DOI DOI 10.1136/BJSP0RTS-2012-091676; Rakobowchuk M, 2008, AM J PHYSIOL-REG I, V295, pR236, DOI 10.1152/ajpregu.00069.2008; Ryan DJ, 2015, AGE, V37, DOI 10.1007/s11357-015-9832-7; Ryan DJ, 2018, J PHYS ACTI IN RESS; Ryan DJ W J A, 2018, J PHYS ACTIVITY HLTH; Sawyer BJ, 2016, J APPL PHYSIOL; Steeves JA, 2015, MED SCI SPORT EXER, V47, P952, DOI 10.1249/MSS.0000000000000497; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Townsend N, 2015, CARDIOVASCULAR DIS S; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Van Holle V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1785-3; van Uffelen JGZ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-458; Wullems JA, 2015, HLTH AGEING MOL ORG; Wullems JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188215; Wullems JA, 2016, BIOGERONTOLOGY, V17, P547, DOI 10.1007/s10522-016-9640-1	51	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195712	10.1371/journal.pone.0195712	http://dx.doi.org/10.1371/journal.pone.0195712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672534	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000430446800038
J	Fuertinger, DH; Kappel, F; Zhang, HJ; Thijssen, S; Kotanko, P				Fuertinger, Doris H.; Kappel, Franz; Zhang, Hanjie; Thijssen, Stephan; Kotanko, Peter			Prediction of hemoglobin levels in individual hemodialysis patients by means of a mathematical model of erythropoiesis	PLOS ONE			English	Article							PARAMETER-ESTIMATION; EPOETIN ALPHA; ANEMIA; RATS; MICE; NEOCYTOLYSIS; RELEVANCE	Anemia commonly occurs in people with chronic kidney disease (CKD) and is associated with poor clinical outcomes. The management of patients with anemia in CKD is challenging, due to its severity, frequent hypo-responsiveness to treatment with erythropoiesis stimulating agents (ESA) and common hemoglobin cycling. Nonlinear dose-response curves and long delays in the effect of treatment on red blood cell population size complicate predictions of hemoglobin (Hgb) levels in individual patients. A comprehensive physiology based mathematical model for erythropoiesis was adapted individually to 60 hemodialysis patients treated with ESAs by identifying physiologically meaningful key model parameters from temporal Hgb data. Crit-Line (R) Ill monitors provided non-invasive Hgb measurements for every hemodialysis treatment. We used Hgb data during a 150-day baseline period together to estimate a patient's individual red blood cell lifespan, effects of the ESA on proliferation of red cell progenitor cells, endogenous erythropoietin production and ESA half-life. Estimated patient specific parameters showed excellent alignment with previously conducted clinical studies in hemodialysis patients. Further, the model qualitatively and quantitatively reflected empirical hemoglobin dynamics in demographically, anthropometrically and clinically diverse patients and accurately predicted the Hgb response to ESA therapy in individual patients for up to 21 weeks. The findings suggest that estimated model parameters can be used as a proxy for parameters that are clinically very difficult to quantify. The presented method has the potential to provide new insights into the individual pathophysiology of renal anemia and its association with clinical outcomes and can potentially be used to guide personalized anemia treatment.	[Fuertinger, Doris H.; Zhang, Hanjie; Thijssen, Stephan; Kotanko, Peter] Renal Res Inst, New York, NY 10065 USA; [Kappel, Franz] Karl Franzens Univ Graz, Inst Math & Sci Comp, Graz, Austria; [Kotanko, Peter] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Fuertinger, Doris H.] Fresenius Med Care Germany, Global Res & Dev, Bad Homburg, Germany	Renal Research Institute; University of Graz; Icahn School of Medicine at Mount Sinai	Fuertinger, DH (corresponding author), Renal Res Inst, New York, NY 10065 USA.; Fuertinger, DH (corresponding author), Fresenius Med Care Germany, Global Res & Dev, Bad Homburg, Germany.	doris.fueritnger@fmc-ag.com	Kotanko, Peter/AAE-5721-2019	Kotanko, Peter/0000-0003-4373-412X; Zhang, Hanjie/0000-0002-0015-5614; Fuertinger, Doris/0000-0001-6321-2367				Ackleh AS, 2006, MATH BIOSCI, V204, P21, DOI 10.1016/j.mbs.2006.08.004; Ackleh AS, 2008, MATH BIOSCI ENG, V5, P601, DOI 10.3934/mbe.2008.5.601; Adimy M, 2006, B MATH BIOL, V68, P2321, DOI 10.1007/s11538-006-9121-9; Alfrey CP, 2007, NEPHRON CLIN PRACT, V106, P149, DOI 10.1159/000104425; Artunc F, 2007, NEPHROL DIAL TRANSPL, V22, P2900, DOI 10.1093/ndt/gfm316; Banks HT, 2004, MATH BIOSCI ENG, V1, P15, DOI 10.3934/mbe.2004.1.15; BELAIR J, 1995, MATH BIOSCI, V128, P317, DOI 10.1016/0025-5564(94)00078-E; Besarab A, 2002, AM J KIDNEY DIS, V40, P439, DOI 10.1053/ajkd.2002.34881; Collins AJ, 2005, AM J KIDNEY DIS, V46, P481, DOI 10.1053/j.ajkd.2005.05.018; Crauste F, 2008, J THEOR BIOL, V250, P322, DOI 10.1016/j.jtbi.2007.09.041; Crauste F, 2010, J THEOR BIOL, V263, P303, DOI 10.1016/j.jtbi.2009.12.026; Cross AR, BLOOD FACTS STAT; Davidian M, 2009, CH CRC HANDB MOD STA, P107; Demin I., 2010, Journal of Biological Dynamics, V4, P59, DOI 10.1080/17513750902777642; Fishbane S, 2005, KIDNEY INT, V68, P1337, DOI 10.1111/j.1523-1755.2005.00532.x; Floege Jr, 2010, COMPREHENSIVE CLIN N, Vxxii; Fuertinger DH, 2013, LECT NOTES ENG COMPU; Fuertinger DH, 2013, J MATH BIOL, V66, P1209, DOI 10.1007/s00285-012-0530-0; Greer JP, 2014, WINTROBES CLIN HEMAT, Vxxvii; Grenier E, 2014, ESAIM-MATH MODEL NUM, V48, P1303, DOI 10.1051/m2an/2013140; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Jones E., 2001, SCIPY OPEN SOURCE SC; Kaushansky K, 2010, WILLIAMS HEMATOLOGY, Vxxiii; LOEFFLER M, 1989, CELL TISSUE KINET, V22, P13, DOI 10.1111/j.1365-2184.1989.tb00198.x; Ma J, 2017, BLOOD PURIFICAT, V43, P200, DOI 10.1159/000452728; Macdougall IC, 1999, J AM SOC NEPHROL, V10, P2392; Mahaffy J.M., 1999, AGE STRUCTURED MODEL; Mahaffy JM, 1998, J THEOR BIOL, V190, P135, DOI 10.1006/jtbi.1997.0537; Nachman PH., 2012, BRENNER RECTORS KIDN, V9, P1121; NADLER SB, 1962, SURGERY, V51, P224; Owen JS, 2014, INTRODUCTION TO POPULATION PHARMACOKINETIC/PHARMACODYNAMIC ANALYSIS WITH NONLINEAR MIXED EFFECTS MODELS, P250; Rice L, 2005, CELL PHYSIOL BIOCHEM, V15, P245, DOI 10.1159/000087234; Rice L, 1999, AM J KIDNEY DIS, V33, P59, DOI 10.1016/S0272-6386(99)70258-1; Roeder I, 2002, EXP HEMATOL, V30, P853, DOI 10.1016/S0301-472X(02)00832-9; Roeder I, 2006, CURR OPIN HEMATOL, V13, P222, DOI 10.1097/01.moh.0000231418.08031.48; United States Renal Data System, 2015, USRDS ANN DAT REP EP; WICHMANN HE, 1989, CELL TISSUE KINET, V22, P31, DOI 10.1111/j.1365-2184.1989.tb00199.x; WULFF H, 1989, CELL TISSUE KINET, V22, P51, DOI 10.1111/j.1365-2184.1989.tb00200.x	38	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195918	10.1371/journal.pone.0195918	http://dx.doi.org/10.1371/journal.pone.0195918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668766	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200066
J	von Tscharner, V; Ullrich, M; Mohr, M; Marquez, DC; Nigg, BM				von Tscharner, Vinzenz; Ullrich, Martin; Mohr, Maurice; Marquez, Daniel Comaduran; Nigg, Benno M.			A wavelet based time frequency analysis of electromyograms to group steps of runners into clusters that contain similar muscle activation patterns	PLOS ONE			English	Article							MOTOR-UNIT SYNCHRONIZATION; FIBER CONDUCTION-VELOCITY; MEAN POWER FREQUENCY; SURFACE EMG; ELECTROMECHANICAL DELAY; ISOMETRIC CONTRACTIONS; DYNAMIC CONTRACTIONS; VASTUS LATERALIS; SYNAPTIC INPUT; SPECTRUM	Purpose To wavelet transform the electromyograms of the vastii muscles and generate wavelet intensity patterns (WIP) of runners. Test the hypotheses: 1) The WIP of the vastus medialis (VM) and vastus lateralis (VL) of one step are more similar than the WIPs of these two muscles, offset by one step. 2) The WIPs within one muscle differ by having maximal intensities in specific frequency bands and these intensities are not always occurring at the same time after heel strike. 3) The WIPs that were recorded form one muscle for all steps while running can be grouped into clusters with similar WIPs. It is expected that clusters might have distinctly different, cluster specific mean WIPs. Methods The EMG of the vastii muscles from at least 1000 steps from twelve runners were recorded using a bipolar current amplifier and yielded WIPs. Based on the weights obtained after a principal component analysis the dissimilarities (1-correlation) between the WIPs were computed. The dissimilarities were submitted to a hierarchical cluster analysis to search for groups of steps with similar WIPs. The clusters formed by random surrogate WIPs were used to determine whether the groups were likely to be created in a non-random manner. Results The steps were grouped in clusters showing similar WIPs. The grouping was based on the frequency bands and their timing showing that they represented defining parts of the WIPs. The correlations between the WIPs of the vastii muscles that were recorded during the same step were higher than the correlations of WPIs that were recorded during consecutive steps, indicating the non-randomness of the WIPs. Conclusions The spectral power of EMGs while running varies during the stance phase in time and frequency, therefore a time averaged power spectrum cannot reflect the timing of events that occur while running. It seems likely that there might be a set of predefined patterns that are used upon demand to stabilize the movement.	[von Tscharner, Vinzenz; Ullrich, Martin; Mohr, Maurice; Marquez, Daniel Comaduran; Nigg, Benno M.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	University of Calgary	von Tscharner, V (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	tvvon@ucalgary.ca	Mohr, Maurice/AAA-1436-2020; Ullrich, Martin/AAJ-5581-2020	Mohr, Maurice/0000-0003-3726-730X; von Tscharner, Vinzenz/0000-0002-5779-6244	Biomechanigg Sport & Health Research Inc. Calgary; German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes)	Biomechanigg Sport & Health Research Inc. Calgary; German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes)	This project was supported by Biomechanigg Sport & Health Research Inc. Calgary. The funder provided support in the form of salaries for authors [MM, BMN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MU was a visiting student from Friedrich Alexander University Erlangen-Nuremberg, Germany, supervised by WT and was supported by the German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes).	ARENDTNIELSEN L, 1985, ELECTROEN CLIN NEURO, V60, P130, DOI 10.1016/0013-4694(85)90019-7; Barandun M, 2009, J ELECTROMYOGR KINES, V19, P65, DOI 10.1016/j.jelekin.2007.07.003; BIGLANDRITCHIE B, 1981, J APPL PHYSIOL, V51, P1300, DOI 10.1152/jappl.1981.51.5.1300; Chen HY, 2012, J ORTHOP SPORT PHYS, V42, P791, DOI 10.2519/jospt.2012.3973; Duchateau J, 2006, J APPL PHYSIOL, V101, P1766, DOI 10.1152/japplphysiol.00543.2006; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Farina D, 2008, J APPL PHYSIOL, V105, P1683, DOI 10.1152/japplphysiol.91174.2008; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; Farina D, 2015, EXERC SPORT SCI REV, V43, P23, DOI 10.1249/JES.0000000000000032; GERDLE B, 1991, ACTA PHYSIOL SCAND, V142, P457, DOI 10.1111/j.1748-1716.1991.tb09180.x; Hermens H, 1999, ROESSINGH RES; Karlsson S, 2001, J ELECTROMYOGR KINES, V11, P131, DOI 10.1016/S1050-6411(00)00046-8; Keenan KG, 2005, J APPL PHYSIOL, V98, P120, DOI 10.1152/japplphysiol.00894.2004; Kudina LP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00075; Laine CM, 2015, J NEUROSCI, V35, P12207, DOI 10.1523/JNEUROSCI.0240-15.2015; Maurer C, 2013, J ELECTROMYOGR KINES, V23, P673, DOI 10.1016/j.jelekin.2013.01.007; Merletti R, 1997, J ELECTROMYOGR KINES, V7, P241, DOI 10.1016/S1050-6411(97)00010-2; Merlo E, 2005, J NEUROSCI METH, V142, P267, DOI 10.1016/j.jneumeth.2004.09.002; Mohr M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142048; PAN ZS, 1989, MED BIOL ENG COMPUT, V27, P14, DOI 10.1007/BF02442164; Potvin JR, 2004, J ELECTROMYOGR KINES, V14, P389, DOI 10.1016/j.jelekin.2003.10.005; Sacco ICN, 2014, J BIOMECH, V47, P2475, DOI 10.1016/j.jbiomech.2014.04.007; Stirling LM, 2011, J ELECTROMYOGR KINES, V21, P566, DOI 10.1016/j.jelekin.2011.02.005; VANBOXTEL A, 1984, EUR J APPL PHYSIOL O, V52, P207, DOI 10.1007/BF00433394; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; von Tscharner V, 2008, J APPL PHYSIOL, V105, P1671, DOI 10.1152/japplphysiol.90598.2008; von Tscharner V, 2013, J ELECTROMYOGR KINES, V23, P1044, DOI 10.1016/j.jelekin.2013.07.011; von Tscharner V, 2010, J ELECTROMYOGR KINES, V20, P1021, DOI 10.1016/j.jelekin.2010.04.002; VOS EJ, 1990, EUR J APPL PHYSIOL O, V60, P467, DOI 10.1007/BF00705038; Wakeling JM, 2009, J ELECTROMYOGR KINES, V19, P199, DOI 10.1016/j.jelekin.2007.09.006; Wakeling JM, 2004, J EXP BIOL, V207, P2519, DOI 10.1242/jeb.01042; Yao WX, 2000, J NEUROPHYSIOL, V83, P441, DOI 10.1152/jn.2000.83.1.441	32	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195125	10.1371/journal.pone.0195125	http://dx.doi.org/10.1371/journal.pone.0195125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668731	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200028
J	Lindegaard, B; Hvid, T; Mygind, HW; Mortensen, OH; Grondal, T; Abildgaard, J; Gerstoft, J; Pedersen, BK; Baranowski, M				Lindegaard, Birgitte; Hvid, Thine; Mygind, Helene Wolsk; Mortensen, Ole Hartvig; Grondal, Thomas; Abildgaard, Julie; Gerstoft, Jan; Pedersen, Bente Klarlund; Baranowski, Marcin			Low expression of IL-18 and IL-18 receptor in human skeletal muscle is associated with systemic and intramuscular lipid metabolism-Role of HIV lipodystrophy (vol 13, e0186755, 2018)	PLOS ONE			English	Correction													Pedersen, Bente Klarlund/AGR-3217-2022; Lindegaard, Birgitte/AGY-9629-2022; Abildgaard, Julie/ABB-2325-2020; Mortensen, Ole Hartvig/AAA-8835-2019	Pedersen, Bente Klarlund/0000-0001-6508-6288; Abildgaard, Julie/0000-0003-1317-7051; Mortensen, Ole Hartvig/0000-0003-1118-6317				Lindegaard B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186755	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196241	10.1371/journal.pone.0196241	http://dx.doi.org/10.1371/journal.pone.0196241			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664933	Green Published, gold			2022-12-27	WOS:000430262300065
J	Pokhoday, M; Scheepers, C; Shtyrov, Y; Myachykov, A				Pokhoday, Mikhail; Scheepers, Christoph; Shtyrov, Yury; Myachykov, Andriy			Motor (but not auditory) attention affects syntactic choice	PLOS ONE			English	Article							VISUAL-SPATIAL ATTENTION; SENTENCE PRODUCTION; STRUCTURAL CHOICE; PARIETAL CORTEX; CUES; INTEGRATION; SALIENCE; LANGUAGE; ENGLISH; TACTILE	Understanding the determinants of syntactic choice in sentence production is a salient topic in psycholinguistics. Existing evidence suggests that syntactic choice results from an interplay between linguistic and non-linguistic factors, and a speaker's attention to the elements of a described event represents one such factor. Whereas multimodal accounts of attention suggest a role for different modalities in this process, existing studies examining attention effects in syntactic choice are primarily based on visual cueing paradigms. Hence, it remains unclear whether attentional effects on syntactic choice are limited to the visual modality or are indeed more general. This issue is addressed by the current study. Native English participants viewed and described line drawings of simple transitive events while their attention was directed to the location of the agent or the patient of the depicted event by means of either an auditory (monaural beep) or a motor (unilateral key press) lateral cue. Our results show an effect of cue location, with participants producing more passive-voice descriptions in the patient-cued conditions. Crucially, this cue location effect emerged in the motor-cue but not (or substantially less so) in the auditory-cue condition, as confirmed by a reliable interaction between cue location (agent vs. patient) and cue type (auditory vs. motor). Our data suggest that attentional effects on the speaker's syntactic choices are modality-specific and limited to the visual and motor, but not the auditory, domain.	[Pokhoday, Mikhail; Shtyrov, Yury; Myachykov, Andriy] Natl Res Univ, Higher Sch Econ, Ctr Cognit & Decis Making, Moscow, Russia; [Scheepers, Christoph] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Shtyrov, Yury] Aarhus Univ, CFIN, Dept Clin Med, Aarhus, Denmark; [Myachykov, Andriy] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England	HSE University (National Research University Higher School of Economics); University of Glasgow; Aarhus University; Northumbria University	Pokhoday, M (corresponding author), Natl Res Univ, Higher Sch Econ, Ctr Cognit & Decis Making, Moscow, Russia.	mpokhoday@hse.ru	Pokhoday, Mikhail Y/K-3351-2015; Shtyrov, Yury/ABI-2266-2020; Myachykov, Andriy/ABA-7129-2020; Pokhoday, Mikhail/M-7482-2019	Pokhoday, Mikhail Y/0000-0002-9688-7704; Shtyrov, Yury/0000-0001-7203-4902; Pokhoday, Mikhail/0000-0002-9688-7704	Russian Academic Excellence Project '5-100'	Russian Academic Excellence Project '5-100'(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	The article was prepared within the framework of the Basic Research Program at the National Research University Higher School of Economics (HSE) and supported within the framework of a subsidy by the Russian Academic Excellence Project '5-100'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton-Mendez I, 2017, APPL PSYCHOLINGUIST, V38, P601, DOI 10.1017/S0142716416000345; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Caffarra S, 2013, COGN NEUROSCI-UK, V4, P217, DOI 10.1080/17588928.2013.823392; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; FERREIRA F, 1994, J MEM LANG, V33, P715, DOI 10.1006/jmla.1994.1034; Garagnani M, 2008, EUR J NEUROSCI, V27, P492, DOI 10.1111/j.1460-9568.2008.06015.x; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gleitman LR, 2007, J MEM LANG, V57, P544, DOI 10.1016/j.jml.2007.01.007; GOLDBERG ME, 1987, NEUROPSYCHOLOGIA, V25, P107, DOI 10.1016/0028-3932(87)90047-9; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Ho C, 2006, COMPUT HUM BEHAV, V22, P733, DOI 10.1016/j.chb.2005.12.008; Ho C, 2005, TRANSPORT RES F-TRAF, V8, P397, DOI 10.1016/j.trf.2005.05.002; Ho C, 2006, ACCIDENT ANAL PREV, V38, P988, DOI 10.1016/j.aap.2006.04.002; Hwang H, 22 CUNY C SENT PROC; Hwang H, 2015, J MEM LANG, V84, P190, DOI 10.1016/j.jml.2015.06.004; Iacoboni M, 2006, NEUROPSYCHOLOGIA, V44, P2691, DOI 10.1016/j.neuropsychologia.2006.04.029; Ibbotson P, 2013, COGN LINGUIST, V24, P457, DOI 10.1515/cog-2013-0020; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Iwabuchi T, 2013, NEUROREPORT, V24, P298, DOI 10.1097/WNR.0b013e32835f8826; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Kong LQ, 2014, CEREB CORTEX, V24, P773, DOI 10.1093/cercor/bhs359; Kostov K, 2012, COGN PROCESS, V13, pS215, DOI 10.1007/s10339-012-0452-1; Rayleigh,, 1907, PHILOS MAG, V13, P214, DOI 10.1080/14786440709463595; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Montag JL, CHOICE REFERRING EXP; Myachykov A, 2018, DISCOURSE PROCESS, V55, P218, DOI 10.1080/0163853X.2017.1330044; Myachykov A, 2008, J COGN SCI, V9, P31; Myachykov A, 2012, ACTA PSYCHOL, V141, P304, DOI 10.1016/j.actpsy.2012.09.006; Myachykov A, 2011, LANG LINGUIST COMPAS, V5, P95, DOI 10.1111/j.1749-818x.2010.00265.x; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Roland D, 2007, J MEM LANG, V57, P348, DOI 10.1016/j.jml.2007.03.002; Rommers J, 2017, NEUROPSYCHOLOGIA, V95, P101, DOI 10.1016/j.neuropsychologia.2016.12.013; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Scott JJ, 2008, HUM FACTORS, V50, P264, DOI 10.1518/001872008X250674; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Spence C, 2001, EXP BRAIN RES, V141, P324, DOI 10.1007/s002210100883; Spence C, 2010, ANN NY ACAD SCI, V1191, P182, DOI 10.1111/j.1749-6632.2010.05440.x; Spence C, 2009, HEARING RES, V258, P134, DOI 10.1016/j.heares.2009.04.015; SPENCE CJ, 1994, J EXP PSYCHOL HUMAN, V20, P555, DOI 10.1037/0096-1523.20.3.555; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Tomlin R. S., 1997, LANGUAGE CONCEPTUALI, P162, DOI DOI 10.1017/CBO9781139086677.007; Tomlin R. S., 1995, WORD ORDER DISCOURSE, P517, DOI [DOI 10.1075/TS1.30.18TOM, 10.1075/TSL.30.18TOM, DOI 10.1075/TSL.30.18TOM]; Tomlin RS, 2015, HANDB SPRACH KOMMUN, V39, P31; Yates MJ, 2009, ATTEN PERCEPT PSYCHO, V71, P847, DOI 10.3758/APP.71.4.847	47	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195547	10.1371/journal.pone.0195547	http://dx.doi.org/10.1371/journal.pone.0195547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659592	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000430061100021
J	Ab Rahman, SK; Yusof, NA; Abdullah, AH; Mohammad, F; Idris, A; Al-Lohedan, HA				Ab Rahman, Siti Khadijah; Yusof, Nor Azah; Abdullah, Abdul Halim; Mohammad, Faruq; Idris, Azni; Al-Lohedan, Hamad A.			Evaluation of porogen factors for the preparation of ion imprinted polymer monoliths used in mercury removal	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; CAPILLARY COLUMN; PRECONCENTRATION; RECOGNITION; SEPARATION; SAMPLES	In the present study, ion imprinted polymer monoliths (IIPMs) were developed to overcome the limitations of ion imprinted polymer particles (IIPPs) used for the removal of Hg(II) ions from waste water samples. The adsorbents preparation, characterization and Hg(II) removal were very well reported. The IIPMs on porogen optimization was prepared using the molding technique with Hg(II) as a template ion, [2-(methacryloyloxy)ethyl]trimethylammonium cysteine (MAETC) as ligand, methacrylic acid (MAA) as functional monomer, ethylene glycol dimethacrylamide (EGDMA) as cross-linker, benzoyl peroxide as an initiator and methanol and acetonitrile as porogen in the polypropylene tube (drinking straw) as mold. The IIPMs prepared with higher volumes of porogen were indicated to have a good adsorption rate for the Hg(II) removal along with good water permeability and larger porosity as compared to a lower volume of porogen. The IIPMs prepared using the binary porogen were able to improve the porosity and surface area of the monolithic polymers as compared to the single porogen added IIPMs. Finally, we indicate from our analysis that the IIPM having the efficient capacity for the Hg(II) ions is easy to prepare, and has higher water permeability along with high porosity and high adsorption capacity and all these factors making it one of the suitable adsorbent for the successful removal of Hg(II) ions.	[Ab Rahman, Siti Khadijah; Yusof, Nor Azah; Abdullah, Abdul Halim] Univ Putra Malaysia, Dept Chem, Fac Sci, Serdang, Selangor, Malaysia; [Yusof, Nor Azah; Abdullah, Abdul Halim] Univ Putra Malaysia, Inst Adv Technol, Serdang, Selangor, Malaysia; [Mohammad, Faruq; Al-Lohedan, Hamad A.] King Saud Univ, Dept Chem, Coll Sci, Surfactant Res, Riyadh, Saudi Arabia; [Idris, Azni] Univ Putra Malaysia, Chem Engn & Environm Dept, Fac Engn, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; King Saud University; Universiti Putra Malaysia	Yusof, NA (corresponding author), Univ Putra Malaysia, Dept Chem, Fac Sci, Serdang, Selangor, Malaysia.; Yusof, NA (corresponding author), Univ Putra Malaysia, Inst Adv Technol, Serdang, Selangor, Malaysia.; Mohammad, F (corresponding author), King Saud Univ, Dept Chem, Coll Sci, Surfactant Res, Riyadh, Saudi Arabia.	azahy@upm.edu.my; fmohammad@ksu.edu.sa	Ab Rahman, Siti Khadijah/AAM-2268-2021; Mohammad, Faruq/F-9654-2019	Ab Rahman, Siti Khadijah/0000-0003-2490-6176; Mohammad, Faruq/0000-0002-9318-9986; Yusof, Nor Azah/0000-0002-1400-5764	Ministry of Higher Education (MOHE); Deanship of Scientific Research, King Saud University	Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR)); Deanship of Scientific Research, King Saud University(King Saud University)	The authors (SKAR, NAY, AHA, and Al) acknowledge the Ministry of Higher Education (MOHE) for the financial support in the form of Prototype Research Grant Scheme (PRGS) and My Brain 15. Also, Drs. FM and HAAL are grateful to the Deanship of Scientific Research, King Saud University for funding through Vice Deanship of Scientific Research Chairs program.	Alizadeh T, 2011, ANAL CHIM ACTA, V689, P52, DOI 10.1016/j.aca.2011.01.036; Asanuma H, 2004, J INCL PHENOM MACRO, V50, P51, DOI 10.1007/10.1007/s10847-003-8838-4; Dakova I, 2009, TALANTA, V78, P523, DOI 10.1016/j.talanta.2008.12.005; Deng QL, 2011, CHINESE CHEM LETT, V22, P1351, DOI 10.1016/j.cclet.2011.05.044; Hu YL, 2013, TRAC-TREND ANAL CHEM, V43, P37, DOI 10.1016/j.trac.2012.08.014; Jin YF, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/903210; Lin ZA, 2013, J CHROMATOGR A, V1284, P8, DOI 10.1016/j.chroma.2013.02.042; Liu YW, 2005, ANAL CHIM ACTA, V538, P85, DOI 10.1016/j.aca.2005.02.017; Lohani MB, 2008, J HAZARD MATER, V159, P626, DOI 10.1016/j.jhazmat.2008.02.072; Mane S., 2016, CAN CHEM T, V4, P210, DOI DOI 10.13179/canchemtrans.2016.04.02.0304; Mondal D.K., 2013, J ENVIRON CHEM ENG, V1, P891, DOI [10.1016/j.jece.2013.07.034, DOI 10.1016/J.JECE.2013.07.034]; Mu LN, 2011, J CHROMATOGR A, V1218, P9236, DOI 10.1016/j.chroma.2011.10.079; Singh DK, 2010, DESALINATION, V257, P177, DOI 10.1016/j.desal.2010.02.026; Sun XL, 2009, TALANTA, V79, P926, DOI 10.1016/j.talanta.2009.05.033; Tan J, 2012, TRAC-TREND ANAL CHEM, V39, P207, DOI 10.1016/j.trac.2012.05.009; Xie XY, 2016, REV ANAL CHEM, V35, P87, DOI 10.1515/revac-2016-0005; Yang JJ, 2015, ANAL CHIM ACTA, V872, P35, DOI 10.1016/j.aca.2015.02.058; Zhai HY, 2015, ANAL CHIM ACTA, V865, P16, DOI 10.1016/j.aca.2015.01.028	18	9	9	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195546	10.1371/journal.pone.0195546	http://dx.doi.org/10.1371/journal.pone.0195546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649325	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900053
J	Ortega, JL; Rajapakse, W; Bagga, S; Apodaca, K; Lucero, Y; Sengupta-Gopalan, C				Ortega, Jose Luis; Rajapakse, Wathsala; Bagga, Suman; Apodaca, Kimberly; Lucero, Yvonne; Sengupta-Gopalan, Champa			An intragenic approach to confer glyphosate resistance in chile (Capsicum annuum) by introducing an in vitro mutagenized chile EPSPS gene encoding for a glyphosate resistant EPSPS protein	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; ESCHERICHIA-COLI; HERBICIDE GLYPHOSATE; TRANSGENIC TOBACCO; PROVIDES INSIGHTS; STRUCTURAL BASIS; EVOLUTION; PLANTS; SUBSTITUTION	Chile pepper (Capsicum annuum) is an important high valued crop worldwide, and when grown on a large scale has problems with weeds. One important herbicide used is glyphosate. Glyphosate inactivates the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), a key enzyme in the synthesis of aromatic amino acids. A transgenic approach towards making glyphosate resistant plants, entails introducing copies of a gene encoding for glyphosate-resistant EPSPS enzyme into the plant. The main objective of our work was to use an intragenic approach to confer resistance to glyphosate in chile which would require using only chile genes for transformation including the selectable marker. Tobacco was used as the transgenic system to identify different gene constructs that would allow for the development of the intragenic system for chile, since chile transformation is inefficient. An EPSPS gene was isolated from chile and mutagenized to introduce substitutions that are known to make the encoded enzyme resistant to glyphosate. The promoter for EPSPS gene was isolated from chile and the mutagenized chile EPSPS cDNA was engineered behind both the CaMV35S promoter and the EPSPS promoter. The leaves from the transformants were checked for resistance to glyphosate using a cut leaf assay. In tobacco, though both gene constructs exhibited some degree of resistance to glyphosate, the construct with the CaMV35S promoter was more effective and as such chile was transformed with this gene construct. The chile transformants showed resistance to low concentrations of glyphosate. Furthermore, preliminary studies showed that the mutated EPSPS gene driven by the CaMV35S promoter could be used as a selectable marker for transformation. We have shown that an intragenic approach can be used to confer glyphosate-resistance in chile. However, we need a stronger chile promoter and a mutated chile gene that encodes for a more glyphosate resistant EPSPS protein.	[Ortega, Jose Luis; Rajapakse, Wathsala; Bagga, Suman; Apodaca, Kimberly; Lucero, Yvonne; Sengupta-Gopalan, Champa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA	New Mexico State University	Sengupta-Gopalan, C (corresponding author), New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA.	csgopalan@nmsu.edu		Apodaca, Kimberly/0000-0002-4218-3728	New Mexico Chile Association; New Mexico State University, Agricultural Experiment Station; New Mexico State University, Graduate Research Enhancement Grant; Howard Hughes Medical Institute, Science Education Grant [52008103]	New Mexico Chile Association; New Mexico State University, Agricultural Experiment Station; New Mexico State University, Graduate Research Enhancement Grant; Howard Hughes Medical Institute, Science Education Grant	Funded by New Mexico Chile Association. New Mexico State University, Agricultural Experiment Station. New Mexico State University, Graduate Research Enhancement Grant, supported WR. Howard Hughes Medical Institute, Science Education Grant # 52008103, supported KA.	Aza-Gonzalez C, 2011, PLANT CELL REP, V30, P695, DOI 10.1007/s00299-010-0968-8; Cao GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038718; Clemente TE, 2000, CROP SCI, V40, P797, DOI 10.2135/cropsci2000.403797x; COMAI L, 1983, SCIENCE, V221, P370, DOI 10.1126/science.221.4608.370; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Dill GM, 2005, PEST MANAG SCI, V61, P219, DOI 10.1002/ps.1008; Dong YF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00885; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Dun BQ, 2007, APPL ENVIRON MICROB, V73, P7997, DOI 10.1128/AEM.00956-07; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Funke T, 2009, J BIOL CHEM, V284, P9854, DOI 10.1074/jbc.M809771200; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Green JM, 2009, WEED SCI, V57, P108, DOI 10.1614/WS-08-030.1; He M, 2003, BIOSCI BIOTECH BIOCH, V67, P1405, DOI 10.1271/bbb.67.1405; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; Holme IB, 2012, PLANT BIOTECHNOL J, V10, P237, DOI 10.1111/j.1467-7652.2011.00660.x; Howe AR, 2002, MOL BREEDING, V10, P153, DOI 10.1023/A:1020396708088; Huang ZF, 2014, MOL BIOL REP, V41, P2077, DOI 10.1007/s11033-014-3056-2; Imran M, 2017, PHYSIOL MOL BIOL PLA, V23, P453, DOI 10.1007/s12298-017-0424-0; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kost TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143980; Kothari SL, 2010, BIOTECHNOL ADV, V28, P35, DOI 10.1016/j.biotechadv.2009.08.005; Liu JX, 2009, AGR SCI CHINA, V8, P947, DOI 10.1016/S1671-2927(08)60299-0; Liu YJ, 2015, TRANSGENIC RES, V24, P753, DOI 10.1007/s11248-015-9874-8; Ochoa-Alejo N, 2001, IN VITRO CELL DEV-PL, V37, P701; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; PILANEE V, 2007, PROCESS BIOCHEM, V42, P592; Powles SB, 2010, P NATL ACAD SCI USA, V107, P955, DOI 10.1073/pnas.0913433107; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Rajapakse W, 2015, TRANSGENIC CISGENIC; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Schouten HJ, 2006, NAT BIOTECHNOL, V24, P753, DOI 10.1038/nbt0706-753; Seger M, 2009, PLANT SCI, V176, P119, DOI 10.1016/j.plantsci.2008.10.006; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; Sundar IK, 2008, J PLANT PHYSIOL, V165, P1698, DOI 10.1016/j.jplph.2008.08.002; Tian YS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0327-0; Tian YS, 2013, WORLD J MICROB BIOT, V29, P549, DOI 10.1007/s11274-012-1209-9; Tian YS, 2011, APPL ENVIRON MICROB, V77, P8409, DOI 10.1128/AEM.05271-11; Vanblaere T, 2014, PLANT BIOTECHNOL J, V12, P2, DOI 10.1111/pbi.12110; Wang HY, 2003, J PLANT RES, V116, P455, DOI 10.1007/s10265-003-0120-8; Yang X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175820; Yu Q, 2015, PLANT PHYSIOL, V167, P1440, DOI 10.1104/pp.15.00146; Zhang XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158384	46	7	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194666	10.1371/journal.pone.0194666	http://dx.doi.org/10.1371/journal.pone.0194666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649228	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900012
J	Boatman, TG; Davey, PA; Lawson, T; Geider, RJ				Boatman, Tobias G.; Davey, Phillip A.; Lawson, Tracy; Geider, Richard J.			The physiological cost of diazotrophy for Trichodesmium erythraeum IMS101	PLOS ONE			English	Article							MARINE CYANOBACTERIUM TRICHODESMIUM; PHOTOSYNTHETIC ELECTRON-TRANSPORT; NORTH PACIFIC-OCEAN; NITROGEN-FIXATION; OXYGEN EVOLUTION; PHOTOSYSTEM-II; CULTURED POPULATIONS; COMMUNITY STRUCTURE; CO2 ASSIMILATION; EUKARYOTIC ALGAE	Trichodesmium plays a significant role in the oligotrophic oceans, fixing nitrogen in an area corresponding to half of the Earth's surface, representing up to 50% of new production in some oligotrophic tropical and subtropical oceans. Whilst Trichodesmium blooms at the surface exhibit a strong dependence on diazotrophy, colonies at depth or at the surface after a mixing event could be utilising additional N-sources. We conducted experiments to establish how acclimation to varying N-sources affects the growth, elemental composition, light absorption coefficient, N-2 fixation, PSII electron transport rate and the relationship between net and gross photosynthetic O-2 exchange in T. erythraeum IMS101. To do this, cultures were acclimated to growth medium containing NH4 (+) and NO3 -(replete concentrations) or N-2 only (diazotrophic control). The light dependencies of O-2 evolution and O-2 uptake were measured using membrane inlet mass spectrometry (MIMS), while PSII electron transport rates were measured from fluorescence light curves (FLCs). We found that at a saturating light intensity, Trichodesmium growth was similar to 10% and 13% lower when grown on N-2 than with NH4 (+) and NO3 (-), respectively. Oxygen uptake increased linearly with net photosynthesis across all light intensities ranging from darkness to 1100 mu mol photons m(-2) s(-1). The maximum rates and initial slopes of light response curves for C-specific gross and net photosynthesis and the slope of the relationship between gross and net photosynthesis increased significantly under non-diazotrophic conditions. We attribute these observations to a reduced expenditure of reductant and ATP for nitrogenase activity under non-diazotrophic conditions which allows NADPH and ATP to be re-directed to CO2 fixation and/ or biosynthesis. The energy and reductant conserved through utilising additional N-sources could enhance Trichodesmium's productivity and growth and have major implications for its role in ocean C and N cycles.	[Boatman, Tobias G.; Davey, Phillip A.; Lawson, Tracy; Geider, Richard J.] Univ Essex, Sch Biol Sci, Colchester, Essex, England	University of Essex	Boatman, TG (corresponding author), Univ Essex, Sch Biol Sci, Colchester, Essex, England.	tboatman@chelsea.co.uk			UK Natural Environment Research Council PhD studentship [NE/J500379/1]	UK Natural Environment Research Council PhD studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Tobias Boatman was supported by a UK Natural Environment Research Council PhD studentship (NE/J500379/1 DTB). Funding obtained by RJG and TL.	Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; Bergman B, 2013, FEMS MICROBIOL REV, V37, P286, DOI 10.1111/j.1574-6976.2012.00352.x; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Berman-Frank I, 2007, LIMNOL OCEANOGR, V52, P2260, DOI 10.4319/lo.2007.52.5.2260; Boatman TG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168796; Breitbarth E, 2008, MAR ECOL PROG SER, V359, P25, DOI 10.3354/meps07241; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Campbell L, 2005, VIE MILIEU, V55, P185; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CAPONE DG, 1990, APPL ENVIRON MICROB, V56, P3532, DOI 10.1128/AEM.56.11.3532-3536.1990; CARPENTER EJ, 1992, NATO ADV SCI I C-MAT, V362, P211; CARPENTER EJ, 1975, LIMNOL OCEANOGR, V20, P389, DOI 10.4319/lo.1975.20.3.0389; Carr H, 2003, J PHYCOL, V39, P1125, DOI 10.1111/j.0022-3646.2003.02-077.x; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Coles VJ, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2002JC001754; Davis CS, 2006, SCIENCE, V312, P1517, DOI 10.1126/science.1123570; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Edwards G., 1983, C3 C4 MECH CELLULAR; Eichner M, 2014, PHYSIOL PLANTARUM, V152, P316, DOI 10.1111/ppl.12172; FALKOWSKI PG, 1986, BIOCHIM BIOPHYS ACTA, V849, P183, DOI 10.1016/0005-2728(86)90024-1; Finzi-Hart JA, 2009, P NATL ACAD SCI USA, V106, P6345, DOI 10.1073/pnas.0810547106; Flameling IA, 1998, LIMNOL OCEANOGR, V43, P284, DOI 10.4319/lo.1998.43.2.0284; Fryer MJ, 1998, PLANT PHYSIOL, V116, P571, DOI 10.1104/pp.116.2.571; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; Glibert P, 1988, EOS, V69, P3996; Goering JJ, 1966, LIMNOLOGY OCEANOGRAP, P614; Grosskopf T, 2012, FRONT AQUAT MICROBIO, V3, P1; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Guerrero M. G., 1987, The Cyanobacteria., P163; Helbling EW, 1994, EFFECTS ULTRAVIOLET; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Hood RR, 2004, J GEOPHYS RES, V109, DOI DOI 10.1029/2002JC001753; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Kupper H, 2004, PLANT PHYSIOL, V135, P2120, DOI 10.1104/pp.104.045963; Kupper H, BIOCH BIOPHYSICA ACT; Letelier RM, 1996, MAR ECOL PROG SER, V133, P263, DOI 10.3354/meps133263; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Levitan O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015104; LUQUE I, 1994, EMBO J, V13, P2862, DOI 10.1002/j.1460-2075.1994.tb06580.x; McGillicuddy DJ, 2014, GLOBAL BIOGEOCHEM CY, V28, P103, DOI 10.1002/2013GB004652; McKew BA, 2013, NEW PHYTOLOGIST, DOI 10.1111/nph.12352; Milligan AJ, 2007, J PHYCOL, V43, P845, DOI 10.1111/j.1529-8817.2007.00395.x; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Moore JK, 2006, TELLUS B, V58, P560, DOI 10.1111/j.1600-0889.2006.00209.x; MOREL A, 1978, DEEP-SEA RES, V25, P673, DOI 10.1016/0146-6291(78)90623-9; Mulholland MR, 2001, J PHYCOL, V37, P1001, DOI 10.1046/j.1529-8817.2001.00080.x; Mulholland MR, 2001, LIMNOL OCEANOGR, V46, P436, DOI 10.4319/lo.2001.46.2.0436; Mulholland MR, 1999, J PHYCOL, V35, P977, DOI 10.1046/j.1529-8817.1999.3550977.x; Mulholland MR, 1999, MAR ECOL PROG SER, V188, P33, DOI 10.3354/meps188033; Mulholland MR, 2000, TRENDS PLANT SCI, V5, P148, DOI 10.1016/S1360-1385(00)01576-4; OHKI K, 1991, ARCH MICROBIOL, V156, P335, DOI 10.1007/BF00248706; PLATT T, 1976, J PHYCOL, V12, P421, DOI 10.1111/j.1529-8817.1976.tb02866.x; RADMER RJ, 1976, PLANT PHYSIOL, V58, P336, DOI 10.1104/pp.58.3.336; RAVEN JA, 1991, LIMNOL OCEANOGR, V36, P1701, DOI 10.4319/lo.1991.36.8.1701; Sandh G, 2011, PROTEOMICS, V11, P406, DOI 10.1002/pmic.201000382; Silsbe GM, 2015, LIMNOL OCEANOGR-METH, V13, P138, DOI 10.1002/lom3.10014; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; Suggett DJ, 2004, LIMNOL OCEANOGR-METH, V2, P316, DOI 10.4319/lom.2004.2.316; Sundberg B, 1997, PLANTA, V201, P138, DOI 10.1007/BF01007698; Villareal TA, 2003, MICROB ECOL, V45, P1, DOI 10.1007/s00248-002-1012-5; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Woniak B., 1999, OCEANOLOGIA, V41, P187; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	72	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195638	10.1371/journal.pone.0195638	http://dx.doi.org/10.1371/journal.pone.0195638			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641568	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000429742900079
J	Costa, T; Barri, F				Costa, Thiago; Barri, Fernando			Lama guanicoe remains from the Chaco ecoregion (Cordoba, Argentina): An osteological approach to the characterization of a relict wild population	PLOS ONE			English	Article							CONSERVATION BIOLOGY; GRAN CHACO; GUANACO; ARTIODACTYLA; PALEOZOOLOGY; PALEOBIOLOGY; PERSPECTIVE; VEGETATION; EXPANSION; CAMELIDAE	Guanacos (Lama guanicoe) are large ungulates that have been valued by human populations in South America since the Late Pleistocene. Even though they were very abundant until the end of the 19th century (before the high deforestation rate of the last decades), guanacos have nearly disappeared in the Gran Chaco ecoregion, with relicts and isolated populations surviving in some areas, such as the shrubland area near the saline depressions of Cordoba province, Argentina. In this report, we present the first data from a locally endangered guanaco wild population, through the study of skeletal remains recovered in La Providencia ranch. Our results showed that most of the elements belonged to adults aged between 36 and 96 months; sex evaluation showed similar numbers of males and females. Statistical analysis of the body size of modern samples from Cordoba demonstrated that guanacos from the Chaco had large dimensions and presented lower size variability than the modern and archaeological specimens in our database. Moreover, they exhibited dimensions similar to those of modern guanacos from Patagonia and San Juan, and to archaeological specimens from Ongamira and Cerro Colorado, although further genetic studies are needed to corroborate a possible phylogenetic relationship. Finally, we used archaeozoological techniques to provide a first characterization of a relict guanaco population from the Chaco ecoregion, demonstrating its value to the study of modern skeletal remains and species conservation biology.	[Costa, Thiago] Univ Nacl Cordoba, CONICET, Fac Filosofia & Humanidades, IDACOR,Museo Antropol, Cordoba, Argentina; [Barri, Fernando] Univ Nacl Cordoba, CONICET, Inst Diversidad & Ecol Anim, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Costa, T (corresponding author), Univ Nacl Cordoba, CONICET, Fac Filosofia & Humanidades, IDACOR,Museo Antropol, Cordoba, Argentina.	thfcosta@gmail.com	Costa, Thiago/V-4015-2019	Costa, Thiago/0000-0003-3476-102X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Financial support was provided by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET).	Acebes P, 2010, MAMMALIA, V74, P57, DOI 10.1515/MAMM.2009.071; Barnosky AD, 2017, SCIENCE, V355, DOI 10.1126/science.aah4787; Borrero Luis Alberto, 2007, BAR International Series, V1601, P219; Bradshaw RHW, 2003, FOREST ECOL MANAG, V181, P267, DOI 10.1016/S0378-1127(03)00138-5; Calder WA., 1984, SIZE FUNCTION LIFE H; Cattaneo GR, 2015, PATRIMONIO ARQUEOLOG; Cattaneo R, 2013, RELACIONES, V38, P559; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Costa T., REV MUS ANTROPOL, V9, P93; Costa T, 2016, INT J OSTEOARCHAEOL, DOI [10.1002/oa.2531, DOI 10.1002/OA.2531]; Costa T., 2016, ARQUEOLOGIA VALLE ON, P117; Cuéllar Erika, 2014, Therya, V5, P39, DOI 10.12933/therya-14-181; De Nigris ME, 2005, INTERSEC ANTROPOL; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Fabra M, 2012, REV ARG ANTROPOL BIO, V14; Flores CE, 2012, RANGELAND J, V34, P439, DOI 10.1071/RJ12040; Franklin W.L., 1983, Special Publication American Society of Mammalogists, P573; Gentile M., 2012, ANUARIO JURIDICO EC, VXLV, P581; Gonzalez BA, 2006, MAMMAL REV, V36, P157, DOI 10.1111/j.1365-2907.2006.00084.x; Gonzalez ME, 2012, INT J OSTEOARCHAEOL, V22, P523, DOI 10.1002/oa.1271; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Izeta A. D., 2012, GUIA OSTEOMETRICA CA; Izeta AD, 2007, BAR INT SERIES, P47; Izeta Andres D., 2009, REV MUSEO ANTROPOLOG, V2, P169, DOI DOI 10.31048/1852.4826.V2.N1.5416; KAUFMANN C. L. G., 2009, THESIS; Kaufmann Cristian A, 2013, Mastozool. neotrop., V20, P47; Kent JD, 1982, THESIS; Kufner Maura B., 2001, Boletin de la Academia Nacional de Ciencias (Cordoba), V66, P109; Lefevre C, 2003, EXPLOTACION RECURSOS, V31, P63; Leynaud GC, 2005, FOREST ECOL MANAG, V213, P384, DOI 10.1016/j.foreco.2005.04.003; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; Lyman RL, 2012, BIOL REV, V87, P513, DOI 10.1111/j.1469-185X.2011.00207.x; Lyman RL, 2006, EVOL ANTHROPOL, V15, P11, DOI 10.1002/evan.20083; Malmierca M.P., 1997, RELAC SOC ARGENT ANT, VXXII, P389; Martinez Gustavo, 2004, BAR International Series, V1298, P81; Massigoge A, 2010, MAMUL MAPU PASADO PR, VI, P309; Medina ME, 2014, INTERSECCIONES ANTRO, V15, P339; Mengoni Gonalons G.L., 1999, THESIS; Mengoni Gorialons GL, 2014, ICAZ 2014 12 INT C A, P108; Metcalf JL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501682; Monchot H, 1999, QUATERNARY RES, V52, P259, DOI 10.1006/qres.1999.2066; Nacuzzi LR, 2007, CHUNGARA, V39, P221, DOI 10.4067/S0717-73562007000200005; Neme G, 2012, ARCHAEOFAUNA, V21, P207; Nores R., 2011, REV MUSEO ANTROPOLOG, V4, P187; Nori J, 2016, DIVERS DISTRIB, V22, P1212, DOI 10.1111/ddi.12497; Nori J, 2013, BIOL CONSERV, V159, P507, DOI 10.1016/j.biocon.2012.11.020; Olivera D., 2009, REV MUS ANTROPOL, V2, p151?168, DOI [10.31048/1852.4826.v2.n1.5415, DOI 10.31048/1852.4826.V2.N1.5415]; Oporto N., 1979, REV ARGENTINA PRODUC, V4, P965; Otaola C, 2008, MAGALLANIA, V36, P205, DOI 10.4067/S0718-22442008000200016; Periago ME, 2015, MAMMAL REV, V45, P41, DOI 10.1111/mam.12031; Politis GG, 2011, J ARCHAEOL SCI, V38, P1405, DOI 10.1016/j.jas.2011.01.013; Raedeke K., 1979, THESIS; Grau HR, 2015, J ARID ENVIRON, V123, P40, DOI 10.1016/j.jaridenv.2014.12.006; Rick TC, 2013, CONSERV BIOL, V27, P45, DOI 10.1111/j.1523-1739.2012.01920.x; Rio M, 1905, GEOGRAFIA PROVINCIA, VII, P690; Rio ME, 1904, GEOGRAFIA PROVINCIA, VI, P570; Rivals F, 2013, J ARCHAEOL SCI, V40, P2971, DOI 10.1016/j.jas.2013.03.005; Rivero D, 2013, SAMAR SERIES, V24, P76; Rivero DE., 2010, ZOOARQUEOLOGIA PRINC, P321; Romero J, 2016, PLAN CONSERVAC UNPUB, P55; Silva LCR, 2011, PLANT SOIL, V349, P261, DOI 10.1007/s11104-011-0868-x; Szabo P, 2010, ENVIRON CONSERV, V37, P380, DOI 10.1017/S0376892910000718; Todd Lawrence C., 1987, HORNER SITE TYPE SIT, P107, DOI DOI 10.1016/B978-0-12-268566-8.50012-9; WHEELER J, 1982, LLAMA WORLD, V1, P12; Yacobaccio H.D., 2010, ZOOARQUEOLOGIA PRINC, VXXI, P65; Yanes Y, 2014, HOLOCENE, V24, P1193, DOI 10.1177/0959683614540959; Zak MR, 2008, ENVIRON MANAGE, V42, P181, DOI 10.1007/s00267-008-9101-y; Zak MR, 2002, APPL VEG SCI, V5, P213, DOI 10.1111/j.1654-109X.2002.tb00551.x	68	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194727	10.1371/journal.pone.0194727	http://dx.doi.org/10.1371/journal.pone.0194727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641579	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900041
J	Debashi, M; Vickers, P				Debashi, Mohamed; Vickers, Paul			Sonification of network traffic flow for monitoring and situational awareness	PLOS ONE			English	Article								Maintaining situational awareness of what is happening within a computer network is challenging, not only because the behaviour happens within machines, but also because data traffic speeds and volumes are beyond human ability to process. Visualisation techniques are widely used to present information about network traffic dynamics. Although they provide operators with an overall view and specific information about particular traffic or attacks on the network, they often still fail to represent the events in an understandable way. Also, because they require visual attention they are not well suited to continuous monitoring scenarios in which network administrators must carry out other tasks. Here we present SoN-STAR (Sonification of Networks for SiTuational AwaReness), a real-time sonification system for monitoring computer networks to support network administrators' situational awareness. SoNSTAR provides an auditory representation of all the TCP/IP traffic within a network based on the different traffic flows between between network hosts. A user study showed that SoNSTAR raises situational awareness levels by enabling operators to understand network behaviour and with the benefit of lower workload demands (as measured by the NASA TLX method) than visual techniques. SoNSTAR identifies network traffic features by inspecting the status flags of TCP/IP packet headers. Combinations of these features define particular traffic events which are mapped to recorded sounds to generate a soundscape that represents the real-time status of the network traffic environment. The sequence, timing, and loudness of the different sounds allow the network to be monitored and anomalous behaviour to be detected without the need to continuously watch a monitor screen.	[Debashi, Mohamed; Vickers, Paul] Northumbria Univ, Dept Comp & Informat Sci, Newcastle Upon Tyne, Tyne & Wear, England	Northumbria University	Debashi, M; Vickers, P (corresponding author), Northumbria Univ, Dept Comp & Informat Sci, Newcastle Upon Tyne, Tyne & Wear, England.	mohamed.debashi@northumbria.ac.uk; paul.vickers@northumbria.ac.uk	; Vickers, Paul/E-1752-2013	Debashi, Mohamed/0000-0001-5819-2699; Vickers, Paul/0000-0003-0963-5005	Libyan Embassy Cultural Attache, London [10233]	Libyan Embassy Cultural Attache, London	This work was supported by Libyan Embassy Cultural Attache, London (http://culturalaffairs.libyanembassy.org/En/), Student Number: 10233; Mohamed Debashi is the author who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshammari R, 2011, COMPUT NETW, V55, P1326, DOI 10.1016/j.comnet.2010.12.002; Angerman W. S., 2004, THESIS; Baier G., 2006, ICAD 2006, P148; Ballora M, 2011, ALGORITHMS APPL, V8064, P80640; Ballora M, 2012, ALGORITHMS APPL, V8407; Ballora M, 2010, PROC SPIE, V7709, DOI 10.1117/12.850319; Barford P, 2002, IMW 2002: PROCEEDINGS OF THE SECOND INTERNET MEASUREMENT WORKSHOP, P71, DOI 10.1145/637201.637210; Bass T, 2000, COMMUN ACM, V43, P99, DOI 10.1145/332051.332079; Bernaille L, PASSIVE ACTIVE NETWO; Bowman WB, 1997, US Patent, Patent No. [5,627,886, 5627886]; Brownlee N, 1999, TRAFFIC FLOW MEASURE; Carrier B., 2003, INT J DIGITAL EVIDEN, V1, P1; Chafe C, 2001, P 8 INT C AUD DISPL, P50; Chen L., 2009, ENCY DATABASE SYSTEM; Criado R, 2005, J MATH MODELLING ALG, V4, P307, DOI DOI 10.1007/S10852-005-9006-1; Debashi M, 2017, SONIFICATION NETWORK; Di Pietro R, 2008, ADV INFORM SECUR, V38, P17; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; Fairfax T, 2014, HDB RES DIGITAL CRIM, P334; Giot R, 2012, P 18 INT C AUD DISPL, P235; HART S G, 1988, P139; Hildebrandt T., 2014, BUS PROC MAN WORKSH, P529; Hunt A, 2011, SONIFICATION HDB, P273; Jajodia S, 2010, ADV INFORM SECUR, V46, P139, DOI 10.1007/978-1-4419-0140-8_7; Kimoto M, 2002, P 2002 INT COMP MUS, P273; KRAMER G, 1994, SFI S SCI C, V18, P185; Kramer G, 1999, SONIFICATION REPORT; Lakkaraju Kiran, 2004, P ACM WORKSHOP VISUA, P65, DOI DOI 10.1145/1029208.1029219; Malandrino D, 2003, P 2003 INT C AUD DIS, P251; Mancuso VF, 2015, PROCEDIA MANUF, V3, P5214, DOI 10.1016/j.promfg.2015.07.589; Mukkamala S, 2006, CYBER SECURITY CHALL, P125; Neuhoff JG, 2002, J EXP PSYCHOL-APPL, V8, P17, DOI 10.1037//1076-898X.8.1.17; Panchen S, 2001, MON CORPORATIONS SFL; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Preface Kramer G., 1994, AUDITORY DISPLAY, VXVIII, pxxiii; Rutz HH, 2015, ICAD 15, P188; Schafer RM, 1977, TUNING WORLD, DOI DOI 10.2307/3345272; Schuba CL, 1997, P IEEE S SECUR PRIV, P208, DOI 10.1109/SECPRI.1997.601338; Shah K, 2004, P AMER CONTR CONF, P988; Soniya B, 2008, SITIS 2008: 4TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY AND INTERNET BASED SYSTEMS, PROCEEDINGS, P646, DOI 10.1109/SITIS.2008.33; Srinivasan T, 2006, 2006 INTERNATIONAL CONFERENCE ON COMPUTING & INFORMATICS (ICOCI 2006), P350; Stallings W, 2014, COMPUTER SECURITY HANDBOOK, 6TH EDITION, VOL 1; Vickers P., 2016, NUSON SOCS SELF ORG; Vickers P., 2011, SONIFICATION HDB, P455; Vickers P, 2017, DISPLAYS, V47, P12, DOI 10.1016/j.displa.2016.05.002; Wikipedia contributors, 2018, INT PROT SUIT WIK FR; Wolf KatieAnna E, 2015, P 20 INT C INT C INT, P97, DOI DOI 10.1145/2732158.2732188; Wolf KE, 2013, NIME 13, P503; Worrall D., 2015, P 21 INT C AUD DISPL, P337; Yang JP, 2015, Proceedings of the Second International Symposium - Management, Innovation and Development, P289	50	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195948	10.1371/journal.pone.0195948	http://dx.doi.org/10.1371/journal.pone.0195948			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672543	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000430446800064
J	Vaidya, G; Lepage, D; Guralnick, R				Vaidya, Gaurav; Lepage, Denis; Guralnick, Robert			The tempo and mode of the taxonomic correction process: How taxonomists have corrected and recorrected North American bird species over the last 127 years	PLOS ONE			English	Article							ORNITHOLOGISTS UNION CHECKLIST; SUPPLEMENT; INFLATION; PROGRESS; NUMBERS; RATES	While studies of taxonomy usually focus on species description, there is also a taxonomic correction process that retests and updates existing species circumscriptions on the basis of new evidence. These corrections may themselves be subsequently retested and recorrected. We studied this correction process by using the Check-List of North and Middle American Birds, a well-known taxonomic checklist that spans 130 years. We identified 142 lumps and 95 splits across sixty-three versions of the Check-List and found that while lumping rates have markedly decreased since the 1970s, splitting rates are accelerating. We found that 74% of North American bird species recognized today have never been corrected (i.e., lumped or split) over the period of the checklist, while 16% have been corrected exactly once and 10% have been corrected twice or more. Since North American bird species are known to have been extensively lumped in the first half of the 20th century with the advent of the biological species concept, we determined whether most splits seen today were the result of those lumps being recorrected. We found that 5% of lumps and 23% of splits fully reverted previous corrections, while a further 3% of lumps and 13% of splits are partial reversions. These results show a taxonomic correction process with moderate levels of recorrection, particularly of previous lumps. However, 81% of corrections do not revert any previous corrections, suggesting that the majority result in novel circumscriptions not previously recognized by the Check-List. We could find no order or family with a significantly higher rate of correction than any other, but twenty-two genera as currently recognized by the AOU do have significantly higher rates than others. Given the currently accelerating rate of splitting, prediction of the end-point of the taxonomic recorrection process is difficult, and many entirely new taxonomic concepts are still being, and likely will continue to be, proposed and further tested.	[Vaidya, Gaurav] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Lepage, Denis] Bird Studies Canada, Port Rowan, ON, Canada; [Guralnick, Robert] Univ Florida, Dept Nat Hist, Gainesville, FL USA; [Guralnick, Robert] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	University of Colorado System; University of Colorado Boulder; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Vaidya, G (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	gaurav@ggvaidya.com	Vaidya, Gaurav/E-9766-2010	Vaidya, Gaurav/0000-0003-0587-0454	National Evolutionary Synthesis Center (NESCent, NSF) [EF-0905606]	National Evolutionary Synthesis Center (NESCent, NSF)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	GV's initial work on this project was funded by a graduate fellowship at the National Evolutionary Synthesis Center (NESCent, NSF #EF-0905606) under the supervision of Hilmar Lapp. Some of the very early planning and design of this project was carried out there, but NESCent had no later role in any aspect of this work. No other authors received specific funding for this work.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Aldrich J. W., 1946, Wilson Bulletin Ann Arbor, V58, P94; Alroy J, 2002, P NATL ACAD SCI USA, V99, P3706, DOI 10.1073/pnas.062691099; American Ornithologists Union, 1998, CHECK LIST N AM BIRD, V7th; American Ornithologists' Union, 1998, COMM CLASS NOM CHECK; American Ornithologists' Union, 1931, CHECK LIST N AM BIRD, DOI [10.5962/bhl.title.6394, DOI 10.5962/BHL.TITLE.6394]; American Ornithologists' Union, 1983, CHECKL N AM BIRDS, DOI [10.5962/bhl.title.50892, DOI 10.5962/BHL.TITLE.50892]; American Ornithologists' Union (aou), 1976, AUK, V93, P875; AOU Committee, 1923, Auk Lancaster Pa, V40, P513; Audubon John James, 1834, ORNITHOLOGICAL BIOGR, V2, DOI [10.5962/bhl.title.48976, DOI 10.5962/BHL.TITLE.48976]; Banks RC, 2004, AUK, V121, P985, DOI 10.1642/0004-8038(2004)121[0985:FSTTAO]2.0.CO;2; Barrowclough GF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166307; Bebber DP, 2007, P R SOC B, V274, P1651, DOI 10.1098/rspb.2007.0464; California Academy of Sciences, 2017, INATURALIST; Catesby Mark, 1771, NATURAL HIST CAROLIN; Chen M., 2014, CORR, P1; Chesser RT, 2016, AUK, V133, P544, DOI 10.1642/AUK-16-77.1; Chesser RT, 2015, AUK, V132, P748, DOI 10.1642/AUK-15-73.1; Chesser RT, 2013, AUK, V130, P558, DOI 10.1525/auk.2013.130.3.1; Chesser RT, 2011, AUK, V128, P600, DOI 10.1525/auk.2011.128.3.600; Chesser RT, 2014, AUK, V131, pCSi, DOI [10.1642/AUK-14-124.1, DOI 10.1642/AUK-14-124.1]; Costello MJ, 2013, SYST BIOL, V62, P616, DOI 10.1093/sysbio/syt024; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Cracraft J., 1983, Current Ornithology, V1, P159; Cui H, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1352-7; EISENMANN E, 1973, AUK, V90, P411; Eisenmann E., 1982, AUK, V99, p1CC; Franz NM, 2009, SYST BIODIVERS, V7, P5, DOI 10.1017/S147720000800282X; Franz NM, 2008, SYST ASSOC SPEC VOL, V76, P63; Franz NM, 2016, SYST BIOL, V65, P561, DOI 10.1093/sysbio/syw023; Gill FB, 2014, AUK, V131, P150, DOI 10.1642/AUK-13-206.1; Grinnell J., 1935, CONDOR, V37, P90, DOI [10.2307/1363882, DOI 10.2307/1363882]; Groves CP, 2014, ANNU REV ANTHROPOL, V43, P27, DOI 10.1146/annurev-anthro-102313-030232; Heller R, 2013, SYST BIOL, V62, P490, DOI 10.1093/sysbio/syt004; IISE, 2011, RETR SOS 2000 2009 D; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Johnson NK, 1999, P INT ORN C, P1470; Joppa LN, 2011, TRENDS ECOL EVOL, V26, P551, DOI 10.1016/j.tree.2011.07.010; Laurenne N, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-40; Lepage D., 2015, BIRD STUDIES CANADA; Lepage D, 2014, ZOOKEYS, P117, DOI 10.3897/zookeys.420.7089; Mayr E, 1942, SYSTEMATICS ORIGIN S; McNEILL J., 2012, INT CODE NOMENCLATUR; Miller JA, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e5063; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; National Audubon Society, 2017, AUD BIRD GUID APP; OLSON SL, 1987, AUK, V104, P538, DOI 10.2307/4087560; Padial JM, 2006, SYST BIOL, V55, P859, DOI 10.1080/1063515060081588; Page RDM, 2013, PEERJ, V1, DOI 10.7717/peerj.190; Remsen D, 2016, ZOOKEYS, P207, DOI 10.3897/zookeys.550.9546; Remsen JV, 2015, J FIELD ORNITHOL, V86, DOI 10.1111/jofo.12102; Ride W.D.L., 1999, INT CODE ZOOLOGICAL; Ridgway R., 1923, AUK, V40, P375; RISING JD, 1972, SYST ZOOL, V21, P438, DOI 10.2307/2412436; Sangster G, 2015, SYST BIOL, V64, P144, DOI 10.1093/sysbio/syu069; Sangster G, 2014, BIOL REV, V89, P199, DOI 10.1111/brv.12051; Sangster G, 2009, P ROY SOC B-BIOL SCI, V276, P3185, DOI 10.1098/rspb.2009.0582; Schulenberg TS, 2014, UPDATING EBIRD CLEME; Sibley D., 2012, NAME CHANGES BIRDS 2; Sluys R, 2013, BIODIVERS CONSERV, V22, P1095, DOI 10.1007/s10531-013-0472-x; Stan Development Team, 2017, RSTAN R INT STAN; STONE WITMER, 1935, AUK, V52, P31; Swainson W, 1831, BIRDS FAUNA BOREAL 2, DOI [10.5962/bhl.title.63874, DOI 10.5962/BHL.TITLE.63874]; Swarth H. S., 1931, Condor Berkeley, V33, P160, DOI 10.2307/1363682; Swick N., 2016, 2016 AOU CHECK LIS 1; Tancoigne E, 2013, CLADISTICS, V29, P567, DOI 10.1111/cla.12019; Taxonomic Names and Concepts interest group, 2006, TAX CONC TRANSF SCHE; The American Ornithologists' Union, 2017, COMM CLASS NOM N MID; Weakley AS, 2015, FLORA SO MIDATLANTIC; Wetmore A, 1944, AUK, V63, P428	70	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195736	10.1371/journal.pone.0195736	http://dx.doi.org/10.1371/journal.pone.0195736			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672539	Green Published, gold, Green Submitted			2022-12-27	WOS:000430446800041
J	Makunts, T; Cohen, IV; Lee, KC; Abagyan, R				Makunts, Tigran; Cohen, Isaac V.; Lee, Kelly C.; Abagyan, Ruben			Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain	PLOS ONE			English	Article							TO-MODERATE DEPRESSION; CANCER-PATIENTS; DOUBLE-BLIND; SODIUM; DRUGS; PHARMACOKINETICS; BIOAVAILABILITY	Currently approved monoamine modulating antidepressant and anxiolytic pharmaceutics fail in over one third of patients due to delayed and variable therapeutic effect, adverse reactions preceding the therapeutic action, and adherence issues. Even with adequate adherence to the regimen and tolerability, one third of the patients do not respond to any class of antidepressants. There is a strong correlation between treatment resistant depression and increase in inflammatory cytokines in plasma and cerebrospinal fluid. Furthermore, epidemiological studies suggest that depression and anxiety are commonly comorbid with pain and inflammation. While a link between pain, inflammation and depression has been suggested it remains unclear which anti-inflammatory treatment may be beneficial to patients with depression and anxiety due to pain. Here, we analyzed 430,783 FDA adverse effect reports of patients treated for pain to identify potential antidepressant and anxiolytic effects of various anti-inflammatory medications. Patients treated for depression or patients taking any known antidepressants were excluded. The odds ratio analysis of 139,072 NSAID reports revealed that ketoprofen was associated with decreased reports of depression by a factor of 2.32 (OR 0.43 and 95% Confidence Interval [0.31, 0.59]) and decreased reports of anxiety by a factor of 2.86 (OR 0.35 [0.22, 0.56]), diclofenac with decreased depression reports by a factor of 2.22 (OR 0.45 [0.40, 0.49]) and anxiety by a factor of 2.13 (OR 0.47 [0.41, 0.54]), while naproxen decreased depression reports by a factor of 1.92 (OR 0.52 [0.49, 0.57]) and anxiety by a factor of 1.23 (OR 0.81 [0.75, 0.88]). Other NSAIDs did not exhibit any noticeable antidepressant and/or anxiolytic effect.	[Makunts, Tigran; Cohen, Isaac V.; Lee, Kelly C.; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Abagyan, R (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	ruben@ucsd.edu	Lee, Kelly/Q-9073-2018	Cohen, Isaac/0000-0003-1827-2429; Abagyan, Ruben/0000-0001-9309-2976; Makunts, Tigran/0000-0001-5536-1266; Lee, Kelly/0000-0002-1674-4210	USA NIH NIGMS (National Institutes of Health, National Institute of General Medical Sciences), of the United States National Institutes of Health [GM071872]	USA NIH NIGMS (National Institutes of Health, National Institute of General Medical Sciences), of the United States National Institutes of Health	This work was supported by the USA NIH NIGMS (National Institutes of Health, National Institute of General Medical Sciences), of the United States National Institutes of Health, grant number GM071872). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatawi YM, 2017, EXPERT OPIN DRUG SAF, V16, P761, DOI 10.1080/14740338.2017.1323867; Alberich S, 2016, REV PSIQUIATR SALUD; Altman R, 2015, DRUGS, V75, P859, DOI 10.1007/s40265-015-0392-z; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; BANNWARTH B, 1989, BIOMED PHARMACOTHER, V43, P121, DOI 10.1016/0753-3322(89)90140-6; BANNWARTH B, 1988, EUR J CLIN PHARMACOL, V33, P643, DOI 10.1007/BF00542503; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Bruce Travis O, 2008, Curr Psychiatry Rep, V10, P258, DOI 10.1007/s11920-008-0042-1; Cohen IV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01590-x; De La Garza R, 2003, BRAIN RES, V977, P70, DOI 10.1016/S0006-8993(03)02757-4; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; GAMST ON, 1984, INT J CLIN PHARM TH, V22, P99; Gold PW, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/581976; Husain MI, 2017, NEUROPSYCH DIS TREAT, V13, P1, DOI 10.2147/NDT.S115002; Jafarinia M, 2016, J AFFECT DISORDERS, V204, P1, DOI 10.1016/j.jad.2016.05.076; Kohler O, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.338; Leo Raphael J, 2005, Curr Treat Options Neurol, V7, P403, DOI 10.1007/s11940-005-0032-0; Maciejewski M, 2017, ELIFE, V6, DOI 10.7554/eLife.25818; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Marzo A, 2000, ARZNEIMITTEL-FORSCH, V50, P43; Mohammadinejad P, 2015, ANN PHARMACOTHER, V49, P953, DOI 10.1177/1060028015592215; Muller N, 2008, CURR PHARM DESIGN, V14, P1452, DOI 10.2174/138161208784480243; Musselman DL, 2001, AM J PSYCHIAT, V158, P1252, DOI 10.1176/appi.ajp.158.8.1252; Novakova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086806; O'Brien SM, 2007, J PSYCHIAT RES, V41, P326, DOI 10.1016/j.jpsychires.2006.05.013; Rahola JG, 2012, CURR NEUROPHARMACOL, V10, P139, DOI 10.2174/157015912800604533; Rosenblat JD, 2016, BIPOLAR DISORD, V18, P89, DOI 10.1111/bdi.12373; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Sansone Randy A, 2012, Innov Clin Neurosci, V9, P41; Savitz J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000643; SEVELIUS H, 1980, BRIT J CLIN PHARMACO, V10, P259, DOI 10.1111/j.1365-2125.1980.tb01753.x	34	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195521	10.1371/journal.pone.0195521	http://dx.doi.org/10.1371/journal.pone.0195521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668764	gold, Green Published			2022-12-27	WOS:000430290200045
J	Raine, A; Liljedahl, U; Nordlund, J				Raine, Amanda; Liljedahl, Ulrike; Nordlund, Jessica			Data quality of whole genome bisulfite sequencing on Illumina platforms	PLOS ONE			English	Article							DNA METHYLATION; SITES	The powerful HiSeq X sequencers with their patterned flowcell technology and fast turnaround times are instrumental for many large-scale genomic and epigenomic studies. However, assessment of DNA methylation by sodium bisulfite treatment results in sequencing libraries of low diversity, which may impact data quality and yield. In this report we assess the quality of WGBS data generated on the HiSeq X system in comparison with data generated on the HiSeq 2500 system and the newly released NovaSeq system. We report a systematic issue with low basecall quality scores assigned to guanines in the second read of WGBS when using certain Real Time Analysis (RTA) software versions on the HiSeq X sequencer, reminiscent of an issue that was previously reported with certain HiSeq 2500 software versions. However, with the HD.3.4.0 /RTA 2.7.7 software upgrade for the HiSeq X system, we observed an overall improved quality and yield of the WGBS data generated, which in turn empowers cost-effective and high quality DNA methylation studies.	[Raine, Amanda; Liljedahl, Ulrike; Nordlund, Jessica] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden	Uppsala University	Raine, A; Nordlund, J (corresponding author), Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden.	Amanda.Raine@medsci.uu.se; Jessica.Nordlund@medsciu.uu.se	Raine, Amanda/L-1354-2019	Raine, Amanda/0000-0002-2775-6516; Nordlund, Jessica/0000-0001-8699-9959	Swedish Council for Research Infrastructures and Science for Life Laboratory	Swedish Council for Research Infrastructures and Science for Life Laboratory	Sequencing was performed at the SNP&SEQ Technology Platform in Uppsala, which is part of the National Genomics Infrastructure (NGI) funded by the Swedish Council for Research Infrastructures and Science for Life Laboratory. Computational analysis was performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) through the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX).	Ewels Philip, 2016, F1000Res, V5, P2824, DOI 10.12688/f1000research.10335.2; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Illumina, 2014, LOW DIV SEQ ILL HISE; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krueger F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016607; Kunze S, 2018, METHODS MOL BIOL, V1708, P515, DOI 10.1007/978-1-4939-7481-8_26; Mitra A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120520; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Raine A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1110; ROSENFELD C, 1977, EUR J CANCER, V13, P377, DOI 10.1016/0014-2964(77)90085-8; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; Toh H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3392-9	16	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195972	10.1371/journal.pone.0195972	http://dx.doi.org/10.1371/journal.pone.0195972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668744	Green Submitted, gold, Green Published			2022-12-27	WOS:000430290200071
J	Sanchez-Dalmau, B; Martinez-Lapiscina, EH; Pulido-Valdeolivas, I; Zubizarreta, I; Llufriu, S; Blanco, Y; Sola-Valls, N; Sepulveda, M; Guerrero, A; Alba, S; Andorra, M; Camos, A; Sanchez-Vela, L; Alfonso, V; Saiz, A; Villoslada, P				Sanchez-Dalmau, Bernardo; Martinez-Lapiscina, Elena H.; Pulido-Valdeolivas, Irene; Zubizarreta, Irati; Llufriu, Sara; Blanco, Yolanda; Sola-Valls, Nuria; Sepulveda, Maria; Guerrero, Ana; Alba, Salut; Andorra, Magi; Camos, Anna; Sanchez-Vela, Laura; Alfonso, Veronica; Saiz, Albert; Villoslada, Pablo			Predictors of vision impairment in Multiple Sclerosis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; COLOR-VISION; VISUAL PATHWAY; DISABILITY; MS; RECOMMENDATIONS; NEURITIS; COHORT	Visual impairment significantly alters the quality of life of people with Multiple Sclerosis (MS). The objective of this study was to identify predictors (independent variables) of visual outcomes, and to define their relationship with neurological disability and retinal atrophy when assessed by optical coherence tomography (OCT). We performed a cross-sectional analysis of 119 consecutive patients with MS, assessing vision using high contrast visual acuity (Log-Mar), 2.5% and 1.25% low contrast visual acuity (Sloan charts), and color vision (Hardy-Rand-Rittler plates). Quality of vision is a patient reported outcome based on an individual's unique perception of his or her vision and was assessed with the Visual Functioning Questionnaire- 25 (VFQ-25) with the 10 neuro-ophthalmologic items. MS disability was assessed using the expanded disability status scale (EDSS), the MS functional composite (MSFC) and the brief repetitive battery-neuropsychology (BRB-N). Retinal atrophy was assessed using spectral domain OCT, measuring the thickness of the peripapillar retinal nerve fiber layer (pRNFL) and the volume of the ganglion cell plus inner plexiform layer (GCIPL). The vision of patients with MS was impaired, particularly in eyes with prior optic neuritis. Retinal atrophy (pRNFL and GCIPL) was closely associated with impaired low contrast vision and color vision, whereas the volume of the GCIPL showed a trend (p = 0.092) to be associated with quality of vision. Multiple regression analysis revealed that EDSS was an explanatory variable for high contrast vision after stepwise analysis, GCIPL volume for low contrast vision, and GCIPL volume and EDSS for color vision. The explanatory variables for quality of vision were high contrast vision and color vision. In summary, quality of vision in MS depends on the impairment of high contrast visual acuity and color vision due to the disease.	[Sanchez-Dalmau, Bernardo; Camos, Anna] Hosp Clin Barcelona, Dept Ophthalmol, Barcelona, Spain; [Martinez-Lapiscina, Elena H.; Pulido-Valdeolivas, Irene; Zubizarreta, Irati; Llufriu, Sara; Blanco, Yolanda; Sola-Valls, Nuria; Sepulveda, Maria; Guerrero, Ana; Alba, Salut; Andorra, Magi; Sanchez-Vela, Laura; Saiz, Albert; Villoslada, Pablo] Univ Barcelona, Dept Neurol, Barcelona, Spain; [Martinez-Lapiscina, Elena H.; Pulido-Valdeolivas, Irene; Zubizarreta, Irati; Llufriu, Sara; Blanco, Yolanda; Sola-Valls, Nuria; Sepulveda, Maria; Guerrero, Ana; Alba, Salut; Andorra, Magi; Sanchez-Vela, Laura; Saiz, Albert; Villoslada, Pablo] Univ Barcelona, IDIBAPS, Barcelona, Spain; [Alfonso, Veronica] Trial Form Support, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Villoslada, P (corresponding author), Univ Barcelona, Dept Neurol, Barcelona, Spain.; Villoslada, P (corresponding author), Univ Barcelona, IDIBAPS, Barcelona, Spain.	pvilloslada@clinic.ub.es	Villoslada, Pablo/AAF-9547-2019; Llufriu, Sara/T-6761-2019; Martinez-Lapiscina, Elena H/L-1161-2014; Llufriu, Sara/K-2987-2014; Andorra, Magi/D-8726-2015	Martinez-Lapiscina, Elena H/0000-0003-4272-0826; Sanchez-Dalmau, Bernardo F./0000-0001-8950-9759; Llufriu, Sara/0000-0003-4273-9121; Zubizarreta Nafarrate, Irati/0000-0001-7637-7830; Andorra, Magi/0000-0002-0491-3144; PULIDO-VALDEOLIVAS, IRENE/0000-0003-0188-2458	Institute de Salud Carlos III; FEDER funds ("Otra forma de hacer Europa") from the European Commission [PI15/0061, PI15/00587]; Spanish MS Network [REEM: RD16/0015/0002, RD16/0015/0003]; CERCA Programme / Generalitat de Catalunya; TFS	Institute de Salud Carlos III(Instituto de Salud Carlos III); FEDER funds ("Otra forma de hacer Europa") from the European Commission; Spanish MS Network; CERCA Programme / Generalitat de Catalunya; TFS	This work was supported by the Institute de Salud Carlos III with FEDER funds ("Otra forma de hacer Europa") from the European Commission (PI15/0061, to PV; PI15/00587 to SL and AS), the Spanish MS Network (REEM: RD16/0015/0002 to AS; and RD16/0015/0003 to PV), and CERCA Programme / Generalitat de Catalunya. VA is an employee of Trial Form Support (TFS) and she was in charge of the statistical analysis. TFS provided support in the form of salaries for authors [VA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The corresponding author has full access to data and analysis.	Balcer LJ, 2017, MULT SCLER J, V23, P734, DOI 10.1177/1352458517690822; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Balcer LJ, 2000, MULT SCLER J, V6, P163, DOI 10.1191/135245800701566025; Balk LJ, 2018, MULT SCLER J, V24, P767, DOI 10.1177/1352458517708463; Cole BL, 2006, CLIN EXP OPTOM, V89, P73, DOI 10.1111/j.1444-0938.2006.00015.x; Costello F, 2016, SEMIN NEUROL, V36, P185, DOI 10.1055/s-0036-1579692; Cruz-Herranz A, 2016, NEUROLOGY, V86, P2303, DOI 10.1212/WNL.0000000000002774; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; GALETTA SL, 2015, NEUR R NEUR NEUR, V2, DOI DOI 10.1212/NXI.0000000000000135; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Jasse L, 2013, MULT SCLER J, V19, P1618, DOI 10.1177/1352458513479840; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lampert EJ, 2015, J NEUROL, V262, P2491, DOI 10.1007/s00415-015-7876-3; Longbrake EE, 2016, MULT SCLER RELAT DIS, V10, P198, DOI 10.1016/j.msard.2016.10.009; Ma SL, 2002, AM J OPHTHALMOL, V133, P686, DOI 10.1016/S0002-9394(02)01337-5; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; Martinez-Lapiscina Elena H, 2014, BMC Res Notes, V7, P910, DOI 10.1186/1756-0500-7-910; Martinez-Lapiscina EH, 2014, MULT SCLER J, V20, P1207, DOI 10.1177/1352458513517591; Owidzka M, 2014, GRAEF ARCH CLIN EXP, V252, P673, DOI 10.1007/s00417-014-2590-x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Raphael BA, 2006, AM J OPHTHALMOL, V142, P1026, DOI 10.1016/j.ajo.2006.06.060; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; Salter AR, 2013, MULT SCLER J, V19, P953, DOI 10.1177/1352458512469694; Sanchez-Dalmau B, 2018, MULT SCLER J, V24, P1196, DOI 10.1177/1352458517718628; Schinzel J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-31; Sepulcre J, 2006, MULT SCLER J, V12, P187, DOI 10.1191/1352458506ms1258oa; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Villoslada P, 2012, MULT SCLER J, V18, P991, DOI 10.1177/1352458511431972; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032	30	14	14	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195856	10.1371/journal.pone.0195856	http://dx.doi.org/10.1371/journal.pone.0195856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664921	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300038
J	Taniguchi, D; LoGerfo, J; van Pelt, M; Mielcarek, B; Huster, K; Haider, M; Thomas, B				Taniguchi, Dawn; LoGerfo, James; van Pelt, Maurits; Mielcarek, Bessie; Huster, Karin; Haider, Mahri; Thomas, Bernadette			Evaluation of a multi-faceted diabetes care program including community-based peer educators in Takeo province, Cambodia, 2007-2013 (vol 12, e0181582, 2017)	PLOS ONE			English	Correction																		Taniguchi D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181582	1	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196192	10.1371/journal.pone.0196192	http://dx.doi.org/10.1371/journal.pone.0196192			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664971	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300062
J	Fischer, MCM; Eschweiler, J; Schick, F; Asseln, M; Damm, P; Radermacher, K				Fischer, Maximilian C. M.; Eschweiler, Joerg; Schick, Fabian; Asseln, Malte; Damm, Philipp; Radermacher, Klaus			Patient-specific musculoskeletal modeling of the hip joint for preoperative planning of total hip arthroplasty: A validation study based on in vivo measurements	PLOS ONE			English	Article							SIT-TO-STAND; CONTACT FORCES; REPLACEMENT PATIENTS; LOWER-EXTREMITY; LOWER-LIMB; MUSCLE; GAIT; PREDICTION; PATTERNS; SYSTEM	Validation of musculoskeletal models for application in preoperative planning is still a challenging task. Ideally, the simulation results of a patient-specific musculoskeletal model are compared to corresponding in vivo measurements. Currently, the only possibility to measure in vivo joint forces is to implant an instrumented prosthesis in patients undergoing a total joint replacement. In this study, a musculoskeletal model of the AnyBody Modeling System was adapted patient-specifically and validated against the in vivo hip joint force measurements of ten subjects performing one-leg stance and level walking. The impact of four model parameters was evaluated; hip joint width, muscle strength, muscle recruitment, and type of muscle model. The smallest difference between simulated and in vivo hip joint force was achieved by using the hip joint width measured in computed tomography images, a muscle strength of 90 N/cm(2), a third order polynomial muscle recruitment, and a simple muscle model. This parameter combination reached mean deviations between simulation and in vivo measurement during the peak force phase of 12% +/- 14% in magnitude and 11 degrees +/- 5 degrees in orientation for one-leg stance and 8% +/- 6% in magnitude and 10 degrees +/- 5 degrees in orientation for level walking.	[Fischer, Maximilian C. M.; Eschweiler, Joerg; Schick, Fabian; Asseln, Malte; Radermacher, Klaus] Rhein Westfal TH Aachen, Chair Med Engn, Helmholtz Inst Biomed Engn, Aachen, Germany; [Eschweiler, Joerg] Univ Hosp RWTH Aachen, Dept Orthopaed Surg, Aachen, Germany; [Damm, Philipp] Charite Univ Med Berlin, Julius Wolff Inst Biomech & Musculoskeletal Regen, Berlin, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fischer, MCM (corresponding author), Rhein Westfal TH Aachen, Chair Med Engn, Helmholtz Inst Biomed Engn, Aachen, Germany.	m.fischer@hia.rwth-aachen.de	Radermacher, Klaus/V-5850-2017	Radermacher, Klaus/0000-0003-4395-3197; Fischer, Maximilian/0000-0001-7832-5671; Damm, Philipp/0000-0001-8471-7284	'Instrumented Implants' team of the Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Charite-Universitatsmedizin Berlin, Germany	'Instrumented Implants' team of the Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Charite-Universitatsmedizin Berlin, Germany	We would like to thank the 'Instrumented Implants' team of the Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Charite-Universitatsmedizin Berlin, Germany for their support and access to the data of the OrthoLoad project.	Andersen MS, 2010, COMPUT METHOD BIOMEC, V13, P171, DOI 10.1080/10255840903067080; AnyBody, 2016, ANYBODY MAN MOD REP; AnyBody, 2017, ANYBODY MOD SYST; Babisch J, 2001, COMPUTER ASSISTED BI, P37; Babisch J, 2013, NAVIGATION ROBOTICS, P82, DOI [10.1007/978-3-642-59290-4_10, DOI 10.1007/978-3-642-59290-4_10]; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bergmann G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155612; Bischoff JE, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026258; Bonnin MP, 2011, HIP INT, V21, P428, DOI 10.5301/HIP.2011.8582; Corazza S, 2006, ANN BIOMED ENG, V34, P1019, DOI 10.1007/s10439-006-9122-8; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; Damm P, 2010, MED ENG PHYS, V32, P95, DOI 10.1016/j.medengphy.2009.10.003; Damsgaard M, 2006, SIMUL MODEL PRACT TH, V14, P1100, DOI 10.1016/j.simpat.2006.09.001; de Zee M, 2007, J BIOMECH, V40, P1219, DOI 10.1016/j.jbiomech.2006.05.030; Delp SL, PARAMTERS MODEL LOWE; Dendorfer S, 2008, 2138508NLPA ESA; Eschweiler J, 2012, P I MECH ENG H, V226, P955, DOI 10.1177/0954411912445261; Farahani SD, 2016, MULTIBODY SYST DYN, V36, P37, DOI 10.1007/s11044-015-9468-5; Foucher KC, 2007, J BIOMECH, V40, P3432, DOI 10.1016/j.jbiomech.2007.05.020; Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Holmberg LJ, 2012, MULTIBODY SYST DYN, V28, P283, DOI 10.1007/s11044-011-9277-4; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; Hsu J., 2017, CAOS, V1, P175; JOHNSTON RC, 1979, J BONE JOINT SURG AM, V61, P639, DOI 10.2106/00004623-197961050-00001; Kim Y, 2016, J MECH SCI TECHNOL, V30, P2891, DOI 10.1007/s12206-016-0548-0; Kinney AL, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023255; Kloster BV, 2017, PARAMETERIZING RUNNI; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Kurtz SM, 2007, J BONE JOINT SURG AM, V89A, P144, DOI 10.2106/JBJS.G.00587; Li JY, 2014, CLIN BIOMECH, V29, P747, DOI 10.1016/j.clinbiomech.2014.06.005; Lund M.E., 2015, INT BIOMECH, V2, P1, DOI [10.1080/23335432.2014.993706, DOI 10.1080/23335432.2014.993706]; Lund ME, 2012, P I MECH ENG H, V226, P82, DOI 10.1177/0954411911431516; MacInnes S.J., 2012, RECENT ADV ARTHROPLA, P275, DOI [10.5772/26975, DOI 10.5772/26975]; Maloney WJ, 2001, J BONE JOINT SURG AM, V83A, P1582, DOI 10.2106/00004623-200110000-00020; Marek C., 2005, INT S COMP SIM BIOM; McCrory JL, 2001, GAIT POSTURE, V14, P104, DOI 10.1016/S0966-6362(01)00140-0; Mellon SJ, 2015, J BIOMECH, V48, P318, DOI 10.1016/j.jbiomech.2014.11.027; Mellon SJ, 2013, P I MECH ENG H, V227, P799, DOI 10.1177/0954411913483639; Modenese L, 2011, J BIOMECH, V44, P2185, DOI 10.1016/j.jbiomech.2011.06.019; Morlock M, 2001, J BIOMECH, V34, P873, DOI 10.1016/S0021-9290(01)00035-5; OECD, 2015, HIP KNEE REPL HLTH G, P112, DOI [10.1787/health_glance-2015-36-en, DOI 10.1787/HEALTH_GLANCE-2015-36-EN]; Patil S, 2008, J ARTHROPLASTY, V23, P550, DOI 10.1016/j.arth.2007.04.035; Pedersen DR, 2005, MED ENG PHYS, V27, P323, DOI 10.1016/j.medengphy.2004.09.004; Pierrepont JW, 2016, RECONSTRUCT REV, V6, P27, DOI DOI 10.15438/RR.6.4.148; Pivec R, 2012, LANCET, V380, P1768, DOI 10.1016/S0140-6736(12)60607-2; Rasmussen J, 2001, J BIOMECH, V34, P409, DOI 10.1016/S0021-9290(00)00191-3; Stansfield BW, 2003, J BIOMECH, V36, P929, DOI 10.1016/S0021-9290(03)00072-1; Stops A, 2012, COMPUT METHOD BIOMEC, V15, P963, DOI 10.1080/10255842.2011.567983; Talis VL, 2008, CLIN BIOMECH, V23, P424, DOI 10.1016/j.clinbiomech.2007.11.010; Vanhegan IS, 2012, J BONE JOINT SURG BR, V94B, P619, DOI 10.1302/0301-620X.94B5.27073; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Weber T, 2012, P I MECH ENG H, V226, P939, DOI 10.1177/0954411912447728; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zhang X, 2015, P I MECH ENG H, V229, P477, DOI 10.1177/0954411915589115	57	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195376	10.1371/journal.pone.0195376	http://dx.doi.org/10.1371/journal.pone.0195376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649235	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900041
J	Hoffmann, B; Gruat-Henry, C; Mulinti, P; Jiang, L; Brooks, BD; Brooks, AE				Hoffmann, Bradley; Gruat-Henry, Catherine; Mulinti, Pranothi; Jiang, Long; Brooks, Benjamin D.; Brooks, Amanda E.			Using hydrodynamic focusing to predictably alter the diameter of synthetic silk fibers	PLOS ONE			English	Article							MAJOR AMPULLATE SILK; SPIDER SILK; MECHANICAL-PROPERTIES; AQUEOUS-SOLUTIONS; ARGIOPE-AURANTIA; TERMINAL DOMAIN; FIBROIN; PROTEINS; SEQUENCE; BIOMATERIALS	Spiders and silkworms provide a model of superior processing for multifunctional and highly versatile high-performance fibers. Mimicking the spider's complex control system for chemical and mechanical gradients has remained an ongoing obstacle for synthetic silk production. In this study, the use of hydrodynamic fluid focusing within a 3D printed biomimetic spinning system to recapitulate the biological spinneret is explored and shown to produce predictable, small diameter fibers. Mirroring in silico fluid flow simulations using a hydrodynamic microfluidic spinning technique, we have developed a model correlating spinning rates, solution viscosity and fiber diameter outputs that will significantly advance the field of synthetic silk fiber production. The use of hydrodynamic focusing to produce controlled output fiber diameter simulates the natural silk spinning process and continues to build upon a 3D printed biomimetic spinning platform.	[Hoffmann, Bradley; Jiang, Long] North Dakota State Univ, Dept Mech Engn, Fargo, ND USA; [Gruat-Henry, Catherine; Brooks, Benjamin D.] North Dakota State Univ, Dept Elect Engn, Fargo, ND USA; [Mulinti, Pranothi; Brooks, Amanda E.] North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	North Dakota State University Fargo; North Dakota State University Fargo; North Dakota State University Fargo	Brooks, AE (corresponding author), North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA.	Amanda.e.brooks@ndsu.edu	Mulinti, Pranothi/GLT-9446-2022	Hoffmann, Bradley/0000-0002-3855-5939	North Dakota State University Department of Mechanical Engineering; North Dakota NASA Experimental Program Stimulate Competitive Research; North Dakota Department of Commerce Phase 1 Venture grant; National Science Foundation [1746111]; North Dakota State University Department of Mechanical Engineering, ND NASA EPSCoR	North Dakota State University Department of Mechanical Engineering; North Dakota NASA Experimental Program Stimulate Competitive Research; North Dakota Department of Commerce Phase 1 Venture grant; National Science Foundation(National Science Foundation (NSF)); North Dakota State University Department of Mechanical Engineering, ND NASA EPSCoR	This work was funded by North Dakota State University Department of Mechanical Engineering, North Dakota NASA Experimental Program Stimulate Competitive Research (http://ndnasaepscor.und.edu/), the North Dakota Department of Commerce Phase 1 Venture grant (https://www.commerce.nd.gov/research/Programs/), and the National Science Foundation (grant # 1746111) (https://www.nsf.gov/).; This work was funded by North Dakota State University Department of Mechanical Engineering, ND NASA EPSCoR, the North Dakota Department of Commerce Phase 1 Venture grant and the National Science Foundation (grant # 1746111).	Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Andersson M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081290; [Anonymous], 1980, VISCOELASTIC PROPERT; Brooks AE, 2007, J APPL BIOMATER BIOM, V5, P158; Brooks AE, 2005, BIOMACROMOLECULES, V6, P3095, DOI 10.1021/bm050421e; Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p; Brooks Amanda E., 2005, V41, P1; Creager MS, 2010, BIOMACROMOLECULES, V11, P2039, DOI 10.1021/bm100399x; Cubaud T, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2911716; Doblhofer E, 2015, APPL MICROBIOL BIOT, V99, P9361, DOI 10.1007/s00253-015-6948-8; Ebrahimi D, 2015, ACS BIOMATER SCI ENG, V1, P864, DOI 10.1021/acsbiomaterials.5b00152; Eisoldt L, 2012, BIOPOLYMERS, V97, P355, DOI 10.1002/bip.22006; Eisoldt L, 2011, MATER TODAY, V14, P80, DOI 10.1016/S1369-7021(11)70057-8; Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hoffmann B, 2016, BIOMED SCI INSTRUM, V52; Hoffmann B, 2017, BIOMED SCI INSTRUM, V53; Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762; Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k; Kang E, 2011, NAT MATER, V10, P877, DOI [10.1038/nmat3108, 10.1038/NMAT3108]; Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624; Lee GB, 2006, J MICROMECH MICROENG, V16, P1024, DOI 10.1088/0960-1317/16/5/020; Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g; Luo J, 2014, INT J BIOL MACROMOL, V66, P319, DOI 10.1016/j.ijbiomac.2014.02.049; Madurga R, 2017, EUR POLYM J, V97, P26, DOI 10.1016/j.eurpolymj.2017.09.037; Madurga R, 2017, GREEN CHEM, V19, P3380, DOI 10.1039/c7gc01254c; Malay AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27573; Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J; Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3; Rising A, 2015, NAT CHEM BIOL, V11, P309, DOI [10.1038/NCHEMBIO.1789, 10.1038/nchembio.1789]; Sampath S, 2015, RSC ADV, V5, P1462, DOI 10.1039/c4ra13936d; Slotta U, 2012, CHEM ENG PROG, V108, P43; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; Tokareva O, 2014, ACTA BIOMATER, V10, P1612, DOI 10.1016/j.actbio.2013.08.020; Tow KH, 2015, 146401 ESA EPFL; Vollrath F, 2000, J Biotechnol, V74, P67; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wei W, 2011, J MATER RES, V26, P1100, DOI 10.1557/jmr.2011.47; Yan JP, 2010, BIOMACROMOLECULES, V11, P1, DOI 10.1021/bm900840h; Zhou GQ, 2009, ADV MATER, V21, P366, DOI 10.1002/adma.200800582; Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049	45	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195522	10.1371/journal.pone.0195522	http://dx.doi.org/10.1371/journal.pone.0195522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649239	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900051
J	Karjalainen, M; Kontunen, A; Saari, S; Ronkko, T; Lekkala, J; Roine, A; Oksala, N				Karjalainen, Markus; Kontunen, Anton; Saari, Sampo; Ronkko, Topi; Lekkala, Jukka; Roine, Antti; Oksala, Niku			The characterization of surgical smoke from various tissues and its implications for occupational safety	PLOS ONE			English	Article							OPERATING-ROOM; PARTICULATE MATTER; AIR-POLLUTION; TERM EXPOSURE; STROKE; RISK; CLEARANCE; PARTICLE; PLUME; LUNG	Electrosurgery produces surgical smoke. Different tissues produce different quantities and types of smoke, so we studied the particle characteristics of this surgical smoke in order to analyze the implications for the occupational health of the operation room personnel. We estimated the deposition of particulate matter (PM) from surgical smoke on the respiratory tract of operation room personnel using clinically relevant tissues from Finnish landrace porcine tissues including skeletal muscle, liver, subcutaneous fat, renal pelvis, renal cortex, lung, bronchus, cerebral gray and white matter, and skin. In order to standardize the electro-surgical cuts and smoke concentrations, we built a customized computer-controlled platform. The smoke particles were analyzed with an electrical low pressure impactor (ELPI), which measures the concentration and aerodynamic size distribution of particles with a diameter between 7 nm and 10 mu m. There were significant differences in the mass concentration and size distribution of the surgical smoke particles depending on the electrocauterized tissue. Of the various tissues tested, liver yielded the highest number of particles. In order to better estimate the health hazard, we propose that the tissues can be divided into three distinct classes according to their surgical smoke production: 1) high-PM tissue for liver; 2) medium-PM tissues for renal cortex, renal pelvis, and skeletal muscle; and 3) low PM tissues for skin, gray matter, white matter, bronchus, and subcutaneous fat.	[Karjalainen, Markus; Kontunen, Anton; Lekkala, Jukka] Tampere Univ Technol, BioMediTech Inst, Tampere, Finland; [Karjalainen, Markus; Kontunen, Anton; Lekkala, Jukka] Tampere Univ Technol, Fac Biomed Sci & Engn, Tampere, Finland; [Saari, Sampo; Ronkko, Topi] Tampere Univ Technol, Aerosol Phys, Fac Nat Sci, Tampere, Finland; [Roine, Antti] Hatanpaa Hosp, Dept Surg, Tampere, Finland; [Oksala, Niku] Univ Tampere, Div Vasc Surg, Tampere Univ Hosp, Tampere, Finland; [Oksala, Niku] Univ Tampere, Fac Med & Life Sci, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University; Tampere University Hospital; Tampere University	Karjalainen, M (corresponding author), Tampere Univ Technol, BioMediTech Inst, Tampere, Finland.; Karjalainen, M (corresponding author), Tampere Univ Technol, Fac Biomed Sci & Engn, Tampere, Finland.	markus.karjalainen@tut.fi	Roine, Antti/AAU-5071-2020; Lekkala, Jukka/G-4263-2014	Roine, Antti/0000-0002-1811-2671; Ronkko, Topi/0000-0002-1555-3367; Lekkala, Jukka/0000-0001-9293-2240; Kontunen, Anton/0000-0002-2220-1351	Finnish Foundation for Technology Promotion (TES); Tampereen Tuberkuloosisaatio (Tampere Tuberculosis Foundation); Emil Aaltonen foundation; Pirkanmaan sairaanhoitopiiri (PSHP) [9s045, 1511303, 9T044, 9U042, 150618, 9V044]	Finnish Foundation for Technology Promotion (TES); Tampereen Tuberkuloosisaatio (Tampere Tuberculosis Foundation); Emil Aaltonen foundation; Pirkanmaan sairaanhoitopiiri (PSHP)	This study was supported by grants from following foundations: Finnish Foundation for Technology Promotion (TES) to M.K., Tampereen Tuberkuloosisaatio (Tampere Tuberculosis Foundation), Emil Aaltonen foundation, and Pirkanmaan sairaanhoitopiiri (PSHP) grants 9s045, 1511303, 9T044, 9U042, 150618, and 9V044 to N. O., which were used partially for salaries for authors M.K. and A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Olfactomics Ltd did not provide any funding for the study and did not play any role in the study design.	Beelen R, 2015, ENVIRON HEALTH PERSP, V123, P525, DOI 10.1289/ehp.1408095; Bellmann B, 1994, ANN OCCUP HYG     S1, V38, P303; Bruske-Hohlfeld Irene, 2008, J Occup Med Toxicol, V3, P31, DOI 10.1186/1745-6673-3-31; Capizzi PJ, 1998, LASER SURG MED, V23, P172, DOI 10.1002/(SICI)1096-9101(1998)23:3<172::AID-LSM7>3.0.CO;2-M; Charvet A, 2015, AEROSOL SCI TECH, V49, P1263, DOI 10.1080/02786826.2015.1117568; Choi SH, 2014, SURG ENDOSC, V28, P2374, DOI 10.1007/s00464-014-3472-3; Desikan A, 2016, STROKE, V47, P2916, DOI 10.1161/STROKEAHA.116.014242; Garden JM, 2002, ARCH DERMATOL, V138, P1303, DOI 10.1001/archderm.138.10.1303; Gates MA, 2007, SCAND J WORK ENV HEA, V33, P140, DOI 10.5271/sjweh.1117; Gonzalez-Bayon L, 2006, EJSO-EUR J SURG ONC, V32, P619, DOI 10.1016/j.ejso.2006.03.019; Hill DS, 2012, J PLAST RECONSTR AES, V65, P911, DOI 10.1016/j.bjps.2012.02.012; Hinds W.C., 2012, AEROSOL TECHNOLOGY P; Hinz KP, 2011, ANAL BIOANAL CHEM, V401, P3165, DOI 10.1007/s00216-011-5465-6; KESKINEN J, 1992, J AEROSOL SCI, V23, P353, DOI 10.1016/0021-8502(92)90004-F; Krones CJ, 2007, EUR SURG, V39, P118, DOI 10.1007/s10353-006-0305-1; Le Moual N, 2013, J OCCUP ENVIRON MED, V55, P973, DOI 10.1097/JOM.0b013e318297325b; LEHNERT BE, 1989, AM J RESP CELL MOL, V1, P145, DOI 10.1165/ajrcmb/1.2.145; Lin HL, 2017, STROKE, V48, P1191, DOI [10.1161/STROKEAHA.116.015739, 10.1161/strokeaha.116.015739]; Ljungman PL, 2014, STROKE, V45, P3734, DOI 10.1161/STROKEAHA.114.003130; Maheswaran R, 2005, STROKE, V36, P239, DOI 10.1161/01.STR.0000151363.71221.12; Maheswaran R, 2011, STROKE, P43; Marjamaki M, 2005, AEROSOL SCI TECH, V39, P575, DOI 10.1080/027868291009189; Massarweh NN, 2006, J AM COLL SURGEONS, V202, P520, DOI 10.1016/j.jamcollsurg.2005.11.017; Matsuo R, 2016, STROKE, V47, P3032, DOI 10.1161/STROKEAHA.116.015303; Munro MG, 2012, SAGES MANUAL ON THE FUNDAMENTAL USE OF SURGICAL ENERGY (FUSE), P15, DOI 10.1007/978-1-4614-2074-3_2; Oberg T, 2008, AM J INFECT CONTROL, V36, P276, DOI 10.1016/j.ajic.2007.07.008; Pillinger SH, 2003, BRIT J SURG, V90, P1068, DOI 10.1002/bjs.4214; Pirjola L, 2012, ATMOS ENVIRON, V63, P156, DOI 10.1016/j.atmosenv.2012.09.022; Saari S, 2016, ATMOS ENVIRON, V126, P136, DOI 10.1016/j.atmosenv.2015.11.047; Semmler M, 2004, INHAL TOXICOL, V16, P453, DOI 10.1080/08958370490439650; Spearman J, 2007, ANN ROY COLL SURG, V89, P162, DOI 10.1308/003588407X155752; Tokar JL, 2013, GASTROINTEST ENDOSC, V78, P197, DOI 10.1016/j.gie.2013.04.164; van den Elshout S, 2014, SCI TOTAL ENVIRON, V488, P463, DOI 10.1016/j.scitotenv.2013.10.060; Wake D, 1997, ANN OCCUP HYG, V41, P636, DOI DOI 10.1093/ANNHYG/41.INHALED_PARTICLES_VIII.636; Wang HK, 2015, INT UROL NEPHROL, V47, P1671, DOI 10.1007/s11255-015-1080-3; Wardoyo A., 2012, INT J ENG SCI, V1, P161; Yli-Ojanpera J, 2010, AEROSOL AIR QUAL RES, V10, P360, DOI 10.4209/aaqr.2009.10.0060	37	40	40	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195274	10.1371/journal.pone.0195274	http://dx.doi.org/10.1371/journal.pone.0195274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649244	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900036
J	Oyebamiji, OK; Wilkinson, DJ; Jayathilake, PG; Rushton, SP; Bridgens, B; Li, BW; Zuliani, P				Oyebamiji, Oluwole K.; Wilkinson, Darren J.; Jayathilake, Pahala Gedara; Rushton, Steve P.; Bridgens, Ben; Li, Bowen; Zuliani, Paolo			A Bayesian approach to modelling the impact of hydrodynamic shear stress on biofilm deformation	PLOS ONE			English	Article							PARTICLE-SIZE ANALYSIS; DETACHMENT; GROWTH	We investigate the feasibility of using a surrogate-based method to emulate the deformation and detachment behaviour of a biofilm in response to hydrodynamic shear stress. The influence of shear force, growth rate and viscoelastic parameters on the patterns of growth, structure and resulting shape of microbial biofilms was examined. We develop a statistical modelling approach to this problem, using combination of Bayesian Poisson regression and dynamic linear models for the emulation. We observe that the hydrodynamic shear force affects biofilm deformation in line with some literature. Sensitivity results also showed that the expected number of shear events, shear flow, yield coefficient for heterotrophic bacteria and extracellular polymeric substance (EPS) stiffness per unit EPS mass are the four principal mechanisms governing the bacteria detachment in this study. The sensitivity of the model parameters is temporally dynamic, emphasising the significance of conducting the sensitivity analysis across multiple time points. The surrogate models are shown to perform well, and produced 480 fold increase in computational efficiency. We conclude that a surrogate-based approach is effective, and resulting biofilm structure is determined primarily by a balance between bacteria growth, viscoelastic parameters and applied shear stress.	[Oyebamiji, Oluwole K.; Wilkinson, Darren J.] Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jayathilake, Pahala Gedara; Bridgens, Ben] Newcastle Univ, Sch Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rushton, Steve P.] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Li, Bowen; Zuliani, Paolo] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE4 5TG, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Oyebamiji, OK (corresponding author), Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	wolemi2@yahoo.com	Oyebamiji, Oluwole/ABF-8407-2020	Oyebamiji, Oluwole/0000-0002-6561-9459; Wilkinson, Darren James/0000-0003-0736-802X; Jayathilake, Pahala Gedara/0000-0001-7691-0949; Bridgens, Benjamin/0000-0002-9461-100X	EPSRC under the Newcastle University Frontiers in Engineering Biology (NUFEB) project [EP/K039083/1]; EPSRC [EP/K039083/1] Funding Source: UKRI	EPSRC under the Newcastle University Frontiers in Engineering Biology (NUFEB) project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the EPSRC (grant No EP/K039083/1) under the Newcastle University Frontiers in Engineering Biology (NUFEB) project.	Breyers JD., 1988, PHYSL MODELS MICROBI, V2, P109; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; Celler K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03649; Chan AB, 2009, IEEE I CONF COMP VIS, P545, DOI 10.1109/ICCV.2009.5459191; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Choi YC, 2003, WATER SCI TECHNOL, V47, P69, DOI 10.2166/wst.2003.0284; Doss H, 1994, TECHNICAL REPORT; Geyer CJ, 1991, MARKOV CHAIN MONTE C, P156; Head DA, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032702; Jayathilake PG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01865; Jayathilake PG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181965; Kennedy MC, 2001, J R STAT SOC B, V63, P425, DOI 10.1111/1467-9868.00294; Kommedal R, 2003, MODELING PSEUDOMONAS, P3; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Li C, 2015, RSC ADV, V5, P79001, DOI 10.1039/c5ra11041f; Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7; Ma JM, 2006, TRANSPORT RES REC, P24, DOI 10.3141/1950-04; Martin A. D., 2005, MARKOV CHAIN MONTE C; Merkey BV, 2011, ENVIRON MICROBIOL, V13, P2435, DOI 10.1111/j.1462-2920.2011.02535.x; Ni BJ, 2009, WATER RES, V43, P1350, DOI 10.1016/j.watres.2008.12.004; Oakley JE, 2004, J R STAT SOC B, V66, P751, DOI 10.1111/j.1467-9868.2004.05304.x; Oyebamiji OK, 2017, J COMPUT SCI-NETH, V22, P69, DOI 10.1016/j.jocs.2017.08.006; Oyebamiji OK, 2015, STAT MODEL, V15, P499, DOI 10.1177/1471082X14568248; Paul E, 2012, WATER RES, V46, P5499, DOI 10.1016/j.watres.2012.07.029; Petris G, 2009, USE R, P31, DOI 10.1007/b135794_2; Picioreanu C, 2000, BIOTECHNOL BIOENG, V69, P504, DOI 10.1002/1097-0290(20000905)69:5<504::AID-BIT5>3.0.CO;2-S; Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; RITTMANN BE, 1992, WATER SCI TECHNOL, V26, P585, DOI 10.2166/wst.1992.0438; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Santner TJ, 2013, DESIGN ANAL COMPUTER; Schluter J, 2015, ISME J, V9, P139, DOI 10.1038/ismej.2014.174; Shi JQ, 2003, INT J ADAPT CONTROL, V17, P149, DOI 10.1002/acs.744; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Walter M, 2013, CHEM ENG J, V228, P1140, DOI 10.1016/j.cej.2013.05.071; Wanner O, 1996, BIOTECHNOL BIOENG, V49, P172; Wingender J., 1999, MICROBIAL EXTRACELLU, P1; Xavier JD, 2005, BIOTECHNOL BIOENG, V91, P651, DOI 10.1002/bit.20544; Young PC, 2011, TECHNOMETRICS, V53, P29, DOI 10.1198/TECH.2010.07151	39	10	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195484	10.1371/journal.pone.0195484	http://dx.doi.org/10.1371/journal.pone.0195484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649240	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900048
J	Rodger, YS; Greenbaum, G; Silver, M; Bar-David, S; Winters, G				Rodger, Yael S.; Greenbaum, Gili; Silver, Micha; Bar-David, Shirli; Winters, Gidon			Detecting hierarchical levels of connectivity in a population of Acacia tortilis at the northern edge of the species' global distribution: Combining classical population genetics and network analyses	PLOS ONE			English	Article							LARGE MAMMALIAN HERBIVORES; F-STATISTICS; CONSERVATION; DIVERSITY; NEGEV; CENTRALITY; DYNAMICS; LATITUDE; DESERT; NUMBER	Genetic diversity and structure of populations at the edge of the species' spatial distribution are important for potential adaptation to environmental changes and consequently, for the long-term survival of the species. Here, we combined classical population genetic methods with newly developed network analyses to gain complementary insights into the genetic structure and diversity of Acacia tortilis, a keystone desert tree, at the northern edge of its global distribution, where the population is under threat from climatic, ecological, and anthropogenic changes. We sampled A. tortilis from 14 sites along the Dead Sea region and the Arava Valley in Israel and in Jordan. In addition, we obtained samples from Egypt and Sudan, the hypothesized origin of the species. Samples from all sites were genotyped using six polymorphic microsatellite loci. Our results indicate a significant genetic structure in A. tortilis along the Arava Valley. This was detected at different hierarchical levels from the basic unit of the subpopulation, corresponding to groups of trees within ephemeral rivers (wadis), to groups of subpopulations (communities) that are genetically more connected relative to others. The latter structure mostly corresponds to the partition of the major drainage basins in the area. Network analyses, combined with classical methods, allowed for the identification of key A. tortilis subpopulations in this region, characterized by their relatively high level of genetic diversity and centrality in maintaining gene flow in the population. Characterizing such key subpopulations may enable conservation managers to focus their efforts on certain subpopulations that might be particularly important for the population's long-term persistence, thus contributing to species conservation within its peripheral range.	[Rodger, Yael S.; Bar-David, Shirli] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Rodger, Yael S.; Winters, Gidon] Tamar Reg Council, Dead Sea Arava Sci Ctr, Neve Zohar, Israel; [Greenbaum, Gili] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Silver, Micha] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Remote Sensing Lab, Midreshet Ben Gurion, Israel	Ben Gurion University; Stanford University; Ben Gurion University	Winters, G (corresponding author), Tamar Reg Council, Dead Sea Arava Sci Ctr, Neve Zohar, Israel.	wintersg@adssc.org	Silver, Micha/AAD-5367-2019; BAR-DAVID, SHIRLI/F-1512-2012	Silver, Micha/0000-0002-1128-1325; BAR-DAVID, SHIRLI/0000-0001-8103-041X; Winters, Gidon/0000-0001-9997-2034; Rodger, Yael/0000-0003-4248-3058				Adgaba N, 2017, SAUDI J BIOL SCI, V24, P180, DOI 10.1016/j.sjbs.2016.05.002; Allendorf F., 2007, CONSERVATION GENETIC; Ashkenazi S., 1995, ACACIA TREES NEGEV A, pXVII; Avise J, 2004, MOL MARKERS NATURAL; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Charlesworth B., 1998, MOL BIOL EVOL; Cheng E, 2014, MOL ECOL, V23, P2929, DOI 10.1111/mec.12790; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Danin A, 1999, BOT REV, V65, P93, DOI 10.1007/BF02857625; Diekmann OE, 2012, MOL ECOL, V21, P1647, DOI 10.1111/j.1365-294X.2012.05500.x; Donnelly P., 2000, GENETICS; Dyer RJ, 2004, MOL ECOL; Dyer RJ, 2015, ANNU REV ECOL EVOL S, V46, P327, DOI 10.1146/annurev-ecolsys-112414-054150; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Edge MD, 2014, THEOR POPUL BIOL, V97, P20, DOI 10.1016/j.tpb.2014.08.001; Eguiarte LE, 1999, AM J BOT; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Franssen SU, 2014, MAR GENOM, V15, P65, DOI 10.1016/j.margen.2014.03.004; Galil Y, 1972, TEVA VAARETZ, V14, P139; Gapare WJ, 2005, BIOL CONSERV, V123, P113, DOI 10.1016/j.biocon.2004.11.002; Garroway CJ, 2008, EVOL APPL, V1, P620, DOI 10.1111/j.1752-4571.2008.00047.x; Ge XJ, 2005, ANN BOT; Gibson SY, 2009, CONSERV BIOL; Ginat H., 2011, J DEAD SEA ARAV RES, V1, P1; Goldreich Yair, 2001, Israel Journal of Earth Sciences, V50, P53, DOI 10.1560/1V61-FPGF-Y5VK-ADAG; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenbaum G, 2017, MOL ECOL, V26, P2850, DOI 10.1111/mec.14059; Greenbaum G, 2016, GENETICS, V202, P1299, DOI 10.1534/genetics.115.182626; Groner E., 2017, NEGEV DEAD SEA ARAVA, V9, P1; Hackett TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052999; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; Hedrick PW., 2006, ANN REV ECOLOGY EVOL; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hubisz MJ, 2009, MOL ECOL RESOUR; Jakobsson M, 2013, GENETICS; Kark S, 2008, EVOL ECOL RES, V10, P391; KIMURA M, 1964, GENETICS, V49, P561; Klutsch CFC, 2012, CONSERV GENET; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kyalangalilwa B, 2013, BOT J LINN SOC, V172, P500, DOI 10.1111/boj.12047; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Herrera-Arroyo ML, 2013, AM J BOT, V100, P1663, DOI 10.3732/ajb.1200396; Maki M, 1999, AM J BOT; Manel S, 2013, TRENDS ECOLOGY EVOLU; Milton SJ, 1995, Z OKOLOGIE NATURSCHU, V4, P47; Mulumba John W., 2012, International Journal of Botany, V8, P107, DOI 10.3923/ijb.2012.107.116; Munwes I, 2010, MOL ECOL; Munzbergova Z, 2002, J VEG SCI; Neiva J, 2012, J BIOGEOGR, V39, P1167, DOI 10.1111/j.1365-2699.2011.02670.x; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Or K, 2003, AFR J ECOL, V41, P257, DOI 10.1046/j.1365-2028.2003.00451.x; Peakall R., 2012, BIOINFORMATICS; Peterman WE, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1231; Polak T, 2014, ANIM CONSERV, V17, P565, DOI 10.1111/acv.12122; Rohner C, 1999, CONSERV BIOL, V13, P1162, DOI 10.1046/j.1523-1739.1999.97300.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F., 2008, MOL ECOL RESOUR; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; Sheng Y, 2004, ACTA BOT SIN, V46, P675; Sher AA, 2010, J ARID ENVIRON, V74, P338, DOI 10.1016/j.jaridenv.2009.09.007; Shrestha MK, 2002, BIOL CONSERV, V108, P119, DOI 10.1016/S0006-3207(02)00100-3; Stavi I, 2014, CATENA, V114, P149, DOI 10.1016/j.catena.2013.10.006; VANOOSTERHOUT C, 2004, MOL ECOL NOTES; Wang J, 2011, ANN FOREST SCI, V68, P1143, DOI 10.1007/s13595-011-0119-6; Ward D, 1997, BIODIVERS CONSERV, V6, P877, DOI 10.1023/B:BIOC.0000010408.90955.48; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Winters G, 2015, J ARID ENVIRON, V121, P79, DOI 10.1016/j.jaridenv.2015.05.008; Winters G, 2013, CONSERV GENET RESOUR, V5, P807, DOI 10.1007/s12686-013-9913-9; Winters G, 2011, MAR ECOL PROG SER, V435, P83, DOI 10.3354/meps09213; Zaghloul M.S., 2007, CATRINA, V2, P51	74	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194901	10.1371/journal.pone.0194901	http://dx.doi.org/10.1371/journal.pone.0194901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649222	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900016
J	Schafler, ED; Thomas, PA; Ha, S; Wang, Y; Bermudez-Hernandez, K; Tang, ZJ; Fenyo, D; Vigodner, M; Logan, SK				Schafler, Eric D.; Thomas, Phillip A.; Ha, Susan; Wang, Yu; Bermudez-Hernandez, Keria; Tang, Zuojian; Fenyo, David; Vigodner, Margarita; Logan, Susan K.			UXT is required for spermatogenesis in mice	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MOUSE SPERMATOGENESIS; GENE-EXPRESSION; KIT EXPRESSION; PROTEIN; SPERMATOGONIA; TRANSCRIPTION; IDENTIFICATION; COACTIVATOR; CHROMOSOME	Male mammals must simultaneously produce prodigious numbers of sperm and maintain an adequate reserve of stem cells to ensure continuous production of gametes throughout life. Failures in the mechanisms responsible for balancing germ cell differentiation and spermatogonial stem cell (SSC) self-renewal can result in infertility. We discovered a novel requirement for Ubiquitous Expressed Transcript (UXT) in spermatogenesis by developing the first knockout mouse model for this gene. Constitutive deletion of Uxt is embryonic lethal, while conditional knockout in the male germline results in a Sertoli cell-only phenotype during the first wave of spermatogenesis that does not recover in the adult. This phenotype begins to manifest between 6 and 7 days post-partum, just before meiotic entry. Gene expression analysis revealed that Uxt deletion downregulates the transcription of genes governing SSC self-renewal, differentiation, and meiosis, consistent with its previously defined role as a transcriptional co-factor. Our study has revealed the first in vivo function for UXT in the mammalian germline as a regulator of distinct transcriptional programs in SSCs and differentiating spermatogonia.	[Schafler, Eric D.; Thomas, Phillip A.; Ha, Susan; Fenyo, David; Logan, Susan K.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA; [Schafler, Eric D.] NYU, Sch Med, Pathobiol & Translat Med Training Program, New York, NY USA; [Ha, Susan; Wang, Yu; Logan, Susan K.] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Wang, Yu] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Bermudez-Hernandez, Keria; Tang, Zuojian; Fenyo, David] NYU, Inst Syst Genet, Langone Med Ctr, New York, NY USA; [Bermudez-Hernandez, Keria; Tang, Zuojian; Fenyo, David] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Vigodner, Margarita] Yeshiva Univ, Stern Coll, Dept Biol, New York, NY 10033 USA; [Vigodner, Margarita] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA	New York University; New York University; New York University; New York University; New York University; NYU Langone Medical Center; New York University; Yeshiva University; Yeshiva University; Albert Einstein College of Medicine	Logan, SK (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA.; Logan, SK (corresponding author), NYU, Sch Med, Dept Urol, New York, NY 10003 USA.	susan.logan@nyumc.org		THOMAS, PHILLIP A/0000-0003-1704-5072; Logan, Susan/0000-0002-7904-5927	National Institutes of Health [R01CA112226]; Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [NIH/NCI P30CA016087]; NYSTEM [C026719]; NATIONAL CANCER INSTITUTE [R01CA112226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center; NYSTEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01CA112226) (SL). We would like to acknowledge the shared resources of the NYUMC Genome Technology Center, High Throughput Biology Core (HTB), Histopathology Core, and Immunohistochemistry Core, which are all partially supported by the Cancer Center Support Grant NIH/NCI P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. The HTB is also supported by NYSTEM Contract C026719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health (R01CA112226) (SL). We would like to acknowledge the shared resources of the NYUMC Genome Technology Center, High Throughput Biology Core (HTB), Histopathology Core, and Immunohistochemistry Core, which are all partially supported by the Cancer Center Support Grant NIH/NCI P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. The HTB is also supported by NYSTEM Contract C026719. We also thank David Kahler, Yuxuan Xiao, Benjamin E. Lucas, and Sanny S.W. Chung for helpful discussion.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barrios F, 2012, J CELL SCI, V125, P1455, DOI 10.1242/jcs.092593; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Busada JT, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114645; Carter DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095253; Chakraborty P, 2014, STEM CELLS, V32, P860, DOI 10.1002/stem.1584; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Coelho L.P., 2013, JORS, V1, pe3, DOI [10.5334/jors.ac, DOI 10.5334/JORS.AC]; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desimio MG, 2015, CELL CYCLE, V14, P1036, DOI 10.1080/15384101.2015.1007721; Drumond AL, 2011, REPRODUCTION, V142, P145, DOI 10.1530/REP-10-0431; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gely-Pernot A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005501; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hermann BP, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125757; Imai T, 2004, MOL CELL ENDOCRINOL, V214, P107, DOI 10.1016/j.mce.2003.10.065; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirchner J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-36; Kou Y., 2013, P INT C AVAILABILITY, P416; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; LAMPRON C, 1995, DEVELOPMENT, V121, P539; Laronda MM, 2011, ENDOCRINOLOGY, V152, P1606, DOI 10.1210/en.2010-1249; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Liao HF, 2014, DEVELOPMENT, V141, P2402, DOI 10.1242/dev.105130; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/bts690, 10.1093/bioinformatics/btt688]; Markus SM, 2002, MOL BIOL CELL, V13, P670, DOI 10.1091/mbc.01-10-0513; McGilvray R, 2007, FEBS J, V274, P3960, DOI 10.1111/j.1742-4658.2007.05928.x; MCGUINNESS MP, 1992, ANAT REC, V233, P527, DOI 10.1002/ar.1092330406; Mita P, 2011, MOL CELL BIOL, V31, P3639, DOI 10.1128/MCB.05429-11; Moss TN, 2007, IN VITRO CELL DEV-AN, V43, P139, DOI 10.1007/s11626-007-9016-6; Nwachukwu JC, 2009, CANCER RES, V69, P3140, DOI 10.1158/0008-5472.CAN-08-3738; O'Shaughnessy PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035136; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schroer A, 1999, GENOMICS, V56, P340, DOI 10.1006/geno.1998.5712; Shinoda G, 2013, STEM CELLS, V31, P1001, DOI 10.1002/stem.1343; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Su SK, 2016, J CELL SCI, V129, P2343, DOI 10.1242/jcs.185546; Sui SG, 2007, J CELL BIOL, V178, P231, DOI 10.1083/jcb.200611081; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tanaka H, 1997, INT J ANDROL, V20, P361; Taneja SS, 2004, J BIOL CHEM, V279, P13944, DOI 10.1074/jbc.M306576200; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; Vizan P, 2015, FEBS J, V282, P1723, DOI 10.1111/febs.13083; Wolgemuth DJ, 2013, INT J DEV BIOL, V57, P159, DOI 10.1387/ijdb.130047av; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195747	10.1371/journal.pone.0195747	http://dx.doi.org/10.1371/journal.pone.0195747			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649254	Green Submitted, gold, Green Published			2022-12-27	WOS:000429791900078
J	Klema, VJ; Sepuru, KM; Fullbrunn, N; Farris, TR; Dunphy, PS; McBride, JW; Rajarathnam, K; Choi, KH				Klema, Valerie J.; Sepuru, Krishna Mohan; Fullbrunn, Nadia; Farris, Tierra R.; Dunphy, Paige S.; McBride, Jere W.; Rajarathnam, Krishna; Choi, Kyung H.			Ehrlichia chaffeensis TRP120 nucleomodulin binds DNA with disordered tandem repeat domain	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; INTRINSICALLY UNSTRUCTURED PROTEINS; RECOMBINANT 120-KILODALTON PROTEIN; SEQUENCE-SPECIFIC RECOGNITION; AMINO-ACID-SEQUENCE; TAL EFFECTORS; TRANSCRIPTION FACTOR; SERVER; PROTEOMICS; REGIONS	Ehrlichia chaffeensis, the causative agent of human monocytotropic ehrlichiosis, secretes several effector proteins that bind host DNA to modulate host gene expression. The tandem repeat protein 120 (TRP120), one of the largest effector proteins, has four nearly identical tandem repeat (TR) regions that each consists of 80 amino acids. In addition to playing a role in ehrlichial binding and internalization, TRP120 translocates to the host nucleus where it is thought to function as a transcription factor that modulates gene expression. However, sequence analysis of TRP120 does not identify the presence of DNA-binding or trans-activation domains typical of classical eukaryotic transcription factors. Thus, the mechanism by which TRP120 binds DNA and modulates gene expression remains elusive. Herein, we expressed the TR regions of the TRP120 protein, and characterized its solution structure and ability to bind DNA. TRP120, expressed as either a one or two TR repeat, is a monomer in solution, and is mostly disordered as determined by circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy. Using NMR spectroscopy, we further show that the 1 TR construct selectively binds GC-rich DNA. Although low pH was required for TRP120 TR-DNA interaction, acidic pH alone does not induce any significant structural changes in the TR region. This suggests that TRP120 folds into an ordered structure upon forming a protein-DNA complex, and thus folding of TRP120 TR is coupled with DNA binding.	[Klema, Valerie J.; Sepuru, Krishna Mohan; Fullbrunn, Nadia; Rajarathnam, Krishna; Choi, Kyung H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Farris, Tierra R.; Dunphy, Paige S.; McBride, Jere W.] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Choi, KH (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.	kychoi@utmb.edu	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	Sealy and Smith Foundation; University of Texas Medical Branch SCBMB-IHII pilot grant; National Institute of Allergy and Infectious Diseases [AI106859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106859] Funding Source: NIH RePORTER	Sealy and Smith Foundation; University of Texas Medical Branch SCBMB-IHII pilot grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Sealy and Smith Foundation grant to the Sealy Center for Structural Biology and Molecular Biophysics, a University of Texas Medical Branch SCBMB-IHII pilot grant (to KHC and JWM) and National Institute of Allergy and Infectious Diseases grant AI106859 (JWM).	ANDERSON BE, 1992, J CLIN MICROBIOL, V30, P775, DOI 10.1128/JCM.30.4.775-780.1992; ANDERSON BE, 1993, AM J TROP MED HYG, V49, P239, DOI 10.4269/ajtmh.1993.49.239; ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Barnewall RE, 1997, INFECT IMMUN, V65, P1455, DOI 10.1128/IAI.65.4.1455-1461.1997; Blane A, 2015, BIOCHEMISTRY-US, V54, P4001, DOI 10.1021/acs.biochem.5b00155; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dunphy PS, 2013, MICROBES INFECT, V15, P1005, DOI 10.1016/j.micinf.2013.09.011; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Farris TR, 2016, INFECT IMMUN, V84, P3182, DOI 10.1128/IAI.00657-16; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Heitman KN, 2016, AM J TROP MED HYG, V94, P52, DOI 10.4269/ajtmh.15-0540; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KRIWACKI RW, 1992, P NATL ACAD SCI USA, V89, P9759, DOI 10.1073/pnas.89.20.9759; Lina TT, 2016, MBIO, V7, DOI 10.1128/mBio.00672-16; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Luo T, 2011, INFECT IMMUN, V79, P4382, DOI 10.1128/IAI.05608-11; Mak ANS, 2013, CURR OPIN STRUC BIOL, V23, P93, DOI 10.1016/j.sbi.2012.11.001; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mikles DC, 2013, FEBS J, V280, P3669, DOI 10.1111/febs.12360; Olano JR, 2003, EMERG INFECT DIS, V9, P1579, DOI 10.3201/eid0912.020733; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Wakeel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009552; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Yu XJ, 1996, J CLIN MICROBIOL, V34, P2853, DOI 10.1128/JCM.34.11.2853-2855.1996; Yu XJ, 2000, J CLIN MICROBIOL, V38, P369; Zhu B, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00290-17, 10.1128/iai.00290-17]; Zhu B, 2011, INFECT IMMUN, V79, P4370, DOI 10.1128/IAI.05422-11	43	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194891	10.1371/journal.pone.0194891	http://dx.doi.org/10.1371/journal.pone.0194891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641592	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900054
J	Le Blay, K; Preau, L; Morvan-Dubois, G; Demeneix, B				Le Blay, Karine; Preau, Laetitia; Morvan-Dubois, Ghislaine; Demeneix, Barbara			Expression of the inactivating deiodinase, Deiodinase 3, in the pre-metamorphic tadpole retina	PLOS ONE			English	Article							THYROID-HORMONE RECEPTOR; CONE OPSIN EXPRESSION; XENOPUS-LAEVIS; RAINBOW-TROUT; ULTRAVIOLET PHOTOSENSITIVITY; AMPHIBIAN METAMORPHOSIS; EYE DEVELOPMENT; PHOTORECEPTORS; DISRUPTION; THYROXINE	Thyroid hormone (TH) orchestrates amphibian metamorphosis. Thus, this developmental phase is often used to study TH-dependent responses in specific tissues. However, TH signaling appears early in development raising the question of the control of TH availability in specific cell types prior to metamorphosis. TH availability is under strict temporal and tissue-specific control by deiodinases. We examined the expression of the TH-inactivating enzyme, deiodinase type 3 (D3), during early retinal development. To this end we created a Xenopus laevis transgenic line expressing GFP from the Xenopus dio3 promoter region (pdio3) and followed pdio3-GFP expression in pre-metamorphic tadpoles. To validate retinal GFP expression in the transgenic line as a function of dio3 promoter activity, we used in situ hybridization to compare endogenous dio3 expression to reporter-driven GFP activity. Retinal expression of dio3 increased during pre-metamorphosis through stages NF41, 45 and 48. Both sets of results show dio3 to have cell-specific, dynamic expression in the pre-metamorphic retina. At stage NF48, dio3 expression co-localised with markers for photoreceptors, rods, Opsin-S cones and bipolar neurons. In contrast, in post-metamorphic juveniles dio3 expression was reduced and spatially confined to certain photoreceptors and amacrine cells. We compared dio3 expression at stages NF41 and NF48 with TH-dependent transcriptional responses using another transgenic reporter line: THbZIP-GFP and by analyzing the expression of T-3-regulated genes in distinct TH availability contexts. At stage NF48, the majority of retinal cells expressing dio3 were negative for T-3 signaling. Notably, most ganglion cells were virtually both dio3-free and T-3-responsive. The results show that dio3 can reduce TH availability at the cellular scale. Further, a reduction in dio3 expression can trigger fine-tuned T-3 action in cell-type specific maturation at the right time, as exemplified here in photoreceptor survival in the pre-metamorphic retina.	[Le Blay, Karine; Morvan-Dubois, Ghislaine; Demeneix, Barbara] Museum Natl Hist Nat, UMR CNRS, Dept Adaptat Vivant, Evolut Regulat Endocriniennes, Paris, France; [Preau, Laetitia] KIT, Zool Inst, Zell & Entwicklungsbiol, Karlsruhe, Germany; [Morvan-Dubois, Ghislaine] UPMC, Neurosci Paris Seine IBPS, Sorbonne Univ, CNRS UMR8246,Inserm U1130, Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Helmholtz Association; Karlsruhe Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Le Blay, K; Morvan-Dubois, G; Demeneix, B (corresponding author), Museum Natl Hist Nat, UMR CNRS, Dept Adaptat Vivant, Evolut Regulat Endocriniennes, Paris, France.; Morvan-Dubois, G (corresponding author), UPMC, Neurosci Paris Seine IBPS, Sorbonne Univ, CNRS UMR8246,Inserm U1130, Paris, France.	le.blay@mnhn.fr; ghislaine.morvan-dubois@upmc.fr; bdem@mnhn.fr	morvan-dubois, ghislaine/AAI-1765-2019	Morvan-Dubois, ghislaine/0000-0003-1285-9130	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); French ANR "Thrast"; Agence Nationale de la Recherche [11BSV2019 02]; PERSU grant [SU-14-R-PERSU-04]; French Ministry of Research and Education; PERSU grant (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche) [SU-14-R-PERSU-04]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle (MNHN); French ANR "Thrast"(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); PERSU grant; French Ministry of Research and Education; PERSU grant (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Museum National d'Histoire Naturelle (MNHN), the French ANR "Thrast," Agence Nationale de la Recherche (11BSV2019 02) and a PERSU grant (SU-14-R-PERSU-04) to BAD. Laetitia Preau received a PhD grant from the French Ministry of Research and Education and support from the PERSU grant (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche) (SU-14-R-PERSU-04) to BAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Alvarez-Hernan G, 2013, SCI WORLD J, DOI 10.1155/2013/740420; Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; Bessodes N, 2017, NEURAL DEV, V12, DOI 10.1186/s13064-017-0093-2; Bilitou A, 2010, DEV DYNAM, V239, P727, DOI 10.1002/dvdy.22223; BROWMAN HI, 1992, VISION RES, V32, P2303, DOI 10.1016/0042-6989(92)90094-Y; BROWMAN HI, 1994, VISION RES, V34, P1397, DOI 10.1016/0042-6989(94)90139-2; Brown DD, 2005, THYROID, V15, P815, DOI 10.1089/thy.2005.15.815; Cabochette P, 2015, ELIFE, V4, DOI 10.7554/eLife.08488; Chang WS, 1998, J NEUROBIOL, V35, P227; Cossette SMM, 2004, DIFFERENTIATION, V72, P239, DOI 10.1111/j.1432-0436.2004.07205006.x; D'Autilia S, 2006, DEV GENES EVOL, V216, P829, DOI 10.1007/s00427-006-0109-0; Darras VM, 1998, ANN NY ACAD SCI, V839, P80, DOI 10.1111/j.1749-6632.1998.tb10736.x; Dullin JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-110; Fini JB, 2012, ENDOCRINOLOGY, V153, P5068, DOI 10.1210/en.2012-1463; Fini JB, 2007, ENVIRON SCI TECHNOL, V41, P5908, DOI 10.1021/es0704129; Harpavat S, 2003, THYROID, V13, P1013, DOI 10.1089/105072503770867183; Havis E, 2006, EMBO J, V25, P4943, DOI 10.1038/sj.emboj.7601356; Houbrechts AM, 2016, ENDOCRINOLOGY, V157, P3668, DOI 10.1210/en.2016-1077; Houbrechts AM, 2016, MOL CELL ENDOCRINOL, V424, P81, DOI 10.1016/j.mce.2016.01.018; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Ma HW, 2016, ADV EXP MED BIOL, V854, P613, DOI 10.1007/978-3-319-17121-0_81; Mader M, 2006, MOL VIS, V12, P915; Marsh-Armstrong N, 1999, NEURON, V24, P871, DOI 10.1016/S0896-6273(00)81034-X; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Nunez J, 2008, MOL CELL ENDOCRINOL, V287, P1, DOI 10.1016/j.mce.2008.03.006; Parker RO, 2010, ANAT REC, V293, P383, DOI 10.1002/ar.21079; Pessoa CN, 2008, INVEST OPHTH VIS SCI, V49, P2039, DOI 10.1167/iovs.07-0908; Preau L, 2016, MOL CELL ENDOCRINOL, V420, P138, DOI 10.1016/j.mce.2015.11.026; Raine JC, 2010, J EXP BIOL, V213, P493, DOI 10.1242/jeb.036301; Raine JC, 2009, J EXP BIOL, V212, P2781, DOI 10.1242/jeb.030866; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; SJOBERG M, 1992, DEVELOPMENT, V114, P39; Tata JR, 2006, MOL CELL ENDOCRINOL, V246, P10, DOI 10.1016/j.mce.2005.11.024; Turque N, 2005, ENVIRON HEALTH PERSP, V113, P1588, DOI 10.1289/ehp.7992; Wong LL, 2009, DEVELOPMENT, V136, P1707, DOI 10.1242/dev.027607	39	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195374	10.1371/journal.pone.0195374	http://dx.doi.org/10.1371/journal.pone.0195374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641587	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900066
J	Schmitt, DL; Sundaram, A; Jeon, M; Luu, BT; An, S				Schmitt, Danielle L.; Sundaram, Anand; Jeon, Miji; Bao Tran Luu; An, Songon			Spatial alterations of De Novo purine biosynthetic enzymes by Akt-independent PDK1 signaling pathways	PLOS ONE			English	Article							MULTIENZYME COMPLEX; GLUCOSE-METABOLISM; LIVING CELLS; GROWTH; INHIBITION; PURINOSOME; ACTIVATION; S6K1	A macromolecular complex of the enzymes involved in human de novo purine biosynthesis, the purinosome, has been shown to consist of a core assembly to regulate the metabolic activity of the pathway. However, it remains elusive whether the core assembly itself can be selectively controlled in the cytoplasm without promoting the purinosome. Here, we reveal that pharmacological inhibition of the cytoplasmic activity of 3-phosphoinositide-dependent protein kinase 1 (PDK1) selectively promotes the formation of the core assembly, but not the purinosome, in cancer cells. However, alternative signaling cascades that are associated with the plasma membrane-bound PDK1 activity, including Akt-mediated cascades, regulate neither the core assembly nor the purinosome in our conditions. Along with immunofluorescence microscopy and a knock-down study against PDK1 using small interfering RNAs, we reveal that cytoplasmic PDK1-associated signaling pathways regulate subcellular colocalization of three enzymes that form the core assembly of the purinosome in an Akt-independent manner. Collectively, this study reveals a new mode of compartmentalization of purine biosynthetic enzymes controlled by spatially resolved signaling pathways.	[Schmitt, Danielle L.; Sundaram, Anand; Jeon, Miji; Bao Tran Luu; An, Songon] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	An, S (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA.	san@umbc.edu		Schmitt, Danielle/0000-0002-7343-2125; An, Songon/0000-0003-2189-7374	UMBC; NIH/NIGMS Training Grant [T32GM066706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706, R01GM125981] Funding Source: NIH RePORTER	UMBC; NIH/NIGMS Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank UMBC for providing the start-up fund (to S.A). D.L.S., AS., and M.J. were funded in part by NIH/NIGMS Training Grant (T32GM066706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Arsenic R, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-82; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Deng YJ, 2012, J BIOL CHEM, V287, P36201, DOI 10.1074/jbc.M112.407056; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; Fyffe Chanse, 2013, Cancer Manag Res, V5, P271, DOI 10.2147/CMAR.S35026; Gagliardi PA, 2012, NEOPLASIA, V14, P719, DOI 10.1593/neo.12856; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Henderson JF, 1972, REGULATION PURINE BI; Jeon M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20348-7; Kohnhorst CL, 2017, J BIOL CHEM, V292, P9191, DOI 10.1074/jbc.M117.783050; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Kyoung M, 2015, BIOCHEMISTRY-US, V54, P870, DOI 10.1021/bi501480d; McLeod HL, 2000, CLIN CANCER RES, V6, P2677; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pedley AM, 2017, TRENDS BIOCHEM SCI, V42, P141, DOI 10.1016/j.tibs.2016.09.009; Schmitt DL, 2017, BIOCHEMISTRY-US, V56, P3184, DOI 10.1021/acs.biochem.7b00249; Schmitt DL, 2016, ACS CHEM BIOL, V11, P1917, DOI 10.1021/acschembio.6b00039; Scortegagna M, 2014, ONCOGENE, V33, P4330, DOI 10.1038/onc.2013.383; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Yamaoka T, 2001, J BIOL CHEM, V276, P21285, DOI 10.1074/jbc.M011103200; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Zhao H, 2015, J BIOL CHEM, V290, P6705, DOI 10.1074/jbc.M114.628701	31	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195989	10.1371/journal.pone.0195989	http://dx.doi.org/10.1371/journal.pone.0195989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668719	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200072
J	Boraas, LC; Pineda, ET; Ahsan, T				Boraas, Liana C.; Pineda, Emma T.; Ahsan, Tabassum			Actin and myosin II modulate differentiation of pluripotent stem cells	PLOS ONE			English	Article							SHEAR-STRESS; CYTOSKELETAL TENSION; MATRIX ELASTICITY; GENE-EXPRESSION; BINDING; SHAPE; RHOA	Use of stem cell-based therapies in tissue engineering and regenerative medicine is hindered by efficient means of directed differentiation. For pluripotent stem cells, an initial critical differentiation event is specification to one of three germ lineages: endoderm, mesoderm, and ectoderm. Differentiation is known to be regulated by numerous extracellular and intracellular factors, but the role of the cytoskeleton during specification, or early differentiation, is still unknown. In these studies, we used agonists and antagonists to modulate actin polymerization and the actin-myosin molecular motor during spontaneous differentiation of embryonic stem cells in embryoid bodies. We found that inhibiting either actin polymerization or actin-myosin interactions led to a decrease in differentiation to the mesodermal lineage and an increase in differentiation to the endodermal lineage. Thus, targeting processes that regulate cytoskeletal tension may be effective in enhancing or inhibiting differentiation towards cells of the endodermal or mesodermal lineages, which include hepatocytes, islets, cardiomyocytes, endothelial cells, and osteocytes. Therefore, these fundamental findings demonstrate that modulation of the cytoskeleton may be useful in production for a range of cell-based therapies, including for liver, pancreatic, cardiac, vascular, and orthopedic applications.	[Boraas, Liana C.; Pineda, Emma T.; Ahsan, Tabassum] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Ahsan, Tabassum] RoosterBio Inc, Frederick, MD 21703 USA	Tulane University	Ahsan, T (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.; Ahsan, T (corresponding author), RoosterBio Inc, Frederick, MD 21703 USA.	taby.ahsan@gmail.com		Ahsan, Tabassum/0000-0001-8679-0346	National Institutes of Health [P20 GM103629]; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health #P20 GM103629 (TA). The NIH provided support in the form of salaries for authors [LCB, ETP, TA], but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RoosterBio Inc. is the current affiliation of the senior author but did not fund any part of this study.; This work was funded by the National Institutes of Health (#P20 GM103629). The authors have no conflict of interest to report.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Bao X, 2016, NATURE BIOMEDICAL EN, V1; Boraas LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30814; Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Cooper G. M., 2000, CELL MOL APPROACH, DOI DOI 10.1007/978-1-4615-6484-3_4; Daniels BR, 2010, BIOPHYS J, V99, P3563, DOI 10.1016/j.bpj.2010.10.007; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng TS, 2010, STEM CELL REV REP, V6, P74, DOI 10.1007/s12015-010-9115-8; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0; GODDETTE DW, 1985, BIOCHEM BIOPH RES CO, V128, P1087, DOI 10.1016/0006-291X(85)91051-4; Han YL, 2014, DRUG DISCOV TODAY, V19, P763, DOI 10.1016/j.drudis.2014.01.015; Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745; Heo J, 2005, BIOCHEM BIOPH RES CO, V332, P1061, DOI 10.1016/j.bbrc.2005.04.173; INGBER DE, 1993, J CELL SCI, V104, P613; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Liedert A., 2005, MECHANOSENSITIVITY C; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Luo W, 2011, ACTA BIOCH BIOPH SIN, V43, P210, DOI 10.1093/abbs/gmr004; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McKee C, 2017, TISSUE ENG A; Pineda ET, 2013, CELLS TISSUES ORGANS, V197, P399, DOI 10.1159/000346166; Pourati J, 1998, AM J PHYSIOL-CELL PH, V274, pC1283, DOI 10.1152/ajpcell.1998.274.5.C1283; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306; Teramura T, 2012, BIOCHEM BIOPH RES CO, V417, P836, DOI 10.1016/j.bbrc.2011.12.052; Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Walker A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1074; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Wolfe RP, 2013, BIOTECHNOL BIOENG, V110, P1231, DOI 10.1002/bit.24782; Wolfe RP, 2012, INTEGR BIOL-UK, V4, P1263, DOI 10.1039/c2ib20040f	44	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195588	10.1371/journal.pone.0195588	http://dx.doi.org/10.1371/journal.pone.0195588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664925	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300022
J	Mbondji-Wonje, C; Dong, M; Wang, X; Zhao, JQ; Ragupathy, V; Sanchez, AM; Denny, TN; Hewlett, I				Mbondji-Wonje, Christelle; Dong, Ming; Wang, Xue; Zhao, Jiangqin; Ragupathy, Viswanath; Sanchez, Ana M.; Denny, Thomas N.; Hewlett, Indira			Distinctive variation in the U3R region of the 5 ' Long Terminal Repeat from diverse HIV-1 strains	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; CELLULAR TRANSCRIPTION FACTOR; BINDING PROTEINS; GENE-EXPRESSION; TYPE-1 SUBTYPES; FUNCTIONAL INTERACTIONS; DISEASE PROGRESSION; SEQUENCE ELEMENTS; NUCLEAR FACTOR	Functional mapping of the 5'LTR has shown that the U3 and the R regions (U3R) contain a cluster of regulatory elements involved in the control of HIV-1 transcription and expression. As the HIV-1 genome is characterized by extensive variability, here we aimed to describe mutations in the U3R from various HIV-1 clades and CRFs in order to highlight strain specific differences that may impact the biological properties of diverse HIV-1 strains. To achieve our purpose, the U3R sequence of plasma derived virus belonging to different clades (A1, B, C, D, F2) and recombinants (CRF02_AG, CRF01_AE and CRF22_01A1) was obtained using Illumina technology. Overall, the R region was very well conserved among and across different strains, while in the U3 region the average inter-strains nucleotide dissimilarity was up to 25%. The TAR hairpin displayed a strain-distinctive cluster of mutations affecting the bulge and the loop, but mostly the stem. Like in previous studies we found a TATAA motif in U3 promoter region from the majority of HIV-1 strains and a TAAAA motif in CRF01_AE; but also in LTRs from CRF22_01A1 isolates. Although LTRs from CRF22_01A1 specimens were assigned CRF01_AE, they contained two NF-kB sites instead of the single TFBS described in CRF01_AE. Also, as previously describe in clade C isolates, we found no C/EBP binding site directly upstream of the enhancer region in CRF22_01A1 specimens. In our study, one-third of CRF02_AG LTRs displayed three NF-kB sites which have been mainly described in clade C isolates. Overall, the number, location and binding patterns of potential regulatory elements found along the U3R might be specific to some HIV-1 strains such as clade F2, CRF02_AG, CRF01_AE and CRF22_01A1. These features may be worth consideration as they may be involved in distinctive regulation of HIV-1 transcription and replication by different and diverse infecting strains.	[Mbondji-Wonje, Christelle; Wang, Xue; Zhao, Jiangqin; Ragupathy, Viswanath; Hewlett, Indira] US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Mbondji-Wonje, Christelle] Univ Douala, Dept Mol Biol, Fac Med Pharm & Biomed Sci, Douala, Cameroon; [Dong, Ming] US Mil HIV Res Program, Silver Spring, MD USA; [Sanchez, Ana M.; Denny, Thomas N.] Duke Univ, Med Ctr, Dept Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Mbondji-Wonje, Christelle; Hewlett, Indira] US FDA, Mol Virol Lab, CBER, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); Walter Reed Army Institute of Research (WRAIR); Duke University; US Food & Drug Administration (FDA)	Mbondji-Wonje, C; Hewlett, I (corresponding author), US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.; Mbondji-Wonje, C (corresponding author), Univ Douala, Dept Mol Biol, Fac Med Pharm & Biomed Sci, Douala, Cameroon.; Mbondji-Wonje, C; Hewlett, I (corresponding author), US FDA, Mol Virol Lab, CBER, Silver Spring, MD 20993 USA.	Christelle.mbondji@fda.hhs.gov; Indira.hewlett@fda.hhs.gov	mbondji, christelle/Q-3145-2019; Ragupathy, Viswanath/ABA-3444-2021	mbondji, christelle/0000-0001-7222-9849; Zhao, Jiangqin/0000-0003-4672-0735; Denny, Thomas/0000-0002-7364-8276	National Heart, Lung, and Blood Institute (NHLBI) [A-HL-12-002]; Division of AIDS/National Institute of Allergy and Infectious Diseases [AAI 17073, HHSN272201700061C]; NHLBI [A-HL-12-002]; NIAID/DAIDS [AAI 17073]; EQAPOL/Duke University (NIH/DAIDS) [HHSN272201700061C]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of AIDS/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID/DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EQAPOL/Duke University (NIH/DAIDS)	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI) (IAA No A-HL-12-002), https://www.nhlbi.nih.gov/; Division of AIDS/National Institute of Allergy and Infectious Diseases: IAA No AAI 17073; HHSN272201700061C, https://www.niaid.nih.goviabout/daids. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge NHLBI (IAA No A-HL-12-002), NIAID/DAIDS (IAA No AAI 17073) for funding this project, EQAPOL/Duke University (NIH/DAIDS Contract No. HHSN272201700061C) for providing genetically diverse viral isolates and New-York University for providing plasma sample used to generate additional viral isolates for this project. The authors would also want to thank Corinna Lin, Andrew Hwang, Alex Sposito, Krishnakumar Devadas and Mohan Haleyurgirisetty for their help and revision of this manuscript.	Agyingi L, 2014, J MED VIROL, V86, P385, DOI 10.1002/jmv.23846; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Argyropoulos C, 2004, GENES IMMUN, V5, P16, DOI 10.1038/sj.gene.6364034; Bachu M, 2012, J BIOL CHEM, V287, P44714, DOI 10.1074/jbc.M112.397158; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Bassuk AG, 1997, J VIROL, V71, P3563, DOI 10.1128/JVI.71.5.3563-3573.1997; Beerens N, 2000, NUCLEIC ACIDS RES, V28, P4130, DOI 10.1093/nar/28.21.4130; Beerens N, 2000, J VIROL, V74, P2227, DOI 10.1128/JVI.74.5.2227-2238.2000; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; BERKHOUT B, 1995, VIROLOGY, V207, P276, DOI 10.1006/viro.1995.1077; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; Burdo TH, 2004, DNA CELL BIOL, V23, P261, DOI 10.1089/104454904773819842; Churchill MJ, 2001, AIDS RES HUM RETROV, V17, P1481, DOI 10.1089/08892220152644188; Colin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019084; Courtney CR, 2016, AIDS RES HUM RETROV, V32, P381, DOI 10.1089/aid.2015.0286; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dahiya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088116; De Arellano ER, 2005, AIDS RES HUM RETROV, V21, P949, DOI 10.1089/aid.2005.21.949; De Baar MP, 2000, AIDS RES HUM RETROV, V16, P499; DIFAGAGNA FD, 1995, J VIROL, V69, P2765, DOI 10.1128/JVI.69.5.2765-2775.1995; Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498; Duverger A, 2013, J VIROL, V87, P2264, DOI 10.1128/JVI.01594-12; ELKHARROUBI A, 1994, J BIOL CHEM, V269, P19916; Estable MC, 2007, INT J BIOL SCI, V3, P318; Estable MC, 1996, J VIROL, V70, P4053, DOI 10.1128/JVI.70.6.4053-4062.1996; Estable MC, 1998, J VIROL, V72, P6465, DOI 10.1128/JVI.72.8.6465-6474.1998; Estable MC, 1999, J BIOMED SCI, V6, P320, DOI 10.1007/BF02253521; Forns X, 1997, P NATL ACAD SCI USA, V94, P13909, DOI 10.1073/pnas.94.25.13909; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GARCIA JA, 1989, EMBO J, V8, P765, DOI 10.1002/j.1460-2075.1989.tb03437.x; GAYNOR R, 1992, AIDS, V6, P347, DOI 10.1097/00002030-199204000-00001; GAYNOR RB, 1995, CURR TOP MICROBIOL, V193, P51; Gonzalez-Alba JM, 2011, J VIROL, V85, P10755, DOI 10.1128/JVI.00454-11; Guimaraes ML, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-19; Gustavson MD, 2004, MOL CARCINOGEN, V41, P125, DOI 10.1002/mc.20049; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; HOLZMEISTER J, 1993, BIOCHEM BIOPH RES CO, V197, P1229, DOI 10.1006/bbrc.1993.2608; Hora B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157340; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; JONES KA, 1988, GENE DEV, V2, P1101, DOI 10.1101/gad.2.9.1101; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Keller M, 2009, AIDS, V23, P731, DOI 10.1097/QAD.0b013e328326f77f; Kilareski EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118; Kingsman SM, 1996, EUR J BIOCHEM, V240, P491, DOI 10.1111/j.1432-1033.1996.0491h.x; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Kiwanuka N, 2009, AIDS, V23, P2479, DOI 10.1097/QAD.0b013e328330cc08; Kozaczynska K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-59; Krebs F., 2001, HIV SEQUENCE COMPEND, P29; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8; Kurosu T, 2002, MICROBIOL IMMUNOL, V46, P787, DOI 10.1111/j.1348-0421.2002.tb02766.x; Kurosu T, 2001, AIDS RES HUM RETROV, V17, P863, DOI 10.1089/088922201750252061; Leal E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011833; Li YJ, 2014, AIDS, V28, P521, DOI 10.1097/QAD.0000000000000125; Liu YJ, 2010, BIOMED PHARMACOTHER, V64, P672, DOI 10.1016/j.biopha.2010.09.007; Liu Y, 2009, FUTURE MICROBIOL, V4, P299, DOI 10.2217/FMB.09.4; Liu YZ, 1997, BIOCHEM J, V322, P155, DOI 10.1042/bj3220155; Madge B., 2009, ENCY CANC, P947; MARKOVITZ DM, 1992, J VIROL, V66, P3961, DOI 10.1128/JVI.66.6.3961-3965.1992; McAllister JJ, 2000, VIROLOGY, V274, P262, DOI 10.1006/viro.2000.0476; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MONDAL D, 1994, J MOL NEUROSCI, V5, P241, DOI 10.1007/BF02736725; Montano MA, 1996, P NATL ACAD SCI USA, V93, P12376, DOI 10.1073/pnas.93.22.12376; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; MOSES AV, 1994, J VIROL, V68, P298, DOI 10.1128/JVI.68.1.298-307.1994; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Naghavi MH, 2001, J GEN VIROL, V82, P547, DOI 10.1099/0022-1317-82-3-547; Nonnemacher MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150835; Nonnemacher MR, 2004, J NEUROIMMUNOL, V157, P39, DOI 10.1016/j.jneuroim.2004.08.021; Ou S-HI, 1995, THE RETROVIRIDAE, P97; OU SHI, 1994, J VIROL, V68, P7188, DOI 10.1128/JVI.68.11.7188-7199.1994; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Palm AA, 2015, AIDS RES HUM RETROV, V31, P938, DOI [10.1089/aid.2015.0073, 10.1089/AID.2015.0073]; PALMER S, 1993, CLIN EXP IMMUNOL, V93, P344, DOI 10.1111/j.1365-2249.1993.tb08183.x; Panagoulias I, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.3477.3477; Pereira LA, 2002, J BIOMED SCI, V9, P68; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; PERKINS ND, 1994, J VIROL, V68, P6820, DOI 10.1128/JVI.68.10.6820-6823.1994; Powell RLR, 2009, JAIDS-J ACQ IMM DEF, V50, P84, DOI 10.1097/QAI.0b013e31818d5a40; Qu D, 2016, SCI REP-UK, V6, DOI 10.1038/srep34532; Ragupathy V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-185; Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23; Rodriguez MA, 2007, AIDS RES HUM RETROV, V23, P1428, DOI 10.1089/aid.2007.0152; ROEBUCK KA, 1993, J CLIN INVEST, V92, P1336, DOI 10.1172/JCI116707; Romanchikova N, 2003, IMMUNOBIOLOGY, V208, P361, DOI 10.1078/0171-2985-00283; Ross HL, 2001, J VIROL, V75, P1842, DOI 10.1128/JVI.75.4.1842-1856.2001; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; Sanchez AM, 2014, J IMMUNOL METHODS, V409, P117, DOI 10.1016/j.jim.2014.01.004; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schwartz C, 2000, J VIROL, V74, P65, DOI 10.1128/JVI.74.1.65-73.2000; Schwartz C, 1997, NUCLEIC ACIDS RES, V25, P1177, DOI 10.1093/nar/25.6.1177; Shah S, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-92; SHERIDAN PL, 1995, GENE DEV, V9, P2090, DOI 10.1101/gad.9.17.2090; Shiino T, 2014, C RETR OPP INF CROI; Sierra M, 2005, GENETICS EVOLUTION, V5, P209, DOI [10.1016/j.meegid.2004.07.010, DOI 10.1016/J.MEEGID.2004.07.010]; Stojanova A, 2004, J CELL BIOCHEM, V92, P400, DOI 10.1002/jcb.20065; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Terme JM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-81; TESMER VM, 1993, P NATL ACAD SCI USA, V90, P7298, DOI 10.1073/pnas.90.15.7298; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; VANLINT C, 1991, J VIROL, V65, P7066, DOI 10.1128/JVI.65.12.7066-7072.1991; Vemula SV, 2015, VIRUSES-BASEL, V7, P543, DOI 10.3390/v7020543; Verhoef K, 1999, J VIROL, V73, P1331, DOI 10.1128/JVI.73.2.1331-1340.1999; Verma A, 2016, J VIROL, V90, P7046, DOI 10.1128/JVI.00308-16; Vrolijk MM, 2008, NUCLEIC ACIDS RES, V36, P4352, DOI 10.1093/nar/gkn364; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; YAMAMOTO K, 1991, NUCLEIC ACIDS RES, V19, P6107, DOI 10.1093/nar/19.22.6107; YANG ZY, 1993, NUCLEIC ACIDS RES, V21, P2831, DOI 10.1093/nar/21.12.2831; Zhao JQ, 2012, JAIDS-J ACQ IMM DEF, V60, P344, DOI 10.1097/QAI.0b013e318258c7e3; Zhao JQ, 2010, AIDS RES HUM RETROV, V26, P1033, DOI 10.1089/aid.2009.0197; Zhao JR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002449; ZOUMPOURLIS V, 1994, ONCOL REP, V1, P397	126	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195661	10.1371/journal.pone.0195661	http://dx.doi.org/10.1371/journal.pone.0195661			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664930	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300025
J	Ryu, YJ; Choi, YH; Cheon, JE; Park, JE; Kim, WS; Kim, IO				Ryu, Young Jin; Choi, Young Hun; Cheon, Jung-Eun; Park, Ji Eun; Kim, Woo Sun; Kim, In-One			Effect of arm position, presence of medical devices, and off-centering during acquisition of scout image on automatic tube voltage selection and current modulation in pediatric chest CT	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY EXAMINATIONS; DIAGNOSTIC REFERENCE LEVELS; RADIATION-EXPOSURE; NATIONWIDE SURVEY; MULTIDETECTOR CT; OPTIMIZATION; KILOVOLTAGE; ANGIOGRAPHY; CHILDREN; QUALITY	Purpose To evaluate the patients' morphologic factors affecting radiation dose in pediatric chest CT. Materials and methods From November 2013 to May 2015, 315 pediatric chest CT scans were obtained using a CT scanner, and classified into 5 groups according to the patients' age. For each age group, the chest CT scans were divided into two subgroups. A cut-off value used was the 75th percentile of size-specific dose estimates (SSDE), age-specific diagnostic reference level (DRL): less than the 75th percentile of SSDE (Group A, n = 238) and greater than the 75th percentile of SSDE (Group B, n = 77). All CT scans were performed with the same protocol using automatic tube voltage selection and current modulation techniques. The morphologic factors of the patients including body mass index (BMI), arm angles, presence of medical devices in the scan field, and degree of off-centering within the CT gantry were compared between groups A and B. Results Group B showed narrower arm angles on scout and coronal reformatted images, higher frequency of the presence of devices and higher BMI than group A (P < 0.001, P < 0.001; P = 0.018, and P < 0.001, respectively). In multivariate analysis, narrower arm angles, the presence of devices on the scout images and higher BMI were independently associated with higher SSDE (P = 0.001, P = 0.037, and P < 0.001, respectively). Conclusions During acquisition of the scout images, arms-down position and the presence of medical devices were associated with a high radiation dose above age-specific DRLs in pediatric chest CT, regardless of repositioning before the actual scanning. In addition, off-centering had no clinical impact on radiation dose in the routine practice.	[Ryu, Young Jin; Choi, Young Hun; Cheon, Jung-Eun; Kim, Woo Sun; Kim, In-One] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Ryu, Young Jin; Choi, Young Hun; Cheon, Jung-Eun; Kim, Woo Sun; Kim, In-One] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Cheon, Jung-Eun; Kim, Woo Sun; Kim, In-One] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Park, Ji Eun] Kyung Hee Univ, Kyung Hee Univ Hosp, Grad Sch, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Kyung Hee University Hospital	Choi, YH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Choi, YH (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.	iater@snu.ac.kr	Choi, Young Hun/O-3282-2015	Choi, Young Hun/0000-0002-1842-9062				Boone J, 2013, 204 AAPM; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brink M, 2008, RADIOLOGY, V249, P661, DOI 10.1148/radiol.2492080169; Cody DD, 2014, PEDIATR RADIOL, V44, P427, DOI 10.1007/s00247-014-3140-8; Coursey C, 2008, AM J ROENTGENOL, V190, pW54, DOI 10.2214/AJR.07.2017; Dougeni E, 2012, EUR J RADIOL, V81, pE665, DOI 10.1016/j.ejrad.2011.05.025; Fanucci E, 2007, EMERG RADIOL, V13, P251, DOI 10.1007/s10140-006-0554-0; Geleijns J, 2010, PEDIATR RADIOL, V40, P1744, DOI 10.1007/s00247-010-1808-2; Goo HW, 2012, KOREAN J RADIOL, V13, P1, DOI 10.3348/kjr.2012.13.1.1; Granata C, 2015, PEDIATR RADIOL, V45, P695, DOI 10.1007/s00247-014-3201-z; Hough DM, 2012, AM J ROENTGENOL, V199, P1070, DOI 10.2214/AJR.12.8637; Hwang JY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002146; Kaasalainen T, 2014, AM J ROENTGENOL, V203, P123, DOI 10.2214/AJR.13.12028; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Karlo C, 2011, EMERG RADIOL, V18, P285, DOI 10.1007/s10140-011-0948-5; Kuo F, 2012, PEDIATR RADIOL, V42, P508, DOI 10.1007/s00247-011-2292-z; Lee CH, 2008, RADIOGRAPHICS, V28, P1451, DOI 10.1148/rg.285075075; Lee KH, 2012, RADIOLOGY, V265, P437, DOI 10.1148/radiol.12112434; Li JH, 2007, AM J ROENTGENOL, V188, P547, DOI 10.2214/AJR.06.0370; Matsubara K, 2009, AM J ROENTGENOL, V192, P862, DOI 10.2214/AJR.08.1472; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pearce MS, 2011, J MED IMAG RADIAT ON, V55, P107, DOI 10.1111/j.1754-9485.2011.02240.x; Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; Siegel MJ, 2013, RADIOLOGY, V268, P538, DOI 10.1148/radiol.13122438; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Soderberg M, 2016, RADIAT PROT DOSIM, V169, P84, DOI 10.1093/rpd/ncv459; Strauss KJ, 2017, RADIOLOGY, V284, P219, DOI 10.1148/radiol.2017161530; Strauss KJ, 2010, AM J ROENTGENOL, V194, P868, DOI 10.2214/AJR.09.4091; Takei Y, 2016, PEDIATR RADIOL, V46, P280, DOI 10.1007/s00247-015-3474-x; Verdun FR, 2008, EUR RADIOL, V18, P1980, DOI 10.1007/s00330-008-0963-4; Winklehner A, 2011, INVEST RADIOL, V46, P767, DOI 10.1097/RLI.0b013e3182266448	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195807	10.1371/journal.pone.0195807	http://dx.doi.org/10.1371/journal.pone.0195807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664918	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300033
J	Sharma, NK; Sharma, K; Singh, R; Sharma, SK; Anand, A				Sharma, Neel Kamal; Sharma, Kaushal; Singh, Ramandeep; Sharma, Suresh Kumar; Anand, Akshay			CCL2 single nucleotide polymorphism of rs1024611 implicates prominence of inflammatory cascade by univariate modeling in Indian AMD	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOKINE RECEPTOR CX3CR1; GENE REGULATORY REGION; MACULAR DEGENERATION; SERUM-LEVELS; DISEASE; RISK	Background The role of chemotactic protein CCL2/MCP-1 has been widely explored in age related macular degeneration (AMD) patients as well as animal models through our previous studies. Aim Aim of the study was to examine the association of another variance of CCL2, rs1024611 in pathophysiology of AMD. Methods This particular SNP has been found to be involved in inflammatory processes in various diseases. Total 171 subjects were recruited in the study with all demographic details by administering a standard questionnaire. SNP analysis was performed with TaqMan assay. Linear univariate and ANCOVA modeling was performed to show the interaction of rs1024611 with another SNP variant of CCL-2/CCR-2 (rs4586 and rs1799865) and impact of individual genotypes on CCL-2 expression in the context of AMD pathology. Results Results showed that both heterozygous (AG, p = 0.01) and homozygous (GG, p = 0.0001) genotypes are associated with AMD pathology. Allele frequency analysis showed that 'G' allele is frequent in AMD patients as compared to controls (p = 0.0001). Moreover, AMD patients who smoke were found to be associated with 'AG' genotype (p = 0.0145). Although, we did not find any significant interaction between the SNP variants by linear univariate analysis but results show the effect of 'CT' genotype on 'TT' genotype in rs4586 by considering rs1024611 as covariate. Conclusion Based on these results it is imperative that CCL2 mediated pathology may be associated with AMD.	[Sharma, Neel Kamal; Sharma, Kaushal; Anand, Akshay] Post Grad Inst Med Educ & Res, Dept Neurol, Neurosci Res Lab, Chandigarh, India; [Sharma, Neel Kamal] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Sharma, Kaushal; Sharma, Suresh Kumar] Panjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh, India; [Singh, Ramandeep] Post Grad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh, India; [Sharma, Suresh Kumar] Panjab Univ, Dept Stat, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Panjab University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University	Anand, A (corresponding author), Post Grad Inst Med Educ & Res, Dept Neurol, Neurosci Res Lab, Chandigarh, India.; Sharma, SK (corresponding author), Panjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh, India.; Sharma, SK (corresponding author), Panjab Univ, Dept Stat, Chandigarh, India.	ssharma643@yahoo.co.in; akshay1anand@rediffmail.com	anand, Akshay/AAI-1586-2019	Anand, Akshay/0000-0001-9003-3532	Department of Science and Technology, New Delhi, India [SR/SO/HS-109/205]	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	Funding was provided by Department of Science and Technology, New Delhi, India (F.No. SR/SO/HS-109/205 dated 1-05-2007). Funder had no role in study design, data collection and analysis of data.	Al-Odat I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103443; Allina J, 2011, J IMMUNOTOXICOL, V8, P258, DOI 10.3109/1547691X.2011.589412; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anand A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04114; Anand A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/365046; Anand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049905; Cho ML, 2004, AUTOIMMUNITY, V37, P77, DOI 10.1080/08916930310001609446; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Despriet DDG, 2008, INVEST OPHTH VIS SCI, V49, P364, DOI 10.1167/iovs.07-0656; Fenoglio C, 2004, NEUROBIOL AGING, V25, P1169, DOI 10.1016/j.neurobiolaging.2003.11.008; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Jibiki T, 2001, ARTHRITIS RHEUM, V44, P2211, DOI 10.1002/1529-0131(200109)44:9<2211::AID-ART375>3.0.CO;2-A; Kim MP, 2007, ATHEROSCLEROSIS, V193, P366, DOI 10.1016/j.atherosclerosis.2006.06.029; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; McDermott DH, 2005, CIRCULATION, V112, P1113, DOI 10.1161/CIRCULATIONAHA.105.543579; Pham MHT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049498; Pola R, 2004, EXP GERONTOL, V39, P1249, DOI 10.1016/j.exger.2004.05.001; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Raoul W, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-87; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Sharma K, 2015, ANN NEUROSCI, V22, P232, DOI 10.5214/ans.0972.7531.220408; Sharma K, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00151; Sharma NK, 2013, GENE, V523, P106, DOI 10.1016/j.gene.2013.03.052; Sharma NK, 2012, CURR NEUROVASC RES, V9, P256; Sharma NK, 2012, DNA CELL BIOL, V31, P1618, DOI 10.1089/dna.2012.1786; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0193423	10.1371/journal.pone.0193423	http://dx.doi.org/10.1371/journal.pone.0193423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664944	gold, Green Published, Green Submitted			2022-12-27	WOS:000430262300004
J	Jurgens, T; Hohmann, V; Buchner, A; Nogueira, W				Juergens, Tim; Hohmann, Volker; Buechner, Andreas; Nogueira, Waldo			The effects of electrical field spatial spread and some cognitive factors on speech-in-noise performance of individual cochlear implant users-A computer model study	PLOS ONE			English	Article							ELECTRODE DISCRIMINATION; SPECTRAL RIPPLE; RECEPTION THRESHOLD; NORMAL-HEARING; TUNING CURVES; RECOGNITION; PERCEPTION; RESOLUTION; EXCITATION; INTELLIGIBILITY	The relation of the individual speech-in-noise performance differences in cochlear implant (CI) users to underlying physiological factors is currently poorly understood. This study approached this research question by a step-wise individualization of a computer model of speech intelligibility mimicking the details of CI signal processing and some details of the physiology present in CI users. Two factors, the electrical field spatial spread and internal noise (as a coarse model of the individual cognitive performance) were incorporated. Internal representations of speech-in-noise mixtures calculated by the model were classified using an automatic speech recognizer backend employing Hidden Markov Models with a Gaussian probability distribution. One-dimensional electric field spatial spread functions were inferred from electrical field imaging data of 14 CI users. Simplified assumptions of homogenously distributed auditory nerve fibers along the cochlear array and equal distance between electrode array and nerve tissue were assumed in the model. Internal noise, whose standard deviation was adjusted based on either anamnesis data, or text-reception-threshold data, or a combination thereof, was applied to the internal representations before classification. A systematic model evaluation showed that predicted speech-reception-thresholds (SRTs) in stationary noise improved (decreased) with decreasing internal noise standard deviation and with narrower electric field spatial spreads. The model version that was individualized to actual listeners using internal noise alone (containing average spatial spread) showed significant correlations to measured SRTs, reflecting the high correlation of the text-reception threshold data with SRTs. However, neither individualization to spatial spread functions alone, nor a combined individualization based on spatial spread functions and internal noise standard deviation did produce significant correlations with measured SRTs.	[Juergens, Tim; Hohmann, Volker] Carl von Ossietzky Univ Oldenburg, Med Phys, Cluster Excellence Hearing4all, Oldenburg, Germany; [Juergens, Tim; Hohmann, Volker] Carl von Ossietzky Univ Oldenburg, Forschungszentrum Neurosensorik, Oldenburg, Germany; [Buechner, Andreas; Nogueira, Waldo] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Hannover Medical School	Jurgens, T (corresponding author), Carl von Ossietzky Univ Oldenburg, Med Phys, Cluster Excellence Hearing4all, Oldenburg, Germany.; Jurgens, T (corresponding author), Carl von Ossietzky Univ Oldenburg, Forschungszentrum Neurosensorik, Oldenburg, Germany.	tim.juergens@uni-oldenburg.de	Jürgens, Tim/AAO-8994-2021	Jürgens, Tim/0000-0002-1481-6997	DFG Cluster of Excellence [EXC 1077/1]	DFG Cluster of Excellence(German Research Foundation (DFG))	This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all" (http://www.hearing4all.eu). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4a11". Special thanks to Nils Schreiber for performing the FADE model predictions. The authors appreciate thorough and constructive feedback by Manuel Malmierca, Arne Leijon, and one anonymous reviewer on an earlier version of the manuscript.	Abbas PJ, 2004, AUDIOL NEURO-OTOL, V9, P203, DOI 10.1159/000078390; Anderson ES, 2012, J ACOUST SOC AM, V132, P3925, DOI 10.1121/1.4763999; Anderson ES, 2011, J ACOUST SOC AM, V130, P364, DOI 10.1121/1.3589255; Berenstein CK, 2010, HEARING RES, V270, P28, DOI 10.1016/j.heares.2010.10.001; Biesheuvel JD, 2016, EAR HEARING, V37, P572, DOI 10.1097/AUD.0000000000000296; Bingabr M, 2008, HEARING RES, V241, P73, DOI 10.1016/j.heares.2008.04.012; Blamey P, 2013, AUDIOL NEURO-OTOL, V18, P36, DOI 10.1159/000343189; Boex C, 2003, J ACOUST SOC AM, V114, P2058, DOI 10.1121/1.1610452; Cohen LT, 2003, HEARING RES, V179, P72, DOI 10.1016/S0378-5955(03)00096-0; Collins LM, 1997, J ACOUST SOC AM, V101, P440, DOI 10.1121/1.417989; Firszt JB, 2004, EAR HEARING, V25, P375, DOI 10.1097/01.AUD.0000134552.22205.EE; Fredelake S, 2012, HEARING RES, V287, P76, DOI 10.1016/j.heares.2012.03.005; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Hamacher V., 2003, THESIS RTWH AACHEN; Hanekom JJ, 1998, J ACOUST SOC AM, V104, P2372, DOI 10.1121/1.423772; Haumann S, 2012, AUDIOL RES, V2, P55, DOI 10.4081/audiores.2012.e12; Henry BA, 2005, J ACOUST SOC AM, V118, P1111, DOI 10.1121/1.1944567; Henry BA, 2003, J ACOUST SOC AM, V113, P2861, DOI 10.1121/1.1561900; Henry BA, 2000, J ACOUST SOC AM, V108, P1269, DOI 10.1121/1.1287711; Hughes ML, 2008, EAR HEARING, V29, P435, DOI 10.1097/AUD.0b013e31816a0d3d; Jurgens T, 2009, J ACOUST SOC AM, V126, P2635, DOI 10.1121/1.3224721; Khan AM, 2005, ANN OTO RHINOL LARYN, V114, P381, DOI 10.1177/000348940511400508; Kollmeier B, 2016, TRENDS HEAR, V20; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Litvak LM, 2007, J ACOUST SOC AM, V122, P982, DOI 10.1121/1.2749413; Long CJ, 2014, JARO-J ASSOC RES OTO, V15, P293, DOI 10.1007/s10162-013-0437-5; Nelson DA, 2011, J ACOUST SOC AM, V129, P3916, DOI 10.1121/1.3583503; Nogueira W, 2005, EURASIP J APPL SIG P, V2005, P3044, DOI 10.1155/ASP.2005.3044; Nogueira W, 2007, P INT, P2537; Nogueira W, 2015, BIOMEDICAL TECHNOLOG; Nogueira W, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00084; Schadler MR, 2015, INT J AUDIOL, V54, P100, DOI 10.3109/14992027.2015.1061708; Stadler S, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/175243; Vanpoucke FJ, 2004, IEEE T BIO-MED ENG, V51, P2174, DOI 10.1109/TBME.2004.836518; Wagener K.C., 1999, Z AUDIOL, V38, P4; YOUNG S, 1995, HTK BOOK; Yousefian N, 2012, J ACOUST SOC AM, V132, P3399, DOI 10.1121/1.4754539; Zamaninezhad L, 2017, HEARING RES, V344, P50, DOI 10.1016/j.heares.2016.10.023; Zekveld AA, 2007, J SPEECH LANG HEAR R, V50, P576, DOI 10.1044/1092-4388(2007/040); Zwolan TA, 1997, J ACOUST SOC AM, V102, P3673, DOI 10.1121/1.420401	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0193842	10.1371/journal.pone.0193842	http://dx.doi.org/10.1371/journal.pone.0193842			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652892	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000430026900004
J	Zwitserlood, P; Boltel, J; Hofmann, R; Meier, CC; Dobel, C				Zwitserlood, Pienie; Boeltel, Jens; Hofmann, Reinhild; Meier, Claudine C.; Dobel, Christian			Seeing for speaking: Semantic and lexical information provided by briefly presented, naturalistic action scenes	PLOS ONE			English	Article							CASCADE MODEL; PICTURE; ACCESS; ONSET; INTERFERENCE; RECOGNITION; ACTIVATION; ENGLISH; OBJECTS; NAMES	At the interface between scene perception and speech production, we investigated how rapidly action scenes can activate semantic and lexical information. Experiment 1 examined how complex action-scene primes, presented for 150 ms, 100 ms, or 50 ms and subsequently masked, influenced the speed with which immediately following action-picture targets are named. Prime and target actions were either identical, showed the same action with different actors and environments, or were unrelated. Relative to unrelated primes, identical and same-action primes facilitated naming the target action, even when presented for 50 ms. In Experiment 2, neutral primes assessed the direction of effects. Identical and same-action scenes induced facilitation but unrelated actions induced interference. In Experiment 3, written verbs were used as targets for naming, preceded by action primes. When target verbs denoted the prime action, clear facilitation was obtained. In contrast, interference was observed when target verbs were phonologically similar, but otherwise unrelated, to the names of prime actions. This is clear evidence for word-form activation by masked action scenes. Masked action pictures thus provide conceptual information that is detailed enough to facilitate apprehension and naming of immediately following scenes. Masked actions even activate their word-form information-as is evident when targets are words. We thus show how language production can be primed with briefly flashed masked action scenes, in answer to long-standing questions in scene processing.	[Zwitserlood, Pienie; Boeltel, Jens; Meier, Claudine C.] Univ Munster, Inst Psychol, Munster, Germany; [Zwitserlood, Pienie; Boeltel, Jens] Univ Munster, Otto Creutzfeldt Ctr Cognit Neurosci, Munster, Germany; [Hofmann, Reinhild] Univ Munster, Clin Phoniatr & Pediat Audiol, Munster, Germany; [Dobel, Christian] Univ Jena, Med Fac, Dept Otorhinolaryngol, Jena, Germany	University of Munster; University of Munster; University of Munster; Friedrich Schiller University of Jena	Zwitserlood, P (corresponding author), Univ Munster, Inst Psychol, Munster, Germany.; Zwitserlood, P (corresponding author), Univ Munster, Otto Creutzfeldt Ctr Cognit Neurosci, Munster, Germany.	zwitser@uni-muenster.de		Zwitserlood, Pienie/0000-0003-2166-5397; Bolte, Jens/0000-0002-8128-0520; Hofmann, Reinhild/0000-0001-8630-3528	Deutsche Forschungsgemeinschaft [711/4-1]; University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	This study was supported by Deutsche Forschungsgemeinschaft Project Do 711/4-1 to CD and the Open Access Publication Fund of the University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassano C, 2016, BIORXIV, DOI [10.1101/057406, DOI 10.1101/057406]; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; Bogka N, 2003, EUR J COGN PSYCHOL, V15, P371, DOI 10.1080/09541440303607; Braun J, 2003, TRENDS COGN SCI, V7, P7, DOI 10.1016/S1364-6613(02)00008-6; Chabal S, 2015, J EXP PSYCHOL GEN, V144, P539, DOI 10.1037/xge0000075; Crouzet SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051471; Damian MF, 2009, LANG COGNITIVE PROC, V24, P685, DOI 10.1080/01690960802351260; Dobel C, 2007, ACTA PSYCHOL, V125, P129, DOI 10.1016/J.ACTPSY.2006.07.004; DREWS E, 1995, J EXP PSYCHOL HUMAN, V21, P1098, DOI 10.1037/0096-1523.21.5.1098; Glanemann R, 2008, THESIS; Glanemann R, 2016, PSYCHON B REV, V23, P1566, DOI 10.3758/s13423-016-1004-y; Gleitman LR, 2007, J MEM LANG, V57, P544, DOI 10.1016/j.jml.2007.01.007; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Hafri A, 2013, J EXP PSYCHOL GEN, V142, P880, DOI 10.1037/a0030045; Henderson J. M., 2004, INTERFACE LANGUAGE V, P1, DOI DOI 10.4324/9780203488430; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Kreysa H, 2010, EVENT REPRESENTATION, P189; Kreysa H, 2004, THESIS; Larson A, 2012, 12 ANN M VIS SCI SOC; Levelt WJ, 1993, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; LEVELT WJM, 1991, PSYCHOL REV, V98, P122, DOI 10.1037/0033-295X.98.1.122; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Loschky LC, 2010, VIS COGN, V18, P513, DOI 10.1080/13506280902937606; Mace MJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005927; McQueen JM, 2014, ATTEN PERCEPT PSYCHO, V76, P190, DOI 10.3758/s13414-013-0560-8; Meyer AS, 2007, MEM COGNITION, V35, P494, DOI 10.3758/BF03193289; Meyer AS, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P253, DOI 10.1016/B978-044451020-4/50015-3; Moore CM, LIMITS ATTENTION TEM; Morsella E, 2002, J EXP PSYCHOL LEARN, V28, P555, DOI 10.1037//0278-7393.28.3.555; Mousikou P, 2010, EUR J COGN PSYCHOL, V22, P725, DOI 10.1080/09541440903052798; Navarrete E, 2005, J MEM LANG, V53, P359, DOI 10.1016/j.jml.2005.05.001; Neely J. H., 1991, BASIC PROCESSES READ, P264; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Oliva Aude, 2005, P251, DOI 10.1016/B978-012375731-9/50045-8; Papafragou A, 2015, CONCEPTUAL MIND: NEW DIRECTIONS IN THE STUDY OF CONCEPTS, P327; Potter MC, 2014, ATTEN PERCEPT PSYCHO, V76, P270, DOI 10.3758/s13414-013-0605-z; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Potter MC, 2004, J EXP PSYCHOL HUMAN, V30, P478, DOI 10.1037/0096-1523.30.3.478; Rosch E, 2004, COGNITIVE PSYCHOL KE, P448; Schiller NO, 2004, J MEM LANG, V50, P477, DOI 10.1016/j.jml.2004.02.004; SPERBER RD, 1979, MEM COGNITION, V7, P339, DOI 10.3758/BF03196937; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2001, EUR J NEUROSCI, V14, P869, DOI 10.1046/j.0953-816x.2001.01717.x; Timmer K, 2012, BRAIN RES, V1483, P39, DOI 10.1016/j.brainres.2012.09.004; Van den Bussche E, 2009, EXP PSYCHOL, V56, P295, DOI 10.1027/1618-3169.56.5.295; van der Meulen FF, 2001, MEM COGNITION, V29, P512, DOI 10.3758/BF03196402; Vorberg D, 2003, P NATL ACAD SCI USA, V100, P6275, DOI 10.1073/pnas.0931489100; Wu CT, 2015, J COGNITIVE NEUROSCI, V27, P141, DOI 10.1162/jocn_a_00701; Wundt W., 1970, LANGUAGE PSYCHOL HIS, P20; Wurm MF, 2012, NEUROIMAGE, V59, P1551, DOI 10.1016/j.neuroimage.2011.08.038; Zwitserlood P, 1996, LANG COGNITIVE PROC, V11, P589, DOI 10.1080/016909696386980	55	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194762	10.1371/journal.pone.0194762	http://dx.doi.org/10.1371/journal.pone.0194762			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652939	Green Published, gold, Green Submitted			2022-12-27	WOS:000430026900010
J	Lee, J; Arisi, I; Puxeddu, E; Mramba, LK; Amicosante, M; Swaisgood, CM; Pallante, M; Brandy, ML; Skold, CM; Saltini, C				Lee, Jungnam; Arisi, Ivan; Puxeddu, Ermanno; Mramba, Lazarus K.; Amicosante, Massimo; Swaisgood, Carmen M.; Pallante, Marco; Brandy, Mark L.; Skold, C. Magnus; Saltini, Cesare			Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation	PLOS ONE			English	Article							HFE GENE; POLARIZATION; HEMORRHAGE; DIAGNOSIS	Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of unknown cause characterized by alveolar epithelial damage, patchy interstitial fibrosis and diffuse microvascular abnormalities. In IPF, alveolar clustering of iron-laden alveolar macrophages a common sign of microhemorrhage, has been associated with vascular abnormalities and worsening of pulmonary hypertension. As iron-dependent ROS generation has been shown to induce unrestrained macrophage activation in disease models of vascular damage, we explored alveolar macrophage activation phenotype in IPF patients (n = 16) and healthy controls (CTR, n = 7) by RNA sequencing of bronchoalveolar lavage (BAL) cells. The frequencies of macrophages in BAL cells were 86+4% and 83.4+8% in IPF and CTR groups, respectively (p-value = 0.41). In IPF patients, BAL cells showed increased iron-dependent ROS generation (p-value<0.05 vs CTR). Gene expression analysis showed overrepresentation of Gene Ontology processes/functions and KEGG pathways enriched in upregulated M1-type inflammatory (p-value<0.01), M2-type anti-inflammatory/tissue remodeling (p-value<0.0001), and MTPP-type chronic inflammatory/angiogenic (p-value<0.0001) chemokine and cytokine genes. The ex vivo finding was confirmed by the induction of iron-dependent ROS generation and chemokine/cytokine overexpression of Cc14, Cxcl10 (M1), ll1 rn (M2), Cxcl2, and Cxcl7 (MTPP) in MH-S murine immortalized alveolar macrophages exposed to ferric ammonium citrate in culture (p-value<0.05 vs CTR). The data show alveolar macrophage expression of a pro-inflammatory, tissue remodeling and angiogenic complex activation pattern, suggesting that iron accumulation may play a role in macrophage activation.	[Lee, Jungnam; Swaisgood, Carmen M.; Brandy, Mark L.; Saltini, Cesare] Univ Florida, Coll Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32611 USA; [Arisi, Ivan] European Brain Res Inst, Genom Facil, Rome, Italy; [Puxeddu, Ermanno; Amicosante, Massimo; Pallante, Marco] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Mramba, Lazarus K.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Skold, C. Magnus] Karolinska Univ, Hosp Solna, Dept Med, Resp Med Unit, Stockholm, Sweden; [Skold, C. Magnus] Karolinska Univ, Hosp Solna, Lung Allergy Clin, Stockholm, Sweden	State University System of Florida; University of Florida; University of Rome Tor Vergata; State University System of Florida; University of Florida; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Saltini, C (corresponding author), Univ Florida, Coll Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32611 USA.	cesare.saltini@medicine.ufl.edu	PUXEDDU, ERMANNO/AAA-7467-2019; Arisi, Ivan/AAM-1152-2021	PUXEDDU, ERMANNO/0000-0002-5486-7764; Arisi, Ivan/0000-0002-0536-2508	University of Florida [00127916, 00045513]; Department of Biomedicine and Prevention, University of Roma by PAINCAGE FP7 [603191]	University of Florida(University of Florida); Department of Biomedicine and Prevention, University of Roma by PAINCAGE FP7	This study was supported by University of Florida Departmental funds (UF project #00127916(C.S.) and #00045513(M.L.B)), by funds from the Department of Biomedicine and Prevention, University of Roma by PAINCAGE FP7 #603191 (I.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Becker M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13351; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; Capelli A, 2005, EUR RESPIR J, V25, P701, DOI 10.1183/09031936.05.00082604; Cloonan SM, 2017, AM J RESP CRIT CARE, V196, P1103, DOI 10.1164/rccm.201702-0311PP; Colombat M, 2007, HUM PATHOL, V38, P60, DOI 10.1016/j.humpath.2006.06.007; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Foster MW, 2015, J PROTEOME RES, V14, P1238, DOI 10.1021/pr501149m; Fukihara J, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0376-8; Ghio AJ, 1997, J LAB CLIN MED, V129, P53, DOI 10.1016/S0022-2143(97)90161-X; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; GOLDE DW, 1975, BMJ-BRIT MED J, V2, P166, DOI 10.1136/bmj.2.5964.166; Ishii T, 2006, EUR RESPIR J, V27, P300, DOI 10.1183/09031936.06.00090405; Jackson AF, 2013, J PHARMACOL TOX MET, V68, P260, DOI 10.1016/j.vascn.2013.02.008; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keane MP, 2001, AM J RESP CRIT CARE, V164, P2239, DOI 10.1164/ajrccm.164.12.2104106; Kim KH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-37; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Ley B, 2015, EUR RESPIR J, V45, P1374, DOI 10.1183/09031936.00146314; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magro CM, 2006, HUM IMMUNOL, V67, P284, DOI 10.1016/j.humimm.2006.02.026; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Montani D, 2009, EUR RESPIR J, V33, P189, DOI 10.1183/09031936.00090608; Nieuwenhuizen L, 2014, THROMB RES, V133, P390, DOI 10.1016/j.thromres.2013.10.039; Oda K, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0109-y; OLAKANMI O, 1993, J CLIN INVEST, V91, P889, DOI 10.1172/JCI116310; Persson HL, 2011, CHEST, V139, P361, DOI 10.1378/chest.10-0818; Pezzuto G, 2015, SARCOIDOSIS VASC DIF, V32, P32; Philippot Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096285; Puxeddu E, 2014, PULM PHARMACOL THER, V28, P35, DOI 10.1016/j.pupt.2013.12.002; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ren P, 2007, AM J RESP CRIT CARE, V175, P1151, DOI 10.1164/rccm.200607-958OC; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Sangiuolo F, 2015, EUR RESPIR J, V45, P483, DOI 10.1183/09031936.00104814; Schupp JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116775; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; THOMPSON AB, 1991, J LAB CLIN MED, V117, P493; van der Schoot GGF, 2016, EUR J CANCER, V59, P134, DOI 10.1016/j.ejca.2016.02.013; Wijnen PA, 2013, LUNG, V191, P53, DOI 10.1007/s00408-012-9436-2; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zamboni P, 2006, FREE RADICAL BIO MED, V40, P1869, DOI 10.1016/j.freeradbiomed.2006.01.026	43	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194803	10.1371/journal.pone.0194803	http://dx.doi.org/10.1371/journal.pone.0194803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649237	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900015
J	Nagane, M; Kanai, E; Shibata, Y; Shimizu, T; Yoshioka, C; Maruo, T; Yamashita, T				Nagane, Masaki; Kanai, Eiichi; Shibata, Yuki; Shimizu, Takuto; Yoshioka, Chie; Maruo, Takuya; Yamashita, Tadashi			Sulfasalazine, an inhibitor of the cystineglutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma	PLOS ONE			English	Article							COMET ASSAY; MITOTIC CATASTROPHE; RADIATION; CELLS; TRANSPORTER; XCT; RADIORESISTANCE; SENESCENCE; TRIGGERS; SYSTEM	The sodium-independent cystine-glutamate antiporter plays an important role in extracellular cystine uptake. It comprises the transmembrane protein, xCT and its chaperone, CD98. Because glutathione is only weakly cell membrane permeable, cellular uptake of its precursor, cystine, is known to be a key step in glutathione synthesis. Moreover, it has been reported that xCT expression affects the progression of tumors and their resistance to therapy. Sulfasalazine is an inhibitor of xCT that is known to increase cellular oxidative stress, giving it anti-tumor potential. Here, we describe a radio-sensitizing effect of sulfasalazine using a B16F10 melanoma model. Sulfasalazine decreased glutathione concentrations and resistance to H2O2 in B16F10 melanoma cells, but not in mouse embryonic fibroblasts. It synergistically enhanced the cyto-killing effect of X-irradiation in B16F10 cells. It inhibited cellular DNA damage repair and prolonged cell cycle arrest after X-irradiation. Furthermore, in an in vivo transplanted melanoma model, sulfasalazine decreased intratumoral glutathione content, leading to enhanced susceptibility to radiation therapy. These results suggest the possibility of using SAS to augment the treatment of radio-resistant cancers.	[Nagane, Masaki; Shibata, Yuki; Shimizu, Takuto; Yamashita, Tadashi] Azabu Univ, Sch Vet Med, Biochem Lab, Sagamihara, Kanagawa, Japan; [Kanai, Eiichi] Azabu Univ, Sch Vet Med, Lab Vet Radiol, Sagamihara, Kanagawa, Japan; [Yoshioka, Chie; Maruo, Takuya] Azabu Univ, Teaching Anim Hosp, Sagamihara, Kanagawa, Japan	Azabu University; Azabu University; Azabu University	Yamashita, T (corresponding author), Azabu Univ, Sch Vet Med, Biochem Lab, Sagamihara, Kanagawa, Japan.	yamashita@azabu-u.ac.jp	; Nagane, Masaki/K-3431-2013	Yamashita, Tadashi/0000-0001-8022-0158; Shimizu, Takuto/0000-0002-6403-7959; Shibata, Yuki/0000-0002-2532-9916; Nagane, Masaki/0000-0002-3408-7656	Private University Research Branding Project (Ministry of Education, Culture, Sports, Science and Technology, Japan)	Private University Research Branding Project (Ministry of Education, Culture, Sports, Science and Technology, Japan)	This research was partially supported by Private University Research Branding Project (Ministry of Education, Culture, Sports, Science and Technology, Japan).	Bridges CC, 2001, INVEST OPHTH VIS SCI, V42, P47; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chabner B., 2018, CANC CHEMOTHERAPY BI; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CLARK EP, 1984, RADIAT RES, V98, P370, DOI 10.2307/3576244; Day RM, 2014, CELL CYCLE, V13, P2011, DOI 10.4161/cc.29457; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; GUASTAVINO E, 1988, Acta Gastroenterologica Latinoamericana, V18, P107; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Hall EJ, 2011, RADIOBIOLOGY RADIOLO; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; KLOTZ U, 1980, NEW ENGL J MED, V303, P1499, DOI 10.1056/NEJM198012253032602; Kurashige T, 2016, J RADIAT RES, V57, P312, DOI 10.1093/jrr/rrw001; Lee Kyung Shik, 1992, Korean Journal of Internal Medicine (English Edition), V7, P111; Lu HQ, 2015, P NATL ACAD SCI USA, V112, pE4600, DOI 10.1073/pnas.1513433112; Marthandan S, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0095-2; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Nagane M, 2015, BIOCHEM BIOPH RES CO, V456, P541, DOI 10.1016/j.bbrc.2014.12.002; Nagane M, 2013, BIOCHEM BIOPH RES CO, V437, P420, DOI 10.1016/j.bbrc.2013.06.093; Nishida N, 2014, J RADIAT RES, V55, P455, DOI 10.1093/jrr/rrt142; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P1164, DOI 10.1002/art.10228; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Rodman SN, 2016, RADIAT RES, V186, P385, DOI 10.1667/RR14463.1; Sakai Y, 2015, BIOCHEM BIOPH RES CO, V461, P35, DOI 10.1016/j.bbrc.2015.03.163; Sleire L, 2015, ONCOGENE, V34, P5951, DOI 10.1038/onc.2015.60; Tagde A, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.45; Toyoda M, 2014, BRIT J CANCER, V110, P2506, DOI 10.1038/bjc.2014.178; Wada T, 2013, CANCER SCI, V104, P1323, DOI 10.1111/cas.12236; Xie L, 2011, J CANCER RES CLIN, V137, P1739, DOI 10.1007/s00432-011-1050-9; Yamamori T, 2015, MOL BIOL CELL, V26, P4607, DOI 10.1091/mbc.E15-03-0181; Yasui H, 2008, BRIT J CANCER, V99, P1442, DOI 10.1038/sj.bjc.6604720; Yasui H, 2017, CANCER LETT, V390, P160, DOI 10.1016/j.canlet.2017.01.006; Yasui H, 2014, CANCER LETT, V347, P151, DOI 10.1016/j.canlet.2014.02.005; Yoshikawa M, 2013, CANCER RES, V73, P1855, DOI 10.1158/0008-5472.CAN-12-3609-T	36	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195151	10.1371/journal.pone.0195151	http://dx.doi.org/10.1371/journal.pone.0195151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649284	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900029
J	Valdes, C; Bustos, G; Martinez, JL; Lauridolt, C				Valdes, Carlos; Bustos, Gonzalo; Martinez, Jose L.; Lauridolt, Claudio			Antinociceptive antibiotics-loaded into solid lipid nanoparticles of prolonged release: Measuring pharmacological efficiency and time span on chronic monoarthritis rats	PLOS ONE			English	Article							PAIN	Pain is a sensory experience of a complex physiological nature in which is not only involved the nervous system. Among its many features is the development of chronic pain that is more complicated to treat because of the central somatization processes involved, becoming inefficient treatments used in other forms of pain. Among them is the role of glial cells, whose participation is such that some authors have proposed to chronic pain as a gliopathy. Because of this, the drug target of possible treatments focuses on modulating nociceptive response affecting transduction into the central nervous system through affecting synapses in the dorsal horn of the spinal cord. Solid lipid nanoparticles enter the central nervous system, protecting the drug, and in addition to the advantage of having greater absorption surface, all factors that improve drug activity. This work is based on the development and characterization of lipid nanoparticles of solid phase incorporating two antibiotics, minocycline, and ciprofloxacin with antinociceptive properties and challenged them with a rat monoarthritis model using Sprague-Dawley adult male rats. The solid lipid nanoparticles were prepared to modify the lipid, and surfactant amounts to obtain the best encapsulation capacity of the antibiotics, size and z potential. By using the Randall-Selitto test, we measured its pharmacological efficiency as an anti-inflammatory and measuring the time span the antibiotics are active. The encapsulated antibiotics were at least 50% more efficient than the antibiotic alone, and that is possible to measure anti-inflammatory activity up to seven days after the antibiotic application. The former is important for example, in the veterinary field, since a single application of the antibiotic will be necessary for the complete treatment, avoiding excessive stress for the animals. We can conclude that antinociceptive antibiotics encapsulation is a very effective, environmentally safe and inexpensive method for improving the pharmacological efficiency and time span the antibiotics are acting. Since these antibiotics are both anti-microbial and antinociceptive, his use in the field of veterinary presents the advantage of being adequate in single doses, with the saving of time and stress to the animals under treatment.	[Valdes, Carlos; Bustos, Gonzalo; Lauridolt, Claudio] Univ Santiago Chile, Fac Chem & Biol, Dept Biol, Neurobiol Lab, Santiago, Chile; [Martinez, Jose L.] Univ Santiago Chile, Vicerrectory Res Dev & Innovat, Santiago, Chile	Universidad de Santiago de Chile; Universidad de Santiago de Chile	Martinez, JL (corresponding author), Univ Santiago Chile, Vicerrectory Res Dev & Innovat, Santiago, Chile.	joseluis.martinez@usach.cl	Martinez, Jose/AAA-1725-2020		Dicyt, Universidad de Santiago de Chile	Dicyt, Universidad de Santiago de Chile	This study was supported by Dicyt, Universidad de Santiago de Chile.	Abdelbary G, 2009, AAPS PHARMSCITECH, V10, P211, DOI 10.1208/s12249-009-9197-2; Attama AA, 2015, THER DELIV, V6, P669, DOI [10.4155/tde.15.23, 10.4155/TDE.15.23]; Basbaum A, 2005, PAIN 2005 UPDATED RE, P3; Bustos G, 2016, PAK VET J, V36, P366; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Haney MJ, 2011, NANOMEDICINE-UK, V6, P1215, DOI [10.2217/nnm.11.32, 10.2217/NNM.11.32]; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Hou DZ, 2003, BIOMATERIALS, V24, P1781, DOI 10.1016/S0142-9612(02)00578-1; Hu FQ, 2005, COLLOID SURFACE B, V45, P167, DOI 10.1016/j.colsurfb.2005.08.005; Ibrahim WM, 2014, INT J NANOMED, V9, P129, DOI 10.2147/IJN.S54413; KOEPPEN B.M., 2009, BERNE LEVY FISIOLOGI; Labro MT, 2000, CLIN MICROBIOL REV, V13, P615, DOI 10.1128/CMR.13.4.615-650.2000; Luger TJ, 2005, BASIC CLIN PHARMACOL, V96, P366, DOI 10.1111/j.1742-7843.2005.pto_05.x; McNeil SE, 2011, METHODS MOL BIOL, V697, P1, DOI 10.1007/978-1-60327-198-1; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Morales F, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4030; Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455; Qi JP, 2012, CURR DRUG METAB, V13, P418, DOI 10.2174/138920012800166526; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rojewska E, 2014, J NEUROIMMUNOL, V277, P57, DOI 10.1016/j.jneuroim.2014.09.020; Venkateswarlu V, 2004, J CONTROL RELEASE, V95, P627, DOI 10.1016/j.jconrel.2004.01.005; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	22	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0187473	10.1371/journal.pone.0187473	http://dx.doi.org/10.1371/journal.pone.0187473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649262	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900001
J	Pan, CC; Hu, LY; Lu, T; Tu, MS; Shen, CC; Chen, ZJ				Pan, Chih-Chuan; Hu, Li-Yu; Lu, Ti; Tu, Ming-Shium; Shen, Cheng-Che; Chen, Zi-Jun			Risk of hip fractures in patients with depressive disorders: A nationwide, population-based, retrospective, cohort study	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; DIABETIC COMPLICATIONS; POSTMENOPAUSAL WOMEN; BONE METABOLISM; OSTEOPOROSIS; MECHANISMS; DENSITY; DISEASE; DRUGS; MRI	Background Some studies have suggested that depressive disorders may play a vital role in the incidence of hip fractures. However, nationwide data are lacking regarding the association between depressive disorders and hip fractures. Objective We aimed to explore the association between depressive disorders and new-onset hip fractures. Methods We conducted a retrospective study of 11,207 patients with depressive disorders and 11,207 control patients using Taiwan's National Health Insurance Research Database. A Cox regression model was used to evaluate the risk of hip fractures in patients with depressive disorders. Results The incidence rate ratio of hip fractures between patients with depressive disorders and controls was 1.6 (95% confidence interval [CI] = 1.29-1.99, P < .001). After adjustment for potential confounders in multivariate analysis using the Cox regression model, patients with depressive disorders were found to have 1.34 times higher risk of hip fractures than controls (95% CI = 1.08-1.66, P = .008). Furthermore, age (hazard ratio [HR] = 7.43, 95% CI = 4.94-11.19, P < .001), hypertension (HR = 1.63, 95% CI = 1.17-2.28, P =.004), diabetes mellitus (HR = 1.47, 95% CI = 1.08-1.99, P = .014), cerebrovascular disease (HR = 1.76, 95% CI = 1.31-2.35, P < .001), living in rural areas (HR = 1.88, 95% CI = 1.30-2.70, P = .001), and low monthly income ( NT$0-NT$19,000: HR = 4.08, 95% CI = 1.79-9.29, P = .001 and NT $19,100-NT$42,000: HR = 4.09, 95% CI = 1.76-9.49, P =.001) were independent risk factors for new-onset hip fractures in patients with depressive disorders. Conclusion Depressive disorders might increase the risk of new-onset hip fractures, particularly in older patients and patients with hypertension, diabetes mellitus, cerebrovascular disease, or low socioeconomic status.	[Pan, Chih-Chuan; Hu, Li-Yu] Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaohsiung, Taiwan; [Pan, Chih-Chuan; Hu, Li-Yu; Lu, Ti] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Hu, Li-Yu; Shen, Cheng-Che] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei, Taiwan; [Tu, Ming-Shium; Chen, Zi-Jun] Kaohsiung Vet Gen Hosp, Pingtung Branch, Dept Family Med, Pingtung, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan; [Shen, Cheng-Che] Natl Chung Cheng Univ, Dept Informat Management, Chiayi, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Taichung Veterans General Hospital; National Chung Cheng University	Chen, ZJ (corresponding author), Kaohsiung Vet Gen Hosp, Pingtung Branch, Dept Family Med, Pingtung, Taiwan.	zijunchen@gmail.com						Andreescu C, 2008, NEUROPSYCHOPHARMACOL, V33, P2566, DOI 10.1038/sj.npp.1301655; Atteritano M, 2013, INTERN EMERG MED, V8, P485, DOI 10.1007/s11739-011-0628-1; Bacon WE, 2000, J AGING HEALTH, V12, P193, DOI 10.1177/089826430001200203; Bakken MS, 2013, AGE AGEING, V42, P514, DOI 10.1093/ageing/aft009; Beaupre GS, 2006, AM J PHYS MED REHAB, V85, P464, DOI 10.1097/01.phm.0000214275.69286.7a; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1038/nrdp.2016.65; Beyer JL, 2002, BIPOLAR DISORD, V4, P89, DOI 10.1034/j.1399-5618.2002.01157.x; Butt DA, 2012, ARCH INTERN MED, V172, P1739, DOI 10.1001/2013.jamainternmed.469; Carriero FP, 2011, ANN INTERN MED, V155; Cauley JA, 2014, NAT REV ENDOCRINOL, V10, P338, DOI 10.1038/nrendo.2014.51; Cizza G, 2010, HORM METAB RES, V42, P467, DOI 10.1055/s-0030-1252020; Cizza Giovanni, 2011, Dialogues Clin Neurosci, V13, P73; Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003; Corrao G, 2015, DRUG AGING, V32, P927, DOI 10.1007/s40266-015-0306-5; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Eskandari F, 2007, ARCH INTERN MED, V167, P2329, DOI 10.1001/archinte.167.21.2329; Fazeli PK, 2013, PSYCHOSOM MED, V75, P117, DOI 10.1097/PSY.0b013e3182821e91; Fernandes BS, 2016, DRUG AGING, V33, P21, DOI 10.1007/s40266-015-0323-4; Fossati P, 2004, EUR NEUROPSYCHOPHARM, V14, pS503, DOI 10.1016/j.euroneuro.2004.09.001; Romero MJGDT, 2014, MATURITAS, V77, P282, DOI 10.1016/j.maturitas.2013.12.011; Gu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065356; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Hong GRS, 2010, J ADV NURS, V66, P2014, DOI 10.1111/j.1365-2648.2010.05384.x; Hwang HF, 2011, OSTEOPOROSIS INT, V22, P2385, DOI 10.1007/s00198-010-1446-4; Johnston SS, 2012, DIABETES OBES METAB, V14, P634, DOI 10.1111/j.1463-1326.2012.01583.x; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lin HL, 2015, ACTA NEUROL SCAND, V131, P158, DOI 10.1111/ane.12301; Malabu UH, 2014, CLIN EPIDEMIOL, V6, P287, DOI 10.2147/CLEP.S66821; Oderda LH, 2012, ANN PHARMACOTHER, V46, P917, DOI 10.1345/aph.1Q589; Oei L, 2015, CURR OSTEOPOROS REP, V13, P106, DOI 10.1007/s11914-015-0260-5; Pan CC, 2009, INT J GERIATR PSYCH, V24, P847, DOI 10.1002/gps.2206; Porto Carreiro F, 2011, ANN INTERN MED, V155; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Prieto-Alhambra D, 2014, OSTEOPOROSIS INT, V25, P847, DOI 10.1007/s00198-013-2612-2; Rathmann W, 2015, J DIABETES COMPLICAT, V29, P766, DOI 10.1016/j.jdiacomp.2015.05.007; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Ruths S, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0154-5; Shatrugna V, 2005, OSTEOPOROSIS INT, V16, P1827, DOI 10.1007/s00198-005-1933-1; Shea MLO, 2013, OSTEOPOROSIS INT, V24, P1741, DOI 10.1007/s00198-012-2170-z; Shin CS, 2010, BONE, V47, P378, DOI 10.1016/j.bone.2010.03.017; Solomon DH, 2011, J BONE MINER RES, V26, P1561, DOI 10.1002/jbmr.356; Sterling RS, 2011, CLIN ORTHOP RELAT R, V469, P1913, DOI 10.1007/s11999-010-1736-3; Tolea MI, 2007, OSTEOPOROSIS INT, V18, P315, DOI 10.1007/s00198-006-0242-7; Tsapakis EM, 2012, EUR PSYCHIAT, V27, P156, DOI 10.1016/j.eurpsy.2010.10.006; Williams LJ, 2009, PSYCHOTHER PSYCHOSOM, V78, P16, DOI 10.1159/000162297; Wu Q, 2010, OSTEOPOROSIS INT, V21, P1627, DOI 10.1007/s00198-010-1181-x; Yang NP, 2003, J CLIN DENSITOM, V6, P131, DOI 10.1385/JCD:6:2:131; Zingmond DS, 2006, OSTEOPOROSIS INT, V17, P1562, DOI 10.1007/s00198-006-0161-7	51	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194961	10.1371/journal.pone.0194961	http://dx.doi.org/10.1371/journal.pone.0194961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641581	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900056
J	Azoum, M; Clark, GI; Rock, AJ				Azoum, Michelle; Clark, Gavin I.; Rock, Adam J.			The impact of affect labelling on responses to aversive flying-cues	PLOS ONE			English	Article							IN-VIVO EXPOSURE; SOCIAL ANXIETY; IMAGERY; FEELINGS; WORDS; UNCERTAINTY; MEMORIES; PEOPLE; LINK	Individuals with flying phobia experience increases in subjective anxiety in response to flying-related cues. However, the cognitive processes that contribute to cue-reactive anxiety in individuals with flying-related anxiety remain poorly understood. Preliminary research suggests that changes in visual imagery and volitional control may contribute to this cue-reactive anxiety. Engaging in affect labelling during exposure therapy has been shown to reduce cue-reactive anxiety in individuals with fears relating to a variety of stimuli but has not been investigated in the fear of flying. The present study recruited 110 participants with a range of flying-related anxiety scores to complete an online cue-reactivity experiment. The study sought to evaluate whether an aversive flying cue triggered changes in imagery, volitional control and anxiety, and whether changes in imagery and volitional control predicted level of cue-reactive anxiety. Participants were randomly allocated to an affect labelling or non-affect labelling condition to additionally assess whether engaging in labelling one's emotion following exposure to an aversive flying cue would attenuate cue-reactive changes in anxiety relative to a group who did not. Significant cue-reactive changes in anxiety, and volitional control were observed from neutral to aversive flying cue were observed. After accounting for the effects of flying anxiety severity, only volitional control significantly improved the prediction of cue-reactive anxiety. Participants in the affect labelling condition reported significantly smaller increases in anxiety than the non-affect labelling group following exposure to the aversive flight cue. This is the first study to indicate affect labelling may help to regulate aspects of cue-reactive anxiety in response to aversive flying stimuli.	[Azoum, Michelle; Clark, Gavin I.; Rock, Adam J.] Univ New England, Sch Behav Cognit & Social Sci, Armidale, NSW, Australia	University of New England	Rock, AJ (corresponding author), Univ New England, Sch Behav Cognit & Social Sci, Armidale, NSW, Australia.	arock@une.edu.au		Rock, Adam/0000-0002-1430-3745				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], QUALTR VERS 042016 C; Bornas X, 2004, ANXIETY STRESS COPIN, V17, P331, DOI 10.1080/10615800512331328777; Burklund Lisa J, 2014, Front Psychol, V5, P221, DOI 10.3389/fpsyg.2014.00221; Busscher B, 2015, PSYCHOSOM MED, V77, P762, DOI 10.1097/PSY.0000000000000209; Busscher B, 2013, BEHAV RES THER, V51, P98, DOI 10.1016/j.brat.2012.10.009; Busscher B, 2010, J PSYCHOSOM RES, V69, P309, DOI 10.1016/j.jpsychores.2009.12.005; Choy Y, 2007, CLIN PSYCHOL REV, V27, P266, DOI 10.1016/j.cpr.2006.10.002; Clark DM, 1999, BEHAV RES THER, V37, pS5, DOI 10.1016/S0005-7967(99)00048-0; Clark GI, 2017, AUST PSYCHOL, V52, P480, DOI 10.1111/ap.12214; Clark GI, 2017, J GAMBL STUD, V33, P807, DOI 10.1007/s10899-016-9650-6; Clark GI, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00754; Clark GI, 2017, CUE REACTIVE I UNPUB; Dadds M, 2004, MEMORY, V12, P462, DOI 10.1080/09658210444000070; Dandurand F, 2008, BEHAV RES METHODS, V40, P428, DOI 10.3758/BRM.40.2.428; Day S, 2004, MEMORY, V12, P416, DOI 10.1080/09658210444000034; Erblich J, 2009, ADDICT BEHAV, V34, P164, DOI 10.1016/j.addbeh.2008.10.007; Harvey AG., 2004, COGNITIVE BEHAV PROC, DOI [10.1093/med:psych/9780198528883.001.0001, DOI 10.1093/MED:PSYCH/9780198528883.001.0001]; Heiniger LE, 2018, J BEHAV THER EXP PSY, V58, P106, DOI 10.1016/j.jbtep.2017.09.004; Hirsch C, 2004, MEMORY, V12, P496, DOI 10.1080/09658210444000106; Hirsch C.R., 2007, PSYCHIATRY, V6, P161, DOI [10.1016/j.mppsy.2007.01.005, DOI 10.1016/J.MPPSY.2007.01.005]; Hirsch CR, 2006, J BEHAV THER EXP PSY, V37, P159, DOI 10.1016/j.jbtep.2005.03.003; Holmes EA, 2008, EMOTION, V8, P395, DOI 10.1037/1528-3542.8.3.395; Kircanski K, 2012, PSYCHOL SCI, V23, P1086, DOI 10.1177/0956797612443830; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Lieberman MD, 2011, EMOTION, V11, P468, DOI 10.1037/a0023503; Mavromoustakos E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161272; McKeith CFA, 2017, J GAMBL STUD, V33, P617, DOI 10.1007/s10899-016-9635-5; McManus F, 2015, BEHAV COGN PSYCHOTH, V43, P744, DOI 10.1017/S1352465814000435; Moller AT, 1998, J RATION-EMOT COGN-B, V16, P135, DOI [10.1023/A:1024938411949, DOI 10.1023/A:1024938411949]; Niles AN, 2015, BEHAV RES THER, V68, P27, DOI 10.1016/j.brat.2015.03.004; Nousi Aikaterini, 2008, Travel Med Infect Dis, V6, P305, DOI 10.1016/j.tmaid.2008.06.001; Oakes M, 2010, TRAVEL MED INFECT DI, V8, P327, DOI 10.1016/j.tmaid.2010.10.001; Oakes M, 2010, TRAVEL MED INFECT DI, V8, P339, DOI 10.1016/j.tmaid.2010.10.002; Ost LG, 1997, BEHAV RES THER, V35, P987, DOI 10.1016/S0005-7967(97)00077-6; Payer DE, 2012, EMOTION, V12, P229, DOI 10.1037/a0027421; PEKALA RJ, 1986, PERCEPT MOTOR SKILL, V63, P983, DOI 10.2466/pms.1986.63.2.983; Pekala RJ, 1991, QUANTIFYING CONSCIOU; Pratt D, 2004, BEHAV COGN PSYCHOTH, V32, P165, DOI 10.1017/S1352465804001158; Reuman L, 2015, J BEHAV THER EXP PSY, V47, P111, DOI 10.1016/j.jbtep.2014.12.002; Rock A. J., 2007, N AM J PSYCHOL, V9, P387; Rock A. J., 2008, N AM J PSYCHOL, V10, P127; Seeberg I, 1989, NORD J PSYCHIAT, V43, P443, DOI [10.3109/08039488909107869, DOI 10.3109/08039488909107869]; Speckens AEM, 2007, J BEHAV THER EXP PSY, V38, P411, DOI 10.1016/j.jbtep.2007.09.004; Tabibnia G, 2008, EMOTION, V8, P307, DOI 10.1037/1528-3542.8.3.307; Tricker C, 2016, J GAMBL STUD, V32, P661, DOI 10.1007/s10899-015-9549-7; Van Almen K., 2013, AVIATION PSYCHOL APP, V3, P39, DOI [10.1027/2192-0923/a000035, DOI 10.1027/2192-0923/A000035, 10.1027/21920923/a000035]; Van Gerwen LJ, 2002, COGN BEHAV PRACT, V9, P138, DOI 10.1016/S1077-7229(02)80007-4; Van Gerwen LJ, 1999, PSYCHOL ASSESSMENT, V11, P146, DOI 10.1037/1040-3590.11.2.146; Van Gerwen Lucas J, 2004, Travel Med Infect Dis, V2, P27, DOI 10.1016/j.tmaid.2004.01.002; Vanden Bogaerde A, 2013, ANXIETY STRESS COPIN, V26, P343, DOI 10.1080/10615806.2012.673592; Vanden Bogaerde A, 2012, COGNITIVE THER RES, V36, P390, DOI 10.1007/s10608-010-9346-7; VanGerwen LJ, 1997, BEHAV THER, V28, P237, DOI 10.1016/S0005-7894(97)80045-7; Wiederhold BK, 2001, CYBERPSYCHOLOGY MIND, P252, DOI [10.1016/j.tmaid.2004.01.002, DOI 10.1016/J.TMAID.2004.01.002]; Wilhelm FH, 1997, J ANXIETY DISORD, V11, P241, DOI 10.1016/S0887-6185(97)00009-1; Wolitzky-Taylor KB, 2008, CLIN PSYCHOL REV, V28, P1021, DOI 10.1016/j.cpr.2008.02.007; Wright CJ, 2017, PERS INDIV DIFFER, V112, P97, DOI 10.1016/j.paid.2017.02.039	57	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0194519	10.1371/journal.pone.0194519	http://dx.doi.org/10.1371/journal.pone.0194519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672519	Green Published, gold, Green Submitted			2022-12-27	WOS:000430446800011
J	Shin, YB; Kim, JJ; Kim, MK; Kyeong, S; Jung, YH; Eom, H; Kim, E				Shin, Yu-Bin; Kim, Jae-Jin; Kim, Min-Kyeong; Kyeong, Sunghyon; Jung, Young Hoon; Eom, Hyojung; Kim, Eunjoo			Development of an effective virtual environment in eliciting craving in adolescents and young adults with internet gaming disorder	PLOS ONE			English	Article							INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; CUE EXPOSURE; CRITICAL PERIOD; REALITY; ADDICTION; DEPENDENCE; ALCOHOL; MINI; URGE	Internet gaming disorder (IGD) is a new disorder that warrants further investigation, as recently noted in the research criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Offering controlled environments that increase cue-induced craving, virtual reality cue-exposure therapy has been shown to be effective for some addiction disorders. To assess the feasibility of virtual reality for patients with IGD, this study aimed to develop virtual environments that represent risk situations for inducing craving, and assess the effect of virtual reality in cue reactivity. A total of 64 male adolescents and young adults (34 with IGD and 30 without) were recruited for participation. We developed a virtual internet cafe A environment and the participants were exposed to four different tasks. As the primary feasibility outcome, cravings were measured with a visual analogue scale measuring current urge to play a game after exposure to each task. The virtual internet cafe A induced significantly greater cravings in patients with IGD compared to controls. Additionally, patients exhibited a significantly higher acceptance rate of an avatar's invitation to play a game together than that of controls. In IGD, craving response to the tasks was positively associated with the symptom severity score as measured by Young's Internet Addiction Test. These findings reveal that virtual reality laden with complex game-related cues could evoke game craving in patients with IGD and could be used in the treatment of IGD as a cue-exposure therapy tool for eliciting craving.	[Shin, Yu-Bin; Kim, Jae-Jin; Jung, Young Hoon; Eom, Hyojung] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Shin, Yu-Bin; Kim, Jae-Jin; Kim, Min-Kyeong; Kyeong, Sunghyon; Jung, Young Hoon; Eom, Hyojung; Kim, Eunjoo] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; [Kim, Jae-Jin; Kim, Min-Kyeong; Kim, Eunjoo] Yonsei Univ, Gangnam Severance Hosp, Dept Psychiat, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, E (corresponding author), Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea.; Kim, E (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Psychiat, Seoul, South Korea.	EJKIM96@yuhs.ac	Kim, Eunjoo/GLN-2706-2022; Eom, Hyojung/HGE-9901-2022	Eom, Hyojung/0000-0003-4600-320X; Kyeong, Sunghyon/0000-0002-9095-5219; Kim, Jae-Jin/0000-0002-1395-4562; Kim, Min-Kyeong/0000-0001-6044-9422; Kim, Eunjoo/0000-0003-3061-2051	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2015M3C7A1065053]	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2015M3C7A1065053) to Jae-Jin Kim.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ashrafioun L, 2012, J GAMBL STUD, V28, P363, DOI 10.1007/s10899-011-9262-0; Bordnick PS, 2012, RES SOCIAL WORK PRAC, V22, P293, DOI 10.1177/1049731511426880; Bouchard S, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00027; Brand M, 2011, CYBERPSYCH BEH SOC N, V14, P371, DOI 10.1089/cyber.2010.0222; Carter BL, 1999, ADDICTION, V94, P327, DOI 10.1046/j.1360-0443.1999.9433273.x; Chambers R Andrew, 2003, J Gambl Stud, V19, P53, DOI 10.1023/A:1021275130071; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chan Philip A, 2006, Ann Gen Psychiatry, V5, P16, DOI 10.1186/1744-859X-5-16; Conklin CA, 2008, EXP CLIN PSYCHOPHARM, V16, P207, DOI 10.1037/1064-1297.16.3.207; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Donders J, 1997, PSYCHOL ASSESSMENT, V9, P15; Ferguson CJ, 2011, J PSYCHIATR RES, V45, P1573, DOI 10.1016/j.jpsychires.2011.09.005; Fow J, 2009, SURVIVAL GUIDE SOCIA; Fulkerson J., 1993, J GAMBL STUD, V9, P371, DOI DOI 10.1007/BF01014628; Gamito P, 2014, CYBERPSYCH BEH SOC N, V17, P556, DOI 10.1089/cyber.2013.0329; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Giovancarli C, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1224-5; Giroux I, 2013, CYBERPSYCH BEH SOC N, V16, P224, DOI 10.1089/cyber.2012.1573; Glantz K, 2003, PSYCHOTHERAPY, V40, P55, DOI 10.1037/0033-3204.40.1-2.55; Han DH, 2007, J ADDICT MED, V1, P133, DOI 10.1097/ADM.0b013e31811f465f; Hilgard J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00608; Hone-Blanchet A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00844; Kennedy R.S., 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Kim EJ, 2008, EUR PSYCHIAT, V23, P212, DOI 10.1016/j.eurpsy.2007.10.010; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2005, J NERV MENT DIS, V193, P273, DOI 10.1097/01.nmd.0000158373.85150.57; Kuntze MF, 2001, CYBERPSYCHOL BEHAV, V4, P497, DOI 10.1089/109493101750527051; Lee JS, 2008, PSYCHIAT INVEST, V5, P239, DOI 10.4306/pi.2008.5.4.239; Lim K, 2011, ETR&D-EDUC TECH RES, V59, P575, DOI 10.1007/s11423-011-9206-5; Liu L, 2016, ADDICTION BIOL; Lombard M., 2013, J INTERACTIVE ADVERT, V1, P56, DOI [10.1080/15252019.2001.10722051, DOI 10.1080/15252019.2001.10722051]; Loranger C., 2011, J CYBERTHERAPY REHAB, V4, P233; Marlatt G. A., 2005, RELAPSE PREVENTION M; Modesto-Lowe V, 1997, DRUG ALCOHOL DEPEN, V49, P9, DOI 10.1016/S0376-8716(97)00134-8; Musher-Eizenman DR, 2003, J DRUG EDUC, V33, P1, DOI 10.2190/YED0-BQA8-5RVX-95JB; NELSON CA, 1985, CHILD DEV, V56, P58, DOI 10.2307/1130173; Ng BD, 2005, CYBERPSYCHOL BEHAV, V8, P110, DOI 10.1089/cpb.2005.8.110; Park CB, 2015, ADDICT BEHAV, V41, P61, DOI 10.1016/j.addbeh.2014.09.027; Park CB, 2014, CYBERPSYCH BEH SOC N, V17, P262, DOI 10.1089/cyber.2013.0253; Park SY, 2016, COMPUT METH PROG BIO, V129, P99, DOI 10.1016/j.cmpb.2016.01.015; Pawlikowski M, 2011, PSYCHIAT RES, V188, P428, DOI 10.1016/j.psychres.2011.05.017; Pericot-Valverde I, 2014, NICOTINE TOB RES, V16, P1470, DOI 10.1093/ntr/ntu104; Petry NM, 2013, ADDICTION, V108, P1186, DOI 10.1111/add.12162; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; Smith DP, 2015, J GAMBL STUD, V31, P299, DOI 10.1007/s10899-013-9408-3; Tahiroglu AY, 2008, CYBERPSYCHOL BEHAV, V11, P537, DOI 10.1089/cpb.2007.0165; Thompson-Lake D. G., 2014, NICOTINE TOB RES; Tsitsika A, 2009, EUR J PEDIATR, V168, P655, DOI 10.1007/s00431-008-0811-1; Van Gucht D, 2010, J BEHAV THER EXP PSY, V41, P172, DOI 10.1016/j.jbtep.2009.12.004; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019660; Washton AM, 2000, PSYCHOTHERAPEUTIC SK, P139; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Wu CS, 2007, CYBERPSYCHOL BEHAV, V10, P220, DOI 10.1089/cpb.2006.9965; Young K.S., 2009, INTERNET ADDICTION T; Zhang J-T, 2016, SCI REPORTS, V6, DOI [10.1038/s41598-016-0015-2, DOI 10.1038/S41598-016-0015-2]; Zhang Y, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2016.00007, DOI 10.3389/FPSYG.2016.00007]	59	17	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195677	10.1371/journal.pone.0195677	http://dx.doi.org/10.1371/journal.pone.0195677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672530	gold, Green Published, Green Submitted			2022-12-27	WOS:000430446800033
J	Silberstein, E; Serna, C; Fragoso, SP; Nagarkatti, R; Debrabant, A				Silberstein, Erica; Serna, Carylinda; Fragoso, Stenio Perdigao; Nagarkatti, Rana; Debrabant, Alain			A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging	PLOS ONE			English	Article							CHRONIC CHAGAS-DISEASE; PARASITE PERSISTENCE; REPORTER; TISSUE; DYNAMICS; REPLICATION; STRAINS; HOST; TCI	Chagas disease, caused by the intracellular protozoan Trypanosoma cruzi, affects 8-10 million people worldwide and represents a major public health challenge. There is no effective treatment or vaccine to control the disease that is characterized by a mild acute phase followed by a chronic life-long infection. Approximately 30% of chronically infected individuals develop cardiac and/or digestive pathologies. T. cruzi can invade a wide variety of nucleated cells, but only persists at specific tissues in the host. However, the mechanisms that determine tissue tropism and the progression of the infection have not been fully described. Identification of infection niches in animal models has been difficult due to the limited quantity of parasite-infected cells and their focal distribution in tissues during the chronic phase. To better understand the course of chronic infections and parasite dissemination, we developed a bioluminescence imaging system based on the use of transgenic T. cruzi Colombiana strain parasites expressing nanoluciferase. Swiss Webster mice were infected with luminescent trypomastigotes and monitored for 126 days. Whole animal in vivo imaging showed parasites predominantly distributed in the abdominal cavity and surrounding areas throughout the infection. Bioluminescence signal reached a peak between 14 to 21 days post infection (dpi) and decreased progressively over time. Total animal luminescence could still be measured 126 dpi while parasites remained undetectable in blood by microscopy in most animals. Ex vivo imaging of specific tissues and organs dissected post-mortem at 126 dpi revealed a widespread parasite distribution in the skeletal muscle, heart, intestines and mesenteric fat. Parasites were also detected in lungs and liver. This noninvasive imaging model represents a novel tool to study host-parasite interactions and to identify parasite reservoirs of chronic Chagas Disease.	[Silberstein, Erica; Serna, Carylinda; Nagarkatti, Rana; Debrabant, Alain] US FDA, Ctr Biol Evaluat & Res, Lab Emerging Pathogens, Silver Spring, MD USA; [Fragoso, Stenio Perdigao] Fiocruz MS, Inst Carlos Chagas, Lab Mol Biol Trypanosomatids, Curitiba, Parana, Brazil; [Serna, Carylinda] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Fundacao Oswaldo Cruz; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Debrabant, A (corresponding author), US FDA, Ctr Biol Evaluat & Res, Lab Emerging Pathogens, Silver Spring, MD USA.	alain.debrabant@fda.hhs.gov	Fragoso, Stenio/AAB-4703-2019	Fragoso, Stenio/0000-0002-0909-7940	US Food and Drug Administration	US Food and Drug Administration	Research was supported by intramural grants from the US Food and Drug Administration to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriani G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001298; Anez N, 1999, AM J TROP MED HYG, V60, P726, DOI 10.4269/ajtmh.1999.60.726; Barreto-de-Albuquerque J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003849; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Buckner FS, 1999, INFECT IMMUN, V67, P403, DOI 10.1128/IAI.67.1.403-409.1999; Caine EA, 2017, J VIROL, V91, DOI 10.1128/JVI.01759-16; Camandaroba Edson L.P., 2003, Rev. Soc. Bras. Med. Trop., V36, P201, DOI 10.1590/S0037-86822003000200002; Camandaroba Edson Luiz Paes, 2001, Revista da Sociedade Brasileira de Medicina Tropical, V34, P151, DOI 10.1590/S0037-86822001000200001; Canavaci AMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000740; CANÇADO J. Romeu, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P29, DOI 10.1590/S0036-46652002000100006; Capewell P, 2016, ELIFE, V5; Chatelain E, 2015, DRUG DES DEV THER, V9, P4807, DOI 10.2147/DDDT.S90208; de Araujo FF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003451; England CG, 2016, BIOCONJUGATE CHEM, V27, P1175, DOI 10.1021/acs.bioconjchem.6b00112; Espinoza B, 2011, INT J BIOL SCI, V7, P1357, DOI 10.7150/ijbs.7.1357; FEDERICI EE, 1964, AM J TROP MED HYG, V13, P272, DOI 10.4269/ajtmh.1964.13.272; Francisco AF, 2015, ANTIMICROB AGENTS CH, V59, P4653, DOI 10.1128/AAC.00520-15; Germain-Genevois C, 2016, MOL IMAGING BIOL, V18, P62, DOI 10.1007/s11307-015-0864-2; Guarner J, 2001, AM J TROP MED HYG, V65, P152, DOI 10.4269/ajtmh.2001.65.152; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Henriques C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-89; Hyland KV, 2008, INT J PARASITOL, V38, P1391, DOI 10.1016/j.ijpara.2008.04.002; Kessler RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067441; Lewis MD, 2016, CELL MICROBIOL, V18, P1429, DOI 10.1111/cmi.12584; Lewis MD, 2014, CELL MICROBIOL, V16, P1285, DOI 10.1111/cmi.12297; LOPES MF, 1995, EXP PARASITOL, V80, P194, DOI 10.1006/expr.1995.1024; Manne-Goehler J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005033; Ferreira AVM, 2011, MICROBES INFECT, V13, P1002, DOI 10.1016/j.micinf.2011.06.002; McLatchie AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002571; Mello DB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003945; MELO RC, 1978, J PARASITOL, V64, P475, DOI 10.2307/3279787; Morrot A, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2076.00704, 10.3389/fmicb.2016.00704]; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Nagarkatti R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002650; Andreu GLP, 2009, ARZNEIMITTELFORSCH, V59, P207; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Roffe E, 2016, INFECT IMMUN, V84, P1123, DOI 10.1128/IAI.01497-15; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Stacer AC, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00062; Sun CQ, 2014, J VIROL, V88, P2035, DOI 10.1128/JVI.02990-13; Tanowitz HB, 2017, TRENDS PARASITOL, V33, P276, DOI 10.1016/j.pt.2016.11.008; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Teixeira ARL, 2006, MEM I OSWALDO CRUZ, V101, P463, DOI 10.1590/S0074-02762006000500001; Traina Mahmoud, 2016, Curr Heart Fail Rep, V13, P295; Tran V, 2013, J VIROL, V87, P13321, DOI 10.1128/JVI.02381-13; Zhang L, 1999, J INFECT DIS, V180, P480, DOI 10.1086/314889; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	50	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195879	10.1371/journal.pone.0195879	http://dx.doi.org/10.1371/journal.pone.0195879			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672535	Green Published, gold, Green Submitted			2022-12-27	WOS:000430446800055
J	Conrad, Z; Niles, MT; Neher, DA; Roy, ED; Tichenor, NE; Jahns, L				Conrad, Zach; Niles, Meredith T.; Neher, Deborah A.; Roy, Eric D.; Tichenor, Nicole E.; Jahns, Lisa			Relationship between food waste, diet quality, and environmental sustainability	PLOS ONE			English	Article							NUTRITION TRANSITION; GREENHOUSE-GAS; CONSUMPTION; IRRIGATION; PHOSPHORUS; DRIVERS; IMPACTS; WATER; LAND	Improving diet quality while simultaneously reducing environmental impact is a critical focus globally. Metrics linking diet quality and sustainability have typically focused on a limited suite of indicators, and have not included food waste. To address this important research gap, we examine the relationship between food waste, diet quality, nutrient waste, and multiple measures of sustainability: use of cropland, irrigation water, pesticides, and fertilizers. Data on food intake, food waste, and application rates of agricultural amendments were collected from diverse US government sources. Diet quality was assessed using the Healthy Eating Index-2015. A biophysical simulation model was used to estimate the amount of cropland associated with wasted food. This analysis finds that US consumers wasted 422g of food per person daily, with 30 million acres of cropland used to produce this food every year. This accounts for 30% of daily calories available for consumption, one-quarter of daily food (by weight) available for consumption, and 7% of annual cropland acreage. Higher quality diets were associated with greater amounts of food waste and greater amounts of wasted irrigation water and pesticides, but less cropland waste. This is largely due to fruits and vegetables, which are health-promoting and require small amounts of cropland, but require substantial amounts of agricultural inputs. These results suggest that simultaneous efforts to improve diet quality and reduce food waste are necessary. Increasing consumers' knowledge about how to prepare and store fruits and vegetables will be one of the practical solutions to reducing food waste.	[Conrad, Zach; Jahns, Lisa] ARS, USDA, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58203 USA; [Niles, Meredith T.] Univ Vermont, Dept Nutr & Food Sci, Food Syst Program, Burlington, VT USA; [Neher, Deborah A.] Univ Vermont, Dept Plant & Soil Sci, Burlington, VT 05405 USA; [Roy, Eric D.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Tichenor, Nicole E.] Univ New Hampshire, Sustainabil Inst, Durham, NH 03824 USA	United States Department of Agriculture (USDA); University of Vermont; University of Vermont; University of Vermont; University System Of New Hampshire; University of New Hampshire	Conrad, Z (corresponding author), ARS, USDA, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58203 USA.	zach.conard@ars.usda.gov	Neher, Deborah/H-2716-2019	Neher, Deborah/0000-0002-9647-8783; Conrad, Zach/0000-0001-5376-8775; Roy, Eric/0000-0001-6315-3061; Tichenor Blackstone, Nicole/0000-0001-8343-3650	United States Department of Agriculture, Agricultural Research Service [3062-51000-051-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the United States Department of Agriculture, Agricultural Research Service, 3062-51000-051-00D. There was no additional external funding received for this study.	[Anonymous], 2015, AM FACT FINDER ANN E; [Anonymous], 2016, FOOD NUTR DATABASE D; [Anonymous], 1980, LOSS ADJUSTED FOOD A; [Anonymous], 2016, ADV SUST MAT MAN 201; [Anonymous], 2018, NASS AGR SURVEYS; Behrens P, 2017, P NATL ACAD SCI US; Birney CI, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8494; Buzby J.C., 2014, USDA ERS EC INFORM B, V121; Buzby JC, 2006, 31 USDA ERS; Camargo GGT, 2013, BIOSCIENCE, V63, P263, DOI 10.1525/bio.2013.63.4.6; Chen MP, 2016, GLOBAL ENVIRON CHANG, V36, P139, DOI 10.1016/j.gloenvcha.2015.12.005; Dietary Guidelines Advisory Committee, 2015, SCI REP 2015 DIET GU; Eshel G, 2014, P NATL ACAD SCI USA, V111, P11996, DOI 10.1073/pnas.1402183111; Fischer CG, 2016, PLATES PYRAMINDS PLA; Freedman LS, 2008, J NUTR, V138, P1725, DOI 10.1093/jn/138.9.1725; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gill M, 2015, FOOD SECUR, V7, P493, DOI 10.1007/s12571-015-0453-x; Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283; Grocery Manufacturers Association, GROC IND LAUNCH NEW; Hebrok M, 2017, J CLEAN PROD, V151, P380, DOI 10.1016/j.jclepro.2017.03.069; Heller MC, 2015, J IND ECOL, V19, P391, DOI 10.1111/jiec.12174; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; McGuire V.L., 2017, WATER LEVEL RECOVERA; Micha R, 2014, BMJ-BRIT MED J, P348; Micha R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175149; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; National Cancer Institute National Institutes for Health, HEI TOOLS RES; National Cancer Institute National Institutes for Health, OV BACKGR HLTH EAT I; National Cancer Institute National Institutes of Health, REC POT APPR DIET AS; Nelson ME, 2016, ADV NUTR, V7, P1005, DOI 10.3945/an.116.012567; Peters C, 2016, ELEMENTA, P4; Peters CJ, 2007, RENEW AGR FOOD SYST, V22, P145, DOI 10.1017/S1742170507001767; Pimentel D., 2013, INTEGRATED PEST MANA, V3, P47; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Ridoutt BG, 2017, ADV NUTR, V8, P933, DOI 10.3945/an.117.016691; Roark RA, 2013, PUBLIC HEALTH NUTR, V16, P2, DOI 10.1017/S1368980012000985; Rockstrom J, 2016, LANCET, V387, P2364, DOI 10.1016/S0140-6736(16)30681-X; Roe BE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191813; Romani S, 2018, APPETITE, V121, P215, DOI 10.1016/j.appet.2017.11.093; Ruini Luca Fernando, 2015, Front Nutr, V2, P9, DOI 10.3389/fnut.2015.00009; Schindler DW, 2016, ENVIRON SCI TECHNOL, V50, P8923, DOI 10.1021/acs.est.6b02204; Smith JL, 1998, J FOOD PROTECT, V61, P1229, DOI 10.4315/0362-028X-61.9.1229; Spiker ML, 2017, J ACAD NUTR DIET, V117, P1031, DOI 10.1016/j.jand.2017.03.015; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Thyberg KL, 2016, RESOUR CONSERV RECY, V106, P110, DOI 10.1016/j.resconrec.2015.11.016; Thyberg KL, 2015, ENVIRON SCI TECHNOL, V49, P13946, DOI 10.1021/acs.est.5b03880; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; US Department of Agriculture Economic Research Service, 2017, AGR TOT FACT PROD GR; US Department of Health and Human Services and US Department of Agriculture, 2015, DIET GUID AM 2015 20, V8th; US Department of Health and Human Services and US Department of Agriculture, 2015, DIET GUID AM; US Department of Health and Human Services Centers for Disease Control and Prevention (CDC), 2017, NAT HLTH NUTR EX SUR; US Department of Health and Human Services National Center for Health Statistics, 2011, NAT HLTH NUTR EX SUR; VTT Group, VTT SENS DET SPOIL F; Wichelns D, 2006, AGR WATER MANAGE, V86, P114, DOI 10.1016/j.agwat.2006.07.014; Wilson NLW, 2017, FOOD QUAL PREFER, V55, P35, DOI 10.1016/j.foodqual.2016.08.004; Woodside JV, 2013, P NUTR SOC, V72, P236, DOI 10.1017/S0029665112003059	57	102	103	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195405	10.1371/journal.pone.0195405	http://dx.doi.org/10.1371/journal.pone.0195405			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668732	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200041
J	Delihas, N				Delihas, Nicholas			A family of long intergenic non-coding RNA genes in human chromosomal region 22q11.2 carry a DNA translocation breakpoint/AT-rich sequence	PLOS ONE			English	Article							LOW-COPY REPEATS; TRANSPOSABLE ELEMENTS; HUMAN TRANSCRIPTOME; DELETION SYNDROME; NF1 GENE; EXPRESSION; EVOLUTION; GENOMICS; REARRANGEMENTS; POLYMORPHISMS	FAM230C, a long intergenic non-coding RNA (lincRNA) gene in human chromosome 13 (chr13) is a member of lincRNA genes termed family with sequence similarity 230. An analysis using bioinformatics search tools and alignment programs was undertaken to determine properties of FAM230C and its related genes. Results reveal that the DNA translocation element, the Translocation Breakpoint Type A (TBTA) sequence, which consists of satellite DNA, Alu elements, and AT-rich sequences is embedded in the FAM230C gene. Eight lincRNA genes related to FAM230C also carry the TBTA sequences. These genes were formed from a large segment of the 3' half of the FAM230C sequence duplicated in chr22, and are specifically in regions of low copy repeats (LCR22)s, in or close to the 22q.11.2 region. 22q11.2 is a chromosomal segment that undergoes a high rate of DNA translocation and is prone to genetic deletions. FAM230C-related genes present in other chromosomes do not carry the TBTA motif and were formed from the 5' half region of the FAM230C sequence. These findings identify a high specificity in lincRNA gene formation by gene sequence duplication in different chromosomes.	[Delihas, Nicholas] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Delihas, N (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	Nicholas.delihas@stonybrook.edu		Delihas, Nicholas/0000-0002-1704-2587				Babcock M, 2003, GENOME RES, V13, P2519, DOI 10.1101/gr.1549503; Babcock M, 2007, GENOME RES, V17, P451, DOI 10.1101/gr.5651507; Bacolla A, 2006, NUCLEIC ACIDS RES, V34, P2663, DOI 10.1093/nar/gkl354; Bacolla A, 2016, NUCLEIC ACIDS RES, V44, P5673, DOI 10.1093/nar/gkw261; Chen HJ, 2017, GENOM PROTEOM BIOINF, V15, P201, DOI 10.1016/j.gpb.2017.02.003; Chen LL, 2016, TRENDS BIOCHEM SCI, V41, P761, DOI 10.1016/j.tibs.2016.07.003; Delihas N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1958-6; Demaerel W, 2017, AM J HUM GENET, V101, P616, DOI 10.1016/j.ajhg.2017.09.002; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Espinosa JM, 2017, TRENDS GENET, V33, P660, DOI 10.1016/j.tig.2017.07.005; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; FROMMER M, 1984, NUCLEIC ACIDS RES, V12, P2887, DOI 10.1093/nar/12.6.2887; Guna A, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9113-x; Guo XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093972; Guo XY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-71; Hadjiargyrou M, 2013, INT J MOL SCI, V14, P13307, DOI 10.3390/ijms140713307; Hsiao MC, 2014, HUM MUTAT, V35, P891, DOI 10.1002/humu.22569; Huang RY, 2016, CELL PHYSIOL BIOCHEM, V40, P707, DOI 10.1159/000452582; Hubley R, 2016, NUCLEIC ACIDS RES, V44, pD81, DOI 10.1093/nar/gkv1272; Inagaki H, 2005, HUM MUTAT, V26, P332, DOI 10.1002/humu.20228; Inagaki H, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00125; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jandura A, 2017, TRENDS GENET, V33, P665, DOI 10.1016/j.tig.2017.08.002; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Kapusta A, 2014, TRENDS GENET, V30, P439, DOI 10.1016/j.tig.2014.08.004; Kasinathan S, 2018, MOL BIOL EVOL, V35, P949, DOI 10.1093/molbev/msy010; Kato T, 2012, CURR OPIN GENET DEV, V22, P221, DOI 10.1016/j.gde.2012.02.004; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kurahashi H, 2007, GENOME RES, V17, P461, DOI 10.1101/gr.5769507; Lian YF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07954-7; Liu WH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4156-x; Lv XY, 2018, INT J ONCOL, V52, P288, DOI 10.3892/ijo.2017.4195; McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Papatheodorou I, 2018, NUCLEIC ACIDS RES, V46, pD246, DOI 10.1093/nar/gkx1158; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; PROSSER J, 1986, J MOL BIOL, V187, P145, DOI 10.1016/0022-2836(86)90224-X; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Terracciano D, 2017, BBA-REV CANCER, V1868, P449, DOI 10.1016/j.bbcan.2017.09.001; Tong MQ, 2010, HUM MOL GENET, V19, P2630, DOI 10.1093/hmg/ddq150; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wallace M, 2014, HUM MUTAT, V35, pV, DOI [10.1002/humu.22410, DOI 10.1002/HUMU.22410]; Yao K, 2017, H TUMOUR BIOL, V39, DOI [10.1177/1010428317707882, DOI 10.1177/1010428317707882]; Yuan ZX, 2016, INT J ONCOL, V48, P2675, DOI 10.3892/ijo.2016.3447; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141042	49	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195702	10.1371/journal.pone.0195702	http://dx.doi.org/10.1371/journal.pone.0195702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668722	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200053
J	Li, PC; Du, CC; Zhang, YY; Yin, SY; Zhang, EY; Fang, HM; Lin, DZ; Xu, CW; Yang, ZF				Li, Pengcheng; Du, Cancan; Zhang, Yingying; Yin, Shuangyi; Zhang, Enying; Fang, Huimin; Lin, Dezhou; Xu, Chenwu; Yang, Zefeng			Combined bulked segregant sequencing and traditional linkage analysis for identification of candidate gene for purple leaf sheath in maize (vol 13, e0190670, 2018)	PLOS ONE			English	Correction															National Key Technology Research and Development Programof MOST [2016YED0100300]; National Natural Science Foundations [31601810]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundations of Jiangsu Province [BK20150010]; Natural Science Foundation of the Jiangsu Higher Education Institutions [14KJA210005]; Innovative Research Team of Universities in Jiangsu Province	National Key Technology Research and Development Programof MOST; National Natural Science Foundations(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundations of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of the Jiangsu Higher Education Institutions; Innovative Research Team of Universities in Jiangsu Province	This work was supported by grants from National Key Technology Research and Development Program of MOST-2016YED0100300, The National Natural Science Foundations-31601810, The Priority Academic Program Development of Jiangsu Higher Education Institutions, The Natural Science Foundations of Jiangsu Province-BK20150010, Natural Science Foundation of the Jiangsu Higher Education Institutions-14KJA210005, Innovative Research Team of Universities in Jiangsu Province.	Li PC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190670	1	0	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196296	10.1371/journal.pone.0196296	http://dx.doi.org/10.1371/journal.pone.0196296			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668745	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200085
J	Locci, E; Noto, A; Puddu, M; Pomero, G; Demontis, R; Dalmazzo, C; Delogu, A; Fanos, V; d'Aloja, E; Gancia, P				Locci, Emanuela; Noto, Antonio; Puddu, Melania; Pomero, Giulia; Demontis, Roberto; Dalmazzo, Cristina; Delogu, Antonio; Fanos, Vassilios; d'Aloja, Ernesto; Gancia, Paolo			A longitudinal H-1-NMR metabolomics analysis of urine from newborns with hypoxic-ischemic encephalopathy undergoing hypothermia therapy. Clinical and medical legal insights	PLOS ONE			English	Article							NEONATAL ENCEPHALOPATHY; ASPHYXIA; INJURY; BRAIN; MODEL; INFANTS; BIRTH	Perinatal asphyxia is an event affecting around four million newborns worldwide. The 0.5 to 2 per 1000 of full term asphyxiated newborns suffer from hypoxic-ischemic encephalopathy (HIE), which is a frequent cause of death or severe disability and, as consequence, the most common birth injury claim for obstetrics, gynaecologists, and paediatricians. Perinatal asphyxia results from a compromised gas exchange that leads to hypoxemia, hypercapnia, and metabolic acidosis. In this work, we applied a metabolomics approach to investigate the metabolic profiles of urine samples collected from full term asphyxiated newborns with HIE undergoing therapeutic hypothermia (TH), with the aim of identifying a pattern of metabolites associated with HIE and to follow their modifications over time. Urine samples were collected from 10 HIE newborns at birth, during hypothermia (48 hours), at the end of the therapeutic treatment (72 hours), at 1 month of life, and compared with a matched control population of 16 healthy full term newborns. The metabolic profiles were investigated by H-1 NMR spectroscopy coupled with multivariate statistical methods such as principal component analysis and orthogonal partial least square discriminant analysis. Multivariate analysis indicated significant differences between the urine samples of HIE and healthy newborns at birth. The altered metabolic patterns, mainly originated from the depletion of cellular energy and homeostasis, seem to constitute a characteristic of perinatal asphyxia. The HIE urine metabolome changes over time reflected either the effects of TH and the physiological growth of the newborns. Of interest, the urine metabolic profiles of the HIE non-surviving babies, characterized by the increased excretion of lactate, resulted significantly different from the rest of HIE population.	[Locci, Emanuela; Demontis, Roberto; d'Aloja, Ernesto] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy; [Noto, Antonio; Puddu, Melania; Fanos, Vassilios] Univ Cagliari, Dept Surg Sci, Cagliari, Italy; [Noto, Antonio; Puddu, Melania; Fanos, Vassilios] Azienda Osped Univ, Puericulture Inst, Neonatal Intens Care Unit, Cagliari, Italy; [Noto, Antonio; Puddu, Melania; Fanos, Vassilios] Azienda Ospedaliera Univ, Neonatal Sect, Cagliari, Italy; [Pomero, Giulia; Dalmazzo, Cristina; Delogu, Antonio; Gancia, Paolo] ASO S Croce & Carle, Neonatal Intens Care, Neonatol, Cuneo, Italy	University of Cagliari; University of Cagliari; University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari	Locci, E (corresponding author), Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy.	elocci@unica.it	Locci, Emanuela/G-6524-2018; Fanos, Vassilios/AHI-0685-2022; demontis, roberto/AAX-7153-2020; d'Aloja, Ernesto/P-4539-2017	Locci, Emanuela/0000-0003-0237-4228; d'Aloja, Ernesto/0000-0003-4456-6252; Noto, Antonio/0000-0003-3538-0050				Al Yazidi G, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0415-7; American College of Obstetricians and Gynecologists & American Academy of Pediatrics, 2003, NEON ENC CER PALS DE; Ancora G, 2012, RACCOMANDAZIONI ASSI; [Anonymous], 2014, NEONATAL ENCEPHALOPA, P896; Atzori L, 2010, J MATERN-FETAL NEO M, V23, P134, DOI 10.3109/14767058.2010.517033; Beckstrom AC, 2011, J CHROMATOGR A, V1218, P1899, DOI 10.1016/j.chroma.2011.01.086; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Brocker Chad, 2012, Biomol Concepts, V3, P345; Broer S, 2001, J NEUROCHEM, V77, P705, DOI 10.1046/j.1471-4159.2001.00322.x; Carpentieri AM, 2015, OVERVIEW 2015 AM C O, P1; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chu CY, 2006, CLIN BIOCHEM, V39, P203, DOI 10.1016/j.clinbiochem.2006.01.006; Chun PT, 2015, DEV NEUROSCI-BASEL, V37, P161, DOI 10.1159/000370147; d'Aloja E, 2009, J MATERN-FETAL NEO M, V22, P54, DOI 10.1080/14767050903198397; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; Denihan NM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/254076; Donn SM, 2012, MEDICOLEGAL ISSUES P, P58; Donn SM, 2014, SEMIN FETAL NEONAT M, V19, P317, DOI 10.1016/j.siny.2014.08.005; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Fanos V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731620; Fattuoni C, 2015, MOLECULES, V20, P7000, DOI 10.3390/molecules20047000; Gebicki J, 2003, POL J PHARMACOL, V55, P109; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Ide Bergamaschi N, 2015, J PEDIAT NEONAT INDI, V4, P36; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Karlsson M, 2010, ACTA PAEDIATR, V99, P1139, DOI 10.1111/j.1651-2227.2010.01802.x; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; Logitharajah P, 2009, PEDIATR RES, V66, P222, DOI 10.1203/PDR.0b013e3181a9ef34; Longini M, 2015, CLIN CHIM ACTA, V444, P250, DOI 10.1016/j.cca.2015.02.004; Lou BS, 2014, HIGH ALT MED BIOL, V15, P192, DOI 10.1089/ham.2013.1130; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Okereafor A, 2008, PEDIATRICS, V121, P906, DOI 10.1542/peds.2007-0770; Reinke SN, 2013, J PROTEOME RES, V12, P4230, DOI 10.1021/pr400617m; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; Sabir H, 2015, SEMIN FETAL NEONAT M, V20, P115, DOI 10.1016/j.siny.2014.10.006; Sanchez-Illana A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17202-7; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shah P, 2004, ARCH DIS CHILD-FETAL, V89, P152, DOI 10.1136/adc.2002.023093; Shah Sachin, 2004, J Perinatol, V24, P16, DOI 10.1038/sj.jp.7211023; Shankaran S, 2014, CLIN PERINATOL, V41, P149, DOI 10.1016/j.clp.2013.10.008; Sieber M, 2009, TOXICOL SCI, V109, P336, DOI 10.1093/toxsci/kfp070; Skappak C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065035; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Walsh BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050520; Zheng Y, 2017, AM J NEURORADIOL, V38, P827, DOI 10.3174/ajnr.A5066	46	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194267	10.1371/journal.pone.0194267	http://dx.doi.org/10.1371/journal.pone.0194267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668681	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200007
J	Pindus, DM; Mullis, R; Lim, L; Wellwood, I; Rundell, AV; Abd Aziz, NA; Mant, J				Pindus, Dominika M.; Mullis, Ricky; Lim, Lisa; Wellwood, Ian; Rundell, A. Viona; Abd Aziz, Noor Azah; Mant, Jonathan			Stroke survivors' and informal caregivers' experiences of primary care and community healthcare services - A systematic review and meta-ethnography (vol 13, e0192533, 2018)	PLOS ONE			English	Correction														Lim, Lisa/0000-0002-3779-6095; Mant, Jonathan/0000-0002-9531-0268				Pindus DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192533	1	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196185	10.1371/journal.pone.0196185	http://dx.doi.org/10.1371/journal.pone.0196185			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668761	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200080
J	Schuster, TM; Setaro, SD; Tibbits, JFG; Batty, EL; Fowler, RM; McLay, TGB; Wilcox, S; Ades, PK; Bayly, MJ				Schuster, Tanja M.; Setaro, Sabrina D.; Tibbits, Josquin F. G.; Batty, Erin L.; Fowler, Rachael M.; McLay, Todd G. B.; Wilcox, Stephen; Ades, Peter K.; Bayly, Michael J.			Chloroplast variation is incongruent with classification of the Australian bloodwood eucalypts (genus Corymbia, family Myrtaceae)	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; HIGHER-LEVEL RELATIONSHIPS; PHYLOGENETIC ANALYSIS; SEQUENCE DATA; PHYLOGEOGRAPHIC PATTERNS; RETICULATE EVOLUTION; TASMANIAN EUCALYPTS; ANGOPHORA CAV; SPECIES TREES; MORPHOLOGY	Previous molecular phylogenetic analyses have resolved the Australian bloodwood eucalypt genus Corymbia (similar to 100 species) as either monophyletic or paraphyletic with respect to Angophora (9-10 species). Here we assess relationships of Corymbia and Angophora using a large dataset of chloroplast DNA sequences (121,016 base pairs; from 90 accessions representing 55 Corymbia and 8 Angophora species, plus 33 accessions of related genera), skimmed from high throughput sequencing of genomic DNA, and compare results with new analyses of nuclear ITS sequences (119 accessions) from previous studies. Maximum likelihood and maximum parsimony analyses of cpDNA resolve well supported trees with most nodes having >95% bootstrap support. These trees strongly reject monophyly of Corymbia, its two subgenera (Corymbia and Blakella), most taxonomic sections (Abbreviatae, Maculatae, Naviculares, Septentrionales), and several species. ITS trees weakly indicate paraphyly of Corymbia (bootstrap support <50% for maximum likelihood, and 71% for parsimony), but are highly incongruent with the cpDNA analyses, in that they support monophyly of both subgenera and some taxonomic sections of Corymbia. The striking incongruence between cpDNA trees and both morphological taxonomy and ITS trees is attributed largely to chloroplast introgression between taxa, because of geographic sharing of chloroplast clades across taxonomic groups. Such introgression has been widely inferred in studies of the related genus Eucalyptus. This is the first report of its likely prevalence in Corymbia and Angophora, but this is consistent with previous morphological inferences of hybridisation between species. Our findings (based on continent-wide sampling) highlight a need for more focussed studies to assess the extent of hybridisation and introgression in the evolutionary history of these genera, and that critical testing of the classification of Corymbia and Angophora requires additional sequence data from nuclear genomes.	[Schuster, Tanja M.; Batty, Erin L.; Fowler, Rachael M.; McLay, Todd G. B.; Bayly, Michael J.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Schuster, Tanja M.] Royal Bot Gardens Victoria, Natl Herbarium Victoria, Birdwood Ave, South Yarra, Vic, Australia; [Setaro, Sabrina D.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Tibbits, Josquin F. G.] La Trobe Univ, AgriBiosci Ctr, Dept Econ Dev Jobs Transport & Resources, Bundoora, Vic, Australia; [Wilcox, Stephen] Walter & Eliza Hall Inst Med Res, Genom Hub, 1G Royal Parade, Melbourne, Vic, Australia; [Ades, Peter K.] Univ Melbourne, Sch Ecosyst & Forest Sci, Melbourne, Vic, Australia	University of Melbourne; Wake Forest University; La Trobe University; University of Melbourne	Schuster, TM (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.; Schuster, TM (corresponding author), Royal Bot Gardens Victoria, Natl Herbarium Victoria, Birdwood Ave, South Yarra, Vic, Australia.	tanja.schuster@unimelb.edu.au		Schuster, Tanja M./0000-0003-0851-3372; Bayly, Michael/0000-0001-6836-5493	Hermon Slade Foundation [HSF14-09]; Bjarne K. Dahl Trust; University of Melbourne Botany Foundation	Hermon Slade Foundation; Bjarne K. Dahl Trust; University of Melbourne Botany Foundation	This research was funded by The Hermon Slade Foundation (grant HSF14-09 to TMS and JFGT; http://www.hermonslade.org.au), The Bjarne K. Dahl Trust (grants in 2014 and 2015 to MJB and PKA; https://dahltrust.org.au), and The University of Melbourne Botany Foundation (TMS support funds; http://science.unimelb.edu.au/engage/giving-to-science/botany-foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachir O, 2006, CARYOLOGIA, V59, P207, DOI 10.1080/00087114.2006.10797916; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; Barbour RC, 2008, FOREST ECOL MANAG, V256, P1, DOI 10.1016/j.foreco.2008.03.028; Batish DR, 2008, FOREST ECOL MANAG, V256, P2166, DOI 10.1016/j.foreco.2008.08.008; Baum D.A., 2013, TREE THINKING INTRO; Bayly MJ, 2008, CLADISTICS, V24, P131, DOI 10.1111/j.1096-0031.2007.00175.x; Bayly MJ, 2007, MOL PHYLOGENET EVOL, V44, P346, DOI 10.1016/j.ympev.2006.10.027; Bayly Michael J., 2016, Proceedings of the Royal Society of Victoria, V128, P12, DOI 10.1071/RS16002; Bayly MJ, 2013, MOL PHYLOGENET EVOL, V69, P704, DOI 10.1016/j.ympev.2013.07.006; Bentham G., 1866, FLORA AUSTRALIENSIS, VIII; BLAKE S. T., 1977, AUSTROBAILEYA, V1, P43; Blakely WF., 1965, KEY EUCALYPTS; Boland DJ, 2006, FOREST TREES AUSTR; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Burke JM, 2008, AUST SYST BOT, V21, P1, DOI 10.1071/SB07038; Carr DJ, 2002, BOT J LINN SOC, V139, P415, DOI 10.1046/j.1095-8339.2002.00062.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavanilles A.J., 1797, ICONES DESCRIPTIONES, V4; CHAH, 2017, AUSTR PLANT CENSUS; Chippendale G.M., 1988, FLORA AUSTR, V19, P542; CRAVEN L A, 1990, Australian Systematic Botany, V3, P727, DOI 10.1071/SB9900727; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAWSON J W, 1970, Blumea, V18, P431; Dickinson GR, 2012, ANN BOT-LONDON, V109, P1215, DOI 10.1093/aob/mcs050; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Gibbs AK, 2009, AUST SYST BOT, V22, P158, DOI 10.1071/SB08043; Gonzalez-Orozco CE, 2016, NAT CLIM CHANGE, V6, P1110, DOI [10.1038/NCLIMATE3126, 10.1038/nclimate3126]; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; GRIFFIN AR, 1988, AUST J BOT, V36, P41, DOI 10.1071/BT9880041; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hill K. D., 1995, Telopea, V6, P185; Holmes GD, 2014, AUST SYST BOT, V27, P56, DOI 10.1071/SB13045; Jackson HD, 1999, MOL ECOL, V8, P739, DOI 10.1046/j.1365-294X.1999.00614.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Ladiges PY, 2010, SPEC SYST, V3, P267; Ladiges PY, 2003, J BIOGEOGR, V30, P989, DOI 10.1046/j.1365-2699.2003.00881.x; LADIGES PY, 1984, AUST J BOT, V32, P561, DOI 10.1071/BT9840561; LADIGES PY, 1995, AUST SYST BOT, V8, P483, DOI 10.1071/SB9950483; Ladiges PY, 2000, AUST SYST BOT, V13, P149, DOI 10.1071/SB99011; LEACH G J, 1986, Telopea, V2, P749; LOW D, 1974, PLANTA MED, V26, P184, DOI 10.1055/s-0028-1097987; Macpherson J, 1939, MANKIND, V2, P175; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maddison WP, 2013, MESQUITE VERSION 3 1; Maiden JH, 1892, BIBLIO AUSTR EC BOT; Mayol M, 2001, MOL PHYLOGENET EVOL, V19, P167, DOI 10.1006/mpev.2001.0934; McKinnon GE, 2010, MOL ECOL, V19, P1367, DOI 10.1111/j.1365-294X.2010.04579.x; McKinnon GE, 2004, PHILOS T R SOC B, V359, P275, DOI 10.1098/rstb.2003.1391; McKinnon GE, 2001, EVOLUTION, V55, P703, DOI 10.1554/0014-3820(2001)055[0703:CSITTE]2.0.CO;2; McKinnon GE, 1999, AM J BOT, V86, P1038, DOI 10.2307/2656621; McLay TGB, 2017, HIGH QUALITY DNA EXT; Meudt HM, 2008, MOL PHYLOGENET EVOL, V47, P319, DOI 10.1016/j.ympev.2007.12.019; Nevill PG, 2014, TREE GENET GENOMES, V10, P1079, DOI 10.1007/s11295-014-0744-y; Nicolle D, 2015, CLASSIFICATION EUCAL; Ochieng JW, 2007, GENET MOL BIOL, V30, P1125, DOI 10.1590/S1415-47572007000600016; Ochieng JW, 2007, MOL PHYLOGENET EVOL, V44, P752, DOI 10.1016/j.ympev.2007.04.017; Packer J, 2012, J ETHNOPHARMACOL, V139, P244, DOI 10.1016/j.jep.2011.11.008; Paiva JAP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-137; Parra-O C, 2009, THESIS; Parra-O C, 2006, TAXON, V55, P653, DOI 10.2307/25065641; Parra-O C, 2009, AUST SYST BOT, V22, P384, DOI 10.1071/SB09028; Pollock LJ, 2015, AM NAT, V185, P784, DOI 10.1086/680983; Pollock LJ, 2013, J BIOGEOGR, V40, P155, DOI 10.1111/j.1365-2699.2012.02766.x; Pryor LD, 1971, CLASSIFICATION EUCAL; Rambaut A., 2016, FIGTREE TREE FIGURE; Ramezani H, 2002, FITOTERAPIA, V73, P261, DOI 10.1016/S0367-326X(02)00065-5; REID EJ, 1979, PLANTA MED, V36, P164, DOI 10.1055/s-0028-1097257; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Shepherd LD, 2011, J PLANT RES, V124, P311, DOI 10.1007/s10265-010-0379-5; Slee A.V., 2020, EUCLID EUCALYPTS AUS; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steane DA, 1998, AUST SYST BOT, V11, P25, DOI 10.1071/SB96028; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Steane DA, 1999, MOL PHYLOGENET EVOL, V12, P215, DOI 10.1006/mpev.1999.0612; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; THIELE K, 1988, CLADISTICS, V4, P23, DOI 10.1111/j.1096-0031.1988.tb00466.x; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; UDOVICIC F, 1995, MOL PHYLOGENET EVOL, V4, P247, DOI 10.1006/mpev.1995.1023; Udovicic F., 2000, Kew Bulletin, V55, P633, DOI 10.2307/4118780; Whittock S, 2003, T ROY SOC SOUTH AUST, V127, P27; Williams J. E., 1997, EUCALYPT ECOLOGY IND; Wilson PG, 2005, PLANT SYST EVOL, V251, P3, DOI 10.1007/s00606-004-0162-y	86	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195034	10.1371/journal.pone.0195034	http://dx.doi.org/10.1371/journal.pone.0195034			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668710	Green Published, gold			2022-12-27	WOS:000430290200022
J	Herner, A; Haller, B; Mayr, U; Rasch, S; Offman, L; Schmid, R; Huber, W				Herner, Alexander; Haller, Bernhard; Mayr, Ulrich; Rasch, Sebastian; Offman, Lea; Schmid, Roland; Huber, Wolfgang			Accuracy and precision of SCVO2 measured with the CeVOX-device: A prospective study in patients with a wide variation of SCVO2-values	PLOS ONE			English	Article							VENOUS OXYGEN-SATURATION; GOAL-DIRECTED RESUSCITATION; IN-VITRO EVALUATION; CRITICALLY-ILL; HEART-RATE; PRESSURE; OXIMETRY; INDEX	Introduction Central-venous oxygen saturation (SCVO2) is a key parameter of hemodynamic monitoring and has been suggested as therapeutic goal for resuscitation. Several devices offer continuous monitoring features. The CeVOX-device (Pulsion Medical Systems) uses a fibre-optic probe inserted through a conventional central-venous catheter (CVC) to obtain continuous SCVO2. Objectives Since there is a lack of studies validating the CeVOX, we prospectively analyzed data from 24 patients with CeVOX-monitoring. To increase the yield of lower SCVO2-values, 12 patients were equipped with a femoral CVC. Methods During the 8h study period SCVO2_CeVOX was documented immediately before withdrawal of blood to measure SCVO2 by blood gas analysis (SCVO2_BGA) 6min, 1h, 4h, 5h and 8h after the initial calibration. No further calibrations were performed. Results In patients with jugular CVC (primary endpoint; 60 measurements), bias, lower and upper limits of agreement (LLOA; ULOA) and percentage error (PE) of the estimate of SCVO2 (SCVO2_CeVOX_ jug) were acceptable with 0.45%, -13.0%, 13.9% and 16.6%, respectively. As supposed, SCVO2 was lower in the femoral compared to the jugular measurements (69.5 +/- 10.7 vs. 79.4 +/- 5.8%; p<0.001). While the bias (0.64%) was still acceptable, LLOA (-23.8%), ULOA (25.0%) and PE (34.5%) were substantially higher for femoral assessment of SCVO2 by the CeVOX (SCVO2_CeVOX_fem). Analysis of the entire data-pool with jugular as well as femoral CVCs allowed for a multivariate analysis which demonstrated that the position of the CVC per se was not independently associated with the bias SCVO2_CeVOX-SCVO2_BGA. The amount of the bias vertical bar SCVO2_CeVOX-SCVO2_BGA vertical bar was independently associated with the amount of the change of SCVO2_CeVOX compared to the initial calibration to SCVO2_BGA_baseline (vertical bar SCVO2_CeVOX-SCVO2_BGA_baseline vertical bar) as well as with low values of SCVO2_BGA_baseline. Furthermore, increasing time to the initial calibration was associated to the amount of the bias with borderline significance. A statistical model based on vertical bar SCVO2_CeVOX-SCVO2_BGA_baseline vertical bar and ''time to last calibration'' derived from an evaluation dataset (80 of 120 datasets, 16 of 24) provided a ROC-AUC of 0.903 to predict an amount of the bias vertical bar SCVO2_CeVOX-SCVO2_BGA vertical bar >= 5% in an independent validation group (40 datasets of 8 patients). Conclusion These findings suggest that the CeVOX device is capable to detect stability or instability of SCVO2_BGA. SCVO2_CeVOX accurately estimates SCVO2_BGA in case of stable values. However, intermittent measurement of SCVO2_BGA and re-calibration should be performed in case of substantial changes in SCVO2_CeVOX compared to baseline. Therefore, continuous measurement of ScvO(2) with the CeVOX cannot replace SCVO2_BGA in instable patients. On the other hand, CeVOX might be useful for the monitoring of stable patients as a pre-test tool for more differentiated monitoring in case of changes in SCVO2_CeVOX.	[Herner, Alexander; Mayr, Ulrich; Rasch, Sebastian; Offman, Lea; Schmid, Roland; Huber, Wolfgang] Tech Univ Munich, Med Klin & Poliklin 2, Klinikum Rechts Isar, Munich, Germany; [Haller, Bernhard] Tech Univ Munich, Inst Med Stat & Epidemiol, Klinikum Rechts Isar, Munich, Germany	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich	Huber, W (corresponding author), Tech Univ Munich, Med Klin & Poliklin 2, Klinikum Rechts Isar, Munich, Germany.	Wolfgang.Huber@tum.de	Haller, Bernhard/I-1943-2019	Haller, Bernhard/0000-0002-9723-393X; Rasch, Sebastian/0000-0002-7917-8017				Baulig W, 2008, ANAESTHESIA, V63, P412, DOI 10.1111/j.1365-2044.2007.05376.x; Baulig Werner, 2008, J Clin Monit Comput, V22, P183, DOI 10.1007/s10877-008-9123-2; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; Huber D, 2006, PEDIATR ANESTH, V16, P1257, DOI 10.1111/j.1460-9592.2006.01980.x; Huber W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153430; Huber W, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0024-x; Huber W, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.08.005; Huber W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103854; Kissoon N, 2010, ANAESTH INTENS CARE, V38, P883, DOI 10.1177/0310057X1003800512; Molnar Z, 2007, INTENS CARE MED, V33, P1767, DOI 10.1007/s00134-007-0743-7; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Muller M, 2007, PEDIATR ANESTH, V17, P51, DOI 10.1111/j.1460-9592.2006.02026.x; Osthaus WA, 2006, PEDIATR ANESTH, V16, P944, DOI 10.1111/j.1460-9592.2006.01905.x; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rady MY, 1996, AM J EMERG MED, V14, P218, DOI 10.1016/S0735-6757(96)90136-9; Reinhart K, 2004, INTENS CARE MED, V30, P1572, DOI 10.1007/s00134-004-2337-y; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers E P, 2001, Curr Opin Crit Care, V7, P204, DOI 10.1097/00075198-200106000-00011; Squara P, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0579-9; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0192073	10.1371/journal.pone.0192073	http://dx.doi.org/10.1371/journal.pone.0192073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664900	Green Submitted, Green Published, gold			2022-12-27	WOS:000430262300001
J	Figueiredo-Braga, M; Cornaby, C; Bernardes, M; Figueiredo, M; Mesquita, CD; Costa, L; Poole, BD				Figueiredo-Braga, Margarida; Cornaby, Caleb; Bernardes, Miguel; Figueiredo, Marta; Mesquita, Cristina Dos Santos; Costa, Lucia; Poole, Brian D.			Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: The role of suffering in chronic autoimmune disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; COGNITIVE FUNCTION; SLEEP QUALITY; SELF-REPORT; FATIGUE; TELEPHONE; ANXIETY; SCALE	Background Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects a large number of people throughout the world. Anxiety, depression and fatigue are common symptoms of SLE that substantially contribute to decreased quality of life. This study investigates the interplay between physical and psychiatric manifestations of lupus. To this end, an SLE patient cohort was examined for correlations between clinical presentation, laboratory tests, and psychological indicators. Methods Seventy-two lupus patients were evaluated for psychological status using a battery of instruments, including assessments for fatigue (CFS & FSS), depression (HADS), anxiety (HADS), overall health (SF-36 & PSQI) and intimate relationship satisfaction (RAS & CSI). Scores from these assessments were correlated with lupus clinical profiles and laboratory test values. Results The prevalence of depression in the SLE patient cohort was 41.7%, as measured by the hospital depression and anxiety scale. The study identified that pain (p = 0.001), body mass index (p = 0.026), Chalder's fatigue scale (p < 0.001), fatigue severity scale (p < 0.001), and anxiety (p = 0.001) are all positively correlated with depression in SLE patients. Total complement (CH50) (p = 0.032), and SF-36 physical and mental characteristic assessments are negatively correlated with depression. Longitudinal analysis indicated that the disease related complaint alopecia (p = 0.008) and relationship assessment scale scores (p = 0.004) may also be correlated to depression in SLE patients. Multivariant scrutiny of the clinical and psychosocial characteristics identified the fatigue severity scale (p = 0.026), SF-36 physical function (p = 0.040), physical role function (0.030), and mental health (p = 0.002) as the best indicators directly correlated with depression for the SLE cohort. Conclusion These results reveal the influence of physical manifestations of lupus including fatigue, pain, body mass index and anxiety, as well as decreased physical and mental function, on depression. Fatigue is the strongest factor correlated with depression in SLE patients in the cohort. Both physical and social/psychological aspects likely contribute to the depression and anxiety in lupus.	[Figueiredo-Braga, Margarida; Figueiredo, Marta] Univ Porto, Fac Med, Dept Clin Neurosci & Mental Hlth, Med Psychol Unit, Porto, Portugal; [Figueiredo-Braga, Margarida] Inst Invest & Inovacao Saude I3S, Porto, Portugal; [Cornaby, Caleb; Poole, Brian D.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Bernardes, Miguel; Costa, Lucia] Hosp Sao Joao EPE, Rheumatol Dept, Porto, Portugal; [Mesquita, Cristina Dos Santos] Univ Minho, DPA, Minho, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Brigham Young University; Sao Joao Hospital; Universidade do Minho	Poole, BD (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	bpoole@gmail.com	Figueiredo-Braga, Margarida M/L-8040-2013	Figueiredo-Braga, Margarida M/0000-0003-2374-4371; Mesquita, Cristina/0000-0003-3678-1200; Poole, Brian/0000-0002-3205-640X; Cornaby, Caleb/0000-0003-1098-1378	Fulbright commission: Portugal, scholar program; Fulbright scholar program	Fulbright commission: Portugal, scholar program; Fulbright scholar program	BLIP was funded by the Fulbright commission: Portugal, scholar program. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Fulbright scholar program for funding Dr. Poole.	Alexander JJ, 2005, J IMMUNOL, V175, P8312, DOI 10.4049/jimmunol.175.12.8312; [Anonymous], 2007, ARTHRIT RHEUM-ARTHR, V57, P1348, DOI 10.1002/art.23113; Buysse D J, 1989, Psychiatry Res, V28, P193; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Choi ST, 2012, CLIN EXP RHEUMATOL, V30, P665; COHEN BB, 1995, ALCOHOL CLIN EXP RES, V19, P1156, DOI 10.1111/j.1530-0277.1995.tb01595.x; Denburg SD, 1997, J RHEUMATOL, V24, P998; Ferreira P L, 2000, Acta Med Port, V13, P55; Figueiredo-Braga M, 2009, ANN NY ACAD SCI, V1173, P286, DOI 10.1111/j.1749-6632.2009.04647.x; Fonseca RB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/542678; Funk JL, 2007, J FAM PSYCHOL, V21, P572, DOI 10.1037/0893-3200.21.4.572; Gao HX, 2009, J NEUROIMMUNOL, V207, P45, DOI 10.1016/j.jneuroim.2008.11.009; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; Inoue M, 2017, CLIN RHEUMATOL, V36, P1053, DOI 10.1007/s10067-017-3545-5; Iverson GL, 2001, J CLIN PSYCHOL, V57, P1579, DOI 10.1002/jclp.1120; Jorge A, 2017, ARTHRIT CARE RES, V69, P5, DOI 10.1002/acr.22992; Jump RL, 2005, J RHEUMATOL, V32, P1699; Karol DE, 2013, PSYCHOSOMATICS, V54, P443, DOI 10.1016/j.psym.2012.09.004; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Lawrence DA, 2007, J NEUROIMMUNOL, V182, P185, DOI 10.1016/j.jneuroim.2006.10.017; Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428; Mak A, 2013, LUPUS, V22, P254, DOI 10.1177/0961203312471872; Manne S, 2010, PSYCHO-ONCOLOGY, V19, P941, DOI 10.1002/pon.1645; Marcolino José Álvaro Marques, 2007, Rev. Bras. Anestesiol., V57, P157, DOI 10.1590/S0034-70942007000200004; Monk TH, 2013, J SLEEP RES, V22, P201, DOI 10.1111/jsr.12003; Morris G, 2016, MOL NEUROBIOL, V53, P1195, DOI 10.1007/s12035-015-9090-9; Nery FG, 2007, COMPR PSYCHIAT, V48, P14, DOI 10.1016/j.comppsych.2006.04.002; Pais-Ribeiro J, 2007, Psychol Health Med, V12, P225, DOI 10.1080/13548500500524088; Palmieri PA, 2010, J CLIN SLEEP MED, V6, P557; Petri M, 2013, J RHEUMATOL, V40, P1865, DOI 10.3899/jrheum.130046; Postal M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0471-9; Ramsey-Goldman R, 2010, PM&R, V2, P384, DOI 10.1016/j.pmrj.2010.03.026; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Sakic B, 2005, J NEUROIMMUNOL, V169, P68, DOI 10.1016/j.jneuroim.2005.08.010; Segui J, 2000, LUPUS, V9, P584, DOI 10.1191/096120300678828730; SIEMIATYCKI J, 1979, AM J PUBLIC HEALTH, V69, P238, DOI 10.2105/AJPH.69.3.238; Stock AD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00484; Stojanovich L, 2007, AUTOIMMUN REV, V6, P421, DOI 10.1016/j.autrev.2007.02.007; TSAI CY, 1994, SCAND J RHEUMATOL, V23, P57, DOI 10.3109/03009749409103028; van Exel E, 2013, LUPUS, V22, P1462, DOI 10.1177/0961203313508443; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wiseman SJ, 2017, LUPUS, V26, P588, DOI 10.1177/0961203316668417; Xie X, 2016, RHEUMATOL INT, V36, P1705, DOI 10.1007/s00296-016-3559-3; Yilmaz-Oner S, 2016, Z RHEUMATOL; Zhang LJ, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1234-1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zonana-Nacach A, 2000, LUPUS, V9, P101, DOI 10.1191/096120300678828046	49	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195579	10.1371/journal.pone.0195579	http://dx.doi.org/10.1371/journal.pone.0195579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659589	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100022
J	Yap, TA; Koo, MS; Ambrose, RF; Vredenburg, VT				Yap, Tiffany A.; Koo, Michelle S.; Ambrose, Richard F.; Vredenburg, Vance T.			Introduced bullfrog facilitates pathogen invasion in the western United States	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; LARVAL AMPHIBIAN COMMUNITIES; EMERGING INFECTIOUS-DISEASES; CHYTRID FUNGUS; RANA-CATESBEIANA; AMERICAN BULLFROG; CHYTRIDIOMYCOSIS; EMERGENCE; FROGS; BIODIVERSITY	Batrachochytrium dendrobatidis (Bd), a causal agent of the amphibian fungal skin disease chytridiomycosis, has been implicated in the decline and extinction of over 200 species worldwide since the 1970s. Despite almost two decades of research, the history of Bd and its global spread is not well understood. However, the spread of the Global Panzootic Line-age of Bd (Bd-GPL), the lineage associated with amphibian die-offs, has been linked with the American bullfrog (Rana [Aqurana] catesbeiana) and global trade. Interestingly, R. catesbeiana is native to the eastern U.S., where no Bd-related declines have been observed despite Bd's presence since the late 1800s. In contrast Bd has been found to have emerged in California and Mexico in the 1960s and 1970s, after which epizootics (i.e., epidemics in wildlife) ensued. We hypothesize that Bd-GPL spread from the eastern U.S. with the introduction of R. catesbeiana into the western US, resulting in epizootics and declines of native host species. Using museum records, we investigated the historical relationship between R. catesbeiana and Bd invasion in the western US and found that R. catesbeiana arrived in the same year or prior to Bd in most western watersheds that had data for both species, suggesting that Bd-GPL may have originated in the eastern US and R. catesbeiana may have facilitated Bd invasion in the western US. To predict areas with greatest suitability for Bd, we created a suitability model by integrating habitat suitability and host availability. When we incorporated invasion history with high Bd suitability, we found that watersheds with non-native R. catesbeiana in the mountain ranges of the West Coast have the highest disease risk. These findings shed light on the invasion history and disease dynamics of Bd in North America. Targeted historical surveys using archived specimens in natural history collections and present-day field surveys along with more localized, community-level studies, monitoring, and surveillance are needed to further test this hypothesis and grow our understanding of the disease ecology and host-pathogen dynamics of Bd.	[Yap, Tiffany A.; Ambrose, Richard F.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA USA; [Yap, Tiffany A.; Koo, Michelle S.; Vredenburg, Vance T.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Yap, Tiffany A.; Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Ambrose, Richard F.] Univ Calif Los Angeles, Dept Environm Hlth Sci, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Berkeley; California State University System; San Francisco State University; University of California System; University of California Los Angeles	Vredenburg, VT (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.; Vredenburg, VT (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	vancev@sfsu.edu	KOO, Michelle S./AAD-8688-2020	KOO, Michelle S./0000-0003-0410-722X; Vredenburg, Vance/0000-0002-9682-1190	National Science Foundation [1258133, 1633948, 1441652]; NSF [1258133, 1633948, 1441652]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by National Science Foundation 1258133, 1633948 (V.T.V.), and 1441652 (M.S.K.).; We thank Vredenburg Lab collaborators and Bd-Maps for georeferenced Bd occurrence data. We thank the IUCN and AmphibiaWeb for range map data. We thank the United States Geological Survey for R. catesbeiana range data and watershed boundary data. We thank Thomas Gillespie, James Lloyd-Smith, Richard Vance, and anonymous reviewers for valuable feedback and suggestions. We thank the AmphibiaWeb and Biodiversity Informatics undergraduate apprentices at the Museum of Vertebrate Zoology (University of California, Berkeley) for species range work, and we thank MVZ staff for technical support of this research. We thank Ben de Jesus for design assistance with the figures. Funding for this project was from NSF grants 1258133 and 1633948 to VTV. The spatial data was, in part, the product of NSF grant 1441652 ("VertLife Terrestrial") to MSK.	Alroy J, 2015, P NATL ACAD SCI USA, V112, P13003, DOI 10.1073/pnas.1508681112; AmphibiaWeb, 2016, INF AMPH BIOL CONS; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bai CM, 2010, ECOHEALTH, V7, P127, DOI 10.1007/s10393-010-0307-0; Bales EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116405; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Bd-Maps, 2014, GLOB BD MAPP PROJ; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Bielby J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10828; BLAUSTEIN AR, 1994, BIOL CONSERV, V67, P251, DOI 10.1016/0006-3207(94)90616-5; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Borzee AEL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177860; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson C, 2007, ENVIRON SCI TECHNOL, V41, P1771, DOI 10.1021/es0611947; De Leon ME, 2017, ECOHEALTH, V14, P155, DOI 10.1007/s10393-016-1201-1; DiRenzo GV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093356; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Ghirardi R, 2017, BELG J ZOOL, V147, P81, DOI 10.26496/bjz.2017.7; Grant EHC, 2017, FRONT ECOL ENVIRON, V15, P214, DOI 10.1002/fee.1481; Grant EHC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25625; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huss M, 2013, ECOHEALTH, V10, P339, DOI 10.1007/s10393-013-0895-6; James TY, 2015, ECOL EVOL, V5, P4079, DOI 10.1002/ece3.1672; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Liu X, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2506; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mainali KP, 2015, GLOBAL CHANGE BIOL, V21, P4464, DOI 10.1111/gcb.13038; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; McMahon TA, 2014, NATURE, V511, P224, DOI 10.1038/nature13491; Merow C, 2013, PRACTICAL GUIDE MAXE, P1058, DOI [10.1111/j.1600-0587.2013.07872, DOI 10.1111/J.1600-0587.2013.07872]; Muletz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103728; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Padgett-Flohr GE, 2008, HERPETOL CONSERV BIO, V3, P182; Parris MJ, 2004, OECOLOGIA, V140, P626, DOI 10.1007/s00442-004-1631-2; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2013, ECOLOGY, V94, P1409, DOI 10.1890/12-1520.1; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Richgels KLD, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150616; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Rodder D, 2013, NORTH-WEST J ZOOL, V9, P178; Roedder Dennis, 2009, Diversity, V1, P52; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Scheele BC, 2017, CONSERV BIOL, V31, P592, DOI 10.1111/cobi.12830; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Sette CM, 2015, BIOL CONSERV, V192, P20, DOI 10.1016/j.biocon.2015.08.039; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Spitzen-Van der Sluijs A, 2014, CONSERV BIOL, V28, P1302, DOI 10.1111/cobi.12281; Talley BL, 2015, BIOL CONSERV, V182, P254, DOI 10.1016/j.biocon.2014.12.007; Thorne LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043167; van Steenis W., 2021, IUCN RED LIST THREAT, pe.T149165436A149165446, DOI [10.2305/IUCN.UK.2021-3.RLTS.T149165436A149165446.en, DOI 10.2305/IUCN.UK.2021-1.RLTS.T49254712A49256721]; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Vredenburg VT, 2008, THREATENED AMPHIBIAN, P126; Xie GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160746; Yap TA, 2015, SCIENCE, V349, P481, DOI 10.1126/science.aab1052; Yuan ZY, 2016, SYST BIOL, V65, P824, DOI 10.1093/sysbio/syw055	79	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0188384	10.1371/journal.pone.0188384	http://dx.doi.org/10.1371/journal.pone.0188384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659568	Green Published, gold			2022-12-27	WOS:000430061100001
J	Zhang, C; Kong, JJ; Simonovic, SP				Zhang, Chao; Kong, Jingjing; Simonovic, Slobodan P.			Modeling joint restoration strategies for interdependent infrastructure systems	PLOS ONE			English	Article							COMPLEX NETWORKS; CASCADING FAILURES; VULNERABILITY ANALYSIS; RECOVERY; RESILIENCE; TRANSPORTATION; ROBUSTNESS; DESIGN	Life in the modern world depends on multiple critical services provided by infrastructure systems which are interdependent at multiple levels. To effectively respond to infrastructure failures, this paper proposes a model for developing optimal joint restoration strategy for interdependent infrastructure systems following a disruptive event. First, models for (i) describing structure of interdependent infrastructure system and (ii) their interaction process, are presented. Both models are considering the failure types, infrastructure operating rules and interdependencies among systems. Second, an optimization model for determining an optimal joint restoration strategy at infrastructure component level by minimizing the economic loss from the infrastructure failures, is proposed. The utility of the model is illustrated using a case study of electric-water systems. Results show that a small number of failed infrastructure components can trigger high level failures in interdependent systems; the optimal joint restoration strategy varies with failure occurrence time. The proposed models can help decision makers to understand the mechanisms of infrastructure interactions and search for optimal joint restoration strategy, which can significantly enhance safety of infrastructure systems.	[Zhang, Chao] Shanghai Univ Finance & Econ, Res Ctr Modern Serv Sci & Technol, Shanghai, Peoples R China; [Zhang, Chao] Shanghai Univ Finance & Econ, Shanghai Key Lab Financial Informat Technol, Shanghai, Peoples R China; [Kong, Jingjing] Shanghai Normal Univ, Sch Civil Engn, Shanghai, Peoples R China; [Kong, Jingjing; Simonovic, Slobodan P.] Univ Western Ontario, Dept Civil & Environm Engn, London, ON, Canada; [Simonovic, Slobodan P.] Univ Western Ontario, Inst Catastroph Loss Reduct, London, ON, Canada	Shanghai University of Finance & Economics; Shanghai University of Finance & Economics; Shanghai Normal University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Kong, JJ (corresponding author), Shanghai Normal Univ, Sch Civil Engn, Shanghai, Peoples R China.; Kong, JJ (corresponding author), Univ Western Ontario, Dept Civil & Environm Engn, London, ON, Canada.	kongjingjing@shnu.edu.cn		Zhang, Chao/0000-0002-6863-6780; Kong, Jingjing/0000-0001-7543-8144	National Science Foundation of China [71301095, 71704111]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by National Science Foundation of China, grant number 71301095 to CZ and 71704111 to JK; the URL of the funder is "www.nsfc.gov.cn". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arab A, 2015, IEEE T SMART GRID, V6, P1046, DOI 10.1109/TSG.2015.2388736; Bochkov A, 2015, SAFETY SCI, V79, P229, DOI 10.1016/j.ssci.2015.06.008; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Carreras BA, 2009, CHAOS, V19, DOI 10.1063/1.3234238; Carreras BA, 2002, CHAOS, V12, P985, DOI 10.1063/1.1505810; Castet JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060402; Cavdaroglu B, 2013, ANN OPER RES, V203, P279, DOI 10.1007/s10479-011-0959-3; Coffrin C, 2012, P 26 AAAI C ARTIFICI, P455; Cuadra L, 2015, ENERGIES, V8, P9211, DOI 10.3390/en8099211; Cui PS, 2017, PHYSICA A, V469, P777, DOI 10.1016/j.physa.2016.11.068; Duenas-Osorio L, 2007, J INFRASTRUCT SYST, V13, P185, DOI 10.1061/(ASCE)1076-0342(2007)13:3(185); Fang YP, 2015, RISK ANAL, V35, P594, DOI 10.1111/risa.12396; Diniz AMF, 2015, ENERG EFFIC, V8, P417, DOI 10.1007/s12053-014-9292-4; Gonzalez AD, 2016, COMPUT-AIDED CIV INF, V31, P334, DOI 10.1111/mice.12171; Heath E.A., 2016, EURO J COMPUTAT OPTI, V12, P1; Holden R, 2013, SAFETY SCI, V53, P51, DOI 10.1016/j.ssci.2012.08.013; Inanloo B, 2016, SAFETY SCI, V84, P57, DOI 10.1016/j.ssci.2015.11.018; Johansson J, 2010, RELIAB ENG SYST SAFE, V95, P1335, DOI 10.1016/j.ress.2010.06.010; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; KUCZERA G, 1988, J WATER RES PL-ASCE, V114, P365, DOI 10.1061/(ASCE)0733-9496(1988)114:4(365); Lee EE, 2007, IEEE T SYST MAN CY C, V37, P1303, DOI 10.1109/TSMCC.2007.905859; Liu CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112363; Luna R, 2011, J INFRASTRUCT SYST, V17, P25, DOI 10.1061/(ASCE)IS.1943-555X.0000039; MacKenzie CA, 2016, ANN OPER RES, V236, P103, DOI 10.1007/s10479-014-1696-1; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nurre SG, 2012, EUR J OPER RES, V223, P794, DOI 10.1016/j.ejor.2012.07.010; Ouyang M, 2015, RELIAB ENG SYST SAFE, V141, P74, DOI 10.1016/j.ress.2015.03.011; Ouyang M, 2011, RELIAB ENG SYST SAFE, V96, P1462, DOI 10.1016/j.ress.2011.06.002; Ouyang M, 2009, SIMUL MODEL PRACT TH, V17, P817, DOI 10.1016/j.simpat.2009.02.001; Patterson SA, 2007, RELIAB ENG SYST SAFE, V92, P1183, DOI 10.1016/j.ress.2006.08.004; Rinaldi SA, 2001, IEEE CONTR SYST MAG, V21, P11, DOI 10.1109/37.969131; Vugrin ED, 2014, INT J CRIT INFRASTRU, V10, P218, DOI 10.1504/IJCIS.2014.066356; Wang JW, 2011, SAFETY SCI, V49, P807, DOI 10.1016/j.ssci.2010.10.003; Wang JP, 2011, IEEE INFOCOM SER, P1925, DOI 10.1109/INFCOM.2011.5934996; Wang MG, 2010, CHINESE J PHYS, V48, P805; Wang XY, 2017, COMMUN NONLINEAR SCI, V48, P63, DOI 10.1016/j.cnsns.2016.12.019; Xu NX, 2007, EARTHQ ENG STRUCT D, V36, P265, DOI 10.1002/eqe.623; Yijia, 2007, T CHINA ELECTROTECHN, V10, P26; Zhang C, 2018, SAFETY SCI, V102, P169, DOI 10.1016/j.ssci.2017.10.014	41	16	16	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195727	10.1371/journal.pone.0195727	http://dx.doi.org/10.1371/journal.pone.0195727			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649300	gold, Green Submitted, Green Published			2022-12-27	WOS:000429791900077
J	Hsu, TC; Yi, PJ; Lee, TY; Liu, JR				Hsu, Tsui-Chun; Yi, Ping-Jung; Lee, Ting-Yu; Liu, Je-Ruei			Probiotic characteristics and zearalenone-removal ability of a Bacillus licheniformis strain	PLOS ONE			English	Article							ESCHERICHIA-COLI O157H7; AFLATOXIN B-1; LACTOBACILLUS-CASEI; SURFACE BINDING; MYCOTOXIN; DETOXIFICATION; DEGRADATION; ADHESION; METABOLISM; ADSORPTION	Zearalenone (ZEN) is a mycotoxin produced by Fusarium species, which is one of the main animal feed contaminants causing reproductive disorders in livestock. The aim of this study was to evaluate the probiotic characteristics and ZEN removal ability of a Bacillus licheniformis strain CK1. The probiotic properties, including acidic tolerance, bile salt tolerance, adherence capability, and anti-pathogenic activities of CK1 were evaluated. CK1 survived after incubation at pH 2.0 or 3.0 for 3 h, grew well in LB broth containing 0.3% oxgall, possessed adherence capability to Caco-2 cells, and inhibited the growth of Escherichia coli O157: H7 and Listeria monocytogenes. The ZEN removal ability of CK1 was compared with a mineral mycotoxin-adsorbing agent, hydrated sodium calcium aluminosilicate (HSCAS), and a well-characterized biological mycotoxin-adsorbing agent, Lactobacillus rhamnosus GG (LGG). At 37 E C in phosphate-buffered saline (PBS, pH 7.0) containing 5 mu g mL(-1) of ZEN, the ZEN removal percentage of CK1 was 73.0%, which was significantly higher than that of HSCAS and LGG (45.9% and 48.4%, respectively). In the pH range of 2.5-8.0, CK1 removed up to 65% of ZEN. At temperatures between 4 and 42 E C, CK1 removed more than 75% of ZEN. In the adsorption stability analysis, the amounts of ZEN removed by CK1 was over 30% even after five consecutive rounds of washing procedures. These findings demonstrated that CK1 displayed probiotic characteristics and removed ZEN effectively. Therefore, CK1 has a great potential for the development of feed additive to remove ZEN.	[Hsu, Tsui-Chun; Yi, Ping-Jung; Lee, Ting-Yu; Liu, Je-Ruei] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Liu, Je-Ruei] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Liu, Je-Ruei] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Liu, JR (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Liu, JR (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Liu, JR (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan.	jrliu@ntu.edu.tw		LIU, JE-RUEI/0000-0002-2152-7536	National Taiwan University; Ministry of Science and Technology [MOST 105-2313-B-002-042-MY3, MOST 106-3114-B-002-005]; Council of Agriculture, Executive Yuan, Republic of China [105AS-2.3.3-AD-U1, 106AS-2.3.3-AD-U1]	National Taiwan University(National Taiwan University); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Council of Agriculture, Executive Yuan, Republic of China	This research was conducted using funds provided by National Taiwan University, grant MOST 105-2313-B-002-042-MY3 and MOST 106-3114-B-002-005 from the Ministry of Science and Technology, and grants 105AS-2.3.3-AD-U1 and 106AS-2.3.3-AD-U1 from the Council of Agriculture, Executive Yuan, Republic of China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altalhi AD, 2009, J HAZARD MATER, V161, P1166, DOI 10.1016/j.jhazmat.2008.04.068; [Anonymous], 2002, GUIDELINES EVALUATIO; Avantaggiato G, 2005, FOOD ADDIT CONTAM A, V22, P379, DOI 10.1080/02652030500058312; Ayscue P, 2009, FOODBORNE PATHOG DIS, V6, P461, DOI 10.1089/fpd.2008.0235; Belcoeil PA, 2003, VET RES, V34, P737, DOI 10.1051/vetres:2003031; Boudergue C., 2009, EFSA SUPP PUBL, V6, P22, DOI [DOI 10.2903/SP.EFSA.2009.EN-22, 10.2903/sp.efsa.2009.EN-22]; Bueno DJ, 2004, METH MOL B, V268, P133; Cho KJ, 2010, BIOTECHNOL LETT, V32, P1921, DOI 10.1007/s10529-010-0373-y; Danicke S, 2015, FOOD CHEM TOXICOL, V84, P225, DOI 10.1016/j.fct.2015.08.009; Diaz GJ, 2008, POULTRY SCI, V87, P727, DOI 10.3382/ps.2007-00403; DIEKMAN MA, 1992, J ANIM SCI, V70, P1615, DOI 10.2527/1992.7051615x; El-Nezami H, 2004, J AGR FOOD CHEM, V52, P4577, DOI 10.1021/jf049924m; El-Nezami H, 2002, APPL ENVIRON MICROB, V68, P3545, DOI 10.1128/AEM.68.7.3545-3549.2002; Fu GH, 2016, TOXINS, V8, DOI 10.3390/toxins8100300; Galvano F, 2001, J FOOD PROTECT, V64, P120, DOI 10.4315/0362-028X-64.1.120; Hancock IC, 1997, BIOCHEM SOC T, V25, P183, DOI 10.1042/bst0250183; Haskard C, 2000, CHEM-BIOL INTERACT, V128, P39, DOI 10.1016/S0009-2797(00)00186-1; Haskard CA, 2001, APPL ENVIRON MICROB, V67, P3086, DOI 10.1128/AEM.67.7.3086-3091.2001; Hsueh HY, 2010, J AGR FOOD CHEM, V58, P12182, DOI 10.1021/jf1035756; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; Jouany JP, 2007, ANIM FEED SCI TECH, V137, P342, DOI 10.1016/j.anifeedsci.2007.06.009; Kakeya H, 2002, BIOSCI BIOTECH BIOCH, V66, P2723, DOI 10.1271/bbb.66.2723; Karlovsky P, 2011, APPL MICROBIOL BIOT, V91, P491, DOI 10.1007/s00253-011-3401-5; Khanafari A, 2007, Pak J Biol Sci, V10, P2553, DOI 10.3923/pjbs.2007.2553.2556; KUIPERGOODMAN T, 1987, REGUL TOXICOL PHARM, V7, P253, DOI 10.1016/0273-2300(87)90037-7; Lee A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182220; Liu JR, 2005, APPL ENVIRON MICROB, V71, P6769, DOI 10.1128/AEM.71.11.6769-6775.2005; Megharaj M, 1997, LETT APPL MICROBIOL, V24, P329, DOI 10.1046/j.1472-765X.1997.00053.x; Merchant HA, 2011, EUR J PHARM SCI, V42, P3, DOI 10.1016/j.ejps.2010.09.019; Molnar O, 2004, SYST APPL MICROBIOL, V27, P661, DOI 10.1078/0723202042369947; Mumpton FA, 1999, P NATL ACAD SCI USA, V96, P3463, DOI 10.1073/pnas.96.7.3463; Niderkorn V, 2009, J APPL MICROBIOL, V106, P977, DOI 10.1111/j.1365-2672.2008.04065.x; Peltonen K, 2001, J DAIRY SCI, V84, P2152, DOI 10.3168/jds.S0022-0302(01)74660-7; Phillips TD, 1999, TOXICOL SCI, V52, P118, DOI 10.1093/toxsci/52.suppl_1.118; Popiel D, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-82; Ramos AJ, 1996, ANIM FEED SCI TECH, V62, P263, DOI 10.1016/S0377-8401(96)00968-6; Rodrigues I, 2012, TOXINS, V4, P663, DOI 10.3390/toxins4090663; Sanchez B, 2009, MICROBIOL-SGM, V155, P1708, DOI 10.1099/mic.0.025288-0; Sanchez B, 2008, FEMS IMMUNOL MED MIC, V54, P1, DOI 10.1111/j.1574-695X.2008.00454.x; Schatzmayr G, 2006, MOL NUTR FOOD RES, V50, P543, DOI 10.1002/mnfr.200500181; Scott PM, 1985, MYCOTOXINS CANADIAN; Shi YH, 2005, ASIAN AUSTRAL J ANIM, V18, P1305, DOI 10.5713/ajas.2005.1305; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Streit E, 2013, J SCI FOOD AGR, V93, P2892, DOI 10.1002/jsfa.6225; Takahashi-Ando N, 2002, BIOCHEM J, V365, P1, DOI 10.1042/BJ20020450; Tinyiro SE, 2011, FOLIA MICROBIOL, V56, P321, DOI 10.1007/s12223-011-0047-8; Varga J, 2005, INT J FOOD MICROBIOL, V99, P321, DOI 10.1016/j.ijfoodmicro.2004.10.034; Vila-Donat P, 2018, FOOD CHEM TOXICOL, V114, P246, DOI 10.1016/j.fct.2018.02.044; Vinderola CG, 2000, J DAIRY SCI, V83, P1905, DOI 10.3168/jds.S0022-0302(00)75065-X; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wu WJ, 2013, FOOD SCI BIOTECHNOL, V22, P433, DOI 10.1007/s10068-013-0098-5; Xu JH, 2016, FOOD CONTROL, V68, P244, DOI 10.1016/j.foodcont.2016.03.030; Yi PJ, 2011, WORLD J MICROB BIOT, V27, P1035, DOI 10.1007/s11274-010-0548-7; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030; Zoghi A, 2014, MINI-REV MED CHEM, V14, P84, DOI 10.2174/1389557513666131211105554	55	29	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194866	10.1371/journal.pone.0194866	http://dx.doi.org/10.1371/journal.pone.0194866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641608	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900052
J	Davies, TE; Epstein, G; Aguilera, SE; Brooke, CM; Cox, M; Evans, LS; Maxwell, SM; Nenadovic, M; Ban, NC				Davies, Tammy E.; Epstein, Graham; Aguilera, Stacy E.; Brooke, Cassandra M.; Cox, Michael; Evans, Louisa S.; Maxwell, Sara M.; Nenadovic, Mateja; Ban, Natalie C.			Assessing trade-offs in large marine protected areas	PLOS ONE			English	Article							SOCIAL-ECOLOGICAL SYSTEMS; ECOSYSTEM SERVICES; BIODIVERSITY CONSERVATION; MANAGEMENT; RESERVE; GOVERNANCE; SPILLOVER; COMMUNITY; FISHERIES; TOURISM	Large marine protected areas (LMPAs) are increasingly being established and have a high profile in marine conservation. LMPAs are expected to achieve multiple objectives, and because of their size are postulated to avoid trade-offs that are common in smaller MPAs. However, evaluations across multiple outcomes are lacking. We used a systematic approach to code several social and ecological outcomes of 12 LMPAs. We found evidence of three types of trade-offs: trade-offs between different ecological resources (supply trade-offs); trade-offs between ecological resource conditions and the well-being of resource users (supply-demand trade-offs); and trade-offs between the well-being outcomes of different resource users (demand trade-offs). We also found several divergent outcomes that were attributed to influences beyond the scope of the LMPA. We suggest that despite their size, trade-offs can develop in LMPAs and should be considered in planning and design. LMPAs may improve their performance across multiple social and ecological objectives if integrated with larger-scale conservation efforts.	[Davies, Tammy E.; Ban, Natalie C.] Univ Victoria, Sch Environm Studies, Victoria, BC, Canada; [Epstein, Graham] Univ Waterloo, Sch Environm Resources & Sustainabil, Environm Change & Governance Grp, Waterloo, ON, Canada; [Aguilera, Stacy E.] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Miami, FL USA; [Brooke, Cassandra M.] Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Stanford, CA 94305 USA; [Cox, Michael] Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA; [Evans, Louisa S.] Univ Exeter, Coll Life & Environm Sci, Geog, Exeter, Devon, England; [Evans, Louisa S.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia; [Maxwell, Sara M.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Nenadovic, Mateja] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Davies, Tammy E.] BirdLife Int, Cambridge, England	University of Victoria; University of Waterloo; University of Miami; Stanford University; Dartmouth College; University of Exeter; James Cook University; Old Dominion University; Duke University; BirdLife International	Davies, TE (corresponding author), Univ Victoria, Sch Environm Studies, Victoria, BC, Canada.; Davies, TE (corresponding author), BirdLife Int, Cambridge, England.	tedavies23@gmail.com	Epstein, Graham/AAX-4385-2020	Davies, Tammy/0000-0003-2535-1328; Epstein, Graham/0000-0003-3431-8511; Cox, Michael/0000-0002-3462-7798; Ban, Natalie/0000-0002-4682-2144; Brooks, Cassandra/0000-0002-1397-0394	Social Science and Humanities Research Council of Canada [435-2013-0059]; Natural Sciences and Engineering Research Council of Canada [435785]	Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	NCB thanks the Social Science and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca; 435-2013-0059), and Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsrg.gc.ca; 435785) for support.	Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Ban NC, 2017, GLOBAL ENVIRON CHANG, V43, P82, DOI 10.1016/j.gloenvcha.2017.01.003; Ban NC, 2015, ECOL SOC, V20, DOI 10.5751/ES-07857-200402; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bennett NJ, 2014, MAR POLICY, V44, P107, DOI 10.1016/j.marpol.2013.08.017; Biggs D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148862; Boonzaier L, 2016, ORYX, V50, P27, DOI 10.1017/S0030605315000848; Brooks JS, 2017, CONSERV LETT, V10, P23, DOI 10.1111/conl.12231; Brown CJ, 2015, CONSERV LETT, V8, P180, DOI 10.1111/conl.12124; CBD, 2010, C PART 10 COP 10 DEC; Chavarro SB, 2014, ANIM CONSERV, V17, P133, DOI 10.1111/acv.12066; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Christie P., 2004, AM FISH SOC S; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Clifton J, 2013, MAR POLICY, V41, P80, DOI 10.1016/j.marpol.2012.12.015; Cox M, 2014, INT J COMMONS, V8, P265, DOI 10.18352/ijc.406; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Davies TE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08758-5; Daw TM, 2015, P NATL ACAD SCI USA, V112, P6949, DOI 10.1073/pnas.1414900112; Day J., 2015, STOCK ASSESSMENT MAC; Edgar GJ, 2011, AQUAT CONSERV, V21, P313, DOI 10.1002/aqc.1187; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Fabinyi M, 2008, MAR POLICY, V32, P898, DOI 10.1016/j.marpol.2008.01.004; GBRMPA (Great Barrier Reef Marine Park Authority), 2014, GREAT BARR REEF OUTL; Glew L., 2015, STATE BIRDS HEAD SEA; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Gruby RL, 2016, CONSERV LETT, V9, P153, DOI 10.1111/conl.12194; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hicks CC, 2013, GLOBAL ENVIRON CHANG, V23, P1444, DOI 10.1016/j.gloenvcha.2013.07.028; Hirsch PD, 2011, CONSERV BIOL, V25, P259, DOI 10.1111/j.1523-1739.2010.01608.x; Jones PJS, 2013, MAR POLICY, V41, P65, DOI 10.1016/j.marpol.2012.12.019; Kittinger JN, 2011, J MARINE BIOL, V2010; Kittinger JN, 2010, MAR POLICY, V34, P208, DOI 10.1016/j.marpol.2009.06.007; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Koehn LE, 2017, ICES J MAR SCI, V74, P2448, DOI 10.1093/icesjms/fsx072; Leenhardt P, 2013, OCEAN COAST MANAGE, V85, P112, DOI 10.1016/j.ocecoaman.2013.08.013; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Marine Conservation Institute, 2015, MPATLAS SEATTL; Martin-Lopez B, 2011, ECOL ECON, V70, P1481, DOI 10.1016/j.ecolecon.2011.03.009; Maxwell SM, 2014, ENDANGER SPECIES RES, V26, P59, DOI 10.3354/esr00617; Maxwell SM, 2013, NATURE COMMUNICATION, P4; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Mouchet MA, 2014, GLOBAL ENVIRON CHANG, V28, P298, DOI 10.1016/j.gloenvcha.2014.07.012; Mullowney DRJ, 2014, REV FISH BIOL FISHER, V24, P639, DOI 10.1007/s11160-014-9349-7; Nakazawa M., 2015, FMSB FUNCTIONS MED S; Oracion EG, 2005, OCEAN COAST MANAGE, V48, P393, DOI 10.1016/j.ocecoaman.2005.04.013; Orams Mark, 1999, MARINE TOURISM DEV I; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Palacios PH, 2013, TOURISM EC ALTERNATI; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Rodriguez JP, 2006, ECOL SOC, V11; Samonte GP, 2016, J OCEAN COASTAL EC, V3, P2; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Smith MD, 2010, P NATL ACAD SCI USA, V107, P18300, DOI 10.1073/pnas.0907365107; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Team RC., 2013, R LANG ENV STAT COMP; TEEB, 2009, EC EC BIOD NAT INT P; Toonen RJ, 2013, MAR POLLUT BULL, V77, P7, DOI 10.1016/j.marpolbul.2013.10.039; Toral-Granda V, 2008, SEA CUCUMBERS GLOBAL; Velando A, 2011, BIOL CONSERV, V144, P1167, DOI 10.1016/j.biocon.2011.01.004; Wagner D, 2013, SHARED RES AGENDA LA; Wakamatsu M, 2017, MAR POLICY, V77, P97, DOI 10.1016/j.marpol.2016.12.016; Wallace BP, 2016, MARINE REPTILES; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Young HS, 2015, BIOL CONSERV, V181, P226, DOI 10.1016/j.biocon.2014.10.027	73	22	22	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195760	10.1371/journal.pone.0195760	http://dx.doi.org/10.1371/journal.pone.0195760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668750	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000430290200055
J	Gentry, AD; Parham, JF; Ehret, DJ; Ebersole, JA				Gentry, Andrew D.; Parham, James F.; Ehret, Dana J.; Ebersole, Jun A.			A new species of Peritresius Leidy, 1856 (Testudines: Pan-Cheloniidae) from the Late Cretaceous (Campanian) of Alabama, USA, and the occurrence of the genus within the Mississippi Embayment of North America	PLOS ONE			English	Article							SHELL BONE-HISTOLOGY; SEA-TURTLES; MARINE TURTLES; EVOLUTION; FOSSIL; MORPHOLOGY; MIOCENE; SPAIN	Late Cretaceous members of Peritresius belong to a diverse clade of marine adapted turtles currently thought to be some of the earliest representatives of the lineage leading to modern hard-shelled sea turtles (Pan-Cheloniidae). Prior studies have suggested that Peritresius was monospecific, with a distribution restricted to Maastrichtian deposits in North America. However, new Peritresius specimens identified from Alabama and Mississippi, USA, show that the genus contains two taxa, Peritresius ornatus, and a new species Peritresius martini sp. nov. These two taxa are characterized by the presence of a generally cordiform carapace with moderately serrated peripherals, well-developed ventral flanges beginning at the third peripheral, squarish umbilical and lateral plastral fontanelles, and a narrow bridge formed by the contact between the hyoplastron and hypoplastron. Peritresius martini sp. nov. can be distinguished by its lack of dermal ornamentation and the presence of a 'rib-free' 10th peripheral. These new specimens represent the first occurrences of Peritresius from the Late Cretaceous Mississippi Embayment and extend the temporal range of this genus back to the early Campanian. When tested within a global phylogenetic context, Peritresius is placed on the stem of Cheloniidae (Pan-Cheloniidae) along with Ctenochelys and Allopleuron hofmanni. The heavily vascularized and uniquely sculptured dermal elements of P. ornatus are interpreted here as potentially relating to thermoregulation and therefore may have been one of the key factors contributing to the survival of Peritresius into the Maastrichtian, a period of cooling when other lineages of Campanian marine turtles (e.g., Protostegids, Toxochelys, and Ctenochelys) went extinct.	[Gentry, Andrew D.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Parham, James F.] Calif State Univ Fullerton, Dept Geol Sci, Fullerton, CA 92634 USA; [Ehret, Dana J.] New Jersey State Museum, Trenton, NJ USA; [Ebersole, Jun A.] McWane Sci Ctr, Dept Collect, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; California State University System; California State University Fullerton	Gentry, AD (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	gentryd@uab.edu		Ehret, Dana/0000-0002-5041-5699; Gentry, Andrew/0000-0002-4361-725X; Ebersole, Jun/0000-0003-2382-4806	University of Alabama at Birmingham	University of Alabama at Birmingham	The authors would like to thank George Phillips (MMNS) and David Parris (NJSM) for access to the specimens in their care, as well as Thomas Jorstad and Amanda Millhouse with the Department of Paleobiology at USNM, for providing the photograph of the Toxochelys weeksi holotype in Fig 10. The authors also thank Kenneth Whetstone for donating hard-copies of many historical fossil turtle manuscripts to the ALMNH along with Jason Robinson and L. Majure for their donations of Peritresius ornatus specimens to MMNS. We would especially like to thank George Martin for his donation of the Peritresius martini holotype to ALMNH and T. Lynn Harrell Jr. for the additional prep work performed on this specimen following its donation. We thank Sandy Ebersole of the Geological Survey of Alabama for providing the GIS shape files necessary to produce Fig 1. Walter Joyce, Don Brinkman, and Adan Perez-Garcia provided crucial review commentary that greatly improved the quality of the manuscript and figures. Finally, the authors thank Ed Hooks who initiated the study into the type specimen of P. martini and then graciously allowed us to continue and complete his work. Travel to the FMNH was funded in part by a Catherine P. Ireland Travel Grant to ADG from the University of Alabama at Birmingham.	Agassiz L., 1843, RECHERCHES POISSONS, V3; Agassiz L., 1849, P ACAD NAT SCI PHILA, V4, P169; Baird D., 1964, NEW JERSEY STATE MUS, V11, P3; Batsch A.J.G.C., 1788, VERSUCH ANLEITUNG KE, P528; BAUR G, 1893, AM NAT, V27, P672; BOLLL H., 1951, JOUR PALEONTOL, V25, P187; Brinkman Donald, 2006, Paludicola, V5, P111; Brinkman DB, 2015, CAN J EARTH SCI, V52, P581, DOI 10.1139/cjes-2014-0189; Cadena Edwin A., 2015, PALEOBIOS, V32, P1; Caron M., 1985, P17; CobbanWand Kennedy W., 1993, CRETACEOUS AMMONITES, V2073, pB1; COLLINS R. LEE, 1951, JOUR TENNESSEE ACAD SCI, V26, P262; CoPE E. D., 1869, P BOSTON SOC NATURAL, V12, P250; Cope E. D., 1869, AM NAT, V3, DOI DOI 10.1086/270371; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Cope E. D., 1867, P NAT ACAD SCI PHIL, V1867, P41; Cope E. D, 1874, US GEOLOGICAL SURVEY, V1, P3; Cope E.D., 1869, GEOLOGY NEW JERSEY, P733; Cope E. D., 1871, P AM PHILOS SOC, V12, P174; Cope ED, 1873, P ACAD NAT SCI PHILA, V1873, P10; Cope ED., 1868, P ACAD NATURAL SCI, V1868, P242; Crawford NG, 2015, MOL PHYLOGENET EVOL, V83, P250, DOI 10.1016/j.ympev.2014.10.021; de Broin FD, 2014, GEOBIOS-LYON, V47, P111, DOI 10.1016/j.geobios.2014.02.002; Dockery III D, 2008, MISSISSIPPI GEOLOGY, V17, P1; DRANE CR, 1980, HERPETOLOGICA, V36, P60; Emmons E., 1858, REPORT N CAROLINA GE, VXV, P193; Gaffney E.S., 1972, American Museum Novitates, VNo. 2486, P1; Garman S., 1880, B MUS COMP ZOOL HARV, V6, P123; Gentry AD, 2017, J SYST PALAEONTOL, V15, P675, DOI 10.1080/14772019.2016.1217087; Gray JE, 1831, SYNOPSIS REPTILIUM 1, P85; Grigg G, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P297; Hall JT, 2008, PALAIOS, V23, P233, DOI 10.2110/palo.2006.p06-094r; Hay O., 1923, PAN AM GEOLOGIST, V39, p119 ; Hay O.P., 1908, CARNEGIE I WASHINGTO, V75, P568; Hay OP, 1905, B AM MUS NAT HIST, V21, P137; Hirayama R, 2003, PALAEONTOLOGY, V46, P845, DOI 10.1111/1475-4983.00322; Hirayama Ren, 1997, P225, DOI 10.1016/B978-012155210-7/50013-2; Hirayama Ren, 2006, Paleobios, V26, P1; Ikejiri Takehito, 2013, Bulletin Alabama Museum of Natural History, V31, P46; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2013, J PALEONTOL, V87, P612, DOI 10.1666/12-149; Joyce WG, 2004, J PALEONTOL, V78, P989, DOI 10.1666/0022-3360(2004)078<0989:DAPFTC>2.0.CO;2; Kaddumi H., 2006, NEW GENUS SPECIES GI, V3, P14; Laurenti J., 1768, SPECIMEN MEDICUM EXH, P215; Leidy J., 1855, P ACAD NAT SCI PHILA, V7, P395; Leidy J., 1870, P ACAD NAT SCI PHILA, V22, P12; Leidy J., 1856, P ACAD NAT SCI PHILA, V8, P303; Leriche M., 1906, MEMOIRES SOC GEOLOGI, V5, P430; Lindgren J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13187-5; Lydekker R., 1889, CATALOGUE FOSSIL REP, VIII, P239; Mancini EA, 1996, CRETACEOUS RES, V17, P645, DOI 10.1006/cres.1996.0035; Matzke AT, 2007, PALAEONTOLOGY, V50, P669, DOI 10.1111/j.1475-4983.2007.00650.x; Meyer von H., 1843, BRONN GERICHTET NEUE, V1843, P698; Miller H., 1955, J PALEONTOL, V34, p1 ; Mulder E., 2003, ALLOPLEURON HOFMANNI, p23 ; Nicholls E.L., 1988, Journal of Vertebrate Paleontology, V8, P181; Parham James F., 1997, Chelonian Conservation and Biology, V2, P548; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; Parham JF, 2005, J VERTEBR PALEONTOL, V25, P71, DOI 10.1671/0272-4634(2005)025[0071:AROTRO]2.0.CO;2; Parris DC, 2014, P ACAD NAT SCI PHILA, V163, P85, DOI 10.1635/053.163.0105; Perez-Garcia A, 2013, CRETACEOUS RES, V44, P64, DOI 10.1016/j.cretres.2013.03.011; Polcyn MJ, 2014, PALAEOGEOGR PALAEOCL, V400, P17, DOI 10.1016/j.palaeo.2013.05.018; PUCKETT T. M., 1992, T GULF COAST ASS GEO, V42, P613; Puckett TM., 2005, STRATIGRAPHY, V2, P117; Pyenson ND, 2014, PALAEOGEOGR PALAEOCL, V400, P1, DOI 10.1016/j.palaeo.2014.02.018; Rabi M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-203; Raymond D.E., 1988, CIRCULAR, V140, P97; Schein Jason P., 2013, Bulletin Alabama Museum of Natural History, V31, P78; Scheyer TM, 2015, ORG DIVERS EVOL, V15, P199, DOI 10.1007/s13127-014-0188-0; Scheyer TM, 2014, BIOL J LINN SOC, V112, P701, DOI 10.1111/bij.12265; SEIDEL MR, 1979, HERPETOLOGICA, V35, P375; Skutschas PP, 2017, CRETACEOUS RES, V79, P171, DOI 10.1016/j.cretres.2017.07.010; Texas Roemer C., 1849, NATURWISSENSCHAFTLIC, p[i, 1]; Villa A., 2015, B SOC PALEONTOLOGICA, V54, pI; WEEMS RE, 1988, P BIOL SOC WASH, V101, P109; WEEMS RE, 1974, J PALEONTOL, V48, P278; Weems RE, 2014, J VERTEBR PALEONTOL, V34, P80, DOI 10.1080/02724634.2013.792826; Wieland GR, 1896, AM J SCI, V212, P399, DOI DOI 10.2475/AJS.S4-2.12.399; Witzmann F, 2010, ZOOL J LINN SOC-LOND, V160, P302, DOI 10.1111/j.1096-3642.2009.00599.x; Wyneken, 2001, ANATOMY SEA TURTLES, P172; Zangerl R., 1960, Fieldiana Geology Memoir, V3, P279; ZANGERL R, 1980, AM ZOOL, V20, P585; Zangerl R., 1953, GEOLOGY MEMOIRS, V3, P137; Zangerl R, 1988, BISHOP MUSEUM B ZOOL, V1, P1	84	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195651	10.1371/journal.pone.0195651	http://dx.doi.org/10.1371/journal.pone.0195651			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668704	Green Published, gold			2022-12-27	WOS:000430290200051
J	Seikh, AH; Sherif, EM; Mohammed, SMAK; Baig, M; Alam, MA; Alharthi, N				Seikh, Asiful H.; Sherif, El-Sayed M.; Mohammed, Sohail M. A. Khan; Baig, Muneer; Alam, Mohammad Asif; Alharthi, Nabeel			Microstructure characterization and corrosion resistance properties of Pb-Sb alloys for lead acid battery spine produced by different casting methods	PLOS ONE			English	Article							ELECTROCHEMICAL-BEHAVIOR; SN ALLOYS; ANTIMONY; ELECTRODE; GROWTH; LAYER; NACL; AL	The aim of this study is to find out the microstructure, hardness, and corrosion resistance of Pb-5%Sb spine alloy. The alloy has been produced by high pressure die casting (HPDC), medium pressure die casting (AS) and low pressure die casting (GS) methods, respectively. The microstructure was characterized by using optical microscopy and scanning electron microscopy (SEM). The hardness was also reported. The corrosion resistance of the spines in 0.5M H2SO4 solution has been analyzed by measuring the weight loss, impedance spectroscopy and the potentiodynamic polarization techniques. It has been found that the spine produced by HPDC has defect-free fine grain structure resulting improvement in hardness and excellent corrosion resistance.	[Seikh, Asiful H.; Sherif, El-Sayed M.; Alam, Mohammad Asif; Alharthi, Nabeel] King Saud Univ, CEREM, Riyadh, Saudi Arabia; [Mohammed, Sohail M. A. Khan] Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON, Canada; [Baig, Muneer] Prince Sultan Univ, Engn Management Dept, Riyadh, Saudi Arabia; [Alharthi, Nabeel] King Saud Univ, Mech Engn Dept, Coll Engn, Riyadh, Saudi Arabia	King Saud University; Toronto Metropolitan University; Prince Sultan University; King Saud University	Sherif, EM (corresponding author), King Saud Univ, CEREM, Riyadh, Saudi Arabia.	esherif@ksu.edu.sa	Baig, Muneer P/T-6515-2018; MOHAMMED, SOHAIL M. A. KHAN/D-7689-2016; Alam, Mohammad Asif/AAH-5150-2020; Mohammed, Sohail M. A. Khan/H-1742-2017; Seikh, Asiful H/F-2197-2019; Sherif, El-Sayed M./AAD-6247-2021; Sherif, El-Sayed M./A-5890-2008; alam, mohammed/GXH-3645-2022; Mohammed, Sohail/GXH-5301-2022; SEIKH, ASIFUL/ABA-2071-2021; Sherif, El-Sayed M./P-1069-2017	MOHAMMED, SOHAIL M. A. KHAN/0000-0002-9277-7727; Mohammed, Sohail M. A. Khan/0000-0002-9277-7727; Seikh, Asiful H/0000-0003-1423-4628; Sherif, El-Sayed M./0000-0003-2080-8552; Mohammed, Sohail/0000-0002-9277-7727; Sherif, El-Sayed M./0000-0002-8108-6074; Baig, Muneer/0000-0002-8240-3027	Deanship of Scientific Research at King Saud University [RGP-160]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project No. RGP-160.	Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4; BABIC R, 1994, J POWER SOURCES, V52, P17, DOI 10.1016/0378-7753(94)01925-8; Bode H., 1977, LEAD ACID BATTERIES; Cremasco A, 2008, ELECTROCHIM ACTA, V53, P4867, DOI 10.1016/j.electacta.2008.02.011; Ghasemi Z, 2006, APPL SURF SCI, V252, P3667, DOI 10.1016/j.apsusc.2005.05.043; Gudic S, 2002, ELECTROCHIM ACTA, V47, P3009, DOI 10.1016/S0013-4686(02)00246-3; HAMEENOJA E, 1989, ELECTROCHIM ACTA, V34, P233, DOI 10.1016/0013-4686(89)87091-4; Hirasawa T, 2000, J POWER SOURCES, V85, P44, DOI 10.1016/S0378-7753(99)00380-8; Hrussanova A, 2002, J APPL ELECTROCHEM, V32, P505, DOI 10.1023/A:1016591810240; Linden D., 1984, HDB BATTERIES FUEL C, V1, P1075; Liu HT, 2002, J POWER SOURCES, V103, P173, DOI 10.1016/S0378-7753(01)00839-4; MAHATO BK, 1979, J ELECTROCHEM SOC, V126, P365, DOI 10.1149/1.2129045; MONAHOV B, 1994, J ELECTROCHEM SOC, V141, P2316, DOI 10.1149/1.2055119; Nguyen V. L, 2015, THESIS; Okamoto H, 2011, J PHASE EQUILIB DIFF, V32, P567, DOI 10.1007/s11669-011-9952-4; Osorio WR, 2009, MATER CORROS, V60, P804, DOI 10.1002/maco.200805181; Osorio WR, 2008, J POWER SOURCES, V175, P595, DOI 10.1016/j.jpowsour.2007.08.091; Osorio WR, 2012, J POWER SOURCES, V207, P183, DOI 10.1016/j.jpowsour.2012.01.060; Osorio WR, 2012, MATER DESIGN, V34, P660, DOI 10.1016/j.matdes.2011.05.023; Osorio WR, 2011, ELECTROCHIM ACTA, V56, P8457, DOI 10.1016/j.electacta.2011.07.020; Osorio WR, 2010, ELECTROCHIM ACTA, V55, P759, DOI 10.1016/j.electacta.2009.09.016; Osorio WR, 2010, J POWER SOURCES, V195, P1726, DOI 10.1016/j.jpowsour.2009.09.054; Osorio WR, 2008, J POWER SOURCES, V185, P1471, DOI 10.1016/j.jpowsour.2008.08.040; PAVLOV D, 1991, J ELECTROANAL CHEM, V305, P57, DOI 10.1016/0022-0728(91)85202-Z; PAVLOV D, 1991, ELECTROCHIM ACTA, V36, P2087, DOI 10.1016/0013-4686(91)85214-R; PAVLOV D, 1991, ELECTROCHIM ACTA, V36, P2081, DOI 10.1016/0013-4686(91)85213-Q; Pola A, 2010, T NONFERR METAL SOC, V20, P1774, DOI 10.1016/S1003-6326(09)60373-3; Rao P, 1997, ANTIMONY ARSENIC TIN; Rezaei B, 2006, RUSS J ELECTROCHEM+, V42, P350, DOI 10.1134/S1023193506040100; Seikh AH, 2015, INT J ELECTROCHEM SC, V10, P3054; Sherif EM, 2006, ELECTROCHIM ACTA, V51, P4665, DOI 10.1016/j.electacta.2006.01.007	31	5	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195224	10.1371/journal.pone.0195224	http://dx.doi.org/10.1371/journal.pone.0195224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668709	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200032
J	Sun, XZ; Stewart, DA; Sandhu, R; Kirk, EL; Pathmasiri, WW; McRitchie, SL; Clark, RF; Troester, MA; Sumner, SJ				Sun, Xuezheng; Stewart, Delisha A.; Sandhu, Rupninder; Kirk, Erin L.; Pathmasiri, Wimal W.; McRitchie, Susan L.; Clark, Robert F.; Troester, Melissa A.; Sumner, Susan J.			Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue	PLOS ONE			English	Article							PATTERNS; CELLS	Breast carcinogenesis is a multistep process accompanied by widespread molecular and genomic alterations, both in tumor and in surrounding microenvironment. It is known that tumors have altered metabolism, but the metabolic changes in normal or cancer-adjacent, nonmalignant normal tissues and how these changes relate to alterations in gene expression and histological composition are not well understood. Normal or cancer-adjacent normal breast tissues from 99 women of the Normal Breast Study (NBS) were evaluated. Data of metabolomics, gene expression and histological composition was collected by mass spectrometry, whole genome microarray, and digital image, respectively. Unsupervised clustering analysis determined metabolomics-derived subtypes. Their association with genomic and histological features, as well as other breast cancer risk factors, genomic and histological features were evaluated using logistic regression. Unsupervised clustering of metabolites resulted in two main clusters. The metabolite differences between the two clusters suggested enrichment of pathways involved in lipid metabolism, cell growth and proliferation, and migration. Compared with Cluster 1, subjects in Cluster 2 were more likely to be obese (body mass index >= 30 kg/m(2), p < 0.05), have increased adipose proportion (p < 0.01) and associated with a previously defined Active genomic subtype (p < 0.01). By the integrated analyses of histological, metabolomics and transcriptional data, we characterized two distinct subtypes of non-malignant breast tissue. Further research is needed to validate our findings, and understand the potential role of these alternations in breast cancer initiation, progression and recurrence.	[Sun, Xuezheng; Kirk, Erin L.; Troester, Melissa A.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA; [Stewart, Delisha A.; Pathmasiri, Wimal W.; McRitchie, Susan L.; Sumner, Susan J.] Univ North Carolina Chapel Hill, Nutr Res Inst, Natl Inst Hlth Eastern Reg Comprehens Metabol Res, Dept Nutr, Kannapolis, NC 27599 USA; [Sandhu, Rupninder; Troester, Melissa A.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Clark, Robert F.] RTI Int, Analyt Chem & Pharmaceut, Durham, NC USA; [Troester, Melissa A.] Univ North Carolina Chapel Hill, Dept Pathol, Chapel Hill, NC USA; [Troester, Melissa A.] Univ North Carolina Chapel Hill, Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sumner, SJ (corresponding author), Univ North Carolina Chapel Hill, Nutr Res Inst, Natl Inst Hlth Eastern Reg Comprehens Metabol Res, Dept Nutr, Kannapolis, NC 27599 USA.	susan_sumner@unc.edu		Clark, Robert/0000-0001-5091-8280; Pathmasiri, Wimal/0000-0002-5199-5744	Avon Foundation for Women; North Carolina University Cancer Research Fund; National Cancer Institute [R01 CA179715]; National Institute of Environmental Health Sciences [U01 ES019472]; NIH Common Fund award through the National Institute for Diabetes and Digestive and Kidney Diseases [1U24DK097193]; NATIONAL CANCER INSTITUTE [P30CA016086, U01CA179715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019472] Funding Source: NIH RePORTER	Avon Foundation for Women; North Carolina University Cancer Research Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH Common Fund award through the National Institute for Diabetes and Digestive and Kidney Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Avon Foundation for Women (https://www.avonfoundation.org/grants/, PI-MAT), North Carolina University Cancer Research Fund (http://unclineberger.org/ucrf/, PI-MAT), National Cancer Institute (R01 CA179715, PI-MAT), the National Institute of Environmental Health Sciences (U01 ES019472, PI-MAT); and NIH Common Fund award through the National Institute for Diabetes and Digestive and Kidney Diseases to the NIH Eastern Regional Comprehensive Metabolomics Resource Core at UNC-Chapel Hill, Nutrition Research Institute (1U24DK097193, PI-SJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [XS, DAS, RS, ELK, WWP, SLM, RC, MAT and SJS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Brauer HA, 2013, CLIN CANCER RES, V19, P571, DOI 10.1158/1078-0432.CCR-12-2123; Brown I, 2011, PROSTAG LEUKOTR ESS, V85, P305, DOI 10.1016/j.plefa.2011.09.007; Budczies J, 2013, J PROTEOMICS, V94, P279, DOI 10.1016/j.jprot.2013.10.002; Casbas-Hernandez P, 2015, CANCER EPIDEM BIOMAR, V24, P406, DOI 10.1158/1055-9965.EPI-14-0934; Chandrasekaran S, 1999, J BIOL CHEM, V274, P11408, DOI 10.1074/jbc.274.16.11408; Figueroa JD, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju286; Gaston R, 2017, ARCH MED RES, V48, P46, DOI 10.1016/j.arcmed.2017.01.009; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Jiralerspong S, 2016, J CLIN ONCOL, V34, P4203, DOI 10.1200/JCO.2016.68.4480; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kuemmerle NB, 2011, MOL CANCER THER, V10, P427, DOI 10.1158/1535-7163.MCT-10-0802; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1566, DOI 10.1016/j.bbalip.2013.07.008; Mishra P, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.992217; Nassar A, 2015, BREAST CANCER RES TR, V153, P397, DOI 10.1007/s10549-015-3535-8; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Penkert J, 2016, ONCOTARGET, V7, P67626, DOI 10.18632/oncotarget.11759; Pirone JR, 2012, CANCER EPIDEM BIOMAR, V21, P1735, DOI 10.1158/1055-9965.EPI-12-0451; Research WCRFAIfC, 2017, CONT UPD PROJ REP DI; Roman-Perez E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3152; Sandhu R, 2016, HUM PATHOL, V48, P60, DOI 10.1016/j.humpath.2015.09.031; Sinicrope FA, 2011, J CLIN ONCOL, V29, P4, DOI 10.1200/JCO.2010.32.1752; Sun XZ, 2015, CANCER CAUSE CONTROL, V26, P1803, DOI 10.1007/s10552-015-0673-6; Sun XZ, 2013, CLIN CANCER RES, V19, P4972, DOI 10.1158/1078-0432.CCR-13-0029; Sun XZ, 2012, BREAST CANCER RES TR, V131, P1003, DOI 10.1007/s10549-011-1789-3; Tang XH, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0415-9; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Troester MA, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2016.7	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0193792	10.1371/journal.pone.0193792	http://dx.doi.org/10.1371/journal.pone.0193792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668675	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200004
J	Nguyen, HM; Liu, SX; Daher, W; Tang, F; Besteiro, S				Hoa Mai Nguyen; Liu, Shuxian; Daher, Wassim; Tang, Feng; Besteiro, Sebastien			Characterisation of two Toxoplasma PROPPINs homologous to Atg18/WIPI suggests they have evolved distinct specialised functions	PLOS ONE			English	Article							AUTOPHAGOSOME FORMATION; PROTEIN; ATG21; CONJUGATION; FAMILY; PI3P; LOCALIZATION; COMPLEXES; MUTANTS; KINASES	Toxoplasma gondii is a parasitic protist possessing a limited set of proteins involved in the autophagy pathway, a self-degradative machinery for protein and organelle recycling. This distant eukaryote has even repurposed part of this machinery, centered on protein ATG8, for a non-degradative function related to the maintenance of the apicoplast, a parasite-specific organelle. However, some evidence also suggest Toxoplasma is able to generate autophagic vesicles upon stress, and that some autophagy-related proteins, such as ATG9, might be involved solely in the canonical autophagy function. Here, we have characterised TgPROP1 and TgPROP2, two Toxoplasma proteins containing WD-40 repeat that can bind lipids for their recruitment to vesicular structures upon stress. They belong to the PROPPIN family and are homologues to ATG18/WIPI, which are known to be important for the autophagic process. We conducted a functional analysis of these two Toxoplasma PROPPINs. One of them is dispensable for normal in vitro growth, although it may play a role for parasite survival in specific stress conditions or for parasite fitness in the host, through a canonical autophagy-related function. The other, however, seems important for parasite viability in normal growth conditions and could be primarily involved in a non-canonical function. These divergent roles for two proteins from the same family illustrate the functional versatility of the autophagy-related machinery in Toxoplasma.	[Hoa Mai Nguyen; Daher, Wassim; Besteiro, Sebastien] Univ Montpellier, CNRS, UMR5235, DIMNP, Montpellier, France; [Liu, Shuxian; Tang, Feng] Wenzhou Med Univ, Sch Basic Med Sci, Dept Parasitol, Wenzhou, Zhejiang, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Wenzhou Medical University	Besteiro, S (corresponding author), Univ Montpellier, CNRS, UMR5235, DIMNP, Montpellier, France.; Tang, F (corresponding author), Wenzhou Med Univ, Sch Basic Med Sci, Dept Parasitol, Wenzhou, Zhejiang, Peoples R China.	tanfengsong@163.com; sebastien.besteiro@inserm.fr	DAHER, Wassim/M-7166-2017; Besteiro, Sébastien/F-3622-2014; DAHER, Wassim/AAB-6720-2019	DAHER, Wassim/0000-0001-9026-5333; Besteiro, Sébastien/0000-0003-1853-1494; DAHER, Wassim/0000-0001-9026-5333; Nguyen, Hoa Mai/0000-0003-4624-6375	Agence Nationale de la Recherche [ANR-13-JSV3-0003]; Fondation pour la Recherche Medicale [Equipe FRMDEQ20130326508]; Labex Parafrap (Agence Nationale de la Recherche) [ANR-11-LABX-0024]; National Natural Science Foundation of China [81672052]; Zhejiang Natural Science Funds for Distinguished Young Scientists [LR17H190001]; Zhejiang Xinmiao talent plan [2017R413062]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Labex Parafrap (Agence Nationale de la Recherche)(French National Research Agency (ANR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Funds for Distinguished Young Scientists; Zhejiang Xinmiao talent plan	Work in S.B.'s laboratory is supported by a grant from Agence Nationale de la Recherche (ANR-13-JSV3-0003) and core support from the Fondation pour la Recherche Medicale (Equipe FRMDEQ20130326508) and the Labex Parafrap (Agence Nationale de la Recherche) (ANR-11-LABX-0024). Work in F.T.s laboratory is supported by grants from the National Natural Science Foundation of China (81672052), the Zhejiang Natural Science Funds for Distinguished Young Scientists (LR17H190001) and Zhejiang Xinmiao talent plan (2017R413062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Bakula D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15637; Bansal P, 2017, MBIO, V8, DOI [10.1128/mBio.01468-17, 10.1128/mbio.01468-17]; Barth H, 2002, FEBS LETT, V512, P173, DOI 10.1016/S0014-5793(02)02252-4; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Besteiro S, 2017, CURR OPIN MICROBIOL, V40, P14, DOI 10.1016/j.mib.2017.10.008; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; COUVREUR G, 1988, PARASITOLOGY, V97, P1, DOI 10.1017/S0031182000066695; Daher W, 2015, CELL MICROBIOL, V17, P559, DOI 10.1111/cmi.12383; DeRocher AE, 2008, EUKARYOT CELL, V7, P1518, DOI 10.1128/EC.00081-08; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Ghosh D, 2012, CELL MICROBIOL, V14, P589, DOI 10.1111/j.1462-5822.2011.01745.x; Gopaldass N, 2017, EMBO J, V36, P3274, DOI 10.15252/embj.201796859; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Nguyen HM, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx153; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Juris L, 2015, EMBO J, V34, P955, DOI 10.15252/embj.201488957; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kong-Hap MA, 2013, AUTOPHAGY, V9, P1334, DOI 10.4161/auto.25189; Krick R, 2008, AUTOPHAGY, V4, P896, DOI 10.4161/auto.6801; Leveque Maude F, 2016, Commun Integr Biol, V9, pe1197447, DOI 10.1080/19420889.2016.1197447; Leveque MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep27809; Leveque MF, 2015, MBIO, V6, DOI 10.1128/mBio.01446-15; Matsumura H, 2012, J BIOL CHEM, V287, P26528, DOI 10.1074/jbc.M112.369652; Meiling-Wesse K, 2004, J BIOL CHEM, V279, P37741, DOI 10.1074/jbc.M401066200; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nakatogawa H, 2013, ESSAYS BIOCHEM, V55, P39, DOI [10.1042/bse0550039, 10.1042/BSE0550039]; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Nguyen HM, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12712; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2015, J CELL SCI, V128, P207, DOI 10.1242/jcs.146258; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Thost AK, 2015, METHODS, V75, P69, DOI 10.1016/j.ymeth.2014.11.011; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Walczak M, 2017, ATG8 IS ESSENTIAL SP, DOI [10.1101/195578, DOI 10.1101/195578]; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546	50	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195921	10.1371/journal.pone.0195921	http://dx.doi.org/10.1371/journal.pone.0195921			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659619	Green Submitted, Green Published, gold			2022-12-27	WOS:000430061100041
J	Antoni, G; Marini, E; Curreli, N; Tuveri, V; Comandini, O; Cabras, S; Gabba, S; Madeddu, C; Crisafulli, A; Rinaldi, AC				Antoni, Giorgia; Marini, Elisabetta; Curreli, Nicoletta; Tuveri, Valerio; Comandini, Ornella; Cabras, Stefano; Gabba, Silvia; Madeddu, Clelia; Crisafulli, Antonio; Rinaldi, Andrea C.			Energy expenditure in caving (vol 12, e0170853, 2017)	PLOS ONE			English	Correction														Madeddu, Clelia/0000-0001-8940-6987				Antoni G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170853	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0196028	10.1371/journal.pone.0196028	http://dx.doi.org/10.1371/journal.pone.0196028			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652942	gold, Green Published			2022-12-27	WOS:000430026900054
J	Shamoon, RP; Ali, MD; Shabila, NP				Shamoon, Rawand P.; Ali, Mohamad Dahir; Shabila, Nazar P.			Overview and outcome of Hodgkin's Lymphoma: Experience of a single developing country's oncology centre	PLOS ONE			English	Article							DISEASE; CHILDREN; SURVIVAL; EPIDEMIOLOGY; ADOLESCENTS; DIAGNOSIS; THERAPY; CYCLES; PET	Hodgkin's Lymphoma (HL) reveals variable epidemiological and clinico-pathological features in different geographical locations. In this retrospective study, we aimed to assess the epidemiological and clinic-pathological features, and outcome of HL patients treated at one hemato-oncology centre in Erbil, northern Iraq. Medical records of 103 HL patients treated over more than six years were reviewed. Treatment outcome was evaluated by measuring the 5-year overall and progression-free survival rates. The median age of patients was 23 years, children up to 17 years constituted 31.1%, and male to female ratio was 1:1.05. The majority (96.1%) of patients presented with lymphadenopathy. Nodular sclerosis subtype was the mostly encountered histologic type (48.5%); about half of the patients (49.5%) had stage II disease. Relapse occurred in 20 patients; the 5-year overall survival for children was better (89%) compared to adult patients (79%). The associated risk features found to have adverse effects on the survival, however, only high LDH level and presence of B-symptoms at presentation showed significant correlation. The epidemiological and clinical characteristics of HL in our locality followed the pattern in the western world. The 5-year overall and progression-free survivals were far below the international rates, a matter which may necessitate a revision to HL treatment strategy at our centre.	[Shamoon, Rawand P.] Hawler Med Univ, Dept Pathol, Coll Med, Erbil, Iraq; [Shamoon, Rawand P.] Nanakali Haematooncol Teaching Ctr, Dept Haematopathol, Erbil, Iraq; [Ali, Mohamad Dahir] Nanakali Haematooncol Teaching Ctr, Dept Clin Haematol, Erbil, Iraq; [Shabila, Nazar P.] Hawler Med Univ, Dept Community Med, Erbil, Iraq	Hawler Medical University; Hawler Medical University	Shamoon, RP (corresponding author), Hawler Med Univ, Dept Pathol, Coll Med, Erbil, Iraq.; Shamoon, RP (corresponding author), Nanakali Haematooncol Teaching Ctr, Dept Haematopathol, Erbil, Iraq.	rawand.shamoon@med.hmu.edu.krd	Shabila, Nazar/I-1314-2019	Shabila, Nazar/0000-0002-8921-195X; Shamoon, Rawand/0000-0002-8964-7497				[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V50, P265; [Anonymous], 2009, HODGKINS DIS LYMPHOM; Arya LS, 2006, PEDIATR BLOOD CANCER, V46, P26, DOI 10.1002/pbc.20157; Avagyan Armen, 2016, Asian Pac J Cancer Prev, V17, P101; Baez F, 1997, ANN ONCOL, V8, P247, DOI 10.1023/A:1008200210674; Bazzeh F, 2010, LEUKEMIA LYMPHOMA, V51, P2198, DOI 10.3109/10428194.2010.525724; Brepoels L, 2007, LEUKEMIA LYMPHOMA, V48, P270, DOI 10.1080/10428190601078118; Buyukpamukcu M, 2009, ACTA ONCOL, V48, P44, DOI 10.1080/02841860802310991; Buyukkapu-Bay S, 2015, TURK J PEDIAT, V57; CARBONE PP, 1971, CANCER RES, V31, P1860; Cerci JJ, 2010, J NUCL MED, V51, P1337, DOI 10.2967/jnumed.109.073197; Chen R, 2016, BLOOD, V128, P1562, DOI 10.1182/blood-2016-02-699850; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Eichenauer DA, 2014, ANN ONCOL, V25, P70, DOI 10.1093/annonc/mdu181; Engel M, 2000, J CLIN PATHOL, V53, P182, DOI 10.1136/jcp.53.3.182; Engert A, 2009, ANN ONCOL, V20, P108, DOI 10.1093/annonc/mdp144; Englund A, 2017, ACTA ONCOL IN PRESS; Fadhil MS, 2014, SAUDI MED J, V35, P448; Fadoo Zehra, 2010, J Pediatr Hematol Oncol, V32, pe14, DOI 10.1097/MPH.0b013e3181bdf1f3; Feldman AL, 2006, THE LYMPHOMAS; Friedmann AM, 2002, J CLIN ONCOL, V20, P3088, DOI 10.1200/JCO.2002.03.051; Geller SA, 2013, VIRCHOWS ARCH, V463, P353, DOI 10.1007/s00428-013-1442-0; Glaser SL, 1997, INT J CANCER, V70, P375, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;375::AID-IJC1&gt;3.0.CO;2-T; Herbst C, 2010, HAEMATOL-HEMATOL J, V95, P494, DOI 10.3324/haematol.2009.015644; Hjalgrim H, 2003, NEW ENGL J MED, V349, P1324, DOI 10.1056/NEJMoa023141; Horwich A, 1997, EUR J CANCER, V33, P848, DOI 10.1016/S0959-8049(96)00518-7; Jachimowicz RD, 2014, ACTA HAEMATOL-BASEL, V132, P274, DOI 10.1159/000360205; Jain S, 2016, PEDIATR BLOOD CANCER, V63, P1024, DOI 10.1002/pbc.25935; KAPOOR G, 1995, PEDIATR HEMAT ONCOL, V12, P559, DOI 10.3109/08880019509030770; Kuppers R, 2005, EUR J HAEMATOL, V75, P26; Laskar S, 2004, J CLIN ONCOL, V22, P62, DOI 10.1200/JCO.2004.01.021; Miltenyi Z, 2011, ISRN HEMATOL; Noordijk EM, 2006, J CLIN ONCOL, V24, P3128, DOI 10.1200/JCO.2005.05.2746; Pourtsidis A, 2013, PEDIATR HEMAT ONCOL, V30, P532, DOI 10.3109/08880018.2013.823471; Salati M, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.048; Shafi RG, 2017, ONCOL RES TREAT, V40, P288, DOI 10.1159/000460819; Shamoon RP, 2010, ZANCO J MED SCI, V14, P85; Sherief LM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000670; Smith RS, 2003, J CLIN ONCOL, V21, P2026, DOI 10.1200/JCO.2003.07.124; Stefan DC, 2009, LEUKEMIA LYMPHOMA, V50, P196, DOI 10.1080/10428190802663205; Thomas RK, 2002, ANN ONCOL, V13, P147, DOI 10.1093/annonc/mdf652; Trehan A, 2013, J PEDIAT HEMATOL ONC, V35, P174, DOI 10.1097/MPH.0b013e318271f587; Uysal Kamer Mutafoglu, 2007, TURKISH J CANC, V37, P98; Yeole B B, 2001, Indian Pediatr, V38, P1270	44	9	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195629	10.1371/journal.pone.0195629	http://dx.doi.org/10.1371/journal.pone.0195629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649329	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900063
J	Wang, YM; Seppanen-Laakso, T; Rischer, H; Wiebe, MG				Wang, Yanming; Seppanen-Laakso, Tuulikki; Rischer, Heiko; Wiebe, Marilyn G.			Euglena gracilis growth and cell composition under different temperature, light and trophic conditions	PLOS ONE			English	Article							ALPHA-TOCOPHEROL; FATTY-ACIDS; MIXOTROPHIC CULTURE; LIPID PRODUCTION; CULTIVATION; PARAMYLON; BIOMASS; MICROALGAE; BIOTECHNOLOGY; CARBOHYDRATE	Background Euglena gracilis, a photosynthetic protist, produces protein, unsaturated fatty acids, wax esters, and a unique beta-1,3-glucan called paramylon, along with other valuable compounds. The cell composition of E. gracilis was investigated in this study to understand how light and organic carbon (photo-, mixo- and heterotrophic conditions) affected growth and cell composition (especially lipids). Comparisons were primarily carried out in cultures grown at 23 degrees C, but the effect of growth at higher temperatures (27 or 30 degrees C) was also considered. Cell growth Specific growth rates were slightly lower when E. gracilis was grown on glucose in either heterotrophic or mixotrophic conditions than when grown photoautotrophically, although the duration of exponential growth was longer. Temperature determined the rate of exponential growth in all cultures, but not the linear growth rate during light-limited growth in phototrophic conditions. Temperature had less effect on cell composition. Cell composition Although E. gracilis was not expected to store large amounts of paramylon when grown phototrophically, we observed that phototrophic cells could contain up to 50% paramylon. These cells contained up to 33% protein and less than 20% lipophilic compounds, as expected. The biomass contained about 8% fatty acids (measured as fatty acid methyl esters), most of which were unsaturated. The fatty acid content of cells grown in mixotrophic conditions was similar to that observed in phototrophic cells, but was lower in cells grown heterotrophically. Heterotrophic cells contained less unsaturated fatty acids than phototrophic or mixotrophic cells. alpha-Linolenic acid was present at 5 to 18 mg g(-1) dry biomass in cells grown in the presence of light, but at < 0.5 mg g(-1) biomass in cells grown in the dark. Eicosapentaenoic and docosahexaenoic acids were detected at 1 to 5 mg g(-1) biomass. Light was also important for the production of vitamin E and phytol.	[Wang, Yanming; Seppanen-Laakso, Tuulikki; Rischer, Heiko; Wiebe, Marilyn G.] VTT Tech Res Ctr Finland Ltd, Espoo, Finland; [Wang, Yanming] Univ Nottingham, Synthet Biol Res Ctr, Nottingham, England	VTT Technical Research Center Finland; University of Nottingham	Wiebe, MG (corresponding author), VTT Tech Res Ctr Finland Ltd, Espoo, Finland.	marilyn.wiebe@vtt.fi	Rischer, Heiko/ABB-4681-2020	Rischer, Heiko/0000-0002-8004-4526	TEKES; Finnish Funding Agency for Technology and Innovation through the ALGIND project [40149/11]; European Commission [311932]; Ella and Georg Ehrnrooth Foundation; EU FP7	TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Funding Agency for Technology and Innovation through the ALGIND project; European Commission(European CommissionEuropean Commission Joint Research Centre); Ella and Georg Ehrnrooth Foundation; EU FP7(European Commission)	This work was supported by TEKES, the Finnish Funding Agency for Technology and Innovation (https://www.tekes.fi/en/tekes/), through the ALGIND (40149/11) project, and by the European Commission (grant no. 311932, project acronym: SeaBiotech, http://spider.science.strath.ac.uk/seabiotech/), and as a personal grant to YVV by the Ella and Georg Ehrnrooth Foundation (http://www.ellageorg.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VTT (with funds from TEKES and the EU FP7) provided support in the form of salaries for authors [YW, TS-L, HR, MGW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albalasmeh AA, 2013, CARBOHYD POLYM, V97, P253, DOI 10.1016/j.carbpol.2013.04.072; Barsanti L, 2001, J APPL PHYCOL, V13, P59, DOI 10.1023/A:1008105416065; Bischoff H. W., 1963, PHYCOL STUD, V44, P1; CARELL EF, 1970, J CELL BIOL, V47, P525, DOI 10.1083/jcb.47.2.525; Certik M, 1999, J BIOSCI BIOENG, V87, P1, DOI 10.1016/S1389-1723(99)80001-2; CONSTANTOPOULOS G, 1967, J BIOL CHEM, V242, P3538; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuhashi T, 2015, METABOLOMICS, V11, P175, DOI 10.1007/s11306-014-0687-1; Gong MY, 2017, APPL BIOCHEM BIOTECH, V183, P652, DOI 10.1007/s12010-017-2537-x; Grimm P, 2015, J BIOTECHNOL, V215, P72, DOI 10.1016/j.jbiotec.2015.04.004; Hamed I, 2016, COMPR REV FOOD SCI F, V15, P1104, DOI 10.1111/1541-4337.12227; Harun R, 2010, RENEW SUST ENERG REV, V14, P1037, DOI 10.1016/j.rser.2009.11.004; HAYASHI M, 1993, BIOSCI BIOTECH BIOCH, V57, P352, DOI 10.1271/bbb.57.352; Ingebrigtsen RA, 2016, J APPL PHYCOL, V28, P939, DOI 10.1007/s10811-015-0631-4; Inui H, 2017, ADV EXP MED BIOL, V979, P269, DOI 10.1007/978-3-319-54910-1_13; Islam MT, 2015, CHEM-BIOL INTERACT, V240, P60, DOI 10.1016/j.cbi.2015.07.010; Jeong U-Cheol, 2016, [Korean Journal of Fisheries and Aquatic Sciences, 한국수산과학회지], V49, P38; Jones CS, 2012, CURR OPIN BIOTECH, V23, P346, DOI 10.1016/j.copbio.2011.10.013; KAWABATA A, 1982, J PROTOZOOL, V29, P421, DOI 10.1111/j.1550-7408.1982.tb05425.x; KAWABATA A, 1989, J GEN MICROBIOL, V135, P1461; Kitaya Y, 2005, ADV SPACE RES-SERIES, V35, P1584, DOI 10.1016/j.asr.2005.03.039; KOIZUMI N, 1993, ANTIVIR RES, V21, P1, DOI 10.1016/0166-3542(93)90063-O; KORN ED, 1964, J LIPID RES, V5, P352; Krajcovic J, 2015, J BIOTECHNOL, V202, P135, DOI 10.1016/j.jbiotec.2014.11.035; Kumar D, 2017, ENG LIFE SCI, V17, P1030, DOI 10.1002/elsc.201700014; Kunne A, 1996, BOT ACTA, V109, P57; Kusmic C, 1998, J APPL PHYCOL, V10, P555, DOI 10.1023/A:1008022305865; Li X, 2011, BIORESOURCE TECHNOL, V102, P3098, DOI 10.1016/j.biortech.2010.10.055; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo X, 2015, MAR DRUGS, V13, P4231, DOI 10.3390/md13074231; Matsuda F, 2011, BIOSCI BIOTECH BIOCH, V75, P2253, DOI 10.1271/bbb.110482; Millan-Oropeza A, 2017, ENVIRON SCI POLLUT R, V24, P25618, DOI 10.1007/s11356-016-7013-6; Miyatake K, 1985, NIPPON EIYO SHOKURYO, V38, P117, DOI DOI 10.4327/jsnfs.38.117; NAKANO Y, 1987, J BIOCHEM, V102, P1053, DOI 10.1093/oxfordjournals.jbchem.a122143; NICOLAS P, 1980, PLANT PHYSIOL, V65, P631, DOI 10.1104/pp.65.4.631; O'Neill EC, 2015, MOL BIOSYST, V11, P2808, DOI 10.1039/c5mb00319a; Ogawa T, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0264-5; Ogbonna JC, 2002, APPL MICROBIOL BIOT, V58, P532, DOI 10.1007/s00253-001-0901-8; OGBONNA JC, 1995, J FERMENT BIOENG, V80, P369, DOI 10.1016/0922-338X(95)94206-7; Ogbonna JC, 1998, J APPL PHYCOL, V10, P67, DOI 10.1023/A:1008011201437; Ogbonna JC, 2000, J APPL PHYCOL, V12, P207, DOI 10.1023/A:1008194627239; Olaveson MM, 2000, HYDROBIOLOGIA, V433, P39, DOI 10.1023/A:1004006401516; Rezic Tonci, 2013, Agriculturae Conspectus Scientificus, V78, P65; Romano G, 2017, MAR ENVIRON RES, V128, P58, DOI 10.1016/j.marenvres.2016.05.002; ROSENBERG A, 1963, BIOCHEMISTRY-US, V2, P1148, DOI 10.1021/bi00905a042; Schwarzhans JP, 2015, J APPL PHYCOL, V27, P1389, DOI 10.1007/s10811-014-0458-4; Slocombe SP, 2013, BIORESOURCE TECHNOL, V129, P51, DOI 10.1016/j.biortech.2012.10.163; Suzuki K, 2017, ADV EXP MED BIOL, V979, P285, DOI 10.1007/978-3-319-54910-1_14; Takeyama H, 1997, BIOTECHNOL BIOENG, V53, P185, DOI 10.1002/(SICI)1097-0290(19970120)53:2<185::AID-BIT8>3.0.CO;2-K; TANI Y, 1989, AGR BIOL CHEM TOKYO, V53, P305, DOI 10.1080/00021369.1989.10869324; Valverde F, 2016, EUR J PROTISTOL, V55, P95, DOI 10.1016/j.ejop.2016.03.002; Vismara R, 2000, TISSUE CELL, V32, P451, DOI 10.1016/S0040-8166(00)80001-4; Wang Y, 2013, BIORESOURCE TECHNOL, V144, P608, DOI 10.1016/j.biortech.2013.07.027; Ward OP, 2005, PROCESS BIOCHEM, V40, P3627, DOI 10.1016/j.procbio.2005.02.020; Watanabe T, 2013, FOOD FUNCT, V4, P1685, DOI 10.1039/c3fo60256g; Yamane Y, 2001, BIOTECHNOL LETT, V23, P1223, DOI 10.1023/A:1010573218863; Zeng M, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0279-4; Zhang RT, 2017, ALGAL RES, V27, P89, DOI 10.1016/j.algal.2017.08.026	58	31	31	9	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195329	10.1371/journal.pone.0195329	http://dx.doi.org/10.1371/journal.pone.0195329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649233	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900038
J	Cross, MR; Lahti, J; Brown, SR; Chedati, M; Jimenez-Reyes, P; Samozino, P; Eriksrud, O; Morin, JB				Cross, Matt R.; Lahti, Johan; Brown, Scott R.; Chedati, Mehdi; Jimenez-Reyes, Pedro; Samozino, Pierre; Eriksrud, Ola; Morin, Jean-Benoit			Training at maximal power in resisted sprinting: Optimal load determination methodology and pilot results in team sport athletes	PLOS ONE			English	Article							FORCE-VELOCITY PROFILE; MECHANICAL-PROPERTIES; SOCCER PLAYERS; RUGBY UNION; PERFORMANCE; KINEMATICS; INJURY	Aims In the current study we investigated the effects of resisted sprint training on sprinting performance and underlying mechanical parameters (force-velocity-power profile) based on two different training protocols: (i) loads that represented maximum power output (L-opt) and a 50% decrease in maximum unresisted sprinting velocity and (ii) lighter loads that represented a 10% decrease in maximum unresisted sprinting velocity, as drawn from previous research (L-10). Methods Soccer [n = 15 male] and rugby [n = 21; 9 male and 12 female] club-level athletes were individually assessed for horizontal force-velocity and load-velocity profiles using a battery of resisted sprints, sled or robotic resistance respectively. Athletes then performed a 12-session resisted (10 x 20-m; and pre-post-profiling) sprint training intervention following the L-10 or Lopt protocol. Results Both L-10 and L-opt training protocols had minor effects on sprinting performance (average of-1.4 to-2.3% split-times respectively), and provided trivial, small and unclear changes in mechanical sprinting parameters. Unexpectedly, L-opt impacted velocity dominant variables to a greater degree than L-10 (trivial benefit in maximum velocity; small increase in slope of the force-velocity relationship), while L-10 improved force and power dominant metrics (trivial benefit in maximal power; small benefit in maximal effectiveness of ground force orientation). Conclusions Both resisted-sprint training protocols were likely to improve performance after a short training intervention in already sprint trained athletes. However, widely varied individualised results indicated that adaptations may be dependent on pre-training force-velocity characteristics.	[Cross, Matt R.; Samozino, Pierre] Univ Savoie Mt Blanc, Lab Interuniv Biol Motricite, EA, Chambery, France; [Cross, Matt R.] Federat Francaise Ski, Dept Sci & Sportif, Annecy, France; [Cross, Matt R.; Brown, Scott R.; Morin, Jean-Benoit] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Lahti, Johan; Chedati, Mehdi; Morin, Jean-Benoit] Univ Cote Azur, LAMHESS, Nice, France; [Lahti, Johan] Univ Jyvaskyla, Fac Sports & Hlth Sci, Jyvaskyla, Finland; [Brown, Scott R.] Univ Michigan, Med Sch, Dept Phys Med & Rehabil, Neuromuscular & Rehabil Robot Lab NeuRRo Lab, Ann Arbor, MI 48109 USA; [Jimenez-Reyes, Pedro] Catholic Univ San Antonio, Fac Phys Sci & Sport, Murcia, Spain; [Eriksrud, Ola] Norwegian Sch Sports Sci, Dept Phys Performance, Oslo, Norway	Auckland University of Technology; UDICE-French Research Universities; Universite Cote d'Azur; University of Jyvaskyla; University of Michigan System; University of Michigan; Universidad Catolica de Murcia; Norwegian School of Sport Sciences	Morin, JB (corresponding author), Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand.; Morin, JB (corresponding author), Univ Cote Azur, LAMHESS, Nice, France.	jean-benoit.morin@unice.fr	Samozino, Pierre/R-1927-2019; Eriksrud, Ola/AAK-1328-2020; Cross, Matthew/AAP-8022-2021; Jimenez-Reyes, Pedro/P-1075-2016	Eriksrud, Ola/0000-0003-4971-6723; Cross, Matthew/0000-0003-1579-3720; Jimenez-Reyes, Pedro/0000-0002-8156-243X; Morin, Jean-Benoit/0000-0003-3808-6762	1080 Motion AB	1080 Motion AB	From the onset of the study to present, co-author Ola Eriksrud holds a position with 1080 Motion AB. 1080 Motion AB provided support for this project via shipping costs and use of the 1080 Sprint machine for data collection, and monetary support to the Universite Cote d'Azur via a collaboration contract. None of the authors received any commercial funding or salary in any form that would influence the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz PE, 2009, J STRENGTH COND RES, V23, P480, DOI 10.1519/JSC.0b013e318198f92c; Chelly SM, 2001, MED SCI SPORT EXER, V33, P326; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; Cormie P, 2011, SPORTS MED, V41, P17, DOI 10.2165/11537690-000000000-00000; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Cross MR, 2018, EUR J APPL PHYSIOL, V118, P563, DOI 10.1007/s00421-017-3796-5; Cross MR, 2017, INT J SPORT PHYSIOL, V12, P1069, DOI 10.1123/ijspp.2016-0362; Cross MR, 2017, J SPORT SCI, V35, P2198, DOI 10.1080/02640414.2016.1261178; Cross MR, 2017, SPORTS MED, V47, P1255, DOI 10.1007/s40279-016-0653-3; Cross MR, 2015, INT J SPORT PHYSIOL, V10, P695, DOI 10.1123/ijspp.2014-0151; Dorel S, 2012, MED SCI SPORT EXER, V44, P2154, DOI 10.1249/MSS.0b013e3182625423; Dorel S, 2010, MED SCI SPORT EXER, V42, P1174, DOI 10.1249/MSS.0b013e3181c91f35; Giroux C, 2016, J APPL BIOMECH, V32, P59, DOI 10.1123/jab.2015-0070; Haugen T, 2018, INT J SPORT PHYSIOL, V13, P678, DOI 10.1123/ijspp.2017-0441; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jimenez-Reyes P, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00677; Kawamori N, 2014, J SPORT SCI, V32, P1139, DOI 10.1080/02640414.2014.886129; Lockie RG, 2003, J STRENGTH COND RES, V17, P760; Mangine GT, 2018, J STRENGTH COND RES, V32, P1531, DOI 10.1519/JSC.0000000000002030; Marrier B, 2017, INT J SPORT PHYSIOL, V12, P1163, DOI 10.1123/ijspp.2016-0607; Mendiguchia J, 2016, J SPORT SCI, V34, P535, DOI 10.1080/02640414.2015.1122207; Mendiguchia J, 2014, INT J SPORTS MED, V35, P690, DOI 10.1055/s-0033-1363192; Morin JB, 2017, INT J SPORT PHYSIOL, V12, P840, DOI 10.1123/ijspp.2016-0444; Morin JB, 2016, INT J SPORT PHYSIOL, V11, P267, DOI 10.1123/ijspp.2015-0638; Morin JB, 2011, MED SCI SPORT EXER, V43, P1680, DOI 10.1249/MSS.0b013e318216ea37; Petrakos G, 2016, SPORTS MED, V46, P381, DOI 10.1007/s40279-015-0422-8; Samozino P, 2016, SCAND J MED SCI SPOR, V26, P648, DOI 10.1111/sms.12490; Samozino P, 2014, INT J SPORTS MED, V35, P505, DOI 10.1055/s-0033-1354382; Samozino P, 2012, MED SCI SPORT EXER, V44, P313, DOI 10.1249/MSS.0b013e31822d757a; Spinks CD, 2007, J STRENGTH COND RES, V21, P77, DOI 10.1519/00124278-200702000-00015	30	46	46	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195477	10.1371/journal.pone.0195477	http://dx.doi.org/10.1371/journal.pone.0195477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641589	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900071
J	Ejtahed, HS; Heshmat, R; Motlagh, ME; Hasani-Ranjbar, S; Ziaodini, H; Taheri, M; Ahadi, Z; Aminaee, T; Shafiee, G; Goodarzi, A; Qorbani, M; Kelishadi, R				Ejtahed, Hanieh-Sadat; Heshmat, Ramin; Motlagh, Mohammad Esmaeil; Hasani-Ranjbar, Shirin; Ziaodini, Hasan; Taheri, Majzoubeh; Ahadi, Zeinab; Aminaee, Tahereh; Shafiee, Gita; Goodarzi, Azam; Qorbani, Mostafa; Kelishadi, Roya			Association of parental obesity with cardiometabolic risk factors in their children: The CASPIAN-V study	PLOS ONE			English	Article							METABOLIC SYNDROME; CHILDHOOD OBESITY; OVERWEIGHT; WEIGHT; FAMILY; ADOLESCENTS; DETERMINANTS; QUALITY; PLASMA; BMI	Background The family environment has a crucial role in the development of childhood obesity and related cardiometabolic disorders. This study aims to investigate the association of parental obesity and cardiometabolic risk factors in their children. Methods This multicentric cross-sectional study was performed on 14400 students (aged 7-18 years) and one of their parents. Students were recruited by multistage, stratified cluster sampling from urban and rural areas of 30 provinces of Iran. Fasting venous blood was obtained from a random sample of 4200 students. Demographic, anthropometric and clinical variables were collected. Results Data of 14002 students and results of blood samples of 3483 of them were complete and included in the current study. The prevalence of obesity in children, fathers, and mothers was 11.4%, 10.6%, and 24.2%, respectively. In students, the most commonly observed metabolic abnormality was low HDL-C (29.5%); the prevalence of metabolic syndrome and dyslipidemia was 5% and 55.7%, respectively. Significant correlations were observed between the body mass index (BMI) and waist circumference of parents and weight, height, BMI, and waist circumference, as well as systolic and diastolic blood pressure (BP) of their children (P< 0.05). In the multivariate model, the risk of excess weight (OR: 1.30, 95% CI: 1.17-1.44), obesity (OR: 1.36, 95% CI: 1.18-1.59), abdominal obesity (OR: 1.16, 95% CI: 1.05-1.29) and elevated BP (OR: 1.17, 95% CI: 1.04-1.31) were higher in those students whose parents had excess weight compared with other students. Parental obesity did not have significant association with metabolic syndrome and dyslipidemia in their children. Conclusions Parental history of obesity could be used as a practical approach for the early preventive measures and identification of children at risk of cardiometabolic complications.	[Ejtahed, Hanieh-Sadat; Hasani-Ranjbar, Shirin] Univ Tehran Med Sci, Obes & Eating Habits Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran; [Heshmat, Ramin; Ahadi, Zeinab; Shafiee, Gita; Qorbani, Mostafa] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Chron Dis Res Ctr, Tehran, Iran; [Motlagh, Mohammad Esmaeil] Ahvaz Jundishapur Univ Med Sci, Dept Pediat, Ahvaz, Iran; [Hasani-Ranjbar, Shirin] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran; [Ziaodini, Hasan] Educ Minist, Hlth Psychol Res Ctr, Tehran, Iran; [Taheri, Majzoubeh; Aminaee, Tahereh] Minist Hlth & Med Educ, Off Adolescents & Sch Hlth, Tehran, Iran; [Goodarzi, Azam] Tarbiat Modares Univ, Fac Med, Tehran, Iran; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran; [Kelishadi, Roya] Isfahan Univ Med Sci, Child Dept Pediat, Child Growth & Dev Res Ctr, Res Inst Primordial Prevent Noncommunicable Dis, Esfahan, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Tarbiat Modares University; Isfahan University Medical Science	Qorbani, M (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Chron Dis Res Ctr, Tehran, Iran.; Qorbani, M (corresponding author), Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran.; Kelishadi, R (corresponding author), Isfahan Univ Med Sci, Child Dept Pediat, Child Growth & Dev Res Ctr, Res Inst Primordial Prevent Noncommunicable Dis, Esfahan, Iran.	mqorbani1379@yahoo.com; kelishadi@med.mui.ac.ir	Kelishadi, Roya/E-6154-2012; Heshmat, Ramin/S-7435-2017; Qorbani, Mostafa/M-8171-2017; motlagh, Mohammad Esmaiel/AAC-2653-2019; ejtahed, hanieh/AAH-4921-2021	Kelishadi, Roya/0000-0001-7455-1495; motlagh, Mohammad Esmaiel/0000-0002-2971-8660; Ahadi, Zeinab/0000-0001-9722-7540	Child Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran	Child Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran	This work was supported by Child Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi F, 2010, ARCH IRAN MED, V13, P426, DOI 010135/AIM.0011; Bahreynian M, 2017, J CLIN RES PEDIATR E, V9, P111, DOI 10.4274/jcrpe.3790; Baxi R, 2016, J DIABETES, V8, P494, DOI 10.1111/1753-0407.12319; Berge JM, 2016, J ADOLESCENT HEALTH, V59, P530, DOI 10.1016/j.jadohealth.2016.06.007; Bilic-Kirin Vesna, 2014, Coll Antropol, V38, P553; Bralic I, 2005, COLLEGIUM ANTROPOL, V29, P481; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; Davey G, 2000, INT J OBESITY, V24, P1523, DOI 10.1038/sj.ijo.0801408; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; Esmaili H, 2015, IRAN J PEDIATR, V25, DOI 10.5812/ijp.25(3)2015.401; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Gibson LY, 2007, MED J AUSTRALIA, V186, P591, DOI 10.5694/j.1326-5377.2007.tb01061.x; Greene-Cramer B, 2016, GLOB HLTH PROMOT; Gurnani M, 2015, PEDIATR CLIN N AM, V62, P821, DOI 10.1016/j.pcl.2015.04.001; Haines J, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0393-7; Hernandez-Valero MA, 2007, OBESITY, V15, P2512, DOI 10.1038/oby.2007.298; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Kelishadi R, 2008, CHILD CARE HLTH DEV, V34, P44, DOI 10.1111/j.1365-2214.2007.00744.x; Kelishadi R, 2012, INT J PREVENTIVE MED, V3, P699; Lee CY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090567; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Llewellyn A, 2016, OBES REV, V17, P56, DOI 10.1111/obr.12316; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; Motlagh M E, 2009, East Mediterr Health J, V15, P302; Motlagh ME, 2016, INT J PREV MED, V7; Muthuri SK, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0147746, 10.1371/journal.p]; Parrino C, 2016, J ENDOCRINOL INVEST, V39, P1315, DOI 10.1007/s40618-016-0501-1; Semmler C, 2009, OBESITY, V17, P814, DOI 10.1038/oby.2008.621; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; Treuth MS, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.4.e49; Vik KL, 2014, INT J EPIDEMIOL, V43, P760, DOI 10.1093/ije/dyt250; World Health Organization, 1995, PHYS STAT US INT ANT; Yoon JM, 2014, PEDIATR GASTROENTERO, V17, P85, DOI 10.5223/pghn.2014.17.2.85; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	34	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193978	10.1371/journal.pone.0193978	http://dx.doi.org/10.1371/journal.pone.0193978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641604	Green Submitted, gold, Green Published			2022-12-27	WOS:000429742900020
J	Underwood, J; De Francesco, D; Leech, R; Sabine, CA; Winston, A				Underwood, Jonathan; De Francesco, Davide; Leech, Robert; Sabine, Caroline A.; Winston, Alan		Pharmacokinetic Clinical Observati	Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment	PLOS ONE			English	Article							NEUROCOGNITIVE IMPAIRMENT; ANTIRETROVIRAL THERAPY; ERA; POPULATION; PREVALENCE; STATISTICS; INFECTION; DISORDERS; DEMENTIA; CHARTER	Objective The reported prevalence of cognitive impairment remains similar to that reported in the pre-antiretroviral therapy era. This may be partially artefactual due to the methods used to diagnose impairment. In this study, we evaluated the diagnostic performance of the HIV-associated neurocognitive disorder (Frascati criteria) and global deficit score (GDS) methods in comparison to a new, multivariate method of diagnosis. Methods Using a simulated 'normative' dataset informed by real-world cognitive data from the observational Pharmacokinetic and Clinical Observations in PeoPle Over fiftY (POPPY) cohort study, we evaluated the apparent prevalence of cognitive impairment using the Frascati and GDS definitions, as well as a novel multivariate method based on the Mahalanobis distance. We then quantified the diagnostic properties (including positive and negative predictive values and accuracy) of each method, using bootstrapping with 10,000 replicates, with a separate 'test' dataset to which a pre-defined proportion of 'impaired' individuals had been added. Results The simulated normative dataset demonstrated that up to similar to 26% of a normative control population would be diagnosed with cognitive impairment with the Frascati criteria and similar to 20% with the GDS. In contrast, the multivariate Mahalanobis distance method identified impairment in similar to 5%. Using the test dataset, diagnostic accuracy [95% confidence intervals] and positive predictive value (PPV) was best for the multivariate method vs. Frascati and GDS (accuracy: 92.8% [90.3 +/- 95.2%] vs. 76.1% [72.1 +/- 80.0%] and 80.6% [76.6 +/- 84.5%] respectively; PPV: 61.2% [48.3 +/- 72.2%] vs. 29.4% [22.2 +/- 36.8%] and 33.9% [25.6 +/- 42.3%] respectively). Increasing the a priori false positive rate for the multivariate Mahalanobis distance method from 5% to 15% resulted in an increase in sensitivity from 77.4% (64.5 +/- 89.4%) to 92.2% (83.3 +/- 100%) at a cost of specificity from 94.5% (92.8 +/- 95.2%) to 85.0% (81.2 +/- 88.5%). Conclusion Our simulations suggest that the commonly used diagnostic criteria of HIV-associated cognitive impairment label a significant proportion of a normative reference population as cognitively impaired, which will likely lead to a substantial over-estimate of the true proportion in a study population, due to their lower than expected specificity. These findings have important implications for clinical research regarding cognitive health in people living with HIV. More accurate methods of diagnosis should be implemented, with multivariate techniques offering a promising solution.	[Underwood, Jonathan; Winston, Alan] Imperial Coll London, Div Infect Dis, London, England; [De Francesco, Davide; Sabine, Caroline A.] UCL, Dept Infect & Populat Hlth, London, England; [Leech, Robert] Imperial Coll London, Div Brain Sci, London, England	Imperial College London; University of London; University College London; Imperial College London	Underwood, J (corresponding author), Imperial Coll London, Div Infect Dis, London, England.	jonathan.underwood@imperial.ac.uk	Leech, Robert/AAE-8254-2019; Winston, Alan/AGZ-3015-2022	Leech, Robert/0000-0002-5801-6318; Winston, Alan/0000-0002-5847-8416; Anderson, Jane/0000-0001-5294-8707; Underwood, Jonathan/0000-0001-6963-2821; De Francesco, Davide/0000-0002-6185-0514	BMS; Gilead Sciences; Janssen; Merck; ViiV Healthcare; European Union [FP-7-HEALTH 305522]; MRC [MR/M004236/1] Funding Source: UKRI	BMS(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); ViiV Healthcare; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The POPPY study is funded from investigator initiated grants from BMS, Gilead Sciences, Janssen, Merck and ViiV Healthcare. JU was supported by a European Union Seventh Framework Programme grant to the Comorbidity in Relation to AIDS (COBRA) project (FP-7-HEALTH 305522) - https://ec.europa.eu/research/fp7/index.en.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cole MA, 2007, NEUROLOGY, V69, P2213, DOI 10.1212/01.WNL.0000277520.94788.82; Cysique LAJ, 2006, ARCH CLIN NEUROPSYCH, V21, P185, DOI 10.1016/j.acn.2005.07.011; De Francesco D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1970-8; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Grant I, 2014, NEUROLOGY, V82, P2055, DOI 10.1212/WNL.0000000000000492; Hanninen T, 1996, AGE AGEING, V25, P201, DOI 10.1093/ageing/25.3.201; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2015, CLIN INFECT DIS, V60, P473, DOI 10.1093/cid/ciu862; Huizenga HM, 2007, NEUROPSYCHOLOGIA, V45, P2534, DOI 10.1016/j.neuropsychologia.2007.03.011; McDonnell J, 2014, JAIDS-J ACQ IMM DEF, V67, P120, DOI 10.1097/QAI.0000000000000273; Overton ET, 2011, AIDS BEHAV, V15, P1902, DOI 10.1007/s10461-011-0033-9; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Sacktor N, 2016, NEUROLOGY, V86, P334, DOI 10.1212/WNL.0000000000002277; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; STEIGER JH, 1980, MULTIVAR BEHAV RES, V15, P335, DOI 10.1207/s15327906mbr1503_7; Su Tanja, 2015, AIDS, V29, P547, DOI 10.1097/QAD.0000000000000573; Taylor MJ, J INT NEUROPSYCHOLOG, V7, P867; Underwood J, 2017, HIV MED, V18, P363, DOI 10.1111/hiv.12434; Venables WN., 2002, MODERN APPL STAT S	23	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194760	10.1371/journal.pone.0194760	http://dx.doi.org/10.1371/journal.pone.0194760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641619	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000429742900044
J	Kharel, Y; Agah, S; Huang, T; Mendelson, AJ; Eletu, OT; Barkey-Bircannl, P; Gesualdil, J; Smith, JS; Santos, WL; Lynch, KR				Kharel, Yugesh; Agah, Sayeh; Huang, Tao; Mendelson, Anna J.; Eletu, Oluwafunmilayo T.; Barkey-Bircannl, Peter; Gesualdil, James; Smith, Jeffrey S.; Santos, Webster L.; Lynch, Kevin R.			Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors	PLOS ONE			English	Article							SPHINGOSINE KINASE; ASSAY; 1-PHOSPHATE; DISCOVERY; POTENT; CELLS	Successful medicinal chemistry campaigns to discover and optimize sphingosine kinase inhibitors require a robust assay for screening chemical libraries and for determining rank order potencies. Existing assays for these enzymes are laborious, expensive and/or low throughput. The toxicity of excessive levels of phosphorylated sphingoid bases for the budding yeast, Saccharomyces cerevisiae, affords an assay wherein inhibitors added to the culture media rescue growth in a dose-dependent fashion. Herein, we describe our adaptation of a simple, inexpensive, and high throughput assay for assessing inhibitors of sphingosine kinase types 1 and 2 as well as ceramide kinase and for testing enzymatic activity of sphingosine kinase type 2 mutants. The assay was validated using recombinant enzymes and generally agrees with the rank order of potencies of existing inhibitors.	[Kharel, Yugesh; Agah, Sayeh; Huang, Tao; Mendelson, Anna J.; Eletu, Oluwafunmilayo T.; Barkey-Bircannl, Peter; Gesualdil, James; Lynch, Kevin R.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Smith, Jeffrey S.] Univ Virginia, Biochem & Mol Genet, Charlottesville, VA USA; [Santos, Webster L.] Virginia Tech, Dept Chem, Blacksburg, VA USA; [Santos, Webster L.] Virginia Tech, VT Ctr Drug Discovery, Blacksburg, VA USA	University of Virginia; University of Virginia; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Lynch, KR (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	krl2z@virginia.edu	; lynch, kevin/F-3996-2012	Santos, Webster/0000-0002-4731-8548; Kharel, Yugesh/0000-0001-9241-6860; Smith, Jeffrey/0000-0001-7129-5094; lynch, kevin/0000-0002-7376-922X	NIH/NIGMS [R01 GM104366, R01 GM121075]; NIH [R01 GM075240]; NIGMS; University of Virginia Summer Research Internship Program fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121075, R01GM075240, R01GM104366] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Virginia Summer Research Internship Program fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NIGMS R01 GM104366 & NIH/NIGMS R01 GM121075 to KRL & WLS, NIH R01 GM075240 to JSS, NIGMS: https://www.nigms.nih.gov/Pages/default.aspx; University of Virginia Summer Research Internship Program fellowships to JG and PBB https://med.virginia.edu/diversity/programs/srip/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DL, 2013, BBA-MOL CELL BIOL L, V1831, P139, DOI 10.1016/j.bbalip.2012.09.006; Billich A, 2004, ANAL BIOCHEM, V326, P114, DOI 10.1016/j.ab.2003.11.018; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; French KJ, 2003, CANCER RES, V63, P5962; Graf C, 2008, MOL PHARMACOL, V74, P925, DOI 10.1124/mol.108.048652; Highkin MK, 2011, J BIOMOL SCREEN, V16, P272, DOI 10.1177/1087057110391656; Kashem MA, 2016, ASSAY DRUG DEV TECHN, V14, P39, DOI 10.1089/adt.2015.671; Kharel Y, 2015, J PHARMACOL EXP THER, V355, P23, DOI 10.1124/jpet.115.225862; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Kharel Y, 2011, ANAL BIOCHEM, V411, P230, DOI 10.1016/j.ab.2011.01.003; Kim S, 2000, GENETICS, V156, P1519; Patwardhan NN, 2015, J MED CHEM, V58, P1879, DOI 10.1021/jm501760d; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Pitson SM, 2001, FEBS LETT, V509, P169; Roberts JL, 2004, ANAL BIOCHEM, V331, P122, DOI 10.1016/j.ab.2004.03.030; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; Wang J, 2014, ACS MED CHEM LETT, V5, P1329, DOI 10.1021/ml5004074; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Xiang YB, 2009, BIOORG MED CHEM LETT, V19, P6119, DOI 10.1016/j.bmcl.2009.09.022; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905; Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6	23	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0192179	10.1371/journal.pone.0192179	http://dx.doi.org/10.1371/journal.pone.0192179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672528	Green Published, gold, Green Submitted			2022-12-27	WOS:000430446800003
J	Tuominen, PPA; Raitanen, J; Husu, P; Kujala, UM; Luoto, RM				Tuominen, Pipsa P. A.; Raitanen, Jani; Husu, Pauliina; Kujala, Urho M.; Luoto, Riitta M.			The effects of mothers' musical background on sedentary behavior, physical activity, and exercise adherence in their 5-6-years-old children using movement-to-music video program	PLOS ONE			English	Article							ACTIVITY PARTICIPATION; INTERVENTIONS; ASSOCIATIONS; INSTRUMENT; ENJOYMENT; DOMAIN; DANCE	Objectives The purpose of this study was to examine whether mothers' musical background has an effect on their own and their children's sedentary behavior (SB) and physical activity (PA). The aim was also to assess children's and their mothers' exercise adherence when using movement-to-music video program. Design Sub-group analysis of an intervention group in a randomized controlled trial (ISRCTN33885819). Method Seventy-one mother-child-pairs were divided into two categories based on mothers' musical background. Each pair performed 8 weeks exercise intervention using movement-to-music video program. SB and PA were assessed objectively by accelerometer, and exercise activity, fidelity, and enjoyment were assessed via exercise diaries and questionnaires. Logistic regression model was used to analyze associations in the main outcomes between the groups. Results Those children whose mothers had musical background (MB) had greater probability to increase their light PA during the intervention, but not moderate-to-vigorous PA compared to those children whose mothers did not have musical background (NMB). SB increased in both groups. Mothers in the NMB group had greater probability to increase their light and moderate-to-vigorous PA and decrease their SB than mothers in the MB group. However, exercise adherence decreased considerably in all groups. Completeness, fidelity, and enjoyment were higher among the NMB group compared to the MB group. Conclusions The present results showed that mothers without musical background were more interested in movement-to-music exercises, as well as their children. For further studies it would be important to evaluate an effect of children's own music-based activities on their SB and PA.	[Tuominen, Pipsa P. A.; Raitanen, Jani; Husu, Pauliina; Luoto, Riitta M.] UKK Inst Hlth Promot Res, Tampere, Finland; [Tuominen, Pipsa P. A.; Kujala, Urho M.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Raitanen, Jani; Luoto, Riitta M.] Univ Tampere, Fac Social Sci, Hlth Sci, Tampere, Finland	UKK Institute; University of Jyvaskyla; Tampere University	Tuominen, PPA (corresponding author), UKK Inst Hlth Promot Res, Tampere, Finland.; Tuominen, PPA (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.	pipsa.p.a.tuominen@jyu.fi	Vähä-Ypyä, Henri/GSO-2044-2022; Raitanen, Jani/AAW-9233-2021; Kujala, Urho/AAP-2547-2020	Husu, Pauliina/0000-0003-1502-7428; Raitanen, Jani/0000-0001-7674-0978; Kujala, Urho/0000-0002-9262-1992	Academy of Finland [277079]; Pirkanmaa Hospital District [9S034]	Academy of Finland(Academy of Finland); Pirkanmaa Hospital District	Funding for this study was provided under an Academy of Finland research grant (number 277079, http://www.aka.fi/en) to Riitta M Luoto and via Competitive Research Funding from Pirkanmaa Hospital District (code 9S034, htps:// www.pshp.fi/en-US/Hospital_District) for Riitta M Luoto and the research group for 4 years' time (2014-2017) for NELLI - Lifestyle, counseling and exercise in maternity care project 5-year follow-up study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott G, 2016, J PHYS ACT HEALTH, V13, P269, DOI 10.1123/jpah.2015-0136; [Anonymous], 2016, REC PHYS ACT EARL CH, P21; [Anonymous], 2015, IST VAH VOI PAR KANS; Australian Government Department of Health, 2014, MAK YOUR MOV SIT LES; Briscoe D., 2016, MUSIC EDUC J, V103, P41; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Chin TC, 2012, MUSIC PERCEPT, V29, P429, DOI 10.1525/MP.2012.29.4.429; Clark IN, 2016, NORD J MUSIC THER, V25, P76, DOI 10.1080/08098131.2015.1008558; Denac O, 2008, EARLY CHILD EDUC J, V35, P439, DOI 10.1007/s10643-007-0205-4; Dieringer ST, 2013, PALAESTRA, V27, P42; Gao Z, 2013, J SPORT HEALTH SCI, V2, P122, DOI 10.1016/j.jshs.2012.07.001; Gao Z, 2013, J SPORT HEALTH SCI, V2, P146, DOI 10.1016/j.jshs.2013.01.005; Heisz JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168534; Huijg JM, 2015, PHYS THER, V95, P539, DOI 10.2522/ptj.20130457; Jago R, 2013, EUR J PEDIATR, V172, P1543, DOI 10.1007/s00431-013-2077-5; Jekauc D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01145; Karageorghis C, 2008, INT J SPORTS MED, V29, P613, DOI 10.1055/s-2007-989266; Karageorghis CI, 2016, APPL MUSIC EXERCISE; Karageorghis CI., 2008, SPORT EXERCISE PSYCH, P109; Karageorghis CI, 2006, J SPORT SCI, V24, P899, DOI 10.1080/02640410500298107; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; Lindsay AC, 2017, J SPEC PEDIATR NURS, V22, DOI 10.1111/jspn.12182; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; O'Dwyer MV, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-117; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Remmers T, 2015, J PHYS ACT HEALTH, V12, P1066, DOI 10.1123/jpah.2014-0011; Rhodes RE, 2015, ANN BEHAV MED, V49, P715, DOI 10.1007/s12160-015-9704-5; Saarikallio S, 2018, MUSIC SCI, V17, P27; Saarikallio S, 2013, MUSIC SCI, V17, P27, DOI 10.1177/1029864912462381; Saunders RP, 2017, HEALTH EDUC BEHAV; Temmerman N., 2000, BRIT J MUSIC EDUC, V17, P51, DOI [10.1017/S0265051700000140, DOI 10.1017/S0265051700000140]; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Tuominen PPA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183317; Tuominen PPA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1701-z; Tuominen PPA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2347-4; Vaha-Ypya H, 2017, SCAND J MED SCI SPOR; Vaha-Ypya H, 2015, CLIN PHYSIOL FUNCT I, V35, P64, DOI 10.1111/cpf.12127; Ward DS, 2010, MED SCI SPORT EXER, V42, P526, DOI 10.1249/MSS.0b013e3181cea406	39	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195837	10.1371/journal.pone.0195837	http://dx.doi.org/10.1371/journal.pone.0195837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668726	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200061
J	Abras, A; Ballart, C; Llovet, T; Roig, C; Gutierrez, C; Tebar, S; Berenguer, P; Pinazo, MJ; Posada, E; Gascon, J; Schijman, AG; Gallego, M; Munoz, C				Abras, Alba; Ballart, Cristina; Llovet, Teresa; Roig, Carme; Gutierrez, Cristina; Tebar, Silvia; Berenguer, Pere; Pinazo, Maria-Jesus; Posada, Elizabeth; Gascon, Joaquim; Schijman, Alejandro G.; Gallego, Montserrat; Munoz, Carmen			Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: A comparative study of sample treatments, DNA extraction methods and real-time PCR assays	PLOS ONE			English	Article							NUCLEIC-ACID EXTRACTION; CHRONIC CHAGAS-DISEASE; ECONOMIC-EVALUATION; SATELLITE DNA; AMPLIFICATION; AGREEMENT; SEQUENCES	Background Polymerase chain reaction (PCR) has become a useful tool for the diagnosis of Trypanosoma cruzi infection. The development of automated DNA extraction methodologies and PCR systems is an important step toward the standardization of protocols in routine diagnosis. To date, there are only two commercially available Real-Time PCR assays for the routine laboratory detection of T. cruzi DNA in clinical samples: TCRUZIDNA. CE (Diagnostic Bioprobes Srl) and RealCycler CHAG (Progenie Molecular). Our aim was to evaluate the RealCycler CHAG assay taking into account the whole process. Methodology/Principal findings We assessed the usefulness of an automated DNA extraction system based on magnetic particles (EZ1 Virus Mini Kit v2.0, Qiagen) combined with a commercially available RealTime PCR assay targeting satellite DNA (SatDNA) of T. cruzi (RealCycler CHAG), a methodology used for routine diagnosis in our hospital. It was compared with a well-known strategy combining a commercial DNA isolation kit based on silica columns (High Pure PCR Template Preparation Kit, Roche Diagnostics) with an in-house Real-Time PCR targeting SatDNA. The results of the two methodologies were in almost perfect agreement, indicating they can be used interchangeably. However, when variations in protocol factors were applied (sample treatment, extraction method and Real-Time PCR), the results were less convincing. A comprehensive fine-tuning of the whole procedure is the key to successful results. Guanidine EDTA-blood (GEB) samples are not suitable for DNA extraction based on magnetic particles due to inhibition, at least when samples are not processed immediately. Conclusions/Significance This is the first study to evaluate the RealCycler CHAG assay taking into account the overall process, including three variables (sample treatment, extraction method and Real-Time PCR). Our findings may contribute to the harmonization of protocols between laboratories and to a wider application of Real-Time PCR in molecular diagnostic laboratories associated with health centers.	[Abras, Alba; Ballart, Cristina; Tebar, Silvia; Gallego, Montserrat] Univ Barcelona, Fac Farm & Ciencies Alimentacio, Dept Biol Sanitat & Medi Ambient, Seccio Parasitol, Barcelona, Spain; [Abras, Alba; Ballart, Cristina; Tebar, Silvia; Pinazo, Maria-Jesus; Posada, Elizabeth; Gascon, Joaquim; Gallego, Montserrat] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Abras, Alba] Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain; [Llovet, Teresa; Roig, Carme; Gutierrez, Cristina; Berenguer, Pere; Munoz, Carmen] Hosp Santa Creu & Sant Pau, Serv Microbiol, Barcelona, Spain; [Llovet, Teresa; Munoz, Carmen] Univ Autonoma Barcelona, Dept Genet & Microbiol, Cerdanyola Del Valles, Spain; [Schijman, Alejandro G.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol Dr Hector N Tor, LaBMECh, Buenos Aires, DF, Argentina; [Munoz, Carmen] Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau IB St Pau, Barcelona, Spain	University of Barcelona; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Universitat de Girona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital of Santa Creu i Sant Pau	Gallego, M (corresponding author), Univ Barcelona, Fac Farm & Ciencies Alimentacio, Dept Biol Sanitat & Medi Ambient, Seccio Parasitol, Barcelona, Spain.; Gallego, M (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.; Munoz, C (corresponding author), Hosp Santa Creu & Sant Pau, Serv Microbiol, Barcelona, Spain.; Munoz, C (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Cerdanyola Del Valles, Spain.; Munoz, C (corresponding author), Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau IB St Pau, Barcelona, Spain.	mgalIego@ub.edu; cmunoz@santpau.cat	Martinez, Silvia Tebar/C-8046-2019; Culleré, Montserrat Gállego/T-6246-2017; Abras, Alba/X-6320-2019; Gascon, Joaquim/M-3598-2015; Delgado, Maria Jesús Pinazo/X-6093-2018; Abras, Alba/J-6466-2017; Munoz, Carmen/P-9183-2015	Martinez, Silvia Tebar/0000-0002-2959-7555; Culleré, Montserrat Gállego/0000-0002-8143-9773; Abras, Alba/0000-0003-2002-1186; Gascon, Joaquim/0000-0002-5045-1585; Delgado, Maria Jesús Pinazo/0000-0002-4237-1075; Munoz-Batet, Carmen/0000-0002-4150-8834	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya [2014SGR026]; Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau); Plan Nacional de I +D+i; Institute de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competividad, Spanish Network for Research in Infectious Diseases [REIPI RD12/0015]; European Development Regional Fund (ERDF); RICET, a Tropical Disease Cooperative Research Network in Spain [RD12/0018/0010]	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya; Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau); Plan Nacional de I +D+i; Institute de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competividad, Spanish Network for Research in Infectious Diseases; European Development Regional Fund (ERDF)(European Commission); RICET, a Tropical Disease Cooperative Research Network in Spain	This study was partially supported by Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya (grant 2014SGR026), Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau) and by Plan Nacional de I +D+i and Institute de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competividad, Spanish Network for Research in Infectious Diseases (grant REIPI RD12/0015); cofinanced by European Development Regional Fund (ERDF) "A way to achieve Europe". A.A., C.B., S.T., M-J.P., E.P., J.G., and M.G. belong to RICET, a Tropical Disease Cooperative Research Network in Spain (grant RD12/0018/0010). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. The supporters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2015, ACTA TROP, V151, P126, DOI 10.1016/j.actatropica.2015.07.005; Abras A, 2017, J CLIN MICROBIOL, V55, P1396, DOI [10.1128/jcm.02248-16, 10.1128/JCM.02248-16]; Abras A, 2016, J CLIN MICROBIOL, V54, P1566, DOI 10.1128/JCM.00142-16; Aebischer A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-137; Albajar-Vinas P, 2011, EUROSURVEILLANCE, V16, P19975, DOI DOI 10.2807/ESE.16.38.19975-EN; Alonso-Padilla J, 2017, EXPERT REV MOL DIAGN, V17, P699, DOI 10.1080/14737159.2017.1338566; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2002, WHO TECHN REP SER; Balouz V, 2017, ADV PARASIT, V97, P1, DOI 10.1016/bs.apar.2016.10.001; Berensmeier S, 2006, APPL MICROBIOL BIOT, V73, P495, DOI 10.1007/s00253-006-0675-0; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Besuschio SA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005779; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Bua J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002476; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Burgos JM, 2009, DIAGN MICR INFEC DIS, V65, P58, DOI 10.1016/j.diagmicrobio.2009.04.010; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Caballero ZC, 2007, CLIN VACCINE IMMUNOL, V14, P1045, DOI 10.1128/CVI.00127-07; Carlier Y, 2015, MEM I OSWALDO CRUZ, V110, P363, DOI [10.1590/0074-02760140410, 10.1590/0074-02760140405]; Carlier Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001250; Ramirez JC, 2015, J MOL DIAGN, V17, P605, DOI 10.1016/j.jmoldx.2015.04.010; Carolina M, 2003, MOL BIOCHEM PARASIT, V129, P1, DOI 10.1016/S0166-6851(03)00054-9; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; Cura CI, 2017, J MOL DIAGN, V19, P673, DOI 10.1016/j.jmoldx.2017.05.010; Duffy T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002000; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; Dundas N, 2008, J MOL DIAGN, V10, P311, DOI 10.2353/jmoldx.2008.070149; Eguez KE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005501; Elias MCQB, 2005, MOL BIOCHEM PARASIT, V140, P221, DOI 10.1016/j.molbiopara.2004.12.016; Ferrer Elizabeth, 2015, Saber, V27, P359; Flores-Chavez M, 2010, ENFERM INFEC MICR CL, V28, P284, DOI 10.1016/j.eimc.2009.07.005; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Imaz-Iglesia I, 2015, ACTA TROP, V148, P77, DOI 10.1016/j.actatropica.2015.04.014; Santos FLN, 2016, AM J TROP MED HYG, V94, P1034, DOI 10.4269/ajtmh.15-0820; Otani MM, 2009, TRANSFUSION, V49, P1076, DOI 10.1111/j.1537-2995.2009.02107.x; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Picado A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005148; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Poma HR, 2012, REV ARGENT MICROBIOL, V44, P144; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Requena-Mendez A, 2017, LANCET GLOB HEALTH, V5, pE439, DOI 10.1016/s2214-109x(17)30073-6; Rivero R, 2017, DIAGN MICR INFEC DIS, V89, P26, DOI 10.1016/j.diagmicrobio.2017.06.012; Schijman AG, 2018, ACTA TROP, DOI [10.1016/J.ACTATR0PICA.2018.02.019, DOI 10.1016/J.ACTATR0PICA.2018.02.019]; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Seiringer P, 2017, DIAGN MICR INFEC DIS, V88, P225, DOI 10.1016/j.diagmicrobio.2017.04.003; Sicuri E, 2011, ACTA TROP, V118, P110, DOI 10.1016/j.actatropica.2011.02.012; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0; Telleria J, 2006, EXP PARASITOL, V114, P279, DOI 10.1016/j.exppara.2006.04.005; Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13	53	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195738	10.1371/journal.pone.0195738	http://dx.doi.org/10.1371/journal.pone.0195738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664973	gold, Green Published			2022-12-27	WOS:000430262300030
J	Corbella, S; Veronesi, P; Galimberti, V; Weinstein, R; Del Fabbro, M; Francetti, L				Corbella, Stefano; Veronesi, Paolo; Galimberti, Viviana; Weinstein, Roberto; Del Fabbro, Massimo; Francetti, Luca			Is periodontitis a risk indicator for cancer? A meta-analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TOOTH LOSS; ORAL-CANCER; PORPHYROMONAS-GINGIVALIS; POSTMENOPAUSAL WOMEN; HEALTH-PROFESSIONALS; HUMAN-PAPILLOMAVIRUS; VASCULAR-DISEASE; ASSOCIATION; HEAD	Background The aim of the present systematic review was to evaluate the hypothesis of an association between periodontitis and the development of cancer. Methods Two reviewers independently screened electronic and manual sources for pertinent articles. Primary outcome measures were the occurrence of neoplasm diagnosis in exposed and non-exposed groups, reported to evaluate association between cancer and periodontitis. Results Of the 490 initially retrieved papers 10 were included in the qualitative synthesis and eight in the quantitative synthesis; the eight papers covered six studies. Considering hazard ratios, a statistically significant association was found for all cancers studied (1.14; CI 95%: 1.04, 1.24), digestive tract cancer (1.34; CI 95%: 1.05, 1.72), pancreatic cancer (1.74; CI 95%: 1.21, 2.52), prostate cancer (1.25; CI 95%: 1.04, 1.51), breast cancer (1.11; CI 95%: 1.00, 1.23), corpus uteri cancer (2.20; CI 95%: 1.16, 4.18), lung cancer (1.24; CI 95%: 1.06, 1.45), hematological cancer (1.30; CI 95%: 1.11, 1.53), esophagus / oropharyngeal cancer pooled together (2.25; CI 95%: 1.30, 3.90) and Non-Hodgkin lymphoma (1.30; CI 95%: 1.11, 1.52). Conclusions Despite the sparse scientific evidence and considering the low statistical power of the results, this systematic review revealed a substantial lack of studies with standardized and comparable methods to speculate about the association between periodontitis and cancer; more studies are need in order to explore further the scientific evidence of such correlation.	[Corbella, Stefano; Del Fabbro, Massimo; Francetti, Luca] IRCCS Ist Ortoped Galeazzi, Milan, Italy; [Corbella, Stefano; Del Fabbro, Massimo; Francetti, Luca] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy; [Veronesi, Paolo; Galimberti, Viviana] European Inst Oncol, Div Senol, Milan, Italy; [Veronesi, Paolo] Univ Milan, Milan, Italy; [Weinstein, Roberto] D&S ICH Humanitas Dent Ctr, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; University of Milan; IRCCS European Institute of Oncology (IEO); University of Milan	Corbella, S (corresponding author), IRCCS Ist Ortoped Galeazzi, Milan, Italy.; Corbella, S (corresponding author), Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy.	stefano.corbella@gmail.com	VERONESI, PAOLO/AAS-4132-2020; Corbella, Stefano/ABC-4274-2020; Francetti, Luca A/CAI-6331-2022; Del Fabbro, Massimo/I-2444-2012; Francetti, Luca A/C-1758-2017; GALIMBERTI, Viviana Enrica/AAS-3963-2020	VERONESI, PAOLO/0000-0001-8926-4106; Corbella, Stefano/0000-0001-8428-8811; Francetti, Luca A/0000-0001-5775-8961; Del Fabbro, Massimo/0000-0001-7144-0984; Francetti, Luca A/0000-0001-5775-8961; GALIMBERTI, Viviana Enrica/0000-0002-5036-7439				Aran D, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0995-z; Arora M, 2010, AM J EPIDEMIOL, V171, P253, DOI 10.1093/aje/kwp340; Barton MK, 2017, CA CANC J CLIN; Bernabe E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104808; Bertrand KA, 2017, INT J CANCER, V140, P1020, DOI 10.1002/ijc.30518; Budzynski J, 2016, INT J ANGIOL, V25, P3, DOI 10.1055/s-0035-1547385; Conway DI, 2008, INT J CANCER, V122, P2811, DOI 10.1002/ijc.23430; Corbella S, 2016, QUINTESSENCE INT, V47, P193, DOI 10.3290/j.qi.a34980; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cullinan MP, 2013, PERIODONTOL 2000, V62, P271, DOI 10.1111/prd.12007; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eliot MN, 2013, CANCER CAUSE CONTROL, V24, P1315, DOI 10.1007/s10552-013-0209-x; Faggion Jr CM, 2016, J PERIODONTAL RES; Fitzpatrick SG, 2010, J DENT, V38, P83, DOI 10.1016/j.jdent.2009.10.007; Freudenheim JL, 2016, CANCER EPIDEM BIOMAR, V25, P43, DOI 10.1158/1055-9965.EPI-15-0750; Gondivkar S. M., 2013, Experimental Oncology, V35, P163; Han Y W, 2014, Adv Dent Res, V26, P47, DOI 10.1177/0022034514528334; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hormia M, 2005, J PERIODONTOL, V76, P358, DOI 10.1902/jop.2005.76.3.358; Hujoel PP, 2003, ANN EPIDEMIOL, V13, P312, DOI 10.1016/S1047-2797(02)00425-8; Javed F, 2016, CRIT REV ONCOL HEMAT, V97, P197, DOI 10.1016/j.critrevonc.2015.08.018; Joshipura KJ, 2002, J PUBLIC HEALTH DENT, V62, P115, DOI 10.1111/j.1752-7325.2002.tb03431.x; Joshipura KJ, 1996, J PUBLIC HEALTH DENT, V56, P205, DOI 10.1111/j.1752-7325.1996.tb02437.x; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Katz J, 2011, INT J ORAL SCI, V3, P209, DOI 10.4248/IJOS11075; Kuboniwa M, 2008, MICROBES INFECT, V10, P122, DOI 10.1016/j.micinf.2007.10.011; LaMonte MJ, 2014, J PERIODONTOL, V85, P1489, DOI 10.1902/jop.2014.140185; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; Mai XD, 2016, J PERIODONTOL, V87, P257, DOI 10.1902/jop.2015.150433; Mai XD, 2016, CANCER CAUSE CONTROL, V27, P217, DOI 10.1007/s10552-015-0699-9; Mai XD, 2014, CANCER CAUSE CONTROL, V25, P1045, DOI 10.1007/s10552-014-0405-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mantovani A, 2008, CANCER LETT, V267, P180, DOI 10.1016/j.canlet.2008.05.003; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Mazul AL, 2017, CANCER-AM CANCER SOC, V123, P71, DOI 10.1002/cncr.30312; Meyer MS, 2008, CANCER CAUSE CONTROL, V19, P895, DOI 10.1007/s10552-008-9163-4; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Michaud DS, 2007, JNCI-J NATL CANCER I, V99, P171, DOI 10.1093/jnci/djk021; Michaud DS, 2016, ANN ONCOLOGY OFFICIA; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Momen-Heravi F, 2017, INT J CANCER, V140, P646, DOI 10.1002/ijc.30486; Papapanou PN, 2015, INT DENT J, V65, P283, DOI 10.1111/idj.12185; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Sahingur SE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00214; Salazar CR, 2012, CARCINOGENESIS, V33, P399, DOI 10.1093/carcin/bgr284; Salehi R, 2010, J CARDIOVASC THORAC, V2, P19; Sayehmiri F, 2015, INT J IMMUNOPATH PH, V28, P160, DOI 10.1177/0394632015586144; Saygun I, 2005, J PERIODONTAL RES, V40, P187, DOI 10.1111/j.1600-0765.2005.00790.x; Schmitt A, 2015, J CLIN PERIODONTOL, V42, P977, DOI 10.1111/jcpe.12467; Simpson TC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004714.pub3; Slots J, 2006, J PERIODONTAL RES, V41, P235, DOI 10.1111/j.1600-0765.2006.00865.x; Sommer I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2227-y; Tezal M, 2005, J PERIODONTOL, V76, P406, DOI 10.1902/jop.2005.76.3.406; Valentine JC, 2010, J EDUC BEHAV STAT, V35, P215, DOI 10.3102/1076998609346961; van der Velden U, 2015, J CLIN PERIODONTOL, V42, P824, DOI 10.1111/jcpe.12446; Yao QW, 2014, TUMOR BIOL, V35, P7073, DOI 10.1007/s13277-014-1951-8; Zeng XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079017	59	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195683	10.1371/journal.pone.0195683	http://dx.doi.org/10.1371/journal.pone.0195683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664916	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300026
J	Thapa, S; Chitale, V; Rijal, SJ; Bisht, N; Shrestha, BB				Thapa, Sunil; Chitale, Vishwas; Rijal, Srijana Joshi; Bisht, Neha; Shrestha, Bharat Babu			Understanding the dynamics in distribution of invasive alien plant species under predicted climate change in Western Himalaya	PLOS ONE			English	Article							LANTANA-CAMARA L.; PARTHENIUM-HYSTEROPHORUS ASTERACEAE; POTENTIAL DISTRIBUTION; MAXIMUM-ENTROPY; DISTRIBUTION PATTERNS; BIOLOGICAL INVASIONS; SPATIAL-DISTRIBUTION; HABITAT MODELS; INDIA; IMPACTS	Invasive alien plant species (IAPS) can pose severe threats to biodiversity and stability of native ecosystems, therefore, predicting the distribution of the IAPS plays a crucial role in effective planning and management of ecosystems. In the present study, we use Maximum Entropy (MaxEnt) modelling approach to predict the potential of distribution of eleven IAPS under future climatic conditions under RCP 2.6 and RCP 8.5 in part of Kailash sacred landscape region in Western Himalaya. Based on the model predictions, distribution of most of these invasive plants is expected to expand under future climatic scenarios, which might pose a serious threat to the native ecosystems through competition for resources in the study area. Native scrublands and subtropical needle-leaved forests will be the most affected ecosystems by the expansion of these IAPS. The present study is first of its kind in the Kailash Sacred Landscape in the field of invasive plants and the predictions of potential distribution under future climatic conditions from our study could help decision makers in planning and managing these forest ecosystems effectively.	[Thapa, Sunil; Chitale, Vishwas; Rijal, Srijana Joshi; Bisht, Neha] Int Ctr Integrated Mt Dev ICIMOD, Kathmandu, Nepal; [Shrestha, Bharat Babu] Tribhuvan Univ, Kathmandu, Nepal	Tribhuvan University	Thapa, S; Chitale, V (corresponding author), Int Ctr Integrated Mt Dev ICIMOD, Kathmandu, Nepal.	sunil.thapa@icimod.org; vishwas.chitale@icimod.org	Shrestha, Bharat Babu/V-2006-2019	Shrestha, Bharat Babu/0000-0002-9457-2637	Department for International Development (DFID)-UK Aid; German Federal Ministry of Economic Cooperation and Development; German International Cooperation (GIZ); ICIMOD	Department for International Development (DFID)-UK Aid; German Federal Ministry of Economic Cooperation and Development; German International Cooperation (GIZ); ICIMOD	The study was carried out under the Kailash Sacred Landscape Conservation and Development Initiative (KSLCDI) of the International Centre for Integrated Mountain Development (ICIMOD). We would like to thank the Department for International Development (DFID)-UK Aid, German Federal Ministry of Economic Cooperation and Development and German International Cooperation (GIZ) for providing financial support for the KSLCDI. This study was partially supported by core funds from ICIMOD contributed by the Governments of Afghanistan, Australia, Austria, Bangladesh, Bhutan, China, India, Myanmar, Nepal, Norway, Pakistan, Switzerland and the UK. The authors would like to express their gratitude to the three anonymous reviewers whose comments helped us improve the manuscript.	Adhikari D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134665; Adkins S, 2014, PEST MANAG SCI, V70, P1023, DOI 10.1002/ps.3708; Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708; Alexander JM, 2016, ALPINE BOT, V126, P89, DOI 10.1007/s00035-016-0172-8; [Anonymous], [No title captured]; [Anonymous], 2014, CLIM CHANG 2014 IMP; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bhattarai KR, 2014, J MT SCI-ENGL, V11, P688, DOI 10.1007/s11629-013-2821-3; Bisht N., 2016, MANUAL INVASIVE ALIE; Blossey B., 1999, Biological Invasions, V1, P301, DOI 10.1023/A:1010084724526; Chitale VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115264; Choudhury MR, 2016, ECOL ENG, V97, P23, DOI 10.1016/j.ecoleng.2016.07.018; Christen D, 2006, CONSERV BIOL, V20, P385, DOI 10.1111/j.1523-1739.2006.00315.x; Dhileepan K, 2000, BIOL CONTROL, V19, P9, DOI 10.1006/bcon.2000.0847; Dhileepan K, 2009, WEED RES, V49, P557, DOI 10.1111/j.1365-3180.2009.00728.x; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; Duggin JA, 1998, FOREST ECOL MANAG, V109, P279, DOI 10.1016/S0378-1127(98)00252-7; Early R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1356, DOI 10.1111/geb.12208; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fei SL, 2014, ANNU REV ECOL EVOL S, V45, P69, DOI 10.1146/annurev-ecolsys-120213-091928; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gallardo B, 2013, BIOL CONSERV, V160, P225, DOI 10.1016/j.biocon.2013.02.001; Gnanavel I., 2013, INT J AGR ENV BIOTEC, V6, P261; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hoffman JD, 2008, INVAS PLANT SCI MANA, V1, P359, DOI 10.1614/IPSM-07-048.1; IGES I, 2013, TECHN REP CLIM CHANG; Johnston FM, 2004, ARCT ANTARCT ALP RES, V36, P201, DOI 10.1657/1523-0430(2004)036[0201:IORDOS]2.0.CO;2; Kannan R, 2016, FOREST ECOL MANAG, V376, P166, DOI 10.1016/j.foreco.2016.06.016; Kohli RK, 2006, BIOL INVASIONS, V8, P1501, DOI 10.1007/s10530-005-5842-1; Kosaka Y, 2010, MT RES DEV, V30, P252, DOI 10.1659/MRD-JOURNAL-D-10-00036.1; Kotru R., 2016, KAILASH SACRED LANDS, P101; Kowarik I., 2003, BIOL INVASIONS, V5, P293, DOI DOI 10.1023/B:BINV.0000005574.15074.66; Leyequien E, 2007, INT J APPL EARTH OBS, V9, P1, DOI 10.1016/j.jag.2006.08.002; Love A, 2009, CURR SCI INDIA, V97, P1421; Lowe S, 2004, ENCY BIOL INVASIONS, P715; Lutz AF, 2016, INT J CLIMATOL, V36, P3988, DOI 10.1002/joc.4608; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDougall KL, 2011, MT RES DEV, V31, P380, DOI 10.1659/MRD-JOURNAL-D-11-00082.1; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; Muniappan R, 2009, J AGR URBAN ENTOMOL, V26, P167, DOI 10.3954/1523-5475-26.4.167; Oli K.P., 2011, KAILASH SACRED LANDS, DOI [10.53055/ICIMOD.545, DOI 10.53055/ICIMOD.545]; Paini DR, 2016, P NATL ACAD SCI USA, V113, P7575, DOI 10.1073/pnas.1602205113; Pauchard A, 2009, FRONT ECOL ENVIRON, V7, P479, DOI 10.1890/080072; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Qin Z, 2016, CLIMATIC CHANGE, V134, P193, DOI 10.1007/s10584-015-1500-5; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Reddy CS, 2008, LIFE SCI J, V5, P84; Reddy CS, 2012, BIOHERAL, V2, P110; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Schapire, 2005, MAXENT SOFTWARE SPEC; Shrestha BB, 2015, WEED RES, V55, P132, DOI 10.1111/wre.12133; Shrestha B. B., 2016, FRONTIERS BOT, P269; Shrestha BB., 2014, DISTRIBUTION I UNPUB; Shrestha BB, 2018, INVENTORY I IN PRESS; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Simberloff D, 2011, BIOL INVASIONS, V13, P1255, DOI 10.1007/s10530-011-9956-3; Siwakoti M., 2005, INVENTORY ASSESSMENT; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Taylor S, 2013, J ENVIRON MANAGE, V114, P414, DOI 10.1016/j.jenvman.2012.10.039; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Vithanage M, 2014, J ENVIRON MANAGE, V141, P95, DOI 10.1016/j.jenvman.2014.02.030; Vitousek PM, 1996, AM SCI, V84, P468; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; Wabuyele Emily, 2014, Journal of East African Natural History, V103, P49; Wan FH, 2010, SCI CHINA LIFE SCI, V53, P1291, DOI 10.1007/s11427-010-4080-7; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; Wilson CD, 2011, BIOL CONSERV, V144, P821, DOI 10.1016/j.biocon.2010.11.014; Wintle BA, 2006, ECOL APPL, V16, P1945, DOI 10.1890/1051-0761(2006)016[1945:MSRWSA]2.0.CO;2; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wittenberg R, 2001, INVASIVE ALIEN SPECI; Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4; Zomer RJ, 2014, CLIMATIC CHANGE, V125, P445, DOI 10.1007/s10584-014-1176-2	81	69	71	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195752	10.1371/journal.pone.0195752	http://dx.doi.org/10.1371/journal.pone.0195752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664961	Green Submitted, Green Published, gold			2022-12-27	WOS:000430262300031
J	Lyam, PT; Duque-Lazo, J; Durka, W; Hauenschild, F; Schnitzler, J; Michalak, I; Ogundipe, OT; Muellner-Riehi, AN				Lyam, Paul Terwase; Duque-Lazo, Joaquin; Durka, Walter; Hauenschild, Frank; Schnitzler, Jan; Michalak, Ingo; Ogundipe, Oluwatoyin Temitayo; Muellner-Riehi, Alexandra Nora			Genetic diversity and distribution of Senegalia senegal (L.) Britton under climate change scenarios in West Africa	PLOS ONE			English	Article							ACACIA-SENEGAL; PLANT DIVERSITY; POPULATIONS; MARKERS; CHLOROPLAST; PREDICTION; INFERENCE; WOODLANDS; SOFTWARE; IMPACTS	Climate change is predicted to impact species' genetic diversity and distribution. We used Senegalia senegal (L.) Britton, an economically important species distributed in the Sudano-Sahelian savannah belt of West Africa, to investigate the impact of climate change on intraspecific genetic diversity and distribution. We used ten nuclear and two plastid micro-satellite markers to assess genetic variation, population structure and differentiation across thirteen sites in West Africa. We projected suitable range, and potential impact of climate change on genetic diversity using a maximum entropy approach, under four different climate change scenarios. We found higher genetic and haplotype diversity at both nuclear and plastid markers than previously reported. Genetic differentiation was strong for chloroplast and moderate for the nuclear genome. Both genomes indicated three spatially structured genetic groups. The distribution of Senegalia senegal is strongly correlated with extractable nitrogen, coarse fragments, soil organic carbon stock, precipitation of warmest and coldest quarter and mean temperature of driest quarter. We predicted 40.96 to 6.34 per cent of the current distribution to favourably support the species' ecological requirements under future climate scenarios. Our results suggest that climate change is going to affect the population genetic structure of Senegalia senegal, and that patterns of genetic diversity are going to influence the species' adaptive response to climate change. Our study contributes to the growing evidence predicting the loss of economically relevant plants in West Africa in the next decades due to climate change.	[Lyam, Paul Terwase; Hauenschild, Frank; Schnitzler, Jan; Michalak, Ingo; Muellner-Riehi, Alexandra Nora] Univ Leipzig, Inst Biol, Dept Mol Evolut & Plant Systemat, Leipzig, Germany; [Lyam, Paul Terwase; Hauenschild, Frank; Schnitzler, Jan; Michalak, Ingo; Muellner-Riehi, Alexandra Nora] Univ Leipzig, Inst Biol, Herbarium LZ, Leipzig, Germany; [Lyam, Paul Terwase] Natl Ctr Genet Resources & Biotechnol, Ibadan, Nigeria; [Lyam, Paul Terwase; Duque-Lazo, Joaquin; Durka, Walter; Muellner-Riehi, Alexandra Nora] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Duque-Lazo, Joaquin] Univ Cordoba, DendrodatLab ERSAF, Lab Dendrochronol Silviculture & Global Change, Dept Forest Engn, Campus Rabanales, Cordoba, Spain; [Duque-Lazo, Joaquin] Univ Leipzig, Inst Biol, Dept Systemat Bot & Funct Biodivers, Leipzig, Germany; [Durka, Walter] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol BZF, Halle, Germany; [Ogundipe, Oluwatoyin Temitayo] Univ Lagos, Dept Bot, Lagos, Nigeria	Leipzig University; Leipzig University; Universidad de Cordoba; Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Lagos	Lyam, PT (corresponding author), Univ Leipzig, Inst Biol, Dept Mol Evolut & Plant Systemat, Leipzig, Germany.; Lyam, PT (corresponding author), Univ Leipzig, Inst Biol, Herbarium LZ, Leipzig, Germany.; Lyam, PT (corresponding author), Natl Ctr Genet Resources & Biotechnol, Ibadan, Nigeria.; Lyam, PT (corresponding author), German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany.	pauliam003@gmail.com	Michalak, Ingo/C-1487-2013; Duque-Lazo, Joaquín/L-3722-2019; Durka, Walter/E-4667-2010; Muellner-Riehl, Alexandra N/C-6261-2013	Michalak, Ingo/0000-0002-8664-3968; Duque-Lazo, Joaquín/0000-0003-4223-5070; Durka, Walter/0000-0002-6611-2246; Muellner-Riehl, Alexandra N/0000-0002-2710-469X; Schnitzler, Jan/0000-0002-0843-4503; Lyam, Paul/0000-0002-2215-7717	Alexander von Humboldt Foundation (AVH), Germany under the International Climate Protection Fellowship (ICPC); German Academic Exchange Service (DAAD); National Centre for Genetic resources and Biotechnology (NACGRAB) Ibadan, Nigeria	Alexander von Humboldt Foundation (AVH), Germany under the International Climate Protection Fellowship (ICPC)(Alexander von Humboldt Foundation); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); National Centre for Genetic resources and Biotechnology (NACGRAB) Ibadan, Nigeria	This work was funded by the Alexander von Humboldt Foundation (AVH), Germany under the auspices of an International Climate Protection Fellowship (ICPC), and partly by the German Academic Exchange Service (DAAD), both granted to Paul Terwase Lyam and hosted by Alexandra Muellner-Riehl. Field work and data collection was additionally supported by the National Centre for Genetic resources and Biotechnology (NACGRAB) Ibadan, Nigeria. Apart from this, the funders have no role in the study design, subsequent data collection and analysis, decision to publish or preparation of the manuscript.	Arnell NW, 2014, CLIMATIC CHANGE, V122, P127, DOI 10.1007/s10584-013-0948-4; Assoumane AA, 2009, MOL ECOL RESOUR, V9, P1380, DOI 10.1111/j.1755-0998.2009.02669.x; Assoumane A, 2012, GENET RESOUR CROP EV, V59, P39, DOI 10.1007/s10722-011-9665-x; Bernard-Reversat F., 1980, Nitrogen cycling in West African ecosystems., P363; BESHAI AA, 1984, OXFORD B ECON STAT, V46, P371, DOI 10.1111/j.1468-0084.1984.mp46004006.x; Bocksberger G, 2016, J VEG SCI, V27, P306, DOI 10.1111/jvs.12360; Bouchenak-Khelladi Y, 2010, MOL PHYLOGENET EVOL, V57, P495, DOI 10.1016/j.ympev.2010.07.019; Brenan JPM, 1983, MANUAL TAXONOMY ACAC; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Chidumayo EN., 2010, DRY FORESTS WOODLAND, P1; Duque-Lazo J, 2017, FOREST ECOL MANAG, V392, P90, DOI 10.1016/j.foreco.2017.02.047; Duque-Lazo J, 2016, ECOL MODEL, V320, P62, DOI 10.1016/j.ecolmodel.2015.09.019; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eisa MA, 2008, ACACIA SENEGAL GUM A; Eliades, 2009, HAPLOTYPE ANAL SOFTW; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagg C., 2004, TROP FOR, V42, P261; Falush D, 2003, GENETICS, V164, P1567; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gaisberger H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184457; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Githae E. W., 2011, African Journal of Plant Science, V5, P475; Goncalves-Oliveira RC, 2017, AM J BOT, V104, P868, DOI 10.3732/ajb.1600410; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gray A, 2013, PLANT SOIL, V369, P479, DOI 10.1007/s11104-013-1593-4; Gwali S., 2015, Forests, Trees and Livelihoods, V24, P163, DOI 10.1080/14728028.2014.956808; Habeballa RS, 2010, AFR J BIOTECHNOL, V9, P4655; Hamilton B., 1999, NATURE, V401, P129; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Heubes J, 2013, J ARID ENVIRON, V96, P48, DOI 10.1016/j.jaridenv.2013.04.008; Heywood HV, 1995, GLOBAL BIODIVERSITY; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Joker D., 2000, ACACIA SENEGAL L WIL; Josiah CC, 2008, AFR J BIOTECHNOL, V7, P2333; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kundzewicz ZW, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P173; Kyalangalilwa B, 2013, BOT J LINN SOC, V172, P500, DOI 10.1111/boj.12047; Leadley P., 2010, CBD TECHNICAL SERIES; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lewis PO, GENETIC DATA ANAL CO; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161972; Calle ML, 2011, HUM HERED, V72, P121, DOI 10.1159/000330778; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Maundu P, 2005, TECHNICAL HDB; McClean CJ, 2005, ANN MO BOT GARD, V92, P139; Miller RL, 2014, J ADV MODEL EARTH SY, V6, P441, DOI 10.1002/2013MS000266; Mujawamariya G, 2013, INT FOREST REV, V15, P182, DOI 10.1505/146554813806948477; Mulumba John W., 2012, International Journal of Botany, V8, P107, DOI 10.3923/ijb.2012.107.116; Naimi B., UNCERTAINTY ANAL SPE, V1, P1; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Nazarenko L, 2015, J ADV MODEL EARTH SY, V7, P244, DOI 10.1002/2014MS000403; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Noreen AME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082632; Nvarro-Cerrillo RM, 2016, REV ECOSISTEMAS, V25, P6; Odee DW, 2012, HEREDITY, V109, P372, DOI 10.1038/hdy.2012.52; Omondi S. F., 2010, Tropical Plant Biology, V3, P59, DOI 10.1007/s12042-009-9037-2; Ouinsavi C., 2009, International Journal of Forestry Research, V2009, P210179; Pachauri RK., 2015, CLIMATE CHANGE SYNTH; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pfenninger M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-224; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Poczai P, 2012, MOL BASIS PLANT GENE, P3; Pritchard JK, 2000, GENETICS, V155, P945; Quinn GP, 2003, EXPT DESIGN DATA ANA; Raddad EY, 2005, PLANT SOIL, V275, P261, DOI 10.1007/s11104-005-2152-4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robledo-Arnuncio JJ, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0016-3; Rozzi R, 1997, PLANT ECOL, V132, P171, DOI 10.1023/A:1009747118914; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Serdeczny O, 2017, REG ENVIRON CHANGE, V17, P1585, DOI 10.1007/s10113-015-0910-2; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Sommer JH, 2010, P ROY SOC B-BIOL SCI, V277, P2271, DOI 10.1098/rspb.2010.0120; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; Tandon R, 2001, BOT J LINN SOC, V135, P251, DOI [10.1006/bojl.2000.0401, 10.1111/j.1095-8339.2001.tb01094.x]; Traore S, 2012, J ARID ENVIRON, V87, P144, DOI 10.1016/j.jaridenv.2012.07.010; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Wang Z, 2014, CLIN INTERV AGING, V9, P1, DOI [10.2147/CIA.S41356, 10.1186/1556-276X-9-643]; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Winters G, 2013, CONSERV GENET RESOUR, V5, P807, DOI 10.1007/s12686-013-9913-9; Xu JP, 2008, MOL ECOL, V17, P1238, DOI 10.1111/j.1365-294X.2007.03665.x; Zerbo I., 2016, Journal of Botany, V2016, P9523685	89	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194726	10.1371/journal.pone.0194726	http://dx.doi.org/10.1371/journal.pone.0194726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659603	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100005
J	Record, S; Strecker, A; Tuanmu, MN; Beaudrot, L; Zarnetske, P; Belmaker, J; Gerstner, B				Record, Sydne; Strecker, Angela; Tuanmu, Mao-Ning; Beaudrot, Lydia; Zarnetske, Phoebe; Belmaker, Jonathan; Gerstner, Beth			Does scale matter? A systematic review of incorporating biological realism when predicting changes in species distributions	PLOS ONE			English	Review							DISTRIBUTION MODELS; CLIMATE-CHANGE; GRAIN-SIZE; BIOTIC INTERACTIONS; DISPERSAL DISTANCE; PLANT-DISTRIBUTION; SENSITIVITY; MAMMALS; ACCOUNT; FUTURE	Background There is ample evidence that biotic factors, such as biotic interactions and dispersal capacity, can affect species distributions and influence species' responses to climate change. However, little is known about how these factors affect predictions from species distribution models (SDMs) with respect to spatial grain and extent of the models. Objectives Understanding how spatial scale influences the effects of biological processes in SDMs is important because SDMs are one of the primary tools used by conservation biologists to assess biodiversity impacts of climate change. Data sources and study eligibility criteria We systematically reviewed SDM studies published from 2003-2015 using ISI Web of Science searches to: (1) determine the current state and key knowledge gaps of SDMs that incorporate biotic interactions and dispersal; and (2) understand how choice of spatial scale may alter the influence of biological processes on SDM predictions. Synthesis methods and limitations We used linear mixed effects models to examine how predictions from SDMs changed in response to the effects of spatial scale, dispersal, and biotic interactions. Results There were important biases in studies including an emphasis on terrestrial ecosystems in northern latitudes and little representation of aquatic ecosystems. Our results suggest that neither spatial extent nor grain influence projected climate-induced changes in species ranges when SDMs include dispersal or biotic interactions. Conclusions We identified several knowledge gaps and suggest that SDM studies forecasting the effects of climate change should: 1) address broader ranges of taxa and locations; and 1) report the grain size, extent, and results with and without biological complexity. The spatial scale of analysis in SDMs did not affect estimates of projected range shifts with dispersal and biotic interactions. However, the lack of reporting on results with and without biological complexity precluded many studies from our analysis.	[Record, Sydne] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA; [Strecker, Angela] Portland State Univ, Dept Environm Sci & Management, Portland, OR 97207 USA; [Tuanmu, Mao-Ning] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Beaudrot, Lydia] Univ Michigan, Dept Ecol & Evolutionary Biol & Michigan Soc Fell, Ann Arbor, MI 48109 USA; [Zarnetske, Phoebe] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA; [Zarnetske, Phoebe; Gerstner, Beth] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA; [Belmaker, Jonathan] Tel Aviv Univ, Sch Zool, Tel Aviv, Israel; [Belmaker, Jonathan] Tel Aviv Univ, Steinhardt Museum Nat Hist, Tel Aviv, Israel; [Gerstner, Beth] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Bryn Mawr College; Portland State University; Academia Sinica - Taiwan; University of Michigan System; University of Michigan; Michigan State University; Michigan State University; Tel Aviv University; Tel Aviv University; Michigan State University	Record, S (corresponding author), Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA.	srecord@brynmawr.edu	Zarnetske, Phoebe/V-3974-2019; Strecker, Angela/GWC-1818-2022; Belmaker, Jonathan/I-1004-2019; Tuanmu, Mao-Ning/ABI-5979-2020; Beaudrot, L./M-6936-2017	Zarnetske, Phoebe/0000-0001-6257-6951; Strecker, Angela/0000-0001-9387-1654; Belmaker, Jonathan/0000-0002-5618-7359; Tuanmu, Mao-Ning/0000-0002-8233-2935; Beaudrot, L./0000-0001-8135-7519; Record, Sydne/0000-0001-7293-2155	NSF EAGER collaborative grants [1550770, 1550786, 1550765]; Michigan State University (MSU); United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project [1010055]; MSU; Ecological Society of America	NSF EAGER collaborative grants; Michigan State University (MSU); United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project; MSU; Ecological Society of America	This work was funded by NSF EAGER collaborative grants 1550770 (awarded to SR), 1550786 (awarded to AS), and 1550765 (awarded to PLZ). PLZ was supported by Michigan State University (MSU) and the United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project 1010055. BG was supported by MSU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Ecological Society of America for sponsoring the 2013 Scaling-Up: Continental Scale Ecology Workshop for Early Career Scientists, the planning committee, Deborah Goldberg, Matthew Fitzpatrick, Janet Franklin, Robert Guralnick and Katherine Suding, as well as Jill Petraglia Parsons, Clifford Duke and all of the workshop participants. This work was funded by NSF EAGER collaborative grants 1550770 (awarded to SR), 1550786 (awarded to AS), and 1550765 (awarded to PLZ). PLZ was supported by Michigan State University (MSU) and the United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project 1010055. BG was supported by MSU.	Arau AjoMB, 2013, ECOGRAPHY; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bateman BL, 2013, DIVERS DISTRIB, V19, P1224, DOI 10.1111/ddi.12107; Beck J, 2012, ECOGRAPHY, V35, P673, DOI 10.1111/j.1600-0587.2012.07364.x; Belmaker J, 2015, GLOBAL ECOL BIOGEOGR, V24, P750, DOI 10.1111/geb.12311; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Evans MEK, 2016, TRENDS ECOL EVOL, V31, P860, DOI 10.1016/j.tree.2016.08.005; Feeley KJ, 2011, GLOBAL CHANGE BIOL, V17, P626, DOI 10.1111/j.1365-2486.2010.02239.x; Fitzpatrick MC, 2012, ECOL APPL, V22, P472, DOI 10.1890/11-0009.1; Franklin J., 2010, MAPPING SPECIES DIST, DOI DOI 10.1017/CBO9780511810602; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Godsoe W, 2012, ECOGRAPHY, V35, P811, DOI 10.1111/j.1600-0587.2011.07103.x; Gottschalk TK, 2011, ECOL MODEL, V222, P3403, DOI 10.1016/j.ecolmodel.2011.07.008; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hanberry BB, 2013, ECOL INFORM, V15, P8, DOI 10.1016/j.ecoinf.2013.02.003; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Hellmann JJ, 2012, ANN NY ACAD SCI, V1249, P18, DOI 10.1111/j.1749-6632.2011.06410.x; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kissling WD, 2012, J BIOGEOGR, V39, P2163, DOI 10.1111/j.1365-2699.2011.02663.x; Lauzeral C, 2013, ECOGRAPHY, V36, P778, DOI 10.1111/j.1600-0587.2013.07696.x; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Merow C, 2014, ECOGRAPHY, V37, P1267, DOI 10.1111/ecog.00845; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nobis MP, 2014, ECOGRAPHY, V37, P1282, DOI 10.1111/ecog.00930; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Record S, 2013, GLOBAL ECOL BIOGEOGR, V22, P760, DOI 10.1111/geb.12017; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Romo H, 2014, ECOGRAPHY, P1063; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Song W, 2013, ECOL MODEL, V248, P113, DOI 10.1016/j.ecolmodel.2012.09.012; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Urban MC, 2013, ANN NY ACAD SCI, V1297, P44, DOI 10.1111/nyas.12184; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Vittoz P, BOT HELVETICA, V117, P109; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitmee S, 2013, J ANIM ECOL, V82, P211, DOI 10.1111/j.1365-2656.2012.02030.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zarnetske PL, 2012, SCIENCE, V336, P1516, DOI 10.1126/science.1222732	52	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194650	10.1371/journal.pone.0194650	http://dx.doi.org/10.1371/journal.pone.0194650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652936	gold, Green Published			2022-12-27	WOS:000430026900007
J	Ternman, E; Pastell, M; Hanninen, L; Agenas, S; Nielsen, PP				Ternman, Emma; Pastell, Matti; Hanninen, Laura; Agenas, Sigrid; Nielsen, Per P.			First-night effect on sleep time in dairy cows	PLOS ONE			English	Article							NIGHT; ADAPTATION; PATTERNS	In human sleep studies, the probability of discomfort from the electrodes and the change in environment usually results in first-night recordings being discarded. Sleep recordings from the first night in human subjects often differ in amount of REM (rapid eye movement) sleep and the overall sleep architecture. This study investigated whether recordings of sleep states in dairy cows also show a first-night effect. Non-invasive electrophysiological recordings were carried out on nine cows of the Swedish Red breed during three consecutive 24-hour periods (recording days 1 +/- 3). Overall, cows spent 12.9 +/- 1.4 hours awake, 8.2 +/- 1 hours ruminating, 57.2 +/- 20.3 min drowsing, 44.1 +/- 20.2 min in REM sleep and 64.3 +/- 38.1 min in NREM (non-rapid eye movement) sleep (mean +/- SD) and there were no significant differences between recording days in total duration for any of the sleep and awake states. However, the bouts of REM sleep and rumination were longer, and the awake bouts were shorter, at night time compared to daytime, regardless of recording day. The awake bouts also showed an interaction effect with longer bouts at daytime during day 1 compared to daytime on day 3. Data on sleep and awake states recorded in adult dairy cows during three consecutive 24-h periods showed great variation in sleep time between cows, but total time for each state was not significantly affected by recording day. Further and more detailed studies of how sleep architecture is affected by recording day is necessary to fully comprehend the first-night effect in dairy cows.	[Ternman, Emma] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Pastell, Matti] Green Technol, Natl Resources Inst Finland Luke, Helsinki, Finland; [Hanninen, Laura] Univ Helsinki, Finland & Res Ctr Anim Welf, Dept Prod Anim Med, Helsinki, Finland; [Agenas, Sigrid] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden; [Nielsen, Per P.] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg C, Denmark	Aarhus University; Natural Resources Institute Finland (Luke); University of Helsinki; Swedish University of Agricultural Sciences; University of Copenhagen	Ternman, E (corresponding author), Aarhus Univ, Dept Anim Sci, Tjele, Denmark.	emma.ternman@anis.au.dk	Ternman, Emma/Y-2917-2019; Pastell, Matti/T-5025-2018; Ternman, Emma/AAG-8684-2019; Hänninen, Laura Talvikki/E-6683-2011; Nielsen, Per Peetz/N-3454-2013	Ternman, Emma/0000-0001-6966-8621; Pastell, Matti/0000-0002-5810-4801; Hänninen, Laura Talvikki/0000-0001-5118-8451; Nielsen, Per Peetz/0000-0002-1359-2952	Swedish Research Council Formas [2011-1094]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was funded by the Swedish Research Council Formas and was given grant number 2011-1094, http://proj.formas.se/detail.asp?arendeid=25678&x=250&y=20&sprak=1&redovisning=0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; BELL FR, 1973, PHYSIOL BEHAV, V11, P503, DOI 10.1016/0031-9384(73)90037-1; DeVries TJ, 2005, J DAIRY SCI, V88, P625, DOI 10.3168/jds.S0022-0302(05)72726-0; Fregonesi JA, 2007, J DAIRY SCI, V90, P3349, DOI 10.3168/jds.2006-794; Hanninen L, 2008, APPL ANIM BEHAV SCI, V111, P235, DOI 10.1016/j.applanim.2007.06.009; Ito K, 2009, J DAIRY SCI, V92, P4412, DOI 10.3168/jds.2009-2235; Kis A, 2014, BEHAV SLEEP MED, V12, P469, DOI 10.1080/15402002.2013.829062; Le Bon O, 2001, J PSYCHIATR RES, V35, P165, DOI 10.1016/S0022-3956(01)00019-X; Lee KA, 2000, OBSTET GYNECOL, V95, P14, DOI 10.1016/S0029-7844(99)00486-X; MENDELS J, 1967, ELECTROEN CLIN NEURO, V22, P556, DOI 10.1016/0013-4694(67)90063-6; RECHTSCHAFFEN A, 1964, PERCEPT MOTOR SKILL, V19, P947, DOI 10.2466/pms.1964.19.3.947; Ruckebusch Y., 1975, Applied Animal Ethology, V1, P207, DOI 10.1016/0304-3762(75)90100-5; RUCKEBUSCH Y, 1974, AM J VET RES, V35, P1309; RUCKEBUSCH Y, 1972, ANIM BEHAV, V20, P637, DOI 10.1016/S0003-3472(72)80136-2; Sporndly R., 2003, FOREDTABELLER IDISSL; Takeuchi T, 2002, BEHAV BRAIN RES, V136, P193, DOI 10.1016/S0166-4328(02)00123-7; Ternman E, 2012, APPL ANIM BEHAV SCI, V140, P25, DOI 10.1016/j.applanim.2012.05.005; von Keyserlingk MAG, 2008, J DAIRY SCI, V91, P1011, DOI 10.3168/jds.2007-0532; WAUQUIER A, 1991, BEHAV BRAIN RES, V42, P7, DOI 10.1016/S0166-4328(05)80034-8	19	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195593	10.1371/journal.pone.0195593	http://dx.doi.org/10.1371/journal.pone.0195593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652904	Green Published, gold, Green Submitted			2022-12-27	WOS:000430026900031
J	Zhang, LJ; Hui, GY; Hu, YB; Zhao, ZH				Zhang, Lianjin; Hui, Gangying; Hu, Yanbo; Zhao, Zhonghua			Spatial structural characteristics of forests dominated by Pinus tabulaeformis Carr.	PLOS ONE			English	Article							NEAREST-NEIGHBOR INDEXES; BROAD-LEAVED FOREST; BIVARIATE DISTRIBUTION; NATURE-RESERVE; DIVERSITY; POPULATION; PLANTATION; MANAGEMENT; MOUNTAIN; PATTERNS	The Chinese pine (Pinus tabulaeformis Carr.) is an ecologically and economically important evergreen coniferous tree which dominates warm temperate forests throughout northern China. We established two permanent plots within the Chinese pine forest in the Jiulong Mountains, Beijing, China. To understand the structural characteristics and dynamics of these plots, we analyzed the spatial structural characteristics within nearest-neighbor relationships using the bivariate distributions of the stand spatial structural parameters: uniform angle index, W; mingling index, M; dominance index, U; and crowding index, C. Results revealed that most trees in the forest were randomly distributed. The predominant individuals and randomly arranged trees were in very dense areas and surrounded by the same species. In addition, both plots exhibited a uniform size differentiation pattern. The two plots differed mainly in the level of species mixture and dominance. The majority of reference trees in the pure Chinese pine forest (plot 1) exhibited poor species mingling and low dominance, whereas trees in the mixed Chinese pine forest (plot 2) were evenly distributed in each mingling class and most trees were of intermediate dominance. The study results are useful for optimizing forest management activities in the studied stands, promoting tree growth, regeneration and habitat diversity, and improving forest quality at a fine scale.	[Zhang, Lianjin] Chinese Acad Forestry, Expt Ctr Forestry North China, Beijing, Peoples R China; [Hui, Gangying; Hu, Yanbo; Zhao, Zhonghua] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China; [Hui, Gangying; Hu, Yanbo; Zhao, Zhonghua] State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China	Chinese Academy of Forestry; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Zhang, LJ (corresponding author), Chinese Acad Forestry, Expt Ctr Forestry North China, Beijing, Peoples R China.	zlianjin1102@126.com		Zhang, Lianjin/0000-0001-6765-1391	Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB20140A035]; National Key Research and Development Program of China [2016YFD0600203]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF; National Key Research and Development Program of China	This paper was financially supported by the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (Grant No. CAFYBB20140A035) and the National Key Research and Development Program of China (Grant No.2016YFD0600203).	Aguirre O, 2003, FOREST ECOL MANAG, V183, P137, DOI 10.1016/S0378-1127(03)00102-6; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Daume S, 1995, DURCHFORSTUNGSSIMULA; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Gadow K. von, 1993, Forst und Holz, V48, P602; Gadow KV, 2012, FOREST STRUCTURE DIV, P29; Gao G, 2013, FOREST SYST, V22, P147, DOI 10.5424/fs/2013221-03294; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Hu Ercha, 2011, Forest Research, V24, P363; Hu Y, 2015, INT J ANTENN PROPAG, V2015, DOI 10.1155/2015/873134; Hui G., 2010, GUIDE STRUCTURE BASE; Hui G., 2003, QUANTITATIVE ANAL FO, P16; Hui G., 2016, PRINCIPLES STRUCTURE; Hui GY, 2002, ALLG FORST JAGDZTG, V173, P173; Hui GY, 2007, STURCTURE BASED FORE, P28; Corral-Rivas JJ, 2010, J FOREST RES-JPN, V15, P218, DOI 10.1007/s10310-010-0181-1; Kint V, 2003, FOREST SCI, V49, P36; Kuuluvainen Timo, 1996, Silva Fennica, V30, P315; Laarmann D, 2009, FOREST ECOL MANAG, V258, pS187, DOI 10.1016/j.foreco.2009.07.014; Lexerod NL, 2006, FOREST ECOL MANAG, V222, P17, DOI 10.1016/j.foreco.2005.10.046; Li YF, 2014, FOREST ECOL MANAG, V23, P1180; Li YF, 2017, IFOREST, V10, P561, DOI 10.3832/ifor2115-010; Li YF, 2014, FOREST ECOL MANAG, V314, P17, DOI 10.1016/j.foreco.2013.11.012; Li YF, 2012, J VEG SCI, V23, P1180, DOI 10.1111/j.1654-1103.2012.01431.x; Liu WenZhen, 2011, Forest Research, Beijing, V24, P437; Mason WL, 2007, FORESTRY, V80, P564, DOI 10.1093/forestry/cpm038; Morisita M, 1954, J ANIM ECOL, V36, P1; Ni RQ, 2014, FOREST ECOL MANAG, V316, P139, DOI 10.1016/j.foreco.2013.10.012; Pastorella F., 2013, Journal of Forest Science (Prague), V59, P159, DOI 10.17221/75/2012-JFS; Petritan AM, 2012, FOREST ECOL MANAG, V280, P140, DOI 10.1016/j.foreco.2012.06.007; Pommerening A, 2006, FOREST ECOL MANAG, V224, P266, DOI 10.1016/j.foreco.2005.12.039; Pommerening A, 2002, FORESTRY, V75, P305, DOI 10.1093/forestry/75.3.305; Pommerening A, 2008, THESIS, P36; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Spies TA, 1998, NORTHWEST SCI, V72, P34; State Forestry Administration of China, 2014, REP FOR RES CHIN 200; UPTON G, 1985, SPATIAL DATA ANAL EX, VI; Wang Luo-xin, 2016, Shengtaixue Zazhi, V35, P314; Wang Qing, 2014, Journal of Northeast Forestry University, V42, P32; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wu G, 1994, ACTA ECOLOGICA SINIC, V14, P415; Zenner EK, 2000, FOREST ECOL MANAG, V129, P75, DOI 10.1016/S0378-1127(99)00140-1; Zhang Lian-jin, 2015, Shengtaixue Zazhi, V34, P60; Zhang Yun, 2009, Chinese Journal of Applied and Environmental Biology, V15, P175, DOI 10.3724/SP.J.1145.2009.00175	44	20	25	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194710	10.1371/journal.pone.0194710	http://dx.doi.org/10.1371/journal.pone.0194710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652916	gold, Green Published, Green Submitted			2022-12-27	WOS:000430026900008
J	Ajani, PA; Verma, A; Lassudrie, M; Doblin, MA; Murray, SA				Ajani, Penelope A.; Verma, Arjun; Lassudrie, Malwenn; Doblin, Martina A.; Murray, Shauna A.			A new diatom species P. hallegraeffii sp nov belonging to the toxic genus Pseudo-nitzschia (Bacillariophyceae) from the East Australian Current	PLOS ONE			English	Article							NEW-SOUTH-WALES; COMPLEX BACILLARIOPHYCEAE; DOMOIC ACID; DELICATISSIMA BACILLARIOPHYCEAE; PSEUDODELICATISSIMA COMPLEX; PUNGENS BACILLARIOPHYCEAE; MOLECULAR PHYLOGENY; MALAYSIAN BORNEO; COASTAL STATION; SIZE-REDUCTION	A new species belonging to the toxin producing diatom genus Pseudo-nitzschia, P. hallegraeffii sp. nov., is delineated and described from the East Australian Current (EAC). Clonal cultures were established by single cell isolation from phytoplankton net hauls collected as part of a research expedition in the EAC region in 2016 on the RV Investigator. Cultures were assessed for their morphological and genetic characteristics, their sexual compatibility with other Pseudo-nitzschia species, and their ability to produce domoic acid. Light and transmission electron microscopy revealed cells which differed from their closest relatives by their cell width, rows of poroids, girdle band structure and density of band straie. Phylogenetic analyses based on sequencing of nuclear-encoded ribosomal deoxyribonucleic acid (rDNA) regions showed this novel genotype clustered within the P. delicatissima complex, but formed a discrete Glade from its closest relatives P. dolorosa, P. simulans, P. micropora and P. delicatissima. Complementary base changes (CBCs) were observed in the secondary structure of the 3' nuclear ribosomal transcribed spacer sequence region (ITS2) between P. hallegraeffii sp. nov. and its closest related taxa, P. simulans and P. dolorosa. Under laboratory conditions, and in the absence of any zooplankton cues, strains of P. hallegraeffiisp. nov. did not produce domoic acid (DA) and were not sexually compatible with any other Pseudo-nitzschia clones tested. A total of 18 Pseudo-nitzschia species, including three confirmed toxigenic species (P. cuspidata, P. multistriata and P. australis) have now been unequivocally confirmed from eastern Australia.	[Ajani, Penelope A.; Verma, Arjun; Lassudrie, Malwenn; Doblin, Martina A.; Murray, Shauna A.] Univ Technol Sydney, C3, Broadway, NSW, Australia; [Lassudrie, Malwenn] IFREMER LER BO, Stn Biol Marine, Pl Croix, Concarneau, France	University of Technology Sydney; Ifremer	Ajani, PA (corresponding author), Univ Technol Sydney, C3, Broadway, NSW, Australia.	penelope.ajani@uts.edu.au	Verma, Arjun/J-7055-2019; Doblin, Martina/L-1804-2019; Malwenn, Lassudrie/V-9956-2018; Doblin, Martina A/E-8719-2013; Ajani, Penelope/K-9987-2019; Murray, Shauna A/K-5781-2015	Verma, Arjun/0000-0003-0119-9915; Doblin, Martina/0000-0001-8750-3433; Malwenn, Lassudrie/0000-0002-7004-926X; Doblin, Martina A/0000-0001-8750-3433; Murray, Shauna A/0000-0001-7096-1307; Ajani, Penelope/0000-0001-5364-9936	CSIRO [IN2016_V04]; Australian Research Council (LIEF) [LE140100055]; University of Technology Sydney Chancellor's Postdoctoral Fellowship	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Research Council (LIEF)(Australian Research Council); University of Technology Sydney Chancellor's Postdoctoral Fellowship	The authors would like to thank Australia's Marine National Facility for sea time on board the RV Investigator, management of the vessel and support of the IN2016_V04 voyage by MNF staff at CSIRO, and all of the officers and crew on board. We would also like to thank the deputy chief scientist, Prof lain Suthers, for his assistance, Christine Rees and Stephen Tibben (Oceans and Atmosphere Hydrochemistry, CSIRO) for environmental data acquisition and processing, Emmanuel Laurenceau-Cornec (Institute for Marine and Antarctic Studies, University of Tasmania) for assistance with map editing, and Katie McBean (Physics and Advanced Materials & Microstructural Analysis Unit, University of Technology Sydney) for transmission electron microscopy assistance. We would also like to thank the Sydney Institute of Marine Science for ongoing support. Finally, we would like to thank the Australian Research Council (LIEF grant LE140100055) for the LCMS facility and PA would also like to thank the University of Technology Sydney Chancellor's Postdoctoral Fellowship scheme for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani P, 2001, P LINN SOC N S W, V123, P1; Ajani P, 2016, PHYCOL RES, V64, P312, DOI 10.1111/pre.12142; Ajani P, 2013, J PHYCOL, V49, P765, DOI 10.1111/jpy.12087; Ajani P, 2013, PHYCOL RES, V61, P237, DOI 10.1111/pre.12020; Ajani PA, 2014, LIMNOL OCEANOGR, V59, P2240, DOI 10.4319/lo.2014.59.6.2240; Ajani PA, 2014, LIMNOL OCEANOGR, V59, P519, DOI 10.4319/lo.2014.59.2.0519; Amato A, 2005, J PHYCOL, V41, P542, DOI 10.1111/j.1529-8817.2005.00080.x; Amato A, 2008, PHYCOLOGIA, V47, P487, DOI 10.2216/07-92.1; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Ankenbrand MJ, 2015, MOL BIOL EVOL, V32, P3030, DOI 10.1093/molbev/msv174; ARMSTRONG FA, 1967, DEEP-SEA RES, V14, P381, DOI 10.1016/0011-7471(67)90082-4; BATES SS, 1989, CAN J FISH AQUAT SCI, V46, P1203, DOI 10.1139/f89-156; Casteleyn G, 2008, HARMFUL ALGAE, V7, P241, DOI 10.1016/j.hal.2007.08.004; Chepurnov VA, 2005, EUR J PHYCOL, V40, P379, DOI 10.1080/09670260500254735; Churro CI, 2009, DIATOM RES, V24, P35; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Fernandes LF, 2014, DEEP-SEA RES PT II, V103, P139, DOI 10.1016/j.dsr2.2013.06.022; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; HALLEGRAEFF GM, 1981, MAR BIOL, V61, P107, DOI 10.1007/BF00386650; HALLEGRAEFF GM, 1994, BOT MAR, V37, P397, DOI 10.1515/botm.1994.37.5.397; Haroardottir S, 2015, MAR DRUGS, V13, P3809, DOI 10.3390/md13063809; HASLE GR, 1970, T AM MICROSC SOC, V89, P469, DOI 10.2307/3224555; HASLE GR, 1995, J PHYCOL, V31, P428, DOI 10.1111/j.0022-3646.1995.00428.x; HASLE GR, 1994, J PHYCOL, V30, P1036, DOI 10.1111/j.0022-3646.1994.01036.x; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Quijano-Scheggia SI, 2009, PHYCOLOGIA, V48, P492, DOI 10.2216/08-21.1; Jameson I., 2010, ALGAE AUSTR PHYTOPLA, P16; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kerouel R, 1997, J MARINE CHEM, V57; Kim JH, 2015, J PHYCOL, V51, P159, DOI 10.1111/jpy.12263; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LaJeunesse DR, 2001, GENETICS, V158, P667; Lapworth C., 2001, P 9 INT C HARMF ALG; Lelong A, 2012, PHYCOLOGIA, V51, P168, DOI 10.2216/11-37; Li Y, 2017, HARMFUL ALGAE, V67, P119, DOI 10.1016/j.hal.2017.06.008; Lim HC, 2013, J PHYCOL, V49, P902, DOI 10.1111/jpy.12101; Lim HC, 2012, J PHYCOL, V48, P1232, DOI 10.1111/j.1529-8817.2012.01213.x; Lundholm N, 2006, J PHYCOL, V42, P464, DOI 10.1111/j.1529-8817.2006.00211.x; Lundholm N, 2003, J PHYCOL, V39, P797, DOI 10.1046/j.1529-8817.2003.02031.x; Lundholm N, 2002, PHYCOLOGIA, V41, P480, DOI 10.2216/i0031-8884-41-5-480.1; Lundholm Nina, 2017, Harmful Algae News, V56, P5; Lundholm N, 2012, J PHYCOL, V48, P436, DOI 10.1111/j.1529-8817.2012.01132.x; McNabb P, 2005, J AOAC INT, V88, P761; Moschandreou KK, 2012, EUR J PHYCOL, V47, P321, DOI 10.1080/09670262.2012.713998; Moschandreou KK, 2010, BOT MAR, V53, P159, DOI 10.1515/BOT.2010.014; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; Orive E, 2013, J PHYCOL, V49, P1192, DOI 10.1111/jpy.12130; Orsini L, 2004, MAR ECOL PROG SER, V271, P87, DOI 10.3354/meps271087; Ridgway KR, 1997, J GEOPHYS RES-OCEANS, V102, P22921, DOI 10.1029/97JC00227; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sato SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021783; Scalco E, 2014, J PHYCOL, V50, P817, DOI 10.1111/jpy.12225; Scholin C. A., 1994, Natural Toxins, V2, P152, DOI 10.1002/nt.2620020403; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Teng ST, 2016, J PHYCOL, V52, P973, DOI 10.1111/jpy.12448; Teng ST, 2015, J PHYCOL, V51, P706, DOI 10.1111/jpy.12313; Teng ST, 2014, HARMFUL ALGAE, V34, P17, DOI 10.1016/j.hal.2014.02.005; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Verma A, 2016, HARMFUL ALGAE, V60, P116, DOI 10.1016/j.hal.2016.11.004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; [No title captured]	66	19	21	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195622	10.1371/journal.pone.0195622	http://dx.doi.org/10.1371/journal.pone.0195622			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649303	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900062
J	Canivell, S; Muller, O; Gencer, B; Heg, D; Klingenberg, R; Raber, L; Carballo, D; Matter, C; Luscher, T; Windecker, S; Mach, F; Rodondi, N; Nanchen, D				Canivell, Silvia; Muller, Olivier; Gencer, Baris; Heg, Dik; Klingenberg, Roland; Raber, Lorenz; Carballo, David; Matter, Christian; Luscher, Thomas; Windecker, Stephan; Mach, Francois; Rodondi, Nicolas; Nanchen, David			Prognosis of cardiovascular and non cardiovascular multimorbidity after acute coronary syndrome	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; ARTERY-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; HEALTH-CARE; ATHEROSCLEROSIS; INFLAMMATION; COMORBIDITY; MANAGEMENT; MECHANISMS; MORTALITY	Objective To examine the prognosis of patients with cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome compared to patients without prior multimorbidity. Methods This multicenter prospective cohort study in Switzerland included 5,635 patients hospitalized with acute coronary syndrome between 2009 and 2014, with a one-year follow-up period. We defined cardiovascular and non-cardiovascular multimorbidity as having at least two prior comorbidities before the index hospitalization. Multivariable adjusted Cox proportional models were built to assess the one-year risk of recurrent cardiovascular events, defined as cardiovascular mortality and non-fatal myocardial infarction or stroke. The final model was adjusted for age, gender, body mass index, tobacco consumption, education, and family history of cardiovascular disease, prescription of high-dose statinsat discharge and use of cardiac rehabilitation after discharge. Results Overall, 3,664 patients (65%) had no multimorbidity, 1,839 (33%) had cardiovascular multimorbidity, 62 (1%) had non-cardiovascular multimorbidity, and 70 (1%) had both cardiovascular and non-cardiovascular multimorbidity. The multivariate risk of recurrent cardiovascular events was increased among patients with cardiovascular multimorbidity (hazard ratio (HR) 2.05, 95% CI: 1.54-2.73, p<0.001) and patients with non-cardiovascular multimorbidity (HR 2.57, 95% CI: 1.04-6.35, p = 0.04) compared to patients without multimorbidity. Patients with cardiovascular and non-cardiovascular multimorbidity had the highest risk of recurrence with a HR of 5.19, 95% CI: 2.79-9.64, p<0.001, compared to patients without multimorbidity. Conclusions Multimorbidity increased by two-fold the risk of cardiovascular events over the year after an acute coronary syndrome. The magnitude of this increased risk was similar for patients with cardiovascular or non-cardiovascular multimorbidity.	[Canivell, Silvia; Nanchen, David] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Muller, Olivier] Lausanne Univ Hosp, Serv Cardiol, Lausanne, Switzerland; [Gencer, Baris; Carballo, David; Mach, Francois] Geneva Univ Hosp, Div Cardiol, Fac Med, Geneva, Switzerland; [Heg, Dik] Univ Bern, Inst Social & Prevent Med, Dept Clin Res, Bern, Switzerland; [Heg, Dik] Univ Bern, Clin Trials Unit, Dept Clin Res, Bern, Switzerland; [Klingenberg, Roland; Matter, Christian; Luscher, Thomas] Univ Hosp Zurich, Univ Heart Ctr, Dept Cardiol, Zurich, Switzerland; [Raber, Lorenz; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, Bern, Switzerland; [Rodondi, Nicolas] Univ Bern, Univ Hosp Bern, Dept Gen Internal Med, Inselspital, Bern, Switzerland; [Rodondi, Nicolas] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Bern; University of Bern; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Nanchen, D (corresponding author), Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland.	david.nanchen@chuv.ch	Gencer, Baris/AAO-2305-2020; Nanchen, David/AAQ-1118-2021	Nanchen, David/0000-0002-2493-3505; Heg, Dik/0000-0002-8766-7945; Canivell, Silvia/0000-0002-0280-5035; Gencer, Baris/0000-0002-8954-9694; Rodondi, Nicolas/0000-0001-9083-6896	Swiss National Science Foundation [SNSF 33CM30-124112]; SNSF [32473B_163271]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNSF(Swiss National Science Foundation (SNSF))	The SPUM-ACS cohort is supported by the Swiss National Science Foundation [SNSF 33CM30-124112, "Inflammation and Acute Coronary Syndromes (ACS) Novel Strategies for Prevention and Clinical Management," and SNSF 32473B_163271, "Long-Term Benefit of the Multi-Center, Multi-Dimensional Secondary Prevention Program in Patients With Acute Coronary Syndromes". None of the funding had any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Alfredsson J, 2016, CLIN GERIATR MED, V32, P291, DOI 10.1016/j.cger.2016.01.009; Arnett DK, 2014, CIRCULATION, V64, P1851, DOI DOI 10.1161/CIR.0000000000000128; Auer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093147; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Chen HY, 2013, CLIN EPIDEMIOL, V5, P439, DOI [DOI 10.2147/CLEP.S49485, 10.2147/CLEP.S49485]; Di Angelantonio E, 2015, JAMA-J AM MED ASSOC, V314, P52, DOI 10.1001/jama.2015.7008; Dunlay SM, 2016, CURR CARDIOVASC RISK, V10, DOI 10.1007/s12170-016-0491-8; Farmer C, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4843; Gencer B, 2016, EUR HEART J, V37, P546, DOI 10.1093/eurheartj/ehv637; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Nguyen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108998; Hughes LD, 2012, AGE AGEING, V41, P24; Klingenberg R, 2018, EUR HEART J-ACUTE CA, V7, P129, DOI 10.1177/2048872616684678; Klingenberg R, 2015, HEART, V101, P854, DOI 10.1136/heartjnl-2014-306925; Lee TC, 2010, AM J CARDIOL, V105, P1083, DOI 10.1016/j.amjcard.2009.12.005; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Mamas MA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003348; McManus David D, 2012, Clin Epidemiol, V4, P115, DOI 10.2147/CLEP.S30883; Nanchen D, 2016, CIRCULATION, V134, P698, DOI 10.1161/CIRCULATIONAHA.116.023007; Nanchen D, 2015, EUR HEART J, V36, P2438, DOI 10.1093/eurheartj/ehv289; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Roversi S, 2014, EUR J CLIN INVEST, V44, P93, DOI 10.1111/eci.12181; Sachdev M, 2004, J AM COLL CARDIOL, V43, P576, DOI 10.1016/j.jacc.2003.10.031; Sanchis J, 2017, MAYO CLIN PROC, V92, P934, DOI 10.1016/j.mayocp.2017.01.018; Saunders C, 2013, DIABETIC MED, V30, P300, DOI 10.1111/dme.12047; Tisminetzky M, 2016, AM J MED, V129, P608, DOI 10.1016/j.amjmed.2015.11.029	28	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195174	10.1371/journal.pone.0195174	http://dx.doi.org/10.1371/journal.pone.0195174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649323	gold, Green Published, Green Accepted			2022-12-27	WOS:000429791900031
J	Rylee, JC; Sinlard, DJ; Doucette, K; Zentner, GE; Zelhof, AC				Rylee, Johnathan C.; Sinlard, Dylan J.; Doucette, Kaitlin; Zentner, Gabriel E.; Zelhof, Andrew C.			Expanding the genetic toolkit of Tribolium castaneum	PLOS ONE			English	Article							TRANSGENE EXPRESSION; FLOUR BEETLE; EYE-COLOR; DROSOPHILA; INSECTS; REVEALS; LINKAGE; COLEOPTERA; PROMOTER; REVISION	The red flour beetle, Tribolium castaneum, is an important model insect and agricultural pest. However, many standard genetic tools are lacking or underdeveloped in this system. Here, we present a set of new reagents to augment existing Tribolium genetic tools. We demonstrate a new GAL4 driver line that employs the promoter of a ribosomal protein gene to drive expression of a UAS responder in the fat body. We also present a novel dual fluorescent reporter that labels cell membranes and nuclei with different fluorophores for the analysis of cellular morphology. This approach also demonstrates the functionality of the viral T2A peptide for bicistronic gene expression in Tribolium. To facilitate classical genetic analysis, we created lines with visible genetic markers by CRISPR-mediated disruption of the yellowand ebony body color loci with a cassette carrying an attP site, enabling future phi C31-mediated integration. Together, the reagents presented here will facilitate more robust genetic analysis in Tribolium and serve as a blueprint for the further development of this powerful model's genetic toolkit.	[Rylee, Johnathan C.; Sinlard, Dylan J.; Doucette, Kaitlin; Zentner, Gabriel E.; Zelhof, Andrew C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Sinlard, Dylan J.] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA	Indiana University System; Indiana University Bloomington; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zentner, GE; Zelhof, AC (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	gzentner@indiana.edu; azelhof@indiana.edu		Zelhof, Andrew/0000-0001-7085-822X; Zentner, Gabriel/0000-0002-0801-7646	Indiana University startup funds; National Science Foundation [IOS-1353267]	Indiana University startup funds; National Science Foundation(National Science Foundation (NSF))	This work was supported by Indiana University startup funds (to GEZ) and National Science Foundation grant IOS-1353267 (to ACZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Beeman RW, 1996, J HERED, V87, P224, DOI 10.1093/oxfordjournals.jhered.a022989; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Bortoluzzi S, 2001, BIOINFORMATICS, V17, P1152, DOI 10.1093/bioinformatics/17.12.1152; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; BROWN E, 1978, CAN J GENET CYTOL, V20, P139, DOI 10.1139/g78-014; Brown SJ, 1999, EVOL DEV, V1, P11, DOI 10.1046/j.1525-142x.1999.99013.x; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; DAWSON PS, 1984, CAN J GENET CYTOL, V26, P762, DOI 10.1139/g84-120; Dippel S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0304-z; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; Goodman CL, 2012, IN VITRO CELL DEV-AN, V48, P426, DOI 10.1007/s11626-012-9524-x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Grubbs N, 2015, GENETICS, V199, P749, DOI 10.1534/genetics.114.173971; Guimaraes JC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1104-z; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Lorenzen MD, 2007, INSECT MOL BIOL, V16, P265, DOI 10.1111/j.1365-2583.2007.00727.x; Lorenzen MD, 2002, GENETICS, V160, P225; Lorenzen MD, 2002, INSECT MOL BIOL, V11, P399, DOI 10.1046/j.1365-2583.2002.00349.x; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Mocelin G, 1996, J HERED, V87, P27, DOI 10.1093/oxfordjournals.jhered.a022949; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nie J, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0056-y; Osanai-Futahashi M, 2012, J BIOL CHEM, V287, P17706, DOI 10.1074/jbc.M111.321331; Sauert M, 2015, BIOCHIMIE, V114, P39, DOI 10.1016/j.biochi.2014.12.011; Schinko JB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-53; Schmitt-Engel C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8822; Siebert KS, 2008, INSECT BIOCHEM MOLEC, V38, P749, DOI 10.1016/j.ibmb.2008.04.007; Silver K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06840; SOKOLOFF A, 1987, J HERED, V78, P2, DOI 10.1093/oxfordjournals.jhered.a110299; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; Viktorinova I, 2007, INSECT BIOCHEM MOLEC, V37, P246, DOI 10.1016/j.ibmb.2006.11.010	37	17	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195977	10.1371/journal.pone.0195977	http://dx.doi.org/10.1371/journal.pone.0195977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649291	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900107
J	Fryzek, JP; Reichert, H; Summers, N; Townes, L; Deuson, R; Alexander, DD; Vanderpuye-Orgle, J				Fryzek, Jon P.; Reichert, Heidi; Summers, Nicholas; Townes, Lindsay; Deuson, Robert; Alexander, Dominik D.; Vanderpuye-Orgle, Jackie			Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen	PLOS ONE			English	Article							ABIRATERONE ACETATE; ENZALUTAMIDE; SURVIVAL; INTERVENTIONS; CHEMOTHERAPY	Background The objective of this study was to conduct an indirect treatment comparison between cabazitaxel, abiraterone and enzalutamide to determine the clinical efficacy and safety of cabazitaxel relative to comparators in the treatment of patients with metastatic castrate-resistant prostate cancer who progress on docetaxel-based therapies. Methods A systematic literature review was conducted to inform the network meta-analysis of cabazitaxel, abiraterone and enzalutamide. Due to a lack of head-to-head trials, studies with a comparator arm of best supportive care were included in the analysis. Overall survival, progression-free survival, and adverse events were compared within both Bayesian and Frequentist frameworks. The ratios for survival outcomes were estimated using hazard ratios (HR), and the ratios for adverse events between groups were estimated using odds ratios (ORs); uncertainty was reported as 95% confidence (Frequentist) and credible (Baysesian) Intervals. Results Three of thirteen trials identified for abstraction were relevant for analyses. Median overall survival was not statistically significantly different for abiraterone (HR = 1.04; 95% CI = 0.83-1.28) or enzalutamide (HR = 0.88; 95% CI = 0.69-1.11) when compared to cabazitaxel in the Bayesian analysis. Anaemia (OR = 3.71; 95% CI = 1.01-10.44), diarrhoea (OR = 16.60; 95% CI = 1.41-75.31) and haematuria (OR = 3.88; 95% CI = 1.03-10.09) were more likely to occur in the cabazitaxel group than the abiraterone group, while pyrexia risk was higher in cabazitaxel compared to enzalutamide (OR = 36.23; 95% CI = 1.14-206.40). Frequentist analyses produced similar results. Conclusions The scarcity of clinical studies and lack of a common comparator limited analyses. The adverse event results must be interpreted with caution as many were based on small numbers. The results from this analysis indicate comparable survival outcomes and adverse event profiles. As these pivotal studies may not reflect the contemporary treatment landscape and patient profiles, additional research, including head-to-head clinical trials and real world observational studies, should be conducted to further elucidate the beneficial effects of these therapies.	[Fryzek, Jon P.; Reichert, Heidi; Townes, Lindsay] EpidStat Inst, Ann Arbor, MI 48105 USA; [Summers, Nicholas; Alexander, Dominik D.; Vanderpuye-Orgle, Jackie] Precis Hlth Econ, Los Angeles, CA 90025 USA; [Deuson, Robert] Medenomics LLC, Moorpark, CA USA		Fryzek, JP (corresponding author), EpidStat Inst, Ann Arbor, MI 48105 USA.; Summers, N (corresponding author), Precis Hlth Econ, Los Angeles, CA 90025 USA.	jon@epidstat.com; nick.summers@pheconomics.com			Sanofi	Sanofi(Sanofi-Aventis)	This research was funded by Sanofi to NS. Sanofi contributed to the study design and reviewed the final version of the manuscript to ensure that the descriptions of Sanofi products are medically accurate, but did not take part in the writing of the manuscript.	American Cancer Society, 2016, KEY STAT PROST CANC; Brodszky Valentin, 2014, Magy Onkol, V58, P189; Cancer Research UK, 2016, PROST CANC STAT; Centre for Reviews Dissemination, SYSTEMATIC REV CRDS, V009; de Bono J. S., 2001, NEW ENGL J MED, V364, P1995, DOI DOI 10.1056/; Dearden L, 2014, VALUE HEALTH, V17, pA616, DOI 10.1016/j.jval.2014.08.2170; Dias S, 2011, 2 NICE DSU; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Green AK, 2015, ONCOLOGIST, V20, P516, DOI 10.1634/theoncologist.2014-0432; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Joulain F., 201001 SAN; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Stata Corp, 2015, STAT STAT SOFTW REL; Summers N, 2017, CURR MED RES OPIN, V33, P1995, DOI 10.1080/03007995.2017.1341869; Tan PS, 2014, CLIN MED INSIGHTS-ON, V8, P29, DOI 10.4137/CMO.S13671; Woods BS, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-54; Zhang W, 2016, ASIAN J ANDROL	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195790	10.1371/journal.pone.0195790	http://dx.doi.org/10.1371/journal.pone.0195790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641566	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900093
J	Huang, H; Chen, YH; Chen, HS; Ma, YY; Chiang, PW; Zhong, J; Liu, XY; Asan; Wu, J; Su, Y; Li, X; Deng, JL; Huang, YP; Zhang, XX; Li, Y; Fan, N; Wang, Y; Tang, LH; Shen, JT; Chen, MY; Zhang, XQ; Te, D; Banerjee, S; Liu, H; Qi, M; Yi, X				Huang, Hui; Chen, Yanhua; Chen, Huishuang; Ma, Yuanyuan; Chiang, Pei-Wen; Zhong, Jing; Liu, Xuyang; Asan; Wu, Jing; Su, Yan; Li, Xin; Deng, Jianlian; Huang, Yingping; Zhang, Xinxin; Li, Yang; Fan, Ning; Wang, Ying; Tang, Lihui; Shen, Jinting; Chen, Meiyan; Zhang, Xiuqing; Te, Deng; Banerjee, Santasree; Liu, Hui; Qi, Ming; Yi, Xin			Systematic evaluation of a targeted gene capture sequencing panel for molecular diagnosis of retinitis pigmentosa	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; BARDET-BIEDL-SYNDROME; INHERITED RETINAL DYSTROPHIES; BBS1 MUTATIONS; IDENTIFICATION; FAMILIES; DISORDER; THERAPY; TULP1	Background Inherited eye diseases are major causes of vision loss in both children and adults. Inherited eye diseases are characterized by clinical variability and pronounced genetic heterogeneity. Genetic testing may provide an accurate diagnosis for ophthalmic genetic disorders and allow gene therapy for specific diseases. Methods A targeted gene capture panel was designed to capture exons of 283 inherited eye disease genes including 58 known causative retinitis pigmentosa (RP) genes. 180 samples were tested with this panel, 68 were previously tested by Sanger sequencing. Systematic evaluation of our method and comprehensive molecular diagnosis were carried on 99 RP patients. Results 96.85% targeted regions were covered by at least 20 folds, the accuracy of variants detection was 99.994%. In 4 of the 68 samples previously tested by Sanger sequencing, mutations of other diseases not consisting with the clinical diagnosis were detected by next-generation sequencing (NGS) not Sanger. Among the 99 RP patients, 64 (64.6%) were detected with pathogenic mutations, while in 3 patients, it was inconsistent between molecular diagnosis and their initial clinical diagnosis. After revisiting, one patient's clinical diagnosis was reclassified. In addition, 3 patients were found carrying large deletions. Conclusions We have systematically evaluated our method and compared it with Sanger sequencing, and have identified a large number of novel mutations in a cohort of 99 RP patients. The results showed a sufficient accuracy of our method and suggested the importance of molecular diagnosis in clinical diagnosis.	[Huang, Hui; Chen, Yanhua; Chen, Huishuang; Ma, Yuanyuan; Zhong, Jing; Wu, Jing; Su, Yan; Li, Xin; Deng, Jianlian; Huang, Yingping; Zhang, Xinxin; Li, Yang; Tang, Lihui; Shen, Jinting; Chen, Meiyan; Zhang, Xiuqing; Banerjee, Santasree; Qi, Ming; Yi, Xin] BGI Shenzhen, Shenzhen, Peoples R China; [Chen, Yanhua] South China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Chiang, Pei-Wen] Casey Eye Inst, Mol Diagnost Lab, Portland, OR USA; [Liu, Xuyang; Fan, Ning; Wang, Ying] Jinan Univ, Shenzhen Eye Hosp, Shenzhen, Peoples R China; [Asan; Yi, Xin] BGI Shenzhen, BGI Tianjin, Tianjin, Peoples R China; [Wang, Ying] Shenzhen Univ, Key Lab Optoelect Devices & Syst Guangdong Prov, Shenzhen, Peoples R China; [Zhang, Xiuqing] Shenzhen Key Lab Genom, Shenzhen, Peoples R China; [Zhang, Xiuqing] Guangdong Enterprise Key Lab Human Dis Genom, Shenzhen, Peoples R China; [Te, Deng] Nanshan Matern & Child Healthcare Hosp Shenzhen, Shenzhen, Peoples R China; [Liu, Hui] Anhui Med Univ, Maternal & Child Hlth Clin Coll, Matern & Child Hlth Hosp Anhui Prov, Hefei, Anhui, Peoples R China; [Qi, Ming] Zhejiang Univ, Sch Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Qi, Ming] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Funct Genom Ctr, West Henrietta, NY 14467 USA	Beijing Genomics Institute (BGI); South China University of Technology; Jinan University; Beijing Genomics Institute (BGI); Shenzhen University; Anhui Medical University; Zhejiang University; University of Rochester	Qi, M; Yi, X (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.; Yi, X (corresponding author), BGI Shenzhen, BGI Tianjin, Tianjin, Peoples R China.; Liu, H (corresponding author), Anhui Med Univ, Maternal & Child Hlth Clin Coll, Matern & Child Hlth Hosp Anhui Prov, Hefei, Anhui, Peoples R China.; Qi, M (corresponding author), Zhejiang Univ, Sch Basic Med Sci, Hangzhou, Zhejiang, Peoples R China.; Qi, M (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Funct Genom Ctr, West Henrietta, NY 14467 USA.	593130772@qq.com; mingqi@ziu.edu.cn; yix@genomics.cn			Shenzhen Municipal Government of China [CXZZ20130517144604091, GJHZ20130417140916986]; Shenzhen Key Laboratory of Genomics [CX6200903110066A]; Guangdong Enterprise Key Laboratory of Human Disease Genomics [2011A060906007]	Shenzhen Municipal Government of China; Shenzhen Key Laboratory of Genomics; Guangdong Enterprise Key Laboratory of Human Disease Genomics	This research was supported by the Shenzhen Municipal Government of China (NO. CXZZ20130517144604091, NO. GJHZ20130417140916986), the Shenzhen Key Laboratory of Genomics (NO.CX6200903110066A) and the Guangdong Enterprise Key Laboratory of Human Disease Genomics (N0.2011A060906007).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ajmal M, 2012, MOL VIS, V18, P1226; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Bellos E, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku849; Bowne SJ, 2011, INVEST OPHTH VIS SCI, V52, P494, DOI 10.1167/iovs.10-6180; Chiang J, 2015, CURR OPIN OPHTHALMOL, V26, P346, DOI 10.1097/ICU.0000000000000185; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Cideciyan AV, 2009, HUM MOL GENET, V18, P931, DOI 10.1093/hmg/ddn421; Coppieters F, 2014, GENET MED, V16, P671, DOI 10.1038/gim.2014.24; Coppieters F, 2012, GENET MED, V14, P576, DOI 10.1038/gim.2011.51; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Drack AV, 2010, AM J OPHTHALMOL, V149, P10, DOI 10.1016/j.ajo.2009.08.038; Estrada-Cuzcano A, 2012, ARCH OPHTHALMOL-CHIC, V130, P1425, DOI 10.1001/archophthalmol.2012.2434; Fu Q, 2013, INVEST OPHTH VIS SCI, V54, P4158, DOI 10.1167/iovs.13-11672; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Gu SM, 1998, LANCET, V351, P1103, DOI 10.1016/S0140-6736(05)79384-3; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee K, 2015, GENET MED, V17, P245, DOI 10.1038/gim.2015.15; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Nakamura M, 2006, ADV EXP MED BIOL, V572, P49; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Paloma E, 2000, INVEST OPHTH VIS SCI, V41, P656; Pereiro I, 2011, EUR J HUM GENET, V19, P485, DOI 10.1038/ejhg.2010.207; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shihab HA, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-11; Tosi JQ, 2009, CURR EYE RES, V34, P395, DOI 10.1080/02713680902859639; Van Den Bossche MJ, 2012, AM J MED GENET B, V159B, P465, DOI 10.1002/ajmg.b.32053; Wang X, 2013, J MED GENET; Wei XM, 2014, EUR J HUM GENET, V22, P110, DOI 10.1038/ejhg.2013.82; Weisschuh N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145951; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Xu Y, 2014, HUM GENET, V133, P1255, DOI 10.1007/s00439-014-1460-2; Young Terri L, 2003, Curr Opin Ophthalmol, V14, P296, DOI 10.1097/00055735-200310000-00011; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P3736, DOI 10.1167/iovs.05-1637	44	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0185237	10.1371/journal.pone.0185237	http://dx.doi.org/10.1371/journal.pone.0185237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641573	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900001
J	Mumtaz, S; Khan, L; Ahmed, S; Badar, R				Mumtaz, Sidra; Khan, Laiq; Ahmed, Saghir; Badar, Rabiah			Indirect adaptive soft computing based wavelet-embedded control paradigms for WT/PV/SOFC in a grid/charging station connected hybrid power system (vol 12, e0183750, 2017)	PLOS ONE			English	Correction									[Badar, Rabiah] COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Badar, R (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan.		badar, rabiah/ABA-6115-2021					Mumtaz S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183750	1	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195914	10.1371/journal.pone.0195914	http://dx.doi.org/10.1371/journal.pone.0195914			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641616	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900096
J	Politimou, N; Stewart, L; Mullensiefen, D; Franco, F				Politimou, Nina; Stewart, Lauren; Mullensiefen, Daniel; Franco, Fabia			Music@Home: A novel instrument to assess the home musical environment in the early years	PLOS ONE			English	Article							INFANTS PREFERENTIAL ATTENTION; LANGUAGE EXPERIENCE; SCHOOL READINESS; YOUNG-CHILDREN; VOCABULARY; PARENTS; NUMBER; MOTHERS; SPEECH; PREDICTORS	The majority of children under the age of 5 appear to show spontaneous enjoyment of singing, being exposed to music and interacting with musical instruments, but whether variations in engaging in such activities in the home could contribute to developmental outcomes is still largely unknown. Critically, researchers lack a comprehensive instrument with good psychometric properties to assess the home musical environment from infancy to the preschool years. To address this gap, this paper presents two studies that describe the development and validation of the Music@Home questionnaire, which comprises two versions: Infant and Preschool. In Study 1, an initial pool of items was generated and administered to a wide audience of parents (n = 287 for the Infant, n = 347 for the Preschool version). Exploratory factor analysis was used to identify different dimensions comprising the home musical environment of both infants and pre-schoolers, and to reduce the initial pool of items to a smaller number of meaningful items. In Study 2, convergent and divergent validity and internal and test-retest reliability of the new instrument were established, using data from a different sample of participants (n = 213 for the Infant, n = 213 for the Preschool version). The second study also investigated associations between the Music@Home and musical characteristics of the parents, such as their musical education and personal engagement with music. Overall, the Music@Home constitutes a novel, valid and reliable instrument that allows for the systematic assessment of distinct aspects of the home musical environment in families with children under the age of 5. Furthermore, the Infant and Preschool versions of the Music@Home present differential associations with musical characteristics of the parents opening a new area of inquiry into how musical exposure and interaction in the home may vary across different developmental stages.	[Politimou, Nina; Franco, Fabia] Middlesex Univ, Dept Psychol, London, England; [Stewart, Lauren; Mullensiefen, Daniel] Goldsmiths Univ London, Dept Psychol, London, England	Middlesex University; University of London; Goldsmiths University London	Politimou, N (corresponding author), Middlesex Univ, Dept Psychol, London, England.	a.politimou@mdx.ac.uk	Stewart, Lauren/HHC-2911-2022	stewart, lauren/0000-0002-6221-6064	Middlesex University PhD scholarship; Middlesex University	Middlesex University PhD scholarship; Middlesex University	The authors received no specific funding for this work, however, the first author was supported by a Middlesex University PhD scholarship.; The authors would like to thank Olivia Brancatisano for her contribution to the generation of the initial pool of items for the Music@Home. We would also like to thank Prof Wendy Valerio, Dr Alison Reynolds and Prof Grant Morgan for granting us access to their data regarding validation of the Children's Musical Behavior Inventory. We finally extend our thanks to Middlesex University for funding the first author's PhD studies which made this project possible, and to all the participants who completed the Music@Home questionnaires.	Anders Y, 2012, EARLY CHILD RES Q, V27, P231, DOI 10.1016/j.ecresq.2011.08.003; [Anonymous], 2003, PSYCHOL MUSIC, DOI DOI 10.1177/03057356030314002; Arnup S., 2014, J NEONATAL NURS, V20, P115, DOI [10.1016/j.jnn.2013.09.007, DOI 10.1016/J.JNN.2013.09.007]; Baker CE, 2012, EARLY EDUC DEV, V23, P833, DOI 10.1080/10409289.2011.607359; Barrett MS, 2009, J EARLY CHILD RES, V7, P115, DOI 10.1177/1476718X09102645; Barrett MS, 2011, PSYCHOL MUSIC, V39, P403, DOI 10.1177/0305735610373054; Beaujean AA, 2014, LATENT VARIABLE MODE, DOI DOI 10.4324/9781315869780; BRAND M, 1986, J RES MUSIC EDUC, V34, P111, DOI 10.2307/3344739; Brand M, 1985, PSYCHOL MUSIC, V13, P40, DOI 10.1177/0305735685131004; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chazan-Cohen R, 2009, EARLY EDUC DEV, V20, P958, DOI 10.1080/10409280903362402; Chen FF, 2006, MULTIVAR BEHAV RES, V41, P189, DOI 10.1207/s15327906mbr4102_5; Cho E, 2015, MUSIC EDUC RES, V17, P162, DOI 10.1080/14613808.2014.895313; Costa-Giomi E, 2014, MUSIC PERCEPT, V32, P160, DOI 10.1525/MP.2014.32.2.160; Costa-Giomi E, 2014, J RES MUSIC EDUC, V62, P188, DOI 10.1177/0022429414530564; Custodero L.A., 2003, J RES MUSIC EDUC, V51, P102, DOI [10.2307/3345844, DOI 10.2307/3345844]; Custodero LA, 2003, J APPL DEV PSYCHOL, V24, P553, DOI 10.1016/j.appdev.2003.08.005; Custodero LA, 2008, EARLY CHILD DEV CARE, V178, P15, DOI 10.1080/03004430600601115; Custodero LA, 2006, J RES MUSIC EDUC, V54, P37, DOI 10.1177/002242940605400104; Dai DY, 2002, GIFTED CHILD QUART, V46, P135, DOI 10.1177/001698620204600206; de Vries P, 2009, EARLY CHILD DEV CARE, V179, P395, DOI 10.1080/03004430802691914; Dege F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00124; Dinno A, 2009, STATA J, V9, P291, DOI 10.1177/1536867X0900900207; Dreyer BP, STIM Q COGNITIVE HOM; Driscoll Virginia, 2015, Cochlear Implants Int, V16, P137, DOI 10.1179/1754762814Y.0000000103; Farrant BM, 2013, FIRST LANG, V33, P280, DOI 10.1177/0142723713487617; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; FERNALD A, 1989, J CHILD LANG, V16, P477, DOI 10.1017/S0305000900010679; Flohr J.W., 2005, MUSICAL LIVES YOUNG; Francois C, 2013, CEREB CORTEX, V23, P2038, DOI 10.1093/cercor/bhs180; Hartas D, 2011, BRIT EDUC RES J, V37, P893, DOI 10.1080/01411926.2010.506945; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huttenlocher J, 2010, COGNITIVE PSYCHOL, V61, P343, DOI 10.1016/j.cogpsych.2010.08.002; Ilari B., 2016, CHILDRENS HOME MUSIC, P92; Ilari B., 2016, CHILDRENS HOME MUSIC; Ilari B, 2005, EARLY CHILD DEV CARE, V175, P647, DOI 10.1080/0300443042000302573; Kleemans T, 2012, EARLY CHILD RES Q, V27, P471, DOI 10.1016/j.ecresq.2011.12.004; Kuhl P.K., 2011, OXFORD HDB SOCIAL NE, P649; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Lebedeva GC, 2010, INFANT BEHAV DEV, V33, P419, DOI 10.1016/j.infbeh.2010.04.006; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; McDonald RP, 1999, TEST THEORY UNIFIED; Mehr SA, 2014, J RES MUSIC EDUC, V62, P78, DOI 10.1177/0022429413520008; Moog H., 1976, PSYCHOL MUSIC, V4, P38, DOI DOI 10.1177/030573567642005; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Nakata T, 2004, INFANT BEHAV DEV, V27, P455, DOI 10.1016/j.infbeh.2004.03.002; Oberski D, 2014, J STAT SOFTW, V57, P1; Pan BA, 2005, CHILD DEV, V76, P763, DOI 10.1111/j.1467-8624.2005.00876.x; Putkinen V, 2013, EUR J NEUROSCI, V37, P654, DOI 10.1111/ejn.12049; R Core Team, 2012, LANG ENV STAT COMP; RAINBOW E, 1981, B COUN RES MUSIC ED, P69; Revelle W, 1979, Multivariate Behav Res, V14, P403, DOI 10.1207/s15327906mbr1404_2; Revelle W., 2018, USE PSYCH PACKAGE FA; Revelle W, 2013, J RES PERS, V47, P493, DOI 10.1016/j.jrp.2013.04.012; Rose David., 2005, NATL STAT SOCIO EC C; Rowe ML, 2009, SCIENCE, V323, P951, DOI 10.1126/science.1167025; Rutkowski J., 2013, PHENOMENON SINGING, P201; SCHMID J, 1957, PSYCHOMETRIKA, V22, P53, DOI 10.1007/BF02289209; Schon D, 2008, COGNITION, V106, P975, DOI 10.1016/j.cognition.2007.03.005; Senechal M, 2008, EARLY EDUC DEV, V19, P27, DOI 10.1080/10409280701838710; Sichivitsa VO, 2007, RES STUD MUSIC EDUC, V29, P55, DOI 10.1177/1321103X07087568; Thiessen ED, 2009, ANN NY ACAD SCI, V1169, P225, DOI 10.1111/j.1749-6632.2009.04547.x; Trehub SE, 2016, SOC DEV, V25, P665, DOI 10.1111/sode.12164; Trehub SE, 1997, CAN J EXP PSYCHOL, V51, P385, DOI 10.1037/1196-1961.51.4.385; TREHUB SE, 1993, INFANT BEHAV DEV, V16, P285, DOI 10.1016/0163-6383(93)80036-8; Trehub SE, 1997, DEV PSYCHOL, V33, P500, DOI 10.1037/0012-1649.33.3.500; Valerio WH, 2012, J RES MUSIC EDUC, V60, P186, DOI 10.1177/0022429412444450; Van Puyvelde M, INTERACTION MUSIC LA; Van Puyvelde M, 2010, INFANT BEHAV DEV, V33, P387, DOI 10.1016/j.infbeh.2010.04.003; Van Puyvelde M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106920; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Weisleder A, 2013, PSYCHOL SCI, V24, P2143, DOI 10.1177/0956797613488145; Welch G. F., 2006, CHILD MUSICIAN HDB M, P311, DOI DOI 10.1093/ACPROF:OSO/9780198530329.003.0016; Williams KE, 2015, EARLY CHILD RES Q, V31, P113, DOI 10.1016/j.ecresq.2015.01.004; Wolff HG, 2005, BEHAV RES METHODS, V37, P48, DOI 10.3758/BF03206397; Youm HK, 2013, J RES MUSIC EDUC, V61, P280, DOI 10.1177/0022429413497233; Young S, 2008, INT J MUSIC EDUC, V26, P33, DOI 10.1177/0255761407085648	80	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193819	10.1371/journal.pone.0193819	http://dx.doi.org/10.1371/journal.pone.0193819			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641607	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000429742900018
J	Yang, SH; Wang, Y; Wang, LL; Shi, ZY; Ou, XQ; Wu, D; Zhang, XM; Hui, H; Yuan, J; Wang, W; Cao, FH; Liu, GQ				Yang, Shaohua; Wang, Ying; Wang, Lulu; Shi, Zhaoyuan; Ou, Xiaoqian; Wu, Dan; Zhang, Xinmiao; Hui, Hao; Yuan, Jia; Wang, Wei; Cao, Fuhu; Liu, Guoqing			RNA-Seq reveals differentially expressed genes affecting polyunsaturated fatty acids percentage in the Huangshan Black chicken population	PLOS ONE			English	Article							MEAT QUALITY TRAITS; IN-VIVO; DECORIN; IDENTIFICATION; TISSUES; FADS2; TRANSCRIPTOME; ADIPOGENESIS; ASSOCIATION; METABOLISM	Fatty acids metabolic products determine meat quality in chickens. Identifying genes associated with fatty acids composition could provide valuable information for the complex genetic networks of genes with underlying variations in fatty acids synthesis. RNA sequencing (RNA-Seq) was conducted to explore the chicken transcriptome from the thigh muscle tissue of 6 Huangshan Black Chickens with 3 extremely high and low phenotypic values for percentage of polyunsaturated fatty acids (PUFAs). In total, we obtained 41,139,108-44,901,729 uniquely mapped reads, which covered 74.15% of the current annotated transcripts including 18964 mRNA transcripts, across all the six thigh muscle tissue samples. Of these, we revealed 274 differentially expressed genes (DEGs) with a highly significant correlation with polyunsaturated fatty acids percentage between the comparison groups based on the ratio of PUFA/SFA. Gene ontology and pathway analysis indicated that the DEGs were enriched in particular biological processes affecting fatty acids metabolism, biosynthesis of unsaturated fatty acids (USFAs), and cell junction-related pathways. Integrated interpretation of differential gene expression and formerly reported quantitative trait loci (QTL) demonstrated that FADS2, DCN, FRZB, OGN, PRKAG3, LHFP, CHCHD10, CYTL1, FBLN5, and ADGRD1 are the most promising candidate genes affecting polyunsaturated fatty acids percentage.	[Yang, Shaohua; Wang, Ying; Wang, Lulu; Shi, Zhaoyuan; Ou, Xiaoqian; Wu, Dan; Zhang, Xinmiao; Hui, Hao; Yuan, Jia; Cao, Fuhu; Liu, Guoqing] Hefei Univ Technol, Coll Food Sci & Engn, Hefei, Anhui, Peoples R China; [Wang, Wei] Agr Prod Qual & Safety Supervis & Management Bur, Xuancheng, Anhui, Peoples R China	Hefei University of Technology	Cao, FH; Liu, GQ (corresponding author), Hefei Univ Technol, Coll Food Sci & Engn, Hefei, Anhui, Peoples R China.	fhcao@hfut.edu.en; 13675512000@163.com		Cao, Fu-Hu/0000-0002-5484-700X	Industry University-Research in Hefei University of Technology [XC2016JZBZ03]; Fundamental Research Funds for the Central Universities [JZ2017HGTA0228]; innovation Project for College Students [2017CXCYS235]; Wanjiang Institute of Poultry Technology [XC2015AKKG002]; Science and Technology Bureau of AnHui [XC2015XKKJ02, XC2015AKKG003]	Industry University-Research in Hefei University of Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); innovation Project for College Students; Wanjiang Institute of Poultry Technology; Science and Technology Bureau of AnHui	This work was supported by Industry University-Research in Hefei University of Technology XC2016JZBZ03 Dr Shaohua Yang; Fundamental Research Funds for the Central Universities JZ2017HGTA0228 Dr Shaohua Yang; the innovation Project for College Students 2017CXCYS235 Dr Shaohua Yang; Wanjiang Institute of Poultry Technology XC2015AKKG002 Dr Shaohua Yang; the Science and Technology Bureau of AnHui XC2015XKKJ02, XC2015AKKG003 Dr Shaohua Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Blech-Hermoni Y, 2015, GENOM DATA, V6, P74, DOI 10.1016/j.gdata.2015.08.014; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chan YF, 2012, CURR BIOL, V22, P794, DOI 10.1016/j.cub.2012.03.011; Chen SJ, 2011, EXP EYE RES, V92, P444, DOI 10.1016/j.exer.2010.05.008; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; Demeure O, 2004, ANIM GENET, V35, P123, DOI 10.1111/j.1365-2052.2004.01102.x; Donati G, 2014, P NATL ACAD SCI USA, V111, pE1501, DOI 10.1073/pnas.1312880111; Fan B, 2010, ASIAN AUSTRAL J ANIM, V23, P833, DOI 10.5713/ajas.2010.r.03; Fife MS, 2011, ANIM GENET, V42, P134, DOI 10.1111/j.1365-2052.2010.02090.x; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Kartikasari LR, 2012, PROSTAG LEUKOTR ESS, V87, P103, DOI 10.1016/j.plefa.2012.07.005; Kongkham PN, 2010, ONCOGENE, V29, P3017, DOI 10.1038/onc.2010.32; Li C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26813; Li WJ, 2009, BRIT POULTRY SCI, V50, P188, DOI 10.1080/00071660902755409; Liu L, 2017, ANIM REPROD SCI, V176, P1, DOI 10.1016/j.anireprosci.2016.11.002; Liu RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061172; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Lopes-Marques M, 2017, COMP BIOCHEM PHYS B, V203, P84, DOI 10.1016/j.cbpb.2016.09.007; Lorda-Diez CI, 2014, GENE EXPR PATTERNS, V15, P52, DOI 10.1016/j.gep.2014.04.003; Miao XY, 2015, BIOCHEM BIOPH RES CO, V467, P413, DOI 10.1016/j.bbrc.2015.09.129; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Ogluszka M, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0552-8; Okuyama T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02535-0; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ren LJ, 2009, BIOPROC BIOSYST ENG, V32, P837, DOI 10.1007/s00449-009-0310-4; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Solakivi T, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-80; Song ZK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/928178; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Sun Y, 2016, J ANIM BREED GENET, V133, P197, DOI 10.1111/jbg.12186; Szostak A, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0517-4; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Truong AD, 2015, VET IMMUNOL IMMUNOP, V166, P116, DOI 10.1016/j.vetimm.2015.06.008; Twining CW, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.165373; Wang J, 2017, COMP BIOCHEM PHYS D, V21, P56, DOI 10.1016/j.cbd.2016.12.003; Wang ZX, 2014, GENE, V543, P198, DOI 10.1016/j.gene.2014.04.023; Wardecka Barbara, 2002, Journal of Applied Genetics, V43, P319; Williamson RE, 2008, HEARING RES, V237, P57, DOI 10.1016/j.heares.2007.12.006; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; [徐晨希 Xu Chenxi], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P2194; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yang YZ, 2016, ANIM BIOTECHNOL, V27, P13, DOI 10.1080/10495398.2015.1069300; Zagris N, 2011, INT J DEV BIOL, V55, P633, DOI 10.1387/ijdb.113321nz; Zhang T, 2015, GENET MOL RES, V14, P10452, DOI 10.4238/2015.September.8.6; Zhao CJ, 2006, J ANIM BREED GENET, V123, P349, DOI 10.1111/j.1439-0388.2006.00607.x; Zhu SK, 2014, GENET MOL RES, V13, P3329, DOI 10.4238/2014.April.29.11	53	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195132	10.1371/journal.pone.0195132	http://dx.doi.org/10.1371/journal.pone.0195132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672513	gold, Green Published, Green Submitted			2022-12-27	WOS:000430446800020
J	King, NB; Harper, S; Young, M; Berry, SC; Voigt, K				King, Nicholas B.; Harper, Sam; Young, Meredith; Berry, Sarah C.; Voigt, Kristin			The impact of social and psychological consequences of disease on judgments of disease severity: An experimental study	PLOS ONE			English	Article							MEASURING HEALTH	Background The Global Burden of Disease (GBD) project systematically assesses mortality, healthy life expectancy, and disability across 195 countries and territories, using the disability-adjusted life year (DALY). Disability weights in the DALY are based upon surveys that ask users to rate health states based on lay descriptions. We conducted an experimental study to examine whether the inclusion or removal of psychological, social, or familial implications from a health state description might affect individual judgments about disease severity, and thus relative disability weights. Methods We designed a survey consisting of 36 paired descriptions in which information about plausible psychological, social, or familial implications of a health condition was either present or absent. Using a Web-based platform, we recruited 1,592 participants, who were assigned to one of two experimental groups, each of which were asked to assign a value to the health state description from 0 to 100 using a slider, with 0 as the "worst possible health" and 100 as the "best possible health. "We tested five hypotheses: (1) the inclusion of psychological, social, or familial consequences in health state descriptions will reduce the average rating of a health state; (2) the effect will be stronger for diseases with lower disability weights (i.e., less severe diseases); (3) the effect will vary across the type of additional information added to the health state description; (4) the impact of adding information on familial consequences will be stronger for female than male; (5) the effect of additional consequences on ratings of health state descriptions will not differ by levels of completed education and age. Results On average, adding social, psychological, or familial consequences to the health state description lowered individual ratings of that description by 0.78 points. The impact of adding information had a stronger impact on ratings of the least severe conditions, reducing average ratings in this category by 1.67 points. Addition of information about child-rearing had the strongest impact, reducing average ratings by 2.09 points. We found little evidence that the effect of adding information on ratings of health descriptions varied by gender, education, or age. Conclusions Including information about health states not directly related to major functional consequences or symptoms, particularly with respect to child-rearing and specifically for descriptions of less severe conditions, can lead to lower ratings of health. However, this impact was not consistent across all conditions or types of information, and was most pronounced for inclusion of information about child-rearing, and among the least severe conditions.	[King, Nicholas B.; Berry, Sarah C.] McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada; [King, Nicholas B.; Harper, Sam] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [King, Nicholas B.; Harper, Sam; Voigt, Kristin] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Young, Meredith] McGill Univ, Dept Med, Montreal, PQ, Canada; [Young, Meredith] McGill Univ, Ctr Med Educ, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	King, NB (corresponding author), McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada.; King, NB (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; King, NB (corresponding author), McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada.	nicholas.king@mcgill.ca		Voigt, Kristin/0000-0002-6452-7712	Canadian Institutes for Health Research (CIHR) [EPP-122908]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research (CIHR), Operating Grant EPP-122908, "Measuring Global Health." The funder had no role in the design of the study, in the collection, analysis, or interpretation of data, or in writing the manuscript.	Allotey P, 2003, SOC SCI MED, V57, P949, DOI 10.1016/S0277-9536(02)00463-X; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Broome J, 2002, SUMMARY MEASURES POP; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Reidpath DD, 2003, HEALTH POLICY PLANN, V18, P351, DOI 10.1093/heapol/czg043; Salomon JA, 2004, HEALTH ECON, V13, P281, DOI 10.1002/hec.834; Salomon JA, 2012, LANCET, V380, P1; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Van Boven L, 2003, J EXP SOC PSYCHOL, V39, P263, DOI 10.1016/S0022-1031(02)00516-4	12	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195338	10.1371/journal.pone.0195338	http://dx.doi.org/10.1371/journal.pone.0195338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664972	Green Submitted, gold, Green Published			2022-12-27	WOS:000430262300018
J	Aiba, H; Yamada, S; Mizutani, J; Yamamoto, N; Okamoto, H; Hayashi, K; Kimura, H; Takeuchi, A; Miwa, S; Higuchi, T; Abe, K; Taniguchi, Y; Araki, Y; Tsuchiya, H; Otsuka, T				Aiba, Hisaki; Yamada, Satoshi; Mizutani, Jun; Yamamoto, Norio; Okamoto, Hideki; Hayashi, Katsuhiro; Kimura, Hiroaki; Takeuchi, Akihiko; Miwa, Shinji; Higuchi, Takashi; Abe, Kensaku; Taniguchi, Yuta; Araki, Yoshihiro; Tsuchiya, Hiroyuki; Otsuka, Takanobu			Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series	PLOS ONE			English	Article							RESPONSE EVALUATION CRITERIA; NEOADJUVANT CHEMOTHERAPY; REGIONAL HYPERTHERMIA; HISTOLOGIC RESPONSE; IN-VITRO; TUMORS; RADIOTHERAPY; ADRIAMYCIN; SENSITIVITY; DEPENDENCE	Purpose Radio-hyperthermo-chemo (RHC) therapy, which combines radiotherapy, hyperthermia, and chemotherapy, for malignant soft tissue tumors has been introduced with the aim of decreasing the possibility of local recurrence after surgery. To avoid unnecessary neoadjuvant therapy and to plan the appropriate surgical treatment, surveillance of RHC therapeutic efficacy during treatment is necessary. In this study, we determined the optimal response criteria to evaluate the efficacy of RHC by comparing preoperative images before and after RHC with pathological evaluation of necrosis in the resected tumor. Patients and methods From 2004 to 2014, 20 patients were enrolled into this study. Needle biopsy revealed 6 cases of myxoid liposarcoma, 6 cases of undifferentiated pleomorphic sarcoma, 4 cases of myxofibrosarcoma, and 4 cases of synovial sarcoma. Based on the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 or modified RECIST, we calculated the responses to RHC therapy by comparing pre-and post-RHC therapy images. In addition, resected specimens underwent pathological analysis to evaluate response based on tumor necrosis. The correlation between assessment based on preoperative images and resected tumors were evaluated by the Spearman's rank-order correlation coefficient. Result From the surgical specimens, pathological assessment of necrosis in resected tumor were assessed as less than 50% (2 cases), 50-90% (9 cases), 90-99% (6 cases), and total necrosis (3 cases). Use of the RECIST 1.1 underestimated good responders as stable disease (SD) or progressive disease (PD) in 5 out of 15 cases; on the other hand, use of the modified RECIST did not underestimate the pathological assessment of necrosis. The correlations between responses based on preoperative images and those based on histological assessments were 0.23 (RECIST 1.1) and 0.76 (modified RECIST). Conclusion Because pathological responses can be underestimated using the RECIST 1.1, the modified RECIST, which take into consideration tumor viability, as assessed by contrast MRI, should also be considered when evaluating the efficacy of RHC.	[Aiba, Hisaki; Yamada, Satoshi; Mizutani, Jun; Okamoto, Hideki; Kimura, Hiroaki; Miwa, Shinji; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Aiba, Hisaki; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Takeuchi, Akihiko; Miwa, Shinji; Higuchi, Takashi; Abe, Kensaku; Taniguchi, Yuta; Araki, Yoshihiro; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan	Nagoya City University; Kanazawa University	Yamada, S (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan.	yamada_ncu_ortho@yahoo.co.jp	Takeuchi, Akihiko/AAJ-1563-2020; Hayashi, K/C-4685-2015; Miwa, Shinji/AAI-9309-2020	Takeuchi, Akihiko/0000-0002-4071-5620; Hayashi, K/0000-0001-8665-2154; Miwa, Shinji/0000-0002-5962-8287				Aiba H, 2016, HYPERTHERMIC ONCOLOG, P227; Aiba H, 2018, CANCER MED-US, V7, P1560, DOI 10.1002/cam4.1366; Canter RJ, 2010, ANN SURG ONCOL, V17, P2578, DOI 10.1245/s10434-010-1156-3; Chung PWM, 2009, CANCER-AM CANCER SOC, V115, P3254, DOI 10.1002/cncr.24375; Dalal KM, 2008, J SURG ONCOL, V97, P298, DOI 10.1002/jso.20975; Davis LE, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0346-4; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Haas RLM, 2016, RADIOTHER ONCOL, V119, P14, DOI 10.1016/j.radonc.2015.12.002; HAHN GM, 1975, P NATL ACAD SCI USA, V72, P937, DOI 10.1073/pnas.72.3.937; HAJDU SI, 1981, CA-CANCER J CLIN, V31, P271, DOI 10.3322/canjclin.31.5.271; HERMAN TS, 1983, CANCER RES, V43, P517; HEW L, 1994, J SURG ONCOL, V57, P111; Issels RD, 2010, LANCET ONCOL, V11, P561, DOI 10.1016/S1470-2045(10)70071-1; Jacobs Andrew J., 2015, Sarcoma, V2015, P279601, DOI 10.1155/2015/279601; Jolesch A, 2012, EUR J CELL BIOL, V91, P48, DOI 10.1016/j.ejcb.2011.02.001; Lindner LH, 2011, CURR TREAT OPTION ON, V12, P12, DOI 10.1007/s11864-011-0144-6; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lucas DR, 2008, ONCOLOGIST, V13, P451, DOI 10.1634/theoncologist.2007-0220; NAGAOKA S, 1986, JPN J CANCER RES, V77, P205; O'Sullivan B, 2002, LANCET, V359, P2235, DOI 10.1016/S0140-6736(02)09292-9; Otsuka H, 2009, J MED INVESTIG, V56, P136, DOI 10.2152/jmi.56.136; Otsuka Takanobu, 2001, International Journal of Clinical Oncology, V6, P253, DOI 10.1007/PL00012114; Padhani AR, 2001, BRIT J RADIOL, V74, P983, DOI 10.1259/bjr.74.887.740983; RHEE JG, 1984, INT J RADIAT ONCOL, V10, P393, DOI 10.1016/0360-3016(84)90060-9; Stahl R, 2009, INT J HYPERTHER, V25, P289, DOI 10.1080/02656730902873616; Tanaka K, 2015, JPN J CLIN ONCOL, V45, P555, DOI 10.1093/jjco/hyv042; Tirkes T, 2013, RADIOGRAPHICS, V33, P1323, DOI 10.1148/rg.335125214; Ueda T, 2008, J ORTHOP SCI, V13, P304, DOI 10.1007/s00776-008-1235-5; URANO M, 1990, INT J HYPERTHER, V6, P563, DOI 10.3109/02656739009140952; WESTRA A, 1971, INT J RADIAT BIOL RE, V19, P467, DOI 10.1080/09553007114550601; WILLETT CG, 1987, CANCER, V60, P1500, DOI 10.1002/1097-0142(19871001)60:7<1500::AID-CNCR2820600716>3.0.CO;2-1	31	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195289	10.1371/journal.pone.0195289	http://dx.doi.org/10.1371/journal.pone.0195289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659611	gold, Green Published, Green Submitted			2022-12-27	WOS:000430061100011
J	Vilhelmsson, A; Ostergren, PO				Vilhelmsson, Andreas; Ostergren, Per-Olof			Reducing health inequalities with interventions targeting behavioral factors among individuals with low levels of education - A rapid review	PLOS ONE			English	Review							PHYSICAL-ACTIVITY INTERVENTIONS; PROGRAM; INCREASE; OUTCOMES; INFANT; SWEDEN; TRIAL	Individuals with low levels of education systematically have worse health than those with medium or high levels of education. Yet there are few examples of attempts to summarize the evidence supporting the efficacy of interventions targeting health-related behavior among individuals with low education levels, and a large part of the literature is descriptive rather than analytical. A rapid review was carried out to examine the impact of such interventions. Special attention was given to the relative impact of the interventions among individuals with low education levels and their potential to reduce health inequality. Of 1,365 articles initially identified, only 31 were deemed relevant for the review, and of those, nine met the inclusion and quality criteria. The comparability of included studies was limited due to differences in study design, sample characteristics, and definitions of exposure and outcome variables. Therefore, instead of performing a formal meta-analysis, an overall assessment of the available evidence was made and summarized into some general conclusions. We found no support for the notion that the methods used to reduce smoking decrease inequalities in health between educational groups. Evidence was also limited for decreasing inequality through interventions regarding dietary intake, physical activity and mental health. Only one study was found using an intervention designed to decrease socioeconomic inequalities by increasing the use of breast cancer screening. Thus, we concluded that there is a lack of support regarding this type of intervention as well. Therefore, the main conclusion is that solid evidence is lacking for interventions aimed at individual determinants of health and that more research is needed to fill this gap in knowledge.	[Vilhelmsson, Andreas; Ostergren, Per-Olof] Lund Univ, Dept Clin Sci Malmo, Div Social Med & Global Hlth, Malmo, Sweden	Lund University	Vilhelmsson, A (corresponding author), Lund Univ, Dept Clin Sci Malmo, Div Social Med & Global Hlth, Malmo, Sweden.	andreas.vilhelmsson@med.lu.se	Vilhelmsson, Andreas/D-3879-2018	Vilhelmsson, Andreas/0000-0002-6635-8182				Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Batis C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002057; Bhalotra S, 2017, J EUR ECON ASSOC, V15, P1101, DOI 10.1093/jeea/jvw028; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Bremberg S, 2009, PAED CHILD HEALT-CAN, V14, P677, DOI 10.1093/pch/14.10.677; Cameron AJ, 2014, PREV MED, V58, P58, DOI 10.1016/j.ypmed.2013.10.021; Cantrell J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052206; de Camargo KR, 2011, GLOB PUBLIC HEALTH, V6, P102, DOI 10.1080/17441692.2010.514617; DeSocio JE, 2013, RES NURS HEALTH, V36, P158, DOI 10.1002/nur.21525; Everson-Hock ES, 2013, PREV MED, V56, P265, DOI 10.1016/j.ypmed.2013.02.023; Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56; Health Technology Assessment and Assessment of Social Services (SBU), 2014, UT MET HALS SJUK HDB; Hill S, 2014, TOB CONTROL, V23, DOI 10.1136/tobaccocontrol-2013-051110; Hogberg U, 2004, AM J PUBLIC HEALTH, V94, P1312, DOI 10.2105/AJPH.94.8.1312; Kreuter MW, 2010, PATIENT EDUC COUNS, V81, pS6, DOI 10.1016/j.pec.2010.09.008; Lorenc T, 2014, J EPIDEMIOL COMMUN H, V68, P288, DOI 10.1136/jech-2013-203118; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Marmot M., 2004, STATUS SYNDROME, DOI 10.1111/J.1740-9713.2004.00058.X; Marmot M., 2010, FAIR SOC HLTHY LIVES; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Ndumbe-Eyoh S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1056; Overby NC, 2012, AM J CLIN NUTR, V96, P1100, DOI 10.3945/ajcn.111.033399; Oxman AD, 2009, HEALTH RES POLICY SY, V7, DOI 10.1186/1478-4505-7-S1-S10; Schaap MM, 2008, TOB CONTROL, V17, P248, DOI 10.1136/tc.2007.024265; Solar O., 2010, CONCEPTUAL FRAMEWORK, DOI DOI 10.13016/17CR-AQB9; Stanczyk NE, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2153; The National Board of Health and Welfare Swedish Association of Local Authorities and Regions The Public Health Agency of Sweden, 2015, REG COMP 2014 PUBL H; Vallgarda S, 2010, J EPIDEMIOL COMMUN H, V64, P495, DOI 10.1136/jech.2009.102459; van der Waerden JEB, 2013, SOC SCI MED, V91, P84, DOI 10.1016/j.socscimed.2013.05.015; Vander Ploeg KA, 2014, SOC SCI MED, V112, P80, DOI 10.1016/j.socscimed.2014.04.032; Wendel-Vos GCW, 2009, AM J PREV MED, V37, P50, DOI 10.1016/j.amepre.2009.03.015	31	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195774	10.1371/journal.pone.0195774	http://dx.doi.org/10.1371/journal.pone.0195774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659598	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100030
J	Glippa, O; Engstrom-Ost, J; Kanerva, M; Rein, A; Vuori, K				Glippa, Olivier; Engstrom-Ost, Jonna; Kanerva, Mirella; Rein, Anni; Vuori, Kristiina			Oxidative stress and antioxidant defense responses in Acartia copepods in relation to environmental factors	PLOS ONE			English	Article							XYLENOL ORANGE METHOD; HISTORY TRADE-OFFS; BALTIC SEA; OCEAN ACIDIFICATION; CLIMATE-CHANGE; ULTRAVIOLET-RADIATION; MARINE-PHYTOPLANKTON; ENZYME-ACTIVITIES; GULF; TEMPERATURE	On a daily basis, planktonic organisms migrate vertically and thus experience widely varying conditions in their physico-chemical environment. In the Gulf of Finland, these changes are larger than values predicted by climate change scenarios predicted for the next century (up to 0.5 units in pH and 5 degrees C in temperature). In this work, we are interested in how temporal variations in physico-chemical characteristics of the water column on a daily and weekly scale influence oxidative stress level and antioxidant responses in the planktonic copepod of the genus Acartia. Responses were determined from samples collected during a two-week field survey in the western Gulf of Finland, Baltic Sea. Our results showed that GST (Glutathione-S-transferase) enzyme activity increased in the surface waters between Weeks I and II, indicating antioxidant defense mechanism activation. This is most likely due to elevating temperature, pH, and dissolved oxygen observed between these two weeks. During Week II also GSSG (oxidized glutathione) was detected, indicating that copepods responded to stressor(s) in the environment. Our results suggest that Acartia copepods seem fairly tolerant to weekly fluctuations in environmental conditions in coastal and estuarine areas, in terms of antioxidant defense and oxidative stress. This could be directly connected to a very efficient glutathione cycling system acting as antioxidant defense system for neutralizing ROS and avoiding elevated levels of LPX.	[Glippa, Olivier; Engstrom-Ost, Jonna; Rein, Anni] Novia Univ Appl Sci, Ekenas, Finland; [Kanerva, Mirella; Vuori, Kristiina] Univ Turku, Dept Biol, Physiol Anim Lab, Turku, Finland; [Kanerva, Mirella] Ehime Univ, Ctr Marine Environm Studies CMES, Matsuyama, Ehime, Japan	Novia University of Applied Sciences; University of Turku; Ehime University	Glippa, O (corresponding author), Novia Univ Appl Sci, Ekenas, Finland.	olivg62@gmail.com	Engström-Öst, Jonna/C-7373-2008	Engström-Öst, Jonna/0000-0003-1792-7702; GLIPPA, Olivier/0000-0001-8990-9461	Academy of Finland [276947]; Societas pro Fauna et Flora Fennica	Academy of Finland(Academy of Finland); Societas pro Fauna et Flora Fennica	This work was supported by the Academy of Finland (project nr. 276947, http://www.aka.fi.en) to Jonna Engstrom-Ost and Societas pro Fauna et Flora Fennica (http://www.societasfff.fi/?lang=en) to Anni Rein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P1; Abele D, 1998, MAR ECOL PROG SER, V163, P179, DOI 10.3354/meps163179; Almen AK, 2014, J EXP MAR BIOL ECOL, V460, P120, DOI 10.1016/j.jembe.2014.07.001; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; [Anonymous], 2014, PHYS SCI BAS WORK GR; Borgeraas J, 2000, J PLANKTON RES, V22, P1167, DOI 10.1093/plankt/22.6.1167; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; Brutemark A, 2011, OCEANOL HYDROBIOL ST, V40, P91, DOI 10.2478/s13545-011-0034-3; Cailleaud K, 2007, COMP BIOCHEM PHYS A, V147, P841, DOI 10.1016/j.cbpa.2006.09.012; Caramujo MJ, 2012, MAR DRUGS, V10, P998, DOI 10.3390/md10050998; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; de Almeida EA, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P381; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Elliott DT, 2011, MAR ECOL PROG SER, V427, P1, DOI 10.3354/meps09063; Engstrom-Ost J, 2015, J PLANKTON RES, V37, P388, DOI 10.1093/plankt/fbv004; Eymard S, 2003, EUR J LIPID SCI TECH, V105, P497, DOI 10.1002/ejlt.200300768; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fritz KS, 2011, CHEM RES TOXICOL, V24, P1411, DOI 10.1021/tx200169n; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Fujii Toyonobu, 2012, Biology - Basel, V1, P597, DOI 10.3390/biology1030597; Gorokhova E, 2013, AQUAT TOXICOL, V127, P46, DOI 10.1016/j.aquatox.2012.01.022; Hader DP, 2000, ADV SPACE RES, V26, P2029, DOI DOI 10.1016/S0273-1177(00)00170-8; Halliwell B., 2007, FREE RADICALS BIOL M; Hansen PJ, 2002, AQUAT MICROB ECOL, V28, P279, DOI 10.3354/ame028279; Havenhand JN, 2012, AMBIO, V41, P637, DOI 10.1007/s13280-012-0326-x; Hermes-Lima M, 2015, FREE RADICAL BIO MED, V89, P1122, DOI 10.1016/j.freeradbiomed.2015.07.156; Hogfors H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112692; Kabel K, 2012, NAT CLIM CHANGE, V2, P871, DOI [10.1038/NCLIMATE1595, 10.1038/nclimate1595]; Kanerva M, 2014, THESIS; Kong XH, 2008, MAR BIOL, V154, P269, DOI 10.1007/s00227-008-0920-4; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Li EC, 2008, AQUACULTURE, V274, P80, DOI 10.1016/j.aquaculture.2007.11.001; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Martinez M, 2017, J EXP MAR BIOL ECOL, V487, P79, DOI 10.1016/j.jembe.2016.11.016; Mauchline J, 1998, BIOL CALANOID COPEPO; McConville K, 2013, MAR POLLUT BULL, V73, P428, DOI 10.1016/j.marpolbul.2013.02.010; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Moreira DC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00702; Paital B, 2010, COMP BIOCHEM PHYS C, V151, P142, DOI 10.1016/j.cbpc.2009.09.007; Pinheiro LC, 2016, J EXP ZOOL PART A, V325, P318, DOI 10.1002/jez.2019; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Puthumana J, 2017, AQUAT TOXICOL, V184, P116, DOI 10.1016/j.aquatox.2017.01.011; Raja-aho S, 2012, PHYSIOL BIOCHEM ZOOL, V85, P148, DOI 10.1086/664826; Rodriguez-Grana L, 2010, MAR ECOL PROG SER, V401, P1, DOI 10.3354/meps08459; Saiz E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14962; SALONEN K, 1981, WATER RES, V15, P403, DOI 10.1016/0043-1354(81)90049-X; Souza MS, 2010, LIMNOL OCEANOGR, V55, P1024, DOI 10.4319/lo.2010.55.3.1024; Tremblay N, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P89; Tremblay N, 2010, LIMNOL OCEANOGR, V55, P2570, DOI 10.4319/lo.2010.55.6.2570; Turja R, 2014, TOXICON, V78, P68, DOI 10.1016/j.toxicon.2013.11.015; Turja R, 2013, COMP BIOCHEM PHYS C, V157, P80, DOI 10.1016/j.cbpc.2012.09.006; Vehmaa A, 2013, ECOL EVOL, V3, P4548, DOI 10.1002/ece3.839; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Vuori K, 2012, J FISH BIOL, V81, P1815, DOI 10.1111/j.1095-8649.2012.03386.x; Vuori KA, 2015, MAR ECOL PROG SER, V538, P131, DOI 10.3354/meps11471; Vuori KA, 2008, ENVIRON SCI TECHNOL, V42, P2668, DOI 10.1021/es702632c; Waldbusser GG, 2014, ANNU REV MAR SCI, V6, P221, DOI 10.1146/annurev-marine-121211-172238; Wang MJ, 2009, AQUAT TOXICOL, V95, P99, DOI 10.1016/j.aquatox.2009.08.006; Webster CN, 2015, MAR BIOL, V162, P1429, DOI 10.1007/s00227-015-2679-8; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Whitfield AK, 2012, ESTUAR COAST SHELF S, V97, P78, DOI 10.1016/j.ecss.2011.11.026; Wilhelm D, 2001, AQUACULTURE, V203, P149, DOI 10.1016/S0044-8486(01)00599-3; Wolinski L, 2016, ENVIRON POLLUT, V213, P135, DOI 10.1016/j.envpol.2016.02.016; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	69	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195981	10.1371/journal.pone.0195981	http://dx.doi.org/10.1371/journal.pone.0195981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652897	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900052
J	Han, BF; Yuan, QL; Shi, YH; Wei, L; Hou, JL; Shang, J; Hans, Y; Jin, CD; Chan, PL; Zhuang, H; Li, J; Cui, FQ				Han, Bingfeng; Yuan, Qianli; Shi, Yuhui; Wei, Lai; Hou, Jinlin; Shang, Jia; Hans, Ying; Jin, Cunduo; Chan, Po-Lin; Zhuang, Hui; Li, Jie; Cui, Fuqiang			The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; KNOWLEDGE; STIGMA; PREVENTION; VIRUS; VACCINATION; INFECTION; MOTHERS; LIFE	Objectives To assess chronic hepatitis B (CHB) patients' knowledge about hepatitis B and their experience of discrimination with regard to study, work, and daily life. Methods We administered a questionnaire to 797 CHB patients in four provinces of China and used one-way analysis of variance (ANOVA) and a generalized linear model (GLM) to identify factors associated with discrimination. Results CHB patients had low levels of knowledge about hepatitis B. Patients under 40 years of age with a junior college education or above knew more about hepatitis B than CHB patients over 40 years of age who had only a high school education. Three-fourths of patients had experienced discrimination because of their hepatitis B infection, with no differences in the proportion experiencing discrimination by sex or age. People with more education reported less discrimination. Patients in Beijing and Henan province perceived less discrimination than those in Shaanxi and Guangdong provinces. Discrimination was significantly associated with negative emotions. CHB patients had little awareness of China's anti-discrimination laws and policies. Among patients who had experienced discrimination, fewer than 10% knew organizations or institutions that could offer help. Over 60% of CHB patients who experienced discrimination chose not to respond. Conclusion CHB patients in China commonly experienced discrimination, which was associated with significant, negative emotional stress. To mitigate the damaging effects of discrimination, our study suggests raising general population knowledge about hepatitis B, raising awareness of the availability of legal protection and organizations that can fight discrimination, and providing psychological support for CHB patients.	[Han, Bingfeng; Shi, Yuhui; Cui, Fuqiang] Peking Univ, Sch Publ Hlth, Dept Laboratorial Sci & Technol, Beijing, Peoples R China; [Yuan, Qianli] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Wei, Lai] Peking Univ, Hepatol Unit, Peoples Hosp, Beijing, Peoples R China; [Hou, Jinlin] Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China; [Shang, Jia] Henan Prov Peoples Hosp, Hepatol Unit, Zhengzhou, Henan, Peoples R China; [Hans, Ying] Fourth Mil Med Univ, Xijing Hosp, Hepatol Unit, Xian, Shaanxi, Peoples R China; [Jin, Cunduo] 302 Mil Hosp China, Cent Sterile Supply Dept, Beijing, Peoples R China; [Chan, Po-Lin] World Hlth Org China, Beijing, Peoples R China; [Zhuang, Hui; Li, Jie] Peking Univ, Sch Basic Med Sci, Dept Microbiol, Hlth Sci Ctr, Beijing, Peoples R China; [Zhuang, Hui; Li, Jie] Peking Univ, Sch Basic Med Sci, Ctr Infect Dis, Hlth Sci Ctr, Beijing, Peoples R China	Peking University; Chinese Center for Disease Control & Prevention; Peking University; Southern Medical University - China; Zhengzhou University; Air Force Military Medical University; Fifth Medical Center of Chinese PLA General Hospital; World Health Organization; Peking University; Peking University	Cui, FQ (corresponding author), Peking Univ, Sch Publ Hlth, Dept Laboratorial Sci & Technol, Beijing, Peoples R China.; Li, J (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Microbiol, Hlth Sci Ctr, Beijing, Peoples R China.; Li, J (corresponding author), Peking Univ, Sch Basic Med Sci, Ctr Infect Dis, Hlth Sci Ctr, Beijing, Peoples R China.	jieli@bjmu.edu.cn; cuifug@126.com		Chan, Polin/0000-0003-1708-5170	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Chen Y, 2010, 13 NAT C PSYCH, V451; Cotler SJ, 2012, J VIRAL HEPATITIS, V19, P147, DOI 10.1111/j.1365-2893.2011.01462.x; Cui FQ, 2017, EMERG INFECT DIS, V23, P765, DOI 10.3201/eid2305.161477; Dam L, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/1910292; Dun-Dery F, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2490-x; Han ZY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178671; Haq N, 2014, VALUE HEALTH, V17, pA807, DOI 10.1016/j.jval.2014.08.529; Huang JX, 2016, LIVER INT, V36, P1595, DOI 10.1111/liv.13168; Hyun S, 2018, J IMMIGR MINOR HEALT, V20, P943, DOI 10.1007/s10903-017-0609-1; Kan QC, 2015, LANCET, V386, P245, DOI 10.1016/S0140-6736(15)61276-4; Leng AL, 2016, HUM VACC IMMUNOTHER, V12, P1164, DOI 10.1080/21645515.2015.1131883; Li C, 2006, CHIN J PUBL HLTH, V22, P132; Li YY, 2017, MILITARY MED RES, V4, DOI 10.1186/s40779-016-0110-5; Liu K, 2016, LIVER INT, V36, P1582, DOI 10.1111/liv.13189; Lu Y, 2017, VACCINE, V35, P40, DOI 10.1016/j.vaccine.2016.11.061; [莫显昆 Mo Xiankun], 2015, [中国卫生统计, Chinese Journal of Health Statistics], V32, P948; Modabbernia A, 2013, ARCH IRAN MED, V16, P114, DOI 013162/AIM.0013; Na L, 2013, J HEALTH COMMUN, V18, P71, DOI 10.1080/10810730.2012.688449; Ouyang D, 2013, J COMMUN HEALTH, V38, P471, DOI 10.1007/s10900-012-9631-3; Rafique I, 2014, E MEDITERR HEALTH J, V20, P796, DOI 10.26719/2014.20.12.796; Ren H, 2017, J VIRAL HEPATITIS, V24, P4, DOI 10.1111/jvh.12793; Shi JC, 2013, J APPL SOC PSYCHOL, V43, pE46, DOI 10.1111/jasp.12040; Valizadeh L, 2017, GASTROENTEROL NURS, V40, P143, DOI 10.1097/SGA.0000000000000223; Wang AL, 2015, B WORLD HEALTH ORGAN, V93, P52, DOI 10.2471/BLT.14.139626; WANG P, 2013, J NURSES TRAIN, V28, P1570; WHO, GLOB HEP REP 2017; Wu H, 2009, CAN J GASTROENTEROL, V23, P31, DOI 10.1155/2009/608352; Yang T, 2011, LANCET, V378, P1059, DOI 10.1016/S0140-6736(11)61460-8; Yu LJ, 2016, HUM VACC IMMUNOTHER, V12, P70, DOI 10.1080/21645515.2015.1069932; Yu Lijie, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P771; Zhu FC, 2016, VACCINE, V34, P2656, DOI 10.1016/j.vaccine.2016.04.042	31	18	21	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195455	10.1371/journal.pone.0195455	http://dx.doi.org/10.1371/journal.pone.0195455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649232	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900046
J	Kelly, CA; Crampin, AC; Mortimer, K; Dube, A; Malava, J; Johnston, D; Unterhalter, E; Glynn, JR				Kelly, Christine A.; Crampin, Amelia C.; Mortimer, Kevin; Dube, Albert; Malava, Jullita; Johnston, Deborah; Unterhalter, Elaine; Glynn, Judith R.			From kitchen to classroom: Assessing the impact of cleaner burning biomass-fuelled cookstoves on primary school attendance in Karonga district, northern Malawi	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RURAL MALAWI; STOVE USE; INTERVENTION; CHILDREN; HEALTH; PREVALENCE; STACKING; COOKING; AFRICA	Household air pollution from burning solid fuels is responsible for an estimated 2.9 million premature deaths worldwide each year and 4.5% of global disability-adjusted life years, while cooking and fuel collection pose a considerable time burden, particularly for women and children. Cleaner burning biomass-fuelled cookstoves have the potential to lower exposure to household air pollution as well as reduce fuelwood demand by increasing the combustion efficiency of cooking fires, which may in turn yield ancillary benefits in other domains. The present paper capitalises on opportunities offered by the Cooking and Pneumonia Study (CAPS), the largest randomised trial of biomass-fuelled cookstoves on health outcomes conducted to date, the design of which allows for the evaluation of additional outcomes at scale. This mixed methods study assesses the impact of cookstoves on primary school absenteeism in Karonga district, northern Malawi, in particular by conferring health and time and resource gains on young people aged 5-18. The analysis combines quantitative data from 6168 primary school students with in-depth interviews and focus group discussions carried out among 48 students in the same catchment area in 2016. Negative binomial regression models find no evidence that the cookstoves affected primary school absenteeism overall [IRR 0.92 (0.71-1.18), p = 0.51]. Qualitative analysis suggests that the cookstoves did not sufficiently improve household health to influence school attendance, while the time and resource burdens associated with cooking activities-although reduced in intervention households-were considered to be compatible with school attendance in both trial arms. More research is needed to assess whether the cookstoves influenced educational outcomes not captured by the attendance measure available, such as timely arrival to school or hours spent on homework.	[Kelly, Christine A.; Crampin, Amelia C.; Glynn, Judith R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Crampin, Amelia C.; Dube, Albert; Malava, Jullita] Malawi Epidemiol & Intervent Res Unit, Chilumba Lilongwe, Malawi; [Mortimer, Kevin] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Mortimer, Kevin] Malawi Liverpool Wellcome Trust Programme, Blantyre, Malawi; [Johnston, Deborah] Univ London, Dept Econ, SOAS, London, England; [Unterhalter, Elaine] UCL, Inst Educ, Dept Educ Practice & Soc, London, England	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit; Liverpool School of Tropical Medicine; University of Malawi; University of London; University of London School Oriental & African Studies (SOAS); University of London; University College London; UCL Institute of Education	Kelly, CA (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	christine.kelly@lsthm.ac.uk		Unterhalter, Elaine/0000-0002-2302-6583; Mortimer, Kevin/0000-0002-8118-8871	Wellcome Trust [098610/Z/12/Z, MR/K006533/1]; Medical Research Council; UK Department for International Development; Medical Research Council [MR/L002515/1]; Bloomsbury Colleges PhD Studentship; London School of Hygiene; Tropical Medicine Research Degree Travelling Scholarship; Economic and Social Research Council [ES/L013967/1] Funding Source: researchfish; Medical Research Council [MR/K006533/1] Funding Source: researchfish; National Institute for Health Research [CL-2006-12-004] Funding Source: researchfish; ESRC [ES/L013967/1] Funding Source: UKRI; MRC [MR/K006533/1, MR/L002515/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bloomsbury Colleges PhD Studentship; London School of Hygiene; Tropical Medicine Research Degree Travelling Scholarship; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Data collection for the Karonga Health and Demographic Surveillance System and the nested qualitative study was funded by a Wellcome Trust programme grant (Ref: 098610/Z/12/Z). The Cooking and Pneumonia Study (CAPS) was funded by a Joint Global Health Trials Grant from the Medical Research Council, UK Department for International Development and Wellcome Trust (Ref: MR/K006533/1) and a New Investigator Research Grant from the Medical Research Council (Ref: MR/L002515/1). CK's doctoral studies were supported by a Bloomsbury Colleges PhD Studentship and a London School of Hygiene and Tropical Medicine Research Degree Travelling Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M, 2005, J DEV STUD, V41, P412, DOI 10.1080/0022038042000313318; Cluver L, 2012, J ADOLESCENT RES, V27, P581, DOI 10.1177/0743558411417868; Crampin AC, 2012, INT J EPIDEMIOL, V41, P676, DOI 10.1093/ije/dys088; Cundale K, 2017, SOC SCI MED, V183, P1, DOI 10.1016/j.socscimed.2017.04.017; Evans DK, 2007, DEMOGRAPHY, V44, P35, DOI 10.1353/dem.2007.0002; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gordon Stephen, 2006, Malawi Med J, V18, P134; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Government of Malawi, 2009, MAL BIOM EN STRAT; Guest G., 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hanna R, 2012, SMOKE INFLUENCE HOUS; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; International Labour Organization, ILO CONV REC CHILD L; Jagger P, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/125004; Jary HR, 2014, INT J TUBERC LUNG D, V18, P240, DOI 10.5588/ijtld.13.0485; Kadzamira E, 2003, INT J EDUC DEV, V23, P501, DOI 10.1016/S0738-0593(03)00026-9; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Martin WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001455; Mortimer K, 2017, LANCET, V389, P167, DOI 10.1016/S0140-6736(16)32507-7; Mustapha BA, 2013, INT J TUBERC LUNG D, V17, P982, DOI 10.5588/ijtld.12.0434; Nankhuni FJ, 2004, AGR ECON-BLACKWELL, V31, P123, DOI [10.1016/j.agecon.2004.09.022, 10.1111/j.1574-0862.2004.tb00251.x]; National Statistical Office ICF Macro., 2011, MAL DEM HLTH SURV 20; Orkin K, 2011, CREATE PATHWAYS ACCE, V60; Perez-Padilla R, 2010, INT J TUBERC LUNG D, V14, P1079; Piedrahita R, 2016, ENERGY SUSTAIN DEV, V34, P67, DOI 10.1016/j.esd.2016.07.007; Porter G, 2012, WORLD DEV, V40, P2136, DOI 10.1016/j.worlddev.2012.05.004; Romieu I, 2009, AM J RESP CRIT CARE, V180, P649, DOI 10.1164/rccm.200810-1556OC; Ruiz-Mercado I, 2015, ECOHEALTH, V12, P42, DOI 10.1007/s10393-015-1009-4; Ruiz-Mercado I, 2011, ENERG POLICY, V39, P7557, DOI 10.1016/j.enpol.2011.03.028; Stanistreet D, 2015, J HEALTH COMMUN, V20, P84, DOI 10.1080/10810730.2014.999896; Sunny BS, 2017, INT J EDUC DEV, V52, P68, DOI 10.1016/j.ijedudev.2016.10.004; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webbink E, 2012, WORLD DEV, V40, P631, DOI 10.1016/j.worlddev.2011.07.005; Wodon Q, 2006, GENDER TIME USE POVE; Wong GWK, 2013, LANCET RESP MED, V1, P386, DOI 10.1016/S2213-2600(13)70073-0; World Bank, 2010, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-8198-4	36	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0193376	10.1371/journal.pone.0193376	http://dx.doi.org/10.1371/journal.pone.0193376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649227	gold, Green Accepted, Green Published			2022-12-27	WOS:000429791900004
J	Lui, M; Hsu, M				Lui, Ming; Hsu, Ming			Viewing sexual images is associated with reduced physiological arousal response to gambling loss	PLOS ONE			English	Article							PICTURE-PROCESSING INTERFERES; DECISION-MAKING; LOSS AVERSION; NEURAL BASIS; RISK; TESTOSTERONE; AMYGDALA	Erotic imagery is one highly salient emotional signal that exists everywhere in daily life. The impact of sexual stimuli on human decision-making, however, has rarely been investigated. This study examines the impact of sexual stimuli on financial decision-making under risk. In each trial, either a sexual or neutral image was presented in a picture categorization task before a gambling task. Thirty-four men made gambling decisions while their physiological arousal, measured by skin conductance responses (SCRs), was recorded. Behaviorally, the proportion of gambling decisions did not differ between the sexual and neutral image trials. Physiologically, participants had smaller arousal differences, measured in micro-siemen per dollar, between losses and gains in the sexual rather than in the neutral image trials. Moreover, participants' SCRs to losses relative to gains predicted the proportion of gambling decisions in the neutral image trials but not in the sexual image trials. The results were consistent with the hypothesis that the presence of emotionally salient sexual images reduces attentional and arousal-related responses to gambling losses. Our results are consistent with the theory of loss attention involving increased cognitive investment in losses compared to gains. The findings also have potential practical implications for our understanding of the specific roles of sexual images in human financial decision making in everyday life, such as gambling behaviors in the casino.	[Lui, Ming] Hong Kong Baptist Univ, Dept Educ Studies, Hong Kong, Hong Kong, Peoples R China; [Hsu, Ming] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	Hong Kong Baptist University; University of California System; University of California Berkeley	Lui, M (corresponding author), Hong Kong Baptist Univ, Dept Educ Studies, Hong Kong, Hong Kong, Peoples R China.	m-lui@u.northwestern.edu		Lui, Ming/0000-0001-7996-0386	Hong Kong Baptist University Faculty Research Grants [FRG1/14-15/067]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043196] Funding Source: NIH RePORTER	Hong Kong Baptist University Faculty Research Grants; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Hong Kong Baptist University Faculty Research Grants (FRG1/14-15/067) given to ML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2014, PSYCHONEUROENDOCRINO, V39, P58, DOI 10.1016/j.psyneuen.2013.09.025; Ariely D, 2006, J BEHAV DECIS MAKING, V19, P87, DOI 10.1002/bdm.501; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; Berridge Kent C, 2009, Oxf Ser Soc Cogn Soc Neurosci, V2009, P509; Childress AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001506; Cueva C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11206; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; De Martino B, 2008, J NEUROSCI, V28, P10746, DOI 10.1523/JNEUROSCI.2895-08.2008; Dewitte S., 2006, P ROY SOC LOND B BIO, V273, P2091; Erev I, 2008, J BEHAV DECIS MAKING, V21, P575, DOI 10.1002/bdm.602; Hochman G, 2011, J BEHAV DECIS MAKING, V24, P140, DOI 10.1002/bdm.692; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Koepp MJ, 2009, NEUROIMAGE, V44, P252, DOI 10.1016/j.neuroimage.2008.08.032; Koritzky G, 2010, J BEHAV DECIS MAKING, V23, P83, DOI 10.1002/bdm.660; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Laier C, 2014, ARCH SEX BEHAV, V43, P473, DOI 10.1007/s10508-013-0119-8; Laier C, 2013, J SEX RES, V50, P642, DOI 10.1080/00224499.2012.716873; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; McGraw AP, 2010, PSYCHOL SCI, V21, P1438, DOI 10.1177/0956797610381504; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Most SB, 2007, COGNITION EMOTION, V21, P964, DOI 10.1080/02699930600959340; Naqvi N, 2006, CURR DIR PSYCHOL SCI, V15, P260, DOI 10.1111/j.1467-8721.2006.00448.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Richter M, 2009, PSYCHOPHYSIOLOGY, V46, P451, DOI 10.1111/j.1469-8986.2009.00795.x; ROLLS ET, 1999, BRAIN EMOTION; Ronay R, 2010, SOC PSYCHOL PERS SCI, V1, P57, DOI 10.1177/1948550609352807; Scott-Van Zeeland AA, 2010, AUTISM RES, V3, P53, DOI 10.1002/aur.122; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Stanton SJ, 2011, HORM BEHAV, V59, P252, DOI 10.1016/j.yhbeh.2010.12.003; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Van den Bergh B, 2008, J CONSUM RES, V35, P85, DOI 10.1086/525505; Wilson M, 2004, P ROY SOC B-BIOL SCI, V271, pS177, DOI 10.1098/rsbl.2003.0134; Yechiam E, 2007, J MATH PSYCHOL, V51, P75, DOI 10.1016/j.jmp.2006.11.002; Yechiam E, 2013, PSYCHOL BULL, V139, P497, DOI 10.1037/a0029383	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195748	10.1371/journal.pone.0195748	http://dx.doi.org/10.1371/journal.pone.0195748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649287	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900079
J	Mayne, ES; Mayne, ALH; Louw, SJ				Mayne, Elizabeth S.; Mayne, Anthony L. H.; Louw, Susan J.			Pathogenic factors associated with development of disseminated intravascular coagulopathy (DIC) in a tertiary academic hospital in South Africa	PLOS ONE			English	Article							HIV-INFECTION; COAGULATION; SEPSIS; INFLAMMATION; MANAGEMENT; THROMBOSIS; PATIENT	Introduction Disseminated intravascular coagulopathy (DIC) is a thrombotic microangiopathy arising from consumption of both coagulation factors and platelets. DIC is triggered by a number of clinical conditions including severe infection, trauma and obstetric complications. Early diagnosis and treatment of the underlying condition is paramount. A high clinical index of suspicion is needed to ensure that patients at risk of developing DIC are appropriately investigated. Methods In order to establish the clinical conditions most frequently associated with DIC, we reviewed all DIC screens received at a tertiary hospital in Johannesburg, South Africa over a 1 year period. Results The commonest clinical condition associated with DIC in our population was infection with 84% of patients infected with an identified pathogen. The most frequently diagnosed pathogen was HIV followed by Mycobacterium tuberculosis and other bacterial infections. In the majority of cases, bacteria were isolated from blood cultures. In 47 patients, HIV was the only pathogen which could be isolated. A relative risk ratio of 2.73 and an odds ratio of 29.97 was attributed to HIV for development of a DIC. A malignancy was present in 51 of the patients of which approximately 60% had co-existing infection. No cause could be attributed in 30 patients. Conclusion Infection was identified in the majority of the patients diagnosed with DIC in this study. HIV showed the highest relative risk ratio of all pathogens although previous studies have not suggested that HIV was strongly associated with DIC. In almost half of the HIV infected patients, there was no other pathogen isolated despite extensive investigation. This suggests that HIV has a strong association with the development of DIC, warranting further research into the relationship between HIV and disseminated microvascular thrombosis.	[Mayne, Elizabeth S.; Mayne, Anthony L. H.; Louw, Susan J.] Univ Witwatersrand, Dept Mol Med & Haematol, Fac Hlth Sci, Johannesburg, South Africa; [Mayne, Elizabeth S.; Louw, Susan J.] Natl Hlth Lab Serv, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service	Mayne, ES (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Fac Hlth Sci, Johannesburg, South Africa.; Mayne, ES (corresponding author), Natl Hlth Lab Serv, Johannesburg, South Africa.	elizabeth.mayne@nhls.ac.za	mayne, anthony leland hamilton/GMW-6063-2022	mayne, anthony leland hamilton/0000-0003-4173-6340; Mayne, Elizabeth/0000-0002-6360-3488	National Research Foundation Thuthuka Grant [TTK20110801000022866]; Discovery Foundation Academic Award	National Research Foundation Thuthuka Grant; Discovery Foundation Academic Award	This work was supported by the National Research Foundation Thuthuka Grant TTK20110801000022866; Discovery Foundation Academic Award.	[Anonymous], 2013, J THROMB HAEMOST; Arildsen H, 2013, HIV MED, V14, P1, DOI 10.1111/j.1468-1293.2012.01027.x; Becker S, 2004, CLIN INFECT DIS, V39, pS267, DOI 10.1086/422363; Benjamin M, 2009, CLIN INFECT DIS, V48, P1129, DOI 10.1086/597471; Bick RL, 1999, HAEMOSTASIS, V29, P111; BILGRAMI S, 1994, TRANSFUSION, V34, P248, DOI 10.1046/j.1537-2995.1994.34394196624.x; Brecher ME, 2008, J CLIN APHERESIS, V23, P186, DOI 10.1002/jca.20176; Davies S, 1999, CAN J ANAESTH, V46, P456, DOI 10.1007/BF03012944; Dirajlal-Fargo S, 2017, AIDS, V31, P1917, DOI 10.1097/QAD.0000000000001556; FERA G, 1993, INFECTION, V21, P171, DOI 10.1007/BF01710541; Funderburg NT, 2014, THROMB RES, V133, pS21, DOI 10.1016/j.thromres.2014.03.012; Gando S, 1999, ANN SURG, V229, P121, DOI 10.1097/00000658-199901000-00016; Huson MAM, 2016, BRIT J HAEMATOL, V173, P918, DOI 10.1111/bjh.14006; Iba T, 2018, CLIN APPL THROMB-HEM, V24, P439, DOI 10.1177/1076029617720069; Kinasewitz GT, 2004, CRIT CARE, V8, pR82, DOI 10.1186/cc2459; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2009.07600.x, 10.1111/j.1365-2141.2008.07445.x]; Ronit A, 2017, J INFECT DIS; Singer M, 2016, INTENS CARE MED, V42, P2027, DOI 10.1007/s00134-016-4600-4; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Toh CH, 2013, HEMATOL-AM SOC HEMAT, P286, DOI 10.1182/asheducation-2013.1.286; Vaughan JL, 2017, SAMJ S AFR MED J, V107, P264, DOI [10.7196/SAMJ.2017.v107i3.11206, 10.7196/samj.2017.v107i3.11206]; Wada H, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-15; Zimba S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2455-0	24	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195793	10.1371/journal.pone.0195793	http://dx.doi.org/10.1371/journal.pone.0195793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649339	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900090
J	Kang, H; Lee, Y; Lee, S; Song, Y; Lim, TH; Oh, J; Lee, J; Shin, H				Kang, Hyunggoo; Lee, Yoonje; Lee, Sanghyun; Song, Yeongtak; Lim, Tae Ho; Oh, Jaehoon; Lee, Juncheol; Shin, Hyungoo			Protection afforded by respirators when performing endotracheal intubation using a direct laryngoscope, GlideScope (R), and i-gel (R) device: A randomized trial	PLOS ONE			English	Article							FILTERING FACEPIECE RESPIRATORS; HEALTH-CARE WORKERS; TRACHEAL INTUBATION; N95; DESATURATION; PENETRATION; INFECTIONS; LEAKAGE	Emergency physicians are at risk of infection during invasive procedures, and wearing a respirator can reduce this risk. The aim of this study was to determine whether the protection afforded by a respirator during intubation is affected by the type of airway device used. In this randomized crossover study, 26 emergency physicians underwent quantitative fit tests for a N95 respirator (cup-type or fold-type) before and during intubation with a direct laryngoscope, GlideScope (R), or i-gel (R) airway device. The primary outcome was the fit factor value of the respirator and the secondary outcome was the level of acceptable protection provided (percentage of fit factor scores above 100). Compared with the GlideScope and i-gel device, the fit factor values and level of acceptable protection provided were lower when physicians wore the cup-type respirator while intubating using the direct laryngoscope (200 fit factor [152 - 200] and 200 fit factor [121.25 - 200] versus 166 fit factor [70 - 200], 100% and 100% versus 75%, respectively; all P < 0.001). There were no significant differences in the fit factor value or level of acceptable protection provided when the physicians wore the fold-type respirator while intubating using any of the three airway devices (all P > 0.05). The type of airway device used for endotracheal intubation may influence the protective performance of some types of respirators. Emergency physicians should consider the effects of airway device types on fit factor of N95 respirators, when they perform intubation at risk of infection.	[Kang, Hyunggoo; Lee, Yoonje; Lee, Sanghyun; Lim, Tae Ho; Oh, Jaehoon; Lee, Juncheol; Shin, Hyungoo] Hanyang Univ, Dept Emergency Med, Coll Med, Seoul, South Korea; [Kang, Hyunggoo; Lee, Yoonje; Song, Yeongtak; Lim, Tae Ho; Oh, Jaehoon] Hanyang Univ, Convergence Technol Ctr Disaster Preparedness, Seoul, South Korea; [Lee, Sanghyun] Hallym Univ, Dept Emergency Med, Coll Med, Seoul, South Korea	Hanyang University; Hanyang University; Hallym University	Lee, S (corresponding author), Hanyang Univ, Dept Emergency Med, Coll Med, Seoul, South Korea.; Lee, S (corresponding author), Hallym Univ, Dept Emergency Med, Coll Med, Seoul, South Korea.	gagul81@gmail.com	; Shin, Hyungoo/R-7752-2016; LEE, YOONJE/R-7311-2016	Kang, Hyunggoo/0000-0002-9522-2532; Shin, Hyungoo/0000-0003-3203-1672; LEE, YOONJE/0000-0001-6478-7568	Hallym University Research Fund [HURF-2017-63]	Hallym University Research Fund	This study was funded by a grant from Hallym University Research Fund 2017 (HURF-2017-63) to Dr. Sanghyun Lee.	Benumof JL, 1997, ANESTHESIOLOGY, V87, P979, DOI 10.1097/00000542-199710000-00034; CDC, 2005, INT DOM GUID US RESP; CDC, 2005, GUID PREV TRANSM MYC; Conly JM, 2006, CAN MED ASSOC J, V175, P263, DOI 10.1503/cmaj.060685; Crutchfield C D, 1999, Appl Occup Environ Hyg, V14, P827; Eshbaugh JP, 2009, J OCCUP ENVIRON HYG, V6, P52, DOI 10.1080/1545962080255X196; Fowler RA, 2004, AM J RESP CRIT CARE, V169, P1198, DOI 10.1164/rccm.200305-715OC; Gamage B, 2005, AM J INFECT CONTROL, V33, P114, DOI 10.1016/j.ajic.2004.12.002; Grinshpun SA, 2009, J OCCUP ENVIRON HYG, V6, P593, DOI 10.1080/15459620903120086; HACK A, 1974, SELECTION RESP TEST; Harber Philip, 2015, J Occup Environ Hyg, V12, P369, DOI 10.1080/15459624.2015.1006636; Harber P, 2013, J OCCUP ENVIRON HYG, V10, P556, DOI 10.1080/15459624.2013.818235; Haruta H., 2008, J INT SOC RESP PROT, V25, P75; Henderson JJ, 1997, ANAESTHESIA, V52, P552, DOI 10.1111/j.1365-2222.1997.129-az0125.x; Kiely PM, 2009, CLIN EXP OPTOM, V92, P490, DOI 10.1111/j.1444-0938.2009.00420.x; Lee S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/975649; Lei ZP, 2014, ANN OCCUP HYG, V58, P1186, DOI 10.1093/annhyg/meu064; Lim T, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7565706; Malik MA, 2009, CAN J ANAESTH, V56, P802, DOI 10.1007/s12630-009-9165-z; Niezgoda G, 2015, J OCCUP ENVIRON HYG, V10, P419; Niezgoda George, 2013, J Occup Environ Hyg, V10, P419, DOI 10.1080/15459624.2013.801246; Or P, 2012, WORKPLACE HEALTH SAF, V60, P511, DOI 10.3928/21650799-20121128-76; Rebmann T, 2013, AM J INFECT CONTROL, V41, P1218, DOI 10.1016/j.ajic.2013.02.017; Rengasamy S, 2014, J OCCUP ENVIRON HYG, V11, P388, DOI 10.1080/15459624.2013.866715; Rengasamy S, 2012, ANN OCCUP HYG, V56, P568, DOI 10.1093/annhyg/mer122; Sakles JC, 2012, J EMERG MED, V42, P400, DOI 10.1016/j.jemermed.2011.05.019; Sepkowitz KA, 1996, ANN INTERN MED, V125, P826, DOI 10.7326/0003-4819-125-10-199611150-00007; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195745	10.1371/journal.pone.0195745	http://dx.doi.org/10.1371/journal.pone.0195745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672533	gold, Green Submitted, Green Published			2022-12-27	WOS:000430446800043
J	Pol, S; Fox-Lewis, S; Neou, L; Parker, M; Kingori, P; Turner, C				Pol, Sreymom; Fox-Lewis, Shivani; Neou, Leakhena; Parker, Michael; Kingori, Patricia; Turner, Claudia			If you come from a well-known organisation, I will trust you: Exploring and understanding the community's attitudes towards healthcare research in Cambodia	PLOS ONE			English	Article							INFORMED-CONSENT	Objective To explore Cambodian community members' understanding of and attitudes towards healthcare research. Design This qualitative study generated data from semi-structured interviews and focus group discussions. This study was conducted at a non-governmental paediatric hospital and in nearby villages in Siem Reap province, Cambodia. A total of ten semi-structured interviews and four focus group discussions were conducted, involving 27 participants. Iterative data collection and analysis were performed concurrently. Data were analysed by thematic content analysis and the coding structure was developed using relevant literature. Results Participants did not have a clear understanding of what activities related to research compared with those for routine healthcare. Key attitudes towards research were responsibility and trust: personal (trust of the researcher directly) and institutional (trust of the institution as a whole). Villagers believe the village headman holds responsibility for community activities, while the village headman believes that this responsibility should be shared across all levels of the government system. Conclusions It is essential for researchers to understand the structure and relationship within the community they wish to work with in order to develop trust among community participants. This aids effective communication and understanding among all parties, enabling high quality ethical research to be conducted.	[Pol, Sreymom; Fox-Lewis, Shivani; Turner, Claudia] Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [Pol, Sreymom; Turner, Claudia] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Fox-Lewis, Shivani; Turner, Claudia] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Neou, Leakhena] Angkor Hosp Children, Siem Reap, Cambodia; [Parker, Michael; Kingori, Patricia] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford, England; [Pol, Sreymom] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Microbiol Dept, Siem Reap, Cambodia	Mahidol University; University of Oxford; University of Oxford	Pol, S (corresponding author), Cambodia Oxford Med Res Unit, Siem Reap, Cambodia.; Pol, S (corresponding author), Mahidol Univ, Fac Trop Med, Bangkok, Thailand.; Pol, S (corresponding author), Angkor Hosp Children, Cambodia Oxford Med Res Unit, Microbiol Dept, Siem Reap, Cambodia.	Sreymom@tropmedres.ac			Global Health Bioethics Network; Wellcome Trust [096527]	Global Health Bioethics Network; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Global Health Bioethics Network and the Wellcome Trust (Award No. 096527) (http://e-mops.ning.com/page/projects-test) to SP/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ACT CONSORTIUM GUIDA; Bennett Marlyn, 2004, FIRST PEOPLES CHILD, V1, P19; Cleary SM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-320; GLOBAL C, 2016, CAMB GUID LANG CULT; Goldberg-Freeman C, 2007, YOUVE GOT UNDERSTAND, P1; Goyet S, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0217-1; Kengne-Ouafo JA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1026; Kerasidou A, 2017, MED HEALTH CARE PHIL, V20, P43, DOI 10.1007/s11019-016-9721-6; Kingori P, 2015, CURR SOCIOL, V63, P763, DOI 10.1177/0011392115590093; Marshall PA, INFORM CONSENT INT H; Marshall PA, 2006, J EMPIR RES HUM RES, V1, P25, DOI 10.1525/jer.2006.1.1.25; Molyneux S, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-13; O'Neil's O, 2002, AUTONOMY TRUST BIOET, V2002, P25; Olshansky E, USE COMMUNITY BASED, P269; Olshansky E, USE COMMUNITY BASED, P7; Quinn SC, 2012, J EMPIR RES HUM RES, V7, P44, DOI 10.1525/jer.2012.7.5.44; Silverman D., 2011, QUALITATIVE METHODOL; Turner C, 2016, NEONATAL HLTH PERCEP, P17	18	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195251	10.1371/journal.pone.0195251	http://dx.doi.org/10.1371/journal.pone.0195251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668693	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200035
J	van Heyningen, T; Honikman, S; Tomlinson, M; Field, S; Myer, L				van Heyningen, Thandi; Honikman, Simone; Tomlinson, Mark; Field, Sally; Myer, Landon			Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in South African women	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; POSTNATAL DEPRESSION; POSTPARTUM DEPRESSION; PRIMARY-CARE; DSM-IV; VALIDATION; VALIDITY; SCALE; PREVALENCE; PHQ-9	Background Antenatal depression and anxiety disorders are highly prevalent in low and middle-income countries. Screening of pregnant women in primary care antenatal settings provides an opportunity for entry to care, but data are needed on the performance of different screening tools. We compared five widely-used questionnaires in a sample of pregnant women in urban South Africa. Method Pregnant women attending a primary care antenatal clinic were administered five tools by trained research assistants: the Edinburgh Postnatal Depression Scale (EPDS), the Patient Health Questionnaire (PHQ-9), the Kessler Psychological Distress scale (K10) and a shortened 6-item version (K6), the Whooley questions and the two-item Generalised Anxiety Disorder scale (GAD-2). Following this, a registered mental health counsellor administered the MINI Plus, a structured clinical diagnostic interview. The Area Under the Curve (AUC) from Receiver Operator Characteristic curve analysis was used to summarise screening test performance and Cronbach's a used to assess internal consistency. Results Of 376 participants, 32% were diagnosed with either MDE and/or anxiety disorders. All five questionnaires demonstrated moderate to high performance (AUC = 0.78-0.85). The EPDS was the best performing instrument for detecting MDE and the K10 and K6 for anxiety disorder. For MDE and/or anxiety disorders, the EPDS had the highest AUC (0.83). Of the short instruments, the K10 (AUC = 0.85) and the K6 (AUC = 0.85) performed the best, with the K6 showing good balance between sensitivity (74%) and specificity (85%) and a good positive predictive value (70%). The Whooley questions (AUC = 0.81) were the best performing ultra-short instrument. Internal consistency ranged from good to acceptable (a = 0.89-0.71). However, the PPV of the questionnaires compared with the diagnostic interview, ranged from 54% to 71% at the optimal cut-off scores. Conclusions Universal screening for case identification of antenatal depression and anxiety disorders in low-resource settings can be conducted with a number of commonly used screening instruments. Short and ultra-short screening instruments such as the K6 and the Whooley questions may be feasible and acceptable for use in these settings.	[van Heyningen, Thandi; Honikman, Simone; Field, Sally] Univ Cape Town, Dept Psychiat & Mental Hlth, Alan J Flisher Ctr Publ Mental Hlth, Perinatal Mental Hlth Project, Cape Town, South Africa; [van Heyningen, Thandi; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Tomlinson, Mark] Stellenbosch Univ, Dept Psychol, Stellenbosch, South Africa; [Tomlinson, Mark] Univ Witwatersrand, Ctr Excellence Human Dev, Johannesburg, South Africa	University of Cape Town; University of Cape Town; Stellenbosch University; University of Witwatersrand	van Heyningen, T (corresponding author), Univ Cape Town, Dept Psychiat & Mental Hlth, Alan J Flisher Ctr Publ Mental Hlth, Perinatal Mental Hlth Project, Cape Town, South Africa.; van Heyningen, T (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa.	thandivh@gmail.com	Honikman, Simone/O-1657-2018	van Heyningen, Thandi/0000-0002-5812-6170; Honikman, Simone/0000-0002-7045-5532; Field, Sally/0000-0002-7917-2598	National Research Foundation of South Africa; Harry Crossley Foundation [VHYTHE001/ 1232209]; Medical Research Council of South Africa [415865]; Cordaid Netherlands [103/10002 G Sub 7]; Truworths Community Foundation Trust, South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa); Harry Crossley Foundation; Medical Research Council of South Africa(South African Medical Research Council); Cordaid Netherlands(Netherlands Government); Truworths Community Foundation Trust, South Africa	TvH was supported by the National Research Foundation of South Africa and the Harry Crossley Foundation. VHYTHE001/ 1232209. MT is supported by the National Research Foundation of South Africa. The research project was funded by the Medical Research Council of South Africa (fund no. 415865), Cordaid Netherlands (Project 103/10002 G Sub 7) and the Truworths Community Foundation Trust, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akena D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-187; Austin MP, 2015, IDENTIFYING PERINATAL DEPRESSION AND ANXIETY: EVIDENCE-BASED PRACTICE IN SCREENING, PSYCHOSOCIAL ASSESSMENT, AND MANAGEMENT, P121; Austin MP, 2014, BEST PRACT RES CL OB, V28, P179, DOI 10.1016/j.bpobgyn.2013.08.016; Baggaley RF, 2007, TROP MED INT HEALTH, V12, P1225, DOI 10.1111/j.1365-3156.2007.01906.x; Baron EC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1291-z; Bhana A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0503-0; Biaggi A, 2016, J AFFECT DISORDERS, V191, P62, DOI 10.1016/j.jad.2015.11.014; Chae SY, 2012, FAM MED, V44, P698; Cholera R, 2014, J AFFECT DISORDERS, V167, P160, DOI [10.1016/j.jad.2014.06.003, 10.1016/]; Condon J, 2010, ARCH WOMEN MENT HLTH, V13, P5, DOI 10.1007/s00737-009-0114-1; Cooper P.J., 2004, S AFRICAN J PSYCHOL, V34, P113, DOI [10.1177/008124630403400107, DOI 10.1177/008124630403400107]; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Day C., 2012, S AFRICAN HLTH REV, V369, P207; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Fernandes MC, 2011, ARCH WOMEN MENT HLTH, V14, P209, DOI 10.1007/s00737-010-0190-2; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Gjerdingen D, 2008, WOMEN HEALTH ISS, V18, P44, DOI 10.1016/j.whi.2007.09.001; Gjerdingen D, 2009, ANN FAM MED, V7, P63, DOI 10.1370/afm.933; Honikman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001222; Howard LM, 2016, M NICE GUIDELINE POS; Howard LM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7394; Kabir K, 2008, PEDIATRICS, V122, pE696, DOI 10.1542/peds.2007-1759; Kagee A, 2013, INT HEALTH, V5, P11, DOI 10.1093/inthealth/ihs004; Kaminer D, 2001, BRIT J PSYCHIAT, V178, P373, DOI 10.1192/bjp.178.4.373; Kendrick T, 2012, BRIT J GEN PRACT, V62, P47, DOI 10.3399/bjgp12X616481; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lawrie TA, 1998, S AFR MED J, V88, P1340; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Marce A International Society for Perinatal Mental Health, 2013, PSYCH ASS DEPR SCREE, P1; Marsay C, 2017, SAJP-S AFR J PSYCHI, V23, DOI 10.4102/sajpsychiatry.v23i0.1013; Matthey S, 2013, J AFFECT DISORDERS, V146, P224, DOI 10.1016/j.jad.2012.09.009; Meltzer-Brody S, 2015, BJOG-INT J OBSTET GY, V122, P321, DOI 10.1111/1471-0528.12839; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; NICE, 2007, CG55 INT CAR MAN DEL, P1; Onah MN, 2017, ARCH WOMEN MENT HLTH, V20, P321, DOI 10.1007/s00737-016-0706-5; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Patel VH, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-4; Paulden M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5203; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2013, B WORLD HEALTH ORGAN, V38, P1; Rochat TJ, 2013, ARCH WOMEN MENT HLTH, V16, P401, DOI 10.1007/s00737-013-0353-z; Rochat TJ, 2011, J AFFECT DISORDERS, V135, P362, DOI 10.1016/j.jad.2011.08.011; Sawyer A, 2010, J AFFECT DISORDERS, V123, P17, DOI 10.1016/j.jad.2009.06.027; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sidebottom AC, 2012, ARCH WOMEN MENT HLTH, V15, P367, DOI 10.1007/s00737-012-0295-x; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Spies G, 2009, ARCH WOMEN MENT HLTH, V12, P69, DOI 10.1007/s00737-009-0050-0; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Statistics South Africa, 2015, TECHNICAL REPORT; Tesfaye M, 2010, J AFFECT DISORDERS, V122, P102, DOI 10.1016/j.jad.2009.06.020; Tsai AC, 2014, ARCH WOMEN MENT HLTH, V17, P423, DOI 10.1007/s00737-014-0426-7; Tsai AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082521; van Heyningen T, 2017, ARCH WOMEN MENT HLTH, V20, P765, DOI 10.1007/s00737-017-0768-z; van Heyningen T, 2016, J AFFECT DISORDERS, V203, P121, DOI 10.1016/j.jad.2016.05.052; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x	62	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0193697	10.1371/journal.pone.0193697	http://dx.doi.org/10.1371/journal.pone.0193697			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668725	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200002
J	Jung, YS; Oh, CM; Kim, Y; Jung, KW; Ryu, J; Won, YJ				Jung, Yuh-Seog; Oh, Chang-Mo; Kim, Yeol; Jung, Kyu-Won; Ryu, Junsun; Won, Young-Joo			Long-term survival of patients with thyroid cancer according to the methods of tumor detection: A nationwide cohort study in Korea	PLOS ONE			English	Article							OVERDIAGNOSIS; PREVALENCE; MICROCARCINOMA; STATISTICS; CARCINOMA; DIAGNOSIS; MORTALITY; EPIDEMIC; IMPACT	In this retrospective cohort study, we compared the survival of patients detected by screening with those detected based on symptoms, according to their tumor stages. After propensity score matching, 2,130 patients with papillary or follicular thyroid cancer, identified by screening detection (SD) and clinical detection (CD), were included. We compared the survival rates of patients identified by SD and CD in the early and advanced stages of thyroid cancer. Cox proportional hazard models were used to compare the hazard ratios (HRs) for mortality between the two groups. Of the 1,065 patients in each group, 12 (1.1%) died in the SD group, compared to 44 (4.1%) in the CD group, during an average 9.4 years (p<0.001). For early stage, there was no significant difference in all-cause and thyroid cancer-specific mortality between the two groups (p = 0.08, p = 0.0502). However, for advanced stage, the survival rates in the SD group were significantly higher than in the CD group (p<0.001, p = 0.004). Moreover, after adjusting for covariates, the HRs of all-cause mortality of the SD group was significantly lower than that of the CD group for the advanced stage patients (HRs: 0.37 [95% CIs: 0.17-0.80]), while no significant difference was observed in the early stage. While screening for thyroid cancer was not beneficial for early stage patients, our findings suggest that detection via screening is associated with better survival for patients with advanced stage cancer. However, the effects of selection bias and lead time bias could not be entirely excluded.	[Jung, Yuh-Seog; Ryu, Junsun] Natl Canc Ctr Hosp, Ctr Thyroid Canc, Head & Neck Oncol Clin, Goyang, South Korea; [Jung, Yuh-Seog; Ryu, Junsun] Natl Canc Ctr, Res Inst, Specif Organs Canc Branch, Goyang, South Korea; [Jung, Yuh-Seog; Kim, Yeol; Won, Young-Joo] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea; [Oh, Chang-Mo; Jung, Kyu-Won; Won, Young-Joo] Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea; [Oh, Chang-Mo] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Kim, Yeol] Natl Canc Ctr, Natl Canc Control Inst, Div Canc Management & Policy, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Kyung Hee University; National Cancer Center - Korea (NCC)	Won, YJ (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea.; Won, YJ (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea.	astra67@ncc.re.kr		Won, Young-Joo/0000-0001-9861-6740; Ryu, Junsun/0000-0002-6730-6755	National Cancer Center [NCC-1610170, 610200]	National Cancer Center	This work was supported by grants from the National Cancer Center (grant numbers NCC-1610170 and 1610200 to YJW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; Albertsen PC, 2011, J CLIN ONCOL, V29, P1335, DOI 10.1200/JCO.2010.31.2330; Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P1882, DOI 10.1001/jama.2017.4011; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Cham S, 2014, THYROID, V24, P975, DOI 10.1089/thy.2013.0470; Choi YJ, 2008, YONSEI MED J, V49, P748, DOI 10.3349/ymj.2008.49.5.748; Chow SM, 2003, CANCER-AM CANCER SOC, V98, P31, DOI 10.1002/cncr.11442; Chung WY, 2001, SURG TODAY, V31, P763, DOI 10.1007/s005950170044; CocaPerraillon M., 2007, SAS GLOB FOR ORL FL; Duffy SW, 2008, AM J EPIDEMIOL, V168, P98, DOI 10.1093/aje/kwn120; Egevad, 2007, CANC INCIDENCE 5 CON, P61; Greene F, 2002, AJCC CANC STAGING MA, P77; Hay ID, 2008, SURGERY, V144, P980, DOI 10.1016/j.surg.2008.08.035; Ho AS, 2015, CANCER-AM CANCER SOC, V121, P1793, DOI 10.1002/cncr.29289; ISHIDA T, 1988, JPN J CLIN ONCOL, V18, P289; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Jung KW, 2013, CANCER RES TREAT, V45, P162, DOI 10.4143/crt.2013.45.3.162; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Lee JH, 2014, LANCET, V384, P1848, DOI 10.1016/S0140-6736(14)62242-X; Lehtimaki T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3080; Loeb S, 2016, J CLIN ONCOL, V34, P2684, DOI 10.1200/JCO.2016.68.2138; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Oh CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099054; Park S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5745; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Vaccarella S, 2016, NEW ENGL J MED, V375, P614, DOI 10.1056/NEJMp1604412; Wada N, 2007, J CLIN ENDOCR METAB, V92, P215, DOI 10.1210/jc.2006-1443; Yamada H, 2000, Nihon Jibiinkoka Gakkai Kaiho, V103, P13; Yi KH, 2015, J KOREAN MED ASSOC, V58, P302, DOI 10.5124/jkma.2015.58.4.302	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194743	10.1371/journal.pone.0194743	http://dx.doi.org/10.1371/journal.pone.0194743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659584	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100006
J	Zhang, CH; Feng, RC; Ma, RJ; Shen, ZJ; Cai, ZX; Song, ZZ; Peng, B; Yu, ML				Zhang, Chunhua; Feng, Ruchao; Ma, Ruijuan; Shen, Zhijun; Cai, Zhixiang; Song, Zhizhong; Peng, Bin; Yu, Mingliang			Genome-wide analysis of basic helix-loop-helix superfamily members in peach	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; EVOLUTIONARY ANALYSIS; ARABIDOPSIS-THALIANA; BHLH; IDENTIFICATION; GENES; RICE; EXPRESSION; R2R3-MYB; MYB	The basic helix-loop-helix (bHLH) transcription factor family is a superfamily found in all eukaryotes that plays important roles in regulating growth and development. Over the past several decades, many bHLH superfamily genes have been identified and characterized in herbaceous and woody plants. However, the genes belonging to the bHLH superfamily in peach (Prunus persica) have not yet been comprehensively identified and characterized. Here, we identified 95 members of the bHLH superfamily in the peach genome, and these genes were classified into 19 subfamilies based on a phylogenetic comparison with bHLH proteins from Arabidopsis. The members within each subfamily were highly conserved according to the analysis of motif compositions and exon/intron organizations. The 95 bHLH genes were unevenly distributed on chromosomes 1 to 8 of the peach genome. We identified 57 pairs of bHLH members that were orthologous between peach and Arabidopsis. Additionally, 48 pairs of paralogous bHLH genes were identified on the eight chromosomes of the peach genome. Coupled with relative expression analysis of bHLH genes in red-fleshed peach fruit at five developmental stages, we identified several bHLH genes that might be involved in fruit development and anthocyanin biosynthesis. This study provides insight into the molecular mechanisms through which these genes are involved in the regulation of biological and biochemical processes in peach and lays the foundation for further studies on these genes.	[Zhang, Chunhua; Feng, Ruchao; Ma, Ruijuan; Shen, Zhijun; Cai, Zhixiang; Song, Zhizhong; Peng, Bin; Yu, Mingliang] Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Yu, ML (corresponding author), Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China.	mly1008@aliyun.com	Song, Zhizhong/AAG-8447-2021		National Natural Science Foundation of China [31471848, 31401851]; China Agriculture Research System [CARS-30]; earmarked fund of the China Agriculture Research System [CARS-30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; earmarked fund of the China Agriculture Research System	This work was supported by National Natural Science Foundation of China (No. 31471848), https://isisn.nsfc.gov.cn/egrantweb/, ML Yu received the funding; National Natural Science Foundation of China (No. 31401851), https://isisn.nsfc.gov.cn/egrantweb/, CH Zhang received the funding; and China Agriculture Research System (No. CARS-30), http://123.127.160.231/, ML Yu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the National Natural Science Foundation of China (No. 31471848 and No. 31401851) and the earmarked fund of the China Agriculture Research System (No. CARS-30) for providing financial support.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Buck MJ, 2003, J MOL EVOL, V56, P742, DOI 10.1007/s00239-002-2449-3; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Chen YY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0319-0; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Gao C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181843; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Guo XJ, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1038-y; Hajiebrahimi A, 2017, GENOME, V60, P797, DOI 10.1139/gen-2017-0059; Heang D, 2012, BREEDING SCI, V62, P133, DOI 10.1270/jsbbs.62.133; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hou XJ, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2362-4; Kavas M, 2016, MOL GENET GENOMICS, V291, P129, DOI 10.1007/s00438-015-1095-6; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Liu T, 2015, SCI HORTIC-AMSTERDAM, V184, P142, DOI 10.1016/j.scienta.2015.01.003; Liu T, 2009, DEVELOPMENT, V136, P2265, DOI 10.1242/dev.032938; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00480; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Montefiori M, 2015, J EXP BOT, V66, P1427, DOI 10.1093/jxb/eru494; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Niu X, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4044-4; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Song XM, 2014, MOL GENET GENOMICS, V289, P77, DOI 10.1007/s00438-013-0791-3; Song Y, 2017, J INTEGR AGR, V16, P591, DOI 10.1016/S2095-3119(16)61461-2; Sun H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1209-2; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Trainotti L, 2006, PLANT SCI, V170, P606, DOI 10.1016/j.plantsci.2005.10.015; Verde I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3606-9; Wang RQ, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010054; Xiang LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143892; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Xu HF, 2017, PLANT MOL BIOL, V94, P149, DOI 10.1007/s11103-017-0601-0; Yamaoka S, 2018, CURR BIOL, V28, P479, DOI 10.1016/j.cub.2017.12.053; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331; Zhang CH, 2012, GENET MOL RES, V11, P4789, DOI 10.4238/2012.October.17.6; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zhao H, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2422-9; Zhou H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00908; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Ziliotto F, 2005, ACTA HORTIC, P237, DOI 10.17660/ActaHortic.2005.682.25	48	35	37	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195974	10.1371/journal.pone.0195974	http://dx.doi.org/10.1371/journal.pone.0195974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659634	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100043
J	Thorpe, M; Fu, ZR; Chahal, G; Akula, S; Kervinen, J; de Garavilla, L; Hellman, L				Thorpe, Michael; Fu, Zhirong; Chahal, Gurdeep; Akula, Srinivas; Kervinen, Jukka; de Garavilla, Lawrence; Hellman, Lars			Extended cleavage specificity of human neutrophil cathepsin G: A low activity protease with dual chymase and tryptase-type specificities	PLOS ONE			English	Article							MAST-CELL CHYMASE; SUBSTRATE RECOGNITION PROFILE; LUNG-PROTECTIVE IMMUNITY; ANGIOTENSIN-II; SERINE PROTEASES; STREPTOCOCCUS-PNEUMONIAE; MYCOBACTERIAL INFECTIONS; MAMMALIAN EVOLUTION; INNATE IMMUNITY; HOST-DEFENSE	Human neutrophils express at least four active serine proteases, cathepsin G, N-elastase, proteinase 3 and neutrophil serine protease 4 (NSP4). They have all been extensively studied due to their importance in neutrophil biology and immunity. However, their extended cleavage specificities have never been determined in detail. Here we present a detailed cleavage specificity analysis of human cathepsin G (hCG). The specificity was determined by phage display analysis and the importance of individual amino acids in and around the cleavage site was then validated using novel recombinant substrates. To provide a broader context to this serine protease, a comparison was made to the related mast cell protease, human chymase (HC). hCG showed similar characteristics to HC including both the primary and extended specificities. As expected, Phe, Tyr, Trp and Leu were preferred in the P1 position. In addition, both proteases showed a preference for negatively charged amino acids in the P2 A position of substrates and a preference for aliphatic amino acids both upstream and downstream of the cleavage site. However, overall the catalytic activity of hCG was similar to 10-fold lower than HC. hCG has previously been reported to have a dual specificity consisting of chymase and tryptase-type activities. In our analysis, tryptase activity against substrates with Lys in P1 cleavage position was indeed only 2-fold less efficient as compared to optimal chymase substrates supporting strong dual-type specificity. We hope the information presented here on extended cleavage specificities of hCG and HC will assist in the search for novel in vivo substrates for these proteases as well as aid in the efforts to better understand the role of hCG in immunity and bacterial defence.	[Thorpe, Michael; Fu, Zhirong; Chahal, Gurdeep; Akula, Srinivas; Hellman, Lars] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [Kervinen, Jukka] Fraunhofer USA Ctr Mol Biotechnol, Newark, DE USA; [de Garavilla, Lawrence] GDL Pharmaceut Consulting & Contracting, Downingtown, PA USA	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Akula, Srinivas/GYJ-1463-2022	Hellman, Lars/0000-0003-1459-3815; Chahal, Gurdeep/0000-0001-9601-3057	Swedish Research Council [621-2011-5007]; GDL Pharmaceutical Consulting and Contracting	Swedish Research Council(Swedish Research CouncilEuropean Commission); GDL Pharmaceutical Consulting and Contracting	This study was funded by the Swedish Research Council (621-2011-5007). GDL Pharmaceutical Consulting and Contracting provided support in the form of salary for Lawrence de Garavilla and the provision of reagents. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143091; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Benabid R, 2012, J BIOL CHEM, V287, P34883, DOI 10.1074/jbc.M112.361352; Borregaard N, 2005, J LEUKOCYTE BIOL, V77, P439, DOI 10.1189/jlb.0704381; Caughey GH, 2008, J BIOL CHEM, V283, P13943, DOI 10.1074/jbc.M710502200; Chahal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129511; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; de Haar SF, 2006, INFECT IMMUN, V74, P5284, DOI 10.1128/IAI.02016-05; Eipper S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151509; Fu ZR, 2017, J IMMUNOL, V198, P1474, DOI 10.4049/jimmunol.1601223; Fu ZR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131720; Gale AJ, 2008, THROMB HAEMOSTASIS, V99, P44, DOI 10.1160/TH07-08-0495; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Hahn I, 2011, INFECT IMMUN, V79, P4893, DOI 10.1128/IAI.05593-11; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Itoh H, 1996, BIOCHEM J, V314, P923, DOI 10.1042/bj3140923; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kervinen J, 2008, J BIOL CHEM, V283, P427, DOI 10.1074/jbc.M707157200; KINOSHITA A, 1991, J BIOL CHEM, V266, P19192; Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Lopez-boado YS, 2004, J IMMUNOL, V172, P509, DOI 10.4049/jimmunol.172.1.509; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; O'Donoghue AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075141; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; Ortega-Gomez A, 2016, CIRCULATION, V134, P1176, DOI 10.1161/CIRCULATIONAHA.116.024790; Owen CA, 1998, J IMMUNOL, V160, P1436; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; PEREIRA HA, 1990, LIFE SCI, V46, P189, DOI 10.1016/0024-3205(90)90104-Y; Perera NC, 2012, EXPERT REV CLIN IMMU, V8, P501, DOI 10.1586/ECI.12.39; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Polanowska J, 1998, BBA-PROTEIN STRUCT M, V1386, P189, DOI 10.1016/S0167-4838(98)00085-5; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Raymond WW, 2010, J IMMUNOL, V185, P5360, DOI 10.4049/jimmunol.1002292; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; REILLY CF, 1982, J BIOL CHEM, V257, P8619; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Sanker S, 1997, J BIOL CHEM, V272, P2963, DOI 10.1074/jbc.272.5.2963; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seignez C, 2017, CURR OPIN HEMATOL, V24, P3, DOI 10.1097/MOH.0000000000000300; Srivastava M, 2007, CELL MICROBIOL, V9, P738, DOI 10.1111/j.1462-5822.2006.00824.x; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Steinwede K, 2012, J IMMUNOL, V188, P4476, DOI 10.4049/jimmunol.1103346; TANAKA T, 1985, BIOCHEMISTRY-US, V24, P2040, DOI 10.1021/bi00329a036; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Thorpe M, 2016, DEV COMP IMMUNOL, V63, P84, DOI 10.1016/j.dci.2016.05.013; Thorpe M, 2012, INT IMMUNOL, V24, P771, DOI 10.1093/intimm/dxs081; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Water K, 2015, J IMMUNOL, V195, P3325, DOI 10.4049/jimmunol.1501012; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Yang H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00302	62	22	22	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195077	10.1371/journal.pone.0195077	http://dx.doi.org/10.1371/journal.pone.0195077			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652924	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900017
J	Bangley, CW; Paramore, L; Dedman, S; Rulifson, RA				Bangley, Charles W.; Paramore, Lee; Dedman, Simon; Rulifson, Roger A.			Delineation and mapping of coastal shark habitat within a shallow lagoonal estuary	PLOS ONE			English	Article							NORTHWEST ATLANTIC-OCEAN; JUVENILE SANDBAR SHARKS; LARGE MARINE ECOSYSTEM; MUSTELUS-CANIS; SMOOTH DOGFISH; NURSERY AREAS; SPINY DOGFISH; UNITED-STATES; BULL SHARKS; RHIZOPRIONODON-TERRAENOVAE	Estuaries function as important nursery and foraging habitats for many coastal species, including highly migratory sharks. Pamlico Sound, North Carolina, is one of the largest estuaries in the continental United States and provides a variety of potential habitats for sharks. In order to identify and spatially delineate shark habitats within Pamlico Sound, shark catch and environmental data were analyzed from the 2007-2014 North Carolina Division of Marine Fisheries (NCDMF) gillnet and longline surveys conducted within the estuary. Principal species were identified and environmental data recorded at survey sites (depth, temperature, salinity, dissolved oxygen, submerged aquatic vegetation (SAV) distance, and inlet distance) were interpolated across Pamlico Sound to create seasonal environmental grids with a 90-m(2) cell size. Boosted Regression Tree (BRT) analysis was used to identify the most important environmental factors and ranges associated with presence of each principal species, and the resulting models were used to predict shark capture probability based on the environmental values within the grid cells. The Atlantic Sharpnose Shark (Rhizoprionodon terraenovae), Blacktip Shark (Carcharhinus limbatus), Bull Shark (Carcharhinus leucas), Sandbar Shark (Carcharhinus plumbeus), Smooth Dogfish (Mustelus canis), and Spiny Dogfish (Squalus acanthias) were the principal species in Pamlico Sound. Most species were associated with proximity to the inlet and/or high salinity, and warm temperatures, but the Bull Shark preferred greater inlet distances and the Spiny Dogfish preferred lower temperatures than the other species. Extensive Smooth Dogfish habitat overlap with sea grass beds suggests that seagrass may be a critical part of nursery habitat for this species. Spatial delineation of shark habitat within the estuary will allow for better protection of essential habitat and assessment of potential interactions with other species.	[Bangley, Charles W.; Rulifson, Roger A.] East Carolina Univ, Inst Coastal Sci & Policy, Greenville, NC 27858 USA; [Bangley, Charles W.] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA; [Paramore, Lee] Northern Dist Off, North Carolina Div Marine Fisheries, Elizabeth City, NC USA; [Dedman, Simon] Farallon Inst, Petaluma, CA USA; [Rulifson, Roger A.] East Carolina Univ, Dept Biol, Greenville, NC USA	University of North Carolina; East Carolina University; Smithsonian Institution; Smithsonian Environmental Research Center; University of North Carolina; East Carolina University	Bangley, CW (corresponding author), East Carolina Univ, Inst Coastal Sci & Policy, Greenville, NC 27858 USA.; Bangley, CW (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	bangleyc@si.edu	Dedman, Simon/E-9668-2017; Rulifson, Roger A./U-9659-2019	Dedman, Simon/0000-0002-9108-972X; Rulifson, Roger A./0000-0002-3591-9223; Bangley, Charles/0000-0002-6044-7694				[Anonymous], 2021, LANG ENV STAT COMP; Attrill MJ, 2002, ESTUAR COAST SHELF S, V55, P929, DOI 10.1006/ecss.2002.1036; Baillie CJ, 2015, ESTUAR COAST, V38, P1414, DOI 10.1007/s12237-014-9898-y; BEAMISH RJ, 1992, T AM FISH SOC, V121, P444, DOI 10.1577/1548-8659(1992)121<0444:SDPOCA>2.3.CO;2; Bethea DM, 2015, ENVIRON BIOL FISH, V98, P1233, DOI 10.1007/s10641-014-0355-3; Buchheister A, 2015, J FISH BIOL, V86, P967, DOI 10.1111/jfb.12621; Burkholder DA, 2013, J ANIM ECOL, V82, P1192, DOI 10.1111/1365-2656.12097; Bush A, 2002, J EXP MAR BIOL ECOL, V278, P157, DOI 10.1016/S0022-0981(02)00332-5; Carlson JK, 2008, ESTUAR COAST, V31, P931, DOI 10.1007/s12237-008-9075-2; Castro J. I, 2011, SHARKS N AM; Castro JI, 1996, B MAR SCI, V59, P508; CASTRO JI, 1993, ENVIRON BIOL FISH, V38, P37, DOI 10.1007/BF00842902; Chapman DD, 2015, ANNU REV MAR SCI, V7, P547, DOI 10.1146/annurev-marine-010814-015730; Conrath CL, 2008, ENVIRON BIOL FISH, V82, P123, DOI 10.1007/s10641-007-9263-0; Conrath CL, 2002, FISH B-NOAA, V100, P674; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Dedman S, PLOS ONE IN PRESS; Dedman S, 2015, ECOL MODEL, V312, P77, DOI 10.1016/j.ecolmodel.2015.05.010; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; DUNSON WA, 1991, AM NAT, V138, P1067, DOI 10.1086/285270; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fautin D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011914; FERGUSON RL, 1993, AQUAT BOT, V46, P91, DOI 10.1016/0304-3770(93)90066-6; Fodrie FJ, 2015, OECOLOGIA, V178, P75, DOI 10.1007/s00442-014-3212-3; Fonseca M. S., 2009, US NMFS MAR FISH REV, V71, P20; Froeschke J, 2010, MAR ECOL PROG SER, V407, P279, DOI 10.3354/meps08546; Gelsleichter J, 1999, ENVIRON BIOL FISH, V54, P205, DOI 10.1023/A:1007527111292; Grubbs R. Dean, 2007, V50, P63; Grubbs R. Dean, 2007, V50, P87; Guttridge TL, 2012, MAR ECOL PROG SER, V445, P279, DOI 10.3354/meps09423; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; HAYDEN BP, 1984, ENVIRON CONSERV, V11, P199, DOI 10.1017/S0376892900014211; HAYDEN BP, 1979, J SEDIMENT PETROL, V49, P1061; Heihaus Michael R., 2007, V50, P3; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Heithaus MR, 2001, OIKOS, V92, P542, DOI 10.1034/j.1600-0706.2001.920315.x; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2002, MAR FRESHWATER RES, V53, P543, DOI 10.1071/MF01132; Hovgard H, 2000, FAO FISH TECH PAP; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Jensen C. F., 2002, SHARK NURSERY GROUND, P61; Jensen CF, 2001, EVALUATION BYCATCH N; Kajiura SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150911; Kenworthy W. J., 2012, DEV AQUATIC VEGETATI; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Lacroix GL, 2014, CAN J FISH AQUAT SCI, V71, P343, DOI 10.1139/cjfas-2013-0458; LIPCIUS RN, 1986, ECOLOGY, V67, P1361, DOI 10.2307/1938692; MAIN KL, 1987, ECOLOGY, V68, P170, DOI 10.2307/1938817; Matich P, 2014, J ANIM ECOL, V83, P199, DOI 10.1111/1365-2656.12106; McCandless C, 2007, AM FISHERIES SOC S; MCCANDLESS CT, 2002, SHARK NURSERY GROUND; Merson RR, 2001, ENVIRON BIOL FISH, V61, P13, DOI 10.1023/A:1011017109776; Paterson AW, 2000, ESTUAR COAST SHELF S, V51, P359, DOI 10.1006/ecss.2000.0640; Peterson CD, 2017, MAR ECOL PROG SER, V579, P81, DOI 10.3354/meps12288; ROELOFS E. W., 1953, BULL MARINE SCI GULF AND CARIBBEAN, V3, P181; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; Ross SW, 2003, FISH B-NOAA, V101, P384; Rountree RA, 1996, FISH B-NOAA, V94, P522; Sagarese SR, 2014, CAN J FISH AQUAT SCI, V71, P847, DOI 10.1139/cjfas-2013-0342; Sagarese SR, 2014, CAN J FISH AQUAT SCI, V71, P567, DOI 10.1139/cjfas-2013-0259; Schlaff AM, 2014, REV FISH BIOL FISHER, V24, P1089, DOI 10.1007/s11160-014-9364-8; Schwartz Frank J., 2012, Journal of the North Carolina Academy of Science, V128, P88; Shaw AL, 2016, MAR COAST FISH, V8, P46, DOI 10.1080/19425120.2015.1121940; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stehlik L.L., 2007, NOAA TECHNICAL MEMOR; Ulrich Glenn F., 2007, V50, P125; Vaudo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061907; Ward-Paige CA, 2015, MAR ECOL-EVOL PERSP, V36, P419, DOI 10.1111/maec.12151; Wiley TR, 2007, B MAR SCI, V80, P189	72	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195221	10.1371/journal.pone.0195221	http://dx.doi.org/10.1371/journal.pone.0195221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649261	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900034
J	Esposito, S; Loppi, S; Monaci, F; Paoli, L; Vannini, A; Sorbo, S; Maresca, V; Fusaro, L; Karam, EA; Lentini, M; De Lillo, A; Conte, B; Cianciullo, P; Basile, A				Esposito, Sergio; Loppi, Stefano; Monaci, Fabrizio; Paoli, Luca; Vannini, Andrea; Sorbo, Sergio; Maresca, Viviana; Fusaro, Lina; Karam, Elham Asadi; Lentini, Marco; De Lillo, Alessia; Conte, Barbara; Cianciullo, Piergiorgio; Basile, Adriana			In-field and in-vitro study of the moss Leptodictyum riparium as bioindicator of toxic metal pollution in the aquatic environment: Ultrastructural damage, oxidative stress and HSP70 induction	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SARNO RIVER-BASIN; HEAVY-METALS; ITALIAN TRIANGLE; BRYOPHYTA; LEAVES; DEATH; ACCUMULATION; RESPONSES; PLANTS	This study evaluates the effects of toxic metal pollution in the highly contaminated Sarno River (South Italy), by using the aquatic moss Leptodictyum riparium in bags at 3 representative sites of the river. Biological effects were assessed by metal bioaccumulation, ultra structural changes, oxidative stress, as Reactive Oxygen Species (ROS) production and Glutathione S-transferase (GST) activity, as well as Heat Shock Proteins 70 (HSP70s) induction. The results showed that L. riparium is a valuable bioindicator for toxic metal pollution of water ecosystem, accumulating different amounts of toxic metals from the aquatic environment. Toxic metal pollution caused severe ultrastructural damage, as well as increased ROS production and induction of GST and HSP70s, in the samples exposed at the polluted sites. To assess the role and the effect of toxic metals on L. riparium, were also cultured in vitro with Cd, Cr, Cu, Fe, Ni, Pb, Zn at the same concentrations as measured at the 3 sites. Ultrastructure, ROS, GST, and HSP70s resulted severely affected by toxic metals. Based on our findings, we confirm L. riparium as a model organism in freshwater biomonitoring surveys, and GST and HSP70s as promising biomarkers of metal toxicity.	[Esposito, Sergio; Maresca, Viviana; Lentini, Marco; De Lillo, Alessia; Conte, Barbara; Basile, Adriana] Univ Naples Federico II, Dipartimento Biol, Complesso Univ Monte St Angelo, Naples, Italy; [Loppi, Stefano; Monaci, Fabrizio; Paoli, Luca; Vannini, Andrea; Cianciullo, Piergiorgio] Univ Siena, Dipartimento Sci Vita, Siena, Italy; [Sorbo, Sergio] Univ Naples Federico II, CeSMA, Sect Microscopy, Complesso Univ Monte St Angelo, Naples, Italy; [Fusaro, Lina] Univ Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Karam, Elham Asadi] Shahid Bahonar Univ Kerman, Dept Biol, Kerman, Iran	University of Naples Federico II; University of Siena; University of Naples Federico II; Sapienza University Rome; Shahid Bahonar University of Kerman (SBUK)	Basile, A (corresponding author), Univ Naples Federico II, Dipartimento Biol, Complesso Univ Monte St Angelo, Naples, Italy.; Sorbo, S (corresponding author), Univ Naples Federico II, CeSMA, Sect Microscopy, Complesso Univ Monte St Angelo, Naples, Italy.	sersorbo@unina.it; adbasile@unina.it	BASILE, Adriana/ABC-8500-2021; Vannini, Andrea/AAE-1916-2021; Maresca, Viviana/AEP-6443-2022; Esposito, Sergio/I-4862-2014; Maresca, Viviana/AAW-9990-2021; Cianciullo, Piergiorgio/AAY-8040-2021; Monaci, Fabrizio/B-6611-2012; Conte, Barbara/H-8456-2019; FUSARO, LINA/Q-4369-2017	BASILE, Adriana/0000-0002-2001-8959; Vannini, Andrea/0000-0003-3789-6691; Maresca, Viviana/0000-0002-4656-320X; Esposito, Sergio/0000-0002-0899-1967; Monaci, Fabrizio/0000-0001-5489-1310; Conte, Barbara/0000-0003-0851-9985; Cianciullo, Piergiorgio/0000-0003-0292-8892; FUSARO, LINA/0000-0003-3316-707X				Albanese S, 2013, ENVIRON GEOCHEM HLTH, V35, P283, DOI 10.1007/s10653-012-9483-x; Arienzo M, 2001, WATER AIR SOIL POLL, V131, P349, DOI 10.1023/A:1011908019933; Basile A, 2015, ECOTOX ENVIRON SAFE, V114, P93, DOI 10.1016/j.ecoenv.2015.01.009; Basile A, 2012, ENVIRON POLLUT, V166, P208, DOI 10.1016/j.envpol.2012.03.018; Basile A, 2011, PLANT BIOSYST, V145, P77, DOI 10.1080/11263504.2010.509935; Basile A, 2001, ANN BOT-LONDON, V87, P537, DOI 10.1006/anbo.2001.1368; Basile A, 2008, FRESEN ENVIRON BULL, V17, P1956; Basile A, 2017, ENVIRON SCI POLLUT R, V24, P26185, DOI 10.1007/s11356-017-9304-y; Basile A, 2017, J TRACE ELEM MED BIO, V43, P80, DOI 10.1016/j.jtemb.2016.11.014; Basile A, 2013, ENVIRON POLLUT, V182, P209, DOI 10.1016/j.envpol.2013.07.014; Bassham DC, 2009, BBA-MOL CELL RES, V1793, P1397, DOI 10.1016/j.bbamcr.2009.01.001; Brehelin C, 2007, TRENDS PLANT SCI, V12, P260, DOI 10.1016/j.tplants.2007.04.003; Cardi M, 2013, PLANT PHYSIOL BIOCH, V73, P266, DOI 10.1016/j.plaphy.2013.10.008; Carginale V, 2004, PROTOPLASMA, V223, P53, DOI 10.1007/s00709-003-0028-0; Cesa M, 2015, ENVIRON SCI POLLUT R, V22, P5030, DOI 10.1007/s11356-015-4129-z; Ceschin S, 2012, ECOL INDIC, V14, P74, DOI 10.1016/j.ecolind.2011.08.020; Dalla Vecchia F, 2005, PLANT SCI, V168, P329, DOI 10.1016/j.plantsci.2004.07.025; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Dazy M, 2009, CHEMOSPHERE, V75, P297, DOI 10.1016/j.chemosphere.2008.12.045; Esposit S, 2007, CARYOLOGIA, V60, P115, DOI 10.1080/00087114.2007.10589557; Esposito S, 2012, INT J PHYTOREMEDIAT, V14, P443, DOI 10.1080/15226514.2011.620904; Fujita M, 2003, PHYSIOL PLANTARUM, V117, P85, DOI 10.1034/j.1399-3054.2003.1170111.x; Gecheva G, 2011, B ENVIRON CONTAM TOX, V87, P480, DOI 10.1007/s00128-011-0377-x; Ghosh S, 2001, PLANT PHYSIOL BIOCH, V39, P777, DOI 10.1016/S0981-9428(01)01296-7; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goletta del fiume Sarno, 2014, AN NUM RIFL SULL BAC; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Habig W H, 1981, Methods Enzymol, V77, P398; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hossain MZ, 2006, BIOL PLANTARUM, V50, P210, DOI 10.1007/s10535-006-0009-1; Hu YL, 2009, PLANT GROWTH REGUL, V59, P51, DOI 10.1007/s10725-009-9387-7; Inupakutika MA, 2016, J EXP BOT, V67, P5933, DOI 10.1093/jxb/erw382; KELLY MG, 1987, WATER RES, V21, P1429, DOI 10.1016/0043-1354(87)90019-4; LEBEL CP, 1990, TOXICOL APPL PHARM, V104, P17, DOI 10.1016/0041-008X(90)90278-3; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Mullineaux PM, 2010, PLANT PHYSIOL, V154, P521, DOI 10.1104/pp.110.161406; Nath M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01574; Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x; Sassmann S, 2015, ENVIRON EXP BOT, V110, P1, DOI 10.1016/j.envexpbot.2014.08.010; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Senior K, 2004, LANCET ONCOL, V5, P525, DOI 10.1016/S1470-2045(04)01561-X; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; Todeschini V, 2011, ENVIRON EXP BOT, V71, P50, DOI 10.1016/j.envexpbot.2010.10.018; Trocchia S., 2015, INT J SCI ENG RES, V6, P449; Uchimiya M, 2010, CHEMOSPHERE, V80, P935, DOI 10.1016/j.chemosphere.2010.05.020; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Whitton B., 1981, HEAVY METALS NO ENGL; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhou QF, 2008, ANAL CHIM ACTA, V606, P135, DOI 10.1016/j.aca.2007.11.018	49	19	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195717	10.1371/journal.pone.0195717	http://dx.doi.org/10.1371/journal.pone.0195717			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649272	gold, Green Published			2022-12-27	WOS:000429791900074
J	Hailegiorgis, MT; Berheto, TM; Sibamo, EL; Asseffa, NA; Tesfa, G; Birhanu, F				Hailegiorgis, Muluken Tigistu; Berheto, Tezera Moshago; Sibamo, Ephrem Lejore; Asseffa, Netsanet Abera; Tesfa, Gashaw; Birhanu, Fitsum			Psychological wellbeing of children at public primary schools in Jimma town: An orphan and non-orphan comparative study	PLOS ONE			English	Article							DISTRESS	Introduction Orphans face multiple challenges including insufficient food, shelter, schooling, and medical care. Most research on orphans in developing countries concentrates on nutrition and health status. The present study aims to explore the psychological wellbeing of in-school orphaned and non-orphaned children. Method A comparative cross-sectional study design was used in 370 randomly selected children aged between 10 and 18. Two rosters (one for orphans and one for non-orphans) were created, and then 185 were selected from each roster. Trained field workers used structured questionnaires to obtain information from participants. An adapted Ryff Psychological Wellbeing Scale was used to measure psychological wellbeing. Mean scores were determined for each dimension and for total psychological wellbeing. The mean split was used to divide psychological wellbeing into "high" and "low". Data were coded, entered, cleaned, and analyzed using SPSS version 20. The independent sample t-test was used to determine statistically significant differences in psychological wellbeing between orphaned and non orphaned children. P values < 0.05 were deemed statistically significant. Results Of 370 children, 185 (50%) were orphans. Among orphaned children, only 62 (33.5%) scored high on the total psychological wellbeing scale whereas 107 (57.8%) of their non orphaned peers scored highly. The non-orphaned children had about 10.8 higher mean psychological wellbeing scores than their orphan counterparts (P<0.001). The mean (SD) psychological wellbeing of the non-orphaned children was 164.0 (17.2) vs. 153.2 (17.2) in the orphaned group. Conclusion The psychological wellbeing of orphans is significantly lower than their non-orphaned peers. Orphan support projects must consider psychosocial wellbeing in addition to material support.	[Hailegiorgis, Muluken Tigistu] Jimma Univ, Dept Psychol, Coll Social Sci, Jimma, Ethiopia; [Berheto, Tezera Moshago; Sibamo, Ephrem Lejore; Asseffa, Netsanet Abera] Wolaita Sodo Univ, Sch Publ Hlth, Coll Hlth Sci & Med, Sodo, Ethiopia; [Tesfa, Gashaw; Birhanu, Fitsum] Jimma Univ, Dept Psychol, Coll Social Sci, Jimma, Ethiopia	Jimma University; Jimma University	Asseffa, NA (corresponding author), Wolaita Sodo Univ, Sch Publ Hlth, Coll Hlth Sci & Med, Sodo, Ethiopia.	aberanet@gmail.com	Asseffa, Netsanet Abera/AFM-7982-2022	Asseffa, Netsanet Abera/0000-0001-8848-2822; Lejore, Ephrem/0000-0003-0090-4184				Amongin HC, 2012, UGANDA, V2, P87; [Anonymous], 2005, PSYCHOL HEALTH MED, V5, P263; Atwine B, 2005, SOC SCI MED, V61, P555, DOI 10.1016/j.socscimed.2004.12.018; Center for Social and Economic Research, 2012, EC BEN REM CAS STUD, P1; Cluver LD, 2008, J ADOLESC HLTH, V42; Delva W, 2005, SAMJ S AFR MED J, V95, P656; Department JTF and E, 2014, ANN REP PLAN EC DEP; Erango MA, 2015, RISK MANAG HEALTHC P, V8, P169, DOI 10.2147/RMHP.S89473; Getachew H, 2011, ETHIOP J HEALTH DEV, V25, P135; Gilborn L, 2006, POPUL COUNC REP; He ZH, 2007, TROP MED INT HEALTH, V12, P1180, DOI 10.1111/j.1365-3156.2007.01900.x; Hong Y, 2010, COMMUNITY MENT HLT J, V46, P33, DOI 10.1007/s10597-009-9201-z; Makame V, 2002, ACTA PAEDIATR, V91, P459, DOI 10.1080/080352502317371724; Nyamukapa CA, 2008, AM J PUBLIC HEALTH, V98, P133, DOI 10.2105/AJPH.2007.116038; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Sebsibe Tadesse, 2014, ACAD J, V6; Sengendo J, 1997, Health Transit Rev, V7 Suppl, P105; Shekmnesh Asfawesen, 2013, GREENER J MED SCI, V3; Tsegaye A., 2013, COMP STUDY PSYCHOL W; Unisa S., 2017, J HLTH SOCIAL SCI, V2, P195, DOI [10.19204/2017/qltt6, DOI 10.19204/2017/QLTT6]; USAID, 2014, ORPH VULN CHILDR AFF; Zhao JF, 2010, AIDS BEHAV, V14, P1302, DOI 10.1007/s10461-009-9629-8; Zhao Q, 2010, J ASSOC NURSE AIDS C, V21, P335, DOI 10.1016/j.jana.2009.12.001	23	6	6	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195377	10.1371/journal.pone.0195377	http://dx.doi.org/10.1371/journal.pone.0195377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649248	gold, Green Submitted, Green Published			2022-12-27	WOS:000429791900042
J	Slingerland, BCGC; Keehnen, M; Ouwerling, B; Tavakol, M; Snijders, SV; Verbrugh, HA; Vos, MC; Remarque, EJ; Langermans, JAM; van Wamel, WJB				Slingerland, Bibi C. G. C.; Keehnen, Merei; Ouwerling, Boudewijn; Tavakol, Mehri; Snijders, Susan V.; Verbrugh, Henri A.; Vos, Margreet C.; Remarque, Edmond J.; Langermans, Jan A. M.; van Wamel, Willem J. B.			An experimental Staphylococcus aureus carriage and decolonization model in rhesus macaques (Macaca mulatto)	PLOS ONE			English	Article							PERSISTENT NASAL CARRIERS; COLONIZATION; LYSOSTAPHIN; INFECTIONS; STRAINS; RISK	Our human model of nasal colonization and eradication of S. aureus is limited by safety issues. As rhesus macaques are closely related to humans and natural hosts for S. aureus, we developed an experimental decolonization and inoculation protocol in these animals. Animals were screened for nasal carriage of S. aureus and 20 carriers were selected. Decolonization was attempted using nasal mupirocin (10 animals) or mupirocin plus trimethoprim/sulfadiazine intramuscularly (10 animals) both once daily for 5 days, and checked by followup cultures for 10 weeks. Intranasal inoculation was performed with S. aureus strain 8325-4 in culture-negative animals. 11/20 animals, of which 5 received mupirocin and 6 the combination treatment, became culture-negative for S. aureus for 10 weeks and these 11 animals were subsequently inoculated. Swabs were taken once a week for 5 weeks to test for the presence of the inoculated strain. In 3 animals, strain 8325-4 was cultured from the nose 1 week after inoculation, indicating short-term survival of this strain only, a finding similar to that previously found in our human model. These data demonstrate that rhesus macaques may constitute a relevant animal model to perform S. aureus eradication and inoculation studies with relatively limited invasive handling of the animals.	[Slingerland, Bibi C. G. C.; Tavakol, Mehri; Snijders, Susan V.; Verbrugh, Henri A.; Vos, Margreet C.; van Wamel, Willem J. B.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Keehnen, Merei; Ouwerling, Boudewijn; Langermans, Jan A. M.] Biomed Primate Res Ctr, Dept Anim Sci, Rijswijk, Netherlands; [Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands	Erasmus University Rotterdam; Erasmus MC	Slingerland, BCGC (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	b.slingerland@erasmusmc.nl	Remarque, Ed/AAE-8643-2020	van Wamel, Willem/0000-0001-9145-9121; Langermans, Jan/0000-0002-4806-4412				Ammerlaan HSM, 2011, J ANTIMICROB CHEMOTH, V66, P2418, DOI 10.1093/jac/dkr250; Baur S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004089; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Burian M, 2010, J INFECT DIS, V201, P1414, DOI 10.1086/651619; Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09; Desbois AP, 2013, J ANTIMICROB CHEMOTH, V68, P2569, DOI 10.1093/jac/dkt243; FERNANDEZ C, 1995, J ANTIMICROB CHEMOTH, V35, P399, DOI 10.1093/jac/35.3.399; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kokai-Kun JF, 2003, ANTIMICROB AGENTS CH, V47, P1589, DOI 10.1128/AAC.47.5.1589-1597.2003; Mollema FPN, 2010, J CLIN MICROBIOL, V48, P202, DOI 10.1128/JCM.01499-09; Moodley A, 2011, EPIDEMIOL INFECT, V139, P1594, DOI 10.1017/S0950268810002888; Nouwen J, 2004, INFECT IMMUN, V72, P6685, DOI 10.1128/IAI.72.11.6685-6688.2004; Nouwen J, 2006, J CLIN MICROBIOL, V44, P2233, DOI 10.1128/JCM.02083-05; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; NOVICK RP, 1965, J BACTERIOL, V90, P467, DOI 10.1128/JB.90.2.467-480.1965; Park B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025880; Ritchie SR, 2016, J INFECTION, V72, P295, DOI 10.1016/j.jinf.2015.12.010; Slingerland BCGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048896; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van den Berg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026170; Verhoeven PO, 2012, CLIN MICROBIOL INFEC, V18, P551, DOI 10.1111/j.1469-0691.2011.03611.x; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P343, DOI 10.1111/j.1469-0691.2010.03227.x; Verstappen KM, 2014, VET MICROBIOL, V174, P483, DOI 10.1016/j.vetmic.2014.09.019; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Winstel V, 2015, MBIO, V6, DOI 10.1128/mBio.00632-15; Xu SX, 2015, TOXINS, V7, P1821, DOI 10.3390/toxins7051821	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194718	10.1371/journal.pone.0194718	http://dx.doi.org/10.1371/journal.pone.0194718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649257	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900013
J	Wang, ZY; Wu, YX; Bu, SH; Hang, PC; Zhang, GY				Wang, ZeYu; Wu, YanXia; Bu, ShuHui; Hang, PengCheng; Zhang, GuoYin			Structural inference embedded adversarial networks for scene parsing	PLOS ONE			English	Article							FEATURES	Explicit structural inference is one key point to improve the accuracy of scene parsing. Meanwhile, adversarial training method is able to reinforce spatial contiguity in output segmentations. To take both advantages of the structural learning and adversarial training simultaneously, we propose a novel deep learning network architecture called Structural Inference Embedded Adversarial Networks (SIEANs) for pixel-wise scene labeling. The generator of our SIEANs, a novel designed scene parsing network, makes full use of convolutional neural networks and long short-term memory networks to learn the global contextual information of objects in four different directions from RGB-(D) images, which is able to describe the (three-dimensional) spatial distributions of objects in a more comprehensive and accurate way. To further improve the performance, we explore the adversarial training method to optimize the generator along with a discriminator, which can not only detect and correct higher-order inconsistencies between the predicted segmentations and corresponding ground truths, but also exploit full advantages of the generator by fine-tuning its parameters so as to obtain higher consistencies. The experimental results demonstrate that our proposed SIEANs is able to achieve a better performance on PASCAL VOC 2012, SIFT FLOW, PASCAL Person-Part, Cityscapes, Stanford Background, NYUDv2, and SUNRGBD datasets compared to the most of state-of-the-art methods.	[Wang, ZeYu; Wu, YanXia; Zhang, GuoYin] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Bu, ShuHui; Hang, PengCheng] Northwestern Polytech Univ, Sch Aeronaut, Xian, Shaanxi, Peoples R China; [Bu, ShuHui] Shaanxi Key Lab Integrated & Intelligent Nav, Xian, Shaanxi, Peoples R China	Harbin Engineering University; Northwestern Polytechnical University	Wu, YX (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	wuyanxia@hrbeu.edu.cn	Wu, yanxia/HGA-0318-2022		National Key Research and Development Program [2016YFB1000400]; Central University Free Exploration Fund [HEUCF170605]; Harbin Outstanding Young Talents Fund [2017RAYXJ016]; National Natural Science Foundation of China [60903098, 61573284]	National Key Research and Development Program; Central University Free Exploration Fund; Harbin Outstanding Young Talents Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program, http://program.most.gov.cn/, Award Number: 2016YFB1000400, Recipient: YanXia Wu; the Central University Free Exploration Fund, http://www.hrbeu.edu.cn/, Award Number: HEUCF170605, Recipient: YanXia Wu; the Harbin Outstanding Young Talents Fund, http://www.hljkjt.gov.cn/, Award Number: 2017RAYXJ016, Recipient: YanXia Wu; the National Natural Science Foundation of China, http://www.nsfc.gov.cn/, Award Number: 60903098, Recipient: ShuHui Bu; and the National Natural Science Foundation of China, http://www.nsfc.gov.cn/, Award Number: 61573284, Recipient: ShuHui Bu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bojarski Mariusz, 2016, arXiv; Bu SH, 2016, PATTERN RECOGN, V59, P188, DOI 10.1016/j.patcog.2016.01.027; Chen L.C., 2014, ARXIV; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Chen LC, 2016, PROC CVPR IEEE, P3640, DOI 10.1109/CVPR.2016.396; Chen XJ, 2014, PROC CVPR IEEE, P1979, DOI 10.1109/CVPR.2014.254; Chen X, 2015, PROC CVPR IEEE, P2422, DOI 10.1109/CVPR.2015.7298856; Cordts M, 2016, PROC CVPR IEEE, P3213, DOI 10.1109/CVPR.2016.350; Dai JF, 2015, IEEE I CONF COMP VIS, P1635, DOI 10.1109/ICCV.2015.191; Everingham M, 2015, INT J COMPUT VISION, V111, P98, DOI 10.1007/s11263-014-0733-5; Fan H, 2016, ARXIV160702537; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Ghiasi G, 2016, LECT NOTES COMPUT SC, V9907, P519, DOI 10.1007/978-3-319-46487-9_32; Goodfellow I, 2020, COMMUN ACM, V63, P139, DOI 10.1145/3422622; Gould S, 2009, IEEE I CONF COMP VIS, P1, DOI 10.1109/ICCV.2009.5459211; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Guclu U, 2017, ARXIV170303305; Gupta S, 2015, INT J COMPUT VISION, V112, P133, DOI 10.1007/s11263-014-0777-6; Hariharan B, 2011, IEEE I CONF COMP VIS, P991, DOI 10.1109/ICCV.2011.6126343; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang Q, 2016, ARXIV161107485; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Jin X, 2016, ARXIV160807706; Kendall A., 2015, ARXIV151102680; Khan SH, 2016, INT J COMPUT VISION, V117, P1, DOI 10.1007/s11263-015-0843-8; Krizhevsky A., P 25 INT C NEUR INF, P1097; Ledig C, 2017, PROC CVPR IEEE, P105, DOI 10.1109/CVPR.2017.19; Li C, 2016, LECT NOTES COMPUT SC, V9907, P702, DOI 10.1007/978-3-319-46487-9_43; Li Z, 2016, LECT NOTES COMPUT SC, V9906, P541, DOI 10.1007/978-3-319-46475-6_34; Liang M, 2015, ADV NEURAL INFORM PR, P937; Liang XD, 2016, PROC CVPR IEEE, P3185, DOI 10.1109/CVPR.2016.347; Liang XD, 2016, LECT NOTES COMPUT SC, V9905, P125, DOI 10.1007/978-3-319-46448-0_8; LIN GS, 2016, PROC CVPR IEEE, P3194, DOI DOI 10.1109/CVPR.2016.348; Lin GS, 2017, PROC CVPR IEEE, P5168, DOI 10.1109/CVPR.2017.549; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Liu C, 2011, IEEE T PATTERN ANAL, V33, P978, DOI 10.1109/TPAMI.2010.147; Liu ZW, 2015, IEEE I CONF COMP VIS, P1377, DOI 10.1109/ICCV.2015.162; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Luc P., 2016, NIPS WORKSHOP ADVERS; Mostajahi M, 2015, PROC CVPR IEEE, P3376, DOI 10.1109/CVPR.2015.7298959; Pan J., 2017, ARXIV170101081; Pathak D, 2016, PROC CVPR IEEE, P2536, DOI 10.1109/CVPR.2016.278; Peng Z, 2016, ARXIV160401931; Pinheiro P H, 2013, ARXIV13062795, P2; Qin XL, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON PROGNOSTICS AND HEALTH MANAGEMENT (ICPHM), P1, DOI 10.1109/ICPHM.2017.7998297; Radford A., 2015, COMPUT SCI, DOI DOI 10.1051/0004-6361/201527329; Ren XF, 2012, PROC CVPR IEEE, P2759, DOI 10.1109/CVPR.2012.6247999; Schwing A. G., 2015, ARXIV PREPRINT ARXIV; Sharma S., 2015, ACTION RECOGNITION U; Shuai B, 2016, PROC CVPR IEEE, P3620, DOI 10.1109/CVPR.2016.394; Silberman N, 2012, LECT NOTES COMPUT SC, V7576, P746, DOI 10.1007/978-3-642-33715-4_54; Song SR, 2015, PROC CVPR IEEE, P567, DOI 10.1109/CVPR.2015.7298655; Szegedy C., 2015, P IEEE C COMPUTER VI, P1; Visin F., 2015, ARXIV150500393; Wang AR, 2015, IEEE T IMAGE PROCESS, V24, P4459, DOI 10.1109/TIP.2015.2465133; Wu C, 2014, ROBOTICS SCI SYSTEMS; Xia F., 2016, ECCV, P648; Yan ZC, 2016, ACM T GRAPHIC, V35, DOI 10.1145/2790296; Yu F., 2015, MULTISCALE CONTEXT A, DOI DOI 10.16373/J.CNKI.AHR.150049.1511.07122; Zhang R, 2017, ARXIV170205839; Zheng S, 2015, IEEE I CONF COMP VIS, P1529, DOI 10.1109/ICCV.2015.179	62	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195114	10.1371/journal.pone.0195114	http://dx.doi.org/10.1371/journal.pone.0195114			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649294	gold, Green Submitted, Green Published			2022-12-27	WOS:000429791900025
J	Liefer, JD; Garg, A; Campbell, DA; Irwin, AJ; Finkel, ZV				Liefer, Justin D.; Garg, Aneri; Campbell, Douglas A.; Irwin, Andrew J.; Finkel, Zoe V.			Nitrogen starvation induces distinct photosynthetic responses and recovery dynamics in diatoms and prasinophytes	PLOS ONE			English	Article							PHOTOSYSTEM-II; CHLOROPHYLL-A; CELL-SIZE; CARBON ASSIMILATION; ENERGY-DISSIPATION; LUTEIN-EPOXIDE; SHADE LEAVES; PHYTOPLANKTON; GROWTH; PHOTOPROTECTION	Nitrogen stress is an important control on the growth of phytoplankton and varying responses to this common condition among taxa may affect their relative success within phytoplankton communities. We analyzed photosynthetic responses to nitrogen (N) stress in two classes of phytoplankton that often dominate their respective size ranges, diatoms and prasinophytes, selecting species of distinct niches within each class. Changes in photosynthetic structures appeared similar within each class during N stress, but photophysiological and growth responses were more species-or niche-specific. In the coastal diatom Thalassiosira pseudonana and the oceanic diatom T. weissflogii, N starvation induced large declines in photosynthetic pigments and Photosystem II (PSII) quantity and activity as well as increases in the effective absorption cross-section of PSII photochemistry (sigma'(PSII)). These diatoms also increased photoprotection through energy-dependent non-photochemical quenching (NPQ) during N starvation. Resupply of N in diatoms caused rapid recovery of growth and relaxation of NPQ, while recovery of PSII photochemistry was slower. In contrast, the prasinophytes Micromonas sp., an Arctic Ocean species, and Ostreococcus tauri, a temperate coastal eutrophile, showed little change in photosynthetic pigments and structures and a decline or no change, respectively, in sigma'(PSII) with N starvation. Growth and PSII function recovered quickly in Micromonas sp. after resupply of N while O. tauri failed to recover N-replete levels of electron transfer from PSII and growth, possibly due to their distinct photoprotective strategies. O. tauri induced energy-dependent NPQ for photoprotection that may suit its variable and nutrient-rich habitat. Micromonas sp. relies upon both energy-dependent NPQ and a sustained, energy-independent NPQ mechanism. A strategy in Micromonas sp. that permits photoprotection with little change in photosynthetic structures is consistent with its Arctic niche, where low temperatures and thus low biosynthetic rates create higher opportunity costs to rebuild photosynthetic structures.	[Liefer, Justin D.; Garg, Aneri; Finkel, Zoe V.] Mt Allison Univ, Dept Geog & Environm, Sackville, NB, Canada; [Campbell, Douglas A.] Mt Allison Univ, Dept Biol, Sackville, NB, Canada; [Irwin, Andrew J.] Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB, Canada	Mount Allison University; Mount Allison University; Mount Allison University	Liefer, JD (corresponding author), Mt Allison Univ, Dept Geog & Environm, Sackville, NB, Canada.	jliefer@mta.ca	Campbell, Douglas A./B-3768-2010; Finkel, Zoe/B-9626-2008	Campbell, Douglas A./0000-0001-8996-5463; Irwin, Andrew/0000-0001-7784-2319; Finkel, Zoe/0000-0003-4212-3917; Liefer, Justin/0000-0001-5161-940X	Macromolecular Models of Marine Microbes grant from the Gordon and Betty Moore Foundation [3378]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs program	Macromolecular Models of Marine Microbes grant from the Gordon and Betty Moore Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by the Macromolecular Models of Marine Microbes grant from the Gordon and Betty Moore Foundation, ID#3378, as well as Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chairs program (D.A.C and Z.V.F).	ADAMS WW, 1995, PLANT CELL ENVIRON, V18, P117, DOI 10.1111/j.1365-3040.1995.tb00345.x; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BANSE K, 1976, J PHYCOL, V12, P135; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; Berman-Frank I, 1999, BIOSCIENCE, V49, P29, DOI 10.2307/1313491; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; BUMA AGJ, 1993, J PHYCOL, V29, P407, DOI 10.1111/j.1529-8817.1993.tb00141.x; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Cullen JJ, PRIMARY PRODUCTIVITY; Demmig-Adams B, 2012, PHOTOSYNTH RES, V113, P75, DOI 10.1007/s11120-012-9761-6; Dolhi JM, 2013, EXTREMOPHILES, V17, P711, DOI 10.1007/s00792-013-0571-3; EPPLEY RW, 1969, J PHYCOL, V5, P375, DOI 10.1111/j.1529-8817.1969.tb02628.x; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Finkel ZV, 2001, LIMNOL OCEANOGR, V46, P86, DOI 10.4319/lo.2001.46.1.0086; Forster B, 2011, PLANT PHYSIOL, V156, P393, DOI 10.1104/pp.111.173369; FOYER CH, 1994, PLANT PHYSIOL, V104, P171, DOI 10.1104/pp.104.1.171; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; GEIDER RJ, 1993, J PHYCOL, V29, P755, DOI 10.1111/j.0022-3646.1993.00755.x; Goldman J. C, 1988, THEORY BIOL PHYSICAL, P273, DOI [10.1007/978-94-009-3023-0_15, DOI 10.1007/978-94-009-3023-0_15]; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; GROVER JP, 1989, J PHYCOL, V25, P402, DOI 10.1111/j.1529-8817.1989.tb00138.x; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Halsey KH, 2014, METABOLITES, V4, P260, DOI 10.3390/metabo4020260; Halsey KH, 2013, NEW PHYTOL, V198, P1030, DOI 10.1111/nph.12209; HEIN M, 1995, MAR ECOL PROG SER, V118, P247, DOI 10.3354/meps118247; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Huot Y, 2010, DEVEL APPL PHYCOL, V4, P31, DOI 10.1007/978-90-481-9268-7_3; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Kamalanathan M, 2016, J APPL PHYCOL, V28, P1509, DOI 10.1007/s10811-015-0726-y; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Latasa M, 2004, J PHYCOL, V40, P1149, DOI 10.1111/j.1529-8817.2004.03136.x; Lauritano C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12092-1; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; LEGENDRE L, 1995, OPHELIA, V41, P153, DOI 10.1080/00785236.1995.10422042; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Loebl M, 2010, LIMNOL OCEANOGR, V55, P2150, DOI 10.4319/lo.2010.55.5.2150; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Matsubara S, 2005, J EXP BOT, V56, P461, DOI 10.1093/jxb/eri012; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murphy CD, 2017, LIMNOL OCEANOGR-METH, V15, P54, DOI 10.1002/lom3.10142; Ni G, 2017, PHOTOSYNTH RES, V131, P203, DOI 10.1007/s11120-016-0310-6; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; OTTANDER C, 1995, PLANTA, V197, P176, DOI 10.1007/BF00239954; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pedersen MF, 1997, MAR ECOL PROG SER, V161, P155, DOI 10.3354/meps161155; Premvardhan L, 2010, BBA-BIOENERGETICS, V1797, P1647, DOI 10.1016/j.bbabio.2010.05.002; Richter M, 1999, BIOCHEMISTRY-US, V38, P12718, DOI 10.1021/bi983009a; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; SHOAF WT, 1976, LIMNOL OCEANOGR, V21, P926, DOI 10.4319/lo.1976.21.6.0926; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; Six C, 2008, LIMNOL OCEANOGR, V53, P255, DOI 10.4319/lo.2008.53.1.0255; Six C, 2009, PLANT PHYSIOL, V151, P379, DOI 10.1104/pp.109.140566; Strzepek RF, 2000, MAR ECOL PROG SER, V206, P107, DOI 10.3354/meps206107; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Swingley WD, 2010, BBA-BIOENERGETICS, V1797, P1458, DOI 10.1016/j.bbabio.2010.04.017; Szyszka B, 2007, BBA-BIOENERGETICS, V1767, P789, DOI 10.1016/j.bbabio.2006.12.001; Thompson P, 1999, J PHYCOL, V35, P1215, DOI 10.1046/j.1529-8817.1999.3561215.x; Tirichine L, 2011, PLANT J, V66, P45, DOI 10.1111/j.1365-313X.2011.04540.x; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; VANHEUKELEM L, 1994, MAR ECOL PROG SER, V114, P303, DOI 10.3354/meps114303; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Ware MA, 2015, PHOTOSYNTH RES, V126, P261, DOI 10.1007/s11120-015-0102-4; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Xu K, 2017, BBA-BIOENERGETICS, V1858, P459, DOI 10.1016/j.bbabio.2017.03.003; Young EB, 2003, J PHYCOL, V39, P897, DOI 10.1046/j.1529-8817.2003.03042.x; Young JN, 2015, NEW PHYTOL, V205, P172, DOI 10.1111/nph.13021; Zhu SN, 2014, BIORESOURCE TECHNOL, V152, P292, DOI 10.1016/j.biortech.2013.10.092; Zorz Jackie K., 2015, Life-Basel, V5, P403, DOI 10.3390/life5010403	78	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195705	10.1371/journal.pone.0195705	http://dx.doi.org/10.1371/journal.pone.0195705			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641594	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900086
J	Li, J; Wu, XP; Gebremikael, MT; Wu, HJ; Cai, DX; Wang, BS; Li, BG; Zhang, JC; Li, YS; Xi, JL				Li, Jing; Wu, Xueping; Gebremikael, Mesfin Tsegaye; Wu, Huijun; Cai, Dianxiong; Wang, Bisheng; Li, Baoguo; Zhang, Jiancheng; Li, Yongshan; Xi, Jilong			Response of soil organic carbon fractions, microbial community composition and carbon mineralization to high-input fertilizer practices under an intensive agricultural system	PLOS ONE			English	Article							INORGANIC FERTILIZERS; NITROGEN MINERALIZATION; FUNCTIONAL DIVERSITY; ENZYME-ACTIVITIES; TERM; BIOMASS; MATTER; SEQUESTRATION; CROP; POOLS	Microbial mechanisms associated with soil organic carbon (SOC) decomposition are poorly understood. We aim to determine the effects of inorganic and organic fertilizers on soil labile carbon (C) pools, microbial community structure and C mineralization rate under an intensive wheat-maize double cropping system in Northern China. Soil samples in 0-10 cm layer were collected from a nine-year field trial involved four treatments: no fertilizer, CK; nitrogen (N) and phosphorus (P) fertilizers, NP; maize straw combined with NP fertilizers, NPS; and manure plus straw and NP fertilizers, NPSM. Soil samples were analyzed to determine labile C pools (including dissolved organic C, DOC; light free organic C, LFOC; and microbial biomass C, MBC), microbial community composition (using phospholipid fatty acid (PLFA) profiles) and SOC mineralization rate (from a 124-day incubation experiment). This study demonstrated that the application of chemical fertilizers (NP) alone did not alter labile C fractions, soil microbial communities and SOC mineralization rate from those observed in the CK treatment. Whereas the use of straw in conjunction with chemical fertilizers (NPS) became an additional labile substrate supply that decreased C limitation, stimulated growth of all PLFA-related microbial communities, and resulted in 53% higher cumulative mineralization of C compared to that of CK. The SOC and its labile fractions explained 78.7% of the variance of microbial community structure. Further addition of manure on the top of straw in the NPSM treatment did not significantly increase microbial community abundances, but it did alter microbial community structure by increasing G+/G- ratio compared to that of NPS. The cumulative mineralization of C was 85% higher under NPSM fertilization compared to that of CK. Particularly, the NPSM treatment increased the mineralization rate of the resistant pool. This has to be carefully taken into account when setting realistic and effective goals for long-term soil C stabilization.	[Li, Jing; Wu, Xueping; Wu, Huijun; Cai, Dianxiong; Wang, Bisheng] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing, Peoples R China; [Li, Jing; Li, Baoguo] China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China; [Li, Jing; Gebremikael, Mesfin Tsegaye] Univ Ghent, Dept Soil Management, Ghent, Belgium; [Zhang, Jiancheng] Shanxi Acad Agr Sci, Wheat Res Inst, Linfen, Peoples R China; [Li, Yongshan; Xi, Jilong] Shanxi Acad Agr Sci, Cotton Res Inst, Yuncheng, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ghent University; Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shanxi Agricultural University	Wu, XP (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing, Peoples R China.	wuxueping@caas.cn	Gebremikael, Mesfin/AHE-1590-2022	Wu, Xueping/0000-0002-7772-0773; Gebremikael, Mesfin Tsegaye/0000-0001-8696-9960	Science and Technology Program [2015BAD22B03]; National Key Research and Development Program of China [2016YFD0300804]; National 863 Program of China [2013AA102901]; Special Fund for Agro-scientific Research in the Public Interest [201203077]	Science and Technology Program(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund); National Key Research and Development Program of China; National 863 Program of China; Special Fund for Agro-scientific Research in the Public Interest	This work was supported jointly by the Science and Technology Program (2015BAD22B03 to XW), the National Key Research and Development Program of China (2016YFD0300804 to XW), the National 863 Program of China (2013AA102901 to XW) and the Special Fund for Agro-scientific Research in the Public Interest (201203077 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Bardgett RD, 1999, BIOL FERT SOILS, V29, P282, DOI 10.1007/s003740050554; Bastida F, 2013, SOIL BIOL BIOCHEM, V57, P892, DOI 10.1016/j.soilbio.2012.10.037; Brar BS, 2013, SOIL TILL RES, V128, P30, DOI 10.1016/j.still.2012.10.001; Buyer JS, 2010, SOIL BIOL BIOCHEM, V42, P831, DOI 10.1016/j.soilbio.2010.01.020; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; Dai XQ, 2017, SCI TOTAL ENVIRON, V580, P556, DOI 10.1016/j.scitotenv.2016.11.212; Demoling F, 2007, SOIL BIOL BIOCHEM, V39, P2485, DOI 10.1016/j.soilbio.2007.05.002; Ding XL, 2012, SOIL TILL RES, V122, P36, DOI 10.1016/j.still.2012.02.002; Dong WY, 2014, APPL SOIL ECOL, V84, P140, DOI 10.1016/j.apsoil.2014.06.007; Dorodnikov M, 2011, SOIL BIOL BIOCHEM, V43, P579, DOI 10.1016/j.soilbio.2010.11.026; Dou X, 2016, SCI REP-UK, V6, DOI 10.1038/srep31737; Elfstrand S, 2007, APPL SOIL ECOL, V35, P610, DOI 10.1016/j.apsoil.2006.09.011; Eo J, 2016, AGR ECOSYST ENVIRON, V231, P176, DOI 10.1016/j.agee.2016.06.039; Fang X, 2016, BIOL FERT SOILS, V52, P353, DOI 10.1007/s00374-015-1081-5; Filep T, 2011, GEODERMA, V162, P312, DOI 10.1016/j.geoderma.2011.03.002; Geisseler D, 2014, SOIL BIOL BIOCHEM, V75, P54, DOI 10.1016/j.soilbio.2014.03.023; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; Gong W, 2009, PLANT SOIL, V314, P67, DOI 10.1007/s11104-008-9705-2; Guo LJ, 2015, BIOL FERT SOILS, V51, P65, DOI 10.1007/s00374-014-0951-6; Huang ZQ, 2008, APPL SOIL ECOL, V40, P229, DOI 10.1016/j.apsoil.2008.04.009; Juarez S, 2013, BIOL FERT SOILS, V49, P939, DOI 10.1007/s00374-013-0784-8; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lazcano C, 2013, BIOL FERT SOILS, V49, P723, DOI 10.1007/s00374-012-0761-7; Li J, 2018, SOIL TILL RES, V175, P281, DOI 10.1016/j.still.2017.08.008; Li J, 2015, J INTEGR AGR, V14, P2500, DOI 10.1016/S2095-3119(15)61229-1; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Long GQ, 2015, SOIL TILL RES, V146, P270, DOI 10.1016/j.still.2014.09.020; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Mbuthia LW, 2015, SOIL BIOL BIOCHEM, V89, P24, DOI 10.1016/j.soilbio.2015.06.016; Mi J, 2015, LANDSCAPE ECOL, V30, P1683, DOI 10.1007/s10980-014-0040-0; Mohanty S, 2013, EUR J SOIL BIOL, V58, P113, DOI 10.1016/j.ejsobi.2013.07.004; Murphy DV, 2011, SOIL RES, V49, P582, DOI 10.1071/SR11203; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Ngosong C, 2010, APPL SOIL ECOL, V46, P134, DOI 10.1016/j.apsoil.2010.07.004; Peacock AD, 2001, SOIL BIOL BIOCHEM, V33, P1011, DOI 10.1016/S0038-0717(01)00004-9; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Sleutel S, 2005, EUR J SOIL SCI, V56, P505, DOI 10.1111/j.1365-2389.2004.00685.x; Sollins P, 2007, BIOGEOCHEMISTRY, V85, P1, DOI 10.1007/s10533-007-9099-x; Stromberger ME, 2012, SOIL BIOL BIOCHEM, V46, P155, DOI 10.1016/j.soilbio.2011.11.024; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; Wang JH, 2015, NUTR CYCL AGROECOSYS, V102, P371, DOI 10.1007/s10705-015-9710-9; Wang YD, 2015, BIOL FERT SOILS, V51, P583, DOI 10.1007/s00374-015-1007-2; Wu MN, 2011, BIOL FERT SOILS, V47, P397, DOI 10.1007/s00374-010-0535-z; Xu XF, 2013, GLOBAL ECOL BIOGEOGR, V22, P737, DOI 10.1111/geb.12029; Yang XY, 2014, J INTEGR AGR, V13, P402, DOI 10.1016/S2095-3119(13)60425-6; Yang XY, 2012, GEODERMA, V177, P49, DOI 10.1016/j.geoderma.2012.01.033; Yang ZC, 2015, SOIL TILL RES, V146, P47, DOI 10.1016/j.still.2014.06.011; Zhang HJ, 2015, BIOL FERT SOILS, V51, P137, DOI 10.1007/s00374-014-0957-0; Zhang HJ, 2013, SOIL BIOL BIOCHEM, V57, P228, DOI 10.1016/j.soilbio.2012.08.024	54	32	37	19	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195144	10.1371/journal.pone.0195144	http://dx.doi.org/10.1371/journal.pone.0195144			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668702	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200029
J	Parto, S; Lartillot, N				Parto, Sahar; Lartillot, Nicolas			Molecular adaptation in Rubisco: Discriminating between convergent evolution and positive selection using mechanistic and classical codon models (vol 13, e0192697, 2018)	PLOS ONE			English	Correction															Natural Sciences and Engineering Research Council of Canada (NSERC) [ANR-15-CE32-0005]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Research Council of Canada (NSERC), ANR-15-CE32-0005 "Convergenomix". Part of the analyses were run on the PRABI cluster.	Parto S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192697	1	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196267	10.1371/journal.pone.0196267	http://dx.doi.org/10.1371/journal.pone.0196267			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668760	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200082
J	Tissier, J; Becker, D; Codrea, V; Costeur, L; Farcas, C; Solomon, A; Venczel, M; Maridet, O				Tissier, Jeremy; Becker, Damien; Codrea, Vlad; Costeur, Loic; Farcas, Cristina; Solomon, Alexandru; Venczel, Marton; Maridet, Olivier			New data on Amynodontidae (Mammalia, Perissodactyla) from Eastern Europe: Phylogenetic and palaeobiogeographic implications around the Eocene-Oligocene transition	PLOS ONE			English	Article							RHINOCEROTOIDEA MAMMALIA; FOSSIL MAMMALS; GENUS; CALIFORNIA; EVOLUTION; HISTORY; PALEOGEOGRAPHY; PALEOGENE; NORTHERN; PAKISTAN	Amynodontidae is a family of Rhinocerotoidea (Mammalia, Perissodactyla) known from the late Early Eocene to the latest Oligocene, in North America and Eurasia. European Amynodontidae are very rare, and all remains belong almost exclusively to a single post Grande Coupure genus from the Oligocene, Cadurcotherium. The "Grande Coupure" defines an extinctions and dispersal-generated originations event in Europe that is nearly contemporaneous with the Eocene-Oligocene transition. Perissodactyls are one of the major groups affected by this event: Palaeotheriidae went almost extinct during this crisis, whereas Rhino-cerotidae appeared for the first time in Europe. Study of fossiliferous Eastern-European localities from this age is crucial for the understanding of this crisis. We report here three new localities of Amynodontidae in Eastern Europe. Two of them are dated from the Eocene (Morlaca, Romania; Dorog, Hungary), whereas the other is either Late Eocene or Early Oligocene (Dobarca, Romania). The skull from this latter locality belongs unexpectedly to the same individual as a previously described mandible attributed to "Cadurcodon" zimborensis. As a result, this specimen can be allocated to its proper locality, Dobarca, and is assigned to a new genus, Sellamynodon gen. nov. It is characterised by an extraordinary growth of the nuchal crest, a unique character among amynodontids. Along with this remarkable material from Dobarca, two specimens from another Romanian locality, Morlaca, have been recently discovered and are dated from the Late Eocene. They belong, as well as new material from Dorog (Middle Eocene, Hungary), to the genus Amynodontopsis, also found in North America. The new Hungarian material represents the earliest occurrence of Amynodontidae in Europe. New phylogenetic hypotheses of Rhinocerotoidea are proposed, including the new material presented here, and show that Amynodontidae may be closer to the polyphyletic family 'Hyracodontidae' than to Rhinocerotidae. Amynodontidae, with their deep preorbital fossa and extremely reduced premolars, display in fact a very derived condition, compared to rhinocerotids.	[Tissier, Jeremy; Becker, Damien; Maridet, Olivier] Jurass Museum, Porrentruy, Switzerland; [Tissier, Jeremy; Becker, Damien; Maridet, Olivier] Univ Fribourg, Dept Geosci, Fribourg, Switzerland; [Codrea, Vlad; Solomon, Alexandru] Babea Bolyai Univ, Fac Biol Geol, Dept Geol, Cluj Napoca, Romania; [Costeur, Loic] Naturhist Museum Basel, Basel, Switzerland; [Farcas, Cristina] Babea Bolyai Univ, Fac Environm Sci, Cluj Napoca, Romania; [Venczel, Marton] Tarii Crisurilor Museum, Dept Nat Hist, Oradea, Romania	University of Fribourg	Tissier, J (corresponding author), Jurass Museum, Porrentruy, Switzerland.; Tissier, J (corresponding author), Univ Fribourg, Dept Geosci, Fribourg, Switzerland.	jeremy.tissier@unifr.ch	Venczel, Marton/C-3234-2011; Solomon, Alexandru A/A-2420-2017; Maridet, Olivier/H-5313-2019; Solomon, Alexandru/ABB-6672-2020; Tissier, Jérémy/ABE-5773-2020; Codrea, Vlad/C-2721-2011	Venczel, Marton/0000-0003-2200-3619; Maridet, Olivier/0000-0002-0956-0712; Solomon, Alexandru/0000-0002-7264-6527; Tissier, Jérémy/0000-0002-8517-1612; Codrea, Vlad/0000-0002-5575-4139; Costeur, Loic/0000-0001-6213-8556	SYNTHESYS Project by the European Community Research Infrastructure Action under the FP7 "Capacities" Program [HU-TAF-6724]; Swiss National Science Foundation [200021-162359]	SYNTHESYS Project by the European Community Research Infrastructure Action under the FP7 "Capacities" Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research received support from the SYNTHESYS Project http://www.synthesys.info/ which is financed by European Community Research Infrastructure Action under the FP7 "Capacities" Program (HU-TAF-6724) (JT). DB, LC, OM and JT are financially supported by Swiss National Science Foundation (grant 200021-162359).	Antoine Pierre-Olivier, 2002, Memoires du Museum National d'Histoire Naturelle, V188, P1; Antoine PO, 2010, ZOOL J LINN SOC-LOND, V160, P139, DOI 10.1111/j.1096-3642.2009.00597.x; Antoine PO, 2003, CAN J EARTH SCI, V40, P365, DOI 10.1139/E02-101; Antoine PO, 2004, J ASIAN EARTH SCI, V24, P71, DOI 10.1016/j.jaes.2003.09.005; Averianov A, 2017, J SYST PALAEONTOL, V15, P927, DOI 10.1080/14772019.2016.1256914; Averianov AO, 2005, GEODIVERSITAS, V27, P221; Bai B, 2017, PALAEONTOLOGY, V60, P837, DOI 10.1111/pala.12319; Bai B, 2017, B AM MUS NAT HIST, P1; Bai Bin, 2012, Vertebrata Palasiatica, V50, P204; Bayshashov BU, 1994, SELEVINIA, V1, P74; Becker D, 2013, J SYST PALAEONTOL, V11, P947, DOI 10.1080/14772019.2012.699007; Becker D, 2009, SWISS J GEOSCI, V102, P489, DOI 10.1007/s00015-009-1330-4; Biryukov MD, 1961, AKAD NAUK KAZAKHSKOI, V3, P20; Bjork P. R., 1967, Journal of Paleontology, V41, P227; Boehme Madelaine, 2013, Zitteliana Reihe A Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Geologie, V53, P121; Borissiak AA, 1923, MEMOIRES SOC GEOLOGI, V59, P1; Borissiak AA, 1918, MONOGRAFYA ROSSIYSKO; Brunet M., 1979, GRANDS MAMMIFERES CH; BUCUR I., 2011, CALCAREOUS ALGAE ROM, P137; Campos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142339; CHIU CHAN-SIANG, 1962, VERTEBR PALASIAT, V6, P57; Chow M., 1964, Vertebrata Palasiatica, V8, P355; Chow M., 1965, Vertebrata Palasiatica, V9, P190; Codrea AV., 2005, STUD U BABES-BOL GEO, V50, P19, DOI [10.5038/1937-8602.50.1.3, DOI 10.5038/1937-8602.50.1.3]; Codrea V, 1989, OLIGOCENE TRANSYLVAN, P319; Codrea V., 1998, MUZEUL BRUKENTHAL ST, V27, P121; Codrea V, 2000, RINOCERI SI TAPIRI T; Codrea Vlad, 1996, Acta Zoologica Cracoviensia, V39, P83; Colbert EH, 1938, B AM MUS NAT HIST, V74, P255; Crusafont M., 1973, B REAL SOC HIST NATU, V71, P21; De Bonis Louis, 1995, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V236, P157; De Bonis Louis, 1995, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V236, P177; Emry RJ, 1998, B CARNEGIE MUSEUM NA, V34, P298; Farcas C., 2011, THESIS; Forster-Cooper C, 1934, PHILOS T R SOC LON B, V223, P569, DOI 10.1098/rstb.1934.0013; Forster-Cooper C., 1924, PHILOS T R SOC B, V212, P35, DOI [10.1098/rstb.1924.0002, DOI 10.1098/RSTB.1924.0002]; Forster-Cooper C, 1924, PHILOS T ROY SOC LON, V212, P369, DOI [10.1098/rstb.1924.0009, DOI 10.1098/RSTB.1924.0009]; Forster-Cooper C., 1922, ANN MAG NAT HIST SER, V9, P617, DOI [10.1080/00222932208632717, DOI 10.1080/00222932208632717]; Forster-Cooper Clive, 1913, ANN MAG NAT HIST, V8, P376; FORSTERCOOPER C, 1911, ANN MAGAZINE NATURAL, V8, P711; Franzosa EA, 2007, TREEROT VERSION 3; Gervais P., 1873, J ZOOL, V2, P362; GINSBURG L, 1987, Annales de Paleontologie, V73, P83; Goloboff P, 2008, CLADISTICS, V24, P91; Grandi F, 2017, CR PALEVOL, DOI [10.1016/6crpv.2017.04.002, DOI 10.1016/6CRPV.2017.04.002]; Granger W, 1937, B AM MUS NAT HIST, V72, P1; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P296; Gromova V., 1960, Travaux Inst Paleont Acad Sci URSS, V77, P128; Gromova V., 1954, AKAD NAUK SSSR T PAL, V55, P85; Gromova VI, 1958, VERTEBRAT PALASIATIC, VII, P110; Hanson B.C., 1989, EVOLUTION PERISSODAC, P379; Heissig K., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P101; Heissig Kurt, 2012, Zitteliana Reihe A, V52, P79; Holbrook LT, 1999, CLADISTICS, V15, P331, DOI 10.1111/j.1096-0031.1999.tb00270.x; Holbrook LT, 1997, J VERTEBR PALEONTOL, V17, P384, DOI 10.1080/02724634.1997.10010983; Holbrook LT, 2001, ZOOL J LINN SOC, V131, P0; Hooker J.J., 1992, P494; Hooker JJ, 2009, GEOL SOC AM SPEC PAP, V452, P179, DOI 10.1130/2009.2452(12); Hooker J. J., 1987, MUNCHNER GEOWISSENSC, V10, P109; Hooker JJ, 2004, J GEOL SOC LONDON, V161, P161, DOI 10.1144/0016-764903-091; HOOKER JJ, 1989, BIOL J LINN SOC, V38, P9, DOI 10.1111/j.1095-8312.1989.tb01558.x; Huang Xue-Shi, 2001, Vertebrata Palasiatica, V39, P197; Jimenez-Hidalgo E, 2015, J S AM EARTH SCI, V57, P39, DOI 10.1016/j.jsames.2014.12.001; Kocsis L, 2002, NEUES JAHRB GEOL P-M, P649; Kotsakis T, 2004, PALAEOGEOGR PALAEOCL, V210, P67, DOI 10.1016/j.palaeo.2004.03.013; KRETZOI MIKLOS, 1940, ANN MUS NATION HUNGARICI, V33, P87; KRETZOI MIKLOS, 1942, FOLDTANI KOZLONY, V72, P139; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Li Qian, 2003, Vertebrata Palasiatica, V41, P203; Lucas S.G., 1989, Oxford Monographs on Geology and Geophysics, P358; Lucas SG, 1996, J PALEONTOL, V70, P691, DOI 10.1017/S0022336000023647; Lucas SG, 2001, P BIOL SOC WASH, V114, P517; Lucas SG, 2004, NEW MEXICO MUSEUM NA, V26, P81; Lucas Spencer G., 2006, Paleobios, V26, P7; Lucas Spencer G., 1996, Tertiary Research, V17, P51; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; Maddison WP., 2019, CHROMASEQ MESQUITE P; Malez M., 1985, PALEONTOL JUGOSLAVIC, V34, P1; Manning E., 1985, Mississippi Geology, V6, P1; Maxim I., 1965, COMUNICARI GEOL, V3, P229; MCKENNA MC, 1975, ANN MO BOT GARD, V62, P335, DOI 10.2307/2395200; Mennecart B, PALAEOGEOGR IN PRESS, DOI [10.1016/j.palaeo.2018.01.011, DOI 10.1016/J.PALAEO.2018.01.011]; Menouret B, 2015, ANN PALEONTOL, V101, P241, DOI 10.1016/j.annpal.2015.06.002; Meszaros N., 1996, CONVERGENTE TRANSILV CONVERGENTE TRANSILV, V4, P42; Meszaros N, 1977, MUZ BRUKENTHAL STUD, V21, P9; Metais G, 2017, CR PALEVOL, V16, P382, DOI 10.1016/j.crpv.2017.01.001; Meulenkamp JE, 2003, PALAEOGEOGR PALAEOCL, V196, P209, DOI 10.1016/S0031-0182(03)00319-5; Mihlbachler MC, 2008, B AM MUS NAT HIST, P1; Mihlbachler MC, 2011, J VERTEBR PALEONTOL, V31, P202, DOI 10.1080/02724634.2011.539653; Nikolov I., 1985, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V25, P61; Ogg J, 2017, TSCREATOR VISUALIZAT; Osborn H. F., 1923, American Museum Novitates, VNo. 78, P1; Osborn H. F., 1924, American Museum Novitates, Vno. 147, P1; OSBORN HENRY FAIRFIELD, 1936, AMER MUS NOVITATES, V859, P1; Owen R., 1848, ARCHETYPE HOMOLOGIES, DOI [10.5962/bhl.title.118611, DOI 10.5962/BHL.TITLE.118611]; Pandolfi L, 2015, ANN PALEONTOL, V101, P67, DOI 10.1016/j.annpal.2014.10.001; Peterson O. A., 1919, ANN CARNEGIE MUS, V12, P40; Popescu B., 1978, REV ROUM GEOL GEOPH, V22, P99; Popov S, 2004, COUR FORSCHUNGSINSTI, P250; Prothero D. R., 2005, EVOLUTION N AM RHINO; Prothero D. R., 2013, RHINOCEROS GIANTS PA; PROTHERO DR, 1986, ZOOL J LINN SOC-LOND, V87, P341, DOI 10.1111/j.1096-3642.1986.tb01340.x; Prothero DR, 1993, P INT RHIN C, P81; Qi Tao, 1992, Vertebrata Palasiatica, V30, P229; Qiu Z-X., 2007, PALAEONT SIN C, V29, P1; Radinsky L. B., 1967, Bulletin of the American Museum of Natural History, V136, P1; RADINSKY LB, 1966, J MAMMAL, V47, P631, DOI 10.2307/1377893; Radinsky LB., 1967, AM MUS NOVIT, V2316, P1; Rasser MW, 2008, GEOLOGY CENTRAL EURO, V2; Remy J.A., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P169; RESHETOV V, 1993, GEOBIOS-LYON, V26, P715, DOI 10.1016/S0016-6995(93)80054-U; Rogl F, 1999, GEOL CARPATH, V50, P339; Roman F., 1909, ARCH MUSEUM HIST NAT, V10, P1; Roman MF, 1911, ARCH MUS HIST NAT LY, V11, P1; Schlosser M., 1902, GEOL PALAONT ABH, V3, P117; Scott W. B., 1887, B MUS COMP ZOOL HARV, V13, P151; Scott W. B., 1941, T AM PHILOS SOC, V28, P747, DOI [10.2307/, DOI 10.2307/]; Scott W. B., 1890, T AM PHILOS SOC, V16, P461; Scott WB, 1883, CONTRIBUTIONS E M MU, V3, P3; Scott William B., 1945, TRANS AMER PHIL SOC, V34, P209, DOI 10.2307/1005542; Stehlin HG., 1909, B SOC GEOLOGIQUE FRA, V4 e surie, Tome IX:, P488; Stock C, 1936, P NATL ACAD SCI USA, V22, P260, DOI 10.1073/pnas.22.5.260; Stock C, 1939, P NATL ACAD SCI USA, V25, P270, DOI 10.1073/pnas.25.6.270; Stock C, 1933, P NATL ACAD SCI USA, V19, P762, DOI 10.1073/pnas.19.8.762; Swofford D.L., 2002, PHYLOGENETIC ANAL US; TARI G, 1993, TECTONOPHYSICS, V226, P433, DOI 10.1016/0040-1951(93)90131-3; Tissier J, 2018, MORPHOMUSEUM, P3, DOI [10.18563/m3.3.4.e5, DOI 10.18563/M3.3.4.E5]; Tomida Yikimitsu, 1996, Bulletin of the National Science Museum Series C (Geology and Paleontology), V22, P117; Troxell EL, 1921, AM J SCI, V2, P34; Troxell EL, 1922, AM J SCI, V4, P38; Troxell EL, 1921, AM J SCI, V2, P21; Uhlig U., 1999, NEUE FOLGE; von Koenigswald W, 2011, ACTA PALAEONTOL POL, V56, P11, DOI 10.4202/app.2010.0021; von Linnaeus C., 1758, SYSTEMA NATURAE REGN; Wall W.P., 1989, Oxford Monographs on Geology and Geophysics, P341; Wall W. P., 1982, 3 N AM PAL CONV P, P563; WALL WP, 1982, J PALEONTOL, V56, P434; WALL WP, 1980, J PALEONTOL, V54, P968; WALL WP, 1986, J PALEONTOL, V60, P911, DOI 10.1017/S0022336000043079; Wang Banyue, 1992, P529; Wang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep39607; Wilson JA, 1981, PEARCE SELLARDS SERI, V33, P1; Wood H. E., 1929, American Museum Novitates, Vno. 395, P1; Wood HE, 1933, B AM MUS NAT HIST, V67, P181; WOOD HORACE E., 1963, AMER MUS NOVITATES, V2146, P1; Xu Y. X., 1966, VERTEBRAT PALASIATIC, V10, P123; Xu Y-X, 1961, VERTEBRAT PALASIATIC, V4, P315; XU YU-XUAN, 1965, VERTEBRATA PALASIAT, V9, P83; Young C. C., 1937, Bulletin of the Geological Society of China, V17, P413; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	150	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0193774	10.1371/journal.pone.0193774	http://dx.doi.org/10.1371/journal.pone.0193774			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668673	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200003
J	Astudillo-Rubio, D; Delgado-Gaete, A; Bellot-Arcis, C; Montiel-Company, JM; Pascual-Moscardo, A; Almerich-Silla, JM				Astudillo-Rubio, Daniela; Delgado-Gaete, Andres; Bellot-Arcis, Carlos; Montiel-Company, Jose Maria; Pascual-Moscardo, Agustin; Almerich-Silla, Jose Manuel			Mechanical properties of provisional dental materials: A systematic review and meta-analysis (vol 13, e0193162, 2018)	PLOS ONE			English	Correction												jose.maria.montiel@uv.es	Montiel-Company, José María/S-1836-2018; BELLOT-ARCIS, CARLOS/AGP-0731-2022	Montiel-Company, José María/0000-0002-3952-7681; BELLOT-ARCIS, CARLOS/0000-0003-4363-2713				Astudillo-Rubio D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193162	1	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196264	10.1371/journal.pone.0196264	http://dx.doi.org/10.1371/journal.pone.0196264			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664965	Green Published, gold			2022-12-27	WOS:000430262300068
J	Simko, I; Hayes, RJ				Simko, Ivan; Hayes, Ryan J.			Accuracy, reliability, and timing of visual evaluations of decay in fresh-cut lettuce	PLOS ONE			English	Article							SHELF-LIFE; ROMAINE LETTUCE; ICEBERG LETTUCE; BREEDING LINES; RESISTANCE; SYMPTOMS; QUALITY; ASSESSMENTS; PERFORMANCE; SEVERITY	Visual assessments are used for evaluating the quality of food products, such as fresh-cut lettuce packaged in bags with modified atmosphere. We have compared the accuracy and the reliability of visual evaluations of decay on fresh-cut lettuce performed with experienced and inexperienced raters. In addition, we have analyzed decay data from over 4.5 thousand bags to determine the optimum timing for evaluations to detect differences among accessions. Lin's concordance coefficient (rho(c)) that takes into consideration both the closeness of the data and the conformance to the identity line showed high repeatability (intra-rater reliability, rho(c) = 0.97), reproducibility (inter-rater reliability, rho(c) = 0.92), and accuracy (rho(c) = 0.96) for experienced raters. Inexperienced raters did not perform as well and their ratings showed decreased repeatability (rho(c) = 0.93), but even larger reduction in reproducibility (rho(c) = 0.80) and accuracy (rho(c) = 0.90). We have detected that 5.3% of ratings were outside of the 95% limits of agreement. These under-or overestimates were predominantly found for bags with intermediate levels of decay, which corresponds to the middle of the rating scale. This occurs because intermediate amounts of decay are more difficult to discriminate than extremes. The frequencies of aberrant ratings for experienced raters ranged from 0.6% to 4.4% (mean = 2.1%), for inexperienced raters the frequencies were substantially higher, ranging from 6.1% to 15.6% (mean = 9.4%). Therefore, we recommend that new raters receive training that includes practical examples in this range of decay, use of standard area diagrams, and continuing interaction with experienced raters (consultation during actual rating). Very high agreement among experienced raters indicate that visual ratings can be successfully used for evaluations of decay, until a more objective, rapid, and affordable method is developed. We recommend evaluating samples at multiple time points until 42 days after processing (about 80% decay on average) and then combining these individual ratings into the area under the decay progress stairs (AUDePS) score. Applying this approach, experienced evaluators can accurately detect difference among lettuce accessions and identify lettuce cultivars with reduced decay.	[Simko, Ivan] ARS, USDA, US Agr Res Stn, Crop Improvement & Protect Res Unit, Salinas, CA 93905 USA; [Hayes, Ryan J.] USDA, Natl Forage Seed Prod Res Ctr, Corvallis, OR USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Simko, I (corresponding author), ARS, USDA, US Agr Res Stn, Crop Improvement & Protect Res Unit, Salinas, CA 93905 USA.	ivan.simko@ars.usda.gov	Simko, Ivan/N-4033-2019	Simko, Ivan/0000-0002-8769-8477				Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; [Anonymous], 2015, MONTEREY COUNTY CROP; Bardsley SJ, 2013, PLANT PATHOL, V62, P460, DOI 10.1111/j.1365-3059.2012.02651.x; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bock CH, 2010, CRIT REV PLANT SCI, V29, P59, DOI 10.1080/07352681003617285; Bock CH, 2009, PLANT DIS, V93, P412, DOI 10.1094/PDIS-93-4-0412; Everitt B.S., 2010, CAMBRIDGE DICT STAT, DOI DOI 10.1017/CBO9780511779633; Glaser L. K., 2001, AGR INFORM B, V767; Hayes RJ, 2016, ACTA HORTIC, V1141, P65, DOI 10.17660/ActaHortic.2016.1141.7; Hayes RJ., 2017, CLUSTER RANDOMISED T, V2nd edn, P1; Hayes RJ, 2008, J AM SOC HORTIC SCI, V133, P228, DOI 10.21273/JASHS.133.2.228; Hayes RJ, 2014, J AM SOC HORTIC SCI, V139, P388, DOI 10.21273/JASHS.139.4.388; Hayes RJ, 2014, HORTSCIENCE, V49, P18, DOI 10.21273/HORTSCI.49.1.18; Hayes RJ, 2011, HORTSCIENCE, V46, P501, DOI 10.21273/HORTSCI.46.3.501; HORSFALL JG, 1945, PHYTOPATHOLOGY, V35, P655; Kim JG, 2005, J SCI FOOD AGR, V85, P1622, DOI 10.1002/jsfa.2158; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Nita M, 2003, PHYTOPATHOLOGY, V93, P995, DOI 10.1094/PHYTO.2003.93.8.995; NUTTER FW, 1993, PHYTOPATHOLOGY, V83, P806, DOI 10.1094/Phyto-83-806; NUTTER FW, 1995, CAN J PLANT PATHOL, V17, P174, DOI 10.1080/07060669509500709; Simko I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01985; Simko I, 2015, POSTHARVEST BIOL TEC, V106, P44, DOI 10.1016/j.postharvbio.2015.04.007; Simko I, 2014, CSSA SPEC PUBL, V33, P53, DOI 10.2135/cssaspecpub33.c4; Simko I, 2014, HORTSCIENCE, V49, P679, DOI 10.21273/HORTSCI.49.5.679; Simko I, 2012, CROP SCI, V52, P2131, DOI 10.2135/cropsci2012.02.0111; Simko I, 2012, PHYTOPATHOLOGY, V102, P381, DOI 10.1094/PHYTO-07-11-0216; Simko I, 2010, HORTSCIENCE, V45, P670, DOI 10.21273/HORTSCI.45.4.670; Smyth AB, 1998, J AGR FOOD CHEM, V46, P4556, DOI 10.1021/jf980208s; Toivonen P.M.A., 2009, MODIFIED CONTROLLED, P463; Tudela JA, 2016, POSTHARVEST BIOL TEC, V120, P36, DOI 10.1016/j.postharvbio.2016.05.009; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Yadav NVS, 2013, PLANT PATHOL, V62, P325, DOI 10.1111/j.1365-3059.2012.02641.x; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908; Zhang FZ, 2007, J EXP BOT, V58, P1433, DOI 10.1093/jxb/erm006	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194635	10.1371/journal.pone.0194635	http://dx.doi.org/10.1371/journal.pone.0194635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664945	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300008
J	Zhang, L; Du, HR; Zhao, YN; Wu, RW; Zhang, XL				Zhang, Lu; Du, Hongru; Zhao, Yannan; Wu, Rongwei; Zhang, Xiaolei			Urban networks among Chinese cities along "the Belt and Road": A case of web search activity in cyberspace (vol 12, e0188868, 2017)	PLOS ONE			English	Correction																		Zhang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188868	1	0	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196141	10.1371/journal.pone.0196141	http://dx.doi.org/10.1371/journal.pone.0196141			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664947	Green Published, gold			2022-12-27	WOS:000430262300055
J	Casal, D; Mota-Silva, E; Iria, I; Alves, S; Farinho, A; Pen, C; Lourenco-Silva, N; Mascarenhas-Lemos, L; Silva-Ferreira, J; Ferraz-Oliveira, M; Vassilenko, V; Videira, PA; Goyri-O'Neill, J; Pais, D				Casal, Diogo; Mota-Silva, Eduarda; Iria, Ines; Alves, Sara; Farinho, Ana; Pen, Claudia; Lourenco-Silva, Nuno; Mascarenhas-Lemos, Luis; Silva-Ferreira, Jose; Ferraz-Oliveira, Mario; Vassilenko, Valentina; Videira, Paula Alexandra; Goyri-O'Neill, Joao; Pais, Diogo			Reconstruction of a 10-mm-long median nerve gap in an ischemic environment using autologous conduits with different patterns of blood supply: A comparative study in the rat	PLOS ONE			English	Article							BRACHIAL-PLEXUS RECONSTRUCTION; FUNCTIONAL RECOVERY; MOTOR FUNCTION; AXONAL REGENERATION; EXPERIMENTAL-MODEL; THERMOGRAPHIC EVALUATION; QUANTITATIVE ASSESSMENT; CONDUCTION-VELOCITY; CARBONIC-ANHYDRASE; PERIPHERAL-NERVES	The aim of this study was to evaluate in the Wistar rat the efficacy of various autologous nerve conduits with various forms of blood supply in reconstructing a 10-mm-long gap in the median nerve (MN) under conditions of local ischemia. A 10-mm-long median nerve defect was created in the right arm. A loose silicone tube was placed around the nerve gap zone, in order to simulate a local ischemic environment. Rats were divided in the following experimental groups (each with 20 rats): the nerve Graft (NG) group, in which the excised MN segment was reattached; the conventional nerve flap (CNF) and the arterialized neurovenous flap (ANVF) groups in which the gap was bridged with homonymous median nerve flaps; the prefabricated nerve flap (PNF) group in which the gap was reconstructed with a fabricated flap created by leaving an arteriovenous fistula in contact with the sciatic nerve for 5 weeks; and the two control groups, Sham and Excision groups. In the latter group, the proximal stump of the MN nerve was ligated and no repair was performed. The rats were followed for 100 days. During this time, they did physiotherapy. Functional, electroneuromyographic and histological studies were performed. The CNF and ANVF groups presented better results than the NG group in the following assessments: grasping test, nociception, motor stimulation threshold, muscle weight, and histomorphometric evaluation. Radial deviation of the operated forepaw was more common in rats that presented worse results in the other outcome variables. Overall, CNFs and ANVFs produced a faster and more complete recovery than NGs in the reconstruction of a 10-mm-long median nerve gap in an ischemic environment in the Wistar rat. Although, results obtained with CNFs were in most cases were better than ANVFs, these differences were not statistically significant for most of the outcome variables.	[Casal, Diogo; Mascarenhas-Lemos, Luis; Goyri-O'Neill, Joao; Pais, Diogo] Univ Nova Lisboa, NOVA Med Sch, Anat Dept, Lisbon, Portugal; [Casal, Diogo] Hosp Sao Jose, Ctr Hosp Lisboa Cent, Plast & Reconstruct Surg Dept, Lisbon, Portugal; [Casal, Diogo] Hosp Sao Jose, Ctr Hosp Lisboa Cent, Burn Unit, Lisbon, Portugal; [Casal, Diogo; Videira, Paula Alexandra] Univ Nova Lisboa, Fac Sci & Technol, Life Sci Dept, UCIBIO, Caparica, Portugal; [Casal, Diogo; Iria, Ines; Farinho, Ana; Lourenco-Silva, Nuno; Videira, Paula Alexandra] Univ Nova Lisboa, NOVA Med Sch, CEDOC, Lisbon, Portugal; [Mota-Silva, Eduarda; Vassilenko, Valentina] Univ Nova Lisboa, Fac Ciencias & Tecnol, Phys Dept, LIBPhys, Lisbon, Portugal; [Alves, Sara; Pen, Claudia; Mascarenhas-Lemos, Luis; Silva-Ferreira, Jose; Ferraz-Oliveira, Mario] Hosp Sao Jose, Ctr Hosp Lisboa Cent, Pathol Dept, Lisbon, Portugal	Universidade Nova de Lisboa; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa	Casal, D (corresponding author), Univ Nova Lisboa, NOVA Med Sch, Anat Dept, Lisbon, Portugal.; Casal, D (corresponding author), Hosp Sao Jose, Ctr Hosp Lisboa Cent, Plast & Reconstruct Surg Dept, Lisbon, Portugal.; Casal, D (corresponding author), Hosp Sao Jose, Ctr Hosp Lisboa Cent, Burn Unit, Lisbon, Portugal.; Casal, D (corresponding author), Univ Nova Lisboa, Fac Sci & Technol, Life Sci Dept, UCIBIO, Caparica, Portugal.; Casal, D (corresponding author), Univ Nova Lisboa, NOVA Med Sch, CEDOC, Lisbon, Portugal.	diogo_bogalhao@yahoo.co.uk	PEN, Claudia/GXG-5286-2022; Pen Freitas, Claudia/ABA-2505-2021; Casal, Diogo/ABD-9769-2020; Videira, P A/A-5901-2013; Vassilenko, Valentina/H-8912-2012	Casal, Diogo/0000-0002-5537-9340; Videira, P A/0000-0001-5987-2485; Vassilenko, Valentina/0000-0002-7913-7047; PAIS, DIOGO/0000-0001-9837-0197; Mota da Silva, Eduarda/0000-0002-4305-8216; Alves, Sara/0000-0002-2913-5975; Farinho, Ana/0000-0002-0955-8348; Iria, Ines/0000-0002-3661-3760; Lourenco-Silva, Nuno/0000-0001-8133-4667; Silva, Jose/0000-0003-0616-9301	"Programme for Advanced Medical Education" - "Fundacao Calouste Gulbenkian"; Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia, Portugal	"Programme for Advanced Medical Education" - "Fundacao Calouste Gulbenkian"; Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	One of the authors (D.C.) received a grant from "The Programme for Advanced Medical Education" sponsored by "Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude and Fundacao para a Ciencia e Tecnologia, Portugal." The authors have no financial or commercial interests to declare in relation to the content of this article.; One of the authors (D.C.) received a grant from "The Programme for Advanced Medical Education" sponsored by "Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Sande and Fundacao para a Ciencia e Tecnologia, Portugal".	Afifi A. K, 2005, FUNCTIONAL NEUROANAT, P3; ANGELICA-ALMEIDA M, 2014, ARCH ANATOMY, V2, P8; Angelica-Almeida M, 2013, ACTA MEDICA PORT, V26, P243; Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056; [Anonymous], 2015, PLAST AESTHET RES; [Anonymous], WIST RAT WEIGHT PENN; Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127; BENNETT GJ, 1991, PAIN, V45, P61, DOI 10.1016/0304-3959(91)90165-T; Bennett K, 2012, J PROTEOMICS, V75, P3925, DOI 10.1016/j.jprot.2012.04.045; BERTELLI JA, 1995, MICROSURG, V16, P77, DOI 10.1002/micr.1920160207; BERTELLI JA, 1993, J NEUROSCI METH, V46, P203, DOI 10.1016/0165-0270(93)90068-3; BERTELLI JA, 1995, J NEUROSCI METH, V58, P151, DOI 10.1016/0165-0270(94)00169-H; Bertelli JA, 2006, MICROSURG, V26, P230, DOI 10.1002/micr.20234; Blackburn-Munro G, 2004, TRENDS PHARMACOL SCI, V25, P299, DOI 10.1016/j.tips.2004.04.008; BodineFowler SC, 1997, MUSCLE NERVE, V20, P29, DOI 10.1002/(SICI)1097-4598(199701)20:1<29::AID-MUS4>3.0.CO;2-J; Bontioti E, 2005, THESIS, P36; Bontioti EN, 2003, J PERIPHER NERV SYST, V8, P159, DOI 10.1046/j.1529-8027.2003.03023.x; Boyd KU., 2015, NERVE SURG, P75; Brandt J, 1999, J HAND SURG-BRIT EUR, V24B, P284, DOI 10.1054/jhsb.1999.0074; BREIDENBACH W, 1984, CLIN PLAST SURG, V11, P65; BREIDENBACH W C, 1986, Journal of Reconstructive Microsurgery, V3, P43, DOI 10.1055/s-2007-1007038; BREIDENBACH WC, 1987, ANN PLAS SURG, V18, P137, DOI 10.1097/00000637-198702000-00007; BROWN CJ, 1989, MICROSURG, V10, P226, DOI 10.1002/micr.1920100317; Carstens E, 2000, ILAR J, V41, P62; CASAL D, 2014, ARCH ANATOMY, V2, P31; Casal D, 2017, FLAP SURG; Casal D, 2017, JOVE-J VIS EXP, DOI 10.3791/55281; Casal D, 2016, PLAST RECONSTR SURG, V138, P459, DOI 10.1097/PRS.0000000000002390; CAVADAS PC, 1994, MICROSURG, V15, P877, DOI 10.1002/micr.1920151210; Chan Rebecca K Y, 2002, Hand Surg, V7, P251, DOI 10.1142/S0218810402001229; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chojnowski Marek, 2017, Reumatologia (Warsaw), V55, P38, DOI 10.5114/reum.2017.66686; Chuang David Chwei-Chin, 2009, Plast Reconstr Surg, V124, pe359, DOI 10.1097/PRS.0b013e3181bcf16c; Costa LM, 2009, INT REV NEUROBIOL, V87, P127, DOI 10.1016/S0074-7742(09)87007-4; Dahlin LB., 2006, PERIPHERAL NERVE SUR, P1; Daly WT, 2012, BIOMATERIALS, V33, P6660, DOI 10.1016/j.biomaterials.2012.06.002; Deacon RMJ, 2006, NAT PROTOC, V1, P936, DOI 10.1038/nprot.2006.120; Desouches C, 2005, REV NEUROL-FRANCE, V161, P1045; Dijkstra JR, 2000, J NEUROSCI METH, V96, P89, DOI 10.1016/S0165-0270(99)00174-0; Donzelli R, 2016, NEUROL RES, V38, P669, DOI 10.1080/01616412.2016.1198527; Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120; Ferrante MA, 2015, NERVE SURG, P59; FRAZIER WH, 1978, JACEP-J AM COLL EMER, V7, P265, DOI 10.1016/S0361-1124(78)80336-0; Friedman AH, 2009, NEUROSURGERY, V65, pA3, DOI 10.1227/01.NEU.0000346252.53722.D3; FU SY, 1995, J NEUROSCI, V15, P3886; Fukui A, 2004, EXPT CLIN RECONSTRUC, P35; Galtrey CM, 2007, J PERIPHER NERV SYST, V12, P11, DOI 10.1111/j.1529-8027.2007.00113.x; GEROW G, 1990, J MANIP PHYSIOL THER, V13, P257; Geuna S, 2005, MICROSC RES TECHNIQ, V66, P270, DOI 10.1002/jemt.20167; Geuna S, 2001, ANAT EMBRYOL, V204, P1, DOI 10.1007/s004290100188; Geuna S, 2008, J NEUROSURG, V109, P360, DOI 10.3171/JNS/2008/109/8/0360; Geuna S, 2014, J BRACHIAL PLEX PERI, V9, DOI 10.1186/1749-7221-9-3; Giusti G, 2016, MICROSURG, V36, P134, DOI 10.1002/micr.22371; Giusti G, 2012, J BONE JOINT SURG AM, V94A, P410, DOI 10.2106/JBJS.K.00253; Gordon T, 2016, EUR J NEUROSCI, V43, P336, DOI 10.1111/ejn.13005; GU YD, 1985, ANN PLAS SURG, V15, P332, DOI 10.1097/00000637-198510000-00010; Guo Lifei, 2009, Plast Reconstr Surg, V124, pe340, DOI 10.1097/PRS.0b013e3181bcf094; GUTH L, 1956, PHYSIOL REV, V36, P441, DOI 10.1152/physrev.1956.36.4.441; Hadlock TA, 1999, J PERIPHER NERV SYST, V4, P258; Havenaar Rea, 2001, PRINCIPLES LAB ANIMA, P29; HEMS TEJ, 1992, BRIT J PLAST SURG, V45, P497, DOI 10.1016/0007-1226(92)90141-J; Holland SK, 2010, MODERN PATHOL, V23, P1173, DOI 10.1038/modpathol.2010.104; Holman C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002331; Hong MKH, 2006, PLAST RECONSTR SURG, V118, P148, DOI 10.1097/01.prs.0000221075.91038.08; Howard RF, 2001, ANESTHESIOLOGY, V95, P421, DOI 10.1097/00000542-200108000-00026; HRUSKA RE, 1979, LIFE SCI, V25, P171, DOI 10.1016/0024-3205(79)90389-8; Ikeda M, 2012, BRAIN BEHAV, V2, P382, DOI 10.1002/brb3.61; Isaacs Jonathan, 2014, Hand (N Y), V9, P131, DOI 10.1007/s11552-014-9601-6; Jabaley M, 2006, PERIPHERAL NERVE SUR, P23; Jivan S, 2006, EXP BRAIN RES, V170, P245, DOI 10.1007/s00221-005-0207-7; Kakinoki R, 2007, J BRACHIAL PLEX PERI, V2, DOI 10.1186/1749-7221-2-18; Kambiz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126892; Kaplan HM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5558-4; KARCHER H, 1986, J MAXILLOFAC SURG, V14, P341, DOI 10.1016/S0301-0503(86)80321-6; Kilinc A, 2009, CHIR MAIN, V28, P87, DOI 10.1016/j.main.2009.01.001; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; KOSHIMA I, 1985, J HAND SURG-AM, V10A, P64, DOI 10.1016/S0363-5023(85)80249-5; KOSHIMA I, 1981, Journal of Microsurgery, V2, P225; Kovacic U, 2003, EXP NEUROL, V184, P479, DOI 10.1016/S0014-4886(03)00269-3; Lambert GA, 2009, J NEUROSCI METH, V177, P420, DOI 10.1016/j.jneumeth.2008.10.033; Lankhorst AJ, 2001, J NEUROTRAUM, V18, P203, DOI 10.1089/08977150150502622; Lopez-Alvarez VM, 2015, PAIN, V156, P1812, DOI 10.1097/j.pain.0000000000000268; Ludwig N, 2014, INFRARED PHYS TECHN, V62, P1, DOI 10.1016/j.infrared.2013.09.011; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Manoli Theodora, 2014, Eplasty, V14, pe17; Matsumine H, 2014, J RECONSTR MICROSURG, V30, P127, DOI 10.1055/s-0033-1357500; Meek MF, 2004, J NEUROSCI METH, V136, P179, DOI 10.1016/j.jneumeth.2004.01.005; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Millesi H, 2007, ACTA NEUROCHIR SUPPL, V100, P37; Missios S, 2014, J NEUROSURG, V120, P244, DOI 10.3171/2013.8.JNS13550; Murovic JA, 2009, NEUROSURGERY, V65, pA11; Myckatyn TM, 2004, NEUROL RES, V26, P124, DOI 10.1179/016164104225013743; National Research Council (U. S. ) . Committee for the update of the Guide for the Care and Use of Laboratory Animals.  Institute or Laboratory Animal Research (U. S. )  National Academies Press (U. S. ), 2011, GUIDE CARE USE LAB A, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Navarro X, 2009, INT REV NEUROBIOL, V87, P105, DOI 10.1016/S0074-7742(09)87006-2; Ney KW, 1921, ANN SURG, V74, P37; Nichols CM, 2005, BEHAV BRAIN RES, V163, P143, DOI 10.1016/j.bbr.2005.05.003; Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003; Nolte J., 2002, HUMAN BRAIN INTRO IT, P197; OCHOA JL, 1993, PAIN, V54, P191, DOI 10.1016/0304-3959(93)90208-7; Papalia I, 2006, J NEUROSCI METH, V154, P198, DOI 10.1016/j.jneumeth.2005.12.012; Papalia I, 2003, J NEUROSCI METH, V127, P43, DOI 10.1016/S0165-0270(03)00098-0; PHILIPEAUX JM, 1870, ARCH PHYSL NORM PATH, V3, P618; de Sousa MVP, 2014, J NEUROSCI METH, V232, P1, DOI 10.1016/j.jneumeth.2014.04.017; Pitcher GM, 1999, J NEUROSCI METH, V87, P185, DOI 10.1016/S0165-0270(99)00004-7; PITTS GC, 1977, AM J PHYSIOL, V232, pR38, DOI 10.1152/ajpregu.1977.232.1.R38; Puigdellivol-Sanchez A, 2005, RESTOR NEUROL NEUROS, V23, P97; Raimondo S, 2009, INT REV NEUROBIOL, V87, P81, DOI 10.1016/S0074-7742(09)87005-0; RAKONCZAY Z, 1986, J NEUROCHEM, V46, P280, DOI 10.1111/j.1471-4159.1986.tb12959.x; RILEY DA, 1988, BRAIN RES, V453, P79, DOI 10.1016/0006-8993(88)90145-X; Ring EFJ, 2012, PHYSIOL MEAS, V33, pR33, DOI 10.1088/0967-3334/33/3/R33; Rinker B, 2017, ANN PLAS SURG, V78, pS292, DOI 10.1097/SAP.0000000000001037; Roglio I, 2008, NEUROSCIENCE, V155, P673, DOI 10.1016/j.neuroscience.2008.06.034; Ronchi G, 2010, J NEUROSCI METH, V188, P71, DOI 10.1016/j.jneumeth.2010.01.024; Ronchi G, 2009, J NEUROSCI METH, V179, P51, DOI 10.1016/j.jneumeth.2009.01.011; Rosberg HE, 2004, SCAND J PLAST RECONS, V38, P347, DOI 10.1080/02844310410022117; Rupp AF, 2007, FUNCTIONAL ELECTROPH; Rupp A, 2007, SOMATOSENS MOT RES, V24, P1, DOI 10.1080/08990220601116329; Sacharuk VZ, 2011, CLINICS, V66, P1259, DOI 10.1590/S1807-59322011000700023; Safa B, 2016, HAND CLIN, V32, P127, DOI 10.1016/j.hcl.2015.12.012; Santos AP, 2007, ANAT REC, V290, P477, DOI 10.1002/ar.20519; Sarikcioglu L, 2001, INT J NEUROSCI, V109, P173, DOI 10.3109/00207450108986533; SEDDON HJ, 1947, BRIT J SURG, V35, P151, DOI 10.1002/bjs.18003513808; Shin RH, 2009, J BONE JOINT SURG AM, V91A, P2194, DOI 10.2106/JBJS.H.01301; Shterenshis M, 2017, CENT ASIAN J GLOB HE, V6, DOI 10.5195/cajgh.2017.289; Stossel M, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.813; STRANGE FGS, 1947, BRIT J SURG, V34, P423, DOI 10.1002/bjs.18003413617; Strasberg JE, 1999, J RECONSTR MICROSURG, V15, P287, DOI 10.1055/s-2007-1000103; Sulaiman W, 2013, OCHSNER J, V13, P100; SZABOLCS MJ, 1991, J HISTOCHEM CYTOCHEM, V39, P1617, DOI 10.1177/39.12.1719070; TAYLOR GI, 1976, PLAST RECONSTR SURG, V57, P413, DOI 10.1097/00006534-197604000-00001; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; TOWNSEND PLG, 1984, BRIT J PLAST SURG, V37, P1, DOI 10.1016/0007-1226(84)90034-1; Urbanchek MS, 1999, J RECONSTR MICROSURG, V15, P143, DOI 10.1055/s-2007-1000085; Valero-Cabre A, 2001, BRAIN RES, V919, P302, DOI 10.1016/S0006-8993(01)03052-9; Van Meeteren N. L. U., 1993, Physiotherapy Theory and Practice, V9, P77, DOI 10.3109/09593989309052919; vanMeeteren NLU, 1997, ARCH PHYS MED REHAB, V78, P70, DOI 10.1016/S0003-9993(97)90013-7; Vargel I, 2009, J RECONSTR MICROSURG, V25, P425, DOI 10.1055/s-0029-1223852; Vargel I, 2009, J RECONSTR MICROSURG, V25, P243, DOI 10.1055/s-0028-1104557; Vincent R., 2006, PERIPHERAL NERVE SUR, P299; WAKISAKA S, 1991, PAIN, V46, P299, DOI 10.1016/0304-3959(91)90113-C; WALL PD, 1979, PAIN, V7, P103, DOI 10.1016/0304-3959(79)90002-2; Wang YR, 2013, HAND CLIN, V29, P349, DOI 10.1016/j.hcl.2013.04.004; Wang YX, 2010, ACAD RADIOL, V17, P1492, DOI 10.1016/j.acra.2010.07.007; Werdin F, 2009, J NEUROSCI METH, V182, P71, DOI 10.1016/j.jneumeth.2009.05.017; West MJ, 2012, BASIC STEREOLOGY BIO, V1, P31; Wood M. J., 2015, NERVE SURG, V1, P1; World I, 2017, NEUR ANT STAIN PROT; Wu Y., 2013, ELECTRODIAGNOSIS NEW; Yanase Y., 2004, EXPT CLIN RECONSTRUC, P44; Zochodne DW, 2008, NEUROBIOLOGY OF PERIPHERAL NERVE REGENERATION, P153, DOI 10.1017/CBO9780511541759.007; Zochodne DW, 2008, NEUROBIOLOGY OF PERIPHERAL NERVE REGENERATION, P8, DOI 10.1017/CBO9780511541759.002	152	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195692	10.1371/journal.pone.0195692	http://dx.doi.org/10.1371/journal.pone.0195692			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659600	gold, Green Submitted, Green Published			2022-12-27	WOS:000430061100025
J	Chaykovska, L; Heunisch, F; von Einem, G; Hocher, CF; Tsuprykov, O; Pavkovic, M; Sandner, P; Kretschmer, A; Chu, C; Elitok, S; Stasch, JP; Hocher, B				Chaykovska, Lyubov; Heunisch, Fabian; von Einem, Gina; Hocher, Carl-Friedrich; Tsuprykov, Oleg; Pavkovic, Mira; Sandner, Peter; Kretschmer, Axel; Chu, Chang; Elitok, Saban; Stasch, Johannes-Peter; Hocher, Berthold			Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; CYCLIC GUANOSINE-MONOPHOSPHATE; ACUTE KIDNEY INJURY; SOLUBLE GUANYLATE-CYCLASE; INDUCED NEPHROPATHY; NITRIC-OXIDE; HEART-FAILURE; CARDIAC-CATHETERIZATION; REPLACEMENT THERAPY; CHRONIC HYPOXIA	Background The use of iodine-based contrast agents entails the risk of contrast induced nephropathy (CIN). Radiocontrast agents elicit the third most common cause of nephropathy among hospitalized patients, accounting for 11-12% of cases. CIN is connected with clinically significant consequences, including increased morbidity, prolonged hospitalization, increased risk of complications, potential need for dialysis, and increased mortality rate. The number of in hospital examinations using iodine-based contrast media has been significantly increasing over the last decade. In order to protect patients from possible complications of such examinations, new biomarkers are needed that are able to predict a risk of contrast-induced nephropathy. Urinary and plasma cyclic guanosine monophosphate (cGMP) concentrations are influenced by renal function. Urinary cGMP is primarily of renal cellular origin. Therefore, we assessed if urinary cGMP concentration may predict major adverse renal events (MARE) after contrast media exposure during coronary angiography. Methods Urine samples were prospectively collected from non-randomized consecutive patients with either diabetes or preexisting impaired kidney function receiving intra-arterial contrast medium (CM) for emergent or elective coronary angiography at the Charite Campus Mitte, University Hospital Berlin. Urinary cGMP concentration in spot urine was analyzed 24 hours after CM exposure. Patients were followed up over 90 days for occurrence of death, initiation of dialysis, doubling of plasma creatinine concentration or MARE. Results In total, 289 consecutive patients were included into the study. Urine cGMP/creatinine ratio 24 hours before CM exposure expressed as mean +/- SD was predictive for the need of dialysis (no dialysis: 89.77 +/- 92.85 mu M/mM, n = 277; need for dialysis: 140.3 +/- 82.90 mu M/mM, n = 12, p = 0.008), death (no death during follow-up: 90.60 +/- 92.50 mu M/mM, n = 280; death during follow-up: 169.88 +/- 81.52 mu M/mM, n = 9; p = 0.002), and the composite endpoint MARE (no MARE: 86.02 +/- 93.17 mu M/mM, n = 271; MARE: 146.64 +/- 74.68 mu M/mM, n = 18, p<0.001) during the follow-up of 90 days after contrast media application. cGMP/creatinine ratio stayed significantly increased at values exceeding 120 pM/mM in patients who developed MARE, required dialysis or died. Conclusions Urinary cGMP/creatinine ratio >= 120 mu M/mM before CM exposure is a promising biomarker for the need of dialysis and all-cause mortality 90 days after CM exposure in patients with preexisting renal impairment or diabetes.	[Chaykovska, Lyubov; Heunisch, Fabian; von Einem, Gina; Hocher, Carl-Friedrich] Charite Univ Med Berlin, Ctr Cardiovasc Res, Berlin, Germany; [Chaykovska, Lyubov] Univ Hosp Zurich, Dept Vasc Surg, Zurich, Switzerland; [Chaykovska, Lyubov; Tsuprykov, Oleg; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Pavkovic, Mira; Sandner, Peter; Kretschmer, Axel] Bayer AG, Biomarker Res, Wuppertal, Germany; [Chu, Chang] Jinan Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Elitok, Saban] Klinikum Ernst von Bergmann, Dept Nephrol & Endocrinol Diabetol, Potsdam, Germany; [Stasch, Johannes-Peter] Martin Luther Univ Halle Wittenberg, Sch Pharm, Dept Pharmacol, Halle, Germany; [Stasch, Johannes-Peter] Bayer AG, Cardiovasc Res, Wuppertal, Germany; [Hocher, Berthold] Hunan Normal Univ, Sch Med, Key Lab Study & Discovery Small Targeted Mol Huna, Changsha, Hunan, Peoples R China; [Hocher, Berthold] Jinan Univ, Div Histol & Embryol, Coll Med, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; University Zurich Hospital; University of Potsdam; Bayer AG; Jinan University; Klinikum Ernst von Bergmann; Martin Luther University Halle Wittenberg; Bayer AG; Hunan Normal University; Jinan University	Hocher, B (corresponding author), Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.; Hocher, B (corresponding author), Hunan Normal Univ, Sch Med, Key Lab Study & Discovery Small Targeted Mol Huna, Changsha, Hunan, Peoples R China.; Hocher, B (corresponding author), Jinan Univ, Div Histol & Embryol, Coll Med, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China.	hocher@uni-potsdam.de	Hocher, Berthold/AAC-3510-2020; Chu, Chang/ABB-5967-2021	Hocher, Berthold/0000-0001-8143-0579; Chaykovska, Lyubov/0000-0002-6250-4007	Bayer Pharma AG, Wuppertal, Germany	Bayer Pharma AG, Wuppertal, Germany	This work was supported by Bayer Pharma AG, Wuppertal, Germany provided measurements of cGMP as well as salary for authors[MP, PS, AK, JPS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO K, 1988, KLIN WOCHENSCHR, V66, P768, DOI 10.1007/BF01726575; Andreucci M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/362725; Andreucci M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872574; [Anonymous], 1968, World Health Organ Tech Rep Ser, V405, P5; [Anonymous], 2013, KIDNEY INT SUPPL, V3, P19, DOI DOI 10.1038/KISUP.2012.64; Au TH, 2014, ANN PHARMACOTHER, V48, P1332, DOI 10.1177/1060028014541996; Bae EH, 2011, KOREAN J PHYSIOL PHA, V15, P273, DOI 10.4196/kjpp.2011.15.5.273; BLONDE L, 1974, J CLIN INVEST, V53, P163, DOI 10.1172/JCI107534; Boerrigter G, 2007, HYPERTENSION, V49, P1128, DOI 10.1161/HYPERTENSIONAHA.106.083832; BROADUS AE, 1970, J CLIN INVEST, V49, P2222, DOI 10.1172/JCI106441; BURNETT JC, 2007, BMC PHARM SUPPL 1, V7; Cannone V, 2013, HYPERTENSION, V62, P860, DOI 10.1161/HYPERTENSIONAHA.113.01344; Chapman AB, 1998, KIDNEY INT, V54, P2056, DOI 10.1046/j.1523-1755.1998.00217.x; Chaykovska L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145723; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Gami AS, 2004, MAYO CLIN PROC, V79, P211, DOI 10.4065/79.2.211; Glode A, 2017, MOL METAB, V6, P276, DOI 10.1016/j.molmet.2016.12.010; Go AS, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-22; Greene SJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000536; GUAN ZG, 1995, KIDNEY INT, V47, P1569, DOI 10.1038/ki.1995.220; Harel Z, 2013, KIDNEY INT, V83, P901, DOI 10.1038/ki.2012.451; HEIM JM, 1988, Z KARDIOL, V77, P41; HEIM JM, 1990, KLIN WOCHENSCHR, V68, P709, DOI 10.1007/BF01647578; Heunisch F, MEDICINE BALTIMORE, V96, pe6065; JAKOB G, 1994, CLIN CHEM, V40, P96; JAKOB G, 1994, HORM METAB RES, V26, P121, DOI 10.1055/s-2007-1000788; Jarocka IT, 2013, ADV MED SCI-POLAND, V58, P369, DOI 10.2478/ams-2013-0006; Klein SJ, 2018, INTENS CARE MED, V44, P323, DOI 10.1007/s00134-018-5126-8; Krawutschke C, 2015, ARTERIOSCL THROM VAS, V35, P2011, DOI 10.1161/ATVBAHA.115.306133; Kuno Y, 2011, BRIT J PHARMACOL, V162, P1389, DOI 10.1111/j.1476-5381.2010.01149.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mair J, 1998, CIRCULATION, V97, P1209, DOI 10.1161/01.CIR.97.12.1209; Maliborski A, 2011, MED SCI MONITOR, V17, pRA199, DOI 10.12659/MSM.881923; Malyszko J, 2009, RENAL FAILURE, V31, P910, DOI 10.3109/08860220903216113; MARUMO F, 1990, CLIN CHEM, V36, P1650; Matata BM, 2001, DIABETES, V50, P2603, DOI 10.2337/diabetes.50.11.2603; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Neylon M, 1997, J PHYSIOL-LONDON, V501, P243, DOI 10.1111/j.1469-7793.1997.243bo.x; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Rodriguez-Iturbe B, 2005, KIDNEY INT, V68, P2131, DOI 10.1111/j.1523-1755.2005.00669.x; Sato A, 2017, INT J CARDIOL, V227, P424, DOI 10.1016/j.ijcard.2016.11.019; SIRAGY HM, 1992, HYPERTENSION, V19, P775, DOI 10.1161/01.HYP.19.6.775; Stasch JP, 2015, CURR OPIN PHARMACOL, V21, P95, DOI 10.1016/j.coph.2014.12.014; Stasch JP, 2002, BRIT J PHARMACOL, V135, P344, DOI 10.1038/sj.bjp.0704483; Takiyama Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/837421; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; TSUTAMOTO T, 1994, CIRCULATION, V90, P823, DOI 10.1161/01.CIR.90.2.823; VORDERWINKLER KP, 1991, CLIN CHEM, V37, P186; Wald R, 2014, CRIT CARE MED, V42, P868, DOI 10.1097/CCM.0000000000000042; Wang YR, 2006, AM J PHYSIOL-RENAL, V290, pF167, DOI 10.1152/ajprenal.00197.2005; WONG KR, 1988, AM J PHYSIOL, V255, pF1220, DOI 10.1152/ajprenal.1988.255.6.F1220	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195828	10.1371/journal.pone.0195828	http://dx.doi.org/10.1371/journal.pone.0195828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649334	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900095
J	Dolmatov, IY; Afanasyev, SV; Boyko, AV				Dolmatov, Igor Yu.; Afanasyev, Sergey V.; Boyko, Alexey V.			Molecular mechanisms of fission in echinoderms: Transcriptome analysis	PLOS ONE			English	Article							CUCUMBER STICHOPUS-JAPONICUS; CATCH CONNECTIVE-TISSUE; COLLAGEN CROSS-LINKING; SEA-CUCUMBER; ASEXUAL REPRODUCTION; BODY-WALL; MATRIX METALLOPROTEINASES; FIBRILLIN MICROFIBRILS; MULTIPOTENT EPITHELIUM; ANTERIOR REGENERATION	Echinoderms are capable of asexual reproduction by fission. An individual divides into parts due to changes in the strength of connective tissue of the body wall. The structure of connective tissue and the mechanisms of variations in its strength in echinoderms remain poorly studied. An analysis of transcriptomes of individuals during the process of fission provides a new opportunity to understand the mechanisms of connective tissue mutability. In the holothurian Cladolabes schmeltzii, we have found a rather complex organization of connective tissue. Transcripts of genes encoding a wide range of structural proteins of extracellular matrix, as well as various proteases and their inhibitors, have been discovered. All these molecules may constitute a part of the mechanism of connective tissue mutability. According to our data, the extracellular matrix of echinoderms is substantially distinguished from that of vertebrates by the lack of elastin, fibronectins, and tenascins. In case of fission, a large number of genes of transcription factors and components of different signaling pathways are expressed. Products of these genes are probably involved in regulation of asexual reproduction, connective tissue mutability, and preparation of tissues for subsequent regeneration. It has been shown that holothurian tensilins are a special group of tissue inhibitors of metalloproteinases, which has formed within the class Holothuroidea and is absent from other echinoderms. Our data can serve a basis for the further study of the mechanisms of extracellular matrix mutability, as well as the mechanisms responsible for asexual reproduction in echinoderms.	[Dolmatov, Igor Yu.; Boyko, Alexey V.] Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Natl Sci Ctr Marine Biol, Vladivostok, Russia; [Dolmatov, Igor Yu.; Boyko, Alexey V.] Far Eastern Fed Univ, Vladivostok, Russia; [Afanasyev, Sergey V.] Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia	Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Far Eastern Federal University; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Dolmatov, IY (corresponding author), Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Natl Sci Ctr Marine Biol, Vladivostok, Russia.; Dolmatov, IY (corresponding author), Far Eastern Fed Univ, Vladivostok, Russia.	idolmatov@mail.ru	Boyko, Alexey/AAK-4081-2020; Dolmatov, Igor Yu/A-7704-2014; Afanasyev, Sergey V/K-9309-2015	Boyko, Alexey/0000-0003-0342-9104; Dolmatov, Igor Yu/0000-0003-3923-8131; Afanasyev, Sergey V/0000-0002-8393-820X	Russian Foundation for Basic Research [17-04-01334]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Basic Research (grant No 17-04-01334) for IYD, http://www.rfbr.ru/rffi/eng.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Ba HZ, 2015, GENE, V565, P96, DOI 10.1016/j.gene.2015.03.071; Balavoine G, 2014, INT J DEV BIOL, V58, P469, DOI 10.1387/ijdb.140148gb; Balser E.J., 2004, P3, DOI 10.1201/9780203970881.pt1; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barbaglio A, 2015, ZOOLOGY, V118, P147, DOI 10.1016/j.zool.2014.10.003; Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200; Bely AE, 2001, DEVELOPMENT, V128, P2781; Birenheide R, 1998, BIOL BULL-US, V194, P253, DOI 10.2307/1543095; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brusca RC, 2003, INVERTEBRATES; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Chen L, 2016, CELL TISSUE RES, V366, P509, DOI 10.1007/s00441-016-2451-5; Chiquet-Ehrismann R, 2011, COLD SPRING HARB PER, V3; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Clouse RM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150377; Conand C, 1996, OCEANOL ACTA, V19, P209; Conand C., 1997, SPC BECHE DE MER INF, V9, P5; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Crocker SJ, 2004, J NEUROSCI RES, V75, P1, DOI 10.1002/jnr.10836; Davies JA, 2001, EXTRACELLULAR MATRIX; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Dolmatov IY, 2014, RUSS J MAR BIOL+, V40, P228, DOI 10.1134/S1063074014030031; Dolmatov IY, 2012, RUSS J MAR BIOL+, V38, P243, DOI 10.1134/S1063074012030042; Dolmatov Igor Yu, 2014, ScientificWorldJournal, V2014, P527234, DOI 10.1155/2014/527234; Dolmatov IY, 2016, ZOOMORPHOLOGY, V135, P173, DOI 10.1007/s00435-015-0299-y; Eaves AA, 2003, NATURE, V425, P146, DOI 10.1038/425146a; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Elphick MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044492; EMSON RH, 1987, J EXP MAR BIOL ECOL, V111, P195, DOI 10.1016/0022-0981(87)90028-1; Engelstadter J, 2008, BIOESSAYS, V30, P1138, DOI 10.1002/bies.20833; English WR, 2001, J BIOL CHEM, V276, P42018, DOI 10.1074/jbc.M107783200; ERLINGER R, 1993, J ANAT, V183, P1; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Faunes F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022569; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Fields GB, 2015, MATRIX BIOL, V44-46, P239, DOI 10.1016/j.matbio.2015.01.002; Finnerty JR, 2003, INT J DEV BIOL, V47, P523; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; FUJIWARA S, 1992, DEV GROWTH DIFFER, V34, P463; Gasparini F, 2016, MOL PHYLOGENET EVOL, V95, P46, DOI 10.1016/j.ympev.2015.11.001; Geng H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2551; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Girich AS, 2017, WOUND REPAIR REGEN, V25, P828, DOI 10.1111/wrr.12591; Giusti B, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00237; Green KA, 2005, BIOESSAYS, V27, P894, DOI 10.1002/bies.20281; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hyman LH, 1955, INVERTEBRATES ECHINO; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Hynes RO., 2012, COLD SPRING HARB PER, V4, pA004903, DOI [10.1101/cshperspect.a004903, DOI 10.1101/CSHPERSPECT.A004903]; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Ivanova-Kazas O.M, 1977, ASEXUAL REPROD ANIMA; Janssen T, 2015, MOL PHYLOGENET EVOL, V92, P82, DOI 10.1016/j.ympev.2015.06.004; Jo J, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw006; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kamenev YO, 2013, TISSUE CELL, V45, P126, DOI 10.1016/j.tice.2012.10.002; Kamenev YO, 2017, MICROSC RES TECHNIQ, V80, P183, DOI 10.1002/jemt.22786; Kamenev YO, 2015, MICROSC RES TECHNIQ, V78, P540, DOI 10.1002/jemt.22507; Kariya Y, 1997, CARBOHYD RES, V297, P273, DOI 10.1016/S0008-6215(96)00258-3; KARIYA Y, 1990, J BIOL CHEM, V265, P5081; KAWAMURA K, 1994, INT J DEV BIOL, V38, P369; Kawamura K, 2013, DEV BIOL, V384, P343, DOI 10.1016/j.ydbio.2013.10.004; Kielty CM, 2002, PHILOS T R SOC B, V357, P207, DOI 10.1098/rstb.2001.1029; Kikuchi M, 2015, DEV GENES EVOL, V225, P275, DOI 10.1007/s00427-015-0510-7; Kim YS, 2012, BIOMOL THER, V20, P133, DOI 10.4062/biomolther.2012.20.2.133; Klopfenstein D, 2016, TANGHAIBAO GOATOOLS, DOI [10.5281/zenodo.159493, DOI 10.5281/ZENODO.159493]; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Lamash NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058433; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lee NV, 2005, J BIOL CHEM, V280, P34796, DOI 10.1074/jbc.M506980200; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Mashanov Vladimir S, 2012, Mob Genet Elements, V2, P244; Mashanov VS, 2012, GENE EXPR PATTERNS, V12, P24, DOI 10.1016/j.gep.2011.10.003; MENTON DN, 1973, J MORPHOL, V141, P185, DOI 10.1002/jmor.1051410206; Miller AK, 2017, MOL PHYLOGENET EVOL, V111, P110, DOI 10.1016/j.ympev.2017.02.014; Mladenov Philip V., 1994, P339; Mo J, 2016, P NATL ACAD SCI USA, V113, pE6362, DOI 10.1073/pnas.1609341113; Motokawa T, 2004, BIOL BULL-US, V206, P4, DOI 10.2307/1543193; Motokawa T, 2003, BIOL BULL-US, V205, P261, DOI 10.2307/1543290; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; MOTOKAWA T, 1982, J EXP BIOL, V99, P29; Motokawa T, 2015, J EXP BIOL, V218, P703, DOI 10.1242/jeb.115972; Motokawa T, 2012, BIOL BULL-US, V222, P150, DOI 10.1086/BBLv222n2p150; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Myers JC, 2007, BIOCHEM J, V404, P535, DOI 10.1042/BJ20070201; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Nyberg KG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-287; Ozpolat BD, 2015, DEV BIOL, V405, P123, DOI 10.1016/j.ydbio.2015.06.001; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Olivieri J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-24; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Onai T, 2009, DEV BIOL, V332, P223, DOI 10.1016/j.ydbio.2009.05.571; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pavelitz T, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-23; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Pfeiffer BJ, 2005, MATRIX BIOL, V24, P451, DOI 10.1016/j.matbio.2005.07.001; Purwati P., 2004, SPC BECHE DE MER INF, V20, P26; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Ribeiro AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023364; Ribeiro AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049016; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Ryan JF, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-37; Sakurai T, 2012, INT J DEV BIOL, V56, P173, DOI 10.1387/ijdb.113439ts; Schwarzbauer JE, 2011, COLD SPRING HARB PER, V3; Scimone ML, 2016, ELIFE, V5, DOI 10.7554/eLife.12845; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5; Shivdasani RA, 2002, DEV BIOL, V249, P191, DOI 10.1006/dbio.2002.0765; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Smiley Scott, 1994, P401; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Sun LN, 2013, GENET MOL RES, V12, P5321, DOI 10.4238/2013.November.7.7; Szulgit G, 2007, BIOESSAYS, V29, P645, DOI 10.1002/bies.20597; Takehana Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085644; Takemae N, 2009, BIOL BULL-US, V216, P45; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178; Tamori M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155673; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Thurmond FA, 1997, CONNECT TISSUE RES, V36, P211, DOI 10.3109/03008209709160221; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; Trotter JA, 1996, MATRIX BIOL, V15, P99, DOI 10.1016/S0945-053X(96)90151-1; Trotter JA, 1999, MATRIX BIOL, V18, P569, DOI 10.1016/S0945-053X(99)00050-5; Trotter JA, 2000, COMP BIOCH PHYSL, V126, P95; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; Uthicke S, 2001, MAR FRESHWATER RES, V52, P205, DOI 10.1071/MF00064; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Whittaker CA, 2006, DEV BIOL, V300, P252, DOI 10.1016/j.ydbio.2006.07.044; Wilkie IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120339; Wilkie IC, 2005, PROG MOLEC, V39, P221; Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185; WILKIE IC, 1984, MAR BEHAV PHYSIOL, V11, P1, DOI 10.1080/10236248409387032; Yamada A, 2010, J EXP BIOL, V213, P3416, DOI 10.1242/jeb.044149; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yan LJ, 2014, J AGR FOOD CHEM, V62, P4769, DOI 10.1021/jf500923y; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353; Yu CP, 2017, FISH SHELLFISH IMMUN, V70, P553, DOI 10.1016/j.fsi.2017.09.011; Yurchenco P.D., 2011, COLD SPRING HARB PER, V3; Zhang XJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003790; Zhou DY, 2014, FOOD CHEM, V158, P192, DOI 10.1016/j.foodchem.2014.02.105; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zorn AM, 2007, INT REV CYTOL, V259, P49, DOI 10.1016/S0074-7696(06)59002-3	166	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195836	10.1371/journal.pone.0195836	http://dx.doi.org/10.1371/journal.pone.0195836			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649336	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900097
J	Feinberg, M; Wehling, E				Feinberg, Matthew; Wehling, Elisabeth			A moral house divided: How idealized family models impact political cognition	PLOS ONE			English	Article							METAPHOR; CONSERVATIVES; INHERITANCE; EMBODIMENT; PERSUASION; DOMINANCE; LIBERALS; STYLE	People's political attitudes tend to fall into two groups: progressive and conservative. Moral Politics Theory asserts that this ideological divide is the product of two contrasting moral worldviews, which are conceptually anchored in individuals' cognitive models about ideal parenting and family life. These models, here labeled the strict and nurturant models, serve as conceptual templates for how society should function, and dictate whether one will endorse more conservative or progressive positions. According to Moral Politics Theory, individuals map their parenting ideals onto the societal domain by engaging the nation-as-family metaphor, which facilitates reasoning about the abstract social world (the nation) in terms of more concrete world experience (family life). In the present research, we conduct an empirical examination of these core assertions of Moral Politics Theory. In Studies 1-3, we experimentally test whether family ideals directly map onto political attitudes while ruling out alternative explanations. In Studies 4-5, we use both correlational and experimental methods to examine the nation-as-family metaphor's role in facilitating the translation of family beliefs into societal beliefs and, ultimately, political attitudes. Overall, we found consistent support for Moral Politics Theory's assertions that family ideals directly impact political judgment, and that the nation-as-family metaphor serves a mediating role in this phenomenon.	[Feinberg, Matthew] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada; [Wehling, Elisabeth] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of Toronto; University of California System; University of California Berkeley	Feinberg, M (corresponding author), Univ Toronto, Rotman Sch Management, Toronto, ON, Canada.	matthew.feinberg@rotman.utoronta.ca			U.S. Department of Defense [W911NF-12-C-0022]; German Academic Exchange Service London	U.S. Department of Defense(United States Department of Defense); German Academic Exchange Service London	This work was supported by the U.S. Department of Defense, W911NF-12-C-0022 (Dr. Elisabeth Wehling); and the German Academic Exchange Service London (Dr. Elisabeth Wehling).	Abend L, 2008, TIME MAGAZINE   0122; Adorno Theodor W, 1950, AUTHORITARIAN PERSON; Altemeyer R.A., 1996, AUTHORITARIAN SPECTE; [Anonymous], 2017, PRIMAL STUDIOS; Bai M., 2005, NEW YORK TIMES MAGAZ; Bar-Lev Z, 2007, J LANG POLIT, V6, P459, DOI 10.1075/jlp.6.3.11bar; Barker D, 2005, POLIT BEHAV, V27, P375, DOI 10.1007/s11109-005-8145-4; Barker DC, 2006, AM POLIT SCI REV, V100, P249, DOI 10.1017/S0003055406062149; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Blekesaune M, 2003, EUR SOCIOL REV, V19, P415, DOI 10.1093/esr/19.5.415; Bougher LD, 2012, POLIT PSYCHOL, V33, P145, DOI 10.1111/j.1467-9221.2011.00865.x; Casasanto D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011805; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; CharterisBlack J, 2005, POLITICIANS AND RHETORIC: THE PERSUASIVE POWER OF METAPHOR, P1, DOI 10.1057/9780230501706; Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054; Cienki A, 2005, COGN LINGUIST, V16, P279, DOI 10.1515/cogl.2005.16.2.279; Cienki A., 2005, INFORM DESIGN J DOCU, V131, P27; Cienki Alan, 2004, J LANG POLIT, V3, P409, DOI [10.1075/jlp.3.3.04cie, DOI 10.1075/JLP.3.3.04CIE]; Deason G, 2012, BASIC APPL SOC PSYCH, V34, P254, DOI 10.1080/01973533.2012.674450; Degani, 2015, FRAMING RHETORIC LEA; Duriez B, 2007, EUR J PERSONALITY, V21, P507, DOI 10.1002/per.623; Feinberg M, 2015, PERS SOC PSYCHOL B, V41, P1665, DOI 10.1177/0146167215607842; Feinberg M, 2013, PSYCHOL SCI, V24, P56, DOI 10.1177/0956797612449177; FELDMAN S, 1988, AM J POLIT SCI, V32, P416, DOI 10.2307/2111130; Fraley RC, 2012, PSYCHOL SCI, V23, P1425, DOI 10.1177/0956797612440102; Gibbs R., 2006, EMBODIMENT COGNITIVE; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; Gibbs RW, 1996, COGNITION, V61, P309, DOI 10.1016/S0010-0277(96)00723-8; Gibbs RW, 1997, J MEM LANG, V37, P141, DOI 10.1006/jmla.1996.2506; GLASS J, 1986, AM SOCIOL REV, V51, P685, DOI 10.2307/2095493; Goren P, 2005, AM J POLIT SCI, V49, P881, DOI 10.1111/j.1540-5907.2005.00161.x; Grady J., 1997, FDN MEANING PRIMARY; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Greeley Andrew M., 2006, TRUTH CONSERVATIVE C; Hadjar A, 2008, YOUNG, V163, P279; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hayes A.F., 2012, CISC VIS NETW IND GL; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Iyengar S, 2005, FORUM, V3, P1; Janoff-Bulman R., 2014, J SOCIAL POLITICAL P, V2, P43, DOI [10.5964/jspp.v2i1.243, DOI 10.5964/JSPP.V2I1.243]; Janoff-Bulman R, 2008, J EXP SOC PSYCHOL, V44, P1091, DOI 10.1016/j.jesp.2007.11.003; Jennings M.Kent., 1982, GENERATIONS POLITICS; JENNINGS MK, 1968, AM POLIT SCI REV, V62, P169, DOI 10.2307/1953332; Jensen LA, 2009, J SCI STUD RELIG, V48, P121, DOI 10.1111/j.1468-5906.2009.01433.x; Johnson C., 1997, CULTURAL TYPOLOGICAL, P155; Johnson M., 1987, BODY MIND BODILY BAS; Jost JT, 2009, ANNU REV PSYCHOL, V60, P307, DOI 10.1146/annurev.psych.60.110707.163600; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Lakoff G., 1980, METAPHORS WE LIVE; Lakoff G., 2012, LITTLE BLUE BOOK ESS; Lakoff G., 1996, MORAL POLITICS CONSE; Lakoff G., POLITICAL MIND WHY Y; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Landau MJ, 2009, PSYCHOL SCI, V20, P1421, DOI 10.1111/j.1467-9280.2009.02462.x; Layman G., 2007, ANN M SO POL SCI ASS; McAdams DP, 2008, J PERS SOC PSYCHOL, V95, P978, DOI 10.1037/a0012650; MCCLOSKY H, 1985, BRIT J POLIT SCI, V15, P329, DOI 10.1017/S0007123400004221; McClosky Herbert., 1984, AM ETHOS PUBLIC ATTI, DOI DOI 10.4159/HARVARD.9780674428522; McCrummen S., WASHINGTON POST; McDevitt M, 2006, INT J PUBLIC OPIN R, V18, P67, DOI 10.1093/ijpor/edh079; Meier BP, 2007, J PERS SOC PSYCHOL, V93, P699, DOI 10.1037/0022-3514.93.5.699; Meyer J., 2016, AM INTEREST; MILBURN MA, 1995, POLIT PSYCHOL, V16, P447, DOI 10.2307/3792222; Moeller SK, 2008, PSYCHOL SCI, V19, P355, DOI 10.1111/j.1467-9280.2008.02093.x; Moses JF., 2014, POLITICAL PSYCHOL; Musolff A, 2006, METAPHOR SYMBOL, V21, P23, DOI 10.1207/s15327868ms2101_2; Musolff A, 2004, METAPHOR AND POLITICAL DISCOURSE: ANALOGICAL REASONING IN DEBATES ABOUT EUROPE, P1, DOI 10.1057/9780230504516; Narvaez D, 2010, PERSPECT PSYCHOL SCI, V5, P185, DOI 10.1177/1745691610362353; Nelson TE, 2005, POLIT PSYCHOL, V26, P489, DOI 10.1111/j.1467-9221.2005.00428.x; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; NIEMI RG, 1991, AM J POLIT SCI, V35, P970, DOI 10.2307/2111502; Ohl JJ, 2013, COMMUN STUD, V64, P488, DOI 10.1080/10510974.2013.832340; Oppenheimer DM, 2010, SOC COGNITION, V28, P651, DOI 10.1521/soco.2010.28.5.651; Ottati V, 1999, J PERS SOC PSYCHOL, V77, P688, DOI 10.1037/0022-3514.77.4.688; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Rapoport E., 2016, OPEN DEMOCRACY; Rokeach M., 1973, NATURE HUMAN VALUES; Schlesinger M, 1997, J HEALTH POLIT POLIC, V22, P937, DOI 10.1215/03616878-22-4-937; Schlesinger M, 2000, AM POLIT SCI REV, V94, P611, DOI 10.2307/2585834; Schonpflug U, 2001, J CROSS CULT PSYCHOL, V32, P174, DOI 10.1177/0022022101032002005; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Skitka LJ, 2008, POLIT PSYCHOL, V29, P29, DOI 10.1111/j.1467-9221.2007.00611.x; Skitka LJ, 2005, J PERS SOC PSYCHOL, V88, P895, DOI 10.1037/0022-3514.88.6.895; Sontag S, 2002, ILLNESS METAPHOR AID; Sopory P, 2002, HUM COMMUN RES, V28, P382, DOI 10.1093/hcr/28.3.382; SWEETSER EE, 1992, POETICS TODAY, V13, P705, DOI 10.2307/1773295; Sweetser Eve., 1987, P 13 ANN M BERK LING, P446; Swift D., 2009, THESIS; Thibodeau PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016782; Turner M., 1987, DEATH IS MOTHER BEAU; WEBER SJ, 1972, PSYCHOL BULL, V77, P273, DOI 10.1037/h0032351; Wehling E, 2018, MORAL POLITICS SCALE; Wehling E., 2013, THESIS; Willems RM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.039.2009; Williams L, 2010, PSYCHOL SCI, V19, P302; Yun S.H., 2010, ADV SOCIAL WORK, V11, P174, DOI [https://doi.org/10.18060/437, DOI 10.18060/437]; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	100	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193347	10.1371/journal.pone.0193347	http://dx.doi.org/10.1371/journal.pone.0193347			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641618	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900012
J	Yetton, BD; McDevitt, EA; Cellini, N; Shelton, C; Mednick, SC				Yetton, Benjamin D.; McDevitt, Elizabeth A.; Cellini, Nicola; Shelton, Christian; Mednick, Sara C.			Quantifying sleep architecture dynamics and individual differences using big data and Bayesian networks	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; STAGE TRANSITIONS; WAKE TRANSITIONS; RISK-FACTORS; MEMORY; AGE; CONSOLIDATION; COGNITION; CHILDREN; PATTERN	The pattern of sleep stages across a night (sleep architecture) is influenced by biological, behavioral, and clinical variables. However, traditional measures of sleep architecture such as stage proportions, fail to capture sleep dynamics. Here we quantify the impact of individual differences on the dynamics of sleep architecture and determine which factors or set of factors best predict the next sleep stage from current stage information. We investigated the influence of age, sex, body mass index, time of day, and sleep time on static (e.g. minutes in stage, sleep efficiency) and dynamic measures of sleep architecture (e.g. transition probabilities and stage duration distributions) using a large dataset of 3202 nights from a non-clinical population. Multi-level regressions show that sex effects duration of all Non-Rapid Eye Movement (NREM) stages, and age has a curvilinear relationship for Wake After Sleep Onset (WASO) and slow wave sleep (SWS) minutes. Bayesian network modeling reveals sleep architecture depends on time of day, total sleep time, age and sex, but not BMI. Older adults, and particularly males, have shorter bouts (more fragmentation) of Stage 2, SWS, and they transition less frequently to these stages. Additionally, we showed that the next sleep stage and its duration can be optimally predicted by the prior 2 stages and age. Our results demonstrate the potential benefit of big data and Bayesian network approaches in quantifying static and dynamic architecture of normal sleep.	[Yetton, Benjamin D.; Cellini, Nicola; Mednick, Sara C.] Univ Calif Irvine, Dept Psychol, Irvine, CA 92697 USA; [McDevitt, Elizabeth A.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Cellini, Nicola] Univ Padua, Dept Gen Psychol, Padua, Italy; [Shelton, Christian] Univ Calif Riverside, Dept Comp Sci, Riverside, CA 92521 USA	University of California System; University of California Irvine; Princeton University; University of Padua; University of California System; University of California Riverside	Mednick, SC (corresponding author), Univ Calif Irvine, Dept Psychol, Irvine, CA 92697 USA.	mednicks@uci.edu	Cellini, Nicola/AAB-3926-2019; Shelton, Christian/GQJ-1146-2022	Cellini, Nicola/0000-0003-0306-4408; Shelton, Christian/0000-0001-6698-7838; Yetton, Benjamin/0000-0001-7729-9723; McDevitt, Elizabeth/0000-0001-9112-3775	National Science Foundation [GRFP2015211602, IIS 1510741]; NIH [R01AG046646]	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A National Science Foundation Graduate Research Fellowship Program (https://www.nsfgrfp.org/) supported Ben Yetton (Fellow Number GRFP2015211602). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For Sara Mednick's R01AG046646 (https://grants.nih.gov/grants/funding/r01.htm) NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Christian Shelton was supported by the National Science Foundation, IIS 1510741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1999, WIEN MED WOCHENSCHR, V145, P402; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Baker FC, 2015, PSYCHONEUROENDOCRINO, V60, P96, DOI 10.1016/j.psyneuen.2015.06.005; Berry RB, 2015, AASM MANUAL SCORING; BETTS TA, 1985, EUR J CLIN PHARMACOL, V28, P65, DOI 10.1007/BF00543712; Bianchi MT, 2012, J SLEEP RES, V21, P330, DOI 10.1111/j.1365-2869.2011.00937.x; Bianchi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011356; BIRKELAND AJ, 1982, NEUROENDOCRINOLOGY, V34, P126, DOI 10.1159/000123289; Bizzotto R, 2010, J PHARMACOKINET PHAR, V37, P137, DOI 10.1007/s10928-009-9148-2; Blackwell T, 2011, J AM GERIATR SOC, V59, P2217, DOI 10.1111/j.1532-5415.2011.03731.x; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Borbely A.A, 1982, HUM NEUROBIOL; Buckelmuller J, 2006, NEUROSCIENCE, V138, P351, DOI 10.1016/j.neuroscience.2005.11.005; Carskadon MA, 2005, PRINCIPLES PRACTICE, P13, DOI DOI 10.1016/B0-72-160797-7/50009-4; Cellini N, 2014, NEUROBIOL LEARN MEM, V114, P141, DOI 10.1016/j.nlm.2014.06.006; Chu-Shore J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014204; Cohen-Zion M, 2009, ADDICT BEHAV, V34, P976, DOI 10.1016/j.addbeh.2009.05.011; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Coyne KS, 2003, BJU INT, V92, P948, DOI 10.1111/j.1464-410X.2003.04527.x; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Alvares LD, 2013, NEUROSCIENCE, V244, P42, DOI 10.1016/j.neuroscience.2013.04.005; Dean DA, 2016, SLEEP, V39, P1151, DOI 10.5665/sleep.5774; Diekelmann S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00074; Diekelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077621; Diekelmann S, 2011, NEUROFORUM, V17, P74; Diekelmann S, 2013, SLEEP, V36, P149, DOI 10.5665/sleep.2322; Diekelmann S, 2012, NEUROBIOL LEARN MEM, V98, P103, DOI 10.1016/j.nlm.2012.07.002; Diekelmann S, 2010, BEHAV BRAIN RES, V208, P425, DOI 10.1016/j.bbr.2009.12.021; Drake C, 2013, J CLIN SLEEP MED, V9, P1195, DOI 10.5664/jcsm.3170; Drake CL, 2003, DEPRESS ANXIETY, V18, P163, DOI 10.1002/da.10151; EHLERS CL, 1989, ELECTROEN CLIN NEURO, V72, P118, DOI 10.1016/0013-4694(89)90172-7; El-Ad B, 2005, INT REV PSYCHIATR, V17, P277, DOI 10.1080/09540260500104508; Ferrillo F, 2007, SLEEP, V30, P157, DOI 10.1093/sleep/30.2.157; Fischer S, 2011, J SLEEP RES, V20, P267, DOI 10.1111/j.1365-2869.2010.00881.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; HEATH AC, 1990, SLEEP, V13, P318, DOI 10.1093/sleep/13.4.318; Hibbs AM, 2014, BEHAV SLEEP MED, V12, P412, DOI 10.1080/15402002.2013.825838; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Iber C., 2007, AASM MANUAL SCORING; Kemp B, 2000, IEEE T BIO-MED ENG, V47, P1185, DOI 10.1109/10.867928; KEMP B, 1986, SLEEP, V9, P405, DOI 10.1093/sleep/9.3.405; Kishi A, 2008, AM J PHYSIOL-REG I, V294, pR1980, DOI 10.1152/ajpregu.00925.2007; Kishi A, 2011, SLEEP, V34, P1423, DOI 10.5665/SLEEP.1292; Kjellsson MC, 2011, PHARM RES-DORDR, V28, P2610, DOI 10.1007/s11095-011-0490-x; Ko PRT, 2015, J CLIN SLEEP MED, V11, P1455, DOI 10.5664/jcsm.5288; Kupfer DJ, 1981, ELECTRONEUROPHYSIOLO, P87; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Latta F, 2005, SLEEP, V28, P1519, DOI 10.1093/sleep/28.12.1519; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; Mander BA, 2017, NEURON, V94, P19, DOI 10.1016/j.neuron.2017.02.004; Mander BA, 2016, TRENDS NEUROSCI, V39, P552, DOI 10.1016/j.tins.2016.05.002; McArdle N, 2001, AM J RESP CRIT CARE, V164, P1459, DOI 10.1164/ajrccm.164.8.2008146; McClelland GH, 2015, J CONSUM PSYCHOL, V25, P679, DOI 10.1016/j.jcps.2015.05.006; Mednick SC, 2006, TAKE NAP CHANGE YOUR; Minakawa EN, 2017, NEUROSCI LETT, V653, P362, DOI 10.1016/j.neulet.2017.05.054; MOFFITT PF, 1991, J INTERN MED, V230, P245, DOI 10.1111/j.1365-2796.1991.tb00438.x; Mong JA, 2011, J NEUROSCI, V31, P16107, DOI 10.1523/JNEUROSCI.4175-11.2011; Moser D, 2009, SLEEP, V32, P139, DOI 10.1093/sleep/32.2.139; Murphy K., 2001, COMPUTING SCI STAT, V33, P1024; Nettersheim A, 2015, J NEUROSCI, V35, P6696, DOI 10.1523/JNEUROSCI.1236-14.2015; Novelli L, 2010, J SLEEP RES, V19, P238, DOI 10.1111/j.1365-2869.2009.00785.x; O'Reilly C, 2014, J SLEEP RES, V23, P628, DOI 10.1111/jsr.12169; Ohayon MM, 2003, SLEEP, V31, P20; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Quan SF, 1997, SLEEP, V20, P1077; Rao MN, 2009, SLEEP, V32, P483, DOI 10.1093/sleep/32.4.483; Rechtschaffen K, 1968, MANUAL STANDARDIZED; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 1999, AM J RESP CRIT CARE, V159, P1527, DOI 10.1164/ajrccm.159.5.9809079; Redline S, 1998, SLEEP, V21, P759; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; SACK RL, 1986, J PINEAL RES, V3, P379, DOI 10.1111/j.1600-079X.1986.tb00760.x; Salvatier J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.55; Sattari N, NEUROBIOL LEARN MEM, DOI [10.1523/JNEUROSCI.4175-11.2011, DOI 10.1523/JNEUROSCI.4175-11.2011]; Schlemmer A, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0093; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seibold M, 2017, MEMORY, P1; Serra J., 1982, IMAGE ANAL MATH MORP, pChap11; Spilsbury JC, 2005, SLEEP, V28, P1419, DOI 10.1093/sleep/28.11.1419; Spira AP, 2008, J AM GERIATR SOC, V56, P45, DOI 10.1111/j.1532-5415.2007.01506.x; Suh M, 2014, J CARDIOVASC NURS, V29, pE10, DOI 10.1097/JCN.0b013e318291ee43; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Terzano MG, 2002, SLEEP MED, V3, P187, DOI 10.1016/S1389-9457(02)00003-5; The MathWorks Inc, 2015, MATLAB, VR2015a; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wamsley EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165141; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Wei Y, 2017, SLEEP, V40, P5; Wei Y, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx117; Whitehurst LN, 2016, P NATL ACAD SCI USA, DOI [10.1073/pnas.2016, DOI 10.1073/PNAS.2016]; Wilson S, 2012, BRIT J PSYCHIAT, V200, P273, DOI 10.1192/bjp.bp.111.104091; Young T, 2003, SLEEP, V26, P667, DOI 10.1093/sleep/26.6.667; Zhang L, 2006, AM J EPIDEMIOL, V164, P529, DOI 10.1093/aje/kwj231	100	25	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194604	10.1371/journal.pone.0194604	http://dx.doi.org/10.1371/journal.pone.0194604			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641599	gold, Green Published			2022-12-27	WOS:000429742900038
J	Yooyangket, T; Muangpat, P; Polseela, R; Tandhavanant, S; Thanwisai, A; Vitta, A				Yooyangket, Temsiri; Muangpat, Paramaporn; Polseela, Raxsina; Tandhavanant, Sarunporn; Thanwisai, Aunchalee; Vitta, Apichat			Identification of entomopathogenic nematodes and symbiotic bacteria from Nam Nao National Park in Thailand and larvicidal activity of symbiotic bacteria against Aedes aegypti and Aedes albopictus	PLOS ONE			English	Article							SP N.; PHOTORHABDUS-LUMINESCENS; DIPTERA-CULICIDAE; SOIL-TEMPERATURE; XENORHABDUS; STEINERNEMATIDAE; RHABDITIDA; MOISTURE; GROWTH; SEQUENCES	Entomopathogenic nematodes (EPNs) that are symbiotically associated with Xenorhabdus and Photorhabdus bacteria can kill target insects via direct infection and toxin action. There are limited reports identifying such organisms in the National Park of Thailand. Therefore, the objectives of this study were to identify EPNs and symbiotic bacteria from Nam Nao National Park, Phetchabun Province, Thailand and to evaluate the larvicidal activity of bacteria against Aedes aegypti and Ae. albopictus. A total of 12 EPN isolates belonging to Steinernema and Heterorhabditis were obtained form 940 soil samples between February 2014 and July 2016. EPNs were molecularly identified as S. websteri (10 isolates) and H. baujardi (2 isolates). Symbiotic bacteria were isolated from EPNs and molecularly identified as P. luminescens subsp. akhurstii (13 isolates), X. stockiae (11 isolates), X. vietnamensis (2 isolates) and X. japonica (1 isolate). For the bioassay, bacterial suspensions were evaluated for toxicity against third to early fourth instar larvae of Aedes spp. The larvae of both Aedes species were orally susceptible to symbiotic bacteria. The highest larval mortality of Ae. aegypti was 99% after exposure to X. stockiae (bNN112.3_TH) at 96 h, and the highest mortality of Ae. albopictus was 98% after exposure to P. luminescens subsp. akhurstii (bNN121.4_TH) at 96 h. In contrast to the control groups (Escherichia coli and distilled water), the mortality rate of both mosquito larvae ranged between 0 and 7% at 72 h. Here, we report the first observation of X. vietnamensis in Thailand. Additionally, we report the first observation of P. luminescens subsp. akhurstii associated with H. baujardi in Thailand. X. stockiae has potential to be a biocontrol agent for mosquitoes. This investigation provides a survey of the basic diversity of EPNs and symbiotic bacteria in the National Park of Thailand, and it is a bacterial resource for further studies of bioactive compounds.	[Yooyangket, Temsiri; Muangpat, Paramaporn; Polseela, Raxsina; Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand; [Polseela, Raxsina; Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, CEMB, Phitsanulok, Thailand; [Tandhavanant, Sarunporn] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand	Naresuan University; Naresuan University; Mahidol University	Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand.; Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, CEMB, Phitsanulok, Thailand.	apichatv@nu.ac.th	Vitta, Apichat/HHZ-5460-2022; Tandhavanant, Sarunporn/Q-7376-2019; Tandhavanant, Sarunporn/R-7620-2019	Vitta, Apichat/0000-0002-2483-0100; Tandhavanant, Sarunporn/0000-0003-0261-3233; Tandhavanant, Sarunporn/0000-0003-0261-3233	Naresuan University [R25586073]	Naresuan University	This work was supported by Naresuan University (Grant Number R25586073) to AV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate BA, 2016, NEMATOLOGY, V18, P235, DOI 10.1163/15685411-00002956; Ahantarig A, 2009, APPL ENVIRON MICROB, V75, P4627, DOI 10.1128/AEM.00221-09; BEDDING RA, 1975, NEMATOLOGICA, V21, P109, DOI 10.1163/187529275X00419; Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Cimen H, 2015, J HELMINTHOL, V89, P415, DOI 10.1017/S0022149X14000182; Cimen H, 2014, ZOOTAXA, V3821, P337, DOI 10.11646/zootaxa.3821.3.3; Cimen H, 2016, J NEMATOL, V48, P148; Cimen H, 2016, NEMATOLOGY, V18, P439, DOI 10.1163/15685411-00002968; da Silva JJ, 2007, REV SOC BRAS MED TRO, V40, P612, DOI 10.1590/S0037-86822007000600002; da Silva OS, 2013, PARASITOL RES, V112, P2891, DOI 10.1007/s00436-013-3460-x; de Brida AL, 2017, SCI REP-UK, V7, DOI 10.1038/srep45254; Dillman AR, 2012, P NATL ACAD SCI USA, V109, pE2324, DOI 10.1073/pnas.1211436109; DUNPHY GB, 1984, J INSECT PHYSIOL, V30, P883, DOI 10.1016/0022-1910(84)90063-5; Eom S, 2014, J MICROBIOL, V52, P161, DOI 10.1007/s12275-014-3251-9; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Fukruksa C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2383-2; Glaeser SP, 2016, INT J SYST EVOL MICR, V67, P1046; Grant JA, 2003, ENVIRON ENTOMOL, V32, P80, DOI 10.1603/0046-225X-32.1.80; Grundmann F, 2014, J NAT PROD, V77, P779, DOI 10.1021/np4007525; Hominick WM, 1997, J HELMINTHOL, V71, P271, DOI 10.1017/S0022149X00016096; Jallouli W, 2010, PROCESS BIOCHEM, V45, P706, DOI 10.1016/j.procbio.2010.01.007; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Phan KL, 2014, NEMATOLOGY, V16, P761, DOI 10.1163/15685411-00002806; Ke LP, 2001, RUSS J NEMATOL, V9, P1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KUNG SP, 1991, J INVERTEBR PATHOL, V57, P242, DOI 10.1016/0022-2011(91)90123-8; Lee MM, 2010, J INVERTEBR PATHOL, V104, P67, DOI 10.1016/j.jip.2010.01.005; Lemine AMM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1978-y; Li Xing-Yue, 2012, Zootaxa, V3569, P25; Lucia A, 2009, PARASITOL RES, V104, P1101, DOI 10.1007/s00436-008-1294-8; Malan AP, 2014, J HELMINTHOL, V88, P139, DOI 10.1017/S0022149X12000806; Maneesakorn P, 2015, INT J NEMATOL; Maneesakorn P, 2010, J NEMATOL, V42, P281; Maneesakorn P, 2011, MOL PHYLOGENET EVOL, V59, P271, DOI 10.1016/j.ympev.2011.02.012; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; MOLYNEUX AS, 1986, EXP PARASITOL, V62, P169, DOI 10.1016/0014-4894(86)90021-4; Mratek Z, 2009, CHINA J INVERTEBR PA, V102, P69, DOI [10.1016/j.jip.2009.05.006, DOI 10.1016/J.JIP.2009.05.006]; Muangpat P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01142; Namsena P., 2016, BIORESOUR BIOPROCESS, V3, P19, DOI [10.1186/s40643-016-0097-5, DOI 10.1186/S40643-016-0097-5]; Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9; Nikdel M., 2011, Nematologia Mediterranea, V39, P17; Nthenga I, 2014, NEMATOLOGY, V16, P475, DOI 10.1163/15685411-00002780; Park Y, 2000, J INSECT PHYSIOL, V46, P1469, DOI 10.1016/S0022-1910(00)00071-8; Park Y, 2016, J ECON ENTOMOL, V109; Park Y, 2015, J ASIA-PAC ENTOMOL, V18, P459, DOI 10.1016/j.aspen.2015.05.002; Puza V, 2017, J HELMINTHOL, V91, P20, DOI 10.1017/S0022149X15001157; Rodou A, 2010, TOXINS, V2, P1250, DOI 10.3390/toxins2061250; Rohde C, 2010, NEOTROP ENTOMOL, V39, P608, DOI 10.1590/S1519-566X2010000400022; da Silva JLR, 2017, J ECON ENTOMOL, V110, P378, DOI 10.1093/jee/tow224; Salokhe SG, 2012, PARASITOL RES, V111, P1325, DOI 10.1007/s00436-012-2968-9; Stock SP, 1998, SYST PARASITOL, V41, P105, DOI 10.1023/A:1006087017195; Stock SP, 2001, J PARASITOL, V87, P877, DOI 10.2307/3285148; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; Tailliez P, 2010, INT J SYST EVOL MICR, V60, P1921, DOI 10.1099/ijs.0.014308-0; Tangchitsomkid Nuchanart, 1998, Kasetsart Journal Natural Sciences, V32, P347; Thanwisai A, 2012, THESIS; Thanwisai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043835; Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649; Vitta A, 2017, SE ASIAN J TROP MED, V48, P18; Vitta A, 2015, SE ASIAN J TROP MED, V46, P564; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; World Health Organization, 2016, ZIK VIR; Yadav Arun K., 2012, Journal of Parasitic Diseases, V36, P175, DOI 10.1007/s12639-012-0099-y	68	30	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195681	10.1371/journal.pone.0195681	http://dx.doi.org/10.1371/journal.pone.0195681			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641570	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900085
J	Gotthelf, L; Chen, YT; Rajagopalan, S; Wu, ECT; Doshi, I; Addy, C				Gotthelf, Linda; Chen, Ya-Ting; Rajagopalan, Srinivasan; Wu, Elise Chi-Tao; Doshi, Ishita; Addy, Carol			High intensity lifestyle intervention and long-term impact on weight and clinical outcomes	PLOS ONE			English	Article							PRACTICE GUIDELINES; AMERICAN-COLLEGE; OBESE ADULTS; RISK-FACTORS; TASK-FORCE; OVERWEIGHT; MANAGEMENT; ASSOCIATION; PROGRAM; PHONE	Background Obesity increases the risk for diabetes and cardiovascular events, with a corresponding growth in medical costs. High intensity lifestyle intervention (HILI) is the cornerstone for weight management. We assessed the effectiveness of clinic-based HILI on weight loss and associated clinical outcomes by duration of program participation and comorbid conditions. Methods This was a retrospective cohort study of patients who enrolled in HILI weight management programs at Health Management Resources (HMR) clinics located across the U.S. Patients completed health risk assessments (HRA) and were enrolled for up to 24 months at the time of follow-up HRA. HMR programs provide weekly group coaching to achieve reduced calorie intake, increased fruit/vegetable intake, and physical activity >= 2,000 kcal/wk. A Markov model predicted avoidance of diabetes and cardiovascular events and projected cost savings due to weight loss. Results Of the 500 patients included in the analysis, 67% were female and mean age was 54.1 years (s.d. 11.6). The baseline weight and BMI were 243.5 lbs (range 144.0-545.0) and 38.8 kg/m(2) (range 25.4-85.0), respectively. Overall, patients lost an average of 47.4 lbs (18.9% of initial body weight [IBW]); the amount of weight loss was consistent among those with diabetes/pre-diabetes (50%), high/moderate risk for dyslipidemia (60%), hypertension/pre-hypertension (86%), and severe obesity (37%). The mean IBW lost was 16.4%, 19.3%, 20.7% for <= 6 months (n = 165), 7-12 months (n = 140), 13-24 months (n = 195) of program participation, respectively. The simulation model estimated 22 diabetes and 30 cardiovascular events and $1,992,370 medical costs avoided over 5 years in the 500 patients evaluated. Conclusion Patients in the HMR clinic-based HILI program achieved substantial weight loss regardless of duration of program participation, risk profile and comorbid status. The HMR program could be an effective strategy to prevent costly diabetes and cardiovascular events, particularly in high risk patients.	[Gotthelf, Linda; Addy, Carol] HMR Weight Management Serv Corp, Boston, MA 02110 USA; [Chen, Ya-Ting] Merck & Co Inc, Healthcare Serv & Solut, Ctr Outcomes Res & Real World Evidence, Kenilworth, NJ USA; [Rajagopalan, Srinivasan] Med Data Analyt Inc, Milltown, NJ USA; [Wu, Elise Chi-Tao] Merck & Co Inc, Ctr Outcomes Res & Real World Evidence, Econ & Data Sci, Kenilworth, NJ USA; [Doshi, Ishita] Merck & Co Inc, Ctr Outcomes Res & Real World Evidence, Study Management, Kenilworth, NJ USA	Merck & Company; Merck & Company; Merck & Company	Addy, C (corresponding author), HMR Weight Management Serv Corp, Boston, MA 02110 USA.	Caddy@HMRBoston.com			HMR Weight Management Services Corp; Healthcare Services and Solutions; Merck Co., Inc.; Med Data Analytics, Inc.	HMR Weight Management Services Corp; Healthcare Services and Solutions; Merck Co., Inc.(Merck & Company); Med Data Analytics, Inc.	The authors received no specific funding for this work. HMR Weight Management Services Corp, Healthcare Services and Solutions, Merck & Co., Inc., Med Data Analytics, Inc., Economics and Data Science, Merck & Co., Inc., and Study Management, Merck & Co. Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anderson JW, 2011, POSTGRAD MED, V123, P205, DOI 10.3810/pgm.2011.09.2476; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Balkau B, 2008, DIABETES, V57, P2613, DOI 10.2337/db07-1605; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Cawley J, 2015, PHARMACOECONOMICS, V33, P707, DOI 10.1007/s40273-014-0230-2; cdc.gov, 2017, OB OV; cdc.gov, BURD TOB US US; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coleman CD, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0062-8; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Donnelly JE, 2007, INT J OBESITY, V31, P1270, DOI 10.1038/sj.ijo.0803568; Donnelly Joseph E, 2013, Obesity (Silver Spring), V21, P1951, DOI 10.1002/oby.20334; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Framinghamheartstudy.org, 2017, FRAM HEART STUD; Furlow EA, 2009, J AM DIET ASSOC, V109, P1417, DOI 10.1016/j.jada.2009.05.003; Garvey WT, 2016, ENDOCR PRACT, V22, P842, DOI 10.4158/EP161356.ESGL; icer-review.org, ICER REL FIN REP US; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Keehan SP, 2017, HEALTH AFFAIR, V36, P553, DOI 10.1377/hlthaff.2016.1627; Kennedy RC, 2016, J DIAB OBES, V3, P1; Larson-Meyer DE, 2006, OBESITY, V14, P73, DOI 10.1038/oby.2006.10; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Ostbye T, 2014, OBESITY, V22, P1179, DOI 10.1002/oby.20669; Redmon JB, 2010, DIABETES CARE, V33, P1153, DOI 10.2337/dc09-2090; Unick JL, 2015, OBESITY, V23, P1353, DOI 10.1002/oby.21112; Yang L, 2015, JAMA INTERN MED, V175, P1412, DOI 10.1001/jamainternmed.2015.2405	27	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195794	10.1371/journal.pone.0195794	http://dx.doi.org/10.1371/journal.pone.0195794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668741	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200057
J	Caughron, B; Yang, Y; Young, MRI				Caughron, Blaine; Yang, Yi; Young, M. Rita I.			Role of IL-23 signaling in the progression of premalignant oral lesions to cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; T-CELLS; COLORECTAL-CANCER; TH17 CELLS; INFLAMMATION; HEAD; MICE; NECK; PREVENTION; PHENOTYPE	Mice bearing carcinogen-induced premalignant oral lesions were previously shown to have a pro-inflammatory phenotype, which is replaced with an immune inhibitory phenotype as lesions progress to cancer. Since Th17 cells are prominent at the premalignant lesion state and their levels are supported by IL-23, studies used mice that were IL-23 receptor deficient (IL-23R KO) to determine the requirement for IL-23 signaling in the immunological and clinical status of mice with premalignant oral lesions. The results showed a dependence on IL 23 signaling for the pro-inflammatory state of mice with oral lesions as levels of IL-2, IFN-y, IL-6, IL-17 and TNF-a were elevated in wildtype mice with premalignant oral lesions, but not in IL-23R KO mice. In contrast, as lesions progressed to cancer, the pro-inflammatory phenotype subsided and was replaced with the inhibitory mediator IL-10 and with Treg cells in wildtype mice, although not in IL-23R KO mice. Clinically, early progression of premalignant oral lesions to cancer was enhanced in IL-23R KO mice compared to progression in wildtype mice. These results show the importance of IL-23 signaling in both the pro-inflammatory phenotype characteristic of premalignant oral lesions and the inhibitory phenotype as lesions progress to cancer.	[Caughron, Blaine; Young, M. Rita I.] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA; [Yang, Yi] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC USA; [Young, M. Rita I.] Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina	Young, MRI (corresponding author), Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA.	youngmr@musc.edu			Clinical Sciences Research Program of the Department of Veterans Affairs [I01 CX000851]	Clinical Sciences Research Program of the Department of Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Clinical Sciences Research Program of the Department of Veterans Affairs; Grant number I01 CX000851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amicarella F, 2017, GUT, V66, P692, DOI 10.1136/gutjnl-2015-310016; Courau T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85974; De Costa AMA, 2012, INT IMMUNOPHARMACOL, V13, P322, DOI 10.1016/j.intimp.2012.05.004; De Costa AMA, 2012, CANCER IMMUNOL IMMUN, V61, P927, DOI 10.1007/s00262-011-1154-8; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; Freeman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110928; Glosson-Byers NL, 2014, J IMMUNOL, V193, P2631, DOI 10.4049/jimmunol.1401202; Hardikar S, 2014, CANCER EPIDEM BIOMAR, V23, P2393, DOI 10.1158/1055-9965.EPI-14-0384; He YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079769; Johnson SD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00379; Kathania M, 2016, NAT IMMUNOL, V17, P997, DOI 10.1038/ni.3488; Lee JY, 2017, J CANCER, V8, P1249, DOI 10.7150/jca.18230; Liu HP, 2015, EUR J IMMUNOL, V45, P1010, DOI 10.1002/eji.201444726; Liu SL, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0406-x; Mohammed J, 2010, J INVEST DERMATOL, V130, P2295, DOI 10.1038/jid.2010.92; Mori K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1587-0; Ohman J, 2015, ANTICANCER RES, V35, P311; Samadder NJ, 2017, DIGEST DIS SCI, V62, P2126, DOI 10.1007/s10620-016-4435-4; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Sun YJ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5715719; Thibaudin M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1055444; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wang L, 2017, CANCER RES, V77, P1119, DOI 10.1158/0008-5472.CAN-16-1373; Wei L, 2016, MOL MED REP, V13, P1673, DOI 10.3892/mmr.2015.4694; Woodford Danielle, 2014, J Clin Cell Immunol, V5; Xia J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/516395; Yan BL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00721-8; Yan YY, 2015, J IMMUNOTHER, V38, P341, DOI 10.1097/CJI.0000000000000094; Yoshida N, 2016, ANN SURG ONCOL, V23, P919, DOI 10.1245/s10434-015-4923-3; Young MRI, 2016, INT J CANCER, V138, P2487, DOI 10.1002/ijc.29989; Yu GT, 2015, ONCOTARGET, V6, P42067, DOI 10.18632/oncotarget.5955; Zhang QY, 2017, PROSTATE, V77, P888, DOI 10.1002/pros.23343; Zhou GY, 2017, GASTROENTEROLOGY, V153, P1107, DOI 10.1053/j.gastro.2017.06.017	33	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196034	10.1371/journal.pone.0196034	http://dx.doi.org/10.1371/journal.pone.0196034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664967	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300051
J	Pairet, N; Mang, S; Fois, G; Keck, M; Kuhnbach, M; Gindele, J; Frick, M; Dietl, P; Lamb, DJ				Pairet, N.; Mang, S.; Fois, G.; Keck, M.; Kuehnbach, M.; Gindele, J.; Frick, M.; Dietl, P.; Lamb, D. J.			TRPV4 inhibition attenuates stretch-induced inflammatory cellular responses and lung barrier dysfunction during mechanical ventilation	PLOS ONE			English	Article							POTENTIAL VANILLOID 4; RESPIRATORY-DISTRESS-SYNDROME; RUTHENIUM RED; ALVEOLAR MACROPHAGES; CYTOKINE RELEASE; CATION CHANNEL; IN-VITRO; EPITHELIAL-CELLS; PULMONARY-EDEMA; INJURY	Mechanical ventilation is an important tool for supporting critically ill patients but may also exert pathological forces on lung cells leading to Ventilator-Induced Lung Injury (VILI). We hypothesised that inhibition of the force-sensitive transient receptor potential vanilloid (TRPV4) ion channel may attenuate the negative effects of mechanical ventilation. Mechanical stretch increased intracellular Ca2+ influx and induced release of pro-inflammatory cytokines in lung epithelial cells that was partially blocked by about 30% with the selective TRPV4 inhibitor GSK2193874, but nearly completely blocked with the pan-calcium channel blocker ruthenium red, suggesting the involvement of more than one calcium channel in the response to mechanical stress. Mechanical stretch also induced the release of pro-inflammatory cytokines from M1 macrophages, but in contrast this was entirely dependent upon TRPV4. In a murine ventilation model, TRPV4 inhibition attenuated both pulmonary barrier permeability increase and pro-inflammatory cytokines release due to high tidal volume ventilation. Taken together, these data suggest TRPV4 inhibitors may have utility as a prophylactic pharmacological treatment to improve the negative pathological stretch-response of lung cells during ventilation and potentially support patients receiving mechanical ventilation.	[Pairet, N.; Mang, S.; Keck, M.; Kuehnbach, M.; Gindele, J.; Lamb, D. J.] Boehringer Ingelheim Pharma GmbH & Co KG, Immunol & Resp Dis Res, Biberach, Germany; [Pairet, N.; Fois, G.; Gindele, J.; Frick, M.; Dietl, P.] Univ Ulm, Dept Gen Physiol, Ulm, Germany; [Mang, S.] Hannover Med Sch, Inst Immunol, Hannover, Germany	Boehringer Ingelheim; Ulm University; Hannover Medical School	Pairet, N (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Immunol & Resp Dis Res, Biberach, Germany.; Pairet, N (corresponding author), Univ Ulm, Dept Gen Physiol, Ulm, Germany.	nicolas.pairet@web.de	Frick, Manfred/E-1374-2012; Fois, Giorgio/AAD-5657-2022	Frick, Manfred/0000-0002-4763-1104; Fois, Giorgio/0000-0001-5414-1149	Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	Boehringer Ingelheim Pharma GmbH & Co. KG did not play a role in the study and only provided financial support in the form of authors' salaries and/or research materials. The funder provided support in the form of salaries for authors [N Pairet, D Lamb, J Gindele, M Keck, S Mang, M Kuhnbach], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Balakrishna S, 2014, AM J PHYSIOL-LUNG C, V307, pL158, DOI 10.1152/ajplung.00065.2014; Beitler JR, 2016, CRIT CARE MED, V44, P91, DOI 10.1097/CCM.0000000000001355; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; CARDOSO CM, 1993, BIOCHEM J, V296, P49, DOI 10.1042/bj2960049; Carrasco Loza R, 2015, Open Respir Med J, V9, P112, DOI 10.2174/1874306401509010112; Cheung M, 2017, ACS MED CHEM LETT, V8, P549, DOI 10.1021/acsmedchemlett.7b00094; DEINUM J, 1985, BIOCHIM BIOPHYS ACTA, V838, P197, DOI 10.1016/0304-4165(85)90079-0; Dos Santos CC, 2000, J APPL PHYSIOL, V89, P1645, DOI 10.1152/jappl.2000.89.4.1645; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1993, AM REV RESPIR DIS, V148, P1194, DOI 10.1164/ajrccm/148.5.1194; Eyal FG, 2007, INTENS CARE MED, V33, P1212, DOI 10.1007/s00134-007-0651-x; Frank J, 2002, CRITICAL CARE, V7, P233, DOI DOI 10.1186/CC1829; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Gerstmair A, 2009, J APPL PHYSIOL, V107, P613, DOI 10.1152/japplphysiol.00012.2009; Halbertsma FJJ, 2005, NETH J MED, V63, P382; Hamanaka K, 2007, AM J PHYSIOL-LUNG C, V293, pL923, DOI 10.1152/ajplung.00221.2007; Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009; Hegeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057374; Henry CO, 2016, AM J PHYSIOL-LUNG C, V311, pL664, DOI 10.1152/ajplung.00442.2015; Jurek SC, 2014, AM J RESP CELL MOL, V50, P1107, DOI 10.1165/rcmb.2013-0163OC; Kuebler WM, 2002, AM J PHYSIOL-LUNG C, V282, pL917, DOI 10.1152/ajplung.00275.2001; Mang S, 2018, AM J RESP C IN PRESS; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; Michalick L, 2017, ANESTHESIOLOGY, V126, P300, DOI 10.1097/ALN.0000000000001443; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nayak PS, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0224-4; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Parker JC, 1998, J APPL PHYSIOL, V84, P1113, DOI 10.1152/jappl.1998.84.4.1113; Protti A, 2014, CURR OPIN CRIT CARE, V20, P33, DOI 10.1097/MCC.0000000000000047; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; ROYALL JA, 1989, AM J PHYSIOL, V257, pL399, DOI 10.1152/ajplung.1989.257.6.L399; SASAKI T, 1992, J BIOL CHEM, V267, P21518; Scheraga RG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00503; Scheraga RG, 2016, J IMMUNOL, V196, P428, DOI 10.4049/jimmunol.1501688; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Slutsky AS, 2003, INTENS CARE MED, V29, P1218, DOI 10.1007/s00134-003-1793-0; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; SLUTSKY AS, 1993, CHEST, V104, P1833, DOI 10.1378/chest.104.6.1833; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Takahashi N, 2011, CELL CALCIUM, V50, P279, DOI 10.1016/j.ceca.2011.04.006; Tao F, 2002, AM J RESP CELL MOL, V26, P499, DOI 10.1165/ajrcmb.26.4.4749; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Vlahakis NE, 1999, AM J PHYSIOL-LUNG C, V277, pL167, DOI 10.1152/ajplung.1999.277.1.L167; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Yamada A, 2000, BIOCHEM J, V349, P797, DOI 10.1042/bj3490797; Yamashiro K, 2010, BIOCHEM BIOPH RES CO, V398, P284, DOI 10.1016/j.bbrc.2010.06.082; Yin J, 2016, AM J RESP CELL MOL, V54, P370, DOI 10.1165/rcmb.2014-0225OC; Yin J, 2010, CELL BIOCHEM BIOPHYS, V56, P1, DOI 10.1007/s12013-009-9067-2; Zhang F, 2007, J CELL PHYSIOL, V213, P730, DOI 10.1002/jcp.21141	55	30	34	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196055	10.1371/journal.pone.0196055	http://dx.doi.org/10.1371/journal.pone.0196055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664963	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300052
J	Wang, LH; Zhang, YH; Xu, KY; Dong, T; Rowland-Jones, S; Yindom, LM				Wang, Linghang; Zhang, Yonghong; Xu, Keyi; Dong, Tao; Rowland-Jones, Sarah; Yindom, Louis-Marie			Killer-cell immunoglobulin-like receptors associate with HIV-1 infection in a narrow-source Han Chinese cohort	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HEPATITIS-C VIRUS; SLOW PROGRESSORS; DISEASE PROGRESSION; BLOOD-DONORS; GENE-CONTENT; NK CELLS; CLASS-I; HLA-B; KIR	Background The HIV pandemic remains the most serious challenge to public health worldwide. The hallmark characteristics of the disease is the eventual failure of the immune system to control opportunistic infections and death. However not everyone who has HIV develops the disease at the same rate and so we are studying how the immune system works to control the virus in those who have been infected for decades and remain relatively healthy without the need of anti-retroviral therapy (ART). Methods Genomic DNA samples from 513 Chinese Han individuals from Henan province were typed for 15 KIR and 3 HLA class I genes. Genotype frequencies were compared between a village cohort of 261 former plasma donors (SM cohort) infected with HIV-1 through an illegal plasma donor scheme who survived more than 10 years of infection without ART and 252 ethnically-matched healthy controls from a nearby village. KIR and HLA were molecularly typed using a combination of polymerase chain reaction (PCR) with sequence-specific primers (PCR-SSP) and sequence based techniques. Results All 15 KIR genes were observed in the study population at various frequencies. KIR2DL3 was significantly less common in the HIV-1 infected group (95.8% vs 99.2%, p = 0.021). The combination of KIR3DS1 with homozygosity for HLA-Bw4 alleles (the putative ligand for KIR3DS1) was significantly less frequent in the HIV-1 infected group than in the control group (6.0% vs 12.0% respectively, p = 0.023). Conclusion Specific KIR-HLA compound genotypes associate with differential outcomes to infection and disease progression following exposure to a narrow-source HIV-1.	[Wang, Linghang; Xu, Keyi] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Wang, Linghang; Dong, Tao; Rowland-Jones, Sarah; Yindom, Louis-Marie] Nuffield Dept Med, Oxford, England; [Wang, Linghang; Zhang, Yonghong; Dong, Tao] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Zhang, Yonghong] Capital Med Univ, Beijing You An Hosp, Beijing, Peoples R China	Capital Medical University; University of Oxford; University of Oxford; Capital Medical University	Yindom, LM (corresponding author), Nuffield Dept Med, Oxford, England.	louis-marie.yindom@ndm.ox.ac.uk		Wang, Linghang/0000-0002-1948-5461; Yindom, Louis-Marie/0000-0001-8078-7146; Dong, Tao/0000-0003-3545-3758	Medical Research Council UK; Li Ka Shing Foundation; National Key Clinical Department of Infectious Diseases; Beijing High-Level Healthcare Intelligent Culture Plan [2015-3-109]; National Natural Science Foundation of China [81320108017]; Beijing municipal administration of hospitals [XMLX201411, ZYLX201711]; Beijing Municipal Science & Technology Commission [Z171100001017078]; Beijing Key Laboratory [BZ0373]; MRC [MC_UU_00008/11, G0801751, G1001046, MR/L018942/1, G0600520] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Li Ka Shing Foundation; National Key Clinical Department of Infectious Diseases; Beijing High-Level Healthcare Intelligent Culture Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing municipal administration of hospitals; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Key Laboratory; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK, the Li Ka Shing Foundation, the National Key Clinical Department of Infectious Diseases, the Beijing High-Level Healthcare Intelligent Culture Plan (2015-3-109), the National Natural Science Foundation of China (81320108017), the Beijing municipal administration of hospitals (XMLX201411 and ZYLX201711), the Beijing Municipal Science & Technology Commission (Z171100001017078), and the Beijing Key Laboratory (BZ0373).; This work was supported by the Medical Research Council UK, the Li Ka Shing Foundation, the National Key Clinical Department of Infectious Diseases, the Beijing High-Level Healthcare Intelligent Culture Plan (2015-3-109), the National Natural Science Foundation of China (81320108017), the Beijing municipal administration of hospitals (XMLX201411 and ZYLX201711), the Beijing Municipal Science & Technology Commission (Z171100001017078), and the Beijing Key Laboratory (BZ0373). We are very grateful to all participants in this study. We also thank all the clinical staff who made major contributions to establishing the SM cohort and collecting all the samples.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Bao XJ, 2010, HUM IMMUNOL, V71, P289, DOI 10.1016/j.humimm.2009.12.004; Barbour JD, 2007, PLOS PATHOG, V3, P471, DOI 10.1371/journal.ppat.0030043; Burian A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163297; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; Carrington M, 2008, TRENDS MICROBIOL, V16, P620, DOI 10.1016/j.tim.2008.09.002; Cheent K, 2009, IMMUNOLOGY, V126, P449, DOI 10.1111/j.1365-2567.2009.03045.x; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Dong T, 2011, BLOOD, V118, P98, DOI 10.1182/blood-2010-06-291963; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gendzekhadze K, 2006, IMMUNOGENETICS, V58, P474, DOI 10.1007/s00251-006-0108-3; Gillespie GMA, 2002, AIDS, V16, P961, DOI 10.1097/00002030-200205030-00002; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Jiang K, 2005, TISSUE ANTIGENS, V65, P556, DOI 10.1111/j.1399-0039.2005.00412.x; Jiang YJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-405; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lu ZM, 2008, CELL MOL IMMUNOL, V5, P457, DOI 10.1038/cmi.2008.57; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Miyashita R, 2006, ARTHRITIS RHEUM-US, V54, P992, DOI 10.1002/art.21653; O'Connell KA, 2009, J VIROL, V83, P5028, DOI 10.1128/JVI.02551-08; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; Parham P, 2008, SEMIN IMMUNOL, V20, P311, DOI 10.1016/j.smim.2008.10.002; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Shilling HG, 2002, J IMMUNOL, V168, P2307, DOI 10.4049/jimmunol.168.5.2307; TROWSDALE J, 2001, GENES IMMUN, V15, P363; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Vilches C, 2000, IMMUNOGENETICS, V51, P639, DOI 10.1007/s002510000184; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Yawata M, 2008, BLOOD, V112, P2369, DOI 10.1182/blood-2008-03-143727; Yindom LM, 2010, J VIROL, V84, P8202, DOI 10.1128/JVI.00116-10; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang ZN, 2010, MICROBIOL IMMUNOL, V54, P625, DOI 10.1111/j.1348-0421.2010.00259.x	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195452	10.1371/journal.pone.0195452	http://dx.doi.org/10.1371/journal.pone.0195452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664957	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300020
J	Tophoj, J; Wollenberg, RD; Sondergaard, TE; Eriksen, NT				Tophoj, Jakob; Wollenberg, Rasmus Dam; Sondergaard, Teis Esben; Eriksen, Niels Thomas			Feeding and growth of the marine heterotrophic nanoflagellates, Procryptobia sorokini and Paraphysomonas imperforata on a bacterium, Pseudoalteromonas sp with an inducible defence against grazing	PLOS ONE			English	Article							PROTIST PREDATION; SIZE-STRUCTURE; EFFICIENCIES; STRAIN; TEMPERATURE; ENERGETICS; ORGANISMS; KINETICS; PROTOZOA; ECOLOGY	Heterotrophic marine nanoflagellates are important grazers on bacteria in the water column. Some marine bacteria appear more resistant to grazing than do others. Marine nanoflagellates can be grown in the laboratory in batch cultures fed specific bacterial isolates. In some cultures, the flagellates appear unable to completely deplete the bacterial prey even when the bacterial strain otherwise is an excellent prey. This may indicate that some marine bacteria are able to induce defence mechanisms if they are grazed by nanoflagellates. Four morphologically distinct marine heterotrophic nanoflagellates, of which 3 were still identified as Procryptobia sorokini (Kinetoplastea) and one as Paraphysomonas imperforata (Chryso-phyceae) were isolated from a coastal location along with 3 isolates of the marine bacterium Pseudoalteromonas sp. Flagellate growth and grazing on bacterial prey were analysed in batch cultures. Pseudoalteromonas was a suitable prey for all 4 flagellate isolates. They grazed and grew on Pseudoalteromonas as sole prey with maximal cell-specific growth rates of 0.1 +/- 0.25 h(-1) and gross growth efficiencies of 38 +/- 61%. Exposure to dense flagellate cultures or their supernatants did, however, cause a fraction of the Pseudoalteromonas cells to aggregate and the bacterium became apparently resistant to grazing. Concentrations of suspended Pseudoalteromonas cells were therefore not decreased below 1,700 +/- 7,500 cells mu L-1 by any of the flagellate isolates. These results indicate that Pseudoalteromonas sp. can be an excellent prey to marine nanoflagellates but also that is in possession of inducible mechanisms that protect against flagellate grazing.	[Tophoj, Jakob; Wollenberg, Rasmus Dam; Sondergaard, Teis Esben; Eriksen, Niels Thomas] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark	Aalborg University	Eriksen, NT (corresponding author), Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark.	nte@bio.aau.dk	Sondergaard, Teis/F-4122-2014; Eriksen, Niels T/I-6895-2012	Sondergaard, Teis/0000-0002-4455-7498; Eriksen, Niels T/0000-0003-0792-3601	Villum Fonden [9278]	Villum Fonden(Villum Fonden)	This work was supported by a research grant (9278) from Villum Fonden to NTE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersen P., 1989, MAR MICRO FOOD WEBS, V3, P35; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baumgartner M, 2016, J EVOLUTION BIOL, V29, P2297, DOI 10.1111/jeb.12957; Beardsley C, 2003, APPL ENVIRON MICROB, V69, P2624, DOI 10.1128/AEM.69.5.2624-2630.2003; Blom JF, 2010, APPL ENVIRON MICROB, V76, P6156, DOI 10.1128/AEM.01455-10; Blom JF, 2010, ENVIRON MICROBIOL, V12, P2486, DOI 10.1111/j.1462-2920.2010.02222.x; Boenigk J, 2000, AQUAT MICROB ECOL, V22, P243, DOI 10.3354/ame022243; Boenigk J, 2004, APPL ENVIRON MICROB, V70, P5787, DOI 10.1128/AEM.70.10.5787-5793.2004; CHOI JW, 1992, APPL ENVIRON MICROB, V58, P593, DOI 10.1128/AEM.58.2.593-599.1992; Corno G, 2006, APPL ENVIRON MICROB, V72, P78, DOI 10.1128/AEM.72.1.78-86.2006; Corno G, 2008, ENVIRON MICROBIOL, V10, P2857, DOI 10.1111/j.1462-2920.2008.01713.x; Corno G, 2008, J LIMNOL, V67, P107, DOI 10.4081/jlimnol.2008.107; ECCLESTONPARRY JD, 1994, MAR ECOL PROG SER, V105, P167, DOI 10.3354/meps105167; FENCHEL T, 1982, MAR ECOL PROG SER, V9, P35, DOI 10.3354/meps009035; FENCHEL T, 1982, MAR ECOL PROG SER, V8, P225, DOI 10.3354/meps008225; FERGUSON RL, 1976, LIMNOL OCEANOGR, V21, P141, DOI 10.4319/lo.1976.21.1.0141; Frolov Alexander O., 2001, Protistology, V2, P85; Fu YT, 2003, APPL ENVIRON MICROB, V69, P6848, DOI 10.1128/AEM.69.11.6848-6855.2003; GEIDER RJ, 1988, MAR ECOL PROG SER, V47, P169, DOI 10.3354/meps047169; Gonzalez JM, 1996, MAR BIOL, V126, P785, DOI 10.1007/BF00351345; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Guiry, 2018, ALGAEBASE; Hahn MW, 1999, APPL ENVIRON MICROB, V65, P4863; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Ishigaki T, 2001, MICROB ECOL, V41, P264, DOI 10.1007/s002480000060; Jeuck A, 2013, PROTIST, V164, P842, DOI 10.1016/j.protis.2013.08.003; Martel CM, 2008, PROTIST, V159, P41, DOI 10.1016/j.protis.2007.05.003; Massana R, 2003, AQUAT MICROB ECOL, V32, P11, DOI 10.3354/ame032011; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2002, FEMS MICROBIOL ECOL, V39, P57, DOI 10.1111/j.1574-6941.2002.tb00906.x; Pelegri SP, 1999, MICROBIAL ECOL, V37, P276, DOI 10.1007/s002489900150; Peters F, 1996, MAR ECOL PROG SER, V134, P235, DOI 10.3354/meps134235; Rose JM, 2009, ISME J, V3, P252, DOI 10.1038/ismej.2008.96; SHERR BF, 1983, APPL ENVIRON MICROB, V45, P1196, DOI 10.1128/AEM.45.4.1196-1201.1983; SIBBALD MJ, 1988, APPL ENVIRON MICROB, V54, P613, DOI 10.1128/AEM.54.2.613-616.1988; Sleigh MA, 1998, EUR J PROTISTOL, V34, P273, DOI 10.1016/S0932-4739(98)80054-0; Snyder RA, 1996, HYDROBIOLOGIA, V341, P113, DOI 10.1007/BF00018115; Zubkov MV, 2000, J EUKARYOT MICROBIOL, V47, P62, DOI 10.1111/j.1550-7408.2000.tb00012.x	39	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195935	10.1371/journal.pone.0195935	http://dx.doi.org/10.1371/journal.pone.0195935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652905	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900048
J	Kim, MJ; Hur, BY; Lee, ES; Parka, B; Joo, J; Kim, MJ; Park, SC; Baek, JY; Chang, HJ; Kim, DY; Oh, JH				Kim, Min Ju; Hur, Bo Yun; Lee, Eun Sun; Parka, Boram; Joo, Jungnam; Kim, Min Jung; Park, Sung Chan; Baek, Ji Yeon; Chang, Hee Jin; Kim, Dae Yong; Oh, Jae Hwan			Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; APPARENT DIFFUSION-COEFFICIENT; RADIATION-THERAPY; CHEMORADIATION THERAPY; PERITONEAL REFLECTION; COLORECTAL-CANCER; CARCINOMA; DISSECTION; CHEMOTHERAPY; INVOLVEMENT	Purpose To investigate the predictive factors for lateral pelvic lymph node (LPLN) metastasis in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy (CRT). Materials and methods Fifty-seven patients with locally advanced rectal cancer and LPLNs larger than 5 mm underwent LPLN dissection (LPLD) after preoperative CRT. The MRI findings, including the apparent diffusion coefficient value and LPLN size reduction rate before/after CRT; clinical factors; and pathologic results were evaluated to identify the predictive factors associated with LPLN metastasis. Results LPLN metastasis was confirmed in 23 patients (40.4%). Metastasis was significantly higher in LPLNs with multiplicity, short-axis diameter >= 8 mm before CRT, short-axis diameter >5 mm after CRT, size reduction rate <= 33.3%, heterogeneous signal intensity, and irregular margin (P<0.05) on MR. Multivariable analysis showed that pre-CRT short-axis diameter of LPLNs >= 8 mm, size reduction rate <= 33.3%, and heterogeneous signal intensity were independently associated with LPLN metastasis. Conclusions The size and signal intensity of LPLN before and after CRT are useful MRI findings to predict LPLN metastasis and are helpful to determine the indications for LPLD.	[Kim, Min Ju; Hur, Bo Yun; Kim, Min Jung; Park, Sung Chan; Baek, Ji Yeon; Chang, Hee Jin; Kim, Dae Yong; Oh, Jae Hwan] Natl Canc Ctr, Res Inst & Hosp, Ctr Colorectal Canc, Goyang Si, South Korea; [Lee, Eun Sun] Chung Ang Univ Hosp, Dept Radiol, Seoul, South Korea; [Parka, Boram; Joo, Jungnam] Natl Canc Ctr, Res Inst & Hosp, Biometr Res Branch, Goyang Si, South Korea	National Cancer Center - Korea (NCC); Chung Ang University; Chung Ang University Hospital; National Cancer Center - Korea (NCC)	Oh, JH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Ctr Colorectal Canc, Goyang Si, South Korea.	jayoh@ncc.re.kr	Lee, Eun Sun/AAW-2726-2020	Kim, Min Jung/0000-0002-3105-9633; Park, Boram/0000-0003-2683-8795	National Cancer Center [1610460]	National Cancer Center	This study was supported by a grant (1610460) from the National Cancer Center. (http://www.ncc.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2015, ANN SURG ONCOL, V22, pS614, DOI 10.1245/s10434-015-4565-5; Ali TFT, 2012, EGYPT J RADIOL NUC M, V43, P173, DOI 10.1016/j.ejrnm.2012.01.008; Barbaro B, 2010, RADIOGRAPHICS, V30, P699, DOI 10.1148/rg.303095085; Beets-Tan RGH, 2004, RADIOLOGY, V232, P335, DOI 10.1148/radiol.2322021326; Beets-Tan RGH, 2001, LANCET, V357, P497, DOI 10.1016/S0140-6736(00)04040-X; Berrak S, 2011, ACAD RADIOL, V18, P1225, DOI 10.1016/j.acra.2011.06.009; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Brown G, 2003, BRIT J SURG, V90, P355, DOI 10.1002/bjs.4034; Cheng J, 2013, J MAGN RESON IMAGING, V37, P1436, DOI 10.1002/jmri.23925; Cho EY, 2013, EUR J RADIOL, V82, pE662, DOI 10.1016/j.ejrad.2013.08.007; Choi HJ, 2006, AM J ROENTGENOL, V187, P741, DOI 10.2214/AJR.05.0944; ENKER WE, 1995, J AM COLL SURGEONS, V181, P335; Fornasa F, 2012, J MAGN RESON IMAGING, V36, P858, DOI 10.1002/jmri.23706; Fujita S, 2009, INT J COLORECTAL DIS, V24, P1085, DOI 10.1007/s00384-009-0704-4; Georgiou P, 2009, LANCET ONCOL, V10, P1053, DOI 10.1016/S1470-2045(09)70224-4; Havenga K, 1999, EUR J SURG ONCOL, V25, P368, DOI 10.1053/ejso.1999.0659; Hosonuma Tomonori, 2006, Magn Reson Med Sci, V5, P173, DOI 10.2463/mrms.5.173; Kim DJ, 2010, RADIOGRAPHICS, V30, P503, DOI 10.1148/rg.302095046; Kim JK, 2008, J MAGN RESON IMAGING, V28, P714, DOI 10.1002/jmri.21480; Kim JH, 2004, EUR J RADIOL, V52, P78, DOI 10.1016/j.ejrad.2003.12.005; Kim Mi-Kyung, 2015, [JOURNAL OF MICE & TOURISM RESEARCH, MICE관광연구], V15, P111; Kim SH, 2009, RADIOLOGY, V253, P116, DOI 10.1148/radiol.2532090027; Kim SH, 2016, CANCER RES TREAT, V48, P998, DOI 10.4143/crt.2015.254; Kim TH, 2008, ANN SURG ONCOL, V15, P729, DOI 10.1245/s10434-007-9696-x; Kuo LJ, 2005, DIS COLON RECTUM, V48, P23, DOI 10.1007/s10350-004-0787-5; Kusters M, 2010, EJSO-EUR J SURG ONC, V36, P470, DOI 10.1016/j.ejso.2009.11.011; Matsuoka H, 2004, ANTICANCER RES, V24, P4097; Matsuoka H, 2007, ANTICANCER RES, V27, P3529; MORIKAWA E, 1994, DIS COLON RECTUM, V37, P219, DOI 10.1007/BF02048158; Nougaret S, 2013, RADIOLOGY, V268, P329, DOI 10.1148/radiol.13121361; Oh HK, 2014, ANN SURG ONCOL, V21, P2280, DOI 10.1245/s10434-014-3559-z; Park MJ, 2011, RADIOLOGY, V260, P771, DOI 10.1148/radiol.11102135; Park SO, 2009, J MAGN RESON IMAGING, V29, P383, DOI 10.1002/jmri.21635; Rao SX, 2008, EUR J RADIOL, V65, P299, DOI 10.1016/j.ejrad.2007.04.001; Rechichi G, 2013, EUR RADIOL, V23, P65, DOI 10.1007/s00330-012-2575-2; Roy C, 2010, EUR RADIOL, V20, P1803, DOI 10.1007/s00330-010-1736-4; Sato H, 2006, DIS COLON RECTUM, V49, pS3, DOI 10.1007/s10350-006-0699-7; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Shihab OC, 2011, BRIT J SURG, V98, P1798, DOI 10.1002/bjs.7662; Sugihara K, 1996, CANCER-AM CANCER SOC, V78, P1871, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1871::AID-CNCR5>3.3.CO;2-9; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; SUZUKI K, 1995, SURG TODAY, V25, P795, DOI 10.1007/BF00311455; Syk E, 2010, DIS COLON RECTUM, V53, P744, DOI 10.1007/DCR.0b013e3181cf8841; Takahashi T, 2000, DIS COLON RECTUM, V43, pS59, DOI 10.1007/BF02237228; Ueno H, 2001, ANN SURG, V234, P190, DOI 10.1097/00000658-200108000-00008; Ueno H, 2007, ANN SURG, V245, P80, DOI 10.1097/01.sla.0000225359.72553.8c; Ueno M, 2005, BRIT J SURG, V92, P756, DOI 10.1002/bjs.4975; Yasui O, 2009, TOHOKU J EXP MED, V218, P177, DOI 10.1620/tjem.218.177; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	49	23	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195815	10.1371/journal.pone.0195815	http://dx.doi.org/10.1371/journal.pone.0195815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649321	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900093
J	Watchorn, RT; Maechtle, T; Fedy, BC				Watchorn, Ryan T.; Maechtle, Thomas; Fedy, Bradley C.			Assessing the efficacy of fathead minnows (Pimephales promelas) for mosquito control	PLOS ONE			English	Article							GREATER SAGE-GROUSE; WEST-NILE-VIRUS; BIOLOGICAL-CONTROL; LARVIVOROUS FISH; HABITAT; POPULATIONS; ISOTOPES; IMPACTS; DISEASE; HEALTH	Mosquitoes function as important vectors for many diseases globally and can have substantial negative economic, environmental, and health impacts. Specifically, West Nile virus (WNv) is a significant and increasing threat to wildlife populations and human health throughout North America. Mosquito control is an important means of controlling the spread of WNv, as the virus is primarily spread between avian and mosquito vectors. This is of particular concern for avian host species such as the Greater sage-grouse (Centrocercus urophasianus), in which WNv negatively impacts fitness parameters. Most mosquito control methods focus on the larval stages. In North America, control efforts are largely limited to larvicides, which require repeated application and have potentially negative ecological impacts. There are multiple potential advantages to using indigenous fish species as an alternative for larval control including lowered environmental impact, decreased costs in terms of time and financial inputs, and the potential for the establishment of self-sustaining fish populations. We tested the efficacy of using fathead minnows (Pimephales promelas) as biological control for mosquito populations in livestock reservoirs of semiarid rangelands. We introduced minnows into 10 treatment reservoirs and monitored an additional 6 non treated reservoirs as controls over 3 years. Adult mosquitoes of species known to transmit WNv (e.g., Culex tarsalis) were captured at each site and mosquito larvae were also present at all sites. Stable isotope analysis confirmed that introduced fathead minnows were feeding at the mosquito larvae trophic level in all but one treatment pond. Treatment ponds demonstrated suppressed levels of mosquito larva over each season compared to controls with a model-predicted 114% decrease in larva density within treatment ponds. Minnows established self-sustaining populations throughout the study in all reservoirs that maintained sufficient water levels. Minnow survival was not influenced by water quality. Though minnows did not completely eradicate mosquito larvae, minnows are a promising alternative to controlling mosquito larvae density within reservoirs. We caution that careful site selection is critical to avoid potential negative impacts, but suggest the introduction of fathead minnows in reservoirs can dramatically reduce mosquito larva abundance and potentially help mitigate vector-borne disease transmission.	[Watchorn, Ryan T.; Fedy, Bradley C.] Univ Waterloo, Sch Environm Resources & Sustainabil, Waterloo, ON, Canada; [Maechtle, Thomas] Big Horn Environm Consultants, Sheridan, WY USA	University of Waterloo	Fedy, BC (corresponding author), Univ Waterloo, Sch Environm Resources & Sustainabil, Waterloo, ON, Canada.	bfedy@uwaterloo.ca	Fedy, Bradley C/A-6017-2015		Northeast Sage-Grouse Local Working Group; Wolf Creek Charitable Foundation	Northeast Sage-Grouse Local Working Group; Wolf Creek Charitable Foundation	This work received support from Northeast Sage-Grouse Local Working Group. Wolf Creek Charitable Foundation. BCF received all funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bighorn Environmental Consultants loaned the project a vehicle and provided logistical support. TM did not receive salary for his contributions to the research.	Aditya G, 2012, J VECTOR DIS, V49, P217; Aldridge CL, 2002, J WILDLIFE MANAGE, V66, P433, DOI 10.2307/3803176; Beasley DWC, 2013, ANTIVIR RES, V99, P1, DOI 10.1016/j.antiviral.2013.04.015; Chandra G, 2008, INDIAN J MED RES, V127, P13; Clark L, 2006, J WILDLIFE DIS, V42, P14, DOI 10.7589/0090-3558-42.1.14; Darsie RFJ, 2005, IDENTIFICATION GEOGR; DENNY JS, 1987, GUIDELINES CULTURE F; Donnelly JP, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1208; Eaton BR, 2005, CAN J ZOOL, V83, P1532, DOI 10.1139/Z05-151; Fedy BC, 2014, WILDLIFE MONOGR, V190, P1, DOI 10.1002/wmon.1014; Fedy BC, 2012, J WILDLIFE MANAGE, V76, P1062, DOI 10.1002/jwmg.337; FLETCHER M, 1992, ACTA TROP, V52, P155, DOI 10.1016/0001-706X(92)90032-S; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; Grant SCH, 2002, CAN J FISH AQUAT SCI, V59, P759, DOI 10.1139/F02-054; Griffin LF, 2012, WETL ECOL MANAG, V20, P243, DOI 10.1007/s11273-012-9248-4; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Howard AFV, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-199; IGRAM R, 1979, COMP BIOCHEM PHYS A, V62, P895, DOI 10.1016/0300-9629(79)90024-0; Irwin P, 2009, J AM MOSQUITO CONTR, V25, P301, DOI 10.2987/09-0013.1; KLINGER SA, 1982, ENVIRON BIOL FISH, V7, P113, DOI 10.1007/BF00001781; Lemon SM, 2008, WORKSH SUMM; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; Naugle DE, 2005, WILDLIFE SOC B, V33, P616, DOI 10.2193/0091-7648(2005)33[616:WNVASW]2.0.CO;2; Naugle DE, 2004, ECOL LETT, V7, P704, DOI 10.1111/j.1461-0248.2004.00631.x; Oli K., 2005, Tropical Biomedicine, V22, P249; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103; Rowland MM, 2006, BIOL CONSERV, V129, P323, DOI 10.1016/j.biocon.2005.10.048; Scott W.B., 1973, B FISHERIES RES BOAR, V184; Taylor RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071256; Tranchida MC, 2010, BIOL CONTROL, V53, P183, DOI 10.1016/j.biocontrol.2009.11.006; Walker BL, 2011, STUD AVIAN BIOL, P127; Zimmer KD, 2000, CAN J FISH AQUAT SCI, V57, P76, DOI 10.1139/cjfas-57-1-76; Zimmer KD, 2001, ECOSYSTEMS, V4, P346, DOI 10.1007/s10021-001-0016-1; Zou L, 2006, J MED ENTOMOL, V43, P1034, DOI 10.1603/0022-2585(2006)43[1034:MLHMUR]2.0.CO;2	35	0	0	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194304	10.1371/journal.pone.0194304	http://dx.doi.org/10.1371/journal.pone.0194304			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649226	Green Submitted, gold, Green Published			2022-12-27	WOS:000429791900010
J	Wilson, JL; Warburton, R; Taylor, L; Toksoz, D; Hill, N; Polgar, P				Wilson, Jamie L.; Warburton, Rod; Taylor, Linda; Toksoz, Deniz; Hill, Nicholas; Polgar, Peter			Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension	PLOS ONE			English	Article							RHO-KINASE INHIBITOR; SIGNAL-TRANSDUCTION; ACTIN-BINDING; INDUCED CONTRACTION; CALMODULIN-BINDING; ACTOMYOSIN-ATPASE; C-TERMINUS; CALDESMON; PHOSPHORYLATION; ACTIVATION	Contraction of human pulmonary artery smooth muscle cells (HPASMC) isolated from pulmonary arterial hypertensive (PAH) and normal (non-PAH) subject lungs was determined and measured with real-time electrical impedance. Treatment of HPASMC with vasoactive peptides, endothelin-1 (ET-1) and bradykinin (BK) but not angiotensin II, induced a temporal decrease in the electrical impedance profile mirroring constrictive morphological change of the cells which typically was more robust in PAH as opposed to non-PAH cells. Inhibition with LIMKi3 and a cofilin targeted motif mimicking cell permeable peptide (MMCPP) had no effect on ET-1 induced HPASMC contraction indicating a negligible role for these actin regulatory proteins. On the other hand, a MMCPP blocking the activity of caldesmon reduced ET-1 promoted contraction pointing to a regulatory role of this protein and its activation pathway in HPASMC contraction. Inhibition of this MEK/ERK/p9ORSK pathway, which is an upstream regulator of caldesmon phosphorylation, reduced ET-1 induced cell contraction. While the regulation of ET-1 induced cell contraction was found to be similar in PAH and non-PAH cells, a key difference was the response to pharmacological inhibitors and to siRNA knockdown of Rho kinases (ROCK1/ROCK2). The PAH cells required much higher concentrations of inhibitors to abrogate ET-1 induced contractions and their contraction was not affected by siRNA against either ROCK1 or ROCK2. Lastly, blocking of L-type and T-type Ca2+ channels had no effect on ET-1 or BK induced contraction. However, inhibiting the activity of the sarcoplasmic reticulum Ca2+ ATPase blunted ET-1 and BK induced HPASMC contraction in both PAH and non-PAH derived HPASMC. In summary, our findings here together with previous communications illustrate similarities and differences in the regulation PAH and non-PAH smooth muscle cell contraction relating to calcium translocation, RhoA/ROCK signaling and the activity of caldesmon. These findings may provide useful tools in achieving the regulation of the vascular hypercontractility taking place in PAH.	[Wilson, Jamie L.; Warburton, Rod; Taylor, Linda; Toksoz, Deniz; Hill, Nicholas; Polgar, Peter] Tufts Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02111 USA	Tufts Medical Center	Wilson, JL (corresponding author), Tufts Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02111 USA.	jwilson8@tuftsmedicalcenter.org	Wilson, Jamie/J-5913-2019		National Heart, Lung, and Blood Institute of the National Institutes of Health [HL25776, HL133796]; Actelion Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL133796, R01HL025776] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Actelion Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants HL25776 (PP) and HL133796 (JW) from the National Heart, Lung, and Blood Institute of the National Institutes of Health. Additional funding to support this work was provided by Actelion Pharmaceuticals (NH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Alahyan M, 2006, J BIOL CHEM, V281, P19433, DOI 10.1074/jbc.M507602200; Baik J, 2014, INT J BIOL SCI, V10, P1108, DOI 10.7150/ijbs.9797; Barman SA, 2007, AM J PHYSIOL-LUNG C, V293, pL472, DOI 10.1152/ajplung.00101.2006; Bravo DD, 2018, J PHARMACOL TOX MET, V89, P47, DOI 10.1016/j.vascn.2017.10.006; Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652; Cacoub P, 1997, CARDIOVASC RES, V33, P196, DOI 10.1016/S0008-6363(96)00189-7; Comhair SAA, 2012, AM J RESP CELL MOL, V46, P723, DOI 10.1165/rcmb.2011-0416TE; Dai YP, 2006, VASC PHARMACOL, V44, P275, DOI 10.1016/j.vph.2005.11.008; Dai YP, 2008, ADV PHARMACOL SCI, V2008, DOI 10.1155/2008/362741; Do E Z, 2009, CIRC J, V73, P1731, DOI 10.1253/circj.CJ-09-0135; Do KH, 2009, EXP MOL MED, V41, P569, DOI 10.3858/emm.2009.41.8.062; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Frazier AA, 2012, SEMIN ULTRASOUND CT, V33, P535, DOI 10.1053/j.sult.2012.06.002; Fujita H, 2010, HEART VESSELS, V25, P144, DOI 10.1007/s00380-009-1176-8; Fukumoto Y, 2005, HEART, V91, P391, DOI 10.1136/hrt.2003.029470; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; GOTO K, 1989, P NATL ACAD SCI USA, V86, P3915, DOI 10.1073/pnas.86.10.3915; Guan RG, 2013, EUR J MED CHEM, V70, P613, DOI 10.1016/j.ejmech.2013.10.048; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hedges JC, 2000, AM J PHYSIOL-CELL PH, V278, pC718, DOI 10.1152/ajpcell.2000.278.4.C718; HEMRIC ME, 1993, J BIOL CHEM, V268, P15305; Hong ZG, 2014, J MOL MED, V92, P995, DOI 10.1007/s00109-014-1162-1; Huang RJ, 2006, FEBS LETT, V580, P63, DOI 10.1016/j.febslet.2005.11.047; Ishikura K, 2006, CIRC J, V70, P174, DOI 10.1253/circj.70.174; Jernigan NL, 2008, AM J PHYSIOL-LUNG C, V295, pL515, DOI 10.1152/ajplung.00355.2007; Jiang QF, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-6; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; Kawanabe Y, 2002, J CARDIOVASC PHARM, V40, P438, DOI 10.1097/00005344-200209000-00013; Kordowska J, 2006, J BIOMED SCI, V13, P159, DOI 10.1007/s11373-005-9060-8; Li JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013955; Liao MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056331; LINZ W, 1995, PHARMACOL REV, V47, P25; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Tu L, 2012, AM J RESP CRIT CARE, V186, P666, DOI 10.1164/rccm.201202-0309OC; MARSTON SB, 1991, BIOCHEM J, V279, P1; Mohacsi Attila, 2004, Current Vascular Pharmacology, V2, P53, DOI 10.2174/1570161043476528; Neylon CB, 1999, CLIN EXP PHARMACOL P, V26, P149, DOI 10.1046/j.1440-1681.1999.03013.x; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Patchell VB, 2002, BBA-PROTEIN STRUCT M, V1596, P121, DOI 10.1016/S0167-4838(02)00210-8; Paulin R, 2014, EUR RESPIR J, V43, P531, DOI 10.1183/09031936.00181312; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shin CY, 2002, J PHARMACOL EXP THER, V302, P924, DOI 10.1124/jpet.302.3.924; SOBUE K, 1985, BIOCHEM BIOPH RES CO, V132, P645, DOI 10.1016/0006-291X(85)91181-7; Steinbach SK, 2011, ARTERIOSCL THROM VAS, V31, P2938, DOI 10.1161/ATVBAHA.111.232975; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Tirapelli CR, 2005, BRIT J PHARMACOL, V146, P903, DOI 10.1038/sj.bjp.0706388; VELAZ L, 1990, J BIOL CHEM, V265, P2929; WANG CLA, 1991, J BIOL CHEM, V266, P9166; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Wang Z, 1997, J BIOL CHEM, V272, P16896, DOI 10.1074/jbc.272.27.16896; Wilson Jamie L, 2015, Curr Top Pept Protein Res, V16, P1; Wilson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123662; Wilson JL, 2012, EXP CELL RES, V318, P1125, DOI 10.1016/j.yexcr.2012.03.029; Wynne BM, 2009, J AM SOC HYPERTENS, V3, P84, DOI 10.1016/j.jash.2008.09.002; Yamamura A, 2013, CIRC RES, V112, P640, DOI 10.1161/CIRCRESAHA.113.300897; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; Yao CX, 2015, INT J MASS SPECTROM, V378, P347, DOI 10.1016/j.ijms.2014.10.006; Yu J, 2013, J CELL PHYSIOL, V228, P322, DOI 10.1002/jcp.24132; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zhao YDD, 2012, AM J PATHOL, V180, P2268, DOI 10.1016/j.ajpath.2012.02.016	67	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195780	10.1371/journal.pone.0195780	http://dx.doi.org/10.1371/journal.pone.0195780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649319	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900086
J	Miyazaki, K				Miyazaki, Kentaro			Molecular engineering of the salicylate-inducible transcription factor Sal7AR for orthogonal and high gene expression in Escherichia coli	PLOS ONE			English	Article							METAGENOME LIBRARIES; ADAPTATION	I have previously identified a metagenomic fragment (similar to 4 kb) containing the salicylate (2-hydroxybenzoate)-responsive transcriptional regulator Sal7AR. Taking advantage of the inert nature of salicylate to common genetic switches used in Escherichia coli, here I developed a salicylate-inducible high expression system in E. coli. I first applied a deletion analysis to the metagenomic fragment to identify the core region (similar to 1 kb) necessary for the salicylate-dependent expression. Sal7AR was subjected to an error-prone PCR, and a library was screened for an enhanced expression of a reporter green fluorescent protein (GFP) gene in the presence of 1 mM salicylate, where virtually no growth inhibition was observed. Three beneficial amino acid substitutions were identified (N282K, Q292R, and V295G), each of which improved the expression of GFP relative to the wildtype by several-fold. The three sites were then completely randomized by saturation mutagenesis either individually or combinatorially to identify three variants carrying a single point mutation, N282L, V295F, or V295S; no further improvements were observed by combining these mutations. Salicylate-dependent expression of these mutants was highly repressed in its absence and escalated in response to similar to 10 mu M salicylate, and gradually increased up to 1 mM salicylate; the induction rate was approximately 15 times greater than that achieved with a lactose promoter. Orthogonality to the lactose-based expression system was also confirmed. This salicylate-based expression system should thus be advantageously used for high-level production of recombinant proteins in combination with common lactose-dependent induction systems.	[Miyazaki, Kentaro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Miyazaki, Kentaro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Miyazaki, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.; Miyazaki, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan.	miyazaki-kentaro@aist.go.jp	Miyazaki, Kentaro/F-7022-2010	Miyazaki, Kentaro/0000-0002-4349-566X	ImPACT Program of Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan)	ImPACT Program of Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan)	This research was funded by ImPACT Program of Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan).	Ahmadi MK, 2015, APPL ENVIRON MICROB, V81, P5290, DOI 10.1128/AEM.01373-15; Kelly CL, 2016, ACS SYNTH BIOL, V5, P1136, DOI 10.1021/acssynbio.6b00030; KUNIN CM, 1995, INFECT IMMUN, V63, P1796, DOI 10.1128/IAI.63.5.1796-1799.1995; Miyazaki K, 1999, J MOL EVOL, V49, P716, DOI 10.1007/PL00006593; Price CTD, 2000, INT J BIOCHEM CELL B, V32, P1029, DOI 10.1016/S1357-2725(00)00042-X; Springael D, 2004, TRENDS MICROBIOL, V12, P53, DOI 10.1016/j.tim.2003.12.010; Tang SY, 2008, J AM CHEM SOC, V130, P5267, DOI 10.1021/ja7109053; Uchiyama T, 2005, NAT BIOTECHNOL, V23, P88, DOI 10.1038/nbt1048; Uchiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075795; Uchiyama T, 2010, METHODS MOL BIOL, V668, P153, DOI 10.1007/978-1-60761-823-2_10; Uchiyama T, 2010, APPL ENVIRON MICROB, V76, P7029, DOI 10.1128/AEM.00464-10; VANDERMEER JR, 1992, MICROBIOL REV, V56, P677, DOI 10.1128/MMBR.56.4.677-694.1992	12	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194090	10.1371/journal.pone.0194090	http://dx.doi.org/10.1371/journal.pone.0194090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641575	Green Submitted, Green Published, gold			2022-12-27	WOS:000429742900024
J	Reguero, BG; Beck, MW; Bresch, DN; Calil, J; Meliane, I				Reguero, Borja G.; Beck, Michael W.; Bresch, David N.; Calil, Juliano; Meliane, Imen			Comparing the cost effectiveness of nature-based and coastal adaptation: A case study from the Gulf Coast of the United States	PLOS ONE			English	Article							SEA-LEVEL RISE; STORM-SURGE; FLOOD RISK; DAMAGE; INFRASTRUCTURE; MITIGATION; DEFENSE; IMPACT; FUTURE	Coastal risks are increasing from both development and climate change. Interest is growing in the protective role that coastal nature-based measures (or green infrastructure), such as reefs and wetlands, can play in adapting to these risks. However, a lack of quantitative information on their relative costs and benefits is one principal factor limiting their use more broadly. Here, we apply a quantitative risk assessment framework to assess coastal flood risk (from climate change and economic exposure growth) across the United States Gulf of Mexico coast to compare the cost effectiveness of different adaptation measures. These include nature-based (e.g. oyster reef restoration), structural or grey (e.g., seawalls) and policy measures (e.g. home elevation). We first find that coastal development will be a critical driver of risk, particularly for major disasters, but climate change will cause more recurrent losses through changes in storms and relative sea level rise. By 2030, flooding will cost $134 +/- 176.6 billion (for different economic growth scenarios), but as the effects of climate change, land subsidence and concentration of assets in the coastal zone increase, annualized risk will more than double by 2050 with respect to 2030. However, from the portfolio we studied, the set of cost-effective adaptation measures (with benefit to cost ratios above 1) could prevent up to $57 +/- 101 billion in losses, which represents 42.8 +/- 57.2% of the total risk. Nature-based adaptation options could avert more than $50 billion of these costs, and do so cost effectively with average benefit to cost ratios above 3.5. Wetland and oyster reef restoration are found to be particularly cost-effective. This study demonstrates that the cost effectiveness of nature-based, grey and policy measures can be compared quantitatively with one another, and that the cost effectiveness of adaptation becomes more attractive as climate change and coastal development intensifies in the future. It also shows that investments in nature-based adaptation could meet multiple objectives for environmental restoration, adaptation and flood risk reduction.	[Reguero, Borja G.; Beck, Michael W.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Reguero, Borja G.; Beck, Michael W.; Meliane, Imen] Nature Conservancy, Santa Cruz, CA USA; [Bresch, David N.] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Zurich, Switzerland; [Calil, Juliano] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Nature Conservancy; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Santa Cruz	Reguero, BG (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.; Reguero, BG (corresponding author), Nature Conservancy, Santa Cruz, CA USA.	breguero@ucsc.edu	Beck, Michael W./AAB-2844-2019; Bresch, David N./D-5298-2018; Reguero, Borja/L-8621-2014	Beck, Michael W./0000-0002-5107-9973; Bresch, David N./0000-0002-8431-4263; Calil, Juliano/0000-0002-6568-4883; Reguero, Borja/0000-0001-5526-7157	Anne Ray Charitable Trust; Kingfisher Foundation; Lyda Hill Foundation; Science for Nature And People Partnership; Pew Marine Conservation Fellowship	Anne Ray Charitable Trust; Kingfisher Foundation; Lyda Hill Foundation; Science for Nature And People Partnership; Pew Marine Conservation Fellowship	This work was supported in part by the Anne Ray Charitable Trust, Kingfisher Foundation and the Lyda Hill Foundation as well as the Science for Nature And People Partnership; MWB was also supported by a Pew Marine Conservation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JCJH, 2013, RISK ANAL, V33, P772, DOI 10.1111/risa.12008; Anderson DG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188142; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; [Anonymous], 2012, COASTAL LOUISIANA RI; Barbier EB, 2015, ECOSYST SERV, V11, P32, DOI 10.1016/j.ecoser.2014.06.010; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Blake E.S., 2011, DEADLIEST COSTLIEST; Borsje BW, 2011, ECOL ENG, V37, P113, DOI 10.1016/j.ecoleng.2010.11.027; Bresch D.N, 2014, CLIMADA THE OPEN SOU; Bresch D.N., 2016, CLIMATE CHANGE ADAPT, P241, DOI DOI 10.1007/978-3-319-40773-9_13; Bresch DN, 2014, CLIMADA MANUAL, P1; Bridges T., 2013, COASTAL RISK REDUCTI; Broekx S, 2011, NAT HAZARDS, V57, P245, DOI 10.1007/s11069-010-9610-x; Calil J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187011; Chapman MG, 2011, J EXP MAR BIOL ECOL, V400, P302, DOI 10.1016/j.jembe.2011.02.025; Cheong SM, 2013, NAT CLIM CHANGE, V3, P787, DOI 10.1038/NCLIMATE1854; Cobell Z, 2013, J COASTAL RES, P88, DOI 10.2112/SI_67_7; Cooper JAG, 2014, OCEAN COAST MANAGE, V94, P90, DOI 10.1016/j.ocecoaman.2013.09.006; ECA, 2009, SHAP CLIM RES DEV FR; Edwards PET, 2013, MAR POLICY, V38, P65, DOI 10.1016/j.marpol.2012.05.020; EU, 2015, EU RES INN POL AG NA, DOI DOI 10.2777/765301; EU, 2013, COMMUNICATION, P249; Exec. Office of the President, 2013, PRESIDENTS CLIMATE A; FEMA, 2015, GULF MEX COAST REG; FEMA, 2011, ENG NAT, P3; FEMA, 2014, HOM GUID RETR, V3rd; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Flores P., 2006, NAT HAZARDS REV, V7, P72, DOI [10.1061/(ASCE)1527-6988(2006)7:2(72), DOI 10.1061/(ASCE)1527-6988(2006)7:2(72)]; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Ghermandi A, 2013, ECOL ECON, V86, P1, DOI 10.1016/j.ecolecon.2012.11.006; Gittman RK, 2015, FRONT ECOL ENVIRON, V13, P301, DOI 10.1890/150065; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hauer ME, 2016, NAT CLIM CHANGE, V6, P691, DOI [10.1038/nclimate2961, 10.1038/NCLIMATE2961]; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Houston JR, 2008, EC VALUE BEACHES 200, P76; Hsiang S, 2017, SCIENCE, V356, P1362, DOI 10.1126/science.aal4369; Ivins ER, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030003; James R, 2014, NAT CLIM CHANGE, V4, P938, DOI 10.1038/nclimate2411; Jongman B, 2012, GLOBAL ENVIRON CHANG, V22, P823, DOI 10.1016/j.gloenvcha.2012.07.004; Karp L, 2005, J PUBLIC ECON, V89, P261, DOI 10.1016/j.jpubeco.2004.02.005; Kroeger T, 2012, NATURE CONSERVANCY; Kron W, 2005, WATER INT, V30, P58, DOI 10.1080/02508060508691837; Kron W, 2013, NAT HAZARDS, V66, P1363, DOI 10.1007/s11069-012-0215-4; Lin N, 2012, NAT CLIM CHANGE, V2, P462, DOI 10.1038/NCLIMATE1389; Losada IJ, 2013, GLOBAL PLANET CHANGE, V104, P34, DOI 10.1016/j.gloplacha.2013.02.006; Louisiana CP, 2012, LOUISIANAS COMPREHEN; Martin D, 2005, COAST ENG, V52, P1027, DOI 10.1016/j.coastaleng.2005.09.006; Mechler R, 2016, SCIENCE, V354, P290, DOI 10.1126/science.aag2514; Mendelsohn R, 2008, REV ENV ECON POLICY, V2, P45, DOI 10.1093/reep/rem023; Moller I, 2014, NAT GEOSCI, V7, P848, DOI [10.1038/ngeo2251, 10.1038/NGEO2287, 10.1038/NGEO2251]; Narayan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154735; NAS, 2014, NAT AC SCI WAT SCI T; National Oceanic and Atmospheric Administration (NOAA), 2010, RESORT WAR 1816 2007; National Research Council, 2014, RED COAST RISKS E GU, DOI [10.17226/18811, DOI 10.17226/18811]; Neumann JE, 2015, CLIMATIC CHANGE, V129, P337, DOI 10.1007/s10584-014-1304-z; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; NOAA, 2013, WHAT WILL AD COST EC; NOAA, 2011, EXPL COAST COMM EC E; NOAA, 2009, SEA LEV VAR US 1854; Nordhaus W, 2007, SCIENCE, V317, P201, DOI 10.1126/science.1137316; Peduzzi P, 2012, NAT CLIM CHANGE, V2, P289, DOI 10.1038/NCLIMATE1410; Peyronnin N, 2013, J COASTAL RES, P1, DOI 10.2112/SI_67_1.1; PINSKY ML, 2013, EC EC SOC AM, V4, DOI DOI 10.1890/ES13-00080.1; Possingham HP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002052; PwC Economics, 2013, WORLD 2050 BRICS PRO; Reddy SMW, 2016, INTEGR ENVIRON ASSES, V12, P328, DOI 10.1002/ieam.1678; Reguero BG, 2018, CLIMADA COASTAL AREA; Reguero BG, 2018, ASSESSING COASTAL RI, DOI [10.17504/protocols.io.miyc4fw, DOI 10.17504/PROTOCOLS.IO.MIYC4FW]; Reguero BG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133409; Res C, 2001, MAPS LANDS VULNERABL, V18, P205; Resio DT, 2015, CURR CLIM CHANGE REP, V1, P74, DOI 10.1007/s40641-015-0011-9; Resio DT, 2009, NAT HAZARDS, V51, P163, DOI 10.1007/s11069-009-9379-y; RESTORE, 2014, GULF COAST EC RES CO; Rodriguez AB, 2014, NAT CLIM CHANGE, V4, P493, DOI [10.1038/NCLIMATE2216, 10.1038/nclimate2216]; Sasmito SD, 2016, WETL ECOL MANAG, V24, P263, DOI 10.1007/s11273-015-9466-7; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Souvignet M., 2016, EC CLIMATE ADAPTATIO; Spalding MD, 2014, CONSERV LETT, V7, P293, DOI 10.1111/conl.12074; Stockdon BHF, 2012, NATL ASSESSMENT HURR; Sutton-Grier AE, 2015, ENVIRON SCI POLICY, V51, P137, DOI 10.1016/j.envsci.2015.04.006; Temmerman S, 2015, SCIENCE, V349, P588, DOI 10.1126/science.aac8312; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Thomson G, 2010, BARRIER ISLAND RESTO; TNC, 2015, NAT CONS; Travis WR, 2014, CLIM RISK MANAG, V1, P1, DOI 10.1016/j.crm.2014.02.003; Tunstall S., 2007, FLOOD RISK MANAG HAZ, P189; USACE, 2015, N ATLANTIC COAST COM; USCensus, 2010, COAST POP TRENDS US; Walsh KJE, 2016, WIRES CLIM CHANGE, V7, P65, DOI 10.1002/wcc.371; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Woodruff JD, 2013, NATURE, V504, P44, DOI 10.1038/nature12855	98	89	90	6	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0192132	10.1371/journal.pone.0192132	http://dx.doi.org/10.1371/journal.pone.0192132			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641611	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900005
J	Dalmases, M; Benitez, ID; Mas, A; Garcia-Codina, O; Medina-Bustos, A; Escarrabill, J; Salto, E; Buysse, DJ; Roure, N; Sanchez-de-la-Torre, M; Rue, M; Barbe, F; de Batlle, J				Dalmases, Mireia; Benitez, Ivan D.; Mas, Anna; Garcia-Codina, Oriol; Medina-Bustos, Antonia; Escarrabill, Joan; Salto, Esteve; Buysse, Daniel J.; Roure, Nuria; Sanchez-de-la-Torre, Manuel; Rue, Montse; Barbe, Ferran; de Batlle, Jordi			Assessing sleep health in a European population: Results of the Catalan Health Survey 2015	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR; SHIFT WORK; DURATION; HYPERTENSION; ADULTS; METAANALYSIS; INSOMNIA; OBESITY	Objective To describe the overall sleep health of the Catalan population using data from the 2015 Catalan Health Survey and to compare the performance of two sleep health indicators: sleep duration and a 5-dimension sleep scale (SATED). Methods Multistage probability sampling representative of the non-institutionalized population aged 15 or more years, stratified by age, gender and municipality size, was used, excluding nightshift-workers. A total of 4385 surveys were included in the analyses. Associations between sleep health and the number of reported chronic diseases were assessed using non-parametric smoothed splines. Differences in the predictive ability of age-adjusted logistic regression models of self-rated health status were assessed. Multinomial logistic regression models were used to assess SATED determinants. Results Overall mean (SD) sleep duration was 7.18 (1.16) hours; and SATED score 7.91 (2.17) (range 0-10), lower (worse) scores were associated with increasing age and female sex. Alertness and efficiency were the most frequently impaired dimensions across age groups. SATED performed better than sleep duration when assessing self-rated health status (area under the curve = 0.856 vs. 0.798; p-value < 0.001), and had a linear relationship with the number of reported chronic diseases, while the sleep duration relationship was u-shaped. Conclusions Sleep health in Catalonia is associated with age and gender. SATED has some advantaged compared to sleep duration assessment, as it relates linearly to health indicators, has a stronger association with self-rated health status, and provides a more comprehensive assessment of sleep health. Therefore, the inclusion of multi-dimensional sleep health assessment tools in national surveys should be considered.	[Dalmases, Mireia; Benitez, Ivan D.; Mas, Anna; Roure, Nuria; Sanchez-de-la-Torre, Manuel; Barbe, Ferran; de Batlle, Jordi] Hosp Univ Amau Vilanova & Santa Maria, IRB Lleida, Grp Translat Res Resp Med, Lleida, Spain; [Dalmases, Mireia; Roure, Nuria; Sanchez-de-la-Torre, Manuel; Barbe, Ferran; de Batlle, Jordi] CIBERES, Madrid, Spain; [Garcia-Codina, Oriol; Medina-Bustos, Antonia; Salto, Esteve] Subdireccie Gen Planificacio Sanit & Profess, Catalan Hlth Dept, Barcelona, Spain; [Escarrabill, Joan] Master Plan Resp Dis PDMAR, Catalan Hlth Dept, Barcelona, Spain; [Buysse, Daniel J.] Univ Pittsburgh, Ctr Sleep & Circadian Sci, Pittsburgh, PA USA; [Rue, Montse] Univ Lleida, IRBLLEIDA, Basic Med Sci Dept, Lleida, Spain	Institut de Recerca Biomedica - IRB Lleida; University Hospital Arnau de Vilanova; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universitat de Lleida	de Batlle, J (corresponding author), Hosp Univ Amau Vilanova & Santa Maria, IRB Lleida, Grp Translat Res Resp Med, Lleida, Spain.; de Batlle, J (corresponding author), CIBERES, Madrid, Spain.	jordidebatlle@gmail.com	Benítez, Iván David/AAI-9379-2020; Buysse, Daniel/AAJ-1608-2021; Barbé, Ferran/A-5988-2010; de la Torre, Manuel Sanchez/B-5578-2009; de Batlle, Jordi/G-6724-2016; Rue, Montserrat/B-5663-2009; Sanchez-de-la-Torre, Manuel/AAP-2663-2020; Sánchez-de-la-Torre, Manuel/AAC-9514-2022	Buysse, Daniel/0000-0002-3288-1864; Barbé, Ferran/0000-0002-2340-8928; de la Torre, Manuel Sanchez/0000-0002-5695-348X; de Batlle, Jordi/0000-0003-3500-6608; Rue, Montserrat/0000-0002-7862-9365; Sanchez-de-la-Torre, Manuel/0000-0002-5695-348X; Benitez, Ivan David/0000-0002-3558-5948	Ministerio de Economia y Competitividad [COFUND2014-51501]	Ministerio de Economia y Competitividad(Spanish Government)	This work was cofunded by Ministerio de Economia y Competitividad [COFUND2014-51501]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaniz-Zanon M, 2014, GAC SANIT, V28, P338, DOI 10.1016/j.gaceta.2013.12.004; [Anonymous], 2015, HLTH SURV CAT ESCA 2; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; Campanini MZ, 2017, SLEEP MED, V35, P27, DOI 10.1016/j.sleep.2017.04.004; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Centers for Disease Control and Prevention, 2013, NAT HLTH NUTR EX SUR; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chen XL, 2014, QUAL LIFE RES, V23, P613, DOI 10.1007/s11136-013-0475-9; Croy I, 2017, BEHAV SLEEP MED, V15, P466, DOI 10.1080/15402002.2016.1163700; Domingo-Salvany A, 2013, GAC SANIT, V27, P263, DOI 10.1016/j.gaceta.2012.12.009; Furihata R, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw075; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Johar H, 2016, SLEEP, V39, P217, DOI 10.5665/sleep.5352; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; King CR, 2008, JAMA-J AM MED ASSOC, V300, P2859, DOI 10.1001/jama.2008.867; Lakerveld J, 2016, OBES REV, V17, P62, DOI 10.1111/obr.12381; Latta F, 2005, SLEEP, V28, P1525, DOI 10.1093/sleep/28.12.1525; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Lim ASP, 2016, STROKE, V47, P516, DOI 10.1161/STROKEAHA.115.011608; Linden M, 2016, NAT SCI SLEEP, V8, P291, DOI 10.2147/NSS.S97241; Mompart-Penina Anna, 2011, Med Clin (Barc), V137 Suppl 2, P3, DOI 10.1016/S0025-7753(11)70021-5; Oishi M, 2005, J HYPERTENS, V23, P2173, DOI 10.1097/01.hjh.0000189870.55914.b3; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rod NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091965; Smagula SF, 2016, SLEEP MED REV, V25, P21, DOI 10.1016/j.smrv.2015.01.003; Stranges S, 2010, J HYPERTENS, V28, P896, DOI 10.1097/HJH.0b013e328335d076; Suwazono Y, 2006, J OCCUP ENVIRON MED, V48, P455, DOI 10.1097/01.jom.0000214355.69182.fa; Thurston RC, 2016, SLEEP; Van Hoorde K, 2014, STAT MED, V33, P2585, DOI 10.1002/sim.6114; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879; Zamanian Zahra, 2016, Electron Physician, V8, P1811, DOI 10.19082/1811	36	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194495	10.1371/journal.pone.0194495	http://dx.doi.org/10.1371/journal.pone.0194495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668685	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200009
J	Fasmer, EE; Fasmer, OB; Berle, JO; Oedegaard, KJ; Hauge, ER				Fasmer, Erlend Eindride; Fasmer, Ole Bernt; Berle, Jan Oystein; Oedegaard, Ketil J.; Hauge, Erik R.			Graph theory applied to the analysis of motor activity in patients with schizophrenia and depression	PLOS ONE			English	Article							TIME-SERIES; SLEEP; MOOD	Depression and schizophrenia are defined only by their clinical features, and diagnostic separation between them can be difficult. Disturbances in motor activity pattern are central features of both types of disorders. We introduce a new method to analyze time series, called the similarity graph algorithm. Time series of motor activity, obtained from actigraph registrations over 12 days in depressed and schizophrenic patients, were mapped into a graph and we then applied techniques from graph theory to characterize these time series, primarily looking for changes in complexity. The most marked finding was that depressed patients were found to be significantly different from both controls and schizophrenic patients, with evidence of less regularity of the time series, when analyzing the recordings with one hour intervals. These findings support the contention that there are important differences in control systems regulating motor behavior in patients with depression and schizophrenia. The similarity graph algorithm we have described can easily be applied to the study of other types of time series.	[Fasmer, Ole Bernt; Berle, Jan Oystein; Oedegaard, Ketil J.; Hauge, Erik R.] Haukeland Hosp, Div Psychiat, Bergen, Norway; [Fasmer, Ole Bernt; Berle, Jan Oystein; Oedegaard, Ketil J.] Univ Bergen, Sect Psychiat, Dept Clin Med, Bergen, Norway; [Fasmer, Ole Bernt; Oedegaard, Ketil J.] KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen	Fasmer, OB (corresponding author), Haukeland Hosp, Div Psychiat, Bergen, Norway.; Fasmer, OB (corresponding author), Univ Bergen, Sect Psychiat, Dept Clin Med, Bergen, Norway.; Fasmer, OB (corresponding author), KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway.	ole.fasmer@uib.no			Gerda Meyer Nyquist Gulbrandson AMP; Gerdt Meyer Nyquist; Western Norway Regional Health Authority	Gerda Meyer Nyquist Gulbrandson AMP; Gerdt Meyer Nyquist; Western Norway Regional Health Authority	This research has been supported by unrestricted grants from the legacy of Gerda Meyer Nyquist Gulbrandson & Gerdt Meyer Nyquist and from Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-San Juan B, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40762-2; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bennabi D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/158746; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; Burton C, 2013, J AFFECT DISORDERS, V145, P21, DOI 10.1016/j.jad.2012.07.001; EHLERS CL, 1995, ARCH GEN PSYCHIAT, V52, P960; Fasmer OB, 2016, PSYCHIAT INVEST, V13, P112, DOI 10.4306/pi.2016.13.1.112; Ravetti MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108004; GOTTSCHALK A, 1995, ARCH GEN PSYCHIAT, V52, P947; Grierson AB, 2016, INT J BIPOLAR DISORD, V4, DOI 10.1186/s40345-015-0043-z; Hauge ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016291; Hirjak D, 2015, SCHIZOPHR RES, V169, P217, DOI 10.1016/j.schres.2015.10.022; Jung SH, 2011, PSYCHIAT INVEST, V8, P22, DOI 10.4306/pi.2011.8.1.22; Kim TS, 2011, PSYCHIAT INVEST, V8, P1, DOI 10.4306/pi.2011.8.1.1; Krane-Gartiser K, 2015, J CLIN PSYCHIAT, V76, P1181, DOI 10.4088/JCP.14m09106; Krane-Gartiser K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089574; Lacasa L, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30001; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Lian B., 2002, 1 COURSE DISCRETE MA; Littner M, 2002, SLEEP, V25, P143, DOI 10.1093/sleep/25.2.143; Luque B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046103; Luque B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022411; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Sacchet MD, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00021; Sedgewick R, 2015, GRAPH JAVA; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; VANHILTEN JJ, 1993, ELECTROEN CLIN NEURO, V89, P359, DOI 10.1016/0168-5597(93)90076-2; Walther S, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00010; Wittekind DA, 2016, BIPOLAR DISORD, V18, P502, DOI 10.1111/bdi.12440; Wulff K, 2012, BRIT J PSYCHIAT, V200, P308, DOI 10.1192/bjp.bp.111.096321	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194791	10.1371/journal.pone.0194791	http://dx.doi.org/10.1371/journal.pone.0194791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668743	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200016
J	Mayhugh, RE; Rejeski, WJ; Petrie, MR; Laurienti, PJ; Gauvin, L				Mayhugh, Rhiannon E.; Rejeski, W. Jack; Petrie, Meredith R.; Laurienti, Paul J.; Gauvin, Lise			Differing patterns of stress and craving across the day in moderate-heavy alcohol consumers during their typical drinking routine and an imposed period of alcohol abstinence	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; EXPERIENCE QUESTIONNAIRE; TIME; CONSUMPTION; REACTIVITY; WITHDRAWAL; ADDICTION; RELAPSE; DESIRE	Background Stress is a known factor related to alcohol use. However, how the relationship between alcohol craving and stress varies across the day is not fully understood. As craving is a consistent predictor of alcohol use disorder (AUD), understanding stress and craving patterns across the day in routine, non-dependent, moderate-heavy alcohol consumers may help in understanding those who may be vulnerable to transitioning into AUD. Method Moderate-heavy drinkers were recruited from the local community (n = 32) and assessed for fluctuations in craving and stress intensity across the day via Ecological Momentary Assessment (EMA) during 3 consecutive days of imposed alcohol abstinence (abstained trial) and their normal drinking routine (normal trial). A multilevel modeling statistical approach assessed differences in diurnal craving and stress patterns with the Alcohol Craving Experience Questionnaire (ACE) examined as a moderator. Results Immediately following alcohol consumption on normal trials, EMA craving levels were significantly reduced compared to pre-drinking levels. Moreover, the post-drinking craving levels were lower than on abstained trials. Higher ACE scores were associated with significantly higher EMA craving across the day and higher peaks at midday. Higher ACE scores were also associated with greater EMA stress across the day. Drinking relieved stress relative to abstained trials, but not in individuals with higher ACE scores. Higher stress was associated with greater EMA craving, which was stronger among those with higher ACE scores. Conclusion These findings suggest that ACE scores are important to understanding patterns of stress and craving experienced across the day in routine, non-dependent, moderate-heavy drinkers and may provide new insights for vulnerability to transitioning into AUD.	[Mayhugh, Rhiannon E.; Laurienti, Paul J.] Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27101 USA; [Mayhugh, Rhiannon E.] Wake Forest Sch Med, Neurosci Program, Winston Salem, NC 27101 USA; [Rejeski, W. Jack; Petrie, Meredith R.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Rejeski, W. Jack; Petrie, Meredith R.] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA; [Rejeski, W. Jack; Laurienti, Paul J.] Wake Forest Univ, Translat Sci Ctr, Winston Salem, NC 27109 USA; [Rejeski, W. Jack] Wake Forest Univ, Dept Geriatr Med, Winston Salem, NC 27109 USA; [Laurienti, Paul J.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Gauvin, Lise] CRCHUM, Montreal, PQ, Canada; [Gauvin, Lise] Univ Montreal, Ecole Sante Publ, Dept Med Sociale & Prevent, Montreal, PQ, Canada	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Universite de Montreal; Universite de Montreal	Mayhugh, RE (corresponding author), Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27101 USA.; Mayhugh, RE (corresponding author), Wake Forest Sch Med, Neurosci Program, Winston Salem, NC 27101 USA.	rmayhugh@wakehealth.edu		Gauvin, Lise/0000-0002-1562-1307	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [T32AA007565, P01AA021099, P50AA026117]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P01AA021099, P50AA026117] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the following: The National Institute on Alcohol Abuse and Alcoholism (www.niaaa.nih.gov/) of the National Institutes of Health under Award Number T32AA007565, P01AA021099, and P50AA026117. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Babor TF, 2000, ADDICTION, V95, P677, DOI 10.1046/j.1360-0443.2000.9556773.x; Becker HC, 2017, NEUROPHARMACOLOGY, V122, P115, DOI 10.1016/j.neuropharm.2017.04.028; Breese GR, 2005, ALCOHOL CLIN EXP RES, V29, P185, DOI 10.1097/01.ALC.0000153544.83656.3C; Cooney NL, 1997, J ABNORM PSYCHOL, V106, P243, DOI 10.1037/0021-843X.106.2.243; de Bruijn C, 2004, J NERV MENT DIS, V192, P494, DOI 10.1097/01.nmd.0000131912.71344.e4; Dua J K, 1993, Genet Soc Gen Psychol Monogr, V119, P515; Dvorak RD, 2016, DRUG ALCOHOL DEPEN, V163, pS46, DOI 10.1016/j.drugalcdep.2015.09.034; Epler AJ, 2014, ALCOHOL CLIN EXP RES, V38, P1461, DOI 10.1111/acer.12386; Fazzino TL, 2013, ALCOHOL CLIN EXP RES, V37, P2161, DOI 10.1111/acer.12191; Higley AE, 2011, PSYCHOPHARMACOLOGY, V218, P121, DOI 10.1007/s00213-011-2355-8; Juliano LM, 1998, EXP CLIN PSYCHOPHARM, V6, P45, DOI 10.1037/1064-1297.6.1.45; Kavanagh DJ, 2005, PSYCHOL REV, V112, P446, DOI 10.1037/0033-295X.112.2.446; May J, 2014, ADDICTION, V109, P728, DOI 10.1111/add.12472; Miranda R, 2014, ADDICT BIOL, V19, P941, DOI 10.1111/adb.12050; National Institute on Alcohol Abuse and Alcoholism (NIAAA), DRINK LEV DEF; Ray LA, 2010, J ABNORM PSYCHOL, V119, P115, DOI 10.1037/a0017550; Serre F, 2015, DRUG ALCOHOL DEPEN, V148, P1, DOI 10.1016/j.drugalcdep.2014.12.024; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Simons JS, 2010, ADDICT BEHAV, V35, P1045, DOI 10.1016/j.addbeh.2010.07.001; Sinha R, 2009, NEUROPSYCHOPHARMACOL, V34, P1198, DOI 10.1038/npp.2008.78; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Statham DJ, 2011, ADDICTION, V106, P1230, DOI 10.1111/j.1360-0443.2011.03442.x; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Swendsen J, 2016, DIALOGUES CLIN NEURO, V18, P213; Vakili S, 2008, ADDICT BEHAV, V33, P1123, DOI 10.1016/j.addbeh.2008.03.009; WANG MQ, 1992, PHARMACOL BIOCHEM BE, V43, P641; Wray TB, 2014, ALCOHOL RES-CURR REV, V36, P19	27	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195063	10.1371/journal.pone.0195063	http://dx.doi.org/10.1371/journal.pone.0195063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668736	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200024
J	Puente, C; Abian-Vicen, J; Del Coso, J; Lara, B; Salinero, JJ				Puente, Carlos; Abian-Vicen, Javier; Del Coso, Juan; Lara, Beatriz; Jose Salinero, Juan			The CYP1A2-163C > A polymorphism does not alter the effects of caffeine on basketball performance	PLOS ONE			English	Article							IMPROVES JUMP PERFORMANCE; ENERGY DRINK; SPRINT PERFORMANCE; ERGOGENICITY; RELIABILITY; VALIDITY; SPORTS	Purpose The aim of this investigation was to analyze the influence of the genetic variations of the - 163C>A polymorphism of the CYP1A2 gene on the ergogenic effects of caffeine in elite basketball players. Methods Nineteen elite basketball players (10 men and 9 women) ingested 3 mg-kg(-1) of caffeine or a placebo 60 min before performing 10 repetitions of the following series: the Abalakov jump test followed by the Change-of-Direction and Acceleration Test (CODAT). The players then competed in a 20-min simulated basketball game. Self-perceived performance and side effects were recorded by questionnaires after the trials. The effects of caffeine on basketball performance were established according to players' CYP1A2 genotype (rs762551): AA homozygotes (n = 10) and C-allele carriers (n = 9). Results In the 10 repetitions, caffeine increased Abalakov jump height by a mean of 2.9 +/- 3.6% in AA homozygotes (p = 0.03) while this effect did not reach statistical significance for C-allele carriers (2.3 +/- 6.8%; p = 0.33). Caffeine did not affect sprint time in the CODAT test in either genotype group but it increased the number of impacts performed during the simulated game in both AA homozygotes (4.1 +/- 5.3%; p = 0.02) and C-allele carriers (3.3 +/- 3.2%; p = 0.01). During the 24 h following the test, AA homozygotes tended to experience increased insomnia with caffeine while C-allele carriers did not present this effect. The remaining variables were unaffected by the genotype. Conclusion The CYP1A2 - 163C>A polymorphism minimally altered the ergogenicity derived from the consumption of a moderate dose of caffeine in elite basketball players.	[Puente, Carlos; Abian-Vicen, Javier; Del Coso, Juan; Lara, Beatriz; Jose Salinero, Juan] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain; [Abian-Vicen, Javier] Univ Castilla La Mancha, Performance & Sport Rehabil Lab, Toledo, Spain	Camilo Jose Cela University; Universidad de Castilla-La Mancha	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdeicoso@ucjc.edu	Salinero, Juan J./GLT-1243-2022; Abián-Vicén, Javier/I-8509-2012; Lara, Beatriz/AAQ-5269-2021; Del Coso, Juan/AAC-7117-2020; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012	Salinero, Juan J./0000-0003-4153-5100; Abián-Vicén, Javier/0000-0001-9635-3289; Del Coso, Juan/0000-0002-5785-984X; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Lara, Beatriz/0000-0001-5516-4852	Camilo Jose Cela University, CAFEGEN project	Camilo Jose Cela University, CAFEGEN project	This investigation was funded by the Vice-Rectorate of Science of the Camilo Jose Cela University, CAFEGEN project (http://www.ucjc.edu/la-universidad/estructura-academica/vicerectorados/vicerectorado-de-innovacion/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abian P, 2015, J SPORT SCI, V33, P1042, DOI 10.1080/02640414.2014.981849; Abian-Vicen J, 2014, AMINO ACIDS, V46, P1333, DOI 10.1007/s00726-014-1702-6; Algrain Haya A., 2016, Journal of Caffeine Research, V6, P34, DOI 10.1089/jcr.2015.0029; Alsene K, 2003, NEUROPSYCHOPHARMACOL, V28, P1694, DOI 10.1038/sj.npp.1300232; Armstrong LE, 2002, INT J SPORT NUTR EXE, V12, P189, DOI 10.1123/ijsnem.12.2.189; Bishop D, 2010, SPORTS MED, V40, P995, DOI 10.2165/11536870-000000000-00000; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; Del Coso J, 2014, INT J SPORT PHYSIOL, V9, P1013, DOI 10.1123/ijspp.2013-0448; Del Coso J, 2013, AMINO ACIDS, V44, P1511, DOI 10.1007/s00726-013-1473-5; Del Coso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031380; Djordjevic N, 2010, EUR J CLIN PHARMACOL, V66, P697, DOI 10.1007/s00228-010-0823-4; Doherty M, 2002, MED SCI SPORT EXER, V34, P1785, DOI 10.1097/00005768-200211000-00015; Duncan MJ, 2013, PHYSIOL BEHAV, V116, P60, DOI 10.1016/j.physbeh.2013.03.020; Ghotbi R, 2007, EUR J CLIN PHARMACOL, V63, P537, DOI 10.1007/s00228-007-0288-2; Hogervorst E, 2008, MED SCI SPORT EXER, V40, P1841, DOI 10.1249/MSS.0b013e31817bb8b7; Lara B, 2015, BRIT J NUTR, V114, P908, DOI 10.1017/S0007114515002573; Lockie RG, 2013, J SPORT SCI MED, V12, P88; Loy Bryan D., 2015, Journal of Caffeine Research, V5, P73, DOI 10.1089/jcr.2014.0035; Marfell-Jones M. J., 2012, INT STANDARDS ANTHRO; Meyers BM, 2005, J APPL PHYSIOL, V99, P1056, DOI 10.1152/japplphysiol.00937.2004; Pataky MW, 2016, SCAND J MED SCI SPOR, V26, P613, DOI 10.1111/sms.12501; Perera V, 2012, CURR DRUG METAB, V13, P667, DOI 10.2174/1389200211209050667; Perez-Lopez A, 2015, MED SCI SPORT EXER, V47, P850, DOI 10.1249/MSS.0000000000000455; Pickering C, 2018, SPORTS MED, V48, P7, DOI 10.1007/s40279-017-0776-1; Puente C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091033; Renda G, 2015, EUR NEUROPSYCHOPHARM, V25, P798, DOI 10.1016/j.euroneuro.2015.03.001; Retey JV, 2007, CLIN PHARMACOL THER, V81, P692, DOI 10.1038/sj.clpt.6100102; Rodriguez-Rosell D, 2017, J STRENGTH COND RES, V31, P196, DOI 10.1519/JSC.0000000000001476; Salinero JJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030269; Salinero JJ, 2014, BRIT J NUTR, V112, P1494, DOI 10.1017/S0007114514002189; Saunders B, 2017, SCAND J MED SCI SPOR, V27, P1240, DOI 10.1111/sms.12793; Skinner TL, 2010, MED SCI SPORT EXER, V42, P571, DOI 10.1249/MSS.0b013e3181b6668b; Thomas RM, 2017, IRISH J MED SCI, V186, P285, DOI 10.1007/s11845-016-1478-7; Womack CJ, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-7	34	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195943	10.1371/journal.pone.0195943	http://dx.doi.org/10.1371/journal.pone.0195943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668752	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200070
J	Kawaguchi, K; Harimaya, K; Matsumoto, Y; Hayashida, M; Okada, S; Iida, K; Kato, G; Tsuchiya, K; Doi, T; Oda, Y; Iwamoto, Y; Nakashima, Y				Kawaguchi, Kenichi; Harimaya, Katsumi; Matsumoto, Yoshihiro; Hayashida, Mitsumasa; Okada, Seiji; Iida, Keiichiro; Kato, Go; Tsuchiya, Kuniyoshi; Doi, Toshio; Oda, Yoshinao; Iwamoto, Yukihide; Nakashima, Yasuharu			Effect of cartilaginous endplates on extruded disc resorption in lumbar disc herniation	PLOS ONE			English	Article							NUCLEUS PULPOSUS; INTERVERTEBRAL-DISK; NATURAL-HISTORY; GROWTH-FACTOR; NEOVASCULARIZATION; ANGIOGENESIS; CLASSIFICATION; DEGENERATION; COMPRESSION; INHIBITION	Objective The aim of this study was to investigate the clinicopathologic features of lumbar disc herniation (LDH) with endplate degeneration and the association between cartilaginous fragments and inflammatory response to the herniated disc. Summary of background data LDH often involves hyaline cartilage fragments pulled from the vertebral endplates. Modic changes are closely associated with LDH that contains hyaline cartilage, and cartilaginous endplates seem to affect resorption of the herniated disc. Methods A total of 78 patients who underwent microscopic discectomy between 9 and 16 weeks after an occurrence of LDH were reviewed. Modic changes, disc degeneration, high-intensity zone, and vertebral corner defect were evaluated using magnetic resonance imaging (MRI). Histopathological observations of cartilaginous endplates and inflamed granulation tissue in the herniated disc were made. In cases with inflamed granulation tissue, neovascularization and macrophage infiltration were also evaluated using immunohistochemical analysis. Results Modic changes were observed in approximately one-third of the patients (26 cases: type 1, 7; type 2, 17; and type 3, 2). Cartilaginous endplates were observed in 32 cases (41%) and in the majority of cases with Modic changes compared with cases without Modic changes (65%, p = 0.001). Although inflamed granulation tissue was observed in 60 cases (77%), no significant differences were detected in patient age and the composition of the herniated material. Immunohistochemical analysis showed that fewer CD34-positive capillaries and CD68-positive cells were found in cases with cartilaginous fragments compared with those without cartilaginous fragments (p < 0.001). In addition, a higher immunoreactivity to CD34 and CD68 was found in herniated discs <25% of whose area was occupied by cartilaginous endplates compared with discs whose area was occupied at 25% or more (p < 0.001). Conclusion There is an association between LDH with endplate degeneration and cartilaginous herniation, with Modic type 2 predominating. Furthermore, neovascularization and macrophage infiltration, especially if the amount of cartilage is high, are likely to be less frequent in cartilaginous herniation, leading to failure in the spontaneous remission of clinical symptoms.	[Kawaguchi, Kenichi; Harimaya, Katsumi; Matsumoto, Yoshihiro; Hayashida, Mitsumasa; Okada, Seiji; Iida, Keiichiro; Iwamoto, Yukihide; Nakashima, Yasuharu] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan; [Kato, Go] Saga Ken Med Ctr, Dept Orthopaed Surg, Saga, Japan; [Tsuchiya, Kuniyoshi] JCHO Kyushu Hosp, Dept Orthopaed Surg, Fukuoka, Japan; [Doi, Toshio] Kyushu Univ, Dept Orthopaed Surg, Beppu Hosp, Oita, Japan; [Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Pathol Sci, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Kawaguchi, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan.	kawaken@ortho.med.kyushu-u.ac.jp		Kato, Go/0000-0002-3098-9759				ADAMS MA, 1982, SPINE, V7, P184, DOI 10.1097/00007632-198205000-00002; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Akagi S, 2000, ORTHOPEDICS, V23, P445; APRILL C, 1992, BRIT J RADIOL, V65, P361, DOI 10.1259/0007-1285-65-773-361; Arai Y, 2000, J Orthop Sci, V5, P229, DOI 10.1007/s007760050156; Autio RA, 2006, SPINE, V31, P1247, DOI 10.1097/01.brs.0000217681.83524.4a; BOZZAO A, 1992, RADIOLOGY, V185, P135, DOI 10.1148/radiology.185.1.1523297; Carreon LY, 1997, SPINE, V22, P1429, DOI 10.1097/00007632-199707010-00001; HARADA Y, 1989, SPINE, V14, P1020, DOI 10.1097/00007632-198909000-00017; Haro H, 2002, J ORTHOP RES, V20, P409, DOI 10.1016/S0736-0266(01)00150-4; Hasegawa T, 2000, SPINE, V25, P937, DOI 10.1097/00007632-200004150-00007; Jensen TS, 2006, SPINE, V31, P1605, DOI 10.1097/01.brs.0000221992.77779.37; Joe E, 2015, AM J ROENTGENOL, V204, P1075, DOI 10.2214/AJR.14.13319; Johnson WEB, 2005, SPINE, V30, P1139, DOI 10.1097/01.brs.0000162624.95262.73; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Kato T, 2004, J ORTHOP RES, V22, P895, DOI 10.1016/j.orthres.2003.11.008; Kawakami M, 2000, CLIN ORTHOP RELAT R, P268; Kobayashi S, 2009, SPINE, V34, P655, DOI 10.1097/BRS.0b013e31819c9d5b; Koike Y, 2003, SPINE, V28, P1928, DOI 10.1097/01.BRS.0000083324.65405.AE; Komori H, 1996, SPINE, V21, P225, DOI 10.1097/00007632-199601150-00013; Lama P, 2014, EUR SPINE J, V23, P1869, DOI 10.1007/s00586-014-3399-3; LIND B, 1993, SPINE, V18, P1550; McCulloch JA, 1990, LUMBAR SPINE, P393; Minamide A, 1999, SPINE, V24, P940, DOI 10.1097/00007632-199905150-00003; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; OLMARKER K, 1993, SPINE, V18, P1425; Olmarker K, 2001, SPINE, V26, P863, DOI 10.1097/00007632-200104150-00007; Ozaki S, 1999, J Orthop Sci, V4, P286, DOI 10.1007/s007760050105; PEDOWITZ RA, 1992, SPINE, V17, P194, DOI 10.1097/00007632-199202000-00013; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Ratsep T, 2013, EUR SPINE J, V22, P2474, DOI 10.1007/s00586-013-2842-1; Rajasekaran S, 2013, SPINE, V38, P1491, DOI 10.1097/BRS.0b013e31829a6fa6; Schmid G, 2004, RADIOLOGY, V231, P352, DOI 10.1148/radiol.2312021708; Seo JY, 2016, EUR SPINE J, V25, P1393, DOI 10.1007/s00586-014-3587-1; Shan Z, 2014, SPINE, V39, P736, DOI 10.1097/BRS.0000000000000259; Summers GC, 2008, BIORHEOLOGY, V45, P365, DOI 10.3233/BIR-2008-0495; Takebayashi T, 2001, SPINE, V26, P940, DOI 10.1097/00007632-200104150-00018; TANAKA M, 1993, SPINE, V18, P1456; URBAN JPG, 1981, CONNECT TISSUE RES, V9, P1, DOI 10.3109/03008208109160234; Veres SP, 2010, EUR SPINE J, V19, P1468, DOI 10.1007/s00586-010-1383-0; Willburger RE, 2004, SPINE, V29, P1655, DOI 10.1097/01.BRS.0000133645.94159.64; YASUMA T, 1993, SPINE, V18, P1761, DOI 10.1097/00007632-199310000-00008	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195946	10.1371/journal.pone.0195946	http://dx.doi.org/10.1371/journal.pone.0195946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664923	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300043
J	Abdulai, I; Jassogne, L; Graefe, S; Asare, R; Van Asten, P; Laderach, P; Vaast, P				Abdulai, Issaka; Jassogne, Laurence; Graefe, Sophie; Asare, Richard; Van Asten, Piet; Laderach, Peter; Vaast, Philippe			Characterization of cocoa production, income diversification and shade tree management along a climate gradient in Ghana	PLOS ONE			English	Article							WEST-AFRICA; AGROFORESTRY; DEFORESTATION; SERVICES; FARMERS	Reduced climatic suitability due to climate change in cocoa growing regions of Ghana is expected in the coming decades. This threatens farmers' livelihood and the cocoa sector. Climate change adaptation requires an improved understanding of existing cocoa production systems and farmers' coping strategies. This study characterized current cocoa production, income diversification and shade tree management along a climate gradient within the cocoa belt of Ghana. The objectives were to 1) compare existing production and income diversification between dry, mid and wet climatic regions, and 2) identify shade trees in cocoa agroforestry systems and their distribution along the climatic gradient. Our results showed that current mean cocoa yield level of 288 kg ha(-1) yr(-1) in the dry region was significantly lower than in the mid and wet regions with mean yields of 712 and 849 kg ha(-1) yr(-1), respectively. In the dry region, farmers diversified their income sources with non-cocoa crops and off-farm activities while farmers at the mid and wet regions mainly depended on cocoa (over 80% of annual income). Two shade systems classified as medium and low shade cocoa agroforestry systems were identified across the studied regions. The medium shade system was more abundant in the dry region and associated to adaptation to marginal climatic conditions. The low shade system showed significantly higher yield in the wet region but no difference was observed between the mid and dry regions. This study highlights the need for optimum shade level recommendation to be climatic region specific.	[Abdulai, Issaka] Univ Gottingen, Trop Plant Prod & Agr Syst Modelling TROPAGS, Gottingen, Germany; [Jassogne, Laurence; Van Asten, Piet] IITA, Kampala, Uganda; [Graefe, Sophie] Univ Goettingen, Trop Silviculture & Forest Ecol, Busgenweg 1, Gottingen, Germany; [Asare, Richard] IITA, Accra, Ghana; [Laderach, Peter] Int Ctr Trop Agr CIAT, Hanoi, Vietnam; [Vaast, Philippe] Univ Montpellier, Ctr Cooperat Int Rech Agron Dev CIRAD, UMR Eco&Sols, Montpellier, France; [Vaast, Philippe] World Agroforestry Ctr ICRAF, Hanoi, Vietnam	University of Gottingen; University of Gottingen; Alliance; International Center for Tropical Agriculture - CIAT; Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Abdulai, I (corresponding author), Univ Gottingen, Trop Plant Prod & Agr Syst Modelling TROPAGS, Gottingen, Germany.	iabdula@gwdg.de		Laderach, Peter/0000-0001-8708-6318	German Ministry for Economic Cooperation and Development (BMZ) [12.1433.7-001.00]; German Ministry for Economic Cooperation and Development (BMZ)	German Ministry for Economic Cooperation and Development (BMZ); German Ministry for Economic Cooperation and Development (BMZ)	This study was funded by the German Ministry for Economic Cooperation and Development (BMZ), project number: 12.1433.7-001.00.; This research is part of the CGIAR programs on Climate Change, Agriculture and Food Security (CCAFS) and Forest, Trees and Agriculture (FTA). The authors thank Mr Sander Muilerman (IITA Ghana), farmers, field assistant (Mr. Aikins Nyameky) and forester (Mr. Joseph Owusu) for their support in data collection. Professor Anthony Whitbread is also acknowledged for the co-establishment of the project at Goettingen University. Funding through the German Ministry for Economic Cooperation and Development (BMZ) is gratefully acknowledged. The project partners, Agro-Eco Louis Bulk Institute, Cocoa Research Institute of Ghana (CRIG) and Kuapa Kokoo Farmers Union are also acknowledged.	Abdulai I, 2018, GLOBAL CHANGE BIOL, V24, P273, DOI 10.1111/gcb.13885; Adjei-Nsiah S., 2012, British Journal of Environment and Climate Change, V2, P137; Alvarez S, 2014, REP CGIAR RES PROGR; Andersen E, 2007, J ENVIRON MANAGE, V82, P353, DOI 10.1016/j.jenvman.2006.04.021; Anim-Kwapong G.J., 2004, COCOA RES I GHANA, V2, P1; [Anonymous], 2014, ETFRN NEWS; Antwi-Agyei P, 2014, REG ENVIRON CHANGE, V14, P1615, DOI 10.1007/s10113-014-0597-9; Asante FA, 2015, CLIMATE, V3, P78, DOI 10.3390/cli3010078; Asante WA, 2017, LAND USE POLICY, V66, P374, DOI 10.1016/j.landusepol.2017.05.010; Asare R., 2005, COCOA AGROFORESTS W; Asare R, 2015, TREE DIVERSITY CANOP, DOI [10.1007/s11056-015-9515-3, DOI 10.1007/S11056-015-9515-3]; Asare R., 2008, STCP WORKING PAPER S, V9; Asare R, 2017, EXP AGR, V53, P416, DOI 10.1017/S0014479716000466; Asare R, 2014, AGROFOREST SYST, V88, P1143, DOI 10.1007/s10457-014-9688-3; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; Bisseleua HBD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056115; Blaser WJ, 2017, AGR ECOSYST ENVIRON, V243, P83, DOI 10.1016/j.agee.2017.04.007; Damnyag L, 2013, BIOL CONSERV, V165, P86, DOI 10.1016/j.biocon.2013.05.024; FAO, 2015, SOC CONT ROL AGR, V717; Fountain AC, 2015, COCOA BAROMETER D LO; Giller KE, 2011, AGR SYST, V104, P191, DOI 10.1016/j.agsy.2010.07.002; Gockowski J., 2011, AGR INTENSIFICATION; Gockowski J, 2004, HABITAT, V29; Gockowski J, 2013, INT J AGR SUSTAIN, V11, P331, DOI 10.1080/14735903.2013.772714; Graefe S, 2017, HUM ECOL, V45, P321, DOI 10.1007/s10745-017-9899-0; Laderach P, 2013, CLIMATIC CHANGE, V119, P841, DOI 10.1007/s10584-013-0774-8; Nath CD, 2010, AGROFOREST SYST, V79, P223, DOI 10.1007/s10457-009-9255-5; Quagrainie K.K., 2009, J APPL SCI ENV MANAG, V13, P13, DOI [10.4314/jasem.v13i2.55294, DOI 10.4314/JASEM.V13I2.55294]; Ruf F, 2015, SUSTAIN SCI, V10, P101, DOI 10.1007/s11625-014-0282-4; Ruf FO, 2011, HUM ECOL, V39, P373, DOI 10.1007/s10745-011-9392-0; Schroth G, 2017, MITIG ADAPT STRAT GL, V22, P903, DOI 10.1007/s11027-016-9707-y; Schroth G, 2016, SCI TOTAL ENVIRON, V556, P231, DOI 10.1016/j.scitotenv.2016.03.024; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Taylor, 1960, SYNECOLOGY SILVICULT; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Vaast P., 2016, CLIMATE CHANGE AGR W, P209, DOI DOI 10.1007/978-94-017-7462-8_16; Vaast P, 2014, AGROFOREST SYST, V88, P947, DOI 10.1007/s10457-014-9762-x; Volta Basin Authority, 2017, AV RAINF AM COURS YE; Waldron A, 2015, ECOL APPL, V25, P361, DOI 10.1890/13-0313.1; WTO, 2014, WTO POL REV GHAN, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]	40	43	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195777	10.1371/journal.pone.0195777	http://dx.doi.org/10.1371/journal.pone.0195777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659629	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100031
J	Haruma, T; Nagasaka, T; Nakamura, K; Haraga, J; Nyuya, A; Nishida, T; Goel, A; Masuyama, H; Hiramatsu, Y				Haruma, Tomoko; Nagasaka, Takeshi; Nakamura, Keiichiro; Haraga, Junko; Nyuya, Akihiro; Nishida, Takeshi; Goel, Ajay; Masuyama, Hisashi; Hiramatsu, Yuji			Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability	PLOS ONE			English	Article							DNA MISMATCH REPAIR; COLORECTAL-CANCER; CLINICOPATHOLOGICAL SIGNIFICANCE; RISK-ASSESSMENT; LYNCH-SYNDROME; PHENOTYPE; CARCINOMA; TUMORS; MLH1; HYPERMETHYLATION	Background The molecular characterization of endometrial cancer (EC) can facilitate identification of various tumor subtypes. Although EC patients with POLE mutations reproducibly demonstrate better prognosis, the outcome of patients with microsatellite instability (MSI) remains controversial. This study attempted to interrogate whether genetic stratification of EC can identify distinct subsets with prognostic significance. Materials and methods A cohort of 138 EC patients who underwent surgical resection with curative intent was enrolled. Sanger sequencing was used to evaluate mutations in the POLE and KRAS genes. MSI analysis was performed using four mononucleotide repeat markers and methylation status of the MLH1 promoter was measured by a fluorescent bisulfite polymerase chain reaction (PCR). Protein expression for mismatch repair (MMR) proteins was evaluated by immunohistochemistry (IHC). Results Extensive hypermethylation of the MLH1 promoter was observed in 69.6% ECs with MLH1 deficiency and 3.5% with MMR proficiency, but in none of the ECs with loss of other MMR genes (P < .0001). MSI-positive and POLE mutations were found in 29.0% and 8.7% EC patients, respectively. Our MSI analysis showed a sensitivity of 92.7% for EC patients with MMR deficiency, and a specificity of 97.9% for EC patients with MMR proficiency. In univariate and multivariate analyses, POLE mutations and MSI status was significantly associated with progression-free survival (P = 0.0129 and 0.0064, respectively) but not with endometrial cancer-specific survival. Conclusions This study provides significant evidence that analyses of proofreading POLE mutations and MSI status based on mononucleotide repeat markers are potentially useful biomarkers to identify EC patients with better prognosis.	[Haruma, Tomoko; Nakamura, Keiichiro; Haraga, Junko; Nishida, Takeshi; Masuyama, Hisashi; Hiramatsu, Yuji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Obstet & Gynecol, Okayama, Japan; [Nagasaka, Takeshi; Nyuya, Akihiro] Kawasaki Med Sch, Dept Clin Oncol, Kurashiki, Okayama, Japan; [Goel, Ajay] Baylor Scott & White Res Inst, Ctr Translat Genom & Oncol, Ctr Gastrointestinal Res, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA	Okayama University; Kawasaki Medical School; Baylor Health Care System; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Nagasaka, T (corresponding author), Kawasaki Med Sch, Dept Clin Oncol, Kurashiki, Okayama, Japan.	takeshin@med.kawasaki-m.ac.jp		Nagasaka, Takeshi/0000-0002-4236-350X	MEXT/JSPS KAKENHI [15K20144, 16K11141]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI (15K20144 to TH and 16K11141 to KN).	Alkushi A, 2010, INT J GYNECOL PATHOL, V29, P343, DOI 10.1097/PGP.0b013e3181cd6552; Bendifallah S, 2015, BRIT J CANCER, V112, P793, DOI 10.1038/bjc.2015.35; Bilbao C, 2010, INT J RADIAT ONCOL, V76, P9, DOI 10.1016/j.ijrobp.2009.09.035; Billingsley CC, 2015, CANCER-AM CANCER SOC, V121, P386, DOI 10.1002/cncr.29046; Black D, 2006, J CLIN ONCOL, V24, P1745, DOI 10.1200/JCO.2005.04.1574; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Boland CR, 1998, CANCER RES, V58, P5248; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Church DN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju402; Colombo N, 2013, ANN ONCOL, V24, P33, DOI 10.1093/annonc/mdt353; Deng GR, 1999, CANCER RES, V59, P2029; Diaz-Padilla I, 2013, CRIT REV ONCOL HEMAT, V88, P154, DOI 10.1016/j.critrevonc.2013.03.002; Esteller M, 1998, ONCOGENE, V17, P2413, DOI 10.1038/sj.onc.1202178; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009393; Hanse RJ, 2016, NAT MED, V22, P1342, DOI 10.1038/nm.4191; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Kato M, 2015, J GYNECOL ONCOL, V26, P40, DOI 10.3802/jgo.2015.26.1.40; Kong TW, 2015, J GYNECOL ONCOL, V26, P32, DOI 10.3802/jgo.2015.26.1.32; Kurman RJ, 2013, GYNECOL ONCOL, V129, P271, DOI 10.1016/j.ygyno.2013.03.029; Kwon JS, 2009, OBSTET GYNECOL, V114, P736, DOI 10.1097/AOG.0b013e3181b96ec6; Lancaster JM, 2015, GYNECOL ONCOL, V136, P3, DOI 10.1016/j.ygyno.2014.09.009; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; MacDonald ND, 2000, CANCER RES, V60, P1750; McAlpine JN, 2016, CANCER-AM CANCER SOC, V122, P2787, DOI 10.1002/cncr.30094; McConechy MK, 2015, GYNECOL ONCOL, V137, P306, DOI 10.1016/j.ygyno.2015.01.541; McMeekin DS, 2016, J CLIN ONCOL, V34, P3062, DOI 10.1200/JCO.2016.67.8722; Meng B, 2014, GYNECOL ONCOL, V134, P15, DOI 10.1016/j.ygyno.2014.05.006; Murali R, 2014, LANCET ONCOL, V15, pE268, DOI 10.1016/S1470-2045(13)70591-6; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nagasaka T, 2008, GASTROENTEROLOGY, V134, P1950, DOI 10.1053/j.gastro.2008.02.094; Nagasaka T, 2006, ACTA MED OKAYAMA, V60, P249; Nakagawa H, 2001, CANCER RES, V61, P6991; Resnick KE, 2010, GYNECOL ONCOL, V117, P234, DOI 10.1016/j.ygyno.2009.12.028; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Steinbakk A, 2010, ANAL CELL PATHOL, V33, P245, DOI [10.3233/ACP-CLO-2010-0550, 10.1155/2010/430389]; Stelloo E, 2016, CLIN CANCER RES, V22, P4215, DOI 10.1158/1078-0432.CCR-15-2878; Stelloo E, 2015, MODERN PATHOL, V28, P836, DOI 10.1038/modpathol.2015.43; Stoffel EM, 2015, J CLIN ONCOL, V33, P209, DOI 10.1200/JCO.2014.58.1322; Takehara Y, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-017-1376-4; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; van Gool IC, 2015, CLIN CANCER RES, V21, P3347, DOI 10.1158/1078-0432.CCR-15-0057; Zighelboim I, 2007, J CLIN ONCOL, V25, P2042, DOI 10.1200/JCO.2006.08.2107	46	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195655	10.1371/journal.pone.0195655	http://dx.doi.org/10.1371/journal.pone.0195655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659608	Green Submitted, Green Published, gold			2022-12-27	WOS:000430061100024
J	Guerchet, MM; Guerra, M; Huang, YQ; Lloyd-Sherlock, P; Sosa, AL; Uwakwe, R; Acosta, I; Ezeah, P; Gallarde, S; Liu, ZR; Mayston, R; de Oca, VM; Wang, H; Prince, MJ				Guerchet, Maelenn M.; Guerra, Mariella; Huang, Yueqin; Lloyd-Sherlock, Peter; Luisa Sosa, Ana; Uwakwe, Richard; Acosta, Isaac; Ezeah, Peter; Gallarde, Sara; Liu, Zhaorui; Mayston, Rosie; Montes de Oca, Veronica; Wang, Hong; Prince, Martin J.			A cohort study of the effects of older adult care dependence upon household economic functioning, in Peru, Mexico and China	PLOS ONE			English	Article							POPULATION-BASED SURVEY; DEVELOPING-COUNTRIES; EXTRA COSTS; DISABILITY; DEMENTIA; PEOPLE; HEALTH; INEQUALITY; POVERTY; INCOMES	Background While links between disability and poverty are well established, there have been few longitudinal studies to clarify direction of causality, particularly among older adults in low and middle income countries. We aimed to study the effect of care dependence among older adult residents on the economic functioning of their households, in catchment area survey sites in Peru, Mexico and China. Methods Households were classified from the evolution of the needs for care of older residents, over two previous community surveys, as 'incident care', 'chronic care' or 'no care', and followed up three years later to ascertain economic outcomes (household income, consumption, economic strain, satisfaction with economic circumstances, healthcare expenditure and residents giving up work or education to care). Results Household income did not differ between household groups. However, income from paid work (Pooled Count Ratio pCR 0.88, 95% CI 0.78-1.00) and government transfers (pCR 0.80, 95% CI 0.69-0.93) were lower in care households. Consumption was 12% lower in chronic care households (pCR 0.88, 95% CI 0.77-0.99). Household healthcare expenditure was higher (pCR 1.55, 95% CI 1.26-1.90), and catastrophic healthcare spending more common (pRR 1.64, 95% CI 1.64-2.22) in care households. Conclusions While endogeneity cannot be confidently excluded as an explanation for the findings, this study indicates that older people's needs for care have a discernable impact on household economics, controlling for baseline indicators of long-term economic status. Although living, typically, in multigenerational family units, older people have not featured prominently in global health and development agendas. Population ageing will rapidly increase the number of households where older people live, and their societal significance. Building sustainable long-term care systems for the future will require some combination of improved income security in old age; incentivisation of informal care through compensation for direct and opportunity costs; and development of community care services to support, and, where necessary, supplement or substitute the central role of informal caregivers.	[Guerchet, Maelenn M.; Mayston, Rosie; Prince, Martin J.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England; [Guerra, Mariella] Natl Inst Mental Hlth Honorio Delgado Hideyo Nogu, Psychogeriatr Unit, Lima, Peru; [Huang, Yueqin; Liu, Zhaorui; Wang, Hong] Peking Univ, Inst Mental Hlth, Beijing, Peoples R China; [Lloyd-Sherlock, Peter] Univ East Anglia, Sch Dev Studies, Norwich, Norfolk, England; [Luisa Sosa, Ana; Acosta, Isaac] Univ Nacl Autonoma Mexico, Natl Inst Neurol & Neurosurg Mexico, Mexico City, DF, Mexico; [Uwakwe, Richard] Nnamdi Azikiwe Univ Teaching Hosp, Nnewi, Anambra State, Nigeria; [Ezeah, Peter] Nnamdi Azikiwe Univ, Dept Sociol Anthropol, Awka, Nigeria; [Gallarde, Sara] Inst Memoria Depres & Enfermedades Riesgo IMEDER, Lima, Peru; [Montes de Oca, Veronica] Univ Nacl Autonoma Mexico, Inst Invest Sociales, Mexico City, DF, Mexico	University of London; King's College London; Peking University; University of East Anglia; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Prince, MJ (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England.	martin.prince@kcl.ac.uk	Harding, Richard/G-9729-2012; Prince, Martin J/A-9170-2010; Ezeah, Peter/AAY-7036-2020; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Castillo, Gilberto Isaac Acosta/CAA-2728-2022; Guerchet, Maëlenn/ABB-5594-2020; Castillo, Gilberto Isaac Acosta/AAY-5476-2020; Mayston, Rosie/N-2414-2013	Prince, Martin J/0000-0003-1379-7146; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Guerchet, Maëlenn/0000-0002-0470-5556; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Lloyd-Sherlock, Peter/0000-0002-1367-0703; Mayston, Rosie/0000-0002-2758-0194	Economic and Social Research Council; Department for International Development Joint Fund for Poverty Alleviation Research [ES/I034331/1]; Wellcome Trust Health Consequences of Population Change Programme [GR080002]; US Alzheimers Association [IIRG-04-1286]; World Health Organization (baseline phase in China); ESRC [ES/I034331/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department for International Development Joint Fund for Poverty Alleviation Research; Wellcome Trust Health Consequences of Population Change Programme(Wellcome Trust); US Alzheimers Association(Alzheimer's Association); World Health Organization (baseline phase in China); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The INDEP study was funded by the Economic and Social Research Council and the Department for International Development Joint Fund for Poverty Alleviation Research https://esrc.ukri.org/research/international-research/international-development/esrc-dfid-joint-fund-for-poverty-alleviation-research/ (ES/I034331/1). Earlier phases of the 10/66 Dementia Research Groups research contributing to this study have been funded by the Wellcome Trust Health Consequences of Population Change Programme (GR080002- Incidence phase in Peru, Mexico and Chinahttps://wellcome.ac.uk), the US Alzheimers Association (IIRG-04-1286-baseline phase in Mexico and Peru-http://www.alz.org/research/alzheimers_grants/overview.asp), and the World Health Organization (baseline phase in China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-285; Agahi N, 2014, J EPIDEMIOL COMMUN H, V68, P734, DOI 10.1136/jech-2013-203698; Cullinan J, 2013, EUR J HEALTH ECON, V14, P171, DOI 10.1007/s10198-011-0357-4; Dushi Irena, 2013, Soc Secur Bull, V73, P23; Fonareva I, 2014, INT PSYCHOGERIATR, V26, P725, DOI 10.1017/S1041610214000039; Groce N, 2011, POVERTY DISABILITY C, V16; Guerra RO, 2008, AGING CLIN EXP RES, V20, P53; Gureje O, 2006, J AM GERIATR SOC, V54, P1784, DOI 10.1111/j.1532-5415.2006.00944.x; Harwood RH, 2004, B WORLD HEALTH ORGAN, V82, P251; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Minh HV, 2015, GLOB PUBLIC HEALTH, V10, pS70, DOI 10.1080/17441692.2014.971332; Hosseinpoor AR, 2013, AM J PUBLIC HEALTH, V103, P1278, DOI 10.2105/AJPH.2012.301115; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Lloyd-Sherlock P, 2012, J AGING STUD, V26, P243, DOI 10.1016/j.jaging.2012.02.003; Mayston R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182360; Mayston R, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-379; Mitra S, 2017, DISABIL HEALTH J, V10, P475, DOI 10.1016/j.dhjo.2017.04.007; Prince M, 2004, INT J GERIATR PSYCH, V19, P170, DOI 10.1002/gps.1046; Prince M, 2008, INT REV PSYCHIATR, V20, P332, DOI 10.1080/09540260802094712; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince M, 2012, INT J GERIATR PSYCH, V27, P670, DOI 10.1002/gps.2727; Prince MJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1913-2; Schofield DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002683; Sousa RM, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-53; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Tajeu GS, 2014, J GERONTOL A-BIOL, V69, P346, DOI 10.1093/gerona/glt105; Tampubolon G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144722; Teerawichitchainan B, 2015, J AGING HEALTH, V27, P1462, DOI 10.1177/0898264315584577; Tellez-Rojo Solis M. M., 2014, IMPACT EVALUATION NO; Uwakwe R, 2009, J AM GERIATR SOC; Wilmoth JM, 2015, J GERONTOL SOC WORK, V58, P399, DOI 10.1080/01634372.2015.1019657; World Bank, 2014, SUMM RES FIND 2011 I; World Health Organization, 2014, GLOB TUB REP 2014, P23; Zaidi A, 2005, REV INCOME WEALTH, P89; Zimmer Z, 2008, SOC SCI MED, V66, P57, DOI 10.1016/j.socscimed.2007.08.032; Zunzunegui MV, 2009, SOC SCI MED, V68, P235, DOI 10.1016/j.socscimed.2008.10.031	37	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195567	10.1371/journal.pone.0195567	http://dx.doi.org/10.1371/journal.pone.0195567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652896	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000430026900028
J	Jmel, H; Romdhane, L; Ben Halima, Y; Hechmi, M; Naouali, C; Dallali, H; Hamdi, Y; Shan, JX; Abid, A; Jamoussi, H; Trabelsi, S; Chouchane, L; Luiselli, D; Abdelhak, S; Kefi, R				Jmel, Haifa; Romdhane, Lilia; Ben Halima, Yosra; Hechmi, Meriem; Naouali, Chokri; Dallali, Hamza; Hamdi, Yosr; Shan, Jingxuan; Abid, Abdelmajid; Jamoussi, Henda; Trabelsi, Sameh; Chouchane, Lotfi; Luiselli, Donata; Abdelhak, Sonia; Kefi, Rym			Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; VIP VARIANTS; GENETIC POLYMORPHISMS; THERAPEUTIC RESPONSE; INFERENCE; CYP2C9; CYP2C9-ASTERISK-2; ACENOCOUMAROL; ASSOCIATION; DIVERSITY	Genetic variation is an important determinant affecting either drug response or susceptibility to adverse drug reactions. Several studies have highlighted the importance of ethnicity in influencing drug response variability that should be considered during drug development. Our objective is to characterize the genetic variability of some pharmacogenes involved in the response to drugs used for the treatment of Metabolic Syndrome (MetS) in Tunisia and to compare our results to the worldwide populations. A set of 135 Tunisians was genotyped using the Affymetrix Chip 6.0 genotyping array. Variants located in 24 Very Important Pharmacogenes (VIP) involved in MetS drug response were extracted from the genotyping data. Analysis of variant distribution in Tunisian population compared to 20 worldwide populations publicly available was performed using R software packages. Common variants between Tunisians and the 20 investigated populations were extracted from genotyping data. Multidimensional screening showed that Tunisian population is clustered with North African and European populations. The greatest divergence was observed with the African and Asian population. In addition, we performed Inter-ethnic comparison based on the genotype frequencies of five VIP biomarkers. The genotype frequencies of the biomarkers rs3846662, rs1045642, rs7294 and rs12255372 located respectively in HMGCR, ABCB1, VKORC1 and TCF7L2 are similar between Tunisian, Tuscan (TSI) and European (CEU). The genotype frequency of the variant rs776746 located in CYP3A5 gene is similar between Tunisian and African populations and different from CEU and TSI. The present study shows that the genetic make up of the Tunisian population is relatively complex in regard to pharmacogenes and reflects previous historical events. It is important to consider this ethnic difference in drug prescription in order to optimize drug response to avoid serious adverse drug reactions. Taking into account similarities with other neighboring populations, our study has an impact not only on the Tunisian population but also on North African population which are underrepresented in pharmacogenomic studies.	[Jmel, Haifa; Romdhane, Lilia; Ben Halima, Yosra; Hechmi, Meriem; Naouali, Chokri; Dallali, Hamza; Hamdi, Yosr; Abdelhak, Sonia; Kefi, Rym] Inst Pasteur Tunis, Lab Biomed Genom & Oncogenet, Tunis, Tunisia; [Jmel, Haifa; Romdhane, Lilia; Hechmi, Meriem; Dallali, Hamza] Univ Carthage, Tunis, Tunisia; [Ben Halima, Yosra; Naouali, Chokri; Abdelhak, Sonia; Kefi, Rym] Univ Tunis El Manar, Tunis, Tunisia; [Shan, Jingxuan; Chouchane, Lotfi] Qatar Fdn, Weill Cornell Med Coll Qatar, Lab Genet Med & Immunol, Doha, Qatar; [Abid, Abdelmajid; Jamoussi, Henda] Natl Inst Nutr & Food Technol, Dept External Consultat, Tunis, Tunisia; [Trabelsi, Sameh] Natl Pharmacovigilance Ctr, Clin Pharmacol Serv, Tunis, Tunisia; [Luiselli, Donata] Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Lab Mol Anthropol, Bologna, Italy	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage; Universite de Tunis-El-Manar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Universite de Tunis-El-Manar; Institut National de Nutrition Technologie Alimentaire; Centre National de Pharmacovigilance; University of Bologna	Kefi, R (corresponding author), Inst Pasteur Tunis, Lab Biomed Genom & Oncogenet, Tunis, Tunisia.; Kefi, R (corresponding author), Univ Tunis El Manar, Tunis, Tunisia.	rym.kefi@pasteur.rns.tn	Chouchane, Lotfi/ABF-1360-2020; Romdhane, Lilia/S-4691-2019; jamoussi, henda/AAH-9354-2021; Hamdi, Yosr/GLT-7117-2022	Hechmi, Meriem/0000-0002-3949-0647; Hamdi, Yosr/0000-0002-2815-1834; Romdhane, Lilia/0000-0001-5310-7272	Ministry of Higher Education and Scientific Research [LR11IPT05]; European Commission [279171-1]	Ministry of Higher Education and Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the Ministry of Higher Education and Scientific Research (LR11IPT05) to Sonia Abdelhak and the European Commission (grant agreement no. 279171-1 for FP7 project MEDIGENE) to Institut Pasteur in Tunis. The Tunisian Ministry of Public Health is the employer of: Abdelmajid Abid, Henda Jamoussi, affiliated with the National Institute of Nutrition and Food Technology, and Sonia Abdelhak and Rym Kefi, affiliated with the Institut Pasteur in Tunis.	Abdelhedi R, 2015, J GENET, V94, P765, DOI 10.1007/s12041-015-0581-2; Arbitrio M, 2016, ONCOTARGET, V7, P54028, DOI 10.18632/oncotarget.9927; Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679; Bains RK, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-34; Belfki H, 2013, PUBLIC HEALTH NUTR, V16, P582, DOI 10.1017/S1368980012003291; Bodin L, 2005, BLOOD, V106, P135, DOI 10.1182/blood-2005-01-0341; Bonifaz-Pena V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Burmester JK, 2010, METHODS MOL BIOL, V632, P99, DOI 10.1007/978-1-60761-663-4_7; Buzoianu AD, 2012, J CELL MOL MED, V16, P2919, DOI 10.1111/j.1582-4934.2012.01606.x; Cadamuro J, 2010, EUR J CLIN PHARMACOL, V66, P253, DOI 10.1007/s00228-009-0768-7; Carvalho B, 2009, GENOTYPING CRLMM PAC; Cherni L, 2016, AM J PHYS ANTHROPOL, V161, P62, DOI 10.1002/ajpa.23008; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; CROOP JM, 1993, CYTOTECHNOLOGY, V12, P1, DOI 10.1007/BF00744656; Dawed AY, 2016, DIABETES CARE, V39, P1902, DOI 10.2337/dc15-2464; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V146, P271, DOI 10.1002/ajpa.21581; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Flynn AA, 2011, DRUG DISCOV TODAY, V16, P862, DOI 10.1016/j.drudis.2011.08.008; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Guzzi PH, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-258; He YJ, 2015, INT J CLIN EXP PATHO, V8, P13293; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Israili Zafar H, 2007, Am J Ther, V14, P386, DOI 10.1097/01.pap.0000249936.05650.0c; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson JA, 2003, TRENDS GENET, V19, P660, DOI 10.1016/j.tig.2003.09.008; KALOW W, 1982, CLIN PHARMACOKINET, V7, P373, DOI 10.2165/00003088-198207050-00001; Kefi R, 2015, MITOCHONDR DNA, V26, P593, DOI 10.3109/19401736.2013.879649; Khouri C, 2016, BRIT J CLIN PHARMACO, V82, P549, DOI 10.1111/bcp.12980; Klen J, 2014, EUR J CLIN PHARMACOL, V70, P421, DOI 10.1007/s00228-014-1641-x; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kurose K, 2012, DRUG METAB PHARMACOK, V27, P9, DOI 10.2133/dmpk.DMPK-11-RV-111; Lee SJ, 2003, PHARMACOGENETICS, V13, P461, DOI 10.1097/00008571-200308000-00004; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116463; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Man M, 2010, J CLIN PHARMACOL, V50, P929, DOI 10.1177/0091270009355161; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; McAlpine DE, 2011, THER DRUG MONIT, V33, P14, DOI 10.1097/FTD.0b013e3181fcf94d; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Millman AL, 2014, CUAJ-CAN UROL ASSOC, V8, P183, DOI 10.5489/cuaj.1884; Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866; Mizzi C, 2014, PHARMACOGENOMICS, V15, P1223, DOI [10.2217/PGS.14.102, 10.2217/pgs.14.102]; Pearson ER, 2007, DIABETES, V56, P2178, DOI 10.2337/db07-0440; Pirmohamed M, 2014, ANNU REV GENOM HUM G, V15, P349, DOI 10.1146/annurev-genom-090413-025419; Pollastro C, 2015, PPAR RES, V2015, DOI 10.1155/2015/415149; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Semiz S, 2010, BOSNIAN J BASIC MED, V10, P287, DOI 10.17305/bjbms.2010.2662; Shan JX, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-121; Sivadas A, 2016, PHARMACOGENOMICS, V17, P1891, DOI 10.2217/pgs-2016-0130; Su J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046366; Verhoef TI, 2013, NEW ENGL J MED, V369, P2304, DOI 10.1056/NEJMoa1311388; Wang L, 2016, DRUG METAB PHARMACOK, V31, P82, DOI 10.1016/j.dmpk.2015.11.007; Wang L, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0232-x; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Wilke RA, 2005, PHARMACOGENET GENOM, V15, P415, DOI 10.1097/01213011-200506000-00007; Willrich MAV, 2008, CLIN CHIM ACTA, V398, P15, DOI 10.1016/j.cca.2008.07.032; Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	70	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194842	10.1371/journal.pone.0194842	http://dx.doi.org/10.1371/journal.pone.0194842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652911	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900012
J	Barker, SF; Zomer, E; O'Toole, J; Sinclair, M; Gibney, K; Liew, D; Leder, K				Barker, S. Fiona; Zomer, Ella; O'Toole, Joanne; Sinclair, Martha; Gibney, Katherine; Liew, Danny; Leder, Karin			Cost of gastroenteritis in Australia: A healthcare perspective	PLOS ONE			English	Article							ACUTE GASTROINTESTINAL ILLNESS; ROTAVIRUS VACCINATION; CASE-DEFINITION; BURDEN; COMMUNITY; DISEASE; HOSPITALIZATIONS	Background Acute gastroenteritis illness is a common illness that causes considerable morbidity, but current estimates of the cost to the Australian healthcare system are unknown. Objective To estimate the current healthcare utilisation and direct public healthcare system costs attributable to acute gastroenteritis illness in Australia. Methods This is an incidence-based cost-of-illness study focused on quantifying direct health care costs using a bottom-up approach. Data on general practitioner consultations, prescribed medications, diagnostic tests, specialist consultations, emergency department visits and hospital admissions were collected from national reports. Results Using 2016 prices, the estimated annual direct per capita cost of acute gastroenteritis illness was AUD$14.87 (USD$10.71), equating to AUD$20.27 (USD$14.59) per case. The estimated overall economic burden in Australia was AUD$359 million (USD$258 million; AUD $1.5 million per 100,000 people). The major contributors to this cost were hospital admissions (57.1%), emergency department visits (17.7%), and general practitioner consultations (14.0%). Children under five years of age have the highest per capita rates of acute gastroenteritis illness; however, service utilisation rates vary by age group and both young children and older adults accounted for a substantial proportion of the overall economic burden attributable to acute gastroenteritis illness. Conclusions Although chronic diseases comprise a large cost burden on the healthcare system, acute illnesses, including acute gastroenteritis illness, also impose substantial direct healthcare system costs. Providing data on current cost estimates is useful for prioritizing public health interventions, with our findings suggesting that it would be ideal if targeted interventions to reduce hospitalisation rates among young children and older adults were available.	[Barker, S. Fiona; Zomer, Ella; O'Toole, Joanne; Sinclair, Martha; Liew, Danny; Leder, Karin] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Gibney, Katherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia	Monash University; University of Melbourne	Barker, SF (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	fiona.barker@monash.edu	Leder, Karin/AAD-2388-2019; Zomer, Ella/AAE-2462-2019; Barker, Fiona/K-7538-2015	Leder, Karin/0000-0003-1368-1039; Zomer, Ella/0000-0002-9993-4297; Barker, Fiona/0000-0002-9203-5766; Liew, Danny/0000-0002-0131-623X				ABS, 2016, 43900 ABS; ABS, 2015, 43900 ABS; ABS, 2010, 43900 ABS; AIHW, 2014, EM DEP CAR 2013 14 A; AIHW, 2015, EM DEP CAR 2014 15 A; AIHW, 2012, MED WORKF 2010; AIHW, 2015, AIHW NAT HOSP MORB D; AIHW, 2014, 4 2 CHRON DIS AUSTR; AIHW, 2017, MET ONL REG; [Anonymous], 2017, PHARM BEN SCHEM PBS; [Anonymous], 2016, AUSTR DEM STAT; [Anonymous], 2017, Q MED STAT TABL 2 NA; [Anonymous], 2017, NAT HOSP MORB DAT SE; Australian Institute of Health and Welfare (AIHW), HLTH EXP AUSTR 2014; Authority IHP, 2021, ROUND 22 NAT HOSP CO; Baumann-Popczyk A, 2012, EPIDEMIOL INFECT, V140, P1173, DOI 10.1017/S0950268811001853; BEACH. BEACH: Bettering the Evaluation and Care of Health, 2006, BEACH BEACH BETT EV; Chen Y, 2016, EPIDEMIOL INFECT, V144, P241, DOI 10.1017/S0950268815001375; Dey A, 2012, MED J AUSTRALIA, V197, P453, DOI 10.5694/mja12.10062; DH, 2016, MED BEN SCHED BOOK O; Edelstein M, 2016, EPIDEMIOL INFECT, V144, P2831, DOI 10.1017/S0950268816000467; Fischer TK, 2007, EMERG INFECT DIS, V13, P855, DOI 10.3201/eid1306.061432; Gibney K, 2012, 100409 WQRA; Gibney KB, 2014, INT J INFECT DIS, V28, P176, DOI 10.1016/j.ijid.2014.08.006; Hall G, 2010, EPIDEMIOL INFECT, V138, P117, DOI 10.1017/S0950268809990112; Hall GV, 2006, EPIDEMIOL INFECT, V134, P111, DOI 10.1017/S0950268805004656; Hellard ME, 2003, J GASTROEN HEPATOL, V18, P322, DOI 10.1046/j.1440-1746.2003.02959.x; Hendrix N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017347; Henson SJ, 2008, INT J FOOD MICROBIOL, V127, P43, DOI 10.1016/j.ijfoodmicro.2008.06.007; Henson SJ, 2011, INT J FOOD MICROBIOL, V147, P86, DOI 10.1016/j.ijfoodmicro.2011.03.008; Herikstad H, 2002, EPIDEMIOLOGY INFECT, V129; Ho SC, 2010, EPIDEMIOL INFECT, V138, P982, DOI 10.1017/S0950268809991087; Independent Hospital Pricing Authority (IHPA), 2014, NAT HOSP COST DAT CO; King D., 2013, PRIVATE PATIENTS PUB; Kirk M, 2014, FOODBORNE ILLNESS AU; Majowicz SE, 2008, EPIDEMIOL INFECT, V136, P886, DOI 10.1017/S0950268807009375; Muller L, 2012, EPIDEMIOL INFECT, V140, P290, DOI 10.1017/S0950268811000471; Najnin N, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-211; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Reyes JF, 2017, VACCINE, V35, P345, DOI 10.1016/j.vaccine.2016.11.056; Scavia G, 2012, EPIDEMIOL INFECT, V140, P1193, DOI 10.1017/S0950268811002020; Tam CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138526; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; van den Brandhof WE, 2004, EPIDEMIOL INFECT, V132, P211, DOI 10.1017/S0950268803001559; Hoang VM, 2015, J KOREAN MED SCI, V30, pS178, DOI 10.3346/jkms.2015.30.S2.S178; Wilcox S., 2014, CHRONIC DIS AUSTR CA; XE, 2017, CURR HIST RAT TABL 2	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195759	10.1371/journal.pone.0195759	http://dx.doi.org/10.1371/journal.pone.0195759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649285	gold, Green Published			2022-12-27	WOS:000429791900082
J	Becker, F; Anokye, N; de Bekker-Grob, EW; Higgins, AL; Relton, C; Strong, M; Fox-Rushby, J				Becker, Frauke; Anokye, Nana; de Bekker-Grob, Esther W.; Higgins, Ai Lish; Relton, Clare; Strong, Mark; Fox-Rushby, Julia			Women's preferences for alternative financial incentive schemes for breastfeeding: A discrete choice experiment	PLOS ONE			English	Article							SMOKING-CESSATION; RANDOM UTILITY; OLDER-PEOPLE; HEALTH-CARE; ACCEPTABILITY; BEHAVIORS; PREGNANCY; PROGRAM; PAY	Background Increasing breastfeeding rates have been associated with reductions in disease in babies and mothers as well as in related costs. 'Nourishing Start for Health (NoSH)', a financial incentive scheme has been proposed as a potentially effective way to increase both the number of mothers breastfeeding and duration of breastfeeding. Aims To establish women's relative preferences for different aspects of a financial incentive scheme for breastfeeding and to identify importance of scheme characteristics on probability on participation in an incentive scheme. Methods A discrete choice experiment (DCE) obtained information on alternative specifications of the NoSH scheme designed to promote continued breastfeeding duration until at least 6 weeks after birth. Four attributes framed alternative scheme designs: value of the incentive; minimum breastfeeding duration required to receive incentive; method of verifying breastfeeding; type of incentive. Three versions of the DCE questionnaire, each containing 8 different choice sets, provided 24 choice sets for analysis. The questionnaire was mailed to 2,531 women in the South Yorkshire Cohort (SYC) aged 16-45 years in IMD quintiles 3-5. The analytic approach considered conditional and mixed effects logistic models to account for preference heterogeneity that may be associated with a variation in effects mediated by respondents' characteristics. Results 564 women completed the questionnaire and a response rate of 22% was achieved. Most of the included attributes were found to affect utility and therefore the probability to participate in the incentive scheme. Higher rewards were preferred, although the type of incentive significantly affected women's preferences on average. We found evidence for preference heterogeneity based on individual characteristics that mediated preferences for an incentive scheme. Conclusions Although participants' opinion in our sample was mixed, financial incentives for breastfeeding may be an acceptable and effective instrument to change behaviour. However, individual characteristics could mediate the effect and should therefore be considered when developing and targeting future interventions.	[Becker, Frauke] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Oxford, England; [Becker, Frauke; Anokye, Nana; Higgins, Ai Lish; Fox-Rushby, Julia] Brunel Univ, Hlth Econ Res Grp, Uxbridge, Middx, England; [de Bekker-Grob, Esther W.] Erasmus Univ, Sect Hlth Technol Assessment, Rotterdam, Netherlands; [de Bekker-Grob, Esther W.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Erasmus Choice Modelling Ctr, Rotterdam, Netherlands; [Relton, Clare; Strong, Mark] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Oxford; Brunel University; Erasmus University Rotterdam; Erasmus University Rotterdam; University of Sheffield	Becker, F (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Oxford, England.; Becker, F (corresponding author), Brunel Univ, Hlth Econ Res Grp, Uxbridge, Middx, England.	frauke.becker@dph.ox.ac.uk	Becker, Frauke/Q-7738-2018; Strong, Mark/A-4638-2010	Becker, Frauke/0000-0003-1175-3932; Strong, Mark/0000-0003-1486-8233; Fox-Rushby, Julia/0000-0003-0748-0871	Medical Research Council (MRC) National Prevention Research Initiative (NPRI) [MR/J000434/1]; MRC [MR/J000434/1] Funding Source: UKRI	Medical Research Council (MRC) National Prevention Research Initiative (NPRI); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge financial support from the Medical Research Council (MRC) National Prevention Research Initiative (NPRI) (grant number MR/J000434/1). The funders had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Adams J, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19940; Bech M, 2005, HEALTH ECON, V14, P1079, DOI 10.1002/hec.984; Bech M, 2011, HEALTH ECON, V20, P273, DOI 10.1002/hec.1587; Bolling K, 2007, INFANT FEEDING SURVE; Cahill K, 2008, COCHRANE DB SYST REV; Clark MD, 2014, PHARMACOECONOMICS, V32, P883, DOI 10.1007/s40273-014-0170-x; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Department of Health, 2012, HLTH START SCHEM RES; Farooqui MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-141; Finch C, 2002, J AM DIET ASSOC, V102, P981, DOI 10.1016/S0002-8223(02)90224-5; Flynn Terry N, 2008, Popul Health Metr, V6, P6, DOI 10.1186/1478-7954-6-6; Giles EL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157403; Giles EL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0549-5; Giles EL, 2015, PREV MED, V73, P145, DOI 10.1016/j.ypmed.2014.12.029; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Groves R.M., 2004, SURVEY ERRORS SURVEY; Hashemi A, 2015, J OBESITY WEIGHT LOS, V5; Hensher DA, 2003, TRANSPORTATION, V30, P133, DOI 10.1023/A:1022558715350; Hicks RL, 2000, LAND ECON, V76, P374, DOI 10.2307/3147035; Hoddinott P, 2014, LANCET, V384, P37; Lancsar E, 2004, HEALTH ECON, V13, P901, DOI 10.1002/hec.870; Lancsar E, 2013, SOC SCI MED, V76, P74, DOI 10.1016/j.socscimed.2012.10.007; Mantzari E, 2015, PREV MED, V75, P75, DOI 10.1016/j.ypmed.2015.03.001; McAndrew F, 2012, INFANT FEEDING SURVE; Morgan H, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19300; Ozdemir S, 2009, J HEALTH ECON, V28, P894, DOI 10.1016/j.jhealeco.2009.04.004; Pokhrel S, 2015, ARCH DIS CHILD, V100, P334, DOI 10.1136/archdischild-2014-306701; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Relton C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010158; Relton C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-640; Renfrew M, 2012, PREVENTING DIS SAVIN; Ryan M, 2008, USING DISCRETE CHOIC, Vxix; Ryan M, 2006, J HEALTH ECON, V25, P927, DOI 10.1016/j.jhealeco.2006.01.001; SCIACCA JP, 1995, J AM DIET ASSOC, V95, P323, DOI 10.1016/S0002-8223(95)00083-6; Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134; Train K., 2003, DISCRETE CHOICE METH, Vvii; Watson V, 2016, DISCRETE CHOICE EXPT; Whelan B, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-355; World Health Organization, 2016, WHO INF YOUNG CHILDR	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194231	10.1371/journal.pone.0194231	http://dx.doi.org/10.1371/journal.pone.0194231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649245	Green Published, gold, Green Accepted			2022-12-27	WOS:000429791900008
J	Salazar, CL; Reyes, C; Cienfuegos-Gallet, AV; Best, E; Atehortua, S; Sierra, P; Correa, MM; Fawley, WN; Paredes-Sabja, D; Wilcox, M; Gonzalez, A				Lina Salazar, Clara; Reyes, Catalina; Vanessa Cienfuegos-Gallet, Astrid; Best, Emma; Atehortua, Santiago; Sierra, Patricia; Correa, Margarita M.; Fawley, Warren N.; Paredes-Sabja, Daniel; Wilcox, Mark; Gonzalez, Angel			Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, Colombia	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; RESTRICTION-ENDONUCLEASE ANALYSIS; POLYMERASE-CHAIN-REACTION; INFECTION; EPIDEMIC; TOXIN; GENE; SUSCEPTIBILITY; TRANSMISSION; GUIDELINES	We aimed to achieve a higher typing resolution within the three dominant Clostridium difficile ribotypes (591,106 and 002) circulating in Colombia. A total of 50 C. difficile isolates we had previously typed by PCR-ribotyping, representing the major three ribotypes circulating in Colombia, were analyzed. Twenty-seven isolates of ribotype 591, 12 of ribotype 106 and 11 of ribotype 002 were subtyped by multiple locus variable-number tandem-repeat analysis (MLVA). The presence of the PaLoc genes (tcdA/tccB), toxin production in culture and antimicrobial susceptibility were also determined. From the total C. difficile ribotypes analyzed, 20 isolates (74%) of ribotype 591, nine (75%) of ribotype 106 and five (45.5%) of ribotype 002 were recovered from patients with Clostridium difficile infection (CDI). MLVA allowed us to recognize four and two different clonal complexes for ribotypes 591 and 002, respectively, having a summed tandem-repeat difference (STRD) <2, whereas none of the ribotype 106 isolates were grouped in a cluster or clonal complex having a STRD >10. Six ribotype 591 and three ribotype 002 isolates belonging to a defined clonal complex were isolated on the same week in two different hospitals. All ribotypes harbored either tcdA(+)/tccB(+) or tcdA(-)/tccB(+) PaLoc genes. Moreover, 94% of the isolates were positive for toxin in culture. All isolates were susceptible to vancomycin and metronidazole, while 75% to 100% of the isolates were resistant to clindamycin, and less than 14.8% of ribotype 591 isolates were resistant to moxifloxacina. No significant differences were found among ribotypes with respect to demographic and clinical patients' data; however, our results demonstrated a high molecular heterogeneity of C. difficile strains circulating in Colombia.	[Lina Salazar, Clara] Univ Antioquia, Sch Microbiol, Res Grp Anaerob Bacteria GIBA, Medellin, Colombia; [Reyes, Catalina; Vanessa Cienfuegos-Gallet, Astrid; Gonzalez, Angel] Univ Antioquia, Sch Microbiol, Basic & Appl Microbiol Res Grp MICROBA, Medellin, Colombia; [Best, Emma; Fawley, Warren N.; Wilcox, Mark] Leeds Teaching Hosp NHS Trust, Dept Microbiol, Leeds, W Yorkshire, England; [Atehortua, Santiago] San Vicente Fdn Univ Hosp, Medellin, Colombia; [Sierra, Patricia] Univ Antioquia, IPS Univ, Clin Leon 13, Medellin, Colombia; [Correa, Margarita M.] Univ Antioquia, Sch Microbiol, Mol Microbiol Grp, Medellin, Colombia; [Paredes-Sabja, Daniel] Univ Andres Bello, Dept Ciencias Biol, Microbiota Host Interact & Clostridia Res Grp, Santiago, Chile	Universidad de Antioquia; Universidad de Antioquia; University of Leeds; Universidad de Antioquia; Universidad de Antioquia; Universidad Andres Bello	Gonzalez, A (corresponding author), Univ Antioquia, Sch Microbiol, Basic & Appl Microbiol Res Grp MICROBA, Medellin, Colombia.	angel.gonzalez@udea.edu.co	Paredes-Sabja, Daniel/ABI-4293-2020; Gonzalez, Angel/ABG-7914-2020	Gonzalez, Angel/0000-0002-7052-7938; Cienfuegos Gallet, Astrid/0000-0002-3407-6463	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia [485-2012, 1115569344410]; Fondo Nacional de Ciencia y Tecnologia de Chile (FONDECYT) [1151025]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Fondo Nacional de Ciencia y Tecnologia de Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia, Project 485-2012 (Code number 1115569344410); and by a grant from Fondo Nacional de Ciencia y Tecnologia de Chile (FONDECYT Grant 1151025). The funders had no role in study design, analysis and interpretation of experiments, decision to publish, or preparation of the manuscript.	Bakker D, 2010, J CLIN MICROBIOL, V48, P3744, DOI 10.1128/JCM.01171-10; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; BOWMAN RA, 1986, FEMS MICROBIOL LETT, V34, P31, DOI 10.1016/0378-1097(86)90265-X; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Davies KA, 2016, EUROSURVEILLANCE, V21, P1; Eckert C, 2011, J MED MICROBIOL, V60, P1088, DOI 10.1099/jmm.0.029009-0; Eyre DW, 2013, J CLIN MICROBIOL, V51, P4141, DOI 10.1128/JCM.01095-13; Fawley WN, 2008, J CLIN MICROBIOL, V46, P954, DOI 10.1128/JCM.01764-07; Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150; Fawley WN, 2011, J CLIN MICROBIOL, V49, P4333, DOI 10.1128/JCM.05873-11; Feher C, 2016, INFECT DIS THER, V5, P207, DOI 10.1007/s40121-016-0122-1; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017; GURTLER V, 1993, J GEN MICROBIOL, V139, P3089, DOI 10.1099/00221287-139-12-3089; Hernandez-Rocha C, 2013, DIAGN MICR INFEC DIS, V75, P361, DOI 10.1016/j.diagmicrobio.2012.12.010; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Indra A, 2008, J MED MICROBIOL, V57, P702, DOI 10.1099/jmm.0.47476-0; Kato H, 1999, FEMS MICROBIOL LETT, V175, P197, DOI [10.1016/S0378-1097(99)00196-2, 10.1111/j.1574-6968.1999.tb13620.x]; KATO N, 1991, J CLIN MICROBIOL, V29, P33, DOI 10.1128/JCM.29.1.33-37.1991; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kuijper E J, 2008, Euro Surveill, V13; Salazar CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184689; Lopez-Urena D, 2014, J MED MICROBIOL, V63, P322, DOI 10.1099/jmm.0.066399-0; Marsh JW, 2006, J CLIN MICROBIOL, V44, P2558, DOI 10.1128/JCM.02364-05; Marsh JW, 2010, J CLIN MICROBIOL, V48, P412, DOI 10.1128/JCM.01315-09; Morfin-Otero R, 2016, BRAZ J INFECT DIS, V20, P8, DOI 10.1016/j.bjid.2015.09.008; Noren T, 2010, CLIN MICROBIOL INFEC, V16, P1104, DOI 10.1111/j.1469-0691.2009.03048.x; Plaza-Garrido A, 2016, EPIDEMIOL INFECT, V144, P976, DOI 10.1017/S0950268815002459; Quesada-Gomez C, 2012, ANAEROBE, V18, P581, DOI 10.1016/j.anaerobe.2012.10.002; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rupnik M, 2003, J CLIN MICROBIOL, V41, P1118, DOI 10.1128/JCM.41.3.1118-1125.2003; Senchyna F, 2017, J CLIN MICROBIOL, V55, P2651, DOI [10.1128/JCM.00563-17, 10.1128/jcm.00563-17]; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Tanner HE, 2010, J CLIN MICROBIOL, V48, P985, DOI 10.1128/JCM.02012-09; Tickler IA, 2014, ANTIMICROB AGENTS CH, V58, P4214, DOI 10.1128/AAC.02775-13; van den Berg RJ, 2007, J CLIN MICROBIOL, V45, P1024, DOI 10.1128/JCM.02023-06; Villegas M, 2016, INFECTIO, V21, P9; Zaiss NH, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-6	39	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195694	10.1371/journal.pone.0195694	http://dx.doi.org/10.1371/journal.pone.0195694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649308	Green Published, gold			2022-12-27	WOS:000429791900072
J	Toutain, J; Goutte-Gattat, D; Horovitz, J; Saura, R				Toutain, Jerome; Goutte-Gattat, Damien; Horovitz, Jacques; Saura, Robert			Confined placental mosaicism revisited: Impact on pregnancy characteristics and outcome	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; SAMPLING RISK-FACTORS; PRENATAL-DIAGNOSIS; CHORIONIC VILLI; UNIPARENTAL DISOMY; CVS MOSAICISM; FETAL; TRISOMY; AMNIOCENTESIS; CONFIRMATION	Objectives We wanted to re-evaluate the influence of confined placental mosaicism subtypes (type 2 and type 3) on pregnancy characteristics and outcome. Material and methods From July 2009 to December 2015, 5512 chorionic villus samplings were performed in our Fetal Medicine Center. Conventional karyotyping was performed after long-term and short-term cultured villi to define type 2 or type 3 confined placental mosaicisms. Karyotype after amniocentesis was performed to exclude true fetal mosaicism, when appropriate. Pregnancy characteristics and outcomes were collected and compared to a control population. Results Thirty-six (0.65%) confined placental mosaicisms were observed (13 type 2 and 23 type 3). Nuchal translucency was not increased for type 2 and type 3 confined placental mosaicisms. Pregnancy characteristics and outcomes were comparable between type 2 confined placental mosaicisms and the control population. In type 3 confined placental mosaicisms, median first trimester serum pregnancy-associated plasma protein A was lower than for the control population (p<0.001), preterm births were noticed in 56% (p<0.001), small for gestational age newborns in 74% (p<0.001), and adverse pregnancy outcome was reported in 35% (p<0.01). Conclusion Although type 2 confined placental mosaicisms appeared to have no influence on pregnancy characteristics and outcome, type 3 confined placental mosaicisms were associated with low levels of first trimester serum pregnancy-associated plasma protein A, preterm birth, small for gestational age newborns, and adverse pregnancy outcomes.	[Toutain, Jerome] CHU Bordeaux, Serv Genet Med, Bordeaux, France; [Goutte-Gattat, Damien; Horovitz, Jacques; Saura, Robert] Univ Bordeaux, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Toutain, J (corresponding author), CHU Bordeaux, Serv Genet Med, Bordeaux, France.	jerome.toutain@chu-bordeaux.fr		Toutain, Jerome/0000-0003-1236-1551; Goutte-Gattat, Damien/0000-0002-6095-8718				Amor DJ, 2006, PRENATAL DIAG, V26, P443, DOI 10.1002/pd.1433; Baffero GM, 2012, PRENATAL DIAG, V32, P1102, DOI 10.1002/pd.3965; Behrman RE, 2007, PRETERM BIRTH CAUSES; Eckmann-Scholz C, 2012, J PERINAT MED, V40, P215, DOI [10.1515/jpm.2011.130, 10.1515/JPM.2011.130]; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; Gaudineau A, 2013, J GYNECOL OBST BIO R, V42, P895, DOI 10.1016/j.jgyn.2013.09.013; Goldberg JD, 1997, AM J OBSTET GYNECOL, V176, P1349, DOI 10.1016/S0002-9378(97)70356-9; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Hahnemann JM, 1997, AM J MED GENET, V70, P179, DOI 10.1002/(SICI)1096-8628(19970516)70:2<179::AID-AJMG15>3.0.CO;2-G; Kalousek DK, 1996, J MED GENET, V33, P529, DOI 10.1136/jmg.33.7.529; KALOUSEK DK, 1991, PRENATAL DIAG, V11, P743, DOI 10.1002/pd.1970111002; Kotzot D, 2008, ULTRASOUND OBST GYN, V31, P100, DOI 10.1002/uog.5133; Krantz D, 2004, AM J OBSTET GYNECOL, V191, P1452, DOI 10.1016/j.ajog.2004.05.068; Malvestiti F, 2015, PRENATAL DIAG, V35, P1117, DOI 10.1002/pd.4656; Pertile MD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1240; Robinson WP, 1997, AM J HUM GENET, V60, P917; ROLAND B, 1994, PRENATAL DIAG, V14, P589, DOI 10.1002/pd.1970140713; Rose S, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1127; Saura R, 2010, PRENATAL DIAG, V30, P387, DOI 10.1002/pd.2476; Sifakis S, 2010, PRENATAL DIAG, V30, P329, DOI 10.1002/pd.2457; SIMONI G, 1992, ANN GENET-PARIS, V35, P110; Spencer K, 2014, PRENATAL DIAG, V34, P291, DOI 10.1002/pd.4285; Stipoljev F, 2001, FETAL DIAGN THER, V16, P4, DOI 10.1159/000053871; Taglauer ES, 2014, PLACENTA, V35, pS64, DOI 10.1016/j.placenta.2013.11.014; Toutain J, 2010, EUR J OBSTET GYN R B, V149, P143, DOI 10.1016/j.ejogrb.2009.12.015; Toutain J, 2013, PRENATAL DIAG, V33, P301, DOI 10.1002/pd.4022; Toutain J, 2010, PRENATAL DIAG, V30, P1155, DOI 10.1002/pd.2631; Van Opstal D, 2016, EXPERT REV MOL DIAGN, V16, P513, DOI 10.1586/14737159.2016.1152890; Wilkins-Haug L, 2006, PRENATAL DIAG, V26, P428, DOI 10.1002/pd.1430; Wolstenholme J, 1996, PRENATAL DIAG, V16, P511, DOI 10.1002/(SICI)1097-0223(199606)16:6<511::AID-PD904>3.0.CO;2-8	30	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195905	10.1371/journal.pone.0195905	http://dx.doi.org/10.1371/journal.pone.0195905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649318	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900104
J	Hyett, MP; Perry, A; Breakspear, M; Wen, W; Parker, GB				Hyett, Matthew P.; Perry, Alistair; Breakspear, Michael; Wen, Wei; Parker, Gordon B.			White matter alterations in the internal capsule and psychomotor impairment in melancholic depression	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; MAJOR DEPRESSION; FRACTIONAL ANISOTROPY; MEAN DIFFUSIVITY; ABNORMALITIES; INTEGRITY; DTI; CLASSIFICATION; DENSITY	Emerging evidence suggests that structural brain abnormalities may play a role in the pathophysiology of melancholic depression. We set out to test whether diffusion-derived estimates of white matter structure were disrupted in melancholia in regions underpinning psychomotor function. We hypothesized that those with melancholia (and evidencing impaired psychomotor function) would show disrupted white matter organization in internal capsule subdivisions. Diffusion magnetic resonance imaging (dMRI) data were acquired from 22 melancholic depressed, 23 non-melancholic depressed, and 29 healthy control participants. Voxel-wise fractional anisotropy (FA), radial diffusivity (RD), and axial diffusivity (AD) values were derived for anterior, posterior, and retrolenticular limbs of the internal capsule and compared between groups. Neuropsychological (reaction time) and psychomotor functioning were assessed and correlated against FA. Fractional anisotropy was distinctly increased, whilst RD was decreased, in the right anterior internal capsule in those with melancholia, compared to controls. The right anterior limb of the internal capsule correlated with clinical ratings of psychomotor disturbance, and reduced psychomotor speed was associated with increased FA values in the right retrolenticular limb in those with melancholia. Our findings highlight a distinct disturbance in the local white matter arrangement in specific regions of the internal capsule in melancholia, which in turn is associated with psychomotor dysfunction. This study clarifies the contribution of structural brain integrity to the phenomenology of melancholia, and may assist future efforts seeking to integrate neurobiological markers into depression subtyping.	[Hyett, Matthew P.; Perry, Alistair; Wen, Wei; Parker, Gordon B.] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Hyett, Matthew P.; Perry, Alistair; Breakspear, Michael] QIMR Berghofer Med Res Inst, Syst Neurosci Grp, Herston, Qld, Australia; [Perry, Alistair; Wen, Wei] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing CHeBA, Sydney, NSW, Australia; [Breakspear, Michael] Royal Brisbane & Womens Hosp, Metro North Mental Hlth Serv, Brisbane, Qld, Australia; [Breakspear, Michael; Parker, Gordon B.] Prince Wales Hosp, Black Dog Inst, Randwick, NSW, Australia	University of New South Wales Sydney; QIMR Berghofer Medical Research Institute; University of New South Wales Sydney; Royal Brisbane & Women's Hospital; Black Dog Institute	Hyett, MP (corresponding author), Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia.; Hyett, MP (corresponding author), QIMR Berghofer Med Res Inst, Syst Neurosci Grp, Herston, Qld, Australia.	matthewhyett@gmail.com	Breakspear, Michael/ABF-6302-2020	Breakspear, Michael/0000-0003-4943-3969; Wen, Wei/0000-0003-2753-3870	National Health and Medical Research Council of Australia [510135, 1037196]; OLD Office of Health and Medical Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); OLD Office of Health and Medical Research	This work was supported by grants from the National Health and Medical Research Council of Australia (Program Grants 510135 and 1037196: MPH, GBP, MJB), and the OLD Office of Health and Medical Research (MJB).	Alba-Ferrara LM, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00009; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Bar-Shir A, 2009, NEUROIMAGE, V48, P109, DOI 10.1016/j.neuroimage.2009.06.019; Beaulieu C., 2014, DIFFUSION MRI QUANTI, P155, DOI [https://doi.org/10.1016/B978-0-12-396460-1.00008-1, DOI 10.1016/B978-0-12-396460-1.00008-1]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hendelman WJ, 2016, ATLAS FUNCTIONAL NEU; Hickie IB, 2007, PSYCHIAT RES-NEUROIM, V155, P211, DOI 10.1016/j.pscychresns.2007.01.006; Holdnack HA, WECHSLER TEST ADULT; Hyett MP, 2015, JAMA PSYCHIAT, V72, P350, DOI 10.1001/jamapsychiatry.2014.2490; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Korgaonkar MS, 2014, BRIT J PSYCHIAT, V205, P321, DOI 10.1192/bjp.bp.113.140376; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lochner C, 2012, J PSYCHIATR NEUROSCI, V37, P193, DOI 10.1503/jpn.110059; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Naidich TP, 2004, AM J NEURORADIOL, V25, P222; Pannek K, 2012, PEDIATR RADIOL, V42, P1169, DOI 10.1007/s00247-012-2427-x; PARKER G, 1994, BRIT J PSYCHIAT, V164, P316, DOI 10.1192/bjp.164.3.316; Parker G., 1996, MELANCHOLIA DISORDER; Parker G, 2013, J AFFECT DISORDERS, V147, P331, DOI 10.1016/j.jad.2012.11.035; Parker G, 2010, AM J PSYCHIAT, V167, P745, DOI 10.1176/appi.ajp.2010.09101525; Pendlebury ST, 1999, STROKE, V30, P956, DOI 10.1161/01.STR.30.5.956; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Roberts G, 2018, MOL PSYCHIATR, V23, P413, DOI 10.1038/mp.2016.216; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stephan KE, 2016, LANCET PSYCHIAT, V3, P77, DOI 10.1016/S2215-0366(15)00361-2; Tham MW, 2011, J AFFECT DISORDERS, V132, P26, DOI 10.1016/j.jad.2010.09.013; Thomas AJ, 2002, BRIT J PSYCHIAT, V181, P129; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Versace A, 2010, BIOL PSYCHIAT, V68, P560, DOI 10.1016/j.biopsych.2010.04.036; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Zhang AF, 2013, NEUROPSYCHOPHARMACOL, V38, P1451, DOI 10.1038/npp.2013.41; Zhu XL, 2011, BRAIN RES, V1369, P223, DOI 10.1016/j.brainres.2010.10.104; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525	51	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195672	10.1371/journal.pone.0195672	http://dx.doi.org/10.1371/journal.pone.0195672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672517	Green Submitted, gold, Green Published			2022-12-27	WOS:000430446800032
J	Lamichhane, BR; Persoon, GA; Leirs, H; Poudel, S; Subedi, N; Pokheral, CP; Bhattarai, S; Thapaliya, BP; de Longh, HH				Lamichhane, Babu Ram; Persoon, Gerard A.; Leirs, Herwig; Poudel, Shashank; Subedi, Naresh; Pokheral, Chiranjibi Prasad; Bhattarai, Santosh; Thapaliya, Bishnu Prasad; de Longh, Hans H.			Spatio-temporal patterns of attacks on human and economic losses from wildlife in Chitwan National Park, Nepal	PLOS ONE			English	Article							TIGERS PANTHERA-TIGRIS; CONFLICT; PEOPLE; CONSERVATION; POPULATION	Wildlife attacks on humans and economic losses often result in reduced support of local communities for wildlife conservation. Information on spatial and temporal patterns of such losses in the highly affected areas contribute in designing and implementing effective mitigation measures. We analyzed the loss of humans, livestock and property caused by wildlife during 1998 to 2016, using victim family's reports to Chitwan National Park authorities and Buffer Zone User Committees. A total of 4,014 incidents were recorded including attacks on humans, livestock depredation, property damage and crop raiding caused by 12 wildlife species. In total > 400,000 US dollar was paid to the victim families as a relief over the whole period. Most of the attacks on humans were caused by rhino, sloth bear, tiger, elephant, wild boar and leopard. A significantly higher number of conflict incidents caused by rhino and elephant were observed during full moon periods. An increase in the wildlife population did not coincide with an equal rise in conflict incidents reported. Underprivileged ethnic communities were attacked by wildlife more frequently than expected. Number of attacks on humans by carnivores and herbivores did not differ significantly. An insignificant decreasing trend of wildlife attacks on humans and livestock was observed with significant variation over the years. Tiger and leopard caused > 90% of livestock depredation. Tigers killed both large (cattle and buffalo) and medium sized (goat, sheep, pig) livestock but leopard mostly killed medium sized livestock. Most (87%) of the livestock killing during 2012-2016 occurred within the stall but close (< 500m) to the forest edge. Both the percentage of households with livestock and average holding has decreased over the years in buffer zone. Decreased forest dependency as well as conflict mitigation measures (electric and mesh wire fences) have contributed to keep the conflict incidents in control. Strengthening mitigation measures like construction of electric or mesh wire fences and predator-proof livestock corrals along with educating local communities about wildlife behavior and timely management of problem animals (man-eater tiger, rage elephant etc.) will contribute to reduce the conflict.	[Lamichhane, Babu Ram; Persoon, Gerard A.] Leiden Univ, Inst Cultural Anthropol & Dev Sociol, Fac Social & Behav Sci, Leiden, Netherlands; [Lamichhane, Babu Ram; Leirs, Herwig; de Longh, Hans H.] Univ Antwerp, Evolutionary Ecol Grp, Fac Sci, Campus Drie Eiken, Antwerp, Belgium; [Lamichhane, Babu Ram; Poudel, Shashank; Subedi, Naresh; Pokheral, Chiranjibi Prasad; Bhattarai, Santosh] NTNC, Khumaltar, Lalitpur, Nepal; [Thapaliya, Bishnu Prasad] DNPWC, Kathmandu, Nepal; [de Longh, Hans H.] Leiden Univ, Fac Sci, Inst Environm Sci CML, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Antwerp; Department of National Parks & Wildlife Conservation (DNPWC); Leiden University; Leiden University - Excl LUMC	Lamichhane, BR (corresponding author), Leiden Univ, Inst Cultural Anthropol & Dev Sociol, Fac Social & Behav Sci, Leiden, Netherlands.; Lamichhane, BR (corresponding author), Univ Antwerp, Evolutionary Ecol Grp, Fac Sci, Campus Drie Eiken, Antwerp, Belgium.; Lamichhane, BR (corresponding author), NTNC, Khumaltar, Lalitpur, Nepal.	baburaml@gmail.com	BHATTARAI, SANTOSH/D-4977-2018; Leirs, Herwig/B-8197-2008; BHATTARAI, SANTOSH/AAG-9139-2021; Lamichhane, Babu Ram/O-2741-2013	Leirs, Herwig/0000-0002-7612-5024; BHATTARAI, SANTOSH/0000-0001-7615-1954; Lamichhane, Babu Ram/0000-0003-0580-7682	US Fish and Wildlife Service (Tiger-Rhino Conservation Fund) [F15AP00804]; Rufford Small Grants Foundation [20823-1]; Leiden University (Louwis Fellowship Fund)	US Fish and Wildlife Service (Tiger-Rhino Conservation Fund); Rufford Small Grants Foundation; Leiden University (Louwis Fellowship Fund)	This work was funded by the US Fish and Wildlife Service (Tiger-Rhino Conservation Fund - Grant No. F15AP00804, URL: https://www.fws.gov/International/wildife-without-borders/rhino- and-tiger-conservation-fund.html; Rufford Small Grants Foundation (Grant No. 20823-1) (BRL), URL: http://www.rufford.org/projects/babu_ram_lamichhane; Leiden University (Louwis Fellowship Fund) (GAP).	Acharya KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161717; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2012, THESIS; Aryal A, 2017, CONSERV BIOL, V31, P1494, DOI 10.1111/cobi.12894; Barlow A.C.D., 2013, Wildlife Biology in Practice, V9, P30; Bhattarai BR, 2017, J MT SCI-ENGL, V14, P964, DOI 10.1007/s11629-016-3980-9; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; CBS, 2011, STATISTICS; CNP, 2017, BIODIVERSITY, P1; CNP, LOSS WILDL REL DISTR; CNP, 2004, CNP ANN REP FY 2003; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; CTEVT, 2014, DYN DIM LAB MIGR NEP; DANGOL D R, 1991, International Journal of Pharmacognosy, V29, P203; Dhungana R, 2018, ORYX, V52, P55, DOI 10.1017/S0030605316001587; DNPWC, 2016, DNPWC ANN REP FY 201; DNPWC, 2006, TIG CONS ACT PLAN 20; DNPWC, 2015, DNPWC ANN REP FY 201; DNPWC, 2014, DNPWC ANN REP FY 201; DNPWC, 2015, REP NAT RHIN COUNT 2; Fox J, 2018, J PEASANT STUD, V45, P610, DOI 10.1080/03066150.2016.1246436; GON, 1996, BUFF ZON MAN RUL 205; Gunn J, 2014, AFR J ECOL, V52, P129, DOI 10.1111/aje.12091; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Gurung B, 2009, ENVIRON CONSERV, V36, P338, DOI 10.1017/S0376892910000160; Gurung H., 2003, SOCIAL DEMOGRAPHY NE; hapa T.B., 2011, THESIS SAURASHTRA U; Heinen J. T., 2000, Journal of Environment & Development, V9, P45; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Joshi AR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501675; Karki J. B., 2009, TIGERS THEIR PREY BA; Karki JB, 2015, ORYX, V49, P150, DOI 10.1017/S0030605313000471; Lamichhane BR, 2017, GLOB ECOL CONSERV, V11, P177, DOI 10.1016/j.gecco.2017.06.003; Martin E.B., 2006, PACHYDERM, V41, P61; Miller JRB, 2016, REG ENVIRON CHANGE, V16, P17, DOI 10.1007/s10113-015-0871-5; MISHRA HR, 1982, AMBIO, V11, P246; NEPAL SK, 1995, INT J SUST DEV WORLD, V2, P11, DOI 10.1080/13504509.1995.10590662; Odden M, 2010, ECOL RES, V25, P875, DOI 10.1007/s11284-010-0723-1; Packer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022285; Pant G, 2016, ORYX, V50, P724, DOI 10.1017/S0030605315000381; Peterson MN, 2010, CONSERV LETT, V3, P74, DOI 10.1111/j.1755-263X.2010.00099.x; QGIS Development Team, 2017, QGIS GEOGRAPHIC INFO; Redpath SM, 2015, ORYX, V49, P222, DOI 10.1017/S0030605314000799; SHARMA UR, 1990, LANDSCAPE URBAN PLAN, V19, P133, DOI 10.1016/0169-2046(90)90049-8; Silwal T, 2017, ORYX, V51, P370, DOI 10.1017/S0030605315001489; Subedi N, 2013, ORYX, V47, P352, DOI 10.1017/S0030605313000562; Traill LW, 2016, J ZOOL, V299, P221, DOI 10.1111/jzo.12343; Tumenta PN, 2012, THESIS; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x	49	36	38	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195373	10.1371/journal.pone.0195373	http://dx.doi.org/10.1371/journal.pone.0195373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672538	Green Published, gold, Green Submitted			2022-12-27	WOS:000430446800026
J	Antoniewicz, L; Novo, M; Bosson, J; Lundback, M				Antoniewicz, Lukasz; Novo, Mirza; Bosson, Jenny; Lundback, Magnus			Brief exposure to Swedish snus causes divergent vascular responses in healthy male and female volunteers	PLOS ONE			English	Article							SMOKELESS TOBACCO SNUS; 12-YEAR FOLLOW-UP; WAVE REFLECTION; ARTERIAL STIFFNESS; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; SMOKING-CESSATION; SEX-DIFFERENCES; MORTALITY RISK; PULSE PRESSURE	Introduction The use of Swedish oral moist snuff, known as snus, has for a long time been limited to the Scandinavian countries. With declining cigarette sales in the western world, tobacco companies have looked to the development of alternative tobacco products. In 2006 snus products were launched in the US. Even though several studies have demonstrated negative health effects, snus is often depicted as harmless. The aim of the present study was to investigate acute vascular effects of snus as measured by arterial stiffness as well as blood pressure and heart rate. Methods Two separate randomized double-blind crossover studies with the same study design were pooled for analysis. Twenty-nine healthy snus-users (17 females, 12 males) were included. Snus (Goteborgs Rape) and tobacco free snus (Onico) were administered in a randomized order at two separate visits. Arterial stiffness, blood pressure and heart rate were measured at baseline as well as every five minutes for 40 minutes during exposure. Following snus removal, measurements continued for 30 minutes post exposure. Arterial stiffness was measured using pulse wave velocity (Vicorder) and pulse wave analysis (Sphygmocor). Results Compared to placebo, snus significantly increased systolic and diastolic blood pressure as well as heart rate, however, only in females (p = 0.004, p = 0.006 and p<0.001 respectively). No changes were seen in arterial stiffness measurements in either gender. Conclusion We observed an increase in blood pressure and heart rate only in females, but not in males due to snus usage as compared to placebo. This novel finding was surprising and needs to be further investigated considering most of the earlier studies have mainly focused on male snus users and the increasing usage of snus among females.	[Antoniewicz, Lukasz] Karolinska Inst, Dept Clin Sci, Div Internal Med, Danderyd Hosp, Stockholm, Sweden; [Antoniewicz, Lukasz; Novo, Mirza; Bosson, Jenny] Umea Univ, Dept Publ Hlth & Clin Med, Div Med Resp Med, Umea, Sweden; [Lundback, Magnus] Karolinska Inst, Dept Clin Sci, Div Cardiovasc Med, Danderyd Hosp, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Umea University; Danderyds Hospital; Karolinska Institutet	Antoniewicz, L (corresponding author), Karolinska Inst, Dept Clin Sci, Div Internal Med, Danderyd Hosp, Stockholm, Sweden.; Antoniewicz, L (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Div Med Resp Med, Umea, Sweden.	lukasz.antoniewicz@ki.se	Antoniewicz, Lukasz/AAL-8165-2020	Antoniewicz, Lukasz/0000-0001-5969-8165; Bosson Damewood, Jenny/0000-0003-2380-2607	Swedish Heart and Lung foundation; Stockholm City Council; Karolinska Institutet [20140603]; Swedish society of Medicine	Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Stockholm City Council; Karolinska Institutet(Karolinska Institutet); Swedish society of Medicine	This work was supported by The Swedish Heart and Lung foundation (ML) https://www.hjart-lung.se/om-oss/about-us-in-english/; the Stockholm City Council and Karolinska Institutet: 20140603 (ML) https://forskningsstod.vmi.se/Ansokan/showSearchSummary.asp?aNr=20140603; and The Swedish society of Medicine (ML) http://www.sls.se/om-oss/the-swedish-society-of-medicine-in-english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos D, 2008, CLIN EXP PHARMACOL P, V35, P458, DOI 10.1111/j.1440-1681.2008.04896.x; Adamopoulos D, 2009, CLIN EXP PHARMACOL P, V36, P784, DOI 10.1111/j.1440-1681.2009.05141.x; Alam M, 2002, J AM SOC ECHOCARDIOG, V15, P1232, DOI 10.1067/mje.2002.124006; ANDERSSON G, 1994, J ORAL PATHOL MED, V23, P161, DOI 10.1111/j.1600-0714.1994.tb01106.x; [Anonymous], 2015, SWED MATCH N AM MRTP; Arefalk G, 2014, CIRCULATION, V130, P325, DOI 10.1161/CIRCULATIONAHA.113.007252; Arefalk G, 2012, EUR J PREV CARDIOL, V19, P1120, DOI 10.1177/1741826711420003; Badimon L, 1999, THROMB HAEMOSTASIS, V82, P1736; BENOWITZ NL, 1982, J PHARMACOL EXP THER, V221, P368; Boffetta P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3060; Bolinder G, 1998, AM J HYPERTENS, V11, P1153, DOI 10.1016/S0895-7061(98)00137-X; BOLINDER G, 1994, AM J PUBLIC HEALTH, V84, P399, DOI 10.2105/AJPH.84.3.399; Christou DD, 2005, CIRCULATION, V111, P494, DOI 10.1161/01.CIR.0000153864.24034.A6; Delnevo CD, 2012, TOB CONTROL, DOI DOI 10.1136/TOBACCOCONTROL2012 050739; Digard H, 2013, NICOTINE TOB RES, V15, P255, DOI 10.1093/ntr/nts123; Digard H, 2009, NICOTINE TOB RES, V11, P1175, DOI 10.1093/ntr/ntp118; Du XJ, 1999, CARDIOVASC RES, V43, P919, DOI 10.1016/S0008-6363(99)00139-X; Fattinger K, 1997, J PHARMACOL EXP THER, V281, P1238; Gatzka CD, 2001, J HYPERTENS, V19, P2197, DOI 10.1097/00004872-200112000-00013; Gilljam H, 2003, ADDICTION, V98, P1183, DOI 10.1046/j.1360-0443.2003.00379.x; Hansson J, 2014, J INTERN MED, V276, P87, DOI 10.1111/joim.12219; Hansson J, 2009, J INTERN MED, V265, P717, DOI 10.1111/j.1365-2796.2009.02081.x; Hansson J, 2012, EUR J EPIDEMIOL, V27, P771, DOI 10.1007/s10654-012-9704-8; Hayward CS, 1997, J AM COLL CARDIOL, V30, P1863, DOI 10.1016/S0735-1097(97)00378-1; Hering D, 2008, BLOOD PRESSURE, V17, P141, DOI 10.1080/08037050802185780; Hubbard R, 2005, TOB CONTROL, V14, P416, DOI 10.1136/tc.2005.011387; Idris AM, 1998, ORAL ONCOL, V34, P558, DOI 10.1016/S1368-8375(98)00047-5; Ikarugi H, 1999, J APPL PHYSIOL, V86, P133, DOI 10.1152/jappl.1999.86.1.133; Jacobs DR, 1999, ARCH INTERN MED, V159, P733, DOI 10.1001/archinte.159.7.733; Janner JH, 2010, AM J HYPERTENS, V23, P180, DOI 10.1038/ajh.2009.234; Johansson SE, 2005, EUR J CARDIOV PREV R, V12, P387, DOI 10.1097/01.hjr.0000169189.22302.99; Joksic G, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-25; Koskinen J, 2012, ATHEROSCLEROSIS, V224, P474, DOI 10.1016/j.atherosclerosis.2012.04.004; Kubozono T, 2011, CIRC J, V75, P698, DOI 10.1253/circj.CJ-10-0552; LEE BL, 1987, CLIN PHARMACOL THER, V41, P474, DOI 10.1038/clpt.1987.59; Lee PA, 2014, J PEDIATR UROL, V10, P7, DOI 10.1016/j.jpurol.2013.11.006; Lee PN, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-36; Lee PN, 2013, REGUL TOXICOL PHARM, V66, P1, DOI 10.1016/j.yrtph.2013.02.010; Leone A, 2015, CURR PHARM DESIGN, V21, P4370, DOI 10.2174/1381612821666150803145149; Mahmud A, 2003, HYPERTENSION, V41, P183, DOI 10.1161/01.HYP.0000047464.66901.60; Martin JS, 2010, EXP BIOL MED, V235, P1263, DOI 10.1258/ebm.2010.009376; McAdam KG, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-151; Mitchell GF, 2008, HYPERTENSION, V51, P1123, DOI 10.1161/HYPERTENSIONAHA.107.108175; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Njolstad I, 1996, CIRCULATION, V93, P450; Ostenson CG, 2012, SCAND J PUBLIC HEALT, V40, P730, DOI 10.1177/1403494812459814; Peeters S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001506; Popova L, 2013, AM J PUBLIC HEALTH, V103, P923, DOI 10.2105/AJPH.2012.301070; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Raaijmakers E, 1999, CRIT CARE MED, V27, P1203, DOI 10.1097/00003246-199906000-00053; Rohani M, 2004, J INTERN MED, V255, P379, DOI 10.1046/j.1365-2796.2003.01279.x; Russo C, 2012, HYPERTENSION, V60, P362, DOI 10.1161/HYPERTENSIONAHA.112.191148; Rutqvist LE, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-38; SCB, 2014, STAT SWED 2014; Stegmayr B, 2005, SCAND J PUBLIC HEALT, V33, P321, DOI 10.1080/14034940510032301; Stepanov I, 2008, NICOTINE TOB RES, V10, P1773, DOI 10.1080/14622200802443544; Sundstrom D, 2012, CLIN PHYSIOL FUNCT I, V32, P106, DOI 10.1111/j.1475-097X.2011.01062.x; Tanino Y, 2009, CIRC J, V73, P1074, DOI 10.1253/circj.CJ-08-0847; TISDALE JE, 1995, ANN PHARMACOTHER, V29, P269, DOI 10.1177/106002809502900309; TURNER JAM, 1977, BMJ-BRIT MED J, V2, P1387, DOI 10.1136/bmj.2.6099.1387; TVERDAL A, 1993, J CLIN EPIDEMIOL, V46, P475, DOI 10.1016/0895-4356(93)90025-V; Tzivoni D, 1998, CARDIOVASC DRUG THER, V12, P239, DOI 10.1023/A:1007757530765; VANROOIJ JGM, 1993, BRIT J IND MED, V50, P623; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Yang QY, 2015, ENVIRON SCI POLLUT R, V22, P1760, DOI 10.1007/s11356-014-3284-y; Zhu SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079332, 10.1371/journal.pone.0071555]	66	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195493	10.1371/journal.pone.0195493	http://dx.doi.org/10.1371/journal.pone.0195493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668699	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200044
J	Cechova, J; Coufal, J; Jagelska, EB; Fojta, M; Brazda, V				Cechova, Jana; Coufal, Jan; Jagelska, Eva B.; Fojta, Miroslav; Brazda, Vaclav			p73, like its p53 homolog, shows preference for inverted repeats forming cruciforms	PLOS ONE			English	Article							SEQUENCE-SPECIFIC BINDING; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; SUPERCOILED DNA; BREAST-CANCER; MUTANT P53; TRANSACTIVATION; P63; PROTEIN; APOPTOSIS	p73 is a member of the p53 protein family and has essential functions in several signaling pathways involved in development, differentiation, DNA damage responses and cancer. As a transcription factor, p73 achieves these functions by binding to consensus DNA sequences and p73 shares at least partial target DNA binding sequence specificity with p53. Transcriptional activation by p73 has been demonstrated for more than fifty p53 targets in yeast and/or human cancer cell lines. It has also been shown previously that p53 binding to DNA is strongly dependent on DNA topology and the presence of inverted repeats that can form DNA cruciforms, but whether p73 transcriptional activity has similar dependence has not been investigated. Therefore, we evaluated p73 binding to a set of p53-response elements with identical theoretical binding affinity in their linear state, but different probabilities to form extra helical structures. We show by a yeast-based assay that transactivation in vivo correlated more with the relative propensity of a response element to form cruciforms than to its expected in vitro DNA binding affinity. Structural features of p73 target sites are therefore likely to be an important determinant of its transactivation function.	[Cechova, Jana; Coufal, Jan; Jagelska, Eva B.; Fojta, Miroslav; Brazda, Vaclav] Czech Acad Sci, Inst Biophys, Brno, Czech Republic; [Cechova, Jana] Masaryk Univ, Dept Biochem, Fac Sci, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno	Brazda, V (corresponding author), Czech Acad Sci, Inst Biophys, Brno, Czech Republic.	vaclav@ibp.cz	Václav, Brázda/F-9582-2011; Brazda, Vaclav/ABH-9460-2020	Václav, Brázda/0000-0003-2837-4226; Brazda, Vaclav/0000-0003-2837-4226	Grant Agency of the Czech Republic [15-21855S, 18-15548S]; SYMBIT project - ERDF [CZ.02.1.01/0.0/0.0/15_003/0000477]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); SYMBIT project - ERDF	This work was supported by the Grant Agency of the Czech Republic (15-21855S, 18-15548S) and by the SYMBIT project reg. no. CZ.02.1.01/0.0/0.0/15_003/0000477 financed from the ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Grant Agency of the Czech Republic (15-21855S, 18-15548S) and by the SYMBIT project reg. no. CZ.02.1.01/0.0/0.0/15_003/0000477 financed from the ERDF. The authors would like to thank Dr. Philip J. Coates for proofreading and editing the manuscript.	Adamik M, 2015, BIOCHEM BIOPH RES CO, V456, P29, DOI 10.1016/j.bbrc.2014.11.027; Bisso A, 2011, CURR PHARM DESIGN, V17, P578, DOI 10.2174/138161211795222667; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Brazda V, 2000, BIOCHEM BIOPH RES CO, V267, P934, DOI 10.1006/bbrc.1999.2056; Brazda V, 2006, BIOCHEM BIOPH RES CO, V351, P499, DOI 10.1016/j.bbrc.2006.10.065; Brazda V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020375; Brazda V, 2017, BIOCHEM BIOPH RES CO, V483, P516, DOI 10.1016/j.bbrc.2016.12.113; Brazda V, 2016, BIOCHEM BIOPH RES CO, V478, P1739, DOI 10.1016/j.bbrc.2016.09.015; Brazda V, 2012, BIOCHEM BIOPH RES CO, V422, P716, DOI 10.1016/j.bbrc.2012.05.065; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Cechova J, 2018, BIOINFORMATICS, V34, P1081, DOI 10.1093/bioinformatics/btx729; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; Ciribilli Y, 2013, NUCLEIC ACIDS RES, V41, P8637, DOI 10.1093/nar/gkt657; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dominguez G, 2001, BREAST CANCER RES TR, V66, P183, DOI 10.1023/A:1010624717311; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Ethayathulla AS, 2012, P NATL ACAD SCI USA, V109, P6066, DOI 10.1073/pnas.1115463109; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Ichimiya S, 2001, MED PEDIATR ONCOL, V36, P42, DOI 10.1002/1096-911X(20010101)36:1<42::AID-MPO1011>3.0.CO;2-K; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Jagelska EB, 2008, BIOCHEM J, V412, P57, DOI 10.1042/BJ20071648; Jagelska EB, 2010, BIOCHEM BIOPH RES CO, V391, P1409, DOI 10.1016/j.bbrc.2009.12.076; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Levrero M, 2000, J CELL SCI, V113, P1661; Lion M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116177; Lokshin M, 2007, NUCLEIC ACIDS RES, V35, P340, DOI 10.1093/nar/gkl1047; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Orzol P, 2015, HISTOL HISTOPATHOL, V30, P503, DOI 10.14670/HH-30.503; Ozaki T, 1999, CANCER RES, V59, P5902; Palecek E, 2004, ONCOGENE, V23, P2119, DOI 10.1038/sj.onc.1207324; Palecek E, 1997, ONCOGENE, V15, P2201, DOI 10.1038/sj.onc.1201398; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Ramos A, 2015, BIOCHEMISTRY-US, V54, P6961, DOI 10.1021/acs.biochem.5b00152; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Tichy V, 2013, BIOCHEM BIOPH RES CO, V433, P445, DOI 10.1016/j.bbrc.2013.02.097; Todolli S, 2017, BIOPHYS J, V112, P416, DOI 10.1016/j.bpj.2016.11.017; Tozluoglu M, 2008, NUCLEIC ACIDS RES, V36, P5033, DOI 10.1093/nar/gkn481; van Doorn R, 2005, J CLIN ONCOL, V23, P3886, DOI 10.1200/JCO.2005.11.353; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Zaika AI, 1999, CANCER RES, V59, P3257; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195835	10.1371/journal.pone.0195835	http://dx.doi.org/10.1371/journal.pone.0195835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668749	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200060
J	Hsu, J; Donnelly, JP; Chaudhary, NS; Moore, JX; Safford, MM; Kim, J; Wang, HE				Hsu, Joann; Donnelly, John P.; Chaudhary, Ninad S.; Moore, Justin X.; Safford, Monika M.; Kim, Junghyun; Wang, Henry E.			Aspirin use and long-term rates of sepsis: A population-based cohort study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; BIAS REDUCTION; ASSOCIATION; PREVENTION; MORTALITY; DISEASE; CLOPIDOGREL; MANAGEMENT; ADHESION	Objective Sepsis is the syndrome of life-threatening organ dysfunction resulting from dysregulated host response to infection. Aspirin, an anti-inflammatory agent, may play a role in attenuating the inflammatory response during infection. We evaluated the association between aspirin use and long-term rates of sepsis as well as sepsis outcomes. Methods We analyzed data from 30,239 adults >= 45 years old in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. The primary exposure was aspirin use, identified via patient interview. The primary outcome was sepsis hospitalization, defined as admission for infection with two or more systemic inflammatory response syndrome criteria. We fit Cox proportional hazards models assessing the association between aspirin use and rates of sepsis, adjusted for participant demographics, health behaviors, chronic medical conditions, medication adherence, and biomarkers. We used a propensity-matched analysis and a series of sensitivity analyses to assess the robustness of our results. We also examined risk of organ dysfunction and hospital mortality during hospitalization for sepsis. Results Among 29,690 REGARDS participants with follow-up data available, 43% reported aspirin use (n = 12,869). Aspirin users had higher sepsis rates (hazard ratio 1.35; 95% CI: 1.22-1.49) but this association was attenuated following adjustment for potential confounders (adjusted HR 0.99; 95% CI: 0.88-1.12). We obtained similar results in propensity-matched and sensitivity analyses. Among sepsis hospitalizations, aspirin use was not associated with organ dysfunction or hospital death. Conclusions In the REGARDS cohort, baseline aspirin use was not associated with long-term rates of sepsis.	[Hsu, Joann] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Donnelly, John P.; Chaudhary, Ninad S.; Moore, Justin X.; Wang, Henry E.] Univ Alabama Birmingham, Dept Emergency Med, Sch Med, Birmingham, AL 35233 USA; [Donnelly, John P.] Univ Alabama Birmingham, Div Prevent Med, Dept Med, Sch Med, Birmingham, AL USA; [Donnelly, John P.; Chaudhary, Ninad S.; Moore, Justin X.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Safford, Monika M.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Kim, Junghyun; Wang, Henry E.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cornell University; University of Texas System; University of Texas Health Science Center Houston	Wang, HE (corresponding author), Univ Alabama Birmingham, Dept Emergency Med, Sch Med, Birmingham, AL 35233 USA.; Wang, HE (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA.	henry.e.wang@uth.tmc.edu	Chaudhary, NINAD/L-7532-2019	Donnelly, John/0000-0002-0646-9470; Moore, Justin Xavier/0000-0002-5496-752X; Chaudhary, Ninad/0000-0003-1350-1093	National Institute for Nursing Research [R01-NR012726]; National Center for Research Resources [UL1-RR025777]; Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service [U01-NS041588]; National Center For Advancing Translational Sciences of the National Institutes of Health [TL1TR001418]; National Institute of General Medical Sciences [1F31GM122180]; National Cancer Institute [R25-CA4788]; NATIONAL CANCER INSTITUTE [R25CA047888] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417, TL1TR001418] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM122180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012726] Funding Source: NIH RePORTER	National Institute for Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center For Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by award R01-NR012726 from the National Institute for Nursing Research, UL1-RR025777 from the National Center for Research Resources, as well as by grants from the Center for Clinical and Translational Science and the Lister Hill Center for Health Policy of the University of Alabama at Birmingham. The parent REGARDS study was supported by cooperative agreement U01-NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Representatives of the funding agencies have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data. Ms. Hsu received support from TL1TR001418 from the National Center For Advancing Translational Sciences of the National Institutes of Health. Mr. Donnelly received support from 1F31GM122180 from the National Institute of General Medical Sciences. Mr. Moore received grant support from R25-CA4788 funded by the National Cancer Institute.; This study was supported by award R01-NR012726 from the National Institute for Nursing Research, UL1-RR025777 from the National Center for Research Resources, as well as by grants from the Center for Clinical and Translational Science and the Lister Hill Center for Health Policy of the University of Alabama at Birmingham.; The parent REGARDS study was supported by cooperative agreement U01-NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service.; Ms. Hsu received support from TL1TR001418 from the National Center For Advancing Translational Sciences of the National Institutes of Health.; Mr. Donnelly received support from 1F31GM122180 from the National Institute of General Medical Sciences. Mr. Moore received grant support from R25-CA4788 funded by the National Cancer Institute.	Al Harbi SA, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0047-z; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Eisen DP, 2012, CRIT CARE MED, V40, P1761, DOI 10.1097/CCM.0b013e318246b9df; Evangelista V, 2005, THROMB HAEMOSTASIS, V94, P568, DOI 10.1160/TH05-01-0020; Falcone M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001595; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Garcia CC, 2010, DISCOV MED, V10, P479; Gupta RG, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1011-9; Hennekens CH, 2014, TRENDS CARDIOVAS MED, V24, P360, DOI 10.1016/j.tcm.2014.08.006; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Ittaman SV, 2014, CLIN MED RES, V12, P147, DOI 10.3121/cmr.2013.1197; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; McMahon AD, 2003, PHARMACOEPIDEM DR S, V12, P551, DOI 10.1002/pds.883; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; Saracco P, 2011, PEDIATRIC REP, V3, P119, DOI 10.4081/pr.2011.e30; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Satran R, 2003, ISR MED ASSOC J, V5, P516; Schror K, 1997, SEMIN THROMB HEMOST, V23, P349, DOI 10.1055/s-2007-996108; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sossdorf M, 2013, CRIT CARE, V17, DOI 10.1186/cc11886; Toner P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1091-6; Trauer J, 2017, CRIT CARE MED, V45, P1871, DOI 10.1097/CCM.0000000000002654; Tsai MJ, 2015, INTENS CARE MED, V41, P806, DOI 10.1007/s00134-015-3760-y; Valerio-Rojas JC, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/782573; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Wang HE, 2017, CRIT CARE MED, V45, P1443, DOI 10.1097/CCM.0000000000002538; Wang HE, 2016, CRIT CARE MED, V44, P1285, DOI 10.1097/CCM.0000000000001666; Wang HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069232; Wiewel MA, 2016, INTENS CARE MED, V42, P352, DOI 10.1007/s00134-015-4171-9; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x; Zhang QH, 2015, CEREBROVASC DIS, V39, P13, DOI 10.1159/000369778	40	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194829	10.1371/journal.pone.0194829	http://dx.doi.org/10.1371/journal.pone.0194829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668690	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200017
J	Lee, YS; Kim, SW; Han, SW				Lee, Yong Seung; Kim, Sang Woon; Han, Sang Won			Different managements for prepubertal epididymitis based on a preexisting genitourinary anomaly diagnosis	PLOS ONE			English	Article							CHILDREN; BOYS; HYPOSPADIAS	There is no clear consensus regarding investigating for accompanying genitourinary anomalies (GUAs) in patients with prepubertal acute epididymitis (AE). Moreover, risk factors for the recurrence and the need for a surgical intervention have never been discussed. The purpose of this study was to evaluate the different clinical courses of prepubertal AE based on knowledge of preexisting GUAs. Between January 2005 and December 2014, AE was diagnosed in 189 pediatric patients <10 years old. Clinical characteristics and treatments were retrospectively analyzed. The median age at first AE was 64.3 months. A GUA was detected prior to the development of AE in 49 patients (known GUA group) including 34 with hypospadias. Among the other 140 patients (unknown GUA status group), six patients were diagnosed with a GUA after the first AE episode. In the known GUA group, 35 patients (71.4%) experienced recurrence and the only risk factor associated with recurrence was the presence of cystic dilated prostatic utricle (p = 0.013). In the unknown GUA status group, the risk factors for an existing GUA were being <1-year-old (p<0.001) and positive urine culture (p = 0.015). Only nine patients (6.4%) in this group experienced recurrence. Vasectomy was recommended for patients with recurrent AE with an accompanying GUA and performed in 19 patients (10.1%). Most GUAs are diagnosed prior to AE development. Clinicians should consider different treatment approaches based on whether the AE patient has been diagnosed with a GUA previously, because the clinical characteristics and the recurrence rate are significantly different.	[Han, Sang Won] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Han, SW (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea.	swhan@yuhs.ac		Lee, Yong Seung/0000-0003-3778-9888; Han, Sang Won/0000-0003-0941-1300; Kim, Sang Woon/0000-0002-5790-1948				Cappele O, 2000, EUR UROL, V38, P627, DOI 10.1159/000020343; Cristoforo TA, 2021, PEDIATR EMERG CARE, V37, pE1675, DOI 10.1097/PEC.0000000000001018; DEVINE CJ, 1980, J UROLOGY, V123, P407, DOI 10.1016/S0022-5347(17)55959-5; GISLASON T, 1980, J UROLOGY, V124, P533, DOI 10.1016/S0022-5347(17)55528-7; Haecker FM, 2005, EUR J PEDIATR SURG, V15, P180, DOI 10.1055/s-2004-830355; Ikoma F, 2014, UROLOGE, V53, P1344, DOI 10.1007/s00120-014-3597-y; Kajbafzadeh AM, 2011, J PEDIATR UROL, V7, P552, DOI 10.1016/j.jpurol.2010.06.002; Kavoussi P, 2012, CAMPBELL WALSH WEIN, V10th, P67; Kojima Y, 2001, UROLOGY, V57, P1151, DOI 10.1016/S0090-4295(01)00954-2; Merlini E, 1998, SCAND J UROL NEPHROL, V32, P273; Moon SH, 2011, NUCL MED MOLEC IMAG, V45, P291, DOI 10.1007/s13139-011-0108-6; Redshaw JD, 2014, J UROLOGY, V192, P1203, DOI 10.1016/j.juro.2014.04.002; Santillanes G, 2011, PEDIATR EMERG CARE, V27, P174, DOI 10.1097/PEC.0b013e31820d647a; SIEGEL A, 1987, J UROLOGY, V138, P1100, DOI 10.1016/S0022-5347(17)43514-2; Somekh E, 2004, J UROLOGY, V171, P391, DOI 10.1097/01.ju.0000102160.55494.1f	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194761	10.1371/journal.pone.0194761	http://dx.doi.org/10.1371/journal.pone.0194761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668706	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200015
J	Min, B; Zheng, MH				Min, Byungjoon; Zheng, Muhua			Correlated network of networks enhances robustness against catastrophic failures	PLOS ONE			English	Article							COMPLEX NETWORKS; PERCOLATION	Networks in nature rarely function in isolation but instead interact with one another with a form of a network of networks (NoN). A network of networks with interdependency between distinct networks contains instability of abrupt collapse related to the global rule of activation. As a remedy of the collapse instability, here we investigate a model of correlated NoN. We find that the collapse instability can be removed when hubs provide the majority of interconnections and interconnections are convergent between hubs. Thus, our study identifies a stable structure of correlated NoN against catastrophic failures. Our result further suggests a plausible way to enhance network robustness by manipulating connection patterns, along with other methods such as controlling the state of node based on a local rule.	[Min, Byungjoon] Chungbuk Natl Univ, Dept Phys, Cheongju 28644, Chungbuk, South Korea; [Min, Byungjoon; Zheng, Muhua] CUNY City Coll, Levich Inst, New York, NY 10031 USA; [Min, Byungjoon; Zheng, Muhua] CUNY City Coll, Phys Dept, New York, NY 10031 USA; [Zheng, Muhua] East China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China	Chungbuk National University; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); East China Normal University	Min, B (corresponding author), Chungbuk Natl Univ, Dept Phys, Cheongju 28644, Chungbuk, South Korea.; Min, B (corresponding author), CUNY City Coll, Levich Inst, New York, NY 10031 USA.; Min, B (corresponding author), CUNY City Coll, Phys Dept, New York, NY 10031 USA.	min.byungjoon@gmail.com	Zheng, Muhua/AAD-9604-2019	Zheng, Muhua/0000-0002-9811-529X	Chungbuk National University; China Scholarship Council [201506140018]	Chungbuk National University; China Scholarship Council(China Scholarship Council)	This work was supported by the research grant of the Chungbuk National University in 2018. MZ was also supported by the China Scholarship Council for one year study at the City College of New York (Grant No.201506140018).	Baxter GJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248701; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; De Domenico M, 2014, P NATL ACAD SCI USA, V111, P8351, DOI 10.1073/pnas.1318469111; Dong GG, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016112; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Gallos LK, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.248701; Gao JX, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.195701; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/NPHYS1746, 10.1038/nphys1746]; Leicht E. A., 2009, ARXIV09070894; Li W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228702; Little RG, 2002, J URBAN TECHNOL, V9, P109, DOI 10.1080/106307302317379855; Liu QH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25617; Min B, 2018, EUR PHYS J B, V91, DOI 10.1140/epjb/e2017-80597-1; Min B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136831; Min B, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.040802; Min B, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042811; Morone F, 2017, P NATL ACAD SCI USA, V114, P3849, DOI 10.1073/pnas.1620808114; Morone F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30062; Morone F, 2015, NATURE, V524, P65, DOI 10.1038/nature14604; Nicosia V, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032805; Parshani R, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/68002; Parshani R, 2011, P NATL ACAD SCI USA, V108, P1007, DOI 10.1073/pnas.1008404108; Parshani R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.048701; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Pei S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05547; Pei S, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12002; Radicchi F, 2015, NAT PHYS, V11, P597, DOI 10.1038/NPHYS3374; Radicchi F, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021014; Reis SDS, 2014, NAT PHYS, V10, P762, DOI 10.1038/NPHYS3081; Rosato V, 2008, INT J CRIT INFRASTRU, V4, P63, DOI 10.1504/IJCIS.2008.016092; Roth K, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.062308; Son SW, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/16006; Son SW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.195702; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Valdez LD, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050803; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang W, 2016, SCI REP-UK, V6, DOI 10.1038/srep29259; Wang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep05097; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang XY, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.038701; Zhao K, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/05/P05005; Zhou D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066103	45	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195539	10.1371/journal.pone.0195539	http://dx.doi.org/10.1371/journal.pone.0195539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668730	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200047
J	Zhu, JJ; Liu, YG; Yang, CH; Yang, W; Chen, Z; Zhang, Y; Yang, SM; Wu, XD				Zhu, Jiajing; Liu, Yongguo; Yang, Changhong; Yang, Wen; Chen, Zhi; Zhang, Yun; Yang, Shangming; Wu, Xindong			A degree-based block model and a local expansion optimization algorithm for anti-community detection in networks	PLOS ONE			English	Article							COMPLEX; CUT	Anti-community detection in networks can discover negative relations among objects. However, a few researches pay attention to detecting anti-community structure and they do not consider the node degree and most of them require high computational cost. Block models are promising methods for exploring modular regularities, but their results are highly dependent on the observed structure. In this paper, we first propose a Degree-based Block Model (DBM) for anti-community structure. DBM takes the node degree into consideration and evolves a new objective function Q(C) for evaluation. And then, a Local Expansion Optimization Algorithm (LEOA), which preferentially considers the nodes with high degree, is proposed for anti-community detection. LEOA consists of three stages: structural center detection, local anti-community expansion and group membership adjustment. Based on the formulation of DBM, we develop a synthetic benchmark DBM-Net for evaluating comparison algorithms in detecting known anti-community structures. Experiments on DBM-Net with up to 100000 nodes and 17 real-world networks demonstrate the effectiveness and efficiency of LEOA for anti-community detection in networks.	[Zhu, Jiajing; Liu, Yongguo; Chen, Zhi; Zhang, Yun; Yang, Shangming] Univ Elect Sci & Technol China, Sch Informat & Software Engn, Knowledge & Data Engn Lab Chinese Med, Chengdu, Sichuan, Peoples R China; [Yang, Changhong; Yang, Wen] Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China; [Wu, Xindong] Univ Louisiana Lafayette, Sch Comp & Informat, Lafayette, LA 70504 USA	University of Electronic Science & Technology of China; University of Louisiana Lafayette	Liu, YG (corresponding author), Univ Elect Sci & Technol China, Sch Informat & Software Engn, Knowledge & Data Engn Lab Chinese Med, Chengdu, Sichuan, Peoples R China.; Yang, W (corresponding author), Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China.	liuyg@uestc.edu.cn; yangwenn@yeah.net	Wu, Xindong/AAB-6713-2022	Wu, Xindong/0000-0003-2396-1704	National Science and Technology Major Project of the Ministry of Science and Technology of China [2018ZX10715003-002]; National Key Research and Development Program of China [2017YFC1703900]; Sichuan Science and Technology Program [2018PTDJ0084]; US National Science Foundation (NSF) [1652107]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Key Research and Development Program of China; Sichuan Science and Technology Program; US National Science Foundation (NSF)(National Science Foundation (NSF))	This research was supported in part by the National Science and Technology Major Project of the Ministry of Science and Technology of China under grant 2018ZX10715003-002 (WY), the National Key Research and Development Program of China under grant 2017YFC1703900 (SY), the Sichuan Science and Technology Program under grant 2018PTDJ0084 (YL), and the US National Science Foundation (NSF) under grant 1652107 (XW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon N, 2000, COMB PROBAB COMPUT, V9, P1, DOI 10.1017/S0963548399004071; [Anonymous], NETWORK DATA NEWMANS; Ball B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036103; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chen L, 2014, INFORM SCIENCES, V275, P293, DOI 10.1016/j.ins.2014.02.040; da Cunha BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142824; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; He DX, 2015, AAAI CONF ARTIF INTE, P130; He JY, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S19; Holme P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056107; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Latouche P, 2011, ANN APPL STAT, V5, P309, DOI 10.1214/10-AOAS382; Miyauchi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147805; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ren W, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036111; Sankowska A, 2016, PHYSICA A, V443, P309, DOI 10.1016/j.physa.2015.09.058; Shen HW, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056111; Trevisan L, 2012, SIAM J COMPUT, V41, P1769, DOI 10.1137/090773714; Wang F., 2008, THESIS; Wu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126845; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	32	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195226	10.1371/journal.pone.0195226	http://dx.doi.org/10.1371/journal.pone.0195226			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668688	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200033
J	Ander, M; Cederberg, JT; von Essen, L; Hoven, E				Ander, Malin; Cederberg, Jenny Thorsell; von Essen, Louise; Hoven, Emma			Exploration of psychological distress experienced by survivors of adolescent cancer reporting a need for psychological support	PLOS ONE			English	Article							QUALITATIVE CONTENT-ANALYSIS; YOUNG-ADULT SURVIVORS; LONG-TERM SURVIVORS; POSTTRAUMATIC STRESS; CHILDHOOD-CANCER; OF-LIFE; DSM-IV; ANXIETY; DEPRESSION; DISORDERS	Objective In this qualitative study, we aimed to provide an in-depth exploration of cancer-related psychological distress experienced by young survivors of cancer during adolescence reporting a need for psychological support. Methods Two individual interviews were held with ten young survivors of cancer diagnosed in adolescence. The interviews were audio-recorded and transcribed verbatim. Analysis followed the guidelines for inductive qualitative manifest content analysis. Results The survivors described distress experienced during and after the end of treatment. Five categories comprising 14 subcategories were generated. The categories included: A tough treatment, Marked and hindered, Not feeling good enough, Struggling with the fragility of life, and finally, An ongoing battle with emotions. Conclusion Young survivors of adolescent cancer reporting a need for psychological support described feeling physically, socially, and mentally marked by the cancer experience. They struggled with powerlessness, insecurity, social disconnection, loneliness, and feelings of being unimportant and a failure, and had difficulties understanding and managing their experiences. These concerns should be addressed in psychological treatments for the population irrespective of which approach or model is used to understand survivors' difficulties. A transdiagnostic approach targeting processes that underpin different manifestations of distress may be effective.	[Ander, Malin; von Essen, Louise; Hoven, Emma] Uppsala Univ, Dept Womens & Childrens Hlth, Clin Psychol Healthcare, Uppsala, Sweden; [Cederberg, Jenny Thorsell] Uppsala Univ, Dept Womens & Childrens Hlth, Pediat Oncol, Uppsala, Sweden	Uppsala University; Uppsala University	Ander, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Clin Psychol Healthcare, Uppsala, Sweden.	malin.ander@kbh.uu.se			Barncancerfonden (The Swedish Childhood Cancer Foundation) [2016-0004, 20130039]; Vetenskapsradet (The Swedish Research Council): SF0 grant; Uppsala University; U-CARE research programme at Uppsala University; Swedish Childhood Cancer Foundation	Barncancerfonden (The Swedish Childhood Cancer Foundation); Vetenskapsradet (The Swedish Research Council): SF0 grant; Uppsala University; U-CARE research programme at Uppsala University; Swedish Childhood Cancer Foundation(European Commission)	This work was supported by the Barncancerfonden (The Swedish Childhood Cancer Foundation): grant numbers 2016-0004, 20130039, (https://www.barncancerfonden.se/ent/for-researchers/) to LvE adn the Vetenskapsradet (The Swedish Research Council): SF0 grant to the research programme U-CARE, Uppsala University (no grant number), (https://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152html) to LvE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the participating young survivors for sharing their stories. We also wish to acknowledge the U-CARE research programme at Uppsala University and the Swedish Childhood Cancer Foundation for financially supporting this study.	Abrams AN, 2007, CANCER TREAT REV, V33, P622, DOI 10.1016/j.ctrv.2006.12.006; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5; Ander M, 2016, PSYCHO-ONCOLOGY, V25, P582, DOI 10.1002/pon.3965; [Anonymous], 1986, World Health Organ Tech Rep Ser, V731, P1; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Carter-Sowell AR, 2008, SOC INFLUENCE, V3, P143, DOI 10.1080/15534510802204868; Chango JM, 2015, J RES ADOLESCENCE, V25, P685, DOI 10.1111/jora.12162; Compas BE, 2014, HEALTH PSYCHOL, V33, P853, DOI 10.1037/hea0000083; Compas BE, 2012, ANNU REV CLIN PSYCHO, V8, P455, DOI 10.1146/annurev-clinpsy-032511-143108; Corrigan, 2014, STIGMA DIS DISABILIT, P165, DOI DOI 10.1037/14297-009; Craig P, 2013, INT J NURS STUD, V50, P587, DOI 10.1016/j.ijnurstu.2012.09.010; Crawshaw MA, 2010, EUR J CANCER CARE, V19, P610, DOI 10.1111/j.1365-2354.2009.01118.x; Dieluweit U, 2011, KLIN PADIATR, V223, P152, DOI 10.1055/s-0031-1271779; Doukkali EB, 2013, CANCER NURS, V36, P400, DOI 10.1097/NCC.0b013e31829fd80e; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Erikson E.H., 1968, IDENTITY YOUTH CRISI; Frank R. I., 2014, TRANSDIAGNOSTIC ROAD; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grinyer A, 2007, CHRONIC ILLN, V3, P265, DOI 10.1177/1742395307085335; Harvey A., 2004, COGNITIVE BEHAV PROC; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Howell D, 2011, CURR ONCOL, V18, P208; Jacobson NS, 2001, CLIN PSYCHOL-SCI PR, V8, P255, DOI 10.1093/clipsy/8.3.255; Kazak AE, 2010, J CLIN ONCOL, V28, P2002, DOI 10.1200/JCO.2009.25.9564; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; Larsson G, 2010, EUR J CANCER, V46, P1062, DOI 10.1016/j.ejca.2010.01.021; Lehmann V, 2014, PSYCHO-ONCOLOGY, V23, P1229, DOI 10.1002/pon.3549; Lewis P, 2013, J PEDIATR ONCOL NURS, V30, P311, DOI 10.1177/1043454213513839; MARCIA JE, 1966, J PERS SOC PSYCHOL, V3, P551, DOI 10.1037/h0023281; Meerwijk EL, 2011, J LOSS TRAUMA, V16, P402, DOI 10.1080/15325024.2011.572044; Meidlinger PC, 2014, WILEY BLACKWELL HANDBOOK OF SOCIAL ANXIETY DISORDER, P223; Ollendick TH, 2002, BIOL PSYCHIAT, V51, P44, DOI 10.1016/S0006-3223(01)01305-1; Palmer Susan, 2007, Palliat Support Care, V5, P127; Phipps S, 2014, J CLIN ONCOL, V32, P641, DOI 10.1200/JCO.2013.49.8212; Robichaud M, 2013, COGN BEHAV PRACT, V20, P251, DOI 10.1016/j.cbpra.2012.09.001; Sales J.M., 2013, HDB ADOLESCENT HLTH, DOI [10.1007/978-1-4614-6633-8_2, DOI 10.1007/978-1-4614-6633-8_2, DOI 10.1007/978-1-4614-6633-8]; Sauter FM, 2009, CLIN CHILD FAM PSYCH, V12, P310, DOI 10.1007/s10567-009-0058-z; Seitz DCM, 2010, EUR J CANCER, V46, P1596, DOI 10.1016/j.ejca.2010.03.001; Seitz DCM, 2009, PSYCHO-ONCOLOGY, V18, P683, DOI 10.1002/pon.1473; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Svedberg P, 2016, EUR J ONCOL NURS, V21, P105, DOI 10.1016/j.ejon.2016.02.008; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wallace ML, 2007, PSYCHO-ONCOLOGY, V16, P1019, DOI 10.1002/pon.1176; Weathers F. W., 1993, ANN M INT SOC TRAUM, DOI [10.1037/t02622-000, DOI 10.1037/T02622-000]; Weems CF, 2006, J AFFECT DISORDERS, V91, P113, DOI 10.1016/j.jad.2006.01.009; Wicks L, 2010, EUR J CANCER CARE, V19, P778, DOI 10.1111/j.1365-2354.2009.01139.x; Wong J, 2014, WILEY BLACKWELL HANDBOOK OF SOCIAL ANXIETY DISORDER, P3; Yalom I.D., 1980, EXISTENTIAL PSYCHOTH	52	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195899	10.1371/journal.pone.0195899	http://dx.doi.org/10.1371/journal.pone.0195899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664926	gold, Green Published, Green Submitted			2022-12-27	WOS:000430262300041
J	Marco, A				Marco, Antonio			SeedVicious: Analysis of microRNA target and near-target sites	PLOS ONE			English	Article							SELECTION; FAMILY	Here I describe seedVicious, a versatile microRNA target site prediction software that can be easily fitted into annotation pipelines and run over custom datasets. SeedVicious finds microRNA canonical sites plus other, less efficient, target sites. Among other novel features, seedVicious can compute evolutionary gains/losses of target sites using maximum parsimony, and also detect near-target sites, which have one nucleotide different from a canonical site. Near-target sites are important to study population variation in microRNA regulation. Some analyses suggest that near-target sites may also be functional sites, although there is no conclusive evidence for that, and they may actually be target alleles segregating in a population. SeedVicious does not aim to outperform but to complement existing microRNA prediction tools. For instance, the precision of TargetScan is almost doubled (from 11% to similar to 20%) when we filter predictions by the distance between target sites using this program. Interestingly, two adjacent canonical target sites are more likely to be present in bona fide target transcripts than pairs of target sites at slightly longer distances. The software is written in Perl and runs on 64-bit Unix computers (Linux and MacOS X). Users with no computing experience can also run the program in a dedicated web-server by uploading custom data, or browse pre-computed predictions. SeedVicious and its associated web-server and database (SeedBank) are distributed under the GPL/GNU license.	[Marco, Antonio] Univ Essex, Sch Biol Sci, Colchester, Essex, England	University of Essex	Marco, A (corresponding author), Univ Essex, Sch Biol Sci, Colchester, Essex, England.	amarco.bio@gmail.com	Marco, Antonio/N-1594-2019	Marco, Antonio/0000-0002-8603-7503	Wellcome Trust [200585/Z/16/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Wellcome Trust to Antonio Marco [grant number 200585/Z/16/Z]; funders website: https://wellcome.ac.uk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This software would not have been made publicly available without the encouragement and support of my colleagues, in particular Mohab Helmy and Sam Griffiths-Jones. I am also grateful to M. Helmy and Andrea Hatlen for discussion, to Roman Cheplyaka for feedback on the program, to Stuart Newman for his invaluable help setting up the web-server, and to the various anonymous reviewers (some more anonymous than others) for helpful comments and suggestions. This work was supported by the Wellcome Trust [grant number 200585/Z/16/Z].	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Clifton BD, 2017, MOL BIOL EVOL, V34, P51, DOI 10.1093/molbev/msw212; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Denzler R, 2016, MOL CELL, V64, P565, DOI 10.1016/j.molcel.2016.09.027; Felsenstein J, 2004, INFERRING PHYLOGENIE; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HOFACKER IL, 2009, CURR PROTOC BIOINFOR, pCH12, DOI DOI 10.1002/0471250953.BI1202S26; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marco A, 2015, G3-GENES GENOM GENET, V5, P2199, DOI 10.1534/g3.115.019497; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pinzon N, 2016, GENOME RES; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Zhang CL, 2013, NUCLEIC ACIDS RES, V41, P6793, DOI 10.1093/nar/gkt421	23	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195532	10.1371/journal.pone.0195532	http://dx.doi.org/10.1371/journal.pone.0195532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664927	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000430262300021
J	Gribsholt, SB; Pedersen, L; Richelsen, B; Dekkers, O; Thomsen, RW				Gribsholt, Sigrid Bjerge; Pedersen, Lars; Richelsen, Bjorn; Dekkers, Olaf; Thomsen, Reimar Wernich			Body Mass Index of 92,027 patients acutely admitted to general hospitals in Denmark: Associated clinical characteristics and 30-day mortality	PLOS ONE			English	Article							OBESITY PARADOX; RISK; POPULATION; FRACTURE; DISEASE; WOMEN; OVERWEIGHT; ASTHMA; BONE; OSTEOPOROSIS	Background Data are sparse on the range of BMI among patients acutely admitted to general hospitals. We investigated BMI values and associated patient characteristics, reasons for hospital admission, and mortality in Denmark. Methods We identified all persons with an acute inpatient admission 2011-2014 in Central Denmark Region and assessed BMI measurements recorded in the Clinical Information System. We used cross-sectional and cohort analyses to examine the BMI distribution and its association with demographic characteristics, comorbidities, medication use, tobacco smoking, reasons for admission, and 30-day mortality. Results Among 92,027 acutely admitted patients (median age 62 years, 49% female) with a BMI measurement, 4% had a BMI (kg/m(2)) < 18.5, 42% a BMI between 18.5 and 25, 34% a BMI between 25 and 30, and 20% a BMI >= 30. Compared with normal-weight patients, 30-day mortality was high among patients with BMI < 18.5 (7.5% vs. 2.8%, age-and smoking-adjusted odds ratio (aOR) 2.4; 95% confidence interval (CI): 2.0-2.9, whereas patients with overweight (aOR 0.7; 95% CI: 0.6-0.8) and obesity class I (aOR 0.8; 95% CI: 0.6-0.9)). Compared with the total population, patients with BMI < 18.5 were older (68 years median); more were female (73%); more had comorbidities (Charlson Comorbidity Index score > 0 in 42% vs. 33% overall), more were current smokers (45% vs. 27% overall), and acute admissions due to respiratory diseases or femoral fractures were frequent. In contrast, patients with BMI >= 30 were relatively young (59 years median), fewer smoked (24%): type 2 diabetes, sleep disorders, cholelithiasis, and heart failure were frequent diagnoses. Prevalence of therapies for metabolic syndrome, pain, and psychiatric disorders increased with higher BMI, while patients with BMI < 18.5 frequently used asthma medications, glucocorticoids, and antibiotics. Conclusion In patients acutely admitted to general hospitals, reasons for hospital admission and associated clinical characteristics differ substantially according to BMI range. BMI < 18.5 is a clinical predictor of high short-term mortality.	[Gribsholt, Sigrid Bjerge; Pedersen, Lars; Dekkers, Olaf; Thomsen, Reimar Wernich] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Gribsholt, Sigrid Bjerge; Richelsen, Bjorn] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Dekkers, Olaf] Leiden Univ, Med Ctr, Dept Clin Epidemiol & Internal Med, Leiden, Netherlands	Aarhus University; Aarhus University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gribsholt, SB (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.; Gribsholt, SB (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark.	sigrid.bjerge.gribsholt@ph.au.dk		Richelsen, Bjoern/0000-0001-8886-9736; Gribsholt, Sigrid Bjerge/0000-0002-8681-6822; Thomsen, Reimar/0000-0001-9135-3474	Department of Clinical Epidemiology, Aarhus University Hospital; Program for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation	Department of Clinical Epidemiology, Aarhus University Hospital; Program for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation(Lundbeckfonden)	The current research was supported by the Department of Clinical Epidemiology, Aarhus University Hospital and the Program for Clinical Research Infrastructure (PROCRIN) established by the Novo Nordisk Foundation and the Lundbeck Foundation to SBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2016, JAMA-J AM MED ASSOC, V315, P1989, DOI 10.1001/jama.2016.4666; [Anonymous], 2014, OBESITY, V22, pS41, DOI 10.1002/oby.20660; Appari A, 2013, HEALTH SERV RES, V48, P354, DOI 10.1111/j.1475-6773.2012.01448.x; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Barba R, 2015, J STROKE CEREBROVASC, V24, P766, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.002; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Coats AJS, 2017, INT J CARDIOL, V235, P33, DOI 10.1016/j.ijcard.2017.02.136; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Dicker D, 2016, EUR J INTERN MED, V32, P43, DOI 10.1016/j.ejim.2016.03.029; Doehner W, 2010, EUR HEART J, V31, P146, DOI 10.1093/eurheartj/ehp339; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Fisher-Hoch SP, 2013, TROP MED INT HEALTH, V18, P1510, DOI 10.1111/tmi.12206; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gho JMIH, 2018, BMJ OPEN, V8; Halldin CN, 2015, CHRON RESP DIS, V12, P47, DOI 10.1177/1479972314562409; Harpsoe MC, 2016, AM J EPIDEMIOL, V183, P1008, DOI 10.1093/aje/kwv300; Jaramillo JD, 2015, ANN AM THORAC SOC, V12, P648, DOI 10.1513/AnnalsATS.201412-591OC; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P13, DOI 10.2147/CLEP.S26958; Kaspersen KA, 2015, EPIDEMIOLOGY, V26, P580, DOI 10.1097/EDE.0000000000000301; Kornum JB, 2010, EUR RESPIR J, V36, P1330, DOI 10.1183/09031936.00184209; Krasagakis K, 2011, CLIN EXP DERMATOL, V36, P351, DOI 10.1111/j.1365-2230.2010.03978.x; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Lau DH, 2017, CIRCULATION, V136, P583, DOI 10.1161/CIRCULATIONAHA.116.023163; Leth RA, 2009, ACTA OBSTET GYN SCAN, V88, DOI 10.1080/00016340903147405; Liu Y, 2015, RESP MED, V109, P851, DOI 10.1016/j.rmed.2015.05.006; Lokkegaard EL, 2004, ACTA OBSTET GYN SCAN, V83, P476, DOI 10.1111/j.0001-6349.2004.00376.x; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Ng SSS, 2015, CHEST, V148, P1193, DOI 10.1378/chest.14-3016; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Phung DT, 2013, OBES REV, V14, P839, DOI 10.1111/obr.12055; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Prieto-Alhambra D, 2014, J BONE MINER RES, V29, P1737, DOI 10.1002/jbmr.2209; Prieto-Alhambra D, 2014, J BONE MINER RES, V29, P268, DOI 10.1002/jbmr.2011; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Roth J, 2009, JAMA-J AM MED ASSOC, V301, P2586, DOI 10.1001/jama.2009.930; Sakr Y, 2015, CRIT CARE MED, V43, P2623, DOI 10.1097/CCM.0000000000001310; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2015, INT J CARDIOL, V187, P462, DOI 10.1016/j.ijcard.2015.03.328; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shapses SA, 2006, J NUTR, V136, P1453, DOI 10.1093/jn/136.6.1453; Shen GS, 2015, INJURY, V46, P1333, DOI 10.1016/j.injury.2015.04.008; Stovitz SD, 2017, CAN J CARDIOL; The Danish Health and Medicines Authorities National Institute of Public Health, 2018, TAL FRA NAT SUNDH 20; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Wang Q, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2549-9; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wogelius P, 2005, EUR J EPIDEMIOL, V20, P17, DOI 10.1007/s10654-004-1501-6; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yang S, 2015, OSTEOPOROSIS INT, V26, P1381, DOI 10.1007/s00198-014-3009-6; Zeng FF, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007784, 10.1097/md.0000000000007784]	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195853	10.1371/journal.pone.0195853	http://dx.doi.org/10.1371/journal.pone.0195853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659630	gold, Green Published			2022-12-27	WOS:000430061100037
J	Hirai, S; Yokoyama, E; Wakui, T; Ishige, T; Nakamura, M				Hirai, Shinichiro; Yokoyama, Eiji; Wakui, Taku; Ishige, Taichiro; Nakamura, Masaki			Enterohemorrhagic Escherichia coli O157 subclade 8b strains in Chiba Prefecture, Japan, produced larger amounts of Shiga toxin 2 than strains in subclade 8a and other clades (vol 13, e0191834, 2018)	PLOS ONE			English	Correction																		Hirai S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191834	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0196027	10.1371/journal.pone.0196027	http://dx.doi.org/10.1371/journal.pone.0196027			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659632	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100047
J	Blanc-Durand, P; Van der Gucht, A; Schaefer, N; Itti, E; Prior, JO				Blanc-Durand, Paul; Van der Gucht, Axel; Schaefer, Niklaus; Itti, Emmanuel; Prior, John O.			Automatic lesion detection and segmentation of F-18-FET PET in gliomas: A full 3D U-Net convolutional neural network study	PLOS ONE			English	Article							BRAIN; DIAGNOSIS	Introduction Amino-acids positron emission tomography (PET) is increasingly used in the diagnostic workup of patients with gliomas, including differential diagnosis, evaluation of tumor extension, treatment planning and follow-up. Recently, progresses of computer vision and machine learning have been translated for medical imaging. Aim was to demonstrate the feasibility of an automated F-18-fluoro-ethyl-tyrosine (F-18-FET) PET lesion detection and segmentation relying on a full 3D U-Net Convolutional Neural Network (CNN). Methods All dynamic F-18-FET PET brain image volumes were temporally realigned to the first dynamic acquisition, coregistered and spatially normalized onto the Montreal Neurological Institute template. Ground truth segmentations were obtained using manual delineation and thresholding (1.3 x background). The volumetric CNN was implemented based on a modified Keras implementation of a U-Net library with 3 layers for the encoding and decoding paths. Dice similarity coefficient (DSC) was used as an accuracy measure of segmentation. Results Thirty-seven patients were included (26 [70%] in the training set and 11 [30%] in the validation set). All 11 lesions were accurately detected with no false positive, resulting in a sensitivity and a specificity for the detection at the tumor level of 100%. After 150 epochs, DSC reached 0.7924 in the training set and 0.7911 in the validation set. After morphological dilatation and fixed thresholding of the predicted U-Net mask a substantial improvement of the DSC to 0.8231 (+ 4.1%) was noted. At the voxel level, this segmentation led to a 0.88 sensitivity [95% CI, 87.1 to, 88.2%] a 0.99 specificity [99.9 to 99.9%], a 0.78 positive predictive value: [76.9 to 78.3%], and a 0.99 negative predictive value [99.9 to 99.9%]. Conclusions With relatively high performance, it was proposed the first full 3D automated procedure for segmentation of F-18-FET PET brain images of patients with different gliomas using a U-Net CNN architecture.	[Blanc-Durand, Paul; Itti, Emmanuel] Henri Mondor Univ Hosp, Dept Nucl Med, Creteil, France; [Blanc-Durand, Paul; Van der Gucht, Axel; Schaefer, Niklaus; Prior, John O.] Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Blanc-Durand, P (corresponding author), Henri Mondor Univ Hosp, Dept Nucl Med, Creteil, France.; Blanc-Durand, P; Van der Gucht, A (corresponding author), Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland.	paul.blancdurand@gmail.com; axel.vandergucht@gmail.com	PRIOR, John O/I-5364-2017	PRIOR, John O/0000-0003-1429-1374; Schaefer, Niklaus/0000-0002-9732-7696; Itti, Emmanuel/0000-0003-1578-4058	Lionel Perrier Foundation (Montreux, Switzerland)	Lionel Perrier Foundation (Montreux, Switzerland)	The PET data acquisition was supported by a grant from the Lionel Perrier Foundation (Montreux, Switzerland). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Bette S, 2016, WORLD NEUROSURG, V89, P230, DOI 10.1016/j.wneu.2016.01.085; Borght TV, 2006, EUR J NUCL MED MOL I, V33, P1374, DOI 10.1007/s00259-006-0206-3; Breen SL, 2007, INT J RADIAT ONCOL, V68, P763, DOI 10.1016/j.ijrobp.2006.12.039; Buvat I, 2017, J NUCL MED, V58; C Nioche, 2016, MEADECINE NUCLEAAIRE, V40, P208, DOI DOI 10.1016/j.mednuc.2016.03.107; Ceccon G, 2017, NEURO-ONCOLOGY, V19, P281, DOI 10.1093/neuonc/now149; Cho J, 2015, ARXIV151106348; Christ Patrick Ferdinand, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P415, DOI 10.1007/978-3-319-46723-8_48; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Dunet V, 2016, NEURO-ONCOLOGY, V18, P426, DOI 10.1093/neuonc/nov148; Filss CP, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0316-x; Gempt J, 2015, WORLD NEUROSURG, V84, P1790, DOI 10.1016/j.wneu.2015.07.067; Goodfellow I.J., 2014, PROC NEURAL INFORM P, DOI DOI 10.1002/RCS.128; Hatt M, 2017, MED PHYS, V44, pE1, DOI 10.1002/mp.12124; Jansen NL, 2012, NEURO-ONCOLOGY, V14, P1473, DOI 10.1093/neuonc/nos259; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; la Fougere C, 2011, NEURO-ONCOLOGY, V13, P806, DOI 10.1093/neuonc/nor054; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Pisano ED, 1998, J DIGIT IMAGING, V11, P193, DOI 10.1007/BF03178082; Popperl G, 2007, EUR J NUCL MED MOL I, V34, P1933, DOI 10.1007/s00259-007-0534-y; Popperl G, 2004, EUR J NUCL MED MOL I, V31, P1464, DOI 10.1007/s00259-004-1590-1; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sasanelli M, 2014, EUR J NUCL MED MOL I, V41, P2017, DOI 10.1007/s00259-014-2822-7; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Suchorska B, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.2058; Wang Jason, 2017, TECHNICAL REPORT; Weller M, 2013, LANCET ONCOL, V14, pE370, DOI 10.1016/S1470-2045(13)70168-2	28	72	73	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195798	10.1371/journal.pone.0195798	http://dx.doi.org/10.1371/journal.pone.0195798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652908	Green Submitted, gold, Green Published			2022-12-27	WOS:000430026900036
J	Calles-Escandon, J; Koch, KL; Hasler, WL; Van Natta, ML; Pasricha, PJ; Tonascia, J; Parkman, HP; Hamilton, F; Herman, WH; Basina, M; Buckingham, B; Earle, K; Kirkeby, K; Hairston, K; Bright, T; Rothberg, AE; Kraftson, AT; Siraj, ES; Subauste, A; Lee, LA; Abell, TL; McCallum, RW; Sarosiek, I; Nguyen, L; Fass, R; Snape, WJ; Vaughn, IA; Miriel, LA; Farrugia, G				Calles-Escandon, Jorge; Koch, Kenneth L.; Hasler, William L.; Van Natta, Mark L.; Pasricha, Pankaj J.; Tonascia, James; Parkman, Henry P.; Hamilton, Frank; Herman, William H.; Basina, Marina; Buckingham, Bruce; Earle, Karen; Kirkeby, Kjersti; Hairston, Kristen; Bright, Tamis; Rothberg, Amy E.; Kraftson, Andrew T.; Siraj, Elias S.; Subauste, Angela; Lee, Linda A.; Abell, Thomas L.; McCallum, Richard W.; Sarosiek, Irene; Nguyen, Linda; Fass, Ronnie; Snape, William J.; Vaughn, Ivana A.; Miriel, Laura A.; Farrugia, Gianrico		NIDDK Gastroparesis Clinical Re	Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study	PLOS ONE			English	Article							UPPER GASTROINTESTINAL DISORDERS; COMPLICATIONS TRIAL/EPIDEMIOLOGY; GLYCEMIC CONTROL; HYPERGLYCEMIA; SYMPTOMS; MELLITUS; INTERVENTIONS; VALIDATION; SEVERITY; MEAL	Erratic blood glucose levels can be a cause and consequence of delayed gastric emptying in patients with diabetes. It is unknown if better glycemic control increases risks of hypoglycemia or improves hemoglobin A1c levels and gastrointestinal symptoms in diabetic gastroparesis. This study investigated the safety and potential efficacy of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) in poorly controlled diabetes with gastroparesis. Forty-five type 1 or 2 patients with diabetes and gastroparesis and hemoglobin A1c > 8% from the NIDDK Gastroparesis Consortium enrolled in a 24 week open-label pilot prospective study of CSII plus CGM. The primary safety outcome was combined numbers of mild, moderate, and severe hypoglycemic events at screening and 24 weeks treatment. Secondary outcomes included glycemic excursions on CGM, hemoglobin A1c, gastroparesis symptoms, quality-of-life, and liquid meal tolerance. Combined mild, moderate, and severe hypoglycemic events occurred similarly during the screening/run-in (1.9/week) versus treatment (2.2/week) phases with a relative risk of 1.18 (95% CI 0.85-1.64, P = 0.33). CGM time in hypoglycemia (< 70 mg/dL) decreased from 3.9% to 1.8% (P<0.0001), time in euglycemia (70-180 mg/dL) increased from 44.0% to 52.0% (P = 0.02), time in severe hyperglycemia (> 300 mg/dL) decreased from 14.2% to 7.0% (P = 0.005), and hemoglobin A1c decreased from 9.4 +/- 1.4% to 8.3 +/- 1.3% (P = 0.001) on CSII plus CGM. Symptom scores decreased from 29.3 +/- 7.1 to 21.9 +/- 10.2 with lower nausea/vomiting, fullness/early satiety, and bloating/distention scores (P <= 0.001). Quality-of-life scores improved from 2.4 +/- 1.1 to 3.1 +/- 1.1 (P<0.0001) and volumes of liquid nutrient meals tolerated increased from 420 +/- 258 to 487 +/- 312 mL (P = 0.05) at 24 weeks. In conclusion, CSII plus CGM appeared to be safe with minimal risks of hypoglycemic events and associated improvements in glycemic control, gastroparesis symptoms, quality-of-life, and meal tolerance in patients with poorly controlled diabetes and gastroparesis. This study supports the safety, feasibility, and potential benefits of improving glycemic control in diabetic gastroparesis.	[Calles-Escandon, Jorge] Case Western Reserve Univ, Endocrinol Sect, MetroHlth Reg, Cleveland, OH 44106 USA; [Koch, Kenneth L.] Wake Forest Univ, Sect Gastroenterol, Winston Salem, NC 27109 USA; [Hasler, William L.] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Van Natta, Mark L.; Vaughn, Ivana A.; Miriel, Laura A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Van Natta, Mark L.; Tonascia, James; Vaughn, Ivana A.; Miriel, Laura A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Pasricha, Pankaj J.; Lee, Linda A.] Johns Hopkins Sch Med, Sect Gastroenterol, Baltimore, MD USA; [Parkman, Henry P.] Temple Univ, Sch Med, Sect Gastroenterol, Philadelphia, PA USA; [Hamilton, Frank] Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD USA; [Herman, William H.; Rothberg, Amy E.; Kraftson, Andrew T.] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Basina, Marina; Buckingham, Bruce] Stanford Univ, Sch Med, Div Pediat Endocrinol, Palo Alto, CA 94304 USA; [Earle, Karen; Kirkeby, Kjersti] Calif Pacific Med Ctr, Div Endocrinol, San Francisco, CA USA; [Hairston, Kristen] Wake Forest Univ, Sect Endocrinol, Winston Salem, NC 27109 USA; [Bright, Tamis] Texas Tech Univ, Sch Med, Div Endocrinol Diabet & Metab, El Paso, TX USA; [Siraj, Elias S.] Temple Univ, Sch Med, Sect Endocrinol, Philadelphia, PA USA; [Subauste, Angela] Univ Mississippi, Div Endocrinol, Jackson, MS 39216 USA; [Abell, Thomas L.] Univ Louisville, Sch Med, Div Gastroenterol, Louisville, KY 40292 USA; [McCallum, Richard W.; Sarosiek, Irene] Texas Tech Univ, Sch Med, Sect Gastroenterol, El Paso, TX USA; [Nguyen, Linda] Stanford Univ, Sch Med, Div Gastroenterol, Palo Alto, CA 94304 USA; [Fass, Ronnie] Case Western Reserve Univ, Gastroenterol Div, MetroHlth Reg, Cleveland, OH 44106 USA; [Snape, William J.] Calif Pacific Med Ctr, Div Gastroenterol, San Francisco, CA USA; [Farrugia, Gianrico] Mayo Clin, Sect Gastroenterol, Rochester, MN USA	Case Western Reserve University; Wake Forest University; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan; Stanford University; California Pacific Medical Center; Wake Forest University; Texas Tech University System; Texas Tech University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Mississippi; University of Louisville; Texas Tech University System; Texas Tech University; Stanford University; Case Western Reserve University; California Pacific Medical Center; Mayo Clinic	Hasler, WL (corresponding author), Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA.	whasler@umich.edu	Basina, Marina/GSM-9201-2022; Siraj, Elias/S-8152-2019	Buckingham, Bruce/0000-0003-4581-4887; ROTHBERG, AMY/0000-0002-0243-9135; Kraftson, Andrew/0000-0002-8860-2588; Hasler, William/0000-0002-6158-2871	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01DK073983, U01DK073975, U01DK074035, U01DK074007, U01DK073985, U01DK073974, U01DK074008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, U01DK074008, U24DK074008, P30DK020572, U01DK074035, U01DK112193] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All funding for this study was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(www.niddk.nih.gov) as part of the funding for the Gastroparesis Clinical Research Consortium including grant numbers U01DK073983 (California Pacific Medical Center-KE KK WJS, Johns Hopkins University-PJP, Stanford University-MB BB LN), U01DK073985 (MetroHealth Medical Center-JCE RF), U01DK073975 (Temple University-HPP ESS), U01DK074035 (Texas Tech Health Sciences Center-TB RWM IS), U01DK074007 (University of Louisville-TLA, University of Mississippi-AS), U01DK073985 (University of Michigan-WLH WHH AER ATK), U01DK073974 (Wake Forest University-KLK KH), U01DK074008 (Mayo Clinic College of Medicine-GF, Johns Hopkins University Bloomberg School of Public Health-MLV JT LAL IAV LAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2014, DIABETES CARE, V37, P17, DOI 10.2337/dc13-2251; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; [Anonymous], 1995, DIABETES, V44, P968; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bharucha AE, 2015, GASTROENTEROLOGY, V149, P330, DOI 10.1053/j.gastro.2015.05.007; Bharucha AE, 2015, CLIN GASTROENTEROL H, V13, P466, DOI 10.1016/j.cgh.2014.06.034; Bytzer P, 2002, AM J GASTROENTEROL, V97, P604; Camilleri M, 1996, ENDOCRIN METAB CLIN, V25, P361, DOI 10.1016/S0889-8529(05)70328-5; Camilleri M, 2007, NEW ENGL J MED, V356, P820, DOI 10.1056/NEJMcp062614; Cao J, 2014, JAMA-J AM MED ASSOC, V312, P543, DOI 10.1001/jama.2014.9440; Chang J, 2013, DIABETIC MED, V30, pE185, DOI 10.1111/dme.12147; Chang J, 2012, DIABETES CARE, V35, P2594, DOI 10.2337/dc12-0028; de la Loge C, 2004, QUAL LIFE RES, V13, P1751, DOI 10.1007/s11136-004-8751-3; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; FRASER RJ, 1990, DIABETOLOGIA, V33, P675, DOI 10.1007/BF00400569; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; HASLER WL, 1995, GASTROENTEROLOGY, V108, P727, DOI 10.1016/0016-5085(95)90445-X; Hebbard GS, 1996, EUR J GASTROEN HEPAT, V8, P211, DOI 10.1097/00042737-199603000-00005; Jacobs MAJM, 1997, DIABETES CARE, V20, P1279, DOI 10.2337/diacare.20.8.1279; Janssen P, 2013, AM J GASTROENTEROL, V108, P1382, DOI 10.1038/ajg.2013.118; Jones KL, 2002, AM J MED, V113, P449, DOI 10.1016/S0002-9343(02)01228-7; Koch KL, 1999, DIGEST DIS SCI, V44, P1061, DOI 10.1023/A:1026647417465; Lachin JM, 2015, DIABETES, V64, P631, DOI 10.2337/db14-0930; Laway BA, 2013, J DIABETES COMPLICAT, V27, P78, DOI 10.1016/j.jdiacomp.2012.08.001; Lee SW, 2004, DIABETES NUTR METAB, V17, P211; Lysy J, 2006, NEUROGASTROENT MOTIL, V18, P433, DOI 10.1111/j.1365-2982.2006.00800.x; Martin CL, 2014, DIABETES CARE, V37, P31, DOI 10.2337/dc13-2114; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Pasricha PJ, 2015, GASTROENTEROLOGY, V149, P1762, DOI 10.1053/j.gastro.2015.08.008; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rentz AM, 2004, QUAL LIFE RES, V13, P1737, DOI 10.1007/s11136-004-9567-x; Revicki DA, 2004, QUAL LIFE RES, V13, P833, DOI 10.1023/B:QURE.0000021689.86296.e4; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sharma D, 2011, DIABETOLOGIA, V54, P2768, DOI 10.1007/s00125-011-2282-6; Tack J, 2003, GUT, V52, P1271, DOI 10.1136/gut.52.9.1271; Tougas G, 2000, AM J GASTROENTEROL, V95, P1456, DOI 10.1111/j.1572-0241.2000.02076.x; Uppalapati SS, 2009, DIGEST DIS SCI, V54, P2404, DOI 10.1007/s10620-009-0975-1	37	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194759	10.1371/journal.pone.0194759	http://dx.doi.org/10.1371/journal.pone.0194759			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652893	Green Submitted, gold, Green Published			2022-12-27	WOS:000430026900009
J	Gog, JR; Lever, AML; Skittrall, JP				Gog, Julia R.; Lever, Andrew M. L.; Skittrall, Jordan P.			A new method for detecting signal regions in ordered sequences of real numbers, and application to viral genomic data	PLOS ONE			English	Article							PROTEIN; CONSERVATION; CODON	We present a fast, robust and parsimonious approach to detecting signals in an ordered sequence of numbers. Our motivation is in seeking a suitable method to take a sequence of scores corresponding to properties of positions in virus genomes, and find outlying regions of low scores. Suitable statistical methods without using complex models or making many assumptions are surprisingly lacking. We resolve this by developing a method that detects regions of low score within sequences of real numbers. The method makes no assumptions a priori about the length of such a region; it gives the explicit location of the region and scores it statistically. It does not use detailed mechanistic models so the method is fast and will be useful in a wide range of applications. We present our approach in detail, and test it on simulated sequences. We show that it is robust to a wide range of signal morphologies, and that it is able to capture multiple signals in the same sequence. Finally we apply it to viral genomic data to identify regions of evolutionary conservation within influenza and rotavirus.	[Gog, Julia R.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge, England; [Lever, Andrew M. L.] Univ Cambridge, Dept Med, Cambridge, England; [Lever, Andrew M. L.] Natl Univ Singapore, Dept Med, Singapore, Singapore; [Skittrall, Jordan P.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England	University of Cambridge; University of Cambridge; National University of Singapore; University of Cambridge	Gog, JR (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge, England.	jrg20@cam.ac.uk	Skittrall, Jordan/ABB-8244-2020	Skittrall, Jordan/0000-0002-8228-3758; Gog, Julia/0000-0003-1240-7214	National Institute for Health Research Academic Clinical Fellowship; National Institute for Health Research (NIHR); Biomedical Research Centre	National Institute for Health Research Academic Clinical Fellowship; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biomedical Research Centre	JPS is funded by a National Institute for Health Research Academic Clinical Fellowship. This article/paper/report presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Work in the laboratory of AMLL is supported by the Biomedical Research Centre.; JPS is funded by a National Institute for Health Research Academic Clinical Fellowship. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Work in the laboratory of AMLL is supported by the Biomedical Research Centre.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; [Anonymous], 2010, ISAST T ELECT SIGNAL; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; BRICE CR, 1970, ARTIF INTELL, V1, P205, DOI 10.1016/0004-3702(70)90008-1; CHANG YL, 1994, IEEE T IMAGE PROCESS, V3, P868, DOI 10.1109/83.336259; Chen JL, 2015, BIOCHEMISTRY-US, V54, P3269, DOI 10.1021/acs.biochem.5b00012; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Erbas B, 2001, J Epidemiol Biostat, V6, P433, DOI 10.1080/135952201317225462; FitzGerald D., 2012, 23 IET IR SIGN SYST; Godreche C, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/07/P07026; Gog JR, 2007, NUCLEIC ACIDS RES, V35, P1897, DOI 10.1093/nar/gkm087; Hojjatoleslami SA, 1998, IEEE T IMAGE PROCESS, V7, P1079, DOI 10.1109/83.701170; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jiang T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156906; Jiang T, 2014, BIOCHEMISTRY-US, V53, P5236, DOI 10.1021/bi500611j; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; LUKAC LP, 1988, APPL ECON, V20, P623, DOI 10.1080/00036848800000113; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; Moss WN, 2012, RNA BIOL, V9, P1305, DOI 10.4161/rna.22343; Ng D, 2016, CLIN CHEM, V62, P1361, DOI 10.1373/clinchem.2016.257055; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Priore SF, 2015, BIOCHEMISTRY-US, V54, P3413, DOI 10.1021/bi501564d; Priore SF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070615PMID:24023714, DOI 10.1371/JOURNAL.P0NE.0070615]; SIERACKI ME, 1989, APPL ENVIRON MICROB, V55, P2762, DOI 10.1128/AEM.55.11.2762-2772.1989; Song HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143618; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAYLOR MP, 1992, J INT MONEY FINANC, V11, P304, DOI 10.1016/0261-5606(92)90048-3; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; von Kirchbach JC, 2010, SILICO ANAL RNA SIGN; Wan SY, 2003, IEEE T IMAGE PROCESS, V12, P1007, DOI 10.1109/TIP.2003.815258; WESZKA JS, 1978, COMPUT VISION GRAPH, V7, P259, DOI 10.1016/0146-664X(78)90116-8; Williams B, 2011, J AM COLL CARDIOL, V57, P951, DOI 10.1016/j.jacc.2010.09.054; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Yakimovsky Y, 1973, AIM209 STANDF U	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195763	10.1371/journal.pone.0195763	http://dx.doi.org/10.1371/journal.pone.0195763			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652903	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900034
J	Lee, AD; Cassiday, PK; Pawloski, LC; Tatti, KM; Martin, MD; Briere, EC; Tondella, ML; Martin, SW				Lee, Adria D.; Cassiday, Pamela K.; Pawloski, Lucia C.; Tatti, Kathleen M.; Martin, Monte D.; Briere, Elizabeth C.; Tondella, M. Lucia; Martin, Stacey W.		Clinical Validation Study Grp	Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT)	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; UNITED-STATES; VACCINATION COVERAGE; MASSACHUSETTS; SERODIAGNOSIS; ADOLESCENTS; ANTIBODIES; DIPHTHERIA; ACCURACY; OUTBREAK	Introduction The appropriate use of clinically accurate diagnostic tests is essential for the detection of pertussis, a poorly controlled vaccine-preventable disease. The purpose of this study was to estimate the sensitivity and specificity of different diagnostic criteria including culture, multi-target polymerase chain reaction (PCR), anti-pertussis toxin IgG (IgG-PT) serology, and the use of a clinical case definition. An additional objective was to describe the optimal timing of specimen collection for the various tests. Methods Clinical specimens were collected from patients with cough illness at seven locations across the United States between 2007 and 2011. Nasopharyngeal and blood specimens were collected from each patient during the enrollment visit. Patients who had been coughing for <= 2 weeks were asked to return in 2 +/- 4 weeks for collection of a second, convalescent blood specimen. Sensitivity and specificity of each diagnostic test were estimated using three methods-pertussis culture as the "gold standard," composite reference standard analysis (CRS), and latent class analysis (LCA). Results Overall, 868 patients were enrolled and 13.6% were B. pertussis positive by at least one diagnostic test. In a sample of 545 participants with non-missing data on all four diagnostic criteria, culture was 64.0% sensitive, PCR was 90.6% sensitive, and both were 100% specific by LCA. CRS and LCA methods increased the sensitivity estimates for convalescent serology and the clinical case definition over the culture-based estimates. Culture and PCR were most sensitive when performed during the first two weeks of cough; serology was optimally sensitive after the second week of cough. Conclusions Timing of specimen collection in relation to onset of illness should be considered when ordering diagnostic tests for pertussis. Consideration should be given to including IgG-PT serology as a confirmatory test in the Council of State and Territorial Epidemiologists (CSTE) case definition for pertussis.	[Lee, Adria D.] Ctr Dis Control & Prevent, IHRC Inc, Contracting Agcy Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Cassiday, Pamela K.; Pawloski, Lucia C.; Tatti, Kathleen M.; Martin, Monte D.; Briere, Elizabeth C.; Tondella, M. Lucia; Martin, Stacey W.] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Martin, Stacey W.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lee, AD (corresponding author), Ctr Dis Control & Prevent, IHRC Inc, Contracting Agcy Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	xda5@cdc.gov	Tatti, Kathleen M/H-5912-2012	Tatti, Kathleen M/0000-0001-9414-7887; Mathis, Adria/0000-0002-1119-095X	IHRC Inc	IHRC Inc	The authors received no specific funding for this work. The funder IHRC Inc provided support in the form of salaries for athor ADL, but did not have any additional roles in the study design, data collection and analysis, decision to publish or preparation of the mansucript. The specific roles of this author are articulated in the author contributions section.	Adams Deborah A, 2014, MMWR Morb Mortal Wkly Rep, V61, P1; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], EPIDEMIOLOGY PREVENT; Baughman AL, 2004, CLIN DIAGN LAB IMMUN, V11, P1045, DOI 10.1128/CDLI.11.6.1045-1053.2004; Baughman AL, 2008, CLIN VACCINE IMMUNOL, V15, P106, DOI 10.1128/CVI.00223-07; Burgos-Rivera B, 2015, J CLIN MICROBIOL, V53, P1842, DOI 10.1128/JCM.03567-14; CDC, 2014, DIAGN CONF 2014; CDC, 2015, BEST PRACT HEALTHC P; Davis JP, 2013, REVISION PERTUSSIS S; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P741; Faulkner AE, 2011, VPD SURVEILLANCE MAN, P1; Frumkin K, 2013, J EMERG MED, V44, P889, DOI 10.1016/j.jemermed.2012.09.037; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; Kirkland K. B., 2007, Morbidity and Mortality Weekly Report, V56, P837; Mandal S, 2012, PEDIATRICS, V129, pE424, DOI 10.1542/peds.2011-1710; Menzies SL, 2009, CLIN VACCINE IMMUNOL, V16, P1781, DOI 10.1128/CVI.00248-09; Pawloski LC, 2016, J PEDIAT INF DIS SOC; Pawloski LC, 2012, CLIN VACCINE IMMUNOL, V19, P875, DOI 10.1128/CVI.05686-11; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Riffelmann M, 2010, J CLIN MICROBIOL, V48, P4459, DOI 10.1128/JCM.01371-10; Rodgers L, 2013, CLIN INFECT DIS, V56, P322, DOI 10.1093/cid/cis888; Salimnia H, 2012, J CLIN MICROBIOL, V50, P472, DOI 10.1128/JCM.01250-11; Seither R, 2014, MMWR-MORBID MORTAL W, V63, P913; Tatti KM, 2008, DIAGN MICR INFEC DIS, V61, P264, DOI 10.1016/j.diagmicrobio.2008.02.017; Tatti KM, 2013, PEDIATR INFECT DIS J, V32, P942, DOI 10.1097/INF.0b013e3182947ef8; Tatti KM, 2011, J CLIN MICROBIOL, V49, P4059, DOI 10.1128/JCM.00601-11; Vaz-de-Lima LRA, 2014, CLIN VACCINE IMMUNOL, V21, P636, DOI 10.1128/CVI.00760-13; Vermunt J, 2002, APPLIED LATENT CLASS; Vermunt J.K., 2005, LATENT GOLD 40 USERS; von Konig CHW, 2014, EXPERT REV VACCINES, V13, P1167, DOI 10.1586/14760584.2014.950237; Watanabe M, 2006, CLIN VACCINE IMMUNOL, V13, P341, DOI 10.1128/CVI.13.3.341-348.2006; Wei SC, 2010, CLIN INFECT DIS, V51, P315, DOI 10.1086/653938; Wendelboe AM, 2006, EXPERT REV MOL DIAGN, V6, P857, DOI 10.1586/14737159.6.6.857; Williams MM, 2015, J CLIN MICROBIOL, V53, P118, DOI 10.1128/JCM.02368-14; Yih WK, 2000, J INFECT DIS, V182, P1409, DOI 10.1086/315863	35	27	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195979	10.1371/journal.pone.0195979	http://dx.doi.org/10.1371/journal.pone.0195979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652945	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900051
J	Bartelds, R; Nematollahi, MH; Pols, T; Stuart, MCA; Pardakhty, A; Asadikaram, G; Poolman, B				Bartelds, Rianne; Nematollahi, Mohammad Hadi; Pols, Tjeerd; Stuart, Marc C. A.; Pardakhty, Abbas; Asadikaram, Gholamreza; Poolman, Bert			Niosomes, an alternative for liposomal delivery	PLOS ONE			English	Article							LIPID-PROTEIN INTERACTIONS; OF-THE-ART; PHOSPHOLIPID-VESICLES; MEMBRANE-PROTEINS; DRUG-DELIVERY; UNILAMELLAR LIPOSOMES; SURFACTANT VESICLES; TRANSPORT-SYSTEM; INDUCED LEAKAGE; MELITTIN	Niosomes are used in studies for drug delivery or gene transfer. However, their physical properties and features relative to liposomes are not well documented. To characterize and more rationally optimize niosome formulations, the properties of these vesicle systems are compared to those of liposomes composed of phosphatidylcholine and phosphatidylethanolamine lipids plus cholesterol. Niosomes are highly stable and only slightly more leaky than liposomes as assayed by calcein leakage; the permeability for ions (KCl) is higher than that of liposomes. Contrary to liposomes, the size of niosomes decreases substantially upon freezing in liquid nitrogen and subsequent thawing, as shown by cryo-EM and dynamic light scattering. The packing of niosomal membranes was determined by laurdan fluorescence and is slightly lower than that of liposomes. We did not succeed in the functional reconstitution of the L-arginine/L-ornithine antiporter ArcD2 in niosomes, which we attribute to the non-ionic nature of the surfactants. The antimicrobial peptides alamethicin and melittin act similarly on niosomes and liposomes composed of unsaturated components, whereas both niosomes and liposomes are unaffected when saturated amphiphiles are used. In conclusion, in terms of stability and permeability for drug-size molecules niosomes are comparable to liposomes and they may offer an excellent, inexpensive alternative for delivery purposes.	[Bartelds, Rianne; Pols, Tjeerd; Poolman, Bert] Univ Groningen, Dept Biochem, Groningen, Netherlands; [Nematollahi, Mohammad Hadi] Sch Med, Dept Clin Biochem, Med Univ Campus, Kerman, Iran; [Stuart, Marc C. A.] Univ Groningen, Dept Electron Microscopy, Groningen, Netherlands; [Pardakhty, Abbas] Kerman Univ Med Sci, Pharmaceut Res Ctr, Inst Neuropharmacol, Med Univ Campus, Kerman, Iran; [Asadikaram, Gholamreza] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran	University of Groningen; University of Groningen; Kerman University of Medical Sciences; Kerman University of Medical Sciences	Poolman, B (corresponding author), Univ Groningen, Dept Biochem, Groningen, Netherlands.	bpoolman@rug.nl	Asadikaram, Gholamreza/AAG-4437-2021; Nematollahi, Hadi/AAD-5922-2019; Pardakhty, Abbas/Y-7245-2018	Asadikaram, Gholamreza/0000-0002-9100-0756; Pardakhty, Abbas/0000-0002-1848-5961; Poolman, Bert/0000-0002-1455-531X; Nematollahi, Mohammad Hadi/0000-0002-9529-4077	European Research Council; Netherlands Organization for Scientific Research (NWO)	European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the European Research Council, and the Netherlands Organization for Scientific Research (NWO).	ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; BAILLIE AJ, 1985, J PHARM PHARMACOL, V37, P863, DOI 10.1111/j.2042-7158.1985.tb04990.x; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Chang HI, 2012, INT J NANOMED, V7, P49, DOI 10.2147/IJN.S26766; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1534, DOI 10.1021/bi00509a019; CROMMELIN DJA, 1984, PHARMACEUT RES, P159, DOI 10.1023/A:1016344523988; Dawidczyk CM, 2014, J CONTROL RELEASE, V187, P133, DOI 10.1016/j.jconrel.2014.05.036; DEAMER DW, 1983, P NATL ACAD SCI-BIOL, V80, P165, DOI 10.1073/pnas.80.1.165; DEAMER DW, 1986, CHEM PHYS LIPIDS, V40, P167, DOI 10.1016/0009-3084(86)90069-1; DEGIER J, 1968, BIOCHIM BIOPHYS ACTA, V150, P666, DOI 10.1016/0005-2736(68)90056-4; DEMEL RA, 1972, BIOCHIM BIOPHYS ACTA, V255, P321, DOI 10.1016/0005-2736(72)90031-4; DUFOURCQ J, 1986, BIOCHIM BIOPHYS ACTA, V859, P33, DOI 10.1016/0005-2736(86)90315-9; DUFOURCQ J, 1977, BIOCHIM BIOPHYS ACTA, V467, P1, DOI 10.1016/0005-2736(77)90236-X; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; HAUSER H, 1973, BIOCHEMISTRY-US, V12, P4507, DOI 10.1021/bi00746a032; Hayashi K, 2013, COLLOID SURFACE B, V106, P258, DOI 10.1016/j.colsurfb.2012.12.022; Hayashi K, 2011, COLLOID SURFACE B, V87, P28, DOI 10.1016/j.colsurfb.2011.04.029; Jibry N, 2004, PHARM RES-DORDR, V21, P1852, DOI 10.1023/B:PHAM.0000045239.22049.70; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; KANO K, 1978, BIOCHIM BIOPHYS ACTA, V509, P289, DOI 10.1016/0005-2736(78)90048-2; Kato K, 2008, LANGMUIR, V24, P10762, DOI 10.1021/la801581f; KENDALL DA, 1982, J BIOL CHEM, V257, P3892; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Laouini A, 2012, J COLLOID SCI BIOTEC, V1, P147, DOI 10.1166/jcsb.2012.1020; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Manosroi A, 2003, COLLOID SURFACE B, V30, P129, DOI 10.1016/S0927-7765(03)00080-8; Moghassemi S, 2014, J CONTROL RELEASE, V185, P22, DOI 10.1016/j.jconrel.2014.04.015; MONETTE M, 1993, BIOCHIM BIOPHYS ACTA, V1149, P319, DOI 10.1016/0005-2736(93)90217-N; Muzzalupo R, 2005, COLLOID SURFACE B, V46, P78, DOI 10.1016/j.colsurfb.2005.09.003; NICHOLS JW, 1980, P NATL ACAD SCI-BIOL, V77, P2038, DOI 10.1073/pnas.77.4.2038; NOZAKI Y, 1981, P NATL ACAD SCI-BIOL, V78, P4324, DOI 10.1073/pnas.78.7.4324; PAPAHADJ.D, 1967, BIOCHIM BIOPHYS ACTA, V135, P639, DOI 10.1016/0005-2736(67)90095-8; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; POTT T, 1995, BIOPHYS J, V68, P965, DOI 10.1016/S0006-3495(95)80272-9; Raghuraman H, 2004, BIOPHYS J, V87, P2419, DOI 10.1529/biophysj.104.043596; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rex S, 1996, BIOPHYS CHEM, V58, P75, DOI 10.1016/0301-4622(95)00087-9; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; SENIOR J, 1982, LIFE SCI, V30, P2123, DOI 10.1016/0024-3205(82)90455-6; Sezgin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123930; STANKOWSKI S, 1989, FEBS LETT, V250, P556, DOI 10.1016/0014-5793(89)80795-1; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; SUBBARAO NK, 1994, BBA-BIOMEMBRANES, V1189, P101, DOI 10.1016/0005-2736(94)90286-0; Uchegbu IF, 1998, INT J PHARM, V172, P33, DOI 10.1016/S0378-5173(98)00169-0; van den Bogaart G, 2007, BIOPHYS J, V93, P154, DOI 10.1529/biophysj.107.106005; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Wessman P, 2008, BIOPHYS J, V95, P4324, DOI 10.1529/biophysj.108.130559; Wessman P, 2010, J COLLOID INTERF SCI, V346, P127, DOI 10.1016/j.jcis.2010.02.032; YAMAUCHI K, 1993, BIOCHIM BIOPHYS ACTA, V1146, P178, DOI 10.1016/0005-2736(93)90353-2; YOSHIOKA T, 1994, INT J PHARM, V105, P1, DOI 10.1016/0378-5173(94)90228-3	54	99	103	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194179	10.1371/journal.pone.0194179	http://dx.doi.org/10.1371/journal.pone.0194179			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649223	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900007
J	Chard, M; French, K; Martin, J; Major, RE				Chard, Matthew; French, Kris; Martin, John; Major, Richard E.			Rain drives foraging decisions of an urban exploiter	PLOS ONE			English	Article							IBIS THRESKIORNIS-MOLUCCA; FLIGHT INITIATION DISTANCE; TITS PARUS-MAJOR; CLIMATE-CHANGE; ECOLOGICAL RESPONSES; FOOD AVAILABILITY; SUBURBAN; BEHAVIOR; BIRDS; POPULATION	Foraging decisions tend to drive individuals toward maximising energetic gains within a patchy environment. This study aims to determine the extent to which rainfall, and associated changes in food availability, can explain foraging decisions within a patchy urbanised landscape, using the Australian white ibis as a model species. Ibis density, food consumption rates and food abundance (both natural and anthropogenic) were recorded during dry and wet weather within urban parks in Sydney, Australia. Rainfall influenced ibis density in these urban parks. Of the four parks assessed, the site with the highest level of anthropogenic food and the lowest abundance of natural food (earthworms), irrespective of weather, was observed to have three times the density of ibis. Rainfall significantly increased the rate of earthworm consumption as well as their relative availability in all sites. Overall, these density and consumption measures indicate that anthropogenic derived foods, mainly from direct feeding by people, explain the apparent distribution of ibis across urban parks. However, there was evidence of prey-switching when the availability of natural foods increased following rainfall, perhaps reflecting selection of particular nutrients.	[Chard, Matthew; French, Kris] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Martin, John] Royal Bot Gardens & Domain Trust, Sydney, NSW, Australia; [Major, Richard E.] Australian Museum, Res Inst, Sydney, NSW, Australia	University of Wollongong; Australian Museum	Chard, M (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	Matthew.chard7@gmail.com	; French, Kris/I-8202-2012	Major, Richard/0000-0002-1334-9864; Martin, John/0000-0003-2731-9292; French, Kris/0000-0001-6938-2017				Adams LW, 1994, URBAN WILDLIFE HABIT; Ausden M, 2001, J APPL ECOL, V38, P320, DOI 10.1046/j.1365-2664.2001.00600.x; Barker D, 1998, ZOO BIOL, V17, P123, DOI 10.1002/(SICI)1098-2361(1998)17:2&lt;123::AID-ZOO7&gt;3.0.CO;2-B; Bell W.J., 2012, SEARCHING BEHAV BEHA; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; BIEBACH H, 1994, ANIM BEHAV, V48, P273, DOI 10.1006/anbe.1994.1241; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Brandis KJ, 2011, ENVIRON MANAGE, V48, P489, DOI 10.1007/s00267-011-9705-5; BRITTINGHAM MC, 1991, NIUW SYMP S, V2, P185; Butt Kevin R., 2000, Field Studies, V9, P701; Canepuccia AD, 2007, WATERBIRDS, V30, P541, DOI 10.1675/1524-4695(2007)030[0541:WRTCIH]2.0.CO;2; CATTERALL CP, 1991, NAT CONSERV SER, P247; Chambers LE, 2006, INT J BIOMETEOROL, V50, P292, DOI 10.1007/s00484-005-0019-2; Chard M, 2017, URBAN ECOSYST, V20, P1285, DOI 10.1007/s11252-017-0680-3; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chuang SC, 2008, INVERTEBR BIOL, V127, P80, DOI 10.1111/j.1744-7410.2007.00117.x; Coogan SC, 2017, BEHAV ECOLOGY; Corben D, 2006, CLUTCH SIZE FLEDGING; Couturier S, 2009, J MAMMAL, V90, P442, DOI 10.1644/07-MAMM-A-279.1; COWIE RJ, 1988, J ANIM ECOL, V57, P611, DOI 10.2307/4928; Crates RA, 2011, EMU, V111, P341, DOI 10.1071/MU10057; Davis A, 2011, LANDSCAPE URBAN PLAN, V100, P295, DOI 10.1016/j.landurbplan.2010.12.017; DILL LM, 1989, CAN J ZOOL, V67, P233, DOI 10.1139/z89-033; Epstein JH, 2006, ECOHEALTH, V3, P290, DOI 10.1007/s10393-006-0064-2; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; French K, 2005, BIOL CONSERV, V121, P545, DOI 10.1016/j.biocon.2004.06.004; GREEN RJ, 1989, EMU, V89, P216, DOI 10.1071/MU9890216; HALSE SA, 1989, EMU, V89, P232, DOI 10.1071/MU9890232; He S, 2006, IEEE C EVOL COMPUTAT, P1257; Jahn AE, 2010, J FIELD ORNITHOL, V81, P340, DOI 10.1111/j.1557-9263.2010.00290.x; Kingsford R. T., 2013, Pacific Conservation Biology, V19, P366; Kingsford RT, 1999, WILDLIFE RES, V26, P351, DOI 10.1071/WR96062; Kingsford RT, 1998, COLON WATERBIRD, V21, P159, DOI 10.2307/1521903; Kohlmann SG, 1998, BEHAV ECOL, V9, P177, DOI 10.1093/beheco/9.2.177; KOTLER BP, 1992, ANN ZOOL FENN, V29, P199; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Machovsky-Capuska GE, 2016, BEHAV ECOL, V27, P219, DOI 10.1093/beheco/arv142; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; MADDOCK M, 1991, COLON WATERBIRD, V14, P133, DOI 10.2307/1521502; Mainwaring MC, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P65; Major RE, 1996, AUST J ECOL, V21, P399, DOI 10.1111/j.1442-9993.1996.tb00626.x; Marchant SJ, HDB AUSTR NZ ANTARCT, V1; Marshal JP, 2005, RANGELAND ECOL MANAG, V58, P360, DOI 10.2111/1551-5028(2005)058[0360:RTAFDA]2.0.CO;2; Martin GR, 2012, IBIS, V154, P626, DOI 10.1111/j.1474-919X.2012.01227.x; Martin J, 2010, WILDLIFE RES, V37, P230, DOI 10.1071/WR10047; Martin JM, 2007, WILDLIFE RES, V34, P319, DOI 10.1071/WR07005; Martin JM, 2010, WATERBIRDS, V33, P264, DOI 10.1675/063.033.0218; Marzluff John M., 2001, P19; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; MCNAMARA J, 1980, J THEOR BIOL, V85, P673, DOI 10.1016/0022-5193(80)90265-9; Meyer-Gleaves Stephanie, 2007, P142; Moller AP, 2014, BEHAV ECOL, V25, P960, DOI 10.1093/beheco/aru073; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Morris A.K, 1983, AUSTR BIRDS, V17, P43; Morrison SA, 2002, OECOLOGIA, V133, P315, DOI 10.1007/s00442-002-1040-3; Murray Nicholas J., 2009, Notornis, V56, P201; Naef-Daenzer B, 2000, ANIM BEHAV, V59, P989, DOI 10.1006/anbe.1999.1380; Naef-Daenzer L, 2000, J AVIAN BIOL, V31, P206, DOI 10.1034/j.1600-048X.2000.310212.x; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Padgham M, 2011, ECOSYSTEMS, V14, P94, DOI 10.1007/s10021-010-9397-3; Parsons H, 2003, LANDSCAPE URBAN PLAN, V66, P43, DOI 10.1016/S0169-2046(03)00094-X; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Paton D.C., 1991, P WORKSH IMP CATS NA, P64; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; Pierotti Raymond, 2001, P307; Porter JL, 2006, AERIAL SURVEYS WETLA; Radford AN, 2001, BIRD STUDY, V48, P214, DOI 10.1080/00063650109461220; Sauter A, 2006, BEHAV ECOL SOCIOBIOL, V60, P465, DOI 10.1007/s00265-006-0187-z; Shochat E, 2004, AM NAT, V164, P232, DOI 10.1086/422222; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; Smith ACM, 2013, POPUL ECOL, V55, P567, DOI 10.1007/s10144-013-0385-2; SMITH GC, 1993, COLON WATERBIRD, V16, P9, DOI 10.2307/1521551; Sofaer HR, 2013, BEHAV ECOL, V24, P698, DOI 10.1093/beheco/ars212; Stephens D.W., 1986, pi; Tryjanowski P, 2015, ENVIRON SCI POLLUT R, V22, P15097, DOI 10.1007/s11356-015-4723-0; Tsurim I, 2008, CONDOR, V110, P772, DOI 10.1525/cond.2008.8572; TWEIT R C, 1986, American Birds, V40, P431; WOLF LL, 1991, ANIM BEHAV, V41, P803, DOI 10.1016/S0003-3472(05)80347-1; WOODALL PF, 1985, AUST WILDLIFE RES, V12, P495, DOI 10.1071/WR9850495	81	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194484	10.1371/journal.pone.0194484	http://dx.doi.org/10.1371/journal.pone.0194484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641609	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900032
J	Herrera, JM; Alagador, D; Salgueiro, P; Mira, A				Herrera, Jose M.; Alagador, Diogo; Salgueiro, Pedro; Mira, Antonio			A distribution-oriented approach to support landscape connectivity for ecologically distinct bird species	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; PLANTATION FORESTS; FRAGMENTATION; CONSERVATION; HABITATS; ECOLOGY; DISPERSAL; REGION; MODEL	Managing landscape connectivity is a widely recognized overarching strategy for conserving biodiversity in human-impacted landscapes. However, planning the conservation and management of landscape connectivity of multiple and ecologically distinct species is still challenging. Here we provide a spatially-explicit framework which identifies and prioritizes connectivity conservation and restoration actions for species with distinct habitat affinities. Specifically, our study system comprised three groups of common bird species, forest-specialists, farmland-specialists, and generalists, populating a highly heterogeneous agricultural countryside in the southwestern Iberian Peninsula. We first performed a comprehensive analysis of the environmental variables underlying the distributional patterns of each bird species to reveal generalities in their guild-specific responses to landscape structure. Then, we identified sites which could be considered pivotal in maintaining current levels of landscape connectivity for the three bird guilds simultaneously, as well as the number and location of sites that need to be restored to maximize connectivity levels. Interestingly, we found that a small number of sites defined the shortest connectivity paths for the three bird guilds simultaneously, and were therefore considered key for conservation. Moreover, an even smaller number of sites were identified as critical to expand the landscape connectivity at maximum for the regional bird assemblage as a whole. Our spatially-explicit framework can provide valuable decision-making support to conservation practitioners aiming to identify key connectivity and restoration sites, a particularly urgent task in rapidly changing landscapes such as agroecosystems.	[Herrera, Jose M.; Alagador, Diogo; Salgueiro, Pedro; Mira, Antonio] Univ Evora, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, InBIO, Dom Augusto Eduardo Nunes 7, Evora, Portugal; [Herrera, Jose M.] CSIC, Dept Ecol Integrat, EBD, Avd Amer Vespucio 26, Seville, Spain	University of Evora; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Herrera, JM (corresponding author), Univ Evora, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, InBIO, Dom Augusto Eduardo Nunes 7, Evora, Portugal.; Herrera, JM (corresponding author), CSIC, Dept Ecol Integrat, EBD, Avd Amer Vespucio 26, Seville, Spain.	herreramirlo@gmail.com	Herrera, José M./L-7432-2013; Mira, Antonio/E-5715-2010; Salgueiro, Pedro A./AAJ-4094-2020	Herrera, José M./0000-0001-7968-3438; Mira, Antonio/0000-0001-6152-0454; Salgueiro, Pedro A./0000-0001-5055-2805	ICDT Call [1/SAESCTN/ALENT-07-0224-FEDER-001755]	ICDT Call	This work was supported by IC&DT Call No 1/SAESCTN/ALENT-07-0224-FEDER-001755.	Alagador D, 2012, LANDSCAPE ECOL, V27, P291, DOI 10.1007/s10980-012-9704-9; Antongiovanni M, 2005, BIOL CONSERV, V122, P441, DOI 10.1016/j.biocon.2004.09.005; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Barbaro L, 2007, J BIOGEOGR, V34, P652, DOI 10.1111/j.1365-2699.2006.01656.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Baudry J, 2003, LANDSCAPE ECOL, V18, P303, DOI 10.1023/A:1024465200284; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Birch CPD, 2007, ECOL MODEL, V206, P347, DOI 10.1016/j.ecolmodel.2007.03.041; Branco P, 2014, J APPL ECOL, V51, P1197, DOI 10.1111/1365-2664.12317; Bras R, 2013, ENVIRON MODELL SOFTW, V40, P336, DOI 10.1016/j.envsoft.2012.08.001; Brodie JF, 2015, CONSERV BIOL, V29, P122, DOI 10.1111/cobi.12337; Bunn AG, 2000, J ENVIRON MANAGE, V59, P265, DOI 10.1006/jema.2000.0373; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V310, P692, DOI 10.1016/j.foreco.2013.09.014; Carvalho F, 2016, LANDSCAPE ECOL, V31, P1021, DOI 10.1007/s10980-015-0326-x; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Cushman SA, 2013, BIODIVERS CONSERV, V22, P2583, DOI 10.1007/s10531-013-0541-1; Cushman SA, 2012, ECOL MODEL, V231, P101, DOI 10.1016/j.ecolmodel.2012.02.011; Donald PF, 2006, J APPL ECOL, V43, P209, DOI 10.1111/j.1365-2664.2006.01146.x; FEO TA, 1995, J GLOBAL OPTIM, V6, P109, DOI 10.1007/BF01096763; Fischer J, 2006, OIKOS, V112, P473, DOI 10.1111/j.0030-1299.2006.14148.x; Frey-Ehrenbold A, 2013, J APPL ECOL, V50, P252, DOI 10.1111/1365-2664.12034; Goodwin BJ, 2002, OIKOS, V99, P552, DOI 10.1034/j.1600-0706.2002.11824.x; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Guiomar N, CORINE LAND COVER NI; Herrera JM, 2016, J BIOGEOGR, V43, P1203, DOI 10.1111/jbi.12720; Herrera JM, 2014, J BIOGEOGR, V41, P700, DOI 10.1111/jbi.12236; Herrera JM, 2011, ECOGRAPHY, V34, P606, DOI 10.1111/j.1600-0587.2010.06521.x; Koen EL, 2014, METHODS ECOL EVOL, V5, P626, DOI 10.1111/2041-210X.12197; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Loos J, 2015, BIODIVERS CONSERV, V24, P33, DOI 10.1007/s10531-014-0786-3; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; Melia P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23705; Mimet A, 2014, ECOL INDIC, V36, P19, DOI 10.1016/j.ecolind.2013.06.029; Mimet A, 2013, METHODS ECOL EVOL, V4, P453, DOI 10.1111/2041-210x.12024; Niebuhr BBS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11898; PALMEIRIM JM, 1994, J FIELD ORNITHOL, V65, P17; Paracchini ML, 2008, HIGH NATURE VALUE FA; Pinto-Correia T, 2011, AGROFOREST SYST, V82, P99, DOI 10.1007/s10457-011-9388-1; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Quinn P.G., 2002, EXPT DESIGN DATA ANA; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Vasudev D, 2015, ECOGRAPHY, V38, P967, DOI 10.1111/ecog.01306; Worboys G.L., 2010, CONNECTIVITY CONSERV; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	51	7	8	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194848	10.1371/journal.pone.0194848	http://dx.doi.org/10.1371/journal.pone.0194848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641610	Green Published, gold, Green Submitted			2022-12-27	WOS:000429742900050
J	Leving, MT; Horemans, HLD; Vegter, RJK; de Groot, S; Bussmann, JBJ; van der Woude, LHV				Leving, Marika T.; Horemans, Henricus L. D.; Vegter, Riemer J. K.; de Groot, Sonja; Bussmann, Johannes B. J.; van der Woude, Lucas H. V.			Validity of consumer-grade activity monitor to identify manual wheelchair propulsion in standardized activities of daily living	PLOS ONE			English	Article							SPINAL-CORD-INJURY; ASSESSING PHYSICAL-ACTIVITY; INPATIENT REHABILITATION; CAPACITY; ADULTS; USERS; ACCELEROMETERS; INDIVIDUALS; VALIDATION; DISCHARGE	Background Hypoactive lifestyle contributes to the development of secondary complications and lower quality of life in wheelchair users. There is a need for objective and user-friendly physical activity monitors for wheelchair-dependent individuals in order to increase physical activity through self-monitoring, goal setting, and feedback provision. Objective To determine the validity of Activ8 Activity Monitors to 1) distinguish two classes of activities: independent wheelchair propulsion from other non-propulsive wheelchair-related activities 2) distinguish five wheelchair-related classes of activities differing by the movement intensity level: sitting in a wheelchair (hands may be moving but wheelchair remains stationary), maneuvering, and normal, high speed or assisted wheelchair propulsion. Methods Sixteen able-bodied individuals performed sixteen various standardized 60s-activities of daily living. Each participant was equipped with a set of two Activ8 Professional Activity Monitors, one at the right forearm and one at the right wheel. Task classification by the Active8 Monitors was validated using video recordings. For the overall agreement, sensitivity and positive predictive value, outcomes above 90% are considered excellent, between 70 and 90% good, and below 70% unsatisfactory. Results Division in two classes resulted in overall agreement of 82.1%, sensitivity of 77.7% and positive predictive value of 78.2%. 84.5% of total duration of all tasks was classified identically by Activ8 and based on the video material. Division in five classes resulted in overall agreement of 56.6%, sensitivity of 52.8% and positive predictive value of 51.9%. 59.8% of total duration of all tasks was classified identically by Activ8 and based on the video material. Conclusions Activ8 system proved to be suitable for distinguishing between active wheelchair propulsion and other non-propulsive wheelchair-related activities. The ability of the current system and algorithms to distinguish five various wheelchair-related activities is unsatisfactory.	[Leving, Marika T.; Vegter, Riemer J. K.; de Groot, Sonja; van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Horemans, Henricus L. D.; Bussmann, Johannes B. J.] Erasmus MC, Univ Med Ctr, Dept Rehabil Med, Rotterdam, Netherlands; [de Groot, Sonja] Amsterdam Rehabil Res Ctr Reade, Amsterdam, Netherlands; [van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Leving, MT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	m.t.leving@umcg.nl	JK, Vegter Riemer/N-3385-2013; Bussmann, Johannes BJ/K-2357-2012; van der Woude, Lucas/E-7986-2018	JK, Vegter Riemer/0000-0002-4294-6086; van der Woude, Lucas/0000-0002-8472-334X; Leving, Marika/0000-0002-2732-4406; de Groot, Sonja/0000-0001-8463-2563				Ainsworth B, 2015, PROG CARDIOVASC DIS, V57, P387, DOI 10.1016/j.pcad.2014.10.005; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; de Groot S, 2016, APPL PHYSIOL NUTR ME, V41, P1190, DOI 10.1139/apnm-2016-0269; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Garcia-Masso X, 2015, SPINAL CORD, V53, P772, DOI 10.1038/sc.2015.81; Hiremath SV, 2013, SPINAL CORD, V51, P705, DOI 10.1038/sc.2013.39; Kooijmans H, 2014, PHYSIOL MEAS, V35, P2297, DOI 10.1088/0967-3334/35/11/2297; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Nooijen CFJ, 2012, SPINAL CORD, V50, P320, DOI 10.1038/sc.2011.152; Nooijen CFJ, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0004-x; Postma K, 2005, SPINAL CORD, V43, P550, DOI 10.1038/sj.sc.3101759; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Tawashy AE, 2009, SPINAL CORD, V47, P301, DOI 10.1038/sc.2008.120; Tsang K, 2016, J REHABIL RES DEV, V53, P641, DOI 10.1682/JRRD.2016.01.0006; van den Berg-Emons RJ, 2008, ARCH PHYS MED REHAB, V89, P2094, DOI 10.1016/j.apmr.2008.04.024; van den Berg-Emons RJ, 2011, ARCH PHYS MED REHAB, V92, P923, DOI 10.1016/j.apmr.2010.12.006; van der Ploeg Hidde P, 2007, J Phys Act Health, V4, P96; van Koppenhagen CF, 2014, J SPINAL CORD MED, V37, P328, DOI 10.1179/2045772313Y.0000000167; Van Remoortel H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-84; van Velzen JM, 2012, J REHABIL MED, V44, P73, DOI 10.2340/16501977-0899	20	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194864	10.1371/journal.pone.0194864	http://dx.doi.org/10.1371/journal.pone.0194864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641582	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900051
J	Ebeling, M; Modig, K; Ahlbom, A; Rau, R				Ebeling, Marcus; Modig, Karin; Ahlbom, Anders; Rau, Roland			The effects of increasing longevity and changing incidence on lifetime risk differentials: A decomposition approach	PLOS ONE			English	Article							DEVELOPING CANCER; TRENDS	Increasing longevity can distort time trends in summary measures of health and mortality, such as the lifetime risk of getting diseased. If not observing a cohort, this lifetime risk is calculated with cross-sectional data on age-specific incidence and survival. In those instances, incidence and survival may work in opposite directions resulting in lifetime risk estimates where, reductions in incidence might be offset by a simultaneous longevity increase. The proposed method decomposes the difference between two lifetime risks into contributions of changing incidence and changing survival. The approach can be extended to measure the contributions of changes in disease related mortality and even case fatality. We illustrate the method with hypothetical examples as well as remaining lifetime risk at age 60 of experiencing a myocardial infarction, colorectal cancer and hip fractures for Swedish males. The empirical examples show that the influence of increasing longevity on the development of lifetime risk depends on the respective age profile of occurrence. In the cases of myocardial infarction and hip fracture, longevity increases of the general population counterbalanced or even exceeded the substantial gains in disease incidence, while for colorectal cancer, the lifetime risk was almost unaffected by the longevity improvement. This was because colorectal cancer has an on average earlier onset than myocardial infarction and hip fracture.	[Ebeling, Marcus; Rau, Roland] Univ Rostock, Chair Demog, Rostock, Germany; [Ebeling, Marcus; Rau, Roland] Max Planck Inst Demog Res, Rostock, Germany; [Modig, Karin; Ahlbom, Anders] Karolinska Inst, Inst Environm Med IMM, Stockholm, Sweden	University of Rostock; Max Planck Society; Karolinska Institutet	Ebeling, M (corresponding author), Univ Rostock, Chair Demog, Rostock, Germany.; Ebeling, M (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	ebeling@demogr.mpg.de	Modig, Karin/H-1542-2014	Modig, Karin/0000-0002-5151-4867; Ebeling, Marcus/0000-0002-6531-8525	Forte [2014-0231]	Forte(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	Financial support for Anders Ahlbom has been provided by Forte (Grant no.: 2014-0231). The funding institution had no influence on the design, analysis and interpretation of the outcomes of this study.	Ahmad AS, 2015, BRIT J CANCER, V112, P943, DOI 10.1038/bjc.2014.606; [Anonymous], 2015, HUM MORTALITY DATAB; Camarda CG, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i01; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Esteve J, 1994, STAT METHODS CANC RE; FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892; GOLDBERG ID, 1956, J NATL CANCER I, V17, P155; Gupta, 1991, MATH POPUL STUD, V3, P105, DOI DOI 10.1080/08898489109525329; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Karampampa K, 2015, BONE, V78, P55, DOI 10.1016/j.bone.2015.04.032; KITAGAWA EM, 1955, J AM STAT ASSOC, V50, P1168, DOI 10.2307/2281213; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; Sasieni PD, 2011, BRIT J CANCER, V105, P460, DOI 10.1038/bjc.2011.250; Team RC., 2013, R LANG ENV STAT COMP; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wun LM, 1998, LIFETIME DATA ANAL, V4, P169, DOI 10.1023/A:1009685507602	16	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195307	10.1371/journal.pone.0195307	http://dx.doi.org/10.1371/journal.pone.0195307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672532	Green Published, gold, Green Submitted			2022-12-27	WOS:000430446800024
J	Hamada, K; Saitoh, S; Nishino, N; Fukushima, D; Horikawa, Y; Nishida, S; Honda, M				Hamada, Koichi; Saitoh, Satoshi; Nishino, Noriyuki; Fukushima, Daizo; Horikawa, Yoshinori; Nishida, Shinya; Honda, Michitaka			Shear wave elastography predicts hepatocellular carcinoma risk in hepatitis C patients after sustained virological response	PLOS ONE			English	Article							TIME TISSUE ELASTOGRAPHY; LIVER FIBROSIS; INTERFERON THERAPY; TRANSIENT ELASTOGRAPHY; NONINVASIVE EVALUATION; ANTIVIRAL THERAPY; LONG-TERM; STIFFNESS; HCV; INFECTION	Aim To evaluate the relationship between fibrosis and HCC after sustained virological response (SVR) to treatment for chronic hepatitis C (HCV). Methods This single-center study retrospectively evaluated 196 patients who achieved SVR after HCV infection. The associations of risk factors with HCC development after HCV eradication were evaluated using univariate and multivariate Cox proportional hazards regression models. Results Among the 196 patients, 8 patients (4.1%) developed HCC after SVR during a median follow-up of 26 months. Multivariate analyses revealed that HCC development was independently associated with age of >= 75 years (risk ratio [RR] = 35.16), alpha-fetoprotein levels of >= 6 ng/mL (RR = 40.30), and SWE results of >= 11 kPa (RR = 28.71). Conclusions Our findings indicate that SWE may facilitate HCC surveillance after SVR and the identification of patients who have an increased risk of HCC after HCV clearance.	[Hamada, Koichi; Nishino, Noriyuki; Fukushima, Daizo; Horikawa, Yoshinori; Honda, Michitaka] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima, Japan; [Hamada, Koichi; Nishida, Shinya; Honda, Michitaka] Southern Tohoku Gen Hosp, Dept Gastroenterol, Koriyama, Fukushima, Japan; [Saitoh, Satoshi] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan	Fukushima Medical University; Toranomon Hospital	Hamada, K (corresponding author), Southern Tohoku Gen Hosp, Dept Gastroenterol, Koriyama, Fukushima, Japan.	koichi.hamada@mt.strins.or.jp	Honda, Michitaka/GRX-6955-2022					Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Arima Y, 2010, HEPATOL RES, V40, P383, DOI 10.1111/j.1872-034X.2009.00618.x; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Bavu E, 2011, ULTRASOUND MED BIOL, V37, P1361, DOI 10.1016/j.ultrasmedbio.2011.05.016; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Hezode C, 2011, ALIMENT PHARM THER, V34, P656, DOI 10.1111/j.1365-2036.2011.04765.x; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Kobayashi M, 2017, J MED VIROL, V89, P476, DOI 10.1002/jmv.24663; Makiyama A, 2004, CANCER-AM CANCER SOC, V101, P1616, DOI 10.1002/cncr.20537; Nagaoki Y, 2011, J GASTROENTEROL, V46, P799, DOI 10.1007/s00535-011-0384-z; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Oze T, 2014, CLIN GASTROENTEROL H, V12, P1186, DOI 10.1016/j.cgh.2013.11.033; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Shiraishi A, 2014, HEPATO-GASTROENTEROL, V61, P2084, DOI 10.5754/hge14574; Sporea I, 2011, Ultraschall Med, V32 Suppl 1, pS46, DOI 10.1055/s-0029-1245360; Suda T, 2017, WORLD J HEPATOL, V9, P64, DOI 10.4254/wjh.v9.i1.64; Tada T, 2017, HEPATOL RES, V47, P1021, DOI 10.1111/hepr.12839; Takaki S, 2014, HEPATOL RES, V44, P280, DOI 10.1111/hepr.12129; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Tapper EB, 2015, CURR OPIN GASTROEN, V31, P192, DOI 10.1097/MOG.0000000000000169; Tatsumi C, 2008, INTERVIROLOGY, V51, P27, DOI 10.1159/000122602; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Wang JH, 2016, LIVER INT, V36, P1793, DOI 10.1111/liv.13179	28	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195173	10.1371/journal.pone.0195173	http://dx.doi.org/10.1371/journal.pone.0195173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672518	Green Submitted, Green Published, gold			2022-12-27	WOS:000430446800021
J	Herrmann, AS; Beutel, ME; Gerzymisch, K; Lane, RD; Pastore-Molitor, J; Wiltink, J; Zwerenz, R; Banerjeet, M; Subic-Wrana, C				Herrmann, Anna S.; Beutel, Manfred E.; Gerzymisch, Katharina; Lane, Richard D.; Pastore-Molitor, Janine; Wiltink, Joerg; Zwerenz, Ruediger; Banerjeet, Mita; Subic-Wrana, Claudia			The impact of attachment distress on affect-centered mentalization: An experimental study in psychosomatic patients and healthy adults	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; EMOTIONAL AWARENESS SCALE; CHILDHOOD EXPERIENCES; UNRESOLVED ATTACHMENT; MATERNAL SENSITIVITY; INFANT ATTACHMENT; COMPLEX EMOTIONS; GERMAN VERSION; MENTAL STATES; MOTHER-INFANT	Introduction We investigated the impact of attachment distress on affect-centered mentalization in a clinical and a non-clinical sample, comparing mentalization in a baseline condition to mentalization under a condition of attachment distress. Methods The sample consisted of 127 adults who underwent inpatient psychosomatic treatment, and 34 mentally healthy adults. Affect-centered mentalization was assessed by analyzing participants' narratives on interpersonal situations in a baseline condition with the Levels of Emotional Awareness Scale (LEAS), and an experimental condition inducing attachment distress with the Adult Attachment Projective Picture System (AAP). Unlike the LEAS, the AAP is specifically designed to trigger attachment distress. In both conditions, the narratives were evaluated using the LEAS scoring system. Additionally, we assessed the impact of childhood trauma on affect-centered mentalization with the Childhood Trauma Questionnaire (CTQ). Results While the non-clinical sample displayed the same level of affect-centered mentalization in both conditions, the majority of the clinical sample reached higher scores in the attachment distress condition. There was no strong relationship between reported trauma and mentalization scores. Discussion Our findings lend strong empirical support to the assumption that affect-centered mentalization is modulated by attachment-related distress. Several possible explanations for the differences between and within the clinical and the non-clinical sample are discussed.	[Herrmann, Anna S.] Univ Med Ctr Mainz, DFG Res Training Grp Life Sci, Life Writing GRK2015 1, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Beutel, Manfred E.; Gerzymisch, Katharina; Pastore-Molitor, Janine; Wiltink, Joerg; Zwerenz, Ruediger; Subic-Wrana, Claudia] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Lane, Richard D.] Univ Arizona, Coll Med, Dept Psychiat, Tucson, AZ USA; [Banerjeet, Mita] Johannes Gutenberg Univ Mainz, Dept English & Linguist, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Arizona; Johannes Gutenberg University of Mainz	Herrmann, AS (corresponding author), Univ Med Ctr Mainz, DFG Res Training Grp Life Sci, Life Writing GRK2015 1, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	anna.herrmann@uni-mainz.de						[Anonymous], 1969, ATTACHMENT LOSS ATTA; Bader K, 2009, Z KLIN PSYCHOL PSYCH, V38; Baeza-Velasco C, 2012, J PSYCHOSOM RES, V73, P398, DOI 10.1016/j.jpsychores.2012.08.008; Baslet G, 2009, J NERV MENT DIS, V197, P655, DOI 10.1097/NMD.0b013e3181b3b20f; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Berthoz S, 2000, ANN MED-PSYCHOL, V158, P665; Bigelow AE, 2006, INFANCY, V9, P313, DOI 10.1207/s15327078in0903_3; Bochand L, 2010, LENCEPHALE, V36, P334, DOI [10.1016/j.encep.2009.12.013, DOI 10.1016/J.ENCEP.2009.12.013]; Bowlby J., 1973, ATTACHMENT LOSS, V2; BOWLBY J, 1980, LOSS SADNESS DEPRESS, V3; Brune M, 2016, COMPR PSYCHIAT, V64, P29, DOI 10.1016/j.comppsych.2015.08.003; Buchheim A, 2008, PSYCHIAT RES-NEUROIM, V163, P223, DOI 10.1016/j.pscychresns.2007.07.001; Bydlowski S, 2005, INT J EAT DISORDER, V37, P321, DOI 10.1002/eat.20132; Carton S, 2010, J CLIN PSYCHOL; Consoli SM, 2010, AM J HYPERTENS, V23, P515, DOI 10.1038/ajh.2010.9; de Sampaio FTP, 2013, PSYCHIAT RES, V210, P1116, DOI 10.1016/j.psychres.2013.08.051; Demers I, 2010, INT J BEHAV DEV, V34, P529, DOI 10.1177/0165025410365802; Donges US, 2005, J NERV MENT DIS, V193, P331, DOI 10.1097/01.nmd.0000161683.02482.19; Dozier M., 2008, HDB ATTACHMENT THEOR, P718; Ensink K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01471; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fizke E, 2013, PSIHOLOGIJA, V46, P161, DOI 10.2298/PSI1302161F; Fonagy P, 1997, DEV PSYCHOPATHOL, V9, P679, DOI 10.1017/S0954579497001399; FONAGY P, 1991, INFANT MENT HEALTH J, V12, P201, DOI 10.1002/1097-0355(199123)12:3<201::AID-IMHJ2280120307>3.0.CO;2-7; Fonagy P., 1998, REFLECTIVE FUNCTIONI; Fonagy P, 2002, AFFECT REGULATION ME, V400, DOI [10.1016/j.jpsychores.2012.08.008, DOI 10.1016/J.JPSYCHORES.2012.08.008]; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; Frewen P, 2008, PSYCHOSOM MED, V70, P27, DOI 10.1097/PSY.0b013e31815f66d4; Frick C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041650; Gandolphe MC, 2013, J BEHAV THER EXP PSY, V44, P114, DOI 10.1016/j.jbtep.2012.07.012; George C., 2012, ADULT ATTACHMENT PRO; Gergely G, 1996, INT J PSYCHOANAL, V77, P1181; Grienenberger J, 2005, ATTACH HUM DEV, V7, P299, DOI 10.1080/14616730500245963; Haag S, 2016, INT J BIPOLAR DISORD, V4, DOI 10.1186/s40345-016-0061-5; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Harrison A, 2010, PSYCHOL MED, V40, P1887, DOI 10.1017/S0033291710000036; Hesse E, 1999, PSYCHOANAL INQ, V19, P481, DOI 10.1080/07351699909534265; Kenyon M, 2012, INT J EAT DISORDER, V45, P377, DOI 10.1002/eat.20967; Labek K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00345; LANE RD, 1990, J PERS ASSESS, V55, P124, DOI 10.1207/s15327752jpa5501&2_12; Lane RD, 1998, COMPR PSYCHIAT, V39, P377, DOI 10.1016/S0010-440X(98)90051-7; LANE RD, 1987, AM J PSYCHIAT, V144, P133; LANE RD, 2015, BEHAV BRAIN SCI, V38; Lane RD, 2015, NEUROSCI BIOBEHAV R, V55, P594, DOI 10.1016/j.neubiorev.2015.06.007; Lane RD, 2011, PSYCHOSOM MED, V73, P185, DOI 10.1097/PSY.0b013e318203b86a; Levine D, 1997, J NERV MENT DIS, V185, P240, DOI 10.1097/00005053-199704000-00004; Lillaz C, 2012, ENCEPHALE, V38, P390, DOI 10.1016/j.encep.2011.11.009; Liotti G, 2011, PSYCHOL PSYCHOTHER-T, V84, P9, DOI 10.1348/147608310X520094; MacIntosh HB, 2013, PSIHOLOGIJA, V46, P193, DOI 10.2298/PSI1302193M; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; Maurage P, 2011, PSYCHIAT RES, V190, P375, DOI 10.1016/j.psychres.2011.06.015; Mayes LC, 2000, SEMIN PERINATOL, V24, P267, DOI 10.1053/sper.2000.9121; Mayes LC, 2006, ANN NY ACAD SCI, V1094, P178, DOI 10.1196/annals.1376.018; Meins E, 2001, J CHILD PSYCHOL PSYC, V42, P637, DOI 10.1111/1469-7610.00759; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Moeller SJ, 2014, JAMA PSYCHIAT, V71, P61, DOI 10.1001/jamapsychiatry.2013.2833; Nazarov A, 2014, ACTA PSYCHIAT SCAND, V129, P193, DOI 10.1111/acps.12142; Nolte T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00816; Nolte T, 2010, J AM PSYCHOANAL ASS, V58, P566; Novick-Kline P, 2005, J ANXIETY DISORD, V19, P557, DOI 10.1016/j.janxdis.2004.06.001; Oppenheim D, 2001, INT J BEHAV DEV, V25, P16, DOI 10.1080/01650250042000096; Parling T, 2010, EAT BEHAV, V11, P205, DOI 10.1016/j.eatbeh.2010.04.001; Pasquier A, 2010, LENCEPHALE, V36, pD97, DOI [10.1016/j.encep.2009.01.007, DOI 10.1016/J.ENCEP.2009.01.007]; Petersen R, 2016, COMPR PSYCHIAT, V64, P12, DOI 10.1016/j.comppsych.2015.10.004; Piaget J., 1974, PSYCHOL INTELLIGENZ; Preissler S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00182; Preller KH, 2014, ADDICT BIOL, V19, P452, DOI 10.1111/adb.12070; Richman MJ, 2015, BRIT J PSYCHIAT, V207, P483, DOI 10.1192/bjp.bp.114.152108; Rommel D, 2013, BRIT J CLIN PSYCHOL, V52, P215, DOI 10.1111/bjc.12010; Sharp C, 2011, J AM ACAD CHILD PSY, V50, P563, DOI 10.1016/j.jaac.2011.01.017; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Stacks AM, 2014, ATTACH HUM DEV, V16, P515, DOI 10.1080/14616734.2014.935452; Stonnington CM, 2013, J PSYCHOSOM RES, V74, P479, DOI 10.1016/j.jpsychores.2013.04.004; Subic-Wrana C, 2005, PSYCHOSOM MED, V67, P483, DOI 10.1097/01.psy.0000160461.19239.13; Subic-Wrana C, 2015, J PSYCHOSOM RES, V78, P625, DOI 10.1016/j.jpsychores.2015.03.125; Subic-Wrana C, 2001, PSYCHOTHERAPEUT, V46, P176, DOI 10.1007/s002780100157; Subic-Wrana C, 2016, DTSCH K PSYCH MED PS; Subic-Wrana C, 2016, Z PSYCHOSOM MED PSYC, V62, P207, DOI 10.13109/zptm.2016.62.3.207; Subic-Wrana C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091846; Subic-Wrana C, 2011, Z PSYCHOSOM MED PSYC, V57, P325, DOI 10.13109/zptm.2011.57.4.325; Subic-Wrana C, 2011, INT J PSYCHOANAL, V92, P289, DOI 10.1111/j.1745-8315.2011.00392.x; Subic-Wrana C, 2010, PSYCHOSOM MED, V72, P404, DOI 10.1097/PSY.0b013e3181d35e83; Sutterby SR, 2012, PSYCHIAT RES, V197, P242, DOI 10.1016/j.psychres.2012.02.014; Taubner S., 2015, KONZEPT MENTALISIERE; Taubner S, 2014, PRAX KINDERPSYCHOL K, V63, P699, DOI 10.13109/prkk.2014.63.9.699; Taubner S, 2013, PSIHOLOGIJA, V46, P177, DOI 10.2298/PSI1302177T; Walker EA, 1999, ARCH GEN PSYCHIAT, V56, P609, DOI 10.1001/archpsyc.56.7.609; Waller E, 2004, J PSYCHOSOM RES, V57, P239, DOI 10.1016/S0022-3999(03)00613-5; Werner H., 1963, SYMBOL FORMATION ORG; Wingenfeld K, 2010, PSYCHOTHER PSYCH MED, V60, P442, DOI 10.1055/s-0030-1247564; Wittchen H.U., 1997, SKID STRUKTURIERTES; Zunhammer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140016	93	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195430	10.1371/journal.pone.0195430	http://dx.doi.org/10.1371/journal.pone.0195430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672540	gold, Green Published, Green Submitted			2022-12-27	WOS:000430446800027
J	Loto, RT				Loto, Roland Tolulope			Electrochemical analysis of the corrosion inhibition effect of trypsin complex on the pitting corrosion of 420 martensitic stainless steel in 2M H2SO4 solution	PLOS ONE			English	Article							PASSIVE FILMS; RESISTANCE	Inhibition effect of trypsin complex (TC) on the pitting corrosion of martensitic stainless steel (type 420) in 1M H2SO4 solution was studied with potentiodynamic polarization, open circuit potential measurement and optical microscopy. TC reduced the corrosion rate of the steel with maximum inhibition efficiency of 80.75%. Corrosion potential shifted anodically due to the electrochemical action of TC. The pitting potential increased from 1.088V(Ag/AgCl) ((3M)) at 0% TC to 1.365V(Ag/AgCl(3M)) at 4% TC. TC shifts the open circuit corrosion potential from -0.270s at 0% TC concentration to -0.255V at 5% TC. The compound completely adsorbed onto the steel according to Langmuir, Frumkin and Temkin isotherms. ATF-FTIR spectroscopy confirmed the inhibition mode to be through surface coverage. Thermodynamic calculations showed physisorption molecular interaction. Corrosion pits are present on the uninhibited 420 morphology in comparison to TC inhibited surface which slightly deteriorated.	[Loto, Roland Tolulope] Covenant Univ, Dept Mech Engn, Ota, Ogun State, Nigeria	Covenant University	Loto, RT (corresponding author), Covenant Univ, Dept Mech Engn, Ota, Ogun State, Nigeria.	tolu.loto@gmail.com	Loto, Tolulope R/C-7956-2015	Loto, Roland Tolulope/0000-0002-1675-8989				Almarshad AI, 2004, J APPL ELECTROCHEM, V34, P67, DOI 10.1023/B:JACH.0000005579.84264.73; [Anonymous], 2011, G103 ASTM; Elayyachy M, 2006, CORROS SCI, V48, P2470, DOI 10.1016/j.corsci.2005.09.016; Guidelli R., 1992, ADSORPTION MOL METAL; Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010; Loto RT, 2016, COGENT CHEM, V2, DOI 10.1080/23312009.2016.1268377; Loto RT, 2017, SURF REV LETT, V24, DOI 10.1142/S0218625X17501219; Loto RT, 2016, ORIENT J CHEM, V32, P2813, DOI 10.13005/ojc/320557; Loto RT, 2016, INT J IND CHEM, V7, P143, DOI 10.1007/s40090-015-0063-7; MAZILLE H, 1995, CORROS SCI, V37, P1365, DOI 10.1016/0010-938X(95)00036-J; Ramana KVS, 2009, MATER DESIGN, V30, P3770, DOI 10.1016/j.matdes.2009.01.039; RAMASUBRAMANIAN N, 1985, J ELECTROCHEM SOC, V132, P793, DOI 10.1149/1.2113959; Ramya S, 2010, CORROS SCI, V52, P2114, DOI 10.1016/j.corsci.2010.02.028; Refaey SAM, 2004, APPL SURF SCI, V236, P175, DOI 10.1016/j.apsusc.2004.04.016; Sastri VS, 1997, CORROSION, V53, P617, DOI 10.5006/1.3290294; Sastri VS., 1998, CORROSION INHIBITORS; Schweitzer P E, 2003, METALLIC MAT PHYS ME, V1, DOI [10.1201/9780203912423, DOI 10.1201/9780203912423]; Schweitzer PA, 2004, ENCY CORROSION TECHN, P432; Souto RM, 2001, CORROSION, V57, P300, DOI 10.5006/1.3290353	19	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195870	10.1371/journal.pone.0195870	http://dx.doi.org/10.1371/journal.pone.0195870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672541	Green Published, Green Submitted, gold			2022-12-27	WOS:000430446800052
J	Booysen, F; Guvuriro, S; Munro, A; Moloi, T; Campher, C				Booysen, Frederik; Guvuriro, Sevias; Munro, Alistair; Moloi, Tshepo; Campher, Celeste			Putting a premium on altruism: A social discounting experiment with South African university students	PLOS ONE			English	Article							RELATIONSHIP CLOSENESS; RECIPROCAL ALTRUISM; DICTATOR GAMES; EVOLUTION; COOPERATION; GENEROSITY; DISTANCE; DELAY	This paper reports on a social discounting experiment conducted with university students in South Africa. In line with other social discounting task experiments, participants identify target individuals at different degrees of intimacy in their social network and then make 10 choices involving sums of money for themselves or their targets. For an altruism premium to exist, senders' donations to recipients should be positive, statistically and economically significant, and independent of relationship closeness. We hypothesize that in addition to the altruism premium for kin documented in the literature, there may be other premia for family in general and for partners and friends. We find that, apart from the "kinship" premium, there is a sizeable "intimacy" premium, which together translates into a substantial "family" premium. The study also finds a "friendship premium", as is documented in various experiments. The closeness of relationships among family and kin, especially close kin, has a significant and large effect on altruism. The results also attest to the importance of the extended family in regards to the "kinship" premium on altruism. These various premiums on altruism emphasise the importance of the supportive role of various social systems. Nevertheless, altruism within families and among close kin might also be enhanced by building more cohesive and stronger families using developmental social welfare programmes.	[Booysen, Frederik] Human Sci Res Council, Populat Hlth Hlth Syst & Innovat, Pretoria, South Africa; [Booysen, Frederik; Guvuriro, Sevias; Moloi, Tshepo; Campher, Celeste] Univ Free State, Dept Econ, Bloemfontein, South Africa; [Munro, Alistair] Natl Grad Inst Policy Studies, Tokyo, Japan	Human Sciences Research Council-South Africa; University of the Free State; National Graduate Institute for Policy Studies	Booysen, F (corresponding author), Human Sci Res Council, Populat Hlth Hlth Syst & Innovat, Pretoria, South Africa.; Booysen, F (corresponding author), Univ Free State, Dept Econ, Bloemfontein, South Africa.	booysenfrikkie@gmail.corn	Munro, Alistair/A-3714-2009; Guvuriro, Sevias/AEW-3295-2022; le R Booysen, Frederik/K-9152-2015; Booysen, Frederik/ABB-2868-2021	Munro, Alistair/0000-0003-3918-8701; Guvuriro, Sevias/0000-0002-1365-3591; le R Booysen, Frederik/0000-0001-7449-3221; 	National Graduate Institute for Policy Studies (GRIPS) [H26-GRIPS-PRC-01]; DST-NRF Centre of Excellence in Human Development [M20150018]; National Research Foundation's (NRF) Human and Social Dynamics Research Programme [ID96132]	National Graduate Institute for Policy Studies (GRIPS); DST-NRF Centre of Excellence in Human Development; National Research Foundation's (NRF) Human and Social Dynamics Research Programme	This work was supported financially by the National Graduate Institute for Policy Studies (GRIPS) (H26-GRIPS-PRC-01) (http://www.grips.ac.jp) to FB, the DST-NRF Centre of Excellence in Human Development (M20150018) (https://www.wits.ac.za/coe-human/) to TM, and the National Research Foundation's (NRF) Human and Social Dynamics Research Programme (ID96132) (http://www.nrf.ac.za/) to FB.	Ale SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063761; Amoateng AY, 2015, S AFR REV SOCIOL, V46, P59, DOI 10.1080/21528586.2015.1109476; Attridge M, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013476054; Baltussen G, 2012, EXP ECON, V15, P418, DOI 10.1007/s10683-011-9306-4; Bechler C, 2015, BEHAV PROCESS, V115, P149, DOI 10.1016/j.beproc.2015.04.003; BERSCHEID E, 1989, J PERS SOC PSYCHOL, V57, P792, DOI 10.1037/0022-3514.57.5.792; Bohnet I, 1999, AM ECON REV, V89, P335, DOI 10.1257/aer.89.1.335; Boyer P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040750; Bradstreet MP, 2012, J BEHAV DECIS MAKING, V25, P502, DOI 10.1002/bdm.750; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Charpak G, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/02/P02006; Curry O, 2013, BRIT J PSYCHOL, V104, P283, DOI 10.1111/j.2044-8295.2012.02119.x; Dibble JL, 2012, PSYCHOL ASSESSMENT, V24, P565, DOI 10.1037/a0026265; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Gachter S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129478; Glenn P. O., 1993, GROUP DECIS NEGOT, V2, P135, DOI [10.1007/BF01884768, DOI 10.1007/BF01884768]; Hamilton E, 2016, FAM PROCESS, V55, P16, DOI 10.1111/famp.12200; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Ito M, 2011, PSYCHOL REC, V61, P59, DOI 10.1007/BF03395746; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; Jones BA, 2009, J EXP ANAL BEHAV, V91, P61, DOI 10.1901/jeab.2009.91-61; Korchmaros JD, 2001, PSYCHOL SCI, V12, P262, DOI 10.1111/1467-9280.00348; Kovarik J, 2012, PHYSICA A, V391, P849, DOI 10.1016/j.physa.2011.08.040; Kurzban R, 2015, ANNU REV PSYCHOL, V66, P575, DOI 10.1146/annurev-psych-010814-015355; Leider S, 2009, Q J ECON, V124, P1815, DOI 10.1162/qjec.2009.124.4.1815; Mandel DR, 2006, J CONFLICT RESOLUT, V50, P584, DOI 10.1177/0022002706290432; Margittai Z, 2015, HORM BEHAV, V73, P75, DOI 10.1016/j.yhbeh.2015.05.019; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Olson EA, 2016, J BEHAV DECIS MAKING, V29, P60, DOI 10.1002/bdm.1876; Osinski J, 2009, PERS INDIV DIFFER, V47, P374, DOI 10.1016/j.paid.2009.04.011; Ostaszewski P, 2011, EUR PSYCHOL, V16, P220, DOI 10.1027/1016-9040/a000054; Peterson D.R., 1983, CLOSE RELATIONSHIPS; Rachlin H, 2008, BEHAV PROCESS, V79, P120, DOI 10.1016/j.beproc.2008.06.002; Rachlin H, 2008, J BEHAV DECIS MAKING, V21, P29, DOI 10.1002/bdm.567; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Sharp C, 2012, J BEHAV DECIS MAKING, V25, P239, DOI 10.1002/bdm.719; Strombach T, 2014, J BEHAV DECIS MAKING, V27, P235, DOI 10.1002/bdm.1802; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x	39	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196175	10.1371/journal.pone.0196175	http://dx.doi.org/10.1371/journal.pone.0196175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664969	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300059
J	Lestini, E; Andrei, C; Zerulla, D				Lestini, Elena; Andrei, Codrin; Zerulla, Dominic			Linear self-assembly and grafting of gold nanorods into arrayed micrometer-long nanowires on a silicon wafer via a combined top-down/bottom-up approach	PLOS ONE			English	Article							WET CHEMICAL SYNTHESIS; X-RAY PHOTOELECTRON; ASPECT-RATIO; SILVER NANORODS; NANOPARTICLES; SURFACES; MANIPULATION; REDUCTION; GROWTH; THIOL	Macroscopically long wire-like arrangements of gold nanoparticles were obtained by controlled evaporation and partial coalescence of an aqueous colloidal solution of capped CTAB-Au nanorods onto a functionalised 3-mercaptopropyl trimethoxysilane (MPTMS) silicon substrate, using a removable, silicon wafer with a hydrophobic surface that serves as a "handrail" for the initial nanorods' linear self-assembly. The wire-like structures display a quasi-continuous pattern by thermal annealing of the gold nanorods when the solvent (i.e. water) is evaporated at temperatures rising from 20 degrees C to 140 degrees C. Formation of both single and self-replicating parallel 1D-superstructures consisting of two or even three wires is observed and explained under such conditions.	[Lestini, Elena; Andrei, Codrin; Zerulla, Dominic] Univ Coll Dublin, Sch Phys, Sci Ctr North, Dublin, Ireland; [Andrei, Codrin] Univ Coll Dublin, Sch Math & Stat, Sci Ctr South, Dublin, Ireland	University College Dublin; University College Dublin	Zerulla, D (corresponding author), Univ Coll Dublin, Sch Phys, Sci Ctr North, Dublin, Ireland.	dominic.zerulla@ucd.ie	Zerulla, Dominic/L-6090-2018	Zerulla, Dominic/0000-0001-8479-9654	Science Foundation Ireland [11/RFP/MTR/3113]; Enterprise Ireland (Core VANTA project)	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Enterprise Ireland (Core VANTA project)	The authors acknowledge financial support of Science Foundation Ireland (Grant Number 11/RFP/MTR/3113) and Enterprise Ireland (Core VANTA project) to DZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge financial support of Science Foundation Ireland (Grant No 11/RFP/MTR/3113) and Enterprise Ireland (Core VANTA project).	Andrei C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109836; Ashall B, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2806224; Aslan K, 2005, J PHYS CHEM B, V109, P3157, DOI 10.1021/jp045186t; Barmparis GD, 2016, MATERIALS, V9, DOI 10.3390/ma9040301; Busbee BD, 2003, ADV MATER, V15, P414, DOI 10.1002/adma.200390095; Carballido-Landeira J, 2012, CHEMPHYSCHEM, V5, P1347; Castner DG, 1996, LANGMUIR, V12, P5083, DOI 10.1021/la960465w; Caswell KK, 2003, J AM CHEM SOC, V125, P13914, DOI 10.1021/ja037969i; Courty A, 2007, NAT MATER, V6, P900, DOI 10.1038/nmat2004; Dewi MR, 2014, RSC ADV, V4, P34217, DOI 10.1039/c4ra05035e; Doyle G, 2007, APPL PHYS A-MATER, V89, P351, DOI 10.1007/s00339-007-4126-2; Dujardin E, 2001, CHEM COMMUN, P1264, DOI 10.1039/b102319p; ESUMI K, 1995, LANGMUIR, V11, P3285, DOI 10.1021/la00009a002; Farcau C, 2010, ACS NANO, V4, P7275, DOI 10.1021/nn102128w; Ferry DK, 2008, SCIENCE, V319, P579, DOI 10.1126/science.1154446; GRUNDNER M, 1986, APPL PHYS A-MATER, V39, P73, DOI 10.1007/BF00616822; Gui Chen, 2012, Cancer Biology Medicine, V9, P221, DOI 10.7497/j.issn.2095-3941.2012.04.002; Halder A, 2007, ADV MATER, V19, P1854, DOI 10.1002/adma.200602325; Hanafusa T., CONTROLLING SELFASSE; Hsieh SC, 2002, J PHYS CHEM B, V106, P231, DOI 10.1021/jp012747x; Hu JQ, 2004, ADV FUNCT MATER, V14, P183, DOI 10.1002/adfm.200304421; Hu MH, 2001, APPL SURF SCI, V181, P307, DOI 10.1016/S0169-4332(01)00399-3; Hu M, 2006, CHEM SOC REV, V35, P1084, DOI 10.1039/b517615h; Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789; Huo ZY, 2008, NANO LETT, V8, P2041, DOI 10.1021/nl8013549; Isfort G, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.033408; Isfort G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.033404; Jana NR, 2001, CHEM COMMUN, P617, DOI 10.1039/b100521i; Jana NR, 2002, J MATER CHEM, V12, P2909, DOI 10.1039/b205225c; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; de Aberasturi DJ, 2016, CHEM MATER, V28, P6779, DOI 10.1021/acs.chemmater.6b03349; Kim F, 2002, J AM CHEM SOC, V124, P14316, DOI 10.1021/ja028110o; Laurent G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045430; Lee MT, 1998, LANGMUIR, V14, P6419, DOI 10.1021/la980724c; Li B, 2015, NANO LETT, V15, P6722, DOI 10.1021/acs.nanolett.5b02582; Li YN, 2011, LANGMUIR, V27, P98, DOI 10.1021/la104131y; Li YN, 2005, J AM CHEM SOC, V127, P3266, DOI 10.1021/ja043425k; Lin J, 2001, MATER LETT, V49, P282, DOI 10.1016/S0167-577X(00)00385-2; Lu XM, 2008, J AM CHEM SOC, V130, P8900, DOI 10.1021/ja803343m; Luderitz LAC, 2013, J COLLOID INTERF SCI, V402, P19, DOI 10.1016/j.jcis.2012.11.007; Mbindyo JKN, 2001, ADV MATER, V13, P249, DOI 10.1002/1521-4095(200102)13:4<249::AID-ADMA249>3.0.CO;2-9; Mikhlin Y, 2010, J ELECTRON SPECTROSC, V177, P24, DOI 10.1016/j.elspec.2009.12.007; Millstone JE, 2005, J AM CHEM SOC, V127, P5312, DOI 10.1021/ja043245a; Ming T, 2008, ANGEW CHEM INT EDIT, V47, P9685, DOI 10.1002/anie.200803642; Moon SY, 2010, NANOSCALE RES LETT, V5, P813, DOI 10.1007/s11671-010-9565-6; Munekata T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052314; Niidome Y, 2003, CHEM COMMUN, P2376, DOI 10.1039/b307836a; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Nikoobakht B, 2000, J PHYS CHEM B, V104, P8635, DOI 10.1021/jp001287p; Norman TJ, 2002, J PHYS CHEM B, V106, P7005, DOI 10.1021/jp0204197; Ormonde A. D., NANOSPEHERE LITOGRAP; Perez-Juste J, 2005, COORDIN CHEM REV, V249, P1870, DOI 10.1016/j.ccr.2005.01.030; Perez-Juste J, 2004, ADV FUNCT MATER, V14, P571, DOI 10.1002/adfm.200305068; Pluchery O, 2016, MRS P, V1817, P60; Rawtani D, 2015, REV ADV MATER SCI, V40, P177; Rodriguez-Leon E, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0804-8; Scarabelli L, 2015, J PHYS CHEM LETT, V6, P4270, DOI 10.1021/acs.jpclett.5b02123; Schubert I, 2016, ADV OPT MATER, V4, P1838, DOI 10.1002/adom.201600430; Schwartzberg AM, 2007, J PHYS CHEM C, V111, P8892, DOI 10.1021/jp067697g; Shi DW, 2013, CHEM COMMUN, V49, P2533, DOI 10.1039/c3cc39093d; Smith PA, 2000, APPL PHYS LETT, V77, P1399, DOI 10.1063/1.1290272; Srivastava S, 2009, SOFT MATTER, V5, P1146, DOI 10.1039/b812115j; Sun YG, 2002, CHEM MATER, V14, P4736, DOI 10.1021/cm020587b; TORIGOE K, 1992, LANGMUIR, V8, P59, DOI 10.1021/la00037a013; Utgenannt A, 2016, ACS NANO, V10, P2232, DOI 10.1021/acsnano.5b06886; Wei ZQ, 2004, LANGMUIR, V20, P4322, DOI 10.1021/la049702i; Wirde M, 1997, NUCL INSTRUM METH B, V131, P245, DOI 10.1016/S0168-583X(97)00140-7; Xiao JY, 2014, NANOSCALE, V6, P996, DOI 10.1039/c3nr05343a; Xiong YJ, 2003, ADV MATER, V15, P405, DOI 10.1002/adma.200390092; Yu YY, 1997, J PHYS CHEM B, V101, P6661; Zerulla D, 1999, LANGMUIR, V15, P5285, DOI 10.1021/la980300i; Zerulla D, 1998, SURF SCI, V402, P604, DOI 10.1016/S0039-6028(98)00015-6; Zhang FX, 2004, LANGMUIR, V20, P2309, DOI 10.1021/la0354638; Zhang Y, 2012, LANGMUIR, V28, P17101, DOI 10.1021/la302290v; Zhang Y, 2012, ADV MATER, V24, P2485, DOI 10.1002/adma.201103991; Zhang Y, 2011, LANGMUIR, V27, P15292, DOI 10.1021/la203863p; Zweifel DA, 2005, CHEM MATER, V17, P4256, DOI 10.1021/cm0506858	77	3	3	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195859	10.1371/journal.pone.0195859	http://dx.doi.org/10.1371/journal.pone.0195859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664920	gold, Green Submitted, Green Published			2022-12-27	WOS:000430262300039
J	Okamoto, M; Miyake, T; Kitai, K; Furukawa, S; Yamamoto, S; Senba, H; Kanzaki, S; Deguchi, A; Koizumi, M; Ishihara, T; Miyaoka, H; Yoshida, O; Hirooka, M; Kumagi, T; Abe, M; Matsuura, B; Hiasa, Y				Okamoto, Masashi; Miyake, Teruki; Kitai, Kohichiro; Furukawa, Shinya; Yamamoto, Shin; Senba, Hidenori; Kanzaki, Sayaka; Deguchi, Akiko; Koizumi, Mitsuhito; Ishihara, Toru; Miyaoka, Hiroaki; Yoshida, Osamu; Hirooka, Masashi; Kumagi, Teru; Abe, Masanori; Matsuura, Bunzo; Hiasa, Yoichi			Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study	PLOS ONE			English	Article							MODERATE ALCOHOL-CONSUMPTION; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; ACTIVE SMOKING; TRANSFERASE; ADIPONECTIN; POPULATION; PREVALENCE; PREDICTOR; NAFLD	Background The effect of cigarette smoking on the onset of nonalcoholic fatty liver disease (NAFLD) is unclear, especially that associated with drinking small amounts of alcohol. We conducted a longitudinal study to investigate the relationship between cigarette smoking and NAFLD onset, which was stratified according to the amount of alcohol consumed. Methods We enrolled 7,905 Japanese subjects who had received annual health checkups more than twice between April 2003 and August 2013, 4,045 of whom met at least one of the following exclusion criteria and were excluded: (a) fatty liver at baseline; (b) hepatitis B or hepatitis C; (c) alcohol consumption (men: >= 210 g/wk; women: >= 140 g/wk); (d) change in alcohol drinking status between baseline and the study's endpoint; (e) change in cigarette smoking habits between baseline and the study's endpoint; or (f) current treatment with antidiabetic agents, antihypertensive agents, and/or lipid-lowering agents. The remaining 3,860 subjects (1,512 men, 2,348 women) were divided into two groups based on average alcohol consumption. Results After adjusting for the variables associated with metabolic disease, smoking was associated with fatty liver disease onset compared with nonsmokers in nondrinkers (adjusted hazard ratio = 1.988, 95% confidence interval 1.057-3.595; p = 0.034). No association was found between smoking and fatty liver disease onset in the low alcohol consumption group (men: <210 g alcohol/week; women: <140 g alcohol/week). The fatty liver disease incidence increased significantly among the nondrinkers as the number of cigarettes smoked increased (p = 0.001). Conclusions Cigarette smoking may be a significant risk factor associated with NAFLD onset in nondrinkers. These results may help clinicians to identify patients who are at a high risk of developing NAFLD and to prevent the progression of NAFLD by promoting earlier interventions that help people discontinue unhealthy lifestyle habits.	[Okamoto, Masashi; Miyake, Teruki; Senba, Hidenori; Kanzaki, Sayaka; Deguchi, Akiko; Koizumi, Mitsuhito; Ishihara, Toru; Yoshida, Osamu; Hirooka, Masashi; Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Toon, Ehime, Japan; [Kitai, Kohichiro; Koizumi, Mitsuhito; Ishihara, Toru] Ehime Gen Hlth Care Assoc, Matsuyama, Ehime, Japan; [Furukawa, Shinya] Ehime Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Toon, Ehime, Japan; [Furukawa, Shinya] Ehime Univ Hosp, Epidemiol & Med Stat Unit, Translat Res Ctr, Toon, Ehime, Japan; [Yamamoto, Shin; Matsuura, Bunzo] Ehime Univ, Dept Lifestyle Related Med & Endocrinol, Grad Sch Med, Toon, Ehime, Japan; [Miyaoka, Hiroaki] Saiseikai Matsuyama Hosp, Dept Internal Med, Matsuyama, Ehime, Japan; [Kumagi, Teru] Ehime Univ, Dept Community Med, Grad Sch Med, Toon, Ehime, Japan	Ehime University; Ehime University; Ehime University; Ehime University; Ehime University	Miyake, T (corresponding author), Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Toon, Ehime, Japan.	teruki-ygc@umin.ac.jp	Furukawa, Shinya/ABB-2804-2020; Kumagi, Teru/AAS-7427-2021; Hiasa, Yoichi/ABD-2759-2021	Furukawa, Shinya/0000-0002-0041-7688; Kumagi, Teru/0000-0002-2292-7750; Hiasa, Yoichi/0000-0003-4117-339X; Miyake, Teruki/0000-0002-9905-5356	Japanese Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI) [15K00874, 15K09006]; Ehime University	Japanese Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ehime University	This work was supported in part by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI 15K00874 to T.M., 15K09006 to Y.H.), and a research grant from Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI 15K00874 to T.M., 15K09006 to Y.H.) and a research grant from Ehime University.	Akbar DH, 2003, DIABETES CARE, V26, P3351, DOI 10.2337/diacare.26.12.3351-a; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Azzalini L, 2010, HEPATOLOGY, V51, P1567, DOI 10.1002/hep.23516; Bae JC, 2011, DIABETES CARE, V34, P727, DOI 10.2337/dc10-1991; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chavez-Tapia NC, 2006, WORLD J GASTROENTERO, V12, P5196; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Fromenty B, 2009, J PHARMACOL EXP THER, V331, P23, DOI 10.1124/jpet.109.155168; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Hamabe A, 2011, J GASTROENTEROL, V46, P769, DOI 10.1007/s00535-011-0376-z; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Ishigami T, 2014, CLIN EXP NEPHROL, V18, P899, DOI 10.1007/s10157-014-0938-5; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Lin C, 2014, ENVIRON RES, V132, P264, DOI 10.1016/j.envres.2014.04.005; Liu Y, 2013, J EPIDEMIOL, V23, P115, DOI 10.2188/jea.JE20120067; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MENDELOFF AI, 1954, J CLIN INVEST, V33, P1298, DOI 10.1172/JCI103005; Moriya A, 2015, J HEPATOL, V62, P921, DOI 10.1016/j.jhep.2014.11.025; Oniki K, 2013, TOXICOL LETT, V220, P143, DOI 10.1016/j.toxlet.2013.04.019; Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; Yuan HW, 2009, J HEPATOL, V51, P535, DOI 10.1016/j.jhep.2009.03.026	26	22	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195147	10.1371/journal.pone.0195147	http://dx.doi.org/10.1371/journal.pone.0195147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664906	Green Published, gold			2022-12-27	WOS:000430262300015
J	Dechner, A; Flesher, KM; Lindell, C; de Oliveira, TV; Maurer, BA				Dechner, Andrea; Flesher, Kevin M.; Lindell, Catherine; de Oliveira, Teo Vega; Maurer, Brian A.			Determining carnivore habitat use in a rubber/forest landscape in Brazil using multispecies occupancy models	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; ATLANTIC FOREST; SOUTHERN BAHIA; CAMERA TRAPS; NASUA-NASUA; WILDLIFE; SELECTION; IMPACTS; CONSERVATION; DISTURBANCE	Understanding the factors that influence the presence and distribution of carnivores in human-dominated agricultural landscapes is one of the main challenges for biodiversity conservation, especially in landscapes where setting aside large protected areas is not feasible. Habitat use models of carnivore communities in rubber plantations are lacking despite the critical roles carnivores play in structuring ecosystems and the increasing expansion of rubber plantations. We investigated the habitat use of a mammalian carnivore community within a 4,200-ha rubber plantation/forest landscape in Bahia, Brazil. We placed two different brands of camera traps in a 90-site grid. We used a multispecies occupancy model to determine the probabilities of habitat use by each species and the effect of different brands of camera traps on their detection probabilities. Species showed significant differences in habitat use with domestic dogs (Canis familiaris) and crab-eating foxes (Cerdocyon thous) having higher probabilities of using rubber groves and coatis (Nasua nasua) having a higher probability of using forest. The moderate level of captures and low detection probabilities (<= 0.1) of tayras (Eira barbara) and wildcats (Leopardus spp.) precluded a precise estimation of habitat use probabilities using the multispecies occupancy model. The different brands of camera traps had a significant effect on the detection probability of all species. Given that the carnivore community has persisted in this 70-year-old landscape, the results show the potential of rubber/forest landscapes to provide for the long-term conservation of carnivore communities in the Atlantic forest, especially in mosaics with 30-40% forest cover and guard patrolling systems. The results also provide insights for mitigating the impact of rubber production on biodiversity.	[Dechner, Andrea; Maurer, Brian A.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Dechner, Andrea; Lindell, Catherine; Maurer, Brian A.] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Flesher, Kevin M.] Reserva Ecol Michelin, Ctr Estudos Biodiversidade, Igrapiuna, BA, Brazil; [Lindell, Catherine] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Lindell, Catherine] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [de Oliveira, Teo Vega] Univ Estadual Feira de Santana, Div Mamiferos, Dept Ciencias Biol, Museu Zool, Feira De Santana, BA, Brazil; [Maurer, Brian A.] Michigan State Univ, Ctr Stat Training & Consulting, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Universidade Estadual de Feira de Santana; Michigan State University	Dechner, A (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.; Dechner, A (corresponding author), Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	dechners@msu.edu		Dechner, Andrea/0000-0002-9704-6798	Reserva Ecologica Michelin, Bahia, Brazil; Michelin	Reserva Ecologica Michelin, Bahia, Brazil; Michelin	This work was funded in whole by a grant to AD from Reserva Ecologica Michelin, Bahia, Brazil. The funder also provided support in the form of salaries for KMF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; We thank Michelin for logistical and financial support, and the Michelin personnel who helped on a daily basis, especially Sonia Freitas da Hora, Tipo da Lapa and Andre Souza dos Santos. We also thank Lauren Philips for her help identifying the Leopardus species, often difficult to distinguish in the photographs. We thank Bernardo Maestrini for his comments on the manuscript. Finally, we thank the editor and the anonymous reviewers who made valuable comments that improved the manuscript.	[Anonymous], 2015, BASIC STEPS GEOSTATI; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; Beissinger SR, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P413, DOI 10.1016/B978-0-12-387020-9.00013-4; Broms KM, 2016, ECOLOGY, V97, P1759, DOI 10.1890/15-1471.1; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Caruso N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150488; Cassano CR, 2012, BIOTROPICA, V44, P818, DOI 10.1111/j.1744-7429.2012.00870.x; Cassano CR, 2009, BIODIVERS CONSERV, V18, P577, DOI 10.1007/s10531-008-9526-x; Cove MV, 2013, TROP CONSERV SCI, V6, P781, DOI 10.1177/194008291300600606; DANIELSON BJ, 1992, EVOL ECOL, V6, P399, DOI 10.1007/BF02270700; DeMatteo KE, 2008, BIOL CONSERV, V141, P2494, DOI 10.1016/j.biocon.2008.07.010; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Estevo CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179489; FAO JRC, 2012, GLOB FOR LAND US CHA; Flesher K., 2006, BIOGEOGRAPHY MEDIUM; Flesher KM, 2013, TROP CONSERV SCI, V6, P181, DOI 10.1177/194008291300600202; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Frigeri E, 2014, TROP CONSERV SCI, V7, P508, DOI 10.1177/194008291400700310; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gompper Matthew E., 1998, Mammalian Species, V580, P1; Hughson DL, 2010, CALIF FISH GAME, V96, P101; Jansen P.A., 2014, PROTOCOL CAMERA TRAP; Jean Desbiez Arnaud Leonard, 2010, Small Carnivore Conservation, V42, P14; Kerry R, 2007, COMPUT GEOSCI-UK, V33, P1212, DOI 10.1016/j.cageo.2007.05.008; Kucera TE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P9, DOI 10.1007/978-4-431-99495-4_2; Lacerda ACR, 2009, ANIM CONSERV, V12, P477, DOI 10.1111/j.1469-1795.2009.00277.x; Lyra-Jorge MC, 2008, BIODIVERS CONSERV, V17, P1573, DOI 10.1007/s10531-008-9366-8; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McDonald PJ, 2017, CONSERV BIOL, V31, P1183, DOI 10.1111/cobi.12905; Meek P, 2016, ECOL EVOL, V6, P3216, DOI 10.1002/ece3.2111; Ministry of Agriculture of Brazil, GOV EST PROD BORR AT; Mudappa D, 2007, SMALL CARNIVORE CONS, V36, P18; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; Paschoal AMO, 2012, MAMMALIA, V76, P67, DOI 10.1515/mammalia-2012-0501; R Core Team, 2015, R LANGUAGE ENV STAT; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Rocha-Santos L, 2012, TROP CONSERV SCI, V5, P475, DOI 10.1177/194008291200500406; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Schlexer FV., 2008, NONINVASIVE SURVEY M; TEAM Network, 2011, TERRESTRIAL VERTEBRA; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tobler MW, 2015, J APPL ECOL, V52, P413, DOI 10.1111/1365-2664.12399; Trolle M, 2003, BIODIVERS CONSERV, V12, P823, DOI 10.1023/A:1022489426920; Trovati RG, 2010, REV BIOL TROP, V58, P1069; Vieira EM, 2007, J ZOOL, V272, P57, DOI 10.1111/j.1469-7998.2006.00237.x; Warren-Thomas E, 2015, CONSERV LETT, V8, P230, DOI 10.1111/conl.12170; Weather CP, 2000, USING STAT UNDERSTAN; Weingarth K, 2013, WALDOKOL LANDSCH FOR, V13, P87; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	55	7	9	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195311	10.1371/journal.pone.0195311	http://dx.doi.org/10.1371/journal.pone.0195311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659594	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100013
J	Lopez-Lopez, J; Garay, J; Wandurraga, E; Camacho, PA; Higuera-Escalante, F; Cohen, D; Lopez-Jaramillo, P				Lopez-Lopez, Jose; Garay, Jennifer; Wandurraga, Edwin; Camacho, Paul A.; Higuera-Escalante, Fernando; Cohen, Daniel; Lopez-Jaramillo, Patricio			The simultaneous assessment of glycosylated hemoglobin, fasting plasma glucose and oral glucose tolerance test does not improve the detection of type 2 diabetes mellitus in Colombian adults	PLOS ONE			English	Article							A1C; PREVALENCE; DIAGNOSIS; HBA(1C)	Introduction Guidelines recommend early detection of type 2 diabetes mellitus (DM2). The objective of the present study was to evaluate the capacity to identify DM2 in subjects that were screened for DM2 simultaneously with all three of the tests recommended-fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c) and a 2-hour post 75-g oral glucose tolerance test (OGTT). Methods and results The present analysis of an anonymous database of 1113 adults from a reference clinical laboratory in Bucaramanga, Colombia, was an observational, descriptive, cross-sectional secondary source study. 259 individuals met at least one of the criteria for DM2: FPG >= 126mg/dL (7.0mmol/L), HbA1c >= 6.5% (48mmol/mol) and OGTT >= 200mg/dL (11.1mmol/L). 30 subjects (2.7%) were diabetic according to FPG, 56 subjects (5.0%) by HbA1c and 250 subjects (22.5%) by OGTT. In total 259 subjects (23.3% [IC 95%: 20.7%-25.8%] were diabetic either by FPG, OGTT or HbA1c. Discussion The largest number of patients were identified as diabetic with the OGTT. The combination of two or three tests did not increase the detection of new cases of DM2. Our findings suggest that routinely requesting FPG, OGTT and HbA1c at the same time may be inappropriate in at risk individuals, as this approach does not significantly improve the diagnostic capacity compared to using FPG+OGTT and substantially increases the financial burden on the health system, insurers or individual.	[Lopez-Lopez, Jose; Garay, Jennifer] Univ Autonoma Bucaramanga UNAB, Internal Med Residence Program, Bucaramanga, Colombia; [Wandurraga, Edwin] Fdn Oftalmol Santander Clin Carlos Ardila Lulle F, Endocrinol Serv, Floridablanca, Colombia; [Camacho, Paul A.; Cohen, Daniel; Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander FOSCAL, Res Dept, Floridablanca, Colombia; [Camacho, Paul A.] Univ Autonoma Bucaramanga UNAB, Fac Ciencias Salud, Bucaramanga, Colombia; [Higuera-Escalante, Fernando] Higuera Escalante Lab, Floridablanca, Colombia; [Cohen, Daniel; Lopez-Jaramillo, Patricio] Univ Santander UDES, MASIRA Inst, Fac Salud, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Autonoma Bucaramanga UNAB, Fac Ciencias Salud, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Tecnol Equinoccial, Fac Ciencias Salud Eugenio Espejo, Quito, Ecuador	Universidad Industrial de Santander	Lopez-Jaramillo, P (corresponding author), Fdn Oftalmol Santander FOSCAL, Res Dept, Floridablanca, Colombia.; Lopez-Jaramillo, P (corresponding author), Univ Santander UDES, MASIRA Inst, Fac Salud, Bucaramanga, Colombia.; Lopez-Jaramillo, P (corresponding author), Univ Autonoma Bucaramanga UNAB, Fac Ciencias Salud, Bucaramanga, Colombia.; Lopez-Jaramillo, P (corresponding author), Univ Tecnol Equinoccial, Fac Ciencias Salud Eugenio Espejo, Quito, Ecuador.	jplopezj@gmail.com		Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Camacho, Paul Anthony/0000-0002-6233-9582				American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Aschner PMV, 2016, COLOMB MEDICA, V2, P109; Barengo NC, 2013, RES REV, DOI [10.1002/dmrr.2462/abstract;jsessionid=1A94693CE7178B9B15B98BB652FEA7D1.f01t04, DOI 10.1002/DMRR.2462/ABSTRACT;JSESSI0NID=]; Barry E, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6538; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Cavagnolli G, 2011, DIABETIC MED, V28, P31, DOI 10.1111/j.1464-5491.2010.03159.x; Choi SH, 2011, DIABETES CARE, V34, P944, DOI 10.2337/dc10-0644; Dagenais GR, 2016, DIABETES CARE, V39, P780, DOI 10.2337/dc15-2338; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; Ehehalt S, 2017, EUR J PEDIATR, V176, P89, DOI 10.1007/s00431-016-2807-6; Gomez-Arbelaez D, 2015, WORLD J DIABETES, V6, P1337, DOI 10.4239/wjd.v6.i17.1337; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; Karnchanasorn R, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/6195494; Kumaravel B, 2012, DIABETES RES CLIN PR, V96, P211, DOI 10.1016/j.diabres.2011.12.004; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Lopez-Jaramillo P, 2014, WORLD J DIABETES, V5, P747, DOI 10.4239/wjd.v5.i6.747; Man B, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160106; Millard AV, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00135; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Shibata K, 2005, J CLIN EPIDEMIOL, V58, P1052, DOI 10.1016/j.jclinepi.2005.01.019; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tunceli K, 2005, DIABETES CARE, V28, P2662, DOI 10.2337/diacare.28.11.2662; Warren B, 2017, LANCET DIABETES ENDO, V5, P34, DOI 10.1016/S2213-8587(16)30321-7; World Health Organization, 2011, US GLYC HAEM HBA1C D	26	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194446	10.1371/journal.pone.0194446	http://dx.doi.org/10.1371/journal.pone.0194446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652881	Green Published, gold, Green Submitted			2022-12-27	WOS:000430026900006
J	Tauras, JA; Xu, X; Huang, JD; King, B; Lavinghouze, SR; Sneegas, KS; Chaloupka, FJ				Tauras, John A.; Xu, Xin; Huang, Jidong; King, Brian; Lavinghouze, S. Rene; Sneegas, Karla S.; Chaloupka, Frank J.			State tobacco control expenditures and tax paid cigarette sales	PLOS ONE			English	Article							CONTROL PROGRAMS; IMPACT	This research is the first nationally representative study to examine the relationship between actual state-level tobacco control spending in each of the 5 CDC's Best Practices for Comprehensive Tobacco Control Program categories and cigarette sales. We employed several alternative two-way fixed-effects regression techniques to estimate the determinants of cigarette sales in the United States for the years 2008-2012. State spending on tobacco control was found to have a negative and significant impact on cigarette sales in all models that were estimated. Spending in the areas of cessation interventions, health communication interventions, and state and community interventions were found to have a negative impact on cigarette sales in all models that were estimated, whereas spending in the areas of surveillance and evaluation, and administration and management were found to have negative effects on cigarette sales in only some models. Our models predict that states that spend up to seven times their current levels could still see significant reductions in cigarette sales. The findings from this research could help inform further investments in state tobacco control programs.	[Tauras, John A.] Univ Illinois, Dept Econ, Chicago, IL 60680 USA; [Xu, Xin; King, Brian; Lavinghouze, S. Rene; Sneegas, Karla S.] Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA USA; [Huang, Jidong] Georgia State Univ, Dept Hlth Management & Policy, Atlanta, GA 30303 USA; [Chaloupka, Frank J.] Univ Illinois, Div Hlth Policy & Adm, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tauras, JA (corresponding author), Univ Illinois, Dept Econ, Chicago, IL 60680 USA.	tauras@uic.edu		Xu, Xin/0000-0002-5219-499X				Abt Associates Inc, 1999, IND EV MASS TOB CONT; Arizona Department of Health Services, 1999, 1999 AR AD TOB SURV; Bauer UE, 2000, JAMA-J AM MED ASSOC, V284, P723, DOI 10.1001/jama.284.6.723; Biener L, 2000, BRIT MED J, V321, P351, DOI 10.1136/bmj.321.7257.351; Campaign for Tobacco Free Kids, 2015, BROK PROM OUR CHILDR; *CDCP, 1999, BEST PRACT COMPR TOB; Center for Disease Control and Prevention, 2014, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention, 2007, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P140; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P966; Ciecierski CC, 2011, HEALTH ECON, V20, P253, DOI 10.1002/hec.1583; Farrelly MC, 2008, AM J PUBLIC HEALTH, V98, P304, DOI 10.2105/AJPH.2006.106377; Farrelly MC, 2003, J HEALTH ECON, V22, P843, DOI 10.1016/S0167-6296(03)00057-2; Florida Department of Health, 2001, 1 FLOR DEP HLTH BUR, V4; Gilpin EA, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015370; Hansen BE, 1999, J ECONOMETRICS, V93, P345, DOI 10.1016/S0304-4076(99)00025-1; Huang J, 2014, STATE TOBACCO CONTRO; Huang J., 2013, TOB CONTROL, V23, piii41, DOI DOI 10.1136/TOBACCONTROL-2013-051515; Institute of Medicine, 2007, END TOB PROBL BLUE P; Lavinghouze R, 2013, J PUBLIC HEALTH MAN, V19, pE28, DOI 10.1097/PHH.0b013e31828554c8; Lavinghouze SR, 2014, AM J PUBLIC HEALTH, V104, pE14, DOI 10.2105/AJPH.2014.302033; Lightwood J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047145; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; MALLOWS CL, 1986, TECHNOMETRICS, V28, P313, DOI 10.2307/1268980; Manley M W, 1997, Tob Control, V6 Suppl 2, pS12, DOI 10.1136/tc.6.suppl_2.S12; Massachusetts Department of Public Health, 2000, AD TOB US MASS TREND; *NAT ASS ATT GEN, MAST SETTL AGR; Orzechowski W, 2013, TAX BURDEN TOBACCO H; Tauras JA, 2005, AM J PUBLIC HEALTH, V95, P338, DOI 10.2105/AJPH.2004.039727; U. S. Bureau of Labor Statistics, 2014, LOC AR UN STAT; U. S. Census Bureau, 2014, POP EST HIST DAT; U. S. Census Bureau, 2014, POP EST ED ATT; US Bureau of Labor Statistics, 2014, CONS PRIC IND; US Department of Health and Human Services, 2000, RED TOB US REP SURG; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Wakefield M, 2000, TOB CONTROL, V9, P177, DOI 10.1136/tc.9.2.177	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e194914	10.1371/journal.pone.0194914	http://dx.doi.org/10.1371/journal.pone.0194914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652890	gold, Green Published, Green Submitted			2022-12-27	WOS:000430026900014
J	Thielmann, A; Gerasimovska-Kitanovska, B; Koskela, TH; Mevsim, V; Weltermann, B				Thielmann, Anika; Gerasimovska-Kitanovska, Biljana; Koskela, Tuomas H.; Mevsim, Vildan; Weltermann, Birgitta		European General Practice Res	Self-care for common colds: A European multicenter survey on the role of subjective discomfort and knowledge about the self-limited course - The COCO study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED TRIAL; THE-COUNTER MEDICATION; ATTITUDES; ILLNESS; IMPACT; INFECTIONS; MANAGEMENT; COMMUNITY; BOOKLETS	Introduction Common colds are the most frequently encountered disease worldwide and the most frequent reason for self-care. According to the cross-sectional European Common Colds study (COCO), patients use as many as 12 items on average for self-care. Little is known about the influence of discomfort and knowledge on self-care for common colds. Main objective To understand the influence of patients' discomfort during a cold and their knowledge about the self-limited disease course on the use of self-care measures. Materials and methods This COCO analysis included 2,204 patients from 22 European primary care sites in 12 countries. Each site surveyed 120 consecutive adults with a 27-item questionnaire asking about patients' self-care, subjective discomfort during a cold (discomfort: yes/no), and knowledge about the self-limited course (yes/no). Country-specific medians of the number of self-care items served as a cut-off to define high and low self-care use. Four groups were stratified based on discomfort (yes/no) and knowledge (yes/no). Results Participants' mean age was 46.5 years, 61.7% were female; 36.3% lacked knowledge; 70.6% reported discomfort. The group has discomfort/no knowledge exhibited the highest mean item use (13.3), followed by has discomfort/has knowledge (11.9), no discomfort/no knowledge (11.1), and no discomfort/has knowledge (8.8). High use was associated with discomfort (OR 1.8; CI 1.5-2.2), female gender (OR 1.7; 1.4-2.0), chronic pain/arthritis (OR 1.6; 1.2-2.1), more years of education (OR 1.3; 1.1-1.6), age <48 years (OR 1.3; 1.0-1.5), and lack of knowledge (OR 1.2; 1.0-1.4). Discussion Counseling on common colds should address patients' discomfort and soothing measures in addition to providing information on the natural disease course.	[Thielmann, Anika] Univ Duisburg Essen, Univ Hosp Essen, Inst Gen Med, Essen, Germany; [Gerasimovska-Kitanovska, Biljana] Univ St Cyril & Methodius, Dept Family Med, Dept Nephrol, Skopje, Macedonia; [Koskela, Tuomas H.] Univ Tampere, Dept Gen Practice, Tampere, Finland; [Mevsim, Vildan] Dokuz Eylul Univ, Dept Family Med, Fac Med, Izmir, Turkey; [Weltermann, Birgitta] Univ Bonn, Univ Hosp Bonn, Inst Gen Practice & Family Med, Bonn, Germany	University of Duisburg Essen; Saints Cyril & Methodius University of Skopje; Tampere University; Dokuz Eylul University; University of Bonn	Weltermann, B (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Gen Practice & Family Med, Bonn, Germany.	Birgitta.Weltermann@uk-essen.de			European General Practice Research Network	European General Practice Research Network	The study was supported by a small project funding of the European General Practice Research Network. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ADAMS PF, 1999, VITAL HLTH STAT, V10, P200; Blaiss MS, 2015, CURR MED RES OPIN, V31, P1527, DOI 10.1185/03007995.2014.1002558; Bramley TJ, 2002, J OCCUP ENVIRON MED, V44, P822, DOI 10.1097/00043764-200209000-00004; DENNY FW, 1995, AM J RESP CRIT CARE, V152, pS4, DOI 10.1164/ajrccm/152.4_Pt_2.S4; Eichenberg C, 2015, PSYCHOTHER PSYCH MED, V65, P304, DOI 10.1055/s-0035-1545311; Figueiras A, 2000, EUR J EPIDEMIOL, V16, P19, DOI 10.1023/A:1007608702063; Gardiner P, 2007, ALTERN THER HEALTH M, V13, P22; German College of General Practitioners and Family Physicians, 2009, 14 DEGAM; German College of General Practitioners and Family Physicians, 2014, 11 DEGAM; Goh LY, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-42; Grief SN, 2013, PRIMARY CARE, V40, P757, DOI 10.1016/j.pop.2013.06.004; Hanna LA, 2011, PATIENT EDUC COUNS, V83, P345, DOI 10.1016/j.pec.2011.02.016; Heaney D, 2001, BRIT MED J, V322, P1218, DOI 10.1136/bmj.322.7296.1218; Kaptein AA, 2010, CURR OPIN ALLERGY CL, V10, P194, DOI 10.1097/ACI.0b013e32833950c1; Little P, 2001, BRIT MED J, V322, P1214, DOI 10.1136/bmj.322.7296.1214; McDonald J.H., 2014, HDB BIOL STAT; MONTO AS, 1974, JAMA-J AM MED ASSOC, V227, P164, DOI 10.1001/jama.227.2.164; Nichol KL, 2006, VACCINE, V24, P6724, DOI 10.1016/j.vaccine.2006.05.033; Parisius LM, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-116; SEGALL A, 1990, MED CARE, V28, P301, DOI 10.1097/00005650-199004000-00002; Shaku F, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0300-3; Stosic Rodney, 2011, Int J Pharm Pract, V19, P236, DOI 10.1111/j.2042-7174.2011.00097.x; Thielmann A, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6949202; Vingilis ER, 1999, CAN J PUBLIC HEALTH, V90, P205, DOI 10.1007/BF03404508; Weltermann BM, 2015, ECAM, V2015; World Health Organization (WHO) Collaborating Center for Drug Statistics Methodology, ATC DDD IND 2017	26	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195564	10.1371/journal.pone.0195564	http://dx.doi.org/10.1371/journal.pone.0195564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652899	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900027
J	Al-Serori, H; Ferk, F; Kundi, M; Bileck, A; Gerner, C; Misik, M; Nersesyan, A; Waldherr, M; Murbach, M; Lah, TT; Herold-Mende, C; Collins, AR; Knasmuller, S				Al-Serori, Halh; Ferk, Franziska; Kundi, Michael; Bileck, Andrea; Gerner, Christopher; Misik, Miroslav; Nersesyan, Armen; Waldherr, Monika; Murbach, Manuel; Lah, Tamara T.; Herold-Mende, Christel; Collins, Andrew R.; Knasmueller, Siegfried			Mobile phone specific electromagnetic fields induce transient DNA damage and nucleotide excision repair in serum-deprived human glioblastoma cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; COMET ASSAY; IN-VITRO; STRAND BREAKS; CANCER; EXPOSURE; GENE; RECOGNITION; EXPRESSION; RADIATION	Some epidemiological studies indicate that the use of mobile phones causes cancer in humans (in particular glioblastomas). It is known that DNA damage plays a key role in malignant transformation; therefore, we investigated the impact of the UMTS signal which is widely used in mobile telecommunications, on DNA stability in ten different human cell lines (six brain derived cell lines, lymphocytes, fibroblasts, liver and buccal tissue derived cells) under conditions relevant for users (SAR 0.25 to 1.00 W/kg). We found no evidence for induction of damage in single cell gel electrophoresis assays when the cells were cultivated with serum. However, clear positive effects were seen in a p53 proficient glioblastoma line (U87) when the cells were grown under serum free conditions, while no effects were found in p53 deficient glioblastoma cells (U251). Further experiments showed that the damage disappears rapidly in U87 and that exposure induced nucleotide excision repair (NER) and does not cause double strand breaks (DSBs). The observation of NER induction is supported by results of a proteome analysis indicating that several proteins involved in NER are up-regulated after exposure to UMTS; additionally, we found limited evidence for the activation of the gamma-interferon pathway. The present findings show that the signal causes transient genetic instability in glioma derived cells and activates cellular defense systems.	[Al-Serori, Halh; Ferk, Franziska; Misik, Miroslav; Nersesyan, Armen; Waldherr, Monika; Knasmueller, Siegfried] Med Univ Vienna, Dept Internal Med 1, Inst Canc Res, Vienna, Austria; [Kundi, Michael] Med Univ Vienna, Dept Environm Hlth, Ctr Publ Hlth, Vienna, Austria; [Bileck, Andrea; Gerner, Christopher] Univ Vienna, Dept Analyt Chem, Fac Chem, Vienna, Austria; [Murbach, Manuel] IT IS Fdn, Zurich, Switzerland; [Lah, Tamara T.] Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia; [Herold-Mende, Christel] Heidelberg Univ, Dept Neurosurg, Expt Neurosurg, Heidelberg, Germany; [Collins, Andrew R.] Univ Oslo, Dept Nutr, Oslo, Norway	Medical University of Vienna; Medical University of Vienna; University of Vienna; National Institute of Biology - Slovenia; Ruprecht Karls University Heidelberg; University of Oslo	Knasmuller, S (corresponding author), Med Univ Vienna, Dept Internal Med 1, Inst Canc Res, Vienna, Austria.	siegfried.knasmueller@meduniwien.ac.at		Gerner, Christopher/0000-0003-4964-0642; Bileck, Andrea/0000-0002-7053-8856; Collins, Andrew/0000-0001-5916-6871	Austrian Workers Compensation Board (Allgemeine Unfallversicherungsanstalt, AUVA)	Austrian Workers Compensation Board (Allgemeine Unfallversicherungsanstalt, AUVA)	This study was supported by the Austrian Workers Compensation Board (Allgemeine Unfallversicherungsanstalt, AUVA).	Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Ahlbom A, 2009, EPIDEMIOLOGY, V20, P639, DOI 10.1097/EDE.0b013e3181b0927d; Al-Serori H, 2017, TOXICOL IN VITRO, V40, P264, DOI 10.1016/j.tiv.2017.01.012; Ames BN, 1997, ENVIRON HEALTH PERSP, V105, P865, DOI 10.2307/3433296; Araujo SJ, 2000, GENE DEV, V14, P349; Attia AMM, 2011, RADIAT PHYS CHEM, V80, P1178, DOI 10.1016/j.radphyschem.2011.06.010; Azqueta A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00288; Bileck A, 2016, ARCH TOXICOL, V90, P1369, DOI 10.1007/s00204-015-1569-7; Bileck A, 2014, J PROTEOME RES, V13, P5989, DOI 10.1021/pr5008625; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Clarkson SG, 2005, DNA REPAIR, V4, P1068, DOI 10.1016/j.dnarep.2005.07.001; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Collins AR, 2015, MUTAGENESIS, V30, P1, DOI 10.1093/mutage/geu079; Collins AR, 2009, ISSUES TOXICOL, V5, P201, DOI 10.1039/9781847559746-00201; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Corbi N, 2002, FASEB J, V16, P1639, DOI 10.1096/fj.02-0123fje; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dexheimer TS, 2013, DNA REPAIR CANC STEM; Ford JM, 2005, MUTAT RES-FUND MOL M, V577, P195, DOI 10.1016/j.mrfmmm.2005.04.005; Groessl M, 2014, J PROTEOME RES, V13, P4773, DOI 10.1021/pr500727h; Heo JH, 2004, BIOCHEM BIOPH RES CO, V325, P892, DOI 10.1016/j.bbrc.2004.10.101; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2013, IARC Monogr Eval Carcinog Risks Hum, V102, P1; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janigro D, 2006, CELL CYCLE CENTRAL N; Kimura M, 1997, J BIOL CHEM, V272, P25851, DOI 10.1074/jbc.272.41.25851; Kundi M, 2009, ENVIRON HEALTH PERSP, V117, P316, DOI 10.1289/ehp.11902; Lee JE, 2002, ANN SURG ONCOL, V9, P587; Lerchl A, 2010, MUTAT RES, V583, p[178, 60]; Lerchl A, 2010, MUTAT RES-GEN TOX EN, V697, P60, DOI 10.1016/j.mrgentox.2010.01.010; Manna D, 2016, ELECTROMAGN BIOL MED, V35, P265, DOI 10.3109/15368378.2015.1092158; Morgan LL, 2015, INT J ONCOL, V46, P1865, DOI 10.3892/ijo.2015.2908; Overmeer RM, 2010, MOL CELL BIOL, V30, P4828, DOI 10.1128/MCB.00285-10; Sannino A, 2009, RADIAT RES, V171, P735, DOI 10.1667/RR1687.1; Schuderer J, 2004, IEEE T MICROW THEORY, V52, P2057, DOI 10.1109/TMTT.2004.832009; Schwarz C, 2008, INT ARCH OCC ENV HEA, V81, P755, DOI 10.1007/s00420-008-0305-5; Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Siddiqui MS, 2015, MUTAT RES-REV MUTAT, V766, P1, DOI 10.1016/j.mrrev.2015.07.001; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Speit G, 2013, MUTAT RES-GEN TOX EN, V755, P163, DOI 10.1016/j.mrgentox.2013.06.014; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; van Steeg H, 2001, TOXICOL LETT, V120, P209, DOI 10.1016/S0378-4274(01)00297-1; Vijayalaxmi, 2014, INT J ENV RES PUB HE, V11, P9376, DOI 10.3390/ijerph110909376; Wang BH, 2005, MUTAT RES-FUND MOL M, V578, P149, DOI 10.1016/j.mrfmmm.2005.05.001; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]	49	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0193677	10.1371/journal.pone.0193677	http://dx.doi.org/10.1371/journal.pone.0193677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649215	Green Submitted, gold, Green Published			2022-12-27	WOS:000429791900005
J	Cruise, A; Watson, DW; Schal, C; Doucet, D				Cruise, Angela; Watson, David W.; Schal, Coby; Doucet, Daniel			Ecological succession of adult necrophilous insects on neonate Sus scrofa domesticus in central North Carolina	PLOS ONE			English	Article							GREEN BOTTLE FLY; ARTHROPOD SUCCESSION; LUCILIA-SERICATA; CARRION; DECOMPOSITION; CALLIPHORIDAE; DIPTERA; FLIES; PATTERNS; STRATEGIES	The necrophilous insect fauna on carcasses varies seasonally and geographically. The ecological succession of insects arriving to decaying neonate pig carcasses in central North Carolina during late summer was sampled using a novel vented-chamber collection method. We collected six blow fly species, flesh flies, house flies and 10 beetle taxa, including four species of scarab beetles. Necrophilous fly activity dominated the early decomposition stages, whereas beetle numbers remained low until day 4. By day 7, more than 50% of the pig carcasses were skeletonized and they attracted few insects. Differences in the taxa and successional patterns documented in this experiment and a previous study in the same location highlight the ecological variation in such investigations, and underscore the need for standardization, as well as for ecological succession studies on finer geographic scales.	[Cruise, Angela; Watson, David W.; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Schal, Coby] North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Cruise, Angela] Carolina Biol Supply Co, Burlington, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Schal, C (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.; Schal, C (corresponding author), North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA.	coby@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358	National Science Foundation (GRFP) [DGE-1252376]; Blanton J. Whitmire Endowment at NC State University	National Science Foundation (GRFP)(National Science Foundation (NSF)); Blanton J. Whitmire Endowment at NC State University	Partial funding for this work was from a Graduate Research Fellowship from the National Science Foundation (GRFP Award DGE-1252376) (AC) and the Blanton J. Whitmire Endowment at NC State University (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Almeida LM, 2009, REV BRAS ENTOMOL, V53, P227, DOI 10.1590/S0085-56262009000200006; Anderson GS, 1996, J FORENSIC SCI, V41, P617; Anderson GS, 2001, FORENSIC ENTOMOLOGY, V143, P76; [Anonymous], 2016, JMP PRO 13 1 0 JMP P; [Anonymous], 2012, SAS 9 4 STAT AN SYST; Archer MS, 2003, MED VET ENTOMOL, V17, P263, DOI 10.1046/j.1365-2915.2003.00430.x; Archer MS, 2003, AUST J ZOOL, V51, P165, DOI 10.1071/ZO02067; Brodie B, 2014, ENTOMOL EXP APPL, V153, P114, DOI 10.1111/eea.12238; Brundage A, 2014, ECOL ENTOMOL, V39, P539, DOI 10.1111/een.12128; Byrd JH, 2000, FORENSIC ENTOMOLOGY, P43; Cammack JA, 2016, J MED ENTOMOL, V53, P67, DOI 10.1093/jme/tjv183; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Cruise AM, 2017, SAMPLING ECOLOGICAL; Cruise A, 2018, J MED ENTOMOL, V55, P947, DOI 10.1093/jme/tjx255; DENNO RF, 1976, ANN ENTOMOL SOC AM, V69, P109; EARLY M, 1986, J MED ENTOMOL, V23, P520, DOI 10.1093/jmedent/23.5.520; Gallagher MB, 2010, J FORENSIC SCI, V55, P438, DOI 10.1111/j.1556-4029.2009.01285.x; Gill-King H., 1996, FORENSIC TAPHONOMY P, P93; Goff M L, 1993, Forensic Sci Rev, V5, P81; Grassberger M, 2004, J MED ENTOMOL, V41, P511, DOI 10.1603/0022-2585-41.3.511; HEWADIKARAM KA, 1991, AM J FOREN MED PATH, V12, P235, DOI 10.1097/00000433-199109000-00013; Hocking MD, 2009, ECOL RES, V24, P1091, DOI 10.1007/s11284-009-0586-5; Hwang C, 2005, MED VET ENTOMOL, V19, P379, DOI 10.1111/j.1365-2915.2005.00583.x; KUUSELA S, 1982, HOLARCTIC ECOL, V5, P337; Lindquist A. W., 1933, Journal of the Kansas Entomological Society, V6, P109; Matuszewski S, 2016, INT J LEGAL MED, V130, P221, DOI 10.1007/s00414-015-1145-y; Merritt R. W., 2015, CARRION ECOLOGY EVOL, P65, DOI DOI 10.1201/B18819-6; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Paczkowski S, 2012, J FORENSIC SCI, V57, P1497, DOI 10.1111/j.1556-4029.2012.02245.x; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Pechal J. L., 2015, FORENSIC ENTOMOLOGY, P347; Castro CPE, 2011, ANN SOC ENTOMOL FR, V47, P128; PUTMAN RJ, 1978, ECOL ENTOMOL, V3, P133, DOI 10.1111/j.1365-2311.1978.tb00911.x; SCHOENLY K, 1987, OECOLOGIA, V73, P192, DOI 10.1007/BF00377507; Sharanowski BJ, 2008, FORENSIC SCI INT, V179, P219, DOI 10.1016/j.forsciint.2008.05.019; Singh D, 2001, FORENSIC SCI INT, V120, P124, DOI 10.1016/S0379-0738(01)00419-4; Smith AE, 2002, THESIS; Smith KE, 1997, MED VET ENTOMOL, V11, P38, DOI 10.1111/j.1365-2915.1997.tb00287.x; Tabor Kreitlow K.L., 2010, FORENSIC ENTOMOLOGY, V2nd ed., P251; Tomberlin JK, 2011, ANNU REV ENTOMOL, V56, P401, DOI 10.1146/annurev-ento-051710-103143; Tomberlin J.K., 2012, J FORENSIC RES, V3, P1, DOI DOI 10.4172/2157-7145.1000147; Tomberlin JK, 2011, TRENDS ECOL EVOL, V26, P53, DOI 10.1016/j.tree.2010.12.001; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Villet M. H., 2011, Pest Technology, V5, P1; Whitworth T, 2006, P ENTOMOL SOC WASH, V108, P689	45	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195785	10.1371/journal.pone.0195785	http://dx.doi.org/10.1371/journal.pone.0195785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649331	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900088
J	Laranjeira, FO; de Andrade, KRC; Figueiredo, ACMG; Silva, EN; Pereira, MG				Laranjeira, Fernanda O.; de Andrade, Keitty R. C.; Figueiredo, Ana C. M. G.; Silva, Everton N.; Pereira, Mauricio G.			Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials	PLOS ONE			English	Review							NEUTRAL PROTAMINE HAGEDORN; IMPROVED GLYCEMIC CONTROL; BASAL-BOLUS REGIMEN; FASTING BLOOD-GLUCOSE; REGULAR HUMAN INSULIN; LESS WEIGHT-GAIN; GLARGINE HOE 901; NPH INSULIN; NOCTURNAL HYPOGLYCEMIA; INJECTION REGIMENS	Background The comparison between long acting insulin analogues (LAIA) and human insulin (NPH) has been investigated for decades, with many randomized controlled trials (RCTs) and systematic reviews giving mixed results. This overlapping and contradictory evidence has increased uncertainty on coverage decisions at health systems level. Aim To conduct an overview of systematic reviews and update existing reviews, preparing new meta-analysis to determine whether LAIA are effective for T1D patients compared to NPH. Methods We identified systematic reviews of RCTs that evaluated the efficacy of LAIA glargine or detemir, compared to NPH insulin for T1D, assessing glycated hemoglobin (A1C) and hypo-glycemia. Data sources included Pubmed, Cochrane Library, EMBASE and hand-searching. The methodological quality of studies was independently assessed by two reviewers, using AMSTAR and Jadad scale. We found 11 eligible systematic reviews that contained a total of 25 relevant clinical trials. Two reviewers independently abstracted data. Results We found evidence that LAIA are efficacious compared to NPH, with estimates showing a reduction in nocturnal hypoglycemia episodes (RR 0.66; 95% CI 0.57; 0.76) and A1C (95% CI 0.23; 0.12). No significance was found related to severe hypoglycemia (RR 0.94; 95% CI 0.71; 1.24). Conclusion This study design has allowed us to carry out the most comprehensive assessment of RCTs on this subject, filling a gap in diabetes research. Our paper addresses a question that is important not only for decision makers but also for clinicians.	[Laranjeira, Fernanda O.; Figueiredo, Ana C. M. G.; Silva, Everton N.] Univ Brasilia, Fac Hlth Sci, Brasilia, DF, Brazil; [de Andrade, Keitty R. C.; Pereira, Mauricio G.] Univ Brasilia, Fac Med Sci, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia	de Andrade, KRC (corresponding author), Univ Brasilia, Fac Med Sci, Brasilia, DF, Brazil.	keittyregina@hotmail.com	Figueiredo, Ana Claudia Morais Godoy/D-8123-2019; de Andrade, Keitty Regina Cordeiro/AAN-6623-2021; Figueiredo, Ana/GWU-6748-2022	Figueiredo, Ana Claudia Morais Godoy/0000-0003-2842-9848; Silva, Everton/0000-0001-8747-4185; Cordeiro de Andrade, Keitty Regina/0000-0002-8882-6856	Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education	Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education	FOL received a PhD scholarship by Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	[Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; [Anonymous], 2015, INTEGRATED CLIN TRIA, P1; Ashwell SG, 2006, DIABETIC MED, V23, P285, DOI 10.1111/j.1464-5491.2005.01781.x; Bartley PC, 2008, DIABETIC MED, V25, P442, DOI 10.1111/j.1464-5491.2007.02407.x; Becker L. A., 2011, COCHRANE HDB SYSTEMA; Bergenstal RM, 2015, DIABETOLOGIA, V58, pS65; Bolli GB, 2009, NUTR METAB CARDIOVAS, V19, P571, DOI 10.1016/j.numecd.2008.05.003; Bowker SL, 2005, CAN J DIABETES, V29, P230; de Souza ALC, 2014, APPL HEALTH ECON HEA, V12, P19, DOI 10.1007/s40258-013-0073-6; Chase HP, 2008, J PEDIATR, V153, P547, DOI 10.1016/j.jpeds.2008.04.063; Chatterjee S, 2007, DIABETES RES CLIN PR, V77, P215, DOI 10.1016/j.diabres.2006.11.002; Cheung A., 2012, IMPLEMENT SCI, V1, P1; Childs BP, 2005, DIABETES CARE, V28, P1245; Sanches ACC, 2013, BRAZ J PHARM SCI, V49, P501, DOI 10.1590/S1984-82502013000300011; Sanches ACC, 2011, DIABETES RES CLIN PR, V94, P333, DOI 10.1016/j.diabres.2011.09.001; Danne T, 2013, PEDIATR DIABETES, V14, P593, DOI 10.1111/pedi.12051; Dawoud D, 2015, VALUE HEALTH, V18, pA339, DOI 10.1016/j.jval.2015.09.136; Donicova Viera, 2011, J Diabetes Sci Technol, V5, P1124; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esposito K, 2012, DIABETES CARE, V35, P2698, DOI 10.2337/dc12-0698; Frier BM, 2013, DIABETES OBES METAB, V15, P978, DOI 10.1111/dom.12106; Fulcher GR, 2005, INTERN MED J, V35, P536, DOI 10.1111/j.1445-5994.2005.00902.x; Gabriel EE, 2014, BIOSTATISTICS, V15, P251, DOI 10.1093/biostatistics/kxt055; Genuth S, 2001, J PEDIATR-US, V139, P804, DOI 10.1067/mpd.2001.118887; Godman B, 2014, BASIC CLIN PHARMACOL, V115, P72; Goldman J, 2015, ANN PHARMACOTHER, V49, P1153, DOI 10.1177/1060028015597915; Gomes MB, 2012, DIABETES RES CLIN PR, V97, P63, DOI 10.1016/j.diabres.2012.02.008; Grunberger G, 2014, DIABETES CARE, V37, P1767, DOI 10.2337/dc14-0031; Guyatt G, 2008, JAMA EVIDENCE; Hassan K, 2008, PEDIATRICS, V121, pE466, DOI 10.1542/peds.2007-1679; Heinemann L, 2016, J DIABETES SCI TECHN, V10, P457; Hermansen K, 2004, DIABETOLOGIA, V47, P622, DOI 10.1007/s00125-004-1365-z; Hermansen K, 2001, DIABETES CARE, V24, P296, DOI 10.2337/diacare.24.2.296; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holden E, 2012, DIABETES MANAGE, V2, P173; Home P, 2003, DIABETES, V52, pA122; Home P, 2004, DIABETES CARE, V27, P1081, DOI 10.2337/diacare.27.5.1081; Home PD, 2005, DIABETES-METAB RES, V21, P545, DOI 10.1002/dmrr.572; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kolendorf K, 2006, DIABETIC MED, V23, P729, DOI 10.1111/j.1464-5491.2006.01862.x; Krentz AJ, 2015, DIABETES MANAG, V5, P405; Life Sciences & Transformational Health, 2017, PMRREP11674 LIF SCI; Linnebjerg H, 2015, DIABETES CARE, V38, P2226, DOI 10.2337/dc14-2623; Ly TT, 2014, PEDIATR DIABETES, V15, P180, DOI 10.1111/pedi.12174; Mianowska Beata, 2007, Pediatr Endocrinol Diabetes Metab, V13, P189; Mullins P, 2007, CLIN THER, V29, P1607, DOI 10.1016/j.clinthera.2007.08.020; Murphy NP, 2003, DIABETES CARE, V26, P799, DOI 10.2337/diacare.26.3.799; *NAT I CLIN EXC, 2004, TYP 1 DIAB DIAGN MAN; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Pedersen-Bjergaard U, 2014, LANCET DIABETES ENDO, V2, P553, DOI 10.1016/S2213-8587(14)70073-7; Pieber TR, 2005, DIABETIC MED, V22, P850, DOI 10.1111/j.1464-5491.2005.01545.x; Pieber TR, 2000, DIABETES CARE, V23, P157, DOI 10.2337/diacare.23.2.157; Pollock M, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0367-5; Porcellati F, 2004, DIABETIC MED, V21, P1213, DOI 10.1111/j.1464-5491.2004.01323.x; Raskin P, 2000, DIABETES CARE, V23, P1666, DOI 10.2337/diacare.23.11.1666; Ratner RE, 2000, DIABETES CARE, V23, P639, DOI 10.2337/diacare.23.5.639; Robertson KJ, 2007, DIABETIC MED, V24, P27, DOI 10.1111/j.1464-5491.2007.02024.x; Rosenstock J, 2000, DIABETES CARE, V23, P1137, DOI 10.2337/diacare.23.8.1137; Rossetti P, 2003, DIABETES CARE, V26, P1490, DOI 10.2337/diacare.26.5.1490; Rotenstein LS., 2012, CLIN DIABETES, V30, P138, DOI DOI 10.2337/DIACLIN.30.4.138; Russell-Jones D, 2004, CLIN THER, V26, P724, DOI 10.1016/S0149-2918(04)90072-0; Rys P, 2015, ACTA DIABETOL, V52, P649, DOI 10.1007/s00592-014-0698-4; Schober E, 2002, J PEDIATR ENDOCR MET, V15, P369; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Singh SR, 2009, CAN MED ASSOC J, V180, P385, DOI 10.1503/cmaj.081041; Standl Eberhard, 2004, Diabetes Technol Ther, V6, P579, DOI 10.1089/dia.2004.6.579; Sterne C, 2003, ESSENTIAL MED STAT; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Szypowska A, 2009, DIABETOLOGIA, V52, pS387; Szypowska A, 2011, POL ARCH MED WEWN, V121, P237, DOI 10.20452/pamw.1065; Thalange N, 2013, DIABETIC MED, V30, P216, DOI 10.1111/dme.12041; Tran K, 2007, 92 CAN AG DRUGS TECH; Tricco C, 2014, BMJ-BRIT MED J, V349, P1; Tsujino D, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0167-z; US Department of Health and Human Services CDER, 2008, GUID IND DIAB MELL D; Vague P, 2003, DIABETES CARE, V26, P590, DOI 10.2337/diacare.26.3.590; Vardi M., 2008, COCHRANE DB SYST REV, V4, P3; Wang F, 2003, CLIN THER, V25, P1541, DOI 10.1016/S0149-2918(03)80156-X; Warren E, 2004, HEALTH TECHNOL ASSES, V8, P41; Zygalo KD, 2015, ACTA DIABETOL, V52, P231, DOI 10.1007/s00592-014-0604-0	82	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194801	10.1371/journal.pone.0194801	http://dx.doi.org/10.1371/journal.pone.0194801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649221	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900014
J	Shen, MW; Zhu, CF; Liao, HY; Zhang, HH; Zhou, JF; Gao, ZF				Shen, Mowei; Zhu, Chengfeng; Liao, Huayu; Zhang, Haihang; Zhou, Jifan; Gao, Zaifeng			Guilt leads to enhanced facing-the-viewer bias	PLOS ONE			English	Article							BIOLOGICAL MOTION; VISUAL-PERCEPTION; SELF-PUNISHMENT; SHAME; EMOTIONS; MODERATOR; PRONENESS; STIMULI; FIGURES; GENDER	As an important moral emotion, guilt plays a critical role in social interaction. It has been found that people tended to exhibit prosocial behavior under circumstances of guilt. However, all extant studies have predominantly focused on the influence of guilt on macro-level behavior. So far, no study has investigated whether guilt affects people's micro-level perception. The current study closes this gap by examining whether guilt affects one's inclination to perceive approaching motion. We achieved this aim by probing a facing-the-viewer bias (FTV bias). Specifically, when an ambiguous walking biological motion display is presented to participants via the point-light display technique, participants tend to perceive a walking agent approaching them. We hypothesized that guilt modulated FTV bias. To test this hypothesis, we adopted a two-person situation induction task to induce guilt, whereby participants were induced to feel that because of their poor task performance, their partner did not receive a satisfactory payment. We found that when participants were told that the perceived biological motion was motion-captured from their partner, the FTV bias was significantly increased for guilty participants relative to neutral participants. However, when participants were informed that the perceived biological motion was from a third neutral agent, the FTV bias was not modulated by guilt. These results suggest that guilt influences one's inclination to perceive approaching motion, but this effect is constrained to the person towards whom guilt is directed.	[Shen, Mowei; Zhu, Chengfeng; Liao, Huayu; Zhang, Haihang; Zhou, Jifan; Gao, Zaifeng] Zhejiang Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhou, JF; Gao, ZF (corresponding author), Zhejiang Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China.	jifanzhou@zju.edu.cn; zaifengg@zju.edu.cn	Gao, Zaifeng/B-6398-2011	Gao, Zaifeng/0000-0001-9727-8524	National Natural Science Foundation of China [31271089, 31571119, 31600881]; Ministry of Science and Technology of the People's Republic of China [2016YFE0130400]; Postdoctoral Science Foundation of China [2016M600459]; MOE Project of Humanities and Social Sciences [17YJA190005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); MOE Project of Humanities and Social Sciences	This research was supported by awards from the National Natural Science Foundation of China (31271089; 31571119; 31600881), the grant Project of Ministry of Science and Technology of the People's Republic of China (2016YFE0130400), Postdoctoral Science Foundation of China (2016M600459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by awards from the National Natural Science Foundation of China (31771202; 31571119; 31600881), the grant Project of Ministry of Science and Technology of the People's Republic of China (2016YFE0130400), and MOE Project of Humanities and Social Sciences (No. 17YJA190005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breugelmans SM, 2006, J PERS SOC PSYCHOL, V91, P1111, DOI 10.1037/0022-3514.91.6.1111; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Cavalera C, 2014, PROCD SOC BEHV, V112, P457, DOI 10.1016/j.sbspro.2014.01.1189; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Cohen TR, 2012, CURR DIR PSYCHOL SCI, V21, P355, DOI 10.1177/0963721412454874; Covert MV, 2003, J SOC CLIN PSYCHOL, V22, P1, DOI 10.1521/jscp.22.1.1.22765; de Hooge IE, 2011, J PERS SOC PSYCHOL, V100, P462, DOI 10.1037/a0021459; Dolcos F, 2014, FRONT NEUROSCI-SWITZ, V8, DOI [10.3389/fnint.2014.00083, 10.3389/fnins.2014.00268]; Dunning D, 2013, CURR DIR PSYCHOL SCI, V22, P33, DOI 10.1177/0963721412463693; Firestone C, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X15000965; Fontaine JRJ, 2001, EUR J PERSONALITY, V15, P449, DOI 10.1002/per.428; Gantman AP, 2014, COGNITION, V132, P22, DOI 10.1016/j.cognition.2014.02.007; Heenan A, 2015, ACTA PSYCHOL, V157, P93, DOI 10.1016/j.actpsy.2015.02.012; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Malti T, 2013, CHILD DEV, V84, P397, DOI 10.1111/j.1467-8624.2012.01851.x; Nelissen RMA, 2007, J EXP SOC PSYCHOL, V43, P280, DOI 10.1016/j.jesp.2006.01.009; Nelissen RMA, 2014, J PERS SOC PSYCHOL, V106, P257, DOI 10.1037/a0034711; Nelissen RMA, 2012, SOC PSYCHOL PERS SCI, V3, P139, DOI 10.1177/1948550611411520; Nelissen RMA, 2009, EMOTION, V9, P118, DOI 10.1037/a0014540; Rebega OL, 2013, PROCD SOC BEHV, V78, P536, DOI 10.1016/j.sbspro.2013.04.346; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; TANGNEY JP, 1992, J PERS SOC PSYCHOL, V62, P669, DOI 10.1037/0022-3514.62.4.669; Tangney JP, 1998, J PERS SOC PSYCHOL, V75, P256, DOI 10.1037/0022-3514.75.1.256; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Tignor SM, 2017, J PERS, V85, P341, DOI 10.1111/jopy.12244; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; Vanrie J, 2008, VIS COGN, V16, P585, DOI 10.1080/13506280701269334; Vanrie J, 2006, PERCEPT PSYCHOPHYS, V68, P601, DOI 10.3758/BF03208762	32	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195590	10.1371/journal.pone.0195590	http://dx.doi.org/10.1371/journal.pone.0195590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649338	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900058
J	Boswihi, SS; Udo, EE; Monecke, S; Mathew, B; Noronha, B; Verghese, T; Tappa, SB				Boswihi, Samar S.; Udo, Edet E.; Monecke, Stefan; Mathew, Bindu; Noronha, Bobby; Verghese, Tina; Tappa, Sajida B.			Emerging variants of methicillin-resistant Staphylococcus aureus genotypes in Kuwait hospitals	PLOS ONE			English	Article							MEC SCCMEC TYPE; FUSIDIC ACID; SEQUENCE TYPE; MULTIRESISTANT; IDENTIFICATION; EMERGENCE; CLONES	Background Frequent changes in the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) occurring worldwide demand regular surveillance to study their composition and distribution in healthcare facilities. We investigated the genotypic characteristics of MRSA obtained in Kuwait hospitals to better understand their clonal distribution. Materials and methods A total of 1,327 MRSA isolates obtained from clinical samples in 13 Kuwait hospitals from 1 January to 31 December 2016 were investigated using antibiogram, SCCmec typing, spa typing and DNA microarray. Results The isolates belonged to six SCCmec types with the majority belonging to type IV (658; 49.5%) and type V (355; 26.7%). Two hundred and sixty-one spa types were identified with spa types t688, t304, t860, t127, t044, t311, t002, t223, t267, t019, t3841, t005, t084, t852, and t657 constituting 51.0% (n = 677) of the isolates. Among the 1,327 MRSA isolates, 102 (7.68%) isolates were identified as novel variants of internationally recognized MRSA clones. These 102 isolates were investigated further and belonged to 14 clonal complexes (CCs) with CC361 (32; 32.3%), CC30 (15; 14.7%), CC22 (13; 12.7%) and CC1 (11, 10.7%) as the dominant CCs. Eighty-one (79.4%) of the novel isolates harbored SCCmec IV or V +fusC composite genetic elements. Four isolates (3.9%) harbored unusual combinations of ccrand mec complexes comprising of CC6-MRSA [IV+fusC+ccrC], CC97-MRSA [V/V-r+fusC+ccrAB2], CC121-MRSA [VN-r+fusC+ccrB4] and CC1-MRSA-pseudoSCCmec [class B mec+fusc+ccrAB1]. Forty-six (45.1%) of these isolates were positive for PVL and 89 (87.2%) were resistant to fusidic acid mediated by fusC. Conclusions The study showed the emergence of novel variants of previously recognized MRSA genotypes with unusual genetic characteristics including high prevalence of PVL and fusidic acid resistance in Kuwait hospitals. This has added to the dynamic lists of known variations in MRSA genomes which can impose serious challenges for infection control and treatment of MRSA infections.	[Boswihi, Samar S.; Udo, Edet E.; Mathew, Bindu; Noronha, Bobby; Verghese, Tina; Tappa, Sajida B.] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait; [Monecke, Stefan] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] InfectoGnost Res Campus, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany	Kuwait University; Alere; Technische Universitat Dresden	Udo, EE (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	EDET@hsc.edu.kw	Udo, Edet E/H-7367-2016	Udo, Edet E/0000-0002-7269-7949	Kuwait University [YM02/12]	Kuwait University	This work was funded by Research Sector, Kuwait University Grant no. YM02/12 to SSB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; [Anonymous], 2015, M100S25 CLSI; Aqel AA, 2015, J INFECT PUBLIC HEAL, V8, P90, DOI 10.1016/j.jiph.2014.05.007; Balakuntla J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094293; Boswihi SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162744; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Coll F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9745; Collignon P, 1998, LANCET, V352, P145, DOI 10.1016/S0140-6736(98)85051-4; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; El-Mahdy TS, 2014, CLIN MICROBIOL INFEC, V20, P169, DOI 10.1111/1469-0691.12240; Ellington MJ, 2015, INT J ANTIMICROB AG, V45, P477, DOI 10.1016/j.ijantimicag.2015.01.009; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Ghaznavi-Rad E, 2010, J CLIN MICROBIOL, V48, P867, DOI 10.1128/JCM.01112-09; Gosbell IB, 2001, MED J AUSTRALIA, V174, P627, DOI 10.5694/j.1326-5377.2001.tb143470.x; Goudarzi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155529; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Khairalla AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07713-8; Kinnevey PM, 2013, ANTIMICROB AGENTS CH, V57, P524, DOI 10.1128/AAC.01689-12; Meric G, 2015, GENOME BIOL EVOL, V7, P1313, DOI 10.1093/gbe/evv066; Monecke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162654; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nadig S, 2010, J MED MICROBIOL, V59, P815, DOI 10.1099/jmm.0.017632-0; Raji MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00911; Senok A., 2016, New Microbes and New Infections, V14, P13, DOI 10.1016/j.nmni.2016.07.009; Shore AC, 2008, ANTIMICROB AGENTS CH, V52, P4407, DOI 10.1128/AAC.00447-08; Shore AC, 2012, ANTIMICROB AGENTS CH, V56, P5340, DOI 10.1128/AAC.01247-12; Sonnevend A, 2012, J CLIN PATHOL, V65, P178, DOI 10.1136/jclinpath-2011-200436; Udo E. E., 2016, New Microbes and New Infections, V12, P24, DOI 10.1016/j.nmni.2016.03.008; Udo E E, 1998, Int J Infect Dis, V3, P82, DOI 10.1016/S1201-9712(99)90014-0; Udo EE, 2013, MED PRIN PRACT, V22, P20, DOI 10.1159/000354201; Udo EE, 2017, J INFECT DEV COUNTR, V11, P513, DOI 10.3855/jidc.8954; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Vogel A, 2016, NEW ZEAL MED J, V129, P77; Weber S, 2010, GENETIC FINGERPRINTI; Williamson DA, 2014, CLIN INFECT DIS, V59, P1451, DOI 10.1093/cid/ciu658; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	40	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195933	10.1371/journal.pone.0195933	http://dx.doi.org/10.1371/journal.pone.0195933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668723	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200067
J	Dimitrov, D; Du, ZB; da Fonseca, CM				Dimitrov, Darko; Du, Zhibin; da Fonseca, Carlos M.			The minimal-ABC trees with B-1-branches	PLOS ONE			English	Article							ATOM-BOND CONNECTIVITY; DEGREE SEQUENCE; STRUCTURAL-PROPERTIES; EXTREMAL TREES; PENDENT PATHS; LENGTH 3; INDEX; CONJECTURE; ALKANES; GRAPHS	The atom-bond connectivity index (or, for short, ABC index) is a molecular structure descriptor bridging chemistry to graph theory. It is probably the most studied topological index among all numerical parameters of a graph that characterize its topology. For a given graph G = (V, E), the ABC index of G is defined as ABC(G) = Sigma(ij is an element of E)root(d(i) + d(j) 2)/(d(i)d(j)), where d(i) denotes the degree of the vertex i, and ij is the edge incident to the vertices land j. A combination of physicochemical and the ABC index properties are commonly used to foresee the bioactivity of different chemical composites. Additionally, the applicability of the ABC index in chemical thermodynamics and other areas of chemistry, such as in dendrimer nanostars, benzenoid systems, fluoranthene congeners, and phenylenes is well studied in the literature. While finding of the graphs with the greatest ABC-value is a straightforward assignment, the characterization of the tree(s) with minimal ABC index is a problem largely open and has recently given rise to numerous studies and conjectures. A B-1-branch of a graph is a pendent path of order 2. In this paper, we provide an important step forward to the full characterization of these minimal trees. Namely, we show that a minimal-ABC tree contains neither 4 nor 3 B-1-branches. The case when the number of B-1-branches is 2 is also considered.	[Dimitrov, Darko] Hsch Tech & Wirtschaft Berlin, Wilhelminenhofstr 75A, D-12459 Berlin, Germany; [Du, Zhibin] Zhaoqing Univ, Sch Math & Stat, Zhaoqing 526061, Guangdong, Peoples R China; [da Fonseca, Carlos M.] Univ Primorska, Dept Math, Glagoljsaska 8, Koper 6000, Slovenia; [Dimitrov, Darko] Fac Informat Studies, Novo Mesto, Slovenia	Zhaoqing University; University of Primorska	Du, ZB (corresponding author), Zhaoqing Univ, Sch Math & Stat, Zhaoqing 526061, Guangdong, Peoples R China.	zhibindu@126.com	Dimitrov, Darko/AAI-9957-2020; da Fonseca, Carlos M./K-2142-2019; du, zhibin/GPT-2615-2022; Du, Zhibin/T-8529-2019	da Fonseca, Carlos M./0000-0001-7742-4416; du, zhibin/0000-0001-5795-3580; 	National Natural Science Foundation of China [11701505]; Guangdong Provincial Natural Science Foundation of China [2014A030310277]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (grant number 11701505 to Dr. Zhibin Du) and the Guangdong Provincial Natural Science Foundation of China (grant number 2014A030310277 to Dr. Zhibin Du). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi MB, 2013, MATCH-COMMUN MATH CO, V69, P565; Ahmadi MB, 2010, OPTOELECTRON ADV MAT, V4, P1040; Das KC, 2016, MATCH-COMMUN MATH CO, V76, P159; Dimitrov D., 2017, MATH CHEM MONOGRPAHS, V20, P53; Dimitrov D, 2018, DISCRETE APPL MATH, V236, P165, DOI 10.1016/j.dam.2017.11.003; Dimitrov D, 2017, APPL MATH COMPUT, V313, P418, DOI 10.1016/j.amc.2017.06.014; Dimitrov D, 2017, DISCRETE APPL MATH, V222, P222, DOI 10.1016/j.dam.2017.01.019; Dimitrov D, 2016, DISCRETE APPL MATH, V204, P90, DOI 10.1016/j.dam.2015.10.010; Dimitrov D, 2016, APPL MATH COMPUT, V282, P276, DOI 10.1016/j.amc.2016.02.019; Dimitrov D, 2014, DISCRETE APPL MATH, V172, P28, DOI 10.1016/j.dam.2014.03.009; Dimitrov D, 2013, APPL MATH COMPUT, V224, P663, DOI 10.1016/j.amc.2013.08.089; Du ZB, 2016, DISCRETE APPL MATH, V202, P37, DOI 10.1016/j.dam.2015.08.017; Estrada E, 1998, INDIAN J CHEM A, V37, P849; Estrada E, 2008, CHEM PHYS LETT, V463, P422, DOI 10.1016/j.cplett.2008.08.074; Furtula B, 2009, DISCRETE APPL MATH, V157, P2828, DOI 10.1016/j.dam.2009.03.004; Gan L, 2012, MATCH-COMMUN MATH CO, V68, P137; Gao YB, 2016, MATCH-COMMUN MATH CO, V76, P141; Gutman I, 2013, FILOMAT, V27, P1075, DOI 10.2298/FIL1306075G; Gutman I, 2012, MATCH-COMMUN MATH CO, V68, P131; Gutman I, 2012, MATCH-COMMUN MATH CO, V67, P467; Hosseini SA, 2014, MATCH-COMMUN MATH CO, V71, P5; Ke XL, 2012, POLYCYCL AROMAT COMP, V32, P27, DOI 10.1080/10406638.2011.637101; Lin WS, 2016, MATCH-COMMUN MATH CO, V76, P131; Lin WS, 2013, MATCH-COMMUN MATH CO, V69, P571; Lin WS, 2013, MATCH-COMMUN MATH CO, V69, P549; Liu JP, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/609208; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; Wang H, 2008, DISCRETE MATH, V308, P3407, DOI 10.1016/j.disc.2007.06.026; Xing RD, 2012, FILOMAT, V26, P683, DOI 10.2298/FIL1204683X; Yang J., 2011, INT MATH FORUM, V6, P2001	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195153	10.1371/journal.pone.0195153	http://dx.doi.org/10.1371/journal.pone.0195153			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668696	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200030
J	Lawrence, DW; Richards, D; Comper, P; Hutchison, MG				Lawrence, David Wyndham; Richards, Doug; Comper, Paul; Hutchison, Michael G.			Earlier time to aerobic exercise is associated with faster recovery following acute sport concussion	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; REST; SYMPTOMS; METAANALYSIS; OUTCOMES; CHILDREN; ADULTS	Objective To determine whether earlier time to initiation of aerobic exercise following acute concussion is associated with time to full return to (1) sport and (2) school or work. Methods A retrospective stratified propensity score survival analysis of acute (<= 14 days) concussion was used to determine whether time (days) to initiation of aerobic exercise post-concussion was associated with, both, time (days) to full return to (1) sport and (2) school or work. Results A total of 253 acute concussions [median (IQR) age, 17.0 (15.0-20.0) years; 148 (58.5%) males] were included in this study. Multivariate Cox regression models identified that earlier time to aerobic exercise was associated with faster return to sport and school/work adjusting for other covariates, including quintile propensity strata. For each successive day in delay to initiation of aerobic exercise, individuals had a less favourable recovery trajectory. Initiating aerobic exercise at 3 and 7 days following injury was associated with a respective 36.5% (HR, 0.63; 95% CI, 0.53-0.76) and 73.2% (HR, 0.27; 95% CI, 0.16-0.45) reduced probability of faster full return to sport compared to within 1 day; and a respective 45.9% (HR, 0.54; 95% CI, 0.44-0.66) and 83.1% (HR, 0.17; 95% CI, 0.10-0.30) reduced probability of faster full return to school/work. Additionally, concussion history, symptom severity, LOC deleteriously influenced concussion recovery. Conclusion Earlier initiation of aerobic exercise was associated with faster full return to sport and school or work. This study provides greater insight into the benefits and safety of aerobic exercise within the first week of the injury.	[Lawrence, David Wyndham; Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Lawrence, David Wyndham; Comper, Paul] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Lawrence, David Wyndham] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto	Lawrence, DW (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.; Lawrence, DW (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.; Lawrence, DW (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	dw.lawrence@mail.utoronto.ca		Richards, Douglas/0000-0001-5098-4341				Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bidonde J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012700; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Chieffi S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00188; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Edmonds M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003200.PUB2; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hsu CL, 2018, BRIT J SPORT MED, V52, P184, DOI 10.1136/bjsports-2016-096846; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Krogh J, 2011, J CLIN PSYCHIAT, V72, P529, DOI 10.4088/JCP.08r04913blu; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P., 2017, 5 INT C CONC SPORT H; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Pang MYC, 2013, CEREBROVASC DIS, V35, P7, DOI 10.1159/000346075; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Winters-Stone KM, 2014, BRIT J SPORT MED, V48, P987, DOI 10.1136/bjsports-2012-091732; Wipfli BM, 2008, J SPORT EXERCISE PSY, V30, P392, DOI 10.1123/jsep.30.4.392	34	52	53	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196062	10.1371/journal.pone.0196062	http://dx.doi.org/10.1371/journal.pone.0196062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668716	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200076
J	Schwarz, KRL; de Castro, FC; Schefer, L; Botigelli, RC; Paschoal, DM; Fernandes, H; Leal, CLV				Schwarz, Katia R. L.; de Castro, Fernanda C.; Schefer, Leticia; Botigelli, Ramon C.; Paschoal, Daniela M.; Fernandes, Hugo; Leal, Claudia L. V.			The role of cGMP as a mediator of lipolysis in bovine oocytes and its effects on embryo development and cryopreservation (vol 13, e0191023, 2018)	PLOS ONE			English	Correction													Botigelli, Ramon/ABF-2847-2020; Leal, Cláudia/F-3518-2012	Botigelli, Ramon/0000-0002-2796-6062; Leal, Cláudia/0000-0002-9061-2574	CNPq, Brazil [308216/2014-8]	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by CNPq, Brazil, grant # 308216/2014-8 to CLVL.	Schwarz KRL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191023	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196268	10.1371/journal.pone.0196268	http://dx.doi.org/10.1371/journal.pone.0196268			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668728	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200083
J	Su, HL; Huo, CC; Wang, BT; Li, WH; Xu, GC; Liu, QY; Li, ZY				Su, Honglun; Huo, Congcong; Wang, Bitian; Li, Wenhao; Xu, Gongcheng; Liu, Qianying; Li, Zengyong			Alterations in the coupling functions between cerebral oxyhaemoglobin and arterial blood pressure signals in post-stroke subjects	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; LOW-FREQUENCY OSCILLATIONS; WAVELET COHERENCE ANALYSIS; ELDERLY SUBJECTS; PREFRONTAL CORTEX; INTRACRANIAL-PRESSURE; TRANSCRANIAL DOPPLER; TISSUE OXYGENATION; AUTOREGULATION; SYNCHRONIZATION	Cerebral autoregulation (CA) is the complex homeostatic regulatory relationship between blood pressure (BP) and cerebral blood flow (CBF). This study aimed to analyze the frequency-specific coupling function between cerebral oxyhemoglobin concentrations (delta [HbO(2)]) and mean arterial pressure (MAP) signals based on a model of coupled phase oscillators and dynamical Bayesian inference. Delta [HbO(2)] was measured by 24-channel near infrared spectroscopy (NIRS) and arterial BP signals were obtained by simultaneous resting-state measurements in patients with stroke, that is, 9 with left hemiparesis (L-H group), 8 with right hemiparesis (R-H group), and 17 age-matched healthy individuals as control (healthy group). The coupling functions from MAP to delta [HbO(2)] oscillators were identified and analyzed in four frequency intervals (I, 0.6-2 Hz; II, 0.145-0.6 Hz; III, 0.052-0.145 Hz; and IV, 0.021-0.052 Hz). In L-H group, the CS from MAP to delta [HbO(2)] in interval III in channel 8 was significantly higher than that in healthy group (p = 0.003). Compared with the healthy controls, the coupling in MAP)delta [HbO(2)] showed higher amplitude in interval I and IV in patients with stroke. The increased CS and coupling amplitude may be an evidence of impairment in CA, thereby confirming the presence of impaired CA in patients with stroke. In interval III, the CS in L-H group from MAP to delta [HbO(2)] in channel 16 (p = 0.001) was significantly lower than that in healthy controls, which might indicate the compensatory mechanism in CA of the unaffected side in patients with stroke. No significant difference in region-wise CS between affected and unaffected sides was observed in stroke groups, indicating an evidence of globally impaired CA. These findings provide a method for the assessment of CA and will contribute to the development of therapeutic interventions in stroke patients.	[Su, Honglun; Wang, Bitian; Li, Wenhao; Liu, Qianying] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China; [Huo, Congcong; Xu, Gongcheng] Shandong Univ, Sch Mech Engn, Jinan, Shandong, Peoples R China; [Li, Zengyong] Natl Res Ctr Rehabil Tech Aids, Beijing Key Lab Rehabil Tech Aids Old Age Disabil, Beijing, Peoples R China; [Li, Zengyong] Minist Civil Affairs, Key Lab Rehabil Aids Technol & Syst, Beijing, Peoples R China	Beihang University; Shandong University	Li, ZY (corresponding author), Natl Res Ctr Rehabil Tech Aids, Beijing Key Lab Rehabil Tech Aids Old Age Disabil, Beijing, Peoples R China.; Li, ZY (corresponding author), Minist Civil Affairs, Key Lab Rehabil Aids Technol & Syst, Beijing, Peoples R China.	lizengyong@nrcrta.cn	liu, qian/HDM-2936-2022		National Natural Science Foundation of China (NSFC) [31771071, 61761166007]; Fundamental Research Funds for Central Public Welfare Research Institutes [118009001000160001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Public Welfare Research Institutes	The project was supported by the National Natural Science Foundation of China (NSFC No. 31771071 and 61761166007) and Fundamental Research Funds for Central Public Welfare Research Institutes (118009001000160001) to ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Addison Paul S, 2015, IEEE Rev Biomed Eng, V8, P78, DOI 10.1109/RBME.2015.2436978; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Bandrivskyy A., 2004, CARDIOVASC ENG, V4, P89, DOI [10.1023/B:CARE.0000025126.63253.43, DOI 10.1023/B:CARE.0000025126.63253.43]; Bellapart J, 2009, ULTRASOUND MED BIOL, V35, P883, DOI 10.1016/j.ultrasmedbio.2009.01.005; Bernjak A, 2012, FLUCT NOISE LETT, V11, DOI 10.1142/S0219477512400135; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Cheng R, 2012, NEUROIMAGE, V62, P1445, DOI 10.1016/j.neuroimage.2012.05.069; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Daunizeau J, 2009, PHYSICA D, V238, P2089, DOI 10.1016/j.physd.2009.08.002; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; FOLKOW B, 1964, CIRC RES, V15, P279; Gagnon L, 2011, NEUROIMAGE, V56, P1362, DOI 10.1016/j.neuroimage.2011.03.001; Gao YJ, 2015, BEHAV BRAIN RES, V278, P330, DOI 10.1016/j.bbr.2014.10.019; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Han QY, 2014, MICROVASC RES, V95, P108, DOI 10.1016/j.mvr.2014.08.001; Hogenhout M., 2013, MOL CELL BIOL, V8, P4889, DOI [10.1152/jn.00516.2003, DOI 10.1152/JN.00516.2003]; Irani F, 2007, CLIN NEUROPSYCHOL, V21, P9, DOI 10.1080/13854040600910018; Johnson PC, 1991, MYOGENIC RESPONSE, P159; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Katsogridakis E, 2013, J CEREBR BLOOD F MET, V33, P519, DOI 10.1038/jcbfm.2012.191; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Kralemann B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3418; Kurths J, 2002, AM J PHYS, V70, P47; Kvernmo HD, 1998, MICROVASC RES, V56, P173, DOI 10.1006/mvre.1998.2108; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; LEVINE BD, 1994, CIRCULATION, V90, P298, DOI 10.1161/01.CIR.90.1.298; Li ZY, 2014, PHYSIOL MEAS, V35, P777, DOI 10.1088/0967-3334/35/5/777; Li ZY, 2013, MICROVASC RES, V88, P32, DOI 10.1016/j.mvr.2013.04.003; Li ZY, 2010, MICROVASC RES, V80, P142, DOI 10.1016/j.mvr.2010.02.004; Medvedev AV, 2008, BRAIN RES, V1236, P145, DOI 10.1016/j.brainres.2008.07.122; Mertins A., 1999, SIGNAL ANAL WAVELETS; MEYER JU, 1988, MICROVASC RES, V35, P193, DOI 10.1016/0026-2862(88)90062-3; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Moro SB, 2014, NEUROIMAGE, V85, P451, DOI 10.1016/j.neuroimage.2013.05.031; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Panerai RB, 2009, CLIN AUTON RES, V19, P197, DOI 10.1007/s10286-009-0011-8; Papademetriou MD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.067008; Peng TY, 2008, PHYSIOL MEAS, V29, P1055, DOI 10.1088/0967-3334/29/9/005; Penny WD, 2009, J NEUROSCI METH, V183, P19, DOI 10.1016/j.jneumeth.2009.06.029; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Reinhard M, 2008, CEREBROVASC DIS, V26, P147, DOI 10.1159/000139662; Reinhard M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.097005; Ronney BP, 1998, PHYSIOL MEAS, V19, P305; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Sasai S, 2012, NEUROIMAGE, V63, P179, DOI 10.1016/j.neuroimage.2012.06.011; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; Schwabedal JTC, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046218; Schwarz S, 2002, STROKE, V33, P998, DOI 10.1161/01.STR.0000014584.17714.2E; Schwarz S, 2002, STROKE, V33, P497, DOI 10.1161/hs0202.102376; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; Smelyanskiy VN, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098101; Stankovski T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/035002; Stankovski T, 2014, EUR PHYS J-SPEC TOP, V223, P2685, DOI 10.1140/epjst/e2014-02286-7; Stankovski T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.024101; Stefanovska A, 1999, CONTEMP PHYS, V40, P31, DOI 10.1080/001075199181693; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Tan QT, 2015, MED PHYS, V42, P5391, DOI 10.1118/1.4928672; Tarumi T, 2014, J ALZHEIMERS DIS, V41, P765, DOI 10.3233/JAD-132018; Terborg C, 2000, STROKE, V31, P924, DOI 10.1161/01.STR.31.4.924; Ticcinelli V, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00749; Tomislav S, 2016, PHILOS T, V374; Tong YJ, 2010, NEUROIMAGE, V53, P553, DOI 10.1016/j.neuroimage.2010.06.049; Townsend NW, 2003, LOCATING FEATURES PH; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; von Toussaint U, 2011, REV MOD PHYS, V83, P943, DOI 10.1103/RevModPhys.83.943; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; WOLLNER L, 1979, BRIT MED J, V1, P1117, DOI 10.1136/bmj.1.6171.1117; Xu GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188329; Yokota, 2013, BONFERRONI CORRECTIO; Zhang Q, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804706; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Zhang R, 2007, HYPERTENSION, V49, P1149, DOI 10.1161/HYPERTENSIONAHA.106.084939	84	8	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195936	10.1371/journal.pone.0195936	http://dx.doi.org/10.1371/journal.pone.0195936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668713	Green Submitted, gold, Green Published			2022-12-27	WOS:000430290200068
J	Wu, MN; Tseng, PT; Chen, TY; Chen, YW; Liou, LM; Lin, PY; Hsu, CY				Wu, Meng-Ni; Tseng, Ping-Tao; Chen, Tien-Yu; Chen, Yen-Wen; Liou, Li-Min; Lin, Pao-Yen; Hsu, Chung-Yao			The efficacy and tolerability of rotigotine on patients with periodic limb movement in sleep: A systematic review and meta-analysis	PLOS ONE			English	Review							RESTLESS-LEGS-SYNDROME; DOPAMINE-RECEPTOR AGONISTS; DOUBLE-BLIND; TRANSDERMAL PATCH; BEHAVIOR DISORDER; PRAMIPEXOLE; ROPINIROLE; AUGMENTATION; SAFETY; MANAGEMENT	Objective There is still no consensus on the treatment for periodic limb movement in sleep (PLMS). This study aimed to determine the efficacy and tolerability of rotigotine in patients suffering from PLMS. Methods Publications listed in PubMed, ScienceDirect, The Cochrane Library, and ClinicalTrials.gov were reviewed to assess the efficacy of rotigotine on PLMS. Analyses of PLMS frequency before and after rotigotine treatments (pre- and post-intervention studies) and PLMS frequency between placebo and rotigotine treatments (placebo-controlled trial studies) were included in our study. A systematic review and meta-analysis was conducted. Results Five publications involving 197 participants were included in this study. Among these articles, pre- and post-intervention data involving 55 participants were available from three articles, while placebo-controlled trial data from 107 participants receiving rotigotine and 70 participants receiving a placebo were available from an additional three articles. In the pre and post-intervention studies, the periodic limb movement index was significantly decreased after therapy with rotigotine with a difference in means of -5.866/h (95% CI, -10.570 to - 1.162, p = 0.015). In comparison with the placebo, the use of rotigotine significantly lowered the periodic limb movement index, with a difference in means of -32.105/h (95% CI, - 42.539 to -21.671, p < 0.001), reduced the PLMS with arousal index, with a difference in means of 7.160/h (95% CI, -9.310 to -5.010, p < 0.001), and increased the withdrawal rate, with an odds ratio of 3.421 (95% CI, 1.230 to 9.512, p = 0.018). Conclusions This meta-analysis revealed the considerable efficacy of rotigotine in alleviating the frequency of PLMS. However, the high withdrawal rate should be taken into account.	[Wu, Meng-Ni; Liou, Li-Min; Hsu, Chung-Yao] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Wu, Meng-Ni; Liou, Li-Min; Hsu, Chung-Yao] Kaohsiung Med Univ, Dept Masters Program Neurol, Fac Med, Kaohsiung, Taiwan; [Tseng, Ping-Tao] Tsyr Huey Mental Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Tseng, Ping-Tao] WinShine Clin Specialty Psychiat, Kaohsiung, Taiwan; [Chen, Tien-Yu] Natl Def Med Ctr, Triserv Gen Hosp, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chen, Yen-Wen] Prospect Clin Otorhinolaryngol & Neurol, Kaohsiung, Taiwan; [Lin, Pao-Yen] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lin, Pao-Yen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lin, Pao-Yen] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Hsu, CY (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.; Hsu, CY (corresponding author), Kaohsiung Med Univ, Dept Masters Program Neurol, Fac Med, Kaohsiung, Taiwan.	cyhsu@kmu.edu.tw	Lin, Pao-Yen/V-2495-2019	Hsu, Chung-Yao/0000-0002-9880-5944; Chen, Tien-Yu/0000-0001-8462-1311				Allen R, 2004, SLEEP, V27, P907, DOI 10.1093/sleep/27.5.907; Allen RP, 2011, SLEEP MED, V12, P431, DOI 10.1016/j.sleep.2011.03.003; Aurora RN, 2012, SLEEP, V35, P1039, DOI 10.5665/sleep.1988; Bauer A, 2016, NEUROLOGY, V86, P1785, DOI 10.1212/WNL.0000000000002649; Bekci TT, 2012, SLEEP BREATH, V16, P117, DOI 10.1007/s11325-010-0464-y; Bliwise DL, 2005, SLEEP MED, V6, P141, DOI 10.1016/j.sleep.2004.12.002; Bogan RK, 2014, CLIN THER, V36, P436, DOI 10.1016/j.clinthera.2014.01.021; Bogan RK, 2006, MAYO CLIN PROC, V81, P17, DOI 10.4065/81.1.17; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Chen JJ, 2009, PHARMACOTHERAPY, V29, P1452, DOI 10.1592/phco.29.12.1452; Clemens S, 2006, NEUROLOGY, V67, P125, DOI 10.1212/01.wnl.0000223316.53428.c9; Coldwell MC, 1999, BRIT J PHARMACOL, V127, P1696, DOI 10.1038/sj.bjp.0702673; Dauvilliers Y, 2016, AM J KIDNEY DIS, V68, P434, DOI 10.1053/j.ajkd.2015.12.027; Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160; de Mello MT, 2004, SPINAL CORD, V42, P218, DOI 10.1038/sj.sc.3101575; Ding J, 2015, J HUAZHONG U SCI-MED, V35, P169, DOI 10.1007/s11596-015-1406-5; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elshoff JP, 2016, SLEEP MED; EspinarSierra J, 1997, PSYCHIAT CLIN NEUROS, V51, P103, DOI 10.1111/j.1440-1819.1997.tb02370.x; Fantini ML, 2002, NEUROLOGY, V59, P1889, DOI 10.1212/01.WNL.0000038348.94399.F6; Ferini-Strambi L, 2002, SLEEP MED, V3, pS23, DOI 10.1016/S1389-9457(02)00144-2; Fulda S, 2015, SLEEP MED CLIN, V10, P241, DOI 10.1016/j.jsmc.2015.05.013; Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022; Garcia-Borreguero D, 2014, SLEEP, V37, P635, DOI 10.5665/sleep.3558; Garcia-Borreguero D, 2012, MOVEMENT DISORD, V27, P277, DOI 10.1002/mds.24889; Hanly PJ, 1996, CHEST, V109, P1497, DOI 10.1378/chest.109.6.1497; Happe S, 2004, CNS DRUGS, V18, P27, DOI 10.2165/00023210-200418010-00003; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Hornyak M, 2006, SLEEP MED REV, V10, P169, DOI 10.1016/j.smrv.2005.12.003; Hornyak M, 2004, SLEEP MED, V5, P597, DOI 10.1016/j.sleep.2004.07.008; Hornyak M, 2014, SLEEP MED REV, V18, P153, DOI 10.1016/j.smrv.2013.03.004; Hornyak M, 2012, SLEEP MED, V13, P228, DOI 10.1016/j.sleep.2011.09.013; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Inoue Y, 2013, PROG NEURO-PSYCHOPH, V40, P326, DOI 10.1016/j.pnpbp.2012.10.012; Jama L, 2009, SLEEP MED, V10, P630, DOI 10.1016/j.sleep.2008.05.014; Jung HH, 2010, CLIN J AM SOC NEPHRO, V5, P1607, DOI 10.2215/CJN.08881209; Koo BB, 2016, AM J GERIAT PSYCHIAT, V24, P1105, DOI 10.1016/j.jagp.2016.04.003; Koo BB, 2015, HYPERTENSION, V65, P70, DOI 10.1161/HYPERTENSIONAHA.114.04193; Koo BB, 2011, CIRCULATION, V124, P1223, DOI 10.1161/CIRCULATIONAHA.111.038968; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindner A, 2012, J SLEEP RES, V21, P297, DOI 10.1111/j.1365-2869.2011.00956.x; Lipford MC, 2012, SLEEP MED, V13, P1280, DOI 10.1016/j.sleep.2012.08.004; Manconi M, 2011, NEUROLOGY, V77, P110, DOI 10.1212/WNL.0b013e3182242d91; Mirza M, 2013, J AM SOC ECHOCARDIOG, V26, P783, DOI 10.1016/j.echo.2013.03.018; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Montplaisir J, 2000, SLEEP MED, V1, P163, DOI 10.1016/S1389-9457(00)00014-9; Moore H, 2014, SLEEP, V37, P1535, DOI 10.5665/sleep.4006; Murase Kimihiko, 2014, Ann Am Thorac Soc, V11, P375, DOI 10.1513/AnnalsATS.201306-144OC; Oertel W, 2011, LANCET NEUROL, V10, P710, DOI 10.1016/S1474-4422(11)70127-2; Oertel WH, 2008, SLEEP MED, V9, P228, DOI 10.1016/j.sleep.2007.04.010; Oertel WH, 2010, SLEEP MED, V11, P848, DOI 10.1016/j.sleep.2010.02.014; Partinen M, 2006, SLEEP MED, V7, P407, DOI 10.1016/j.sleep.2006.03.011; Piercey MF, 1998, CLIN NEUROPHARMACOL, V21, P141; Priano L, 2006, DRUG AGING, V23, P357, DOI 10.2165/00002512-200623050-00001; Quilici S, 2008, SLEEP MED, V9, P715, DOI 10.1016/j.sleep.2007.11.020; Rijsman RM, 2004, NEPHROLOGY, V9, P353, DOI 10.1111/j.1440-1797.2004.00330.x; Salas RE, 2010, CLIN CHEST MED, V31, P383, DOI 10.1016/j.ccm.2010.02.006; Saletu M, 2002, EUR ARCH PSY CLIN N, V252, P185, DOI 10.1007/s00406-002-0380-7; Sasai T, 2012, TOHOKU J EXP MED, V226, P177, DOI 10.1620/tjem.226.177; Sasai T, 2011, J NEUROL, V258, P1971, DOI 10.1007/s00415-011-6051-8; Scholz Hanna, 2011, Cochrane Database Syst Rev, pCD006009, DOI 10.1002/14651858.CD006009.pub2; Sieb JP, 2015, CURR MED RES OPIN, V31, P967, DOI 10.1185/03007995.2015.1030376; Silber Michael H, 2013, Continuum (Minneap Minn), V19, P170, DOI 10.1212/01.CON.0000427207.13553.68; Soriano JB, 1999, INT J EPIDEMIOL, V28, P728, DOI 10.1093/ije/28.4.728; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Trenkwalder C, 2008, LANCET NEUROL, V7, P595, DOI 10.1016/S1474-4422(08)70112-1; Vignatelli L, 2006, EUR J NEUROL, V13, P1049, DOI 10.1111/J.1468-1331.2006.01410.x; Wang Y, 2016, J CLIN SLEEP MED, V12, P1403, DOI 10.5664/jcsm.6200; WARNES H, 1993, J SLEEP RES, V2, P38, DOI 10.1111/j.1365-2869.1993.tb00059.x; Wijemanne Subhashie, 2017, Pract Neurol, V17, P444, DOI 10.1136/practneurol-2017-001762; Wilt TJ, 2013, JAMA INTERN MED, V173, P496, DOI 10.1001/jamainternmed.2013.3733; Winkelman JW, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx023; Winkelman JW, 2016, SLEEP MED, V23, P18, DOI 10.1016/j.sleep.2016.05.004; Wood M, 2015, BRIT J PHARMACOL, V172, P1124, DOI 10.1111/bph.12988; Yumino D, 2011, AM J CARDIOL, V107, P447, DOI 10.1016/j.amjcard.2010.09.037; Zou R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003294	77	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195473	10.1371/journal.pone.0195473	http://dx.doi.org/10.1371/journal.pone.0195473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668694	Green Submitted, Green Published, gold			2022-12-27	WOS:000430290200042
J	Martin, AR; De Leener, B; Cohen-Adad, J; Kalsi-Ryan, S; Cadotte, DW; Wilson, JR; Tetreauttl, L; Nouri, A; Crawley, A; Mikulis, DJ; Ginsberg, H; Massicotte, EM; Fehlings, MG				Martin, Allan R.; De Leener, Benjamin; Cohen-Adad, Julien; Kalsi-Ryan, Sukhvinder; Cadotte, David W.; Wilson, Jefferson R.; Tetreault, Lindsay; Nouri, Aria; Crawley, Adrian; Mikulis, David J.; Ginsberg, Howard; Massicotte, Eric M.; Fehlings, Michael G.			Monitoring for myelopathic progression with multiparametric quantitative MRI	PLOS ONE			English	Article							CERVICAL SPONDYLOTIC MYELOPATHY; OF-THE-ART; SPINAL-CORD; CONSERVATIVE TREATMENT; NATURAL-HISTORY; RELIABILITY; MILD; VALIDATION; MANAGEMENT; STRENGTH	Background Patients with mild degenerative cervical myelopathy (DCM) are often managed non-operatively, and surgery is recommended if neurological progression occurs. However, detection of progression is often subjective. Quantitative MRI (qMRI) directly measures spinal cord (SC) tissue changes, detecting axonal injury, demyelination, and atrophy. This longitudinal study compared multiparametric qMRI with clinical measures of progression in non-operative DCM patients. Methods 26 DCM patients were followed. Clinical data included modified Japanese Orthopedic Association (mJOA) and additional assessments. 3T qMRI data included cross sectional area, diffusion fractional anisotropy, magnetization transfer ratio, and T2*-weighted white/grey matter signal ratio, extracted from the compressed SC and above/below. Progression was defined as 1) patients' subjective impression, 2) 2-point mJOA decrease, 3) >= 3 clinical measures worsening >= 5%, 4) increased compression on MRI, or 5) >= 1 of 10 qMRI measures or composite score worsening (p < 0.004, corrected). Results Follow-up (13.5 +/- 4.9 months) included mJOA in all 26 patients, MRI in 25, and clinical/qMRI in 22. 42.3% reported subjective worsening, compared with mJOA (11.5%), MRI (20%), comprehensive assessments (54.6%), and qMRI (68.2%). Relative to subjective worsening, qMRI showed 100% sensitivity and 53.3% specificity compared with comprehensive assessments (75%, 60%), mJOA (27.3%, 100%), and MRI (18.2%, 81.3%). A decision-making algorithm incorporating qMRI identified progression and recommended surgery for 11 subjects (42.3%). Conclusions Quantitative MRI shows high sensitivity to detect myelopathic progression. Our results suggest that neuroplasticity and behavioural adaptation may mask progressive SC tissue injury. qMRI appears to be a useful method to confirm subtle myelopathic progression in individual patients, representing an advance toward clinical translation of qMRI.	[Martin, Allan R.; Kalsi-Ryan, Sukhvinder; Cadotte, David W.; Wilson, Jefferson R.; Tetreault, Lindsay; Nouri, Aria; Crawley, Adrian; Mikulis, David J.; Ginsberg, Howard; Massicotte, Eric M.; Fehlings, Michael G.] Univ Toronto, Toronto, ON, Canada; [De Leener, Benjamin; Cohen-Adad, Julien] Polytech Montreal, Montreal, PQ, Canada	University of Toronto; Universite de Montreal; Polytechnique Montreal	Fehlings, MG (corresponding author), Univ Toronto, Toronto, ON, Canada.	Michael.Fehlings@uhn.ca	Nouri, Aria/I-1642-2019; Mikulis, David J/H-5167-2019; De Leener, Benjamin/H-3765-2019	Nouri, Aria/0000-0002-4965-3059; De Leener, Benjamin/0000-0002-1378-2756; Fehlings, Michael/0000-0002-5722-6364; Mikulis, David/0000-0003-3956-0892; Kalsi-Ryan, Sukhvinder/0000-0003-2332-5986				Bartels RHMA, 2010, NEUROSURGERY, V66, P1013, DOI 10.1227/01.NEU.0000368391.79314.6F; Beaton DE, 2005, J BONE JOINT SURG AM, V87A, P1038, DOI 10.2106/JBJS.D.02060; Bednarik J, 1999, SPINE, V24, P1593, DOI 10.1097/00007632-199908010-00014; BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Cadotte DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045560; Cohen-Adad J, 2014, NEUROIMAGE, V93, P189, DOI 10.1016/j.neuroimage.2013.01.023; De Leener B, 2017, NEUROIMAGE, V145, P24, DOI 10.1016/j.neuroimage.2016.10.009; Ellaway PH, 2013, SPINAL CORD, V51, P120, DOI 10.1038/sc.2012.96; Fehlings MG, 2017, GLOB SPINE J, V7, p70S, DOI 10.1177/2192568217701914; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Grabher P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24636; HAMILTON GF, 1992, J ORTHOP SPORT PHYS, V16, P215, DOI 10.2519/jospt.1992.16.5.215; Jutzeler C, 2017, J NEUROTRAUMA; Kadanka Z, 2000, EUR SPINE J, V9, P538, DOI 10.1007/s005860000132; Kadanka Z, 2011, EUR SPINE J, V20, P1533, DOI 10.1007/s00586-011-1811-9; Kalsi-Ryan S, 2013, SPINE, V38, pS111, DOI 10.1097/BRS.0b013e3182a7f499; Kalsi-Ryan S, 2012, J NEUROTRAUM, V29, P905, DOI 10.1089/neu.2010.1504; Karadimas SK, 2013, SPINE, V38, pS21, DOI 10.1097/BRS.0b013e3182a7f2c3; Kerkovsky M, 2012, SPINE, V37, P48, DOI 10.1097/BRS.0b013e31820e6c35; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Levy S, 2015, NEUROIMAGE, V119, P262, DOI 10.1016/j.neuroimage.2015.06.040; Martin AR, 2017, AM J NEURORADIOL, V38, P1257, DOI 10.3174/ajnr.A5163; Martin AR, 2017, AM J NEURORADIOL, V38, P1266, DOI 10.3174/ajnr.A5162; Martin AR, 2016, NEUROIMAGE-CLIN, V10, P192, DOI 10.1016/j.nicl.2015.11.019; Matsumoto M, 2001, SPINE, V26, P1592, DOI 10.1097/00007632-200107150-00021; Matsumoto M, 2000, SPINE, V25, P677, DOI 10.1097/00007632-200003150-00005; Matz PG, 2009, J NEUROSURG-SPINE, V11, P104, DOI 10.3171/2009.1.SPINE08716; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Oh J, 2013, MULT SCLER J, V19, P427, DOI 10.1177/1352458512456614; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Rhee JM, 2013, SPINE, V38, pS55, DOI 10.1097/BRS.0b013e3182a7f41d; Samson RS, 2013, NMR BIOMED, V26, P1823, DOI 10.1002/nbm.3022; Shimomura T, 2007, SPINE, V32, P2474, DOI 10.1097/BRS.0b013e3181573aee; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Sumi M, 2012, J NEUROSURG-SPINE, V16, P8, DOI 10.3171/2011.8.SPINE11395; Taso M, 2016, NMR BIOMED, V29, P817, DOI 10.1002/nbm.3530; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Yoshimatsu H, 2001, Spine J, V1, P269, DOI 10.1016/S1529-9430(01)00082-1	41	37	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195733	10.1371/journal.pone.0195733	http://dx.doi.org/10.1371/journal.pone.0195733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664964	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000430262300029
J	Ekrikpo, UE; Kengne, AP; Bello, AK; Effa, EE; Noubiap, JJ; Salako, BL; Rayner, BL; Remuzzi, G; Okpechi, IG				Ekrikpo, Udeme E.; Kengne, Andre P.; Bello, Aminu K.; Effa, Emmanuel E.; Noubiap, Jean Jacques; Salako, Babatunde L.; Rayner, Brian L.; Remuzzi, Giuseppe; Okpechi, Ikechi G.			Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis	PLOS ONE			English	Review							GLOMERULAR-FILTRATION-RATE; PATIENTS RECEIVING DIALYSIS; STAGE RENAL-DISEASE; RISK-FACTORS; ANTIRETROVIRAL THERAPY; CLINICAL CHARACTERISTICS; SERUM CREATININE; COCKCROFT-GAULT; HIGH PREVALENCE; APOL1 VARIANTS	Introduction The widespread use of antiretroviral therapies (ART) has increased life expectancy in HIV patients, predisposing them to chronic non-communicable diseases including Chronic Kidney Disease (CKD). We performed a systematic review and meta-analysis (PROSPERO registration number CRD42016036246) to determine the global and regional prevalence of CKD in HIV patients. Methods We searched PubMed, Web of Science, EBSCO and AJOL for articles published between January 1982 and May 2016. CKD was defined as estimated glomerular filtration rate (eGFR) <60ml/min using the MDRD, Cockcroft-Gault or CKD-EPI equations. Random effects model was used to combine prevalence estimates from across studies after variance stabilization via Freeman-Tukey transformation. Result Sixty-one eligible articles (n = 209,078 HIV patients) in 60 countries were selected. The overall CKD prevalence was 6.4% (95% CI 5.2-7.7%) with MDRD, 4.8% (95% CI 2.9-7.1%) with CKD-EPI and 12.3% (95% CI 8.4-16.7%) with Cockcroft-Gault; p = 0.003 for difference across estimators. Sub-group analysis identified differences in prevalence by WHO region with Africa having the highest MDRD-based prevalence at 7.9% (95% CI 5.2-11.1%). Within Africa, the pooled MDRD-based prevalence was highest in West Africa [14.6% (95% CI 9.9-20.0%)] and lowest in Southern Africa (3.2%, 95% CI 3.0-3.4%). The heterogeneity observed could be explained by WHO region, comorbid hypertension and diabetes mellitus, but not by gender, hepatitis B or C coinfection, CD4 count or antiretroviral status. Conclusion CKD is common in HIV-infected people, particularly in Africa. HIV treatment programs need to intensify screening for CKD with added need to introduce global guidelines for CKD identification and treatment in HIV positive patients.	[Ekrikpo, Udeme E.; Rayner, Brian L.; Okpechi, Ikechi G.] Groote Schuur Hosp, Div Nephrol & Hypertens, Cape Town, South Africa; [Ekrikpo, Udeme E.; Noubiap, Jean Jacques; Rayner, Brian L.; Okpechi, Ikechi G.] Univ Cape Town, Cape Town, South Africa; [Ekrikpo, Udeme E.] Univ Uyo, Dept Med, Renal Unit, Uyo, Nigeria; [Ekrikpo, Udeme E.; Noubiap, Jean Jacques; Rayner, Brian L.; Okpechi, Ikechi G.] Groote Schuur Hosp, Dept Med, Cape Town, South Africa; [Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Bello, Aminu K.] Univ Alberta, Div Nephrol & Immunol, Dept Med, Edmonton, AB, Canada; [Effa, Emmanuel E.] Univ Calabar, Dept Med, Renal Unit, Calabar, Nigeria; [Salako, Babatunde L.] Univ Ibadan, Dept Med, Coll Med, Ibadan, Nigeria; [Rayner, Brian L.; Okpechi, Ikechi G.] Univ Cape Town, Kidney & Hypertens Res Unit, Cape Town, South Africa; [Remuzzi, Giuseppe] Clin Res Ctr Rare Dis Aldo & Cele Dacco, IRCCS Ist Ric Farmacol Mario Negri, Bergamo, Italy	University of Cape Town; University of Cape Town; University of Uyo; University of Cape Town; South African Medical Research Council; University of Alberta; University of Calabar; University of Ibadan; University of Cape Town; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Okpechi, IG (corresponding author), Groote Schuur Hosp, Div Nephrol & Hypertens, Cape Town, South Africa.; Okpechi, IG (corresponding author), Univ Cape Town, Cape Town, South Africa.; Okpechi, IG (corresponding author), Groote Schuur Hosp, Dept Med, Cape Town, South Africa.; Okpechi, IG (corresponding author), Univ Cape Town, Kidney & Hypertens Res Unit, Cape Town, South Africa.	Ikechi.Okpechi@uct.ac.za	Ekrikpo, Udeme/H-7129-2016; Kengne, Andre Pascal/ABB-3696-2020; Effa, Emmanuel Edet/AAA-6009-2022; Rayner, Brian/AAA-3174-2021	Ekrikpo, Udeme/0000-0002-3911-5564; Effa, Emmanuel Edet/0000-0002-5654-2963; Kengne, Andre Pascal/0000-0002-5183-131X; Okpechi, Ikechi/0000-0002-6545-9715; Noubiap, Jean Jacques/0000-0002-7722-9757; Bello, Aminu K/0000-0002-6905-5937	Postgraduate Academic Mobility for African Physician Scientists (PAMAPS)	Postgraduate Academic Mobility for African Physician Scientists (PAMAPS)	UEE received funding from the Postgraduate Academic Mobility for African Physician Scientists (PAMAPS) for this study.	Achhra AC, 2015, HIV MED, V16, P55, DOI 10.1111/hiv.12234; Adedeji Tewogbade Adeoye, 2015, J Int Assoc Provid AIDS Care, V14, P434, DOI 10.1177/2325957415587570; Agbaji Oche O, 2011, Niger Med J, V52, P182, DOI 10.4103/0300-1652.86133; AIDSinfo, 2016, GUID US ANT AG HIV 1; Al-Sheikh H, 2013, ANN SAUDI MED, V33, P347, DOI 10.5144/0256-4947.2013.347; Al-Wakeel JS, 2016, ANN SAUDI MED, V36, P128, DOI 10.5144/0256-4947.2016.28.3.1715; Anyabolu E N, 2016, Indian J Nephrol, V26, P10, DOI 10.4103/0971-4065.156115; AU, 2009, STRENGTH POP PART AF, p[11, 62]; Bandera A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124252; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Barraclough K, 2009, NEPHRON CLIN PRACT, V111, pC39, DOI 10.1159/000178978; Barril G, 2005, ENFERM INFEC MICR CL, V23, P335, DOI 10.1157/13076172; Bhasin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082028; Bonjoch A, 2014, AIDS PATIENT CARE ST, V28, P524, DOI 10.1089/apc.2014.0172; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Cailhol J, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-40; Calza L, 2014, CLIN EXP NEPHROL, V18, P104, DOI 10.1007/s10157-013-0817-5; Campbell LJ, 2009, HIV MED, V10, P329, DOI 10.1111/j.1468-1293.2008.00691.x; Cao Y, 2013, NEPHROLOGY, V18, P307, DOI 10.1111/nep.12031; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Cheung CY, 2007, NEPHROL DIAL TRANSPL, V22, P3186, DOI 10.1093/ndt/gfm350; Choi AI, 2007, CLIN INFECT DIS, V45, P1633, DOI 10.1086/523729; Choi AI, 2010, KIDNEY INT, V78, P478, DOI 10.1038/ki.2010.171; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Colson AW, 2010, ACTA CLIN BELG, V65, P392, DOI 10.1179/acb.2010.65.6.004; Crum-Cianflone N, 2010, AIDS PATIENT CARE ST, V24, P353, DOI 10.1089/apc.2009.0326; Department of Health RoSA, 2016, S AFR ANT TREATM GUI; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Edwards JK, 2015, T ROY SOC TROP MED H, V109, P440, DOI 10.1093/trstmh/trv038; Egger M, 1998, BRIT MED J, V316, P470; Ekat MH, 2013, MED SANTE TROP, V23, P176, DOI 10.1684/mst.2013.0170; Estrella MM, 2011, JAIDS-J ACQ IMM DEF, V57, P380, DOI 10.1097/QAI.0b013e318222f461; Evans RDR, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0446-4; Fernando SK, 2008, AM J MED SCI, V335, P89, DOI 10.1097/MAJ.0b013e31812e6b34; Fischer MJ, 2010, JAIDS-J ACQ IMM DEF, V53, P222, DOI 10.1097/QAI.0b013e3181b980d4; Flandre P, 2011, CLIN J AM SOC NEPHRO, V6, P1700, DOI 10.2215/CJN.09191010; Fulop T, 2010, CLIN NEPHROL, V73, P190; Ganesan A, 2013, HIV MED, V14, P65, DOI 10.1111/j.1468-1293.2012.01036.x; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; George E, 2010, AIDS, V24, P387, DOI 10.1097/QAD.0b013e3283359253; Glaser N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130453; Gonzalez-Lopez A, 2014, NEFROLOGIA, V34, P126, DOI 10.3265/Nefrologia.pre2013.Oct.12248; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Gracey D, 2013, INTERN MED J, V43, P410, DOI 10.1111/j.1445-5994.2012.02933.x; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Halle MP, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0044-2; Han TM, 2006, KIDNEY INT, V69, P2243, DOI 10.1038/sj.ki.5000339; Health NDo, NAT CONS GUID PREV M; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsieh MH, 2015, J MICROBIOL IMMUNOL, V48, P256, DOI 10.1016/j.jmii.2013.08.013; Ibrahim F, 2012, NEPHROL DIAL TRANSPL, V27, P2291, DOI 10.1093/ndt/gfr657; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kamkuemah M, 2015, TROP MED INT HEALTH, V20, P518, DOI 10.1111/tmi.12446; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li YM, 2012, AM J NEPHROL, V35, P327, DOI 10.1159/000337151; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Longo AL, 2012, JAIDS-J ACQ IMM DEF, V59, P59, DOI 10.1097/QAI.0b013e31823587b0; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Lucas GM, 2010, JAIDS-J ACQ IMM DEF, V55, P491, DOI 10.1097/QAI.0b013e3181e8d5a8; Madala ND, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-61; Madala ND, 2012, INT UROL NEPHROL, V44, P847, DOI 10.1007/s11255-011-9928-7; Mayor AM, 2010, ETHNICITY DIS S1, V20; Menezes AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026042; Mizushima D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079885; Mocroft A, 2014, HIV MED, V15, P144, DOI 10.1111/hiv.12095; Mocroft A, 2011, HIV MED, V12, P1, DOI 10.1111/j.1468-1293.2010.00854.x; Mocroft A, 2016, LANCET HIV, V3, pE23, DOI 10.1016/S2352-3018(15)00211-8; Mocroft A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040245; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Msango L, 2011, AIDS, V25, P1421, DOI 10.1097/QAD.0b013e328348a4b1; Mulay A V, 2017, Indian J Nephrol, V27, P124, DOI 10.4103/0971-4065.200515; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Muramatsu Takashi, 2013, Kansenshogaku Zasshi, V87, P14; Musso Carlos G, 2016, World J Nephrol, V5, P33, DOI 10.5527/wjn.v5.i1.33; Naicker S, 2008, SEMIN NEPHROL, V28, P348, DOI 10.1016/j.semnephrol.2008.04.003; Nakamura Yuya, 2008, Nihon Jinzo Gakkai Shi, V50, P499; Nigeria FMoH, 2016, NAT GUID HIV AIDS TR; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Obirikorang C, 2014, PLOS ONE, V9; Odongo P, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0035-3; Okafor U H, 2011, Afr J Infect Dis, V5, P28, DOI 10.4314/ajid.v5i2.66509; Onodugo Obinna D, 2013, J Int Assoc Provid AIDS Care; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; Owiredu WKBA, 2013, AFR HEALTH SCI, V13, P101, DOI 10.4314/ahs.v13i1.14; Papeta N, 2011, J AM SOC NEPHROL, V22, P1991, DOI 10.1681/ASN.2011040434; Peck RN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0125-2; Poignet JL, 1999, NEPHROLOGIE, V20, P159; Prakash J, 2015, Indian J Nephrol, V25, P86, DOI 10.4103/0971-4065.138696; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Rosenberg AZ, 2015, NAT REV NEPHROL, V11, P150, DOI 10.1038/nrneph.2015.9; Sakajiki A. M., 2014, Annals of Nigerian Medicine, V8, P69, DOI 10.4103/0331-3131.153356; Santiago P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093748; Sarfo FS, 2013, J INFECTION, V67, P43, DOI 10.1016/j.jinf.2013.03.008; Schoffelen AF, 2015, J INFECT DIS, V212, P264, DOI 10.1093/infdis/jiv026; Schwartz EJ, 2005, J AM SOC NEPHROL, V16, P2412, DOI 10.1681/ASN.2005040340; Sorli ML, 2008, JAIDS-J ACQ IMM DEF, V48, P506, DOI 10.1097/QAI.0b013e31817bbecb; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Stohr W, 2008, ANTIVIR THER, V13, P761; Struik GM, 2011, INT J STD AIDS, V22, P457, DOI 10.1258/ijsa.2011.010521; Sumaili EK, 2009, NEPHROL DIAL TRANSPL, V24, P117, DOI 10.1093/ndt/gfn469; Szczech LA, 2010, HIV MED, V11, P419, DOI 10.1111/j.1468-1293.2009.00805.x; Tayo BO, 2013, INT UROL NEPHROL, V45, P485, DOI 10.1007/s11255-012-0263-4; Trullas JC, 2008, AIDS RES HUM RETROV, V24, P1229, DOI 10.1089/aid.2008.0158; Ulasi II, 2013, NEPHRON CLIN PRACT, V123, P123, DOI 10.1159/000353223; Umeizudike TI, 2012, NEPHROLOGY REV, V4, P22, DOI DOI 10.4081/NR.2012.E5; Vachiat AI, 2013, CLIN KIDNEY J, V6, P584, DOI 10.1093/ckj/sft128; Viera AJ, 2005, FAM MED, V37, P360; Vigneau C, 2005, KIDNEY INT, V67, P1509, DOI 10.1111/j.1523-1755.2005.00229.x; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Winston JA, 2010, ADV CHRONIC KIDNEY D, V17, P19, DOI 10.1053/j.ackd.2009.08.006; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223; Wyatt CA, 2008, AIDS, V22, P1799, DOI 10.1097/QAD.0b013e32830e0152; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601; Wyatt CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018352; Xie P, 2013, INT UROL NEPHROL, V45, P1057, DOI 10.1007/s11255-012-0325-7; Yanagisawa N, 2011, NEPHRON CLIN PRACT, V118, pC285, DOI 10.1159/000322278; Yanagisawa Naoki, 2010, Kansenshogaku Zasshi, V84, P28; Zachor H, 2016, AIDS, V30, P1221, DOI 10.1097/QAD.0000000000001041; Zhao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135462	126	60	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195443	10.1371/journal.pone.0195443	http://dx.doi.org/10.1371/journal.pone.0195443			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659605	gold, Green Published, Green Submitted			2022-12-27	WOS:000430061100015
J	Kolesnikova, TD; Goncharov, FP; Zhimulev, IF				Kolesnikova, Tatyana D.; Goncharov, Fedor P.; Zhimulev, Igor F.			Similarity in replication timing between polytene and diploid cells is associated with the organization of the Drosophila genome	PLOS ONE			English	Article							OVARIAN PSEUDONURSE CELLS; INTERCALARY HETEROCHROMATIN; DNA-REPLICATION; GENETIC ORGANIZATION; MELANOGASTER; CHROMOSOMES; CHROMATIN; DOMAINS; TRANSCRIPTION; SUUR	Morphologically, polytene chromosomes of Drosophila melanogaster consist of compact "black" bands alternating with less compact "grey" bands and interbands. We developed a comprehensive approach that combines cytological mapping data of FlyBase-annotated genes and novel tools for predicting cytogenetic features of chromosomes on the basis of their protein composition and determined the genomic coordinates for all black bands of polytene chromosome 2R. By a PCNA immunostaining assay, we obtained the replication timetable for all the bands mapped. The results allowed us to compare replication timing between polytene chromosomes in salivary glands and chromosomes from cultured diploid cell lines and to observe a substantial similarity in the global replication patterns at the band resolution level. In both kinds of chromosomes, the intervals between black bands correspond to early replication initiation zones. Black bands are depleted of replication initiation events and are characterized by a gradient of replication timing; therefore, the time of replication completion correlates with the band length. The bands are characterized by low gene density, contain predominantly tissue-specific genes, and are represented by silent chromatin types in various tissues. The borders of black bands correspond well to the borders of topological domains as well as to the borders of the zones showing H3K27me3, SUUR, and LAMIN enrichment. In conclusion, the characteristic pattern of polytene chromosomes reflects partitioning of the Drosophila genome into two global types of domains with contrasting properties. This partitioning is conserved in different tissues and determines replication timing in Drosophila.	[Kolesnikova, Tatyana D.; Goncharov, Fedor P.; Zhimulev, Igor F.] SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Kolesnikova, Tatyana D.; Zhimulev, Igor F.] Novosibirsk State Univ, Novosibirsk, Russia	Russian Academy of Sciences; Novosibirsk State University	Kolesnikova, TD (corresponding author), SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia.; Kolesnikova, TD (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.	kolesnikova@mcb.nsc.ru	Kolesnikova, Tatyana/N-5461-2015; Zhimulev, Igor F/N-7978-2015	Kolesnikova, Tatyana/0000-0002-5107-1445; Zhimulev, Igor/0000-0002-6220-3028	Russian Science Foundation [14-14-00934]; Russian Foundation for Basic Research (RFBR) [15-04-03898]; Russian Science Foundation [17-14-00038] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	Genome mapping of bands and data analysis were funded by a grant from the Russian Science Foundation to I.F.Z. (14-14-00934, http://www.rscf.ru/). Analysis of replication was funded by a grant from the Russian Foundation for Basic Research (RFBR) project to I.F.Z. (15-04-03898, http:/www.rfbr.ru/rffi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyenkova NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083319; [Anonymous], 2017, R LANG ENV STAT COMP; Audit Benjamin, 2013, Subcell Biochem, V61, P57, DOI 10.1007/978-94-007-4525-4_3; BEERMANN W, 1952, CHROMOSOMA, V5, P139; BEERMANN W., 1965, Genetics today. Proceedings of the XI International Congress of Genetics, The Hague, the Netherlands, September, 1963., V2, P375; Belyaeva ES, 2008, CHROMOSOMA, V117, P411, DOI 10.1007/s00412-008-0163-7; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyaeva ES, 1998, P NATL ACAD SCI USA, V95, P7532, DOI 10.1073/pnas.95.13.7532; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Boldyreva LV, 2017, CURR GENOMICS, V18, P214, DOI 10.2174/1389202917666160512164913; Boulos RE, 2015, FEBS LETT, V589, P2944, DOI 10.1016/j.febslet.2015.04.015; Bridges CB, 1939, J HERED, V30, P475, DOI 10.1093/oxfordjournals.jhered.a104634; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chintapalli V., 2010, FLYATLAS SURVEY ADUL; Comoglio F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003419; Cuenca JB, 1998, CHROMOSOMA, V107, P113, DOI 10.1007/s004120050287; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; Demakov S, 2004, GENETICA, V122, P311, DOI 10.1007/s10709-004-2839-0; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Demakova O V, 2016, Tsitologiia, V58, P248; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar BA, 2014, NAT REV MOL CELL BIO, V15, P197, DOI 10.1038/nrm3756; El-Sharnouby S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172725; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Graveley BR, 2011, D MELANOGASTER TRANS; Guilbaud G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002322; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Khoroshko VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157147; Kolesnikova T D, 2016, Tsitologiia, V58, P262; Kolesnikova TD, 2013, CHROMOSOMA, V122, P55, DOI 10.1007/s00412-012-0390-9; Koryakov DE, 2015, CHROMOSOMA, V124, P95, DOI 10.1007/s00412-014-0487-4; Koryakov DE, 2012, CHROMOSOMA, V121, P573, DOI 10.1007/s00412-012-0382-9; KOZLOVA TY, 1994, GENETICS, V136, P1063; LAKHOTIA SC, 1983, CHROMOSOMA, V88, P265, DOI 10.1007/BF00292903; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lefevre G., 1976, GENET BIOL DROSOPHIL, P31; Maksimov DA, 2014, CHROMOSOMA, V123, P253, DOI 10.1007/s00412-013-0445-6; Makunin IV, 2002, GENETICS, V160, P1023; MALCEVA NI, 1995, CHROMOSOME RES, V3, P191, DOI 10.1007/BF00710713; Maqbool SB, 2010, J CELL SCI, V123, P4095, DOI 10.1242/jcs.064519; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Milon B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-988; MISHRA A, 1982, CHROMOSOMA, V85, P221, DOI 10.1007/BF00294967; Nordman JT, 2014, CELL REP, V9, P841, DOI 10.1016/j.celrep.2014.10.005; Pavan C., 1959, Proceedings 10th Internat Congr Genetics, V1, P321; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Petryk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10208; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pokholkova GV, 2015, CHROMOSOMA, V124, P209, DOI 10.1007/s00412-014-0491-8; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Posukh OV, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0163-z; Posukh OV, 2017, NUCLEUS, V6, P249; Powell SK, 2015, EMBO J, V34, P531, DOI 10.15252/embj.201488307; Prioleau MN, 2016, GENE DEV, V30, P1683, DOI 10.1101/gad.285114.116; REDFERN CPF, 1981, CHROMOSOMA, V84, P33, DOI 10.1007/BF00293361; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; RUDKIN GT, 1959, P NATL ACAD SCI USA, V45, P997, DOI 10.1073/pnas.45.7.997; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Saura A., 1986, THESIS; SAURA AO, 1991, HEREDITAS, V114, P15, DOI 10.1111/j.1601-5223.1991.tb00549.x; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; SINHA P, 1987, CHROMOSOMA, V95, P108, DOI 10.1007/BF00332183; SORSA V, 1973, HEREDITAS, V74, P297; SPIERER A, 1984, NATURE, V307, P176, DOI 10.1038/307176a0; Spradling AC, 1999, GENETICS, V153, P135; Stadler MR, 2017, ELIFE, V6, DOI 10.7554/eLife.29550; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Vatolina T Iu, 2011, Genetika, V47, P597; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; White R, 2012, BRIEF FUNCT GENOMICS, V11, P347, DOI 10.1093/bfgp/els020; Yarosh W, 2014, GENE DEV, V28, P1840, DOI 10.1101/gad.245811.114; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0; Zhimulev IF, 1999, ADV GENET, V39, P1, DOI 10.1016/S0065-2660(08)60476-9; Zhimulev IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101631; Zhimulev IF, 2012, BIOESSAYS, V34, P498, DOI 10.1002/bies.201100142; Zielke T, 2016, CHROMOSOMA, V125, P423, DOI 10.1007/s00412-015-0554-5	93	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195207	10.1371/journal.pone.0195207	http://dx.doi.org/10.1371/journal.pone.0195207			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659604	gold, Green Published, Green Submitted			2022-12-27	WOS:000430061100010
J	Borner, R; Kowerko, D; Hadzic, MCAS; Konig, SLB; Ritter, M; Sigel, RKO				Boerner, Richard; Kowerko, Danny; Hadzic, Melodie C. A. S.; Koenig, Sebastian L. B.; Ritter, Marc; Sigel, Roland K. O.			Simulations of camera-based single-molecule fluorescence experiments	PLOS ONE			English	Article							ALTERNATING-LASER EXCITATION; ABSOLUTE FRET EFFICIENCY; CONFORMATIONAL DYNAMICS; SPECTROSCOPY; LOCALIZATION; ORIENTATION; DEPENDENCE; MARKOV; TIME	Single-molecule microscopy has become a widely used technique in (bio) physics and ( bio) chemistry. A popular implementation is single-molecule Forster Resonance Energy Transfer (smFRET), for which total internal reflection fluorescence microscopy is frequently combined with camera-based detection of surface-immobilized molecules. Camera-based smFRET experiments generate large and complex datasets and several methods for video processing and analysis have been reported. As these algorithms often address similar aspects in video analysis, there is a growing need for standardized comparison. Here, we present a Matlab-based software (MASH-FRET) that allows for the simulation of camer-abased smFRET videos, yielding standardized data sets suitable for benchmarking video processing algorithms. The software permits to vary parameters that are relevant in cameras-based smFRET, such as video quality, and the properties of the system under study. Experimental noise is modeled taking into account photon statistics and camera noise. Finally, we survey how video test sets should be designed to evaluate currently available data analysis strategies in camera-based sm fluorescence experiments. We complement our study by pre-optimizing and evaluating spot detection algorithms using our simulated video test sets.	[Boerner, Richard; Hadzic, Melodie C. A. S.; Koenig, Sebastian L. B.; Sigel, Roland K. O.] Univ Zurich, Dept Chem, Zurich, Switzerland; [Kowerko, Danny] Tech Univ Chemnitz, Dept Comp Sci, Chemnitz, Germany; [Koenig, Sebastian L. B.] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Ritter, Marc] Mittweida Univ Appl Sci, Dept Appl Comp & Biosci, Mittweida, Germany	University of Zurich; Technische Universitat Chemnitz; University of Zurich	Borner, R; Sigel, RKO (corresponding author), Univ Zurich, Dept Chem, Zurich, Switzerland.	richard.boerner@ozh.ch; roland.sigel@chem.uzh.ch	Börner, Richard/AAV-4493-2020; Kowerko, Danny/J-4847-2019; Sigel, Roland/O-9883-2016	Kowerko, Danny/0000-0002-4538-7814; Sigel, Roland/0000-0002-1307-7993	European Research Council (ERC) [MIRNA 259092]; University of Zurich [FK-14-096, FK-15-095, FK-13-108, FK-13-091, FK-57010302]; Swiss National Science Foundation; Swiss State Secretariat for Education and Research (COST Action) [CM1105]; Federal Ministry of Education and Research (BMBF, Germany) [03IPT608X]	European Research Council (ERC)(European Research Council (ERC)European Commission); University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss State Secretariat for Education and Research (COST Action); Federal Ministry of Education and Research (BMBF, Germany)(Federal Ministry of Education & Research (BMBF))	Financial support by the European Research Council (ERC Starting Grant MIRNA 259092, to RKOS, http://erc.europa.eu/), the University of Zurich (to RKOS and Forschungskredit Grants FK-14-096 and FK-15-095, to RB; FK-13-108, to DK; FK-13-091, to MCASH; FK-57010302, to SLBK, http://www.researchers.uzh.ch/en/funding.html), as well as from the Swiss National Science Foundation, and the Swiss State Secretariat for Education and Research (COST Action CM1105, to RKOS) is gratefully acknowledged. This work was also partially accomplished within the project localizeIT (funding code 03IPT608X, to MR, http://localize-it.de/) funded by the Federal Ministry of Education and Research (BMBF, Germany, https://www.bmbf.de/) in the program of Entrepreneurial Regions InnoProfile-Transfer (https://www.unternehmen-region.de/de/1849.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriluka Mykhaylo, 2014, IEEE C COMP VIS PATT; [Anonymous], 1288 EMVA STAND; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanco M, 2010, METHOD ENZYMOL, V472, P153, DOI 10.1016/S0076-6879(10)72011-5; Borner R, 2016, J FLUORESC, V26, P963, DOI 10.1007/s10895-016-1784-5; Borner R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4759108; Borner R, 2016, COORDIN CHEM REV, V327, P123, DOI 10.1016/j.ccr.2016.06.002; Chen J, 2014, P NATL ACAD SCI USA, V111, P664, DOI 10.1073/pnas.1315735111; Chen JX, 2016, J PHYS CHEM B, V120, P7128, DOI 10.1021/acs.jpcb.6b05697; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Cordes T, 2010, BIOCHEMISTRY-US, V49, P9171, DOI 10.1021/bi101184g; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; FICHTHORN KA, 1991, J CHEM PHYS, V95, P1090, DOI 10.1063/1.461138; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; Gopich IV, 2010, J PHYS CHEM B, V114, P15221, DOI 10.1021/jp105359z; Greenfeld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030024; Ha T, 1996, IEEE J SEL TOP QUANT, V2, P1115, DOI 10.1109/2944.577342; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Hadzic MCAS, 2016, PROC SPIE, V9711, DOI 10.1117/12.2211191; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hirsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053671; Hohlbein J, 2014, CHEM SOC REV, V43, P1156, DOI 10.1039/c3cs60233h; Hohlbein J, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/031001; Holden SJ, 2010, BIOPHYS J, V99, P3102, DOI 10.1016/j.bpj.2010.09.005; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; J Janesick, 1985, 29 ANN TECHN S SPIE, P7; Jahne B, 2004, VDI BERICHT, V1829, P317; Joo C., 2012, COLD SPRING HARB PRO, V7, P1223, DOI DOI 10.1101/PDB.TOPO72058.PDB.TOPO72058; Juette MF, 2016, NAT METHODS, V13, P341, DOI [10.1038/NMETH.3769, 10.1038/nmeth.3769]; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Konig I, 2015, NAT METHODS, V12, P773, DOI [10.1038/nmeth.3475, 10.1038/NMETH.3475]; Konig SLB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084157; Koh HR, 2013, P NATL ACAD SCI USA, V110, P151, DOI 10.1073/pnas.1212917110; Kowerko D, 2015, P NATL ACAD SCI USA, V112, P3403, DOI 10.1073/pnas.1322759112; Lakowicz JR, 2010, PRINCIPLES FLUORESCE, VXXVI; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; McCann JJ, 2010, BIOPHYS J, V98, p186A, DOI 10.1016/j.bpj.2009.12.998; McCann JJ, 2010, BIOPHYS J, V99, P961, DOI 10.1016/j.bpj.2010.04.063; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Preus S, 2016, BIOPHYS J, V111, P1278, DOI 10.1016/j.bpj.2016.07.047; Preus S, 2015, NAT METHODS, V12, P593, DOI 10.1038/nmeth.3435; Preus S, 2012, CHEMBIOCHEM, V13, P1990, DOI 10.1002/cbic.201200400; Sage D, 2015, NAT METHODS, V12, P717, DOI [10.1038/NMETH.3442, 10.1038/nmeth.3442]; Saurabh S, 2012, OPT EXPRESS, V20, P7338, DOI 10.1364/OE.20.007338; Schmied JJ, 2012, NAT METHODS, V9, P1133, DOI 10.1038/nmeth.2254; Schuler B, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-S1-S2; Schuler B, 2013, CURR OPIN STRUC BIOL, V23, P36, DOI 10.1016/j.sbi.2012.10.008; Schuler Benjamin, 2007, V350, P115; Selvin P., 2008, SINGLE MOL TECHNIQUE; Selvin PR, 2008, SINGLE MOL TECHNIQUE, VVii; Seneta E, 1996, INT STAT REV, V64, P255, DOI 10.2307/1403785; Small A, 2014, NAT METHODS, V11, P267, DOI [10.1038/NMETH.2844, 10.1038/nmeth.2844]; Sobral A., 2013, 9 WORKSH VIS COMP WV; Steffen FD, 2016, PHYS CHEM CHEM PHYS, V18, P29045, DOI 10.1039/c6cp04277e; Steiner M, 2009, ANGEW CHEM INT EDIT, V48, P9739, DOI 10.1002/anie.200903809; Tan P, 2005, INTRO DATA MINING, VXxi; Valeur B., 2002, MOL FLUORESCENCE PRI, Vxiv; von Borczyskowski C, 2016, SELF ASSEMBLED ORGAN; Zhang B, 2007, APPL OPTICS, V46, P1819, DOI 10.1364/AO.46.001819; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017; Zhu P, 2012, ANNU REV BIOPHYS, V41, P269, DOI 10.1146/annurev-biophys-050511-102338	67	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195277	10.1371/journal.pone.0195277	http://dx.doi.org/10.1371/journal.pone.0195277			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652886	Green Published, gold, Green Accepted			2022-12-27	WOS:000430026900020
J	Carter, H; Weston, D; Betts, N; Wilkinson, S; Amlot, R				Carter, Holly; Weston, Dale; Betts, Naomi; Wilkinson, Simon; Amlot, Richard			Public perceptions of emergency decontamination: Effects of intervention type and responder management strategy during a focus group study	PLOS ONE			English	Article								In the event of an incident involving the release of a hazardous chemical, first responders may decide to initiate emergency decontamination in order to remove any contaminant from affected casualties. Recent initiatives such as the UK Home Office-led Initial Operational Response Programme have introduced new evidence-based decontamination protocols that reduce the time taken to initiate the decontamination process, including an increased emphasis on rapidly removing contaminated clothing (disrobe), and the use of improvised dry decontamination methods. The current study used a series of focus groups to examine public perceptions of different decontamination interventions and responder management strategies. Results revealed that a decontamination shower was perceived to be more effective than dry decontamination methods and that a management strategy that included effective responder communication resulted in increased willingness to comply with the need for decontamination. This study demonstrates that public understanding and acceptance of novel decontamination methods such as dry decontamination may present additional challenges for first responders. Increased emphasis on effective communication during decontamination is needed. Furthermore, provision of information during the focus group study resulted in an increase in participants' knowledge and confidence in taking recommended decontamination actions, which was maintained three months after the study. The longitudinal nature of these effects suggest that it may be possible to increase public awareness about actions to take during chemical incidents by developing pre-incident public education; however, further research is needed to examine this more fully.	[Carter, Holly; Weston, Dale; Betts, Naomi; Amlot, Richard] Publ Hlth England, Emergency Response Dept Sci &Technol, Salisbury, Wilts, England; [Wilkinson, Simon] Newcastle Univ, Med Toxicol Ctr, Wolfson Bldg,Claremont Pl, Newcastle Upon Tyne, Tyne & Wear, England	Public Health England; Newcastle University - UK	Carter, H (corresponding author), Publ Hlth England, Emergency Response Dept Sci &Technol, Salisbury, Wilts, England.	holly.carter@phe.gov.uk		Carter, Holly/0000-0002-2084-7263	National Institute for Health Research Health Protection Research Unit in Modelling Methodologies at Imperial College; Public Health England	National Institute for Health Research Health Protection Research Unit in Modelling Methodologies at Imperial College; Public Health England	This research was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response at King's College London in partnership with Public Health England. Dale Weston and Richard AmIot are part-funded by the National Institute for Health Research Health Protection Research Unit in Modelling Methodologies at Imperial College in partnership with Public Health England. The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health, or Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlot R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179309; Carter H, 2015, J APPL SOC PSYCHOL, V45, P173, DOI 10.1111/jasp.12286; Carter H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089846; Carter H, 2013, BASIC APPL SOC PSYCH, V35, P575, DOI 10.1080/01973533.2013.840634; Chilcott RP, 2014, ENVIRON INT, V72, P37, DOI 10.1016/j.envint.2014.02.006; Cibulsky SM, 2010, SUMM S CHEM DEC HUM; Fire and Rescue Service, 2003, NAT GUID DOC FIR SER; Haslam SA, 2006, J APPL PSYCHOL, V91, P1037, DOI 10.1037/0021-9010.91.5.1037; National Ambulance Resilience Unit, 2013, WAY NHS RESP HAZMAT; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rubin GJ, 2012, BIOSECUR BIOTERROR, V10, P383, DOI 10.1089/bsp.2012.0043; Spencer M., 2012, COUNTERPROLIFERATION, V52; Truitt A., 2008, SCI PSYCHOSOCIAL PRO, V21, P15; Vogt B. M., 2002, CLEAN IS SAFE IMPROV	14	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195922	10.1371/journal.pone.0195922	http://dx.doi.org/10.1371/journal.pone.0195922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652927	gold, Green Published, Green Submitted			2022-12-27	WOS:000430026900047
J	Dalaba, MA; Welaga, P; Oduro, A; Danchaka, LL; Matsubara, C				Dalaba, Maxwell Ayindenaba; Welaga, Paul; Oduro, Abraham; Danchaka, Laata Latif; Matsubara, Chieko			Cost of malaria treatment and health seeking behaviour of children under-five years in the Upper West Region of Ghana	PLOS ONE			English	Article							NORTHERN GHANA; INSURANCE SCHEME; DISTRICT; PROGRAM	Background There is limited knowledge on cost of treating malaria in children under-five years in northern Ghana which poses a challenge in determining whether interventions such as the National Health Insurance Scheme (NHIS) and Community-based Health Planning and Services (CHPS) have reduced the economic burden of malaria to households or not. This study examined the malaria care seeking and cost of treatment in children under-five years in the Upper West Region of Ghana. Methods The study used a cross-sectional, quantitative design and data were collected between July and August 2016 in three districts in the Upper West Region of Ghana. A total of 574 women who had under-five children were interviewed. Socio-demographic characteristics of respondents, malaria seeking patterns for under-five children with malaria as well as direct medical and non-medical costs associated with treating under-five children with malaria were collected from the patient perspective. Analysis was performed using STATA 12. Results Out of 574 women visited, about 63% (360) had children who had malaria and sought treatment. Most treatment was done at formal health facilities such as the health centres (37%) and the CHPS (35%) while 3% had self-treatment at home. The main reason for choice of place of treatment outside home was nearness to home (53%). The average direct medical and non-medical costs associated with treating an under-five child with malaria were US $4.13 and US$3.04 respectively. The average cost on transportation alone was US$2.64. Overall, the average direct medical and non-medical cost associated with treating an under-five child with malaria was US$4.91(range: minimum = US$0.13-maximum = US$46.75). Children who were enrolled into the NHIS paid an average amount of US$4.76 compared with US$5.88 for those not enrolled, though the difference was not statistically significant (p-value = 0.15). Conclusions The average cost to households in treating an under-five child with malaria was US$4.91. This amount is considerably high given the poverty level in the area. Children not insured paid a little over one US dollar for malaria treatment compared to those insured. Efforts to improve enrolment into the NHIS may be needed to reduce the cost of malaria treatment to households. Construction of more health facilities near to community members and at hard to reach areas will improve access to health care and reduce direct non-medical cost such as transportation costs.	[Dalaba, Maxwell Ayindenaba; Welaga, Paul; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Danchaka, Laata Latif] Community Dev Alliance Ghana, Wa, Ghana; [Matsubara, Chieko] Bur Int Med Cooperat, Natl Ctr Global Hlth & Med, Tokyo, Japan	Navrongo Health Research Center; National Center for Global Health & Medicine - Japan	Dalaba, MA (corresponding author), Navrongo Hlth Res Ctr, Navrongo, Ghana.	madalaba@yahoo.com		ODURO, ABRAHAM/0000-0002-4191-7419; Dalaba, Maxwell/0000-0002-7101-769X	Ministry of Health, Labor and Welfare, Japan [H26-1]	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This research was funded by Research Grant for International Health, H26-1, by the Ministry of Health, Labor and Welfare, Japan (http://www.ncgm.go.jp/kaihatsu/).	Adams I, 2004, B HLTH INFORM, V1, P28; Akazili J, 2008, AFR J HLTH SCI, V14; Akazili J, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0121-7; Akazili J, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1289735; Akazili J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0637-7; Akweongo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079880; Alhassan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165151; Asante Felix Ankomah, 2003, EC BURDEN MALARIA GH; Awoonor-Williams JK, 2013, GLOB HEALTH-SCI PRAC, V1, P117, DOI 10.9745/GHSP-D-12-00012; Blanchet N J, 2012, Ghana Med J, V46, P76; Chankova S, 2008, HEALTH POLICY PLANN, V23, P264, DOI 10.1093/heapol/czn011; Dalaba M, 2012, AFR J HLTH SCI, V21, DOI [10.1093/heapol/czh031, DOI 10.1093/HEAPOL/CZH031]; Dalaba MA, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2676-3; Dalaba MA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0659-1; Dalaba MA, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23848; Dalinjong PA, 2017, HEALTH ECON REV, V7, DOI 10.1186/s13561-017-0180-4; Dalinjong PA, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-13; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Fenny Ama Pokuaa, 2016, Glob Health Res Policy, V1, P18, DOI 10.1186/s41256-016-0018-3; Fenny AP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1696-3; Franco LM, 2008, B WORLD HEALTH ORGAN, V86, P830, DOI 10.2471/BLT.08.051045; Ghana Health Service, 2014, NAT MAL CONTR PROGR; Ghana Health Service, 2014, UPP W REG HLTH SERV; Ghana Statistical Service, 2014, GHAN DEM HLTH SURV; Ghana Statistical Service, 2014, 6 GHAN STAT SERV; Ghana Statistical Service Ghana Health Service & ICF International, 2014, GHAN DEM HLTH SURV; Jehu-Appiah C, 2012, HEALTH POLICY PLANN, V27, P222, DOI 10.1093/heapol/czr032; Kizito J, 2012, MALARIA J, V11, DOI [10.1186/PREACCEPT-2317562776368437, 10.1186/1475-2875-11-55]; Kotoh AM, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0320-1; Kusi A, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-014-0130-2; Maka DE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1639-1; Matovu F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-222; Mitiku I, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1798-8; Nest GH, 2012, GHANA HLTH NEST; NHIS, 2015, NHIS SUBSCR HDB; Nonvignon J, 2016, MALARIA J, V15, DOI [10.1186/s12936-015-1079, DOI 10.1186/S12936-015-1079-]; Nonvignon J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1506-0; Nonvignon J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1418-z; Onwujekwe O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078362; Roca-Feltrer A, 2012, AM J TROP MED HYG, V86, P96, DOI 10.4269/ajtmh.2012.11-0397; Sarpong N, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0772-6; Sicuri E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-307; Tawiah T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1116-x; WHO, 2015, WORLD MAL REP 2015; World Economic Forum, 2006, BUS MAL NEGL THREAT	45	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195533	10.1371/journal.pone.0195533	http://dx.doi.org/10.1371/journal.pone.0195533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652938	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900025
J	Huang, HY; Li, YP; Luo, XY; Cheng, X; Shi, B; Li, JT				Huang, Hanyao; Li, Yeping; Luo, Xiangyou; Cheng, Xu; Shi, Bing; Li, Jingtao			Mechanical analyses of critical surgical maneuvers in the correction of cleft lip nasal deformity	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; CEPHALIC TRIM; TIP SUPPORT; PALATE; SEPTUM; STABILITY; SKELETON; MODEL; NOSE	The relapse of nasal deformity is a challenge for modern correction of cleft lip. A comprehensive understanding in the biomechanical perspective of both the formation and correction of the cleft lip nasal deformity would lead to improved stability of the corrective outcome. In this study, a finite element model of secondary cleft lip nasal deformity was constructed, on which two critical corrective maneuvers were mimicked in the form of force-loading. The intercrural suture was simulated by a force loaded at the intermediate crus of the alar cartilage directing anteriorly and medially, and the suture suspending the alar cartilage to the upper lateral cartilage was simulated by a force loaded at the lateral crus directing superiorly and medially. The equivalent von-mises stress and the total deformation consequent to different patterns of loading were captured. Our biomechanical analyses suggested that the intercrural suture at the nasal tip might be more effective in generating widespread morphological change than the suspension suture, but left much higher level of stress within the skin envelope if placed too high. Synergistic effect was observed between the two sutures in both the resultant deformation and stress. In addition, our simulations were partially supported by clinical photogrammetry data.	[Li, Jingtao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Chengdu, Sichuan, Peoples R China; Sichuan Univ, West China Hosp Stomatol, Dept Oral Maxillofacial Surg, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, JT (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.	lijingtao86@163.com	li, ye/GWN-2672-2022; Huang, Hanyao/AAX-9478-2020	Huang, Hanyao/0000-0002-6805-0157; Li, Jingtao/0000-0002-0774-194X	National Natural Science Foundation of China [81500829]; Sichuan Science and Technology Program [2017RZ0036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science and Technology Program	This work was supported by the National Natural Science Foundation of China (grant No. 81500829) and Sichuan Science and Technology Program (grant No. 2017RZ0036) grant to J.L.	Byrd HS, 2000, PLAST RECONSTR SURG, V106, P1276, DOI 10.1097/00006534-200011000-00007; Fisher DM, 1998, PLAST RECONSTR SURG, V101, P1448, DOI 10.1097/00006534-199805000-00003; HUFFMAN WC, 1949, PLAST RECONSTR SURG, V4, P225, DOI 10.1097/00006534-194905000-00001; Jung JW, 2014, INT J PRECIS ENG MAN, V15, P2611, DOI 10.1007/s12541-014-0634-0; Leary RP, 2015, JAMA FACIAL PLAST SU, V17, P413, DOI 10.1001/jamafacial.2015.0941; Lee JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153056; Lee JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119996; Lee SJ, 2010, LARYNGOSCOPE, V120, P1931, DOI 10.1002/lary.21072; Lee SJ, 2010, LARYNGOSCOPE, V120, P1508, DOI 10.1002/lary.20976; Liong Kyrin, 2013, J Med Eng, V2013, P250274, DOI 10.1155/2013/250274; Luo XY, 2015, BIOMATERIALS, V57, P59, DOI 10.1016/j.biomaterials.2015.03.062; Manuel CT, 2017, ANN BIOMED ENG, V45, P829, DOI 10.1007/s10439-016-1729-9; Manuel CT, 2014, LARYNGOSCOPE, V124, P649, DOI 10.1002/lary.24321; Mau T, 2007, LARYNGOSCOPE, V117, P1902, DOI 10.1097/MLG.0b013e3181255ec4; MCCOMB H, 1985, PLAST RECONSTR SURG, V75, P791, DOI 10.1097/00006534-198506000-00003; McComb HK, 1996, CLEFT PALATE-CRAN J, V33, P23, DOI 10.1597/1545-1569(1996)033<0023:PROTUC>2.3.CO;2; Nagasao T, 2009, CLEFT PALATE-CRAN J, V46, P154, DOI 10.1597/07-177.1; Oliaei S, 2012, ARCH FACIAL PLAST S, V14, P27, DOI 10.1001/archfacial.2011.1354; Olmez S, 2014, ANGLE ORTHOD, V84, P815, DOI 10.2319/080613-586.1; Pan XG, 2007, CLEFT PALATE-CRAN J, V44, P149, DOI 10.1597/05-161.1; Rifley W, 1996, CLIN PLAST SURG, V23, P81; Shamouelian D, 2015, LARYNGOSCOPE, V125, P326, DOI 10.1002/lary.24845; Smahel Z, 1991, Acta Chir Plast, V33, P47; Smahel Z, 1999, CLEFT PALATE-CRAN J, V36, P310, DOI 10.1597/1545-1569(1999)036<0310:EOPROT>2.3.CO;2; Tjoa T, 2016, JAMA FACIAL PLAST SU, V18, P136, DOI 10.1001/jamafacial.2015.1954; Wolfe SA, 2004, PLAST RECONSTR SURG, V114, P1, DOI 10.1097/01.PRS.0000130416.86351.24; Yin Ningbei, 2015, Zhonghua Kou Qiang Yi Xue Za Zhi, V50, P278	27	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195583	10.1371/journal.pone.0195583	http://dx.doi.org/10.1371/journal.pone.0195583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652906	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900030
J	Kalsbeek, A; Veenstra, J; Westra, J; Disselkoen, C; Koch, K; McKenzie, KA; O'Bott, J; Vander Woude, J; Fischer, K; Shearers, GC; Harris, WS; Tintle, NL				Kalsbeek, Anya; Veenstra, Jenna; Westra, Jason; Disselkoen, Craig; Koch, Kristin; McKenzie, Katelyn A.; O'Bott, Jacob; Vander Woude, Jason; Fischer, Karen; Shearers, Greg C.; Harris, William S.; Tintle, Nathan L.			A genome-wide association study of red-blood cell fatty acids and ratios incorporating dietary covariates: Framingham Heart Study Offspring Cohort	PLOS ONE			English	Article							GENETIC-VARIANTS; AGING RESEARCH; PLASMA; LOCI; METAANALYSES; CHINESE; MICE	Recent analyses have suggested a strong heritable component to circulating fatty acid (FA) levels; however, only a limited number of genes have been identified which associate with FA levels. In order to expand upon a previous genome wide association study done on participants in the Framingham Heart Study Offspring Cohort and FA levels, we used data from 2,400 of these individuals for whom red blood cell FA profiles, dietary information and genotypes are available, and then conducted a genome-wide evaluation of potential genetic variants associated with 22 FAs and 15 FA ratios, after adjusting for relevant dietary covariates. Our analysis found nine previously identified loci associated with FA levels (FADS, ELOVL2, PCOLCE2, LPCAT3, AGPAT4, NTAN1/PDXDC1, PKD2L1, HBS1L/MYB and RAB3GAP1/MCM6), while identifying four novel loci. The latter include an association between variants in CALN1 (Chromosome 7) and eicosapentaenoic acid (EPA), DHRS4L2 (Chromosome 14) and a FA ratio measuring delta-9-desaturase activity, as well as two loci associated with less well understood proteins. Thus, the inclusion of dietary covariates had a modest impact, helping to uncover four additional loci. While genome-wide association studies continue to uncover additional genes associated with circulating FA levels, much of the heritable risk is yet to be explained, suggesting the potential role of rare genetic variation, epistasis and gene-environment interactions on FA levels as well. Further studies are needed to continue to understand the complex genetic picture of FA metabolism and synthesis.	[Kalsbeek, Anya; Veenstra, Jenna; Westra, Jason; Disselkoen, Craig; Vander Woude, Jason; Fischer, Karen; Tintle, Nathan L.] Dordt Coll, Dept Math Stat & Comp Sci, Sioux Ctr, IA 51250 USA; [Koch, Kristin] Baylor Univ, Dept Stat, Waco, TX 76798 USA; [McKenzie, Katelyn A.] Duke Univ, Dept Stat, Durham, NC USA; [O'Bott, Jacob] Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA; [Shearers, Greg C.] Penn State Univ, Dept Nutr Sci, State Coll, PA USA; [Harris, William S.] OmegaQuant, Sioux Falls, SD USA	Baylor University; Duke University; University System of Maryland; University of Maryland Baltimore County; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Tintle, NL (corresponding author), Dordt Coll, Dept Math Stat & Comp Sci, Sioux Ctr, IA 51250 USA.	nathan.tintle@doradt.edu	Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353; Kalsbeek, Anya/0000-0001-7215-1236; Tintle, Nathan/0000-0003-1447-9107; Vander Woude, Jason/0000-0002-7672-6321	National Human Genome Research Institute (NT) [1R15HG006915, 2R15HG006915]; National Heart Lung and Blood Institute (NHLBI) [R01-HL089590]; Framingham Heart Study (NHLBI); Boston University School of Medicine;  [N01-HC-25195]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG006915] Funding Source: NIH RePORTER	National Human Genome Research Institute (NT); National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Framingham Heart Study (NHLBI); Boston University School of Medicine; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the National Human Genome Research Institute (1R15HG006915 and 2R15HG006915; NT). The Framingham Heart Study is supported in part by the National Heart Lung and Blood Institute (NHLBI; R01-HL089590) and by Contract N01-HC-25195, the Framingham Heart Study (NHLBI) and Boston University School of Medicine. Omega Quant provided support in the form of salaries for author WH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andersen MK, 2016, PLOS GENET, V193, P1, DOI DOI 10.1097/YPG.0B013E32834ACD07; Bray JE, 2009, CHEM-BIOL INTERACT, V178, P99, DOI 10.1016/j.cbi.2008.10.058; Cupples LA, 2007, BMC MED GENET S1, V8, pS1; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Emsley R, 2003, CNS DRUGS, V17, P1081, DOI 10.2165/00023210-200317150-00003; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gonzalez-Baro MR, 2017, BBA-MOL CELL BIOL L, V1862, P49, DOI 10.1016/j.bbalip.2016.06.023; Govindaraju DR, 2008, ADV GENET, V62, P33, DOI 10.1016/S0065-2660(08)00602-0; Guan WH, 2014, CIRC-CARDIOVASC GENE, V7, P321, DOI 10.1161/CIRCGENETICS.113.000208; Harris WS, 2013, J CLIN LIPIDOL, V7, P433, DOI 10.1016/j.jacl.2013.05.001; Harris WS, 2012, ATHEROSCLEROSIS, V225, P425, DOI 10.1016/j.atherosclerosis.2012.05.030; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hu Y, 2016, HUM MOL GENET, V25, P1215, DOI 10.1093/hmg/ddw002; Huertas-Vazquez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059905; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Kabir I, 2016, J BIOL CHEM; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Lai YL, 2016, HEMOGLOBIN, V40, P405, DOI 10.1080/03630269.2016.1253586; Laugharne JDE, 1996, LIPIDS, V31, pS163, DOI 10.1007/BF02637070; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li ZQ, 2015, GASTROENTEROLOGY, V149, P1519, DOI 10.1053/j.gastro.2015.07.012; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Magiera R, 2014, CLIN LAB, V60, P1617, DOI 10.7754/Clin.Lab.2014.140219; Meierhofer D, 2014, J PROTEOME RES, V13, P5592, DOI 10.1021/pr5005828; Ohi K, 2016, PSYCHIAT GENET, V26, P142, DOI 10.1097/YPG.0000000000000127; Pollard RD, 2015, J BIOL CHEM, V290, P15496, DOI 10.1074/jbc.M115.646240; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rong X, 2015, ELIFE, V4; Schuchardt JP, 2016, J NUTR HEALTH AGING, V20, P611, DOI 10.1007/s12603-016-0720-3; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Smith CE, 2015, MOL NUTR FOOD RES, V59, P1373, DOI 10.1002/mnfr.201400734; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thom CS, 2014, DEV CELL, V30, P688, DOI 10.1016/j.devcel.2014.07.021; Tintle NL, 2015, PROSTAG LEUKOTR ESS, V94, P65, DOI 10.1016/j.plefa.2014.11.007; Tintle NL, 2015, METABOLOMICS, V11, P1327, DOI 10.1007/s11306-015-0787-6; Wang B, 2016, CELL METAB; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wu JHY, 2013, CIRC-CARDIOVASC GENE, V6, P171, DOI 10.1161/CIRCGENETICS.112.964619; Xia SH, 2015, NEUROSCI LETT, V602, P110, DOI 10.1016/j.neulet.2015.07.001; Zhang JY, 2016, CURR OPIN CLIN NUTR, V19, P103, DOI 10.1097/MCO.0000000000000254; Zhang RY, 2014, CARCINOGENESIS, V35, P1528, DOI 10.1093/carcin/bgu076	49	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194882	10.1371/journal.pone.0194882	http://dx.doi.org/10.1371/journal.pone.0194882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652918	Green Published, gold, Green Submitted			2022-12-27	WOS:000430026900013
J	Mba, JME; Bisseye, C; Ndong, JMN; Mombo, LE; Bengone, C; Migolet, GM; M'batchi, B; Kosiorek, HE; Butterfield, RJ; Roberts, LR; Borad, MJ; Nagalo, BM				Mba, Jean Marie Eko; Bisseye, Cyrille; Ndong, Jophrette Mireille Ntsame; Mombo, Landry Erik; Bengone, Calixte; Migolet, Guy Mouelet; M'batchi, Bertrand; Kosiorek, Heidi E.; Butterfield, Richard J.; Roberts, Lewis R.; Borad, Mitesh J.; Nagalo, Bolni Marius			Prevalent hepatitis B surface antigen among first-time blood donors in Gabon	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RURAL POPULATIONS; DELTA-VIRUS; C VIRUSES; SEROPREVALENCE; SYPHILIS; DIVERSITY; DISEASES; MARKERS; URBAN	Despite chronic Hepatitis B virus (HBV) infection being the main cause of younger-onset complex liver disease including cirrhosis and hepatocellular carcinoma (HCC) in Africa, very little is known regarding the seroprevalence of HBV in the Gabonese general population. This investigation aimed to provide strong epidemiological data and risk factors associated with HBV infection in first-time blood donors representative of the urban adult population. The screening of HBsAg was carried out using 4th generation ELISA kits. The overall seroprevalence of HBsAg was 7.28%. The frequency of HBsAg was differential and marked by annual variations in blood donors from 2009 to 2016. Seroprevalence was 2-fold higher among males versus females (OR = 1.90 (95% CI: 1.75-2.06), P<0.001). HBsAg seroprevalence was significantly higher in donors of the age group 25-35 years old compared to donors of the age group < 18 years (OR = 1.64 (95% CI: 1.03-2.60), P = 0.04). The seroprevalence of HBsAg in family/replacement donors (FRD) was significantly higher than that of voluntary non-remunerated donors (VNRD) (OR = 0.88 (95% CI: 0.83-0.94), P < 0.001). The simultaneous comparison of HBsAg seroprevalence with blood donation type, gender and age showed that the higher prevalence in FRD was significant only in males between 18 and 45 years and in females between 25 and 34 years of age. This study confirms the high endemicity of HBV in Gabon while identifying the most infected age groups for both men and women.	[Mba, Jean Marie Eko; Ndong, Jophrette Mireille Ntsame; Bengone, Calixte; Migolet, Guy Mouelet] Ctr Natl Transfus Sanguine, Libreville, Gabon; [Mba, Jean Marie Eko; Bisseye, Cyrille; Mombo, Landry Erik; M'batchi, Bertrand; Nagalo, Bolni Marius] Univ Sci & Tech Masuku, Lab Biol Mol & Cellulaire LABMC, Franceville, Gabon; [Kosiorek, Heidi E.; Butterfield, Richard J.] Mayo Clin, Div Biostat, Scottsdale, AZ USA; [Roberts, Lewis R.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Borad, Mitesh J.; Nagalo, Bolni Marius] Mayo Clin, Div Hematol Oncol, Scottsdale, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Bisseye, C (corresponding author), Univ Sci & Tech Masuku, Lab Biol Mol & Cellulaire LABMC, Franceville, Gabon.	cbisseye@gmail.com	Bisseye, C./AFO-0118-2022; Bisseye, Cyrille/AGP-8782-2022	Bisseye, Cyrille/0000-0002-6888-6317; Butterfield, Richard/0000-0001-6758-2875; Roberts, Lewis/0000-0001-7885-8574	Centre National de Transfusion Sanguine (CNTS); Agence Universitaire de la Francophonie [G950/442/BACGL 2016/AO/PFD]	Centre National de Transfusion Sanguine (CNTS); Agence Universitaire de la Francophonie	This work was supported by Centre National de Transfusion Sanguine (CNTS) and Agence Universitaire de la Francophonie (Ref.: G950/442/BACGL 2016/AO/PFD) to CB. The sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adouani B, 2013, TRANSFUSION MED, V23, P432, DOI 10.1111/tme.12054; Allain Jean-Pierre, 2016, Asian J Transfus Sci, V10, P5, DOI 10.4103/0973-6247.164270; Allain JP, 2011, BRIT J HAEMATOL, V154, P763, DOI 10.1111/j.1365-2141.2011.08708.x; Ankouane F, 2016, TRANSFUS CLIN BIOL, V23, P72, DOI 10.1016/j.tracli.2015.11.008; Arivelo RZ, 2011, BLOOD TRANSFUS-ITALY, V9, P475, DOI 10.2450/2011.0102-10; Bertherat E, 1998, INT J STD AIDS, V9, P31, DOI 10.1258/0956462981921008; Bivigou-Mboumba B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143869; Coppola N, 2016, WORLD J HEPATOL, V8, P273, DOI 10.4254/wjh.v8.i5.273; Diarra A, 2009, TRANSFUS CLIN BIOL, V16, P444, DOI 10.1016/j.tracli.2009.09.004; DUPONT A, 1988, ANN SOC BELG MED TR, V68, P157; Farshadpour F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157615; Fessehaye N, 2011, PAN AFR MED J, V9; Francois-Souquiere S, 2016, INFECT GENET EVOL, V39, P12, DOI 10.1016/j.meegid.2015.12.021; Nebenzahl HG, 2013, SAMJ S AFR MED J, V103, P186, DOI [10.7196/SAMJ.6097, 10.7196/samj.6097]; Kabinda JM, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.385.4328; Kolou Malewe, 2017, Open Virol J, V11, P1, DOI 10.2174/1874357901710011001; Lopez-Balderas N, 2015, J INFECT DEV COUNTR, V9, P274, DOI 10.3855/jidc.4812; Makuwa M, 2008, J CLIN MICROBIOL, V46, P754, DOI 10.1128/JCM.02142-07; Makuwa M, 2009, J CLIN MICROBIOL, V47, P2265, DOI 10.1128/JCM.02012-08; Mavenyengwa RT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-424; Mueller A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1129-z; Nagalo BM, 2012, TROP MED INT HEALTH, V17, P247, DOI 10.1111/j.1365-3156.2011.02902.x; Nambei WS, 2016, MED SANTE TROP, V26, P192, DOI 10.1684/mst.2016.0553; Noah Dominique Noah, 2013, Pan Afr Med J, V16, P111, DOI 10.11604/pamj.2013.16.111.2760; Nzaji MK, 2013, SANTE PUBLIQUE, V25, P213; Rerambiah LK, 2014, BLOOD TRANSFUS-ITALY, V12, P330, DOI 10.2450/2013.0144-13; RICHARDLENOBLE D, 1995, AM J TROP MED HYG, V53, P338, DOI 10.4269/ajtmh.1995.53.338; Rufai T, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.53.3390; Tao Issoufou, 2014, Hepat Res Treat, V2014, P781843, DOI 10.1155/2014/781843; Tauma G, 2016, PUBLIC HEALTH ACTION, V6, P261, DOI 10.5588/pha.16.0068; Twagirumugabe T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2149-z; UNICEF, 2014, DIV DONN DLREDP; WHO, 2014, IMP VACC HEP B MEILL; Xie DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139947; Yang JD, 2017, LANCET GASTROENTEROL, V2, P103, DOI 10.1016/S2468-1253(16)30161-3; Yildiz SM, 2015, TRANSFUS APHER SCI, V53, P308, DOI 10.1016/j.transci.2015.05.022; Ziraba AK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-191	37	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194285	10.1371/journal.pone.0194285	http://dx.doi.org/10.1371/journal.pone.0194285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652917	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900005
J	Colombo, M; Duev, G; Nuijten, MB; Sprenger, J				Colombo, Matteo; Duev, Georgi; Nuijten, Michele B.; Sprenger, Jan			Statistical reporting inconsistencies in experimental philosophy	PLOS ONE			English	Article							INTUITIONS	Experimental philosophy (x-phi) is a young field of research in the intersection of philosophy and psychology. It aims to make progress on philosophical questions by using experimental methods traditionally associated with the psychological and behavioral sciences, such as null hypothesis significance testing (NHST). Motivated by recent discussions about a methodological crisis in the behavioral sciences, questions have been raised about the methodological standards of x-phi. Here, we focus on one aspect of this question, namely the rate of inconsistencies in statistical reporting. Previous research has examined the extent to which published articles in psychology and other behavioral sciences present statistical inconsistencies in reporting the results of NHST. In this study, we used the R package statcheck to detect statistical inconsistencies in x-phi, and compared rates of inconsistencies in psychology and philosophy. We found that rates of inconsistencies in x-phi are lower than in the psychological and behavioral sciences. From the point of view of statistical reporting consistency, x-phi seems to do no worse, and perhaps even better, than psychological science.	[Colombo, Matteo] Tilburg Univ, Dept Philosophy, Tilburg, Netherlands; [Colombo, Matteo] Tilburg Univ, Tilburg Ctr Log Eth & Philosophy Sci TiLPS, Tilburg, Netherlands; [Duev, Georgi] Tiilburg Univ, Tilburg Sch Econ & Management, Ctr Econ Res Ctr, Tilburg, Netherlands; [Nuijten, Michele B.] Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands; [Sprenger, Jan] Univ Torino, Dept Philosophy & Educ Sci, Turin, Italy; [Sprenger, Jan] Univ Torino, Ctr Log Language & Cognit LLC, Turin, Italy	Tilburg University; Tilburg University; Tilburg University; Tilburg University; University of Turin; University of Turin	Sprenger, J (corresponding author), Univ Torino, Dept Philosophy & Educ Sci, Turin, Italy.; Sprenger, J (corresponding author), Univ Torino, Ctr Log Language & Cognit LLC, Turin, Italy.	jan.sprenger@unito.it	Nuijten, Michèle B./N-2483-2014	Nuijten, Michèle B./0000-0002-1468-8585	European Research Council [640638]	European Research Council(European Research Council (ERC)European Commission)	This research has been supported by the European Research Council through Starting Investigator Grant No. 640638 (J.S.).	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Alfano M., 2016, STANFORD ENCY PHILOS; Alicke MD, 2011, J PHILOS, V108, P670, DOI 10.5840/jphil20111081238; Bakker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103360; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Bakker M, 2011, BEHAV RES METHODS, V43, P666, DOI 10.3758/s13428-011-0089-5; Cova F, 2021, REV PHILOS PSYCHOL, V12, P9, DOI 10.1007/s13164-018-0400-9; Cullen S, 2010, REV PHILOS PSYCHOL, V1, P275, DOI 10.1007/s13164-009-0016-1; Gigerenzer G., 2004, J SOCIO-ECON, V33, P587, DOI DOI 10.1016/J.SOCEC.2004.09.033; Icard TF, 2017, COGNITION, V161, P80, DOI 10.1016/j.cognition.2017.01.010; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Knobe J, 2003, ANALYSIS, V63, P190, DOI 10.1111/1467-8284.00419; Knobe J., 2008, EXPT PHILOS; Knobe J, 2008, PHENOMENOL COGN SCI, V7, P67, DOI 10.1007/s11097-007-9066-y; Lam B, 2010, COGNITION, V115, P320, DOI 10.1016/j.cognition.2009.12.018; Leggett NC, 2013, Q J EXP PSYCHOL, V66, P2303, DOI 10.1080/17470218.2013.863371; Leslie AM, 2006, PSYCHOL SCI, V17, P421, DOI 10.1111/j.1467-9280.2006.01722.x; Machery E, 2004, COGNITION, V92, pB1, DOI 10.1016/j.cognition.2003.10.003; Machery E, 2015, NOUS; Machery Edouard, 2017, PHILOS ITS PROPER BO; Caperos JM, 2013, PSICOTHEMA, V25, P408, DOI 10.7334/psicothema2012.207; Nahmias E, 2005, PHILOS PSYCHOL, V18, P561, DOI 10.1080/09515080500264180; Nichols S, 2007, NOUS, V41, P663, DOI 10.1111/j.1468-0068.2007.00666.x; Nuijten MB, 2018, VALIDITY TOOL FEMINI; Nuijten MB, 2016, BEHAV RES METHODS, V48, P1205, DOI 10.3758/s13428-015-0664-2; Rose D, 2013, METAPHILOSOPHY, V44, P512, DOI 10.1111/meta.12045; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; Sytsma J, 2010, PHILOS STUD, V151, P299, DOI 10.1007/s11098-009-9439-x; Veldkamp CLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114876; Weinberg J.M., 2001, PHILOS TOPICS, V29, P429, DOI DOI 10.5840/PHILTOPICS2001291/217; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Woolfolk RL, 2013, METAPHILOSOPHY, V44, P79, DOI 10.1111/meta.12016	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194360	10.1371/journal.pone.0194360	http://dx.doi.org/10.1371/journal.pone.0194360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649220	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900011
J	Peter, A; Routledge, E				Peter, Aji; Routledge, Edwin			Present-day monitoring underestimates the risk of exposure to pathogenic bacteria from cold water storage tanks	PLOS ONE			English	Article							PLATE-COUNT BACTERIA; LEGIONELLA-PNEUMOPHILA; DRINKING-WATER; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; LEGIONNAIRES-DISEASE; POTABLE WATER; DISTRIBUTION-SYSTEMS; MICROBIAL-GROWTH; LOW-TEMPERATURES	Water-borne bacteria, found in cold water storage tanks, are causative agents for various human infections and diseases including Legionnaires' disease. Consequently, regular microbiological monitoring of tank water is undertaken as part of the regulatory framework used to control pathogenic bacteria. A key assumption is that a small volume of water taken from under the ball valve (where there is easy access to the stored water) will be representative of the entire tank. To test the reliability of this measure, domestic water samples taken from different locations of selected tanks in London properties between November 2015 and July 2016 were analysed for TVCs, Pseudomonas and Legionella at an accredited laboratory, according to regulatory requirements. Out of similar to 6000 tanks surveyed, only 15 were selected based on the ability to take a water sample from the normal sampling hatch (located above the ball valve) and from the far end of the tank (usually requiring disassembly of the tank lid with risk of structural damage), and permission being granted by the site manager to undertake the additional investigation and sampling. Despite seasonal differences in water temperature, we found 100% compliance at the ball valve end. In contrast, 40% of the tanks exceeded the regulatory threshold for temperature at the far end of the tank in the summer months. Consequently, 20% of the tanks surveyed failed to trigger appropriate regulatory action based on microbiological analyses of the water sample taken under the ball valve compared to the far end sample using present-day standards. These data show that typical water samples collected for routine monitoring may often underestimate the microbiological status of the water entering the building, thereby increasing the risk of exposure to water bourne pathogens with potential public health implications. We propose that water storage tanks should be redesigned to allow access to the far end of tanks for routine monitoring purposes, and that water samples used to ascertain the regulatory compliance of stored water in tanks should be taken at the point at which water is abstracted for use in the building.	[Peter, Aji; Routledge, Edwin] Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England; [Peter, Aji] Aqua Technol Europe Ltd, Hounslow, Middx, England	Brunel University	Peter, A (corresponding author), Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England.; Peter, A (corresponding author), Aqua Technol Europe Ltd, Hounslow, Middx, England.	ajipeter2012@gmail.com	Routledge, Edwin John/V-2336-2019; Routledge, Edwin/AGI-0283-2022	Routledge, Edwin/0000-0001-7695-364X	Europe Ltd	Europe Ltd	The authors received no specific funding for this work. Aqua Technologies Europe Ltd provided support in the form of salaries for authors [AP] and access to sites, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Harbi AH, 2003, AQUAC RES, V34, P517, DOI 10.1046/j.1365-2109.2003.00832.x; Allen MJ, 2004, INT J FOOD MICROBIOL, V92, P265, DOI 10.1016/j.ijfoodmicro.2003.08.017; Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530; Armon R, 1997, WATER SCI TECHNOL, V35, P293, DOI 10.1016/S0273-1223(97)00275-8; ASHRAE, 2000, MIN RISK LEG ASS BUI; BARKO JW, 1986, ECOLOGY, V67, P1328, DOI 10.2307/1938689; Betancourt WQ, 2004, VET PARASITOL, V126, P219, DOI 10.1016/j.vetpar.2004.09.002; Borella P, 2004, EMERG INFECT DIS, V10, P457, DOI 10.3201/eid1003.020707; Brandsema PS, 2014, EPIDEMIOL INFECT, V142, P2360, DOI 10.1017/S0950268813003476; Brown J, 2001, Commun Dis Intell Q Rep, V25, P63; CIESIELSKI CA, 1984, APPL ENVIRON MICROB, V48, P984, DOI 10.1128/AEM.48.5.984-987.1984; Cramer M, 2003, AM J CRIT CARE, V12, P234, DOI 10.4037/ajcc2003.12.3.234; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Declerck P, 2009, MICROBIOL RES, V164, P593, DOI 10.1016/j.micres.2007.06.001; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; DWI (Drinking Water Inspectorate), 2010, WATER, P1; DWI (Drinking Water Inspectorate), 2005, COLD WAT SERV STOR C; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Falkinham JO, 2015, ENVIRON HEALTH PERSP, V123, P749, DOI 10.1289/ehp.1408692; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; GIVSKOV M, 1994, J BACTERIOL, V176, P7, DOI 10.1128/JB.176.1.7-14.1994; Gray J.R., 2000, 004191 US GEOL SURV; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HSE, 2000, LEG DIS CONTR LEG BA; HSE (Health and Safety Executive), 2002, POT WAT LEG CONTR; Figueras MJ, 2010, INT J ENV RES PUB HE, V7, P4179, DOI 10.3390/ijerph7124179; KAPPERUD G, 1982, ACTA PATH MICRO IM B, V90, P185; Karlowsky JA, 2003, ANTIMICROB AGENTS CH, V47, P1681, DOI 10.1128/AAC.47.5.1681-1688.2003; Kennedy Emily, 2012, THESIS; Kilb B, 2003, INT J HYG ENVIR HEAL, V206, P563, DOI 10.1078/1438-4639-00258; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Konishi T, 2006, J BIOSCI BIOENG, V101, P478, DOI 10.1263/jbb.101.478; Lautenschlager K, 2010, WATER RES, V44, P4868, DOI 10.1016/j.watres.2010.07.032; Lee HKH, 2010, J CLASSIF, V27, P41, DOI 10.1007/s00357-010-9044-x; Liu Z, 2006, J APPL MICROBIOL, V101, P437, DOI 10.1111/j.1365-2672.2006.02970.x; Manuel CM, 2007, WATER RES, V41, P551, DOI 10.1016/j.watres.2006.11.007; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; Moritz MM, 2010, INT J HYG ENVIR HEAL, V213, P190, DOI 10.1016/j.ijheh.2010.05.003; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2014, LEG QUEST ANSW; Pepper IL, 2004, INT J FOOD MICROBIOL, V92, P289, DOI 10.1016/j.ijfoodmicro.2003.08.021; Peter A., 2017, Environmental Technology Reviews, V6, P145, DOI 10.1080/21622515.2017.1335352; Ramsey CA, 2005, ENVIRON FORENSICS, V6, P71, DOI 10.1080/15275920590913877; ROGERS J, 1994, APPL ENVIRON MICROB, V60, P1842, DOI 10.1128/AEM.60.6.1842-1851.1994; ROSSO L, 1995, APPL ENVIRON MICROB, V61, P610, DOI 10.1128/AEM.61.2.610-616.1995; Soderberg MA, 2004, J BACTERIOL, V186, P3712, DOI 10.1128/JB.186.12.3712-3720.2004; Soderberg MA, 2008, APPL ENVIRON MICROB, V74, P5583, DOI 10.1128/AEM.00067-08; Sousa AM, 2014, PATHOGENS, V3, P680, DOI 10.3390/pathogens3030680; Stojek NM, 2006, ANN AGR ENV MED, V13, P323; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Storey MV, 2011, WATER RES, V45, P741, DOI 10.1016/j.watres.2010.08.049; STOUT JE, 1985, APPL ENVIRON MICROB, V49, P221, DOI 10.1128/AEM.49.1.221-228.1985; Temmerman R, 2006, APPL ENVIRON MICROB, V72, P4323, DOI 10.1128/AEM.00070-06; Turetgen I, 2007, ENVIRON MONIT ASSESS, V125, P271, DOI 10.1007/s10661-006-9519-8; WADOWSKY RM, 1985, APPL ENVIRON MICROB, V49, P1197, DOI 10.1128/AEM.49.5.1197-1205.1985; WHO (World Health Organisation), 1997, WAT SAMPL AN; Worrall E., 2015, CLIMATE CHANGE INCRE; Yang CY, 1998, STROKE, V29, P411, DOI 10.1161/01.STR.29.2.411	58	8	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195635	10.1371/journal.pone.0195635	http://dx.doi.org/10.1371/journal.pone.0195635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649274	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900064
J	Sarandy, MM; Miranda, LL; Altoe, LS; Novaes, RD; Zanuncio, VV; Leite, JPV; Goncalves, RV				Sarandy, Mariaurea Matias; Miranda, Lyvia Lopes; Altoe, Luciana Schultheis; Novaes, Romulo Dias; Zanuncio, Virginia Vinha; Viana Leite, Joo Paulo; Goncalves, Reggiani Vilela			Strychnos pseudoquina modulates the morphological reorganization of the scar tissue of second intention cutaneous wounds in rats	PLOS ONE			English	Article							MAST-CELLS; OXIDATIVE DAMAGE; REACTIVE OXYGEN; HUMAN BLOOD; LATE-PHASE; EXTRACT; PROLIFERATION; INFLAMMATION; ANTIOXIDANTS; MODEL	Natural substances are used in folk medicines to treat injuries. Strychnos pseudoquina has scarring, antipyretic, and antimalarial actions. The present study aimed to analyze the effect of S. pseudoquina on cutaneous wound healing in rats. The S. pseudoquina extract was submitted to phytochemical prospection. The levels of flavonoids and total phenolic compounds in the extract were 50.7 mg/g and 2.59 mg/g, respectively. Thirty Wistar rats were individualized in cages with food and water ad libitum (registration no. 730/2014). After anesthesia, three circular wounds (12mm diameter) were made in the animals, which were randomly separated into five treatments: Sal, saline; VO, ointment vehicles (lanolin and Vaseline); SS, positive control (silver sulfadiazine 1%); LE 5, freeze-dried extract 5%; and LE 10, lyophilized extract 10%. The animals were treated with the ointment daily for 21 days. Every seven days, the area and the rate of wound contraction were evaluated. Tissue samples were removed for histopathological analysis of the number of mast cells, elastic and collagen fibers, and biochemical analyses, quantification of malondialdehyde (MDA), carbonylated proteins (PCN), superoxide dismutase (SOD), catalase (CAT), transforming growth factor beta (TGF-beta), Interleukin 10 (IL-10) and tumor necrosis factor (TNF). The number of mast cells, collagen and elastic fibers in the rat wounds were higher in the treatments with the plant. The extract also stimulated the activity of antioxidant enzymes, particularly SOD, presenting high levels, and maintained low levels of PCN. The TGF-beta and IL-10 concentration was higher in the LE5 and LE10 treatment of the extract than in the Sal, OV and SS treatments on day 7. The ointment based on S. pseudoquina closed the wound faster and accelerated wound healing in animals.	[Sarandy, Mariaurea Matias; Goncalves, Reggiani Vilela] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil; [Miranda, Lyvia Lopes; Altoe, Luciana Schultheis] Univ Fed Vicosa, Inst Biomed Sci, Dept Gen Biol, Vicosa, MG, Brazil; [Novaes, Romulo Dias] Univ Fed Alfenas, Dept Biol Struct, Alfenas, MG, Brazil; [Zanuncio, Virginia Vinha] Univ Fed Vicosa, Dept Med & Nursing, Vicosa, MG, Brazil; [Viana Leite, Joo Paulo] Univ Fed Vicosa, Dept Agr Biochem, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Alfenas; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Goncalves, RV (corresponding author), Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil.	reggiani.goncalves@ufv.br	SOUZA, MARIAUREA/GQP-7833-2022; Gonçalves, Reggiani V/J-1550-2016; Novaes, Romulo D/F-1210-2015	Gonçalves, Reggiani V/0000-0002-5831-3590; Novaes, Romulo D/0000-0002-3186-5328	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [PPM 00687-17]; CNPq [303972/2017-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by the following Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (RVG), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (edital PPM 00687-17) (RVG). The author Romulo Dias Novaes thanks CNPq for the fellowship granted to the research in productivity (process 303972/2017-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abood WN, 2015, BOSNIAN J BASIC MED, V15, P25, DOI 10.17305/bjbms.2015.39; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al-Khamis A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006213.pub3; Andrade-Neto VF, 2003, J ETHNOPHARMACOL, V87, P253, DOI 10.1016/S0378-8741(03)00141-7; Arcanjo DDR, 2012, BRAZ J BIOL, V72, P505, DOI 10.1590/S1519-69842012000300013; de Brito TLA, 2014, LIFE SCI, V100, P138, DOI [10.1016/j.lfs.2014.02.007, 10.1016/j.lfs2014.02.007]; Baltzis D, 2014, ADV THER, V31, P817, DOI 10.1007/s12325-014-0140-x; Barreiros A.L.B.S, 2003, Rev. bras. farmacogn., V13, P8; Belhadj F, 2016, FOOD CHEM, V204, P29, DOI 10.1016/j.foodchem.2016.02.111; Bladt S, 2009, SSBM, V2, P74; Bonamin F, 2011, J ETHNOPHARMACOL, V138, P47, DOI 10.1016/j.jep.2011.08.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18; Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021; Cheng PG, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/671252; Cortes MA, 2013, POLIMEROS, V23, P402, DOI 10.4322/polimeros.2013.085; Curtis BJ, 2014, ALCOHOL CLIN EXP RES, V38, P1347, DOI 10.1111/acer.12369; da Silva MA, 2005, CHEM PHARM BULL, V53, P881, DOI 10.1248/cpb.53.881; da Silva MAB, 2010, REV BRAS FARMACOGN, V20, P549, DOI 10.1590/S0102-695X2010000400014; Dalmolin F, 2016, ARQ BRAS MED VET ZOO, V68, P687, DOI 10.1590/1678-4162-8276; Carvalho Camilo Amaro de, 2011, Arq. Gastroenterol., V48, P276, DOI 10.1590/S0004-28032011000400011; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Dong XL, 2012, MOL MED REP, V5, P1487, DOI 10.3892/mmr.2012.851; Fujiwara T, 2016, EXP DERMATOL, V25, P206, DOI 10.1111/exd.12909; Gharibi S, 2013, IND CROP PROD, V50, P154, DOI 10.1016/j.indcrop.2013.07.038; Goncalves RV, 2010, BRAZ J MED BIOL RES, V43, P350, DOI 10.1590/S0100-879X2010007500022; Goncalves RV, 2016, LIFE SCI, V152, P67, DOI 10.1016/j.lfs.2016.03.019; Goncalves RV, 2014, CELLS TISSUES ORGANS, V199, P266, DOI 10.1159/000365504; Goncalves RV, 2012, INT J EXP PATHOL, V93, P370, DOI 10.1111/j.1365-2613.2012.00835.x; Goncalves RV, 2010, PHOTOMED LASER SURG, V28, P597, DOI 10.1089/pho.2009.2669; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Hartmann RM, 2012, DIGEST DIS SCI, V57, P2038, DOI 10.1007/s10620-012-2134-3; Heal C, 2014, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD011426; Houreld NN, 2010, LASER SURG MED, V42, P494, DOI 10.1002/lsm.20812; Iba Y, 2004, INT IMMUNOPHARMACOL, V4, P1873, DOI 10.1016/j.intimp.2004.08.009; Jana K, 2014, MOL REPROD DEV, V81, P833, DOI 10.1002/mrd.22354; Junqueira LCU, 2005, BIOL CELULAR MOL; Kant V, 2015, J SURG RES, V193, P978, DOI 10.1016/j.jss.2014.10.019; Kiraithe MN, 2016, J ETHNOPHARMACOL, V178, P266, DOI 10.1016/j.jep.2015.12.013; Kurek-Gorecka A, 2014, MOLECULES, V19, P78, DOI 10.3390/molecules19010078; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lee Soo-Jin, 2012, Evid Based Complement Alternat Med, V2012, P190370, DOI 10.1155/2012/190370; Lorenzi H., 2002, PLANTAS MED BRASIL N; Martin A, 1996, DERMATOL SURG, V22, P156, DOI 10.1111/j.1524-4725.1996.tb00499.x; Martinez Carlos Augusto Real, 2015, J. Coloproctol. (Rio J.), V35, P90, DOI 10.1016/j.jcol.2015.02.007; Mohan S., 2015, INTERNATIONALJOURNAL, V3, P599; Mukai K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115564; Muthusubramaniam L, 2014, TISSUE ENG PT A, V20, P2728, DOI [10.1089/ten.tea.2013.0539, 10.1089/ten.TEA.2013.0539]; Ng MFY, 2010, INT WOUND J, V7, P55, DOI 10.1111/j.1742-481X.2009.00651.x; Novaes RD, 2016, INT J EXP PATHOL, V97, P114, DOI 10.1111/iep.12183; Nunan R, 2014, DIS MODEL MECH, V7, P1205, DOI 10.1242/dmm.016782; Pomari E, 2015, FASEB J, V29, P508, DOI 10.1096/fj.14-251363; Reddy GK, 2003, LASER SURG MED, V33, P344, DOI 10.1002/lsm.10227; Sarandy M. M., 2015, EVID-BASED COMPL ALT, V2015, P1; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Shiota N, 2010, INT ARCH ALLERGY IMM, V151, P80, DOI 10.1159/000232573; Siddiqui IA, 2005, CANCER LETT, V227, P125, DOI 10.1016/j.canlet.2004.10.046; SILAEVA S A, 1990, Byulleten' Eksperimental'noi Biologii i Meditsiny, V109, P180; Su YJ, 2015, ADV WOUND CARE, V4, P631, DOI 10.1089/wound.2014.0559; Sydow AKV, 2016, J CELL BIOCHEM, V117, P1622, DOI [10.1002/jcb.25455, DOI 10.1002/JCB.25455]; de Jesus NZT, 2009, REV BRAS FARMACOGN, V19, P130, DOI 10.1590/S0102-695X2009000100023; Urb M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002619; Vasconcelos SML, 2007, QUIM NOVA, V30, P1323, DOI 10.1590/S0100-40422007000500046; Webster J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009261.pub2; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Xie ZW, 2013, ACTA BIOMATER, V9, P9351, DOI 10.1016/j.actbio.2013.07.030; Younan GJ, 2011, PLAST RECONSTR SURG, V128, p649E, DOI 10.1097/PRS.0b013e318230c55d	70	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195786	10.1371/journal.pone.0195786	http://dx.doi.org/10.1371/journal.pone.0195786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649320	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900089
J	Tolley, EE; Guthrie, KM; Zissette, S; Fava, JL; Gill, K; Louw, CE; Kotze, P; Reddy, K; MacQueen, K				Tolley, Elizabeth E.; Guthrie, Kate Morrow; Zissette, Seth; Fava, Joseph L.; Gill, Katherine; Louw, Cheryl E.; Kotze, Philip; Reddy, Krishnaveni; MacQueen, Kathleen			Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling	PLOS ONE			English	Article							VACCINE EFFICACY TRIAL; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; MEDICATION-ADHERENCE; CLINICAL-TRIALS; AFRICAN WOMEN; SELF-EFFICACY; DRUG-USERS; HIGH-RISK; PARTICIPATION	Background Low adherence in recent HIV prevention clinical trials highlights the need to better understand, measure, and support product use within clinical trials. Conventional self-reported adherence instruments within HIV prevention trials, often relying on single-item questions, have proven ineffective. While objective adherence measures are desirable, none currently exist that apply to both active and placebo arms. Scales are composed of multiple items in the form of questions or statements that, when combined, measure a more complex construct that may not be directly observable. When psychometrically validated, such measures may better assess the multiple factors contributing to adherence/non-adherence. This study aimed to develop and psychometrically evaluate tools to screen and monitor trial participants' adherence to HIV prevention products within the context of clinical trial research. Methods and findings Based on an extensive literature review and conceptual framework, we identified and refined 86 items assessing potential predictors of adherence and 48 items assessing adherence experience. A structured survey, including adherence items and other variables, was administered to former ASPIRE and Ring Study participants and similar non-trial participants (n = 709). We conducted exploratory factor analyses (EFA) to identify a reduced set of constructs and items that could be used at screening to predict potential adherence, and at follow-up to monitor and intervene on adherence. We examined associations with other variables to assess content and construct validity. The EFA of screener items resulted in a 6-factor solution with acceptable to very good internal reliability (alpha: .62-.84). Similar to our conceptual framework, factors represent trial-related commitment (Distrust of Research and Commitment to Research); alignment with trial requirements (Visit Adherence and Trial Incompatibility); Belief in Trial Benefits and Partner Disclosure. The EFA on monitoring items resulted in 4 Product-specific factors that represent Vaginal Ring Doubts, Vaginal Ring Benefits, Ring Removal, and Side Effects with good to very good internal reliability (alpha = .71-.82). Evidence of content and construct validity was found; relationship to social desirability bias was examined. Conclusions These scales are easy and inexpensive to administer, available in several languages, and are applicable regardless of randomization. Once validated prospectively, they could (1) screen for propensity to adhere, (2) target adherence support/counselling, and (3) complement biomarker measures in determining true efficacy of the experimental product.	[Tolley, Elizabeth E.; Zissette, Seth; MacQueen, Kathleen] FHI 360, Durham, NC 27701 USA; [Guthrie, Kate Morrow; Fava, Joseph L.] Miriam Hosp, Ctr Behav Med, Providence, RI 02906 USA; [Guthrie, Kate Morrow; Fava, Joseph L.] Miriam Hosp, Ctr Prevent Med, Providence, RI 02906 USA; [Guthrie, Kate Morrow] Brown Univ, Deptartment Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [Gill, Katherine] Desmond Tutu HIV Ctr, Cape Town, South Africa; [Louw, Cheryl E.] Madibeng Ctr Res, Brits, South Africa; [Louw, Cheryl E.] Univ Pretoria, Dept Family Med, Fac Hlth Sci, Hatfield, South Africa; [Kotze, Philip] Qhakaza Mbokodo Res Clin, Ladysmith, South Africa; [Reddy, Krishnaveni] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa	FHI 360; Lifespan Health Rhode Island; Miriam Hospital; Lifespan Health Rhode Island; Miriam Hospital; Brown University; University of Pretoria	Tolley, EE (corresponding author), FHI 360, Durham, NC 27701 USA.	btolley@fhi360.org	Gill, Katherine/ABG-3230-2021	Gill, Katherine/0000-0002-3372-9506; Fava, Joseph/0000-0001-7129-7903; Zissette, Seth/0000-0002-6502-2986; Kotze, Philip/0000-0003-1346-7833	United States Agency for International Development [AID-OAA-A-14-00003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069463] Funding Source: NIH RePORTER	United States Agency for International Development(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the United States Agency for International Development under the terms of the Adherence Measurement and Optimization of Long-Acting ARV-Based Vaginal Ring Agreement, AID-OAA-A-14-00003. KM was principal investigator of the award. ET was a co-principal investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RA, 2010, SOC INDIC RES, V97, P357, DOI 10.1007/s11205-009-9506-x; Aby JS, 1996, ANN ALLERG ASTHMA IM, V76, P348, DOI 10.1016/S1081-1206(10)60036-1; af Wahlberg AE, 2010, J SAFETY RES, V41, P99, DOI 10.1016/j.jsr.2010.02.005; Amico KR, 2017, AIDS BEHAV, V21, P1361, DOI 10.1007/s10461-016-1458-y; Amico KR, 2014, JAIDS-J ACQ IMM DEF, V66, P530, DOI 10.1097/QAI.0000000000000216; Aragones C, 2011, MEDICC REV, V13, P17, DOI 10.37757/MR2011V13.N2.6; AVAC CONRAD., 2014, WORKSH ALT TRIAL DES; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balfour L, 2010, AIDS CARE, V22, P1403, DOI 10.1080/09540121003693522; Bova C, 2006, RES NURS HEALTH, V29, P477, DOI 10.1002/nur.20158; Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Braunstein JB, 2008, MEDICINE, V87, P1, DOI 10.1097/MD.0b013e3181625d78; BUCKSHEE K, 1990, Advances in Contraception, V6, P177, DOI 10.1007/BF01849492; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Coetzee B, 2013, AIDS BEHAV, V17, P319, DOI 10.1007/s10461-012-0374-z; Colfax G, 2005, JAIDS-J ACQ IMM DEF, V39, P359, DOI 10.1097/01.qai.0000152039.88422.ec; Colwell HH, 2006, QUAL LIFE RES, V15, P1621, DOI 10.1007/s11136-006-0026-8; Corneli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125458; Corneli AL, 2014, JAIDS-J ACQ IMM DEF, V66, P324, DOI 10.1097/QAI.0000000000000158; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Leite JCD, 2011, EUR J PSYCHOL ASSESS, V27, P228, DOI 10.1027/1015-5759/a000077; DeVellis R., 2017, SCALE DEV THEORY APP, V4; Dhalla S, 2011, AIDS CARE, V23, P1430, DOI 10.1080/09540121.2011.555750; DiMatteo MR, 1993, ADHERENCE DETERMINAN; Doshi MS, 2013, J MED ETHICS, V39, P391, DOI 10.1136/medethics-2012-100755; Gabbay M, 2004, CONTROL CLIN TRIALS, V25, P388, DOI 10.1016/j.cct.2004.06.004; Gilmore HJ, 2013, AIDS PATIENT CARE ST, V27, P560, DOI 10.1089/apc.2013.0116; Haberer JE, 2015, AIDS, V29, P1277, DOI 10.1097/QAD.0000000000000647; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Horne R., 2005, CONCORDANCE ADHERENC, P40; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Horne R, 2007, JAIDS-J ACQ IMM DEF, V45, P334; Huang L, 2013, J ASSOC NURSE AIDS C, V24, P145, DOI 10.1016/j.jana.2012.04.006; Johnson MO, 2007, J BEHAV MED, V30, P359, DOI 10.1007/s10865-007-9118-3; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; Lee SJ, 2005, J RHEUMATOL, V32, P2317; MacPhail C, 2012, PATIENT PREFER ADHER, V6, P579, DOI 10.2147/PPA.S30759; MacQueen KM, 1999, J ACQ IMMUN DEF SYND, V21, P243, DOI 10.1097/00126334-199907010-00010; MacQueen KM, 2014, J INT AIDS SOC S2, V17, P19158, DOI DOI 10.7448/IAS.17.3.19158; Magazi B, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-88; MAHONEY CA, 1995, HEALTH EDUC RES, V10, P1, DOI 10.1093/her/10.1.1-a; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Montgomery ET, 2015, AIDS BEHAV, V19, P784, DOI 10.1007/s10461-014-0950-5; Montgomery ET, 2011, AIDS BEHAV, V15, P959, DOI 10.1007/s10461-010-9806-9; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; Newman PA, 2007, PREV MED, V44, P554, DOI 10.1016/j.ypmed.2006.12.007; Newman PA, 2011, AM J PUBLIC HEALTH, V101, P1749, DOI 10.2105/AJPH.2011.300208; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Perisse AR, 2000, J ACQ IMMUN DEF SYND, V25, P459, DOI 10.1097/00126334-200012150-00012; Rosenbaum JR, 2005, J CLIN EPIDEMIOL, V58, P1109, DOI 10.1016/j.jclinepi.2005.03.014; Schuber PA, 2008, J NURS MEAS, V16, P136, DOI 10.1891/1061-3749.16.2.136; Sengupta S, 2000, J ACQ IMMUN DEF SYND, V24, P275; Stalter RM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20746; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tolley E, 2015, DRUG DELIVERY AND DEVELOPMENT OF ANTI-HIV MICROBICIDES, P569; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20642; van der Straten A, 2015, AIDS, V29, P2161, DOI 10.1097/QAD.0000000000000801; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Voytek CD, 2011, VACCINE, V29, P6130, DOI 10.1016/j.vaccine.2011.06.064; Williams AB, 2013, AIDS BEHAV, V17, P284, DOI 10.1007/s10461-012-0172-7; Wilson K J, 2004, Sex Health, V1, P251, DOI 10.1071/SH04020; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]; Wu JR, 2008, HEART LUNG, V37, P334, DOI 10.1016/j.hrtlng.2007.10.001	72	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195499	10.1371/journal.pone.0195499	http://dx.doi.org/10.1371/journal.pone.0195499			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649249	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900049
J	Vors, O; Marqueste, T; Mascret, N				Vors, Olivier; Marqueste, Tanguy; Mascret, Nicolas			The Trier Social Stress Test and the Trier Social Stress Test for groups: Qualitative investigations	PLOS ONE			English	Article							PSYCHOSOCIAL STRESS; CORTISOL RESPONSES; HPA AXIS; EXPERIENCE; SELF; PERFORMANCE; REACTIVITY; QUESTION; COURSES; SPORT	The Trier Social Stress Test (TSST) and its version for groups (TSST-G) are the gold standard for inducing acute psychosocial stress in human experimental settings and have been used in numerous studies since the early 1990s. The TSST and the TSST-G lead to effects on different physiological and psychological markers, such as salivary cortisol, anxiety, and emotional states. These effects were assessed with quantitative methods comparing pretest and post-test measures with statistical analyses. But to date, no qualitative analyses have been conducted to examine the meaningful experience of participants during the TSST and the TSST-G. This study is the first to conduct qualitative investigations to further clarify the stressful experience of participants confronted with these procedures. Preliminary results showed as expected that the TSST and the TSST-G effectively induced psychosocial stress, with cortisol levels, cognitive anxiety, somatic anxiety, and arousal increases, and with pleasure and dominance decreases. At the qualitative level, the results evidenced that the two theoretically stressful components of the TSST and the TSST-G, namely social-evaluative threat and uncontrollability, were experienced as stress-inducing by the participants. Two case studies confirmed these findings. But the results also showed on one hand that psychosocial stress is a dynamic phenomenon, with important fluctuations throughout the tasks (mainly for the TSST-G); and on the other hand that despite the similar physiological and psychological responses between the TSST and the TSST-G evidenced by the literature, the experience of the participants was both similar and specific. Use of a qualitative method allowed us to provide a complementary point of view to understand the meaningful experience of participants during these stressful procedures, apprehending the dynamic of the subjective stress experience without disrupting it.	[Vors, Olivier; Marqueste, Tanguy; Mascret, Nicolas] Aix Marseille Univ, CNRS, ISM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Vors, O (corresponding author), Aix Marseille Univ, CNRS, ISM, Marseille, France.	oliver.vors@univ-amu.fr	Vors, Olivier/T-6318-2017; Marqueste, Tanguy/AAM-9751-2021	Vors, Olivier/0000-0001-8437-8825; Marqueste, Tanguy/0000-0002-2620-1551				Allen AP, 2017, NEUROBIOL STRESS, V6, P113, DOI 10.1016/j.ynstr.2016.11.001; Allen AP, 2014, NEUROSCI BIOBEHAV R, V38, P94, DOI 10.1016/j.neubiorev.2013.11.005; Boesch M, 2014, PSYCHONEUROENDOCRINO, V43, P41, DOI 10.1016/j.psyneuen.2014.02.003; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bussing A, 1999, HUM RELAT, V52, P999, DOI 10.1023/A:1016979523846; Campbell J, 2012, PSYCHONEUROENDOCRINO, V37, P1111, DOI 10.1016/j.psyneuen.2011.12.010; Childs E, 2006, PSYCHOPHYSIOLOGY, V43, P366, DOI 10.1111/j.1469-8986.2006.00414.x; Cohen L., 2013, RES METHODS ED; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Doron J, 2016, SCANDINAVIAN J MED S, V27, P2080; Durand Marc., 2014, DIALOGUE ENTRE CONCE, P13; Froese T, 2011, PRAGMAT COGN, V19, P1, DOI 10.1075/pc.19.1.01fro; Gesbert V, 2017, FRONT PSYCHOL, P8, DOI [10.3389/fpsyg.2017.00854/full, DOI 10.3389/FPSYG.2017.00854/FULL]; Giles GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113618; Goette L, 2015, PSYCHONEUROENDOCRINO, V54, P115, DOI 10.1016/j.psyneuen.2015.01.019; Gold SA, 2004, BIOL PSYCHOL, V67, P261, DOI 10.1016/j.biopsycho.2003.12.001; Goodman WK, 2017, PSYCHONEUROENDOCRINO, V80, P26, DOI 10.1016/j.psyneuen.2017.02.030; Hauw D, 2008, J SPORT SCI MED, V7, P8; Hauw D, 2017, QUEST, V69, P256, DOI 10.1080/00336297.2016.1220320; Het S, 2009, PSYCHONEUROENDOCRINO, V34, P1075, DOI 10.1016/j.psyneuen.2009.02.008; Horcik Z, 2014, SIMUL HEALTHC, V9, P94, DOI 10.1097/SIH.0000000000000021; Jourand C, 2017, PHYS EDUC SPORT PEDA, P1; Keegan RJ, 2014, PSYCHOL SPORT EXERC, V15, P97, DOI 10.1016/j.psychsport.2013.10.006; Kemeny ME, 2004, PSYCHOL INQ, V15, P153; Kimura K, 2007, BIOL PSYCHOL, V74, P39, DOI 10.1016/j.biopsycho.2006.06.006; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kudielka B. M., 2007, SOC NEUROSCI-UK, P56, DOI DOI 10.1007/978-1-4614-6852-3; Lamarche L, 2012, BODY IMAGE, V9, P145, DOI 10.1016/j.bodyim.2011.10.004; Lesage FX, 2012, INT J OCCUP MED ENV, V25, P178, DOI 10.2478/S13382-012-0024-8; Maier SF, 2016, PSYCHOL REV, V123, P349, DOI 10.1037/rev0000033; Martinent G, 2010, PSYCHOL SPORT EXERC, V11, P51, DOI 10.1016/j.psychsport.2009.05.001; Mascret N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157215; McGann M, 2013, REV GEN PSYCHOL, V17, P203, DOI 10.1037/a0032935; Mohamed S, 2015, J SPORT SCI MED, V14, P340; Mottet M, 2016, SPAT COGN COMPUT, V16, P220, DOI 10.1080/13875868.2016.1166229; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P758, DOI 10.1016/j.psyneuen.2007.05.006; Norman D. A., 1993, THINGS MAKE US SMART; Philippe RA, 2016, SPORT PSYCHOL, V30, P361, DOI 10.1123/tsp.2016-0039; Ria L., 2003, J EDUC TEACHING, V29, P219, DOI [10.1080/0260747032000120114, DOI 10.1080/0260747032000120114]; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; RKiouak M, 2016, FRONT PSYCHOL, P7; Rochat N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173667; Salama-Younes M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-22; Salvador A, 2009, NEUROSCI BIOBEHAV R, V33, P160, DOI 10.1016/j.neubiorev.2008.09.005; Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Seifert L, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00075; Seve C, 2007, PSYCHOL SPORT EXERC, V8, P25, DOI 10.1016/j.psychsport.2006.01.004; Stalder T, 2016, PSYCHONEUROENDOCRINO, V63, P414, DOI 10.1016/j.psyneuen.2015.10.010; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Theureau J, 2003, HUM FAC ER, P55; Theureau J., 2015, COURS ACTION ENACTIO; Thompson E., 2005, PHENOMENOL COGN SCI, V4/, P407, DOI [10.1007/s11097-005--9003-x, DOI 10.1007/S11097-005-9003-X]; THOMPSON SC, 1981, PSYCHOL BULL, V90, P89, DOI 10.1037/0033-2909.90.1.89; Varela F.J., 1992, EMBODIED MIND COGNIT; von Dawans B, 2011, PSYCHONEUROENDOCRINO, V36, P514, DOI 10.1016/j.psyneuen.2010.08.004; Vors O, 2015, PHYS EDUC SPORT PEDA, V20, P647, DOI 10.1080/17408989.2014.882889; Vors O, 2015, EUR PHYS EDUC REV, V21, P340, DOI 10.1177/1356336X15569373; Wiemers US, 2013, STRESS, V16, P254, DOI 10.3109/10253890.2012.714427; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yim IS, 2010, PSYCHONEUROENDOCRINO, V35, P241, DOI 10.1016/j.psyneuen.2009.06.014	62	18	18	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195722	10.1371/journal.pone.0195722	http://dx.doi.org/10.1371/journal.pone.0195722			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641572	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900087
J	Bartolo, I; Diniz, AR; Borrego, P; Ferreira, JP; Bronze, MR; Barroso, H; Pinto, R; Cardoso, C; Pinto, JF; Diaz, RC; Broncano, PG; Munoz-Fernandez, MA; Taveira, N				Bartolo, Ines; Diniz, Ana Rita; Borrego, Pedro; Ferreira, Joao Pedro; Bronze, Maria Rosario; Barroso, Helena; Pinto, Rui; Cardoso, Carlos; Pinto, Joao F.; Cena Diaz, Rafael; Garcia Broncano, Pilar; Angel Munoz-Fernandez, Maria; Taveira, Nuno			Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women	PLOS ONE			English	Article							DOUBLE-BLIND; IN-VITRO; INFECTION; PREFORMULATION; SUSCEPTIBILITY; FORMULATION; SPERMICIDE; RESISTANCE; TENOFOVIR; MODEL	Microbicides are an important strategy for preventing the sexual transmission of HIV but, so far, the most advanced tenofovir-based microbicides have had modest efficacy. This has been related to adherence problems and high prevalence of tenofovir-resistant HIV-1 strains. P3 is a new peptide with potent activity against HIV that may be a good microbicide candidate. In this work P3 was formulated in a gel of hydroxyethyl cellulose and its activity, stability and safety profile in Balb/c mice were evaluated. HIV infection was fully blocked by a 1.5% gel containing P3 at the IC90 (366.4 nM) concentration. The antiviral activity did not change at 4 degrees C during 4 months and at 25, 37 and 65 degrees C for 1 week. P3 was stable and fully functional at acidic pH up to 24h, under different concentrations of hydrogen peroxide and in the presence of genital fluids up to 48h. P3 had no antibacterial activity and did not affect sperm motility and vitality. Finally, P3 didn't cause significant alterations in the vaginal epithelium of Balb/c mice at 0.06 (456.8 mu M) and 0.2 mg/day (1522.7 mu M) doses. These findings indicate that P3 is an excellent candidate for further development as a microbicide gel for the prevention of HIV transmission in women.	[Bartolo, Ines; Diniz, Ana Rita; Borrego, Pedro; Ferreira, Joao Pedro; Bronze, Maria Rosario; Pinto, Rui; Pinto, Joao F.; Taveira, Nuno] Univ Lisbon, Res Inst Med iMed ULisboa, Fac Farm, Lisbon, Portugal; [Borrego, Pedro; Taveira, Nuno] Univ Lisbon, ISCSP, CAPP, Lisbon, Portugal; [Barroso, Helena] Inst Super Ciencias Saude Egas Moniz, CiiEM, Caparica, Portugal; [Pinto, Rui; Cardoso, Carlos] Lab Anal Clin Dr Joaquim Chaves, Joaquim Chaves Saude, Miraflores Alge, Portugal; [Cena Diaz, Rafael; Garcia Broncano, Pilar; Angel Munoz-Fernandez, Maria] Hosp Gen Univ Gregorio Maranon, Lab InmunoBiol Mol, Madrid, Spain; [Cena Diaz, Rafael; Garcia Broncano, Pilar; Angel Munoz-Fernandez, Maria] Spanish HIV HGM Biobank, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Cena Diaz, Rafael; Garcia Broncano, Pilar; Angel Munoz-Fernandez, Maria] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Taveira, N (corresponding author), Univ Lisbon, Res Inst Med iMed ULisboa, Fac Farm, Lisbon, Portugal.; Taveira, N (corresponding author), Univ Lisbon, ISCSP, CAPP, Lisbon, Portugal.	ntaveira@ff.ul.pt	Pinto, Rui Manuel/M-4386-2019; Bártolo, Inês/A-7477-2014; Pinto, Rui Manuel/A-8425-2014; Ferreira, João Pedro/AAB-2489-2022; Taveira, Nuno C/A-6252-2014; Broncano, Pilar Garcia/AAC-5058-2019; iMed.ULisboa, EEPHIV/B-4222-2014; iMed.ULisboa, InTraCellADD/B-4826-2014; Pinto, João F/C-6595-2008; Bronze, Maria/I-1376-2012; Borrego, Pedro/H-6968-2013	Pinto, Rui Manuel/0000-0002-1667-7871; Bártolo, Inês/0000-0002-2022-8921; Pinto, Rui Manuel/0000-0002-1667-7871; Ferreira, João Pedro/0000-0002-2304-6138; Taveira, Nuno C/0000-0003-0176-5585; Broncano, Pilar Garcia/0000-0002-3413-2189; Pinto, João F/0000-0001-6499-310X; Cena-Diez, Rafael/0000-0001-9987-395X; Bronze, Maria/0000-0001-5016-4634; Barroso, Helena/0000-0003-4098-5433; Borrego, Pedro/0000-0002-1949-9484; Munoz-Fernandez/0000-0002-0813-4500	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, EDCTP2 program - European Union [VIH/SAU/0029/2011]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BPD/76225/2011, SFRH/BD/89140/2012]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, EDCTP2 program - European Union; Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	Financial support for this research was provided by the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal (project VIH/SAU/0029/2011), part of the EDCTP2 program supported by the European Union. Ines Bartolo is supported by a post-doc fellowship (SFRH/BPD/76225/2011) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. Ana Rita Diniz is supported by a PhD grant (SFRH/BD/89140/2012) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal, https://www.fct.pt/.	Al-Mushrif S., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P63; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2014, GUID IND VAG MICR DE; Baeten JM, 2016, NEW ENGLAND J MED; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Borrego P, 2013, AIDS, V27, P1081, DOI 10.1097/QAD.0b013e32835edc1d; Borrego P, 2012, ANTIVIR THER, V17, P565, DOI 10.3851/IMP1996; Buckheit KW, 2016, CURR TOP MED CHEM, V16, P1118, DOI 10.2174/1568026615666150901113939; Buckheit RW, 2012, CURR HIV RES, V10, P97, DOI 10.2174/157016212799304698; Chonco L, 2012, J CONTROL RELEASE, V161, P949, DOI 10.1016/j.jconrel.2012.04.050; Clarke JG, 2002, SEX TRANSM DIS, V29, P288, DOI 10.1097/00007435-200205000-00007; Clinical and Laboratory Standards Institute (CLSI), 2015, PERF STAND ANT DISK, V12th; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Gandhi M, 2016, C RETR OPP INF BOST; Gregson J, 2016, LANCET INFECT DIS, V16, P565, DOI 10.1016/S1473-3099(15)00536-8; Gupta G, 2005, EUR J CONTRACEP REPR, V10, P212, DOI 10.1080/13625180500280753; Gupta SK, 2013, HIV AIDS-RES PALLIAT, V5, P295, DOI 10.2147/HIV.S39164; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Kiernan JA, 2007, BIOTECH HISTOCHEM, V82, P73, DOI 10.1080/10520290701375278; Kikwai L, 2004, J PHARM PHARMACOL, V56, P19, DOI 10.1111/j.2042-7158.2004.tb02573.x; Leddy A, 2016, AIDS CARE, V28, P228, DOI 10.1080/09540121.2015.1080792; Liu A, 2016, C RETR OPP INF BOST; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Martin DH, 2016, J INFECT DIS, V214, pS36, DOI 10.1093/infdis/jiw184; Martin DH, 2012, AM J MED SCI, V343, P2, DOI 10.1097/MAJ.0b013e31823ea228; Mayer KH, 2015, CURR OPIN HIV AIDS, V10, P226, DOI 10.1097/COH.0000000000000170; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Melis G B, 2000, Minerva Ginecol, V52, P111; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; Mulligan K, 2015, CLIN INFECT DIS, V61, P572, DOI 10.1093/cid/civ324; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; Neff CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020209; Oliyai R, 2001, NUCLEOS NUCLEOT NUCL, V20, P1295, DOI 10.1081/NCN-100002540; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Petrova MI, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00081; Pirrone V, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-33; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rees H., 2015, CROI 2015; Sassi AB, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-27; Schwartz JL, 2007, CONTRACEPTION, V75, P136, DOI 10.1016/j.contraception.2006.09.003; Segarra TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027675; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Theys K, 2016, AIDS RES HUM RETROV, V32, P427, DOI [10.1089/aid.2015.0095, 10.1089/AID.2015.0095]; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Togni G, 2011, ANTIMICROB AGENTS CH, V55, P2490, DOI 10.1128/AAC.01623-10; Tomas MSJ, 2004, METH MOL B, V268, P337; UNAIDS, 2016, AIDS BY THE NUMB; UNAIDS, 2016, HIV FACT SHEET NOV 2; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Volkin David B, 2002, Pharm Biotechnol, V14, P1; Wilkinson D, 2002, LANCET INFECT DIS, V2, P613, DOI 10.1016/S1473-3099(02)00396-1; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Xiong S, 2016, J VIROL	58	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195744	10.1371/journal.pone.0195744	http://dx.doi.org/10.1371/journal.pone.0195744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668740	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200054
J	Gun, X; Zhang, H; Tian, TH				Gun, Xue; Zhang, Hu; Tian, Tianhai			Development of stock correlation networks using mutual information and financial big data	PLOS ONE			English	Article							COMPLEX NETWORKS; SPANNING-TREES; MARKETS	Stock correlation networks use stock price data to explore the relationship between different stocks listed in the stock market. Currently this relationship is dominantly measured by the Pearson correlation coefficient. However, financial data suggest that nonlinear relationships may exist in the stock prices of different shares. To address this issue, this work uses mutual information to characterize the nonlinear relationship between stocks. Using 280 stocks traded at the Shanghai Stocks Exchange in China during the period of 2014-2016, we first compare the effectiveness of the correlation coefficient and mutual information for measuring stock relationships. Based on these two measures, we then develop two stock networks using the Minimum Spanning Tree method and study the topological properties of these networks, including degree, path length and the power-law distribution. The relationship network based on mutual information has a better distribution of the degree and larger value of the power-law distribution than those using the correlation coefficient. Numerical results show that mutual information is a more effective approach than the correlation coefficient to measure the stock relationship in a stock market that may undergo large fluctuations of stock prices.	[Gun, Xue; Zhang, Hu] Zhongnan Univ Econ & Law, Sch Stat & Math, Wuhan, Hubei, Peoples R China; [Tian, Tianhai] Monash Univ, Sch Math Sci, Clayton, Vic, Australia	Zhongnan University of Economics & Law; Monash University	Tian, TH (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic, Australia.	tianhai.tian@monash.edu	Li, Wang/M-1612-2019; Tian, Tianhai/AAU-2335-2021	Tian, Tianhai/0000-0001-6191-0209	National Natural Science Foundation of China [11571368]; National Social Science Fund of China [17BTJ017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Fund of China	This work was supported by National Natural Science Foundation of China 11571368 and the National Social Science Fund of China (17BTJ017) (http://www.nsfc.gov.cn/publish/portal1/, X.G. and T.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research work is supported by the National Natural Science Foundation of China (11571368), and the National Social Science Fund of China (17BTJ017).	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Aste T, 2005, PHYSICA A, V346, P20, DOI 10.1016/j.physa.2004.08.045; Birch J, 2016, COMPUT ECON, V47, P501, DOI 10.1007/s10614-015-9481-z; Boginski V, 2005, COMPUT STAT DATA AN, V48, P431, DOI 10.1016/j.csda.2004.02.004; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Chen H, 2014, PHYSICA A, V414, P360, DOI 10.1016/j.physa.2014.07.039; Coronnello C, 2005, ACTA PHYS POL B, V36, P2653; Curme C, 2014, QUANT FINANC, V15; Fiedor P, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052801; Gilmore CG, 2010, PHYSICA A, V389, P4875, DOI 10.1016/j.physa.2010.06.057; Han RQ, 2017, FLUCT NOISE LETT, V16, DOI 10.1142/S0219477517500183; Huang WQ, 2009, PHYSICA A, V388, P2956, DOI 10.1016/j.physa.2009.03.028; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lopes dSF, 1989, BRIAN TOPOGRAPH, V2, P9, DOI [10.1007/BF01128839, DOI 10.1007/BF01128839]; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Onnela JP, 2004, EUR PHYS J B, V38, P353, DOI 10.1140/epjb/e2004-00128-7; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Ralf S, 2014, BMC BIOINFORMATICS, V5, P118; Ren F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097711; Roberts S, 2001, INDEPENDENT COMPONEN; Sandoval L, 2015, J RISK FINANC MANAG, V8, P227, DOI 10.3390/jrfm8020227; Sandoval L, 2012, PHYSICA A, V391, P187, DOI 10.1016/j.physa.2011.07.023; Sensoy A, 2014, PHYSICA A, V414, P387, DOI 10.1016/j.physa.2014.07.067; Shen J, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/48005; Song DM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026108; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Tse CK, 2010, J EMPIR FINANC, V17, P659, DOI 10.1016/j.jempfin.2010.04.008; Tumminello M, 2007, EUR PHYS J B, V55, P209, DOI 10.1140/epjb/e2006-00414-4; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Tumminello M, 2010, J ECON BEHAV ORGAN, V75, P40, DOI 10.1016/j.jebo.2010.01.004; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Wang YXR, 2014, J THEOR BIOL, V362, P53, DOI 10.1016/j.jtbi.2014.03.040; You T, 2015, J RISK FINANC MANAG, V8, P266, DOI 10.3390/jrfm8020266; Zhao LF, 2016, PHYS LETT A, V380, P654, DOI 10.1016/j.physleta.2015.11.015	37	34	34	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195941	10.1371/journal.pone.0195941	http://dx.doi.org/10.1371/journal.pone.0195941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668715	Green Published, gold, Green Submitted			2022-12-27	WOS:000430290200069
J	Karakavuk, M; Aldemir, D; Mercier, A; Sahar, EA; Can, H; Murat, JB; Donduren, O; Can, S; Ozdemir, HG; Doskaya, AD; Pektas, B; Darde, ML; Guruz, AY; Doskaya, M				Karakavuk, Muhammet; Aldemir, Duygu; Mercier, Aurelien; Sahar, Esra Atalay; Can, Huseyin; Murat, Jean-Benjamin; Donduren, Omer; Can, Sengul; Ozdemir, Huseyin Gokhan; Doskaya, Aysu Degirmenci; Pektas, Bayram; Darde, Marie-Laure; Guruz, Adnan Yuksel; Doskaya, Mert			Prevalence of toxoplasmosis and genetic characterization of Toxoplasma gondii strains isolated in wild birds of prey and their relation with previously isolated strains from Turkey	PLOS ONE			English	Article							FATAL TOXOPLASMOSIS; MOLECULAR CHARACTERIZATION; CONGENITAL TOXOPLASMOSIS; CLINICAL FINDINGS; DIVERSITY; GENOTYPES; BRAZIL; CATS; PCR; SEROPREVALENCE	Toxoplasma gondii is a protozoon parasite that causes congenital toxoplasmosis, as well as other serious clinical presentations, in immune compromised humans. Analyses of the prevalence and genotyping of strains from the definitive host and intermediate hosts will help to understanding the circulation of the different strains and elucidating the role of the genotype (s) in human toxoplasmosis. Turkey has a specific geographic location bridging Africa, Europe, and Asia. We hypothesized that T. gondii strains may have been transferred to Turkey from these continents via migratory birds or vice versa. The present study aimed to assess the prevalence of toxoplasmosis in wild birds of prey of Izmir and Manisa provinces as well as genetically characterize T. gondii strains from these wild birds to show the relation between bird strains and neighboring stray cats as well as human strains previously isolated in Turkey. Tissues obtained from 48 wild birds were investigated for the presence of T. gondii DNA and then bioassayed in mouse. Isolated strains were genotyped using 15 microsatellite markers. The prevalence of T. gondii DNA was found to be 89.6% (n: 43/48) in wild birds. Out of 43 positive samples, a total of 14 strains were genotyped by 15 microsatellite markers. Among them, eight were type II, three were type III and three were mixture of genotypes (two type II/II and one was II/III). These are the first data that showed the presence of T. gondii and types II and III genotypes in wild birds of Turkey. Moreover, Africa 1 was not detected. In addition, cluster analysis showed that T. gondiistrains within type II and III lineage have close relation with strains previously isolated from stray cats in Izmir. Further studies are required to isolate more strains from human cases, other intermediate hosts, and water sources to reveal this relation.	[Karakavuk, Muhammet; Sahar, Esra Atalay; Doskaya, Aysu Degirmenci; Guruz, Adnan Yuksel; Doskaya, Mert] Ege Univ, Dept Parasitol, Fac Med, Izmir, Turkey; [Aldemir, Duygu] Uludag Univ, Dept Internal Med, Fac Vet Med, Inst Hlth Sci, Gorukle Campus, Nilufer Bursa, Turkey; [Aldemir, Duygu] Municipal Izmir, Izmir Wildlife Pk, Izmir, Turkey; [Mercier, Aurelien; Murat, Jean-Benjamin; Darde, Marie-Laure] Univ Limoges, Ctr Hosp Univ Dupuytren, Toxoplasmose Toxoplasma Biol Resource Ctr BRC, Fac Med,CNR, Limoges, France; [Mercier, Aurelien; Murat, Jean-Benjamin; Darde, Marie-Laure] Univ Limoges, Lab Parasitol Mycol, Neuroepidemiol Trop, Fac Med,INSERM,UMR 1094, Limoges, France; [Can, Huseyin] Ege Univ, Mol Biol Sect, Dept Biol, Fac Sci, Izmir, Turkey; [Donduren, Omer; Ozdemir, Huseyin Gokhan] Protect & Dev Union Izmir Bird Paradise, Izmir, Turkey; [Can, Sengul] Manisa Celal Bayar Univ, Comp Res & Applicat Ctr, Muradiye, Manisa, Turkey; [Pektas, Bayram] Ataturk Training & Res Hosp, Dept Microbiol, Izmir, Turkey	Ege University; Uludag University; Izmir Metropolitan Municipality; CHU Limoges; Universite de Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges; Ege University; Celal Bayar University; Izmir Ataturk Training & Research Hospital	Doskaya, M (corresponding author), Ege Univ, Dept Parasitol, Fac Med, Izmir, Turkey.	mert.doskaya@ege.edu.tr	Karakavuk, Muhammet/AAV-7794-2021; Can, Hüseyin/J-2987-2019; Can, Hüseyin/AAG-3152-2020; Degirmenci, Aysu/DET-8805-2022; karakavuk, muhammet/ABC-8038-2020; Mercier, Aurelien/Q-4683-2016; Doskaya, Mert/W-4682-2017	Can, Hüseyin/0000-0001-9633-9786; karakavuk, muhammet/0000-0002-2468-5564; Mercier, Aurelien/0000-0003-4332-5879; Doskaya, Mert/0000-0001-6868-008X	Scientific Research Projects Branch Directorate of Ege University, Turkey [2014-TIP-073]	Scientific Research Projects Branch Directorate of Ege University, Turkey(Ege University)	This study was supported by the grant given by the Scientific Research Projects Branch Directorate of Ege University, Turkey (Grant No: 2014-TIP-073) to A.Y.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Ajzenberg D, 2010, J CLIN MICROBIOL, V48, P4641, DOI 10.1128/JCM.01152-10; Ajzenberg D, 2009, J INFECT DIS, V199, P1155, DOI 10.1086/597477; Al-Kappany YM, 2010, J PARASITOL, V96, P1112, DOI 10.1645/GE-2608.1; Aubert D, 2010, VET PARASITOL, V171, P346, DOI 10.1016/j.vetpar.2010.03.033; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Cabezon O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029549; Can H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104930; Cassaing S, 2006, J CLIN MICROBIOL, V44, P720, DOI 10.1128/JCM.44.3.720-724.2006; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chaichan P, 2017, INFECT GENET EVOL, V53, P227, DOI 10.1016/j.meegid.2017.06.002; Darde ML, 2008, PARASITE, V15, P366, DOI 10.1051/parasite/2008153366; de Barros LD, 2014, REV BRAS PARASITOL V, V23, P443, DOI [10.1590/S1984-29612014073, 10.1590/s1984-29612014073]; Delhaes L, 2010, PRENATAL DIAG, V30, P902, DOI 10.1002/pd.2563; Doskaya M, 2013, PARASITOL INT, V62, P471, DOI 10.1016/j.parint.2013.06.008; Doskaya Mert, 2013, Turkiye Parazitoloji Dergisi, V37, P44, DOI 10.5152/tpd.2013.11; Dubey JP, 2008, J PARASITOL, V94, P68, DOI 10.1645/GE-1362.1; Dubey JP, 2013, VET PARASITOL, V195, P42, DOI 10.1016/j.vetpar.2012.12.051; Dubey JP, 2010, J PARASITOL, V96, P937, DOI 10.1645/GE-2501.1; Dubey JP, 2010, VET PARASITOL, V172, P195, DOI 10.1016/j.vetpar.2010.05.013; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; Ferreira FC, 2012, AVIAN DIS, V56, P774, DOI 10.1637/10063-011912-Case.1; Galal L, 2018, TRENDS PARASITOL, V34, P140, DOI 10.1016/j.pt.2017.10.010; Gennari SM, 2014, VET PARASITOL, V200, P193, DOI 10.1016/j.vetpar.2013.10.003; Gennari SM, 2016, VET PARASITOL, V226, P50, DOI 10.1016/j.vetpar.2016.06.016; Gennari SM, 2016, J ZOO WILDLIFE MED, V47, P364, DOI 10.1638/2015-0103.1; Howe L, 2014, AVIAN DIS, V58, P171, DOI 10.1637/10625-080413-Case.1; Huang SY, 2012, J PARASITOL, V98, P681, DOI 10.1645/GE-3038.1; Inci A, 2002, FIRAT U SAGHK BILIML, V16, P177; Jokelainen P, 2014, J WILDLIFE DIS, V50, P117, DOI 10.7589/2013-03-057; Karatepe Mustafa, 2011, Turkiye Parazitoloji Dergisi, V35, P23, DOI 10.5152/tpd.2011.06; Khademvatan S, 2013, BRIT POULTRY SCI, V54, P76, DOI 10.1080/00071668.2013.763899; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Lindsay DS, 2003, J EUKARYOT MICROBIOL, V50, P687, DOI 10.1111/j.1550-7408.2003.tb00688.x; LITERAK I, 1992, AVIAN PATHOL, V21, P659, DOI 10.1080/03079459208418887; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Mercier A, 2011, INFECT GENET EVOL, V11, P1378, DOI 10.1016/j.meegid.2011.05.003; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; Muz MN, 2015, KAFKAS UNIV VET FAK, V21, P173, DOI 10.9775/kvfd.2014.11983; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Rajendran C, 2012, INFECT GENET EVOL, V12, P359, DOI 10.1016/j.meegid.2011.12.010; Rigoulet J, 2014, PARASITE, V21, DOI 10.1051/parasite/2014062; Salant H, 2009, VET PARASITOL, V159, P24, DOI 10.1016/j.vetpar.2008.10.011; Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844; Straub MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143018; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Szabo KA, 2004, J PARASITOL, V90, P907, DOI 10.1645/GE-270R; Tidy A, 2017, VET PARASITOL, V235, P47, DOI 10.1016/j.vetpar.2017.01.004; Turcekova L, 2014, ANN AGR ENV MED, V21, P235, DOI 10.5604/1232-1966.1108582; Vilares A, 2014, VET PARASITOL, V205, P506, DOI 10.1016/j.vetpar.2014.08.006; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053483; Weiss L.M., 2007, MODEL APICOMPLEXAN P; Work TM, 2016, J WILDLIFE DIS, V52, P253, DOI 10.7589/2015-09-235; Yu L, 2013, PARASITOL RES, V112, P1333, DOI 10.1007/s00436-012-3187-0; Zhou YZ, 2013, VET PARASITOL, V193, P270, DOI 10.1016/j.vetpar.2012.11.031; Zia-Ali N, 2007, PARASITOL RES, V101, P111, DOI 10.1007/s00436-007-0461-7	56	21	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196159	10.1371/journal.pone.0196159	http://dx.doi.org/10.1371/journal.pone.0196159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668747	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200079
J	Metwally, DM; Qassim, LE; Al-Turaiki, IM; Almeer, RS; El-Khadragy, MF				Metwally, Dina M.; Qassim, Latifa E.; Al-Turaiki, Isra M.; Almeer, Rafa S.; El-Khadragy, Manal F.			Gene-based molecular analysis of COX1 in Echinococcus granulosus cysts isolated from naturally infected livestock in Riyadh, Saudi Arabia	PLOS ONE			English	Article							CERVID STRAIN; HUMANS; IRAN; CATTLE; IDENTIFICATION; VARIANTS; GENOTYPE; SEQUENCE; POSITION; ANIMALS	The diversity and importance of Echinococcus species in domesticated animals in Saudi Arabia are poorly understood. In this study, 108 singular (hydatid) cysts were collected from goats (n = 25), sheep (n = 56) and camels (n = 27). DNA was extracted from the protoscoleces of individual fertile cysts and used for polymerase chain reaction (PCR) amplification of mitochondrial subunit 1 of the cytochrome c oxidase 1 (cox1) gene. Amplicon sequencing results revealed the presence of Echinococcus granulosus sensustricto (s.s.) (genotypes G1-G3) in 16 of the17 sheep cysts and 2 of the 27 camel cysts.of these samples, 18 (2 camel and 16 sheep) were divided into genotypes G1, G2, and G3.	[Metwally, Dina M.; Qassim, Latifa E.; Almeer, Rafa S.; El-Khadragy, Manal F.] King Saud Univ, Fac Sci, Zool Dept, Riyadh, Saudi Arabia; [Metwally, Dina M.] Zagazig Univ, Fac Vet Med, Parasitol Dept, Zagazig, Egypt; [Al-Turaiki, Isra M.] King Saud Univ, Coll Comp & Informat Sci, Informat Technol Dept, Riyadh, Saudi Arabia; [El-Khadragy, Manal F.] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Zagazig University; King Saud University; Egyptian Knowledge Bank (EKB); Helwan University	Metwally, DM (corresponding author), King Saud Univ, Fac Sci, Zool Dept, Riyadh, Saudi Arabia.; Metwally, DM (corresponding author), Zagazig Univ, Fac Vet Med, Parasitol Dept, Zagazig, Egypt.	molbody7@yahoo.com	Al-Turaiki, Isra/S-7930-2019	Al-Turaiki, Isra/0000-0003-0550-5115; metwally, dina/0000-0002-0595-0609; Metwally, Dina M./0000-0001-6042-4137	Deanship of Scientific Research at King Saud University [RG-1439-034]	Deanship of Scientific Research at King Saud University(King Saud University)	This research project was supported by a grant from the Deanship of Scientific Research at King Saud University for funding this research through the Research Group project no. RG-1439-034. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this research through the Research Group project no. RG-1439-034.	Abushhewa MH, 2010, MOL CELL PROBE, V24, P346, DOI 10.1016/j.mcp.2010.07.005; Al-Malki JS, EPIDEMIOLOGICAL STUD; Alvarez Rojas CA, 2014, INT J PARASITOL, V44, P9, DOI 10.1016/j.ijpara.2013.08.008; Bardonnet K, 2002, T ROY SOC TROP MED H, V96, P383, DOI 10.1016/S0035-9203(02)90369-X; BOWLES J, 1994, PARASITOLOGY, V109, P215, DOI 10.1017/S0031182000076332; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Capuano F, 2006, VET PARASITOL, V137, P262, DOI 10.1016/j.vetpar.2006.01.016; Casulli A, 2008, VET PARASITOLOGY, V155; de la Rue ML, 2011, VET PARASITOL, V177, P97, DOI 10.1016/j.vetpar.2010.11.018; Eckert J, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P100; Elzein FE, 2016, WORLD J NEPHROLOGY U, V5, P16; Espinoza S, 2014, PARASITOL RES, V113, P139, DOI 10.1007/s00436-013-3636-4; Faraji R, ADV MICROBIOLOGY; Farhadi M, 2015, PARASITOL RES, V114, P4363, DOI 10.1007/s00436-015-4673-y; Giri DK, 2016, INTASPOLIVET, V17; Haag KL, 2004, J PARASITOL, V90, P234, DOI 10.1645/GE-173R; Hajialilo E, 2012, J HELMINTHOL, V86, P263, DOI 10.1017/S0022149X11000320; Huttner M, 2008, INT J PARASITOL, V38, P861, DOI 10.1016/j.ijpara.2007.10.013; Ibrahim MM, 2010, ACTA TROP, V113, P26, DOI 10.1016/j.actatropica.2009.08.029; Kamenetzky L, 2002, INFECT GENET EVOL, V2, P129, DOI 10.1016/S1567-1348(02)00131-4; Kedra AH, 1999, ACTA PARASITOL, V44, P248; Khalifa NO., 2014, AM J EPIDEMIOL INF D, V2, P74; Latif AA, 2010, VET PARASITOL, V170, P44, DOI 10.1016/j.vetpar.2010.02.003; Lavikainen A, 2003, PARASITOLOGY, V127, P207, DOI 10.1017/S0031182003003780; M'rad S, 2010, OPEN VET SCI J, V4; Maillard S, 2007, PARASITOL RES, V100, P495, DOI 10.1007/s00436-006-0286-9; McManus DP, 2010, ADV PARASIT, V72, P267, DOI 10.1016/S0065-308X(10)72010-8; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; Nakao M, 2010, INT J PARASITOL, V40, P379, DOI 10.1016/j.ijpara.2009.09.006; Nejad MR, 2012, J HELMINTHOL, V86, P485, DOI 10.1017/S0022149X1100071X; Nikmanesh B, 2014, IRAN J PARASITOL, V9, P20; OKAMOTO M, 1995, PARASITOL RES, V81, P451, DOI 10.1007/BF00931785; Okamoto M, 2010, PARASITOL INT, V59, P70, DOI 10.1016/j.parint.2009.10.007; Pednekar RP, 2009, VET PARASITOL, V165, P58, DOI 10.1016/j.vetpar.2009.06.021; Pezeshki A, 2013, J HELMINTHOL, V87, P387, DOI 10.1017/S0022149X1200051X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scott JC, 1997, PARASITOLOGY, V114, P37, DOI 10.1017/S0031182096008062; Sharbatkhori M, 2011, PARASITOL RES, V108, P521, DOI 10.1007/s00436-010-2092-7; Sharma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082904; Sharma M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002262; Simsek S, 2011, PARASITOL RES, V109, P411, DOI 10.1007/s00436-011-2269-8; Thompson RCA, 2002, TRENDS PARASITOL, V18, P452, DOI 10.1016/S1471-4922(02)02358-9; Toulah Fawzia H., 2012, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V42, P563; Utuk AE, 2008, ACTATROPICA, V107; Vural G, 2008, VET PARASITOL, V154, P347, DOI 10.1016/j.vetpar.2008.03.020; Zhang WB, 2015, ACTA TROP, V141, P235, DOI 10.1016/j.actatropica.2014.03.014	47	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195016	10.1371/journal.pone.0195016	http://dx.doi.org/10.1371/journal.pone.0195016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668701	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200021
J	Teuliere, J; Kovacevic, I; Bao, ZR; Garriga, G				Teuliere, Jerome; Kovacevic, Ismar; Bao, Zhirong; Garriga, Gian			The Caenorhabditis elegans gene ham-1 regulates daughter cell size asymmetry primarily in divisions that produce a small anterior daughter cell	PLOS ONE			English	Article							C-ELEGANS; NEUROBLAST DIVISIONS; APOPTOSIS; LINEAGE; PROTEIN; EXPRESSION; MIGRATION; NEMATODE; POLARITY; FAMILY	C. elegans cell divisions that produce an apoptotic daughter cell exhibit Daughter Cell Size Asymmetry (DCSA), producing a larger surviving daughter cell and a smaller daughter cell fated to die. Genetic screens for mutants with defects in apoptosis identified several genes that are also required for the ability of these divisions to produce daughter cells that differ in size. One of these genes, ham-1, encodes a putative transcription factor that regulates a subset of the asymmetric cell divisions that produce an apoptotic daughter cell. In a survey of C. elegans divisions, we found that ham-1 mutations affect primarily anterior/posterior divisions that produce a small anterior daughter cell. The affected divisions include those that generate an apoptotic cell as well as those that generate two surviving cells. Our findings suggest that HAM-1 primarily promotes DCSA in a certain class of asymmetric divisions.	[Teuliere, Jerome; Garriga, Gian] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Kovacevic, Ismar; Bao, Zhirong] Sloan Kettering Inst, Dev Biol Program, New York, NY USA	University of California System; University of California Berkeley; Memorial Sloan Kettering Cancer Center	Garriga, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	garriga@berkeley.edu		Teuliere, Jerome/0000-0002-0965-4399	National Institute of Health Office of Research Infrastructure Programs [P40 OD010440]; National Institutes of Health [NS32057]; Association pour la Recherche sur le Cancer; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032057] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440, R24OD016474] Funding Source: NIH RePORTER	National Institute of Health Office of Research Infrastructure Programs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institute of Health Office of Research Infrastructure Programs (P40 OD010440). This work was supported by National Institutes of Health grant NS32057 to G.G. J.T. was supported by a fellowship from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by National Institutes of Health grant NS32057 to G.G. J.T. was supported by a fellowship from the Association pour la Recherche sur le Cancer.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; BRENNER S, 1974, GENETICS, V77, P71; Chakraborty S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10126; Chapman JO, 2008, DEV BIOL, V324, P245, DOI 10.1016/j.ydbio.2008.09.014; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Costa G, 2016, NAT CELL BIOL, V18, P1292, DOI 10.1038/ncb3443; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Feng GX, 2013, DEVELOPMENT, V140, P3838, DOI 10.1242/dev.098723; Feng HY, 2013, GENESIS, V51, P163, DOI 10.1002/dvg.22365; Frank CA, 2005, DEV BIOL, V284, P301, DOI 10.1016/j.ydbio.2005.05.026; Gallaud E, 2017, RESULTS PROBL CELL D, V61, P183, DOI 10.1007/978-3-319-53150-2_8; Guenther C, 1996, DEVELOPMENT, V122, P3509; Gurling Mark, 2015, Worm, V4, pe979697, DOI 10.4161/21624054.2014.979697; Gurling M, 2014, DEVELOPMENT, V141, P2724, DOI 10.1242/dev.110486; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Lam AK, 2017, RESULTS PROBL CELL D, V61, P83, DOI 10.1007/978-3-319-53150-2_4; Leung A, 2016, DEV BIOL, V410, P56, DOI 10.1016/j.ydbio.2015.12.011; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Offenburger SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04375-4; Ooi SL, 2006, PLOS GENET, V2, P883, DOI 10.1371/journal.pgen.0020097; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Pacquelet A, 2017, RESULTS PROBL CELL D, V61, P115, DOI 10.1007/978-3-319-53150-2_5; Singhvi A, 2011, CURR BIOL, V21, P948, DOI 10.1016/j.cub.2011.04.025; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Teuliere J, 2017, RESULTS PROBL CELL D, V61, P141, DOI 10.1007/978-3-319-53150-2_6; Teuliere J, 2014, GENETICS, V198, P229, DOI 10.1534/genetics.114.167189; Wei H, 2017, GENETICS, V206, P2069, DOI 10.1534/genetics.117.202754	36	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195855	10.1371/journal.pone.0195855	http://dx.doi.org/10.1371/journal.pone.0195855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668718	gold, Green Submitted, Green Published			2022-12-27	WOS:000430290200062
J	Marlet, J; Gaudy-Graffini, C; Marc, D; Boennec, R; Goudeau, A				Marlet, Julien; Gaudy-Graffini, Catherine; Marc, Daniel; Boennec, Ronan; Goudeau, Alain			Factors associated with influenza vaccination failure and severe disease in a French region in 2015	PLOS ONE			English	Article							SEASONAL INFLUENZA; A(H1N1)PDM09; PROTECTION; VIRUSES; RISK	Current influenza vaccination strategy is based on limited analyses of circulating strains and has some drawbacks, as illustrated during the 2014 +/- 2015 season with the circulation of A (H3N2) viruses belonging to divergent genetic subgroups. We reasoned that these strains, poorly neutralized in vitro, may have been associated with vaccination failure and more severe diseases. We conducted a study on a continuous series of 249 confirmed influenza infections. Incidence was three fold greater than in the previous three years. Most isolates were A(H3N2) viruses (78%) and clustered in subgroups 3C.2a (57%) and 3C.3b (43%). We identified 23 non-synonymous mutations that had already been identified during previous seasons at low frequencies, except mutation Q197H, present in 26% of 3C.3b isolates. We identified lung disorder, tobacco smoking and A(H1N1)pdm09 infection as risk factor of severe influenza disease. In contrast, young age (<5 years), A(H3N2) infection and initial admission to an emergency department were associated with a better outcome of influenza infection.	[Marlet, Julien; Gaudy-Graffini, Catherine; Goudeau, Alain] INSERM, French Natl Inst Hlth & Med Res, U1259, Tours, France; [Marlet, Julien; Gaudy-Graffini, Catherine; Boennec, Ronan; Goudeau, Alain] Univ Tours, Tours, France; [Marc, Daniel] INRA, French Natl Inst Agr Res, Avian Immune Response & Pathogenesis, Nouzilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; INRAE	Marlet, J (corresponding author), INSERM, French Natl Inst Hlth & Med Res, U1259, Tours, France.; Marlet, J (corresponding author), Univ Tours, Tours, France.	jul.marlet@gmail.com	Marlet, Julien/GZG-4349-2022; Marlet, Julien/ABF-1619-2020; Marc, Daniel/M-4296-2015	Marlet, Julien/0000-0002-8645-8703; Marc, Daniel/0000-0003-3604-1958				[Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; Bonmarin I., 2015, Eurosurveillance, V20, P21310; Bonmarin I., 2015, SAISON 2014 2015, P593; CDC, PEOPL HIGH RISK DEV; CDC, SEAS INFL VACC EFF 2; ECDC ERLI-Net, 2014, INFL VIR CHAR SUMM E; ECDC ERLI-Net, 2015, INFL VIR CHAR; ECDC ERLI-Net, 2014, INFL VIR CHAR; Flannery B, 2016, J INFECT DIS, V214, P1010, DOI 10.1093/infdis/jiw181; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Huang JW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S31; INVS, 2015, BIL SAIS GRIPP 2014; INVS UPMC, 2015, B RES SENT 15 04 15; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klein SL, 2014, J INFECT DIS, V209, pS114, DOI 10.1093/infdis/jiu066; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lehners N, 2013, EMERG INFECT DIS, V19, P748, DOI [10.3201/eid1905.120034, 10.3201/eid1905.130034]; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mostafa A, 2016, ARCH VIROL, V161, P1505, DOI 10.1007/s00705-016-2815-x; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Reed C, 2014, CLIN INFECT DIS, V59, P166, DOI 10.1093/cid/ciu285; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Song JY, 2010, VACCINE, V28, P3929, DOI 10.1016/j.vaccine.2010.03.067; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van der Werf S., 2015, B EP HEBD, P599; WHO, 2015, WHO INF MOL DIAGN IN; Wong JY, 2015, AM J EPIDEMIOL, V182, P294, DOI 10.1093/aje/kwv054; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195611	10.1371/journal.pone.0195611	http://dx.doi.org/10.1371/journal.pone.0195611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664931	Green Published, Green Submitted, gold			2022-12-27	WOS:000430262300023
J	Ammar, E; Hall, DG; Hosseinzadeh, S; Heck, M				Ammar, El-Desouky; Hall, David G.; Hosseinzadeh, Saeed; Heck, Michelle			The quest for a non-vector psyllid: Natural variation in acquisition and transmission of the huanglongbing pathogen 'Candidatus Liberibacter asiaticus' by Asian citrus psyllid isofemale lines	PLOS ONE			English	Article							WHITEFLY BEMISIA-TABACI; DIAPHORINA-CITRI; VIRUS TRANSMISSION; HEMIPTERA LIVIIDAE; LUTEOVIRUS TRANSMISSION; RHOPALOSIPHUM-PADI; COUPLING GENETICS; FEEDING-BEHAVIOR; ABDOMINAL COLOR; MYZUS-PERSICAE	Genetic variability in insect vectors is valuable to study vector competence determinants and to select non-vector populations that may help reduce the spread of vector-borne pathogens. We collected and tested vector competency of 15 isofemale lines of Asian citrus psyllid, Diaphorina citri, vector of `Candidatus Liberibacter asiaticus' (CLas). CLas is associated with huanglongbing (citrus greening), the most serious citrus disease worldwide. D. citri adults were collected from orange jasmine (Murraya paniculata) hedges in Florida, and individual pairs (females and males) were caged on healthy Murraya plants for egg laying. The progeny from each pair that tested CLas-negative by qPCR were maintained on Murraya plants and considered an isofemale line. Six acquisition tests on D. citri adults that were reared as nymphs on CLas-infected citrus, from various generations of each line, were conducted to assess their acquisition rates (percentage of qPCR-positive adults). Three lines with mean acquisition rates of 28 to 32%, were classified as 'good' acquirers and three other lines were classified as 'poor' acquirers, with only 5 to 8% acquisition rates. All lines were further tested for their ability to inoculate CLas by confining CLas-exposed psyllids for one week onto healthy citrus leaves (6 +/- 10 adults/leaf/week), and testing the leaves for CLas by qPCR. Mean inoculation rates were 19 to 28% for the three good acquirer lines and 0 to 3% for the three poor acquirer lines. Statistical analyses indicated positive correlations between CLas acquisition and inoculation rates, as well as between CLas titer in the psyllids and CLas acquisition or inoculation rates. Phenotypic and molecular characterization of one of the good and one of the poor acquirer lines revealed differences between them in color morphs and hemocyanin expression, but not the composition of bacterial endosymbionts. Understanding the genetic architecture of CLas transmission will enable the development of new tools for combating this devastating citrus disease.	[Ammar, El-Desouky; Hall, David G.] USDA ARS, US Hort Res Lab, Ft Pierce, FL USA; [Ammar, El-Desouky] Univ Florida, Lake Alfred, FL USA; [Ammar, El-Desouky] Univ Florida, Ft Pierce, FL USA; [Heck, Michelle] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Heck, Michelle] USDA ARS, Emerging Pests & Pathogens Res Unit, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Heck, Michelle] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); Cornell University	Heck, M (corresponding author), Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA.; Heck, M (corresponding author), USDA ARS, Emerging Pests & Pathogens Res Unit, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.; Heck, M (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA.	michelle.cilia@ars.usda.gov	Hosseinzadeh, Saeed/T-6370-2018	Hosseinzadeh, Saeed/0000-0001-7414-8591; Heck, Michelle/0000-0003-0921-4489	California Citrus Research Board grants [5300-163, 5300-155]; USDA National Institute of Food and Agriculture grant [2016-70016-24779]	California Citrus Research Board grants; USDA National Institute of Food and Agriculture grant	The authors received funding from California Citrus Research Board grants 5300-163, 5300-155, and USDA National Institute of Food and Agriculture grant 2016-70016-24779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dossi FCA, 2014, MICROB ECOL, V68, P881, DOI 10.1007/s00248-014-0463-9; Ammar El-D., 1994, PROPAGATIVE TRANSMIS, P289; Ammar ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159594; Ammar E, 2013, J ECON ENTOMOL, V106, P25, DOI 10.1603/EC12245; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Arp AP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00570; Badillo-Vargas IE, 2012, J VIROL, V86, P8793, DOI 10.1128/JVI.00285-12; Barker H, 1999, LUTEOVIRIDAE, Vxviii; Bencharki B, 2000, EUR J PLANT PATHOL, V106, P455, DOI 10.1023/A:1008749231129; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Burrows ME, 2007, HEREDITY, V98, P106, DOI 10.1038/sj.hdy.6800909; Burrows ME, 2006, PHYTOPATHOLOGY, V96, P828, DOI 10.1094/PHYTO-96-0828; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Chu CC, 2016, MICROB ECOL, V71, P999, DOI 10.1007/s00248-016-0733-9; Cilia M, 2011, J VIROL, V85, P2148, DOI 10.1128/JVI.01504-10; Cilia M, 2011, PROTEOMICS, V11, P2440, DOI 10.1002/pmic.201000519; COSTA A. S., 1965, Plant Protection Bulletin, F.A.O., V13, P121; Coy MR, 2015, FLA ENTOMOL, V98, P356, DOI 10.1653/024.098.0157; da Graca JV, 2016, J INTEGR PLANT BIOL, V58, P373, DOI 10.1111/jipb.12437; Dedryver CA, 2005, EUR J PLANT PATHOL, V111, P341, DOI 10.1007/s10658-004-4890-1; Douglas AE, 2011, P ROY SOC B-BIOL SCI, V278, P333, DOI 10.1098/rspb.2010.1563; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; Ghanim M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33418; GLADDERS DW, 1986, ANN APPL BIOL, V109, P499, DOI 10.1111/j.1744-7348.1986.tb03207.x; Gotz M, 2012, J VIROL, V86, P13241, DOI 10.1128/JVI.00880-12; Gooding RH, 1996, CLIN MICROBIOL REV, V9, P301, DOI 10.1128/CMR.9.3.301; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gray S, 2014, ADV VIRUS RES, V89, P141, DOI 10.1016/B978-0-12-800172-1.00004-5; Gray SM, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2501; Guo JQ, 1996, CAN ENTOMOL, V128, P209, DOI 10.4039/Ent128209-2; Haapalainen M, 2014, ANN APPL BIOL, V165, P172, DOI 10.1111/aab.12149; Hall DG, 2018, J APPL ENTOMOL, V142, P97, DOI 10.1111/jen.12466; Hall DG, 2016, J ECON ENTOMOL, V109, P558, DOI 10.1093/jee/tow009; Hall DG, 2015, J ECON ENTOMOL, V108, P1198, DOI 10.1093/jee/tov052; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2010, ANN ENTOMOL SOC AM, V103, P611, DOI 10.1603/AN10004; Hogenhout SA, 2003, TRENDS MICROBIOL, V11, P264, DOI 10.1016/S0966-842X(03)00120-3; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Ipe D., 1987, P 12 ANN SAS US GROU; Jain M, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00171-17; Killiny Nabil, 2018, Virulence, V9, P99, DOI 10.1080/21505594.2017.1339008; Kliot A, 2014, J VIROL, V88, P5652, DOI 10.1128/JVI.00071-14; Kruse A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179531; Liu WW, 2015, MOL CELL PROTEOMICS, V14, P2229, DOI 10.1074/mcp.M114.046763; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucio-Zavaleta E, 2001, PHYTOPATHOLOGY, V91, P792, DOI 10.1094/PHYTO.2001.91.8.792; Mann M, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00889-17, 10.1128/iai.00889-17]; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; Martini X, 2014, ANN ENTOMOL SOC AM, V107, P842, DOI 10.1603/AN14028; Marubayashi Julio Massaharu, 2010, Summa phytopathol., V36, P158, DOI 10.1590/S0100-54052010000200009; Nakabachi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082612; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Ogada PA, 2016, ECOL EVOL, V6, P7911, DOI 10.1002/ece3.2484; Pelz-Stelinski KS, 2016, ANN ENTOMOL SOC AM, V109, P371, DOI 10.1093/aesa/saw007; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Pinheiro PV, 2017, MOL CELL PROTEOMICS, V16, pS230, DOI [10.1074/mcp.M116.063495, 10.1074/mcp.m116.063495]; Pitino M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00982; Raiol LL, 2017, PLANT DIS, V101, P409, DOI 10.1094/PDIS-08-16-1093-RE; Ramsey JS, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160545; Ramsey JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140826; Saha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050067; Storey HH, 1932, P R SOC LOND B-CONTA, V112, P46, DOI 10.1098/rspb.1932.0077; Storey HH, 1925, ANN APPL BIOL, V12, P422, DOI 10.1111/j.1744-7348.1925.tb04238.x; Symmes EJ, 2007, J ECON ENTOMOL, V100, P1764, DOI 10.1603/0022-0493(2007)100[1764:IVIZYM]2.0.CO;2; Tamborindeguy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071620; Thomas GH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-24; Turpin T, USDA NATL I FOOD AGR; Vyas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130328; Walter AJ, 2012, PLANT DIS, V96, P827, DOI 10.1094/PDIS-08-11-0668; Walter AJ, 2012, HORTSCIENCE, V47, P1; Wang N, 2017, ANNU REV PHYTOPATHOL, V55, P451, DOI 10.1146/annurev-phyto-080516-035513; Wang NA, 2017, PHYTOPATHOLOGY, V107, P380, DOI 10.1094/PHYTO-12-16-0426-RVW; Wang YL, 2010, J PROTEOME RES, V9, P1257, DOI 10.1021/pr9007392; Wenninger EJ, 2008, ANN ENTOMOL SOC AM, V101, P585, DOI 10.1603/0013-8746(2008)101[585:DASPIA]2.0.CO;2; Wu TY, 2016, ENTOMOL EXP APPL, V161, P104, DOI 10.1111/eea.12496; Yan Q, 2013, MOL PLANT PATHOL, V14, P391, DOI 10.1111/mpp.12015; Yang XL, 2008, J VIROL, V82, P291, DOI 10.1128/JVI.01736-07	79	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195804	10.1371/journal.pone.0195804	http://dx.doi.org/10.1371/journal.pone.0195804			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652934	Green Submitted, gold, Green Published			2022-12-27	WOS:000430026900037
J	Dontje, ML; Dall, PM; Skelton, DA; Gill, JMR; Chastin, SFM				Dontje, Manon L.; Dall, Philippa M.; Skelton, Dawn A.; Gill, Jason M. R.; Chastin, Sebastien F. M.		Seniors USP Team	Reliability, minimal detectable change and responsiveness to change: Indicators to select the best method to measure sedentary behaviour in older adults in different study designs	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVITY-MONITOR; FEASIBILITY; VALIDITY; POSTURE; TIME	Introduction Prolonged sedentary behaviour (SB) is associated with poor health. It is unclear which SB measure is most appropriate for interventions and population surveillance to measure and interpret change in behaviour in older adults. The aims of this study: to examine the relative and absolute reliability, Minimal Detectable Change (MDC) and responsiveness to change of subjective and objective methods of measuring SB in older adults and give recommendations of use for different study designs. Methods SB of 18 older adults (aged 71 (IQR 7) years) was assessed using a systematic set of six subjective tools, derived from the TAxonomy of Self report Sedentary behaviour Tools (TASST), and one objective tool (activPAL3c), over 14 days. Relative reliability (Intra Class Correlation coefficients-ICC), absolute reliability (SEM), MDC, and the relative responsiveness (Cohen's d effect size (ES) and Guyatt's Responsiveness coefficient (GR)) were calculated for each of the different tools and ranked for different study designs. Results ICC ranged from 0.414 to 0.946, SEM from 36.03 to 137.01 min, MDC from 1.66 to 8.42 hours, ES from 0.017 to 0.259 and GR from 0.024 to 0.485. Objective average day per week measurement ranked as most responsive in a clinical practice setting, whereas a one day measurement ranked highest in quasi-experimental, longitudinal and controlled trial study designs. TV viewing Previous Week Recall (PWR) ranked as most responsive subjective measure in all study designs. Conclusions The reliability, Minimal Detectable Change and responsiveness to change of subjective and objective methods of measuring SB is context dependent. Although TV viewing-PWR is the more reliable and responsive subjective method in most situations, it may have limitations as a reliable measure of total SB. Results of this study can be used to guide choice of tools for detecting change in sedentary behaviour in older adults in the contexts of population surveillance, intervention evaluation and individual care.	[Dontje, Manon L.; Dall, Philippa M.; Skelton, Dawn A.; Chastin, Sebastien F. M.] Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Gill, Jason M. R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Chastin, Sebastien F. M.] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium; [Dontje, Manon L.] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia	Glasgow Caledonian University; University of Glasgow; Ghent University; University of Western Australia	Dall, PM (corresponding author), Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland.	philippa.dall@gcu.ac.uk	Chastin, Sebastien/ABF-1455-2020; Skelton, Dawn A/B-7552-2013	Chastin, Sebastien/0000-0003-1421-9348; Skelton, Dawn A/0000-0001-6223-9840; Dall, Philippa/0000-0002-1958-1517; Dontje, Manon/0000-0002-0348-9556	UK Medical Research Council (MRC) as part of the Lifelong Health and Wellbeing Initiative (LLHW) [MR/K025023/1]; MRC [MR/K025023/1, MR/K00414X/1] Funding Source: UKRI	UK Medical Research Council (MRC) as part of the Lifelong Health and Wellbeing Initiative (LLHW)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Seniors USP (understanding sedentary patterns) project is funded by the UK Medical Research Council (MRC) as part of the Lifelong Health and Wellbeing Initiative (LLHW) [MR/K025023/1].	Aadland E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133296; [Anonymous], 2014, AUSTR PHYS ACT SED B; Beaton DE, 2001, J CLIN EPIDEMIOL, V54, P1204, DOI 10.1016/S0895-4356(01)00407-3; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Dall PM, 2017, TAXONOMY SELF REPORT, V7; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Department of Health, 2011, START ACT STAY ACT R; Donaldson SC, 2016, MED SCI SPORT EXER, V48, P755, DOI 10.1249/MSS.0000000000000828; Fitzsimons CF, 2013, PREV MED, V57, P718, DOI 10.1016/j.ypmed.2013.07.017; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; Gibbs BB, 2017, J AGING HEALTH, V29, P247, DOI 10.1177/0898264316635564; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Grant PM, 2008, J AGING PHYS ACTIV, V16, P201, DOI 10.1123/japa.16.2.201; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Harvill L.M., 1991, EDUC MEAS-ISSUES PRA, V10, P33, DOI [DOI 10.1111/J.1745-3992.1991.TB00195.X, 10.1111/j.1745-3992.1991.tb00195.x]; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; Kelly P, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0351-4; Kolotkin RL, 2001, OBES RES, V9, P564, DOI 10.1038/oby.2001.73; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Martin A, 2015, BRIT J SPORT MED, V49, P1056, DOI 10.1136/bjsports-2014-094524; Norman GR, 2007, QUAL LIFE RES, V16, P815, DOI 10.1007/s11136-007-9180-x; Norman GR, 1997, J CLIN EPIDEMIOL, V50, P869, DOI 10.1016/S0895-4356(97)00097-8; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; O'Connell SE, 2014, ANN HUM BIOL, V41, P1, DOI 10.3109/03014460.2013.827737; Overend T, 2010, PHYSIOTHER CAN, V62, P122, DOI 10.3138/physio.62.2.122; Pedersen ESL, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3890-3; R Development Core Team, 2009, R LANG ENV STAT COMP; Ries JD, 2009, PHYS THER, V89, P569, DOI 10.2522/ptj.20080258; Sellers C, 2016, GAIT POSTURE, V43, P42, DOI 10.1016/j.gaitpost.2015.10.020; STUCKI G, 1995, J CLIN EPIDEMIOL, V48, P1369, DOI 10.1016/0895-4356(95)00054-2; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	33	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195424	10.1371/journal.pone.0195424	http://dx.doi.org/10.1371/journal.pone.0195424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649234	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000429791900043
J	Martinez-Marquez, D; Mirnajafizadeh, A; Carty, CP; Stewart, RA				Martinez-Marquez, Daniel; Mirnajafizadeh, Ali; Carty, Christopher P.; Stewart, Rodney A.			Application of quality by design for 3D printed bone prostheses and scaffolds	PLOS ONE			English	Article							OF-THE-ART; PATIENT-SPECIFIC IMPLANTS; BY-DESIGN; FREEFORM FABRICATION; MECHANICAL-BEHAVIOR; CONTACT FORCES; FAILURE MODE; TISSUE; SURFACE; TITANIUM	3D printing is an emergent manufacturing technology recently being applied in the medical field for the development of custom bone prostheses and scaffolds. However, successful industry transformation to this new design and manufacturing approach requires technology integration, concurrent multi-disciplinary collaboration, and a robust quality management framework. This latter change enabler is the focus of this study. While a number of comprehensive quality frameworks have been developed in recent decades to ensure that the manufacturing of medical devices produces reliable products, they are centred on the traditional context of standardised manufacturing techniques. The advent of 3D printing technologies and the prospects for mass customisation provides significant market opportunities, but also presents a serious challenge to regulatory bodies tasked with managing and assuring product quality and safety. Before 3D printing bone prostheses and scaffolds can gain traction, industry stakeholders, such as regulators, clients, medical practitioners, insurers, lawyers, and manufacturers, would all require a high degree of confidence that customised manufacturing can achieve the same quality outcomes as standardised manufacturing. A Quality by Design (QbD) approach to custom 3D printed prostheses can help to ensure that products are designed and manufactured correctly from the beginning without errors. This paper reports on the adaptation of the QbD approach for the development process of 3D printed custom bone prosthesis and scaffolds. This was achieved through the identification of the Critical Quality Attributes of such products, and an extensive review of different design and fabrication methods for 3D printed bone prostheses. Research outcomes include the development of a comprehensive design and fabrication process flow diagram, and categorised risks associated with the design and fabrication processes of such products. An extensive systematic literature review and post-hoc evaluation survey with experts was completed to evaluate the likely effectiveness of the herein suggested QbD framework.	[Martinez-Marquez, Daniel; Stewart, Rodney A.] Griffith Univ, Sch Engn, Gold Coast, Qld, Australia; [Mirnajafizadeh, Ali] Univ Calif Berkeley, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; [Carty, Christopher P.] Griffith Univ, Menzies Hlth Inst Queensland, Sch Allied Hlth Sci & Innovat Hlth Technol, Gold Coast, Qld, Australia; [Carty, Christopher P.] Griffith Univ, Ctr Musculoskeletal Res, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Carty, Christopher P.] Childrens Hlth Queensland Hosp & Hlth Serv, Queensland Childrens Gait Lab, Queensland Paediat Rehabil Serv, Brisbane, Qld, Australia	Griffith University; University of California System; University of California Berkeley; Griffith University; Menzies Health Institute Queensland; Griffith University; Menzies Health Institute Queensland	Stewart, RA (corresponding author), Griffith Univ, Sch Engn, Gold Coast, Qld, Australia.	r.stewart@griffith.edu.au	Stewart, Rodney A/H-5561-2018	Stewart, Rodney A/0000-0002-6013-3505; Carty, Christopher/0000-0002-8969-5181; Martinez Marquez, Daniel/0000-0001-7326-1015	Griffith University International Postgraduate Award (GUIPA)	Griffith University International Postgraduate Award (GUIPA)	This is a PhD project by a Griffith University International Postgraduate Award (GUIPA). This is a scholarship stipend covering living costs and tuition.	Afshar M, 2016, J MECH BEHAV BIOMED, V62, P481, DOI 10.1016/j.jmbbm.2016.05.027; Ahn D, 2007, INT J MACH TOOL MANU, V47, P593, DOI 10.1016/j.ijmachtools.2006.05.004; Ahn SH, 2002, RAPID PROTOTYPING J, V8, P248, DOI 10.1108/13552540210441166; Almeida HA, 2014, MED ENG PHYS, V36, P1033, DOI 10.1016/j.medengphy.2014.05.006; Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790; Amid A, 2006, INT J PROD ECON, V104, P394, DOI 10.1016/j.ijpe.2005.04.012; Amini AR, 2012, CRITICAL REV BIOMEDI, V40; An J, 2015, ENGINEERING-PRC, V1, P261, DOI 10.15302/J-ENG-2015061; Anderson C, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7408141; [Anonymous], 2009, ICH GUID NONCL SAF S, P4; Arango-Ospina M, 2014, 15 INT C BIOM ENG; Arealis G, 2015, INJURY, V46, pS20, DOI 10.1016/S0020-1383(15)30050-4; Asiedu Y, 1998, INT J PROD RES, V36, P883, DOI 10.1080/002075498193444; Bachynskyi M, 2014, P 32 ANN ACM C HUM F; Badawy SIF, 2016, J PHARM SCI-US, V105, P168, DOI 10.1016/j.xphs.2015.11.023; Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f; Bandyopadhyay A, 2013, CHARACTERIZATION OF BIOMATERIALS, P1; Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001; Bauer S., 2010, EUROP CELLS MAT, V20, P16; Bell C., 2014, MAINTAINING TROUBLES, P327; Bellotti C, 2014, MED C CONTR AUTOMAT, P175, DOI 10.1109/MED.2014.6961367; Bhatia SK, 2014, CHEM ENG PROG, V110, P28; Bi G, 2013, J MATER PROCESS TECH, V213, P463, DOI 10.1016/j.jmatprotec.2012.10.006; Bibb R, 2010, RADIOGRAPHY, V16, P78, DOI 10.1016/j.radi.2009.10.005; Bikas H, 2016, INT J ADV MANUF TECH, V83, P389, DOI 10.1007/s00170-015-7576-2; Binder WJ, 2016, AM J COSMETIC SURG; Blackmon K., 2005, RES BUSINESS MANAGEM; Bogue R, 2013, ASSEMBLY AUTOM, V33, P307, DOI 10.1108/AA-06-2013-055; Bordat C, 2004, ANAL COST OVERRUNS T, P11; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Brown A, 2008, 2008 IEEE INT ENG MA; Butler J, 2011, ASSEMBLY AUTOM, V31, P212, DOI 10.1108/01445151111150541; Chae MP, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00025; Chahine G, 2008, JOM-US, V60, P50, DOI 10.1007/s11837-008-0148-2; Chang PSH, 2003, J CRANIOFAC SURG, V14, P164, DOI 10.1097/00001665-200303000-00006; Chantarapanich N, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/407805; Chavan S.D., 2015, J PHARM QUALITY ASSU, V1; Chen JN, 2013, J MECH BEHAV BIOMED, V20, P387, DOI 10.1016/j.jmbbm.2012.08.019; Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Choi JY, 2002, INT J ORAL MAX SURG, V31, P23, DOI 10.1054/ijom.2000.0135; Chua CK, 2003, INT J ADV MANUF TECH, V21, P291, DOI 10.1007/s001700300034; CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228; Coelho PG, 2015, MED ENG PHYS, V37, P287, DOI 10.1016/j.medengphy.2015.01.004; Cogdill R.P., 2008, J PHARM INNOV, V3, P23, DOI [10.1007/s12247-008-9025-3, DOI 10.1007/s12247-008-9025-3, DOI 10.1007/S12247-008-9025-3]; Colasante C, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0127-4; Colledani M, 2014, CIRP ANN-MANUF TECHN, V63, P773, DOI 10.1016/j.cirp.2014.05.002; Colligan L, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-7; COOPER RG, 1986, J PROD INNOVAT MANAG, V3, P71, DOI 10.1111/1540-5885.320071; Cordonnier T, 2011, ADV ENG MATER, V13, pB135, DOI 10.1002/adem.201080098; Craeghs T., 2011, PROC ANN INT SOLID F, P212; Cun DM, 2011, EUR J PHARM BIOPHARM, V77, P26, DOI 10.1016/j.ejpb.2010.11.008; De Nardo L, 2012, COATINGS FOR BIOMEDICAL APPLICATIONS, P106; Denry I, 2016, DENT MATER, V32, P43, DOI 10.1016/j.dental.2015.09.008; Derand P, 2012, CRANIOMAX TRAUM REC, V5, P137, DOI 10.1055/s-0032-1313357; Devedzic G, 2012, COMPUT APPL ENG EDUC, V20, P434, DOI 10.1002/cae.20411; Dhandayuthapani B, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/290602; Di Prima Matthew, 2016, 3D Print Med, V2, DOI 10.1186/s41205-016-0005-9; Lantada AD, 2012, ANNU REV BIOMED ENG, V14, P73, DOI [10.1146/annurev-bioeng-071811-150112, 10.1146/annurev.bioeng-071811-150112]; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Downey J, 2016, PROC CIRP, V41, P920, DOI 10.1016/j.procir.2015.12.008; Duan B, 2011, MRS BULL, V36, P998, DOI 10.1557/mrs.2011.270; Dubey A, 2012, AAPS PHARMSCITECH, V13, P231, DOI 10.1208/s12249-011-9723-x; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557; Enab TA, 2013, MATER DESIGN, V44, P454, DOI 10.1016/j.matdes.2012.08.017; Erdman AG, 2013, IEEE T BIO-MED ENG, V60, P700, DOI 10.1109/TBME.2013.2244600; Fahmy R, 2012, AAPS PHARMSCITECH, V13, P1243, DOI 10.1208/s12249-012-9844-x; Fan HB, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0723-2; FDA, 2007, GUID IND REV STAFF T; Fernandez J, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0084; Ferraris S, 2016, MAT SCI ENG C-MATER, V61, P965, DOI 10.1016/j.msec.2015.12.062; Forging Industry Association, HEAT TREATM TIT ALL; Frazier WE, 2014, J MATER ENG PERFORM, V23, P1917, DOI 10.1007/s11665-014-0958-z; Gabbrielli R, 2008, KEY ENG MAT; Galloway F, 2012, J BIOMECH, V45, P191, DOI 10.1016/j.jbiomech.2011.09.009; Gardan N., 2014, INT J MANUFACTURING, V2014; Garvin D.A., 1984, SLOAN MANAGEMENT REV, V26; Garvin D. A., 1987, HARVARD BUSINESS REV; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Giannitelli SM, 2014, ACTA BIOMATER, V10, P580, DOI 10.1016/j.actbio.2013.10.024; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Gogolewski S, 2000, INJURY, V31, pS28; Groen WM, 2017, J ORTHOP RES, V35, P2089, DOI 10.1002/jor.23602; Gulati K, 2012, THER DELIV, V3, P857, DOI 10.4155/TDE.12.66; Guo N, 2013, FRONT MECH ENG-PRC, V8, P215, DOI 10.1007/s11465-013-0248-8; Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297; Hansen DC, 2008, ELECTROCHEM SOC INTE, V17, P31; Harrell Margaret, 2009, DATA COLLECTION METH; Hemmert M, 2004, RES POLICY, V33, P1019, DOI 10.1016/j.respol.2004.04.003; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Henkel J, 2013, BONE RES, V1, P216, DOI 10.4248/BR201303002; Heynick M, 2006, LAPA DIG TECHN SEM W; Hieu LC, 2005, ASSEMBLY AUTOM, V25, P284, DOI 10.1108/01445150510626415; Hieu LC, 2003, RAPID PROTOTYPING J, V9, P175, DOI 10.1108/13552540310477481; Hiller JD, 2009, P SOL FREEF FABR S C; Hillson D., 2002, INT J PROJ MANAG, V20, P235, DOI DOI 10.1016/S0263-7863(01)00074-6; Hitzler L, 2018, ADV ENG MATER, V20, DOI 10.1002/adem.201700658; Ho CMB, 2015, INT J PRECIS ENG MAN, V16, P1035, DOI 10.1007/s12541-015-0134-x; Hollister SJ, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/012001; Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977; Hollister SJ, 2000, INT J ORAL MAX SURG, V29, P67, DOI 10.1034/j.1399-0020.2000.290115.x; Hollister SJ, 2005, BONE TISSUE ENGINEERING, P167; Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hubert C, 2014, J PHARMACEUT BIOMED, V88, P401, DOI 10.1016/j.jpba.2013.09.026; Huotilainen E, 2014, J CRANIO MAXILL SURG, V42, pE259, DOI 10.1016/j.jcms.2013.10.001; Imanishi J, 2015, INT J SURG CASE REP, V10, P83, DOI 10.1016/j.ijscr.2015.02.037; Jahed Z, 2014, BIOMATERIALS, V35, P9363, DOI 10.1016/j.biomaterials.2014.07.022; Jardini AL, 2014, VIRTUAL PHYS PROTOTY, V9, P115, DOI 10.1080/17452759.2014.900857; Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x; Kang Y-H, 2014, J NANOMATER, V2014, P1; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Karatas Orhan Hakki, 2014, Eur J Dent, V8, P132, DOI 10.4103/1305-7456.126269; Kircher R, 2009, ELECT BEAM MELTED EB, P436; Kirk D, 2015, EVALUATION HUMAN WOR; Konrath JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176016; Kroonenburgh I, 2012, DIGITAL DENT NEWS, V6, P60; Krucoff MW, 2012, JACC-CARDIOVASC INTE, V5, P790, DOI 10.1016/j.jcin.2012.03.023; Kruth JP, 2011, CIRP ANN-MANUF TECHN, V60, P821, DOI 10.1016/j.cirp.2011.05.006; Kulkarni M., 2014, NANOMEDICINE, V111, P111, DOI DOI 10.1016/J.CARBON.2011.02.021; Kummer KM, 2013, J BIOMED MATER RES B, V101B, P677, DOI 10.1002/jbm.b.32870; Kuznetsova D, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa6725; Lambert WJ, 2010, AAPS PHARMSCITECH, V11, P1476, DOI 10.1208/s12249-010-9521-x; Lamecker H, 2007, P COMP AID SURG HEAD, P94; Larson E.W., 2011, PROJECT MANAGEMENT M, P211; Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI [10.2217/nnm.10.54, 10.2217/NNM.10.54]; Le C, 2011, ROMANIAN REV PRECISI, V40, P11; Lee MH, 2010, TISSUE ENG PART B-RE, V16, P41, DOI [10.1089/ten.teb.2009.0449, 10.1089/ten.TEB.2009.0449]; Lee MY, 2002, IEEE ENG MED BIOL, V21, P38, DOI 10.1109/MEMB.2002.1000184; Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9; Leutenecker-Twelsiek B, 2016, PROC CIRP, V50, P408, DOI 10.1016/j.procir.2016.05.016; Li J, 2012, AUSTRALASIAN J CONST, V8, P34, DOI [10.5130/ajceb.v8i1.2996, DOI 10.5130/AJCEB.V8I1.2996]; Li L, 2002, ROBOT CIM-INT MANUF, V18, P53, DOI 10.1016/S0736-5845(01)00026-6; Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033; Little TA, 2014, BIOPROCESS INT, V12, P3; Liu H., 2014, NUMERICAL ANAL THERM; Liu HC, 2013, EXPERT SYST APPL, V40, P828, DOI 10.1016/j.eswa.2012.08.010; Liu XS, 2013, REV ADV MATER SCI, V33, P266; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001; Ma Z, 2010, COMPUT METHOD BIOMEC, V13, P235, DOI 10.1080/10255840903131878; Maji PK, 2014, RAPID PROTOTYPING J, V20, P480, DOI 10.1108/RPJ-07-2012-0066; Majstorovic V, 2013, CIRP ANN-MANUF TECHN, V62, P167, DOI 10.1016/j.cirp.2013.03.081; Mallepree T, 2009, RAPID PROTOTYPING J, V15, P325, DOI 10.1108/13552540910993842; Marro A, 2015, CURRENT PROBLEMS DIA; Mauch PD, 2009, QUALITY MANAGEMENT T; Mazumder S, 2017, INT J PHARM; Mazzoli A, 2013, MED BIOL ENG COMPUT, V51, P245, DOI 10.1007/s11517-012-1001-x; McConnell J., 2010, J VAL TECHNOL, V16, P30; McCutcheon D. M., 1993, Journal of Operations Management, V11, P239, DOI 10.1016/0272-6963(93)90002-7; McGurk M, 1997, ANN ROY COLL SURG, V79, P169; Pinto JM, 2015, MED ENG PHYS, V37, P328, DOI 10.1016/j.medengphy.2015.01.009; Miles MB., 2018, QUALITATIVE DATA ANA, DOI DOI 10.1016/0149-7189(96)88232-2; Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260; Mitsouras D, 2015, RADIOGRAPHICS, V35, P1966, DOI 10.1148/rg.2015140320; Monzon MD, 2015, INT J ADV MANUF TECH, V76, P1111, DOI 10.1007/s00170-014-6334-1; Morrison RJ, 2015, CTS-CLIN TRANSL SCI, V8, P594, DOI 10.1111/cts.12315; Moursi AM, 1997, J CELL SCI, V110, P2187; Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004; Naidu NVR, 2006, TOTAL QUALITY MANAGE; Neacsu P, 2014, INT J BIOCHEM CELL B, V55, P187, DOI 10.1016/j.biocel.2014.09.006; Negi S, 2014, RAPID PROTOTYPING J, V20, P256, DOI 10.1108/RPJ-07-2012-0065; Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722; Omar M, 2017, INT J MED ROBOT COMP, V13, DOI 10.1002/rcs.1803; Orlandini S, 2013, ANAL BIOANAL CHEM, V405, P443, DOI 10.1007/s00216-012-6302-2; Oropallo W, 2016, ENG COMPUT-GERMANY, V32, P135, DOI 10.1007/s00366-015-0407-0; Oyegoke A, 2011, INT J MANAG PROJ BUS, V4, P573, DOI 10.1108/17538371111164029; Padala S, 2012, J COMPUTER TECHNOLOG, V3, P17; Pankaj P, 2013, INT J NUMER METH BIO, V29, P233, DOI 10.1002/cnm.2536; Park JH, 2012, ACTA BIOMATER, V8, P1966, DOI 10.1016/j.actbio.2011.11.026; Pasko A, 2011, GRAPH MODELS, V73, P165, DOI 10.1016/j.gmod.2011.03.001; Pham DT, 1998, INT J MACH TOOL MANU, V38, P1257, DOI 10.1016/S0890-6955(97)00137-5; Pizzolato C, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00096; Podshivalov L, 2013, PROC CIRP, V5, P247, DOI 10.1016/j.procir.2013.01.049; Poelert S, 2013, P I MECH ENG H, V227, P464, DOI 10.1177/0954411912467884; Popov I., 2009, Journal of Medical Engineering & Technology, V33, P454, DOI 10.1080/03091900902952634; Prince J. Dale, 2014, Journal of Electronic Resources in Medical Libraries, V11, P39, DOI 10.1080/15424065.2014.877247; Qian B, 2013, J ASIAN CERAM SOC, V1, P315, DOI 10.1016/j.jascer.2013.08.004; Rahmati S, 2011, INT J ADV DESIGN MAN, V3, P11; Raina H, 2017, J DRUG DELIV SCI TEC, V39, P180, DOI 10.1016/j.jddst.2017.02.013; Ramin E, 2009, P I MECH ENG H, V223, P289, DOI 10.1243/09544119JEIM452; Ramsden JJ, 2007, CIRP ANN-MANUF TECHN, V56, P687, DOI 10.1016/j.cirp.2007.10.001; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Robbins J, 2016, ADDITIVE MANUFACTURI; Robiony M, 2007, J ORAL MAXIL SURG, V65, P1198, DOI 10.1016/j.joms.2005.12.080; Rose K. H., 2013, GUID PROJ MAN BOD KN; Russell RK, 2008, EMJ-ENG MANAG J, V20, P36, DOI 10.1080/10429247.2008.11431775; Saijo H, 2009, J ARTIF ORGANS, V12, P200, DOI 10.1007/s10047-009-0462-7; Saini M, 2015, WORLD J CLIN CASES, V3, P52, DOI 10.12998/wjcc.v3.i1.52; Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026; Salmi M, 2012, RAPID PROTOTYPING J, V18, P209, DOI 10.1108/13552541211218126; Sangshetti JN, 2014, ARABIAN J CHEM; Saxby DJ, 2016, GAIT POSTURE, V49, P78, DOI 10.1016/j.gaitpost.2016.06.014; Schmidt AH, 2013, J PHARMACEUT BIOMED, V78-79, P65, DOI 10.1016/j.jpba.2013.01.032; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; Sebastianelli R., 2002, INT J QUAL RELIAB MA, V19, P442, DOI [10.1108/02656710210421599, DOI 10.1108/02656710210421599]; Sharkey PF, 1999, J ARTHROPLASTY, V14, P281, DOI 10.1016/S0883-5403(99)90052-9; Sharples S, 2012, DISPLAYS, V33, P221, DOI 10.1016/j.displa.2011.12.001; SHAW B, 1985, R&D MANAGE, V15, P283, DOI 10.1111/j.1467-9310.1985.tb00039.x; Shirazi SFS, 2016, SCI TECHNOLOGY ADV M; Shrivats AR, 2014, DRUG DISCOV TODAY, V19, P781, DOI 10.1016/j.drudis.2014.04.010; Siitonen, 1993, J MANAGEMENT ACCOUNT, V5, P243; Silva DN, 2008, J CRANIO MAXILL SURG, V36, P443, DOI 10.1016/j.jcms.2008.04.003; Simonelli M, 2014, MAT SCI ENG A-STRUCT, V616, P1, DOI 10.1016/j.msea.2014.07.086; Singare S, 2004, MED ENG PHYS, V26, P671, DOI 10.1016/j.medengphy.2004.06.001; Singare S, 2009, RAPID PROTOTYPING J, V15, P19, DOI 10.1108/13552540910925027; Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x; Slotwinski JA, 2014, J RES NATL INST STAN, V119, P460, DOI 10.6028/jres.119.018; Stamatis D.H., 2003, FAILURE MODE EFFECT; Starly B, 2006, COMPUT AIDED DESIGN, V38, P115, DOI 10.1016/J.CAD.2005.08.001; Starly B, 2004, P 9 ACM S SOL MOD AP; Stemler S., 2001, PRACT ASSESS RES EVA, V7, P137, DOI DOI 10.7275/Z6FM-2E34; Stoor P, 2014, J CRANIO MAXILL SURG, V42, P1644, DOI 10.1016/j.jcms.2014.05.006; Straub J, 2015, MACHINES, V3, P55, DOI 10.3390/machines3020055; Sun P, 2016, POWDER TECHNOL, V301, P331, DOI 10.1016/j.powtec.2016.06.022; Sun T, 2007, J MATER SCI-MATER M, V18, P321, DOI 10.1007/s10856-006-0696-3; Sun W, 2005, COMPUT AIDED DESIGN, V37, P1097, DOI 10.1016/j.cad.2005.02.002; Suska F, 2016, J ORAL MAXILLOFACIAL; Tang HP, 2015, JOM-US, V67, P555, DOI 10.1007/s11837-015-1300-4; Tang Y, 2004, ACCURACY ANAL IMPROV; Tapia G, 2014, J MANUF SCI E-T ASME, V136, DOI 10.1115/1.4028540; Tetsworth K, 2017, SICOT-J, V3, DOI 10.1051/sicotj/2016043; Thambyah A, 2005, KNEE, V12, P383, DOI 10.1016/j.knee.2004.12.005; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tontowi AE, 2001, RAPID PROTOTYPING J, V7, P180, DOI 10.1108/13552540110395637; Toth T, 2015, QUAL INNOV PROSPER, V19, P9, DOI 10.12776/QIP.V19I1.393; Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677; Tuomi J, 2014, SURG INNOV, V21, P553, DOI 10.1177/1553350614524838; U. S. Department of Health and Human Services, 2013, ISO10993 US DEP HLTH; U. S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation Research Center for Drug Evaluation Research, 2006, GUID IND Q9 QUAL RIS; U.S. Food and Drug Administration, 2011, MED DEV INN IN WHIT; Vasconcelos DM, 2016, BIOMATERIALS, V84, P262, DOI 10.1016/j.biomaterials.2016.01.046; Verma S, 2009, INT J PHARMACEUT, V377, P185, DOI 10.1016/j.ijpharm.2009.05.006; Vogt FG, 2011, J PHARM SCI-US, V100, P797, DOI 10.1002/jps.22325; Von Woedtke T, 2008, GMS KRANKENHHYG INTE, V3, P3; Nguyen VH, 2017, COMPUT METHOD BIOMEC, V20, P1312, DOI 10.1080/10255842.2017.1357703; Walker J., 2014, ADDITIVE MANUFACTURI; Wang CS, 2010, COMPUT IND, V61, P187, DOI 10.1016/j.compind.2009.09.005; Wang XJ, 2016, BIOMATERIALS, V83, P127, DOI 10.1016/j.biomaterials.2016.01.012; Wegner A, 2011, SFF S AUST TEX US; Wettergreen MA, 2005, COMPUT AIDED DESIGN, V37, P1141, DOI 10.1016/j.cad.2005.02.005; Winder J, 2005, J ORAL MAXIL SURG, V63, P1006, DOI 10.1016/j.joms.2005.03.016; Wu SL, 2013, SURF COAT TECH, V233, P13, DOI 10.1016/j.surfcoat.2012.10.023; Xue C, 2012, INT J ADV COMPUTING, V4; Yan CZ, 2015, J MECH BEHAV BIOMED, V51, P61, DOI 10.1016/j.jmbbm.2015.06.024; Yavari SA, 2016, ACS APPL MATER INTER, V8, P17080, DOI 10.1021/acsami.6b03152; Yeong WY, 2014, HIGH VALUE MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID PROTOTYPING, P115, DOI 10.1201/b15961-23; Yin Robert., 2002, CASE STUDY RES DESIG; Yoo DJ, 2011, BIOMATERIALS, V32, P7741, DOI 10.1016/j.biomaterials.2011.07.019; Yoo DJ, 2012, INT J PRECIS ENG MAN, V13, P527, DOI 10.1007/s12541-012-0068-5; Yoo DJ, 2011, INT J PRECIS ENG MAN, V12, P61, DOI 10.1007/s12541-011-0008-9; Yoo D, 2013, MAT SCI ENG C-MATER, V33, P1759, DOI 10.1016/j.msec.2012.12.092; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Zachow S, 2007, 3D RECONSTRUCTION IN; Zadpoor AA, 2016, J BIOMED MATER RES A, V104, P3164, DOI 10.1002/jbm.a.35855; Zarringhalam H, 2006, MAT SCI ENG A-STRUCT, V435, P172, DOI 10.1016/j.msea.2006.07.084; Zhang J, 2014, MAP CLIENT USER FRIE; Zhang LC, 2011, SCRIPTA MATER, V65, P21, DOI 10.1016/j.scriptamat.2011.03.024; Zhang L, 2013, AAPS PHARMSCITECH, V14, P277, DOI 10.1208/s12249-012-9919-8; Zhao FH, 2015, BIOMECH MODEL MECHAN, V14, P231, DOI 10.1007/s10237-014-0599-z	263	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195291	10.1371/journal.pone.0195291	http://dx.doi.org/10.1371/journal.pone.0195291			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649231	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900037
J	Zhao, HQ; Wang, ZH; Gao, XC; Liu, CH; Qi, HB				Zhao, Hai-qian; Wang, Zhong-hua; Gao, Xing-cun; Liu, Cheng-hao; Qi, Han-bing			Optimization of NO oxidation by H2O2 thermal decomposition at moderate temperatures	PLOS ONE			English	Article							GAS-PHASE OXIDATION; HYDROGEN-PEROXIDE; NITROGEN-OXIDES; NITRIC-OXIDE; KINETIC DATA; COMBUSTION; ABSORPTION; EMISSIONS; REMOVAL; ACID	H2O2 was adopted to oxidize NO in simulated flue gas at 100-500 degrees C. The effects of the H2O2 evaporation conditions, gas temperature, initial NO concentration, H2O2 concentration, and H2O2:NO molar ratio on the oxidation efficiency of NO were investigated. The reason for the narrow NO oxidation temperature range near 500 degrees C was determined. The NO oxidation products were analyzed. The removal of NOx using NaOH solution at a moderate oxidation ratio was studied. It was proven that rapid evaporation of the H2O2 solution was critical to increase the NO oxidation efficiency and broaden the oxidation temperature range. the NO oxidation efficiency was above 50% at 300-500 degrees C by contacting the outlet of the syringe needle and the stainless -steel gas pipe together to spread H2O2 solution into a thin film on the surface of the stainless-steel gas pipe, which greatly accelerated the evaporation of H2O2. The NO oxidation efficiency and the NO oxidation rate increased with increasing initial NO concentration. This method was more effective for the oxidation of NO at high concentrations. H2O2 solution with a concentration higher than 15% was more efficient in oxidizing NO. High temperatures decreased the influence of the H2O2 concentration on the NO oxidation efficiency. The oxidation efficiency of NO increased with an increase in the H2O2:NO molar ratio, but the ratio of H2O2 to oxidized NO decreased. Over 80% of the NO oxidation product was NO2, which indicated that the oxidation ratio of NO did not need to be very high. An 86.7% NO removal efficiency was obtained at an oxidation ratio of only 53.8% when combined with alkali absorption.	[Zhao, Hai-qian; Wang, Zhong-hua; Gao, Xing-cun; Liu, Cheng-hao; Qi, Han-bing] Northeast Petr Univ, Dept Civil Engn & Architecture, Daqing, Peoples R China	Northeast Petroleum University	Zhao, HQ (corresponding author), Northeast Petr Univ, Dept Civil Engn & Architecture, Daqing, Peoples R China.	dqzhaohaiqian@163.com		Zhao, Hai qian/0000-0002-5629-3100	National Natural Science Foundation of China [51606036]; Natural Science Foundation of Heilongjiang Province [QC2014C047]; Heilongjiang Provincial Department of Education Project [12541093]; National Natural Science Foundation of China; Science and Technology Department of Heilongjiang Province; Education Department of Heilongjiang Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Heilongjiang Provincial Department of Education Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Heilongjiang Province; Education Department of Heilongjiang Province	This work is supported by National Natural Science Foundation of China (no. 51606036, to HZ), Natural Science Foundation of Heilongjiang Province (no. QC2014C047, to HZ) and Heilongjiang Provincial Department of Education Project (no. 12541093, to HZ). Publishing fee and material fee (including chemical reagents and personal protective equipment) are supported by (no. 51606036). Experimental system renovation fee is supported by Natural Science Foundation of Heilongjiang Province (no. QC2014C047) and Heilongjiang Provincial Department of Education Project (no. 12541093). National Natural Science Foundation of China is sponsored by National Natural Science Foundation of China, http//www.nsfc.gov.cn/. Natural Science Foundation of Heilongjiang Province is sponsored by Science and Technology Department of Heilongjiang Province, http/www.hlikjt.gov.cn/. Heilongjiang Provincial Department of Education Project is sponsored by Education Department of Heilongjiang Province, https//www.hljedu.gov.cn/.	Ali-Zade NI, 2006, KINET CATAL+, V47, P64, DOI 10.1134/S0023158406010101; [Anonymous], GB132232011; Atkinson R, 2004, ATMOS CHEM PHYS, V4, P1461, DOI 10.5194/acp-4-1461-2004; BAULCH DL, 1992, J PHYS CHEM REF DATA, V21, P411, DOI 10.1063/1.555908; Bokare AD, 2014, J HAZARD MATER, V275, P121, DOI 10.1016/j.jhazmat.2014.04.054; Chakraborty D, 1998, CHEM PHYS, V231, P39, DOI 10.1016/S0301-0104(98)00033-0; Collins MM, 2001, J ENVIRON ENG-ASCE, V127, P329, DOI 10.1061/(ASCE)0733-9372(2001)127:4(329); CONWAY DC, 1957, J PHYS CHEM-US, V61, P1579, DOI 10.1021/j150557a034; Ding J, 2014, CHEM ENG J, V243, P176, DOI 10.1016/j.cej.2013.12.101; Glemser O., 1963, HDB PREPARATIVE INOR, P658; Haywood JM, 1998, J AIR WASTE MANAGE, V48, P238, DOI 10.1080/10473289.1998.10463679; Kasper JM, 1996, J AIR WASTE MANAGE, V46, P127, DOI 10.1080/10473289.1996.10467444; Lange N.A., 1944, HDB CHEM, V14th; Limvoranusorn P, 2005, J ENVIRON ENG, V131, P518, DOI 10.1061/(ASCE)0733-9372(2005)131:4(518); LIN CC, 1991, INT J CHEM KINET, V23, P971, DOI 10.1002/kin.550231103; Mok JS, 2005, J PROPUL POWER, V21, P942, DOI 10.2514/1.13284; National Bureau of Statistics of China, 2016, DISCH MAJ POLL WAST, V11, P22; Pradhan MP, 1997, CHEM ENG SCI, V52, P4569, DOI 10.1016/S0009-2509(97)00300-X; Pradhan MP, 1999, AICHE J, V45, P38, DOI 10.1002/aic.690450105; Thomas D, 2000, CHEM ENG TECHNOL, V23, P449, DOI 10.1002/(SICI)1521-4125(200005)23:5<449::AID-CEAT449>3.0.CO;2-L; TSANG W, 1991, J PHYS CHEM REF DATA, V20, P609, DOI 10.1063/1.555890; Vorontsov A, 2007, CATAL COMMUN, V8, P2100, DOI 10.1016/j.catcom.2007.04.027; Zamansky VM, 1996, TWENTY-SIXTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P2125; Zhang XH, 2010, ASIA-PAC J CHEM ENG, V5, P473, DOI 10.1002/apj.335; Zhu RS, 2003, J CHEM PHYS, V119, P10667, DOI 10.1063/1.1619373	25	8	10	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0192324	10.1371/journal.pone.0192324	http://dx.doi.org/10.1371/journal.pone.0192324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668672	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200001
J	Taylor, DL; Knowles, DA; Scott, LJ; Ramirez, AH; Casale, FP; Wolford, BN; Guan, L; Varshney, A; Albanus, RD; Parker, SCJ; Narisu, N; Chines, PS; Erdos, MR; Welch, RP; Kinnunen, L; Saramies, J; Sundvall, J; Lakka, TA; Laakso, M; Tuomilehto, J; Koistinen, HA; Stegle, O; Boehnke, M; Birney, E; Collins, FS				Taylor, D. Leland; Knowles, David A.; Scott, Laura J.; Ramirez, Andrea H.; Casale, Francesco Paolo; Wolford, Brooke N.; Guan, Li; Varshney, Arushi; Albanus, Ricardo D'Oliveira; Parker, Stephen C. J.; Narisu, Narisu; Chines, Peter S.; Erdos, Michael R.; Welch, Ryan P.; Kinnunen, Leena; Saramies, Jouko; Sundvall, Jouko; Lakka, Timo A.; Laakso, Markku; Tuomilehto, Jaakko; Koistinen, Heikki A.; Stegle, Oliver; Boehnke, Michael; Birney, Ewan; Collins, Francis S.			Interactions between genetic variation and cellular environment in skeletal muscle gene expression	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; TRANSCRIPTION FACTORS; HUMAN GENOME; CHROMATIN; DISCOVERY; GENOTYPE; PLASTICITY; FORMINS; FHOD3; PHOSPHORYLATION	From whole organisms to individual cells, responses to environmental conditions are influenced by genetic makeup, where the effect of genetic variation on a trait depends on the environmental context. RNA-sequencing quantifies gene expression as a molecular trait, and is capable of capturing both genetic and environmental effects. In this study, we explore opportunities of using allele-specific expression (ASE) to discover cis-acting genotype-environment interactions (GxE)-genetic effects on gene expression that depend on an environmental condition. Treating 17 common, clinical traits as approximations of the cellular environment of 267 skeletal muscle biopsies, we identify 10 candidate environmental response expression quantitative trait loci (reQTLs) across 6 traits (12 unique gene-environment trait pairs; 10% FDR per trait) including sex, systolic blood pressure, and low-density lipoprotein cholesterol. Although using ASE is in principle a promising approach to detect GxE effects, replication of such signals can be challenging as validation requires harmonization of environmental traits across cohorts and a sufficient sampling of heterozygotes for a transcribed SNP. Comprehensive discovery and replication will require large human transcriptome datasets, or the integration of multiple transcribed SNPs, coupled with standardized clinical phenotyping.	[Taylor, D. Leland; Narisu, Narisu; Chines, Peter S.; Erdos, Michael R.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Taylor, D. Leland; Casale, Francesco Paolo; Stegle, Oliver; Birney, Ewan] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Hinxton, Cambs, England; [Knowles, David A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Scott, Laura J.; Welch, Ryan P.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Scott, Laura J.; Welch, Ryan P.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Ramirez, Andrea H.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Wolford, Brooke N.; Guan, Li; Albanus, Ricardo D'Oliveira; Parker, Stephen C. J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Varshney, Arushi; Parker, Stephen C. J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Kinnunen, Leena; Sundvall, Jouko; Tuomilehto, Jaakko; Koistinen, Heikki A.] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Helsinki, Finland; [Saramies, Jouko] South Karelia Social & Hlth Care Dist, Lappeenranta, Finland; [Lakka, Timo A.] Univ Eastern Finland, Inst Biomed Physiol, Kuopio, Finland; [Lakka, Timo A.] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Lakka, Timo A.] Univ Eastern Finland, Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, Kuopio, Finland; [Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Dept Neurosci & Prevent Med, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah, Saudi Arabia; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman, Kuwait; [Koistinen, Heikki A.] Univ Helsinki, Dept Med, Haartmaninkatu 4, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Abdominal Ctr Endocrinol, Haartmaninkatu 4, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Haartmaninkatu 4, Helsinki, Finland; [Koistinen, Heikki A.] Minerva Fdn, Biomed 2U, Tukholmankatu 8, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); European Molecular Biology Laboratory (EMBL); Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Finland National Institute for Health & Welfare; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Danube University Krems; King Abdulaziz University; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Collins, FS (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.; Birney, E (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Hinxton, Cambs, England.	birney@ebi.ac.uk; Francis.Collins3@nih.gov	Albanus, Ricardo D'Oliveira/AAQ-2431-2021; Parker, Stephen/ABF-1063-2021; Narisu, Narisu/T-6908-2019; Stegle, Oliver/AAU-9177-2020; Wolford, Brooke/GQZ-2025-2022; Kinnunen, Leena/B-7059-2012; Wolford, Brooke/Y-3162-2019; Taylor, Leland/Q-5705-2019; Koistinen, Heikki/J-7313-2016	Stegle, Oliver/0000-0002-8818-7193; Kinnunen, Leena/0000-0001-8739-4812; Wolford, Brooke/0000-0003-3153-1552; Taylor, Leland/0000-0001-6498-6970; Koistinen, Heikki/0000-0001-7870-070X; Varshney, Arushi/0000-0001-9177-9707; Birney, Ewan/0000-0001-8314-8497; D'Oliveira Albanus, Ricardo/0000-0003-3651-0136	US National Institutes of Health [1-ZIA-HG000024, U01DK062370, R00DK099240]; American Diabetes Association Pathway to Stop Diabetes Grant [1-14-INI-07]; Academy of Finland [271961, 272741, 258753]; European Molecular Biology Laboratory; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024, T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, U01DK062370] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Pathway to Stop Diabetes Grant; Academy of Finland(Academy of Finland); European Molecular Biology Laboratory; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by US National Institutes of Health grants 1-ZIA-HG000024 (to F.S.C.), U01DK062370 (to M.B.), R00DK099240 (to S.C.J.P.), the American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-07 (to S.C.J.P.), Academy of Finland Grants 271961, 272741 (to M.L.), 258753 (to H.A.K.), and the European Molecular Biology Laboratory (O.S. and E.B.).	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Allum F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8211; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gagneur J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003803; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grundberg E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001279; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Idaghdour Y, 2012, P NATL ACAD SCI USA, V109, P16786, DOI 10.1073/pnas.1204945109; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Keen JC, 2015, J PERS MED, V5, P22, DOI 10.3390/jpm5010022; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Knowles DA, 2017, NAT METHODS, V14, P699, DOI 10.1038/nmeth.4298; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Lippert C., 2014, LIMIX GENETIC NALYSI, DOI [10.1101/003905v2, DOI 10.1101/003905V2]; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mangravite LM, 2013, NATURE, V502, P377, DOI 10.1038/nature12508; Maranville JC, 2012, TRANSCR-AUSTIN, V3, P56, DOI 10.4161/trns.19497; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Moyerbrailean GA, 2016, GENOME RES, V26, P1627, DOI 10.1101/gr.209759.116; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Rosado M, 2014, MOL BIOL CELL, V25, P811, DOI 10.1091/mbc.E13-08-0443; Runcie DE, 2012, MOL ECOL, V21, P4547, DOI 10.1111/j.1365-294X.2012.05717.x; Sambandan D, 2008, GENETICS, V179, P1079, DOI 10.1534/genetics.108.086769; Scott LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11764; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Varshney A, 2017, P NATL ACAD SCI USA, V114, P2301, DOI 10.1073/pnas.1621192114; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737	64	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195788	10.1371/journal.pone.0195788	http://dx.doi.org/10.1371/journal.pone.0195788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659628	gold, Green Published, Green Submitted			2022-12-27	WOS:000430061100032
J	Hu, Y; Hao, XR; Chen, LF; Akhberdi, O; Yu, X; Liu, YJ; Zhu, XD				Hu, Yang; Hao, Xiaoran; Chen, Longfei; Akhberdi, Oren; Yu, Xi; Liu, Yanjie; Zhu, Xudong			G alpha-cAMP/PKA pathway positively regulates pigmentation, chaetoglobosin A biosynthesis and sexual development in Chaetomium globosum	PLOS ONE			English	Article							G-PROTEIN; SECONDARY METABOLITES; PESTALOTIOPSIS-MICROSPORA; PENICILLIUM-CHRYSOGENUM; SIGNALING PATHWAY; GENE; FUNGUS; CONIDIATION; SUBUNITS; GROWTH	Sensing the environmental signals, the canonical G alpha-cAMP/PKA pathway modulates mycelial growth and development, and negatively regulates some secondary metabolism in filamentous fungi, e.g. aflatoxin in Aspergillus nidulans. Here we report the characterization of this signaling pathway in Chaetomium globosum, a widely spread fungus known for synthesizing abundant secondary metabolites, e.g. chaetoglobosin A (ChA). RNAi-mediated knockdown of a putative Ga-encoding gene gna-1, led to plural changes in phenotype, e.g. albino mycelium, significant restriction on perithecium development and decreased production of ChA. RNA-seq profiling and qRT-PCR verified significantly fall in expression of corresponding genes, e.g. pks-1 and CgcheA. These defects could be restored by simultaneous knock-down of the pkaR gene encoding a regulatory subunit of cAMP-dependent protein kinase A (PKA), suggesting that pkaR had a negative effect on the above mentioned traits. Confirmatively, the intracellular level of cAMP in wild-type strain was about 3.4-fold to that in gna-1 silenced mutant pG14, and addition of a cAMP analog, 8-Br-cAMP, restored the same defects, e.g., the expression of CgcheA. Furthermore, the intracellular cAMP in gna-1 and pkaR double silenced mutant was approaching the normal level. The following activity inhibition experiment proved that the expression of CgcheA was indeed regulated by PKA. Down-regulation of LaeA/VeA/SptJ expression in gna-1 mutant was also observed, implying that Ga signaling may crosstalk to other regulatory pathways. Taken together, this study proposes that the heterotrimeric G alpha protein-cAMP/PKA signaling pathway positively mediates the sexual development, melanin biosynthesis, and secondary metabolism in C. globosum.	[Hu, Yang] Tianjin Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Tianjin, Peoples R China; [Hao, Xiaoran] Beijing Normal Univ, Sch Life Sci, Natl Expt Teaching Demonstrating Ctr, Beijing, Peoples R China; [Chen, Longfei; Akhberdi, Oren; Yu, Xi] Nankai Univ, Dept Microbiol, Coll Life Sci, Tianjin, Peoples R China; [Liu, Yanjie; Zhu, Xudong] Beijing Normal Univ, Inst Biochem & Biotechnol, Sch Life Sci, Beijing Key Lab Genet Engn Drug & Biotechnol, Beijing, Peoples R China; [Chen, Longfei] Zhejiang Med Co LTD, Xinchang Pharmaceut Factory, Dept Biopharmaceut, Shaoxing, Peoples R China; [Yu, Xi] Karlsruhe Inst Technol, Inst Appl Biosci, Dept Microbiol, Karlsruhe, Germany	Tianjin Medical University; Beijing Normal University; Nankai University; Beijing Normal University; Helmholtz Association; Karlsruhe Institute of Technology	Hao, XR (corresponding author), Beijing Normal Univ, Sch Life Sci, Natl Expt Teaching Demonstrating Ctr, Beijing, Peoples R China.; Zhu, XD (corresponding author), Beijing Normal Univ, Inst Biochem & Biotechnol, Sch Life Sci, Beijing Key Lab Genet Engn Drug & Biotechnol, Beijing, Peoples R China.	2015xrhao@bnu.edu.cn; zhu11187@briu.edu.en			National Natural Science Foundation of China (NSFC) [31470251]; National Basic Research Program of China ("973" Program) [2007CB707801]; Fundamental Research Funds for the Central Universities [2015NT10]; Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education [201502]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China ("973" Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education	This work is supported by a National Natural Science Foundation of China (NSFC grant #31470251 to XZ), a National Basic Research Program of China ("973" Program #2007CB707801 to XZ), a grant from the Fundamental Research Funds for the Central Universities (# 2015NT10 to XH), and an Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education (#201502 to XH).; Our sincere thanks are given to Dr. Jinzhu Song and Dr. Qian Yang (Harbin Institute of Technology, China) for the kind gift of the vector pSilent-1. This work is supported by a National Natural Science Foundation of China (NSFC grant #31470251), a National Basic Research Program of China ("973" Program #2007CB707801), a grant from the Fundamental Research Funds for the Central Universities (#2015NT10), and an Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education (#201502).	Abdel-Azeem AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01477; Aghcheh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112799; Amare MG, 2014, FUNGAL GENET BIOL, V66, P11, DOI 10.1016/j.fgb.2014.02.008; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Carrasco-Navarro U, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0564-x; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Garcia-Rico RO, 2008, MICROBIOL-SGM, V154, P3567, DOI 10.1099/mic.0.2008/019091-0; Hao X., 2012, AFR J BIOTECHNOL, V11, P771, DOI DOI 10.5897/AJB11.2715; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Hu Y, 2013, J AGR FOOD CHEM, V61, P41, DOI 10.1021/jf304314g; Hu Y, 2012, SCI CHINA LIFE SCI, V55, P1100, DOI 10.1007/s11427-012-4409-5; Hua CY, 2013, IMMUNOBIOLOGY, V218, P292, DOI 10.1016/j.imbio.2012.05.015; Huang S, 2016, MAR DRUGS, V14, DOI 10.3390/md14100172; Ichihara A, 1996, BIOSCI BIOTECH BIOCH, V60, P360, DOI 10.1271/bbb.60.360; Jiang T, 2016, J NAT PROD, V79, P2487, DOI 10.1021/acs.jnatprod.6b00333; Jiao WX, 2004, J NAT PROD, V67, P1722, DOI 10.1021/np030460g; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Leeder AC, 2011, NAT REV MICROBIOL, V9, P440, DOI 10.1038/nrmicro2580; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; Liu H, 2007, EMBO J, V26, P690, DOI 10.1038/sj.emboj.7601536; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longoni P, 2012, APPL ENVIRON MICROB, V78, P3693, DOI 10.1128/AEM.00124-12; Lu KY, 2013, MOLECULES, V18, P10944, DOI 10.3390/molecules180910944; Macheleidt J, 2016, ANNU REV GENET, V50, P371, DOI 10.1146/annurev-genet-120215-035203; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Nakazawa T, 2013, J AM CHEM SOC, V135, P13446, DOI 10.1021/ja405128k; Niu XL, 2015, J MICROBIOL BIOTECHN, V25, P579, DOI 10.4014/jmb.1409.09067; Park G, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P50; Scherlach K, 2010, NAT PROD REP, V27, P869, DOI 10.1039/b903913a; Schumann J, 2007, J AM CHEM SOC, V129, P9564, DOI 10.1021/ja072884t; SEKITA S, 1982, CHEM PHARM BULL, V30, P1609, DOI 10.1248/cpb.30.1609; Serena C, 2003, ANTIMICROB AGENTS CH, V47, P3161, DOI 10.1128/AAC.47.10.3161-3164.2003; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Tag A, 2000, MOL MICROBIOL, V38, P658, DOI 10.1046/j.1365-2958.2000.02166.x; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2006, J MICROBIOL, V44, P145; Yu X, 2017, MICROBIOL RES, V203, P29, DOI 10.1016/j.micres.2017.06.003; Zhang Q, 2012, MINI-REV MED CHEM, V12, P127, DOI 10.2174/138955712798995066	40	7	8	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195553	10.1371/journal.pone.0195553	http://dx.doi.org/10.1371/journal.pone.0195553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652900	Green Published, Green Submitted, gold			2022-12-27	WOS:000430026900026
J	Carrel, M; Zahrieh, D; Young, SG; Oleson, J; Ryckman, KK; Wels, B; Simmons, DL; Saftlas, A				Carrel, Margaret; Zahrieh, David; Young, Sean G.; Oleson, Jacob; Ryckman, Kelli K.; Wels, Brian; Simmons, Donald L.; Saftlas, Audrey			High prevalence of elevated blood lead levels in both rural and urban Iowa newborns: Spatial patterns and area-level covariates (vol 12, e0177930, 2017	PLOS ONE			English	Correction													Young, Sean G/H-6469-2014	Young, Sean G/0000-0002-0054-0627				Carrel M, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0177930, DOI 10.1371/J0URNAL.P0NE.0177930]; Carrel M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177930	2	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0196002	10.1371/journal.pone.0196002	http://dx.doi.org/10.1371/journal.pone.0196002			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649311	gold, Green Published			2022-12-27	WOS:000429791900108
J	Gardner, PC; Goossens, B; Wern, JGE; Kretzschmar, P; Bohm, T; Vaughan, IP				Gardner, Penny C.; Goossens, Benoit; Wern, Jocelyn Goon Ee; Kretzschmar, Petra; Bohm, Torsten; Vaughan, Ian P.			Spatial and temporal behavioural responses of wild cattle to tropical forest degradation	PLOS ONE			English	Article							HEAT-STRESS; RAIN-FOREST; LOGGING INTENSITY; ACTIVITY PATTERNS; BODY-TEMPERATURE; DAIRY-CATTLE; SABAH; VEGETATION; IMPACTS; BIODIVERSITY	Identifying the consequences of tropical forest degradation is essential to mitigate its effects upon forest fauna. Large forest-dwelling mammals are often highly sensitive to environmental perturbation through processes such as fragmentation, simplification of habitat structure, and abiotic changes including increased temperatures where the canopy is cleared. Whilst previous work has focused upon species richness and rarity in logged forest, few look at spatial and temporal behavioural responses to forest degradation. Using camera traps, we explored the relationships between diel activity, behavioural expression, habitat use and ambient temperature to understand how the wild free-ranging Bornean banteng (Bos javanicus lowi) respond to logging and regeneration. Three secondary forests in Sabah, Malaysian Borneo were studied, varying in the time since last logging (6-23 years). A combination of generalised linear mixed models and generalised linear models were constructed using >36,000 trap-nights. Temperature had no significant effect on activity, however it varied markedly between forests, with the period of intense heat shortening as forest regeneration increased over the years. Bantengs regulated activity, with a reduction during the wet season in the most degraded forest (z = -2.6, Std. Error = 0.13, p = 0.01), and reductions during midday hours in forest with limited regeneration, however after >20 years of regrowth, activity was more consistent throughout the day. Foraging and use of open canopy areas dominated the activity budget when regeneration was limited. As regeneration advanced, this was replaced by greater investment in travelling and using a closed canopy. Forest degradation modifies the ambient temperature, and positively influences flooding and habitat availability during the wet season. Retention of a mosaic of mature forest patches within commercial forests could minimise these effects and also provide refuge, which is key to heat dissipation and the prevention of thermal stress, whilst retention of degraded forest could provide forage.	[Gardner, Penny C.; Goossens, Benoit; Wern, Jocelyn Goon Ee] Danau Girang Field Ctr, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Gardner, Penny C.; Goossens, Benoit; Vaughan, Ian P.] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales; [Goossens, Benoit] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sustainable Places Res Inst, Cardiff, S Glam, Wales; [Kretzschmar, Petra; Bohm, Torsten] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Cardiff University; Cardiff University; Leibniz Institut fur Zoo und Wildtierforschung	Gardner, PC; Goossens, B (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales.; Goossens, B (corresponding author), Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia.; Goossens, B (corresponding author), Cardiff Univ, Sustainable Places Res Inst, Cardiff, S Glam, Wales.	pennygardner14@hotmail.com; GoossensBR@cardiff.ac.uk	Vaughan, Ian/A-4782-2010	Vaughan, Ian/0000-0002-7263-3822; Gardner, Penny/0000-0002-3360-8747; Bohm, Torsten/0000-0001-5446-2321	Federal Ministry of Education and Research (BMBF) (Bundesministerium fur Bildung und Forschung); Zoo Leipzig; SOS Rhino; Houston Zoo; Malaysian Palm Oil Council; Woodland Park Zoo; Mohamed bin Zayed Species Conservation Fund; Yayasan Sime Darby	Federal Ministry of Education and Research (BMBF) (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Zoo Leipzig; SOS Rhino; Houston Zoo; Malaysian Palm Oil Council; Woodland Park Zoo; Mohamed bin Zayed Species Conservation Fund; Yayasan Sime Darby	This work was supported by the Federal Ministry of Education and Research (BMBF) (Bundesministerium fur Bildung und Forschung) to PK - https://www.bmbf.de/en/index.html; Zoo Leipzig to PK - http://www.zoo-leipzig.de/en/ homepage/; SOS Rhino to PK - now defunct; Houston Zoo to PCG - https://www.houstonzoo.org/; Malaysian Palm Oil Council to PCG - http://www.mpoc.org.my/; Woodland Park Zoo to PCG https:/www.zoo.org/; Mohamed bin Zayed Species Conservation Fund to PCG - https://www.speciesconservation.org/; and Yayasan Sime Darby to PCG - http://ww.yayasansimedarby.com/our-projects/environment.	Allred BW, 2013, GLOBAL CHANGE BIOL, V19, P1875, DOI 10.1111/gcb.12183; Ancrenaz M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04024; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Bagchi R, 2011, PHILOS T R SOC B, V366, P3246, DOI 10.1098/rstb.2011.0034; Bergstedt J, 2001, FOREST ECOL MANAG, V154, P105, DOI 10.1016/S0378-1127(00)00642-3; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bischoff W, 2005, FOREST ECOL MANAG, V218, P174, DOI 10.1016/j.foreco.2005.07.009; Boan JJ, 2011, FOREST ECOL MANAG, V262, P1704, DOI 10.1016/j.foreco.2011.07.022; Bradshaw CJA, 2007, GLOBAL CHANGE BIOL, V13, P2379, DOI 10.1111/j.1365-2486.2007.01446.x; Brian A, 2017, PACKAGE MASS; Brodie Jedediah, 2011, Small Carnivore Conservation, V44, P1; Brodie JF, 2015, CONSERV BIOL, V29, P110, DOI 10.1111/cobi.12389; Bryan JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069679; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Burivalova Z, 2017, CONSERV LETT, V10, P4, DOI 10.1111/conl.12244; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Costa FRC, 2003, BIOTROPICA, V35, P103, DOI 10.1111/j.1744-7429.2003.tb00267.x; Dash S, 2016, VET WORLD, V9, P235, DOI 10.14202/vetworld.2016.235-244; Douglas A, 2017, PACKAGE IME4, DOI [10.2307/2533043, DOI 10.2307/2533043]; Edwards DP, 2014, ECOL APPL, V24, P2029, DOI 10.1890/14-0010.1; Estes JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044601; Gine GAF, 2012, J ZOOL, V286, P131, DOI 10.1111/j.1469-7998.2011.00855.x; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; FINCH VA, 1986, J ANIM SCI, V62, P531, DOI 10.2527/jas1986.622531x; Gardner PC, 2015, NATURAL HIST NONINVA; Gardner PC, 2014, ECOLOGY, EVOLUTION AND BEHAVIOUR OF WILD CATTLE: IMPLICATIONS FOR CONSERVATION, P216; Gokbulak F, 2008, WATER RESOUR MANAG, V22, P635, DOI 10.1007/s11269-007-9183-y; Gray TNE, 2011, RAFFLES B ZOOL, V59, P311; Guo ST, 2008, CONSERV BIOL, V22, P1055, DOI 10.1111/j.1523-1739.2008.00975.x; Hansen PJ, 2004, ANIM REPROD SCI, V82-3, P349, DOI 10.1016/j.anireprosci.2004.04.011; Hardus ME, 2012, BIOL CONSERV, V146, P177, DOI 10.1016/j.biocon.2011.12.014; Heydon MJ, 1997, J APPL ECOL, V34, P484, DOI 10.2307/2404892; Hopkin M, 2007, NATURE, DOI [10.1038/news070806-13, DOI 10.1038/NEWS070806-13]; Journeaux KL, 2018, ENDANGER SPECIES RES, V35, P141, DOI 10.3354/esr00882; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; Meijaard Erik, 2005, pi; Melletti M, 2014, ECOLOGY, EVOLUTION AND BEHAVIOUR OF WILD CATTLE: IMPLICATIONS FOR CONSERVATION, P1; Neumann W, 2013, LANDSCAPE URBAN PLAN, V114, P9, DOI 10.1016/j.landurbplan.2013.02.002; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Pandit BR, 2000, BARK STRIPPING SAMBA, V126, P865; PAYNE J, 1985, FIELD GUIDE MAMMALS; Pinard M, 1996, BIOTROPICA, V28, P2, DOI 10.2307/2388766; Prosser NS, 2016, BMC ZOOL, V1, DOI 10.1186/s40850-016-0007-5; Ramesh T, 2012, J ZOOL, V287, P269, DOI 10.1111/j.1469-7998.2012.00908.x; Reimoser F, 1996, FOREST ECOL MANAG, V88, P107, DOI 10.1016/S0378-1127(96)03816-9; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Ross J, 2013, J ZOOL, V290, P96, DOI 10.1111/jzo.12018; Rowe MF, 2013, J EXP BIOL, V216, P1774, DOI 10.1242/jeb.076521; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Shrestha AK, 2014, INT J BIOMETEOROL, V58, P41, DOI 10.1007/s00484-012-0622-y; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Soriani N, 2013, J DAIRY SCI, V96, P5082, DOI 10.3168/jds.2013-6620; Team RC., 2013, R LANG ENV STAT COMP; Timmins R., 2008, IUCN 2012 IUCN RED L; Tucker CB, 2007, APPL ANIM BEHAV SCI, V105, P1, DOI [10.1016/j.applanim.2006.06.009, 10.1016/j.applanim.2007.03.015]; van Beest FM, 2012, ANIM BEHAV, V84, P723, DOI 10.1016/j.anbehav.2012.06.032; van Strien N.J., 1974, Mededelingen LandbHoogesch Wageningen, V74, P1; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Yadav B, 2016, ASIAN AUSTRAL J ANIM, V29, P1585, DOI 10.5713/ajas.15.0693	59	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195444	10.1371/journal.pone.0195444	http://dx.doi.org/10.1371/journal.pone.0195444			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649279	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900045
J	Turakhia, MP; Shafrin, J; Bognar, K; Trocio, J; Abdulsattar, Y; Wiederkehr, D; Goldman, DP				Turakhia, Mintu P.; Shafrin, Jason; Bognar, Katalin; Trocio, Jeffrey; Abdulsattar, Younos; Wiederkehr, Daniel; Goldman, Dana P.			Estimated prevalence of undiagnosed atrial fibrillation in the United States	PLOS ONE			English	Article							MEDICARE BENEFICIARIES; RISK-FACTORS; STROKE; ANTICOAGULATION; PROJECTIONS; MORTALITY; SCHEMES; DISEASE; ADULTS	Introduction As atrial fibrillation (AF) is often asymptomatic, it may remain undiagnosed until or even after development of complications, such as stroke. Consequently the observed prevalence of AF may underestimate total disease burden. Methods To estimate the prevalence of undiagnosed AF in the United States, we performed a retrospective cohort modeling study in working age (18-64) and elderly (>= 65) people using commercial and Medicare administrative claims databases. We identified patients in years 2004-2010 with incident AF following an ischemic stroke. Using a back-calculation methodology, we estimated the prevalence of undiagnosed AF as the ratio of the number of post stroke AF patients and the CHADS(2)-specific stroke probability for each patient, adjusting for age and gender composition based on United States census data. Results The estimated prevalence of AF (diagnosed and undiagnosed) was 3,873,900 (95%/CI: 3,675,200-4,702,600) elderly and 1,457,100 (95%CI: 1,218,500-1,695,800) working age adults, representing 10.0% and 0.92% of the respective populations. Of these, 698,900 were undiagnosed: 535,400 (95%CI: 331,900-804,400) elderly and 163,500 (95%CI: 17,700-400,000) working age adults, representing 1.3% and 0.09% of the respective populations. Among all undiagnosed cases, 77% had a CHADS(2) score >= 1, and 56% had CHADS(2) score >= 2. Conclusions Using a back-calculation approach, we estimate that the total AF prevalence in 2009 was 5.3 million of which 0.7 million (13.1% of AF cases) were undiagnosed. Over half of the modeled population with undiagnosed AF was at moderate to high risk of stroke.	[Turakhia, Mintu P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Shafrin, Jason; Bognar, Katalin] Precis Hlth Econ, Los Angeles, CA USA; [Trocio, Jeffrey; Abdulsattar, Younos; Wiederkehr, Daniel] Pfizer Inc, New York, NY USA; [Goldman, Dana P.] Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	Stanford University; Pfizer; University of Southern California	Turakhia, MP (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	mintu@stanford.edu	Goldman, Dana P/E-7667-2013; Shafrin, Jason/AAI-7041-2020	Goldman, Dana P/0000-0001-8498-6396; Shafrin, Jason/0000-0001-8444-5979; Bognar, Katalin/0000-0001-8357-8569; Turakhia, Minang/0000-0001-8025-0904	Bristol-Myers Squibb; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	The research reported in this manuscript was funded by Bristol-Myers Squibb and Pfizer based on a proposal that co-author Dana P. Goldman and Mintu P. Turakhia presented to the sponsors. Jason Shafrin and Katalin Bognar are employees of; Dana P. Goldman serves as a consultant to Precision Health Economics, who were paid consultants to Pfizer in connection with the development of this manuscript. Jeffrey Trocio, Younos Abdulsattar, and Daniel Wiederkehr are employees and shareholders of Pfizer, Inc. Bristol-Myers Squibb provided funding but was not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Through Pfizer affiliated coauthors, Pfizer was involved in the design of the study, the interpretation of data, and the preparation, review, and approval of the manuscript for publication.	BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Claes N, 2012, ACTA CARDIOL, V67, P273, DOI 10.1080/AC.67.3.2160714; Clua-Espuny JL, 2013, REV ESP CARDIOL, V66, P545, DOI 10.1016/j.rec.2013.03.003; DiCiccio TJ, 1996, STAT SCI, V11, P189; Egan JR, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0096; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Marfella R, 2013, J AM COLL CARDIOL, V62, P525, DOI 10.1016/j.jacc.2013.02.091; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Pope GC, 2011, EVALUATION CMS HCC R; Samol A, 2013, EUROPACE, V15, P657, DOI 10.1093/europace/eus366; Suissa L, 2013, J STROKE CEREBROVASC, V22, P991, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.015; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Turakhia MP, 2013, AM HEART J, V166, P573, DOI 10.1016/j.ahj.2013.07.003; U. S. Census, 2012, AG SEX COMP US 2012; Weber-Kruger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067602	20	65	70	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195088	10.1371/journal.pone.0195088	http://dx.doi.org/10.1371/journal.pone.0195088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649277	Green Published, gold			2022-12-27	WOS:000429791900022
J	Sahib, AK; Erb, M; Marquetand, J; Martin, P; Elshahabi, A; Klamer, S; Vulliemoz, S; Scheffler, K; Ethofer, T; Focke, NK				Sahib, Ashish Kaul; Erb, Michael; Marquetand, Justus; Martin, Pascal; Elshahabi, Adham; Klamer, Silke; Vulliemoz, Serge; Scheffler, Klaus; Ethofer, Thomas; Focke, Niels K.			Evaluating the impact of fast-fMRI on dynamic functional connectivity in an event-based paradigm (vol 13, e0190480, 2018)	PLOS ONE			English	Correction													Focke, Niels/AAO-7012-2020; Ethofer, Silke/AAC-4570-2022	Ethofer, Silke/0000-0002-6726-0531				Sahib AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190480	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195916	10.1371/journal.pone.0195916	http://dx.doi.org/10.1371/journal.pone.0195916			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641591	gold, Green Published, Green Submitted			2022-12-27	WOS:000429742900097
J	Wang, M; Gong, WW; Hu, RY; Wang, H; Guo, Y; Bian, Z; Lv, J; Chen, ZM; Li, LM; Yu, M				Wang, Meng; Gong, Wei-Wei; Hu, Ru-Ying; Wang, Hao; Guo, Yu; Bian, Zheng; Lv, Jun; Chen, Zheng-Ming; Li, Li-Ming; Yu, Min			Age at natural menopause and associated factors in adult women: Findings from the China Kadoorie Biobank study in Zhejiang rural area	PLOS ONE			English	Article							REPRODUCTIVE FACTORS; OVARIAN-CANCER; FOLLOW-UP; RISK; DETERMINANTS; TRANSITION; PREMATURE; METAANALYSIS; PREDICTORS; SYMPTOMS	Objectives To investigate the factors associated with age at natural menopause in a large population of Chinese adult women. Methods This cross-sectional study was part of the baseline survey of China Kadoorie Biobank in Zhejiang Province. A total of 17,076 postmenopausal women were included in the present study. Relevant data of socio-demographic, lifestyle, dietary and reproductive characteristics were collected. Multinomial logistic regression models were used to examine the associated factors of age at natural menopause with adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) were reported. Results The mean age at natural menopause was 48.94 years, with 3.40% of the women experienced premature menopause and 6.75% early menopause. Younger age, higher education, consumption of meat (1-3 days per week) and increased parity were associated with late menopause. Current smoking, underweight, higher physical activity, consumption of sea food (1-3 days per week), fresh eggs (>4 days per week), fresh fruits (>= 1 day per week), taking vitamins, experiencing severe food shortage, earlier age at menarche and older age at first birth were associated with earlier age at natural menopause. Conclusions These results suggest that certain factors involved with socio-demographic, lifestyle, dietary and reproductive characteristics are related to the age at natural menopause in Chinese women.	[Wang, Meng; Gong, Wei-Wei; Hu, Ru-Ying; Wang, Hao; Yu, Min] Zhejiang Prov Ctr Dis Control & Prevent, Dept NCDs Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Guo, Yu; Bian, Zheng] Chinese Acad Med Sci, Beijing, Peoples R China; [Lv, Jun; Li, Li-Ming] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol, Beijing, Peoples R China; [Chen, Zheng-Ming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Chen, Zheng-Ming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England	Zhejiang Provincial Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking University; University of Oxford; University of Oxford	Yu, M (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept NCDs Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	mycdc1234@163.com	Lv, Jun/O-4746-2019	Lv, Jun/0000-0001-7916-3870; Yu, Min/0000-0001-5473-0736	National Key Research and Development Program of China [2016YFC0900500, 2016YFC0900501, 2016YFC0900502, 2016YFC0900504]; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust in the UK [088158/Z/09/Z, 104085/Z/14/Z]; MRC [MC_UU_12026/2, MC_U137686851] Funding Source: UKRI	National Key Research and Development Program of China; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust in the UK(Instituto de Salud Carlos IIIWellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The National Key Research and Development Program of China (grants 2016YFC0900500, 2016YFC0900501, 2016YFC0900502, 2016YFC0900504), to LML, were in the role of study design, data collection and analysis, decision to publish and preparation of the manuscript. Grants from the Kadoorie Charitable Foundation in Hong Kong were in the role of study design. Grants (088158/Z/09/Z, 104085/Z/14/Z) from Wellcome Trust in the UK to ZMC were in the role of study design and decision to publish.	Ali AT, 2014, INT J GYNECOL CANCER, V24, P384, DOI 10.1097/IGC.0000000000000075; Bosetti C, 2001, J CLIN EPIDEMIOL, V54, P902, DOI 10.1016/S0895-4356(01)00362-6; Cairns BJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-7; Cassou B, 2007, AM J EPIDEMIOL, V166, P429, DOI 10.1093/aje/kwm104; Cauley JA, 2012, MENOPAUSE, V19, P1200, DOI 10.1097/gme.0b013e31825ae17e; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Dorjgochoo T, 2008, MENOPAUSE, V15, P924, DOI 10.1097/gme.0b013e3181786adc; Dratva J, 2009, MENOPAUSE, V16, P385, DOI 10.1097/gme.0b013e31818aefef; Ebong IA, 2015, MENOPAUSE, V22, P527, DOI [10.1097/GME.0000000000000342, 10.1097/gme.0000000000000342]; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Gold EB, 2013, AM J EPIDEMIOL, V178, P70, DOI 10.1093/aje/kws421; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Hardy R, 2005, BJOG-INT J OBSTET GY, V112, P346, DOI 10.1111/j.1471-0528.2004.00348.x; Henderson KD, 2008, AM J EPIDEMIOL, V167, P1287, DOI 10.1093/aje/kwn046; Kaczmarek M, 2007, MATURITAS, V57, P139, DOI 10.1016/j.maturitas.2006.12.001; Lewington S, 2014, INT J EPIDEMIOL, V43, P1252, DOI 10.1093/ije/dyu035; Li H, 2017, J EPIDEMIOL, V27, P143, DOI 10.1016/j.je.2016.05.002; Li Li-ming, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P249; Li L, 2012, MATURITAS, V73, P354, DOI 10.1016/j.maturitas.2012.09.008; Li Y, 2008, MATURITAS, V61, P238, DOI 10.1016/j.maturitas.2008.09.002; Luborsky JL, 2003, HUM REPROD, V18, P199, DOI 10.1093/humrep/deg005; MATTISON DR, 1978, LANCET, V1, P187; McKnight KK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.014; McTiernan A, 2004, CANCER RES, V64, P2923, DOI 10.1158/0008-5472.CAN-03-3393; Meek MD, 1999, ENVIRON RES, V80, P9, DOI 10.1006/enrs.1998.3872; Mishra GD, 2017, HUM REPROD, V32, P679, DOI 10.1093/humrep/dew350; Mishra GD, 2009, WOMENS HEALTH, V5, P175, DOI 10.2217/17455057.5.2.175; Muka T, 2016, JAMA CARDIOL, V1, P767, DOI 10.1001/jamacardio.2016.2415; Nagel G, 2005, MATURITAS, V52, P337, DOI 10.1016/j.maturitas.2005.05.013; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Parazzini F, 2007, MATURITAS, V56, P280, DOI 10.1016/j.maturitas.2006.09.003; Pokoradi AJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.059; Rodstrom K, 2005, MENOPAUSE, V12, P275, DOI 10.1097/01.GME.0000135247.11972.B3; Schoenaker DAJM, 2014, INT J EPIDEMIOL, V43, P1542, DOI 10.1093/ije/dyu094; SOBERON J, 1966, AM J OBSTET GYNECOL, V96, P96, DOI 10.1016/S0002-9378(16)34647-6; Stepaniak U, 2013, MATURITAS, V75, P87, DOI 10.1016/j.maturitas.2013.02.008; Sun L, 2012, MENOPAUSE, V19, P126, DOI 10.1097/gme.0b013e318224f9ac; Szegda KL, 2017, HUM REPROD, V32, P2522, DOI 10.1093/humrep/dex304; Tao XY, 2015, MENOPAUSE, V22, P469, DOI [10.1097/GME.0000000000000324, 10.1097/gme.0000000000000324]; TORGERSON DJ, 1994, MATURITAS, V19, P83, DOI 10.1016/0378-5122(94)90057-4; Tsilidis KK, 2011, BRIT J CANCER, V105, P1436, DOI 10.1038/bjc.2011.371; Yasui T, 2012, MATURITAS, V72, P249, DOI 10.1016/j.maturitas.2012.04.002	43	32	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195658	10.1371/journal.pone.0195658	http://dx.doi.org/10.1371/journal.pone.0195658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668705	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200052
J	Saito, H; Hirayama, A; Umemura, T; Joshita, S; Mukawa, K; Suga, T; Tanaka, E; Ota, M				Saito, Hiromi; Hirayama, Atsuhiro; Umemura, Takeji; Joshita, Satoru; Mukawa, Kenji; Suga, Tomoaki; Tanaka, Eiji; Ota, Masao			Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RECEPTOR GENES; GENOTYPE; POLYMORPHISMS; SELECTION; ALLELES; LIGAND	Inflammatory bowel disease (IBD) consists of ulcerative colitis (UC) and Crohn's disease (CD). Natural killer cell responses play a crucial role in autoimmune disease through innate immunity, in which killer cell immunoglobulin-like receptors (KIRs) are closely involved. Although the genetic combination of KIRs with their specific HLA class I ligands has been associated with IBD in Caucasians, such KIR-HLA receptor-ligand combinations are not fully understood in the Japanese. We investigated 14 KIR genes along with HLA-Bw and -C ligands in 90 patients with UC and 50 patients with CD and compared them with the characteristics of 325 healthy control subjects. The frequency of HLA-Bw4 was significantly increased in patients with UC (P = 1.3 x 10(-6); odds ratio [OR] = 3.39) and CD (P = 0.0065; OR = 2.32) versus controls. The UC group had a significantly higher frequency of KIR2DS3 (P = 0.024; OR = 1.94) and lower frequency of KIR2DS4 (P = 0.019; OR = 0.40) and KIR2DL1-HLA-C2 (P = 0.035; OR = 0.47). The Tel-A/B haplotype was significantly decreased in UC patients (P = 0.0056; OR = 0.49). The frequency of KIR3DL1-HLA-Bw4 was significantly higher in patients with UC (P = 4.3 x 10(-6); OR = 3.12) and CD (P = 0.0067; OR = 2.30). In conclusion, HLA-Bw4 and KIR-HLA pairs may play an important role in the genetic susceptibility to IBD in the Japanese.	[Saito, Hiromi; Hirayama, Atsuhiro; Umemura, Takeji; Joshita, Satoru; Suga, Tomoaki; Tanaka, Eiji; Ota, Masao] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano, Japan; [Mukawa, Kenji] Suwa Red Cross Hosp, Dept Gastroenterol, Suwa, Japan	Shinshu University	Umemura, T (corresponding author), Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano, Japan.	tumemura@shinshu-u.ac.jp	Joshita, Satoru/K-5679-2019	Joshita, Satoru/0000-0002-6364-9654; Umemura, Takeji/0000-0001-7985-919X	Japan Society for the Promotion of Science KAKENHI [17K09416]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in a part by a research grant from the Japan Society for the Promotion of Science KAKENHI (17K09416) (TU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Diaz-Pena R, 2016, HUM IMMUNOL, V77, P104, DOI 10.1016/j.humimm.2015.10.020; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; Fuyuno Y, 2016, J GASTROENTEROL, V51, P672, DOI 10.1007/s00535-015-1135-3; Hollenbach JA, 2009, IMMUNOGENETICS, V61, P663, DOI 10.1007/s00251-009-0396-5; Jones DC, 2006, GENES IMMUN, V7, P576, DOI 10.1038/sj.gene.6364333; Lin L, 2014, J IMMUNOL, V193, P940, DOI 10.4049/jimmunol.1400093; Lopez-Hernandez R, 2016, MICROBIOL IMMUNOL, V60, P787, DOI 10.1111/1348-0421.12447; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Nozawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083381; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Saito H, 2018, ONCOTARGET IN PRESS; Tajik N, 2010, INT J IMMUNOGENET, V37, P159, DOI 10.1111/j.1744-313X.2010.00906.x; Umemura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29770; Umemura T, 2014, HUM IMMUNOL, V75, P822, DOI 10.1016/j.humimm.2014.06.003; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Wilson TJ, 2010, HUM IMMUNOL, V71, P293, DOI 10.1016/j.humimm.2009.12.006; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	28	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195778	10.1371/journal.pone.0195778	http://dx.doi.org/10.1371/journal.pone.0195778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649328	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900085
J	Lian, HY; Lum, H; Alvarez, A; Garduno-Garcia, JD; Daniel, BJ; Musi, N				Lian, Hanyu; Lum, Helen; Alvarez, Andrea; Garduno-Garcia, Jose de Jesus; Daniel, Benjamin J.; Musi, Nicolas			A low dose lipid infusion is sufficient to induce insulin resistance and a pro-inflammatory response in human subjects	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; ADIPOSE-TISSUE; PROTEIN-KINASE; OBESITY; ACTIVATION; EXPRESSION; MONOCYTES; MUSCLE; TYPE-2; CELLS	Objective The root cause behind the low-grade inflammatory state seen in insulin resistant (obesity and type 2 diabetes) states is unclear. Insulin resistant subjects have elevations in plasma free fatty acids (FFA), which are ligands for the pro-inflammatory toll-like receptor (TLR)4 pathway. We tested the hypothesis that an experimental elevation in plasma FFA (within physiological levels) in lean individuals would upregulate TLR4 and activate downstream pathways (e.g., MAPK) in circulating monocytes. Research design and methods Twelve lean, normal glucose-tolerant subjects received a low dose (30 ml/h) 48 h lipid or saline infusion on two different occasions. Monocyte TLR4 protein level, MAPK phosphorylation, and expression of genes in the TLR pathway were determined before and after each infusion. Results The lipid infusion significantly increased monocyte TLR4 protein and phosphorylation of JNK and p38 MAPK. Lipid-mediated increases in TLR4 and p38 phosphorylation directly correlated with reduced peripheral insulin sensitivity (M value). Lipid increased levels of multiple genes linked to inflammation, including several TLRs, CD180, MAP3K7, and CXCL10. Monocytes exposed in vivoto lipid infusion exhibited enhanced in vitro basal and LPS-stimulated IL-1 beta secretion. Conclusions In lean subjects, a small increase in plasma FFA (as seen in insulin resistant subjects) is sufficient to upregulate TLR4 and stimulate inflammatory pathways (MAPK) in monocytes. Moreover, lipids prime monocytes to endotoxin. We provide proof-of-concept data in humans indicating that the low-grade inflammatory state characteristic of obesity and type 2 diabetes could be caused (at least partially) by pro-inflammatory monocytes activated by excess lipids present in these individuals.	[Lian, Hanyu; Lum, Helen; Musi, Nicolas] UT Hlth San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Lian, Hanyu; Lum, Helen; Alvarez, Andrea; Garduno-Garcia, Jose de Jesus; Musi, Nicolas] UT Hlth San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Lian, Hanyu; Lum, Helen; Musi, Nicolas] Audie L Murphy VA Med Ctr, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Daniel, Benjamin J.] UT Hlth San Antonio, Dept Microbiol, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio	Musi, N (corresponding author), UT Hlth San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.; Musi, N (corresponding author), UT Hlth San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA.; Musi, N (corresponding author), Audie L Murphy VA Med Ctr, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA.	musi@uthscsa.edu	de Jesus Garduño Garcia, Jose/AAQ-7154-2021; de Jesus Garduño Garcia, Jose/AAK-2413-2020	de Jesus Garduño Garcia, Jose/0000-0003-2823-5955; 	National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK80157, R01-DK089229]; American Diabetes Association (GlaxoSmithKline) [7-13-GSK-01]; UTHSCSA, NIH-NCI [P30 CA054174-20, UL1TR001120];  [UL1TR000149];  [P30 AG044271];  [AG013319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080157, R01DK089229] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association (GlaxoSmithKline); UTHSCSA, NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK80157 and R01-DK089229), and the American Diabetes Association (GlaxoSmithKline grant number 7-13-GSK-01) to N.M. This work also was supported by grants UL1TR000149, P30 AG044271, and AG013319. This work was the result of work supported with resources and the use of facilities at South Texas Veterans Health Care System, San Antonio, Texas. Data for TLR cell surface expression and intracellular MAPK phosphorylation were generated in the Flow Cytometry Shared Resource Facility which is supported by UTHSCSA, NIH-NCI P30 CA054174-20 (CTRC at UTHSCSA) and UL1TR001120 (CTSA grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Chow S, 2005, CYTOM PART A, V67A, P4, DOI 10.1002/cyto.a.20167; Clemente-Postigo M, 2012, J LIPID RES, V53, P973, DOI 10.1194/jlr.P020909; Coen PM, 2010, METABOLISM, V59, P1775, DOI 10.1016/j.metabol.2010.05.002; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; de Mello VDF, 2008, DIABETOLOGIA, V51, P2060, DOI 10.1007/s00125-008-1132-7; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Hussey SE, 2014, DIABETOLOGIA, V57, P582, DOI 10.1007/s00125-013-3111-x; Hussey SE, 2013, BIOSCIENCE REP, V33, P37, DOI 10.1042/BSR20120098; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; REAVEN GM, 1988, AM J MED, V85, P106, DOI 10.1016/0002-9343(88)90402-0; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Reyna SM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/107805; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; van Oostrom AJ, 2004, NETH J MED, V62, P320; Viardot A, 2012, DIABETES-METAB RES, V28, P447, DOI 10.1002/dmrr.2302; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132575	35	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195810	10.1371/journal.pone.0195810	http://dx.doi.org/10.1371/journal.pone.0195810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649324	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900092
J	Sakr, S; Elshawi, R; Ahmed, A; Qureshi, WT; Brawner, C; Keteyian, S; Blaha, MJ; Al-Mallah, MH				Sakr, Sherif; Elshawi, Radwa; Ahmed, Amjad; Qureshi, Waqas T.; Brawner, Clinton; Keteyian, Steven; Blaha, Michael J.; Al-Mallah, Mouaz H.			Using machine learning on cardiorespiratory fitness data for predicting hypertension: The Henry Ford Exercise Testing (FIT) Project	PLOS ONE			English	Article							PROBABILISTIC NETWORKS; BAYESIAN NETWORKS; CLASSIFICATION; REGRESSION; KNOWLEDGE	This study evaluates and compares the performance of different machine learning techniques on predicting the individuals at risk of developing hypertension, and who are likely to benefit most from interventions, using the cardiorespiratory fitness data. The dataset of this study contains information of 23,095 patients who underwent clinician-referred exercise treadmill stress testing at Henry Ford Health Systems between 1991 and 2009 and had a complete 10-year follow-up. The variables of the dataset include information on vital signs, diagnosis and clinical laboratory measurements. Six machine learning techniques were investigated: LogitBoost (LB), Bayesian Network classifier (BN), Locally Weighted Naive Bayes (LWB), Artificial Neural Network (ANN), Support Vector Machine (SVM) and Random Tree Forest (RTF). Using different validation methods, the RTF model has shown the best performance (AUC = 0.93) and outperformed all other machine learning techniques examined in this study. The results have also shown that it is critical to carefully explore and evaluate the performance of the machine learning models using various model evaluation methods as the prediction accuracy can significantly differ.	[Sakr, Sherif; Ahmed, Amjad; Al-Mallah, Mouaz H.] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Sakr, Sherif; Ahmed, Amjad; Al-Mallah, Mouaz H.] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Brawner, Clinton; Keteyian, Steven; Al-Mallah, Mouaz H.] Henry Ford Hosp Syst, Heart & Vasc Inst, Detroit, MI USA; [Elshawi, Radwa] Princess Nourah Bint Abdulrahman Univ, Riyadh, Saudi Arabia; [Qureshi, Waqas T.] Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC USA; [Blaha, Michael J.] Johns Hopkins Med, Baltimore, MD USA; [Sakr, Sherif; Elshawi, Radwa] Univ Taru, Taru, Estonia	King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Henry Ford Health System; Princess Nourah bint Abdulrahman University; Wake Forest University; Johns Hopkins University; Johns Hopkins Medicine	Sakr, S (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia.; Sakr, S (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.; Sakr, S (corresponding author), Univ Taru, Taru, Estonia.	sakrs@ksau-hs.edu.sa	Ahmed, Amjad M./AAW-7624-2020; Brawner, Clinton A./K-6859-2019; Sakr, Sherif/B-1439-2018; Shawi, Radwa/AAB-9237-2020; Qureshi, Waqas/H-3498-2019	Ahmed, Amjad M./0000-0002-8711-4865; Sakr, Sherif/0000-0002-2503-523X; Qureshi, Waqas/0000-0002-5189-4417; Al-Mallah, Mouaz/0000-0003-2348-0484; El Shawi, Radwa/0000-0002-5679-9099	King Abdullah International Medical Research Center [SP16/100]	King Abdullah International Medical Research Center	Funding was provided by King Abdullah International Medical Research Center. Funding grant number SP16/100 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AA, 2011, 2011 2 INT C INT SYS, P113; Abramovici M, 2008, P IPMU, V8, P379; Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P457; Al-Mallah MH, 2014, CLIN CARDIOL, V37, P456, DOI 10.1002/clc.22302; Al-Nozha MM, 2007, SAUDI MED J, V28, P77; Alghamdi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179805; Arbib MA., 2003, HDB BRAIN THEORY NEU; Blake C L, 1998, UCI REPOSITORY MACHI, P55; Bouckaert RR, 2001, BAYESIAN BELIEF NETW; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Buntine W, 1996, IEEE T KNOWL DATA EN, V8, P195, DOI 10.1109/69.494161; Carson JL, 2015, LANCET, V385, P1183, DOI 10.1016/S0140-6736(14)62286-8; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chawla NV, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P875, DOI 10.1007/978-0-387-09823-4_45; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cheng J, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P101; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Echouffo-Tcheugui Justin B, 2013, PLoS One, V8, pe67370, DOI 10.1371/journal.pone.0067370; Frank E., 2002, P 19 C UNC ART INT A, P249; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Haykin S., 1994, NEURAL NETWORKS COMP, V1st; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hung RK, 2014, MAYO CLIN PROC, V89, P1644, DOI 10.1016/j.mayocp.2014.07.011; Jeppesen J, 2000, HYPERTENSION, V36, P226, DOI 10.1161/01.HYP.36.2.226; Juraschek SP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001268; Juraschek SP, 2015, DIABETES CARE, V38, P1075, DOI 10.2337/dc14-2714; KAYYALI Basel, 2013, BIG DATA REVOLUTION; KENT JT, 1983, BIOMETRIKA, V70, P163, DOI 10.1093/biomet/70.1.163; Kubat M., 1997, ADDRESSING CURSE IMB, P179, DOI DOI 10.1007/S13398-014-0173-7.2; Kung Hsiang-Ching, 2015, NCHS Data Brief, P1; Kurgan L, 2001, IC-AI'2001: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS I-III, P980; Lee SM, 2003, J BIOMED INFORM, V36, P389, DOI 10.1016/j.jbi.2003.09.022; Marsland S, 2015, MACHINE LEARNING ALG, DOI DOI 10.1201/B17476; Members C, 2002, J AM COLL CARDIOL, V40, P1531, DOI [10.1016/S0735-1097(02)02164-2, DOI 10.1016/S0735-1097(02)02164-2]; Organization WH, 2005, CLIN GUID MAN HYP; Platt J., 1998, ADV KERNEL METHODS S, P41, DOI [10.1109/iske.2008.4731075, DOI 10.1109/ISKE.2008.4731075]; POLI R, 1991, COMPUTER, V24, P64, DOI 10.1109/2.73514; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Qureshi WT, 2015, CIRCULATION, V132, pE395, DOI 10.1161/CIRCULATIONAHA.115.018758; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Ross K, 2009, ENCY DATABASE SYSTEM; Sakr S, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0566-6; Samant R, 2013, INT J COMPUTER APPL, V81, DOI [10.5120/14067-2331, DOI 10.5120/14067-2331]; Su CT, 2008, EXPERT SYST APPL, V34, P754, DOI 10.1016/j.eswa.2006.10.010; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Ture M, 2005, EXPERT SYST APPL, V29, P583, DOI 10.1016/j.eswa.2005.04.014; Waljee AK, 2010, AM J GASTROENTEROL, V105, P1224, DOI 10.1038/ajg.2010.173; Walker S. John, 2014, BIG DATA REVOLUTION; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Yuret D., 1993, 2 TURK S ART INT NEU, P208	56	49	51	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195344	10.1371/journal.pone.0195344	http://dx.doi.org/10.1371/journal.pone.0195344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668729	gold, Green Published, Green Submitted			2022-12-27	WOS:000430290200039
J	Seifi, M; Walter, MA				Seifi, Morteza; Walter, Michael A.			Accurate prediction of functional, structural, and stability changes in PITX2 mutations using in silico bioinformatics algorithms	PLOS ONE			English	Article							AXENFELD-RIEGER-SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISMS; AMINO-ACID SUBSTITUTIONS; PROTEIN STABILITY; MOLECULAR-MECHANISMS; GENETIC-VARIANTS; SPECTRUM; FOXC1; SERVER; SEQUENCE	Mutations in PITX2 have been implicated in several genetic disorders, particularly Axenfeld-Rieger syndrome. In order to determine the most reliable bioinformatics tools to assess the likely pathogenicity of PITX2 variants, the results of bioinformatics predictions were compared to the impact of variants on PITX2 structure and function. The MutPred, Provean, and PMUT bioinformatic tools were found to have the highest performance in predicting the pathogenicity effects of all 18 characterized missense variants in PITX2, all with sensitivity and specificity >93%. Applying these three programs to assess the likely pathogenicity of 13 previously uncharacterized PITX2 missense variants predicted 12/13 variants as deleterious, except A30V which was predicted as benign variant for all programs. Molecular modeling of the PITX2 homoedomain predicts that of the 31 known PITX2 variants, L54Q, F58L, V83F, V83L, W86C, W86S, and R91P alter PITX2's structure. In contrast, the remaining 24 variants are not predicted to change PITX2's structure. The results of molecular modeling, performed on all the PITX2 missense mutations located in the homeodomain, were compared with the findings of eight protein stability programs. CUPSAT was found to be the most reliable in predicting the effect of missense mutations on PITX2 stability. Our results showed that for PITX2, and likely other members of this homeodomain transcription factor family, MutPred, Provean, PMUT, molecular modeling, and CUPSAT can reliably be used to predict PITX2 missense variants pathogenicity.	[Seifi, Morteza; Walter, Michael A.] Univ Alberta, Dept Med Genet, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta	Walter, MA (corresponding author), Univ Alberta, Dept Med Genet, Fac Med & Dent, Edmonton, AB, Canada.	mwalter@ualberta.ca	Seifi, Moretza/B-4507-2015	Seifi, Moretza/0000-0002-1609-8490	Canadian Institute for Health Research [G118160216]; Alberta Innovates Health Solutions graduate studentship [201500029]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions graduate studentship	This work was supported by the Canadian Institute for Health Research (MA. Walter, [grant number G118160216], http://www.cihr-irsc.gc.ca/e/193.html) and Alberta Innovates Health Solutions graduate studentship (M. Seifi, [award number 201500029], http://www.aihealthsolutions.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Amendt BA, 2000, CELL MOL LIFE SCI, V57, P1652, DOI 10.1007/PL00000647; Aydin H, 2014, PROTEIN SCI, V23, P603, DOI 10.1002/pro.2442; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Bao L, 2005, BIOINFORMATICS, V21, P2185, DOI 10.1093/bioinformatics/bti365; Brooks Brian P, 2004, Ophthalmic Genet, V25, P57, DOI 10.1076/opge.25.1.57.29002; Calloni G, 2005, J BIOL CHEM, V280, P10607, DOI 10.1074/jbc.M412951200; Campuzano O, 2015, SCI REP-UK, V5, DOI 10.1038/srep07953; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Chaney BA, 2005, BIOCHEMISTRY-US, V44, P7497, DOI 10.1021/bi0473253; Chen CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S5; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; D'haene B, 2011, INVEST OPHTH VIS SCI, V52, P324, DOI 10.1167/iovs.10-5309; Doss CGP, 2012, APPL TRANSL GENOM, V1, P37, DOI 10.1016/j.atg.2012.06.002; Dressler S, 2010, CASE REP MED, V2010, DOI 10.1155/2010/621984; Espinoza HM, 2002, HUM MOL GENET, V11, P743, DOI 10.1093/hmg/11.7.743; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Footz T, 2009, INVEST OPHTH VIS SCI, V50, P2599, DOI 10.1167/iovs.08-3251; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Geourjon C, 2001, PROTEIN SCI, V10, P788, DOI 10.1110/ps.30001; Gromiha MM, 2007, BIOCHEM SOC T, V35, P1569, DOI 10.1042/BST0351569; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Huang LT, 2007, BIOINFORMATICS, V23, P1292, DOI 10.1093/bioinformatics/btm100; Huang XB, 2015, INT J MOL MED, V36, P1111, DOI 10.3892/ijmm.2015.2325; Idrees F, 2006, AM J MED GENET B, V141B, P184, DOI 10.1002/ajmg.b.30237; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Jia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138022; Judkins T, 2005, MUTAT RES-FUND MOL M, V573, P168, DOI 10.1016/j.mrfmmm.2004.07.024; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kimura Masashi, 2014, Hum Genome Var, V1, P14005, DOI 10.1038/hgv.2014.5; Kniestedt C, 2006, OPHTHALMOLOGY, V113, P1791, DOI 10.1016/j.ophtha.2006.05.017; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; Kozlowski K, 2000, HUM MOL GENET, V9, P2131, DOI 10.1093/hmg/9.14.2131; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulak SC, 1998, HUM MOL GENET, V7, P1113, DOI 10.1093/hmg/7.7.1113; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Laskowski RA, 2016, HUM MOL GENET, V25, P927, DOI 10.1093/hmg/ddv625; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li DD, 2008, MOL VIS, V14, P2205; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lines MA, 2002, HUM MOL GENET, V11, P1177, DOI 10.1093/hmg/11.10.1177; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer-Marcotty P, 2008, J ORAL PATHOL MED, V37, P504, DOI 10.1111/j.1600-0714.2008.00650.x; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pace CN, 2014, PROTEIN SCI, V23, P652, DOI 10.1002/pro.2449; Pandurangan AP, 2017, NUCLEIC ACIDS RES, V45, pW229, DOI 10.1093/nar/gkx439; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Perveen R, 2000, INVEST OPHTH VIS SCI, V41, P2456; Phillips JC, 2002, OPHTHALMIC RES, V34, P324, DOI 10.1159/000065602; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Priston M, 2001, HUM MOL GENET, V10, P1631, DOI 10.1093/hmg/10.16.1631; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Randles LG, 2006, J BIOL CHEM, V281, P24216, DOI 10.1074/jbc.M603593200; Reis LM, 2012, EUR J HUM GENET, V20, P1224, DOI 10.1038/ejhg.2012.80; Saadi I, 2006, BIRTH DEFECTS RES A, V76, P175, DOI 10.1002/bdra.20226; Saadi I, 2001, J BIOL CHEM, V276, P23034, DOI 10.1074/jbc.M008592200; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seifi M, 2017, HUM MUTAT, V38, P169, DOI 10.1002/humu.23141; Seifi M, 2016, ACTA OPHTHALMOL, V94, pE571, DOI 10.1111/aos.13030; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shields M B, 1983, Trans Am Ophthalmol Soc, V81, P736; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stefl S, 2013, J MOL BIOL, V425, P3919, DOI 10.1016/j.jmb.2013.07.014; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Sun Y., 2015, MATH PROBL ENG, V3, P1, DOI DOI 10.1016/J.GENE.2015.12.001; Tang HM, 2016, BIOINFORMATICS, V32, P2230, DOI 10.1093/bioinformatics/btw222; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; VAUX C, 1992, J MED GENET, V29, P256, DOI 10.1136/jmg.29.4.256; Vieira V, 2006, MOL VIS, V12, P1448; Wallqvist A, 2000, BIOINFORMATICS, V16, P988, DOI 10.1093/bioinformatics/16.11.988; Wang J, 2013, DNA CELL BIOL, V32, P708, DOI 10.1089/dna.2013.2185; Wang J, 2014, EUR J MED GENET, V57, P25, DOI 10.1016/j.ejmg.2013.11.004; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wei D, 2014, INT J MOL MED, V33, P1201, DOI 10.3892/ijmm.2014.1689; Weisschuh N, 2006, INVEST OPHTH VIS SCI, V47, P3846, DOI 10.1167/iovs.06-0343; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Xia K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022434; Yang YQ, 2013, INT J CARDIOL, V168, P2873, DOI 10.1016/j.ijcard.2013.03.141; Young DL, 2015, MOL BIOL CELL, V26, P3904, DOI 10.1091/mbc.E15-03-0153; Yuan F, 2013, INT J MED SCI, V10, P1422, DOI 10.7150/ijms.6809; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	96	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195971	10.1371/journal.pone.0195971	http://dx.doi.org/10.1371/journal.pone.0195971			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664915	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300046
J	Pasupa, K; Kudisthalert, W				Pasupa, Kitsuchart; Kudisthalert, Wasu			Virtual screening by a new Clustering-based Weighted Similarity Extreme Learning Machine approach	PLOS ONE			English	Article							BINARY KERNEL DISCRIMINATION; NETWORKS	Machine learning techniques are becoming popular in virtual screening tasks. One of the powerful machine learning algorithms is Extreme Learning Machine (ELM) which has been applied to many applications and has recently been applied to virtual screening. We propose the Weighted Similarity ELM (WS-ELM) which is based on a single layer feed-forward neural network in a conjunction of 16 different similarity coefficients as activation function in the hidden layer. It is known that the performance of conventional ELM is not robust due to random weight selection in the hidden layer. Thus, we propose a Clustering-based WS-ELM (CWS-ELM) that deterministically assigns weights by utilising clustering algorithms i.e. k-means clustering and support vector clustering. The experiments were conducted on one of the most challenging datasets-Maximum Unbiased Validation Dataset-which contains 17 activity classes carefully selected from PubChem. The proposed algorithms were then compared with other machine learning techniques such as support vector machine, random forest, and similarity searching. The results show that CWS-ELM in conjunction with support vector clustering yields the best performance when utilised together with Sokal/Sneath(1) coefficient. Furthermore, ECFP_6 fingerprint presents the best results in our framework compared to the other types of fingerprints, namely ECFP_4, FCFP_4, and FCFP_6.	[Pasupa, Kitsuchart; Kudisthalert, Wasu] King Mongkuts Inst Technol Ladkrabang, Fac Informat Technol, Bangkok 10520, Thailand	King Mongkuts Institute of Technology Ladkrabang	Pasupa, K (corresponding author), King Mongkuts Inst Technol Ladkrabang, Fac Informat Technol, Bangkok 10520, Thailand.	kitsuchart@it.kmitl.ac.th	Pasupa, Kitsuchart/ABB-2573-2020; Pasupa, Kitsuchart/A-8902-2010	Pasupa, Kitsuchart/0000-0001-8359-9888; Pasupa, Kitsuchart/0000-0001-8359-9888				Ben-Hur A, 2002, J MACH LEARN RES, V2, P125, DOI 10.1162/15324430260185565; Cao JW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/103054; Certara LP, 2017, UNITY FINGERPRINTS; Chen BN, 2006, J CHEM INF MODEL, V46, P478, DOI 10.1021/ci0505426; Chorowski J, 2014, NEUROCOMPUTING, V128, P507, DOI 10.1016/j.neucom.2013.08.009; Czarnecki WM, 2015, IEEE COMPUT INTELL M, V10, P19, DOI 10.1109/MCI.2015.2437312; Daylight Chemical Information Systems Inc, 2017, DAYL FING; Digital Chemistry Ltd, 2017, BCI FING; Edgar SJ, 2000, J MOL GRAPH MODEL, V18, P343, DOI 10.1016/S1093-3263(00)00061-9; Ellis D, 1993, PERSPECTIVES INFORM, V3, P128; Gardiner EJ, 2011, FUTURE MED CHEM, V3, P405, DOI [10.4155/fmc.11.4, 10.4155/FMC.11.4]; Han LY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-401; Holliday JD, 2002, COMB CHEM HIGH T SCR, V5, P155; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Jain AN, 2008, J COMPUT AID MOL DES, V22, P133, DOI 10.1007/s10822-008-9196-5; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Kudisthalert W, 2016, LECT NOTES COMPUT SC, V9947, P441, DOI 10.1007/978-3-319-46687-3_49; Kudisthalert W, 2016, INT CONF KNOWL SMART, P43, DOI 10.1109/KST.2016.7440525; Kurczab R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175410; Lan Y, 2008, IEEE IJCNN, P1859, DOI 10.1109/IJCNN.2008.4634051; Leach A. R., 2007, INTRO CHEMOINFORMATI; Lima AN, 2016, EXPERT OPIN DRUG DIS, V11, P225, DOI 10.1517/17460441.2016.1146250; Muegge I., 2006, DRUG DISCOV TODAY-TE, V3, P405, DOI [10.1016/j.ddtec.2006.12.002, DOI 10.1016/j.ddtec.2006.12.002, DOI 10.1016/J.DDTEC.2006.12.002]; Myint KZ, 2012, MOL PHARMACEUT, V9, P2912, DOI 10.1021/mp300237z; Nicholls A, 2008, J COMPUT AID MOL DES, V22, P239, DOI 10.1007/s10822-008-9170-2; Pasupa K., 2013, 13 IEEE INT C BIOINF, P1, DOI [10.1109/BIBE.2013.6701529, DOI 10.1109/BIBE.2013.6701529]; Pasupa K, 2012, KMITL J INFORM TECHN, V1, P60; Patra BK, 2015, KNOWL-BASED SYST, V82, P163, DOI 10.1016/j.knosys.2015.03.001; Riniker S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-26; Rohrer SG, 2009, J CHEM INF MODEL, V49, P169, DOI 10.1021/ci8002649; Siegel S., 1988, NONPARAMETRIC STAT B; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Wang G, NEUROCOMPUTING; Wilton DJ, 2006, J CHEM INF MODEL, V46, P471, DOI 10.1021/ci050397w; Xu D., 2015, ANN DATA SCI, V2, P165, DOI [10.1007/s40745-015-0040-1, DOI 10.1007/S40745-015-0040-1]	36	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195478	10.1371/journal.pone.0195478	http://dx.doi.org/10.1371/journal.pone.0195478			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652912	Green Submitted, gold, Green Published			2022-12-27	WOS:000430026900023
J	McIntosh, J; Alonso, A; MacLure, K; Stewart, D; Kempen, T; Mair, A; Castel-Branco, M; Codina, C; Fernandez-Llimos, F; Fleming, G; Gennimata, D; Gillespie, U; Harrison, C; Illario, M; Junius-Walker, U; Kampolis, CF; Kardas, P; Lewek, P; Malva, J; Menditto, E; Scullin, C; Wiese, B				McIntosh, Jennifer; Alonso, Albert; MacLure, Katie; Stewart, Derek; Kempen, Thomas; Mair, Alpana; Castel-Branco, Margarida; Codina, Carles; Fernandez-Llimos, Fernando; Fleming, Glenda; Gennimata, Dimitra; Gillespie, Ulrika; Harrison, Cathy; Illario, Maddalena; Junius-Walker, Ulrike; Kampolis, Christos F.; Kardas, Przemyslaw; Lewek, Pawel; Malva, Joao; Menditto, Enrica; Scullin, Claire; Wiese, Birgitt		SIMPATHY Consortium	A case study of polypharmacy management in nine European countries: Implications for change management and implementation	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; CARE MANAGEMENT; RISK-FACTORS; HEALTH-CARE; PREVALENCE; MULTIMORBIDITY; DISEASE; BURDEN	Background Multimorbidity and its associated polypharmacy contribute to an increase in adverse drug events, hospitalizations, and healthcare spending. This study aimed to address: what exists regarding polypharmacy management in the European Union (EU); why programs were, or were not, developed; and, how identified initiatives were developed, implemented, and sustained. Methods Change management principles (Kotter) and normalization process theory (NPT) informed data collection and analysis. Nine case studies were conducted in eight EU countries: Germany (Lower Saxony), Greece, Italy (Campania), Poland, Portugal, Spain (Catalonia), Sweden (Uppsala), and the United Kingdom (Northern Ireland and Scotland). The workflow included a review of country/region specific polypharmacy policies, key informant interviews with stakeholders involved in policy development and implementation and, focus groups of clinicians and managers. Data were analyzed using thematic analysis of individual cases and framework analysis across cases. Results Polypharmacy initiatives were identified in five regions (Catalonia, Lower Saxony, Northern Ireland, Scotland, and Uppsala) and included all care settings. There was agreement, even in cases without initiatives, that polypharmacy is a significant issue to address. Common themes regarding the development and implementation of polypharmacy management initiatives were: locally adapted solutions, organizational culture supporting innovation and teamwork, adequate workforce training, multidisciplinary teams, changes in workflow, redefinition of roles and responsibilities of professionals, policies and legislation supporting the initiative, and data management and information and communication systems to assist development and implementation. Depending on the setting, these were considered either facilitators or barriers to implementation. Conclusion Within the studied EU countries, polypharmacy management was not widely addressed. These results highlight the importance of change management and theory-based implementation strategies, and provide examples of polypharmacy management initiatives that can assist managers and policymakers in developing new programs or scaling up existing ones, particularly in places currently lacking such initiatives.	[McIntosh, Jennifer; Alonso, Albert] Fundacio Clin Recerca Biorned, Dept Recerca & Innovacio, Barcelona, Spain; [MacLure, Katie; Stewart, Derek] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland; [Kempen, Thomas; Gillespie, Ulrika] Uppsala Univ Hosp, Pharm Dept, Uppsala, Sweden; [Mair, Alpana] Scottish Govt, Effect Prescribing & Therapeut, Hlth & Social Care Directorate, Edinburgh, Midlothian, Scotland; [Castel-Branco, Margarida] Univ Coimbra, Lab Pharmacol & Pharmaceut Care, Fac Pharm, Coimbra, Portugal; [Codina, Carles] Hosp Clin Barcelona, Serv Farm, Barcelona, Spain; [Fernandez-Llimos, Fernando] Univ Lisbon, Inst Med Res, Dept Social Pharm, Fac Pharm, Lisbon, Portugal; [Fleming, Glenda] Northern Hlth & Social Care Trust, Pharm Dept, Belfast, Antrim, North Ireland; [Fleming, Glenda] Northern Hlth & Social Care Trust, Reg Med Optimisat Innovat Ctr MOIC, Belfast, Antrim, North Ireland; [Gennimata, Dimitra; Kampolis, Christos F.] Univ Peloponnese, Dept Social & Educ Policy, Korinthos, Greece; [Gennimata, Dimitra; Kampolis, Christos F.] Ist Reg Hlth Author Attica, eHlth Innovat Unit, Athens, Greece; [Harrison, Cathy] Dept Hlth, Belfast, Antrim, North Ireland; [Illario, Maddalena] Federico II Univ Hosp, Naples, Italy; [Junius-Walker, Ulrike; Wiese, Birgitt] Hannover Med Sch, Inst Gen Practice, Hannover, Germany; [Kardas, Przemyslaw; Lewek, Pawel] Med Univ Lodz, Dept Family Med, Lodz, Poland; [Malva, Joao] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci, Coimbra, Portugal; [Malva, Joao] Univ Coimbra, Fac Med, Inst Pharmacol & Expt Therapeut, Coimbra, Portugal; [Menditto, Enrica] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy; [Scullin, Claire] Queens Univ, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland	Robert Gordon University; Uppsala University; Uppsala University Hospital; Universidade de Coimbra; University of Barcelona; Hospital Clinic de Barcelona; Universidade de Lisboa; University of Peloponnese; University of Naples Federico II; Hannover Medical School; Medical University Lodz; Universidade de Coimbra; Universidade de Coimbra; University of Naples Federico II; Queens University Belfast	McIntosh, J (corresponding author), Fundacio Clin Recerca Biorned, Dept Recerca & Innovacio, Barcelona, Spain.	mcintosh@clinic.cat	Fernandez-Llimos, Fernando/B-8931-2008; Castel-Branco, Maria Margarida/A-2093-2017; iMed.ULisboa, PEPSocPh/B-4101-2014; MacLure, Katie/GRJ-8912-2022; Malva, Joao/L-3557-2014	Fernandez-Llimos, Fernando/0000-0002-8529-9595; Castel-Branco, Maria Margarida/0000-0002-6533-9932; Alonso, Albert/0000-0003-0921-8033; fleming, glenda/0000-0001-7321-8092; orlando, valentina/0000-0002-8209-8878; McIntosh, Jenifer/0000-0002-8140-9304; Kempen, Thomas/0000-0001-5173-5005; Kardas, Przemyslaw/0000-0002-6078-2628; MacLure, Katie/0000-0003-0686-948X; Malva, Joao/0000-0002-5438-4447; menditto, enrica/0000-0001-8633-5650; Lewek, Pawel/0000-0003-3690-7096	SIMPATHY project [663082]; European Commission CHAFEA Health Program	SIMPATHY project; European Commission CHAFEA Health Program	This work has been supported by the SIMPATHY project, grant agreement number 663082 to AM, co-funded by the European Commission CHAFEA Health Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Benziger CP, 2016, GLOB HEART, V11, P393, DOI 10.1016/j.gheart.2016.10.024; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Canadian Electronic Library (Firm), BETT HLTH BETT CAR B; Cooper JA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009235; Craig P, 2006, DEV EVALUATING COMPL; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Foster M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1270-4; Fu S, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140205; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Guiding principles for the care of older adults with multimorbidity: an approach for clinicians, 2012, J Am Geriatr Soc, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Holtrop JS, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1613-1; Iles V, 2001, NATL COORDINATING CT; Institute of Medicine (U. S.), 2001, COMM QUAL HLTH CAR A, pxx; Jager C, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-016-0535-y; Kojima G, 2012, JAMDA, V13, pe11; Kotter J. P, 2012, LEADING CHANGE; Lee JK, 2013, J AM GERIATR SOC, V61, P1119, DOI 10.1111/jgs.12323; Loffler C, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0151-7; Mair AF-LF, 2017, SIMPATHY CONSORTIUM; Marcum ZA, 2012, J AM GERIATR SOC, V60, P34, DOI 10.1111/j.1532-5415.2011.03772.x; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Molokhia M, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0642-0; OECD/EU, 2016, 2016 STAT HLTH EU CY; Patterson SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008165.pub3, 10.1002/14651858.CD008165.pub4]; Payne RA, 2011, BRIT J GEN PRACT, V61, P83, DOI 10.3399/bjgp11X556146; Petrovic M, 2016, DRUG AGING, V33, P179, DOI 10.1007/s40266-016-0352-7; Rollason V, 2003, DRUG AGING, V20, P817, DOI 10.2165/00002512-200320110-00003; Stewart D, 2017, PLOS ONE; Stewart D, 2017, EXPERT OPIN DRUG SAF, V16, P203, DOI 10.1080/14740338.2017.1265503; Stewart D, 2016, INT J CLIN PHARM-NET, V38, P615, DOI 10.1007/s11096-015-0216-y; Stoehr GP, 2008, AM J GERIATR PHARMAC, V6, P255, DOI 10.1016/j.amjopharm.2008.11.001; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Valentijn PP, 2013, INT J INTEGR CARE, V13; Valentijn PP, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0278-x; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54; van Oostrom SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160264; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; World Health Organization, 2017, MED HARM; World Health Organization, 2016, MULT TECHN SER SAF P; Yin R.K., 2017, APPL CASE STUDY RES; Yuksel I., 2012, IJBM, V7, P14; Zulman DM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007771	50	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195232	10.1371/journal.pone.0195232	http://dx.doi.org/10.1371/journal.pone.0195232			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668763	Green Published, gold			2022-12-27	WOS:000430290200034
J	Mitchell, R; Buckingham, L; Cobleigh, M; Rotmensch, J; Burgess, K; Usha, L				Mitchell, Rachel; Buckingham, Lela; Cobleigh, Melody; Rotmensch, Jacob; Burgess, Kelly; Usha, Lydia			Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?	PLOS ONE			English	Article							BILATERAL PROPHYLACTIC MASTECTOMY; FETAL CELL MICROCHIMERISM; BREAST-CANCER; OVARIAN-CANCER; GLIOBLASTOMA-MULTIFORME; MUTATION CARRIERS; DONOR TRANSMISSION; MALIGNANT-MELANOMA; GENE MUTATION; RISK	Hereditary breast and ovarian cancer syndrome (HBOC) is most frequently caused by mutations in BRCA1 or BRCA2 (in short, BRCA) genes. The incidence of hereditary breast and ovarian cancer in relatives of BRCA mutation carriers who test negative for the familial mutation (non-carriers) may be increased. However, the data is controversial, and at this time, these individuals are recommended the same cancer surveillance as general population. One possible explanation for BRCA phenocopies (close relatives of BRCA carriers who have developed cancer consistent with HBOC but tested negative for a familial mutation) is natural chimerism where lack of detectable mutation in blood may not rule out the presence of the mutation in the other tissues. To test this hypothesis, archival tumor tissue from eleven BRCA phenocopies was investigated. DNA from the tumor tissue was analyzed using sequence-specific PCR, capillary electrophoresis, and pyrosequencing. The familial mutations were originally detected in the patients' first-degree relatives by commercial testing. The same testing detected no mutations in the blood of the patients under study. The test methods targeted only the known familial mutation in the tumor tissue. Tumor diagnoses included breast, ovarian, endometrial and primary peritoneal carcinoma. None of the familial mutations were found in the tumor samples tested. These results do not support, but do not completely exclude, the possibility of chimerism in these patients. Further studies with comprehensive sequence analysis in a larger patient group are warranted as a chimeric state would further refine the predictive value of genetic testing to include BRCA phenocopies.	[Mitchell, Rachel; Cobleigh, Melody; Burgess, Kelly; Usha, Lydia] Rush Univ, Med Ctr, Dept Internal Med, Div Hematol Oncol & Cell Therapy, Chicago, IL 60612 USA; [Buckingham, Lela] Rush Univ, Med Ctr, Dept Pathol, Div Med Lab Sci, Chicago, IL 60612 USA; [Rotmensch, Jacob] Rush Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol, Chicago, IL 60612 USA	Rush University; Rush University; Rush University	Usha, L (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Div Hematol Oncol & Cell Therapy, Chicago, IL 60612 USA.	Lydia_usha@rush.edu		Cobleigh, Melody/0000-0001-6385-4693				Abuelo D, 2009, AM J MED GENET C, V151C, P148, DOI 10.1002/ajmg.c.30213; Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127; [Anonymous], 2017, THE MYR ADV; [Anonymous], WHAT AR SINGL NUCL P; [Anonymous], 2017, GENETIC FAMILIAL HIG; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Azzollini J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171663; Bajaj NS, 2010, TRANSPL INT, V23, pe26, DOI 10.1111/j.1432-2277.2010.01090.x; Broestl L, 2018, BRAIN PATHOL, V28, P484, DOI 10.1111/bpa.12557; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Cirello V, 2016, J CANCER RES CLIN, V142, P1697, DOI 10.1007/s00432-015-2110-3; Cuzick J, 2017, J CLIN ONCOL, V35, P743, DOI 10.1200/JCO.2016.69.8944; Daly MB, 2010, J NATL COMPR CANC NE, V8, P562, DOI 10.6004/jnccn.2010.0043; Dhillon KK, 2011, CANCER SCI, V102, P663, DOI 10.1111/j.1349-7006.2010.01840.x; Domchek SM, 2010, BREAST CANCER RES TR, V119, P409, DOI 10.1007/s10549-009-0611-y; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; EASTON DF, 1995, AM J HUM GENET, V56, P265; Evans DG, 2017, J MED GENET, V54, P104, DOI 10.1136/jmedgenet-2016-104125; Fatt MA, 2008, J COMPUT ASSIST TOMO, V32, P407, DOI 10.1097/RCT.0b013e318076b472; Fischer C, 2012, CLIN GENET, V82, P478, DOI 10.1111/j.1399-0004.2011.01788.x; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Gadi VK, 2007, CANCER RES, V67, P9035, DOI 10.1158/0008-5472.CAN-06-4209; Gadi VK, 2010, BREAST CANCER RES TR, V121, P241, DOI 10.1007/s10549-009-0548-1; Geiger AM, 2005, ARCH INTERN MED, V165, P516, DOI 10.1001/archinte.165.5.516; Goldgar D, 2007, J MED GENET, V44; Gronwald J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048462; Hamdi Y, 2017, BREAST CANCER RES TR, V161, P117, DOI 10.1007/s10549-016-4018-2; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Heemskerk-Gerritsen BAM, 2007, ANN SURG ONCOL, V14, P3335, DOI 10.1245/s10434-007-9449-x; Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jackish Christian, 2003, Archives of Gynecology and Obstetrics, V268, P69; Jonas S, 1996, TRANSPLANT INT, V9, P426, DOI 10.1111/j.1432-2277.1996.tb00903.x; Kallenbach LR, 2011, CANCER RES, V71, P8, DOI 10.1158/0008-5472.CAN-10-0618; Kim JK, 2009, CLIN TRANSPLANT, V23, P571, DOI 10.1111/j.1399-0012.2008.00928.x; Korde LA, 2011, BREAST CANCER RES TR, V125, P169, DOI 10.1007/s10549-010-0923-y; Kuchenbaecker KB, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw302; Kurian AW, 2011, J CLIN ONCOL, V29, P4505, DOI 10.1200/JCO.2010.34.4440; Lipsker D, 2008, ARCH DERMATOL, V144, P327, DOI 10.1001/archderm.144.3.327; Malone KE, 2010, J CLIN ONCOL, V28, P2404, DOI 10.1200/JCO.2009.24.2495; Mangold KA, 2010, J MOL DIAGN, V12, P20, DOI 10.2353/jmoldx.2010.090023; Marcus JN, 1996, CANCER-AM CANCER SOC, V77, P697, DOI 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W; Maurel MC, 2008, BIOL REPROD, V79, P2, DOI 10.1095/biolreprod.107.065607; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; Metcalfe KA, 2009, BRIT J CANCER, V100, P421, DOI 10.1038/sj.bjc.6604830; Miura K, 2005, J HUM GENET, V50, P1, DOI 10.1007/s10038-004-0216-6; Nemescu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147675; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Peters HE, 2017, TWIN RES HUM GENET, V20, P161, DOI 10.1017/thg.2017.4; Pinborg A, 2005, HUM REPROD, V20, P2821, DOI 10.1093/humrep/dei142; Pinborg A, 2006, BRIT J HOSP MED, V67, P417, DOI 10.12968/hmed.2006.67.8.21976; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Rinkevich Baruch, 2011, Chimerism, V2, P1, DOI 10.4161/chim.2.1.14725; Robson M, 2011, J CLIN ONCOL, V29, P4477, DOI 10.1200/JCO.2011.37.6483; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Sawicki JA, 2008, CANCER RES, V68, P9567, DOI 10.1158/0008-5472.CAN-08-3008; Schorge JO, 2010, GYNECOL ONCOL, V119, P7, DOI 10.1016/j.ygyno.2010.06.003; Smith A, 2007, J MED GENET, V44, P10, DOI 10.1136/jmg.2006.043091; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Uysal NS, 2018, J OBSTET GYNAECOL RE, V44, P576, DOI 10.1111/jog.13514; VALBERNAL F, 1993, HUM PATHOL, V24, P1256, DOI 10.1016/0046-8177(93)90224-5; Venkitaraman AR, 2002, CELL, DOI [10.1073/pnas.171174298, DOI 10.1073/PNAS.171174298]; von Boehmer L, 2012, LUNG CANCER, V76, P118, DOI 10.1016/j.lungcan.2011.10.001; Williams CA, 2004, HUM REPROD, V19, P2816, DOI 10.1093/humrep/deh533; Win AK, 2012, J CLIN ONCOL, V30, P958, DOI 10.1200/JCO.2011.39.5590; Ye Y, 2010, INT J MOL EPIDEMIOL, V1, P350; Yunis EJ, 2007, IMMUNOL RES, V38, P213, DOI 10.1007/s12026-007-0013-3; Zhang LY, 2009, J MOL DIAGN, V11, P176, DOI 10.2353/jmoldx.2009.080137; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298	76	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195497	10.1371/journal.pone.0195497	http://dx.doi.org/10.1371/journal.pone.0195497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659587	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100019
J	Rivera, SF; Vasselon, V; Ballorain, K; Carpentier, A; Wetzel, CE; Ector, L; Bouchez, A; Rimet, F				Rivera, Sinziana F.; Vasselon, Valentin; Ballorain, Katia; Carpentier, Alice; Wetzel, Carlos E.; Ector, Luc; Bouchez, Agnes; Rimet, Frederic			DNA metabarcoding and microscopic analyses of sea turtles biofilms: Complementary to understand turtle behavior	PLOS ONE			English	Article							THROUGHPUT SEQUENCING HTS; MARINE TURTLES; EPIZOAN COMMUNITIES; GREEN TURTLES; BARNACLES CIRRIPEDIA; NOV. BACILLARIOPHYTA; SPATIAL-DISTRIBUTION; DIATOM COMMUNITIES; BENTHIC DIATOMS; CHELONIA-MYDAS	Sea turtles are distributed in tropical and subtropical seas worldwide. They play several ecological roles and are considered important indicators of the health of marine ecosystems. Studying epibiotic diatoms living on turtle shells suggestively has great potential in the study of turtle behavior because diatoms are always there. However, diatom identification at the species level is time consuming, requires well-trained specialists, and there is a high probability of finding new taxa growing on turtle shells, which makes identification tricky. An alternative approach based on DNA barcoding and high throughput sequencing (HTS), metabarcoding, has been developed in recent years to identify species at the community level by using a DNA reference library. The suitabilities of morphological and molecular approaches were compared. Diatom assemblages were sampled from seven juvenile green turtles (Chelonia mydas) from Mayotte Island, France. The structures of the epibiotic diatom assemblages differed between both approaches. This resulted in different clustering of the turtles based on their diatom communities. Metabarcoding allowed better discrimination between turtles based on their epibiotic diatom assemblages and put into evidence the presence of a cryptic diatom diversity. Microscopy, for its part, provided more ecological information of sea turtles based on historical bibliographical data and the abundances of ecological guilds of the diatom species present in the samples. This study shows the complementary nature of these two methods for studying turtle behavior.	[Rivera, Sinziana F.; Vasselon, Valentin; Bouchez, Agnes; Rimet, Frederic] Univ Savoie Mt Blanc, INRA, UMR CARRTEL, Thonon Les Bains, France; [Ballorain, Katia] Agence Francaise Biodiversite, Parc Nat Marin Mayotte,14 Lot Darine Montjoly, Iloni, Mayotte, France; [Ballorain, Katia; Carpentier, Alice] Assoc Escale, 13 Bis Rue Foundi Madi Attoumani, Mronabeja, Mayotte, France; [Wetzel, Carlos E.; Ector, Luc] LIST, 41 Rue Brill, Belvaux, Luxembourg	INRAE; Luxembourg Institute of Science & Technology	Rivera, SF (corresponding author), Univ Savoie Mt Blanc, INRA, UMR CARRTEL, Thonon Les Bains, France.	sinzianaflorina@gmail.com	RIMET, Frédéric/S-2702-2018; Vasselon, Valentin/Q-7670-2019; Vasselon, Valentin/X-8504-2018	RIMET, Frédéric/0000-0002-5514-869X; Vasselon, Valentin/0000-0001-5038-7918; Vasselon, Valentin/0000-0001-5038-7918; Bouchez, Agnes/0000-0001-8802-6966; Carpentier, Alice/0000-0001-9673-7864; Rivera, Sinziana F./0000-0002-0812-9031	French Agency for Biodiversity (AFB, Agence Francaise de la Biodiversite); French Agency for Biodiversity (AFB, Agence Francaise pour la Biodiversite)	French Agency for Biodiversity (AFB, Agence Francaise de la Biodiversite); French Agency for Biodiversity (AFB, Agence Francaise pour la Biodiversite)	This work was supported by the French Agency for Biodiversity (AFB, Agence Francaise de la Biodiversite). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the French Agency for Biodiversity (AFB, Agence Francaise pour la Biodiversite) for its support.	Apotheloz-Perret-Gentil L, 2017, MOL ECOL RESOUR, V17, P1231, DOI 10.1111/1755-0998.12668; Ballorain K, 2013, MAR ECOL PROG SER, V483, P289, DOI 10.3354/meps10301; Ballorain K, 2010, MAR BIOL, V157, P2581, DOI 10.1007/s00227-010-1520-7; BIGGS BJF, 1993, NEW ZEAL J MAR FRESH, V27, P39, DOI 10.1080/00288330.1993.9516544; Bjorndal KA, 2003, CRC MAR BIOL SER, P259; Bjorndal Karen A., 1997, P199; Bouchard SS, 2000, ECOLOGY, V81, P2305, DOI 10.1890/0012-9658(2000)081[2305:STABTO]2.0.CO;2; Bourjea Jerome, 2006, Western Indian Ocean Journal of Marine Science, V5, P209; Bugoni L, 2001, MAR POLLUT BULL, V42, P1330, DOI 10.1016/S0025-326X(01)00147-3; Casale P, 2012, CRUSTACEANA, V85, P533, DOI 10.1163/156854012X634393; CEN, 2016, 230N1008 CENTC, P7; CEN, 2002, 13946 CEN, P718; CEN, 2003, 14407 CEN, P13; Chessman B, 1999, FRESHWATER BIOL, V41, P317, DOI 10.1046/j.1365-2427.1999.00433.x; Cox E.J., 1984, VERH INT VER LIMNOL, V22, P924; Eckert Scott A., 1999, P88; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Semary NA, 2016, BANGL J BOT, V45, P1113; Enstipp MR, 2011, J EXP BIOL, V214, P4010, DOI 10.1242/jeb.062943; Epperly SP, 1996, OCEANOGR LIT REV, V1, P61; Evans KM, 2008, J PHYCOL, V44, P215, DOI 10.1111/j.1529-8817.2007.00454.x; Fayolle S, 2016, CRYPTOGAMIE ALGOL, V37, P221, DOI 10.7872/crya/v37.iss4.2016.221; Frankovich TA, 2016, PHYTOTAXA, V272, P101, DOI 10.11646/phytotaxa.272.2.1; Frankovich TA, 2015, PHYTOTAXA, V234, P227, DOI 10.11646/phytotaxa.234.3.3; Frankovich TA, 2015, PHYTOTAXA, V204, P33, DOI 10.11646/phytotaxa.204.1.3; FRAZIER J, 1985, MAR ECOL-P S Z N I, V6, P127, DOI 10.1111/j.1439-0485.1985.tb00134.x; Frazier J., 1999, USITC PUBL, V4; FRAZIER JG, 1992, B MAR SCI, V51, P1; FRAZIER JG, 1991, B MAR SCI, V48, P763; Fukuoka T, 2015, ENDANGER SPECIES RES, V28, P1, DOI 10.3354/esr00671; Fuller WJ, 2010, J NAT HIST, V44, P1743, DOI 10.1080/00222931003624820; Gerrodette T, 1999, USITC PUBL, V4; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guilcher A, 1965, RECIFS CORALLIENS LA; Hannan LB, 2007, ECOLOGY, V88, P1053, DOI 10.1890/06-0629; Hayashi R, 2008, ECOL RES, V23, P121, DOI 10.1007/s11284-007-0349-0; Hayashi R, 2013, J MAR BIOL ASSOC UK, V93, P143, DOI 10.1017/S0025315412000847; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hein Michael K., 2008, V19; Henwood TA, 1999, USITC PUBL, V4; Jean C, 2010, ORYX, V44, P223, DOI 10.1017/S003060530999072X; Kahlert M, 2009, J APPL PHYCOL, V21, P471, DOI 10.1007/s10811-008-9394-5; Keck F, 2017, FRONT ECOL ENVIRON, V15, P266, DOI 10.1002/fee.1490; Keck F, 2016, ECOL APPL, V26, P861, DOI 10.1890/14-1966; Kelly MG, 2015, DIATOM RES, V30, P27, DOI 10.1080/0269249X.2014.951398; Kermarrec L, 2014, FRESHW SCI, V33, P349, DOI 10.1086/675079; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Levkov Z., 2009, DIATOMS EUROPE, V5, P916; Majewska R, 2016, DIATOMEDEDELINGEN, V40, P35; Majewska R, 2017, NOVA HEDWIGIA, V146, P221; Majewska R, 2017, MICROB ECOL, V74, P969, DOI 10.1007/s00248-017-0987-x; Majewska R, 2017, BOT MAR, V60, P303, DOI 10.1515/bot-2016-0114; Majewska R, 2015, PHYTOTAXA, V233, P236, DOI 10.11646/phytotaxa.233.3.2; Majewska R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130351; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Mann DG, 2004, PHYCOLOGIA, V43, P459, DOI 10.2216/i0031-8884-43-4-459.1; MEDLIN LK, 1991, J PHYCOL, V27, P514, DOI 10.1111/j.0022-3646.1991.00514.x; Medlin LK, 1997, PLANT SYST EVOL, P187; Pavlov A, 2016, DIATOM RES, V31, P85, DOI 10.1080/0269249X.2016.1157376; Pike DA, 2013, GLOBAL ECOL BIOGEOGR, V22, P555, DOI 10.1111/geb.12025; Riaux-Gobin C, 2017, 2 NEW TURSIOCOLA SPE; Riaux-Gobin C, 2015, FOTTEA, V15, P139, DOI 10.5507/fot.2015.015; Riaux-Gobin C, 2012, FOTTEA, V12, P199, DOI 10.5507/fot.2012.015; Richard M., 1987, ATLAS PHYTOPLANKTON, P285; Rimet F, ORG DIVERS EVOL, P1; Rimet F, 2018, FOTTEA, V18, P37, DOI 10.5507/fot.2017.013; Rimet F, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw016; Rimet F, 2012, HYDROBIOLOGIA, V683, P1, DOI 10.1007/s10750-011-0949-0; Rimet F, 2012, ECOL INDIC, V15, P92, DOI 10.1016/j.ecolind.2011.09.014; Rivera SF, 2018, HYDROBIOLOGIA, V807, P37, DOI 10.1007/s10750-017-3381-2; Robinson DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184286; Robinson NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157011; Roos D, 2005, AQUAT LIVING RESOUR, V18, P193, DOI 10.1051/alr:2005021; Rovira L, 2015, J EUKARYOT MICROBIOL, V62, P815, DOI 10.1111/jeu.12240; Schroeder B, 1999, USITC PUBL, V4; Schwartz FJ, 1978, FLORIDA MARINE RES P, V33, P16; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Souffreau C, 2013, PROTIST, V164, P101, DOI 10.1016/j.protis.2012.04.001; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tapolczai K, 2017, SCI TOTAL ENVIRON, V607, P1293, DOI 10.1016/j.scitotenv.2017.07.093; Tison J, 2005, WATER RES, V39, P3177, DOI 10.1016/j.watres.2005.05.029; Trobajo R, 2013, DIATOM RES, V28, P37, DOI 10.1080/0269249X.2012.734531; Vanelslander B, 2009, J PHYCOL, V45, P1278, DOI 10.1111/j.1529-8817.2009.00762.x; Vasselon V, 2018, METHODS ECOL EVOL, V9, P1060, DOI 10.1111/2041-210X.12960; Vasselon V, 2017, ECOL INDIC, V82, P1, DOI 10.1016/j.ecolind.2017.06.024; Vasselon V, 2017, FRESHW SCI, V36, P162, DOI 10.1086/690649; Visco JA, 2015, ENVIRON SCI TECHNOL, V49, P7597, DOI 10.1021/es506158m; Wetzel CE, 2010, VIE MILIEU, V60, P177; Wetzel CE, 2012, DIATOM RES, V27, P1, DOI 10.1080/0269249X.2011.642498; Witkowski A, 2000, ICONOGRAPHIA DIATOMO, V7; Wu SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171910; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	93	34	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195770	10.1371/journal.pone.0195770	http://dx.doi.org/10.1371/journal.pone.0195770			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659610	Green Published, gold, Green Submitted			2022-12-27	WOS:000430061100029
J	Brockett, AT; Kane, GA; Monari, PK; Briones, BA; Vigneron, PA; Barber, GA; Bermudez, A; Dieffenbach, U; Kloth, AD; Buschman, TJ; Gould, E				Brockett, Adam T.; Kane, Gary A.; Monari, Patrick K.; Briones, Brandy A.; Vigneron, Pierre-Antoine; Barber, Gabriela A.; Bermudez, Andres; Dieffenbach, Uma; Kloth, Alexander D.; Buschman, Timothy J.; Gould, Elizabeth			Evidence supporting a role for astrocytes in the regulation of cognitive flexibility and neuronal oscillations through the Ca2+ binding protein S100 beta	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PREFRONTAL CORTEX; MOOD DISORDERS; D-SERINE; IN-VIVO; GAMMA; SCHIZOPHRENIA; PATHOLOGY; RELEASE; PERSPECTIVE	The medial prefrontal cortex (mPFC) is important for cognitive flexibility, the ability to switch between two task-relevant dimensions. Changes in neuronal oscillations and alterations in the coupling across frequency ranges have been correlated with attention and cognitive flexibility. Here we show that astrocytes in the mPFC of adult male Sprague Dawley rats, participate in cognitive flexibility through the astrocyte-specific Ca2+ binding protein S100 beta, which improves cognitive flexibility and increases phase amplitude coupling between theta and gamma oscillations. We further show that reduction of astrocyte number in the mPFC impairs cognitive flexibility and diminishes delta, alpha and gamma power. Conversely, chemogenetic activation of astrocytic intracellular Ca2+ signaling in the mPFC enhances cognitive flexibility, while inactivation of endogenous S100 beta among chemogenetically activated astrocytes in the mPFC prevents this improvement. Collectively, our work suggests that astrocytes make important contributions to cognitive flexibility and that they do so by releasing a Ca2+ binding protein which in turn enhances coordinated neuronal oscillations.	[Brockett, Adam T.; Kane, Gary A.; Monari, Patrick K.; Briones, Brandy A.; Vigneron, Pierre-Antoine; Barber, Gabriela A.; Bermudez, Andres; Dieffenbach, Uma; Buschman, Timothy J.; Gould, Elizabeth] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Brockett, Adam T.; Kane, Gary A.; Monari, Patrick K.; Briones, Brandy A.; Vigneron, Pierre-Antoine; Barber, Gabriela A.; Bermudez, Andres; Dieffenbach, Uma; Buschman, Timothy J.; Gould, Elizabeth] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Kloth, Alexander D.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Kloth, Alexander D.] Univ North Carolina Chapel Hill, Neurosci Ctr, Chapel Hill, NC USA	Princeton University; Princeton University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Gould, E (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.; Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	goulde@princeton.edu	Buschman, Timothy J/B-3056-2009; Core, Vector/CAF-4832-2022	Buschman, Timothy J/0000-0003-1298-2761; Monari, Patrick/0000-0003-4699-3004; Vigneron, Pierre-Antoine/0000-0003-2918-0909; Briones, Brandy/0000-0003-4692-3399				Anderson CM, 2000, GLIA, V32, P1; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Birrell JM, 2000, J NEUROSCI, V20, P4320; Brockett AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124859; Bull C, 2014, NEUROPSYCHOPHARMACOL, V39, P2835, DOI 10.1038/npp.2014.135; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Clasadonte J, 2017, NEURON, V95, P1365, DOI 10.1016/j.neuron.2017.08.022; Dajani DR, 2015, TRENDS NEUROSCI, V38, P571, DOI 10.1016/j.tins.2015.07.003; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khurgel M, 1996, GLIA, V16, P351, DOI 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2; Lee HS, 2014, P NATL ACAD SCI USA, V111, pE3343, DOI 10.1073/pnas.1410893111; Lima A, 2014, MOL PSYCHIATR, V19, P834, DOI 10.1038/mp.2013.182; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Morquette P, 2015, NAT NEUROSCI, V18, P844, DOI 10.1038/nn.4013; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parpura V, 2012, ASN NEURO, V4, P201, DOI 10.1042/AN20120019; Piguet C, 2016, HUM BRAIN MAPP, V37, P1335, DOI 10.1002/hbm.23104; Plume A., 2014, SCI ENG ETHICS, V38, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Poskanzer KE, 2016, P NATL ACAD SCI USA, V113, pE2675, DOI 10.1073/pnas.1520759113; Rajkowska G, 2002, SCHIZOPHR RES, V57, P127, DOI 10.1016/S0920-9964(02)00339-0; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sampedro-Piquero P, 2014, NEUROBIOL LEARN MEM, V114, P16, DOI 10.1016/j.nlm.2014.04.002; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Schmitt A, 2009, ACTA NEUROPATHOL, V117, P395, DOI 10.1007/s00401-008-0430-y; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Scofield MD, 2015, BIOL PSYCHIAT, V78, P441, DOI 10.1016/j.biopsych.2015.02.016; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Takano T, 2014, GLIA, V62, P78, DOI 10.1002/glia.22588; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Thoma P, 2007, SCHIZOPHR RES, V92, P168, DOI 10.1016/j.schres.2007.02.004; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Verkhratsky A, 2016, PROG NEUROBIOL, V144, P188, DOI 10.1016/j.pneurobio.2015.09.003; Voloh B, 2015, P NATL ACAD SCI USA, V112, P8457, DOI 10.1073/pnas.1500438112; Weber B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020396; Xie L, 2013, SCIENCE, V342, P272; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100	43	32	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195726	10.1371/journal.pone.0195726	http://dx.doi.org/10.1371/journal.pone.0195726			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664924	gold, Green Submitted, Green Published			2022-12-27	WOS:000430262300028
J	Nemoto, Y; Sato, S; Takahashi, M; Takeda, N; Matsushita, M; Kitabatake, Y; Maruo, K; Arao, T				Nemoto, Yuta; Sato, Shinichiro; Takahashi, Masaki; Takeda, Noriko; Matsushita, Munehiro; Kitabatake, Yoshinori; Maruo, Kazushi; Arao, Takashi			The association of single and combined factors of sedentary behavior and physical activity with subjective cognitive complaints among community-dwelling older adults: Cross-sectional study	PLOS ONE			English	Article							INTERVENTIONS; RELIABILITY; DEPRESSION; EXERCISE; VALIDITY; HEALTH; SCALE; RISK	Subjective cognitive complaints (SCC) might be a meaningful indicator of dementia onset or mild cognitive impairment, and identifying the related factors of SCC could contribute to preventing these diseases. However, the relationship between SCC and lifestyle factors remains largely unproven. The purpose of this study was to examine the association of type of sedentary behavior, physical activity, or their combination with SCC among community-dwelling older adults. In 2016, 6677 community-living elderly were recruited to participate in a survey investigating cognition, physical activity, and sedentary behavior. In total, 5328 participants responded to the questionnaire (79.8% valid response rate). SCC was assessed using the National Functional Survey Questionnaire (Kihon checklist). The relationships between SCC and physical activity, sedentary behavior (reading books or newspapers, and television viewing), or combined physical activity and sedentary behavior were examined via multiple logistic regression analysis. The analysis revealed that moderate-to-vigorous physical activity (>= 150 min/week) was significantly related with a lower risk of SCC (odds ratio [OR] = 0.85; 95% confidence interval [CI] = 0.74-0.97), and that reading behavior showed a dose-response relationship with SCC (OR for 10-20 min/day = 0.63; 95% CI = 0.53-0.75; OR for 20-30 min/day = 0.59; 95% CI = 0.49-0.71; OR for >= 30 min/day = 0.47; 95% CI = 0.39-0.57). In addition, among those reporting high physical activity and >= 30 min/day for reading time, the OR for SCC was 0.40 (95% CI = 0.32-0.50) compared with the combined group reporting lower physical activity and non-readers. The present study shows that increased physical activity and reading time may be related to a reduced risk for SCC among community-dwelling older adults.	[Nemoto, Yuta] Waseda Univ, Grad Sch Sport Sci, Saitama, Japan; [Sato, Shinichiro] Univ Human Arts & Sci, Fac Hlth Sci, Saitama, Japan; [Takahashi, Masaki] Waseda Univ, Org Univ Res Initiat, Tokyo, Japan; [Takeda, Noriko] Kogakuin Univ, Div Liberal Arts, Tokyo, Japan; [Matsushita, Munehiro] Dokkyo Med Univ, Dept Publ Hlth, Mibu, Tochigi, Japan; [Kitabatake, Yoshinori] Saitama Prefectural Univ, Dept Hlth Sci, Saitama, Japan; [Maruo, Kazushi] Univ Tsukuba, Fac Med, Ibaraki, Japan; [Arao, Takashi] Waseda Univ, Fac Sport Sci, Saitama, Japan	Waseda University; Waseda University; Kogakuin University; Dokkyo Medical University; University of Tsukuba; Waseda University	Arao, T (corresponding author), Waseda Univ, Fac Sport Sci, Saitama, Japan.	tarao@waseda.jp	Maruo, Kazushi/I-2538-2014; Nemoto, Yuta/AAC-9489-2020	Maruo, Kazushi/0000-0002-3093-0386; Nemoto, Yuta/0000-0002-6439-0015; Arao, Takashi/0000-0002-4790-5021; Takahashi, Masaki/0000-0002-4038-8164	Japan Society for the Promotion of Science [15H03089]; Meiji Yasuda Life Foundation of Health and Welfare	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare)	This study was supported by Grant-in-Aid for Scientific Research (15H03089) from the Japan Society for the Promotion of Science and Health science research grant for young researchers from Meiji Yasuda Life Foundation of Health and Welfare. TA and YN received the funding, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2015, GERIATR GERONTOL INT, V15, P518, DOI 10.1111/ggi.12397; Bakrania K, 2018, AM J EPIDEMIOL, V187, P441, DOI 10.1093/aje/kwx273; Bakrania K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2694-9; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bauman A, 2016, GERONTOLOGIST, V56, pS268, DOI 10.1093/geront/gnw031; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; Burmester B, 2016, NEUROPSYCHOL REV, V26, P376, DOI 10.1007/s11065-016-9332-2; Canevelli M, 2013, AM J ALZHEIMERS DIS, V28, P560, DOI 10.1177/1533317513494441; Chomistek AK, 2013, J AM COLL CARDIOL, V61, P2346, DOI 10.1016/j.jacc.2013.03.031; Demirtas H, 2008, STAT MED, V27, P4086, DOI 10.1002/sim.3239; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Falck RS, 2017, BRIT J SPORT MED, V51, P800, DOI 10.1136/bjsports-2015-095551; Geda YE, 2011, J NEUROPSYCH CLIN N, V23, P149, DOI 10.1176/appi.neuropsych.23.2.149; Hamer M, 2014, MED SCI SPORT EXER, V46, P718, DOI 10.1249/MSS.0000000000000156; Hiura M, 2014, J CEREBR BLOOD F MET, V34, P389, DOI 10.1038/jcbfm.2013.220; Kesse-Guyot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047831; Kikuchi H, 2017, GERIATR GERONTOL INT, V17, P1921, DOI 10.1111/ggi.12995; Kikuchi H, 2014, PREV MED, V67, P335, DOI 10.1016/j.ypmed.2014.08.011; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Meguro K., 2012, JPN J GERIATR PSYCHI, V23, P725; Nyunt MSZ, 2009, AGING MENT HEALTH, V13, P376, DOI 10.1080/13607860902861027; Oltmanns J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00117; Rosenberg DE, 2016, J GERONTOL A-BIOL, V71, P78, DOI 10.1093/gerona/glv103; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Saito Tami, 2015, Nihon Koshu Eisei Zasshi, V62, P596, DOI 10.11236/jph.62.10_596; Schmid D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119591; Tomata Y, 2017, GERIATR GERONTOL INT, V17, P1300, DOI 10.1111/ggi.12864; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Vance DE, 2005, J AGING PHYS ACTIV, V13, P294, DOI 10.1123/japa.13.3.294; World Health Organization, GLOB REC PHYS ACT HL; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	32	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195384	10.1371/journal.pone.0195384	http://dx.doi.org/10.1371/journal.pone.0195384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659622	Green Published, Green Submitted, gold			2022-12-27	WOS:000430061100014
J	Minard, G; Tran, FH; Van, VT; Fournier, C; Potier, P; Roiz, D; Mavingui, P; Moro, CV				Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Roiz, David; Mavingui, Patrick; Moro, Claire Valiente			Shared larval rearing environment, sex, female size and genetic diversity shape Ae. albopictus bacterial microbiota	PLOS ONE			English	Article							AEDES-ALBOPICTUS; WING LENGTH; WOLBACHIA; INFECTION; AEGYPTI; DIPTERA; VECTOR; ASAIA; TRANSMISSION; MOSQUITOS	The Asian tiger mosquito Aedes albopictus became of public health concern as it can replicate and transmit viral and filarial pathogens with a strong invasive success over the world. Various strategies have been proposed to reduce mosquito population's vectorial capacity. Among them, symbiotic control of mosquito borne disease offers promising perspectives. Such method is likely to be affected by the dynamics of mosquito-associated symbiotic communities, which might in turn be affected by host genotype and environment. Our previous study suggested a correlation between mosquitoes' origin, genetic diversity and midgut bacterial diversity. To distinguish the impact of those factors, we have been studying the midgut bacterial microbiota of two Ae. albopictus populations from tropical (La Re A union) and temperate (Montpellier) origins under controlled laboratory conditions. the two populations experienced random mating or genetic bottleneck. Microbiota composition did not highlight any variation of the alpha and beta-diversities in bacterial communities related to host's populations. However, sizes of the mosquitoes were negatively correlated with the bacterial a-diversity of females. Variations in mosquito sex were associated with a shift in the composition of bacterial microbiota. The females' mosquitoes also exhibited changes in the microbiota composition according to their size and after experiencing a reduction of their genetic diversity. These results provide a framework to investigate the impact of population dynamics on the symbiotic communities associated with the tiger mosquito.	[Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Mavingui, Patrick; Moro, Claire Valiente] Univ Lyon, Lyon, France; [Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Mavingui, Patrick; Moro, Claire Valiente] Univ Lyon 1, Villeurbanne, France; [Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Mavingui, Patrick; Moro, Claire Valiente] CNRS, UMR 5557, Ecol Microbienne, Villeurbanne, France; [Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Mavingui, Patrick; Moro, Claire Valiente] INRA, UMR 1418, Villeurbanne, France; [Minard, Guillaume] Univ Helsinki, Dept Biosci, Metapopulat Res Ctr, Helsinki, Finland; [Roiz, David] IRD, Infect Dis & Vectors, Ecol Genet Evolut & Control, Montpellier, France; [Mavingui, Patrick] Univ La Reunion, Unite Mixte Proc Infectieux Milieu Insulaire Trop, Plateforme Technol CYROI, INSERM,CNRS 9192,U1187,IRD 249, St Clotilde, Reunion, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; INRAE; University of Helsinki; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion	Minard, G (corresponding author), Univ Lyon, Lyon, France.; Minard, G (corresponding author), Univ Lyon 1, Villeurbanne, France.; Minard, G (corresponding author), CNRS, UMR 5557, Ecol Microbienne, Villeurbanne, France.; Minard, G (corresponding author), INRA, UMR 1418, Villeurbanne, France.; Minard, G (corresponding author), Univ Helsinki, Dept Biosci, Metapopulat Res Ctr, Helsinki, Finland.	guillaume_minard_86@hotmail.com	Roiz, David/F-2082-2011	Roiz, David/0000-0002-5819-3648; Minard, Guillaume/0000-0002-2079-8844; valiente moro, claire/0000-0002-7193-405X	ERA NET BiodivERsA [ANR-13-EBID-0007-01]; FWF [1-1437]; DFG [KL 2087/6-1]; Academy of Finland [273098, 265641]	ERA NET BiodivERsA; FWF(Austrian Science Fund (FWF)); DFG(German Research Foundation (DFG)); Academy of Finland(Academy of Finland)	This research plan was funded by ERA NET BiodivERsA with the national funders ANR-13-EBID-0007-01, FWF 1-1437, and DFG KL 2087/6-1 as part of the 2012-2013 BiodivERsA call for research proposals (http://www.biodiversa.org/) and recieved by PM. The authors acknowledge the contribution of the DTAMB platform of the FR41 Bio-Environment and Health (University Lyon 1) and the Academy of Finland (Decision numbers 273098 and 265641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This publication is dedicated to the memory of our beloved colleague and friend Florence H. TRAN. We acknowledge the contribution of the DTAMB platform of the FR41 Bio-Environment and Health (University Lyon 1) and the Academy of Finland (Decision numbers 273098 and 265641). We also acknowledge Marion Journiac and Morgane Guegan for their help with wings measurements and insectary management respectively.	Zeileis A, 2016, BETAREG BETA REGRESS; Alto BW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004370; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Bisi DC, 2011, APPL ENVIRON MICROB, V77, P4669, DOI 10.1128/AEM.00514-11; Blackmore MS, 2000, J VECTOR ECOL, V25, P212; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2; Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Chaston JM, 2016, APPL ENVIRON MICROB, V82, P671, DOI 10.1128/AEM.03301-15; Chavshin AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-419; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]; Coon KL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1660-9; Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Diaz-Nieto LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153133; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991; Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35; Hothorn T., 2015, PACKAGE LMTEST; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294; Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Linenberg I, 2016, SCI REP-UK, V6, DOI 10.1038/srep38230; Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Minard G, 2013, FEMS MICROBIOL ECOL, V83, P63, DOI 10.1111/j.1574-6941.2012.01455.x; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; NASCI RS, 1990, J MED ENTOMOL, V27, P716, DOI 10.1093/jmedent/27.4.716; Oksanen J., 2022, R PACKAGE VERSION; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Petersen V, 2016, REV SOC BRAS MED TRO, V49, P508, DOI 10.1590/0037-8682-0039-2016; Powell JE, 2016, P NATL ACAD SCI USA, V113, P13887, DOI 10.1073/pnas.1610856113; Price DP, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0863-9; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Ricci I, 2012, CURR OPIN MICROBIOL, V15, P278, DOI 10.1016/j.mib.2012.03.004; Segata N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24207; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Telang A, 2006, J EXP BIOL, V209, P645, DOI 10.1242/jeb.02026; THIERY I, 1991, APPL ENVIRON MICROB, V57, P1354, DOI 10.1128/AEM.57.5.1354-1359.1991; Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700; VANHANDEL E, 1989, J AM MOSQUITO CONTR, V5, P180; Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wood S. N., 2016, MGCV MIXED GAM COMPU; Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222; Yadav KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167409; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388	65	19	19	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194521	10.1371/journal.pone.0194521	http://dx.doi.org/10.1371/journal.pone.0194521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641577	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900033
J	Torres, M; Reina, JC; Fuentes-Monteverde, JC; Fernandez, G; Rodriguez, J; Jimenez, C; Llamas, I				Torres, Marta; Carlos Reina, Jose; Carlos Fuentes-Monteverde, Juan; Fernandez, Gerardo; Rodriguez, Jaime; Jimenez, Carlos; Llamas, Inmaculada			AHL-lactonase expression in three marine emerging pathogenic Vibrio spp. reduces virulence and mortality in brine shrimp (Artemia salina) and Manila clam (Venerupis philippinarum)	PLOS ONE			English	Article							QUORUM-SENSING SIGNAL; ACYLATED HOMOSERINE LACTONES; IN-VITRO; SP-NOV.; ANTIMICROBIAL RESISTANCE; BACTERIAL DISEASE; GENE-EXPRESSION; MOLECULES; IDENTIFICATION; HARVEYI	Bacterial infectious diseases produced by Vibrio are the main cause of economic losses in aquaculture. During recent years it has been shown that the expression of virulence genes in some Vibrio species is controlled by a population-density dependent gene-expression mechanism known as quorum sensing (QS), which is mediated by the diffusion of signal molecules such as N-acylhomoserine lactones (AHLs). QS disruption, especially the enzymatic degradation of signalling molecules, known as quorum quenching (QQ), is one of the novel therapeutic strategies for the treatment of bacterial infections. In this study, we present the detection of AHLs in 34 marine Vibrionaceae strains. Three aquaculture-related pathogenic Vibrio strains, V. mediterranei VibC-Oc-097, V. owensii VibC-Oc-106 and V. coralliilyticus VibC-Oc-193 were selected for further studies based on their virulence and high production of AHLs. This is the first report where the signal molecules have been characterized in these emerging marine pathogens and correlated to the expression of virulence factors. Moreover, the results of AHL inactivation in the three selected strains have been confirmed in vivo against brine shrimps (Artemia salina) and Manila clams (Venerupis philippinarum). This research contributes to the development of future therapies based on AHL disruption, the most promising alternatives for fighting infectious diseases in aquaculture.	[Torres, Marta; Carlos Reina, Jose; Llamas, Inmaculada] Univ Granada, Dept Microbiol, Fac Pharm, Granada, Spain; [Torres, Marta; Llamas, Inmaculada] Univ Granada, Inst Biotechnol, Biomed Res Ctr CIBM, Granada, Spain; [Carlos Fuentes-Monteverde, Juan; Rodriguez, Jaime; Jimenez, Carlos] Univ A Coruna, Fac Sci, Dept Chem, La Coruna, Spain; [Carlos Fuentes-Monteverde, Juan; Rodriguez, Jaime; Jimenez, Carlos] Univ A Coruna, Ctr Adv Sci Res CICA, La Coruna, Spain; [Fernandez, Gerardo] Univ A Coruna, Res Support Serv SAI, Cent Serv ESCI, La Coruna, Spain; [Torres, Marta] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell,CEA, Gif Sur Yvette, France	University of Granada; University of Granada; Universidade da Coruna; Universidade da Coruna; Universidade da Coruna; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Llamas, I (corresponding author), Univ Granada, Dept Microbiol, Fac Pharm, Granada, Spain.; Llamas, I (corresponding author), Univ Granada, Inst Biotechnol, Biomed Res Ctr CIBM, Granada, Spain.	illamas@ugr.es	Torres, Marta/O-2749-2016; Rodriguez, Jaime/AAY-9780-2021; Llamas, Inmaculada/I-2410-2015; Jimenez, Carlos/G-9622-2015; Rodriguez, Jaime/G-8984-2015; Llamas, Inmaculada/AAE-8460-2020	Torres, Marta/0000-0002-0609-9123; Rodriguez, Jaime/0000-0001-5348-6970; Llamas, Inmaculada/0000-0001-6333-5033; Jimenez, Carlos/0000-0003-2628-303X; Rodriguez, Jaime/0000-0001-5348-6970; Llamas, Inmaculada/0000-0001-6333-5033; Fuentes-Monteverde, Juan Carlos/0000-0003-3239-3868; Reina Cabello, Jose Carlos/0000-0002-6418-9805	Ministerio de Economia y Competitividad (Spain) [AGL2012-39274-C02-02, AGL2015-68806-R, AGL2015-63740-C2-2-R]; FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Spain) [FPU15-01717]; University of Granada (Spain)	Ministerio de Economia y Competitividad (Spain); FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Spain); University of Granada (Spain)	This research was supported in part by grants from the Ministerio de Economia y Competitividad (Spain) (http://www.mineco.gob.es/portal/site/inineco/idi)(AGL2012-39274-C02-02; AGL2015-68806-R; AGL2015-63740-C2-2-R). Jose Carlos Reina is supported by a FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Spain) (https://www.mecd.gob.es/portada-macd/) (FPU15-01717) and a Initiation to Research fellowship for Master Students (2016) from the University of Granada (Spain) (http://www.ugr.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbowale OL, 2006, J APPL MICROBIOL, V100, P1103, DOI 10.1111/j.1365-2672.2006.02812.x; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Austin B., 1999, BACTERIAL PATHOGENS, V3rd, P13; BAIRDPARKER AC, 1963, J GEN MICROBIOL, V30, P409, DOI 10.1099/00221287-30-3-409; Balado M, 2015, ACS CHEM BIOL, V10, P2850, DOI 10.1021/acschembio.5b00624; Barrow G.I., 1993, COWAN STEELS MANUAL, V3rd; Beaz-Hidalgo R, 2010, SYST APPL MICROBIOL, V33, P311, DOI 10.1016/j.syapm.2010.06.007; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Bjarnsholt T, 2010, NAT PROTOC, V5, P282, DOI 10.1038/nprot.2009.205; Bruhn JB, 2005, DIS AQUAT ORGAN, V65, P43, DOI 10.3354/dao065043; Buchholtz C, 2006, SYST APPL MICROBIOL, V29, P433, DOI 10.1016/j.syapm.2005.12.007; Cano-Gomez A, 2011, SYST APPL MICROBIOL, V34, P561, DOI 10.1016/j.syapm.2011.09.001; Cano-Gomez A, 2010, FEMS MICROBIOL LETT, V302, P175, DOI 10.1111/j.1574-6968.2009.01850.x; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Choopun N, 2002, APPL ENVIRON MICROB, V68, P995, DOI 10.1128/AEM.68.2.995-998.2002; Chu WH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05446; Cordero D, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Croxatto A, 2004, MOL MICROBIOL, V52, P1677, DOI 10.1111/j.1365-2958.2004.04083.x; Defoirdt T, 2008, J APPL MICROBIOL, V104, P1480, DOI 10.1111/j.1365-2672.2007.03672.x; Defoirdt T, 2004, AQUACULTURE, V240, P69, DOI 10.1016/j.aquaculture.2004.06.031; Defoirdt T, 2011, CURR OPIN MICROBIOL, V14, P251, DOI 10.1016/j.mib.2011.03.004; Dong YH, 2005, J MICROBIOL, V43, P101; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Drummond LC, 2007, J INVERTEBR PATHOL, V95, P1, DOI 10.1016/j.jip.2006.11.010; Dubert J, 2017, J FISH DIS, V40, P1185, DOI 10.1111/jfd.12593; Dubert J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00762; Espada A, 2011, J CHROMATOGR A, V1218, P1790, DOI 10.1016/j.chroma.2011.01.072; Food and Agriculture Organization of the United Nations FAO, 2016, STAT WORLD FISH AQ; Garcia-Aljaro C, 2012, J APPL MICROBIOL, V112, P383, DOI 10.1111/j.1365-2672.2011.05199.x; Golberg K, 2011, MICROB ECOL, V61, P783, DOI 10.1007/s00248-011-9848-1; Gomez-Leon J, 2005, APPL ENVIRON MICROB, V71, P98, DOI 10.1128/AEM.71.1.98-104.2005; Gonzalez JE, 2003, MICROBIOL MOL BIOL R, V67, P574, DOI 10.1128/MMBR.67.4.574-592.2003; Goulden EF, 2012, APPL ENVIRON MICROB, V78, P2841, DOI 10.1128/AEM.07274-11; Ha C, 2014, MICROB PATHOGENESIS, V71-72, P8, DOI 10.1016/j.micpath.2014.04.001; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Igbinosa EO, 2008, RES MICROBIOL, V159, P495, DOI 10.1016/j.resmic.2008.07.001; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; JEFFRIES CD, 1957, J BACTERIOL, V73, P590, DOI 10.1128/JB.73.4.590-591.1957; Kalia VC, 2011, CRIT REV MICROBIOL, V37, P121, DOI 10.3109/1040841X.2010.532479; Kesarcodi-Watson A, 2009, J FISH DIS, V32, P499, DOI 10.1111/j.1365-2761.2009.01006.x; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; Li J, 2017, CORAL REEFS, V36, P1235, DOI 10.1007/s00338-017-1616-3; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Llamas I, 2005, EXTREMOPHILES, V9, P333, DOI 10.1007/s00792-005-0448-1; Llamas I, 2004, APPL ENVIRON MICROB, V70, P3715, DOI [10.1128/AEM.70.6.3715-3723.2004, 10.1128/aem.70.6.3715-3723.2004]; Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283; Marketon MM, 2002, J BACTERIOL, V184, P3466, DOI 10.1128/JB.184.13.3466-3475.2002; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Meron D, 2009, APPL ENVIRON MICROB, V75, P5704, DOI 10.1128/AEM.00198-09; Milton DL, 1997, J BACTERIOL, V179, P3004, DOI 10.1128/jb.179.9.3004-3012.1997; Morelle G, 1989, FOCUS, V11, P7; Morohoshi T, 2004, J BIOSCI BIOENG, V98, P274, DOI 10.1016/S1389-1723(04)00281-6; MOUREY A, 1976, J APPL BACTERIOL, V40, P47, DOI 10.1111/j.1365-2672.1976.tb00589.x; Natrah FMI, 2011, MAR BIOTECHNOL, V13, P109, DOI 10.1007/s10126-010-9346-3; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; O'May C, 2011, APPL ENVIRON MICROB, V77, P3061, DOI 10.1128/AEM.02677-10; Osorio CR, 2015, APPL ENVIRON MICROB, V81, P5867, DOI 10.1128/AEM.01580-15; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P477, DOI 10.1051/alr:2004054; Park SY, 2005, APPL ENVIRON MICROB, V71, P2632, DOI 10.1128/AEM.71.5.2632-2641.2005; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; PICKETT MJ, 1991, J CLIN MICROBIOL, V29, P2322, DOI 10.1128/JCM.29.10.2322-2325.1991; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Prado S, 2015, SYST APPL MICROBIOL, V38, P26, DOI 10.1016/j.syapm.2014.11.005; Purohit AA, 2013, J APPL MICROBIOL, V115, P835, DOI 10.1111/jam.12264; Rasmussen BB, 2014, MAR DRUGS, V12, P5527, DOI 10.3390/md12115527; Richards GP, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01252-14; Richards GP, 2015, APPL ENVIRON MICROB, V81, P292, DOI 10.1128/AEM.02930-14; Rojas R, 2016, FRONT MICROBIOL, V7, P1, DOI [10.3389/fmicb.2016.00001, DOI 10.3389/FMICB.2016.00001]; Romalde JL, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00413; Romero M, 2011, FEMS MICROBIOL ECOL, V75, P205, DOI 10.1111/j.1574-6941.2010.01011.x; Rosenberg E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P451, DOI 10.1007/978-94-007-0114-4_26; Rubio-Portillo E, 2014, ISME J, V8, P1794, DOI 10.1038/ismej.2014.33; Rui HP, 2008, FEMS MICROBIOL LETT, V285, P155, DOI 10.1111/j.1574-6968.2008.01185.x; Ruwandeepika HAD, 2011, ENVIRON MICROBIOL, V13, P506, DOI 10.1111/j.1462-2920.2010.02354.x; Sambrook J., 2001, MOL CLONING LAB MANU; Saurav K, 2017, MAR DRUGS, V15, DOI 10.3390/md15030053; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Smith P, 2008, REV SCI TECH OIE, V27, P243, DOI 10.20506/rst.27.1.1799; SORGELOOS P, 1975, AQUACULTURE, V6, P303, DOI 10.1016/0044-8486(75)90110-6; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Tahrioui Ali, 2013, Life-Basel, V3, P260, DOI 10.3390/life3010260; Tait K, 2010, ENV MICROBIOL REP, V2, P145, DOI 10.1111/j.1758-2229.2009.00122.x; Tarazona E, 2014, SYST APPL MICROBIOL, V37, P320, DOI 10.1016/j.syapm.2014.05.005; Thompson FL, 2001, SYST APPL MICROBIOL, V24, P516, DOI 10.1078/0723-2020-00065; Tinh NTN, 2008, MAR BIOTECHNOL, V10, P1, DOI 10.1007/s10126-007-9054-9; Torres M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01176-7; Torres M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00646; Torres M, 2013, MICROBIOL RES, V168, P547, DOI 10.1016/j.micres.2013.04.011; Uroz S, 2005, MICROBIOL-SGM, V151, P3313, DOI 10.1099/mic.0.27961-0; Uroz S, 2003, MICROBIOL-SGM, V149, P1981, DOI 10.1099/mic.0.26375-0; Uroz S, 2008, FEMS MICROBIOL ECOL, V65, P271, DOI 10.1111/j.1574-6941.2008.00477.x; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; Valiente E, 2009, FEMS MICROBIOL ECOL, V69, P16, DOI 10.1111/j.1574-6941.2009.00691.x; Wang YD, 2013, J BACTERIOL, V195, P3583, DOI 10.1128/JB.00508-13; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Wu YJ, 2009, J CHIN CHEM SOC-TAIP, V56, P688, DOI 10.1002/jccs.200900103; Yang Q, 2011, J APPL MICROBIOL, V110, P1438, DOI 10.1111/j.1365-2672.2011.04998.x; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhao J, 2015, J FISH DIS, V38, P771, DOI 10.1111/jfd.12299; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	103	18	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195176	10.1371/journal.pone.0195176	http://dx.doi.org/10.1371/journal.pone.0195176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664914	Green Submitted, Green Published, gold			2022-12-27	WOS:000430262300016
J	Baksh, RA; Abrahams, S; Auyeung, B; MacPherson, SE				Baksh, R. Asaad; Abrahams, Sharon; Auyeung, Bonnie; MacPherson, Sarah E.			The Edinburgh Social Cognition Test (ESCoT): Examining the effects of age on a new measure of theory of mind and social norm understanding	PLOS ONE			English	Article							BROADER AUTISM PHENOTYPE; EXECUTIVE FUNCTION; FUNCTIONING AUTISM; ASPERGER-SYNDROME; ADULTS; DEFICITS; BRAIN; DECLINE; PERFORMANCE; COMPONENTS	Current measures of social cognition have shown inconsistent findings regarding the effects of healthy aging. Moreover, no tests are currently available that allow clinicians and researchers to examine cognitive and affective theory of mind (ToM) and understanding of social norms within the same test. To address these limitations, we present the Edinburgh Social Cognition Test (ESCoT) which assesses cognitive and affective ToM and inter-and intrapersonal understanding of social norms. We examined the effects of age, measures of intelligence and the Broader Autism Phenotype (BAP) on the ESCoT and established tests of social cognition. Additionally, we investigated the convergent validity of the ESCoT based on traditional social cognition measures. The ESCoT was administered alongside Reading the Mind in Films (RMF), Reading the Mind in Eyes (RME), Judgement of Preference and Social Norm Questionnaire to 91 participants (30 aged 18 +/- 35 years, 30 aged 45 +/- 60 years and 31 aged 65 +/- 85 years). Poorer performance on the cognitive and affective ToM ESCoT subtests were predicted by increasing age. The affective ToM ESCoT subtest and RMF were predicted by gender, where being female predicted better performance. Unlike the ESCoT, better performance on the RMF was predicted by higher verbal comprehension and perceptual reasoning abilities, while better performance on the RME was predicted by higher verbal comprehension scores. Lower scores on inter-and intrapersonal understanding of social norms were both predicted by the presence of more autism-like traits while poorer interpersonal understanding of social norms performance was predicted by increasing age. These findings show that the ESCoT is a useful measure of social cognition and, unlike established tests of social cognition, performance is not predicted by measures of verbal comprehension and perceptual reasoning. This is particularly valuable to obtain an accurate assessment of the influence of age on our social cognitive abilities.	[Baksh, R. Asaad; Abrahams, Sharon; Auyeung, Bonnie; MacPherson, Sarah E.] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Psychol, Edinburgh, Midlothian, Scotland; [Baksh, R. Asaad; Abrahams, Sharon; MacPherson, Sarah E.] Univ Edinburgh, CCACE, Edinburgh, Midlothian, Scotland; [Auyeung, Bonnie] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England	University of Edinburgh; University of Edinburgh; University of Cambridge	Baksh, RA (corresponding author), Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Psychol, Edinburgh, Midlothian, Scotland.; Baksh, RA (corresponding author), Univ Edinburgh, CCACE, Edinburgh, Midlothian, Scotland.	rbaksh@ed.ac.uk	MacPherson, Sarah E/G-8524-2013	MacPherson, Sarah E/0000-0001-8676-6514	University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative [MR/L501530/1]; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC)	University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by a PhD studentship from The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (MR/L501530/1). Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) is gratefully acknowledged.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Ahmed FS, 2011, J AUTISM DEV DISORD, V41, P667, DOI 10.1007/s10803-010-1087-7; Altman DG, 1991, PRACTICAL STAT MED R; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Baez S, 2016, CURRENT TOPICS BEHAV, P1; Baez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057664; Baez S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00302; Bailey PE, 2008, AGING MENT HEALTH, V12, P499, DOI 10.1080/13607860802224243; Bailey PE, 2008, J GERONTOL B-PSYCHOL, V63, pP219, DOI 10.1093/geronb/63.4.P219; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136521; Blanchard-Fields F, 2007, CURR DIR PSYCHOL SCI, V16, P26, DOI 10.1111/j.1467-8721.2007.00469.x; Bottiroli S, 2016, ARCH GERONTOL GERIAT, V62, P152, DOI 10.1016/j.archger.2015.09.009; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Carr AR, 2015, NEUROPSYCHOLOGIA, V78, P73, DOI 10.1016/j.neuropsychologia.2015.09.033; Castelli I, 2010, NEUROPSYCHOLOGIA, V48, P2586, DOI 10.1016/j.neuropsychologia.2010.05.005; Charlton RA, 2009, PSYCHOL AGING, V24, P338, DOI 10.1037/a0015225; Devine RT, 2013, CHILD DEV, V84, P989, DOI 10.1111/cdev.12017; Duval C, 2011, CONSCIOUS COGN, V20, P627, DOI 10.1016/j.concog.2010.10.025; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; Eddy CM, 2013, NEUROPSYCHOLOGY, V27, P37, DOI 10.1037/a0031302; English T, 2014, INT J BEHAV DEV, V38, P195, DOI 10.1177/0165025413515404; Fischer AL, 2016, J GERONTOL B-PSYCHOL; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; German TP, 2006, COGNITION, V101, P129, DOI 10.1016/j.cognition.2005.05.007; Girardi A, 2011, NEUROPSYCHOLOGY, V25, P53, DOI 10.1037/a0020357; Golan O, 2006, SOC NEUROSCI-UK, V1, P111, DOI 10.1080/17470910600980986; Halberstadt J, 2011, PSYCHOL AGING, V26, P133, DOI 10.1037/a0021366; Happe FGE, 1998, DEV PSYCHOL, V34, P358, DOI 10.1037/0012-1649.34.2.358; Heavey L, 2000, J AUTISM DEV DISORD, V30, P225, DOI 10.1023/A:1005544518785; Henry JD, 2015, CURR OPIN PSYCHIATR, V28, P133, DOI 10.1097/YCO.0000000000000139; Henry JD, 2013, PSYCHOL AGING, V28, P826, DOI 10.1037/a0030677; Hess TM, 2005, PSYCHOL BULL, V131, P383, DOI 10.1037/0033-2909.131.3.383; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Keightley ML, 2006, PSYCHOL AGING, V21, P558, DOI 10.1037/0882-7974.21.3.558; Kemp J, 2012, AGEING RES REV, V11, P199, DOI 10.1016/j.arr.2011.12.001; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lee PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06085; Li XM, 2013, INT J PSYCHOL, V48, P715, DOI 10.1080/00207594.2012.673724; Losh M, 2007, J CHILD PSYCHOL PSYC, V48, P105, DOI 10.1111/j.1469-7610.2006.01594.x; Love MCN, 2015, SOCIAL SOGNITION OLD; Luong G, 2011, J SOC PERS RELAT, V28, P9, DOI 10.1177/0265407510391362; MacPherson SE, 2002, PSYCHOL AGING, V17, P598, DOI 10.1037//0882-7974.17.4.598; Maylor EA, 2002, BRIT J PSYCHOL, V93, P465, DOI 10.1348/000712602761381358; McCrimmon AW, 2013, J PSYCHOEDUC ASSESS, V31, P337, DOI 10.1177/0734282912467756; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McKinnon MC, 2007, COGNITION, V102, P179, DOI 10.1016/j.cognition.2005.12.011; Moran JM, 2013, BEHAV BRAIN RES, V237, P32, DOI 10.1016/j.bbr.2012.09.020; Moran JM, 2012, J NEUROSCI, V32, P5553, DOI 10.1523/JNEUROSCI.5511-11.2012; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Pardini M, 2009, EXP AGING RES, V35, P98, DOI 10.1080/03610730802545259; Peterson E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00220; Phillips LH, 2002, J GERONTOL B-PSYCHOL, V57, pP526, DOI 10.1093/geronb/57.6.P526; Phillips LH, 2011, COGNITION, V120, P236, DOI 10.1016/j.cognition.2011.05.003; Piven J, 1997, AM J PSYCHIAT, V154, P185; Rakoczy H, 2012, BRIT J PSYCHOL, V103, P58, DOI 10.1111/j.2044-8295.2011.02040.x; Rankin KP, 2008, SOCIAL NORMS QUESTIO; Roeyers H, 2001, J CHILD PSYCHOL PSYC, V42, P271, DOI 10.1111/1469-7610.00718; Saltzman J, 2000, J INT NEUROPSYCH SOC, V6, P781, DOI 10.1017/S1355617700677056; Sasson NJ, 2013, AUTISM, V17, P655, DOI 10.1177/1362361312455704; Scheibe S, 2010, J GERONTOL B-PSYCHOL, V65, P135, DOI 10.1093/geronb/gbp132; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shamay-Tsoory SG, 2010, CORTEX, V46, P668, DOI 10.1016/j.cortex.2009.04.008; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Slessor G, 2007, PSYCHOL AGING, V22, P639, DOI 10.1037/0882-7974.22.3.639; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Sullivan S, 2004, BRIT J PSYCHOL, V95, P1, DOI 10.1348/000712604322779424; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Wainer AL, 2013, J AUTISM DEV DISORD, V43, P2418, DOI 10.1007/s10803-013-1789-8; Wainer AL, 2011, J PSYCHOPATHOL BEHAV, V33, P459, DOI 10.1007/s10862-011-9259-0; Wallace GL, 2016, AUTISM RES, V9, P1294, DOI 10.1002/aur.1620; Wang YF, 2006, PSYCHOLOGIA, V49, P228, DOI 10.2117/psysoc.2006.228; Wechsler D, 1997, WECHSLER ADULT INTEL; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Zalla T, 2009, J AUTISM DEV DISORD, V39, P373, DOI 10.1007/s10803-008-0634-y	78	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195818	10.1371/journal.pone.0195818	http://dx.doi.org/10.1371/journal.pone.0195818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664917	gold, Green Published, Green Submitted			2022-12-27	WOS:000430262300034
J	Baek, H; Cho, M; Kim, S; Hwang, H; Song, M; Yoo, S				Baek, Hyunyoung; Cho, Minsu; Kim, Seok; Hwang, Hee; Song, Minseok; Yoo, Sooyoung			Analysis of length of hospital stay using electronic health records: A statistical and data mining approach	PLOS ONE			English	Article							OF-STAY; HEART-FAILURE; REHABILITATION; PREDICTORS; OUTCOMES; STROKE; CARE	Background The length of stay (LOS) is an important indicator of the efficiency of hospital management. Reduction in the number of inpatient days results in decreased risk of infection and medication side effects, improvement in the quality of treatment, and increased hospital profit with more efficient bed management. The purpose of this study was to determine which factors are associated with length of hospital stay, based on electronic health records, in order to manage hospital stay more efficiently. Materials and methods Research subjects were retrieved from a database of patients admitted to a tertiary general university hospital in South Korea between January and December 2013. Patients were analyzed according to the following three categories: descriptive and exploratory analysis, process pattern analysis using process mining techniques, and statistical analysis and prediction of LOS. Results Overall, 55% (25,228) of inpatients were discharged within 4 days. The department of rehabilitation medicine (RH) had the highest average LOS at 15.9 days. Of all the conditions diagnosed over 250 times, diagnoses of I63.8 (cerebral infarction, middle cerebral artery), I63.9 (infarction of middle cerebral artery territory) and I21.9 (myocardial infarction) were associated with the longest average hospital stay and high standard deviation. Patients with these conditions were also more likely to be transferred to the RH department for rehabilitation. A range of variables, such as transfer, discharge delay time, operation frequency, frequency of diagnosis, severity, bed grade, and insurance type was significantly correlated with the LOS. Conclusions Accurate understanding of the factors associating with the LOS and progressive improvements in processing and monitoring may allow more efficient management of the LOS of inpatients.	[Baek, Hyunyoung; Kim, Seok; Hwang, Hee; Yoo, Sooyoung] Seoul Natl Univ, Off eHlth Res & Businesses, Bundang Hosp, Seongnam, South Korea; [Cho, Minsu; Song, Minseok] Pohang Univ Sci & Technol, Dept Ind & Management Engn, Pohang, South Korea; [Cho, Minsu] Ulsan Natl Inst Sci & Technol, Sch Management Engn, Ulsan, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Ulsan National Institute of Science & Technology (UNIST)	Yoo, S (corresponding author), Seoul Natl Univ, Off eHlth Res & Businesses, Bundang Hosp, Seongnam, South Korea.; Song, M (corresponding author), Pohang Univ Sci & Technol, Dept Ind & Management Engn, Pohang, South Korea.	mssong@postech.ac.kr; yoosoo0@snubh.org	Cho, Minsu/R-3547-2017; Song, Minseok/U-9378-2019; Cho, Minsu/AAE-2176-2019	Cho, Minsu/0000-0002-9442-9232; Song, Minseok/0000-0002-6813-8853; Cho, Minsu/0000-0002-9442-9232; Yoo, Sooyoung/0000-0001-8620-4925	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2016R1C1B2016346]; Bio & Medical Technology Development Program of the NRF - Korean government, Ministry of Science and ICT (MSIT) [NRF-2017M3A9B6062319]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Bio & Medical Technology Development Program of the NRF - Korean government, Ministry of Science and ICT (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This work was partly supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No.NRF-2016R1C1B2016346), and partly supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, Ministry of Science and ICT (MSIT) (No.NRF-2017M3A9B6062319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshabanat A, 2017, INT J CHRONIC OBSTR, V12, P961, DOI 10.2147/COPD.S124385; BF Van Dongen, 2005, INT C APPL THEOR PET; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Foraker RE, 2014, J HEALTHC QUAL, V36, P45, DOI 10.1111/j.1945-1474.2012.00211.x; Fornaro M, 2018, J AFFECT DISORDERS, V228, P118, DOI 10.1016/j.jad.2017.12.009; Galas FRBG, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-54; Gemmel P, 2008, TOTAL QUAL MANAG BUS, V19, P1207, DOI 10.1080/14783360802351488; Gruther W, 2017, AM J PHYS MED REHAB, V96, P607, DOI 10.1097/PHM.0000000000000718; Hayakawa S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153619; Huntley DA, 1998, PSYCHIAT SERVICES; Kallen MC, 2017, INFECT DIS REPORTS, V9; Kapadohos T, 2017, J THORAC DIS, V9, P70, DOI 10.21037/jtd.2017.01.18; Li BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159733; Liu X, 2017, PALLIAT SUPPORT CARE, V15, P741, DOI 10.1017/S1478951516001164; M Cho, 2014, AS PAC C BUS PROC MA; Neuman MD, 2014, JAMA-J AM MED ASSOC, V311, P2508, DOI 10.1001/jama.2014.6499; Ng YS, 2016, ANN ACAD MED SINGAP, V45, P394; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pietzak EJ, 2014, ANN SURG ONCOL, V21, P4383, DOI 10.1245/s10434-014-3877-1; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; Seo HJ, 2017, HEALTHC INFORM RES, V23, P119, DOI 10.4258/hir.2017.23.2.119; Shanley LA, 2015, J ASTHMA, V52, P471, DOI 10.3109/02770903.2014.984843; Sharma A, 2015, INT J MENT HEALTH SY, V9, DOI 10.1186/s13033-015-0017-7; Shinjo D, 2017, PSYCHIAT CLIN NEUROS, V71, P542, DOI 10.1111/pcn.12521; Sun LS, 2016, JAMA-J AM MED ASSOC, V315, P2312, DOI 10.1001/jama.2016.6967; Van Daalen F, 2017, CLIN MICROBIOLOGY IN; van der Aalst WMP, 2007, INFORM SYST, V32, P713, DOI 10.1016/j.is.2006.05.003; Wong JS, 2016, ARCH PHYS MED REHAB, V97, P561, DOI 10.1016/j.apmr.2015.12.005	28	94	94	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195901	10.1371/journal.pone.0195901	http://dx.doi.org/10.1371/journal.pone.0195901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652932	gold, Green Submitted, Green Published			2022-12-27	WOS:000430026900045
J	Gallagher, RJ; Reagan, AJ; Danforth, CM; Dodds, PS				Gallagher, Ryan J.; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan			Divergent discourse between protests and counter-protests: #BlackLivesMatter and #AllLivesMatter	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SOCIAL MEDIA; NETWORKS	Since the shooting of Black teenager Michael Brown by White police officer Darren Wilson in Ferguson, Missouri, the protest hashtag #BlackLivesMatter has amplified critiques of extrajudicial killings of Black Americans. In response to #BlackLivesMatter, other Twitter users have adopted #A11LivesMatter, a counter-protest hashtag whose content argues that equal attention should be given to all lives regardless of race. Through a multi-level analysis of over 860,000 tweets, we study how these protests and counter-protests diverge by quantifying aspects of their discourse. We find that #A11LivesMatter facilitates opposition between #BlackLivesMatter and hashtags such as #PoliceLivesMatter and #BlueLivesMatter in such a way that historically echoes the tension between Black protesters and law enforcement. In addition, we show that a significant portion of #A11LivesMatter use stems from hijacking by #BlackLivesMatter advocates. Beyond simply injecting #A11LivesMatter with #BlackLivesMatter content, these hijackers use the hashtag to directly confront the counter-protest notion of "All lives matter." Our findings suggest that Black Lives Matter movement was able to grow, exhibit diverse conversations, and avoid derailment on social media by making discussion of counter-protest opinions a central topic of #A11LivesMatter, rather than the movement itself.	[Gallagher, Ryan J.; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Gallagher, Ryan J.; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Computat Story Lab, Vermont Complex Syst Ctr, Burlington, VT 05405 USA; [Gallagher, Ryan J.; Reagan, Andrew J.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Gallagher, RJ (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA.; Gallagher, RJ (corresponding author), Univ Vermont, Computat Story Lab, Vermont Complex Syst Ctr, Burlington, VT 05405 USA.; Gallagher, RJ (corresponding author), Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05405 USA.	ryan.gallagher@uvm.edu			National Science Foundation Big Data Grant [1447634]	National Science Foundation Big Data Grant	PSD and CMD acknowledge support from National Science Foundation Big Data Grant #1447634 (https://www.nsf.gov/awardsearch/showAward?AWD ID=1447634).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2015, 3 STUDENTS SHOT DEAT; Anduiza E, 2014, INFORM COMMUN SOC, V17, P750, DOI 10.1080/1369118X.2013.808360; Barbera P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143611; Berenson T, 2015, EVERYTHING WE KNOW C; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bode L, 2015, ANN AM ACAD POLIT SS, V659, P149, DOI 10.1177/0002716214563923; Bonilla Y, 2015, AM ETHNOL, V42, P4, DOI 10.1111/amet.12112; Borge-Holthoefer J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501158; Borge-Holthoefer J, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P700, DOI 10.1145/2675133.2675163; Boyack KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018029; Caren N., 2011, SOCIAL SCI RES NETWO; Carney N., 2016, HUMANITY SOC, V40, P180, DOI DOI 10.1177/0160597616643868; Christensen H.K., 2011, 1 MONDAY, V16, P2, DOI [10.5210/fm.v16i2.3336, DOI 10.5210/FM.V16I2.3336]; Clark M., 2016, HASHTAGS FERGUSON BL, DOI 10.2139/ssrn.2747066; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055957; Conover MD, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds6; DeLuca K.M., 2012, COMMUNICATION CULTUR, V5, P483, DOI [10.1111/j.1753-9137.2012.01141.x, DOI 10.1111/J.1753-9137.2012.01141.X]; Elmore C, 2015, MAN SHOT KILLED N CH; Freelon D, 2016, NEW MEDIA SOC; Garza A., 2014, FEMINIST WIRE, P1; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gonzalez-Bailon S, 2016, SOC NETWORKS, V44, P95, DOI 10.1016/j.socnet.2015.07.003; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Graham D, 2015, MYSTERIOUS DEATH FRE; Harris FC, 2015, DISSENT, V62, P34, DOI 10.1353/dss.2015.0051; Howard Philip N., 2011, OPENING CLOSED REGIM, DOI DOI 10.2139/SSRN.2595096; Husband T, 2012, EARLY CHILD EDUC J, V39, P365, DOI 10.1007/s10643-011-0458-9; Jackson SJ, 2015, J COMMUN, V65, P932, DOI 10.1111/jcom.12185; Jackson SJ, 2015, INFORM COMMUNICATION, P1; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kang JC, 2015, OUR DEMAND IS SIMPLE; Lackey JAB, 2005, FRAMING SOCIAL PROTE; Langford CatherineL., 2015, J CONT RHETORIC, V5, P78; Larson J, 2016, POL NETW WORKSH C; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; McClam E, 2014, FERGUSON COP D WILSO; Muller B, 2014, 2 NYPD OFFICERS KILL; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Olteanu A, 2015, ARXIV151205671; Orbe M.P., 2015, J CONT RHETORIC, V5, P90; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Papacharissi Z, 2012, J COMMUN, V62, P266, DOI 10.1111/j.1460-2466.2012.01630.x; Pechenick EA, 2015, ARXIV150303512; Pechenick EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137041; Qi H, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0081-5; Ramirez E, 2015, BEYONCE PRINCE PAY T; Rickford Russell, 2016, NEW LABOR FORUM, V25, P34, DOI DOI 10.1177/1095796015620171; Romero Daniel M., 2011, WORLD WIDE WEB PAGES, DOI 10.1145/1963405.1963503; Sanchez R, 2014, PROTESTS NY COP NOT; Schuppe J, 2015, DEATH S BLAND WHAT W; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Smith MA., 2014, PEW RES CTR, V20, P1; Steinert-Threlkeld ZC, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0056-y; Tometi O, 2015, BLACK LIVES MATTER I; Twyman M, 2017, P 2017 ACM C COMP SU; Van Dijk T. A., 1989, GAZETTE, V43, P229, DOI DOI 10.1177/001654928904300305; Van Dijk TA, 2000, ETHNIC MINORITIES ME, P33; Weber Ingmar, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P290	59	56	56	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195644	10.1371/journal.pone.0195644	http://dx.doi.org/10.1371/journal.pone.0195644			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668754	Green Published, Green Submitted, gold			2022-12-27	WOS:000430290200050
J	Lorenz, MW; Gao, L; Ziegelbauer, K; Norata, GD; Empana, JP; Schmidtmann, I; Lin, HJ; McLachlan, S; Bokemark, L; Ronkainen, K; Amato, M; Schminke, U; Srinivasan, SR; Lind, L; Okazaki, S; Stehouwer, CDA; Willeit, P; Polak, JF; Steinmetz, H; Sander, D; Poppert, H; Desvarieux, M; Ikram, MA; Johnsen, SH; Staub, D; Sirtori, CR; Igiseder, B; Beloqui, O; Engstrom, G; Friera, A; Rozza, F; Xie, WX; Parraga, G; Grigore, L; Plichart, M; Blankenberg, S; Su, TC; Schmidt, C; Tuomainen, TP; Veglia, F; Volzke, H; Nijpels, G; Willeit, J; Sacco, RL; Franco, OH; Uthoff, H; Hedblad, B; Suarez, C; Izzo, R; Zhao, D; Wannarong, T; Catapano, A; Ducimetiere, P; Espinola-Klein, C; Chien, KL; Price, JF; Bergstrom, G; Kauhanen, J; Tremoli, E; Dorr, M; Berenson, G; Kitagawa, K; Dekker, JM; Kiechl, S; Sitzer, M; Bickel, H; Rundek, T; Hofman, A; Mathiesen, EB; Castelnuovo, S; Landecho, MF; Rosvall, M; Gabriel, R; de Luca, N; Liu, J; Baldassarre, D; Kavousi, M; de Groot, E; Bots, ML; Yanez, DN; Thompson, SG				Lorenz, Matthias W.; Gao, Lu; Ziegelbauer, Kathrin; Norata, Giuseppe Danilo; Empana, Jean Philippe; Schmidtmann, Irene; Lin, Hung-Ju; McLachlan, Stela; Bokemark, Lena; Ronkainen, Kimmo; Amato, Mauro; Schminke, Ulf; Srinivasan, Sathanur R.; Lind, Lars; Okazaki, Shuhei; Stehouwer, Coen D. A.; Willeit, Peter; Polak, Joseph F.; Steinmetz, Helmuth; Sander, Dirk; Poppert, Holger; Desvarieux, Moise; Ikram, M. Arfan; Johnsen, Stein Harald; Staub, Daniel; Sirtori, Cesare R.; Igiseder, Bernhard; Beloqui, Oscar; Engstrom, Gunnar; Friera, Alfonso; Rozza, Francesco; Xie, Wuxiang; Parraga, Grace; Grigore, Liliana; Plichart, Matthieu; Blankenberg, Stefan; Su, Ta-Chen; Schmidt, Caroline; Tuomainen, Tomi-Pekka; Veglia, Fabrizio; Voelzke, Henry; Nijpels, Giel; Willeit, Johann; Sacco, Ralph L.; Franco, Oscar H.; Uthoff, Heiko; Hedblad, Bo; Suarez, Carmen; Izzo, Raffaele; Zhao, Dong; Wannarong, Thapat; Catapano, Alberico; Ducimetiere, Pierre; Espinola-Klein, Christine; Chien, Kuo-Liong; Price, Jackie F.; Bergstrom, Goren; Kauhanen, Jussi; Tremoli, Elena; Doerr, Marcus; Berenson, Gerald; Kitagawa, Kazuo; Dekker, Jacqueline M.; Kiechl, Stefan; Sitzer, Matthias; Bickel, Horst; Rundek, Tatjana; Hofman, Albert; Mathiesen, Ellisiv B.; Castelnuovo, Samuela; Landecho, Manuel F.; Rosvall, Maria; Gabriel, Rafael; de Luca, Nicola; Liu, Jing; Baldassarre, Damiano; Kavousi, Maryam; de Groot, Eric; Bots, Michiel L.; Yanez, David N.; Thompson, Simon G.		PROG-IMT Study Grp	Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration	PLOS ONE			English	Article							ARTERY INTIMA; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; FOLLOW-UP; METABOLIC SYNDROME; HYPERTENSIVE MEN; VASCULAR RISK; PROGRESSION; POPULATION; DISEASE	Aims Carotid intima media thickness (CIMT) predicts cardiovascular (CVD) events, but the predictive value of CIMT change is debated. We assessed the relation between CIMT change and events in individuals at high cardiovascular risk. Methods and results From 31 cohorts with two CIMT scans (total n = 89070) on average 3.6 years apart and clinical follow-up, subcohorts were drawn: (A) individuals with at least 3 cardiovascular risk factors without previous CVD events, (B) individuals with carotid plaques without previous CVD events, and (C) individuals with previous CVD events. Cox regression models were fit to estimate the hazard ratio (HR) of the combined endpoint (myocardial infarction, stroke or vascular death) per standard deviation (SD) of CIMT change, adjusted for CVD risk factors. These HRs were pooled across studies. In groups A, B and C we observed 3483, 2845 and 1165 endpoint events, respectively. Average common CIMT was 0.79mm (SD 0.16mm), and annual common CIMT change was 0.01mm (SD 0.07mm), both in group A. The pooled HR per SD of annual common CIMT change (0.02 to 0.43mm) was 0.99 (95% confidence interval: 0.95-1.02) in group A, 0.98 (0.93-1.04) in group B, and 0.95 (0.89-1.04) in group C. The HR per SD of common CIMT (average of the first and the second CIMT scan, 0.09 to 0.75mm) was 1.15 (1.07-1.23) in group A, 1.13 (1.05-1.22) in group B, and 1.12 (1.05-1.20) in group C. Conclusions We confirm that common CIMT is associated with future CVD events in individuals at high risk. CIMT change does not relate to future event risk in high-risk individuals.	[Lorenz, Matthias W.; Ziegelbauer, Kathrin; Steinmetz, Helmuth] Goethe Univ, Dept Neurol, Frankfurt, Germany; [Gao, Lu] Univ Forvie Site, MRC, Biostat Unit, Inst Publ Hlth, Cambridge, England; [Norata, Giuseppe Danilo; Tremoli, Elena; Baldassarre, Damiano] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Norata, Giuseppe Danilo] Bassini Hosp, SISA Ctr Study Atherosclerosis, Cinisello Balsamo, Italy; [Empana, Jean Philippe] Univ Paris 05, Sorbonne Paris Cite, UMR, Paris Cardiovasc Res Ctr PARCC, Paris, France; [Schmidtmann, Irene] Univ Med Mainz, IMBEI, Mainz, Germany; [Lin, Hung-Ju; Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [McLachlan, Stela; Price, Jackie F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Bokemark, Lena] Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Wallenberg Lab Cardiovasc Res,Inst Medicin, Gothenburg, Sweden; [Ronkainen, Kimmo; Tuomainen, Tomi-Pekka; Kauhanen, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio Campus, Kuopio, Finland; [Amato, Mauro; Veglia, Fabrizio; Tremoli, Elena; Baldassarre, Damiano] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Schminke, Ulf] Greifswald Univ Clin, Dept Neurol, Greifswald, Germany; [Srinivasan, Sathanur R.] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Cardiovasc Hlth, Dept Epidemiol,Biochem, New Orleans, LA USA; [Lind, Lars] Uppsala Univ, Dept Med, Uppsala, Sweden; [Okazaki, Shuhei] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Willeit, Peter; Willeit, Johann; Kiechl, Stefan] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Willeit, Peter; Thompson, Simon G.] Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England; [Polak, Joseph F.] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA; [Sander, Dirk] Benedictus Hosp Tutzing & Feldafing, Dept Neurol, Feldafing, Germany; [Poppert, Holger] Tech Univ Munich, Dept Neurol, Munich, Germany; [Desvarieux, Moise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Ikram, M. Arfan; Hofman, Albert] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Johnsen, Stein Harald; Mathiesen, Ellisiv B.] Uit, Dept Clin Med, Tromso, Norway; [Johnsen, Stein Harald] Univ Hosp Northern Norway, Dept Neurol, Tromso, Norway; [Staub, Daniel; Uthoff, Heiko] Univ Basel Hosp, Dept Angiol, Basel, Switzerland; [Sirtori, Cesare R.; Castelnuovo, Samuela] Osped Niguarda Ca Granda, Ctr Dyslipidemias, Milan, Italy; [Igiseder, Bernhard] Parcelsus Med Univ, Salzburg, Austria; [Igiseder, Bernhard] Gemeinnutzige Salzburger Landeskliniken Betriebsg, Doppler Klin, Dept Geriatr Med, Salzburg, Austria; [Beloqui, Oscar; Landecho, Manuel F.] Univ Navarra Clin, Dept Internal Med, Navarra, Spain; [Engstrom, Gunnar; Hedblad, Bo] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Friera, Alfonso] Univ Autonoma Madrid, Hosp Univ La Princesa, Dept Radiol, Madrid, Spain; [Rozza, Francesco; Izzo, Raffaele; de Luca, Nicola] Univ Naples Federico II, Sch Med, Naples, Italy; [Xie, Wuxiang; Zhao, Dong; Liu, Jing] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing, Peoples R China; [Parraga, Grace] Western Univ, Roberts Res Inst, London, ON, Canada; [Grigore, Liliana] Bassini Hosp, Ctr Sisa Studio Aterosclerosi, Cinisello Balsamo, Italy; [Plichart, Matthieu] Hop Broca, AP HP, Paris, France; [Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Dept Med 2, Mainz, Germany; [Blankenberg, Stefan] Univ Hosp Hamburg Eppendorf, Dept Cardiol, Hamburg, Germany; [Schmidt, Caroline] Univ Gothenburg, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Voelzke, Henry] German Ctr Cardiovasc Res DZHK, Partner Site Greifswald, Greifswald, Germany; [Voelzke, Henry] Inst Community Med, SHIP Clin Epidemiol Res, Greifswald, Germany; [Nijpels, Giel] Vrije Univ Amsterdam, Dept Gen Practice, Medial Ctr, Amsterdam, Netherlands; [Nijpels, Giel] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Franco, Oscar H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Suarez, Carmen] Univ Autonoma Madrid, Hosp Univ La Princesa, Dept Internal Med, Madrid, Spain; [Wannarong, Thapat] Western Univ, Stroke Prevent & Atherosclerosis Res Ctr, Roberts Res Inst, London, ON, Canada; [Wannarong, Thapat] Mahidol Univ, Dept Internal Med, Fac Med, Siriraj Hosp, Bangkok, Thailand; [Catapano, Alberico] IRCSS Multimed, Milan, Italy; [Catapano, Alberico] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Ducimetiere, Pierre] Univ Paris Sud Xi, Le Kremlin Bicetre, France; [Espinola-Klein, Christine] Johannes Gutenberg Univ Mainz, Dept Med 2, Mainz, Germany; [Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Bergstrom, Goren] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gotheborg, Sweden; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Berenson, Gerald] Tulane Univ, Sch Med, Dept Med, Pediat,Biochem,Epidemiol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Berenson, Gerald] Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Kitagawa, Kazuo] Tokyo Womens Med Univ, Dept Neurol, Tokyo, Japan; [Dekker, Jacqueline M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Sitzer, Matthias] Klinikum Herford, Dept Neuol, Herford, Germany; [Bickel, Horst] Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Rosvall, Maria] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Gabriel, Rafael] Inst Salud Carlos III, Escuela Natl Sanidad, Madrid, Spain; [Kavousi, Maryam] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands; [de Groot, Eric] Imagelabonline & Cardiovasc, Eindhoven, Netherlands; [de Groot, Eric] Imagelabonline & Cardiovasc, Lunteren, Netherlands; [de Groot, Eric] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Yanez, David N.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Goethe University Frankfurt; MRC Biostatistics Unit; University of Cambridge; University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Johannes Gutenberg University of Mainz; National Taiwan University; National Taiwan University Hospital; University of Edinburgh; University of Gothenburg; University of Eastern Finland; IRCCS Centro Cardiologico Monzino; Tulane University; Uppsala University; Osaka University; Maastricht University; Maastricht University; Medical University of Innsbruck; University of Cambridge; Tufts Medical Center; Tufts University; Technical University of Munich; Columbia University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Basel; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Paracelsus Private Medical University; University of Navarra; Lund University; Autonomous University of Madrid; University of Naples Federico II; Capital Medical University; Western University (University of Western Ontario); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Universite Paris Cite; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gothenburg; German Centre for Cardiovascular Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Miami; Erasmus University Rotterdam; Erasmus MC; Autonomous University of Madrid; Western University (University of Western Ontario); Mahidol University; University of Milan; UDICE-French Research Universities; Universite Paris Saclay; Johannes Gutenberg University of Mainz; National Taiwan University; University of Gothenburg; Greifswald Medical School; Tulane University; Tokyo Women's Medical University; Vrije Universiteit Amsterdam; Ruhr University Bochum; Technical University of Munich; University of Munich; Lund University; Instituto de Salud Carlos III; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Washington; University of Washington Seattle	Lorenz, MW (corresponding author), Goethe Univ, Dept Neurol, Frankfurt, Germany.	matthias.lorenz@em.uni-frankfurt.de	Empana, Jean-Philippe/AAF-6923-2021; Amato, Mauro/J-3289-2016; Kauhanen, Jussi/ABC-4064-2021; Dörr, Marcus/F-1919-2010; Xie, Wuxiang/GYU-3990-2022; Norata, Giuseppe Danilo/AAC-2863-2019; Zhao, D/AAX-5040-2021; Parraga, Grace/K-6465-2013; AMATO, Mauro/N-2058-2019; Sacco, Ralph/Y-9278-2019; Desvarieux, Moise/C-4991-2019; Liu, Jing/AAH-8079-2021; Willeit, Peter/HCI-7091-2022; Ikram, M. Arfan/AAM-5225-2021; Kavousi, Maryam/F-1174-2018; Catapano, alberico/AAC-2827-2019; Franco, Óscar H/ABE-2305-2020; Stehouwer, Coen/AAB-3435-2021; TREMOLI, ELENA/I-8126-2018; Baldassarre, Damiano/J-3295-2016; Izzo, Raffaele/G-4892-2011	Empana, Jean-Philippe/0000-0002-1469-7772; Amato, Mauro/0000-0002-0118-5719; Dörr, Marcus/0000-0001-7471-475X; Liu, Jing/0000-0002-3311-0818; Willeit, Peter/0000-0002-1866-7159; Kavousi, Maryam/0000-0001-5976-6519; Catapano, alberico/0000-0002-7593-2094; Franco, Óscar H/0000-0002-4606-4929; TREMOLI, ELENA/0000-0002-0929-6106; Norata, Giuseppe Danilo/0000-0002-6081-1257; Baldassarre, Damiano/0000-0002-2766-8882; Uthoff, Heiko/0000-0003-4787-5659; Stehouwer, Coen/0000-0001-8752-3223; WANNARONG, THAPAT/0000-0003-1839-1903; Nijpels, Giel/0000-0002-3679-9710; Blankenberg, Stefan/0000-0001-6488-2362; Poppert, Holger/0000-0003-2189-7681; SU, TA-CHEN/0000-0001-7523-7166; Price, Jackie/0000-0003-3251-3970; Izzo, Raffaele/0000-0002-0308-2836; Bergstrom, Goran/0000-0003-4289-5722	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG Lo 1569/2-1, DFG Lo 1569/2-3]; British heart Foundation [CH/12/2/29428]; MRC [MR/L003120/1] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC035129, N01HC045133] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020098, R01AG023629, R01AG015928, R56AG023629, R56AG020098, R01AG027058] Funding Source: NIH RePORTER	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); British heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The PROG-IMT project, which includes this publication, has been funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, www.dfg.de) under the grants DFG Lo 1569/2-1 and DFG Lo 1569/2-3, received by MWL. The DFG had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Simon Thompson is supported by the British heart Foundation (CH/12/2/29428). Some of the contributing studies were funded by different parties, as listed in the acknowledgement section. Here, too, the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agewall S, 2001, J INTERN MED, V249, P305, DOI 10.1046/j.1365-2796.2001.00818.x; Baldassarre D, 2000, STROKE, V31, P2426, DOI 10.1161/01.STR.31.10.2426; Baldassarre D, 2010, EUR HEART J, V31, P614, DOI 10.1093/eurheartj/ehp496; Behre CJ, 2006, J INTERN MED, V260, P238, DOI 10.1111/j.1365-2796.2006.01683.x; Beller GA, 2009, J NUCL CARDIOL, V16, P681, DOI 10.1007/s12350-009-9139-0; BonithonKopp C, 1996, ARTERIOSCL THROM VAS, V16, P310, DOI 10.1161/01.ATV.16.2.310; BonithonKopp C, 1996, STROKE, V27, P654, DOI 10.1161/01.STR.27.4.654; Bots ML, 2006, CURR MED RES OPIN, V22, P2181, DOI 10.1185/030079906X148472; Bots ML, 1997, STROKE, V28, P2442, DOI 10.1161/01.STR.28.12.2442; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Costanzo P, 2010, J AM COLL CARDIOL, V56, P2006, DOI 10.1016/j.jacc.2010.05.059; CROUSE JR, 1994, STROKE, V25, P1354, DOI 10.1161/01.STR.25.7.1354; del Sol AI, 2002, EUR HEART J, V23, P934, DOI 10.1053/euhj.2001.2965; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Espinola-Klein C, 2000, STROKE, V31, P2127, DOI 10.1161/01.STR.31.9.2127; Fagerberg B, 1998, AM J HYPERTENS, V11, P14, DOI 10.1016/S0895-7061(97)00363-4; Falk E, 2011, CURR ATHEROSCLER REP, V13, P345, DOI 10.1007/s11883-011-0195-y; Gabriel R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-360; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; Goldberger ZD, 2010, AM HEART J, V160, P701, DOI 10.1016/j.ahj.2010.06.029; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kiechl S, 1999, ARTERIOSCL THROM VAS, V19, P1484, DOI 10.1161/01.ATV.19.6.1484; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Landecho MF, 2011, REV ESP CARDIOL, V64, P373, DOI 10.1016/j.recesp.2010.11.011; Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lloyd KD, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/169323; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Lorenz MW, 2010, AM HEART J, V159, P730, DOI 10.1016/j.ahj.2010.02.008; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Lynch J, 1997, ARTERIOSCL THROM VAS, V17, P513, DOI 10.1161/01.ATV.17.3.513; Norata GD, 2006, STROKE, V37, P1558, DOI 10.1161/01.STR.0000221803.16897.22; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Rodriguez-Macias KA, 2006, ATHEROSCLEROSIS, V189, P393, DOI 10.1016/j.atherosclerosis.2006.02.020; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Sander D, 2000, CIRCULATION, V102, P1536, DOI 10.1161/01.CIR.102.13.1536; Schmidt C, 2003, J INTERN MED, V253, P430, DOI 10.1046/j.1365-2796.2003.01129.x; Sitzer M, 2003, STROKE, V34, P950, DOI 10.1161/01.STR.0000060895.38298.C4; Sourij H, 2008, STROKE, V39, P1349, DOI 10.1161/STROKEAHA.107.502799; Spijkerman AMW, 2004, J INTERN MED, V256, P429, DOI 10.1111/j.1365-2796.2004.01395.x; Staub D, 2006, STROKE, V37, P800, DOI 10.1161/01.STR.0000202589.47401.c6; Stensland-Bugge E, 2000, STROKE, V31, P574, DOI 10.1161/01.STR.31.3.574; Su TC, 2001, STROKE, V32, P2265, DOI 10.1161/str.32.10.2265; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; von Sarnowski B, 2010, STROKE, V41, P2375, DOI 10.1161/STROKEAHA.110.593244; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c; Wannarong T, 2013, STROKE, V44, P1859, DOI 10.1161/STROKEAHA.113.001461	53	45	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0191172	10.1371/journal.pone.0191172	http://dx.doi.org/10.1371/journal.pone.0191172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649236	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900002
J	Neira, RAQ; Hamacher, S; Japiassu, AM				Quintano Neira, Ricardo Alfredo; Hamacher, Silvio; Japiassu, Andre Miguel			Epidemiology of sepsis in Brazil: Incidence, lethality, costs, and other indicators for Brazilian Unified Health System hospitalizations from 2006 to 2015	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; DEFINITIONS; MULTICENTER; COMMUNITY; OUTCOMES; STATES	Background Sepsis is considered a major worldwide health burden, with high mortality and associated costs. Health indicators are essential to define strategies to improve the treatment of diseases, and the epidemiology information of sepsis in developing countries is scarce. Thus, the aim of this work is to assess trends in the incidence, lethality, costs, and other indicators of sepsis for Brazilian Unified Health System (SUS-Sistema Unico de Saude) hospitalizations for the period from January 2006 to December 2015. Materials and methods We conducted this study using data from the SUS hospital information system. We selected registries of SUS hospitalizations of patients diagnosed with sepsis (total of 724,458 cases from 4,271 public and private Brazilian hospitals). Results From 2006 to 2015, the annual sepsis incidence increased 50.5% from 31.5/100,000 to 47.4/100,000 persons. The mean hospital length of stay (LOS) was 9.0 days. A total of 29.1% of the hospitalizations had admission to the intensive care unit (ICU) with a mean ICU LOS of 8.0 days. The mean cost per hospitalization was US$624.0 and for hospitalizations requiring intensive care was U$1,708.1. The overall sepsis lethality rate was 46.3%, and for hospitalizations with admission to the ICU, it was 64.5%. During the study period, the lethality rate for children/teenagers decreased 40.1%, but for all other age groups it increased 11.4%. The sepsis lethality rate in public hospitals (55.5%) was higher than private hospitals (37.0%) (p < 0.001). The mean hospitalization LOS for public hospitals (10.3 days) was higher than private hospitals (7.6 days) (p < 0.001). Conclusions The incidence and lethality rate of sepsis increased in SUS hospitalizations during the study period. The SUS's low reimbursement to hospitals for treating sepsis may be one of the reasons for the high lethality rate.	[Quintano Neira, Ricardo Alfredo; Hamacher, Silvio] Pontificia Univ Catolica Rio de Janeiro, Dept Ind Engn, Rio De Janeiro, RJ, Brazil; [Quintano Neira, Ricardo Alfredo] Philips Res Brazil, Sao Paulo, Brazil; [Japiassu, Andre Miguel] Fundacao Oswaldo Cruz, Inst Nacl Infectol, Rio De Janeiro, RJ, Brazil	Philips; Philips Research; Fundacao Oswaldo Cruz	Japiassu, AM (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol, Rio De Janeiro, RJ, Brazil.	andre.japiassu@ini.fiocruz.br	hamacher, silvio/C-3325-2013	hamacher, silvio/0000-0002-3980-0342	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Philips Research; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306802/2015-5, 403863/2016-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Philips Research; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RAQN is currently receiving a grant from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov and another grant from Philips Research (https://www.philips.com/a-w/research/home.html). SH is currently receiving two grants (306802/2015-5, 403863/2016-3) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http.//cnpq.br/). RAQN is affiliated with Philips Research Brazil to participate in the Clinical Pathways project. His affiliation with Philips Research Brazil does not affect or create any bias in the research study presented in this manuscript. The funders provided support in the form of grants for authors RAQN and SH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acosta CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067175; Adrie C, 2005, J CRIT CARE, V20, P46, DOI 10.1016/j.jcrc.2004.10.005; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Canadian Institute for Health Information, 2009, FOC NAT LOOK SEPS; Carrillo-Esper R, 2009, CIR CIR, V77, P301; Carrillo-Esper R, 2009, CIR CIR, V77, P279; Chalupka AN, 2012, CRIT CARE CLIN, V28, P57, DOI 10.1016/j.ccc.2011.09.003; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Grozdanovski K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/182324; Instituto Brasileiro de Geografia e Estat o A stica (IBGE), 2017, PROJ POP SEX ID; Instituto Brasileiro de Geografia e Estat o A stica (IBGE), 2017, IND NAC PERC CONS AM; Instituto Brasileiro de Geografia e Estat o stica (IBGE), 2017, BRAS SINT DISTR POP; Jolley RJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009487; Jolley RJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0847-3; Kempker JA, 2016, CLIN CHEST MED, V37, P165, DOI 10.1016/j.ccm.2016.01.002; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Liao XL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.51; Machado FR, 2017, LANCET INFECT DIS, V17, P1180, DOI 10.1016/S1473-3099(17)30322-5; Ministe A rio da Sau A de. Secretaria Geral, 1985, TERM BAS SAUD; Gobatto ALN, 2017, SHOCK, V47, P6, DOI 10.1097/SHK.0000000000000703; Papali A, 2017, J CRIT CARE, V38, P35, DOI 10.1016/j.jcrc.2016.09.031; Conde KAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064790; R Core Team, 2015, R LANGUAGE ENV STAT; Rodriguez F, 2011, CRIT CARE MED, V39, P1675, DOI 10.1097/CCM.0b013e318218a35e; Salluh JIF, 2017, INTENS CARE MED, V43, P1703, DOI 10.1007/s00134-017-4760-x; Santos AO, 2009, THESIS, V69 f; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sogayar AMC, 2008, PHARMACOECONOMICS, V26, P425, DOI 10.2165/00019053-200826050-00006; Stoller J, 2016, J CRIT CARE, V31, P58, DOI 10.1016/j.jcrc.2015.09.034; Taniguchi LU, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0608-8; The World Bank, 2017, WORLD DEV IND EXCH R; Tsertsvadze A, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0243-3; United Nations Development Programme, 2017, HUM DEV REP WORK HUM; UOL economia, 2017, COT CAMB DOL COM; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Watts J, 2016, LANCET, V387, P1603, DOI 10.1016/S0140-6736(16)30249-5; World Health Organization, 2017, PREVALENCE OBESITY A	40	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195873	10.1371/journal.pone.0195873	http://dx.doi.org/10.1371/journal.pone.0195873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652944	Green Submitted, Green Published, gold			2022-12-27	WOS:000430026900042
J	Gebrie, A; Alebel, A; Zegeye, A; Tesfaye, B				Gebrie, Alemu; Alebel, Animut; Zegeye, Abriham; Tesfaye, Bekele			Prevalence and predictors of khat chewing among Ethiopian university students: A systematic review and meta-analysis	PLOS ONE			English	Review							ALCOHOL-USE; SCHOOL; BIAS	Background Khat chewing has become a common practice among university students in developing countries like Ethiopia. It has a potential effect on physical, mental, social and cognitive aspects of student functioning. In Ethiopia, study findings regarding the prevalence of khat chewing were highly dispersed and inconsistent. Therefore, this systematic review and meta-analysis estimates the pooled prevalence of khat chewing and its predictors among Ethiopian university students. Method A systematic review and meta-analysis was conducted to assess the prevalence and predictors of khat chewing among university students in Ethiopia. We searched literature from the databases of PubMed, Google Scholar, Science Direct, and the Cochrane Library. A total of 24 Ethiopian studies reporting the prevalence of khat chewing among university students were included. Data were extracted using a standardized data extraction format prepared in Microsoft Excel and the analysis was done using STATA 14 statistical software. To assess heterogeneity, the Cochrane Q test statistics and l(2) test were used. Since the included studies exhibit high heterogeneity, a random effect meta-analysis model was computed to estimate the pooled prevalence of khat chewing. Moreover, the association between predictor variables, and khat chewing practice were examined. Results The meta-analysis of 24 studies revealed that the pooled prevalence of khat chewing among university students in Ethiopia was 23.22% (95% CI: 19.5, 27.0). In the subgroup analysis, the highest prevalence was observed in Oromia region (31.6%; 95CI: 21.2, 41.9) whereas the lowest prevalence was observed in Amhara region (18.1%; 95% CI: 12.4, 23.8). Being male OR: 2.76 (95% CI 1.64, 4.63), family khat chewing practice OR: 2.91 (95% CI 1.06, 7.98), friend khat chewing habit OR: 4.74 (95% CI 3.48, 13.06), alcohol drinking OR: 7.06 (95% CI 5.65, 8.82) and cigarette smoking habit OR: 15.11 (95% CI 8.96, 25.51) were found to be predictors of khat chewing. Conclusion The study found that the prevalence of khat chewing among university students was quite common, with slightly more than 1 in 5 students engaging in the use of this substance. Being male, family khat chewing practice, friend's khat chewing habit, alcohol drinking, and cigarette smoking were found to be predictors of khat chewing practice among university students.	[Gebrie, Alemu; Zegeye, Abriham] Debre Markos Univ, Sch Med, Dept Biomed Sci, Debre Markos, Ethiopia; [Alebel, Animut; Tesfaye, Bekele] Debre Markos Univ, Dept Nursing, Coll Hlth Sci, Debre Markos, Ethiopia		Gebrie, A (corresponding author), Debre Markos Univ, Sch Med, Dept Biomed Sci, Debre Markos, Ethiopia.	alemugebrie2@gmail.com	Gebrie, Alemu/AAD-3275-2020; Alebel, Animut/L-4278-2019; Ayalew, Animut Alebel/U-6092-2019	Gebrie, Alemu/0000-0001-5575-6823; Alebel, Animut/0000-0003-2822-2062; 				Abdeta T, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1284-4; Adane WGK, 2017, J SUBST USE, V22, P176, DOI 10.3109/14659891.2016.1166273; Adere Ashete, 2017, BMC Res Notes, V10, P441, DOI 10.1186/s13104-017-2763-x; Aklilu S, 2014, J PSYCHOL CLIN PSYCH, V1, P8; Al-Habori Molham, 2005, Expert Opin Drug Saf, V4, P1145, DOI 10.1517/14740338.4.6.1145; Al-Juhaishi T, 2013, QATAR MED J, V2012, P5; Al-Motarreb A, 2010, J ETHNOPHARMACOL, V132, P540, DOI 10.1016/j.jep.2010.07.001; al'Absi M, 2013, AM J ADDICTION, V22, P99, DOI 10.1111/j.1521-0391.2013.00302.x; [Anonymous], 2001, KHAT CATHA EDULIS BO; [Anonymous], ETHIOP SCI J PUBLIC, DOI DOI 10.11648/j.sjph.20130105.14; [Anonymous], 2020, BMC PUBLIC HEALTH; Aseffa M, 1983, P INT C KHAT; Astatkie A, 2015, SUBST ABUSE REHABIL, V6, P41, DOI 10.2147/SAR.S78773; Atwoli L, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-34; Bani I., 2011, EUR J SCI RES, V63, P122; Berhanu Megerssa, 2014, Discourse Journal of Agriculture and Food Sciences, V2, P21; Colzato LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020602; Damena T, 2011, ETHIOP J HEALTH SCI, V21, P37; Derese A, 2014, ETHIOP SCI J PUBLIC, V2, P102; Deressa W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-660; Dires E, 2016, FACTORS ASS KHAT CHE; DRAKE PH, 1988, LANCET, V1, P532; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elmi A, 1983, P INT C KHAT ANT MAD, P17; Erica B, 2009, WIEN KLIN WOCHENSCHR, V121; Fekadu A., 2007, AFR J DRUG ALCOHOL S, V6, P40; Fufa G, 2017, PUBLIC HLTH RES, V7, P49; Gebrehanna E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1198; Gebrehanna E, 2014, SUBST ABUS-RES TREAT, V8, P45, DOI 10.4137/SART.S14413; Gebreslassie M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-693; Gelaw Y, 2004, ETHIOP J HEALTH DEV, V18, P179; Gezahegn T, 2014, J ADDICTION, V2014; Hussain M., 2013, J FAM COMMUNITY MED, V15, P3; Ihunwo A O, 2004, East Afr Med J, V81, P468; KALIX P, 1984, B WORLD HEALTH ORGAN, V62, P681; KALIX P, 1992, PHARMACOL TOXICOL, V70, P77, DOI 10.1111/j.1600-0773.1992.tb00434.x; KALIX P, 1984, GEN PHARMACOL, V15, P179, DOI 10.1016/0306-3623(84)90156-3; Kassa A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1044; Kassa A, 2016, AFR HEALTH SCI, V16, P822, DOI 10.4314/ahs.v16i3.24; Kassim S, 2016, ADDICTION, V111, P179, DOI 10.1111/add.13148; Kassim S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/313692; Kassim S, 2013, J ETHNOPHARMACOL, V146, P835, DOI 10.1016/j.jep.2013.02.011; Kebede D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-109; Kebede Y, 2002, East Afr Med J, V79, P274; Kidan AT, 2011, PSYCHO ACTIVE SUBSTA; Lakew A, 2014, ETHIOP ADV APPL SOCI, V4, P225, DOI DOI 10.4236/aasoci.2014.410027; Legese MG, 2014, ASSESSMENT DETERMINA; Liberati A, 2009, PLOS MED, V6, DOI DOI 10.1186/s13643-016-0384-4; LUQMAN W, 1976, ANN INTERN MED, V85, P246, DOI 10.7326/0003-4819-85-2-246; Mamo DB, 2014, ASSESSMENT PREVALENC; Mekonen T, 2017, PSYCHIAT J, V2017; Meressa K., 2009, ETHIOP J HEALTH SCI, V19; Mossie TB., 2015, J PSYCH, V18, P281; Numan N, 2004, ADDICTION, V99, P61, DOI 10.1111/j.1360-0443.2004.00570.x; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; OMOLO OE, 1987, BRIT J ADDICT, V82, P97; Oshodi OY, 2010, AFR J PSYCHIATRY, V13, P52; Osman T, 2016, J ADDICTION, V2016; Reda AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033946; Room R, 2005, ADDICT RES THEORY, V13, P321, DOI 10.1080/16066350500136326; RUCKER G, 2008, BMC MED RES METHODOL, V0008; Selassie S. Gebre, 1996, Bulletin on Narcotics, V48, P53; Sikiru L, 2009, AFRICAN J DRUG ALCOH, V8; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stevenson M, 1996, DRUG ALCOHOL REV, V15, P73, DOI 10.1080/09595239600185691; Tadesse M., 2014, EDUC RES-UK, V5, P368; Tesfaye Fikru, 2008, Prev Chronic Dis, V5, pA89; Teshome G., 2015, OPEN ACCESS LIB J, V2, P1; Tiruneh G., 2013, GLOBAL J MED RES; Tsegay G, 2014, PSYCHOACTIVE SUBSTAN; Wazema D.H., 2017, INT J RES MED SCI, V3, P1751; Yousif Al-Zarouni, 2015, EFFECTS KHAT CATHA E; Zeleke A., 2013, OPEN J EPIDEMIOL, V3, P160, DOI [10.4236/ojepi.2013.34024, DOI 10.4236/OJEPI.2013.34024]	73	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195718	10.1371/journal.pone.0195718	http://dx.doi.org/10.1371/journal.pone.0195718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649253	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900075
J	Sen, B; Borle, NC; Greiner, R; Brown, MRG				Sen, Bhaskar; Borle, Neil C.; Greiner, Russell; Brown, Matthew R. G.			A general prediction model for the detection of ADHD and Autism using structural and functional MRI	PLOS ONE			English	Article							BLIND SEPARATION; ATTENTION; CONNECTIVITY; NETWORK; CORTEX; FMRI	This work presents a novel method for learning a model that can diagnose Attention Deficit Hyperactivity Disorder (ADHD), as well as Autism, using structural texture and functional connectivity features obtained from 3-dimensional structural magnetic resonance imaging (MRI) and 4-dimensional resting-state functional magnetic resonance imaging (fMRI) scans of subjects. We explore a series of three learners: (1) The LEFMS learner first extracts features from the structural MRI images using the texture-based filters produced by a sparse autoencoder. These filters are then convolved with the original MRI image using an unsupervised convolutional network. The resulting features are used as input to a linear support vector machine (SVM) classifier. (2) The LEFMF learner produces a diagnostic model by first computing spatial non-stationary independent components of the fMRI scans, which it uses to decompose each subject's fMRI scan into the time courses of these common spatial components. These features can then be used with a learner by themselves or in combination with other features to produce the model. Regardless of which approach is used, the final set of features are input to a linear support vector machine (SVM) classifier. (3) Finally, the overall LEFMSF learner uses the combined features obtained from the two feature extraction processes in (1) and (2) above as input to an SVM classifier, achieving an accuracy of 0.673 on the ADHD-200 holdout data and 0.643 on the ABIDE holdout data. Both of these results, obtained with the same LEFMSF framework, are the best known, over all hold-out accuracies on these datasets when only using imaging data-exceeding previously-published results by 0.012 for ADHD and 0.042 for Autism. Our results show that combining multi-modal features can yield good classification accuracy for diagnosis of ADHD and Autism, which is an important step towards computer-aided diagnosis of these psychiatric diseases and perhaps others as well.	[Sen, Bhaskar; Borle, Neil C.; Greiner, Russell; Brown, Matthew R. G.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Greiner, Russell] Alberta Machine Intelligence Inst, Edmonton, AB, Canada; [Brown, Matthew R. G.] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada	University of Alberta; University of Alberta	Brown, MRG (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.; Brown, MRG (corresponding author), Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.	mbrown2@ualberta.ca	Greiner, Russell/AAQ-4502-2020	Greiner, Russell/0000-0001-8327-934X	Alberta Machine Intelligence Institute (AMII); Canadian Institutes of Health Research [CSE125741]; Natural Sciences and Engineering Research Council of Canada (NSERC) [203245]; Canadian Institutes of Health Research; Alberta Innovates Technology Frontiers; Alberta Innovates Health Solutions; Alberta Machine Intelligence Institute	Alberta Machine Intelligence Institute (AMII); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Frontiers; Alberta Innovates Health Solutions; Alberta Machine Intelligence Institute	This work was supported by Alberta Machine Intelligence Institute (AMII), formerly the Alberta Innovates Centre for Machine Learning (AICML), Project Title: Patient Specific fMRI-based Psychiatric Diagnosis and Treatment, Recipient: RG, Website: www.aicml.ca; Canadian Institutes of Health Research, Recipient: RG, Grant Number: CSE125741, Website: www.cihr-irsc.gc.ca; and Natural Sciences and Engineering Research Council of Canada (NSERC), Recipient: RG, Grant Number: 203245, Website: www.nserc-crsng.gc.ca.; This research was supported by funding from the Canadian Institutes of Health Research, Alberta Innovates Technology Frontiers, Alberta Innovates Health Solutions, and the Alberta Machine Intelligence Institute. We thank the providers of the ADHD-200 and ABIDE datasets for generously sharing their data with the research community. We would also like to thank Compute Canada for the generous use of their computing resources.	Abraham A, 2017, NEUROIMAGE, V147, P736, DOI 10.1016/j.neuroimage.2016.10.045; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brown MRG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00069; Calhoun VD, 2002, HUM BRAIN MAPP, V16, P131, DOI 10.1002/hbm.10044; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Dai D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00063; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deshpande G, 2015, IEEE T CYBERNETICS, V45, P2668, DOI 10.1109/TCYB.2014.2379621; Eloyan Ani, 2012, Front Syst Neurosci, V6, P61, DOI 10.3389/fnsys.2012.00061; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Ghiassian S., 2013, P 3 NIPS WORKSH MACH; Ghiassian S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166934; Hjelm RD, 2014, NEUROIMAGE, V96, P245, DOI 10.1016/j.neuroimage.2014.03.048; Hyvarinen A., 1999, NOT INT JOINT C NEUR; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kawamoto M, 1998, NEUROCOMPUTING, V22, P157, DOI 10.1016/S0925-2312(98)00055-1; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Lai SH, 1999, MAGN RESON IMAGING, V17, P827, DOI 10.1016/S0730-725X(99)00038-7; LeCun Y., 1995, HDB BRAIN THEORY NEU, V3361, DOI DOI 10.1109/IJCNN.2004.1381049; Li SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049340; Ng A.., 2017, CS229 LECT NOTES; Nielsen JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00599; Olshausen B., 2001, SPARSE CODES SPIKES; Parra L, 2000, IEEE T SPEECH AUDI P, V8, P320, DOI 10.1109/89.841214; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Rish I., 2009, ADV NEURAL INFORM PR, V22, P252; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; Sidhu Gagan S, 2012, Front Syst Neurosci, V6, P74, DOI 10.3389/fnsys.2012.00074; SOULOUMIAC A, 1995, INT CONF ACOUST SPEE, P1912, DOI 10.1109/ICASSP.1995.480586; Souloumiac A, AC SPEECH SIGN PROC, V3, P745, DOI [10.1016/j.neuroimage.2016.10.045, DOI 10.1016/J.NEUROIMAGE.2016.10.045]; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Wang K, 2008, CEREB CORTEX, V18, P697, DOI 10.1093/cercor/bhm105	41	68	70	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194856	10.1371/journal.pone.0194856	http://dx.doi.org/10.1371/journal.pone.0194856			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664902	Green Published, gold, Green Submitted			2022-12-27	WOS:000430262300011
J	Joensen, AM; Joergensen, T; Lundbye-Christensen, S; Johansen, MB; Guzman-Castillo, M; Bandosz, P; Hallas, J; Prescott, EIB; Capewell, S; O'Flaherty, M				Joensen, Albert Marni; Joergensen, Torben; Lundbye-Christensen, Soren; Johansen, Martin Berg; Guzman-Castillo, Maria; Bandosz, Piotr; Hallas, Jesper; Prescott, Eva Irene Bossano; Capewell, Simon; O'Flaherty, Martin			Explaining trends in coronary heart disease mortality in different socioeconomic groups in Denmark 1991-2007 using the IMPACT(SEC) model	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; DECLINE; SYSTEM; HEALTH; DANISH	Aim To quantify the contribution of changes in different risk factors population levels and treatment uptake on the decline in CHD mortality in Denmark from 1991 to 2007 in different socioeconomic groups. Design We used IMPACT(SEC), a previously validated policy model using data from different population registries. Participants All adults aged 25-84 years living in Denmark in 1991 and 2007. Main outcome measure Deaths prevented or postponed (DPP). Results There were approximately 11,000 fewer CHD deaths in Denmark in 2007 than would be expected if the 1991 mortality rates had persisted. Higher mortality rates were observed in the lowest socioeconomic quintile. The highest absolute reduction in CHD mortality was seen in this group but the highest relative reduction was in the most affluent socioeconomic quintile. Overall, the IMPACT(SEC) model explained nearly two thirds of the decline in. Improved treatments accounted for approximately 25% with the least relative mortality reduction in the most deprived quintile. Risk factor improvements accounted for approximately 40% of the mortality decrease with similar gains across all socio-economic groups. The 36% gap in explaining all DPPs may reflect inaccurate data or risk factors not quantified in the current model. Conclusions According to the IMPACT(SEC) model, the largest contribution to the CHD mortality decline in Denmark from 1991 to 2007 was from improvements in risk factors, with similar gains across all socio-economic groups. However, we found a clear socioeconomic trend for the treatment contribution favouring the most affluent groups.	[Joensen, Albert Marni] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Joergensen, Torben] Capital Reg, Ctr Hlth, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Joergensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Joergensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Lundbye-Christensen, Soren; Johansen, Martin Berg] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Guzman-Castillo, Maria; Bandosz, Piotr; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Bandosz, Piotr] Med Univ Gdansk, Dept Prevent Med & Educ, Gdansk, Poland; [Hallas, Jesper] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, Odense, Denmark; [Prescott, Eva Irene Bossano] Capital Reg Denmark, Bispebjerg Univ Hosp, Copenhagen, Denmark	Aalborg University; Aalborg University Hospital; University of Copenhagen; Aalborg University; Aalborg University; Aalborg University Hospital; University of Liverpool; Fahrenheit Universities; Medical University Gdansk; University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital	Joensen, AM (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.	albert.marni.joensen@rn.dk	Johansen, Martin Nygård/L-6845-2014; Shao, Ruitai/AAU-7642-2021; Prescott, Eva/AAJ-7441-2020	Johansen, Martin Nygård/0000-0001-9790-0985; Prescott, Eva/0000-0002-4134-0349; O'Flaherty, Martin/0000-0001-8944-4131; Guzman-Castillo, Maria/0000-0002-1220-9472; Joensen, Albert Marni/0000-0002-9963-9511	EUROHEART II (Predicting future CVD trends under different policy scenarios in the EU: Impact CVD, ADONIS) [A/100946]; Danish Heart Foundation	EUROHEART II (Predicting future CVD trends under different policy scenarios in the EU: Impact CVD, ADONIS); Danish Heart Foundation	This research was funded by EUROHEART II (Predicting future CVD trends under different policy scenarios in the EU: Impact CVD 2020, ADONIS code A/100946), and the Danish Heart Foundation. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguib Yasmine, 2015, Glob Cardiol Sci Pract, V2015, P33, DOI 10.5339/gcsp.2015.33; Amiri M, 2011, J EPIDEMIOL COMMUN H, V65, P676, DOI 10.1136/jech.2010.109058; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Barendregt JJ, 2010, VALUE HEALTH, V13, P388, DOI 10.1111/j.1524-4733.2009.00686.x; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hallas J, 2017, BASIC CLIN PHARMACOL, V120, P419, DOI 10.1111/bcpt.12764; Hotchkiss JW, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1088; Hutchinson J, 2016, PUBLIC HEALTH NUTR, V21, P465; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Osler M, 2011, INT J EPIDEMIOL, V40, P602, DOI 10.1093/ije/dyq041; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Porta M, 2008, DICT EPIDEMIOLOGY; Rasmussen JN, 2007, CARDIOVASC DRUG THER, V21, P449, DOI 10.1007/s10557-007-6058-7; Rasmussen JN, 2007, J EPIDEMIOL COMMUN H, V61, P1091, DOI 10.1136/jech.2006.055525; Townsend N, 2015, EUR HEART J, V36, P2696, DOI 10.1093/eurheartj/ehv428; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427	20	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0194793	10.1371/journal.pone.0194793	http://dx.doi.org/10.1371/journal.pone.0194793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672537	gold, Green Published, Green Submitted			2022-12-27	WOS:000430446800014
J	Alsos, IG; Lammers, Y; Yoccoz, NG; Jorgensen, T; Sjogren, P; Gielly, L; Edwards, ME				Alsos, Inger Greve; Lammers, Youri; Yoccoz, Nigel Giles; Jorgensen, Tina; Sjogren, Per; Gielly, Ludovic; Edwards, Mary E.			Plant DNA metabarcoding of lake sediments: How does it represent the contemporary vegetation	PLOS ONE			English	Article							ENVIRONMENTAL DNA; ANCIENT DNA; HOLOCENE VEGETATION; PERMAFROST SEDIMENTS; FLORISTIC DIVERSITY; ARCTIC VEGETATION; CLIMATE DYNAMICS; POLLEN; CONSERVATION; BIODIVERSITY	Metabarcoding of lake sediments have been shown to reveal current and past biodiversity, but little is known about the degree to which taxa growing in the vegetation are represented in environmental DNA (eDNA) records. We analysed composition of lake and catchment vegetation and vascular plant eDNA at 11 lakes in northern Norway. Out of 489 records of taxa growing within 2 m from the lake shore, 170-49% (mean 31%) of the identifiable taxa recorded were detected with eDNA. Of the 217 eDNA records of 47 plant taxa in the 11 lakes, 73% and 12% matched taxa recorded in vegetation surveys within 2 m and up to about 50 m away from the lakeshore, respectively, whereas 16% were not recorded in the vegetation surveys of the same lake. The latter include taxa likely overlooked in the vegetation surveys or growing outside the survey area. The percentages detected were 61, 47, 25, and 15 for dominant, common, scattered, and rare taxa, respectively. Similar numbers for aquatic plants were 88, 88, 33 and 62%, respectively. Detection rate and taxonomic resolution varied among plant families and functional groups with good detection of e.g. Ericaceae, Roseaceae, deciduous trees, ferns, club mosses and aquatics. The representation of terrestrial taxa in eDNA depends on both their distance from the sampling site and their abundance and is sufficient for recording vegetation types. For aquatic vegetation, eDNA may be comparable with, or even superior to, in-lake vegetation surveys and may therefore be used as an tool for biomonitoring. For reconstruction of terrestrial vegetation, technical improvements and more intensive sampling is needed to detect a higher proportion of rare taxa although DNA of some taxa may never reach the lake sediments due to taphonomical constrains. Nevertheless, eDNA performs similar to conventional methods of pollen and macrofossil analyses and may therefore be an important tool for reconstruction of past vegetation.	[Alsos, Inger Greve; Lammers, Youri; Jorgensen, Tina; Sjogren, Per; Edwards, Mary E.] Univ Tromso, Tromso Museum, Tromso, Norway; [Yoccoz, Nigel Giles] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Gielly, Ludovic] Univ Grenoble Alpes, LECA, Grenoble, France; [Gielly, Ludovic] CNRS, LECA, Grenoble, France; [Edwards, Mary E.] Univ Southampton, Geog & Environm, Southampton, Hants, England	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Southampton	Alsos, IG (corresponding author), Univ Tromso, Tromso Museum, Tromso, Norway.	inger.g.alsos@uit.no	Yoccoz, Nigel/C-8561-2014; Gielly, Ludovic/ADQ-6036-2022; Alsos, Inger G/A-9507-2016; Alsos, Inger Greve/O-8154-2019	Yoccoz, Nigel/0000-0003-2192-1039; Alsos, Inger G/0000-0002-8610-1085; Alsos, Inger Greve/0000-0002-8610-1085	Research Council of Norway [213692/F20, 250963/F20, 230617/E10]	Research Council of Norway(Research Council of Norway)	The work was supported by the Research Council of Norway (grant nos. 213692/F20, 250963/F20 and 230617/E10 to Alsos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JRM, 1999, J BIOGEOGR, V26, P55, DOI 10.1046/j.1365-2699.1999.00284.x; ALM T, 1993, BOREAS, V22, P171, DOI 10.1111/j.1502-3885.1993.tb00178.x; Alsos IG, 2016, HOLOCENE, V26, P627, DOI 10.1177/0959683615612563; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Birks HJB, 2016, REV PALAEOBOT PALYNO, V228, P1, DOI 10.1016/j.revpalbo.2015.12.011; Birks HJB, 2016, NEW PHYTOL, V209, P499, DOI 10.1111/nph.13657; Birks HH, 2012, SCIENCE, V338, DOI 10.1126/science.1225345; Birks HH, 2010, VEG HIST ARCHAEOBOT, V19, P325, DOI 10.1007/s00334-010-0256-0; Boessenkool S, 2014, CONSERV BIOL, V28, P446, DOI 10.1111/cobi.12195; Boessenkool S, 2012, MOL ECOL, V21, P1806, DOI 10.1111/j.1365-294X.2011.05306.x; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown TA, 2015, J QUATERNARY SCI, V30, P144, DOI 10.1002/jqs.2770; Chambert T, 2015, ECOLOGY, V96, P332, DOI 10.1890/14-1507.1; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dieffenbacher-Krall AC, 2013, ENCY QUATERNARY SCI, P684; DRAKE H, 1980, NEW ZEAL J BOT, V18, P257, DOI 10.1080/0028825X.1980.10426924; DUNWIDDIE PW, 1987, ECOLOGY, V68, P1, DOI 10.2307/1938800; Elven R., 2005, NORSK FLORA; ELVEN R, 2011, ANNOTATED CHECKLIST; Epp LS, 2015, QUATERNARY SCI REV, V117, P152, DOI 10.1016/j.quascirev.2015.03.027; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Fahner NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157505; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Giguet-Covex C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4211; Greenacre M, 2010, ECOLOGY, V91, P958, DOI 10.1890/09-0239.1; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Hiiesalu I, 2012, MOL ECOL, V21, P2004, DOI 10.1111/j.1365-294X.2011.05390.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jackson ST, 2007, ENCY QUATERNARY SCI, P2413; Jackson ST, 2012, QUATERNARY SCI REV, V49, P1, DOI 10.1016/j.quascirev.2012.05.020; Jensen C, 2002, REV PALAEOBOT PALYNO, V121, P113, DOI 10.1016/S0034-6667(02)00077-5; Jensen C, 2002, BOREAS, V31, P285, DOI 10.1080/030094802760260391; Jensen C, 2008, J QUATERNARY SCI, V23, P719, DOI 10.1002/jqs.1155; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Lamb EG, 2016, PLANT SOIL, V404, P361, DOI 10.1007/s11104-016-2852-y; Lopes CM, 2017, MOL ECOL RESOUR, V17, P904, DOI 10.1111/1755-0998.12643; Male PJG, 2014, MOL ECOL RESOUR, V14, P966, DOI 10.1111/1755-0998.12246; MCQUEEN D R, 1969, Tuatara, V17, P13; Meltsov V, 2011, REV PALAEOBOT PALYNO, V166, P344, DOI 10.1016/j.revpalbo.2011.06.008; Nguyen NH, 2015, NEW PHYTOL, V205, P1389, DOI 10.1111/nph.12923; Niemeyer B, 2017, MOL ECOL RESOUR, V17, pe46, DOI 10.1111/1755-0998.12689; Oksanen J., 2022, R PACKAGE VERSION; Orlando L, 2014, ANNU REV ECOL EVOL S, V45, P573, DOI 10.1146/annurev-ecolsys-120213-091712; Pansu J, 2015, MOL ECOL, V24, P1485, DOI 10.1111/mec.13136; Parducci L, 2017, NEW PHYTOL, V214, P924, DOI 10.1111/nph.14470; Parducci L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0382; Parducci L, 2013, MOL ECOL, V22, P3511, DOI 10.1111/mec.12298; Parducci L, 2012, SCIENCE, V338, DOI 10.1126/science.1225476; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Paus A, 2015, QUATERNARY SCI REV, V121, P36, DOI 10.1016/j.quascirev.2015.05.004; Pedersen MW, 2016, NATURE, V537, P45, DOI 10.1038/nature19085; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; Pedersen MW, 2013, QUATERNARY SCI REV, V75, P161, DOI 10.1016/j.quascirev.2013.06.006; Pelissier R, 2003, ECOLOGY, V84, P242, DOI 10.1890/0012-9658(2003)084[0242:CBOTAD]2.0.CO;2; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Rawlence NJ, 2014, J QUATERNARY SCI, V29, P610, DOI 10.1002/jqs.2740; Schmid S, 2017, METHODS ECOL EVOL, V8, P1374, DOI 10.1111/2041-210X.12785; Sjogren P, 2017, NEW PHYTOL, V213, P929, DOI 10.1111/nph.14199; Smith O, 2015, SCIENCE, V347, P998, DOI 10.1126/science.1261278; Smol JP, 2001, TERRESTRIAL ALGAL SI; Soininen EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115335; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Suchan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151651; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Torti A, 2015, MAR GENOM, V24, P185, DOI 10.1016/j.margen.2015.08.007; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Vorren TO, 2013, BOREAS, V42, P876, DOI 10.1111/bor.12013; Weiss CL, 2015, ELIFE, V4, DOI 10.7554/eLife.10005.001; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Wilmshurst JM, 2014, CONSERV BIOL, V28, P202, DOI 10.1111/cobi.12150; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zimmermann HH, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100273; Zimmermann HH, 2017, BIOGEOSCIENCES, V14, P575, DOI 10.5194/bg-14-575-2017	91	71	76	13	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195403	10.1371/journal.pone.0195403	http://dx.doi.org/10.1371/journal.pone.0195403			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664954	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000430262300019
J	Capacci, S; Mazzocchi, M; Brasini, S				Capacci, Sara; Mazzocchi, Mario; Brasini, Sergio			Estimation of unobservable selection effects in on-line surveys through propensity score matching: An application to public acceptance of healthy eating policies	PLOS ONE			English	Article							FACE-TO-FACE; WEB SURVEYS; TELEPHONE SURVEYS; INTERNET SURVEYS; DATA-COLLECTION; BIAS; OBESITY; MODE; BEHAVIOR; SUPPORT	The use of model-based propensity scores as matching tools opens the way to the indirect estimation of mode-related measurement effects and selection effects in web surveys, including a component of selection that cannot be traced back to observable characteristics. By matching and comparing respondents from real independent surveys that use the same questionnaire, but different administration modes, it becomes possible to isolate the selection effect induced by unobservable (or unobserved) respondent characteristics. This study applies a stratification matching algorithm to compare a web survey from a proprietary panel with a computer-assisted telephone survey based on random digit-dialing. The experiment is run in two countries (UK and Italy) to check for consistencies across different cultures and different internet penetration rates. The application to the elicitation of support for healthy eating policies indicates large and significant measurement and selection effects. After controlling for differences in the observed characteristics of respondents and the intensity of internet use, findings suggest that web surveys record lower support and higher neutrality. Similarly, after controlling for administration mode and observed respondent characteristics, internet users are less likely to state support compared to non-users. This suggests that unobserved characteristics play a major role, and post-stratification weighting is not a sufficient countermeasure. As demonstrated by the cross-country comparison, rising internet penetration rates are not a guarantee against this type of error, as disparities in these unobserved characteristics are likely to increase at the same time.	[Capacci, Sara; Mazzocchi, Mario; Brasini, Sergio] Univ Bologna, Dept Stat Sci, Bologna, Italy	University of Bologna	Mazzocchi, M (corresponding author), Univ Bologna, Dept Stat Sci, Bologna, Italy.	m.mazzocchi@unibo.it	Mazzocchi, Mario/F-7067-2012	Mazzocchi, Mario/0000-0002-0498-8031	European Union Seventh Framework Programme (FP7) [226713]	European Union Seventh Framework Programme (FP7)	The authors (MM, SC, SB) received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no. 226713, Eatwell Project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askegaard S., 1998, INT BUS REV, V7, P549, DOI [10.1016/S0969-5931(98)00028-6, DOI 10.1016/S0969-5931(98)00028-6]; Baker R., 2004, 8 C HLTH SURV RES ME, V34, P143; Barry CL, 2013, AM J PREV MED, V44, P158, DOI 10.1016/j.amepre.2012.09.065; Barry CL, 2009, MILBANK Q, V87, P7, DOI 10.1111/j.1468-0009.2009.00546.x; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Bethell C, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.1.e2; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Christian LM, 2007, ADV TELEPHONE SURVEY, P250; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Couper MP, 2007, SOC SCI RES, V36, P131, DOI 10.1016/j.ssresearch.2005.10.002; Couper MP, 2011, PUBLIC OPIN QUART, V75, P889, DOI 10.1093/poq/nfr046; Couper MP, 2000, PUBLIC OPIN QUART, V64, P464, DOI 10.1086/318641; de Leeuw ED, 1992, TELEPHONE FACE TO FA; Dehejia RH, 1999, J AM STAT ASSOC, V94, P1053, DOI 10.2307/2669919; Denscombe M, 2006, SOC SCI COMPUT REV, V24, P246, DOI 10.1177/0894439305284522; Dever J.A., 2008, SURV RES METHODS-GER, V2, DOI 10.18148/srm/2008.v2i2.128; Dillman DA, 2009, SOC SCI RES, V38, P3, DOI 10.1016/j.ssresearch.2008.03.007; Duffy B, 2005, INT J MARKET RES, V47, P615, DOI 10.1177/147078530504700602; Evans WD, 2005, AM J PREV MED, V28, P26, DOI 10.1016/j.amepre.2004.09.008; Fan WM, 2010, COMPUT HUM BEHAV, V26, P132, DOI 10.1016/j.chb.2009.10.015; Fricker S, 2005, PUBLIC OPIN QUART, V69, P370, DOI 10.1093/poq/nfi027; Heerwegh D, 2008, PUBLIC OPIN QUART, V72, P836, DOI 10.1093/poq/nfn045; Hilbert A, 2007, J EPIDEMIOL COMMUN H, V61, P585, DOI 10.1136/jech.2006.050906; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Klein JD, 2007, MED CARE, V45, P691, DOI 10.1097/MLR.0b013e3180326145; Kreuter F, 2008, PUBLIC OPIN QUART, V72, P847, DOI 10.1093/poq/nfn063; Lee S., 2006, J OFF STAT, V22, P329; Lee S, 2009, SOCIOL METHOD RES, V37, P319, DOI 10.1177/0049124108329643; Link MW, 2005, EPIDEMIOLOGY, V16, P701, DOI 10.1097/01.ede.0000172138.67080.7f; Little RJ, 2003, STAT MED, V22, P1589, DOI 10.1002/sim.1513; Loosveldt G., 2008, SURV RES METHODS-GER, V2, P93, DOI DOI 10.18148/SRM/2008.V2I2.82; Malhotra N, 2007, POLIT ANAL, V15, P286, DOI 10.1093/pan/mpm003; Malhotra N, 2008, PUBLIC OPIN QUART, V72, P914, DOI 10.1093/poq/nfn050; Mazzocchi M, 2015, HEALTH ECON POLICY L, V10, P267, DOI 10.1017/S1744133114000346; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609; Oliver JE, 2005, J HEALTH POLIT POLIC, V30, P923, DOI 10.1215/03616878-30-5-923; Rizzo L, 2004, PUBLIC OPIN QUART, V68, P267, DOI 10.1093/poq/nfh014; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Schonlau M, 2004, SOC SCI COMPUT REV, V22, P128, DOI 10.1177/0894439303256551; Schonlau M, 2009, SOCIOL METHOD RES, V37, P291, DOI 10.1177/0049124108327128; Schouten B, 2013, SOC SCI RES, V42, P1555, DOI 10.1016/j.ssresearch.2013.07.005; Sikorski C, 2012, PLOS ONE, P7; Sparrow N, 2004, INT J MARKET RES, V46, P23, DOI 10.1177/147078530404600107; Stephenson LB, 2011, INT J PUBLIC OPIN R, V23, P24, DOI 10.1093/ijpor/edq025; The American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C; Thompson ME, 2013, POPULATION, V68, P511, DOI 10.3917/popu.1303.0511; Toepoel V, 2008, PUBLIC OPIN QUART, V72, P985, DOI 10.1093/poq/nfn060; Traill WB, 2010, OBES REV, V11, P895, DOI 10.1111/j.1467-789X.2010.00717.x; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020; [No title captured]	54	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196020	10.1371/journal.pone.0196020	http://dx.doi.org/10.1371/journal.pone.0196020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664975	gold, Green Submitted, Green Published			2022-12-27	WOS:000430262300050
J	Moreno-Kustner, B; Martin, C; Pastor, L				Moreno-Kustner, Berta; Martin, Carlos; Pastor, Loly			Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses	PLOS ONE			English	Review							MAJOR MENTAL-DISORDERS; PSYCHIATRIC-DISORDERS; GENERAL-POPULATION; NONAFFECTIVE PSYCHOSIS; 12-MONTH PREVALENCE; LIFETIME PREVALENCE; SCHIZOPHRENIC DISORDERS; CLINICAL-ASSESSMENT; BIPOLAR DISORDER; COMMUNITY SAMPLE	Objectives The purpose of this study is to provide an updated systematic review to identify studies describing the prevalence of psychosis in order to explore methodological factors that could account for the variation in prevalence estimates. Methods Studies with original data related to the prevalence of psychosis (published between 1990 and 2015) were identified via searching electronic databases and reviewing manual citations. Prevalence estimates were sorted according to prevalence type (point, 12-months and lifetime). The independent association between key methodological variables and the mean effect of prevalence was examined (prevalence type, case-finding setting, method of confirming diagnosis, international classification of diseases, diagnosis category, and study quality) by meta-analytical techniques and random-effects meta-regression. Results Seventy-three primary studies were included, providing a total of 101 estimates of prevalence rates of psychosis. Across these studies, the pooled median point and 12-month prevalence for persons was 3.89 and 4.03 per 1000 respectively; and the median lifetime prevalence was 7.49 per 1000. The result of the random-effects meta-regression analysis revealed a significant effect for the prevalence type, with higher rates of lifetime prevalence than 12-month prevalence (p<0.001). Studies conducted in the general population presented higher prevalence rates than those carried out in populations attended in health/social services (p = 0.006). Compared to the diagnosis of schizophrenia only, prevalence rates were higher in the probable psychotic disorder (p = 0.022) and non-affective psychosis (p = 0.009). Finally, a higher study quality is associated with a lower estimated prevalence of psychotic disorders (p<0.001). Conclusions This systematic review provides a comprehensive comparison of methodologies used in studies of the prevalence of psychosis, which can provide insightful information for future epidemiological studies in adopting the most relevant methodological approach.	[Moreno-Kustner, Berta; Pastor, Loly] Univ Malaga, Dept Personal Assessment & Psychol Treatment, Malaga, Spain; [Moreno-Kustner, Berta] Biomed Res Inst Malaga IBIMA, Andalusian Grp Psychosocial Res, Maristan Network, Malaga, Spain; [Martin, Carlos] North East Granada Sanit Dist, Clin Management Unit Marquesado, Andalusian Hlth Serv, Granada, Spain	Universidad de Malaga; Universidad de Malaga	Moreno-Kustner, B (corresponding author), Univ Malaga, Dept Personal Assessment & Psychol Treatment, Malaga, Spain.; Moreno-Kustner, B (corresponding author), Biomed Res Inst Malaga IBIMA, Andalusian Grp Psychosocial Res, Maristan Network, Malaga, Spain.	bertamk@uma.es		Moreno Kustner, Berta/0000-0002-9541-215X	Consejeria de Salud, Junta de Andalucia [PI-0338/08]; Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia [P10-CTS-5862, CTS-945]	Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia(Junta de Andalucia)	This project was funded by the Consejeria de Salud, Junta de Andalucia (Award Number: PI-0338/08), Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Award Numbers: P10-CTS-5862, CTS-945).	Agius M, 2009, PSYCHIAT DANUB, V21, P508; Almeida N, 1997, BRIT J PSYCHIAT, V171, P524, DOI 10.1192/bjp.171.6.524; Andrade L, 2002, SOC PSYCH PSYCH EPID, V37, P316, DOI 10.1007/s00127-002-0551-x; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; Arajarvi R, 2005, SOC PSYCH PSYCH EPID, V40, P808, DOI 10.1007/s00127-005-0951-9; Awas M, 1999, ACTA PSYCHIAT SCAND, V100, P56, DOI 10.1111/j.1600-0447.1999.tb10695.x; Baxter AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065514; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Binbay T, 2012, TURK PSIKIYATR DERG, V23, P149, DOI 10.5080/u6783; Chien IC, 2004, PSYCHIAT CLIN NEUROS, V58, P611, DOI 10.1111/j.1440-1819.2004.01311.x; Cho MJ, 2007, J NERV MENT DIS, V195, P203, DOI 10.1097/01.nmd.0000243826.40732.45; Chong HY, 2014, VALUE HEALTH, V17, pA767, DOI 10.1016/j.jval.2014.08.293; CLAYER JR, 1995, MED J AUSTRALIA, V163, P124, DOI 10.5694/j.1326-5377.1995.tb127958.x; Cohidon C, 2009, AM J IND MED, V52, P141, DOI 10.1002/ajim.20656; Diaz-Cruz F, 2004, REV ASOCIACION ESPAN, V23, P3082; Diaz-Martinez Alejandro, 2003, Gac Med Mex, V139, P101; Dourado A, 2000, AM J MED GENET, V96, P513; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faravelli C, 2004, PSYCHOTHER PSYCHOSOM, V73, P216, DOI 10.1159/000077740; Fekadu A, 2004, J AFFECT DISORDERS, V80, P1, DOI 10.1016/S0165-0327(02)00345-2; First MB, 2001, STRUCTURED CLIN INTE; Fors BM, 2007, NORD J PSYCHIAT, V61, P252, DOI 10.1080/08039480701414932; Gigantesco A, 2006, PSYCHOTHER PSYCHOSOM, V75, P170, DOI 10.1159/000091774; Goldner EM, 2003, PSYCHIAT SERV, V54, P1017, DOI 10.1176/appi.ps.54.7.1017; Goldner EM, 2002, CAN J PSYCHIAT, V47, P833, DOI 10.1177/070674370204700904; Gureje O, 2010, WORLD PSYCHIATRY, V9, P50; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hosain GMM, 2007, PUBLIC HEALTH, V121, P18, DOI 10.1016/j.puhe.2006.06.018; Hovatta I, 1997, AM J MED GENET, V74, P353, DOI 10.1002/(SICI)1096-8628(19970725)74:4<353::AID-AJMG3>3.3.CO;2-I; Jablensky A., 2000, AUSTR NZ J PSYCHIA S, V34, P26, DOI 10.1046/j.1440-1614.2000.00770.x; Jeffreys SE, 1997, BRIT J PSYCHIAT, V170, P301, DOI 10.1192/bjp.170.4.301; Jenkins R, 1997, PSYCHOL MED, V27, P775, DOI 10.1017/S0033291797005308; Jorgensen L, 2014, NORD J PSYCHIAT, V68, P60, DOI 10.3109/08039488.2013.772234; Kake TR, 2008, AUST NZ J PSYCHIAT, V42, P941, DOI 10.1080/00048670802415376; Kebede D, 2003, SOC PSYCH PSYCH EPID, V38, P625, DOI 10.1007/s00127-003-0678-4; Kebede D, 1999, ACTA PSYCHIAT SCAND, V100, P11, DOI 10.1111/j.1600-0447.1999.tb10688.x; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; Kessler RC, 2005, BIOL PSYCHIAT, V58, P668, DOI 10.1016/j.biopsych.2005.04.034; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kirkbride JB, 2008, BRIT J PSYCHIAT, V193, P18, DOI 10.1192/bjp.bp.107.041566; Kodesh A, 2012, SOC PSYCH PSYCH EPID, V47, P1775, DOI 10.1007/s00127-012-0478-9; Kringlen E, 2001, AM J PSYCHIAT, V158, P1091, DOI 10.1176/appi.ajp.158.7.1091; Kringlen E, 2006, SOC PSYCH PSYCH EPID, V41, P713, DOI 10.1007/s00127-006-0080-0; Kurihara T, 2005, SCHIZOPHR RES, V79, P307, DOI 10.1016/j.schres.2005.07.021; Lindstrom E, 1997, EUR PSYCHIAT, V12, P217, DOI 10.1016/S0924-9338(97)83295-6; MacGrath JJ, 2016, CHALLENGES OPTIONS E; McConnell P, 2002, BRIT J PSYCHIAT, V181, P214, DOI 10.1192/bjp.181.3.214; McCreadie RG, 1997, BRIT J PSYCHIAT, V170, P31, DOI 10.1192/bjp.170.1.31; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; McGrath JJ, 2015, JAMA PSYCHIAT, V72, P697, DOI 10.1001/jamapsychiatry.2015.0575; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moreno B, 2008, SOC PSYCH PSYCH EPID, V43, P782, DOI 10.1007/s00127-008-0368-3; Moreno-Kustner B, 2016, EPIDEMIOL PSYCH SCI, V25, P38, DOI 10.1017/S2045796014000614; Moreno-Kustner B, 2014, SALUD MENT, V37, P127, DOI 10.17711/SM.0185-3325.2014.016; Morgan VA, 2014, PSYCHOL MED, V44, P2163, DOI 10.1017/S0033291713002973; Munn Z, 2015, INT J EVID-BASED HEA, V13, P147, DOI 10.1097/XEB.0000000000000054; Munn Z, 2014, INT J HEALTH POLICY, V3, P123, DOI 10.15171/ijhpm.2014.71; Myles-Worsley M, 1999, AM J MED GENET, V88, P4, DOI 10.1002/(SICI)1096-8628(19990205)88:1<4::AID-AJMG2>3.0.CO;2-H; Nimgaonkar VL, 2000, AM J PSYCHIAT, V157, P1065, DOI 10.1176/appi.ajp.157.7.1065; Ortega MA, 1995, AN PSIQUIATRIA, V2, P320; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Perala J, 2008, SCHIZOPHR RES, V106, P337, DOI 10.1016/j.schres.2008.08.017; Phanthunane P, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-24; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Phillips MR, 2004, LANCET, V364, P1062, DOI 10.1016/S0140-6736(04)17061-X; Pringle DG, 1995, IRISH GEOGRAPHY, V28, P113; R Development Core Team R, 2014, R LANG ENV STAT COMP; Ran MS, 2003, AUST NZ J PSYCHIAT, V37, P452, DOI 10.1046/j.1440-1614.2003.01203.x; Roca M, 1999, SOC PSYCH PSYCH EPID, V34, P410, DOI 10.1007/s001270050162; Ruggeri M, 2000, BRIT J PSYCHIAT, V177, P149, DOI 10.1192/bjp.177.2.149; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Saha S, 2008, INT J METH PSYCH RES, V17, P55, DOI 10.1002/mpr.240; Schrier AC, 2001, EUR PSYCHIAT, V16, P162, DOI 10.1016/S0924-9338(01)00558-2; Scully PJ, 2004, SCHIZOPHR RES, V67, P143, DOI 10.1016/S0920-9964(03)00194-4; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shivashankar S, 2013, SCHIZOPHR RES, V146, P349, DOI 10.1016/j.schres.2013.02.006; Simeone JC, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0578-7; Singleton N, 2003, INT REV PSYCHIATR, V15, P65, DOI 10.1080/0954026021000045967; Suvisaari J., 2009, CLIN SCHIZOPHR RELAT, V2, P289, DOI DOI 10.3371/CSRP.2.4.2; Thornicroft G, 1998, BRIT J PSYCHIAT, V173, P363, DOI 10.1192/bjp.173.5.363; Tizon JL, 2007, ATEN PRIM, V39, P119, DOI 10.1157/13099556; Tizon JL, 2009, SCHIZOPHR RES, V112, P143, DOI 10.1016/j.schres.2009.04.008; Vanasse A, 2012, SOC PSYCH PSYCH EPID, V47, P533, DOI 10.1007/s00127-011-0371-y; Vicente B, 2004, BRIT J PSYCHIAT, V184, P299, DOI 10.1192/bjp.184.4.299; Vicente B, 2006, AM J PSYCHIAT, V163, P1362, DOI 10.1176/appi.ajp.163.8.1362; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Villaverde ML, 1993, METODO EPIDEMIOLOGIC, P187; Waldo MC, 1999, SCHIZOPHR RES, V35, P175, DOI 10.1016/S0920-9964(98)00118-2; Widerlov B, 1997, ACTA PSYCHIAT SCAND, V96, P452, DOI 10.1111/j.1600-0447.1997.tb09947.x; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wu EQ, 2006, PSYCHOL MED, V36, P1535, DOI 10.1017/S0033291706008191; Xiang YT, 2008, SCHIZOPHR RES, V102, P270, DOI 10.1016/j.schres.2008.04.009; Yang JZ, 2014, INT J SOC PSYCHIATR, V60, P482, DOI 10.1177/0020764013498987; Youssef HA, 1999, SCHIZOPHR RES, V37, P233, DOI 10.1016/S0920-9964(98)00171-6	95	163	165	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195687	10.1371/journal.pone.0195687	http://dx.doi.org/10.1371/journal.pone.0195687			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649252	Green Submitted, Green Published, gold			2022-12-27	WOS:000429791900070
J	Jones, CS; Nielsen, JK; Schilling, KE; Weber, LJ				Jones, Christopher S.; Nielsen, Jacob K.; Schilling, Keith E.; Weber, Larry J.			Iowa stream nitrate and the Gulf of Mexico	PLOS ONE			English	Article							MISSISSIPPI RIVER; RACCOON RIVER; NITROGEN; HYPOXIA; NUTRIENT; REDUCTION; FLUX; EUTROPHICATION; CHALLENGES; POLICY	The main objective of this work was to quantify and update the U.S. Midwest agricultural state of Iowa's contribution of nitrate-nitrogen to the Mississippi River stream network against the backdrop of the ongoing problem of Gulf of Mexico hypoxia. To achieve this objective, we used stream nitrate and discharge data collected from 1999 until 2016 at 23 Iowa stream sites near watershed outlets, along with publicly-available data for sites downstream of Iowa on the Missouri and Mississippi Rivers. Our analysis shows that Iowa contributes between 11 and 52% of the long-term nitrate load to the Mississippi-Atchafalaya Basin, 20 to 63% to the Upper Mississippi River Basin, and 20 to 89% to the Missouri River Basin, with averages of 29, 45 and 55% respectively. Since 1999, nitrate loads in the Iowa inclusive basins have increased and these increases do not appear to be driven by changes in discharge and cropping intensity unique to Iowa. The 5-year running annual average of Iowa nitrate loading has been above the 2003 level for ten consecutive years, implying that Gulf hypoxic areal goals, also based on a 5-year running annual average, will be very difficult to achieve if nitrate retention cannot be improved in Iowa. An opportunity exists for land managers, policy makers and conservationists to manifest a positive effect on water quality by targeting and implementing nitrate reducing-practices in areas like Iowa while avoiding areas that are less likely to affect Gulf of Mexico hypoxia.	[Jones, Christopher S.; Nielsen, Jacob K.; Weber, Larry J.] Univ Iowa, IIHR Hydrosci & Engn, Iowa City, IA USA; [Schilling, Keith E.] Iowa Geol Survey, Iowa City, IA USA	University of Iowa	Jones, CS (corresponding author), Univ Iowa, IIHR Hydrosci & Engn, Iowa City, IA USA.	christopher-s-jones@uiowa.edu		weber, larry/0000-0001-7003-4714; Schilling, Keith/0000-0002-3499-220X	Iowa Nutrient Research Center	Iowa Nutrient Research Center	This work was supported by the Iowa Nutrient Research Center to CSJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HELP CROPS IOW FARM; [Anonymous], 2000, EOS, DOI [DOI 10.1029/00E000244, DOI 10.1029/00EO00244]; BAKER JL, 1975, J ENVIRON QUAL, V4, P406, DOI 10.2134/jeq1975.00472425000400030027x; Battaglin WA, 2010, 20095164 US GEOL SUR; Burkart MR, 1999, J ENVIRON QUAL, V28, P850, DOI 10.2134/jeq1999.00472425002800030016x; David MB, 2010, J ENVIRON QUAL, V39, P1657, DOI 10.2134/jeq2010.0115; Diaz R.J., 1999, ECOLOGICAL EC CONSEQ; Ferber D, 2001, SCIENCE, V291, P968, DOI 10.1126/science.291.5506.968; Gilliom R, 2013, AGU FALL M 2013; Goolsby DA, 2001, HYDROL PROCESS, V15, P1209, DOI 10.1002/hyp.210; Goolsby DA, 2000, SCI TOTAL ENVIRON, V248, P75, DOI 10.1016/S0048-9697(99)00532-X; Hatfield JL, 2009, J SOIL WATER CONSERV, V64, P190, DOI 10.2489/jswc.64.3.190; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Iowa Department of Natural Resources (IDNR), 2017, IOW AMB WAT QUAL MON; Iowa State University, 2017, IOW NUTR RED STRAT; Jones CS, 2016, J SOIL WATER CONSERV, V71, P206, DOI 10.2489/jswc.71.3.206; Jones CS, 2018, J AM WATER RESOUR AS, V54, P471, DOI 10.1111/1752-1688.12618; Jones CS, 2015, J SOIL WATER CONSERV, V70, p69A, DOI 10.2489/jswc.70.3.69A; JUSTIC D, 1995, MAR POLLUT BULL, V30, P41, DOI 10.1016/0025-326X(94)00105-I; Justic D, 2003, ESTUARIES, V26, P1, DOI 10.1007/BF02691688; Justic D, 2007, ESTUAR COAST, V30, P791, DOI 10.1007/BF02841334; Lee CJ, 2016, J HYDROL, V542, P185, DOI 10.1016/j.jhydrol.2016.08.059; LEMING TD, 1984, NATURE, V310, P136, DOI 10.1038/310136a0; Li D, 2013, J ENVIRON QUAL, V42, P1822, DOI 10.2134/jeq2013.03.0111; Libra R.D., 1998, IOWA GEOLOGY, V23, P4; LUCEY KJ, 1993, J ENVIRON QUAL, V22, P38, DOI 10.2134/jeq1993.00472425002200010005x; LUMCON Louisiana Universities Marine Consortium, 2017, HYP NO GULF MEX; McIsaac GF, 2003, J ENVIRON QUAL, V32, P2280, DOI 10.2134/jeq2003.2280; Oetking P, 1974033720 SW RES I; Prior J. C., 1991, LANDFORMS IOWA; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Rabotyagov SS, 2014, REV ENV ECON POLICY, V8, P58, DOI 10.1093/reep/ret024; RENAUD ML, 1986, FISH B-NOAA, V84, P19; Scavia D, 2003, LIMNOL OCEANOGR, V48, P951, DOI 10.4319/lo.2003.48.3.0951; Schilling K, 2004, J HYDROL, V295, P305, DOI 10.1016/j.jhydrol.2004.03.010; Schilling KE, 2017, J SOIL WATER CONSERV, V72, P317, DOI 10.2489/jswc.72.4.317; Schilling KE, 2000, J ENVIRON QUAL, V29, P1846, DOI 10.2134/jeq2000.00472425002900060016x; Schilling KE, 2017, ECOL ENG, V102, P98, DOI 10.1016/j.ecoleng.2017.02.006; Sprague LA, 2011, ENVIRON SCI TECHNOL, V45, P7209, DOI 10.1021/es201221s; Tesoriero AJ, 2013, ENVIRON SCI TECHNOL, V47, P3623, DOI 10.1021/es305026x; Turner RE, 2006, MAR POLLUT BULL, V52, P139, DOI 10.1016/j.marpolbul.2005.08.012; Turner RE, 2004, HYDROBIOLOGIA, V511, P79, DOI 10.1023/B:HYDR.0000014031.12067.1a; USDA, 2017, NAT AGR STAT SERV QU; USEPA, 1993, DET NITR NITR NITR A; USEPA, 2017, HIST HYP TASK FORC; USGS, 2017, NAT WAT INF SYST WEB; USGS, 2017, MISS RIV BAS REL NUT; Vymazal J, 2007, SCI TOTAL ENVIRON, V380, P48, DOI 10.1016/j.scitotenv.2006.09.014; WANDER MM, 1994, SOIL SCI SOC AM J, V58, P1130, DOI 10.2136/sssaj1994.03615995005800040018x; Zhao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088732	50	50	50	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195930	10.1371/journal.pone.0195930	http://dx.doi.org/10.1371/journal.pone.0195930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649312	gold, Green Published, Green Submitted			2022-12-27	WOS:000429791900106
J	Elacqua, JJ; McGregor, AL; Lammerding, J				Elacqua, Joshua J.; McGregor, Alexandra L.; Lammerding, Jan			Automated analysis of cell migration and nuclear envelope rupture in confined environments	PLOS ONE			English	Article							BREAST-CANCER; LAMIN A/C; TRACTION FORCE; DEFORMATION; METASTASIS; CONSEQUENCES; PROTEOLYSIS; STIFFNESS; BARRIER; SQUEEZE	Recent in vitro and in vivo studies have highlighted the importance of the cell nucleus in governing migration through confined environments. Microfluidic devices that mimic the narrow interstitial spaces of tissues have emerged as important tools to study cellular dynamics during confined migration, including the consequences of nuclear deformation and nuclear envelope rupture. However, while image acquisition can be automated on motorized microscopes, the analysis of the corresponding time-lapse sequences for nuclear transit through the pores and events such as nuclear envelope rupture currently requires manual analysis. In addition to being highly time-consuming, such manual analysis is susceptible to person-to-person variability. Studies that compare large numbers of cell types and conditions therefore require automated image analysis to achieve sufficiently high throughput. Here, we present an automated image analysis program to register microfluidic constrictions and perform image segmentation to detect individual cell nuclei. The MATLAB program tracks nuclear migration over time and records constriction-transit events, transit times, transit success rates, and nuclear envelope rupture. Such automation reduces the time required to analyze migration experiments from weeks to hours, and removes the variability that arises from different human analysts. Comparison with manual analysis confirmed that both constriction transit and nuclear envelope rupture were detected correctly and reliably, and the automated analysis results closely matched a manual analysis gold standard. Applying the program to specific biological examples, we demonstrate its ability to detect differences in nuclear transit time between cells with different levels of the nuclear envelope proteins lamin A/C, which govern nuclear deformability, and to detect an increase in nuclear envelope rupture duration in cells in which CHMP7, a protein involved in nuclear envelope repair, had been depleted. The program thus presents a versatile tool for the study of confined migration and its effect on the cell nucleus.	[Elacqua, Joshua J.; McGregor, Alexandra L.; Lammerding, Jan] Cornell Univ, Weill Inst Cell & Mol Biol, Meinig Sch Biomed Engn, Ithaca, NY 14850 USA	Cornell University	Lammerding, J (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Meinig Sch Biomed Engn, Ithaca, NY 14850 USA.	jan.lammerding@comell.edu	Lammerding, Jan/A-9498-2016	Lammerding, Jan/0000-0003-4335-8611	National Institutes of Health [R01 HL082792, U54 CA210184]; Department of Defense Breast Cancer Research Program (Congressionally Directed Medical Research Program) [BC150580]; National Science Foundation [CAREER] [CBET-1254846]; Cornell University College of Engineering; National Science Foundation [ECCS-1542081]; NATIONAL CANCER INSTITUTE [U54CA210184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1254846] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program (Congressionally Directed Medical Research Program)(United States Department of Defense); National Science Foundation [CAREER](National Science Foundation (NSF)); Cornell University College of Engineering; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by awards from the National Institutes of Health [R01 HL082792 (National Heart, Lung, and Blood Institute) and U54 CA210184 (National Cancer Institute), to J.L.]; the Department of Defense Breast Cancer Research Program (Congressionally Directed Medical Research Program) [Breakthrough Award BC150580, to J.L.], the National Science Foundation [CAREER Award CBET-1254846, to J.L.; GRFP Award DGE-1144153 to A.L.M.]; and the Cornell University College of Engineering [Engineering Learning Initiatives Grant, to J.E.]. This work was performed in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Coordinated Infrastructure (NNCI), which is supported by the National Science Foundation (Grant ECCS-1542081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell ES, 2016, EUR J CELL BIOL, V95, P449, DOI 10.1016/j.ejcb.2016.06.007; Capo-chichi Callinice D, 2011, Chin J Cancer, V30, P415; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Davidson PM, 2015, INTEGR BIOL-UK, V7, P1534, DOI 10.1039/c5ib00200a; Davidson PM, 2014, CELL MOL BIOENG, V7, P293, DOI 10.1007/s12195-014-0342-y; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Fu Y, 2012, LAB CHIP, V12, P3774, DOI 10.1039/c2lc40477j; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Irianto J, 2016, CELL MOL BIOENG, V9, P258, DOI 10.1007/s12195-016-0437-8; Isermann P, 2017, NUCLEUS-PHILA, V8, P268, DOI 10.1080/19491034.2017.1292191; Krause M, 2015, CELL ADHES MIGR, V9, P357, DOI 10.1080/19336918.2015.1061173; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lautscham LA, 2015, BIOPHYS J, V109, P900, DOI 10.1016/j.bpj.2015.07.025; Lim S, 2016, MOL BIOL CELL, V27, P3210, DOI 10.1091/mbc.E16-02-0098; Malboubi M, 2015, MICROELECTRON ENG, V144, P42, DOI 10.1016/j.mee.2015.02.022; Matsumoto A, 2015, CANCER MED-US, V4, P1547, DOI 10.1002/cam4.495; McGregor AL, 2016, CURR OPIN CELL BIOL, V40, P32, DOI 10.1016/j.ceb.2016.01.011; Mekhdjian AH, 2017, MOL BIOL CELL, V28, P1467, DOI 10.1091/mbc.E16-09-0654; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Robijns J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30325; Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535; Shah P, 2017, TRENDS CELL BIOL, V27, P546, DOI 10.1016/j.tcb.2017.02.008; Skau CT, 2016, CELL, V167, P1571, DOI 10.1016/j.cell.2016.10.023; Stephens AD, 2017, MOL BIOL CELL, V28, P1984, DOI 10.1091/mbc.E16-09-0653; Takaki T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16013; Thomas DG, 2015, J CELL BIOL, V210, P583, DOI 10.1083/jcb.201502039; Wazir U, 2013, CELL MOL BIOL LETT, V18, P595, DOI 10.2478/s11658-013-0109-9; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Zwerger M, 2013, HUM MOL GENET, V22, P2335, DOI 10.1093/hmg/ddt079	31	17	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195664	10.1371/journal.pone.0195664	http://dx.doi.org/10.1371/journal.pone.0195664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649271	Green Published, Green Submitted, gold			2022-12-27	WOS:000429791900068
J	Ning, HL; Yuan, JQ; Dong, QZ; Li, WB; Xuel, H; Wang, YS; Tian, Y; Li, WX				Ning, Hailong; Yuan, Jiaqi; Dong, Quanzhong; Li, Wenbin; Xue, Hong; Wang, Yanshu; Tian, Yu; Li, Wen-Xia			Identification of QTLs related to the vertical distribution and seed-set of pod number in soybean [Glycine max (L.) Merri]	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; YIELD COMPONENTS; AGRONOMIC TRAITS; POPULATION	Pod number is an important factor that influences yield in soybean. Here, we used two associated recombinant inbred line (RIL) soybean populations, RIL3613 (containing 134 lines derived from Dongnong L13 x Heihe 36) and RIL6013 (composed of 156 individuals from Dongnong L13 x Henong 60), to identify quantitative trait loci (QTLs) regulating the vertical distribution and quantity of seeds and seed pods. The numbers of pods were quantified in the upper, middle, and lower sections of the plant, as well as in the plants as a whole, and QTLs regulating these spatial traits were mapped using an inclusive complete interval mapping method. A total of 21 and 26 QTLs controlling pod-number-related traits were detected in RIL3613 and RIL6013, respectively, which explained 1.25 +/- 11.6698% and 0.0001 +/- 7.91% of the phenotypic variation. A total of 34 QTLs were verified by comparison with previous research, were identified in both populations, or were found to regulate multiple traits, indicating their authenticity. These results enhance our understanding of the vertical distribution of pod-number-related traits and support molecular breeding for seed yield.	[Ning, Hailong; Yuan, Jiaqi; Dong, Quanzhong; Li, Wenbin; Xue, Hong; Wang, Yanshu; Tian, Yu; Li, Wen-Xia] Minist Educ, Key Lab Soybean Biol, Harbin, Heilongjiang, Peoples R China; [Ning, Hailong; Yuan, Jiaqi; Dong, Quanzhong; Li, Wenbin; Xue, Hong; Wang, Yanshu; Tian, Yu; Li, Wen-Xia] Minist Agr, Key Lab Soybean Biol & Breeding Genet, Harbin, Heilongjiang, Peoples R China; [Ning, Hailong; Yuan, Jiaqi; Dong, Quanzhong; Li, Wenbin; Xue, Hong; Wang, Yanshu; Tian, Yu; Li, Wen-Xia] Northeast Agr Univ, Soybean Res Inst, Harbin, Heilongjiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Li, WX (corresponding author), Minist Educ, Key Lab Soybean Biol, Harbin, Heilongjiang, Peoples R China.; Li, WX (corresponding author), Minist Agr, Key Lab Soybean Biol & Breeding Genet, Harbin, Heilongjiang, Peoples R China.; Li, WX (corresponding author), Northeast Agr Univ, Soybean Res Inst, Harbin, Heilongjiang, Peoples R China.	liwenixaneau@126.com			Natural Science Foundation of Heilongjiang Province [China] [LC201610, C2015007]; Scientific and Technological Foundation of Education Department of Heilongjiang Province [12541z001]; National Key Research and Development Program of China [2017YFD0101300]	Natural Science Foundation of Heilongjiang Province [China](Natural Science Foundation of Heilongjiang Province); Scientific and Technological Foundation of Education Department of Heilongjiang Province; National Key Research and Development Program of China	Natural Science Foundation of Heilongjiang Province [China] (LC201610) to H.N. and (C2015007) to W-X.L., and the Scientific and Technological Foundation of Education Department of Heilongjiang Province (12541z001) to H.N, grants from the National Key Research and Development Program of China (2017YFD0101300) to H.N.; The authors gratefully acknowledge the financial support for this study provided by Natural Science Foundation of Heilongjiang Province [China] (LC201610) to H.N and, (C2015007) to W-X.L., and the Scientific and Technological Foundation of Education Department of Heilongjiang Province (12541z001) to H.N, grants from the National Key Research and Development Program of China (2017YFD0101300) to H.N.	Bobby R., 2012, Journal of Agricultural Science (Toronto), V4, P98; Chen QingShan, 2007, Agricultural Sciences in China, V6, P399, DOI 10.1016/S1671-2927(07)60062-5; Rodrigues JID, 2016, CROP BREED APPL BIOT, V16, P265, DOI 10.1590/1984-70332016v16n4a41; Vieira Antonio José Dias, 2006, Braz. J. Plant Physiol., V18, P281, DOI 10.1590/S1677-04202006000200004; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Kuroda Y, 2013, ECOL EVOL, V3, P2150, DOI 10.1002/ece3.606; [李灿东 Li Candong], 2008, [分子植物育种, Molecular Plant Breeding], V6, P1091; Li DM, 2010, EUPHYTICA, V172, P49, DOI 10.1007/s10681-009-0036-z; Liu B, 2015, EMIR J FOOD AGR, V27, P258, DOI 10.9755/ejfa.v27i3.18889; Liu NX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3854-8; Liu WeiXian, 2011, Journal of Crop Science and Biotechnology, V14, P65, DOI 10.1007/s12892-010-0115-7; Liu YuPing, 2010, Soybean Science, V29, P796; Machado BQV, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16029696; Palomeque L, 2009, THEOR APPL GENET, V119, P429, DOI 10.1007/s00122-009-1048-8; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Sun DH, 2006, THEOR APPL GENET, V112, P665, DOI 10.1007/s00122-005-0169-y; Wang JianKang, 2009, Acta Agronomica Sinica, V35, P239, DOI 10.3724/SP.J.1006.2009.00239; Wang XianZhi, 2007, Acta Agronomica Sinica, V33, P441; Wu X L, 2001, Yi Chuan Xue Bao, V28, P947; Yang Z, 2013, MOL GENET GENOMICS, V288, P651, DOI 10.1007/s00438-013-0779-z; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang D, 2010, J GENET GENOMICS, V37, P545, DOI 10.1016/S1673-8527(09)60074-6; Zhao GY, 2008, EUPHYTICA, V164, P275, DOI 10.1007/s10681-008-9728-z; Zhou Rong, 2009, Acta Agronomica Sinica, V35, P821, DOI 10.3724/SP.J.1006.2009.00821	24	19	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195830	10.1371/journal.pone.0195830	http://dx.doi.org/10.1371/journal.pone.0195830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664958	Green Published, gold			2022-12-27	WOS:000430262300036
J	Poobathy, R; Zakaria, R; Murugaiyah, V; Subramaniam, S				Poobathy, Ranjetta; Zakaria, Rahmad; Murugaiyah, Vikneswaran; Subramaniam, Sreeramanan			Autofluorescence study and selected cyanidin quantification in the Jewel orchids Anoectochilus sp and Ludisia discolor	PLOS ONE			English	Article							HAEMARIA-DISCOLOR; FUNCTIONAL-ROLE; ANTHOCYANINS; LEAVES; PLANTS; LIGHT; CHLOROPLAST; RED; ARABIDOPSIS; FORMOSANUS	Anoectochilus sp. and Ludisia discolor are known as Jewel orchids. Both species are terrestrial wild orchids that grow in shaded areas of forests. The Jewel orchids are renowned for the beauty of their leaves, which are dark-green laced with silvery or golden veins. The orchids are used as a cure in various parts of Asia. Overharvesting and anthropogenic disturbances threaten the existence of the Jewel orchids in the wild, necessitating human intervention in their survival. An understanding of the structure and adaptations of a plant may assist in its survival when propagated outside of its habitat. In this study, ex vitro leaves of Anoectochilus sp. and L. discolorwere subjected to freehand sectioning, and then inspected through brightfield and fluorescence microscopy. The study indicated that all parts of both plants presented typical monocotyledonous characteristics except the leaves. The leaves displayed dorsiventrality with distinct palisade and spongy mesophyll layers. The spongy mesophyll layer contained cells which fluoresced a bright red when exposed to ultraviolet, blue, and green light wavelengths, hinting at the presence of anthocyanins for photoprotection. Cyanidin was detected in the leaves of L. discolor, as enumerated through high performance liquid chromatography (HPLC). The observations indicated that Anoectochilus sp. and L. discolorare well-adapted to live under shaded conditions with minimal exposure to light.	[Poobathy, Ranjetta; Zakaria, Rahmad; Subramaniam, Sreeramanan] Univ Sains Malaysia, Sch Biol Sci, Gelugor, Pulau Pinang, Malaysia; [Murugaiyah, Vikneswaran] Univ Sains Malaysia, Sch Pharmaceut Sci, Gelugor, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Subramaniam, S (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Gelugor, Pulau Pinang, Malaysia.	sreeramanan@usm.my	Poobathy, Ranjetta/AAH-8924-2020; Subramaniam, Sreeramanan Sree/I-1130-2012; Subramaniam, Sreeramanan/AAA-5094-2022	Poobathy, Ranjetta/0000-0002-0416-1122; Subramaniam, Sreeramanan Sree/0000-0003-4392-285X; Murugaiyah, Vikneswaran/0000-0003-1768-7577	Universiti Sains Malaysia Research University Grant Scheme (USM-RU) [1001/PBIOLOGI/811211]	Universiti Sains Malaysia Research University Grant Scheme (USM-RU)(Universiti Sains Malaysia)	The authors would like to thank the Universiti Sains Malaysia Research University Grant Scheme (USM-RU) 1001/PBIOLOGI/811211 for supporting this study.	[Anonymous], 2010, AGR IN LAO PDR T; Arditti J, 1977, ORCHID BIOL REV PERS, V1; Benzing DH, 1987, ORCHID BIOL REV PERS, V4; Bolhar-Nordenkampf H. R., 1993, P91; Brouillard R., 1988, FLAVONOIDS ADV RES 1, P525, DOI DOI 10.1007/978-1-4899-2913-6_16; Cai ZQ, 2005, PHOTOSYNTHETICA, V43, P91, DOI 10.1007/s11099-005-1098-3; Chou LC, 2004, BOT BULL ACAD SINICA, V45, P143; Feild TS, 2001, PLANT PHYSIOL, V127, P566, DOI 10.1104/pp.010063; Figueroa C, 2008, ANN BOT-LONDON, V101, P509, DOI 10.1093/aob/mcm328; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Gould K.S., 2003, ENCY APPL PLANT SCI, P9, DOI [10.1016/B0-12-227050-9/00124-1, DOI 10.1016/B0-12-227050-9/00124-1]; GOULD KS, 1995, NATURE, V378, P241, DOI 10.1038/378241b0; Gould KS, 2002, PHYSIOL PLANTARUM, V116, P127, DOI 10.1034/j.1399-3054.2002.1160116.x; Gould KS, 2000, J EXP BOT, V51, P1107, DOI 10.1093/jexbot/51.347.1107; Hatier Jean-Hugues B., 2009, P1, DOI 10.1007/978-0-387-77335-3_1; Hawkes AD, 1970, ENCY CULTIVATED ORCH, P238; Hayden WJ., 2016, SEMPERVIRENS, P6; Hoch WA, 2003, PLANT PHYSIOL, V133, P1296, DOI 10.1104/pp.103.027631; Hsieh CC, 2005, INT J APPL SCI ENG T, V3, P175; Hughes NM, 2008, J EXP BOT, V59, P3435, DOI 10.1093/jxb/ern193; Hughes NM, 2005, NEW PHYTOL, V168, P575, DOI 10.1111/j.1469-8137.2005.01546.x; IUCN/SSC Orchid Specialist Group, 1996, ORCH STAT SURV CONS; Jing P, 2008, J AGR FOOD CHEM, V56, P9391, DOI 10.1021/jf8005917; KAN WS, 1979, PHARM BOT; Ket NV, 2004, BIOL PLANTARUM, V48, P339, DOI 10.1023/B:BIOP.0000041084.77832.11; Kong SG, 2014, BBA-BIOENERGETICS, V1837, P522, DOI 10.1016/j.bbabio.2013.12.004; Lai YS, 2016, J AGR FOOD CHEM, V64, P2719, DOI 10.1021/acs.jafc.5b04036; Lambers H., 2008, PLANT PHYSL ECOLOGY, p11Routl, DOI [DOI 10.1007/978-0-387-78341-3_2, 10.1007/978-0-387-78341-3_2]; LIN C-C, 1981, Shoyakugaku Zasshi, V35, P272; LIN C-C, 1981, Shoyakugaku Zasshi, V35, P262; Lorrain B, 2013, MOLECULES, V18, P1076, DOI 10.3390/molecules18011076; Luttge U, 2008, PHYSL ECOLOGY TROPIC, P103, DOI DOI 10.1007/978-3-540-71793-5_4; Ma ZQ, 2010, HORTSCIENCE, V45, P863, DOI 10.21273/HORTSCI.45.6.863; Ong PT, 2013, MALESIAN ORCHID J, V11, P15; Ormerod Paul, 2005, Taiwania, V50, P1; Poustka F, 2007, PLANT PHYSIOL, V145, P1323, DOI 10.1104/pp.107.105064; Robards K, 2003, J CHROMATOGR A, V1000, P657, DOI 10.1016/S0021-9673(03)00058-X; Rohr GE, 2000, STUD NAT PROD CHEM, V21, P497; Roshchina VV, 2012, INT J SPECTROSC, DOI 10.1155/2012/124672; Shiau YJ, 2005, BIOL PLANTARUM, V49, P341, DOI 10.1007/s10535-005-0005-x; Shiau YJ, 2002, BOT BULL ACAD SINICA, V43, P123; Simoes C, 2009, PLANT PHYSIOL BIOCH, V47, P895, DOI 10.1016/j.plaphy.2009.06.005; Staiger CJ, 1997, TRENDS PLANT SCI, V2, P275, DOI 10.1016/S1360-1385(97)86350-9; Stern WL., 2014, ANATOMY MONOCOTYLEDO, VX; Stintzing FC, 2004, TRENDS FOOD SCI TECH, V15, P19, DOI 10.1016/j.tifs.2003.07.004; Suetsugu N, 2012, ADVANCES IN PHOTOSYNTHESIS - FUNDAMENTAL ASPECTS, P215; Sumathi R, 2003, BLUMEA, V48, P285; Teo C. K. H., 1978, American Orchid Society Bulletin, V47, P1028; Teoh E.S., 2015, MED ORCHID ASIA, V5, P59, DOI [10.1007/978-3-319-24274-3_5, DOI 10.1007/978-3-319-24274-3_5]; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Tomlinson PB., 1982, ANATOMY MONOCOTYLEDO; Tsui PYC, 1992, CONSERVATION PROPAGA; Vogelmann TC, 1996, PHYSIOL PLANTARUM, V98, P43, DOI 10.1111/j.1399-3054.1996.tb00674.x; W. C. S. P, 2011, WORLD CHECKL SEL PLA; Wada M, 2003, ANNU REV PLANT BIOL, V54, P455, DOI 10.1016/j.plantsci.2013.05.016; Wada M, 2013, PLANT SCI CELL BIOL, DOI DOI 10.1007/978-1-4614-7881-2_10-3; Wada M, 2016, P JPN ACAD B-PHYS, V92, P387, DOI 10.2183/pjab.92.387; Watson J., 2011, A FOOLPROOF ORCHID, P10; Xu MJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01474; Yeung E.C., 1998, TESTED STUDIES LAB T, V19, P125, DOI DOI 10.1007/1-4020-2985-3_41; Zheng XL, 2009, J ETHNOPHARMACOL, V124, P197, DOI 10.1016/j.jep.2009.04.042	61	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195642	10.1371/journal.pone.0195642	http://dx.doi.org/10.1371/journal.pone.0195642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649288	Green Published, gold, Green Submitted			2022-12-27	WOS:000429791900066
J	Bianchi, CM; Huneau, JF; Barbillon, P; Lluch, A; Egnell, M; Fouillet, H; Verger, EO; Mariotti, F				Bianchi, Clelia M.; Huneau, Jean-Francois; Barbillon, Pierre; Lluch, Anne; Egnell, Manon; Fouillet, Helene; Verger, Eric O.; Mariotti, Francois			A clear trade-off exists between the theoretical efficiency and acceptability of dietary changes that improve nutrient adequacy during early pregnancy in French women: Combined data from simulated changes modeling and online assessment survey	PLOS ONE			English	Article							NUTRITION AWARENESS; PHYSICAL-ACTIVITY; RISK-FACTORS; ADULTS; FOOD; INTERVENTION; FEASIBILITY; ENERGY	Background During pregnancy, the diet of a mother-to-be should be adapted to meet increases in nutrient requirements. We analyzed the theoretical efficiency and acceptability of different types of tailored dietary changes for pregnant women. Methods The nutrient adequacy of the diet was evaluated using the PANDiet score, by comparing the nutrient intakes of 344 non-pregnant premenopausal women (18-44y) with dietary reference intakes for the first trimester of pregnancy. Simulations were performed to evaluate the theoretical efficiency of three types of ten successive tailored dietary changes in improving nutrient adequacy, with graded difficulty in implementation. The acceptability (declared intention to use in the diet) of most efficient dietary changes was evaluated during an online randomized study including 115 French pregnant women (22-41y). Results Modifying the amount consumed of foods (type-1) did not modify the food repertoire and resulted in the smallest theoretical efficiency (increase in the PANDiet score of 9.8 +/- 0.2 points), but changes were the most acceptable (probability of the intention to use: 0.30-0.78). Conversely, replacing food items by items from the same group or eaten at the same time (type-3) broadened the food repertoire (3.6 +/- 1.3 food subgroups added) and resulted in the greatest theoretical efficiency (+23.9 +/- 0.3) but changes were the least acceptable (0.07-0-23). Replacing food items within the same subgroup (type-2) slightly broadened the food repertoire (+8.0 +/- 1.3 foods) and resulted in moderate theoretical efficiency (+14.8 +/- 0.2) and intermediate acceptability (0.11-0.35). Conclusion A clear trade-off exists between the theoretical efficiency and acceptability of dietary changes, with a graded broadening of the food repertoire.	[Bianchi, Clelia M.; Huneau, Jean-Francois; Egnell, Manon; Fouillet, Helene; Mariotti, Francois] Univ Paris Saclay, INRA, AgroParisTech, UMR PNCA, Paris, France; [Barbillon, Pierre] Univ Paris Saclay, INRA, AgroParisTech, UMR MIA, Paris, France; [Lluch, Anne] Danone Nutr Res, Ctr Daniel Carasso, Global Nutr Dept, Palaiseau, France; [Verger, Eric O.] Univ Montpellier, SupAgro, IRD, NUTRIPASS, Montpellier, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Danone Nutricia; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Mariotti, F (corresponding author), Univ Paris Saclay, INRA, AgroParisTech, UMR PNCA, Paris, France.	francois.mariotti@agroparistech.fr	Barbillon, Pierre/O-7790-2019; Mariotti, François/F-9651-2017; Verger, Eric/J-9163-2016; Fouillet, Helene/K-7314-2012	Barbillon, Pierre/0000-0002-7766-7693; Mariotti, François/0000-0002-4516-3853; Verger, Eric/0000-0002-8689-8290; Fouillet, Helene/0000-0003-3932-251X	Fonds Francais Alimentation Sante; Danone Nutricia Research	Fonds Francais Alimentation Sante; Danone Nutricia Research(Danone Nutricia)	This study was carried out within the framework of the ECAP project (http://alimentation-sante.org/aap2013-projet2-2/) supported by grants from the Fonds Francais Alimentation & Sante (FFAS: http://alimentation-sante.org) and from Danone Nutricia Research. The Fonds Francais Alimentation & Sante (FFAS) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors of this manuscript is A Lluch who is employed by Danone Nutricia Research. A Lluch contributed to writing the manuscript, offered critical comments, read and approved the final manuscript.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Afssa (Agence Francaise de Securite Sanitaire des Aliments), 2001, APP NUTR CONS POP FR; Arnault N, 2005, TABLE COMPOSITION AL; Ax E, 2016, BRIT J NUTR, V115, P95, DOI 10.1017/S0007114515004110; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Bellisle F, 2014, BRIT J NUTR, V112, P1674, DOI 10.1017/S0007114514002670; Bernard JY, 2013, J NUTR, V143, P1481, DOI 10.3945/jn.113.178640; Berry AC, 1941, T AM MATH SOC, V49, P122, DOI 10.2307/1990053; Bianchi CM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1078-6; Bianchi CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149858; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Blumfield ML, 2013, NUTR REV, V71, P118, DOI 10.1111/nure.12003; Blumfield ML, 2012, NUTR REV, V70, P322, DOI 10.1111/j.1753-4887.2012.00481.x; Bresson J, 2001, APPORTS NUTR CONSEIL; Brug J, 1999, PATIENT EDUC COUNS, V36, P145, DOI 10.1016/S0738-3991(98)00131-1; Caron P, 2006, ANN ENDOCRINOL-PARIS, V67, P281, DOI 10.1016/S0003-4266(06)72599-9; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; de Vries H, 1999, PATIENT EDUC COUNS, V36, P99; De-Regil LM, 2016, J NUTR; Devine CM, 2000, SOC SCI MED, V50, P567, DOI 10.1016/S0277-9536(99)00314-7; Dodd JM, 2014, BMC MED, pcited 2019 Jun 18 12; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Gazan R., 2016, BR J NUTR, P1; Hawkins M, 2015, DIABETIC MED, V32, P108, DOI 10.1111/dme.12601; King JC, 2016, J NUTR S, VS1, pS8; Krebs P, 2010, PREV MED, V51, P214, DOI 10.1016/j.ypmed.2010.06.004; Lairon D, 2005, AM J CLIN NUTR, V82, P1185, DOI 10.1093/ajcn/82.6.1185; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Maillot M, 2009, J NUTR, V139, P1721, DOI 10.3945/jn.109.107318; Meldrum SJ, 2012, PROSTAG LEUKOTR ESS, V86, P233, DOI 10.1016/j.plefa.2012.03.006; Pouchieu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070733; Refsum H, 2001, BRIT J NUTR, V85, pS109, DOI 10.1079/BJN2000302; Shay CM, 2012, AM J CLIN NUTR, V96, P483, DOI 10.3945/ajcn.111.025056; Szwajcer E, 2012, FAM PRACT, V29, pi82, DOI 10.1093/fampra/cmr107; Szwajcer EM, 2007, EUR J OBSTET GYN R B, V135, P58, DOI 10.1016/j.ejogrb.2006.11.012; Tulchinsky TH, 2010, PUBLIC HEALTH REV, V32, P243, DOI 10.1007/BF03391600; Vandelanotte C, 2004, HEALTH PROMOT INT, V19, P463, DOI 10.1093/heapro/dah408; Verger EO, 2014, J NUTR, V144, P929, DOI 10.3945/jn.113.188284; Verger EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042155; Weinrich N.K., 2011, HANDS ON SOCIAL MARK, V2nd ed.; Whitaker KM, 2016, MIDWIFERY, V34, P211, DOI 10.1016/j.midw.2015.11.005; Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646; World Health Organization & Food and Agriculture Organization, 2003, DIET NUTR PREV CHRON, V916	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194764	10.1371/journal.pone.0194764	http://dx.doi.org/10.1371/journal.pone.0194764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641596	Green Published, Green Submitted, gold			2022-12-27	WOS:000429742900045
